PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Paynter, JJ; Andres-Enguix, I; Fowler, PW; Tottey, S; Cheng, W; Enkvetchakul, D; Bavro, VN; Kusakabe, Y; Sansom, MSP; Robinson, NJ; Nichols, CG; Tucker, SJ				Paynter, Jennifer J.; Andres-Enguix, Isabelle; Fowler, Philip W.; Tottey, Stephen; Cheng, Wayland; Enkvetchakul, Decha; Bavro, Vassiliy N.; Kusakabe, Yoshio; Sansom, Mark S. P.; Robinson, Nigel J.; Nichols, Colin G.; Tucker, Stephen J.			Functional Complementation and Genetic Deletion Studies of KirBac Channels ACTIVATORY MUTATIONS HIGHLIGHT GATING-SENSITIVE DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNELS; MOLECULAR-DYNAMICS SIMULATIONS; RECTIFIER K+ CHANNELS; CRYSTAL-STRUCTURE; SLIDE HELIX; ION-CHANNEL; C-TERMINUS; KIR6.2; SELECTION; MUTANTS	The superfamily of prokaryotic inwardly rectifying (KirBac) potassium channels is homologous to mammalian Kir channels. However, relatively little is known about their regulation or about their physiological role in vivo. In this study, we have used random mutagenesis and genetic complementation in K+-auxotrophic Escherichia coli and Saccharomyces cerevisiae to identify activatory mutations in a range of different KirBac channels. We also show that the KirBac6.1 gene (slr5078) is necessary for normal growth of the cyanobacterium Synechocystis PCC6803. Functional analysis and molecular dynamics simulations of selected activatory mutations identified regions within the slide helix, transmembrane helices, and C terminus that function as important regulators of KirBac channel activity, as well as a region close to the selectivity filter of KirBac3.1 that may have an effect on gating. In particular, the mutations identified in TM2 favor a model of KirBac channel gating in which opening of the pore at the helix-bundle crossing plays a far more important role than has recently been proposed.	[Andres-Enguix, Isabelle; Bavro, Vassiliy N.; Kusakabe, Yoshio; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Paynter, Jennifer J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PU, England; [Fowler, Philip W.; Sansom, Mark S. P.] Univ Oxford, Struct Bioinformat & Computat Biochem Unit, Dept Biochem, Oxford OX1 3PU, England; [Sansom, Mark S. P.; Tucker, Stephen J.] Univ Oxford, OXION Initiat, Oxford OX1 3PU, England; [Tottey, Stephen; Robinson, Nigel J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Enkvetchakul, Decha] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Disorders, St Louis, MO 63110 USA	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Newcastle University - UK; Saint Louis University; Washington University (WUSTL); Washington University (WUSTL)	Tucker, SJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	stephen.tucker@physics.ox.ac.uk	Nichols, Colin/D-6336-2012; Tucker, Stephen J./ABE-7468-2020; Bavro, Vassiliy/I-4846-2019; Sansom, Mark S.P./C-5157-2009; Fowler, Philip/AAD-2392-2020; Robinson, Nigel J/J-6363-2012; Tucker, Stephen J./ABE-6741-2020; Fowler, Philip/C-5116-2009	Tucker, Stephen J./0000-0001-8996-2000; Bavro, Vassiliy/0000-0003-2330-8924; Sansom, Mark S.P./0000-0001-6360-7959; Fowler, Philip/0000-0003-0912-4483; Robinson, Nigel J/0000-0001-5586-1092; Tucker, Stephen J./0000-0001-8996-2000; Fowler, Philip/0000-0003-0912-4483; Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [HL54171, DK069424]; British Heart Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/H006052/1]; BBSRC [BB/H006052/1, BB/F013035/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F013035/1] Funding Source: researchfish; British Heart Foundation [PG/09/016/26992] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54171 (to C.G.N.), DK069424 (to D.E.) and by grants from the British Heart Foundation, the Wellcome Trust, the Biotechnology and Biological Sciences Research Council (BB/H006052/1).	Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Borrelly GPM, 2004, MOL MICROBIOL, V53, P217, DOI 10.1111/j.1365-2958.2004.04106.x; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; Grottesi A, 2005, BIOCHEMISTRY-US, V44, P14586, DOI 10.1021/bi0510429; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; HAGEMANN M, 1992, ARCH MICROBIOL, V158, P429; Haider S, 2007, BIOCHEMISTRY-US, V46, P3643, DOI 10.1021/bi062210f; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Hegermann J, 2006, MICROBIOL-SGM, V152, P2831, DOI 10.1099/mic.0.29002-0; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Kung C, 2004, MOL MICROBIOL, V53, P373, DOI 10.1111/j.1365-2958.2004.04180.x; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Mannikko R, 2010, HUM MOL GENET, V19, P963, DOI 10.1093/hmg/ddp554; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nagaoka Y, 2008, CHEMBIOCHEM, V9, P1725, DOI 10.1002/cbic.200800133; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Parfenova Lyubov V., 2006, V337, P157; Paynter JJ, 2008, CHANNELS, V2, P413, DOI 10.4161/chan.2.6.6874; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Sun S, 2006, PHYSIOL GENOMICS, V26, P1, DOI 10.1152/physiolgenomics.00026.2006; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	46	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40754	40761		10.1074/jbc.M110.175687	http://dx.doi.org/10.1074/jbc.M110.175687			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20876570	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000285414400039
J	Smits, NC; Kurup, S; Rops, AL; ten Dam, GB; Massuger, LF; Hafmans, T; Turnbull, JE; Spillmann, D; Li, JP; Kennel, SJ; Wall, JS; Shworak, NW; Dekhuijzen, PNR; van der Vlag, J; van Kuppevelt, TH				Smits, Nicole C.; Kurup, Sindhulakshmi; Rops, Angelique L.; ten Dam, Gerdy B.; Massuger, Leon F.; Hafmans, Theo; Turnbull, Jeremy E.; Spillmann, Dorothe; Li, Jin-ping; Kennel, Stephen J.; Wall, Jonathan S.; Shworak, Nicholas W.; Dekhuijzen, P. N. Richard; van der Vlag, Johan; van Kuppevelt, Toin H.			The Heparan Sulfate Motif (GlcNS6S-IdoA2S)(3), Common in Heparin, Has a Strict Topography and Is Involved in Cell Behavior and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PHAGE DISPLAY ANTIBODIES; ENDOTHELIAL-CELLS; AA AMYLOIDOSIS; HETEROGENEITY; PROTEOGLYCANS; DIVERSITY; DOMAINS; BINDING; MURINE	Heparan sulfate (HS) is a structurally complex polysaccharide that interacts with a broad spectrum of extracellular effector ligands and thereby is thought to regulate a diverse array of biologic processes. The specificity of HS-ligand interactions is determined by the arrangement of sulfate groups on HS, which creates distinct binding motifs. Biologically important HS motifs are expected to exhibit regulated expression, yet there is a profound lack of tools to identify such motifs; consequently, little is known of their structures and functions. We have identified a novel phage display-derived antibody (NS4F5) that recognizes a highly regulated HS motif (HSNS4F5), which we have rigorously identified as (GlcNS6S-IdoA2S)(3).HSNS4F5 exhibits a restricted expression in healthy adult tissues. Blocking HSNS4F5 on cells in culture resulted in reduced proliferation and enhanced sensitivity to apoptosis. HSNS4F5 is up-regulated in tumor endothelial cells, consistent with a role in endothelial cell activation. Indeed, TNF-alpha stimulated endothelial expression of HSNS4F5, which contributed to leukocyte adhesion. In a mouse model of severe systemic amyloid protein A amyloidosis, HSNS4F5 was expressed within amyloid deposits, which were successfully detected by microSPECT imaging using NS4F5 as a molecularly targeted probe. Combined, our results demonstrate that NS4F5 is a powerful tool for elucidating the biological function of HSNS4F5 and can be exploited as a probe to detect novel polysaccharide biomarkers of disease processes.	[Smits, Nicole C.; ten Dam, Gerdy B.; Hafmans, Theo; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Kurup, Sindhulakshmi; Spillmann, Dorothe; Li, Jin-ping] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Rops, Angelique L.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Nephrol Res Lab,Dept Nephrol, NL-6500 HB Nijmegen, Netherlands; [Massuger, Leon F.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands; [Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England; [Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37920 USA; [Smits, Nicole C.; Shworak, Nicholas W.] Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Dekhuijzen, P. N. Richard] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Uppsala University; Radboud University Nijmegen; Radboud University Nijmegen; University of Liverpool; University of Tennessee System; University of Tennessee Health Science Center; Dartmouth College; Radboud University Nijmegen	van Kuppevelt, TH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, POB 9101, NL-6500 HB Nijmegen, Netherlands.	a.vankuppevelt@ncmls.ru.nl	Dekhuijzen, P NR/H-8024-2014; van Kuppevelt, A.H.M.S.M./L-4463-2015; Van der Vlag, Johan/E-4636-2010; Massuger, Leon F.A.G./H-8072-2014; Shworak, Nicholas/AAJ-6770-2020	Dekhuijzen, P NR/0000-0003-1365-900X; Van der Vlag, Johan/0000-0001-7843-5918; Shworak, Nicholas/0000-0001-7783-4634; Wall, Jonathan/0000-0002-5516-8578	International Human Frontier Science Program Organization [RGP0062/2004-C101]; Dutch Cancer Society [2008-4058]; Netherlands Organization for Scientific Research [902-27-292]; Dutch Kidney Foundation [C05.2152, KJPB09.010]; Swedish Foundation for Strategic Research [A303:156e]; Swedish Research Council [32X-15023]; Swedish Cancer Society [4708-B02-01XAA]; Polysackaridforskning AB (Uppsala, Sweden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Polysackaridforskning AB (Uppsala, Sweden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by International Human Frontier Science Program Organization Grant RGP0062/2004-C101, Dutch Cancer Society Grant nr 2008-4058, Netherlands Organization for Scientific Research Grant 902-27-292 (to A.L.R.), Dutch Kidney Foundation Grants C05.2152 and KJPB09.010 (to A.L.R.), Swedish Foundation for Strategic Research Grant A303:156e, Swedish Research Council Grant 32X-15023, Swedish Cancer Society Grant 4708-B02-01XAA, and Polysackaridforskning AB (Uppsala, Sweden).	Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Jayson GC, 1999, INT J CANCER, V82, P298, DOI 10.1002/(SICI)1097-0215(19990719)82:2<298::AID-IJC23>3.3.CO;2-0; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Leali D, 2001, J BIOL CHEM, V276, P37900; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; MULLER M, 1980, ELECTRON MICROS, V2, P720; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2007, NEPHROL DIAL TRANSPL, V22, P1891, DOI 10.1093/ndt/gfm194; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; vanSetten PA, 1997, KIDNEY INT, V51, P1245, DOI 10.1038/ki.1997.170; Waksman G, 1998, NAT STRUCT BIOL, V5, P527, DOI 10.1038/778; Wall JS, 2006, J NUCL MED, V47, P2016; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2005, AMYLOID, V12, P149, DOI 10.1080/13506120500222359	46	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41143	41151		10.1074/jbc.M110.153791	http://dx.doi.org/10.1074/jbc.M110.153791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20837479	Green Published, hybrid			2022-12-27	WOS:000285414400076
J	Zhang, WB; Wang, Z; Shu, F; Jin, YH; Liu, HY; Wang, QJ; Yang, Y				Zhang, Wen-bin; Wang, Zhuo; Shu, Fei; Jin, Yong-hua; Liu, Hong-yi; Wang, Qiu-juan; Yang, Yong			Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; CANCER CELLS; METHYLTRANSFERASE MGMT; METABOLIC CHECKPOINT; MELANOMA-CELLS; GROWTH; PHOSPHORYLATION; PATHWAY; DEATH; O-6-METHYLGUANINE	Methylating drugs such as temozolomide (TMZ) are widely used in the treatment of brain tumors including malignant glioblastoma. The mechanism of TMZ-induced glioblastoma cell death and apoptosis, however, is not fully understood. Here, we tested the potential involvement of AMP-activated protein kinase (AMPK) in this process. We found that methylating agents TMZ and N-methyl-N'-nitro-N-nitrosoguanidine induce AMPK activation in primary cultured human glioblastoma and glioblastoma cell lines. TMZ-induced O-6-methylguanine production is involved in AMPK activation. O-6-benzylguanine, an O-6-methylguanine-DNA methyltransferase inhibitor, enhances TMZ-induced O-6-methylguanine production, leading to enhanced reactive oxygen species production, which serves as an upstream signal for AMPK activation. Activation of AMPK is involved in TMZ-induced glioblastoma cell death and apoptosis. AMPK inhibitor (Compound C) or AMPK alpha siRNA knockdown inhibits TMZ-induced glioblastoma cell death and apoptosis, whereas AMPK activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside enhances it. In further studies, we found that activation of AMPK is involved in TMZ-induced p53 activation and subsequent p21, Noxa, and Bax up-regulation. Activation of AMPK by TMZ also inhibits mTOR complex 1 (mTORC1) signaling and promotes anti-apoptosis protein Bcl-2 down-regulation, which together mediate TMZ-induced pro-cell apoptosis effects. Our study suggests that activation of AMPK by TMZ contributes to glioblastoma cell apoptosis, probably by promoting p53 activation and inhibiting mTORC1 signaling.	[Zhang, Wen-bin; Wang, Zhuo; Jin, Yong-hua; Wang, Qiu-juan; Yang, Yong] China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Peoples R China; [Zhang, Wen-bin; Liu, Hong-yi] Nanjing Med Univ, Dept Neurosurg, Nanjing 210029, Peoples R China; [Shu, Fei] Nanjing Med Univ, Dept Psychiat, Brain Hosp, Nanjing 210029, Peoples R China	China Pharmaceutical University; Nanjing Medical University; Nanjing Medical University	Yang, Y (corresponding author), 24 Tongjiaxiang, Nanjing 210009, Peoples R China.	valianty@hotmail.com			National Natural Science Foundation of China [30701032, 81072661]; Ministry of Education of China; Fundamental Research Funds for the Central Universities [JKZ2009006]; Natural Science Foundation of Jiangsu Province [BK2009298]; "Major Drug Discovery" science and technology major projects of China [2009ZX09303-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); "Major Drug Discovery" science and technology major projects of China	This work was supported by National Natural Science Foundation of China Grants 30701032 and 81072661, the New Century Excellent Talents Program supported by Ministry of Education of China (2009) (Y. Y.), Fundamental Research Funds for the Central Universities Grant JKZ2009006, Natural Science Foundation of Jiangsu Province Grant BK2009298, and "Major Drug Discovery" science and technology major projects of China Grant 2009ZX09303-001.	Armstrong JL, 2007, APOPTOSIS, V12, P613, DOI 10.1007/s10495-006-0020-1; Bocangel DB, 2002, CLIN CANCER RES, V8, P2725; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; CONRAD CA, 1995, NEUROL CLIN, V13, P795, DOI 10.1016/S0733-8619(18)30018-5; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hirose M, 1998, CANCER LETT, V129, P165, DOI 10.1016/S0304-3835(98)00096-2; Hirose Y, 2001, CANCER RES, V61, P5843; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ji C., 2010, ONCOGENE IN PRESS; Jimenez AI, 2003, CANCER RES, V63, P1382; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; KAINA B, 1991, CARCINOGENESIS, V12, P1857; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; Kim DS, 2007, LIFE SCI, V80, P314, DOI 10.1016/j.lfs.2006.09.019; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Pan W, 2008, ONCOL REP, V20, P1553, DOI 10.3892/or_00000179; Preuss I, 1996, INT J CANCER, V65, P506, DOI 10.1002/(SICI)1097-0215(19960208)65:4<506::AID-IJC19>3.0.CO;2-7; Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tentori L, 1998, J PHARMACOL EXP THER, V285, P884; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Zhang JF, 2007, TRANSPL IMMUNOL, V17, P162, DOI 10.1016/j.trim.2006.12.003; Zhou BP, 2003, SEMIN ONCOL, V30, P38, DOI 10.1053/j.seminoncol.2003.08.006	41	148	149	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40461	40471		10.1074/jbc.M110.164046	http://dx.doi.org/10.1074/jbc.M110.164046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20880848	Green Published, hybrid			2022-12-27	WOS:000285414400008
J	Zhu, L; Sharp, JD; Kobayashi, H; Woychik, NA; Inouye, M				Zhu, Ling; Sharp, Jared D.; Kobayashi, Hiroshi; Woychik, Nancy A.; Inouye, Masayori			Noncognate Mycobacterium tuberculosis Toxin-Antitoxins Can Physically and Functionally Interact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENT-SPECIFIC PROTEIN; MESSENGER-RNA INTERFERASES; PLASMID ADDICTION SYSTEM; MEDIATED CELL-DEATH; ESCHERICHIA-COLI; MYXOCOCCUS-XANTHUS; NONREPLICATING PERSISTENCE; CONTROLLED EXPRESSION; GENOME SEQUENCE; PIN-DOMAIN	The Mycobacterium tuberculosis genome harbors a striking number (> 40) of toxin-antitoxin systems. Among them are at least seven MazF orthologs, designated MazF-mt1 through MazF-mt7, four of which have been demonstrated to function as mRNA interferases that selectively target mRNA for cleavage at distinct consensus sequences. As is characteristic of all toxin-antitoxin systems, each of the mazF-mt toxin genes is organized in an operon downstream of putative antitoxin genes. However, only one of the seven putative upstream antitoxins (designated MazE-mt1 through MazE-mt7) has significant sequence similarity to Escherichia coli MazE, the cognate antitoxin for E. coli MazF. Interestingly, the M. tuberculosis genome contains two independent operons encoding E. coli MazE orthologs, but they are not paired with mazF-mt-like genes. Instead, the genes encoding these two MazE orthologs are each paired with proteins containing a PIN domain, indicating that they may be members of the very large VapBC toxin-antitoxin family. We tested a spectrum of pair-wise combinations of cognate and noncognate Mtb toxin-antitoxins using in vivo toxicity and rescue experiments along with in vitro interaction experiments. Surprisingly, we uncovered several examples of noncognate toxin-antitoxin association, even among different families (e. g. MazF toxins and VapB antitoxins). These results challenge the "one toxin for one antitoxin" dogma and suggest that M. tuberculosis may enlist a sophisticated toxin-antitoxin network to alter its physiology in response to environmental cues.	[Sharp, Jared D.; Woychik, Nancy A.] Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Zhu, Ling; Kobayashi, Hiroshi; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Woychik, NA (corresponding author), Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	nancy.woychik@umdnj.edu; inouye@umdnj.edu	Zhu, Ling/M-3887-2013	Zhu, Ling/0000-0003-0776-1630	National Institutes of Health [1R01GM081567, AI07403]; Takara-Bio, Inc.; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takara-Bio, Inc.; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM081567 (to M. I.). This work was also supported by Takara-Bio, Inc. (to M. I. and N. A. W.) and by National Institutes of Health T32 Training Grant AI07403, Virus-Host Interactions in Eukaryotic Cells from the NIAID to J. D. S. (awarded to S. Pestka).	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; INOUYE S, 1981, J BACTERIOL, V148, P678, DOI 10.1128/JB.148.2.678-683.1981; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kobayashi H, 2009, APPL ENVIRON MICROB, V75, P5356, DOI 10.1128/AEM.00691-09; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Magnuson R, 1998, J BACTERIOL, V180, P6342; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; NAKAMURA K, 1982, EMBO J, V1, P771, DOI 10.1002/j.1460-2075.1982.tb01244.x; NAKANO ET, 1987, J VIROL, V61, P302, DOI 10.1128/JVI.61.2.302-307.1987; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	45	55	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39732	39738		10.1074/jbc.M110.163105	http://dx.doi.org/10.1074/jbc.M110.163105			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20876537	Green Published, hybrid			2022-12-27	WOS:000285185500017
J	McIntosh, J; Dennison, G; Holly, JMP; Jarrett, C; Frankow, A; Foulstone, EJ; Winters, ZE; Perks, CM				McIntosh, Jamie; Dennison, Godwin; Holly, Jeff M. P.; Jarrett, Caroline; Frankow, Alexandra; Foulstone, Emily J.; Winters, Zoe E.; Perks, Claire M.			IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-3; CARCINOMA IN-SITU; FACTOR RECEPTOR; CANCER-CELLS; IMMUNOHISTOCHEMICAL EXPRESSION; SIGNAL-TRANSDUCTION; PROGNOSTIC VALUE; RHO-GTPASES; CCN FAMILY; INTEGRIN	Progression of breast cancer is associated with remodeling of the extracellular matrix, often involving a switch from estrogen dependence to a dependence on EGF receptor (EGFR)/HER-2 and is accompanied by increased expression of the main binding protein for insulin-like growth factors (IGFBP-3). We have examined the effects of IGFBP-3 on EGF responses of breast epithelial cells in the context of changes in the extracellular matrix. On plastic and laminin with MCF-10A normal breast epithelial cells, EGF and IGFBP-3 each increased cell growth and together produced a synergistic response, whereas with T47D breast cancer cells IGFBP-3 alone had no effect, but the ability of EGF to increase cell proliferation was markedly inhibited in the presence of IGFBP-3. In contrast on fibronectin with MCF-10A cells, IGFBP-3 alone inhibited cell growth and blocked EGF-induced proliferation. With the cancer cells, IGFBP-3 alone had no effect but enhanced the EGF-induced increase in cell growth. The insulin-like growth factor-independent effects of IGFBP-3 alone on cell proliferation were completely abrogated in the presence of an EGFR, tyrosine kinase inhibitor, Iressa. Although IGFBP-3 did not affect EGFR phosphorylation [Tyr(1068)], it was found to modulate receptor internalization and was associated with activation of Rho and subsequent changes in MAPK phosphorylation. The levels of fibronectin and IGFBP-3 within breast tumors may determine their dependence on EGFR and their response to therapies targeting this receptor.	[McIntosh, Jamie; Dennison, Godwin; Holly, Jeff M. P.; Jarrett, Caroline; Frankow, Alexandra; Foulstone, Emily J.; Winters, Zoe E.; Perks, Claire M.] Univ Bristol, Southmead Hosp, IGFs & Metab Endocrinol Grp, Sch Clin Sci, Bristol BS10 5NB, Avon, England	Southmead Hospital; University of Bristol	Winters, ZE (corresponding author), Univ Bristol, Southmead Hosp, IGFs & Metab Endocrinol Grp, Sch Clin Sci, Learning & Res Bldg,2nd Floor, Bristol BS10 5NB, Avon, England.	Zoe.Winters@bristol.ac.uk	Winters, Zoe Ellen/GYE-7947-2022	Perks, Claire/0000-0003-1562-891X	Bristol University	Bristol University	This work was supported by The Bristol University Cancer Research Fund.	Abrass CK, 1997, AM J PHYSIOL-RENAL, V273, pF899, DOI 10.1152/ajprenal.1997.273.6.F899; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Bohlke K, 1998, EPIDEMIOLOGY, V9, P570, DOI 10.1097/00001648-199809000-00018; BRUNING PF, 1995, INT J CANCER, V62, P266, DOI 10.1002/ijc.2910620306; Burrows C, 2006, ENDOCRINOLOGY, V147, P3484, DOI 10.1210/en.2006-0005; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215; Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098; DAVIES SC, 1991, CLIN ENDOCRINOL, V34, P501, DOI 10.1111/j.1365-2265.1991.tb00331.x; Edmondson SR, 1999, J CELL PHYSIOL, V179, P201, DOI 10.1002/(SICI)1097-4652(199905)179:2<201::AID-JCP10>3.0.CO;2-9; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Firth SM, 1998, BIOCHEM BIOPH RES CO, V246, P325, DOI 10.1006/bbrc.1998.8615; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; GORCZYCA W, 1993, ANTICANCER RES, V13, P851; Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Hollowood AD, 2002, J CELL BIOCHEM, V86, P583, DOI 10.1002/jcb.10223; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Ioachim E, 1997, VIRCHOWS ARCH, V431, P311, DOI 10.1007/s004280050104; Kansra S, 2000, INT J CANCER, V87, P373, DOI 10.1002/1097-0215(20000801)87:3<373::AID-IJC10>3.0.CO;2-X; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; MARTINEZHERNANDEZ A, 1983, LAB INVEST, V48, P656; McCaig C, 2002, BRIT J CANCER, V86, P1963, DOI 10.1038/sj.bjc.6600355; McCaig C, 2002, J CELL SCI, V115, P4293, DOI 10.1242/jcs.00097; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Mochizuki T, 2006, GROWTH HORM IGF RES, V16, P202, DOI 10.1016/j.ghir.2006.05.002; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nicholson RI, 2005, ENDOCR-RELAT CANCER, V12, pS29, DOI 10.1677/erc.1.00991; Oesterreicher S, 2005, J BIOL CHEM, V280, P9994, DOI 10.1074/jbc.M411754200; Pellegrin Stephanie, 2008, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1408s38; Perbal B, 2001, B CANCER, V88, P645; Perks C, 2003, HORM METAB RES, V35, P828; Pollak M. N., 2004, BIOCHIM BIOPHYS ACTA, V262, p[84, 165]; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Ricort JM, 2004, BIOCHEM BIOPH RES CO, V314, P1044, DOI 10.1016/j.bbrc.2004.01.001; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; SAINSBURY JRC, 1985, J CLIN PATHOL, V38, P1225, DOI 10.1136/jcp.38.11.1225; Singh B, 2004, J BIOL CHEM, V279, P477, DOI 10.1074/jbc.M307322200; SOULE HD, 1990, CANCER RES, V50, P6075; Takaoka M, 2004, CANCER RES, V64, P7711, DOI 10.1158/0008-5472.CAN-04-0715; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tsutsui S, 2002, BREAST CANCER RES TR, V71, P67, DOI 10.1023/A:1013397232011; Vellon L, 2005, ONCOGENE, V24, P3759, DOI 10.1038/sj.onc.1208452; Vestey SB, 2005, BREAST CANCER RES, V7, pR119, DOI 10.1186/bcr963; Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Yu X, 2000, J CELL SCI, V113, P2139	64	29	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38788	38800		10.1074/jbc.M110.177311	http://dx.doi.org/10.1074/jbc.M110.177311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20851879	hybrid, Green Published			2022-12-27	WOS:000284941300008
J	Dyson, OF; Traylen, CM; Akula, SM				Dyson, Ossie F.; Traylen, Christopher M.; Akula, Shaw M.			Cell Membrane-bound Kaposi's Sarcoma-associated Herpesvirus-encoded Glycoprotein B Promotes Virus Latency by Regulating Expression of Cellular Egr-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; INDUCED LYTIC REACTIVATION; TRANSCRIPTION FACTOR EGR-1; PROTEIN-COUPLED RECEPTOR; EFFUSION LYMPHOMA-CELLS; GENE-EXPRESSION; BINDING PROTEIN; CYCLE REPLICATION; KSHV REACTIVATION	One of the important questions in the field of virus research is about the balance between latent and lytic cycles of replication. Kaposi's sarcoma-associated herpesvirus (KSHV) remains predominantly in a latent state, with only 1-3% of cells supporting a lytic replication at any time. KSHV glycoprotein B (gB) is expressed not only on the virus envelope but also on the surfaces of the few cells supporting lytic replication. Using co-culture experiments, we determined that expression of KSHV gB on as few as 1-2% of human dermal microvascular endothelial cells resulted in a 10-fold inhibition of expression of ORF50, a viral gene critical for the onset of lytic replication. Also, we demonstrate that such a profound inhibitory effect of gB on the lytic cycle of virus replication is by repressing the ability of Egr-1 (early growth response-1) to bind and activate the ORF50 promoter. In general, virus-encoded late stage structural proteins, such as gB, are said to play major roles in virus entry and egress. The present report provides initial evidence supporting a role for membrane-associated gB expressed in a minimal number of cells to promote virus latency. These findings may have ramifications leading to a better understanding of the role of virus-encoded structural proteins not only in KSHV-related diseases but also in other viruses causing latent infections.	[Dyson, Ossie F.; Traylen, Christopher M.; Akula, Shaw M.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA; [Traylen, Christopher M.] Univ W England, Fac Sci Appl, Bristol BS16 1QY, Avon, England	University of North Carolina; East Carolina University; University of West England	Akula, SM (corresponding author), E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA.	akulas@ecu.edu			National Institutes of Health, NIBIB [R21EB006483, 5F31CA132560-02]; NATIONAL CANCER INSTITUTE [F31CA132560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006483] Funding Source: NIH RePORTER	National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health, NIBIB, Grants R21EB006483 (to S. M. A.) and 5F31CA132560-02 (to O. F. D.).	Akula SM, 2005, BLOOD, V105, P4516, DOI 10.1182/blood-2004-09-3683; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; Bottero V, 2009, VIROLOGY, V392, P34, DOI 10.1016/j.virol.2009.07.002; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; Bryan BA, 2006, J GEN VIROL, V87, P519, DOI 10.1099/vir.0.81603-0; Cai YY, 2006, VIROLOGY, V355, P152, DOI 10.1016/j.virol.2006.07.012; Cannon M, 2006, BLOOD, V107, P277, DOI 10.1182/blood-2005-06-2350; Cannon M, 2003, J VIROL, V77, P57, DOI 10.1128/JVI.77.1.57-67.2003; CAO XM, 1993, J BIOL CHEM, V268, P16949; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Chappell WH, 2005, CELL CYCLE, V4, P1389, DOI 10.4161/cc.4.10.2028; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Chen SH, 2008, J CLIN INVEST, V118, P3470, DOI 10.1172/JCI35114; Choi YB, 2010, VIROLOGY, V397, P369, DOI 10.1016/j.virol.2009.11.024; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Curreli F, 2002, J VIROL, V76, P5208, DOI 10.1128/JVI.76.10.5208-5219.2002; Darbinian N, 2008, J CELL PHYSIOL, V216, P128, DOI 10.1002/jcp.21382; Deng HY, 2000, J GEN VIROL, V81, P3043, DOI 10.1099/0022-1317-81-12-3043; Dyson OF, 2008, CELL MICROBIOL, V10, P1546, DOI 10.1111/j.1462-5822.2008.01149.x; Dyson OF, 2007, INTERVIROLOGY, V50, P245, DOI 10.1159/000101995; Dyson OF, 2009, J CELL MOL MED, V13, P1920, DOI 10.1111/j.1582-4934.2008.00481.x; Ford PW, 2005, VIRUS RES, V114, P172, DOI 10.1016/j.virusres.2005.06.011; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; Ford PW, 2004, CANCER BIOL THER, V3, P876, DOI 10.4161/cbt.3.9.1054; Ganem D, 1998, CURR CLIN TOPICS INF, V18, P237; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Hamden KE, 2005, LEUKEMIA, V19, P18, DOI 10.1038/sj.leu.2403532; Hamden KE, 2004, J VIROL, V78, P13381, DOI 10.1128/JVI.78.23.13381-13390.2004; Harrington W, 1997, LANCET, V349, P774; Harrison SM, 2008, FEBS LETT, V582, P3080, DOI 10.1016/j.febslet.2008.07.055; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lee BS, 2002, J VIROL, V76, P12185, DOI 10.1128/JVI.76.23.12185-12199.2002; Li QH, 2008, VIROLOGY, V379, P234, DOI 10.1016/j.virol.2008.06.043; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; McAllister SC, 2005, J VIROL, V79, P2626, DOI 10.1128/JVI.79.4.2626-2630.2005; Milligan S, 2004, J VIROL, V78, P2591, DOI 10.1128/JVI.78.5.2591-2596.2004; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Naranatt PP, 2002, ARCH VIROL, V147, P1349, DOI 10.1007/s00705-002-0813-7; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Palm M, 2010, VET RES, V41, DOI 10.1051/vetres/2010001; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Ralph JA, 2007, AM J PATHOL, V170, P1121, DOI 10.2353/ajpath.2007.061000; Robinson L, 1997, P NATL ACAD SCI USA, V94, P7170, DOI 10.1073/pnas.94.14.7170; Romagnoli L, 2008, VIROLOGY, V375, P331, DOI 10.1016/j.virol.2008.02.021; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; Shaw AM, 2000, VIROLOGY, V268, P159, DOI 10.1006/viro.1999.0164; Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509; Subramanian R, 2008, J VIROL, V82, P7144, DOI 10.1128/JVI.00617-08; Subramanian R, 2010, J VIROL, V84, P1704, DOI 10.1128/JVI.01889-09; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; Wang FZ, 2003, J VIROL, V77, P3131, DOI 10.1128/JVI.77.5.3131-3147.2003; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZE, 2004, J VIROL, V78, P4248, DOI 10.1128/JVI.78.8.4248-4267.2004; Wilson SJ, 2007, J VIROL, V81, P13578, DOI 10.1128/JVI.01663-07; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; Yu FQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030044; ZALANI S, 1995, J VIROL, V69, P3816, DOI 10.1128/JVI.69.6.3816-3823.1995	72	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37491	37502		10.1074/jbc.M110.159103	http://dx.doi.org/10.1074/jbc.M110.159103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864524	Green Published, hybrid			2022-12-27	WOS:000284424000041
J	Bontjer, I; Melchers, M; Eggink, D; David, K; Moore, JP; Berkhout, B; Sanders, RW				Bontjer, Ilja; Melchers, Mark; Eggink, Dirk; David, Kathryn; Moore, John P.; Berkhout, Ben; Sanders, Rogier W.			Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; INTERMOLECULAR DISULFIDE BOND; CD4 BINDING-SITE; TYPE-1 ENVELOPE; NEUTRALIZING ANTIBODIES; GP120 GLYCOPROTEIN; MOLECULAR CLONES; PARTIAL DELETION; VARIABLE LOOPS	The envelope glycoproteins (Env) are the focus of HIV-1 vaccine development strategies based on the induction of humoral immunity, but the mechanisms the virus has evolved to limit the induction and binding of neutralizing antibodies (NAbs) constitute substantial obstacles. Conserved neutralization epitopes are shielded by variable regions and carbohydrates, so one strategy to increase their exposure and, it is hoped, their immunogenicity is to delete the overlying variable loops. However, deleting the variable regions from Env trimers can be problematic, because hydrophobic patches that are normally solvent-inaccessible now become exposed, causing protein misfolding or aggregation, for example. Here, we describe the construction and characterization of recombinant gp140 trimers lacking variable domains 1 and 2 (Delta V1V2). The design of the trimers was guided by HIV-1 evolution studies that identified compensatory changes in V1V2-deleted but functional Env proteins (Bontjer, I., Land, A., Eggink, D., Verkade, E., Tuin, K., Baldwin, C., Pollakis, G., Paxton, W. A., Braakman, I., Berkhout, B., and Sanders, R. W. (2009) J. Virol. 83, 368-383). We now show that specific compensatory changes improved the function of Delta V1V2 Env proteins and hence HIV-1 replication. The changes acted by reducing the exposure of a hydrophobic surface either by replacing a hydrophobic residue with a hydrophilic one or by covering the surface with a glycan. The compensatory changes allowed the efficient expression of well folded, soluble gp140 trimers derived from various HIV-1 isolates. The evolved Delta V1V2 Env viruses were extremely sensitive to NAbs, indicating that neutralization epitopes are well exposed, which was confirmed by studies of NAb binding to the soluble Delta V1V2 gp140 trimers. These evolved Delta V1V2 trimers could be useful reagents for immunogenicity and structural studies.	[Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [David, Kathryn; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl		Eggink, Dirk/0000-0002-4248-6008	National Institutes of Health [AI36082, AI45463]; AIDS Fund (Amsterdam, The Netherlands) [2005021, 2008013]; International AIDS Vaccine Initiative; Netherlands Organization for Scientific Research (NWO) Chemical Sciences; American Foundation for AIDS Research; Anton Meelmeijer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082, R01AI036082, R01AI045463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Fund (Amsterdam, The Netherlands)(Netherlands Government); International AIDS Vaccine Initiative; Netherlands Organization for Scientific Research (NWO) Chemical Sciences(Netherlands Organization for Scientific Research (NWO)); American Foundation for AIDS Research; Anton Meelmeijer fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI36082 and AI45463 (to J. P. M.). This work was also supported by AIDS Fund (Amsterdam, The Netherlands) Grants 2005021 (to B. B.) and 2008013 (to R. W. S.) and by the International AIDS Vaccine Initiative.; Recipient of an Anton Meelmeijer fellowship, a VENI fellowship from the Netherlands Organization for Scientific Research (NWO) Chemical Sciences, and a Mathilde Krim fellowship from the American Foundation for AIDS Research.	ALLAWAY GP, 1993, AIDS RES HUM RETROV, V9, P581, DOI 10.1089/aid.1993.9.581; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Beddows S, 2006, AIDS RES HUM RETROV, V22, P569, DOI 10.1089/aid.2006.22.569; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Center RJ, 2001, P NATL ACAD SCI USA, V98, P14877, DOI 10.1073/pnas.261573898; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Das AT, 1999, VIROLOGY, V263, P55, DOI 10.1006/viro.1999.9898; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Eggink D, 2007, TRENDS MICROBIOL, V15, P291, DOI 10.1016/j.tim.2007.05.006; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Gzy J, 2004, VIROLOGY, V318, P493, DOI 10.1016/j.virol.2003.10.009; Harrison JE, 2008, J VIROL, V82, P11695, DOI 10.1128/JVI.01303-08; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Jacobs A, 2008, VACCINE, V26, P3026, DOI 10.1016/j.vaccine.2007.12.026; Jeffs SA, 2002, J GEN VIROL, V83, P2723, DOI 10.1099/0022-1317-83-11-2723; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laakso MM, 2007, PLOS PATHOG, V3, P1118, DOI 10.1371/journal.ppat.0030117; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Lu S, 1998, AIDS RES HUM RETROV, V14, P151, DOI 10.1089/aid.1998.14.151; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McKeating JA, 1996, IMMUNOL LETT, V51, P101, DOI 10.1016/0165-2478(96)02562-X; MOORE JP, 1988, AIDS RES HUM RETROV, V4, P369, DOI 10.1089/aid.1988.4.369; MOORE JP, 1993, AIDS RES HUM RETROV, V9, P1185, DOI 10.1089/aid.1993.9.1185; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; POSNER MR, 1991, J IMMUNOL, V146, P4325; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Robinson J., 1992, J CELL BIOCHEM, V50, P71; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders Rogier W, 2004, Retrovirology, V1, P3, DOI 10.1186/1742-4690-1-3; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Si ZH, 2003, AIDS RES HUM RETROV, V19, P217, DOI 10.1089/088922203763315722; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; SUBRAMANIAM S, 2010, KEYSTONE S HIV VACCI; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Xiang SH, 2005, J VIROL, V79, P6068, DOI 10.1128/JVI.79.10.6068-6077.2005; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	87	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36456	36470		10.1074/jbc.M110.156588	http://dx.doi.org/10.1074/jbc.M110.156588			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20826824	hybrid, Green Published			2022-12-27	WOS:000284146100054
J	Eapen, A; Sundivakkam, P; Song, YQ; Ravindran, S; Ramachandran, A; Tiruppathi, C; George, A				Eapen, Asha; Sundivakkam, Premanand; Song, Yiqiang; Ravindran, Sriram; Ramachandran, Amsaveni; Tiruppathi, Chinnaswammy; George, Anne			Calcium-mediated Stress Kinase Activation by DMP1 Promotes Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; ENDOPLASMIC-RETICULUM STRESS; BONE-FORMATION; TRANSCRIPTIONAL REGULATION; P38; CELLS; APOPTOSIS; OSTERIX; SIGNAL; RUNX2	Calcium signaling and calcium transport play a key role during osteoblast differentiation and bone formation. Here, we demonstrate that DMP1 mediated calcium signaling, and its downstream effectors play an essential role in the differentiation of preosteoblasts to fully functional osteoblasts. DMP1, a key regulatory bone matrix protein, can be endocytosed by preosteoblasts, triggering a rise in cytosolic levels of calcium that initiates a series of downstream events leading to cellular stress. These events include release of store-operated calcium that facilitates the activation of stress-induced p38 MAPK leading to osteoblast differentiation. However, chelation of intracellular calcium and inhibition of the p38 signaling pathway by specific pharmacological inhibitors and dominant negative plasmid suppressed this activation. Interestingly, activated p38 MAPK can translocate to the nucleus to phosphorylate transcription factors that coordinate the expression of downstream target genes such as Runx 2, a key modulator of osteoblast differentiation. These studies suggest a novel paradigm by which DMP1-mediated release of intracellular calcium activates p38 MAPK signaling cascade to regulate gene expression and osteoblast differentiation.	[George, Anne] Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Chicago, IL 60612 USA; [Sundivakkam, Premanand; Tiruppathi, Chinnaswammy] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Chicago, IL 60612 USA.	anneg@uic.edu		GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 11657]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 11657.	Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; BODEN SD, 1990, ORTHOP CLIN N AM, V21, P31; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Davidson SM, 2000, DEV BIOL, V218, P146, DOI 10.1006/dbio.1999.9596; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Goodman SB, 2007, J BIOMED MATER RES A, V81A, P310, DOI 10.1002/jbm.a.30983; GREEN J, 1992, AM J PHYSIOL, V263, pE1070; Hamamura K, 2007, FEBS LETT, V581, P1769, DOI 10.1016/j.febslet.2007.03.063; Hino S, 2010, J BONE MINER METAB, V28, P131, DOI 10.1007/s00774-009-0117-z; Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Kim IS, 2008, DEV GROWTH DIFFER, V50, P553, DOI 10.1111/j.1440-169X.2008.01052.x; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Leonardi R, 2004, CALCIFIED TISSUE INT, V75, P509, DOI 10.1007/s00223-004-0077-1; Liao JH, 2006, CANCER METAST REV, V25, P559, DOI 10.1007/s10555-006-9033-z; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; MUNDY GR, 1995, BONE, V17, pS71, DOI 10.1016/8756-3282(95)00182-D; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; Narayanan K, 2002, CONNECT TISSUE RES, V43, P365, DOI 10.1080/03008200290000592; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Nishihara A, 2003, BIOCHEM BIOPH RES CO, V301, P617, DOI 10.1016/S0006-291X(02)03068-1; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Reilly Gwendolen C, 2005, Cell Commun Signal, V3, P3, DOI 10.1186/1478-811X-3-3; San Miguel SM, 2005, J BIOL CHEM, V280, P37495, DOI 10.1074/jbc.M503861200; Seeman E, 2002, J BONE MINER RES, V17, P373, DOI 10.1359/jbmr.2002.17.3.373; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Sharan K, 2008, INDIAN J MED RES, V127, P274; Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Tindberg N, 2000, NEUROCHEM RES, V25, P527, DOI 10.1023/A:1007520311457; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Walsh David, 1999, Environmental Medicine (Nagoya), V43, P79; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Zayzafoon M, 2002, J BIOL CHEM, V277, P37212, DOI 10.1074/jbc.M200129200	51	45	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36339	36351		10.1074/jbc.M110.145607	http://dx.doi.org/10.1074/jbc.M110.145607			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841352	Green Published, hybrid			2022-12-27	WOS:000284146100079
J	Rodriguez-Colman, MJ; Reverter-Branchat, G; Sorolla, MA; Tamarit, J; Ros, J; Cabiscol, E				Jose Rodriguez-Colman, Maria; Reverter-Branchat, Gemma; Alba Sorolla, M.; Tamarit, Jordi; Ros, Joaquim; Cabiscol, Elisa			The Forkhead Transcription Factor Hcm1 Promotes Mitochondrial Biogenesis and Stress Resistance in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY GROUP PROTEIN; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; CELL-CYCLE; LIFE-SPAN; IN-VIVO; INCREASED DOSAGE; GENE-EXPRESSION; BUDDING YEAST; FOXO PROTEINS	In Saccharomyces cerevisiae, the forkhead transcription factor Hcm1 is involved in chromosome segregation, spindle pole dynamics, and budding. We found that Hcm1 interacts with the histone deacetylase Sir2 and shifts from cytoplasm to the nucleus in the G(1)/S phase or in response to oxidative stress stimuli. The nuclear localization of Hcm1 depends on the activity of Sir2 as revealed by activators and inhibitors of the sirtuins and the Delta sir2 mutant. Hcm1-overexpressing cells display more mitochondria that can be attributed to increased amounts of Abf2, a protein involved in mitochondrial biogenesis. These cells also show higher rates of oxygen consumption and improved resistance to oxidative stress that would be explained by increased catalase and Sod2 activities and molecular chaperones such as Hsp26, Hsp30, and members of Hsp70 family. Microarray analyses also reveal increased expression of genes involved in mitochondrial energy pathways and those allowing the transition from the exponential to the stationary phase. Taken together, these results describe a new and relevant role of Hcm1 for mitochondrial functions, suggesting that this transcription factor would participate in the adaptation of cells from fermentative to respiratory metabolism.	[Jose Rodriguez-Colman, Maria; Reverter-Branchat, Gemma; Alba Sorolla, M.; Tamarit, Jordi; Ros, Joaquim; Cabiscol, Elisa] Univ Lleida, IRBLleida, Biochem Oxidat Stress Grp, Lleida 25008, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Ros, J (corresponding author), Univ Lleida, IRBLleida, Biochem Oxidat Stress Grp, C Montserrat Roig 2, Lleida 25008, Spain.	joaquim.ros@cmb.udl.cat	Sorolla, Maria Alba/E-4780-2012; Tamarit, Jordi/C-6316-2008; Cabiscol, Elisa/A-4584-2009; Rodriguez-Colman Von Gebhardt, Maria José/C-6447-2011; Ros, Joaquim/A-7507-2010; ROS, Joaquim/ABG-7487-2020; Sorolla, Maria Alba/E-4780-2012	Sorolla, Maria Alba/0000-0002-2180-0408; Tamarit, Jordi/0000-0003-3227-6928; Cabiscol, Elisa/0000-0003-2795-7999; ROS, Joaquim/0000-0003-0901-8648; Sorolla, Maria Alba/0000-0002-1728-341X; Rodriguez-Colman, Maria J./0000-0001-8382-5128	Ministerio de Ciencia e Innovacion (Spain) [BFU2007-66249, CSD2007-20]; Generalitat de Catalunya [SGR2009-00196]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported by grants BFU2007-66249 and CSD2007-20 Consolider Ingenio 2010 from the Ministerio de Ciencia e Innovacion (Spain) and SGR2009-00196 from the Generalitat de Catalunya.	Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cho JH, 2001, BBA-GENE STRUCT EXPR, V1522, P175, DOI 10.1016/S0167-4781(01)00333-5; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DAIGNANFORNIER B, 1994, MOL GEN GENET, V243, P575, DOI 10.1007/BF00284206; DENIS CL, 1983, MOL CELL BIOL, V3, P360, DOI 10.1128/MCB.3.3.360; DESTRUELLE M, 1994, MOL CELL BIOL, V14, P2740, DOI 10.1128/MCB.14.4.2740; DIFFLEY JFX, 1992, J BIOL CHEM, V267, P3368; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FISHER RP, 1992, J BIOL CHEM, V267, P3358; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905; Hollenhorst PC, 2000, GENETICS, V154, P1533; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irazusta V, 2006, J BIOL CHEM, V281, P12227, DOI 10.1074/jbc.M511649200; Jakubowski W, 2000, FREE RADICAL BIO MED, V28, P659, DOI 10.1016/S0891-5849(99)00266-X; Jin C, 2007, FEBS LETT, V581, P5658, DOI 10.1016/j.febslet.2007.11.027; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaestner KH, 2000, GENE DEV, V14, P142; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kleinschmidt M, 2006, CURR GENET, V49, P218, DOI 10.1007/s00294-005-0049-7; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LIEBERMAN HB, 2003, METHOD MOL BIOL, P55; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; MAITRA PK, 1971, J BIOL CHEM, V246, P475; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Puig S, 2000, YEAST, V16, P139, DOI 10.1002/(SICI)1097-0061(20000130)16:2<139::AID-YEA512>3.3.CO;2-A; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Reverter-Branchat G, 2007, MICROBIOL-SGM, V153, P3667, DOI 10.1099/mic.0.2007/009340-0; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Saxena D, 2003, EUKARYOT CELL, V2, P552, DOI 10.1128/EC.2.3.552-559.2003; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763; ZHU GF, 1993, MOL CELL BIOL, V13, P1779, DOI 10.1128/MCB.13.3.1779; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	71	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37092	37101		10.1074/jbc.M110.174763	http://dx.doi.org/10.1074/jbc.M110.174763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847055	Green Published, hybrid			2022-12-27	WOS:000284146100053
J	Xu, XP; Vysotskaya, ZV; Liu, QL; Zhou, L				Xu, Xinping; Vysotskaya, Zhanna V.; Liu, Qinglian; Zhou, Lei			Structural Basis for the cAMP-dependent Gating in the Human HCN4 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT ACTIVATION KINETICS; CYCLIC-NUCLEOTIDE BINDING; PACEMAKER CHANNELS; HUMAN HEART; TERMINAL REGION; MOLECULAR-BASIS; GATED CHANNELS; MODULATION; MOVEMENT; LIGAND	Hyperpolarization-activated cAMP-regulated (HCN) channels play important physiological roles in both cardiovascular and central nervous systems. Among the four HCN isoforms, HCN2 and HCN4 show high expression levels in the human heart, with HCN4 being the major cardiac isoform. The previously published crystal structure of the mouse HCN2 (mHCN2) C-terminal fragment, including the C-linker and the cyclic-nucleotide binding domain (CNBD), has provided many insights into cAMP-dependent gating in HCN channels. However, structures of other mammalian HCN channel isoforms have been lacking. Here we used a combination of approaches including structural biology, biochemistry, and electrophysiology to study cAMP-dependent gating in HCN4 channel. First we solved the crystal structure of the C-terminal fragment of human HCN4 (hHCN4) channel at 2.4 angstrom. Overall we observed a high similarity between mHCN2 and hHCN4 crystal structures. Functional comparison between two isoforms revealed that compared with mHCN2, the hHCN4 protein exhibited marked different contributions to channel function, such as a similar to 3-fold reduction in the response to cAMP. Guided by structural differences in the loop region between beta 4 and beta 5 strands, we identified residues that could partially account for the differences in response to cAMP between mHCN2 and hHCN4 proteins. Moreover, upon cAMP binding, the hHCN4 C-terminal protein exerts a much prolonged effect in channel deactivation that could have significant physiological contributions.	[Xu, Xinping; Vysotskaya, Zhanna V.; Liu, Qinglian; Zhou, Lei] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Zhou, L (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA.	lzhou@vcu.edu	Xu, Xinping/AAA-1304-2020	XU, XINPING/0000-0002-9568-4171	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation	Virginia Commonwealth University School of Medicine; Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by startup funds from the Virginia Commonwealth University School of Medicine (to L. Z. and Q. L.) and a New Scholar Award in Aging from the Ellison Medical Foundation (to Q. L.).	[Anonymous], 2002, CURR PROTOC BIOINFOR; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DiFrancesco D, 2005, CURR MED RES OPIN, V21, P1115, DOI 10.1185/030079905X50543; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Ganetzky B, 1999, ANN NY ACAD SCI, V868, P356, DOI 10.1111/j.1749-6632.1999.tb11297.x; Harzheim D, 2008, EMBO J, V27, P692, DOI 10.1038/emboj.2008.3; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Ludwig A, 2008, PROG BIOPHYS MOL BIO, V98, P179, DOI 10.1016/j.pbiomolbio.2009.01.001; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Nof E, 2010, PACE, V33, P100, DOI 10.1111/j.1540-8159.2009.02563.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Stillitano F, 2008, J MOL CELL CARDIOL, V45, P289, DOI 10.1016/j.yjmcc.2008.04.013; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Verkerk AO, 2009, INT J CARDIOL, V132, P318, DOI 10.1016/j.ijcard.2008.12.196; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2008, BIOPHYS J, V94, pL90, DOI 10.1529/biophysj.108.130872; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	50	74	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37082	37091		10.1074/jbc.M110.152033	http://dx.doi.org/10.1074/jbc.M110.152033			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829353	Green Published, hybrid			2022-12-27	WOS:000284146100065
J	Ariyoshi, W; Knudson, CB; Luo, N; Fosang, AJ; Knudson, W				Ariyoshi, Wataru; Knudson, Cheryl B.; Luo, Na; Fosang, Amanda J.; Knudson, Warren			Internalization of Aggrecan G1 Domain Neoepitope ITEGE in Chondrocytes Requires CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ARTICULAR CHONDROCYTES; RECEPTOR-MEDIATED ENDOCYTOSIS; ANTIGEN-INDUCED ARTHRITIS; MATRIX-METALLOPROTEINASE; SYNOVIAL-FLUID; CARTILAGE DEGRADATION; INTERGLOBULAR DOMAIN; HUMAN OSTEOARTHRITIS; ADAMTS FAMILY; IN-VIVO	Degradation of the cartilage proteoglycan aggrecan is one of the earliest events that occurs in association with osteoarthritis. Little is known concerning the fate of the residual N-terminal G1 domains of cleaved aggrecan; domains that remain bound to hyaluronan. In this study, 68-72-kDa bands representative of aggrecan G1 domains containing ITEGE(373) neoepitope were detected within a hyaluronidase-sensitive pool at the cell surface of bovine articular chondrocytes and within a hyaluronidase-insensitive, intracellular pool. To determine the mechanisms that contribute to this distribution, CD44 expression was knocked down by siRNA or function by CD44-DN. Both approaches prevented the retention and internalization of G1-ITEGE. Inhibition of CD44 transit into lipid rafts blocked the endocytosis of G1-ITEGE but not the retention at the cell surface. Chondrocytes derived from CD44 null mice also exhibited limited potential for retention and internalization of G1-VTEGE. The consequence of a lack of chondrocyte-mediated endocytosis of these domains in cartilage of the CD44 null mice was the accumulation of the degradation fragments within the tissue. Additionally, chondrocytes or fibroblasts derived from CD44 null mice exhibited little capacity for retention and internalization of exogenous G1-ITEGE derived from bovine cartilage explants. Bovine or wild type mouse fibroblasts were able to bind and internalize bovine-derived G1-ITEGE. Although several pathways are available for the clearance of these domains, CD44-mediated cellular internalization is the most prominent.	[Knudson, Warren] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Fosang, Amanda J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Fosang, Amanda J.] Royal Childrens Hosp, Arthrit Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of North Carolina; East Carolina University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Knudson, W (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, 600 Moye Blvd, Greenville, NC 27834 USA.	knudsonw@ecu.edu		Fosang, Amanda/0000-0002-5523-5427	National Institutes of Health [RO1-AR43384, R01-AR39507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039507, R01AR043384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-AR43384 (to W. K.) and R01-AR39507 (to C. B. K.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Aguiar DJ, 1999, EXP CELL RES, V252, P292, DOI 10.1006/excr.1999.4641; Chockalingam PS, 2004, ARTHRITIS RHEUM-US, V50, P2839, DOI 10.1002/art.20496; CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734; Durigova M, 2008, OSTEOARTHR CARTILAGE, V16, P98, DOI 10.1016/j.joca.2007.05.002; Embry JJ, 2003, ARTHRITIS RHEUM-US, V48, P3431, DOI 10.1002/art.11323; Flory JJE, 2006, ARTHRITIS RHEUM-US, V54, P443, DOI 10.1002/art.21623; Fosang AJ, 2000, J BIOL CHEM, V275, P33027, DOI 10.1074/jbc.M910207199; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HUA Q, 1993, J CELL SCI, V106, P365; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; Jiang H, 2001, ARTHRITIS RHEUM-US, V44, P2599, DOI 10.1002/1529-0131(200111)44:11<2599::AID-ART440>3.0.CO;2-Y; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; KNUDSON W, 2004, CURR OPIN ORTHOP, V15, P369; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; LARK MW, 1995, J BIOL CHEM, V270, P2550, DOI 10.1074/jbc.270.6.2550; Little CB, 2002, MATRIX BIOL, V21, P271, DOI 10.1016/S0945-053X(02)00004-5; LOHMANDER LS, 1993, ARTHRITIS RHEUM-US, V36, P181, DOI 10.1002/art.1780360207; Mercuri FA, 1999, J BIOL CHEM, V274, P32387, DOI 10.1074/jbc.274.45.32387; MORALES TI, 1988, J BIOL CHEM, V263, P3632; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; Ohno S, 2006, J BIOL CHEM, V281, P17952, DOI 10.1074/jbc.M602750200; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Peterson RS, 2004, J CELL BIOL, V166, P1081, DOI 10.1083/jcb.200402138; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Szanto S, 2004, J IMMUNOL, V172, P6723, DOI 10.4049/jimmunol.172.11.6723; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; van Meurs JBJ, 1998, ARTHRITIS RHEUM, V41, P647, DOI 10.1002/1529-0131(199804)41:4<647::AID-ART11>3.0.CO;2-T; van Meurs JBJ, 1999, ANN RHEUM DIS, V58, P350, DOI 10.1136/ard.58.6.350; van Meurs JBJ, 1999, ARTHRITIS RHEUM, V42, P1128, DOI 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2	41	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36216	36224		10.1074/jbc.M110.129270	http://dx.doi.org/10.1074/jbc.M110.129270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843796	Green Published, hybrid			2022-12-27	WOS:000283845300097
J	Wang, HJ; Holloway, MP; Ma, L; Cooper, ZA; Riolo, M; Samkari, A; Elenitoba-Johnson, KSJ; Chin, YE; Altura, RA				Wang, Haijuan; Holloway, Michael P.; Ma, Li; Cooper, Zachary A.; Riolo, Matthew; Samkari, Ayman; Elenitoba-Johnson, Kojo S. J.; Chin, Y. Eugene; Altura, Rachel A.			Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE RESPONSE FACTOR; SIGNAL TRANSDUCER; IDENTIFICATION; GENE; TRANSCRIPTION-3; EXPRESSION; INHIBITOR; ACTIVATOR; CANCER; EXPORT	The multiple functions of the oncofetal protein survivin are dependent on its selective expression patterns within immuno-chemically distinct subcellular pools. The mechanism by which survivin localizes to these compartments, however, is only partly understood. Here we show that nuclear accumulation of survivin is promoted by CREB-binding protein (CBP)-dependent acetylation on lysine 129 (129K, Lys-129). We demonstrate a mechanism by which survivin acetylation at this position results in its homodimerization, while deacetylation promotes the formation of survivin monomers that heterodimerize with CRM1 and facilitate its nuclear export. Using proteomic analysis, we identified the oncogenic transcription factor STAT3 as a binding partner of nuclear survivin. We show that acetylated survivin binds to the N-terminal transcriptional activation domain of the STAT3 dimer and represses STAT3 transactivation of target gene promoters. Using multiplex PCR and DNA sequencing, we identified a single-nucleotide polymorphism (A -> ) at Lys-129 that exists as a homozygous mutation in a neuroblastoma cell line and corresponds with a defect in survivin nuclear localization. Our results demonstrate that the dynamic equilibrium between survivin acetylation and deacetylation at amino acid 129 determines its interaction with CRM1, its subsequent subcellular localization, and its ability to inhibit STAT3 transactivation, providing a potential route for therapeutic intervention in STAT3-dependent tumors.	[Altura, Rachel A.] Brown Univ, Dept Pediat, Providence, RI 02903 USA; [Ma, Li; Chin, Y. Eugene] Brown Univ, Dept Surg, Providence, RI 02903 USA; Rhode Isl Hosp, Providence, RI 02903 USA; [Elenitoba-Johnson, Kojo S. J.] Univ Michigan Hlth Sci, Dept Pathol, Ann Arbor, MI 48109 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Michigan System; University of Michigan	Altura, RA (corresponding author), 1 Hoppin St, Providence, RI 02903 USA.	rachel_altura@brown.edu		Cooper, Zachary/0000-0003-1059-0940; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health Cancer Research Center [P20RR017695-6A2]; Center for Excellence in Women's Health/Brown University; Women and Infants Hospital Award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER	National Institutes of Health Cancer Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Excellence in Women's Health/Brown University; Women and Infants Hospital Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Cancer Research Center Grant P20RR017695-6A2 ( to R. A. A.) and by a Center for Excellence in Women's Health/Brown University and Women and Infants Hospital Award (to R. A. A.).	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Engelsma D, 2007, TRAFFIC, V8, P1495, DOI 10.1111/j.1600-0854.2007.00629.x; Fortugno P, 2002, J CELL SCI, V115, P575; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Haynes PA, 1998, ELECTROPHORESIS, V19, P939, DOI 10.1002/elps.1150190609; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Mahboubi K, 2001, LAB INVEST, V81, P327, DOI 10.1038/labinvest.3780241; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Stauber RH, 2006, TRAFFIC, V7, P1461, DOI 10.1111/j.1600-0854.2006.00486.x; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	33	69	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36129	36137		10.1074/jbc.M110.152777	http://dx.doi.org/10.1074/jbc.M110.152777			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826784	hybrid, Green Published			2022-12-27	WOS:000283845300089
J	Yamazaki, H; Chan, J; Ikura, M; Michikawa, T; Mikoshiba, K				Yamazaki, Haruka; Chan, Jenny; Ikura, Mitsuhiko; Michikawa, Takayuki; Mikoshiba, Katsuhiko			Tyr-167/Trp-168 in Type 1/3 Inositol 1,4,5-Trisphosphate Receptor Mediates Functional Coupling between Ligand Binding and Channel Opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EMBRYOS; MICE LACKING; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; CALCIUM RELEASE; DOMAINS; SITE; AFFINITY; COMPLEX	The N-terminal similar to 220-amino acid region of the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R)/Ca2+ release channel has been referred to as the suppressor/coupling domain because it is required for both IP3 binding suppression and IP3-induced channel gating. Measurements of IP3-induced Ca2+ fluxes of mutagenized mouse type 1 IP3R (IP(3)R1) showed that the residues responsible for IP3 binding suppression in this domain were not essential for channel opening. On the other hand, a single amino acid substitution of Tyr-167 to alanine completely impaired IP3-induced Ca2+ release without reducing the IP3 binding activity. The corresponding residue in type 3 IP3R (IP3R3), Trp-168, was also critical for channel opening. Limited trypsin digestion experiments showed that the trypsin sensitivities of the C-terminal gatekeeper domain differed markedly between the wild-type channel and the Tyr-167 mutant under the optimal conditions for channel opening. These results strongly suggest that the Tyr/Trp residue (Tyr-167 in IP(3)R1 and Trp-168 in IP3R3) is critical for the functional coupling between IP3 binding and channel gating by maintaining the structural integrity of the C-terminal gatekeeper domain at least under activation gating.	[Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	RIKEN; Japan Science & Technology Agency (JST); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Michikawa, T (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-michikawa@brain.riken.jp; mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015	Ikura, Mitsuhiko/0000-0002-9524-1303	Ministry of Education, Science, Sports, and Culture of Japan [20370054, 20220007]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from the Special Postdoctoral Researchers Program in RIKEN (to H. Y.), Ministry of Education, Science, Sports, and Culture of Japan Grants 20370054 (to T. M.) and 20220007 (to K. M.), a Canadian Institutes of Health Research doctoral award (to J. C.), and a grant from the Heart and Stroke Foundation of Ontario (to M. I.).	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Fukuda N, 2008, EUR J NEUROSCI, V27, P2665, DOI 10.1111/j.1460-9568.2008.06240.x; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Galvan DL, 1999, J BIOL CHEM, V274, P29483, DOI 10.1074/jbc.274.41.29483; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hisatsune C, 2007, J BIOL CHEM, V282, P37225, DOI 10.1074/jbc.M705641200; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; Kume S, 1997, SCIENCE, V278, P1940, DOI 10.1126/science.278.5345.1940; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Muto A, 1996, J CELL BIOL, V135, P181, DOI 10.1083/jcb.135.1.181; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Shah PK, 2001, PROTEIN ENG, V14, P867, DOI 10.1093/protein/14.11.867; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Tu HP, 2005, BIOPHYS J, V88, p269A; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; WATRAS J, 1991, J NEUROSCI, V11, P3239; Yoneshima H, 1997, BIOCHEM J, V322, P591, DOI 10.1042/bj3220591; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yoshikawa F, 1999, BIOCHEM BIOPH RES CO, V257, P792, DOI 10.1006/bbrc.1999.0498; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P16613	57	47	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36081	36091		10.1074/jbc.M110.140129	http://dx.doi.org/10.1074/jbc.M110.140129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20813840	Green Published, hybrid			2022-12-27	WOS:000283845300084
J	Ivanov, SS; Charron, G; Hang, HC; Roy, CR				Ivanov, Stanimir S.; Charron, Guillaume; Hang, Howard C.; Roy, Craig R.			Lipidation by the Host Prenyltransferase Machinery Facilitates Membrane Localization of Legionella pneumophila Effector Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; LEGIONNAIRES-DISEASE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; PHAGOSOME TRAFFICKING; INTRACELLULAR GROWTH; TERMINAL PROTEOLYSIS; FATTY-ACYLATION; HUMAN-MONOCYTES; S-ACYLATION	The intracellular human pathogen Legionella pneumophila translocates multiple proteins in the host cytosol known as effectors, which subvert host cellular processes to create a membrane-bound organelle that supports bacterial replication. It was observed that several Legionella effectors encode a prototypical eukaryotic prenylation CAAX motif (where C represents a cysteine residue and A denotes an aliphatic amino acid). These bacterial motifs mediated posttranslational modification of effector proteins resulting in the addition of either a farnesyl or geranylgeranyl isoprenyl lipid moiety to the cysteine residue of the CAAX tetrapeptide. Lipidation enhanced membrane affinity for most Legionella CAAX motif proteins and facilitated the localization of these effector proteins to host organelles. Host farnesyltransferase and class I geranylgeranyl transferase were both involved in the lipidation of the Legionella CAAX motif proteins. Perturbation of the host prenylation machinery during infection adversely affected there modeling of the Legionella-containing vacuole. Thus, these data indicate that Legionella utilize the host prenylation machinery to facilitate targeting of effector proteins to membrane-bound organelles during intracellular infection.	[Roy, Craig R.] Yale Univ, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, Sch Med, New Haven, CT 06536 USA; [Charron, Guillaume; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA	Yale University; Rockefeller University	Roy, CR (corresponding author), Yale Univ, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, Sch Med, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu	Ivanov, Stanimir/J-4289-2019	Ivanov, Stanimir/0000-0002-3294-7595; Roy, Craig/0000-0003-4490-440X	National Institutes of Health [F32-GM084485, R01-AI048770, R01-AI041699, R01-GM087544]; Rockefeller/Sloan-Kettering/Cornell Tri-Institutional Program in Chemical Biology; Irma T. Hirschl/Monique Weill-Caulier Trust; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048770, R01AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084485, R01GM087544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller/Sloan-Kettering/Cornell Tri-Institutional Program in Chemical Biology; Irma T. Hirschl/Monique Weill-Caulier Trust; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant F32-GM084485 (to S. S. I.), R01-AI048770 (to C. R. R.), R01-AI041699 (to C. R. R.), and R01-GM087544 (to G. C.).; Supported by the Rockefeller/Sloan-Kettering/Cornell Tri-Institutional Program in Chemical Biology.; Supported by the Irma T. Hirschl/Monique Weill-Caulier Trust and the Ellison Medical Foundation.	Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Dowen RH, 2009, J BIOL CHEM, V284, P15867, DOI 10.1074/jbc.M900519200; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Wiater LA, 1998, INFECT IMMUN, V66, P4450; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	64	83	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34686	34698		10.1074/jbc.M110.170746	http://dx.doi.org/10.1074/jbc.M110.170746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813839	hybrid, Green Published			2022-12-27	WOS:000283659100044
J	Miller, A; Chen, JJ; Takasuka, TE; Jacobi, JL; Kaufman, PD; Irudayaraj, JMK; Kirchmaier, AL				Miller, Andrew; Chen, Jiji; Takasuka, Taichi E.; Jacobi, Jennifer L.; Kaufman, Paul D.; Irudayaraj, Joseph M. K.; Kirchmaier, Ann L.			Proliferating Cell Nuclear Antigen (PCNA) Is Required for Cell Cycle-regulated Silent Chromatin on Replicated and Nonreplicated Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; H3 LYSINE-56 ACETYLATION; DNA-POLYMERASE-DELTA; HISTONE H3; SACCHAROMYCES-CEREVISIAE; EPIGENETIC INHERITANCE; FACTOR-C; S-PHASE; PROTEIN; YEAST	In Saccharomyces cerevisiae, silent chromatin is formed at HMR upon the passage through S phase, yet neither the initiation of DNA replication at silencers nor the passage of a replication fork through HMR is required for silencing. Paradoxically, mutations in the DNA replication processivity factor, POL30, disrupt silencing despite this lack of requirement for DNA replication in the establishment of silencing. We tested whether pol30 mutants could establish silencing at either replicated or non-replicated HMR loci during S phase and found that pol30 mutants were defective in establishing silencing at HMR regardless of its replication status. Although previous studies tie the silencing defect of pol30 mutants to the chromatin assembly factors Asf1p and CAF-1, we found pol30 mutants did not exhibit a gross defect in packaging HMR into chromatin. Rather, the pol30 mutants exhibited defects in histone modifications linked to ASF1 and CAF-1-dependent pathways, including SAS-I-and Rtt109p-dependent acetylation events at H4-K16 and H3-K9 (plus H3-K56; Miller, A., Yang, B., Foster, T., and Kirchmaier, A. L. (2008) Genetics 179, 793-809). Additional experiments using FLIM-FRET revealed that Pol30p interacted with SAS-I and Rtt109p in the nuclei of living cells. However, these interactions were disrupted in pol30 mutants with defects linked to ASF1- and CAF-1-dependent pathways. Together, these results imply that Pol30p affects epigenetic processes by influencing the composition of chromosomal histone modifications.	[Miller, Andrew; Takasuka, Taichi E.; Jacobi, Jennifer L.; Kirchmaier, Ann L.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Chen, Jiji; Irudayaraj, Joseph M. K.] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Miller, Andrew; Chen, Jiji; Takasuka, Taichi E.; Jacobi, Jennifer L.; Irudayaraj, Joseph M. K.; Kirchmaier, Ann L.] Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA; [Kaufman, Paul D.] Univ Massachusetts, Sch Med, Program Gene Funct & Gene Express, Slippery Rock, PA 16057 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kirchmaier, AL (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	kirchmaier@purdue.edu	Chen, Jiji/K-5551-2012; Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Kirchmaier, Ann/0000-0001-9938-9105; Kaufman, Paul/0000-0003-3089-313X; Irudayaraj, Joseph/0000-0002-0630-1520	National Institutes of Health [R01 GM55712, GM31105]; Kimmel Scholar Award [SKF-03-010]; National Science Foundation; Purdue Office of the Vice President of Research; American Cancer Society [PF-01-126-01-MBC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031105, R01GM055712, R01GM031105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Scholar Award; National Science Foundation(National Science Foundation (NSF)); Purdue Office of the Vice President of Research; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM55712 (to P. D. K.) and GM31105 (to J. Rine, with whom A. L. K. worked at the time). This work was also supported by Kimmel Scholar Award SKF-03-010 (to A. L. K.), a National Science Foundation award (to A. L. K.), a grant from the Purdue Office of the Vice President of Research (to A. L. K. and J. M. K. I.), and an American Cancer Society institutional research grant to the Purdue University Center for Cancer Research. Support for initial experiments was provided by the American Cancer Society (PF-01-126-01-MBC to A. L. K.).	Adams A, 1997, METHODS YEAST GENETI; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bose ME, 2004, MOL CELL BIOL, V24, P774, DOI 10.1128/MCB.24.2.774-786.2004; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Ehrenhofer-Murray AE, 1999, GENETICS, V153, P1171; EHRENHOFERMURRA.AE, 1997, J GENETICS */* GENET, P923; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Galvani A, 2008, MOL CELL BIOL, V28, P3672, DOI 10.1128/MCB.00510-07; Gardner KA, 1999, GENETICS, V151, P31; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; HUBSCHER U, 1996, DNA REPLICATION EUKA, P525; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Kamakaka RT, 1996, MOL CELL BIOL, V16, P810; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KIMMERLY W, 1988, EMBO J, V7, P2241, DOI 10.1002/j.1460-2075.1988.tb03064.x; Kirchmaier AL, 2006, MOL CELL BIOL, V26, P852, DOI 10.1128/MCB.26.3.852-862.2006; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Li Q, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000684; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; MAGA G, 1995, BIOCHEMISTRY-US, V34, P891, DOI 10.1021/bi00003a023; Martins-Taylor K, 2004, GENETICS, V168, P65, DOI 10.1534/genetics.103.020149; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matecic M, 2006, GENETICS, V173, P1939, DOI 10.1534/genetics.106.055491; McAlear MA, 1996, GENETICS, V142, P65; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; MILLER AM, 1984, EMBO J, V3, P1061, DOI 10.1002/j.1460-2075.1984.tb01927.x; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Miller A, 2008, GENETICS, V179, P793, DOI 10.1534/genetics.107.084525; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nakatani Y, 2004, COLD SPRING HARB SYM, V69, P273, DOI 10.1101/sqb.2004.69.273; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Reifnyder C, 1997, NAT GENET, V16, P109, DOI 10.1038/ng0597-109b; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Shia WJ, 2005, J BIOL CHEM, V280, P11987, DOI 10.1074/jbc.M500276200; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SIEGEL RM, 2000, SCI STKE, pPL1; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1999, MOL CELL BIOL, V19, P3184; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; STEARNS T, 1990, METHOD ENZYMOL, V185, P280; Sutton A, 2003, J BIOL CHEM, V278, P16887, DOI 10.1074/jbc.M210709200; Sutton A, 2001, GENETICS, V158, P587; Tamburini BA, 2006, GENETICS, V173, P599, DOI 10.1534/genetics.105.054783; TAN CK, 1986, J BIOL CHEM, V261, P2310; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; VAN L, 2002, METHODS */* D E METH, V350, P165; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Leeuwen F, 2002, CURR OPIN CELL BIOL, V14, P756, DOI 10.1016/S0955-0674(02)00393-9; Varghese LT, 2008, ANAL CHIM ACTA, V625, P103, DOI 10.1016/j.aca.2008.07.021; Vidi PA, 2008, FEBS LETT, V582, P3985, DOI 10.1016/j.febslet.2008.09.062; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WANG JC, 1982, CELL, V29, P724, DOI 10.1016/0092-8674(82)90433-0; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Xu EY, 1999, GENETICS, V153, P13; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yang B, 2008, J MOL BIOL, V381, P826, DOI 10.1016/j.jmb.2008.06.059; Yang B, 2006, MOL BIOL CELL, V17, P5287, DOI 10.1091/mbc.E06-08-0669; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	119	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35142	35154		10.1074/jbc.M110.166918	http://dx.doi.org/10.1074/jbc.M110.166918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813847	hybrid, Green Published			2022-12-27	WOS:000283659100088
J	Orru, R; Pazmino, DET; Fraaije, MW; Mattevi, A				Orru, Roberto; Pazmino, Daniel E. Torres; Fraaije, Marco W.; Mattevi, Andrea			Joint Functions of Protein Residues and NADP(H) in Oxygen Activation by Flavin-containing Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALF-REACTION; FMO3; MUTATIONS; MECHANISM; GENE	The reactivity of flavoenzymes with dioxygen is at the heart of a number of biochemical reactions with far reaching implications for cell physiology and pathology. Flavin-containing monooxygenases are an attractive model system to study flavin-mediated oxygenation. In these enzymes, the NADP(H) cofactor is essential for stabilizing the flavin intermediate, which activates dioxygen and makes it ready to react with the substrate undergoing oxygenation. Our studies combine site-directed mutagenesis with the usage of NADP(+) analogues to dissect the specific roles of the cofactors and surrounding protein matrix. The highlight of this "double-engineering" approach is that subtle alterations in the hydrogen bonding and stereochemical environment can drastically alter the efficiency and outcome of the reaction with oxygen. This is illustrated by the seemingly marginal replacement of an Asn to Ser in the oxygen-reacting site, which inactivates the enzyme by effectively converting it into an oxidase. These data rationalize the effect of mutations that cause enzyme deficiency in patients affected by the fish odor syndrome. A crucial role of NADP(+) in the oxygenation reaction is to shield the reacting flavin N5 atom by H-bond interactions. A Tyr residue functions as backdoor that stabilizes this crucial binding conformation of the nicotinamide cofactor. A general concept emerging from this analysis is that the two alternative pathways of flavoprotein-oxygen reactivity (oxidation versus monooxygenation) are predicted to have very similar activation barriers. The necessity of fine tuning the hydrogen-bonding, electrostatics, and accessibility of the flavin will represent a challenge for the design and development of oxidases and monoxygenases for biotechnological applications.	[Pazmino, Daniel E. Torres; Fraaije, Marco W.] Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Orru, Roberto; Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	University of Groningen; University of Pavia	Fraaije, MW (corresponding author), Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl; andrea.mattevi@unipv.it	mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019; Orru, Roberto/E-9779-2013; Fraaije, Marco/E-8421-2014	mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Fraaije, Marco/0000-0001-6346-5014	Italian Ministry of Science; Fondazione Cariplo; American Chemical Society [46271-C4]; EU	Italian Ministry of Science(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); American Chemical Society(American Chemical Society); EU(European Commission)	This work was supported by the Italian Ministry of Science (PRIN08 program), Fondazione Cariplo, EU-FP7 (Oxygreen), and the American Chemical Society Petroleum Research Fund (46271-C4).	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; ALWAIZ M, 1987, LANCET, V1, P634; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; CASHMAN JR, 2006, J ANNU REV PHARM TOX, P65; Choi HS, 2003, BIOCHEM BIOPH RES CO, V306, P930, DOI 10.1016/S0006-291X(03)01087-8; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Dolphin CT, 2000, PHARMACOGENETICS, V10, P799, DOI 10.1097/00008571-200012000-00005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Imada Y, 2005, ANGEW CHEM INT EDIT, V44, P1704, DOI 10.1002/anie.200462429; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; Koukouritaki SB, 2007, J PHARMACOL EXP THER, V320, P266, DOI 10.1124/jpet.106.112268; KRUEGER SK, 2005, PHARMACOL THERAPEUT, V106, P3573; Macheroux Peter, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091/6/26; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; PAI EF, 1983, J BIOL CHEM, V258, P1752; Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004; POULSEN LL, 1979, J BIOL CHEM, V254, P6449; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Yeung CK, 2007, ARCH BIOCHEM BIOPHYS, V464, P251, DOI 10.1016/j.abb.2007.04.014; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	28	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35021	35028		10.1074/jbc.M110.161372	http://dx.doi.org/10.1074/jbc.M110.161372			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807767	Green Published, hybrid			2022-12-27	WOS:000283659100076
J	Seymour, LM; Deutscher, AT; Jenkins, C; Kuit, TA; Falconer, L; Minion, FC; Crossett, B; Padula, M; Dixon, NE; Djordjevic, SP; Walker, MJ				Seymour, Lisa M.; Deutscher, Ania T.; Jenkins, Cheryl; Kuit, Tracey A.; Falconer, Linda; Minion, F. Chris; Crossett, Ben; Padula, Matthew; Dixon, Nicholas E.; Djordjevic, Steven P.; Walker, Mark J.			A Processed Multidomain Mycoplasma hyopneumoniae Adhesin Binds Fibronectin, Plasminogen, and Swine Respiratory Cilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCAL M-PROTEIN; ELONGATION-FACTOR TU; ALPHA-ENOLASE; ADHERENCE; GENE; IDENTIFICATION; DOMAINS; VACCINE; REGION; PIGS	Porcine enzootic pneumonia is a chronic respiratory disease that affects swine. The etiological agent of the disease, Mycoplasma hyopneumoniae, is a bacterium that adheres to cilia of the swine respiratory tract, resulting in loss of cilia and epithelial cell damage. A M. hyopneumoniae protein P116, encoded by mhp108, was investigated as a potential adhesin. Examination of P116 expression using proteomic analyses observed P116 as a full-length protein and also as fragments, ranging from 17 to 70 kDa in size. A variety of pathogenic bacterial species have been shown to bind the extracellular matrix component fibronectin as an adherence mechanism. M. hyopneumoniae cells were found to bind fibronectin in a dose-dependent and saturable manner. Surface plasmon resonance was used to show that a recombinant C-terminal domain of P116 bound fibronectin at physiologically relevant concentrations (K-D 24 +/- 6 nM). Plasmin(ogen)-binding proteins are also expressed by many bacterial pathogens, facilitating extracellular matrix degradation. M. hyopneumoniae cells were found to also bind plasminogen in a dose-dependent and saturable manner; the C-terminal domain of P116 binds to plasminogen (K-D 44 +/- 5 nM). Plasminogen binding was abolished when the C-terminal lysine of P116 was deleted, implicating this residue as part of the plasminogen binding site. P116 fragments adhere to the PK15 porcine kidney epithelial-like cell line and swine respiratory cilia. Collectively these data suggest that P116 is an important adhesin and virulence factor of M. hyopneumoniae.	[Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Seymour, Lisa M.; Deutscher, Ania T.; Kuit, Tracey A.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Dixon, Nicholas E.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Minion, F. Chris] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Crossett, Ben] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Padula, Matthew; Djordjevic, Steven P.] Univ Technol Sydney, Inst i3, Sydney, NSW 2007, Australia	University of Queensland; University of Wollongong; University of Wollongong; Iowa State University; University of Sydney; University of Technology Sydney	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Cooper Rd, St Lucia, Qld 4072, Australia.	mark.walker@uq.edu.au	Jenkins, Cheryl/N-1937-2015; Walker, Mark J./F-6940-2011; djordjevic, steven/GNP-4000-2022; Dixon, Nicholas E/A-1226-2008; Padula, Matthew P/R-6150-2016; Djordjevic, Steven/A-2024-2013; Minion, Chris/A-2955-2015; Crossett, Ben/G-2316-2011	Jenkins, Cheryl/0000-0002-5966-072X; djordjevic, steven/0000-0001-9301-5372; Dixon, Nicholas E/0000-0002-5958-6945; Padula, Matthew P/0000-0002-8283-0643; Djordjevic, Steven/0000-0001-9301-5372; Minion, Chris/0000-0003-4876-8396; Walker, Mark/0000-0001-7423-2769; Deutscher, Ania/0000-0002-5917-9223				Adams C, 2005, INFECT IMMUN, V73, P7784, DOI 10.1128/IAI.73.11.7784-7787.2005; Andronicos NM, 1997, BBA-PROTEIN STRUCT M, V1337, P27, DOI 10.1016/S0167-4838(96)00146-X; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baseggio N, 1996, MICROBIOL-SGM, V142, P1429, DOI 10.1099/13500872-142-6-1429; BLANCHARD B, 1992, VET MICROBIOL, V30, P329, DOI 10.1016/0378-1135(92)90020-T; Bower K, 2003, INFECT IMMUN, V71, P4823, DOI 10.1128/IAI.71.8.4823-4827.2003; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Chaussee MS, 2000, INFECT IMMUN, V68, P3226, DOI 10.1128/IAI.68.6.3226-3232.2000; CIPRIAN A, 1988, CAN J VET RES, V52, P434; Cole Jason N., 2008, V425, P295, DOI 10.1007/978-1-60327-210-0_24; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; DALLO SF, 1991, MICROB PATHOGENESIS, V10, P475, DOI 10.1016/0882-4010(91)90113-O; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; DEBEY MC, 1994, INFECT IMMUN, V62, P5312, DOI 10.1128/IAI.62.12.5312-5318.1994; Djordjevic SP, 1997, AUST VET J, V75, P504, DOI 10.1111/j.1751-0813.1997.tb14383.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Fagan PK, 1996, INFECT IMMUN, V64, P1060, DOI 10.1128/IAI.64.3.1060-1064.1996; Giron JA, 1996, INFECT IMMUN, V64, P197; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; Henrich S, 2007, BBA-PROTEINS PROTEOM, V1774, P413, DOI 10.1016/j.bbapap.2006.12.011; Hsu T, 1998, GENE, V214, P13, DOI 10.1016/S0378-1119(98)00247-9; Jenkins C, 2006, INFECT IMMUN, V74, P481, DOI 10.1128/IAI.74.1.481-487.2006; King KW, 1997, VACCINE, V15, P25, DOI 10.1016/S0264-410X(96)00121-1; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Marois C, 2007, VET MICROBIOL, V120, P96, DOI 10.1016/j.vetmic.2006.10.015; May M, 2006, INFECT IMMUN, V74, P1777, DOI 10.1128/IAI.74.3.1777-1785.2006; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Minion FC, 2000, INFECT IMMUN, V68, P3056, DOI 10.1128/IAI.68.5.3056-3060.2000; Mongodin E, 2002, INFECT IMMUN, V70, P620; Oehmcke S, 2004, INFECT IMMUN, V72, P4302, DOI 10.1128/IAI.72.7.4302-4308.2004; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; REDDY SP, 1995, J BACTERIOL, V177, P5943, DOI 10.1128/jb.177.20.5943-5951.1995; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Scarman AL, 1997, MICROBIOL-SGM, V143, P663, DOI 10.1099/00221287-143-2-663; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Wilton JL, 1998, MICROBIOL-UK, V144, P1931, DOI 10.1099/00221287-144-7-1931; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; WISE KS, 1987, J BACTERIOL, V169, P5546, DOI 10.1128/jb.169.12.5546-5555.1987; YAGIHASHI T, 1984, JPN J VET SCI, V46, P705; Yavlovich A, 2001, INFECT IMMUN, V69, P1977, DOI 10.1128/IAI.69.4.1977-1982.2001; Yavlovich A, 2007, FEMS MICROBIOL LETT, V266, P158, DOI 10.1111/j.1574-6968.2006.00534.x; Yazawa S, 2004, VET MICROBIOL, V98, P221, DOI 10.1016/j.vetmic.2003.11.005; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZHANG QJ, 1995, INFECT IMMUN, V63, P1013, DOI 10.1128/IAI.63.3.1013-1019.1995; ZHANG QJ, 1994, INFECT IMMUN, V62, P4367, DOI 10.1128/IAI.62.10.4367-4373.1994; ZIELINSKI GC, 1990, AM J VET RES, V51, P339	49	65	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33971	33978		10.1074/jbc.M110.104463	http://dx.doi.org/10.1074/jbc.M110.104463			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20813843	Green Published, hybrid			2022-12-27	WOS:000283354000044
J	Burrell, M; Hanfrey, CC; Murray, EJ; Stanley-Wall, NR; Michael, AJ				Burrell, Matthew; Hanfrey, Colin C.; Murray, Ewan J.; Stanley-Wall, Nicola R.; Michael, Anthony J.			Evolution and Multiplicity of Arginine Decarboxylases in Polyamine Biosynthesis and Essential Role in Bacillus subtilis Biofilm Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; AMINO-ACID DECARBOXYLASES; X-RAY-STRUCTURE; ORNITHINE-DECARBOXYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DIAMINOPIMELATE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; CHLAMYDOPHILA-PNEUMONIAE	Arginine decarboxylases (ADCs; EC 4.1.1.19) from four different protein fold families are important for polyamine biosynthesis in bacteria, archaea, and plants. Biosynthetic alanine racemase fold (AR-fold) ADC is widespread in bacteria and plants. We report the discovery and characterization of an ancestral form of the AR-fold ADC in the bacterial Chloroflexi and Bacteroidetes phyla. The ancestral AR-fold ADC lacks a large insertion found in Escherichia coli and plant AR-fold ADC and is more similar to the lysine biosynthetic enzyme meso-diaminopimelate decarboxylase, from which it has evolved. An E. coli acid-inducible ADC belonging to the aspartate aminotransferase fold (AAT-fold) is involved in acid resistance but not polyamine biosynthesis. We report here that the acid-inducible AAT-fold ADC has evolved from a shorter, ancestral biosynthetic AAT-fold ADC by fusion of a response regulator receiver domain protein to the N terminus. Ancestral biosynthetic AAT-fold ADC appears to be limited to firmicute bacteria. The phylogenetic distribution of different forms of ADC distinguishes bacteria from archaea, euryarchaeota from crenarchaeota, double-membraned from single-membraned bacteria, and firmicutes from actinobacteria. Our findings extend to eight the different enzyme forms carrying out the activity described by EC 4.1.1.19. ADC gene clustering reveals that polyamine biosynthesis employs diverse and exchangeable synthetic modules. We show that in Bacillus subtilis, ADC and polyamines are essential for biofilm formation, and this appears to be an ancient, evolutionarily conserved function of polyamines in bacteria. Also of relevance to human health, we found that arginine decarboxylation is the dominant pathway for polyamine biosynthesis in human gut microbiota.	[Michael, Anthony J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Burrell, Matthew; Hanfrey, Colin C.; Michael, Anthony J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Murray, Ewan J.; Stanley-Wall, Nicola R.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland	University of Texas System; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Dundee	Michael, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	anthony.michael@utsouthwestern.edu		Stanley-Wall, Nicola/0000-0002-5936-9721	Biotechnology and Biological Sciences Research Council UK [BB/C520404/1, BB/E001572/1, BB/E024467/1]; BBSRC [BB/E024467/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024467/1, BB/C520404/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Biotechnology and Biological Sciences Research Council UK Grants BB/C520404/1 and BB/E001572/1.; Supported by a Biotechnology and Biological Sciences Research Council UK CSG grant and Institute Development Fellowship BB/E024467/1. To whom correspondence should be addressed: Dept. of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9041. Tel.: 214-648-4170; E-mail: anthony.michael@utsouthwestern.edu.	Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Andrell J, 2009, BIOCHEMISTRY-US, V48, P3915, DOI 10.1021/bi900075d; Ballouz S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000672; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; DeLano W.L, PYMOL MOL GRAPHICS S; Deng XY, 2010, J BIOL CHEM, V285, P25708, DOI 10.1074/jbc.M110.121137; Fuell C, 2010, PLANT PHYSIOL BIOCH, V48, P513, DOI 10.1016/j.plaphy.2010.02.008; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Hu TC, 2008, J BIOL CHEM, V283, P21284, DOI 10.1074/jbc.M801823200; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Illingworth C, 2003, FEBS LETT, V549, P26, DOI 10.1016/S0014-5793(03)00756-7; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Irnov I, 2010, MOL MICROBIOL, V76, P559, DOI 10.1111/j.1365-2958.2010.07131.x; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kovacs K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000115; Lake JA, 2008, SYST BIOL, V57, P835, DOI 10.1080/10635150802555933; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Liao S, 2008, BIOSCI BIOTECH BIOCH, V72, P445, DOI 10.1271/bbb.70550; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; McGinnis MW, 2009, FEMS MICROBIOL LETT, V299, P166, DOI 10.1111/j.1574-6968.2009.01744.x; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; MOMANY C, 1995, J MOL BIOL, V252, P643, DOI 10.1006/jmbi.1995.0526; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Ohno S., 1970, EVOLUTION GENE DUPLI; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEGG AE, 1979, BIOCHIM BIOPHYS ACTA, V568, P416, DOI 10.1016/0005-2744(79)90310-3; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; SATISHCHANDRAN C, 1986, J BACTERIOL, V165, P843, DOI 10.1128/jb.165.3.843-848.1986; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Serres MH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-46; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; Shah R, 2007, BIOCHEMISTRY-US, V46, P2831, DOI 10.1021/bi6023447; Shaw FL, 2010, J BIOL CHEM, V285, P14711, DOI 10.1074/jbc.M110.107219; Smith CB, 2008, J BACTERIOL, V190, P7431, DOI 10.1128/JB.00652-08; Takatsuka Y, 2000, J BACTERIOL, V182, P6732, DOI 10.1128/JB.182.23.6732-6741.2000; Tolbert WD, 2003, STRUCTURE, V11, P285, DOI 10.1016/S0969-2126(03)00026-1; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Yanai I, 2002, GENOME BIOL, V3	65	76	79	3	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39224	39238		10.1074/jbc.M110.163154	http://dx.doi.org/10.1074/jbc.M110.163154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876533	Green Published, hybrid			2022-12-27	WOS:000284941300052
J	Kapur, S; Amoui, M; Kesavan, C; Wang, XG; Mohan, S; Baylink, DJ; Lau, KHW				Kapur, Sonia; Amoui, Mehran; Kesavan, Chandrasekhar; Wang, Xiaoguang; Mohan, Subburaman; Baylink, David J.; Lau, K. -H. William			Leptin Receptor (Lepr) Is a Negative Modulator of Bone Mechanosensitivity and Genetic Variations in Lepr May Contribute to the Differential Osteogenic Response to Mechanical Stimulation in the C57BL/6J and C3H/HeJ Pair of Mouse Strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUID SHEAR-STRESS; ESTROGEN-RECEPTOR; IN-VIVO; ANABOLIC RESPONSE; KNOCKOUT MICE; GAP-JUNCTIONS; UP-REGULATION; CELLS; PHOSPHATASE; OSTEOBLASTS	This study investigated the role of leptin receptor (Lepr) signaling in determining the bone mechanosensitivity and also evaluated whether differences in the Lepr signaling may contribute to the differential osteogenic response of the C57BL/6J (B6) and C3H/HeJ (C3H) pair of mouse strains to mechanical stimuli. This study shows that a loading strain of similar to 2,500 mu epsilon, which was insufficient to produce a bone formation response in B6 mice, significantly increased bone formation parameters in leptin-deficient ob(-)/ob(-) mice and that a loading strain of similar to 3,000 mu epsilon also yielded greater osteogenic responses in Lepr-deficient db(-)/db(-) mice than in wild-type littermates. In vitro, a 30-min steady shear stress increased [H-3] thymidine incorporation and Erk1/2 phosphorylation in ob(-)/ob(-) osteoblasts and db(-)/db(-) osteoblasts much greater than those in corresponding wild-type osteoblasts. The siRNA-mediated suppression of Lepr expression in B6 osteoblasts enhanced (but in osteoblasts of C3H (the mouse strain with poor bone mechanosensitivity) restored) their anabolic responses to shear stress. The Lepr signaling (leptin-induced Jak2/Stat3 phosphorylation) in C3H osteoblasts was higher than that in B6 osteoblasts. One of the three single nucleotide polymorphisms in the C3H Lepr coding region yielded an I359V substitution near the leptin binding region, suggesting that genetic variation of Lepr may contribute to a dysfunctional Lepr signaling in C3H osteoblasts. In conclusion, Lepr signaling is a negative modulator of bone mechanosensitivity. Genetic variations in Lepr, which result in a dysfunctional Lepr signaling in C3H mice, may contribute to the poor osteogenic response to loading in C3H mice.	[Kapur, Sonia; Amoui, Mehran; Kesavan, Chandrasekhar; Wang, Xiaoguang; Mohan, Subburaman; Lau, K. -H. William] Jerry L Pettis Mem Vet Affairs Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Mohan, Subburaman; Baylink, David J.; Lau, K. -H. William] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Mohan, Subburaman; Lau, K. -H. William] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Physiol, Loma Linda, CA 92354 USA	Loma Linda University; Loma Linda University; Loma Linda University	Lau, KHW (corresponding author), Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr 151, 11201 Benton St, Loma Linda, CA 92357 USA.	William.Lau@med.va.gov		Lau, Kin-Hing/0000-0003-1109-5052	United States Army Medical Research [DAMD17-01-1-0744]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs	United States Army Medical Research; Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by United States Army Medical Research Acquisition Activity Assistance Award DAMD17-01-1-0744). This work was also supported in part by a Merit Review provided by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs. All work was performed in facilities provided by the Department of Veterans Affairs. Preliminary results were presented in abstract form (55).	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Akhter MP, 1998, CALCIFIED TISSUE INT, V63, P442, DOI 10.1007/s002239900554; Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Biener E, 2005, BIOL CELL, V97, P905; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Roman DD, 2006, ARCH MED RES, V37, P854, DOI 10.1016/j.arcmed.2006.03.009; Devos R, 1997, J BIOL CHEM, V272, P18304, DOI 10.1074/jbc.272.29.18304; DODDS RA, 1993, J BONE MINER RES, V8, P261; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Fairbrother UL, 2007, J BONE MINER RES, V22, P544, DOI 10.1359/jbmr.070114; Fernandez-Moreno C, 2004, FEBS LETT, V557, P64, DOI 10.1016/S0014-5793(03)01445-5; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gordeladze JO, 2003, J CELL BIOCHEM, V88, P706, DOI 10.1002/jcb.10385; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Hirosawa M, 2008, BIOCHEM BIOPH RES CO, V371, P320, DOI 10.1016/j.bbrc.2008.04.073; Hong SC, 2007, MENOPAUSE, V14, P835, DOI 10.1097/gme.0b013e31802cddca; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jessop HL, 2004, J BONE MINER RES, V19, P938, DOI 10.1359/jbmr.2004.19.6.938; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kesavan C, 2005, J APPL PHYSIOL, V99, P1951, DOI 10.1152/japplphysiol.00401.2005; Kesavan C, 2007, BONE, V41, P223, DOI 10.1016/j.bone.2007.04.185; Kesavan C, 2006, BONE, V39, P634, DOI 10.1016/j.bone.2006.03.005; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kodama Y, 2000, CALCIFIED TISSUE INT, V66, P298, DOI 10.1007/s002230010060; Koh JM, 2002, EUR J ENDOCRINOL, V147, P777, DOI 10.1530/eje.0.1470777; Lambrinoudaki IV, 2008, MATURITAS, V59, P62, DOI 10.1016/j.maturitas.2007.10.003; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Lau KHW, 2007, J BONE MINER RES, V22, pS23; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Namae M, 1998, LAB ANIM SCI, V48, P103; Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Pedersen EA, 1999, CALCIFIED TISSUE INT, V65, P41, DOI 10.1007/s002239900655; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Robling AG, 2007, J BONE MINER RES, V22, P984, DOI 10.1359/JBMR.070327; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Sheng MHC, 2004, BONE, V35, P711, DOI 10.1016/j.bone.2004.05.013; Srivastava AK, 2005, J BONE MINER RES, V20, P1041, DOI 10.1359/JBMR.041239; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Thomas T, 2004, CURR OPIN PHARMACOL, V4, P295, DOI 10.1016/j.coph.2004.01.009; Thompson DB, 1997, HUM MOL GENET, V6, P675, DOI 10.1093/hmg/6.5.675; Turner CH, 2005, J BONE MINER RES, V20, pS28; Wang XG, 2007, CALCIFIED TISSUE INT, V80, P374, DOI 10.1007/s00223-007-9026-0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37607	37618		10.1074/jbc.M110.169714	http://dx.doi.org/10.1074/jbc.M110.169714			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851886	Green Published, hybrid			2022-12-27	WOS:000284424000053
J	Lai, AL; Tamm, LK				Lai, Alex L.; Tamm, Lukas K.			Shallow Boomerang-shaped Influenza Hemagglutinin G13A Mutant Structure Promotes Leaky Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BILAYERS; CONFORMATIONAL CHANGE; SECONDARY STRUCTURE; PEPTIDE; DOMAIN; HEMIFUSION; MECHANISM; PROTEIN; NMR; SPECTROSCOPY	Our previous studies showed that an angled boomerang-shaped structure of the influenza hemagglutinin (HA) fusion domain is critical for virus entry into host cells by membrane fusion. Because the acute angle of similar to 105 degrees of the wild-type fusion domain promotes efficient non-leaky membrane fusion, we asked whether different angles would still support fusion and thus facilitate virus entry. Here, we show that the G13A fusion domain mutant produces a new leaky fusion phenotype. The mutant fusion domain structure was solved by NMR spectroscopy in a lipid environment at fusion pH. The mutant adopted a boomerang structure similar to that of wild type but with a shallower kink angle of similar to 150 degrees. G13A perturbed the structure of model membranes to a lesser degree than wild type but to a greater degree than non-fusogenic fusion domain mutants. The strength of G13A binding to lipid bilayers was also intermediate between that of wild type and non-fusogenic mutants. Thesemembrane interactions provide a clear link between structure and function of influenza fusion domains: an acute angle is required to promote clean non-leaky fusion suitable for virus entry presumably by interaction of the fusion domain with the transmembrane domain deep in the lipid bilayer. A shallower angle perturbs the bilayer of the target membrane so that it becomes leaky and unable to form a clean fusion pore. Mutants with no fixed boomerang angle interacted with bilayers weakly and did not promote any fusion or membrane perturbation.	[Lai, Alex L.; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA	University of Virginia	Tamm, LK (corresponding author), Univ Virginia, Ctr Membrane Biol, Dept Mol Physiol & Biol Phys, 480 Ray C Hunt Dr,POB 800886,Snyder Bldg,Rm 350, Charlottesville, VA 22908 USA.	Lkt2e@virginia.edu	Lai, Alex/G-8668-2014		National Institutes of Health [R37 AI030557]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AI030557.	Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bonnafous P, 2000, J BIOL CHEM, V275, P6160, DOI 10.1074/jbc.275.9.6160; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Frolov VA, 2003, BIOPHYS J, V85, P1725, DOI 10.1016/S0006-3495(03)74602-5; Goddard D., 2008, SPARKY 3; Gray C, 1996, BIOPHYS J, V70, pWP269; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Han X, 2000, J MOL BIOL, V304, P953, DOI 10.1006/jmbi.2000.4251; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jiricek R, 1997, BBA-BIOMEMBRANES, V1330, P17, DOI 10.1016/S0005-2736(97)00134-X; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Lai AL, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P279; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; Li YL, 2003, BIOCHEMISTRY-US, V42, P7245, DOI 10.1021/bi0341760; Luginbuhl P, 1996, J BIOMOL NMR, V8, P136; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Tamm LK, 2003, BBA-BIOMEMBRANES, V1614, P14, DOI 10.1016/S0005-2736(03)00159-7; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Tamm LK, 2007, BBA-BIOMEMBRANES, V1768, P3052, DOI 10.1016/j.bbamem.2007.09.010; Tong SG, 1996, BIOCHEMISTRY-US, V35, P4956, DOI 10.1021/bi9526903; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]	30	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37467	37475		10.1074/jbc.M110.153700	http://dx.doi.org/10.1074/jbc.M110.153700			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20826788	Green Published, hybrid			2022-12-27	WOS:000284424000039
J	Adapala, NS; Barbe, MF; Langdon, WY; Nakamura, MC; Tsygankov, AY; Sanjay, A				Adapala, Naga Suresh; Barbe, Mary F.; Langdon, Wallace Y.; Nakamura, Mary C.; Tsygankov, Alexander Y.; Sanjay, Archana			The Loss of Cbl-Phosphatidylinositol 3-Kinase Interaction Perturbs RANKL-mediated Signaling, Inhibiting Bone Resorption and Promoting Osteoclast Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC KINASE-ACTIVITY; NF-KAPPA-B; C-CBL; TYROSINE PHOSPHORYLATION; ENERGY-EXPENDITURE; RESORBING ACTIVITY; FAMILY PROTEINS; BINDING-SITE; DC-STAMP; RECEPTOR	Cbl is an adaptor protein and an E3 ligase that plays both positive and negative roles in several signaling pathways that affect various cellular functions. Tyrosine 737 is unique to Cbl and is phosphorylated by Syk and Src family kinases. Phosphorylated Cbl Tyr(737) creates a binding site for the p85 regulatory subunit of PI3K, which also plays an important role in the regulation of bone resorption by osteoclasts. To investigate the role of Cbl-PI3K interaction in bone homeostasis, we examined the knock-in mice (Cbl(YF/YF)) in which the PI3K binding site in Cbl is ablated due to the mutation in the regulatory tyrosine. We report that in CblYF/YF mice, despite increased numbers of osteoclasts, bone volume is increased due to defective osteoclast function. Additionally, in ex vivo cultures, mature CblYF/YF osteoclasts showed an increased ability to survive in the presence of RANKL due to delayed onset of apoptosis. RANKL-mediated signaling is perturbed in CblYF/YF osteoclasts, and most interestingly, AKT phosphorylation is up-regulated, suggesting that the lack of PI3K sequestration by Cbl results in increased survival and decreased bone resorption. Cumulatively, these in vivo and in vitro results show that, on one hand, binding of Cbl to PI3K negatively regulates osteoclast differentiation, survival, and signaling events (e.g. AKT phosphorylation), whereas on the other hand it positively influences osteoclast function.	[Adapala, Naga Suresh; Barbe, Mary F.; Sanjay, Archana] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Barbe, Mary F.] Temple Univ, Sch Med, Dept Phys Therapy, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.; Sanjay, Archana] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia; [Nakamura, Mary C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; [Nakamura, Mary C.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Western Australia; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sanjay, A (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA.	asanjay@temple.edu	Nakamura, Mary/ABI-2887-2020; Tsygankov, Alexander Y/K-6205-2017	Nakamura, Mary/0000-0001-8127-9426; 	National Institutes of Health [AR055601]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR055601 (to A.S.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Andoniou CE, 1996, ONCOGENE, V12, P1981; Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baron R.A., 1983, BONE HISTOMORPHOMETR, P13; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chiusaroli R, 2003, DEV BIOL, V261, P537, DOI 10.1016/S0012-1606(03)00299-9; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; Feshchenko EA, 1999, ONCOGENE, V18, P3703, DOI 10.1038/sj.onc.1202672; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lakkakorpi PT, 1997, EXP CELL RES, V237, P296, DOI 10.1006/excr.1997.3797; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; Marengere LEM, 1997, J IMMUNOL, V159, P70; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Molero JC, 2006, DIABETES, V55, P3411, DOI 10.2337/db06-0955; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; Nakajima A, 2009, J BONE MINER RES, V24, P1162, DOI [10.1359/JBMR.090205, 10.1359/jbmr.090205]; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patra AK, 2004, J IMMUNOL, V172, P4812, DOI 10.4049/jimmunol.172.8.4812; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sanjay A., 2001, SCI STKE; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Thien CBF, 2010, J BIOL CHEM, V285, P10969, DOI 10.1074/jbc.M109.094920; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Ueno H, 1998, BLOOD, V91, P46, DOI 10.1182/blood.V91.1.46.46_46_53; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xue LZ, 2007, BIOCHEM PHARMACOL, V73, P843, DOI 10.1016/j.bcp.2006.11.021; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8	64	31	31	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36745	36758		10.1074/jbc.M110.124628	http://dx.doi.org/10.1074/jbc.M110.124628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851882	Green Published, hybrid			2022-12-27	WOS:000284146100086
J	Uejima, T; Ihara, K; Goh, T; Ito, E; Sunada, M; Ueda, T; Nakano, A; Wakatsuki, S				Uejima, Tamami; Ihara, Kentaro; Goh, Tatsuaki; Ito, Emi; Sunada, Mariko; Ueda, Takashi; Nakano, Akihiko; Wakatsuki, Soichi			GDP-bound and Nucleotide-free Intermediates of the Guanine Nucleotide Exchange in the Rab5.Vps9 System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; RAB GTPASE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; ACTIVATION; PROGRAM; COMPLEX; SNAPSHOTS; MECHANISM; PHOSPHATE	Many GTPases regulate intracellular transport and signaling in eukaryotes. Guanine nucleotide exchange factors (GEFs) activate GTPases by catalyzing the exchange of their GDP for GTP. Here we present crystallographic and biochemical studies of a GEF reaction with four crystal structures of Arabidopsis thaliana ARA7, a plant homolog of Rab5 GTPase, in complex with its GEF, VPS9a, in the nucleotide-free and GDP-bound forms, as well as a complex with aminophosphonic acid-guanylate ester and ARA7.VPS9a(D185N) with GDP. Upon complex formation with ARA7, VPS9 wedges into the interswitch region of ARA7, inhibiting the coordination of Mg2+ and decreasing the stability of GDP binding. The aspartate finger of VPS9a recognizes GDP beta-phosphate directly and pulls the P-loop lysine of ARA7 away from GDP beta-phosphate toward switch II to further destabilize GDP for its release during the transition from the GDP-bound to nucleotide-free intermediates in the nucleotide exchange reaction.	[Wakatsuki, Soichi] High Energy Accelerator Res Org, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan; [Goh, Tatsuaki; Ito, Emi; Sunada, Mariko; Ueda, Takashi; Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Lab Dev Cell Biol, Tokyo 1130033, Japan; [Nakano, Akihiko] RIKEN Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan	High Energy Accelerator Research Organization (KEK); University of Tokyo; RIKEN		tamami.uejima@kek.jp; kentaro.ihara@kek.jp; soichi.wakatsuki@kek.jp	UEDA, TAKASHI/G-4939-2014; Ueda, Takashi/G-6984-2011; Nakano, Akihiko/G-4942-2014; Goh, Tatsuaki/H-4538-2011; Uejima, Tamami/C-4128-2017; Nakano, Akihiko/A-6420-2016	Ueda, Takashi/0000-0002-5190-892X; Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Wakatsuki, Soichi/0000-0001-5896-7968	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Protein 3000 Project grant and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Goh T, 2007, PLANT CELL, V19, P3504, DOI 10.1105/tpc.107.053876; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Resat H, 2001, P NATL ACAD SCI USA, V98, P6033, DOI 10.1073/pnas.091506998; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Thomas C, 2009, BIOL CHEM, V390, P427, DOI 10.1515/BC.2009.049; Ueda T, 2002, CURR OPIN PLANT BIOL, V5, P513, DOI 10.1016/S1369-5266(02)00299-6; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200	43	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36689	36697		10.1074/jbc.M110.152132	http://dx.doi.org/10.1074/jbc.M110.152132			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833725	Green Published, hybrid			2022-12-27	WOS:000284146100070
J	Hou, YZ; Mortimer, L; Chadee, K				Hou, Yongzhong; Mortimer, Leanne; Chadee, Kris			Entamoeba histolytica Cysteine Proteinase 5 Binds Integrin on Colonic Cells and Stimulates NF kappa B-mediated Pro-inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED KINASE; ANTISENSE INHIBITION; IN-VITRO; EXPRESSION; BETA; COMPLEX; ALPHA; AKT; PHOSPHORYLATION; INTERNALIZATION	Integrins are important mammalian receptors involved in normal cellular functions and the pathogenesis of inflammation and disease. Entamoeba histolytica is a protozoan parasite that colonizes the gut, and in 10% of infected individuals, causes amebic colitis and liver abscess resulting in 10(5) deaths/year. E. histolytica-induced host inflammatory responses are critical in the pathogenesis of the disease, yet the host and parasite factors involved in disease are poorly defined. Here we show that pro-mature cysteine proteinase 5 (PCP5), a major virulent factor that is abundantly secreted and/or present on the surface of ameba, binds via its RGD motif to alpha(V)beta(3) integrin on Caco-2 colonic cells and stimulates NF kappa B-mediated pro-inflammatory responses. PCP5 RGD binding to alpha(V)beta(3) integrin triggered integrin-linked kinase(ILK)-mediated phosphorylation of Akt473 that bound and induced the ubiquitination of NF-kappa B essential modulator (NEMO). As NEMO is required for activation of the IKK alpha-IKK beta complex and NF kappa B signaling, these events markedly up-regulated pro-inflammatory mediator expressions in vitro in Caco-2 cells and in vivo in colonic loop studies in wild-type and Muc2(-/-) mice lacking an intact protective mucus barrier. These results have revealed that EhPCP5 RGD motif is a ligand for alpha(V)beta(3) integrin-mediated adhesion on colonic cells and represents a novel mechanism that E. histolytica trophozoites use to trigger an inflammatory response in the pathogenesis of intestinal amebiasis.	[Chadee, Kris] Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chadee, K (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	kchadee@ucalgary.ca	hou, YONGZHONG/K-7771-2013; hou, yongzhong/E-4658-2011	Hou, Yongzhong/0000-0003-2019-8686	Canadian Institute of Health Research (CIHR); Canadian Association of Gastroenterology-Astra Zeneca-CIHR	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology-Astra Zeneca-CIHR(Canadian Institutes of Health Research (CIHR)AstraZeneca)	This work was supported by a grant from the Canadian Institute of Health Research (CIHR) (to K. C.) and a Canadian Association of Gastroenterology-Astra Zeneca-CIHR Research and Fellowship Award (to Y. H.).	Ankri S, 1998, MOL MICROBIOL, V28, P777, DOI 10.1046/j.1365-2958.1998.00837.x; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Ben-Neriah Y, 2007, NAT IMMUNOL, V8, P479, DOI 10.1038/ni0507-479; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Croyle MA, 1998, HUM GENE THER, V9, P561, DOI 10.1089/hum.1998.9.4-561; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hellberg A, 2001, CELL MICROBIOL, V3, P13, DOI 10.1046/j.1462-5822.2001.00086.x; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; Kammanadiminti SJ, 2007, INFECT IMMUN, V75, P1765, DOI 10.1128/IAI.01442-06; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Lejeune M, 2009, FUTURE MICROBIOL, V4, P105, DOI 10.2217/17460913.4.1.105; Li QT, 2000, GENE DEV, V14, P1729; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Moncada DM, 2006, GASTROENTEROLOGY, V130, P721, DOI 10.1053/j.gastro.2005.11.012; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Nowak N, 2004, J BIOL CHEM, V279, P38260, DOI 10.1074/jbc.M405308200; Papaconstantinou ME, 2005, J BIOL CHEM, V280, P29393, DOI 10.1074/jbc.C500248200; QWARNSTROM EE, 1994, J BIOL CHEM, V269, P30765; REED SL, 1995, J IMMUNOL, V155, P266; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Scatena MT, 2002, TRENDS CARDIOVAS MED, V12, P83, DOI 10.1016/S1050-1738(01)00151-7; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Stockbauer KE, 1998, P NATL ACAD SCI USA, V95, P3128, DOI 10.1073/pnas.95.6.3128; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Tran VQ, 1998, J INFECT DIS, V177, P508, DOI 10.1086/517388; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Verreault M, 2009, OLIGONUCLEOTIDES, V19, P129, DOI 10.1089/oli.2008.0157; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; World Health Organization W, 1998, QUAL CONTR METH MED; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	43	66	66	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35497	35504		10.1074/jbc.M109.066035	http://dx.doi.org/10.1074/jbc.M109.066035			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837477	Green Published, hybrid			2022-12-27	WOS:000283845300028
J	Kozlov, G; Bastos-Aristizabal, S; Maattanen, P; Rosenauer, A; Zheng, FL; Killikelly, A; Trempe, JF; Thomas, DY; Gehring, K				Kozlov, Guennadi; Bastos-Aristizabal, Sara; Maeaettaenen, Pekka; Rosenauer, Angelika; Zheng, Fenglin; Killikelly, April; Trempe, Jean-Francois; Thomas, David Y.; Gehring, Kalle			Structural Basis of Cyclophilin B Binding by the Calnexin/Calreticulin P-domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; RIBONUCLEASE B; CALRETICULIN; CALNEXIN; PROTEIN; ERP57; ER; REFINEMENT	Little is known about how chaperones in the endoplasmic reticulum are organized into complexes to assist in the proper folding of secreted proteins. One notable exception is the complex of ERp57 and calnexin that functions as part the calnexin cycle to direct disulfide bond formation in N-glycoproteins. Here, we report three new complexes composed of the peptidyl prolyl cis-trans-isomerase cyclophilin B and any of the lectin chaperones: calnexin, calreticulin, or calmegin. The 1.7 angstrom crystal structure of cyclophilin with the proline-rich P-domain of calmegin reveals that binding is mediated by the same surface that binds ERp57. We used NMR titrations and mutagenesis to measure low micromolar binding of cyclophilin to all three lectin chaperones and identify essential interfacial residues. The immunosuppressant cyclosporin A did not affect complex formation, confirming the functional independence of the P-domain binding and proline isomerization sites of cyclophilin. Our results reveal the P-domain functions as a unique protein-protein interaction domain and implicate a peptidyl prolyl isomerase as a new element in the calnexin cycle.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Gehring, K (corresponding author), 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019; Thomas, David/M-7661-2017	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Thomas, David/0000-0002-8854-762X	Canadian Institutes of Heath Research [81277, 74567]; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Grants 81277 and 74567 from the Canadian Institutes of Heath Research (to D. Y. T. and K. G.).; Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the CHESS was supported by the National Science Foundation Award DMR 0225180 and the National Institutes of Health Award RR-01646. We thank Ali Fazel for liver microsomes and Daniel Tessier for anti-calreticulin serum.	ARBER S, 1992, J CELL BIOL, V116, P113, DOI 10.1083/jcb.116.1.113; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Braakman I, 2008, SCIENCE, V321, P499, DOI 10.1126/science.1162125; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; DeLano W.L, PYMOL MOL GRAPHICS S; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Hanoulle X, 2007, J BIOL CHEM, V282, P34148, DOI 10.1074/jbc.M706353200; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; HASEL KW, 1991, MOL CELL BIOL, V11, P3484, DOI 10.1128/MCB.11.7.3484; ISHIKAWA Y, 2009, J BIOL CHEM, V6, P6; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Lavoie C, 1996, J CELL SCI, V109, P1415; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; LODISH HF, 1991, J BIOL CHEM, V266, P14835; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang LY, 2003, J BIOL CHEM, V278, P29344, DOI 10.1074/jbc.M300455200; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	35	72	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35551	35557		10.1074/jbc.M110.160101	http://dx.doi.org/10.1074/jbc.M110.160101			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20801878	Green Published, hybrid			2022-12-27	WOS:000283845300033
J	Fischer, MJM; Leffler, A; Niedermirtl, F; Kistner, K; Eberhardt, M; Reeh, PW; Nau, C				Fischer, Michael J. M.; Leffler, Andreas; Niedermirtl, Florian; Kistner, Katrin; Eberhardt, Mirjam; Reeh, Peter W.; Nau, Carla			The General Anesthetic Propofol Excites Nociceptors by Activating TRPV1 and TRPA1 Rather than GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-ROOT-GANGLIA; PRIMARY AFFERENT NEURONS; SUBUNIT MESSENGER-RNAS; ION-CHANNEL TRPA1; SPINAL-CORD; CAPSAICIN RECEPTOR; SENSORY NEURONS; SUBSTANCE-P; IN-VITRO; MOLECULAR DETERMINANT	Anesthetic agents can induce a paradox activation and sensitization of nociceptive sensory neurons and, thus, potentially facilitate pain processing. Here we identify distinct molecular mechanisms that mediate an activation of sensory neurons by 2,6-diisopropylphenol (propofol), a commonly used intravenous anesthetic known to elicit intense pain upon injection. Clinically relevant concentrations of propofol activated the recombinant transient receptor potential (TRP) receptors TRPA1 and TRPV1 heterologously expressed in HEK293t cells. In dorsal root ganglion (DRG) neurons, propofol-induced activation correlated better to expression of TRPA1 than of TRPV1. However, pretreatment with the protein kinase C activator 4 beta-phorbol 12-myristate 13-acetate (PMA) resulted in a significantly sensitized propofol-induced activation of TRPV1 in DRG neurons as well as in HEK293t cells. Pharmacological and genetic silencing of both TRPA1 and TRPV1 only partially abrogated propofol-induced responses in DRG neurons. The remaining propofol-induced activation was abolished by the selective gamma-aminobutyric acid, type A (GABA(A)) receptor antagonist picrotoxin. Propofol but not GABA evokes a release of calcitonin gene-related peptide, a key component of neurogenic inflammation, from isolated peripheral nerves of wild-type but not TRPV1 and TRPA1-deficient mice. Moreover, propofol but not GABA induced an intense pain upon intracutaneous injection. As both the release of calcitonin gene-related peptide and injection pain by propofol seem to be independent of GABA(A) receptors, our data identify TRPV1 and TRPA1 as key molecules for propofol-induced excitation of sensory neurons. This study warrants further investigations into the role of anesthetics to induce nociceptor sensitization and to foster postoperative pain.	[Leffler, Andreas; Niedermirtl, Florian; Nau, Carla] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Fischer, Michael J. M.; Kistner, Katrin; Eberhardt, Mirjam; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Fischer, Michael J. M.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Cambridge	Leffler, A (corresponding author), Univ Erlangen Nurnberg, Dept Anesthesiol, Krankenhausstr 12, D-91054 Erlangen, Germany.	andreas.leffler@kfa.imed.uni-erlangen.de	Leffler, Andreas/K-1191-2012; Reeh, Peter W./J-8981-2012; Fischer, Michael J.M./P-8715-2014	Leffler, Andreas/0000-0003-1121-6387; Reeh, Peter W./0000-0002-4367-094X; Fischer, Michael J.M./0000-0002-3811-7066	Deutsche Forschungsgemeinschaft [NA-350/3-3, LU 728/3-1, KFO 130]; Dr. Robert Pfleger-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Robert Pfleger-Stiftung	This work was supported by Deutsche Forschungsgemeinschaft Grants NA-350/3-3 and LU 728/3-1, KFO 130 (to A. L., C. N., and P. W. R.) and by the Dr. Robert Pfleger-Stiftung (to K. K.).	Aptel H, 2007, MOL CELL NEUROSCI, V36, P293, DOI 10.1016/j.mcn.2007.07.009; AULT B, 1994, NEUROPHARMACOLOGY, V33, P109, DOI 10.1016/0028-3908(94)90104-X; Averbeck B, 2001, NEUROPHARMACOLOGY, V40, P416, DOI 10.1016/S0028-3908(00)00171-4; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BARKER JL, 1975, J PHYSIOL-LONDON, V245, P521, DOI 10.1113/jphysiol.1975.sp010859; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Carlton SM, 1999, NEUROSCIENCE, V93, P713, DOI 10.1016/S0306-4522(99)00101-3; Carr RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008780; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; COLLINS GGS, 1988, BRIT J PHARMACOL, V95, P939, DOI 10.1111/j.1476-5381.1988.tb11724.x; CONCAS A, 1991, BRAIN RES, V542, P225, DOI 10.1016/0006-8993(91)91571-H; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DESARMENIEN M, 1984, EXP BRAIN RES, V54, P521; DESCHENES M, 1976, BRAIN RES, V118, P486, DOI 10.1016/0006-8993(76)90318-8; Dittert I, 1998, J NEUROSCI METH, V82, P195, DOI 10.1016/S0165-0270(98)00051-X; Doenicke AW, 1996, ANESTH ANALG, V82, P472, DOI 10.1097/00000539-199603000-00007; Fischer MJM, 2007, EUR J NEUROSCI, V25, P3570, DOI 10.1111/j.1460-9568.2007.05582.x; FURUYAMA T, 1992, MOL BRAIN RES, V12, P335, DOI 10.1016/0169-328X(92)90136-Y; GALLAGHER JP, 1978, J PHYSIOL-LONDON, V275, P263, DOI 10.1113/jphysiol.1978.sp012189; GO VLW, 1987, J PHYSIOL-LONDON, V391, P141, DOI 10.1113/jphysiol.1987.sp016731; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KLEMENT W, 1991, BRIT J ANAESTH, V67, P281, DOI 10.1093/bja/67.3.281; Koplas PA, 1997, J NEUROSCI, V17, P3525; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lao L, 2005, NEUROSCIENCE, V130, P1013, DOI 10.1016/j.neuroscience.2004.10.019; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MALCANGIO M, 1993, J PHARMACOL EXP THER, V266, P1490; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; PERSOHN E, 1991, NEUROSCIENCE, V42, P497, DOI 10.1016/0306-4522(91)90392-2; Picard P, 2000, ANESTH ANALG, V90, P963; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Poenie M, 1986, Prog Clin Biol Res, V210, P53; Riley RC, 2001, NEUROSCIENCE, V103, P725, DOI 10.1016/S0306-4522(00)00571-6; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; SANTICIOLI P, 1991, LIFE SCI, V48, pPL69, DOI 10.1016/0024-3205(91)90188-H; Sauer SK, 2001, EUR J NEUROSCI, V14, P1203, DOI 10.1046/j.0953-816x.2001.01741.x; STOKES DN, 1989, BRIT J ANAESTH, V62, P202, DOI 10.1093/bja/62.2.202; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sung KW, 2000, J NEUROSCI, V20, P7531; Tsutsumi S, 2001, NEUROSCI LETT, V312, P45, DOI 10.1016/S0304-3940(01)02185-1; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Watt EE, 2008, EUR J PHARMACOL, V590, P120, DOI 10.1016/j.ejphar.2008.06.003; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Yamakage M, 2005, ANESTH ANALG, V101, P385, DOI 10.1213/01.ANE.0000154191.86608.AC; Zhang XB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003386; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	62	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34781	34792		10.1074/jbc.M110.143958	http://dx.doi.org/10.1074/jbc.M110.143958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826794	Green Published, hybrid			2022-12-27	WOS:000283659100054
J	Kasahara, M; Torii, M; Fujita, A; Tainaka, K				Kasahara, Masahiro; Torii, Mayumi; Fujita, Akimitsu; Tainaka, Kengo			FMN Binding and Photochemical Properties of Plant Putative Photoreceptors Containing Two LOV Domains, LOV/LOV Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT RECEPTORS; CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; ARABIDOPSIS; PHOTOTROPIN; OXYGEN; CLOCK; MECHANISM; KINASE; SWITCH	LOV domains function as blue light-sensing modules in various photoreceptors in plants, fungi, algae, and bacteria. A LOV/LOV protein (LLP) has been found from Arabidopsis thaliana (AtLLP) as a two LOV domain-containing protein. However, its function remains unknown. We isolated cDNA clones coding for an LLP homolog from tomato (Solanum lycopersicum) and two homologs from the moss Physcomitrella patens. The tomato LLP (SlLLP) contains two LOV domains (LOV1 and LOV2 domains), as in AtLLP. Most of the amino acids required for association with chromophore are conserved in both LOV domains, except that the amino acid at the position equivalent to the cysteine essential for cysteinyl adduct formation is glycine in the LOV1 domain as in AtLLP. When expressed in Escherichia coli, SlLLP binds FMN and undergoes a self-contained photocycle upon irradiation of blue light. Analyses using mutant SlLLPs revealed that SlLLP binds FMN in both LOV domains, although the LOV1 domain does not show spectral changes on irradiation. However, when Gly(66) in the LOV1 domain, which is located at the position equivalent to the essential cysteine of LOV domains, is replaced by cysteine, the mutated LOV1 domain shows light-induced spectral changes. In addition, all four LOV domains of P. patens LLPs (PpLLP1 and PpLLP2) show the typical features of LOV domains, including the reactive cysteine in each. This study shows that plants have a new LOV domain-containing protein family with the typical biochemical and photochemical properties of other LOV domain-containing proteins such as the phototropins.	[Kasahara, Masahiro; Torii, Mayumi; Fujita, Akimitsu; Tainaka, Kengo] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Shiga 5258577, Japan	Ritsumeikan University	Kasahara, M (corresponding author), 1-1-1 Nojihigashi, Shiga 5258577, Japan.	kasa@sk.ritsumei.ac.jp			Ministry of Education, Sciences and Culture	Ministry of Education, Sciences and Culture	This work was supported in part by the Ministry of Education, Sciences and Culture with a Grant-in-Aid for Young Scientists (B) (to M. K.).	Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Briggs WR, 2007, J BIOMED SCI, V14, P499, DOI 10.1007/s11373-007-9162-6; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kottke T, 2006, BIOPOLYMERS, V82, P373, DOI 10.1002/bip.20510; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Narikawa R, 2006, PHOTOCHEM PHOTOBIOL, V82, P1627, DOI 10.1562/2006-05-02-RA-888; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Ogura Y, 2008, J PLANT RES, V121, P97, DOI 10.1007/s10265-007-0118-8; Ogura Y, 2008, PLANT SIGNAL BEHAV, V3, P966, DOI 10.4161/psb.6150; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tokutomi S, 2008, BBA-PROTEINS PROTEOM, V1784, P133, DOI 10.1016/j.bbapap.2007.09.010	28	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34765	34772		10.1074/jbc.M110.145367	http://dx.doi.org/10.1074/jbc.M110.145367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826774	hybrid, Green Published			2022-12-27	WOS:000283659100052
J	Tsuchiya, Y; Hatakeyama, H; Emoto, N; Wagatsuma, F; Matsushita, S; Kanzaki, M				Tsuchiya, Yo; Hatakeyama, Hiroyasu; Emoto, Natsumi; Wagatsuma, Fumie; Matsushita, Shinichi; Kanzaki, Makoto			Palmitate-induced Down-regulation of Sortilin and Impaired GLUT4 Trafficking in C2C12 Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; PROTEIN-KINASE-C; ALPHA-CONVERTING-ENZYME; KAPPA-B ACTIVATION; FREE FATTY-ACIDS; TNF-ALPHA; PKC-THETA; GLUT4-CONTAINING VESICLES; 3T3-L1 ADIPOCYTES	Elevated saturated FFAs including palmitate (C16:0) are a primary trigger for peripheral insulin resistance characterized by impaired glucose uptake/disposal in skeletal muscle, resulting from impaired GLUT4 translocation in response to insulin. We herein demonstrate that palmitate induces down-regulation of sortilin, a sorting receptor implicated in the formation of insulin-responsive GLUT4 vesicles, via mechanisms involving PKC theta and TNF-alpha-converting enzyme, but not p38, JNK, or mitochondrial reactive oxygen species generation, leading to impaired GLUT4 trafficking in C2C12 myotubes. Intriguingly, unsaturated FFAs such as palmitoleate (C16:1) and oleate (C18:1) had no such detrimental effects, appearing instead to effectively reverse palmitate-induced impairment of insulin-responsive GLUT4 recycling along with restoration of sortilin abundance by preventing aberrant PKC theta activation. On the other hand, shRNA-mediated reduction of sortilin in intact C2C12 myotubes inhibited insulin-induced GLUT4 recycling without dampening Akt phosphorylation. We found that the peroxisome proliferator-activated receptor gamma agonist troglitazone prevented the palmitate-induced sortilin reduction and also ameliorated insulin-responsive GLUT4 recycling without altering the palmitate-evoked insults on signaling cascades; neither highly phosphorylated PKC theta states nor impaired insulin-responsive Akt phosphorylation was affected. Taken together, our data provide novel insights into the pathogenesis of PKC theta-dependent insulin resistance with respect to insulin-responsive GLUT4 translocation, which could occur not only through defects of insulin signaling but also via a reduction of sortilin, which directly controls trafficking/sorting of GLUT4 in skeletal muscle cells. In addition, our data suggest the insulin-sensitizing action of peroxisome proliferator-activated receptor gamma agonists to be at least partially mediated through the restoration of proper GLUT4 trafficking/sorting events governed by sortilin.	[Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kanzaki, Makoto] Japan Sci & Technol Agcy, Tokyo 1020075, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Kanzaki, M (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kanzaki@bme.tohoku.ac.jp	Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955	Ministry of Education, Science, Sports and Culture of Japan; New Energy and Industrial Technology Development Organization; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan and the New Energy and Industrial Technology Development Organization.; Supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Felber JP, 2002, INT J OBESITY, V26, pS39, DOI 10.1038/sj.ijo.0802126; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Griffin ME, 1999, DIABETES, V48, pA276; Haasch D, 2006, BIOCHEM BIOPH RES CO, V343, P361, DOI 10.1016/j.bbrc.2006.02.177; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; Ishaq M, 2003, J BIOL CHEM, V278, P39296, DOI 10.1074/jbc.M302767200; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kaddai V, 2009, DIABETOLOGIA, V52, P932, DOI 10.1007/s00125-009-1273-3; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Karlsson HKR, 2005, DIABETES, V54, P1459, DOI 10.2337/diabetes.54.5.1459; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim YB, 2002, DIABETES, V51, P443, DOI 10.2337/diabetes.51.2.443; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Lambe KG, 1996, EUR J BIOCHEM, V239, P1, DOI 10.1111/j.1432-1033.1996.0001u.x; Lessard SJ, 2007, DIABETES, V56, P1856, DOI 10.2337/db06-1065; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Meyer MM, 2002, DIABETES, V51, P2691, DOI 10.2337/diabetes.51.9.2691; Miyazaki Y, 2003, DIABETES, V52, P1943, DOI 10.2337/diabetes.52.8.1943; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Navarro V, 2002, BIOCHEM BIOPH RES CO, V298, P760, DOI 10.1016/S0006-291X(02)02564-0; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Peterson JM, 2008, AM J PHYSIOL-ENDOC M, V295, pE1307, DOI 10.1152/ajpendo.00738.2007; Pimenta AS, 2008, J CELL PHYSIOL, V217, P478, DOI 10.1002/jcp.21520; Preininger K, 1999, BRIT J PHARMACOL, V126, P372, DOI 10.1038/sj.bjp.0702318; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SHIBUKAWA A, 1995, J CHROMATOGR A, V697, P337, DOI 10.1016/0021-9673(94)00929-4; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Sugii S, 2006, J BIOL CHEM, V281, P23191, DOI 10.1074/jbc.M603215200; Tolosa L, 2005, CELL SIGNAL, V17, P1333, DOI 10.1016/j.cellsig.2005.02.001; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	66	54	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34371	34381		10.1074/jbc.M110.128520	http://dx.doi.org/10.1074/jbc.M110.128520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805226	Green Published, hybrid			2022-12-27	WOS:000283659100011
J	Zannetti, C; Bonnay, F; Takeshita, F; Parroche, P; Menetrier-Caux, C; Tommasino, M; Hasan, UA				Zannetti, Claudia; Bonnay, Francois; Takeshita, Fumihiko; Parroche, Peggy; Menetrier-Caux, Christine; Tommasino, Massimo; Hasan, Uzma A.			C/EBP delta and STAT-1 Are Required for TLR8 Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; DENDRITIC CELLS; BINDING PROTEIN; EXPRESSION; GENE; ACTIVATION; RNA; RECOGNITION; MONOCYTES	Toll-like receptor 8 (TLR8), which is expressed primarily in myeloid cells, plays a central role in initiating immune responses to viral single-stranded RNA. Despite the great interest in the field of TLR8 research, very little is known in terms of TLR8 biology and its transcriptional regulation. Here, we describe the isolation of the hTLR8 promoter and the characterization of the molecular mechanisms involved in its regulation. Reporter gene analysis and ChIP assays demonstrated that the hTLR8 regulation of the basal transcription is regulated via three C/EBP cis-acting elements that required C/EBP delta and C/EBP beta activity. In addition, we observed that R848 stimulation increases TLR8 transcriptional activity via an enhanced binding of C/EBP delta, and not C/EBP beta, to its responsive sites within the TLR8 promoter. Moreover, we showed that IFN-gamma also increased TLR8 transcription activity via the binding of STAT1 transcription factor to IFN-gamma activated sequence elements on the TLR8 promoter and enhanced TLR8 functionality. These results shed new light on the mechanisms involved during TLR8-mediated innate immune response.	[Zannetti, Claudia; Parroche, Peggy; Tommasino, Massimo; Hasan, Uzma A.] Int Agcy Res Canc, Infect & Canc Biol Grp, F-69008 Lyon, France; [Zannetti, Claudia; Parroche, Peggy; Hasan, Uzma A.] Univ Lyon 1, Fac Med, INSERM, U851, F-69310 Pierre Benite, France; [Bonnay, Francois] CNRS, Inst Mol & Cellular Biol, UPR 9022, F-67084 Strasbourg, France; [Takeshita, Fumihiko] Yokohama City Univ, Grad Sch Med, Dept Mol Biodefense Res, Yokohama, Kanagawa 2360004, Japan; [Menetrier-Caux, Christine] INSERM, Ctr Leon Berard, U590, F-69008 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yokohama City University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Zannetti, C (corresponding author), Int Agcy Res Canc, Infect & Canc Biol Grp, F-69008 Lyon, France.	claudia.zannetti@inserm.fr	hasan, uzma A/G-3247-2013	Bonnay, Francois/0000-0002-3860-645X; Menetrier-Caux, christine/0000-0003-4863-374X; Hasan, Uzma/0000-0002-1770-5539				Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Berger M, 2009, J IMMUNOTHER, V32, P262, DOI 10.1097/CJI.0b013e318198bd2a; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Clarke S, 1998, J LEUKOCYTE BIOL, V63, P153, DOI 10.1002/jlb.63.2.153; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Diebold SS, 2008, ADV DRUG DELIVER REV, V60, P813, DOI 10.1016/j.addr.2007.11.004; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; MANIATIS T, 2000, MOL CLONING LAB MANU; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Menetrier-Caux C, 2001, CANCER RES, V61, P3096; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Oh DY, 2008, J INFECT DIS, V198, P701, DOI 10.1086/590431; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Sacre SM, 2008, J IMMUNOL, V181, P8002, DOI 10.4049/jimmunol.181.11.8002; Severa M, 2007, J IMMUNOL, V178, P6208, DOI 10.4049/jimmunol.178.10.6208; Stevenson BJ, 2003, J INFECT DIS, V187, pS308, DOI 10.1086/374755; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Triantafilou K, 2005, EUR J IMMUNOL, V35, P2416, DOI 10.1002/eji.200526149; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Xu SW, 2006, SURGERY, V140, P170, DOI 10.1016/j.surg.2006.03.006	41	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34773	34780		10.1074/jbc.M110.133884	http://dx.doi.org/10.1074/jbc.M110.133884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20829351	Green Published, hybrid			2022-12-27	WOS:000283659100053
J	Oliva, CR; Nozell, SE; Diers, A; McClugage, SG; Sarkaria, JN; Markert, JM; Darley-Usmar, VM; Bailey, SM; Gillespie, GY; Landar, A; Griguer, CE				Oliva, Claudia R.; Nozell, Susan E.; Diers, Anne; McClugage, Samuel G., III; Sarkaria, Jann N.; Markert, James M.; Darley-Usmar, Victor M.; Bailey, Shannon M.; Gillespie, G. Yancey; Landar, Aimee; Griguer, Corinne E.			Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; DNA MUTATIONS; GLIOBLASTOMA-MULTIFORME; CELLULAR BIOENERGETICS; SUPEROXIDE-DISMUTASE; BREAST-CANCER; IN-VIVO; CELLS; APOPTOSIS; DAMAGE	Temozolomide (TMZ) is an oral alkylating agent used for the treatment of high-grade gliomas. Acquired chemoresistance is a severe limitation to this therapy with more than 90% of recurrent gliomas showing no response to a second cycle of chemotherapy. Efforts to better understand the underlying mechanisms of acquired chemoresistance to TMZ and potential strategies to overcome chemoresistance are, therefore, critically needed. TMZ methylates nuclear DNA and induces cell death; however, the impact on mitochondria DNA (mtDNA) and mitochondrial bioenergetics is not known. Herein, we tested the hypothesis that TMZ-mediated alterations in mtDNA and respiratory function contribute to TMZ-dependent acquired chemoresistance. Using an in vitro model of TMZ-mediated acquired chemoresistance, we report 1) a decrease in mtDNA copy number and the presence of large heteroplasmic mtDNA deletions in TMZ-resistant glioma cells, 2) remodeling of the entire electron transport chain with significant decreases of complexes I and V and increases of complexes II/III and IV, and 3) pharmacologic and genetic manipulation of cytochrome c oxidase, which restores sensitivity to TMZ-dependent apoptosis in resistant glioma cells. Importantly, human primary and recurrent pairs of glioblastoma multiforme (GBM) biopsies as well as primary and TMZ-resistant GBM xenograft lines exhibit similar remodeling of the ETC. Overall these results suggest that TMZ-dependent acquired chemoresistance may be due to a mitochondrial adaptive response to TMZ genotoxic stress with a major contribution from cytochrome c oxidase. Thus, abrogation of this adaptive response may reverse chemoresistance and restore sensitivity to TMZ, providing a strategy for improved therapeutic outcomes in GBM patients.	[Oliva, Claudia R.; McClugage, Samuel G., III; Markert, James M.; Gillespie, G. Yancey; Griguer, Corinne E.] Univ Alabama Birmingham, Div Neurosurg, Dept Surg, Birmingham, AL 35294 USA; [Diers, Anne; Darley-Usmar, Victor M.; Bailey, Shannon M.; Landar, Aimee; Griguer, Corinne E.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Bailey, Shannon M.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Diers, Anne; Darley-Usmar, Victor M.; Landar, Aimee] Univ Alabama Birmingham, Dept Pathol, Div Cellular & Mol Pathol, Birmingham, AL 35294 USA; [Nozell, Susan E.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Mayo Clinic	Griguer, CE (corresponding author), Univ Alabama Birmingham, Div Neurosurg, Dept Surg, 1900 Univ Blvd,Rm 1032 THT, Birmingham, AL 35294 USA.	cgriguer@uab.edu	Landar, Aimee/F-7269-2010	Landar, Aimee/0000-0003-2306-9214; Gillespie, George/0000-0001-6436-9542; Oliva, Claudia/0000-0003-0624-5490; , Corinne/0000-0003-3877-5031; Darley-Usmar, Victor/0000-0001-8921-7086; Bailey, Shannon/0000-0003-0002-3424	National Institutes of Health (NCI, USPHS) [P30 CA13148-35]; NCI [P50 CA097247, P50 CA108961, RO1 CA127716, R21 CA139290]; NATIONAL CANCER INSTITUTE [R01CA160821, R21CA139290, P30CA013148, R01CA127716, P50CA108961, P50CA097247] Funding Source: NIH RePORTER	National Institutes of Health (NCI, USPHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 CA13148-35 (NCI, to the University of Alabama Comprehensive Cancer Center Collaborative Programmatic Development Grant Program from the USPHS) and P50 CA097247, P50 CA108961, RO1 CA127716, and R21 CA139290 (NCI).	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Arnold S, 1999, FEBS LETT, V443, P105, DOI 10.1016/S0014-5793(98)01694-9; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Campian JL, 2004, J BIOL CHEM, V279, P46580, DOI 10.1074/jbc.M406685200; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P212, DOI 10.1016/j.ijrobp.2009.04.026; Chiaratti MR, 2006, GENET MOL RES, V5, P55; CRADDOCK VM, 1965, BIOCHEM J, V94, P323, DOI 10.1042/bj0940323; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Dumitru CA, 2009, J CELL PHYSIOL, V221, P688, DOI 10.1002/jcp.21907; Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088; Fern R, 2003, J NEUROSCI RES, V71, P759, DOI 10.1002/jnr.10553; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Griguer CE, 2007, J NEURO-ONCOL, V81, P9, DOI 10.1007/s11060-006-9201-6; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; HIGUCHI Y, 1995, J BIOL CHEM, V270, P7950, DOI 10.1074/jbc.270.14.7950; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Hirose Y, 2001, CANCER RES, V61, P1957; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; JONES DP, 1979, BIOCHIM BIOPHYS ACTA, V576, P17, DOI 10.1016/0005-2795(79)90480-X; KENNEDY FG, 1986, AM J PHYSIOL, V250, pC374, DOI 10.1152/ajpcell.1986.250.3.C374; KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; LeDoux SP, 1998, GLIA, V24, P304, DOI 10.1002/(SICI)1098-1136(199811)24:3<304::AID-GLIA4>3.3.CO;2-J; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Lee W, 2008, EXP MOL MED, V40, P109, DOI 10.3858/emm.2008.40.1.109; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Middlemas DS, 2000, CLIN CANCER RES, V6, P998; Minniti G, 2009, ANTICANCER RES, V29, P5171; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; OBERLEY LW, 1979, CANCER RES, V39, P1141; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Plummer ER, 2005, CLIN CANCER RES, V11, P3402, DOI 10.1158/1078-0432.CCR-04-2353; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Richard SM, 2000, CANCER RES, V60, P4231; ROBERTS JJ, 1963, BIOCHEM PHARMACOL, V12, P1329, DOI 10.1016/0006-2952(63)90202-8; SILBER JR, 1993, CANCER RES, V53, P3416; Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp Roger, 2005, Curr Neurol Neurosci Rep, V5, P198, DOI 10.1007/s11910-005-0047-7; Tentori L, 1997, MOL PHARMACOL, V52, P249, DOI 10.1124/mol.52.2.249; Tseng LM, 2006, GENE CHROMOSOME CANC, V45, P629, DOI 10.1002/gcc.20326; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Watson MB, 2007, ANTI-CANCER DRUG, V18, P749, DOI 10.1097/CAD.0b013e3280a02f43; Wei YH, 1998, P SOC EXP BIOL MED, V217, P53; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037	70	135	136	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39759	39767		10.1074/jbc.M110.147504	http://dx.doi.org/10.1074/jbc.M110.147504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20870728	hybrid, Green Published			2022-12-27	WOS:000285185500020
J	Inanobe, A; Nakagawa, A; Matsuura, T; Kurachi, Y				Inanobe, Atsushi; Nakagawa, Atsushi; Matsuura, Takanori; Kurachi, Yoshihisa			A Structural Determinant for the Control of PIP2 Sensitivity in G Protein-gated Inward Rectifier K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; SODIUM-DEPENDENT ACTIVATION; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; BINDING; DOMAIN; KIR2.1; IDENTIFICATION; MUTATIONS; MECHANISM	Inward rectifier K+ (Kir) channels are activated by phosphatidylinositol-(4,5)-bisphosphate (PIP2), but G protein-gated Kir (K-G) channels further require either G protein beta gamma subunits (G beta gamma) or intracellular Na+ for their activation. To reveal the mechanism(s) underlying this regulation, we compared the crystal structures of the cytoplasmic domain of K-G channel subunit Kir3.2 obtained in the presence and the absence of Na+. The Na+-free Kir3.2, but not the Na+-plus Kir3.2, possessed an ionic bond connecting the N terminus and the CD loop of the C terminus. Functional analyses revealed that the ionic bond between His-69 on the N terminus and Asp-228 on the CD loop, which are known to be critically involved in G beta gamma- and Na+-dependent activation, lowered PIP2 sensitivity. The conservation of these residues within the K-G channel family indicates that the ionic bond is a character that maintains the channels in a closed state by controlling the PIP2 sensitivity.	[Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan; [Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Nakagawa, Atsushi] Osaka Univ, Lab Supramol Crystallog, Suita, Osaka 5650871, Japan; [Matsuura, Takanori] Osaka Univ, Lab Prot Informat, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Inanobe, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Pharmacol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	inanobe@pharma2.med.osaka-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Nakagawa, Atsushi/M-5731-2019; Matsuura, Takanori/J-1413-2012	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Matsuura, Takanori/0000-0003-2001-9537	Ministry of Education, Culture, Sports, Science and Technology of Japan [508 19036011, 516 17079005]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by Grant-in-aid for Scientific Research for Priority Areas and 508 19036011 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. To whom correspondence may be addressed: Dept. of Pharmacology, Graduate School of Medicine, Osaka University, 2-2 Yamada-Oka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-3512; Fax: 81-6-6879-3519; E-mail: inanobe@pharma2.med.osaka-u.ac.jp.; Supported by Grant-in-aid for Scientific Research for Priority Areas 516 17079005 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. To whom correspondence may be addressed: Dept. of Pharmacology, Graduate School of Medicine, Osaka University, 2-2 Yamada-Oka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-3512; Fax: 81-6-6879-3519; E-mail: ykurachi@pharma2.med.osaka-u.ac.jp.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; EISENMAN G, 1962, Biophys J, V2, P259; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 1999, J PHYSIOL-LONDON, V521, P19, DOI 10.1111/j.1469-7793.1999.00019.x; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mao JZ, 2003, J BIOL CHEM, V278, P7091, DOI 10.1074/jbc.M211461200; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rosenhouse-Dantsker A, 2008, NAT CHEM BIOL, V4, P624, DOI 10.1038/nchembio.112; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Yamada M, 1998, PHARMACOL REV, V50, P723; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	40	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38517	38523		10.1074/jbc.M110.161703	http://dx.doi.org/10.1074/jbc.M110.161703			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880843	Green Published, hybrid			2022-12-27	WOS:000284625600057
J	Kozlov, G; Pocanschi, CL; Rosenauer, A; Bastos-Aristizabal, S; Gorelik, A; Williams, DB; Gehring, K				Kozlov, Guennadi; Pocanschi, Cosmin L.; Rosenauer, Angelika; Bastos-Aristizabal, Sara; Gorelik, Alexei; Williams, David B.; Gehring, Kalle			Structural Basis of Carbohydrate Recognition by Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM LUMINAL DOMAIN; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; P-DOMAIN; VIRAL GLYCOPROTEINS; MUTATIONAL ANALYSIS; BINDING-PROPERTIES; IN-VITRO; CALNEXIN; LECTIN	The calnexin cycle is a process by which glycosylated proteins are subjected to folding cycles in the endoplasmic reticulum lumen via binding to the membrane protein calnexin ( CNX) or to its soluble homolog calreticulin ( CRT). CNX and CRT specifically recognize monoglucosylated Glc(1)Man(9)GlcNAc(2) glycans, but the structural determinants underlying this specificity are unknown. Here, we report a 1.95-angstrom crystal structure of the CRT lectin domain in complex with the tetrasaccharide alpha-Glc(1 -> 3)-alpha-Man-(1 -> 2)-alpha-Man-(1 -> 2)-Man.The tetrasaccharide binds to a long channel on CRT formed by a concave beta-sheet. All four sugar moieties are engaged in the protein binding via an extensive network of hydrogen bonds and hydrophobic contacts. The structure explains the requirement for glucose at the nonreducing end of the carbohydrate; the oxygen O-2 of glucose perfectly fits to a pocket formed by CRT side chains while forming direct hydrogen bonds with the carbonyl of Gly(124) and the side chain of Lys(111). The structure also explains a requirement for the Cys(105)-Cys(137) disulfide bond in CRT/CNX for efficient carbohydrate binding. The Cys(105)-Cys(137) disulfide bond is involved in intimate contacts with the third and fourth sugar moieties of the Glc(1)Man(3) tetrasaccharide. Finally, the structure rationalizes previous mutagenesis of CRT and lays a structural groundwork for future studies of the role of CNX/CRT in diverse biological pathways.	[Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Pocanschi, Cosmin L.; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pocanschi, Cosmin L.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	McGill University; University of Toronto; University of Toronto	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Gorelik, Alexei/0000-0001-6236-4633	Canadian Institutes of Health [MOP-81277, MOP-53310]; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Canadian Institutes of Health Research Grants MOP-81277 (to K. G.) and MOP-53310 (to D. B. W.).; Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source was supported by National Science Foundation Award DMR 0225180 and National Institutes of Health Award RR-01646.	BAKSH S, 1995, FEBS LETT, V376, P53, DOI 10.1016/0014-5793(95)01246-4; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Danilczyk UG, 2000, J BIOL CHEM, V275, P13089, DOI 10.1074/jbc.275.17.13089; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Gopalakrishnapai J, 2006, BIOCHEM BIOPH RES CO, V351, P14, DOI 10.1016/j.bbrc.2006.09.164; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Hara-Kuge S, 1999, GLYCOBIOLOGY, V9, P833, DOI 10.1093/glycob/9.8.833; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; KHANNA NC, 1986, J BIOL CHEM, V261, P8883; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Peterson JR, 1999, J CELL SCI, V112, P2775; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; Pieren M, 2005, J BIOL CHEM, V280, P28265, DOI 10.1074/jbc.M501020200; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Rodan AR, 1996, EMBO J, V15, P6921, DOI 10.1002/j.1460-2075.1996.tb01084.x; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Giraldo AMV, 2010, J BIOL CHEM, V285, P4544, DOI 10.1074/jbc.M109.034512; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3	55	98	102	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38612	38620		10.1074/jbc.M110.168294	http://dx.doi.org/10.1074/jbc.M110.168294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880849	Green Published, hybrid			2022-12-27	WOS:000284625600065
J	Boland, B; Smith, DA; Mooney, D; Jung, SS; Walsh, DM; Platt, FM				Boland, Barry; Smith, David A.; Mooney, Declan; Jung, Sonia S.; Walsh, Dominic M.; Platt, Frances M.			Macroautophagy Is Not Directly Involved in the Metabolism of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK-C DISEASE; BETA-PROTEIN; ALZHEIMERS-DISEASE; AUTOPHAGIC VACUOLES; STORAGE DISEASE; ACCUMULATION; AGGREGATION; TRAFFICKING; FRAGMENTS; NEURODEGENERATION	Alterations in the metabolism of amyloid precursor protein (APP) are believed to play a central role in Alzheimer disease pathogenesis. Burgeoning data indicate that APP is proteolytically processed in endosomal-autophagic-lysosomal compartments. In this study, we used both in vivo and in vitro paradigms to determine whether alterations in macroautophagy affect APP metabolism. Three mouse models of glycosphingolipid storage diseases, namely Niemann-Pick type C1, GM1 gangliosidosis, and Sandhoff disease, had mTOR-independent increases in the autophagic vacuole (AV)-associated protein, LC3-II, indicative of impaired lysosomal flux. APP C-terminal fragments (APP-CTFs) were also increased in brains of the three mouse models; however, discrepancies between LC3-II and APP-CTFs were seen between primary (GM1 gangliosidosis and Sandhoff disease) and secondary (Niemann-Pick type C1) lysosomal storage models. APP-CTFs were proportionately higher than LC3-II in cerebellar regions of GM1 gangliosidosis and Sandhoff disease, although LC3-II increased before APP-CTFs in brains of NPC1 mice. Endogenous murine A beta 40 from RIPA-soluble extracts was increased in brains of all three mice. The in vivo relationship between AV and APP-CTF accumulation was also seen in cultured neurons treated with agents that impair primary (chloroquine and leupeptin + pepstatin) and secondary (U18666A and vinblastine) lysosomal flux. However, A beta secretion was unaffected by agents that induced autophagy (rapamycin) or impaired AV clearance, and LC3-II-positive AVs predominantly co-localized with degradative LAMP-1-positive lysosomes. These data suggest that neuronal macroautophagy does not directly regulate APP metabolism but highlights the important anti-amyloidogenic role of lysosomal proteolysis in post-secretase APP-CTF catabolism.	[Boland, Barry] Univ Coll Dublin, Lab Neurodegenerat Res, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland; [Jung, Sonia S.] Centocor Res & Dev Inc, Radnor, PA 19087 USA; [Boland, Barry; Smith, David A.; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University College Dublin; Johnson & Johnson; Johnson & Johnson USA; University of Oxford	Boland, B (corresponding author), Univ Coll Dublin, Lab Neurodegenerat Res, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland.	barry.boland@ucd.ie; dominic.walsh@ucd.ie; frances.platt@pharm.ox.ac.uk	Boland, Barry/D-1235-2010	Boland, Barry/0000-0003-2676-4343; Platt, Frances/0000-0001-7614-0403	Health Research Board of Ireland [PD/2008/40]; University College Dublin; Wellcome Trust [069883/B/02/Z]	Health Research Board of Ireland; University College Dublin; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Health Research Board of Ireland Grant PD/2008/40, University College Dublin Seed Fund, Wellcome Trust Grant 069883/B/02/Z, and Science Foundation Ireland Grant 08/1N.1/B2033.	Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Burns M, 2003, J NEUROSCI, V23, P5645; Burns MP, 2006, NEUROMOL MED, V8, P319, DOI 10.1385/NMM:8:3:319; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1996, J NEUROPATH EXP NEUR, V55, P704, DOI 10.1097/00005072-199606000-00004; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; Dante S, 2002, BIOPHYS J, V83, P2610, DOI 10.1016/S0006-3495(02)75271-5; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; GORDON PB, 1992, BIOCHEM J, V283, P361, DOI 10.1042/bj2830361; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kim JH, 2001, J NEUROSCI, V21, P1327; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; KOZLOWSKI MR, 1992, J NEUROSCI, V12, P1679; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P122, DOI 10.1016/j.bbamem.2006.09.014; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; Ong WY, 2001, EXP BRAIN RES, V141, P218, DOI 10.1007/s002210100870; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; PUNNONEN EL, 1993, EUR J CELL BIOL, V61, P54; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Saito Y, 2002, ANN NEUROL, V52, P351, DOI 10.1002/ana.10266; SANDHOFF K, 1968, Pathologia Europaea, V3, P278; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Savage MJ, 1998, J NEUROSCI, V18, P1743; Schmidt Stephen D., 2004, V299, P279; Schmidt Stephen D., 2004, V299, P267; SIMAN R, 1993, J BIOL CHEM, V268, P16602; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; Taniguchi M, 2001, BRAIN DEV-JPN, V23, P414, DOI 10.1016/S0387-7604(01)00252-2; van der Voorn JP, 2004, ACTA NEUROPATHOL, V107, P539, DOI 10.1007/s00401-004-0848-9; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	71	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37415	37426		10.1074/jbc.M110.186411	http://dx.doi.org/10.1074/jbc.M110.186411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864542	Green Published, hybrid			2022-12-27	WOS:000284424000034
J	Li, SL; Shimono, C; Norioka, N; Nakano, I; Okubo, T; Yagi, Y; Hayashi, M; Sato, Y; Fujisaki, H; Hattori, S; Sugiura, N; Kimata, K; Sekiguchi, K				Li, Shaoliang; Shimono, Chisei; Norioka, Naoko; Nakano, Itsuko; Okubo, Tetsuo; Yagi, Yoshiko; Hayashi, Maria; Sato, Yuya; Fujisaki, Hitomi; Hattori, Shunji; Sugiura, Nobuo; Kimata, Koji; Sekiguchi, Kiyotoshi			Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN-4; EXTRACELLULAR-MATRIX PROTEINS; HEPARAN-SULFATE; CHONDROITIN SULFATE; BASEMENT-MEMBRANES; CRYSTAL-STRUCTURE; ACTIVATION; CELLS; GLYCOSAMINOGLYCANS	Activin A, a member of the transforming growth factor-beta family, plays important roles in hormonal homeostasis and embryogenesis. In this study, we produced recombinant human activin A and examined its abilities to bind to extracellular matrix proteins. Recombinant activin A expressed in 293-F cells was purified as complexes of mature dimeric activin A with its pro-region. Among a panel of extracellular matrix proteins tested, recombinant activin A bound to perlecan and agrin, but not to laminins, nidogens, collagens I and IV, fibronectin, and nephronectin. The binding of recombinant activin A to perlecan was inhibited by heparin and high concentrations of NaCl and abolished by heparitinase treatment of perlecan, suggesting that activin A binds to the heparan sulfate chains of perlecan. In support of this possibility, recombinant activin A was capable of directly binding to heparin and heparan sulfate chains. Site-directed mutagenesis of recombinant activin A revealed that clusters of basic amino acid residues, Lys(259)-Lys(263) and Lys(270)-Lys(272), in the pro-region were required for binding to perlecan. Interestingly, deletion of the peptide segment Lys(259)-Gly(277) containing both basic amino acid clusters from the pro-region did not impair the activity of activin A to stimulate Smad-dependent gene expressions, although it completely ablated the perle-can-binding activity. The binding of activin A to basement membrane heparan sulfate proteoglycans through the basic residues in the pro-region was further confirmed by in situ activin A overlay assays using frozen tissue sections. Taken together, the present results indicate that activin A binds to heparan sulfate proteoglycans through its pro-region and thereby regulates its localization within tissues.	[Sato, Yuya; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Fujisaki, Hitomi; Hattori, Shunji] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Sugiura, Nobuo; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	Osaka University; Aichi Medical University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp			New Energy and Industrial Technology Development Organization of Japan [06001294-0]	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported by Research Contract No. 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan.	Arai KY, 2006, PROTEIN EXPRES PURIF, V49, P78, DOI 10.1016/j.pep.2006.04.003; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Asashima M, 2008, DEV GROWTH DIFFER, V50, pS35, DOI 10.1111/j.1440-169X.2008.00990.x; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Flaumenhaft R, 1991, CURR OPIN CELL BIOL, V3, P817, DOI 10.1016/0955-0674(91)90055-4; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; HUSKENHINDI P, 1994, J BIOL CHEM, V269, P19380; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; IWATA M, 1995, J BIOCHEM-TOKYO, V117, P1298, DOI 10.1093/oxfordjournals.jbchem.a124858; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Khan SA, 2008, AM J PHYSIOL-CELL PH, V294, pC1387, DOI 10.1152/ajpcell.00346.2007; Lamszus K, 1996, AM J PATHOL, V149, P805; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LYON M, 1994, J BIOL CHEM, V269, P11216; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Mellor SL, 2000, J CLIN ENDOCR METAB, V85, P4851, DOI 10.1210/jc.85.12.4851; MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; SPENCER SJ, 1992, J CLIN INVEST, V90, P142, DOI 10.1172/JCI115827; SUGIURA N, 1993, J BIOL CHEM, V268, P15779; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	58	49	52	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36645	36655		10.1074/jbc.M110.177865	http://dx.doi.org/10.1074/jbc.M110.177865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843788	Green Published, hybrid			2022-12-27	WOS:000284146100035
J	Williams, JA; Kane, M; Okabe, T; Enomoto-Iwamoto, M; Napoli, JL; Pacifici, M; Iwamoto, M				Williams, Julie A.; Kane, Maureen; Okabe, Takahiro; Enomoto-Iwamoto, Motomi; Napoli, Joseph L.; Pacifici, Maurizio; Iwamoto, Masahiro			Endogenous Retinoids in Mammalian Growth Plate Cartilage ANALYSIS AND ROLES IN MATRIX HOMEOSTASIS AND TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL PROGENITOR DIFFERENTIATION; ACID RECEPTORS; LOCAL APPLICATION; LIMB DEVELOPMENT; EXPRESSION; GENE; REPRESSION; CHONDROGENESIS; ABNORMALITIES; L-SOX5	The growth plate contains resting and proliferating chondrocytes in its upper zones (UGP) and maturing and hypertrophic chondrocytes in its lower zones (LGP), but the mechanisms by which it operates to sustain skeletal growth are not fully clear. Retinoid signaling was previously found to be nearly absent in UGP, but to be much stronger in LGP coincident with hypertrophy, extracellular matrix turnover and endochondral bone formation. To determine whether such distinct signaling levels and phenotypic events reflect different endogenous retinoid levels, the upper two-thirds and lower one-third of rabbit rib growth plates were microsurgically isolated and processed for ultrasensitive retinoid LC-tandem MS quantification. Indeed, the UGP samples contained only about a 0.6 nM concentration of all-trans- retinoic acid (atRA) that is the most active natural retinoid in tissues, whereas LGP samples contained nearly 3-fold higher atRA levels (about 1.8 nM). Perichondrium was quite rich in atRA (about 4.9 nM). Interestingly, the levels of retinol, the major but inactive atRA precursor, were similar in all tissues (1.1-1.6 mu M), suggesting that the distinct atRA levels in UGP and LGP reflect different retinoid anabolic capacity. Indeed, RALDH2 and CRABP1 transcript levels were much higher in LGP than UGP samples. To determine the minimum effective atRA concentration, chondrogenic cells transfected with a retinoic acid response element (RARE)-luc reporter plasmid were treated with different concentrations of exogenous atRA (0-100 nM). About 3 nM atRA was needed to elicit appreciable RARE-luc reporter activity and to decrease proteoglycan synthesis and activity of an aggrecan enhancer reporter plasmid. In sum, the data indicate that (i) the endogenous levels of atRA are significantly higher in hypertrophic than upper zones of growth plate; (ii) such difference likely reflects distinct retinoid anabolic capacity; and (iii) importantly, atRA levels in hypertrophic portion are within effective ranges to elicit retinoid signaling and action, but those in upper zones are not.	[Williams, Julie A.; Okabe, Takahiro; Enomoto-Iwamoto, Motomi; Pacifici, Maurizio; Iwamoto, Masahiro] Thomas Jefferson Univ, Coll Med, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Kane, Maureen; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Jefferson University; University of California System; University of California Berkeley	Iwamoto, M (corresponding author), Thomas Jefferson Univ, Coll Med, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.	masahiro.iwamoto@jefferson.edu			National Institutes of Health [1RO1 AR056837]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant 1RO1 AR056837 (to M. I. and M. P.).	Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hoffman UM, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300002-00017; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010; IWAMOTO M, 1994, J BIOL CHEM, V269, P17245; IWAMOTO M, 1993, EXP CELL RES, V207, P413, DOI 10.1006/excr.1993.1209; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; KOCHHAR DM, 1973, TERATOLOGY, V7, P289, DOI 10.1002/tera.1420070310; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Malpel S, 2000, DEVELOPMENT, V127, P3057; Mangelsdorf David J., 1994, P319; MENDELSOHN C, 1992, DEV BIOL, V152, P50, DOI 10.1016/0012-1606(92)90155-A; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nozaki Y, 2006, CLIN IMMUNOL, V119, P272, DOI 10.1016/j.clim.2005.11.012; Okuno M, 1999, J HEPATOL, V30, P1073, DOI 10.1016/S0168-8278(99)80262-1; PACIFICI M, 1980, EXP CELL RES, V129, P469, DOI 10.1016/0014-4827(80)90517-0; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; SUCOV HM, 1995, MOL NEUROBIOL, V10, P169, DOI 10.1007/BF02740674; Thacher SM, 2000, CURR PHARM DESIGN, V6, P25, DOI 10.2174/1381612003401415; TICKLE C, 1988, ROUX ARCH DEV BIOL, V197, P27, DOI 10.1007/BF00376038; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; von Schroeder HP, 1998, J ORTHOP RES, V16, P355, DOI 10.1002/jor.1100160312; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Welch ID, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2604; Weston AD, 2000, J CELL BIOL, V148, P679, DOI 10.1083/jcb.148.4.679; Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Yamaguchi M, 1998, P NATL ACAD SCI USA, V95, P7491, DOI 10.1073/pnas.95.13.7491	38	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36674	36681		10.1074/jbc.M110.151878	http://dx.doi.org/10.1074/jbc.M110.151878			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843807	Green Published, hybrid			2022-12-27	WOS:000284146100018
J	Cottonham, CL; Kaneko, S; Xu, L				Cottonham, Charisa L.; Kaneko, Satoshi; Xu, Lan			miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER METASTASIS; RAC ACTIVATOR TIAM1; GROWTH-FACTOR-BETA; TGF-BETA; COLORECTAL-CANCER; E-CADHERIN; REPRESSORS ZEB1; LINE MODEL; MICRORNA	TGF-beta promotes cell migration and invasion, an attribute that is linked to the pro-metastasis function of this cytokine in late stage cancers. The LIM 1863 colon carcinoma organoid undergoes epithelial-mesenchymal transition (EMT) in response to TGF-beta. This process is markedly accelerated by TNF-alpha, and we found that the levels of miR-21 and miR-31 were prominently elevated under the synergistic actions of TGF-beta/TNF-alpha. Consistent with this, overexpression of either miR-21 or miR-31 significantly enhanced the effect of TGF-beta alone on LIM 1863 morphological changes. More importantly, transwell assays demonstrated the positive effects of both miR-21 and miR-31 in TGF-beta regulation of LIM 1863 motility and invasiveness. Elevated levels of miR-21 and miR-31 also enhanced motility and invasiveness of other colon carcinoma cell lines. We present compelling evidence that TIAM1, a guanidine exchange factor of the Rac GTPase, is a direct target of both miR-21 and miR-31. Indeed in LIM 1863 cells, suppression of TIAM1 is required for miR-21/miR-31 to enhance cell migration and invasion. Therefore, we have uncovered miR-21 and miR-31 as downstream effectors of TGF-beta in facilitating invasion and metastasis of colon carcinoma cells.	[Cottonham, Charisa L.; Kaneko, Satoshi; Xu, Lan] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Xu, L (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Rm 308, Worcester, MA 01605 USA.	lan.xu@umassmed.edu			National Institutes of Health [R01CA108509]; Ruth L. Kirschstein NRSA [F31CA142216]; NATIONAL CANCER INSTITUTE [F31CA142216, R01CA108509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA108509 (to L. X.) and a Ruth L. Kirschstein NRSA Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research F31CA142216 (to C. L. C.).	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates RC, 2004, EXP CELL RES, V299, P315, DOI 10.1016/j.yexcr.2004.05.033; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bourguignon LYW, 2000, J CELL BIOL, V150, P177, DOI 10.1083/jcb.150.1.177; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; DALAL BI, 1993, AM J PATHOL, V143, P381; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; HAYWARD IP, 1995, IMMUNOL CELL BIOL, V73, P249, DOI 10.1038/icb.1995.41; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vincan E, 2007, ONCOGENE, V26, P2340, DOI 10.1038/sj.onc.1210026; Vincan E, 2007, CELLS TISSUES ORGANS, V185, P20, DOI 10.1159/000101299; Vincan Elizabeth, 2008, V468, P263, DOI 10.1007/978-1-59745-249-6_21; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WHITEHEAD RH, 1987, CANCER RES, V47, P2683; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316	52	213	225	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35293	35302		10.1074/jbc.M110.160069	http://dx.doi.org/10.1074/jbc.M110.160069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826792	hybrid, Green Published			2022-12-27	WOS:000283845300007
J	Park, SH; Choi, HJ; Yang, H; Do, KH; Kim, J; Lee, DW; Moon, Y				Park, Seong-Hwan; Choi, Hye Jin; Yang, Hyun; Do, Kee Hun; Kim, Juil; Lee, Dong Won; Moon, Yuseok			Endoplasmic Reticulum Stress-activated C/EBP Homologous Protein Enhances Nuclear Factor-kappa B Signals via Repression of Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ER STRESS; EXPRESSION; CHOP; CELLS; BETA; GENE; TRANSCRIPTION; COLITIS; DISEASE	Endoplasmic reticulum (ER) stress is a causative factor of inflammatory bowel diseases. ER stress mediators, including CCAAT enhancer-binding protein (C/EBP) homologous protein (CHOP), are elevated in intestinal epithelia from patients with inflammatory bowel diseases. The present study arose from the question of how chemical ER stress and CHOP protein were associated with nuclear factor-kappa B (NF-kappa B)-mediated epithelial inflammatory response. In a human intestinal epithelial cell culture model, chemical ER stresses induced proinflammatory cytokine interleukin-8 (IL-8) expression and the nuclear translocation of CHOP protein. CHOP was positively involved in ER-activated IL-8 production and was negatively associated with expression of peroxisome proliferator-activated receptor gamma (PPAR gamma). ER stress-induced IL-8 production was enhanced by NF-kappa B activation that was negatively regulated by PPAR gamma. Mechanistically, ER stress-induced CHOP suppressed PPAR gamma transcription by sequestering C/EBP beta and limiting availability of C/EBP beta binding to the PPAR gamma promoter. Due to the CHOP-mediated regulation of PPAR gamma action, ER stress can enhance proinflammatory NF-kappa B activation and maintain an increased level of IL-8 production in human intestinal epithelial cells. In contrast, PPAR gamma was a counteracting regulator of gut inflammatory response through attenuation of NF-kappa B activation. The collective results support the view that balances between CHOP and PPAR gamma are crucial for epithelial homeostasis, and disruption of these balances in mucosal ER stress can etiologically affect the progress of human inflammatory bowel diseases.	[Park, Seong-Hwan; Choi, Hye Jin; Yang, Hyun; Do, Kee Hun; Kim, Juil; Moon, Yuseok] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Lab Syst Mucosal Biomodulat, Yangsan 626813, South Korea; [Lee, Dong Won] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan 626813, South Korea; [Moon, Yuseok] Pusan Natl Univ, Res Inst Basic Sci, Pusan 609735, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Lab Syst Mucosal Biomodulat, Yangsan 626813, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020	MOON, YUSEOK/0000-0001-8686-8166	Ministry of Education, Science and Technology [2009-0087028]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2009-0087028).	Araki E, 2003, INTERNAL MED, V42, P7, DOI 10.2169/internalmedicine.42.7; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cario E, 2008, CURR OPIN GASTROEN, V24, P725, DOI 10.1097/MOG.0b013e32830c4341; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Cowan MJ, 2006, J APPL PHYSIOL, V101, P1127, DOI 10.1152/japplphysiol.01287.2005; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Fujii J, 2008, INFECT IMMUN, V76, P3679, DOI 10.1128/IAI.01581-07; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moon Y, 2008, TOXICOL APPL PHARM, V231, P94, DOI 10.1016/j.taap.2008.03.016; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Noiri E, 1996, AM J PHYSIOL-CELL PH, V270, pC794, DOI 10.1152/ajpcell.1996.270.3.C794; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sansonetti PJ, 2008, CURR OPIN GASTROEN, V24, P435, DOI 10.1097/MOG.0b013e32830007f7; Scholmerich J, 2006, ANN NY ACAD SCI, V1072, P365, DOI 10.1196/annals.1326.026; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sifuentes LY, 2007, APPL ENVIRON MICROB, V73, P7548, DOI 10.1128/AEM.01579-07; Srinivasan M, 2009, CLIN IMMUNOL, V133, P411, DOI 10.1016/j.clim.2009.09.001; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Suyama K, 2008, BIOCHEM BIOPH RES CO, V367, P176, DOI 10.1016/j.bbrc.2007.12.132; Thebault S, 2006, PROTEOMICS, V6, P3926, DOI 10.1002/pmic.200500714; Tsianos EV, 2009, WORLD J GASTROENTERO, V15, P521, DOI 10.3748/wjg.15.521; Von Knethen A, 2001, FASEB J, V15, P535, DOI 10.1096/fj.00-0187com; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Warren CA, 2008, J INFECT DIS, V198, P143, DOI 10.1086/588819; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	57	60	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35330	35339		10.1074/jbc.M110.136259	http://dx.doi.org/10.1074/jbc.M110.136259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829347	Green Published, hybrid			2022-12-27	WOS:000283845300011
J	Sato, H; Hashimoto, Y; Fukatsu, H; Kobayashi, M				Sato, Hiroyoshi; Hashimoto, Yoshiteru; Fukatsu, Hiroshi; Kobayashi, Michihiko			Novel Isonitrile Hydratase Involved in Isonitrile Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-RHODOCHROUS J1; SUBSTITUTED FORMAMIDE DEFORMYLASE; METALLOENZYME NITRILE HYDRATASE; CYSTEINE RESIDUES; REACTION-PRODUCT; GENE-EXPRESSION; PURIFICATION; DISCOVERY; CLONING; ENZYME	We previously discovered N-substituted formamide deformylase (NfdA) in Arthrobacter pascens F164, which degrades N-substituted formamide (Fukatsu, H., Hashimoto, Y., Goda, M., Higashibata, H., and Kobayashi, M. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 13726-13731). In this study, we found an enzyme involved in the first step of isonitrile metabolism, isonitrile hydratase, that hydrates isonitrile to the corresponding N-substituted formamide. First, we investigated the optimum culture conditions for the production of isonitrile hydratase. The highest enzyme activity was obtained when A. pascens F164 was cultured in a nutrient medium containing N-benzylformamide. This Arthrobacter isonitrile hydratase was purified, characterized, and compared with Pseudomonas putida N19-2 isonitrile hydratase (InhA), which is the sole one reported at present. Arthrobacter isonitrile hydratase was found to have a molecular mass of about 530 kDa and to consist of 12 identical subunits. The apparent K-m value for cyclohexyl isocyanide was 0.95 +/- 0.05 mM. A. pascens F164 grew and exhibited the isonitrile hydratase and N-substituted formamide deformylase activities when cultured in a medium containing an isonitrile as the sole carbon and nitrogen sources. However, both enzyme activities were not observed on culture in a medium containing glycerol and (NH4)(2)SO4 as the sole carbon and nitrogen sources, respectively. These findings suggested that the Arthrobacter enzyme is an inducible enzyme, possibly involved in assimilation and/or detoxification of isonitrile. Moreover, gene cloning of the Arthrobacter enzyme revealed no sequence similarity between this enzyme and InhA. Comparison of their properties and features demonstrated that the two enzymes are biochemically, immunologically, and structurally different from each other. Thus, we discovered a new isonitrile hydratase named InhB.	[Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.				Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAFIERI F, 1973, TETRAHEDRON, V29, P4259, DOI 10.1016/0040-4020(73)80267-4; EDENBOROUGH MS, 1988, NAT PROD REP, V5, P229, DOI 10.1039/np9880500229; Fukatsu H, 2005, BIOSCI BIOTECH BIOCH, V69, P228, DOI 10.1271/bbb.69.228; Fukatsu H, 2004, P NATL ACAD SCI USA, V101, P13726, DOI 10.1073/pnas.0405082101; Goda M, 2002, J BIOL CHEM, V277, P45860, DOI 10.1074/jbc.M208571200; Goda M, 2001, J BIOL CHEM, V276, P23480, DOI 10.1074/jbc.M007856200; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; KOBAYASHI M, 1995, P NATL ACAD SCI USA, V92, P714, DOI 10.1073/pnas.92.3.714; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; KOBAYASHI M, 1992, J BIOL CHEM, V267, P20746; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; KOBAYASHI M, 1994, FEMS MICROBIOL LETT, V120, P217, DOI 10.1016/0378-1097(94)90474-X; KOBAYASHI M, 1990, J BACTERIOL, V172, P4807, DOI 10.1128/jb.172.9.4807-4815.1990; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, J BIOL CHEM, V271, P15796, DOI 10.1074/jbc.271.26.15796; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Konishi K, 2006, P NATL ACAD SCI USA, V103, P564, DOI 10.1073/pnas.0505412103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1989, MOL CLONING LAB MANU; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; SCHEUER PJ, 1992, ACCOUNTS CHEM RES, V25, P433, DOI 10.1021/ar00022a001; Zhou ZM, 2009, J BIOL CHEM, V284, P14930, DOI 10.1074/jbc.M808464200; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	25	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34793	34802		10.1074/jbc.M110.150227	http://dx.doi.org/10.1074/jbc.M110.150227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826798	hybrid, Green Published			2022-12-27	WOS:000283659100055
J	Schwarzer, C; Wong, S; Shi, J; Matthes, E; Illek, B; Ianowski, JP; Arant, RJ; Isacoff, E; Vais, H; Foskett, JK; Maiellaro, I; Hofer, AM; Machen, TE				Schwarzer, Christian; Wong, Steven; Shi, James; Matthes, Elizabeth; Illek, Beate; Ianowski, Juan P.; Arant, Ryan J.; Isacoff, Ehud; Vais, Horia; Foskett, J. Kevin; Maiellaro, Isabella; Hofer, Aldebaran M.; Machen, Terry E.			Pseudomonas aeruginosa Homoserine Lactone Activates Store-operated cAMP and Cystic Fibrosis Transmembrane Regulator-dependent Cl- Secretion by Human Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MUCUS SECRETION; CA2+; CALCIUM; RESPONSES; RECEPTOR; EXPRESSION; TRANSPORT; MECHANISM; FLAGELLIN	The ubiquitous bacterium Pseudomonas aeruginosa frequently causes hospital-acquired infections. P. aeruginosa also infects the lungs of cystic fibrosis (CF) patients and secretes N-(3-oxo-dodecanoyl)-S-homoserine lactone (3O-C12) to regulate bacterial gene expression critical for P. aeruginosa persistence. In addition to its effects as a quorum-sensing gene regulator in P. aeruginosa, 3O-C12 elicits cross-kingdom effects on host cell signaling leading to both pro- or anti-inflammatory effects. We find that in addition to these slow effects mediated through changes in gene expression, 3O-C12 also rapidly increases Cl- and fluid secretion in the cystic fibrosis transmembrane regulator (CFTR)-expressing airway epithelia. 3O-C12 does not stimulate Cl- secretion in CF cells, suggesting that lactone activates the CFTR. 3O-C12 also appears to directly activate the inositol trisphosphate receptor and release Ca2+ from the endoplasmic reticulum (ER), lowering [Ca2+] in the ER and thereby activating the Ca2+ -sensitive ER signaling protein STIM1. 3O-C12 increases cytosolic [Ca2+] and, strikingly, also cytosolic [cAMP], the known activator of CFTR. Activation of Cl- current by 3O-C12 was inhibited by a cAMP antagonist and increased by a phosphodiesterase inhibitor. Finally, a Ca2+ buffer that lowers [Ca2+] in the ER similar to the effect of 3O-C12 also increased cAMP and I-C1. The results suggest that 3O-C12 stimulates CFTR-dependent Cl- and fluid secretion in airway epithelial cells by activating the inositol trisphosphate receptor, thus lowering [Ca2+] in the ER and activating STIM1 and store-operated cAMP production. In CF airways, where CFTR is absent, the adaptive ability to rapidly flush the bacteria away is compromised because the lactone cannot affect Cl- and fluid secretion.	[Schwarzer, Christian; Wong, Steven; Shi, James; Matthes, Elizabeth; Arant, Ryan J.; Isacoff, Ehud; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Illek, Beate] Childrens Hosp Oakland Res Inst, Ctr Nutr & Metab, Oakland, CA 94609 USA; [Ianowski, Juan P.] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada; [Vais, Horia; Foskett, J. Kevin] Univ Penn, Dept Physiol, Sch Med, Philadelphia, PA 19104 USA; [Vais, Horia; Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Sch Med, Philadelphia, PA 19104 USA; [Maiellaro, Isabella; Hofer, Aldebaran M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, W Roxbury, MA 02132 USA; [Maiellaro, Isabella; Hofer, Aldebaran M.] Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA	University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Saskatchewan; University of Pennsylvania; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Machen, TE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 231 LSA, Berkeley, CA 94720 USA.	tmachen@berkeley.edu	isacoff, ehud/AAP-1459-2020; Foskett, Kevin/R-2549-2019	Foskett, J. Kevin/0000-0002-8854-0268; Maiellaro, Isabella/0000-0001-5595-8011; Isacoff, Ehud Y./0000-0003-4775-9359	National Institutes of Health [GM056328, MH059937, PN2 EY018241]; Cystic Fibrosis Foundation [MACHEN06, MACHEN07, ILLEK08]; Cystic Fibrosis Research, Inc.; Veterans Affairs; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK088197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R37GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Research, Inc.; Veterans Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM056328, MH059937, and PN2 EY018241. This work was also supported by Cystic Fibrosis Foundation Grants MACHEN06, MACHEN07, and ILLEK08, Cystic Fibrosis Research, Inc., and a Veterans Affairs Merit Review Award (to A. M. H.).	Bjarnsholt T, 2007, PHILOS T R SOC B, V362, P1213, DOI 10.1098/rstb.2007.2046; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Giorgi C, 2008, CURR MOL MED, V8, P119; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Illek B, 2008, AM J PHYSIOL-LUNG C, V295, pL531, DOI 10.1152/ajplung.90292.2008; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Imamura Y, 2004, ANTIMICROB AGENTS CH, V48, P3457, DOI 10.1128/AAC.48.9.3457-3461.2004; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Li HT, 2009, MED MICROBIOL IMMUN, V198, P113, DOI 10.1007/s00430-009-0111-z; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; MAK DOD, 2005, METHODS CALCIUM SIGN, P203; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Smith RS, 2002, J IMMUNOL, V169, P2636, DOI 10.4049/jimmunol.169.5.2636; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	51	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34850	34863		10.1074/jbc.M110.167668	http://dx.doi.org/10.1074/jbc.M110.167668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739289	Green Published, hybrid			2022-12-27	WOS:000283659100060
J	Duning, K; Rosenbusch, D; Schluter, MA; Tian, YM; Kunzelmann, K; Meyer, N; Schulze, U; Markoff, A; Pavenstadt, H; Weide, T				Duning, Kerstin; Rosenbusch, Deike; Schlueter, Marc A.; Tian, Yuemin; Kunzelmann, Karl; Meyer, Nina; Schulze, Ulf; Markoff, Arseni; Pavenstaedt, Hermann; Weide, Thomas			Polycystin-2 Activity Is Controlled by Transcriptional Coactivator with PDZ Binding Motif and PALS1-associated Tight Junction Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN EPITHELIAL-CELLS; KIDNEY-DISEASE; DIRECTIONAL MIGRATION; SIGNALING COMPLEX; CYSTIC-FIBROSIS; PRIMARY CILIUM; HIPPO PATHWAY; TAZ; CHANNEL; INAD	Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent monogenic cause of kidney failure, characterized by the development of renal cysts. ADPKD is caused by mutations of the polycystin-1 (PC1) or polycystin-2 (PC2) genes. PC2 encodes a Ca2+-permeable cation channel, and its dysfunction has been implicated in cyst development. The transcriptional coactivator with PDZ binding motif (TAZ) is required for the integrity of renal cilia. Its absence results in the development of renal cysts in a knock-out mouse model. TAZ directly interacts with PC2, and it has been suggested that another yet unidentified PDZ domain protein may be involved in the TAZ/PC2 interaction. Here we describe a novel interaction of TAZ with the multi-PDZ-containing PALS1-associated tight junction protein (PATJ). TAZ interacts with both the N-terminal PDZ domains 1-3 and the C-terminal PDZ domains 8-10 of PATJ, suggesting two distinct TAZ binding domains. We also show that the C terminus of PC2 strongly interacts with PDZ domains 8-10 and to a weaker extent with PDZ domains 1-3 of PATJ. Finally, we demonstrate that both TAZ and PATJ impair PC2 channel activity when co-expressed with PC2 in oocytes of Xenopus laevis. These results implicate TAZ and PATJ as novel regulatory elements of the PC2 channel and might thus be involved in ADPKD pathology.	[Duning, Kerstin; Rosenbusch, Deike; Schlueter, Marc A.; Meyer, Nina; Schulze, Ulf; Pavenstaedt, Hermann; Weide, Thomas] Univ Munster, Univ Clin Munster, Dept Internal Med D, D-48149 Munster, Germany; [Tian, Yuemin; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany; [Markoff, Arseni] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany	University of Munster; University of Regensburg; University of Munster	Duning, K (corresponding author), Univ Munster, Univ Clin Munster, Dept Internal Med D, D-48149 Munster, Germany.	duning@uni-muenster.de; pavensth@mednet.uni-muenster.de	Tian, Yuemin/AAE-8827-2021	Kunzelmann, Karl/0000-0002-4583-7037	Deutsche Forschungsgemeinschaft [PA 483/14-2, DFG SFB699 A6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft Grants PA 483/14-2 and DFG SFB699 A6.	Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Brereton HM, 2000, MOL CELL BIOCHEM, V214, P63, DOI 10.1023/A:1007193720930; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fu X, 2008, J AM SOC NEPHROL, V19, P1342, DOI 10.1681/ASN.2007070730; Hackmann K, 2005, HUM MOL GENET, V14, P3249, DOI 10.1093/hmg/ddi356; Hamaratoglu F, 2009, J CELL SCI, V122, P2351, DOI 10.1242/jcs.046482; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Houslay MD, 2009, BRIT J PHARMACOL, V158, P483, DOI 10.1111/j.1476-5381.2009.00359.x; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Lee NPY, 2006, FEBS LETT, V580, P923, DOI 10.1016/j.febslet.2006.01.019; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; Schluter MA, 2009, J AM SOC NEPHROL, V20, P1444, DOI 10.1681/ASN.2008090949; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Streets AJ, 2009, J CELL SCI, V122, P1410, DOI 10.1242/jcs.045021; Stumpf A, 2006, CELL PHYSIOL BIOCHEM, V18, P243, DOI 10.1159/000097671; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Treharne KJ, 2007, J BIOL CHEM, V282, P10804, DOI 10.1074/jbc.M610956200; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	46	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33584	33588		10.1074/jbc.C110.146381	http://dx.doi.org/10.1074/jbc.C110.146381			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20833712	hybrid, Green Published			2022-12-27	WOS:000283354000003
J	Sohn, J; Grant, RA; Sauer, RT				Sohn, Jungsan; Grant, Robert A.; Sauer, Robert T.			Allostery Is an Intrinsic Property of the Protease Domain of DegS IMPLICATIONS FOR ENZYME FUNCTION AND EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-SENSOR; HTRA FAMILY; MECHANISM; PROTEINS; BINDING; SIGNALS; RELIEF; SITE	DegS is a periplasmic Escherichia coli protease, which functions as a trimer to catalyze the initial rate-limiting step in a proteolytic cascade that ultimately activates transcription of stress response genes in the cytoplasm. Each DegS subunit consists of a protease domain and a PDZ domain. During protein folding stress, DegS is allosterically activated by peptides exposed in misfolded outer membrane porins, which bind to the PDZ domain and stabilize the active protease. It is not known whether allostery is conferred by the PDZ domains or is an intrinsic feature of the trimeric protease domain. Here, we demonstrate that free DegS(Delta PDZ) equilibrates between active and inactive trimers with the latter species predominating. Substrate binding stabilizes active DegS(Delta PDZ) in a positively cooperative fashion. Mutations can also stabilize active DegS(Delta PDZ) and produce an enzyme that displays hyperbolic kinetics and degrades substrate with a maximal velocity within error of that for fully activated, intact DegS. Crystal structures of multiple DegS(Delta PDZ) variants, in functional and non-functional conformations, support a two-state model in which allosteric switching is mediated by changes in specific elements of tertiary structure in the context of an invariant trimeric base. Overall, our results indicate that protein substrates must bind sufficiently tightly and specifically to the functional conformation of DegS(Delta PDZ) to assist their own degradation. Thus, substrate binding alone may have regulated the activities of ancestral DegS trimers with subsequent fusion of the protease domain to a PDZ domain, resulting in ligand-mediated regulation.	[Sohn, Jungsan; Grant, Robert A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	National Institutes of Health [F32AI-074245-03]; National Center for Research Resources [AI-16892, RR-15301]; United States Department of Defense Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892, F32AI074245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Defense Office of Basic Energy Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Postdoctoral Fellowship F32AI-074245-03 (to J. S.), Grant AI-16892, and Award RR-15301 from the National Center for Research Resources. This work was also supported by the United States Department of Defense Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAMMES GG, 1971, SCIENCE, V172, P1205, DOI 10.1126/science.172.3989.1205; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hardy JA, 2009, J BIOL CHEM, V284, P26063, DOI 10.1074/jbc.M109.001826; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Leskovac V, 2008, J SERB CHEM SOC, V73, P393, DOI 10.2298/JSC0804393L; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zeth K, 2004, FEBS LETT, V569, P351, DOI 10.1016/j.febslet.2004.06.012	26	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34039	34047		10.1074/jbc.M110.135541	http://dx.doi.org/10.1074/jbc.M110.135541			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739286	hybrid, Green Published			2022-12-27	WOS:000283354000050
J	Nabuurs, C; Huijbregts, B; Wieringa, B; Hilbers, CW; Heerschap, A				Nabuurs, Christine; Huijbregts, Bertolt; Wieringa, Be; Hilbers, Cees W.; Heerschap, Arend			P-31 Saturation Transfer Spectroscopy Predicts Differential Intracellular Macromolecular Association of ATP and ADP in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; CREATINE-KINASE; EXCHANGE-REACTIONS; PHOSPHORYL CONVERSION; RAT-HEART; KINETICS; DIFFUSION; INVIVO; PHOSPHOCREATINE; MITOCHONDRIAL	The kinetics of phosphoryl exchange involving ATP and ADP have been investigated successfully by in vivo P-31 magnetic resonance spectroscopy using magnetization transfer. However, magnetization transfer effects seen on the signals of ATP also could arise from intramolecular cross-relaxation. This relaxation process carries information on the association state of ATP in the cell. To disentangle contributions of chemical exchange and cross-relaxation to magnetization transfer effects seen in 31P magnetic resonance spectroscopy of skeletal muscle, we performed saturation transfer experiments on wild type and double-mutant mice lacking the cytosolic muscle creatine kinase and adenylate kinase isoforms. We find that cross-relaxation, observed as nuclear Overhauser effects (NOEs), is responsible for magnetization transfer between ATP phosphates both in wild type and in mutant mice. Analysis of P-31 relaxation properties identifies these effects as transferred NOEs, i.e. underlying this process is an exchange between free cellular ATP and ATP bound to slowly rotating macromolecules. This explains the beta-ATP signal decrease upon saturation of the gamma-ATP resonance. Although this usually is attributed to beta-ADP <-> beta-ATP phosphoryl exchange, we did not detect an effect of this exchange on the beta-ATP signal as expected for free [ADP], derived from the creatine kinase equilibrium reaction. This indicates that in resting muscle, conditions prevail that prevent saturation of beta-ADP spins and puts into question the derivation of free [ADP] from the creatine kinase equilibrium. We present a model, matching the experimental result, for ADP <-> ATP exchange, in which ADP is only transiently present in the cytosol.	[Nabuurs, Christine; Huijbregts, Bertolt; Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6500 HB Nijmegen, Netherlands; [Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; [Hilbers, Cees W.] Radboud Univ Nijmegen, Fac Sci, Phys Chem Lab, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Heerschap, A (corresponding author), Prof Geert Grootepl 10, NL-6500 HB Nijmegen, Netherlands.	A.Heerschap@rad.umcn.nl	Nabuurs, Christine I/I-6044-2012; Wieringa, Berend/A-5346-2011; Heerschap, Arend/G-5228-2010	Wieringa, Berend/0000-0001-9192-8020; 	Netherlands Organization for Scientific Research [834.04.007, 40-00506-98-06021]; Prinses Beatrixfonds [WAR06-0217]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Prinses Beatrixfonds	This work was supported by Netherlands Organization for Scientific Research Grants 834.04.007 and 40-00506-98-06021) and the Prinses Beatrixfonds (Grant WAR06-0217).	ALGER JR, 1984, Q REV BIOPHYS, V17, P83, DOI 10.1017/S0033583500005266; Askenasy N, 2002, AM J PHYSIOL-CELL PH, V282, pC338, DOI 10.1152/ajpcell.00404.2001; BACHERT P, 1992, J MAGN RESON, V100, P146, DOI 10.1016/0022-2364(92)90372-E; BRAUER M, 1981, BIOCHEMISTRY-US, V20, P2060, DOI 10.1021/bi00510a050; BRINDLE KM, 1988, PROG NUCL MAG RES SP, V20, P257, DOI 10.1016/0079-6565(88)80003-7; BRINDLE KM, 1985, BIOCHIM BIOPHYS ACTA, V829, P188, DOI 10.1016/0167-4838(85)90188-8; CAMPBELL SL, 1985, FEBS LETT, V193, P189, DOI 10.1016/0014-5793(85)80148-4; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; de Graaf RA, 2000, BIOPHYS J, V78, P1657, DOI 10.1016/S0006-3495(00)76717-8; DU F, 2008, P INT SOC MAGN RES M, P2337; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; GOUDEMANT JF, 1994, NMR BIOMED, V7, P101, DOI 10.1002/nbm.1940070302; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004; HENTRICH S, 1993, EUR BIOPHYS J BIOPHY, V22, P31, DOI 10.1007/BF00205810; HORVATH LI, 1989, BIOCHEMISTRY-US, V28, P407, DOI 10.1021/bi00427a056; Janssen E, 2003, J BIOL CHEM, V278, P30441, DOI 10.1074/jbc.M303150200; KORETSKY AP, 1985, MAGNET RESON MED, V2, P586, DOI 10.1002/mrm.1910020610; KORETSKY AP, 1986, BIOCHEMISTRY-US, V25, P77, DOI 10.1021/bi00349a012; LeRumeur E, 1997, NMR BIOMED, V10, P67, DOI 10.1002/(SICI)1099-1492(199704)10:2<67::AID-NBM451>3.0.CO;2-D; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; MARTONOSI A, 1960, J BIOL CHEM, V235, P1700; Mathur-De Vre R, 1990, Magn Reson Imaging, V8, P691, DOI 10.1016/0730-725X(90)90003-K; MATTHEWS PM, 1981, BIOCHEM BIOPH RES CO, V103, P1052, DOI 10.1016/0006-291X(81)90915-3; MCGILVERY RW, 1974, J BIOL CHEM, V249, P5845; MOON RB, 1973, J BIOL CHEM, V248, P7276; MURALI N, 1993, BIOCHEMISTRY-US, V32, P12941, DOI 10.1021/bi00210a049; NEEMAN M, 1987, BIOCHIM BIOPHYS ACTA, V930, P179, DOI 10.1016/0167-4889(87)90030-9; Ravalec X, 1999, MAGN RESON MATER PHY, V9, P52; Sehy JV, 2002, MAGN RESON MED, V48, P42, DOI 10.1002/mrm.10181; SHOUBRIDGE EA, 1984, BIOCHIM BIOPHYS ACTA, V805, P72, DOI 10.1016/0167-4889(84)90038-7; SHOUBRIDGE EA, 1982, FEBS LETT, V140, P288, DOI 10.1016/0014-5793(82)80916-2; UGURBIL K, 1987, ANN NY ACAD SCI, V508, P265; VANDEVEN FJM, 1988, J MAGN RESON, V79, P221, DOI 10.1016/0022-2364(88)90216-8; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Vendelin M, 2008, AM J PHYSIOL-CELL PH, V295, pC1302, DOI 10.1152/ajpcell.00313.2008; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; WISEMAN RW, 1995, J BIOL CHEM, V270, P12428, DOI 10.1074/jbc.270.21.12428; Zandt HJAI, 2003, J PHYSIOL-LONDON, V548, P847, DOI 10.1113/jphysiol.2002.034538	39	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39588	39596		10.1074/jbc.M110.164665	http://dx.doi.org/10.1074/jbc.M110.164665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20884612	hybrid, Green Published			2022-12-27	WOS:000285185500003
J	McFie, PJ; Stone, SL; Banman, SL; Stone, SJ				McFie, Pamela J.; Stone, Sandra L.; Banman, Shanna L.; Stone, Scot J.			Topological Orientation of Acyl-CoA:Diacylglycerol Acyltransferase-1 (DGAT1) and Identification of a Putative Active Site Histidine and the Role of the N Terminus in Dimer/Tetramer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; CHOLESTEROL ACYLTRANSFERASE-1; MONOACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; OBESITY RESISTANCE; MEMBRANE TOPOLOGY; ENZYME; METABOLISM; CLONING	Acyl CoA: diacylglycerol acyltransferase (DGAT) is an integral membrane protein of the endoplasmic reticulum that catalyzes the synthesis of triacylglycerols. Two DGAT enzymes have been identified (DGAT1 and DGAT2) with unique roles in lipid metabolism. DGAT1 is a multifunctional acyltransferase capable of synthesizing diacylglycerol, retinyl, and wax esters in addition to triacylglycerol. Here, we report the membrane topology for murine DGAT1 using protease protections assays and indirect immunofluorescence in conjunction with selective permeabilization of cellular membranes. Topology models based on prediction algorithms suggested that DGAT1 had eight transmembrane domains. In contrast, our data indicate that DGAT1 has three transmembrane domains with the N terminus oriented toward the cytosol. The C-terminal region of DGAT1, which accounts for similar to 50% of the protein, is present in the endoplasmic reticulum lumen and contains a highly conserved histidine residue (His-426) that may be part of the active site. Mutagenesis of His-426 to alanine impaired the ability of DGAT1 to synthesize triacylglycerols as well as retinyl and wax esters in an in vitro acyltransferase assay. Finally, we show that the N-terminal domain of DGAT1 is not required for the catalytic activity of DGAT1 but, instead, may be involved in regulating enzyme activity and dimer/tetramer formation.	[McFie, Pamela J.; Stone, Sandra L.; Banman, Shanna L.; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Stone, SJ (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	scot.stone@usask.ca			CIHR [88063-1, 88063] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577; BROADWAY NM, 1995, BIOCHEM J, V310, P989, DOI 10.1042/bj3100989; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cho KH, 2003, BIOCHEM BIOPH RES CO, V309, P864, DOI 10.1016/j.bbrc.2003.08.077; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; Friedman J, 2002, NATURE, V415, P268, DOI 10.1038/415268a; Guo ZY, 2007, BIOCHEMISTRY-US, V46, P10063, DOI 10.1021/bi7011367; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Harrison EH, 2001, J NUTR, V131, P1405, DOI 10.1093/jn/131.5.1405; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; LILLY K, 1990, ARCH BIOCHEM BIOPHYS, V280, P167, DOI 10.1016/0003-9861(90)90532-4; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; MARKWELL MAK, 1976, ARCH BIOCHEM BIOPHYS, V176, P479, DOI 10.1016/0003-9861(76)90191-0; Owen MR, 1997, BIOCHEM J, V323, P17, DOI 10.1042/bj3230017; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang SJY, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-2; Washington L, 2003, J LIPID RES, V44, P1395, DOI 10.1194/jlr.M300123-JLR200; Waterman IJ, 2002, INT J OBESITY, V26, P742, DOI 10.1038/sj.ijo.0801981; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Yu CJ, 2002, BIOCHEMISTRY-US, V41, P3762, DOI 10.1021/bi0120188; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139	52	98	111	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37377	37387		10.1074/jbc.M110.163691	http://dx.doi.org/10.1074/jbc.M110.163691			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876538	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000284424000030
J	Merregaert, J; Van Langen, J; Hansen, U; Ponsaerts, P; El Ghalbzouri, A; Steenackers, E; Van Ostade, X; Sercu, S				Merregaert, Joseph; Van Langen, Johanna; Hansen, Uwe; Ponsaerts, Peter; El Ghalbzouri, Abdoelwaheb; Steenackers, Ellen; Van Ostade, Xaveer; Sercu, Sandy			Phospholipid Scramblase 1 Is Secreted by a Lipid Raft-dependent Pathway and Interacts with the Extracellular Matrix Protein 1 in the Dermal Epidermal Junction Zone of Human Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; LIPOID PROTEINOSIS; HUMAN KERATINOCYTES; LICHEN-SCLEROSUS; PLASMA-MEMBRANE; COLLAGEN FIBRILS; GENE-EXPRESSION; ECM1; CELLS; DIFFERENTIATION	We examined the interaction of ECM1 (extracellular matrix protein 1) using yeast two-hybrid screening and identified the type II transmembrane protein, PLSCR1 (phospholipid scramblase 1), as a binding partner. This interaction was then confirmed by in vitro and in vivo co-immunoprecipitation experiments, and additional pull-down experiments with GST-tagged ECM1a fragments localized this interaction to occur within the tandem repeat region of ECM1a. Furthermore, immunohistochemical staining revealed a partial overlap of ECM1 and PLSCR1 in human skin at the basal epidermal cell layer. Moreover, in human skin equivalents, both proteins are expressed at the basal membrane in a dermal fibroblast-dependent manner. Next, immunogold electron microscopy of ultrathin human skin sections showed that ECM1 and PLSCR1 co-localize in the extracellular matrix, and using antibodies against ECM1 or PLSCR1 cross-linked to magnetic immunobeads, we were able to demonstrate PLSCR1-ECM1 interaction in human skin extracts. Furthermore, whereas ECM1 is secreted by the endoplasmic/Golgi-dependent pathway, PLSCR1 release from HaCaT keratinocytes occurs via a lipid raft-dependent mechanism, and is deposited in the extracellular matrix. In summary, we here demonstrate that PLSCR1 interacts with the tandem repeat region of ECM1a in the dermal epidermal junction zone of human skin and provide for the first time experimental evidence that PLSCR1 is secreted by an unconventional secretion pathway. These data suggest that PLSCR1 is a multifunctional protein that can function both inside and outside of the cell and together with ECM1 may play a regulatory role in human skin.	[Merregaert, Joseph; Van Langen, Johanna; Steenackers, Ellen; Sercu, Sandy] Univ Antwerp, Mol Biotechnol Lab, B-2610 Antwerp, Belgium; [Van Ostade, Xaveer] Univ Antwerp, Lab Prot Sci Prote & Epigenet Signaling, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Ponsaerts, Peter] Univ Antwerp, Lab Expt Hematol, Vaccine & Infect Dis Inst, B-2610 Antwerp, Belgium; [Hansen, Uwe] Univ Hosp Muenster, Dept Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [El Ghalbzouri, Abdoelwaheb] Leiden Univ, Med Ctr, Dept Dermatol, NL-2333 AL Leiden, Netherlands	University of Antwerp; University of Antwerp; University of Antwerp; University of Munster; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Merregaert, J (corresponding author), Univ Pl 1, B-2610 Antwerp, Belgium.	joseph.merregaert@ua.ac.be	Van Ostade, Xaveer/AAG-9587-2020; Ponsaerts, Peter/B-6213-2017; Van Ostade, Xaveer WMP/D-1702-2015	Ponsaerts, Peter/0000-0002-1892-6499; Van Ostade, Xaveer WMP/0000-0003-4078-3014	Deutsche Forschungsgemeinschaft [SFB492, TPA2]; Fund for Scientific Research Flanders; Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fund for Scientific Research Flanders(FWO); Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB492, TPA2).; Recipient of a postdoctoral fellowship of the "Fund for Scientific Research Flanders.; Recipient of a Ph. D. fellowship from the "Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen." Present address: EggCentris NV, J. Wybranlaan 40, 1070 Anderlecht, Belgium.	Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Bateman A, 2009, BIOINFORMATICS, V25, P159, DOI 10.1093/bioinformatics/btn595; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; BHALERAO J, 1995, J BIOL CHEM, V270, P16385, DOI 10.1074/jbc.270.27.16385; Boxman ILA, 1996, ARCH DERMATOL RES, V288, P391, DOI 10.1007/BF02507108; Chan I, 2004, CLIN EXP DERMATOL, V29, P499, DOI 10.1111/j.1365-2230.2004.01573.x; Chan I, 2007, EXP DERMATOL, V16, P881, DOI 10.1111/j.1600-0625.2007.00608.x; Huang Ying, 2006, Shengli Xuebao, V58, P501; Deckers MML, 2001, BONE, V28, P14, DOI 10.1016/S8756-3282(00)00428-2; Dong BH, 2004, J VIROL, V78, P8983, DOI 10.1128/JVI.78.17.8983-8993.2004; El Ghalbzouri A, 2005, J INVEST DERMATOL, V124, P79, DOI 10.1111/j.0022-202X.2004.23549.x; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Fujimoto N, 2005, BIOCHEM BIOPH RES CO, V333, P1327, DOI 10.1016/j.bbrc.2005.06.046; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Horev L, 2005, EXP DERMATOL, V14, P891, DOI 10.1111/j.1600-0625.2005.00374.x; Johnson MR, 1997, MATRIX BIOL, V16, P289, DOI 10.1016/S0945-053X(97)90017-2; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Laniosz V, 2009, J VIROL, V83, P8221, DOI 10.1128/JVI.00576-09; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Nakamaki T, 2002, EXP HEMATOL, V30, P421, DOI 10.1016/S0301-472X(02)00779-8; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Oyama N, 2004, J CLIN INVEST, V113, P1550, DOI 10.1172/GCI200420373; Oyama N, 2003, LANCET, V362, P118, DOI 10.1016/S0140-6736(03)13863-9; Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024; Ponsaerts P, 2004, GENE THER, V11, P1606, DOI 10.1038/sj.gt.3302342; Py B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005006; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Sander CS, 2006, BRIT J DERMATOL, V154, P218, DOI 10.1111/j.1365-2133.2005.07001.x; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Sercu S., 2010, TXB AGING SKIN, P77; Sercu S, 2008, J INVEST DERMATOL, V128, P1397, DOI 10.1038/sj.jid.5701231; Smits P, 1997, GENOMICS, V45, P487, DOI 10.1006/geno.1997.4918; Smits P, 2000, J INVEST DERMATOL, V114, P718, DOI 10.1046/j.1523-1747.2000.00916.x; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Urbach E, 1929, VIRCHOWS ARCH A, V273, P285, DOI 10.1007/BF02158983; Van Hougenhouck-Tulleken W, 2004, BRIT J DERMATOL, V151, P413, DOI 10.1111/j.1365-2133.2004.06076.x; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; WAELTI ER, 1992, J INVEST DERMATOL, V98, P805, DOI 10.1111/1523-1747.ep12499961; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Yu A, 2004, BIOCHEM J, V381, P609, DOI 10.1042/BJ20031857; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200	55	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37823	37837		10.1074/jbc.M110.136408	http://dx.doi.org/10.1074/jbc.M110.136408			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870722	Green Published, hybrid			2022-12-27	WOS:000284424000073
J	Atkin, KE; Brentnall, AS; Harris, G; Bingham, RJ; Erat, MC; Millard, CJ; Schwarz-Linek, U; Staunton, D; Vakonakis, I; Campbell, ID; Potts, JR				Atkin, Kate E.; Brentnall, Andrew S.; Harris, Gemma; Bingham, Richard J.; Erat, Michele C.; Millard, Christopher J.; Schwarz-Linek, Ulrich; Staunton, David; Vakonakis, Ioannis; Campbell, Iain D.; Potts, Jennifer R.			The Streptococcal Binding Site in the Gelatin-binding Domain of Fibronectin Is Consistent with a Non-linear Arrangement of Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; MEDIATE ADHERENCE; ENDOTHELIAL-CELLS; NMR-SPECTROSCOPY; MATRIX TURNOVER; PROTEIN; INTERNALIZATION; BACTERIA	Fibronectin-binding proteins (FnBPs) of Staphylococcus aureus and Streptococcus pyogenes mediate invasion of human endothelial and epithelial cells in a process likely to aid the persistence and/or dissemination of infection. In addition to binding sites for the N-terminal domain (NTD) of fibronectin (Fn), a number of streptococcal FnBPs also contain an upstream region (UR) that is closely associated with an NTD-binding region; UR binds to the adjacent gelatin-binding domain (GBD) of Fn. Previously, UR was shown to be required for efficient streptococcal invasion of epithelial cells. Here we show, using a Streptococcus zooepidemicus FnBP, that the UR-binding site in GBD resides largely in the (8)F1(9)F1 module pair. We also show that UR inhibits binding of a peptide from the alpha 1 chain of type I collagen to (8)F1(9)F1 and that UR binding to (8)F1 is likely to occur through anti-parallel beta-zipper formation. Thus, we propose that streptococcal proteins that contain adjacent NTD- and GBD-binding sites form a highly unusual extended tandem beta-zipper that spans the two domains and mediates high affinity binding to Fn through a large intermolecular interface. The proximity of the UR- and NTD-binding sequences in streptococcal FnBPs is consistent with a non-linear arrangement of modules in the tertiary structure of the GBD of Fn.	[Atkin, Kate E.; Brentnall, Andrew S.; Harris, Gemma; Bingham, Richard J.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Erat, Michele C.; Millard, Christopher J.; Staunton, David; Vakonakis, Ioannis; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Schwarz-Linek, Ulrich] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland	University of York - UK; University of York - UK; University of Oxford; University of St Andrews	Potts, JR (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jp516@york.ac.uk	Bingham, Richard J/H-6169-2019	Bingham, Richard J/0000-0003-3805-0364; Schwarz-Linek, Ulrich/0000-0003-0526-223X; Harris, Gemma/0000-0002-4587-4620; Millard, Chris/0000-0002-1012-0829	BBSRC; British Heart Foundation; FP7 Marie Curie Fellowship; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/D010608/1] Funding Source: researchfish; British Heart Foundation [FS/09/023/27460, FS/07/034/22969] Funding Source: researchfish; BBSRC [BB/D010608/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); FP7 Marie Curie Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the BBSRC.; Supported by the British Heart Foundation.; Supported by a FP7 Marie Curie Fellowship.; Supported by the Wellcome Trust.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; FORASTIERI H, 1985, J BIOL CHEM, V260, P546; Hynes RO, 1990, FIBRONECTINS; Jett BD, 2002, INFECT IMMUN, V70, P4697, DOI 10.1128/IAI.70.8.4697-4700.2002; JOH HJ, 1994, BIOCHEMISTRY-US, V33, P6086, DOI 10.1021/bi00186a007; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Lindmark H, 1996, INFECT IMMUN, V64, P3993, DOI 10.1128/IAI.64.10.3993-3999.1996; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; Millard CJ, 2005, FEBS LETT, V579, P4529, DOI 10.1016/j.febslet.2005.05.082; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Schor SL, 1999, J CELL SCI, V112, P3879; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699; Sottile J, 2005, MOL BIOL CELL, V16, P757, DOI 10.1091/mbc.e04-08-0672; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; TALAY SR, 1992, INFECT IMMUN, V60, P3837, DOI 10.1128/IAI.60.9.3837-3844.1992; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	35	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36977	36983		10.1074/jbc.M110.156935	http://dx.doi.org/10.1074/jbc.M110.156935			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843804	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000284146100036
J	Jun, JH; Yoon, WJ; Seo, SB; Woo, KM; Kim, GS; Ryoo, HM; Baek, JH				Jun, Ji Hae; Yoon, Won-Joon; Seo, Sang-Beom; Woo, Kyung-Mi; Kim, Gwan-Shik; Ryoo, Hyun-Mo; Baek, Jeong-Hwa			BMP2-activated Erk/MAP Kinase Stabilizes Runx2 by Increasing p300 Levels and Histone Acetyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; SERINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PATHWAY; MAPK	Runx2 is a critical transcription factor for osteoblast differentiation. Regulation of Runx2 expression levels and transcriptional activity is important for bone morphogenetic protein (BMP)-induced osteoblast differentiation. Previous studies have shown that extracellular signal-regulated kinase (Erk) activation enhances the transcriptional activity of Runx2 and that BMP-induced Runx2 acetylation increases Runx2 stability and transcriptional activity. Because BMP signaling induces Erk activation in osteoblasts, we sought to investigate whether BMP-induced Erk signaling regulates Runx2 acetylation and stability. Erk activation by overexpression of constitutively active MEK1 increased Runx2 transcriptional activity, whereas U0126, an inhibitor of MEK1/2, suppressed basal Runx2 transcriptional activity and BMP-induced Runx2 acetylation and stabilization. Overexpression of constitutively active MEK1 stabilized Runx2 protein via up-regulation of acetylation and down-regulation of ubiquitination. Erk activation increased p300 protein levels and histone acetyltransferase activity. Knockdown of p300 using siRNA diminished Erk-induced Runx2 stabilization. Overexpression of Smad5 increased Runx2 acetylation and stabilization. Erk activation further increased Smad-induced Runx2 acetylation and stabilization, whereas U0126 suppressed these functions. On the other hand, knockdown of Smad1 and Smad5 by siRNA suppressed both basal and Erk-induced Runx2 protein levels. Erk activation enhanced the association of Runx2 with p300 and Smad1. Taken together these results indicate that Erk signaling increases Runx2 stability and transcriptional activity, partly via increasing p300 protein levels and histone acetyltransferase activity and subsequently increasing Runx2 acetylation by p300. In addition to the canonical Smad pathway, a BMP-induced non-Smad Erk signaling pathway cooperatively regulates osteoblast differentiation partly via increasing the stability and transcriptional activity of Runx2.	[Jun, Ji Hae; Yoon, Won-Joon; Woo, Kyung-Mi; Kim, Gwan-Shik; Ryoo, Hyun-Mo; Baek, Jeong-Hwa] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Jun, Ji Hae; Yoon, Won-Joon; Woo, Kyung-Mi; Kim, Gwan-Shik; Ryoo, Hyun-Mo; Baek, Jeong-Hwa] Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea; [Seo, Sang-Beom] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chung Ang University	Ryoo, HM (corresponding author), Seoul Natl Univ, Sch Dent, Dept Mol Genet, 28 Yeongun Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr; baekjh@snu.ac.kr	Woo, Kyung Mi/A-2793-2009; Baek, Jeong-Hwa/A-8628-2012; Ryoo, Hyun-Mo/D-5839-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341	Ministry of Education, Science, and Technology [311-2006-1-E00093, 531-2007-1-E00070]; Ministry of Health and Welfare [A085021]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grants 311-2006-1-E00093 and 531-2007-1-E00070) and by the Korea Health 21 R&D Project, Ministry of Health and Welfare (Grant A085021).	Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen C, 2004, J BIOL CHEM, V279, P29121, DOI 10.1074/jbc.M313000200; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Hurley MM, 1996, J BONE MINER RES, V11, P1256; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lee HL, 2010, BIOCHEM BIOPH RES CO, V391, P1087, DOI 10.1016/j.bbrc.2009.12.027; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yakmovych I, 2001, FASEB J, V15, P553; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yue JB, 2000, METH MOL B, V142, P125; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	56	124	129	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36410	36419		10.1074/jbc.M110.142307	http://dx.doi.org/10.1074/jbc.M110.142307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851880	Green Published, hybrid			2022-12-27	WOS:000284146100032
J	Lau, AW; Pringle, LM; Quick, L; Riquelme, DN; Ye, Y; Oliveira, AM; Chou, MM				Lau, Alan W.; Pringle, Lashon M.; Quick, Laura; Riquelme, Daisy N.; Ye, Ying; Oliveira, Andre M.; Chou, Margaret M.			TRE17/Ubiquitin-specific Protease 6 (USP6) Oncogene Translocated in Aneurysmal Bone Cyst Blocks Osteoblastic Maturation via an Autocrine Mechanism Involving Bone Morphogenetic Protein Dysregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE-INFLAMMATORY PROTEIN-1-ALPHA; KAPPA-B LIGAND; MC3T3-E1 CELLS; OSTEOCLAST FORMATION; RECEPTOR ACTIVATOR; UBIQUITIN LIGASE; IN-VITRO; DIFFERENTIATION; TRE2; EXPRESSION	Aneurysmal bone cyst (ABC) is a pediatric osseous tumor characterized by extensive destruction of the surrounding bone. The molecular mechanisms underlying its pathogenesis are completely unknown. Recent work showed that translocation of the TRE17/USP6 locus occurs in over 60% of ABC cases resulting in TRE17 overexpression. Immature osteoblasts are presumed to be the cell type harboring translocation of TRE17 in at least a subset of ABCs. However, the effects of TRE17 overexpression on transformation and osteoblast function are unknown. TRE17 encodes a ubiquitin-specific protease (USP) and a TBC (TRE2-Bub2-Cdc16) domain that promotes activation of the Arf6 GTPase. Here we report that TRE17 potently inhibits the maturation of MC3T3 pre-osteoblasts in a USP-dependent and Arf6-independent manner. Notably, we find that TRE17 function is mediated through an autocrine mechanism. Transcriptome analysis of TRE17-expressing cells reveals dysregulation of several pathways with established roles in osteoblast maturation. In particular, signaling through the bone morphogenetic protein (BMP) pathway, a key regulator of osteogenesis, is profoundly altered. TRE17 simultaneously inhibits the expression of BMP-4 while augmenting the BMP antagonist, Gremlin-1. Osteoblastic maturation is restored in TRE17-expressing cells by the addition of exogenous BMP-4, thus establishing a functional role for BMP-4 during TRE17-induced transformation. Because bone homeostasis involves a precise balance between the activities of osteoblasts and osteoclasts, our studies raise the possibility that attenuated osteoblast maturation caused by TRE17 overexpression may contribute to the bone loss/destruction observed in ABC.	[Lau, Alan W.; Pringle, Lashon M.; Quick, Laura; Riquelme, Daisy N.; Ye, Ying; Chou, Margaret M.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lau, Alan W.; Pringle, Lashon M.; Quick, Laura; Riquelme, Daisy N.; Ye, Ying; Chou, Margaret M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Oliveira, Andre M.] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Mayo Clinic	Chou, MM (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, 3615 Civ Ctr Blvd,ARC 816E, Philadelphia, PA 19104 USA.	mmc@mail.med.upenn.edu			National Institutes of Health [RO1 CA081415]; NCI and NIH [P30 AR050950]; National Research Service [F31CA126488]; NIAMS [P30 AR050950]; NATIONAL CANCER INSTITUTE [R01CA081415, F31CA126488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI and NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA081415 (to M. M. C.) from the NCI and NIH Grant P30 AR050950 (Penn Center for Musculoskeletal Disorders). This work was also supported by National Research Service Award Grant F31CA126488 (to L. M. P.).; The Penn Center for Musculoskeletal Disorders was supported by National Institutes of Health Grant P30 AR050950 from the NIAMS.	Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bizimungu C, 2005, BIOCHEM BIOPH RES CO, V335, P883, DOI 10.1016/j.bbrc.2005.07.159; Bizimungu C, 2007, BIOTECHNOL LETT, V29, P1927, DOI 10.1007/s10529-007-9475-6; Cottalorda J, 2007, ARCH ORTHOP TRAUM SU, V127, P105, DOI 10.1007/s00402-006-0223-5; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Fujikawa Y, 2001, BONE, V28, P261, DOI 10.1016/S8756-3282(00)00453-1; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Giuliani N, 2004, EXP HEMATOL, V32, P685, DOI 10.1016/j.exphem.2004.03.015; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Masuda-Robens JM, 2003, MOL CELL BIOL, V23, P2151, DOI 10.1128/MCB.23.6.2151-2161.2003; Nomura K, 2008, BIOCHEM BIOPH RES CO, V367, P881, DOI 10.1016/j.bbrc.2008.01.023; Oba Y, 2005, EXP HEMATOL, V33, P272, DOI 10.1016/j.exphem.2004.11.015; Oliveira AM, 2005, ONCOGENE, V24, P3419, DOI 10.1038/sj.onc.1208506; Oliveira AM, 2004, CANCER RES, V64, P1920, DOI 10.1158/0008-5472.CAN-03-2827; Oliveira AM, 2004, AM J PATHOL, V165, P1773, DOI 10.1016/S0002-9440(10)63432-3; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Saccomanni B, 2008, ARCH ORTHOP TRAUM SU, V128, P1145, DOI 10.1007/s00402-007-0477-6; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Scheven BAA, 1999, BIOCHEM BIOPH RES CO, V254, P773, DOI 10.1006/bbrc.1998.9909; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Shih C, 1996, Zhonghua Yi Xue Za Zhi (Taipei), V57, P85; van de Luijtgaarden ACM, 2009, VIRCHOWS ARCH, V455, P455, DOI 10.1007/s00428-009-0845-4; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Ye Y, 2010, ONCOGENE, V29, P3619, DOI 10.1038/onc.2010.116; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	36	43	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37111	37120		10.1074/jbc.M110.175133	http://dx.doi.org/10.1074/jbc.M110.175133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864534	Green Published, hybrid			2022-12-27	WOS:000284146100063
J	Ma, BY; Nussinov, R				Ma, Buyong; Nussinov, Ruth			Polymorphic C-terminal beta-Sheet Interactions Determine the Formation of Fibril or Amyloid beta-derived Diffusible Ligand-like Globulomer for the Alzheimer A beta 42 Dodecamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ION CHANNELS; EXPERIMENTAL CONSTRAINTS; MOLECULAR-DYNAMICS; SOLVENT PROTECTION; OXIDATIVE STRESS; EMERGING ROLE; PROTEIN; OLIGOMERS; PEPTIDE	The relationship between amyloid deposition and cellular toxicity is still controversial. In addition to fibril-forming oligomers, other soluble A beta forms (amyloid beta-derived diffusible ligands (ADDLs)) were also suggested to form and to present different morphologies and mechanisms of toxicity. One ADDL type, the "globulomer," apparently forms independently of the fibril aggregation pathway. Even though many studies argue that such soluble A beta oligomers are off fibril formation pathways, they may nonetheless share some structural similarity with protofibrils. NMR data of globulomer intermediates, "preglobulomers," suggested parallel in-register C-terminal beta-sheets, with different N-terminal conformations. Based on experimental data, we computationally investigate four classes of A beta dodecamers: fibril, fibril oligomer, prefibril/preglobulomer cluster, and globulomer models. Our simulations of the solvent protection of double-layered fibril and globulomer models reproduce experimental observations. Using a single layer A beta fibril oligomer beta-sheet model, we found that the C-terminal beta-sheet in the fibril oligomer is mostly curved, preventing it from quickly forming a fibril and leading to its breaking into shorter pieces. The simulations also indicate that beta-sheets packed orthogonally could be the most stable species for A beta dodecamers. The major difference between fibril-forming oligomers and ADDL-like oligomers (globulomers) could be the exposure of Met-35 patches. Although the Met-35 patches are necessarily exposed in fibril-forming oligomers to allow their maturation into fibrils, the Met-35 patches in the globulomer are covered by other residues in the orthogonally packed A beta peptides. Our results call attention to the possible existence of certain "critical intermediates" that can lead to both seeds and other soluble ADDL-like oligomers.	[Ma, Buyong; Nussinov, Ruth] NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Ma, BY (corresponding author), NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program, Bldg 469,Rm 151, Frederick, MD 21702 USA.	mabuyong@mail.nih.gov	Ma, Buyong/F-9491-2011	Ma, Buyong/0000-0002-7383-719X; Nussinov, Ruth/0000-0002-8115-6415	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Cancer Institute, National Institutes of Health under contract number HHSN261200800001E and by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research.	Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Butterfield DA, 2010, FREE RADICAL BIO MED, V48, P136, DOI 10.1016/j.freeradbiomed.2009.10.035; Butterfield DA, 2002, PEPTIDES, V23, P1299, DOI 10.1016/S0196-9781(02)00066-9; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Jang H, 2008, BIOPHYS J, V95, P4631, DOI 10.1529/biophysj.108.134551; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Kanski J, 2002, BBA-MOL BASIS DIS, V1586, P190, DOI 10.1016/S0925-4439(01)00097-7; Kanski J, 2002, NEUROTOX RES, V4, P219, DOI 10.1080/10298420290023945; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; Misiti F, 2010, NEUROCHEM INT, V56, P597, DOI 10.1016/j.neuint.2010.01.002; Mustata M, 2009, J AM CHEM SOC, V131, P14938, DOI 10.1021/ja9049299; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	56	31	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37102	37110		10.1074/jbc.M110.133488	http://dx.doi.org/10.1074/jbc.M110.133488			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847046	Green Published, hybrid			2022-12-27	WOS:000284146100066
J	Agarwal, V; Asmat, TM; Dierdorf, NI; Hauck, CR; Hammerschmidt, S				Agarwal, Vaibhav; Asmat, Tauseef M.; Dierdorf, Nina I.; Hauck, Christof R.; Hammerschmidt, Sven			Polymeric Immunoglobulin Receptor-mediated Invasion of Streptococcus pneumoniae into Host Cells Requires a Coordinate Signaling of SRC Family of Protein-tyrosine Kinases, ERK, and c-Jun N-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MICROVASCULAR ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; IG RECEPTOR; BACTERIAL PATHOGENS; MAMMALIAN-CELLS; SECRETORY IGA; ACTIVATION; INTEGRIN	Streptococcus pneumoniae are commensals of the human nasopharynx with the capacity to invade mucosal respiratory cells. PspC, a pneumococcal surface protein, interacts with the human polymeric immunoglobulin receptor (pIgR) to promote bacterial adherence to and invasion into epithelial cells. Internalization of pneumococci requires the coordinated action of actin cytoskeleton rearrangements and the retrograde machinery of pIgR. Here, we demonstrate the involvement of Src protein-tyrosine kinases (PTKs), focal adhesion kinase (FAK), extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) but not p38 mitogen-activated protein kinases (MAPK) in pneumococcal invasion via pIgR. Pharmacological inhibitors of PTKs and MAPKs and genetic interference with Src PTK and FAK functions caused a significant reduction of pIgR-mediated pneumococcal invasion but did not influence bacterial adhesion to host cells. Furthermore, pneumococcal ingestion by host cells induces activation of ERK1/2 and JNK. In agreement with activated JNK, its target molecule and DNA-binding protein c-Jun was phosphorylated. We also show that functionally active Src PTK is essential for activation of ERK1/2 upon pneumococcal infections. In conclusion, these data illustrate the importance of a coordinated signaling between Src PTKs, ERK1/2, and JNK during PspC-pIgR-mediated uptake of pneumococci by host epithelial cells.	[Agarwal, Vaibhav; Asmat, Tauseef M.; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Agarwal, Vaibhav; Hammerschmidt, Sven] Univ Munich, Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Dierdorf, Nina I.; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Dierdorf, Nina I.; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Munich; University of Konstanz; University of Konstanz	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Genom, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010; Asmat, Tauseef M/Q-3801-2019	Hammerschmidt, Sven/0000-0002-6382-6681; 	Deutsche Forschungsgemeinschaft [DFG Ha 3125/2-1, Ha 3125/4-1]; European Union [FP7 CAREPNEUMO EU-CP223111]; German Academic Exchange Service (DAAD)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants DFG Ha 3125/2-1 and Ha 3125/4-1 and European Union Grant FP7 CAREPNEUMO EU-CP223111.; Recipients of German Academic Exchange Service (DAAD) fellowships.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Czerucka D, 2001, INFECT IMMUN, V69, P1298, DOI 10.1128/IAI.69.3.1298-1305.2001; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Ellington JK, 2001, INFECT IMMUN, V69, P5235, DOI 10.1128/IAI.69.9.5235-5242.2001; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lu L, 2003, J BIOL CHEM, V278, P48178, DOI 10.1074/jbc.M306906200; Luton F, 1999, MOL BIOL CELL, V10, P1409, DOI 10.1091/mbc.10.5.1409; Luton F, 1998, MOL BIOL CELL, V9, P1787, DOI 10.1091/mbc.9.7.1787; Maza PK, 2008, MICROBES INFECT, V10, P540, DOI 10.1016/j.micinf.2008.02.004; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; MOSTOV KE, 1984, NATURE, V308, P37, DOI 10.1038/308037a0; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; N'Guessan PD, 2005, THROMB HAEMOSTASIS, V94, P295, DOI 10.1160/TH04-12-0822; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naumann M, 1998, J EXP MED, V188, P1277, DOI 10.1084/jem.188.7.1277; Nerlich A, 2009, J BIOL CHEM, V284, P20319, DOI 10.1074/jbc.M109.016501; Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; PISKURICH JF, 1995, J IMMUNOL, V154, P1735; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Rovedo M, 2008, J VIROL, V82, P8520, DOI 10.1128/JVI.00843-08; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Shimada S, 1999, J IMMUNOL, V163, P5367; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; TAMER CM, 1995, J IMMUNOL, V155, P707; Tang P, 1998, INFECT IMMUN, V66, P1106, DOI 10.1128/IAI.66.3.1106-1112.1998; Watanabe K, 2001, INFECT IMMUN, V69, P6731, DOI 10.1128/IAI.69.11.6731-6737.2001; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	63	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35615	35623		10.1074/jbc.M110.172999	http://dx.doi.org/10.1074/jbc.M110.172999			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829350	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000283845300040
J	Jamros, MA; Oliveira, LC; Whitford, PC; Onuchic, JN; Adams, JA; Blumenthal, DK; Jennings, PA				Jamros, Michael A.; Oliveira, Leandro C.; Whitford, Paul C.; Onuchic, Jose N.; Adams, Joseph A.; Blumenthal, Donald K.; Jennings, Patricia A.			Proteins at Work A COMBINED SMALL ANGLE X-RAY SCATTERING AND THEORETICAL DETERMINATION OF THE MULTIPLE STRUCTURES INVOLVED ON THE PROTEIN KINASE FUNCTIONAL LANDSCAPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL SRC KINASE; TYROSINE KINASE; ENERGY LANDSCAPE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SH2 DOMAIN; C-SRC; CSK; CONFORMATION; RECOGNITION	C-terminal Src kinase (Csk) phosphorylates and down-regulates the Src family tyrosine kinases (SFKs). Crystallographic studies of Csk found an unusual arrangement of the SH2 and SH3 regulatory domains about the kinase core, forming a compact structure. However, recent structural studies of mutant Csk in the presence of an inhibitor indicate that the enzyme accesses an expanded structure. To investigate whether wt-Csk may also access open conformations we applied small angle x-ray scattering (SAXS). We find wt-Csk frequently occupies an extended conformation where the regulatory domains are removed from the kinase core. In addition, all-atom structure-based simulations indicate Csk occupies two free energy basins. These basins correspond to ensembles of distinct global conformations of Csk: a compact structure and an extended structure. The transitions between these structures are entropically driven and accessible via thermal fluctuations that break local interactions. We further characterized the ensemble by generating theoretical scattering curves for mixed populations of conformations from both basins and compared the predicted scattering curves to the experimental profile. This population-combination analysis is more consistent with the experimental data than any rigid model. It suggests that Csk adopts a broad ensemble of conformations in solution, populating extended conformations not observed in the crystal structure that may play an important role in the regulation of Csk. The methodology developed here is broadly applicable to biological macromolecules and will provide useful information about what ensembles of conformations are consistent with the experimental data as well as the ubiquitous dynamic reversible assembly processes inherent in biology.	[Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Oliveira, Leandro C.; Whitford, Paul C.; Onuchic, Jose N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Oliveira, Leandro C.; Whitford, Paul C.; Onuchic, Jose N.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Whitford, Paul C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Los Alamos National Laboratory; Utah System of Higher Education; University of Utah	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pajennin@ucsd.edu	Oliveira, Leandro Cristante de/F-8638-2012	Oliveira, Leandro Cristante de/0000-0002-6932-6792; Blumenthal, Donald/0000-0002-8614-1167	National Institutes of Health [5T32GM008326, DK54441, GM67969]; National Science Foundation [PHY-0822283];  [NSF-MCB-0543906]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM054038, R01GM067969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5T32GM008326, DK54441, and GM67969. Support was also provided by the Center for Theoretical Biological Physics sponsored by National Science Foundation Grant PHY-0822283 with additional support from NSF-MCB-0543906.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Bernado P, 2008, J MOL BIOL, V376, P492, DOI 10.1016/j.jmb.2007.11.066; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BOUGERET C, 1993, ONCOGENE, V8, P1241; BRAUNINGER A, 1992, GENE, V110, P205, DOI 10.1016/0378-1119(92)90649-A; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Chen J, 2008, PHYS CHEM CHEM PHYS, V10, P471, DOI 10.1039/b714141f; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Forster F, 2008, J MOL BIOL, V382, P1089, DOI 10.1016/j.jmb.2008.07.074; Grubisic I, 2010, J STRUCT BIOL, V169, P95, DOI 10.1016/j.jsb.2009.09.010; Hegler JA, 2008, HFSP J, V2, P307, DOI 10.2976/1.3003931; Jiang LQ, 2006, ONCOGENE, V25, P5495, DOI 10.1038/sj.onc.1209554; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kim SJ, 2008, BIOPHYS J, V94, P4924, DOI 10.1529/biophysj.107.123240; Kouza M, 2006, J PHYS CHEM A, V110, P671, DOI 10.1021/jp053770b; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; Lee SS, 2006, J BIOL CHEM, V281, P8183, DOI 10.1074/jbc.M508120200; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Levinson NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007683; Lieser SA, 2006, J BIOL CHEM, V281, P38004, DOI 10.1074/jbc.M607824200; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Lin XF, 2003, J BIOL CHEM, V278, P24072, DOI 10.1074/jbc.M210596200; Lu Q, 2009, J PHYS CHEM B, V113, P1517, DOI 10.1021/jp808923a; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; Mills JE, 2007, J MOL BIOL, V365, P1460, DOI 10.1016/j.jmb.2006.10.076; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NOEL JK, NUCL ACIDS RES S, V38, pW657; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Oliveira LC, 2008, J PHYS CHEM B, V112, P6131, DOI 10.1021/jp0769835; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Roy M, 2005, J MOL BIOL, V348, P335, DOI 10.1016/j.jmb.2005.02.059; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Sun GQ, 1999, ARCH BIOCHEM BIOPHYS, V367, P167, DOI 10.1006/abbi.1999.1253; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang SC, 2009, BIOPHYS J, V96, P4449, DOI 10.1016/j.bpj.2009.03.036	58	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36121	36128		10.1074/jbc.M110.116947	http://dx.doi.org/10.1074/jbc.M110.116947			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20801888	Green Published, hybrid			2022-12-27	WOS:000283845300088
J	Deshmukh, L; Gorbatyuk, V; Vinogradova, O				Deshmukh, Lalit; Gorbatyuk, Vitaliy; Vinogradova, Olga			Integrin beta(3) Phosphorylation Dictates Its Complex with the Shc Phosphotyrosine-binding (PTB) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; PROTEIN SHC; CYTOPLASMIC TAILS; NMR-SPECTROSCOPY; ACTIVATION; MEMBRANE; TALIN; ALPHA(IIB)BETA(3); IDENTIFICATION; RECOGNITION	Adaptor protein Shc plays a key role in mitogen-activated protein kinase (MAPK) signaling pathway, which can be mediated through a number of different receptors including integrins. By specifically recognizing the tyrosine-phosphorylated integrin beta(3), Shc has been shown to trigger integrin outside-in signaling, although the structural basis of this interaction remains nebulous. Here we present the detailed structural analysis of Shc phosphotyrosine-binding (PTB) domain in complex with the bi-phosphorylated beta(3)integrin cytoplasmic tail (CT). We show that this complex is primarily defined by the phosphorylation state of the integrin C-terminal Tyr(759), which fits neatly into the classical PTB pocket of Shc. In addition, we have identified a novel binding interface which concurrently accommodates phosphorylated Tyr(747) of the highly conserved NPXY motif of beta(3). The structure represents the first snapshot of an integrin cytoplasmic tail bound to a target for mediating the outside-in signaling. Detailed comparison with the known Shc PTB structure bound to a target TrkA peptide revealed some significant differences, which shed new light upon the PTB domain specificity.	[Deshmukh, Lalit; Vinogradova, Olga] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Gorbatyuk, Vitaliy] Univ Connecticut, Biotechnol Bioserv Ctr, BioNMR Facil, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Vinogradova, O (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	olga.vinogradova@uconn.edu	Deshmukh, Lalit/C-5073-2015; Vinogradova, Olga/ABE-8367-2020	Vinogradova, Olga/0000-0001-5101-7361	AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098777] Funding Source: NIH RePORTER	AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported in part by AHA grants (to O. V.).	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Farooq A, 2003, STRUCTURE, V11, P905, DOI 10.1016/S0969-2126(03)00134-5; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Higashi T, 2004, BIOCHEM BIOPH RES CO, V322, P700, DOI 10.1016/j.bbrc.2004.07.177; Hoch JC, 1996, NMR DATA PROCESSING; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; KOSEN P, 1989, METHODS ENZYMOLOGY B, P86; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mahoney NM, 2000, J AM CHEM SOC, V122, P7851, DOI 10.1021/ja001240h; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; ZHOU MM, 1995, P NATL ACAD SCI USA, V92, P7784, DOI 10.1073/pnas.92.17.7784; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	43	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34875	34884		10.1074/jbc.M110.159087	http://dx.doi.org/10.1074/jbc.M110.159087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739287	hybrid, Green Published			2022-12-27	WOS:000283659100062
J	Jin, ZG; Wallace, L; Harper, SQ; Yang, J				Jin, Zhigang; Wallace, Lindsay; Harper, Scott Q.; Yang, Jing			PP2A:B56 epsilon, a Substrate of Caspase-3, Regulates p53-dependent and p53-independent Apoptosis during Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; T-LYMPHOCYTE STIMULATION; A-ALPHA SUBUNIT; TUMOR-SUPPRESSOR; CELL-DEATH; CYCLIN-G; SERINE/THREONINE PHOSPHATASES; XENOPUS EMBRYOS; PP2A; P53	Protein phosphatase 2A (PP2A) is one of the most abundantly expressed serine/threonine protein phosphatases. A large body of evidence suggests that PP2A is a tumor suppressor and plays critical roles in regulating apoptosis. PP2A is a heterotrimeric protein complex. Its substrate specificity, localization, and activity are regulated by regulatory subunits of PP2A. A recent study has demonstrated that single nucleotide polymorphism in B56 epsilon (PPP2R5E), a B56 family regulatory subunit of PP2A, is associated with human soft tissue sarcoma. This raises the possibility that B56 epsilon is involved in tumorigenesis and plays important roles in regulating apoptosis. However, this hypothesis has not been tested experimentally. Our previous studies revealed that B56 epsilon regulates a number of developmental signaling pathways during early embryonic patterning. Here we report novel functions of B56 epsilon in regulating apoptosis. We provide evidence that B56 epsilon has both anti-and pro-apoptotic functions. B56 epsilon suppresses p53-independent apoptosis during neural development, but triggers p53-dependent apoptosis. Mechanistically, B56 epsilon regulates the p53-dependent apoptotic pathway solely through controlling the stability of p53 protein. In addition to its function in regulating apoptosis, we show that B56 epsilon undergoes proteolytic cleavage. The cleavage of B56 epsilon is mediated by caspase-3 and occurs on the carboxyl side of an evolutionarily conserved N-terminal "DKXD" motif. These results demonstrate that B56 epsilon, a substrate of caspase-3, is an essential regulator of apoptosis. So far, we have identified an alternative translation isoform and a caspase cleavage product of B56 epsilon. The significance of post-transcriptional regulation of B56 epsilon is discussed.	[Jin, Zhigang; Wallace, Lindsay; Harper, Scott Q.; Yang, Jing] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Yang, J (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43205 USA.	Jing.Yang@nationwidechildrens.org	Jin, Zhigang/T-7125-2019; Harper, Scott/E-3205-2011	Jin, Zhigang/0000-0001-7557-2968; 	National Institutes of Health, NIGMS [1R01GM093217-01A1]; Nationwide Children's Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093217] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nationwide Children's Hospital(Ohio State University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM093217-01A1 from NIGMS (to J. Y.).; Supported by the Nationwide Children's Hospital internal fund.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; CHEN JY, 1993, ONCOGENE, V8, P2159; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; DEMETRICK DJ, 1995, CYTOGENET CELL GENET, V69, P190, DOI 10.1159/000133960; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Gjoerup O, 2001, J VIROL, V75, P9142, DOI 10.1128/JVI.75.19.9142-9155.2001; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; HENSEY C, 1997, J MECH DEV */* Mech, V69, P183; HOWE JA, 1995, GENE DEV, V9, P1164, DOI 10.1101/gad.9.10.1164; JANSSENS V, 2001, J BIOCH J */* BIOCH, V353, P417; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kateneva AV, 2009, DEV CELL, V17, P303, DOI 10.1016/j.devcel.2009.08.016; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Lin SS, 2006, J BIOL CHEM, V281, P23003, DOI 10.1074/jbc.M602648200; Liu W, 2007, MOL CELL PROTEOMICS, V6, P319, DOI 10.1074/mcp.M600272-MCP200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Miossec C, 1997, J BIOL CHEM, V272, P13459, DOI 10.1074/jbc.272.21.13459; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nojima H, 2006, GENOME DYN, V1, P131, DOI 10.1159/000092505; Okamoto K, 1996, MOL CELL BIOL, V16, P6593; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Peng AM, 2008, CELL CYCLE, V7, P3, DOI 10.4161/cc.7.1.5157; Posmantur R, 1998, EXP CELL RES, V244, P302, DOI 10.1006/excr.1998.4214; Rivera T, 2006, BIOESSAYS, V28, P775, DOI 10.1002/bies.20448; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Ruvolo VR, 2008, J BIOL CHEM, V283, P35474, DOI 10.1074/jbc.M800951200; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2007, CELL ADHES MIGR, V1, P140, DOI 10.4161/cam.1.3.4986; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Stack JH, 1997, DEVELOPMENT, V124, P3185; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Tsao CC, 2007, CELL CYCLE, V6, P2377, DOI 10.4161/cc.6.19.4737; VASEVA AV, 2009, BIOCHIM BIOPHYS ACTA, P414; Veenstra GJC, 1998, CELL DEATH DIFFER, V5, P774, DOI 10.1038/sj.cdd.4400416; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; ZAUBERMAN A, 1995, ONCOGENE, V10, P2361	78	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34493	34502		10.1074/jbc.M110.169581	http://dx.doi.org/10.1074/jbc.M110.169581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807766	Green Published, hybrid			2022-12-27	WOS:000283659100024
J	Ouimet, T; Orng, SV; Poras, H; Gagnidze, K; Devi, LA; Fournie-Zaluski, MC; Roques, BP				Ouimet, Tanja; Orng, Sou-Vinh; Poras, Herve; Gagnidze, Khatuna; Devi, Lakshmi A.; Fournie-Zaluski, Marie-Claude; Roques, Bernard P.			Identification of an Endothelin-converting Enzyme-2-specific Fluorigenic Substrate and Development of an in Vitro and ex Vivo Enzymatic Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL ENDOPEPTIDASE ENKEPHALINASE; MEMBRANE-BOUND METALLOPROTEASE; ALZHEIMERS-DISEASE; POTENT INHIBITORS; MOLECULAR-CLONING; ACTIVE-SITE; A-BETA; NEPRILYSIN; ENZYME-1; EXPRESSION	Endothelin-converting enzyme-2 (ECE-2) is a membrane-bound zinc-dependent metalloprotease that shares a high degree of sequence homology with ECE-1, but displays an acidic pH optimum characteristic of maturing enzymes acting late in the secretory pathway. Although ECE-2, like ECE-1, can cleave the big endothelin intermediate to produce the vasoconstrictive endothelin peptide, its true physiological function remains to be elucidated, a task that is hampered by the lack of specific tools to study and discriminate ECE-2 from ECE-1, i.e. specific substrates and/or specific inhibitors. To fill this gap, we searched for novel ECE-specific peptide substrates. To this end, peptides derived from the big endothelin intermediate were tested using ECE-1 and ECE-2, leading to the identification of an ECE-1-specific substrate. Moreover, screening of our proprietary fluorigenic peptide Fluofast(R) libraries using ECE-1 and ECE-2 allowed the identification of Ac-SKG-Pya-F-W-Nop-GGK-NH2 (PL405), as a specific and high affinity ECE-2 substrate. Indeed, ECE-2 cleaved PL405 at the Pya-F amide bond with a specificity constant (k(cat)/K-m) of 8.1 +/- 0.9 x 10(3) M-1 s(-1). Using this novel substrate, we also characterized the first potent (K-i = 7.7 +/- 0.3 nM) and relatively selective ECE-2 inhibitor and developed a quantitative fluorigenic ECE-2 assay. The assay was used to study the ex vivo ECE-2 activity in wild type and ECE-2 knockout tissues and was found to truly reflect ECE-2 expression patterns. The PL405 assay is thus the first tool to study ECE-2 inhibition using high throughput screening or for ex vivo ECE-2 quantification.	[Ouimet, Tanja; Orng, Sou-Vinh; Poras, Herve; Fournie-Zaluski, Marie-Claude; Roques, Bernard P.] Pharmaleads, F-75013 Paris, France; [Gagnidze, Khatuna; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Roques, BP (corresponding author), Pharmaleads, Paris BioPk,11 Rue Watt, F-75013 Paris, France.	bernard.roques@pharmaleads.com	Devi P, Lakshmi/GXM-5982-2022; PORAS, Hervé/ABE-1773-2020	Devi P, Lakshmi/0000-0001-9274-4776; PORAS, Herve/0000-0002-3329-7432	National Institutes of Health [NS26880, DA19521]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA019521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS26880 and DA19521 (to L. A. D.).	Ahn K, 1998, ARCH BIOCHEM BIOPHYS, V359, P258, DOI 10.1006/abbi.1998.0913; AUBRY M, 1987, BIOCHEM CELL BIOL, V65, P398, DOI 10.1139/o87-050; BACK SA, 1989, J NEUROSCI, V9, P4439; Daull P, 2005, AM J HYPERTENS, V18, P1606, DOI 10.1016/j.amjhyper.2005.06.022; DEVAULT A, 1988, J BIOL CHEM, V263, P4033; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fahnoe DC, 2000, J CARDIOVASC PHARM, V36, pS22, DOI 10.1097/00005344-200036051-00009; FOURNIEZALUSKI MC, 1994, P NATL ACAD SCI USA, V91, P4072, DOI 10.1073/pnas.91.9.4072; Funalot B, 2004, MOL PSYCHIATR, V9, P1122, DOI 10.1038/sj.mp.4001584; Gagnidze K, 2008, J MED CHEM, V51, P3378, DOI 10.1021/jm7015478; Ghaddar G, 2000, BIOCHEM J, V347, P419, DOI 10.1042/0264-6021:3470419; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Inguimbert N, 2002, J MED CHEM, V45, P1477, DOI 10.1021/jm0005454; Inguimbert N, 2002, BIOORG MED CHEM LETT, V12, P2001, DOI 10.1016/S0960-894X(02)00248-2; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Luciani N, 2001, BIOCHEM J, V356, P813, DOI 10.1042/0264-6021:3560813; Mzhavia N, 2003, J BIOL CHEM, V278, P14704, DOI 10.1074/jbc.M211242200; Oefner C, 2004, ACTA CRYSTALLOGR D, V60, P392, DOI 10.1107/S0907444903027410; OHNAKA K, 1993, J BIOL CHEM, V268, P26759; Palmer JC, 2009, AM J PATHOL, V175, P262, DOI 10.2353/ajpath.2009.081054; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; RODERICK SL, 1989, BIOCHEMISTRY-US, V28, P1493, DOI 10.1021/bi00430a011; Rodriguiz RM, 2008, GENES BRAIN BEHAV, V7, P418, DOI 10.1111/j.1601-183X.2007.00365.x; Roques BP, 2000, TRENDS PHARMACOL SCI, V21, P475, DOI 10.1016/S0165-6147(00)01571-6; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; ROQUES BP, 1993, BIOCHEM SOC T, V21, P678, DOI 10.1042/bst0210678; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Rose C, 2002, BIOCHEM J, V363, P697, DOI 10.1042/0264-6021:3630697; Schulz H, 2009, J MOL BIOL, V385, P178, DOI 10.1016/j.jmb.2008.10.052; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Tanja O, 2000, BIOCHEM BIOPH RES CO, V271, P565, DOI 10.1006/bbrc.2000.2664; Valdenaire O, 1999, MOL BRAIN RES, V64, P211, DOI 10.1016/S0169-328X(98)00321-0; Valeur B., 2004, INVITATION FLUORESCE; Weeraratna AT, 2007, EXP CELL RES, V313, P450, DOI 10.1016/j.yexcr.2006.10.028; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447	43	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34390	34400		10.1074/jbc.M110.120576	http://dx.doi.org/10.1074/jbc.M110.120576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807771	Green Published, hybrid			2022-12-27	WOS:000283659100013
J	Zheng, ZQ; Sabirzhanov, B; Keifer, J				Zheng, Zhaoqing; Sabirzhanov, Boris; Keifer, Joyce			Oligomeric Amyloid-beta Inhibits the Proteolytic Conversion of Brain-derived Neurotrophic Factor (BDNF), AMPA Receptor Trafficking, and Classical Conditioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SLICE CULTURES; PROTEIN-KINASE-II; IN-VITRO; ALZHEIMERS-DISEASE; SYNAPTIC DELIVERY; SILENT SYNAPSES; MESSENGER-RNA; ACQUISITION; ACTIVATION	Amyloid-beta (A beta) peptide is thought to have a significant role in the progressive memory loss observed in patients with Alzheimer disease and inhibits synaptic plasticity in animal models of learning. We previously demonstrated that brain-derived neurotrophic factor (BDNF) is critical for synaptic AMPA receptor delivery in an in vitro model of eyeblink classical conditioning. Here, we report that acquisition of conditioned responses was significantly attenuated by bath application of oligomeric (200 nM), but not fibrillar, A beta peptide. Western blotting revealed that BDNF protein expression during conditioning is significantly reduced by treatment with oligomeric A beta, as were phosphorylation levels of cAMP-response element-binding protein (CREB), Ca2+/calmodulin-dependent protein kinase II (CaMKII), Ca2+/calmodulin-dependent protein kinase IV (CaMKIV), and ERK. However, levels of PKA and PKC zeta/lambda were unaffected, as was PDK-1. Protein localization studies using confocal imaging indicate that oligomeric A beta, but not fibrillar or scrambled forms, suppresses colocalization of GluR1 and GluR4 AMPA receptor subunits with synaptophysin, indicating that trafficking of these subunits to synapses during the conditioning procedure is blocked. In contrast, coapplication of BDNF with oligomeric A beta significantly reversed these findings. Interestingly, a tolloid-like metalloproteinase in turtle, tTLLs (turtle tolloid-like protein), which normally processes the precursor proBDNF into mature BDNF, was found to degrade oligomeric A beta into small fragments. These data suggest that an A beta-induced reduction in BDNF, perhaps due to interference in the proteolytic conversion of proBDNF to BDNF, results in inhibition of synaptic AMPA receptor delivery and suppression of the acquisition of conditioning.	[Zheng, Zhaoqing; Sabirzhanov, Boris; Keifer, Joyce] Univ S Dakota, Neurosci Grp, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA	University of South Dakota	Zheng, ZQ (corresponding author), Univ S Dakota, Neurosci Grp, Div Basic Biomed Sci, Sanford Sch Med, 414 E Clark St, Vermillion, SD 57069 USA.	zzheng@usd.edu		Keifer, Joyce/0000-0002-5900-0414	National Institutes of Health [NS051187, P20 RR015567]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS051187 and P20 RR015567, which is designated as a Center of Biomedical Research Excellence (to J. K.).	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Anderson CW, 1999, J NEUROPHYSIOL, V81, P1242, DOI 10.1152/jn.1999.81.3.1242; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; KEIFER J, 1995, J NEUROSCI, V15, P5036; Keifer J, 2001, J NEUROSCI, V21, P2434, DOI 10.1523/JNEUROSCI.21-07-02434.2001; Keifer J, 2009, J NEUROSCI, V29, P14956, DOI 10.1523/JNEUROSCI.3649-09.2009; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; Li W, 2008, NEUROSCIENCE, V155, P686, DOI 10.1016/j.neuroscience.2008.06.043; Li W, 2009, NEUROBIOL LEARN MEM, V91, P243, DOI 10.1016/j.nlm.2008.10.002; Lu CB, 2006, J NEUROCHEM, V97, P1104, DOI 10.1111/j.1471-4159.2006.03800.x; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Mokin M, 2007, J NEUROPHYSIOL, V98, P1278, DOI 10.1152/jn.00212.2007; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nakata H, 2007, FEBS LETT, V581, P2047, DOI 10.1016/j.febslet.2007.04.041; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Trommer BL, 2005, NEUROBIOL DIS, V18, P75, DOI 10.1016/j.nbd.2004.08.011; Tucker HM, 2000, J NEUROSCI, V20, P3937; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yu MS, 2004, INT J MOL MED, V14, P917; Zhao DY, 2004, J NEUROPHYSIOL, V92, P2853, DOI 10.1152/jn.00485.2004; Zheng Z, 2008, NEUROSCIENCE, V156, P872, DOI 10.1016/j.neuroscience.2008.08.042; Zheng ZQ, 2009, J NEUROPHYSIOL, V101, P2539, DOI 10.1152/jn.91282.2008	38	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34708	34717		10.1074/jbc.M110.150821	http://dx.doi.org/10.1074/jbc.M110.150821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807770	Green Published, hybrid			2022-12-27	WOS:000283659100046
J	Froese, DS; Kochan, G; Muniz, JRC; Wu, XC; Gileadi, C; Ugochukwu, E; Krysztofinska, E; Gravel, RA; Oppermann, U; Yue, WW				Froese, D. Sean; Kochan, Grazyna; Muniz, Joao R. C.; Wu, Xuchu; Gileadi, Carina; Ugochukwu, Emelie; Krysztofinska, Ewelina; Gravel, Roy A.; Oppermann, Udo; Yue, Wyatt W.			Structures of the Human GTPase MMAA and Vitamin B-12-dependent Methylmalonyl-CoA Mutase and Insight into Their Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBLB COMPLEMENTATION GROUP; COENZYME B-12; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IDENTIFICATION; GENE; ADENOSYLTRANSFERASE; ACIDEMIA; ACIDURIA; METABOLISM	Vitamin B-12 (cobalamin, Cbl) is essential to the function of two human enzymes, methionine synthase (MS) and methylmalonyl-CoA mutase (MUT). The conversion of dietary Cbl to its cofactor forms, methyl-Cbl (MeCbl) for MS and adenosyl-Cbl (AdoCbl) for MUT, located in the cytosol and mitochondria, respectively, requires a complex pathway of intracellular processing and trafficking. One of the processing proteins, MMAA (methylmalonic aciduria type A), is implicated in the mitochondrial assembly of AdoCbl into MUT and is defective in children from the cblA complementation group of cobalamin disorders. To characterize the functional interplay between MMAA and MUT, we have crystallized human MMAA in the GDP-bound form and human MUT in the apo, holo, and substrate-bound ternary forms. Structures of both proteins reveal highly conserved domain architecture and catalytic machinery for ligand binding, yet they show substantially different dimeric assembly and interaction, compared with their bacterial counterparts. We show that MMAA exhibits GTPase activity that is modulated by MUT and that the two proteins interact in vitro and in vivo. Formation of a stable MMAA-MUT complex is nucleotide selective for MMAA (GMPPNP over GDP) and apoenzyme-dependent for MUT. The physiological importance of this interaction is highlighted by a recently identified homoallelic patient mutation of MMAA, G188R, which, we show, retains basal GTPase activity but has abrogated interaction. Together, our data point to a gatekeeping role for MMAA by favoring complex formation with MUT apoenzyme for AdoCbl assembly and releasing the AdoCbl-loaded holoenzyme from the complex, in a GTP-dependent manner.	[Froese, D. Sean; Kochan, Grazyna; Muniz, Joao R. C.; Gileadi, Carina; Ugochukwu, Emelie; Krysztofinska, Ewelina; Oppermann, Udo; Yue, Wyatt W.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DU, England; [Froese, D. Sean; Wu, Xuchu; Gravel, Roy A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Oppermann, Udo] NIHR, Botnar Res Ctr, Oxford Biomed Res Unit, Oxford OX3 7LD, England	University of Oxford; University of Calgary; University of Oxford	Oppermann, U (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DU, England.	udo.oppermann@sgc.ox.ac.uk; wyatt.yue@sgc.ox.ac.uk	Froese, Sean/J-6665-2017; Kochan, Grazyna/A-1094-2009; Froese, D. Sean Sean/AAW-6899-2021; Muniz, Joao R/B-7782-2016	Froese, Sean/0000-0003-1557-3517; Froese, D. Sean Sean/0000-0003-1557-3517; Muniz, Joao R/0000-0003-2731-3966; Kochan, Grazyna/0000-0002-0534-9661	Canadian Institutes for Health Research [MGP-44353]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck and Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; CIHR at the University of Calgary	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck and Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); CIHR at the University of Calgary(Canadian Institutes of Health Research (CIHR))	The Structural Genomics Consortium is a registered charity (Number 1097737) funded by the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. D. S. F. acknowledges funding support by the CIHR Training Program in Genetics, Child Development and Health at the University of Calgary. R. A. G. acknowledges funding support by the Canadian Institutes for Health Research Grant MGP-44353.	Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BATRA JK, 1987, BIOCHEMISTRY-US, V26, P5925, DOI 10.1021/bi00392a052; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENTON WA, 1981, BIOCHEM BIOPH RES CO, V98, P283, DOI 10.1016/0006-291X(81)91900-8; FENTON WA, 1982, ARCH BIOCHEM BIOPHYS, V214, P815, DOI 10.1016/0003-9861(82)90088-1; Froese DS, 2009, MICROBIOL RES, V164, P1, DOI 10.1016/j.micres.2008.08.006; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; JANSEN R, 1989, GENOMICS, V4, P198, DOI 10.1016/0888-7543(89)90300-5; KOLHOUSE JF, 1980, J BIOL CHEM, V255, P2708; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Leal NA, 2003, J BIOL CHEM, V278, P9227, DOI 10.1074/jbc.M212739200; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; MAHONEY MJ, 1975, P NATL ACAD SCI USA, V72, P2799, DOI 10.1073/pnas.72.7.2799; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; MARSH EN, 1989, BIOCHEM J, V260, P353, DOI 10.1042/bj2600353; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merinero B, 2008, J INHERIT METAB DIS, V31, P55, DOI 10.1007/s10545-007-0667-y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Ruzheinikov SN, 2004, J MOL BIOL, V339, P265, DOI 10.1016/j.jmb.2004.03.043; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; TANG WJY, 1993, METHOD CELL BIOL, V37, P95, DOI 10.1016/S0091-679X(08)60245-9; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WILKEMEYER MF, 1990, BIOCHEM J, V271, P449, DOI 10.1042/bj2710449; Yamanishi M, 2005, TRENDS BIOCHEM SCI, V30, P304, DOI 10.1016/j.tibs.2005.04.008; Yang X, 2004, MOL GENET METAB, V82, P329, DOI 10.1016/j.ymgme.2004.05.002	40	79	83	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38204	38213		10.1074/jbc.M110.177717	http://dx.doi.org/10.1074/jbc.M110.177717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876572	Green Published, hybrid			2022-12-27	WOS:000284625600028
J	Wilderman, PR; Shah, MB; Liu, T; Li, S; Hsu, S; Roberts, AG; Goodlett, DR; Zhang, QH; Woods, VL; Stout, CD; Halpert, JR				Wilderman, P. Ross; Shah, Manish B.; Liu, Tong; Li, Sheng; Hsu, Simon; Roberts, Arthur G.; Goodlett, David R.; Zhang, Qinghai; Woods, Virgil L., Jr.; Stout, C. David; Halpert, James R.			Plasticity of Cytochrome P450 2B4 as Investigated by Hydrogen-Deuterium Exchange Mass Spectrometry and X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE; MOLECULAR-DYNAMICS; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES; OPEN CONFORMATION; LIGAND-BINDING; H/D EXCHANGE; P4502B4; ALPHA; SITE	Crystal structures of the xenobiotic metabolizing cytochrome P450 2B4 have demonstrated markedly different conformations in the presence of imidazole inhibitors or in the absence of ligand. However, knowledge of the plasticity of the enzyme in solution has remained scant. Thus, hydrogen-deuterium exchange mass spectrometry (DXMS) was utilized to probe the conformations of ligand-free P450 2B4 and the complex with 4-(4-chlorophenyl) imidazole (4-CPI) or 1-biphenyl-4-methyl-1H-imidazole (1-PBI). The results of DXMS indicate that the binding of 4-CPI slowed the hydrogen-deuterium exchange rate over the B`-and C-helices and portions of the F-Ghelix cassette compared with P450 2B4 in the absence of ligands. In contrast, there was little difference between the ligand-free and 1-PBI-bound exchange sets. In addition, DXMS suggests that the ligand-free P450 2B4 is predominantly open in solution. Interestingly, a new high resolution structure of ligand-free P450 2B4 was obtained in a closed conformation very similar to the 4-CPI complex. Molecular dynamics simulations performed with the closed ligand-free structure as the starting point were used to probe the energetically accessible conformations of P450 2B4. The simulations were found to equilibrate to a conformation resembling the 1-PBI-bound P450 2B4 crystal structure. The results indicate that conformational changes observed in available crystal structures of the promiscuous xenobiotic metabolizing cytochrome P450 2B4 are consistent with its solution structural behavior.	[Wilderman, P. Ross; Shah, Manish B.; Roberts, Arthur G.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Liu, Tong; Li, Sheng; Hsu, Simon; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Zhang, Qinghai; Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Scripps Research Institute	Shah, MB (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,PSB 2131,MC 0703, La Jolla, CA 92093 USA.	m7shah@ucsd.edu	Hsu, Simon/GXZ-6548-2022; Wilderman, Paul/J-8315-2012; Shah, Manish/H-6158-2011	Hsu, Simon/0000-0003-3780-294X; Wilderman, Paul/0000-0002-0264-1704; Shah, Manish/0000-0001-8593-6446	National Institutes of Health [ES003619, CA099835, CA118595, AI076961, AI081982, AI2008031, GM020501, GM066170, RR029388, GM073197, T32-DK07233]; NCRR; United States Department of Energy of Biological and Environmental Research; NATIONAL CANCER INSTITUTE [R21CA099835, R21CA118595, R33CA099835] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, R01AI081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, F32GM020501, P50GM073197, R01GM066170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES003619 (to J. R. H.), CA099835, CA118595, AI076961, AI081982, AI2008031, GM020501, GM066170, and RR029388 (to V. L. W.), and GM073197 (to Q. Z.).; Supported by National Institutes of Health Grant T32-DK07233.; We are grateful to Dr. Sean Gay for critical reading of the manuscript and also to the staff at the Stanford Synchrotron Radiation Lightsource, operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences for assistance with data collection. The Stanford Synchrotron Radiation Lightsource is supported by the National Institutes of Health, NCRR, the Biomedical Technology Program, and the United States Department of Energy of Biological and Environmental Research.	Al-Omari A, 2007, J PHARM PRACT, V20, P206, DOI DOI 10.1177/0897190007304821; Anzenbacher P, 2008, ACTA CHIM SLOV, V55, P63; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bo W, 2008, CHINESE J CHEM PHYS, V21, P217, DOI 10.1088/1674-0068/21/03/217-220; Bumpus NN, 2010, J INORG BIOCHEM, V104, P485, DOI 10.1016/j.jinorgbio.2009.12.017; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Delano WL., 2002, PYMOL MOL GRAPHICS S; Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Eyles SJ, 2004, METHODS, V34, P88, DOI 10.1016/j.ymeth.2004.03.015; Ferguson PL, 2009, CURR ANAL CHEM, V5, P186, DOI 10.2174/157341109787846180; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; FROELICH J W, 1985, Henry Ford Hospital Medical Journal, V33, P122; Gay SC, 2010, MOL PHARMACOL, V77, P529, DOI 10.1124/mol.109.062570; Gay SC, 2009, BIOCHEMISTRY-US, V48, P4762, DOI 10.1021/bi9003765; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Hamuro Y, 2008, J INORG BIOCHEM, V102, P364, DOI 10.1016/j.jinorgbio.2007.10.001; Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Johnson EF, 2005, BIOCHEM BIOPH RES CO, V338, P331, DOI 10.1016/j.bbrc.2005.08.190; Kaltashov IA, 2006, ANAL BIOANAL CHEM, V386, P472, DOI 10.1007/s00216-006-0636-6; Kaltashov IA, 2009, ANAL CHEM, V81, P7892, DOI 10.1021/ac901366n; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Liao WL, 2009, BIOCHEMISTRY-US, V48, P4150, DOI 10.1021/bi900168m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mestres J, 2005, PROTEINS, V58, P596, DOI 10.1002/prot.20354; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muralidhara BK, 2008, J MOL BIOL, V377, P232, DOI 10.1016/j.jmb.2007.12.068; Muralidhara BK, 2007, DRUG METAB REV, V39, P539, DOI 10.1080/03602530701498182; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; OMURA T., 1965, FEDERATION PROC, V24, P1181; OMURA T, 1964, J BIOL CHEM, V239, P2370; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Otyepka M, 2007, BBA-GEN SUBJECTS, V1770, P376, DOI 10.1016/j.bbagen.2006.09.013; Oyeyemi OA, 2010, P NATL ACAD SCI USA, V107, P10074, DOI 10.1073/pnas.1003678107; Pochapsky SS, 2009, BIOCHEMISTRY-US, V48, P4254, DOI 10.1021/bi900002k; Poulos TL, 2005, BIOCHEM BIOPH RES CO, V338, P337, DOI 10.1016/j.bbrc.2005.07.204; Poulos TL, 2005, DRUG METAB DISPOS, V33, P10, DOI 10.1124/dmd.104.002071; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Selevsek N, 2009, J BIOL CHEM, V284, P16419, DOI 10.1074/jbc.M109.001305; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Tsutsui Y, 2007, CURR MED CHEM, V14, P2344, DOI 10.2174/092986707781745596; Wade RC, 2005, BBA-PROTEINS PROTEOM, V1754, P239, DOI 10.1016/j.bbapap.2005.07.044; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wani AH, 2009, P NATL ACAD SCI USA, V106, P20711, DOI 10.1073/pnas.0908617106; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Zhang QH, 2007, ANGEW CHEM INT EDIT, V46, P7023, DOI 10.1002/anie.200701556; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614; Zhao YH, 2007, BBA-GEN SUBJECTS, V1770, P402, DOI 10.1016/j.bbagen.2006.07.006	81	50	50	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38602	38611		10.1074/jbc.M110.180646	http://dx.doi.org/10.1074/jbc.M110.180646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880847	Green Published, hybrid			2022-12-27	WOS:000284625600064
J	Chen, TS; Nayak, N; Majee, SM; Lowenson, J; Schafermeyer, KR; Eliopoulos, AC; Lloyd, TD; Dinkins, R; Perry, SE; Forsthoefel, NR; Clarke, SG; Vernon, DM; Zhou, ZS; Rejtar, T; Downie, AB				Chen, Tingsu; Nayak, Nihar; Majee, Susmita Maitra; Lowenson, Jonathan; Schaefermeyer, Kim R.; Eliopoulos, Alyssa C.; Lloyd, Taylor D.; Dinkins, Randy; Perry, Sharyn E.; Forsthoefel, Nancy R.; Clarke, Steven G.; Vernon, Daniel M.; Zhou, Zhaohui Sunny; Rejtar, Tomas; Downie, A. Bruce			Substrates of the Arabidopsis thaliana Protein Isoaspartyl Methyltransferase 1 Identified Using Phage Display and Biopanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; BOX RNA HELICASE; SEED DORMANCY; O-METHYLTRANSFERASE; MESSENGER-RNA; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CARBOXYL METHYLATION; PROTEOMIC ANALYSIS; ASPARTYL RESIDUES	The role of protein isoaspartyl methyltransferase (PIMT) in repairing a wide assortment of damaged proteins in a host of organisms has been inferred from the affinity of the enzyme for isoaspartyl residues in a plethora of amino acid contexts. The identification of PIMT target proteins in plant seeds, where the enzyme is highly active and proteome long-lived, has been hindered by large amounts of isoaspartate-containing storage proteins. Mature seed phage display libraries circumvented this problem. Inclusion of the PIMT co-substrate, S-adenosylmethionine (AdoMet), during panning permitted PIMT to retain aged phage in greater numbers than controls lacking co-substrate or when PIMT protein binding was poisoned with S-adenosyl homocysteine. After four rounds, phage titer plateaued in AdoMet-containing pans, whereas titer declined in both controls. This strategy identified 17 in-frame PIMT target proteins, including a cupin-family protein similar to those identified previously using on-blot methylation. All recovered phage had at least one susceptible Asp or Asn residue. Five targets were recovered independently. Two in-frame targets were produced in Escherichia coli as recombinant proteins and shown by on-blot methylation to acquire isoAsp, becoming a PIMT target. Both gained isoAsp rapidly in solution upon thermal insult. Mutant analysis of plants deficient in any of three in-frame PIMT targets resulted in demonstrable phenotypes. An over-representation of clones encoding proteins involved in protein production suggests that the translational apparatus comprises a subgroup for which PIMT-mediated repair is vital for orthodox seed longevity. Impaired PIMT activity would hinder protein function in these targets, possibly resulting in poor seed performance.	[Chen, Tingsu; Nayak, Nihar; Majee, Susmita Maitra; Schaefermeyer, Kim R.; Eliopoulos, Alyssa C.; Lloyd, Taylor D.; Downie, A. Bruce] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Perry, Sharyn E.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Lowenson, Jonathan; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Eliopoulos, Alyssa C.] Paul Laurence Dunbar High Sch, Math Sci & Technol Ctr, Lexington, KY 40515 USA; [Dinkins, Randy] Univ Kentucky, Agr Sci Ctr N220C, USDA ARS, Forage Anim Prod Res Unit, Lexington, KY 40546 USA; [Forsthoefel, Nancy R.; Vernon, Daniel M.] Whitman Coll, Dept Biol, Program Biochem Biophys & Mol Biol, Walla Walla, WA 99362 USA; [Zhou, Zhaohui Sunny; Rejtar, Tomas] Northeastern Univ, Dept Chem & Chem Biol, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Chen, Tingsu; Nayak, Nihar; Majee, Susmita Maitra; Schaefermeyer, Kim R.; Eliopoulos, Alyssa C.; Lloyd, Taylor D.; Perry, Sharyn E.; Downie, A. Bruce] Univ Kentucky, Seed Biol Grp, Lexington, KY 40546 USA	University of Kentucky; University of Kentucky; University of California System; University of California Los Angeles; United States Department of Agriculture (USDA); University of Kentucky; Whitman College; Northeastern University; University of Kentucky	Downie, AB (corresponding author), 401A Plant Sci Bldg,1405 Vet Dr, Lexington, KY 40546 USA.	adownie@uky.edu	Vernon, Daniel/L-1333-2016; Lowenson, Jonathan/AAN-6768-2020; Perry, Sharyn/M-9177-2013	Vernon, Daniel/0000-0002-4182-3105; Perry, Sharyn/0000-0002-3011-8240; Dinkins, Randy/0000-0002-2127-273X	National Science Foundation [0449649]; University of Kentucky [14-28]; Paul Laurence Dunbar High School; Direct For Biological Sciences [0922845] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0922978] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Kentucky; Paul Laurence Dunbar High School; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Molecular and Cellular Biochemistry Grant 0449649 (to A. B. D. and S. G. C.). This work was also supported by University of Kentucky undergraduate research and creativity Grant 14-28 (to A. B. D. and T. D. L.).; We acknowledge David Martin and Manoj Majee for excellent technical advice, assistance, and troubleshooting during the phage cDNA library construction and biopanning optimization, Venkata Krishna Doppalapudi for excellent technical assistance planting, screening, harvesting, cleaning, and sowing seeds of the various mutant lines, Dr. Lynnette Dirk for expert advice in recombinant protein production and purification using FPLC, and Dr. Sarah Villa for work defining enzyme kinetics for rAtPIMT1. This work was also supported by the Math Science and Technology Center program, Paul Laurence Dunbar High School (to A. B. D. and A. C. E.) and by the University of Kentucky eUreKa! program.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Bennett EJ, 2003, BIOCHEMISTRY-US, V42, P12844, DOI 10.1021/bi034891+; Bewley J. D., 1994, SEED PHYSL DEV GERMI, P81; Bidinosti M, 2010, J BIOL CHEM, V285, P19402, DOI 10.1074/jbc.M110.120774; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Chang IF, 2005, PLANT PHYSIOL, V137, P848, DOI 10.1104/pp.104.053637; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Clerkx EJM, 2003, PLANT PHYSIOL, V132, P1077, DOI 10.1104/pp.103.022715; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; D'Angelo S, 2001, FREE RADICAL BIO MED, V31, P1, DOI 10.1016/S0891-5849(01)00518-4; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; DESROSIERS RR, 1990, J BIOL CHEM, V265, P21368; Dinkins RD, 2008, PLANT J, V55, P1, DOI 10.1111/j.1365-313X.2008.03471.x; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Forsthoefel NR, 2005, PLANT CELL PHYSIOL, V46, P913, DOI 10.1093/pcp/pci097; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fujikura U, 2009, PLANT J, V59, P499, DOI 10.1111/j.1365-313X.2009.03886.x; Gershater MC, 2007, J BIOL CHEM, V282, P21460, DOI 10.1074/jbc.M701985200; Hara K, 2000, PLANT CELL PHYSIOL, V41, P684, DOI 10.1093/pcp/41.6.684; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hudson ME, 2007, CROP SCI, V47, pS96, DOI 10.2135/cropsci2006.12.0758tpg; Ingrosso D, 2002, EUR J BIOCHEM, V269, P2032, DOI 10.1046/j.1432-1033.2002.02838.x; Ingrosso D, 1997, J NUTR BIOCHEM, V8, P535, DOI 10.1016/S0955-2863(97)00085-5; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Kern R, 2005, J BACTERIOL, V187, P1377, DOI 10.1128/JB.187.4.1377-1383.2005; Kester ST, 1997, J EXP BOT, V48, P943, DOI 10.1093/jxb/48.4.943; LADINO CA, 1992, J CELL PHYSIOL, V153, P297, DOI 10.1002/jcp.1041530209; Lanthier J, 2004, EXP CELL RES, V293, P96, DOI 10.1016/j.yexcr.2003.10.003; Lanthier J, 2002, J NEUROCHEM, V83, P581, DOI 10.1046/j.1471-4159.2002.01150.x; Li SC, 2001, PLANT MOL BIOL, V47, P761, DOI 10.1023/A:1013687412020; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lorkovic ZJ, 1997, MOL CELL BIOL, V17, P2257, DOI 10.1128/MCB.17.4.2257; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mudgett MB, 1996, PLANT MOL BIOL, V30, P723, DOI 10.1007/BF00019007; Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481; MUDGETT MB, 1993, BIOCHEMISTRY-US, V32, P11100, DOI 10.1021/bi00092a020; Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897; OCONNOR CM, 1984, J BIOL CHEM, V259, P2570; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; OWENS MK, 1995, J ARID ENVIRON, V29, P15, DOI 10.1016/S0140-1963(95)80060-3; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; ROBERTS E H, 1973, Seed Science and Technology, V1, P499; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Robinson NE, 2001, J PEPT RES, V57, P483, DOI 10.1034/j.1399-3011.2001.00863.x; Rudgers GW, 2001, PROTEIN ENG, V14, P487, DOI 10.1093/protein/14.7.487; Salaita L, 2005, J EXP BOT, V56, P2059, DOI 10.1093/jxb/eri204; Sallon S, 2008, SCIENCE, V320, P1464, DOI 10.1126/science.1153600; SHENMILLER J, 1995, AM J BOT, V82, P1367, DOI 10.2307/2445863; Smith CD, 2002, PROTEIN SCI, V11, P625, DOI 10.1110/ps.37802; Statistical Analysis System, 1988, SAS STAT US GUID STA; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamura N, 2006, PLANT CELL PHYSIOL, V47, P1081, DOI 10.1093/pcp/pcj078; Thapar N, 2000, PROTEIN EXPRES PURIF, V20, P237, DOI 10.1006/prep.2000.1311; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; Villa ST, 2006, PHYSIOL PLANTARUM, V128, P581, DOI 10.1111/j.1399-3054.2006.00772.x; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Wehmeyer N, 1996, PLANT PHYSIOL, V112, P747, DOI 10.1104/pp.112.2.747; Wolschin F, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-9; Xu Q., 2004, THESIS U KENTUCKY LE; Xu QL, 2004, PLANT PHYSIOL, V136, P2652, DOI 10.1104/pp.104.046094; Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	83	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37281	37292		10.1074/jbc.M110.157008	http://dx.doi.org/10.1074/jbc.M110.157008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870712	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000284424000021
J	Kumar, P; Garg, R; Bolden, G; Pandey, KN				Kumar, Prerna; Garg, Renu; Bolden, Gevoni; Pandey, Kailash N.			Interactive Roles of Ets-1, Sp1, and Acetylated Histones in the Retinoic Acid-dependent Activation of Guanylyl Cyclase/Atrial Natriuretic Peptide Receptor-A Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RESPONSE ELEMENT; DOWN-REGULATION; PROTEIN-KINASE; MESANGIAL CELLS; EMERGING ROLES; LEUKEMIA-CELLS; STEM-CELLS; CYCLIC-GMP; EXPRESSION	Cardiac hormones atrial and brain natriuretic peptides activate guanylyl cyclase/natriuretic peptide receptor-A (GC-A/NPRA), which plays a critical role in reduction of blood pressure and blood volume. Currently, the mechanisms responsible for regulating the Npr1 gene (coding for GC-A/NPRA) transcription are not well understood. The present study was conducted to examine the interactive roles of all-trans retinoic acid (ATRA), Ets-1, Sp1, and histone acetylation on the transcriptional regulation and function of the Npr1 gene. Deletion analysis of the Npr1 promoter and luciferase assays showed that ATRA enhanced a 16-fold Npr1 promoter activity and greatly stimulated guanylyl cyclase (GC) activity of the receptor protein in both atrial natriuretic peptide (ANP)-dependent and -independent manner. As confirmed by gel shift and chromatin immunoprecipitation assays, ATRA enhanced the binding of both Ets-1 and Sp1 to the Npr1 promoter. The retinoic acid receptor alpha (RAR alpha) was recruited by Ets-1 and Sp1 to form a transcriptional activator complex with their binding sites in the Npr1 promoter. Interestingly, ATRA also increased the acetylation of histones H3 and H4 and enhanced their recruitment to Ets-1 and Sp1 binding sites within the Npr1 promoter. Collectively, the present results demonstrate that ATRA regulates Npr1 gene transcription and GC activity of the receptor by involving the interactive actions of Ets-1, Sp1, and histone acetylation.	[Pandey, Kailash N.] Tulane Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Pandey, Kailash N.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Tulane University; Tulane University	Pandey, KN (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Physiol, SL 39,1430 Tulane Ave, New Orleans, LA 70112 USA.	kpandey@tulane.edu			National Institutes of Health [HL 57531, HL 62147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL057531, R01HL057531, R01HL062147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 57531 and HL 62147.	AGUI T, 1995, J BIOCHEM-TOKYO, V118, P500, DOI 10.1093/oxfordjournals.jbchem.a124936; Andres V, 2001, ARTERIOSCL THROM VAS, V21, P342, DOI 10.1161/01.ATV.21.3.342; APPEL RG, 1992, AM J PHYSIOL, V262, pF911, DOI 10.1152/ajprenal.1992.262.6.F911; Arise KK, 2006, BIOCHEM BIOPH RES CO, V349, P131, DOI 10.1016/j.bbrc.2006.08.003; BALLERMANN BJ, 1985, J CLIN INVEST, V76, P2049, DOI 10.1172/JCI112207; Bjorklund S, 1999, CELL, V96, P759, DOI 10.1016/S0092-8674(00)80586-3; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Cao L, 1998, AM J PHYSIOL-RENAL, V275, pF119, DOI 10.1152/ajprenal.1998.275.1.F119; Cederberg A, 1999, J BIOL CHEM, V274, P165, DOI 10.1074/jbc.274.1.165; Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536; DE LUCA LM, 1991, FASEB J, V5, P2924; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; Garg R, 2003, HYPERTENSION, V41, P730, DOI 10.1161/01.HYP.0000051890.68573.94; Garg R, 2002, GENE, V291, P123, DOI 10.1016/S0378-1119(02)00589-9; Gomez R Aruek, 1999, Current Opinion in Pediatrics, V11, P135, DOI 10.1097/00008480-199904000-00007; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; HANEDA M, 1991, KIDNEY INT, V40, P188, DOI 10.1038/ki.1991.199; Hum D, 2004, HYPERTENSION, V43, P1270, DOI 10.1161/01.HYP.0000126920.93207.53; Husmann M, 2000, BIOCHEM J, V352, P763, DOI 10.1042/0264-6021:3520763; Jiang MR, 2008, BBA-MOL CELL RES, V1783, P1055, DOI 10.1016/j.bbamcr.2008.02.007; Kashyap V, 2010, J BIOL CHEM, V285, P14534, DOI 10.1074/jbc.M110.115345; Khanna H, 2006, J BIOL CHEM, V281, P27327, DOI 10.1074/jbc.M605500200; Khurana ML, 1996, MOL CELL BIOCHEM, V158, P97; Konta T, 2001, J BIOL CHEM, V276, P12697, DOI 10.1074/jbc.M011000200; Kumar P, 2006, PEPTIDES, V27, P1762, DOI 10.1016/j.peptides.2006.01.004; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Kumar P, 2009, BIOSCIENCE REP, V29, P57, DOI 10.1042/BSR20080094; Lee ER, 2007, STEM CELLS, V25, P2191, DOI 10.1634/stemcells.2007-0203; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li YH, 2009, ENDOCRINOLOGY, V150, P3759, DOI 10.1210/en.2008-1353; Lie-Venema H, 2003, CIRC RES, V92, P749, DOI 10.1161/01.RES.0000066662.70010.DB; Love WK, 2008, INT J ONCOL, V32, P625; Lu L, 2003, AM J PHYSIOL-HEART C, V285, pH1370, DOI 10.1152/ajpheart.00260.2003; Lucas KA, 2000, PHARMACOL REV, V52, P375; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Manzano VM, 2000, BRIT J PHARMACOL, V131, P1673, DOI 10.1038/sj.bjp.0703728; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Masaki T, 2006, BIOCHEM J, V397, P345, DOI 10.1042/BJ20051863; Nishikimi T, 2005, CARDIOVASC RES, V66, P94, DOI 10.1016/j.cardiores.2004.12.014; Palm-Leis A, 2004, J BIOL CHEM, V279, P54905, DOI 10.1074/jbc.M407383200; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Pandey KN, 2008, J AM SOC HYPERTENS, V2, P210, DOI 10.1016/j.jash.2008.02.001; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Pandey KN, 2002, J BIOL CHEM, V277, P4618, DOI 10.1074/jbc.M106436200; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; PANDEY KN, 1992, BIOCHEM J, V288, P55, DOI 10.1042/bj2880055; Pitzalis MV, 2003, J HYPERTENS, V21, P1491, DOI 10.1097/00004872-200308000-00012; Qi HL, 2006, CANCER RES, V66, P5875, DOI 10.1158/0008-5472.CAN-05-4048; Raouf A, 2000, ONCOGENE, V19, P1969, DOI 10.1038/sj.onc.1203505; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; Sanz-Gonzalez SM, 2000, FRONT BIOSCI, V5, pD619, DOI 10.2741/sanz; Shi SJ, 2003, AM J PHYSIOL-RENAL, V285, pF694, DOI 10.1152/ajprenal.00097.2003; So EN, 2000, IUBMB LIFE, V50, P365, DOI 10.1080/152165400300089394; Tremblay J, 2003, HYPERTENSION, V41, P16, DOI 10.1161/01.HYP.0000042664.75193.1B; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Vellaichamy E, 2005, J BIOL CHEM, V280, P19230, DOI 10.1074/jbc.M411373200; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; Wu JM, 1996, J CLIN INVEST, V97, P1577, DOI 10.1172/JCI118582; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Zhou XF, 1999, MOL ENDOCRINOL, V13, P276, DOI 10.1210/me.13.2.276	68	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37521	37530		10.1074/jbc.M110.132795	http://dx.doi.org/10.1074/jbc.M110.132795			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864529	Green Published, hybrid			2022-12-27	WOS:000284424000044
J	Ren, RY; Hong, ZN; Gong, HY; Laporte, K; Skinner, M; Seldin, DC; Costello, CE; Connors, LH; Trinkaus-Randall, V				Ren, Ruiyi; Hong, Zhenning; Gong, Haiyan; Laporte, Kate; Skinner, Martha; Seldin, David C.; Costello, Catherine E.; Connors, Lawreen H.; Trinkaus-Randall, Vickery			Role of Glycosaminoglycan Sulfation in the Formation of Immunoglobulin Light Chain Amyloid Oligomers and Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; CARDIAC FIBROBLASTS; PROTEIN; PROTEOGLYCANS; AMYLOIDOGENESIS; BLUE; IDENTIFICATION; ACCUMULATION; FIBRILLATION; ASSOCIATION	Primary amyloidosis (AL) results from overproduction of unstable monoclonal immunoglobulin light chains (LCs) and the deposition of insoluble fibrils in tissues, leading to fatal organ disease. Glycosaminoglycans (GAGs) are associated with AL fibrils and have been successfully targeted in the treatment of other forms of amyloidosis. We investigated the role of GAGs in LC fibrillogenesis. Ex vivo tissue amyloid fibrils were extracted and examined for structure and associated GAGs. The GAGs were detected along the length of the fibril strand, and the periodicity of heparan sulfate (HS) along the LC fibrils generated in vitro was similar to that of the ex vivo fibrils. To examine the role of sulfated GAGs on AL oligomer and fibril formation in vitro, a kappa 1 LC purified from urine of a patient with AL amyloidosis was incubated in the presence or absence of GAGs. The fibrils generated in vitro at physiologic concentration, temperature, and pH shared morphologic characteristics with the ex vivo kappa 1 amyloid fibrils. The presence of HS and over-O-sulfated-heparin enhanced the formation of oligomers and fibrils with HS promoting the most rapid transition. In contrast, GAGs did not enhance fibril formation of a non-amyloidogenic kappa 1 LC purified from urine of a patient with multiple myeloma. The data indicate that the characteristics of the full-length kappa 1 amyloidogenic LC, containing post-translational modifications, possess key elements that influence interactions of the LC with HS. These findings highlight the importance of the variable and constant LC regions in GAG interaction and suggest potential therapeutic targets for treatment.	[Ren, Ruiyi; Hong, Zhenning; Costello, Catherine E.; Connors, Lawreen H.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Gong, Haiyan] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Skinner, Martha; Seldin, David C.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Gong, Haiyan; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Ren, Ruiyi; Laporte, Kate; Skinner, Martha; Seldin, David C.; Costello, Catherine E.; Connors, Lawreen H.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Amyloid Treatment & Res Program, Boston, MA 02118 USA; [Hong, Zhenning; Costello, Catherine E.] Boston Univ, Sch Med, Dept Mass Spectrometry Resource, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University	Trinkaus-Randall, V (corresponding author), Boston Univ, Sch Med, Dept Biochem, 80 E Concord St L904, Boston, MA 02118 USA.	vickery@bu.edu	Hong, Zhenning/C-6803-2011	Gong, Haiyan/0000-0002-7204-5019; Connors, Lawreen/0000-0002-4672-4296; Seldin, David C/0000-0003-0168-2333; Ren, Ruiyi/0000-0001-5785-2165; Costello, Catherine/0000-0003-1594-5122; Trinkaus-Randall, Vickery/0000-0002-8573-9108	National Institutes of Health [P01 HL-068705, EY06000, P41 RR10888]; Gerry Foundation and Amyloid Research Foundation; Young Travel Award; Departmental Massachusetts Lions Eye Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006000] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerry Foundation and Amyloid Research Foundation; Young Travel Award; Departmental Massachusetts Lions Eye Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL-068705 (to M. S.), EY06000 (V. T.-R.), and P41 RR10888 (C. E. C.). This work was also supported by grants from the Gerry Foundation and Amyloid Research Foundation (to M. S.), the Young Travel Award (to V. T.-R.), and the Departmental Massachusetts Lions Eye Research Fund.	AILLES L, 1993, LAB INVEST, V69, P443; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Connors LH, 2007, BIOCHEMISTRY-US, V46, P14259, DOI 10.1021/bi7013773; Elimova E, 2009, FASEB J, V23, P3436, DOI 10.1096/fj.09-134981; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; GONG HY, 1992, EXP EYE RES, V55, P691, DOI 10.1016/0014-4835(92)90174-Q; Gruys E, 2006, AMYLOID, V13, P13, DOI 10.1080/13506120500535768; GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666; Ionescu-Zanetti C, 1999, P NATL ACAD SCI USA, V96, P13175, DOI 10.1073/pnas.96.23.13175; Jiang XL, 1997, BIOCHEMISTRY-US, V36, P13187, DOI 10.1021/bi970408h; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Lavatelli F, 2008, MOL CELL PROTEOMICS, V7, P1570, DOI 10.1074/mcp.M700545-MCP200; Lim A, 2001, ANAL BIOCHEM, V295, P45, DOI 10.1006/abio.2001.5187; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Monis GF, 2006, AM J PATHOL, V169, P1939, DOI 10.2353/ajpath.2006.060183; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; NELSON SR, 1991, BIOCHEM J, V275, P67, DOI 10.1042/bj2750067; OHISHI H, 1990, CLIN CHEM, V36, P88; Prokaeva T, 2007, ARTHRITIS RHEUM-US, V56, P3858, DOI 10.1002/art.22959; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; SKINNER M, 1982, PREP BIOCHEM, V12, P461, DOI 10.1080/10826068208070597; SNOW AD, 1987, LAB INVEST, V56, pA75; SNOW AD, 1985, LAB INVEST, V53, P37; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Stevens FJ, 2000, CELL MOL LIFE SCI, V57, P441, DOI 10.1007/PL00000706; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Trinkaus-Randall V, 2005, AM J PATHOL, V166, P197, DOI 10.1016/S0002-9440(10)62244-4; Trinkaus-Randall V., 2000, CORNEA BIOL RESPONSE, P383; Yamamoto K, 2010, FEBS LETT, V584, P3348, DOI 10.1016/j.febslet.2010.06.019; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	39	37	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37672	37682		10.1074/jbc.M110.149575	http://dx.doi.org/10.1074/jbc.M110.149575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870723	hybrid, Green Published			2022-12-27	WOS:000284424000059
J	West, LE; Roy, S; Lachmi-Weiner, K; Hayashi, R; Shi, XB; Appella, E; Kutateladze, TG; Gozani, O				West, Lisandra E.; Roy, Siddhartha; Lachmi-Weiner, Karin; Hayashi, Ryo; Shi, Xiaobing; Appella, Ettore; Kutateladze, Tatiana G.; Gozani, Or			The MBT Repeats of L3MBTL1 Link SET8-mediated p53 Methylation at Lysine 382 to Target Gene Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE-SPECIFIC RECOGNITION; DNA-DAMAGE; STRUCTURAL BASIS; HISTONE H4; CHROMATIN; PROTEIN; BINDING; METHYLTRANSFERASE; 53BP1; TUDOR	The p53 tumor suppressor protein is regulated by multiple post-translational modifications, including lysine methylation. We previously found that monomethylation of p53 at lysine 382 (p53K382me1) by the protein lysine methyltransferase (PKMT) SET8/PR-Set7 represses p53 transactivation of target genes. However, the molecular mechanism linking p53K382 monomethylation to repression is not known. Here we show in biochemical and crystallographic studies the preferential recognition of p53K382me1 by the triple malignant brain tumor (MBT) repeats of the chromatin compaction factor L3MBTL1. We demonstrate that SET8-mediated methylation of p53 at Lys-382 promotes the interaction between L3MBTL1 and p53 in cells, and the chromatin occupancy of L3MBTL1 at p53 target promoters. In the absence of DNA damage, L3MBTL1 interacts with p53K382me1 and p53-target genes are repressed, whereas depletion of L3MBTL1 results in a p53-dependent increase in p21 and PUMA transcript levels. Activation of p53 by DNA damage is coupled to a decrease in p53K382me1 levels, abrogation of the L3MBTL1-p53 interaction, and disassociation of L3MBTL1 from p53-target promoters. Together, we identify L3MBTL1 as the second known methyl-p53 effector protein, and provide a molecular explanation for the mechanism by which p53K382me1 is transduced to regulate p53 activity.	[West, Lisandra E.; Lachmi-Weiner, Karin; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Roy, Siddhartha; Kutateladze, Tatiana G.] Univ Colorado Denver, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Hayashi, Ryo; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center	Kutateladze, TG (corresponding author), 12801 E 17th Ave, Aurora, CO 80045 USA.	tatiana.kutateladze@UCHSC.edu; ogozani@stanford.edu	Gozani, Or P/I-6157-2013	Gozani, Or/0000-0002-1365-4463; Shi, Xiaobing/0000-0001-5242-8189; Kutateladze, Tatiana/0000-0001-7375-6990	National Institutes of Health [GM079641, CA113472]; NATIONAL CANCER INSTITUTE [R01CA113472, ZIABC005599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM079641 (to O. G.) and CA113472 (to T. G. K.) from the National Institutes of Health and the Intramural Research Program of the National Institutes of Health (to E. A.).; Supported by a grant from the National Institutes of Health Stanford Genome Training Grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jang H, 2009, NAT STRUCT MOL BIOL, V16, P910, DOI 10.1038/nsmb.1657; Kachirskaia I, 2008, J BIOL CHEM, V283, P34660, DOI 10.1074/jbc.M806020200; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Morgunkova A, 2006, CELL CYCLE, V5, P1308, DOI 10.4161/cc.5.12.2820; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y., 2007, T Methods Enzymol, V25, P1; Trojer P, 2008, CELL CYCLE, V7, P578, DOI 10.4161/cc.7.5.5544; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615	35	72	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37725	37732		10.1074/jbc.M110.139527	http://dx.doi.org/10.1074/jbc.M110.139527			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870725	Green Published, hybrid			2022-12-27	WOS:000284424000064
J	Atzei, P; Gargan, S; Curran, N; Moynagh, PN				Atzei, Paola; Gargan, Siobhan; Curran, Niamh; Moynagh, Paul N.			Cactin Targets the MHC Class III Protein I kappa B-like (I kappa BL) and Inhibits NF-kappa B and Interferon-regulatory Factor Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR FAMILY; TOLL; ACTIVATION; ADAPTER; EXPRESSION; INTERACTS; MICE; SUSCEPTIBILITY; INTERLEUKIN-1; REQUIRES	Toll-like receptors (TLRs) act as primary sensors of the immune system by recognizing specific microbial motifs and inducing proinflammatory genes that facilitate innate and adaptive immunity. TLRs regulate gene expression by activating transcription factors, such as NF-kappa B and interferon-regulatory factors. Dysregulation of these pathways can lead to inflammatory diseases, and thus they are subject to stringent control by negative regulators of innate immune signaling. Cactin (Cactus interactor) was initially discovered as a novel interactor of Drosophila Cactus, a regulator of Drosophila Toll signaling. We now describe the first functional characterization of the human ortholog of Cactin (hCactin) and show that it acts as a negative regulator of TLRs. Overexpression of hCactin suppresses TLR-induced activation of NF-kappa B and interferon-regulatory factor transcription factors and induction of TLR-responsive genes, whereas knockdown of endogenous hCactin augments TLR induction of these responses. hCactin also interacts with I kappa B-like protein and targets other proteins that are encoded by genes in the MHC Class III region of chromosome 6. We demonstrate that hCactin localizes to the nucleus, and this nuclear localization is critical for manifesting its inhibitory effects on TLR signaling. This study thus defines hCactin as a novel negative regulator of TLR signaling and reveals its capacity to target MHC Class III genes at the molecular and functional level.	[Atzei, Paola; Gargan, Siobhan; Curran, Niamh; Moynagh, Paul N.] Natl Univ Ireland, Inst Immunol, Maynooth 1, Kildare, Ireland	Maynooth University	Moynagh, PN (corresponding author), Natl Univ Ireland, Inst Immunol, Maynooth 1, Kildare, Ireland.	Paul.Moynagh@nuim.ie		Moynagh, Paul/0000-0002-4139-3061; atzei, paola/0000-0002-5986-620X	Science Foundation Ireland [SFI/RFP/BIC1501]; Health Research Board of Ireland; European Union Marie Curie Action (MNIEST)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland; European Union Marie Curie Action (MNIEST)(European Commission)	This work was funded by Science Foundation Ireland Grant SFI/RFP/BIC1501, the Health Research Board of Ireland, and the European Union Marie Curie Action (MNIEST).	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Atzei P, 2010, GENE EXPR PATTERNS, V10, P199, DOI 10.1016/j.gep.2010.03.003; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Bourke E, 2000, J BIOL CHEM, V275, P39996, DOI 10.1074/jbc.M007693200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Curran NM, 2005, J BIOL CHEM, V280, P35797, DOI 10.1074/jbc.M507959200; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; De La Concha EG, 2000, GASTROENTEROLOGY, V119, P1491, DOI 10.1053/gast.2000.20258; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin PH, 2000, MECH DEVELOP, V94, P57, DOI 10.1016/S0925-4773(00)00314-2; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Okamoto K, 2003, AM J HUM GENET, V72, P303, DOI 10.1086/346067; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tannoury H, 2010, DEV BIOL, V341, P176, DOI 10.1016/j.ydbio.2010.02.025; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xie G, 2002, GENOME BIOL, V3; Xie T, 2003, GENOME RES, V13, P2621, DOI 10.1101/gr.1736803; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	42	26	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36804	36817		10.1074/jbc.M110.139113	http://dx.doi.org/10.1074/jbc.M110.139113			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829348	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000284146100040
J	Higashi, Y; Holder, K; Delafontaine, P				Higashi, Yusuke; Holder, Kevin; Delafontaine, Patrice			Thiazolidinediones Up-regulate Insulin-like Growth Factor-1 Receptor via a Peroxisome Proliferator-activated Receptor gamma-Independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA; GENE-EXPRESSION; DEFICIENT MICE; ATHEROSCLEROTIC LESIONS; MONOCLONAL-ANTIBODY; OXIDATIVE STRESS; IGF-1; TROGLITAZONE	There is increasing evidence that thiazolidinediones (TZDs), antidiabetic compounds that are synthetic ligands for the peroxisome proliferator-activated receptor gamma (PPAR gamma), have cardiovascular effects through as yet poorly defined mechanisms. We tested the effect of two TZD class drugs, rosiglitazone and pioglitazone, on human aortic smooth muscle cell (SMC) expression of insulin-like growth factor-1 receptor (IGF-1R). Both TZDs dose dependently up-regulated IGF-1R protein levels (rosiglitazone, 10 mu mol/liter, 67% increase, n = 4, p < 0.01; pioglitazone, 10 mu mol/liter, 41% increase, n = 4, p < 0.01) and increased IGF-1R signaling activity (36% increase in Akt phosphorylation). However, the endogenous PPAR gamma ligand, 15-deoxy-Delta(12,14)-prostaglandin J(2), dose dependently reduced IGF-1R (10 mu mol/liter, 80% decrease, n = 4, p < 0.01), and overexpression of PPAR gamma using an adenovirus likewise reduced IGF-1R (50% decrease versus SMC infected with control adenovirus), suggesting a PPAR gamma-independent action of TZDs. All three PPAR gamma ligands (rosiglitazone, pioglitazone, and 15-deoxy-Delta(12,14)-prostaglandin J2), however, did not change IGF-1R mRNA levels, indicating that their effects were posttranscriptional. Use of bicistronic constructs revealed that TZD induction of IGF-1R translation occurred via internal ribosomal entry. To examine the potential physiological relevance of TZD up-regulation of IGF-1R, we determined the effect of rosiglitazone on oxidized LDL (oxLDL)-induced apoptosis. 20 mu mol/liter of rosiglitazone reduced oxidized LDL-induced apoptosis by 40% and neutralizing antibody to IGF-1R (alpha IR3) counteracted this rescue, suggesting the rosiglitazone survival effect was, at least in part, mediated by IGF-1R. In conclusion, TZDs markedly up-regulate SMC IGF-1R expression and signaling, likely via a PPAR gamma-independent mechanism. This novel action of TZDs may play an important role in their cardiovascular effects.	[Higashi, Yusuke; Holder, Kevin; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA	Tulane University	Delafontaine, P (corresponding author), 1430 Tulane Ave,SL-48, New Orleans, LA 70112 USA.	pdelafon@tulane.edu		Delafontaine, Patrice/0000-0003-3744-3617	NHLBI, National Institutes of Health [R01HL070241, R01HL080682]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL070241 and R01HL080682 from the NHLBI.	Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Barish GD, 2006, J NUTR, V136, P690, DOI 10.1093/jn/136.3.690; Chen Z, 2001, ARTERIOSCL THROM VAS, V21, P372, DOI 10.1161/01.ATV.21.3.372; Chisalita SI, 2009, J MOL ENDOCRINOL, V43, P231, DOI 10.1677/JME-09-0021; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Festuccia WT, 2009, J MOL CELL CARDIOL, V47, P85, DOI 10.1016/j.yjmcc.2009.04.011; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fu MG, 2002, BIOCHEM BIOPH RES CO, V294, P597, DOI 10.1016/S0006-291X(02)00533-8; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Goetze S, 1999, J CARDIOVASC PHARM, V33, P798, DOI 10.1097/00005344-199905000-00018; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI [10.1089/ars.2008.2280, 10.1089/ARS.2008.2280]; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; He GB, 2006, CANCER RES, V66, P1873, DOI 10.1158/0008-5472.CAN-05-3111; Higashi Y, 2005, J LIPID RES, V46, P1266, DOI 10.1194/jlr.M400478-JLR200; Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Itabe H, 1996, J LIPID RES, V37, P45; ITABE H, 1994, J BIOL CHEM, V269, P15274; KHORSANDI MJ, 1992, J CLIN INVEST, V90, P1926, DOI 10.1172/JCI116070; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB; Lonn EM, 2009, J AM COLL CARDIOL, V53, P2028, DOI 10.1016/j.jacc.2008.12.072; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Meng Z, 2008, J CELL PHYSIOL, V217, P172, DOI 10.1002/jcp.21486; Minamikawa J, 1998, J CLIN ENDOCR METAB, V83, P1818, DOI 10.1210/jc.83.5.1818; Nichols TC, 1999, CIRC RES, V85, P1040; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; Okura Y, 2001, J MOL CELL CARDIOL, V33, P1777, DOI 10.1006/jmcc.2001.1441; Scheidegger KJ, 2000, J BIOL CHEM, V275, P26864; Scheidegger KJ, 1999, J BIOL CHEM, V274, P3522, DOI 10.1074/jbc.274.6.3522; Scheidegger KJ, 2000, J BIOL CHEM, V275, P38921, DOI 10.1074/jbc.M004691200; Schiffrin EL, 2005, AM J PHYSIOL-HEART C, V288, pH1037, DOI 10.1152/ajpheart.00677.2004; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257	45	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36361	36368		10.1074/jbc.M110.137661	http://dx.doi.org/10.1074/jbc.M110.137661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843793	Green Published, hybrid			2022-12-27	WOS:000284146100028
J	Wang, WJ; Mazurkewich, S; Kimber, MS; Seah, SYK				Wang, Weijun; Mazurkewich, Scott; Kimber, Matthew S.; Seah, Stephen Y. K.			Structural and Kinetic Characterization of 4-Hydroxy-4-methyl-2-oxoglutarate/4-Carboxy-4-hydroxy-2-oxoadipate Aldolase, a Protocatechuate Degradation Enzyme Evolutionarily Convergent with the HpaI and DmpG Pyruvate Aldolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR PHOSPHOTRANSFERASE SYSTEM; CLASS-II ALDOLASE; CRYSTAL-STRUCTURE; PROTEIN INHIBITOR; MECHANISM; RRAA; PURIFICATION; PATHWAY; DEHYDROGENASE; EXPRESSION	4-Hydroxy-4-methyl-2-oxoglutarate/4-carboxy-4-hydroxy-2- oxoadipate (HMG/CHA) aldolase from Pseudomonas putida F1 catalyzes the last step of the bacterial protocatechuate 4,5-cleavage pathway. The preferred substrates of the enzyme are 2-keto-4-hydroxy acids with a 4-carboxylate substitution. The enzyme also exhibits oxaloacetate decarboxylation and pyruvate alpha-proton exchange activity. Sodium oxalate is a competitive inhibitor of the aldolase reaction. The pH dependence of k(cat)/K-m and k(cat) for the enzyme is consistent with a single deprotonation with pK(a) values of 8.0 +/- 0.1 and 7.0 +/- 0.1 for free enzyme and enzyme substrate complex, respectively. The 1.8 angstrom x-ray structure shows a four-layered alpha-beta-beta-alpha sandwich structure with the active site at the interface of two adjacent subunits of a hexamer; this fold resembles the RNase E inhibitor, RraA, but is novel for an aldolase. The catalytic site contains a magnesium ion ligated by Asp-124 as well as three water molecules bound by Asp-102 and Glu-199'. A pyruvate molecule binds the magnesium ion through both carboxylate and keto oxygen atoms, completing the octahedral geometry. The carbonyl oxygen also forms hydrogen bonds with the guanadinium group of Arg-123, which site-directed mutagenesis confirms is essential for catalysis. A mechanism for HMG/CHA aldolase is proposed on the basis of the structure, kinetics, and previously established features of other aldolase mechanisms.	[Wang, Weijun; Mazurkewich, Scott; Kimber, Matthew S.; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Seah, SYK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	sseah@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Mazurkewich, Scott/0000-0002-9238-0615; wang, weijun/0000-0001-9283-5619; Kimber, Matthew/0000-0001-9454-5586	National Science and Engineering Research Council of Canada [238284, 327280]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Research Council of Canada Discovery Grants 238284 (to S. Y. K. S.) and 327280 (to M. S. K.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker P, 2009, BIOCHEMISTRY-US, V48, P6551, DOI 10.1021/bi9006644; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhuri BN, 2003, STRUCTURE, V11, P753, DOI 10.1016/S0969-2126(03)00106-0; CHELL RM, 1978, BIOCHEM J, V173, P165, DOI 10.1042/bj1730165; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DeLano W.L, PYMOL MOL GRAPHICS S; DENNIS DA, 1973, J BACTERIOL, V113, P521, DOI 10.1128/JB.113.1.521-523.1973; DREYER MK, 1993, J MOL BIOL, V231, P549, DOI 10.1006/jmbi.1993.1307; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Helaine V, 2001, ADV SYNTH CATAL, V343, P692, DOI 10.1002/1615-4169(200108)343:6/7<692::AID-ADSC692>3.3.CO;2-Y; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Horecker B. L, 1972, ENZYMES, P213, DOI DOI 10.1016/S1874-6047(08)60450-3; Johnston JM, 2003, J BACTERIOL, V185, P4057, DOI 10.1128/JB.185.14.4057-4065.2003; KEYSER P, 1976, ENVIRON HEALTH PERSP, V18, P159, DOI 10.2307/3428698; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; Leulliot N, 2005, PROTEIN SCI, V14, P2751, DOI 10.1110/ps.051684005; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Maruyama K, 2001, BIOSCI BIOTECH BIOCH, V65, P2701, DOI 10.1271/bbb.65.2701; MARUYAMA K, 1990, J BIOCHEM-TOKYO, V108, P327, DOI 10.1093/oxfordjournals.jbchem.a123201; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monzingo AF, 2003, J MOL BIOL, V332, P1015, DOI 10.1016/S0022-2836(03)00970-7; Narayanan BC, 2008, BIOCHEMISTRY-US, V47, P167, DOI 10.1021/bi701954p; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POWLOWSKI J, 1993, J BACTERIOL, V175, P377, DOI 10.1128/JB.175.2.377-385.1993; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; Rehse PH, 2004, ACTA CRYSTALLOGR D, V60, P1997, DOI 10.1107/S0907444904021146; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TACK BF, 1972, J BIOL CHEM, V247, P6444; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Wang WJ, 2010, BIOCHEMISTRY-US, V49, P3774, DOI 10.1021/bi100251u; Wang WJ, 2005, BIOCHEMISTRY-US, V44, P9447, DOI 10.1021/bi050607y; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	44	22	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36608	36615		10.1074/jbc.M110.159509	http://dx.doi.org/10.1074/jbc.M110.159509			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843800	hybrid, Green Published			2022-12-27	WOS:000284146100024
J	Orr, CR; Montie, HL; Liu, YH; Bolzoni, E; Jenkins, SC; Wilson, EM; Joseph, JD; McDonnell, DP; Merry, DE				Orr, Christopher R.; Montie, Heather L.; Liu, Yuhong; Bolzoni, Elena; Jenkins, Shannon C.; Wilson, Elizabeth M.; Joseph, James D.; McDonnell, Donald P.; Merry, Diane E.			An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; COOH-TERMINAL INTERACTION; LIGAND-BINDING DOMAIN; ACTIVATION FUNCTION 2; PROSTATE-CANCER; PHOSPHORYLATION SITES; STRUCTURAL BASIS; INDUCED DISEASE; IDENTIFICATION; COACTIVATOR	Polyglutamine expansion within the androgen receptor (AR) causes spinal and bulbar muscular atrophy (SBMA) and is associated with misfolded and aggregated species of the mutant AR. We showed previously that nuclear localization of the mutant AR was necessary but not sufficient for SBMA. Here we show that an interdomain interaction of the AR that is central to its function within the nucleus is required for AR aggregation and toxicity. Ligands that prevent the interaction between the amino-terminal FXXLF motif and carboxyl-terminal AF-2 domain (N/C interaction) prevented toxicity and AR aggregation in an SBMA cell model and rescued primary SBMA motor neurons from 5 alpha-dihydrotestosterone-induced toxicity. Moreover, genetic mutation of the FXXLF motif prevented AR aggregation and 5 alpha-dihydrotestosterone toxicity. Finally, selective androgen receptor modulators, which prevent the N/C interaction, ameliorated AR aggregation and toxicity while maintaining AR function, highlighting a novel therapeutic strategy to prevent the SBMA phenotype while retaining AR transcriptional function.	[Orr, Christopher R.; Montie, Heather L.; Liu, Yuhong; Bolzoni, Elena; Jenkins, Shannon C.; Merry, Diane E.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Joseph, James D.; McDonnell, Donald P.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Labs Reprod Biol, Chapel Hill, NC 27599 USA	Jefferson University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Merry, DE (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 228 Bluemle Life Sci Bldg,223 S 10th St, Philadelphia, PA 19107 USA.	diane.merry@jefferson.edu			National Institutes of Health [R01 NS32214, DK07705, CA139818, HD16910]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA139818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS32214 (to D. E. M.), DK07705 (to H. L. M.), CA139818 (to D. P. M.), and HD16910 (to E. M. W.).	Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Chandra S, 2008, J BIOL CHEM, V283, P23950, DOI 10.1074/jbc.M800467200; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Furutani T, 2005, J PHARMACOL EXP THER, V315, P545, DOI 10.1124/jpet.105.087643; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LAVERY DN, 2008, J BIOCH, V47, P3360; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Montie HL, 2009, HUM MOL GENET, V18, P1937, DOI 10.1093/hmg/ddp115; Norris JD, 2009, CHEM BIOL, V16, P452, DOI 10.1016/j.chembiol.2009.01.016; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perutz MF, 1996, CURR OPIN STRUC BIOL, V6, P848, DOI 10.1016/S0959-440X(96)80016-9; PINSKY L, 1992, CLIN INVEST MED, V15, P456; Pratt William B., 1994, Seminars in Cell Biology, V5, P83; Roy J, 1998, J NEUROSCI, V18, P9673; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sathya G, 2003, CANCER RES, V63, P8029; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Shen HC, 2005, BIOL CHEM, V386, P69, DOI 10.1515/BC.2005.009; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; Zhu ZX, 2001, BIOCHEM BIOPH RES CO, V284, P836, DOI 10.1006/bbrc.2001.5030	53	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35567	35577		10.1074/jbc.M110.146845	http://dx.doi.org/10.1074/jbc.M110.146845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826791	Green Published, hybrid			2022-12-27	WOS:000283845300035
J	Salvador-Recatala, V; Greenberg, RM				Salvador-Recatala, Vicenta; Greenberg, Robert M.			The N Terminus of a Schistosome beta Subunit Regulates Inactivation and Current Density of a Ca(v)2 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; CA2+ CHANNELS; MODULATION; SENSITIVITY; ACTIVATION; CONTRIBUTE; MANSONI; RELEASE; DOMAIN; SITES	The beta subunit of high voltage-activated Ca2+ (Ca-v) channels targets the pore-forming alpha(1) subunit to the plasma membrane and tunes the biophysical phenotype of the Ca-v channel complex. We used a combination of molecular biology and whole-cell patch clamp to investigate the functional role of a long N-terminal polyacidic motif (NPAM) in a Ca-v beta subunit of the human parasite Schistosoma mansoni (beta(Sm)), a motif that does not occur in other known Ca-v beta subunits. When expressed in human embryonic kidney cells stably expressing Ca(v)2.3, beta(Sm) accelerates Ca2+/calmodulin-independent inactivation of Ca(v)2.3. Deleting the first 44 amino acids of beta(Sm), a region that includes NPAM, significantly slows the predominant time constant of inactivation (tau(fast)) under conditions that prevent Ca2+/CaM-dependent inactivation (beta(Sm): tau(fast) = 66 ms; beta(Sm Delta 2-44): tau(fast) = 111 ms, p < 0.01). Interestingly, deleting the amino acids that are N-terminal to NPAM (2-24 or 2-17) results in faster inactivation than with an intact N terminus (tau(fast) = 42 ms with beta(Sm Delta 2-17); tau(fast) = 40 ms with beta(Sm Delta 2-24), p < 0.01). This suggests that NPAM is the structural determinant for accelerating Ca2+/calmodulin-independent inactivation. We also created three chimeric subunits that contain the first 44 amino acids of beta(Sm) attached to mammalian beta(1b), beta(2a), and beta(3) subunits. For any given mammalian beta subunit, inactivation was faster if it contained the N terminus of beta(Sm) than if it did not. Co-expression of the mammalian alpha(2)delta-1 subunit resulted in doubling of the inactivation rate, but the effects of NPAM persisted. Thus, it appears that the schistosome Ca-v channel complex has acquired a new function that likely contributes to reducing the amount of Ca2+ that enters the cells in vivo. This feature is of potential interest as a target for new antihelminthics.	[Salvador-Recatala, Vicenta; Greenberg, Robert M.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Salvador-Recatala, V (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 226 Rosenthal Bldg,3800 Spruce St, Philadelphia, PA 19104 USA.	vicenta@vet.upenn.edu	Salvador, Vicenta/AAE-9733-2020	Salvador Recatala, Vicenta/0000-0002-6094-1422	National Institutes of Health [AI 4052, AI 73660, AI 082390]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030026, R21AI082390, R01AI040522, R01AI073660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 4052, AI 73660, and AI 082390.	Albillos A, 2000, J NEUROSCI, V20, P8323, DOI 10.1523/JNEUROSCI.20-22-08323.2000; ALDRICH RW, 1987, J NEUROSCI, V7, P418; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Carabelli V, 1996, BIOPHYS J, V70, P2144, DOI 10.1016/S0006-3495(96)79780-1; Castro A, 2009, J COMP NEUROL, V513, P188, DOI 10.1002/cne.21952; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; DE WM, 1997, NATURE, V385, P446; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Doenhoff MJ, 2009, PARASITOLOGY, V136, P1825, DOI 10.1017/S0031182009000493; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Jangsangthong W, 2010, PFLUG ARCH EUR J PHY, V459, P399, DOI 10.1007/s00424-009-0738-z; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kamp MA, 2005, EUR J NEUROSCI, V21, P1617, DOI 10.1111/j.1460-9568.2005.03984.x; Karunasekara Y, 2009, EUR BIOPHYS J BIOPHY, V39, P75, DOI 10.1007/s00249-009-0467-4; Kohn AB, 2003, PARASITOLOGY, V127, P349, DOI 10.1017/S003118200300386X; Kohn AB, 2001, PARASITOLOGY, V123, P489, DOI 10.1017/S0031182001008691; Kohn AB, 2001, J BIOL CHEM, V276, P36873, DOI 10.1074/jbc.C100273200; Leroy J, 2003, EUR J NEUROSCI, V18, P841, DOI 10.1046/j.1460-9568.2003.02819.x; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mendonca-Silva DL, 2006, PARASITOLOGY, V133, P67, DOI 10.1017/S0031182006000023; Morad M, 2005, CELL CALCIUM, V38, P223, DOI 10.1016/j.ceca.2005.06.027; Nakhasi HL, 1998, PARASITOL TODAY, V14, P157, DOI 10.1016/S0169-4758(97)01180-0; Novozhilova E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000790; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; OLEARY ME, 1995, J GEN PHYSIOL, V106, P641, DOI 10.1085/jgp.106.4.641; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1996, BIOPHYS J, V71, P2509, DOI 10.1016/S0006-3495(96)79444-4; Qin N, 1998, AM J PHYSIOL-CELL PH, V274, pC1324, DOI 10.1152/ajpcell.1998.274.5.C1324; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Salvador-Recatala Vicenta, 2008, BMC Physiology, V8, P6, DOI 10.1186/1472-6793-8-6; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SHAW MK, 1983, PARASITOLOGY, V86, P439, DOI 10.1017/S0031182000050630; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Twede VD, 2009, IDRUGS, V12, P231; Vais H, 2000, FEBS LETT, V470, P135, DOI 10.1016/S0014-5793(00)01305-3; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; Wang G, 1999, J NEUROSCI, V19, P9235; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yamada Y, 2001, J BIOL CHEM, V276, P47163, DOI 10.1074/jbc.M108049200; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x	49	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35878	35888		10.1074/jbc.M110.144725	http://dx.doi.org/10.1074/jbc.M110.144725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826800	Green Published, hybrid			2022-12-27	WOS:000283845300065
J	Kintner, DB; Chen, XZ; Currie, J; Chanana, V; Ferrazzano, P; Baba, A; Matsuda, T; Cohen, M; Orlowski, J; Chiu, SY; Taunton, J; Sun, DD				Kintner, Douglas B.; Chen, Xinzhi; Currie, Julia; Chanana, Vishal; Ferrazzano, Peter; Baba, Akemichi; Matsuda, Toshio; Cohen, Mike; Orlowski, John; Chiu, Shing-Yan; Taunton, Jack; Sun, Dandan			Excessive Na+/H+ Exchange in Disruption of Dendritic Na+ and Ca2+ Homeostasis and Mitochondrial Dysfunction following in Vitro Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA1 PYRAMIDAL NEURONS; HIPPOCAMPAL-NEURONS; NA+/CA2+ EXCHANGE; CULTURED NEURONS; RAT; INHIBITOR; SODIUM; ASTROCYTES; EXPRESSION; INJURY	Neuronal dendrites are vulnerable to injury under diverse pathological conditions. However, the underlying mechanisms for dendritic Na+ overload and the selective dendritic injury remain poorly understood. Our current study demonstrates that activation of NHE-1 (Na+/H+ exchanger isoform 1) in dendrites presents a major pathway for Na+ overload. Neuronal dendrites exhibited higher pH(i) regulation rates than soma as a result of a larger surface area/volume ratio. Following a 2-h oxygen glucose deprivation and a 1-h reoxygenation, NHE-1 activity was increased by similar to 70-200% in dendrites. This elevation depended on activation of p90 ribosomal S6 kinase. Moreover, stimulation of NHE-1 caused dendritic Na-i(+) accumulation, swelling, and a concurrent loss of Ca-i(2+) homeostasis. The Ca-i(2+) overload in dendrites preceded the changes in soma. Inhibition of NHE-1 or the reverse mode of Na+/Ca2+ exchange prevented these changes. Mitochondrial membrane potential in dendrites depolarized 40 min earlier than soma following oxygen glucose deprivation/reoxygenation. Blocking NHE-1 activity not only attenuated loss of dendritic mitochondrial membrane potential and mitochondrial Ca2+ homeostasis but also preserved dendritic membrane integrity. Taken together, our study demonstrates that NHE-1-mediated Na+ entry and subsequent Na+/Ca2+ exchange activation contribute to the selective dendritic vulnerability to in vitro ischemia.	[Kintner, Douglas B.; Chen, Xinzhi; Currie, Julia; Sun, Dandan] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol Surg, Madison, WI 53705 USA; [Chen, Xinzhi] Univ Wisconsin, Sch Med & Publ Hlth, Neurosci Training Program, Madison, WI 53705 USA; [Chiu, Shing-Yan] Univ Wisconsin, Sch Med & Publ Hlth, Dept Physiol, Madison, WI 53705 USA; [Chanana, Vishal; Ferrazzano, Peter; Sun, Dandan] Univ Wisconsin, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI 53705 USA; [Baba, Akemichi; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Cohen, Mike; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Cohen, Mike; Taunton, Jack] Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94143 USA; [Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Osaka University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; McGill University	Sun, DD (corresponding author), T513 Waisman Ctr,1500 Highland Ave, Madison, WI 53705 USA.	sun@neurosurgery.wisc.edu	sun, dandan/GZG-6540-2022; chanana, vishal/F-3738-2014; Chen, X. Richard/A-7141-2012	Orlowski, John/0000-0001-7371-175X	National Institutes of Health [RO1NS48216, R01 GM071434, RG-4054-A-8, P30 HD03352]; CTSA (University of Wisconsin Institute for Clinical and Translational Research) [1UL1RR02511]; American Heart Association [EIA 0540154]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA (University of Wisconsin Institute for Clinical and Translational Research); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS48216 (to D. S.), R01 GM071434 (to J. T.), MS RG-4054-A-8 (to S.-Y. C.), P30 HD03352 (to the Waisman Center), and CTSA 1UL1RR02511 (University of Wisconsin Institute for Clinical and Translational Research) (to P. F.). This work was also supported by American Heart Association Grant EIA 0540154 (to D. S.).	Avkiran M, 2001, BASIC RES CARDIOL, V96, P306, DOI 10.1007/s003950170037; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; CHOI DW, 1987, J NEUROSCI, V7, P357; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; Dietz RM, 2007, HIPPOCAMPUS, V17, P1049, DOI 10.1002/hipo.20336; Douglas RM, 2001, NEUROSCIENCE, V102, P217, DOI 10.1016/S0306-4522(00)00473-5; FRIEDMAN JE, 1994, BRAIN RES, V641, P57, DOI 10.1016/0006-8993(94)91815-5; Garciarena CD, 2008, J APPL PHYSIOL, V105, P1706, DOI 10.1152/japplphysiol.90616.2008; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Hasbani MJ, 2001, NEUROREPORT, V12, P2731, DOI 10.1097/00001756-200108280-00028; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Iwamoto T, 2004, J BIOL CHEM, V279, P7544, DOI 10.1074/jbc.M310491200; Javadov S, 2005, J MOL CELL CARDIOL, V38, P135, DOI 10.1016/j.yjmcc.2004.10.007; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Kintner DB, 2004, AM J PHYSIOL-CELL PH, V287, pC12, DOI 10.1152/ajpcell.00560.2003; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; Kleeman H W, 1999, IDrugs, V2, P1009; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Luo J, 2007, J BIOL CHEM, V282, P28274, DOI 10.1074/jbc.M702373200; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; Makani S, 2007, J NEUROSCI, V27, P7438, DOI 10.1523/JNEUROSCI.2304-07.2007; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; MORIYAMA Y, 1990, J BIOCHEM, V108, P689, DOI 10.1093/oxfordjournals.jbchem.a123264; MU L, 2000, J NEUROPHYSIOL */* G, V84, P1869; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Musch MW, 2002, AM J PHYSIOL-GASTR L, V283, pG975, DOI 10.1152/ajpgi.00528.2001; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; PAPPAS CA, 1993, GLIA, V9, P280, DOI 10.1002/glia.440090406; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Philippe JM, 2002, GLIA, V37, P365, DOI 10.1002/glia.10041; Raley-Susman KM, 2001, J NEUROPHYSIOL, V86, P2715, DOI 10.1152/jn.2001.86.6.2715; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sheldon C, 2004, J NEUROSCI, V24, P11057, DOI 10.1523/JNEUROSCI.2829-04.2004; Shuttleworth CWR, 2001, J NEUROSCI, V21, P4225, DOI 10.1523/JNEUROSCI.21-12-04225.2001; SPA TA, 2008, CELL CALCIUM */* G C, V44, P51; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Teshima Y, 2003, CIRCULATION, V108, P2275, DOI 10.1161/01.CIR.0000093277.20968.C7; Toda T, 2007, AM J PHYSIOL-HEART C, V293, pH3517, DOI 10.1152/ajpheart.00483.2006; Trudeau LE, 1999, J NEUROPHYSIOL, V81, P2627, DOI 10.1152/jn.1999.81.6.2627; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; VANDER J, 2008, J NEUROSCI */* C W J, V28, P5029; Vitzthum L, 2010, INTEGR BIOL-UK, V2, P58, DOI 10.1039/b918440f	45	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35155	35168		10.1074/jbc.M110.101212	http://dx.doi.org/10.1074/jbc.M110.101212			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817726	Green Published, hybrid			2022-12-27	WOS:000283659100089
J	Majewski, PM; Thurston, RD; Ramalingam, R; Kiela, PR; Ghishan, FK				Majewski, Pawel M.; Thurston, Robert D.; Ramalingam, Rajalakshmy; Kiela, Pawel R.; Ghishan, Fayez K.			Cooperative Role of NF-kappa B and Poly(ADP-ribose) Polymerase 1 (PARP-1) in the TNF-induced Inhibition of PHEX Expression in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED HYPOPHOSPHATEMIA; SIBLING-ASARM-PEPTIDES; DOWN-REGULATION; NUCLEAR TRANSLOCATION; GENE-EXPRESSION; DEFICIENT MICE; BONE-FORMATION; COLITIS; MINERALIZATION; DISEASE	Reduced bone mass is a common complication in chronic inflammatory diseases, although the mechanisms are not completely understood. The PHEX gene encodes a zinc endopeptidase expressed in osteoblasts and contributes to bone mineralization. The aim of this study was to determine the molecular mechanism involved in TNF-mediated down-regulation of Phex gene transcription. We demonstrate down-regulation of the Phex gene in two models of colitis: naive T-cell transfer and in gnotobiotic IL-10(-/-) mice. In vitro, TNF decreased expression of Phex in UMR106 cells and did not require de novo synthesis of a transrepressor. Transfecting UMR-106 cells with a series of deletion constructs of the proximal Phex promoter identified a region located within -74 nucleotides containing NF-kappa B and AP-1 binding sites. After TNF treatment, the RelA/p50 NF-kappa B complex interacted with two cis-elements at positions -70/-66 and -29/-25 nucleotides in the proximal Phex promoter. Inhibition of NF-kappa B signaling increased the basal level of Phex transcription and abrogated the effects of TNF, whereas overexpression of RelA mimicked the effect of TNF. We identified poly(ADP-ribose) polymerase 1 (PARP-1) binding immediately upstream of the NF-kappa B sites and showed that TNF induced poly( ADP-ribosyl)ation of RelA when bound to the Phex promoter. TNF-mediated Phex down-regulation was completely abrogated in vitro by PARP-1 inhibitor and overexpression of poly( ADP-ribose) glucohydrolase (PARG) and in vivo in PARP-1(-/-) mice. Our results suggest that NF-kappa B signaling and PARP-1 enzymatic activity cooperatively contribute to the constitutive and inducible suppression of Phex. The described phenomenon likely contributes to the loss of bone mass density in chronic inflammatory diseases, such as inflammatory bowel disease.	[Majewski, Pawel M.; Thurston, Robert D.; Ramalingam, Rajalakshmy; Kiela, Pawel R.; Ghishan, Fayez K.] Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ 85724 USA; [Majewski, Pawel M.] Univ Warsaw, Fac Biol, Dept Anim Physiol, PL-02096 Warsaw, Poland	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; University of Warsaw	Ghishan, FK (corresponding author), 1501 N Campbell Ave, Tucson, AZ 85724 USA.	fghishan@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Majewski, Pawel/0000-0002-5361-1935; Kiela, Pawel/0000-0002-0014-3517	National Institutes of Health [2P40RR018603, R37DK033209]; NIEHS [ES06694]; NCI [CA023074]; BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Access to the National Gnotobiotic Rodent Resource Center at the University of North Carolina at Chapel Hill was supported by National Institutes of Health Grant 2P40RR018603 provided courtesy of Dr. Balfour R. Sartor.; This work was supported, in whole or in part, by National Institutes of Health Grant R37DK033209 (to F.K.G.). Mass spectrometric data acquired by the Arizona Proteomics Consortium was supported by National Institutes of Health Grant ES06694 from the NIEHS to The Southwest Environmental Health Sciences Center, Grant CA023074 from the NCI to the Arizona Cancer Center, and by the BIO5 Institute of the University of Arizona.	Addison WN, 2008, J BONE MINER RES, V23, pS56; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Alos N, 2005, BONE, V37, P589, DOI 10.1016/j.bone.2005.05.006; BENETPAGES A, 2004, T M BONE, V35, P455; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; COLLINS JF, 1995, AM J PHYSIOL-RENAL, V269, pF439, DOI 10.1152/ajprenal.1995.269.3.F439; Di Paola R, 2005, EUR J PHARMACOL, V527, P163, DOI 10.1016/j.ejphar.2005.09.055; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Hines ER, 2004, J BIOL CHEM, V279, P46406, DOI 10.1074/jbc.M404278200; Hines ER, 2002, AM J PHYSIOL-RENAL, V283, pF356, DOI 10.1152/ajprenal.00357.2001; Hyams JS, 1997, J PEDIATR GASTR NUTR, V24, P289, DOI 10.1097/00005176-199703000-00011; Jijon HB, 2000, AM J PHYSIOL-GASTR L, V279, pG641, DOI 10.1152/ajpgi.2000.279.3.G641; Karrasch T, 2008, INFLAMM BOWEL DIS, V14, P114, DOI 10.1002/ibd.20243; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kiela PR, 2009, LAB INVEST, V89, P7, DOI 10.1038/labinvest.2008.114; Larmonier CB, 2008, AM J PHYSIOL-GASTR L, V295, pG1079, DOI 10.1152/ajpgi.90365.2008; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Popoff I, 2002, J PHARMACOL EXP THER, V303, P1145, DOI 10.1124/jpet.102.039768; Rodriguez-Bores L, 2007, WORLD J GASTROENTERO, V13, P6156, DOI 10.3748/wjg.v13.i46.6156; Sanchez-Fidalgo S, 2007, EUR J PHARMACOL, V563, P216, DOI 10.1016/j.ejphar.2007.01.070; Slomiany BA, 2000, BIOTECHNIQUES, V28, P938, DOI 10.2144/00285st08; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; Tenenhouse HS, 2005, ANNU REV NUTR, V25, P197, DOI 10.1146/annurev.nutr.25.050304.092642; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Uno JK, 2006, GASTROENTEROLOGY, V131, P497, DOI 10.1053/j.gastro.2006.05.020; Vargas MA, 2003, ENDOCRINOLOGY, V144, P4876, DOI 10.1210/en.2003-0253; Varghese S, 2002, J PEDIATR GASTR NUTR, V35, P641, DOI 10.1097/00005176-200211000-00010; Xiao ZS, 1998, AM J PHYSIOL-ENDOC M, V275, pE700, DOI 10.1152/ajpendo.1998.275.4.E700; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zingarelli B, 2004, IMMUNOLOGY, V113, P509, DOI 10.1111/j.1365-2567.2004.01991.x; Zingarelli B, 2003, EUR J PHARMACOL, V469, P183, DOI 10.1016/S0014-2999(03)01726-6; Zoidis E, 2002, EUR J ENDOCRINOL, V146, P97, DOI 10.1530/eje.0.1460097	41	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34828	34838		10.1074/jbc.M110.152868	http://dx.doi.org/10.1074/jbc.M110.152868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817730	Green Published, hybrid			2022-12-27	WOS:000283659100058
J	Noma, A; Ishitani, R; Kato, M; Nagao, A; Nureki, O; Suzuki, T				Noma, Akiko; Ishitani, Ryuichiro; Kato, Megumi; Nagao, Asuteka; Nureki, Osamu; Suzuki, Tsutomu			Expanding Role of the Jumonji C Domain as an RNA Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RIBONUCLEIC-ACID; Y BASE; WYBUTOSINE; NUCLEOSIDE; IDENTIFICATION; ENZYME; PHE	JmjC (Jumonji C) domain-containing proteins are known to be an extensive family of Fe(II)/2-oxoglutarate-dependent oxygenases involved in epigenetic regulation of gene expression by catalyzing oxidative demethylation of methylated histones. We report here that a human JmjC protein named Tyw5p (TYW5) unexpectedly acts in the biosynthesis of a hypermodified nucleoside, hydroxywybutosine, in tRNA(Phe) by catalyzing hydroxylation. The finding provides an insight into the expanding role of JmjC protein as an RNA hydroxylase.	[Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Ishitani, Ryuichiro; Kato, Megumi; Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Struct Biol,Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731	Ministry of Education, Science, Sports, and Culture of Japan; Japan Society for the Promotion of Science; New Energy and Industrial Technology Development Organization	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to T. S. and O. N.), by Japan Society for the Promotion of Science fellowship for Japanese junior scientists (to A. N.), and by a grant from the New Energy and Industrial Technology Development Organization (to T. S.).	BLOBSTEIN SH, 1975, ARCH BIOCHEM BIOPHYS, V167, P668, DOI 10.1016/0003-9861(75)90510-X; BLOBSTEIN SH, 1973, BIOCHEMISTRY-US, V12, P188, DOI 10.1021/bi00726a002; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Kalhor HR, 2005, BIOCHEM BIOPH RES CO, V334, P433, DOI 10.1016/j.bbrc.2005.06.111; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; KASAI H, 1979, NUCLEIC ACIDS RES, V6, P993, DOI 10.1093/nar/6.3.993; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; NAKANISHI K, 1971, NATURE-NEW BIOL, V234, P107, DOI 10.1038/newbio234107b0; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; SUZUKI T, 2005, TOPICS CURRENT GENET; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Suzuki Y, 2009, NUCLEIC ACIDS RES, V37, P2910, DOI 10.1093/nar/gkp158; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Waas WF, 2005, J BIOL CHEM, V280, P37616, DOI 10.1074/jbc.M506939200; Waas WF, 2007, J BIOL CHEM, V282, P26026, DOI 10.1074/jbc.M703391200	23	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34503	34507		10.1074/jbc.M110.156398	http://dx.doi.org/10.1074/jbc.M110.156398			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739293	hybrid, Green Published			2022-12-27	WOS:000283659100025
J	LeBleu, V; Sund, M; Sugimoto, H; Birrane, G; Kanasaki, K; Finan, E; Miller, CA; Gattone, VH; McLaughlin, H; Shield, CF; Kalluri, R				LeBleu, Valerie; Sund, Malin; Sugimoto, Hikaru; Birrane, Gabriel; Kanasaki, Keizo; Finan, Elizabeth; Miller, Caroline A.; Gattone, Vincent H., II; McLaughlin, Heather; Shield, Charles F., III; Kalluri, Raghu			Identification of the NC1 Domain of alpha 3 Chain as Critical for alpha 3 alpha 4 alpha 5 Type IV Collagen Network Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOTYPE-PHENOTYPE CORRELATIONS; LINKED ALPORT-SYNDROME; BASEMENT-MEMBRANE; CRYSTAL-STRUCTURE; NATURAL-HISTORY; 195 FAMILIES; ORGANIZATION; MODEL; GOODPASTURE; ALIGNMENT	The network organization of type IV collagen consisting of alpha 3, alpha 4, and alpha 5 chains in the glomerular basement membrane (GBM) is speculated to involve interactions of the triple helical and NC1 domain of individual alpha-chains, but in vivo evidence is lacking. To specifically address the contribution of the NC1 domain in the GBM collagen network organization, we generated a mouse with specific loss of alpha 3NC1 domain while keeping the triple helical alpha 3 chain intact by connecting it to the human alpha 5NC1 domain. The absence of alpha 3NC1 domain leads to the complete loss of the alpha 4 chain. The alpha 3 collagenous domain is incapable of incorporating the alpha 5 chain, resulting in the impaired organization of the alpha 3 alpha 4 alpha 5 chain-containing network. Although the alpha 5 chain can assemble with the alpha 1, alpha 2, and alpha 6 chains, such assembly is incapable of functionally replacing the alpha 3 alpha 4 alpha 5 protomer. This novel approach to explore the assembly type IV collagen in vivo offers novel insights in the specific role of the NC1 domain in the assembly and function of GBM during health and disease.	[McLaughlin, Heather; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Boston, MA 02115 USA; [Birrane, Gabriel] Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02115 USA; [LeBleu, Valerie; Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Miller, Caroline A.; Gattone, Vincent H., II] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46227 USA; [Shield, Charles F., III] Univ Kansas, Sch Med, Dept Surg, Wichita, KS 66160 USA; [Kalluri, Raghu] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Indiana University System; Indiana University Bloomington; University of Kansas; University of Kansas Medical Center; Harvard University; Massachusetts Institute of Technology (MIT)	Kalluri, R (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Matrix Biol, Ctr Life Sci E CLS 11-090,330 Brookline Ave, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Sund, Malin/0000-0002-7516-9543; Kalluri, Raghu/0000-0002-2190-547X; Birrane, Gabriel/0000-0002-1759-5499				Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Heidet L, 2003, AM J PATHOL, V163, P1633, DOI 10.1016/S0002-9440(10)63520-1; HUDSON BG, 1994, CONTRIB NEPHROL, V107, P163; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Jais JP, 2003, J AM SOC NEPHROL, V14, P2603, DOI 10.1097/01.ASN.0000090034.71205.74; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kang JS, 2008, J BIOL CHEM, V283, P35070, DOI 10.1074/jbc.M806396200; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kobayashi T, 2003, KIDNEY INT, V64, P1986, DOI 10.1046/j.1523-1755.2003.00323.x; Kobayashi T, 2008, BIOCHEM BIOPH RES CO, V366, P60, DOI 10.1016/j.bbrc.2007.12.037; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LeBleu V, 2009, J AM SOC NEPHROL, V20, P2359, DOI 10.1681/ASN.2009010123; LeBleu VS, 2008, LAB INVEST, V88, P284, DOI 10.1038/labinvest.3700715; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; REDDY GK, 1993, BIOCHIM BIOPHYS ACTA, V1157, P241, DOI 10.1016/0304-4165(93)90106-I; RIES A, 1995, J BIOL CHEM, V270, P23790, DOI 10.1074/jbc.270.40.23790; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soder S, 2004, BIOCHEM BIOPH RES CO, V325, P276, DOI 10.1016/j.bbrc.2004.10.034; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P7321, DOI 10.1073/pnas.0601436103; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040	36	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41874	41885		10.1074/jbc.M110.149534	http://dx.doi.org/10.1074/jbc.M110.149534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20847057	hybrid, Green Published			2022-12-27	WOS:000285622600075
J	Mitchell, DA; Mitchell, G; Ling, YP; Budde, C; Deschenes, RJ				Mitchell, David A.; Mitchell, Gayatri; Ling, Yiping; Budde, Cheryl; Deschenes, Robert J.			Mutational Analysis of Saccharomyces cerevisiae Erf2 Reveals a Two-step Reaction Mechanism for Protein Palmitoylation by DHHC Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE LOCALIZATION; H-RAS; PALMITOYLTRANSFERASE; YEAST; TRANSFERASE; DOMAIN; ACYLTRANSFERASES; LIPIDATION; STABILITY; COENZYME	DHHC protein acyltransferases (PATs) catalyze the palmitoylation of eukaryotic proteins through an enzymatic mechanism that remains largely unexplored. In this study we have combined genetic and biochemical approaches to examine the molecular mechanism of palmitate transfer of the yeast Ras PAT, which is composed of Erf2 and Erf4. The palmitoylation reaction consists of two steps; they are autopalmitoylation of the enzyme to create a palmitoyl-Erf2 intermediate followed by the transfer of the palmitoyl moiety to the Ras substrate. Palmitoyl-CoA serves as the palmitate donor. To elucidate the kinetic properties of the Erf2.Erf4 PAT, we have developed a coupled enzyme assay that monitors the turnover of the palmitoyl-enzyme species indirectly by measuring the rate of CoASH release. Mutational analysis indicates that the DHHC motif constitutes the catalytic core of the enzyme required for autopalmitoylation and palmitoyl transfer to the Ras2 substrate. In the absence of Ras2, the palmitoyl-Erf2.Erf4 complex undergoes a cycle of hydrolysis and repalmitoylation, implying that in the presence of palmitoyl-CoA, the complex is autopalmitoylated and competent to transfer palmitate to a protein substrate.	[Mitchell, David A.; Mitchell, Gayatri; Ling, Yiping; Deschenes, Robert J.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Budde, Cheryl] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	State University System of Florida; University of South Florida; Medical College of Wisconsin	Deschenes, RJ (corresponding author), Univ S Florida, Dept Mol Med, MDC7,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	rdeschen@health.usf.edu	Mitchell, David/A-1378-2012; Deschenes, Robert J/E-4926-2010	Deschenes, Robert J/0000-0001-8325-4257	National Institutes of Health [CA50211, GM73976]; NATIONAL CANCER INSTITUTE [R01CA050211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA50211 and GM73976 (to R.J.D.).	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Budde C, 2006, METHODS, V40, P143, DOI 10.1016/j.ymeth.2006.07.017; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; Coats SG, 1999, BIOCHEMISTRY-US, V38, P12926, DOI 10.1021/bi9909290; DEVENDITTIS E, 1981, ANAL BIOCHEM, V115, P278, DOI 10.1016/0003-2697(81)90006-3; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; GARLAND PB, 1965, BIOCHEM J, V97, P587, DOI 10.1042/bj0970587; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kurz LC, 2009, BIOCHEMISTRY-US, V48, P7878, DOI 10.1021/bi9006447; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MANN WR, 1995, J ENZYM INHIB, V9, P303, DOI 10.3109/14756369509036559; MASSEY V, 1960, BIOCHIM BIOPHYS ACTA, V38, P447, DOI 10.1016/0006-3002(60)91280-4; Mesilaty-Gross S, 1999, GENE, V231, P173, DOI 10.1016/S0378-1119(99)00053-0; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Sherman F, 1986, LAB COURSE MANUAL ME; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x	31	115	115	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38104	38114		10.1074/jbc.M110.169102	http://dx.doi.org/10.1074/jbc.M110.169102			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20851885	Green Published, hybrid			2022-12-27	WOS:000284625600018
J	Bruhova, I; Auerbach, A				Bruhova, Iva; Auerbach, Anthony			Subunit Symmetry at the Extracellular Domain-Transmembrane Domain Interface in Acetylcholine Receptor Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; NICOTINIC RECEPTORS; AGONIST-BINDING; CYS-LOOP; CRYSTAL-STRUCTURE; CHARGED RESIDUES; TRANSITION-STATE; PRE-M1; LINKER	Transmitter molecules bind to synaptic acetylcholine receptor channels (AChRs) to promote a global channel-opening conformational change. Although the detailed mechanism that links ligand binding and channel gating is uncertain, the energy changes caused by mutations appear to be more symmetrical between subunits in the transmembrane domain compared with the extracellular domain. The only covalent connection between these domains is the pre-M1 linker, a stretch of five amino acids that joins strand beta 10 with the M1 helix. In each subunit, this linker has a central Arg(Arg(3)'), which only in the non-alpha-subunits is flanked by positively charged residues. Previous studies showed that mutations of Arg(3)' in the alpha-subunit alter the gating equilibrium constant and reduce channel expression. We recorded single-channel currents and estimated the gating rate and equilibrium constants of adult mouse AChRs with mutations at the pre-M1 linker and the nearby residue Glu(45) in non-alpha-subunits. In all subunits, mutations of Arg(3)' had similar effects as in the alpha-subunit. In the epsilon-subunit, mutations of the flanking residues and Glu(45) had only small effects, and there was no energy coupling between epsilon Glu(45) and epsilon Arg(3)'. The non-alpha-subunit Arg3' residues had Phi-values that were similar to those for the alpha-subunit. The results suggest that there is a general symmetry between the AChR subunits during gating isomerization in this linker and that the central Arg is involved in expression more so than gating. The energy transfer through the AChR during gating appears to mainly involve Glu(45), but only in the alpha-subunits.	[Bruhova, Iva; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 309 Cary Hall, Buffalo, NY 14214 USA.	auerbach@buffalo.edu			National Institutes of Health [NS-23513]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023513, R37NS023513, R56NS023513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-23513.	Auerbach A, 1996, J PHYSIOL-LONDON, V494, P155, DOI 10.1113/jphysiol.1996.sp021482; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bafna PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002515; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Engel AG, 2010, J MOL NEUROSCI, V40, P143, DOI 10.1007/s12031-009-9229-0; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Jha A, 2009, BIOPHYS J, V96, P4075, DOI 10.1016/j.bpj.2009.02.030; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; TAMAMIZU S, 1995, CELL MOL NEUROBIOL, V15, P427, DOI 10.1007/BF02071878; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200	32	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38898	38904		10.1074/jbc.M110.169110	http://dx.doi.org/10.1074/jbc.M110.169110			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20864527	hybrid, Green Published			2022-12-27	WOS:000284941300019
J	Binder, BM; Rodriguez, FI; Bleecker, AB				Binder, Brad M.; Rodriguez, Fernando I.; Bleecker, Anthony B.			The Copper Transporter RAN1 Is Essential for Biogenesis of Ethylene Receptors in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE KINASE DOMAIN; P-TYPE ATPASE; MENKES DISEASE; CANDIDATE GENE; SUBCELLULAR-LOCALIZATION; ETR1; BINDING; FAMILY; GROWTH; PERCEPTION	Plants utilize ethylene as a hormone to regulate multiple developmental processes and to coordinate responses to biotic and abiotic stress. In Arabidopsis thaliana, a small family of five receptor proteins typified by ETR1 mediates ethylene perception. Our previous work suggested that copper ions likely play a role in ethylene binding. An independent study indicated that the ran1 mutants, which display ethylene-like responses to the ethylene antagonist trans-cyclooctene, have mutations in the RAN1 copper-transporting P-type ATPase, once again linking copper ions to the ethylene-response pathway. The results presented herein indicate that genetically engineered Saccharomyces cerevisiae expressing ETR1 but lacking the RAN1 homolog Ccc2p (Delta ccc2) lacks ethylene-binding activity. Ethylene-binding activity was restored when copper ions were added to the Delta ccc2 mutants, showing that it is the delivery of copper that is important. Additionally, transformation of the Delta ccc2 mutant yeast with RAN1 rescued ethylene-binding activity. Analysis of plants carrying loss-of-function mutations in ran1 showed that they lacked ethylene-binding activity, whereas seedlings carrying weak alleles of ran1 had normal ethylene-binding activity but were hypersensitive to copper-chelating agents. Altogether, the results show an essential role for RAN1 in the biogenesis of the ethylene receptors and copper homeostasis in Arabidopsis seedlings. Furthermore, the results indicate cross-talk between the ethylene-response pathway and copper homeostasis in Arabidopsis seedling development.	[Binder, Brad M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Rodriguez, Fernando I.; Bleecker, Anthony B.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Rodriguez, Fernando I.; Bleecker, Anthony B.] Univ Wisconsin, Cell & Mol Biol Program, Madison, WI 53706 USA	University of Tennessee System; University of Tennessee Knoxville; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Binder, BM (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, M407 Walters Life Sci Bldg,1414 Cumberland Ave, Knoxville, TN 37996 USA.	bbinder@utk.edu		Binder, Brad/0000-0002-8172-2034	National Science Foundation [MCB-0918430, MCB-0131564]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants MCB-0918430 (to B.M.B.) and MCB-0131564 (to A.B B.).	Abeles F, 1992, ETHYLENE PLANT BIOL; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; BEYER EM, 1976, PLANT PHYSIOL, V58, P268, DOI 10.1104/pp.58.3.268; Binder BM, 2003, ACTA HORTIC, P177, DOI 10.17660/ActaHortic.2003.628.21; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2008, PLANT SCI, V175, P8, DOI 10.1016/j.plantsci.2007.12.001; Binder BM, 2007, FEBS LETT, V581, P5105, DOI 10.1016/j.febslet.2007.09.057; BURG SP, 1967, PLANT PHYSIOL, V42, P144, DOI 10.1104/pp.42.1.144; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; Hall BP, 2007, J PLANT GROWTH REGUL, V26, P118, DOI 10.1007/s00344-007-9000-0; Himelblau E, 2000, CURR OPIN PLANT BIOL, V3, P205, DOI 10.1016/S1369-5266(00)00065-0; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Hyodo H., 1991, PLANT HORMONE ETHYLE; Li HJ, 2007, J PLANT GROWTH REGUL, V26, P106, DOI 10.1007/s00344-007-0015-3; Ma B, 2006, PLANT PHYSIOL, V141, P587, DOI 10.1104/pp.106.080523; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; O'Malley RC, 2005, PLANT J, V41, P651, DOI [10.1111/j.1365-313X.2004.02331.x, 10.1111/j.1365-313X.2004.02331.X]; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Schaller GE, 2007, METHOD ENZYMOL, V422, P270, DOI 10.1016/S0076-6879(06)22013-5; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; SIKORSKI RS, 1989, GENETICS, V122, P19; SISLER E C, 1977, Tobacco Science, V21, P43; SISLER EC, 1979, PLANT PHYSIOL, V64, P538, DOI 10.1104/pp.64.4.538; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; THOMPSON JS, 1983, J AM CHEM SOC, V105, P3522, DOI 10.1021/ja00349a026; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021	61	78	83	5	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37263	37270		10.1074/jbc.M110.170027	http://dx.doi.org/10.1074/jbc.M110.170027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876528	Green Published, hybrid			2022-12-27	WOS:000284424000019
J	Jia, HG; Liu, YJ; Xia, RH; Tong, C; Yue, T; Jiang, J; Jia, JH				Jia, Hongge; Liu, Yajuan; Xia, Ruohan; Tong, Chao; Yue, Tao; Jiang, Jin; Jia, Jianhang			Casein Kinase 2 Promotes Hedgehog Signaling by Regulating both Smoothened and Cubitus Interruptus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT MECHANISMS; ANIMAL DEVELOPMENT; UBIQUITIN LIGASE; REPRESSOR FORMS; PROTEIN; DROSOPHILA; PHOSPHORYLATION; RECEPTOR; DEGRADATION; EXPRESSION	Casein kinase 2 (CK2) is a typical serine/threonine kinase consisting of alpha and beta subunits and has been implicated in many cellular and developmental processes. In this study, we demonstrate that CK2 is a positive regulator of the Hedgehog (Hh) signal transduction pathway. We found that inactivation of CK2 by CK2 beta RNAi enhances the loss-of-Hh wing phenotype induced by a dominant negative form of Smoothened (Smo). CK2 beta RNAi attenuates Hh-induced Smo accumulation and down-regulates Hh target gene expression, whereas increasing CK2 activity by coexpressing CK2 alpha and CK2 beta increases Smo accumulation and induces ectopic Hh target gene expression. We identified the serine residues in Smo that can be phosphorylated by CK2 in vitro. Mutating these serine residues attenuates the ability of Smo to transduce high level Hh signaling activity in vivo. Furthermore, we found that CK2 plays an additional positive role downstream of Smo by regulating the stability of full-length Cubitus-interruptus(Ci). CK2 beta RNAi promotes Ci degradation whereas coexpressing CK2 alpha and CK2 beta increases the half-life of Ci. We showed that CK2 prevents Ci ubiquitination and degradation by the proteasome. Thus, CK2 promotes Hh signaling activity by regulating multiple pathway components.	Univ Kentucky, Lucille P Markey Canc Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Jia, Hongge; Liu, Yajuan; Xia, Ruohan; Jia, Jianhang] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Tong, Chao; Yue, Tao; Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Tong, Chao; Yue, Tao; Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas		Jianhang.jia@uky.edu		Jia, Jianhang/0000-0002-9313-3843; Tong, Chao/0000-0001-6521-5465	National Institutes of Health [GM079684, GM067045, GM061269]; American Heart Association [0830009N]; Welch Foundation [I-1603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067045, R01GM079684, R01GM061269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079684 (to J. Jia) and GM067045 and GM061269 (to J. Jiang). This work was also supported by American Heart Association Grant 0830009N (to J. Jia) and Welch Foundation Grant I-1603 (to J. Jiang).	Aikin RA, 2008, EMBO REP, V9, P330, DOI 10.1038/embor.2008.38; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chen YB, 2010, GENE DEV, V24, P2054, DOI 10.1101/gad.1948710; Cheng SF, 2010, DEV BIOL, V337, P99, DOI 10.1016/j.ydbio.2009.10.014; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2002, GENE DEV, V16, P2315, DOI 10.1101/gad.1027902; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Molnar C, 2007, P NATL ACAD SCI USA, V104, P7963, DOI 10.1073/pnas.0702374104; Penner CG, 1997, J CELL BIOCHEM, V64, P525; RUSSO GL, 1992, J BIOL CHEM, V267, P20317; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Zecca M, 2002, DEVELOPMENT, V129, P1357; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhao Y, 2007, FLY, V1, P333, DOI 10.4161/fly.5570; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	40	63	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37218	37226		10.1074/jbc.M110.174565	http://dx.doi.org/10.1074/jbc.M110.174565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876583	Green Published, hybrid			2022-12-27	WOS:000284424000015
J	Komori, T; Doi, A; Furuta, H; Wakao, H; Nakao, N; Nakazato, M; Nanjo, K; Senba, E; Morikawa, Y				Komori, Tadasuke; Doi, Asako; Furuta, Hiroto; Wakao, Hiroshi; Nakao, Naoyuki; Nakazato, Masamitsu; Nanjo, Kishio; Senba, Emiko; Morikawa, Yoshihiro			Regulation of Ghrelin Signaling by a Leptin-induced Gene, Negative Regulatory Element-binding Protein, in the Hypothalamic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETAGOGUE RECEPTOR GENE; DORSAL-ROOT GANGLIA; ARCUATE NUCLEUS; ONCOSTATIN-M; OBESE GENE; OB/OB MICE; EXPRESSION; IDENTIFICATION; INSULIN; GLUCOSE	Leptin, the product of the ob gene, plays important roles in the regulation of food intake and body weight through its receptor in the hypothalamus. To identify novel transcripts induced by leptin, we performed cDNA subtraction based on selective suppression of the polymerase chain reaction by using mRNA prepared from the forebrain of leptin-injected ob/ob mice. One of the genes isolated was a mouse homolog of human negative regulatory element-binding protein (NREBP). Its expression was markedly increased by leptin in the growth hormone secretagogue-receptor (GHS-R)-positive neurons of the arcuate nucleus and ventromedial hypothalamic nucleus. The promoter region of GHS-R contains one NREBP binding sequence, suggesting that NREBP regulates GHS-R transcription. Luciferase reporter assays showed that NREBP repressed GHS-R promoter activity in a hypothalamic neuronal cell line, GT1-7, and its repressive activity was abolished by the replacement of negative regulatory element in GHS-R promoter. Overexpression of NREBP reduced the protein expression of endogenous GHS-R without affecting the expression of ob-Rb in GT1-7 cells. To determine the functional importance of NREBP in the hypothalamus, we assessed the effects of NREBP on ghrelin action. Although phosphorylation of AMP-activated protein kinase alpha (AMPK alpha) was induced by ghrelin in GT1-7 cells, NREBP repressed ghrelin-induced AMPK alpha phosphorylation. These results suggest that leptin-induced NREBP is an important regulator of GHS-R expression in the hypothalamus and provides a novel molecular link between leptin and ghrelin signaling.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Doi, Asako; Furuta, Hiroto; Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama 6418509, Japan; [Nakao, Naoyuki] Wakayama Med Univ, Dept Neurol Surg, Wakayama 6418509, Japan; [Wakao, Hiroshi] Hokkaido Univ, Sch Med, Dept Environm Biol, Sapporo, Hokkaido 0608638, Japan; [Nakazato, Masamitsu] Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, Miyazaki 8891692, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Hokkaido University; University of Miyazaki	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp	WAKAO, Hiroshi/A-4242-2012		Ministry of Economic Affairs [98_EC_17_A_17_S2_0101]; National Science Council [99-3112-B-400-008, 99-2321-B-400-002]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17019047, 13204074]; Ichiro Kanehara Foundation; Wakayama Medical University	Ministry of Economic Affairs; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ichiro Kanehara Foundation; Wakayama Medical University	This work was supported by Grant-in-aid for Scientific Research 17019047 on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by Grant-in-aid for Scientific Research 13204074 on Priority Areas "Medical Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant provided by the Ichiro Kanehara Foundation; and a research grant on Priority Areas from Wakayama Medical University.	Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; BAILEY CJ, 1975, HORM RES, V6, P380, DOI 10.1159/000178689; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hisaoka T, 2006, EUR J NEUROSCI, V23, P3149, DOI 10.1111/j.1460-9568.2006.04851.x; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kaji H, 1998, J BIOL CHEM, V273, P33885, DOI 10.1074/jbc.273.51.33885; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Kohno D, 2007, ENDOCRINOLOGY, V148, P2251, DOI 10.1210/en.2006-1240; Komori T, 2008, J COMP NEUROL, V511, P92, DOI 10.1002/cne.21838; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Nakano Y, 2005, DIABETES, V54, P3560, DOI 10.2337/diabetes.54.12.3560; Nogueiras R, 2004, DIABETES, V53, P2552, DOI 10.2337/diabetes.53.10.2552; Nogueiras R, 2008, ANN NY ACAD SCI, V1126, P14, DOI 10.1196/annals.1433.054; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tamura S, 2003, EUR J NEUROSCI, V17, P2287, DOI 10.1046/j.1460-9568.2003.02681.x; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; White DW, 2000, DIABETES, V49, P1443, DOI 10.2337/diabetes.49.9.1443; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	33	17	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37884	37894		10.1074/jbc.M110.148973	http://dx.doi.org/10.1074/jbc.M110.148973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876580	Green Published, hybrid			2022-12-27	WOS:000284424000078
J	Namba, T; Hoshino, T; Suemasu, S; Takarada-Iemata, M; Hori, O; Nakagata, N; Yanaka, A; Mizushima, T				Namba, Takushi; Hoshino, Tatsuya; Suemasu, Shintaro; Takarada-Iemata, Mika; Hori, Osamu; Nakagata, Naomi; Yanaka, Akinori; Mizushima, Tohru			Suppression of Expression of Endoplasmic Reticulum Chaperones by Helicobacter pylori and Its Role in Exacerbation of Non-steroidal Anti-inflammatory Drug-induced Gastric Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; OXYGEN-REGULATED PROTEIN; PEPTIC-ULCER DISEASE; INDUCED APOPTOSIS; STRESS-RESPONSE; MUCOSAL CELLS; MONGOLIAN GERBILS; EPITHELIAL-CELLS; CONTROLLED-TRIAL; GENE-EXPRESSION	Both the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, and infection with Helicobacter pylori are major causes of gastric ulcers. Although some clinical studies suggest that infection with H. pylori increases the risk of developing NSAID-induced gastric lesions, the molecular mechanism governing this effect is unknown. We recently found that in cultured gastric cells, expression of endoplasmic reticulum (ER) chaperones (such as 150-kDa oxygen-regulated protein (ORP150) and glucose-regulated protein 78 (GRP78)) is induced by NSAIDs and confers protection against NSAID-induced apoptosis, which is important in the development of NSAID-induced gastric lesions. In this study we have found that co-culture of gastric cells with H. pylori suppresses the expression of ER chaperones. This suppression was regulated at the level of transcription and accompanied by a reduction in the level of activating transcription factor 6 (ATF6), one of the transcription factors for ER chaperone genes. In vivo, inoculation of mice with H. pylori suppressed the expression of ER chaperones at gastric mucosa both with and without administration of indomethacin. Inoculation with H. pylori also stimulated formation of indomethacin-induced gastric lesions and mucosal cell death. In addition, we found that heterozygous ORP150-deficient mice are sensitive to the development of indomethacin-induced gastric lesions and mucosal cell death. The results of this study suggest that H. pylori exacerbates NSAID-induced gastric lesions through suppression of expression of ER chaperones, which stimulates NSAID-induced mucosal cell death.	[Namba, Takushi; Hoshino, Tatsuya; Suemasu, Shintaro; Mizushima, Tohru] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan; [Takarada-Iemata, Mika; Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa 9208640, Japan; [Nakagata, Naomi] Kumamoto Univ, Inst Resource Dev & Anal, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Yanaka, Akinori] Tokyo Univ Sci, Fac Pharmaceut Sci, Div Clin Pharmacol, Noda, Chiba 2788510, Japan	Kumamoto University; Kanazawa University; Kumamoto University; Tokyo University of Science	Mizushima, T (corresponding author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Kumamoto 8620973, Japan.	mizu@gpo.kumamoto-u.ac.jp		Nakagata, Naomi/0000-0002-5737-9993; Takarada-Iemata, Mika/0000-0002-2113-0707	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid of Scientific Research from the Ministry of Health, Labour, and Welfare of Japan, grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants-in-aid of the Japan Science and Technology Agency.	Aburaya M, 2006, J BIOL CHEM, V281, P33422, DOI 10.1074/jbc.M602074200; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Asahi H, 2002, BJU INT, V90, P462, DOI 10.1046/j.1464-410X.2002.02915.x; Ashktorab H, 2002, MICROBES INFECT, V4, P713, DOI 10.1016/S1286-4579(02)01591-5; Boquet P, 2003, TRENDS MICROBIOL, V11, P410, DOI 10.1016/S0966-842X(03)00211-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Chang CC, 2005, WORLD J GASTROENTERO, V11, P104, DOI 10.3748/wjg.v11.i1.104; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; de Leest HTJI, 2007, HELICOBACTER, V12, P477, DOI 10.1111/j.1523-5378.2007.00543.x; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hawkey CJ, 1998, LANCET, V352, P1016, DOI 10.1016/S0140-6736(98)04206-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hong M, 2004, J CELL BIOCHEM, V92, P723, DOI 10.1002/jcb.20118; Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2; Huang T, 2009, J CELL BIOCHEM, V107, P973, DOI 10.1002/jcb.22202; Ishihara T, 2007, BIOCHEM BIOPH RES CO, V356, P711, DOI 10.1016/j.bbrc.2007.03.034; Kanatani K, 2004, J PHYSIOL PHARMACOL, V55, P207; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim H, 2003, ANN NY ACAD SCI, V1010, P90, DOI 10.1196/annals.1299.014; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI200112978; Li Y, 2004, MOL BIOL CELL, V15, P1946, DOI 10.1091/mbc.e03-08-0618; Lichtenberger LM, 2001, BIOCHEM PHARMACOL, V61, P631, DOI 10.1016/S0006-2952(00)00576-1; LIGUMSKY M, 1983, GASTROENTEROLOGY, V84, P756; Lou LX, 2006, LIFE SCI, V79, P1856, DOI 10.1016/j.lfs.2006.06.022; Mine T, 2000, ALIMENT PHARM THERAP, V14, P199, DOI 10.1046/j.1365-2036.2000.014s1199.x; Molinari M, 1997, J BIOL CHEM, V272, P25339, DOI 10.1074/jbc.272.40.25339; Mori K, 2003, TRAFFIC, V4, P519, DOI 10.1034/j.1600-0854.2003.00112.x; Murakami K, 2009, J GASTROENTEROL, V44, P40, DOI 10.1007/s00535-008-2259-5; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Papatheodoridis GV, 2006, CLIN GASTROENTEROL H, V4, P130, DOI 10.1016/j.cgh.2005.10.006; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sakamoto C, 2006, EUR J CLIN PHARMACOL, V62, P765, DOI 10.1007/s00228-006-0171-6; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Shibata W, 2006, J PATHOL, V210, P306, DOI 10.1002/path.2040; Shirin H, 1999, CANCER RES, V59, P2277; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Tomisato W, 2004, BIOCHEM BIOPH RES CO, V323, P1032, DOI 10.1016/j.bbrc.2004.08.205; Tomisato W, 2004, BIOCHEM PHARMACOL, V67, P575, DOI 10.1016/j.bcp.2003.09.020; Tomisato W, 2001, AM J PHYSIOL-GASTR L, V281, pG1092, DOI 10.1152/ajpgi.2001.281.4.G1092; Tomisato W, 2000, DIGEST DIS SCI, V45, P1674, DOI 10.1023/A:1005597902470; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yeo M, 2004, PROTEOMICS, V4, P3335, DOI 10.1002/pmic.200400951; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida N, 2002, GUT, V50, P594, DOI 10.1136/gut.50.5.594	58	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37302	37313		10.1074/jbc.M110.148882	http://dx.doi.org/10.1074/jbc.M110.148882			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861013	Green Published, hybrid			2022-12-27	WOS:000284424000023
J	Cirit, M; Wang, CC; Haugh, JM				Cirit, Murat; Wang, Chun-Chao; Haugh, Jason M.			Systematic Quantification of Negative Feedback Mechanisms in the Extracellular Signal-regulated Kinase (ERK) Signaling Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE; BACTERIAL CHEMOTAXIS; SERUM COMPONENTS; CANCER; CELLS; FIBROBLASTS; ACTIVATION; DESENSITIZATION; ADAPTATION	Cell responses are actuated by tightly controlled signal transduction pathways. Although the concept of an integrated signaling network replete with interpathway cross-talk and feedback regulation is broadly appreciated, kinetic data of the type needed to characterize such interactions in conjunction with mathematical models are lacking. In mammalian cells, the Ras/ERK pathway controls cell proliferation and other responses stimulated by growth factors, and several cross-talk and feedback mechanisms affecting its activation have been identified. In this work, we take a systematic approach to parse the magnitudes of multiple regulatory mechanisms that attenuate ERK activation through canonical (Ras-dependent) and non-canonical (PI3K-dependent) pathways. In addition to regulation of receptor and ligand levels, we consider three layers of ERK-dependent feedback: desensitization of Ras activation, negative regulation of MEK kinase (e.g. Raf) activities, and up-regulation of dual-specificity ERK phosphatases. Our results establish the second of these as the dominant mode of ERK self-regulation in mouse fibroblasts. We further demonstrate that kinetic models of signaling networks, trained on a sufficient diversity of quantitative data, can be reasonably comprehensive, accurate, and predictive in the dynamical sense.	[Cirit, Murat; Wang, Chun-Chao; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Haugh, JM (corresponding author), Box 7905,911 Partners Way, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu	Wang, Chun-Chao/I-5691-2012	Wang, Chun-Chao/0000-0003-4884-3835; Haugh, Jason/0000-0002-2476-4027	National Institutes of Health [GM088987]; NCSU Biomanufacturing Training & Education Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCSU Biomanufacturing Training & Education Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088987 and through a graduate fellowship ( to M. C.) from the NCSU Biomanufacturing Training & Education Center.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Iyengar R, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264eg3; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Klarlund JK, 1996, J BIOL CHEM, V271, P16674, DOI 10.1074/jbc.271.28.16674; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Mogilner A, 2006, DEV CELL, V11, P279, DOI 10.1016/j.devcel.2006.08.004; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; REDDY CC, 1994, BIOTECHNOL PROGR, V10, P377, DOI 10.1021/bp00028a006; Reddy CC, 1996, J CELL PHYSIOL, V166, P512, DOI 10.1002/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Schneider IC, 2004, BIOPHYS J, V86, P599, DOI 10.1016/S0006-3495(04)74138-7; SEGEL LA, 1986, J THEOR BIOL, V120, P151, DOI 10.1016/S0022-5193(86)80171-0; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; VOGEL A, 1980, J CELL BIOL, V85, P377, DOI 10.1083/jcb.85.2.377; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wartmann M, 1997, J BIOL CHEM, V272, P3915, DOI 10.1074/jbc.272.7.3915; WATERS SB, 1995, J BIOL CHEM, V270, P20883, DOI 10.1074/jbc.270.36.20883; WHITMARSH AJ, 2007, J BIOCHIM BIOPHYS AC, V1773, P1285; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	56	65	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36736	36744		10.1074/jbc.M110.148759	http://dx.doi.org/10.1074/jbc.M110.148759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847054	hybrid, Green Published			2022-12-27	WOS:000284146100085
J	Datta, D; Banerjee, P; Gasser, M; Waaga-Gasser, AM; Pal, S				Datta, Dipak; Banerjee, Pallavi; Gasser, Martin; Waaga-Gasser, Ana Maria; Pal, Soumitro			CXCR3-B Can Mediate Growth-inhibitory Signals in Human Renal Cancer Cells by Down-regulating the Expression of Heme Oxygenase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR3; BREAST-CANCER; SPLICE VARIANT; EPITHELIAL-CELLS; UP-REGULATION; MURINE MODEL; I-TAC; METASTASIS; INFLAMMATION; CARCINOMA	The chemokine receptor CXCR3 may play a critical role in the growth and metastasis of tumor cells, including renal tumors. It has been shown that CXCR3 has two splice variants with completely opposite functions; CXCR3-A promotes cell proliferation, whereas CXCR3-B inhibits cell growth. We recently demonstrated that the expression of growth-promoting CXCR3-A is up-regulated, and the growth-inhibitory CXCR3-B is markedly down-regulated in human renal cancer tissues; and the overexpression of CXCR3-B in renal cancer cells can significantly inhibit cell proliferation. However, the growth-inhibitory signal( s) through CXCR3-B are not well characterized. Here, we investigated the effector molecule(s) involved in CXCR3-B-mediated signaling events. We found that the overexpression of CXCR3-B in human renal cancer cells (Caki-1) promoted cellular apoptosis as observed by FACS analysis through Annexin-V staining. To examine whether the overexpression of CXCR3-B could alter the expression of any apoptosis-related genes in renal cancer cells, we performed a protein array. We found that CXCR3-B overexpression significantly down-regulated the expression of antiapoptotic heme oxygenase-1 (HO-1). By utilizing a HO-1 promoter-luciferase plasmid, we showed that CXCR3-B-mediated down-regulation of HO-1 was controlled at the transcriptional level as observed by luciferase assay. We also demonstrated that the inhibition of HO-1 expression using siRNA promoted apoptosis of renal cancer cells. Finally, we observed that human renal cancer tissues expressing low amounts of CXCR3-B significantly overexpress HO-1 at both mRNA and protein level. Together, we suggest that the overexpression of CXCR3-B may prevent the growth of renal tumors through the inhibition of antiapoptotic HO-1.	[Datta, Dipak; Banerjee, Pallavi; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Datta, Dipak; Banerjee, Pallavi; Pal, Soumitro] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gasser, Martin; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145]; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 (to S. P.).	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2008, J AM SOC NEPHROL, V19, P2437, DOI 10.1681/ASN.2008040394; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kelsen SG, 2004, AM J PHYSIOL-LUNG C, V287, pL584, DOI 10.1152/ajplung.00453.2003; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kuroumalis A, 2005, J IMMUNOL, V175, P5403, DOI 10.4049/jimmunol.175.8.5403; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Laxmanan S, 2005, J AM SOC NEPHROL, V16, P2714, DOI 10.1681/ASN.2005010045; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Petrai I, 2008, INT J BIOCHEM CELL B, V40, P1764, DOI 10.1016/j.biocel.2008.01.008; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Romagnani P, 2005, J ALLERGY CLIN IMMUN, V116, P1372, DOI 10.1016/j.jaci.2005.09.035; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Strieter RM, 2004, SEMIN CANCER BIOL, V14, P195, DOI 10.1016/j.semcancer.2003.10.006; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	38	52	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36842	36848		10.1074/jbc.M110.170324	http://dx.doi.org/10.1074/jbc.M110.170324			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855888	Green Published, hybrid			2022-12-27	WOS:000284146100033
J	Lewis, TL; Cao, DF; Lu, HL; Mans, RA; Su, YR; Jungbauer, L; Linton, MF; Fazio, S; LaDu, MJ; Li, L				Lewis, Terry L.; Cao, Dongfeng; Lu, Hailin; Mans, Robert A.; Su, Yan Ru; Jungbauer, Lisa; Linton, MacRae F.; Fazio, Sergio; LaDu, Mary Jo; Li, Ling			Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; SERUM PARAOXONASE ACTIVITY; HUMAN CEREBROSPINAL-FLUID; VASCULAR DEMENTIA; CARDIOVASCULAR-DISEASE; EXCEPTIONAL LONGEVITY; LEARNING-DEFICITS; PRECURSOR PROTEIN; TRANSGENIC MICE	To date there is no effective therapy for Alzheimer disease (AD). High levels of circulating high density lipoprotein (HDL) and its main protein, apolipoprotein A-I (apoA-I), reduce the risk of cardiovascular disease. Clinical studies show that plasma HDL cholesterol and apoA-I levels are low in patients with AD. To investigate if increasing plasma apoA-I/HDL levels ameliorates AD-like memory deficits and amyloid-beta (A beta) deposition, we generated a line of triple transgenic (Tg) mice overexpressing mutant forms of amyloid-beta precursor protein (APP) and presenilin 1 (PS1) as well as human apoA-I (AI). Here we show that APP/PS1/AI triple Tg mice have a 2-fold increase of plasma HDL cholesterol levels. When tested in the Morris water maze for spatial orientation abilities, whereas APP/PS1 mice develop age-related learning and memory deficits, APP/PS1/AI mice continue to perform normally during aging. Interestingly, no significant differences were found in the total level and deposition of A beta in the brains of APP/PS1 and APP/PS1/AI mice, but cerebral amyloid angiopathy was reduced in APP/PS1/AI mice. Also, consistent with the anti-inflammatory properties of apoA-I/HDL, glial activation was reduced in the brain of APP/PS1/AI mice. In addition, A beta-induced production of proinflammatory chemokines/cytokines was decreased in mouse organotypic hippocampal slice cultures expressing human apoA-I. Therefore, we conclude that overexpression of human apoA-I in the circulation prevents learning and memory deficits in APP/PS1 mice, partly by attenuating neuroinflammation and cerebral amyloid angiopathy. These findings suggest that elevating plasma apoA-I/HDL levels may be an effective approach to preserve cognitive function in patients with AD.	[Lewis, Terry L.; Cao, Dongfeng; Lu, Hailin; Mans, Robert A.; Li, Ling] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lewis, Terry L.; Li, Ling] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Mans, Robert A.; Li, Ling] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Cao, Dongfeng; Li, Ling] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Su, Yan Ru; Linton, MacRae F.; Fazio, Sergio] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Jungbauer, Lisa; LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Li, L (corresponding author), 2001 6th St SE,MTRF 4-208, Minneapolis, MN 55455 USA.	lil@umn.edu		LaDu, Mary Jo/0000-0003-2141-1450; Li, Ling/0000-0002-9245-7387; Jungbauer Nikolas, Lisa/0000-0002-5429-3393	National Institutes of Health [AG031846, HL65709, HL086988, AG03012801]; American Health Assistance Foundation [A2010328]; Alzheimer's Association [IIRG-09-131791, ZEN-08-99900]; American Heart Association [0455304B]; University of Illinois Chicago Center for Clinical and Translational Science [UL1RR029879]; Anonymous philanthropic foundations; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065709, R01HL086988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG031846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); University of Illinois Chicago Center for Clinical and Translational Science; Anonymous philanthropic foundations; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG031846, HL65709, HL086988, and AG03012801. This work was also supported by American Health Assistance Foundation Grant A2010328, Alzheimer's Association Grants IIRG-09-131791 and ZEN-08-99900, American Heart Association Grant 0455304B, University of Illinois Chicago Center for Clinical and Translational Science Pilot Grant UL1RR029879, and anonymous philanthropic foundations.	ABBOTT CA, 1995, ARTERIOSCL THROM VAS, V15, P1812, DOI 10.1161/01.ATV.15.11.1812; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Buga GM, 2006, J LIPID RES, V47, P2148, DOI 10.1194/jlr.M600214-JLR200; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Duffy D, 2006, CIRCULATION, V113, P1140, DOI 10.1161/CIRCULATIONAHA.105.593855; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Fagan AM, 2004, AM J PATHOL, V165, P1413, DOI 10.1016/S0002-9440(10)63399-8; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GOLABEK A, 1995, NEUROSCI LETT, V191, P79, DOI 10.1016/0304-3940(95)11565-7; Handattu SP, 2009, NEUROBIOL DIS, V34, P525, DOI 10.1016/j.nbd.2009.03.007; Harr SD, 1996, J NEUROCHEM, V66, P2429; Helbecque N, 2008, DEMENT GERIATR COGN, V25, P97, DOI 10.1159/000112176; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ishiguro H, 2001, J BIOL CHEM, V276, P36742, DOI 10.1074/jbc.M106027200; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Koch S, 2001, J LIPID RES, V42, P1143; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kontush A, 2008, ARTERIOSCL THROM VAS, V28, P1418, DOI 10.1161/ATVBAHA.108.169714; Koudinov AR, 1998, CLIN CHIM ACTA, V270, P75, DOI 10.1016/S0009-8981(97)00207-6; Launer LJ, 2001, NEUROLOGY, V57, P1447, DOI 10.1212/WNL.57.8.1447; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Major AS, 2001, ARTERIOSCL THROM VAS, V21, P1790, DOI 10.1161/hq1101.097798; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; Naderali EK, 2009, AM J ALZHEIMERS DIS, V24, P445, DOI 10.1177/1533317509348208; Navab M, 1998, CURR OPIN LIPIDOL, V9, P449, DOI 10.1097/00041433-199810000-00009; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Paragh G, 2002, EUR ARCH PSY CLIN N, V252, P63, DOI 10.1007/s004060200013; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Prat E, 2000, NEUROSCI LETT, V283, P177, DOI 10.1016/S0304-3940(00)00966-6; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Scarmeas N, 2007, AM J EPIDEMIOL, V165, P993, DOI 10.1093/aje/kwm033; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; SEGREST JP, 1994, CURR OPIN CARDIOL, V9, P404; Shih DM, 2009, CURR OPIN LIPIDOL, V20, P288, DOI 10.1097/MOL.0b013e32832ca1ee; Singh-Manoux A, 2008, ARTERIOSCL THROM VAS, V28, P1556, DOI 10.1161/ATVBAHA.108.163998; Smoak KA, 2010, CELL METAB, V11, P493, DOI 10.1016/j.cmet.2010.04.006; Song H, 1997, NEUROSCI LETT, V231, P175, DOI 10.1016/S0304-3940(97)00558-2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Su YR, 2008, ARTERIOSCL THROM VAS, V28, P1439, DOI 10.1161/ATVBAHA.107.160093; Su YR, 2003, MOL THER, V8, P576, DOI 10.1016/S1525-0016(03)00214-4; Szczepanik AM, 2001, J NEUROCHEM, V77, P304, DOI 10.1046/j.1471-4159.2001.t01-1-00240.x; Vergnes L, 2000, ARTERIOSCL THROM VAS, V20, P2267, DOI 10.1161/01.ATV.20.10.2267; Vollbach H, 2005, ANN NEUROL, V58, P436, DOI 10.1002/ana.20593; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283	68	145	158	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36958	36968		10.1074/jbc.M110.127829	http://dx.doi.org/10.1074/jbc.M110.127829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847045	Green Published, hybrid			2022-12-27	WOS:000284146100062
J	Shamay, M; Greenway, M; Liao, GL; Ambinder, RF; Hayward, SD				Shamay, Meir; Greenway, Melanie; Liao, Gangling; Ambinder, Richard F.; Hayward, S. Diane			De Novo DNA Methyltransferase DNMT3b Interacts with NEDD8-modified Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; UBIQUITIN LIGASE ACTIVITY; HUMAN CANCER-CELLS; MAMMALIAN DEVELOPMENT; ENZYMATIC-PROPERTIES; HISTONE METHYLATION; NEDD8 MODIFICATION; IN-VIVO; HETEROCHROMATIN; PATHWAY	DNA methylation and histone modifications play an important role in transcription regulation. In cancer cells, many promoters become aberrantly methylated through the activity of the de novo DNA methyltransferases DNMT3a and DNMT3b and acquire repressive chromatin marks. NEDD8 is a ubiquitin-like protein modifier that is conjugated to target proteins, such as cullins, to regulate their activity, and cullin 4A (CUL4A) in its NEDD8-modified form is essential for repressive chromatin formation. We found that DNMT3b associates with NEDD8-modified proteins. Whereas DNMT3b interacts directly in vitro with NEDD8, conjugation of NEDD8 to target proteins enhances this interaction in vivo. DNMT3b immunoprecipitated two major bands of endogenously NEDDylated proteins at the size of NEDDylated cullins, and indeed DNMT3b interacted with CUL1, CUL2, CUL3, CUL4A, and CUL5. Moreover, DNMT3b preferentially immunoprecipitated the NEDDylated form of endogenous CUL4A. NEDD8 enhanced DNMT3b-dependent DNA methylation. Chromatin immunoprecipitation assays suggest that DNMT3b recruits CUL4A and NEDD8 to chromatin, whereas deletion of Dnmt3b reduces the association of CUL4A and NEDD8 at a repressed promoter in a cancer cell line.	[Shamay, Meir; Greenway, Melanie; Liao, Gangling; Ambinder, Richard F.; Hayward, S. Diane] Johns Hopkins Sch Med, Sidney Kimmel Canc Ctr, Viral Oncol Program, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Shamay, M (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB1 310, Baltimore, MD 21231 USA.	mshamay1@jhmi.edu			National Institutes of Health [P01 CA113239, P50 CA96888]; NATIONAL CANCER INSTITUTE [P50CA096888, P01CA113239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA113239 (to S. D. H.) and P50 CA96888 (to R. F. A. and M. S.).	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Chairatvit K, 2007, MOL CELL BIOCHEM, V306, P163, DOI 10.1007/s11010-007-9566-7; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen J, 2001, P NATL ACAD SCI USA, V98, P4119, DOI 10.1073/pnas.051004198; Chen LC, 1998, CANCER RES, V58, P3677; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Geiman TM, 2004, BIOCHEM BIOPH RES CO, V318, P544, DOI 10.1016/j.bbrc.2004.04.058; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Kang ES, 2001, BIOCHEM BIOPH RES CO, V289, P862, DOI 10.1006/bbrc.2001.6057; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lee B, 2009, BIOCHEM J, V421, P449, DOI 10.1042/BJ20090142; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lu F, 2003, J VIROL, V77, P11425, DOI 10.1128/JVI.77.21.11425-11435.2003; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shamay M, 2006, P NATL ACAD SCI USA, V103, P14554, DOI 10.1073/pnas.0604469103; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	68	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36377	36386		10.1074/jbc.M110.155721	http://dx.doi.org/10.1074/jbc.M110.155721			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847044	Green Published, hybrid			2022-12-27	WOS:000284146100030
J	Shimobayashi, M; Takematsu, H; Eiho, K; Yamane, Y; Kozutsumi, Y				Shimobayashi, Mitsugu; Takematsu, Hiromu; Eiho, Kazuo; Yamane, Yukari; Kozutsumi, Yasunori			Identification of Ypk1 as a Novel Selective Substrate for Nitrogen Starvation-triggered Proteolysis Requiring Autophagy System and Endosomal Sorting Complex Required for Transport (ESCRT) Machinery Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; PROTEIN-KINASE COMPLEX; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; CELL-GROWTH; TRYPTOPHAN PERMEASE; SECRETORY PATHWAY; AMINOPEPTIDASE-I; BUDDING YEAST; TOR	Nitrogen starvation-mediated reduction of Ypk1 is suggested to suppress translational initiation, possibly in parallel with the target of rapamycin complex 1 (TORC1) signaling. However, the molecular mechanism that regulates Ypk1 in nitrogen-starved cells is poorly understood. Here we report that Ypk1 is a novel selective substrate for nitrogen starvation-triggered proteolysis requiring autophagy system. Among various nutrient starvation methods used to elicit autophagy, rapid Ypk1 degradation was specific to nitrogen starvation. In screening genes required for such nitrogen starvation-specific vacuolar proteolysis, we found that autophagy-related degradation of Ypk1 depended on the endosomal sorting complex required for transport (ESCRT) machinery, which is conventionally thought to function in endosomal trafficking. In microscopic analyses, the disruption of ESCRT subunits resulted in the accumulation of both Ypk1 and autophagosomal Atg8 at a perivacuolar site that was distinct from conventional endosomes. ESCRT machinery was not involved in autophagic flux induced by the TORC1 inhibitor rapamycin, thus suggesting that ESCRT represents an exclusive mechanism of nitrogen starvation-specific proteolysis of Ypk1. Overall, we propose a novel regulation of Ypk1 that is specific to nitrogen limitation.	[Shimobayashi, Mitsugu; Takematsu, Hiromu; Eiho, Kazuo; Yamane, Yukari; Kozutsumi, Yasunori] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Kyoto 6068501, Japan; [Shimobayashi, Mitsugu; Takematsu, Hiromu; Yamane, Yukari; Kozutsumi, Yasunori] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kozutsumi, Y (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Kyoto 6068501, Japan.	yasu@pharm.kyoto-u.ac.jp		Shimobayashi, Mitsugu/0000-0002-6936-0990	Japan Society for the Promotion of Science [19590065]; CREST; Ministry of Education, Culture, Sports, Science and Technology, Japan [16GS0313]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 19590065 (to Y. K.) from the Japan Society for the Promotion of Science and CREST and by Grant-in-aid for Creative Scientific Research 16GS0313 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Brachmann CB, 1998, YEAST, V14, P115; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Gelperin D, 2002, GENETICS, V161, P1453; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Horst M, 1999, MOL BIOL CELL, V10, P2879, DOI 10.1091/mbc.10.9.2879; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jorgensen H, 2002, APPL MICROBIOL BIOT, V59, P310, DOI 10.1007/s00253-002-1017-5; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kobayashi T, 2005, J BIOL CHEM, V280, P18087, DOI 10.1074/jbc.M414138200; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Prick T, 2006, AUTOPHAGY, V2, P241, DOI 10.4161/auto.2743; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Silles E, 2000, J BIOL CHEM, V275, P34054, DOI 10.1074/jbc.M003514200; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanoue D, 2005, ARCH BIOCHEM BIOPHYS, V437, P29, DOI 10.1016/j.abb.2005.02.030; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485	57	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36984	36994		10.1074/jbc.M110.119180	http://dx.doi.org/10.1074/jbc.M110.119180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855891	hybrid, Green Published			2022-12-27	WOS:000284146100074
J	Um, JW; Im, E; Park, J; Oh, Y; Min, B; Lee, HJ; Yoon, JB; Chung, KC				Um, Ji Won; Im, Eunju; Park, Joongkyu; Oh, Yohan; Min, Boram; Lee, Hyun Jung; Yoon, Jong Bok; Chung, Kwang Chul			ASK1 Negatively Regulates the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CASPASE ACTIVATION; FAMILY PROTEINS; ATPASE SUBUNIT; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION; PATHWAY; KINASE; STRESS	The 26 S proteasome, composed of the 20 S core and 19 S regulatory particle, plays a central role in ubiquitin-dependent proteolysis. Disruption of this process contributes to the pathogenesis of the various diseases; however, the mechanisms underlying the regulation of 26 S proteasome activity remain elusive. Here, cell culture experiments and in vitro assays demonstrated that apoptosis signal-regulating kinase 1 (ASK1), a member of the MAPK kinase kinase family, negatively regulated 26 S proteasome activity. Immunoprecipitation/Western blot analyses revealed that ASK1 did not interact with 20 S catalytic core but did interact with ATPases making up the 19 S particle, which is responsible for recognizing polyubiquitinated proteins, unfolding them, and translocating them into the 20 S catalytic core in an ATP-dependent process. Importantly, ASK1 phosphorylated Rpt5, an AAA ATPase of the 19 S proteasome, and inhibited its ATPase activity, an effect that may underlie the ability of ASK1 to inhibit 26 S proteasome activity. The current findings point to a novel role for ASK1 in the regulation of 26 S proteasome and offer new strategies for treating human diseases caused by proteasome malfunction.	[Um, Ji Won; Im, Eunju; Park, Joongkyu; Oh, Yohan; Min, Boram; Lee, Hyun Jung; Chung, Kwang Chul] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Yoon, Jong Bok] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University; Yonsei University	Chung, KC (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seongsan No 262, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Park, Joongkyu/ADZ-1994-2022; Oh, Yohan/C-9107-2013; Im, Eunju/Y-2601-2018; rchnds, rchnds/D-7595-2016	Park, Joongkyu/0000-0002-5675-2872; Oh, Yohan/0000-0002-9249-8664; Im, Eunju/0000-0002-7839-8878; Yoon, Jong-Bok/0000-0002-3563-0702	Ministry of Education, Science and Technology (MEST), Republic of Korea [2009K-001251]; MEST [2010-0018916]; NRF [20100001668]; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A092004]	Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Brain Research Center of the 21st Century Frontier Research Program Technology (Grant 2009K-001251 to K. C. C.) funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea. This work was also supported by the National Research Foundation of Korea (NRF) grant funded by MEST (Grant 2010-0018916 to K. C. C.) and by Basic Science Research Program through NRF (Grant 20100001668 to K. C. C.). This work was also partially supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (Grant A092004 to K. C. C.).	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bardag-Gorce F, 2004, LIFE SCI, V75, P585, DOI 10.1016/j.lfs.2003.12.027; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Beyette J, 1998, BIOCHEM J, V332, P315, DOI 10.1042/bj3320315; Bose S, 1999, MOL BIOL REP, V26, P11, DOI 10.1023/A:1006969517958; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Checler F, 2000, BBA-MOL BASIS DIS, V1502, P133, DOI 10.1016/S0925-4439(00)00039-9; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cohen GM, 2005, CELL DEATH DIFFER, V12, P1218, DOI 10.1038/sj.cdd.4401693; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; He XG, 2003, AM J PATHOL, V163, P243, DOI 10.1016/S0002-9440(10)63647-4; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kohler A, 2001, BIOCHIMIE, V83, P325, DOI 10.1016/S0300-9084(01)01242-1; Kutuzov MA, 2005, J BIOL CHEM, V280, P25388, DOI 10.1074/jbc.M413202200; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Marambaud P, 1996, J NEUROCHEM, V67, P2616; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakayama K, 2001, J IMMUNOL, V167, P1145, DOI 10.4049/jimmunol.167.3.1145; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Reinheckel T, 2000, METH MOL B, V99, P49; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Starace D, 2004, FASEB J, V18, P473, DOI 10.1096/fj.04-2726fje; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	45	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36434	36446		10.1074/jbc.M110.133777	http://dx.doi.org/10.1074/jbc.M110.133777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843792	hybrid, Green Published			2022-12-27	WOS:000284146100073
J	Xiao, CY; Kim, HS; Lahusen, T; Wang, RH; Xu, XL; Gavrilova, O; Jou, W; Gius, D; Deng, CX				Xiao, Cuiying; Kim, Hyun-Seok; Lahusen, Tyler; Wang, Rui-Hong; Xu, Xiaoling; Gavrilova, Oksana; Jou, William; Gius, David; Deng, Chu-Xia			SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B; IN-VIVO; EXPRESSION; GLUT1; TRANSPORTERS; METABOLISM; SIRTUINS; ROLES; MOUSE; CELLS	Glucose homeostasis in mammals is mainly regulated by insulin signaling. It was previously shown that SIRT6 mutant mice die before 4 weeks of age, displaying profound abnormalities, including low insulin, hypoglycemia, and premature aging. To investigate mechanisms underlying the pleiotropic phenotypes associated with SIRT6 deficiency, we generated mice carrying targeted disruption of SIRT6. We found that 60% of SIRT6(-/-) animals had very low levels of blood glucose and died shortly after weaning. The remaining animals, which have relatively higher concentrations of glucose, survived the early post-weaning lethality, but most died within one year of age. Significantly, feeding the mice with glucose-containing water increased blood glucose and rescued 83% of mutant mice, suggesting that the hypoglycemia is a major cause for the lethality. We showed that SIRT6 deficiency results in more abundant membrane association of glucose transporters 1 and 4, which enhances glucose uptake. We further demonstrated that SIRT6 negatively regulates AKT phosphorylation at Ser-473 and Thr-308 through inhibition of multiple upstream molecules, including insulin receptor, IRS1, and IRS2. The absence of SIRT6, consequently, enhances insulin signaling and activation of AKT, leading to hypoglycemia. These data uncover an essential role of SIRT6 in modulating glucose metabolism through mediating insulin sensitivity.	[Xiao, Cuiying; Kim, Hyun-Seok; Lahusen, Tyler; Wang, Rui-Hong; Xu, Xiaoling; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA; [Gavrilova, Oksana; Jou, William] NIDDK, Mouse Metab Core Lab, Bethesda, MD 20892 USA; [Kim, Hyun-Seok; Gius, David] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Deng, CX (corresponding author), 10 Ctr Dr, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016		NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, ZIADK056009, ZICDK070002, ZIADK056010, ZIADK056004, ZIADK056011] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of NIDDK, National Institutes of Health.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Deng Chu-Xia, 2004, Methods Mol Biol, V280, P185; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Diaz M, 2009, AM J PHYSIOL-REG I, V296, pR794, DOI 10.1152/ajpregu.90673.2008; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guettier JM, 2006, ENDOCRIN METAB CLIN, V35, P753, DOI 10.1016/j.ecl.2006.09.005; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAUSDORFF SF, 1995, J BIOL CHEM, V270, P12965, DOI 10.1074/jbc.270.22.12965; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Johnson ES, 2002, J CLIN EPIDEMIOL, V55, P253, DOI 10.1016/S0895-4356(01)00479-6; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Laybutt DR, 1997, AM J PHYSIOL-HEART C, V273, pH1309, DOI 10.1152/ajpheart.1997.273.3.H1309; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Quinn L, 2001, NURS CLIN N AM, V36, pXI; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; TAHA C, 1995, J BIOL CHEM, V270, P24678, DOI 10.1074/jbc.270.42.24678; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wada T, 2007, YAKUGAKU ZASSHI, V127, P143, DOI 10.1248/yakushi.127.143; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Xu XL, 2001, GENESIS, V30, P1, DOI 10.1002/gene.1025; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	44	165	170	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36776	36784		10.1074/jbc.M110.168039	http://dx.doi.org/10.1074/jbc.M110.168039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847051	Green Published, hybrid			2022-12-27	WOS:000284146100051
J	Durante-Rodriguez, G; Valderrama, JA; Mancheno, JM; Rivas, G; Alfonso, C; Arias-Palomo, E; Llorca, O; Garcia, JL; Diaz, E; Carmona, M				Durante-Rodriguez, Gonzalo; Andres Valderrama, J.; Miguel Mancheno, Jose; Rivas, German; Alfonso, Carlos; Arias-Palomo, Ernesto; Llorca, Oscar; Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel			Biochemical Characterization of the Transcriptional Regulator BzdR from Azoarcus sp. CIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAEROBIC CATABOLISM; CRYSTAL-STRUCTURE; SHIKIMATE KINASE; BINDING; GENE; BENZOATE; REPRESSOR; BIOSYNTHESIS; ASSEMBLIES; EXPRESSION	The BzdR transcriptional regulator that controls the P-N promoter responsible for the anaerobic catabolism of benzoate in Azoarcus sp. CIB constitutes the prototype of a new subfamily of transcriptional regulators. Here, we provide some insights about the functional-structural relationships of the BzdR protein. Analytical ultracentrifugation studies revealed that BzdR is homodimeric in solution. An electron microscopy three-dimensional reconstruction of the BzdR dimer has been obtained, and the predicted structures of the respective N- and C-terminal domains of each BzdR monomer could be fitted into such a reconstruction. Gel retardation and ultracentrifugation experiments have shown that the binding of BzdR to its cognate promoter is cooperative. Different biochemical approaches revealed that the effector molecule benzoyl-CoA induces conformational changes in BzdR without affecting its oligomeric state. The BzdR-dependent inhibition of the P-N promoter and its activation in the presence of benzoyl-CoA have been established by in vitro transcription assays. The monomeric BzdR4 and BzdR5 mutant regulators revealed that dimerization of BzdR is essential for DNA binding. Remarkably, a BzdR Delta L protein lacking the linker region connecting the N- and C-terminal domains of BzdR is also dimeric and behaves as a super-repressor of the P-N promoter. These data suggest that the linker region of BzdR is not essential for protein dimerization, but rather it is required to transfer the conformational changes induced by the benzoyl-CoA to the DNA binding domain leading to the release of the repressor. A model of action of the BzdR regulator has been proposed.	[Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain; [Miguel Mancheno, Jose] CSIC, Inst Quim Fis Rocasolano, Dept Crystallog, E-28006 Madrid, Spain; [Rivas, German; Alfonso, Carlos; Arias-Palomo, Ernesto; Llorca, Oscar] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Carmona, M (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	mcarmona@cib.csic.es	Rivas, German/AFL-7528-2022; Valderrama, Jonathan Andres/AAC-1098-2021; Bustelo, Xose R./A-9526-2010; Durante-Rodríguez, Gonzalo/H-3000-2013; Arias Palomo, Ernesto/L-1853-2017; Mancheno, Jose/K-4984-2014; Llorca, Oscar/K-1144-2014; Alfonso, Carlos/K-1316-2014; Llorca, Oscar/P-2784-2019; Rivas, German/AAG-7458-2022; Diaz, Eduardo/F-8605-2016; Garcia, Pedro/L-2808-2017; Garcia Lopez, Jose Luis/G-9139-2015	Rivas, German/0000-0003-3450-7478; Bustelo, Xose R./0000-0001-9398-6072; Durante-Rodríguez, Gonzalo/0000-0003-3113-9868; Mancheno, Jose/0000-0001-6943-3291; Llorca, Oscar/0000-0001-5705-0699; Alfonso, Carlos/0000-0001-7165-4800; Llorca, Oscar/0000-0001-5705-0699; Rivas, German/0000-0003-3450-7478; Diaz, Eduardo/0000-0002-9731-6524; Carmona, Manuel/0000-0002-1591-7618; Garcia, Pedro/0000-0001-6717-8717; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Arias-Palomo, Ernesto/0000-0002-2706-7411; Valderrama Traslavina, J. Andres/0000-0001-7440-4225	Comision Interministerial de Ciencia y Tecnologia [BIO2006-05957, BIO2009-10438, BIO2008-04478-C03-03, BFU2007-67404/BMC, SAF2008-00451, CSD2007-00005]; Comunidad Autonoma de Madrid [P-AMB-259-0505, CAM S-BIO-0214-2006]; Plan Nacional de Formacion de Personal Investigador-MEC; "Factoria de Cristalizacion" Consolider-Ingenio; Autonomous Region of Madrid (Consejer a de Educacion de la Comunidad de Madrid y Fondo Social Europeo); Human Frontiers Science Program [RGP39/2008]; RTICC from the "Instituto de Salud Carlos III" [RD06/0020/1001]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad Autonoma de Madrid(Comunidad de Madrid); Plan Nacional de Formacion de Personal Investigador-MEC; "Factoria de Cristalizacion" Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Region of Madrid (Consejer a de Educacion de la Comunidad de Madrid y Fondo Social Europeo); Human Frontiers Science Program(Human Frontier Science Program); RTICC from the "Instituto de Salud Carlos III"	This work was supported in part by Comision Interministerial de Ciencia y Tecnologia Grants BIO2006-05957, BIO2009-10438, BIO2008-04478-C03-03, BFU2007-67404/BMC, SAF2008-00451, and CSD2007-00005 and Comunidad Autonoma de Madrid Grants P-AMB-259-0505 and CAM S-BIO-0214-2006.; Recipient of a predoctoral fellowship from the Plan Nacional de Formacion de Personal Investigador-MEC.; Supported by "Factoria de Cristalizacion" Consolider-Ingenio 2010.; Supported by a fellowship from the Autonomous Region of Madrid (Consejer a de Educacion de la Comunidad de Madrid y Fondo Social Europeo).; Supported by the Human Frontiers Science Program RGP39/2008 and the RTICC from the "Instituto de Salud Carlos III" Grant RD06/0020/1001.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8399, DOI 10.1021/bi00194a003; Carmona M, 1996, J MOL BIOL, V261, P348, DOI 10.1006/jmbi.1996.0468; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Cervin MA, 1998, NUCLEIC ACIDS RES, V26, P3806, DOI 10.1093/nar/26.16.3806; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Clark TJ, 2004, J BACTERIOL, V186, P1200, DOI 10.1128/JB.186.4.1200-1204.2004; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Durante-Rodriguez G, 2008, MICROBIOL-SGM, V154, P306, DOI 10.1099/mic.0.2007/011361-0; ELY B, 1979, J BACTERIOL, V138, P933, DOI 10.1128/JB.138.3.933-943.1979; GAN J, 2006, X BIOCH, V45, P8539; GAUR NK, 1991, J BACTERIOL, V173, P678, DOI 10.1128/jb.173.2.678-686.1991; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Gu YJ, 2002, J MOL BIOL, V319, P779, DOI 10.1016/S0022-2836(02)00339-X; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Howlett GJ, 2000, METHOD ENZYMOL, V323, P231; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; Koudelka GB, 1998, NUCLEIC ACIDS RES, V26, P669, DOI 10.1093/nar/26.2.669; Krell T, 1998, J MOL BIOL, V278, P983, DOI 10.1006/jmbi.1998.1755; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWICZ JR, 1995, BIOPHYS CHEM, V56, P263, DOI 10.1016/0301-4622(95)00040-5; LAMZIN VS, 1992, EUR J BIOCHEM, V206, P441, DOI 10.1111/j.1432-1033.1992.tb16945.x; Larquet E, 2004, J MOL BIOL, V343, P1159, DOI 10.1016/j.jmb.2004.09.010; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LeFevre KR, 2003, P NATL ACAD SCI USA, V100, P2345, DOI 10.1073/pnas.0537925100; Lewis RJ, 1998, J MOL BIOL, V283, P907, DOI 10.1006/jmbi.1998.2163; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; Mattison K, 2002, J BIOL CHEM, V277, P32714, DOI 10.1074/jbc.M204122200; Maxam A M, 1980, Methods Enzymol, V65, P499; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PTASHNE M, 1976, SCIENCE, V194, P156, DOI 10.1126/science.959843; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; ROBERTS TM, 1977, NATURE, V270, P274, DOI 10.1038/270274a0; Russell A D, 1976, Prog Med Chem, V13, P271, DOI 10.1016/S0079-6468(08)70140-1; Sambrook J., 2001, MOL CLONING LAB MANU; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; TAO T, 1991, J BACTERIOL, V173, P1367, DOI 10.1128/jb.173.4.1367-1375.1991; Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474; TISHKOV VI, 1991, DOKL AKAD NAUK SSSR+, V317, P745; VANHOLDE KE, 1985, PHYS BIOCH; Venien-Bryan C, 2000, J MOL BIOL, V296, P863, DOI 10.1006/jmbi.1999.3480; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; WEISS MA, 1987, BIOCHEMISTRY-US, V26, P897, DOI 10.1021/bi00377a034; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; WOOTTON JC, 1989, PROTEIN ENG, V2, P535, DOI 10.1093/protein/2.7.535; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	64	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35694	35705		10.1074/jbc.M110.143503	http://dx.doi.org/10.1074/jbc.M110.143503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826820	Green Published, hybrid			2022-12-27	WOS:000283845300048
J	Yeligar, SM; Machida, K; Kalra, VK				Yeligar, Samantha M.; Machida, Keigo; Kalra, Vijay K.			Ethanol-induced HO-1 and NQO1 Are Differentially Regulated by HIF-1 alpha and Nrf2 to Attenuate Inflammatory Cytokine Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1 GENE; ANTIOXIDANT RESPONSE ELEMENT; HYPOXIA-INDUCIBLE FACTOR; INDUCED LIVER-INJURY; C-JUN; CELL-PROLIFERATION; KINASE PATHWAYS; ACTIVATION; ALCOHOL; JNK1	Oxidative stress plays an important role in alcohol-induced inflammation and liver injury. Relatively less is known about how Kupffer cells respond to oxidative stress-induced expression of heme oxygenase-1 (HO-1) and NAD(P) H: quinone oxidoreductase (NQO1) to blunt inflammation and liver injury. We showed that Kupffer cells from ethanol-fed rats and ethanol-treated rat Kupffer cells and THP-1 cells displayed increased mRNA expression of HO-1, NQO1, and hypoxia-inducible factor-1 alpha (HIF-1 alpha). Our studies showed that silencing with HIF-1 alpha and JNK-1 siRNAs attenuated ethanol-mediated mRNA expression of HO-1, but not NQO1, whereas Nrf2 siRNA attenuated the mRNA expression of both HO-1 and NQO1. Additionally, JunD but not JunB formed an activator protein-1 (AP-1) oligomeric complex to augment HO-1 promoter activity. Ethanol-induced HO-1 transcription involved antioxidant response elements, hypoxia-response elements, and an AP-1 binding motif in its promoter, as demonstrated by mutation analysis of the promoter, EMSA, and ChIP. Furthermore, livers of ethanol-fed c-Jun(fl/fl) mice showed reduced levels of mRNA for HO-1 but not of NQO1 compared with ethanol-fed control rats, supporting the role of c-Jun or the AP-1 transcriptional complex in ethanol-induced HO-1 expression. Additionally, attenuation of HO-1 levels in ethanol-fed c-Jun(fl/fl) mice led to increased proinflammatory cytokine expression in the liver. These results for the first time show that ethanol regulates HO-1 and NQO1 transcription by different signaling pathways. Additionally, up-regulation of HO-1 protects the liver from excessive formation of inflammatory cytokines. These studies provide novel therapeutic targets to ameliorate alcohol induced inflammation and liver injury.	[Yeligar, Samantha M.; Kalra, Vijay K.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Machida, Keigo] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Yeligar, SM (corresponding author), Emory Univ, Dept Pulmonol, Atlanta, GA 30322 USA.	syeliga@emory.edu; vkalra@usc.edu			Hide Tsukamoto Pilot [P50-AA011999]; Non-Parenchymal Liver Cell Core [R24-AA012885]; Predoctoral Fellowship [T32-AA07578]; National Institutes of Health [CA108302, AA018857]; University of Southern California Research Center for Liver Diseases [P30-DK048522]; NATIONAL CANCER INSTITUTE [R01CA108302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012885, R01AA018857, P50AA011999, T32AA007578] Funding Source: NIH RePORTER	Hide Tsukamoto Pilot; Non-Parenchymal Liver Cell Core; Predoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Research Center for Liver Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Hide Tsukamoto Pilot Grant P50-AA011999 (to V. K. K.), Non-Parenchymal Liver Cell Core Grant R24-AA012885 (to Hide Tsukamoto), Predoctoral Fellowship T32-AA07578 (to S. M. Y.). This work was also supported, in whole or in part, by National Institutes of Health Grants CA108302 and AA018857 (to K. M.) and Analytical-Metabolic-Instrumentation Core, University of Southern California Research Center for Liver Diseases Grant P30-DK048522.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Durbin AD, 2009, J CLIN INVEST, V119, P1558, DOI 10.1172/JCI37958; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Gukovsky I, 2008, AM J PHYSIOL-GASTR L, V294, pG68, DOI 10.1152/ajpgi.00006.2007; Haseba T, 2006, BBA-MOL BASIS DIS, V1762, P276, DOI 10.1016/j.bbadis.2005.11.008; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hill-Kapturczak N, 2003, AM J PHYSIOL-RENAL, V285, pF515, DOI 10.1152/ajprenal.00137.2003; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kodama Y, 2009, HEPATOLOGY, V49, P6, DOI 10.1002/hep.22710; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Liangpunsakul S, 2009, TXB GASTROENTEROLOGY, P2247; LIEBER CS, 1986, ALCOHOL CLIN EXP RES, V10, P550, DOI 10.1111/j.1530-0277.1986.tb05140.x; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Nair S, 2008, BRIT J CANCER, V99, P2070, DOI 10.1038/sj.bjc.6604703; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; NGUYEN T, 1994, J BIOL CHEM, V269, P13656; Ohlmann A, 2003, EXP BIOL MED, V228, P584, DOI 10.1177/15353702-0322805-51; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Pugazhenthi S, 2007, AM J PHYSIOL-ENDOC M, V293, pE645, DOI 10.1152/ajpendo.00111.2007; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Rushworth SA, 2008, J IMMUNOL, V181, P6730, DOI 10.4049/jimmunol.181.10.6730; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; TSUKAMOTO H, 1996, LIVER BILIARY DIS, P125; Tsukamoto Hide, 2008, V447, P33, DOI 10.1007/978-1-59745-242-7_3; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xiong S, 2008, AM J PHYSIOL-GASTR L, V295, pG512, DOI 10.1152/ajpgi.90327.2008; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yang RJ, 2008, INT J BIOCHEM CELL B, V40, P2702, DOI 10.1016/j.biocel.2008.06.012; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Zhong SP, 2007, MOL CELL BIOL, V27, P54, DOI 10.1128/MCB.01365-06	55	104	108	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35359	35373		10.1074/jbc.M110.138636	http://dx.doi.org/10.1074/jbc.M110.138636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833713	Green Published, hybrid			2022-12-27	WOS:000283845300014
J	Ceylan, S; Seidel, V; Ziebart, N; Berndt, C; Dirdjaja, N; Krauth-Siegel, RL				Ceylan, Sevgi; Seidel, Vera; Ziebart, Nicole; Berndt, Carsten; Dirdjaja, Natalie; Krauth-Siegel, R. Luise			The Dithiol Glutaredoxins of African Trypanosomes Have Distinct Roles and Are Closely Linked to the Unique Trypanothione Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; IRON-SULFUR CLUSTER; MIXED DISULFIDE; TRYPAREDOXIN PEROXIDASE; DEPENDENT SYNTHESIS; GLUTATHIONE; THIOREDOXIN; BRUCEI; THIOLTRANSFERASE; PURIFICATION	Trypanosoma brucei, the causative agent of African sleeping sickness, possesses two dithiol glutaredoxins (Grx1 and Grx2). Grx1 occurs in the cytosol and catalyzes protein deglutathionylations with k(cat)/K-m-values of up to 2 x 10(5) M-1 s(-1). It accelerates the reduction of ribonucleotide reductase by trypanothione although less efficiently than the parasite tryparedoxin and has low insulin disulfide reductase activity. Despite its classical CPYC active site, Grx1 forms dimeric iron-sulfur complexes with GSH, glutathionylspermidine, or trypanothione as nonprotein ligands. Thus, contrary to the generally accepted assumption, replacement of the Pro is not a prerequisite for cluster formation. T. brucei Grx2 shows an unusual CQFC active site, and orthologues occur exclusively in trypanosomatids. Grx2 is enriched in mitoplasts, and fractionated digitonin lysis resulted in a co-elution with cytochrome c, suggesting localization in the mitochondrial intermembrane space. Grx2 catalyzes the reduction of insulin disulfide but not of ribonucleotide reductase and exerts deglutathionylation activity 10-fold lower than that of Grx1. RNA interference against Grx2 caused a growth retardation of procyclic cells consistent with an essential role. Grx1 and Grx2 are constitutively expressed with cellular concentrations of about 2 mu M and 200 nM, respectively, in both the mammalian bloodstream and insect procyclic forms. Trypanothione reduces the disulfide form of both proteins with apparent rate constants that are 3 orders of magnitude higher than those with glutathione. Grx1 and, less efficiently, also Grx2 catalyze the reduction of GSSG by trypanothione. Thus, the Grxs play exclusive roles in the trypanothione-based thiol redox metabolism of African trypanosomes.	[Ceylan, Sevgi; Seidel, Vera; Ziebart, Nicole; Dirdjaja, Natalie; Krauth-Siegel, R. Luise] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Berndt, Carsten] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, S-17177 Stockholm, Sweden	Ruprecht Karls University Heidelberg; Karolinska Institutet	Krauth-Siegel, RL (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	luise.krauth-siegel@bzh.uni-heidelberg.de	Berndt, Carsten/X-6260-2018	Berndt, Carsten/0000-0001-8583-7966	Deutsche Forschungsgemeinschaft [SFB 544, B3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 544, "Control of Infectious Tropical Diseases," Project B3 (to R. L. K.-S.).	Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BO H, 1975, J Protozool */* H J, V22, P463; Bocedi A, 2010, FASEB J, V24, P1035, DOI 10.1096/fj.09-146407; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; Caplan JF, 2004, J BIOL CHEM, V279, P7740, DOI 10.1074/jbc.M313049200; Collinson EJ, 2003, J BIOL CHEM, V278, P22492, DOI 10.1074/jbc.M301387200; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2009, INT J PARASITOL, V39, P1059, DOI 10.1016/j.ijpara.2009.05.002; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; ELGA NTH, 2008, J BIOL CHEM */* K D, V283, P32839; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Filser M, 2008, BIOL CHEM, V389, P21, DOI 10.1515/BC.2007.147; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Gommel DU, 1997, EUR J BIOCHEM, V248, P913, DOI 10.1111/j.1432-1033.1997.t01-1-00913.x; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; Krauth-Siegel Luise R., 2007, V44, P231; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; LO NNME, 2008, Antioxid Redox Signa, V10, P547; LU D, 1998, FEBS LETT */* R L FE, V431, P381; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; Marquez VE, 2010, ANTIOXID REDOX SIGN, V12, P787, DOI 10.1089/ars.2009.2907; Melchers J, 2008, BIOMOL NMR ASSIGM, V2, P65, DOI 10.1007/s12104-008-9086-8; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; MIEYAL JJ, 1991, BIOCHEMISTRY-US, V30, P8883, DOI 10.1021/bi00100a023; MOUTIEZ M, 1994, CHEM PHARM BULL, V42, P2641; Noguera V, 2005, J MOL BIOL, V353, P629, DOI 10.1016/j.jmb.2005.08.035; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; PATTON AR, 1968, BIOCH ENERGETICS KIN, P56; PEDRAJAS JR, 2002, J A BIOCH J */* BIOC, V364, P617; Piattoni CV, 2006, ACTA TROP, V97, P151, DOI 10.1016/j.actatropica.2005.10.005; Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4; Reckenfelderbaumer N, 2000, J BIOL CHEM, V275, P7547, DOI 10.1074/jbc.275.11.7547; Reckenfelderbaumer N, 2002, J BIOL CHEM, V277, P17548, DOI 10.1074/jbc.M112115200; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Schmidt A, 2002, MOL BIOCHEM PARASIT, V125, P207, DOI 10.1016/S0166-6851(02)00215-3; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; TABOR H, 1975, J BIOL CHEM, V250, P2648; Xiao RY, 2005, J BIOL CHEM, V280, P21099, DOI 10.1074/jbc.M411476200; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504	64	59	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35224	35237		10.1074/jbc.M110.165860	http://dx.doi.org/10.1074/jbc.M110.165860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826822	Green Published, hybrid			2022-12-27	WOS:000283659100096
J	Neumann, S; Schneider, M; Daugherty, RL; Gottardi, CJ; Eming, SA; Beijer, A; Noegel, AA; Karakesisoglou, I				Neumann, Sascha; Schneider, Maria; Daugherty, Rebecca L.; Gottardi, Cara J.; Eming, Sabine A.; Beijer, Asa; Noegel, Angelika A.; Karakesisoglou, Iakowos			Nesprin-2 Interacts with alpha-Catenin and Regulates Wnt Signaling at the Nuclear Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MEMBRANE PROTEIN; N-CATENIN; EMERIN; CELLS; LOCALIZATION; ACTIVATION; ANCHORAGE; ISOFORMS; DOMAINS	Nesprins and emerin are structural nuclear envelope proteins that tether nuclei to the cytoskeleton. In this work, we identified the cytoskeleton-associated alpha-N/E-catenins as novel nesprin-2-binding partners. The association involves the C termini of nesprin-2 giant and alpha-N/E-catenins. alpha-E/T/N-catenins are known primarily for their roles in cadherin-mediated cell-cell adhesion. Here, we show that, in addition, alpha-catenin forms complexes with nesprin-2 that include beta-catenin and emerin. We demonstrate that the depletion of nesprin-2 reduces both the amount of active beta-catenin inside the nucleus and T-cell factor/lymphoid-enhancing factor-dependent transcription. Taken together, these findings suggest novel nesprin-2 functions in cellular signaling. Moreover, we propose that, in contrast to emerin, nesprin-2 is a positive regulator of the Wnt signaling pathway.	[Neumann, Sascha; Schneider, Maria; Beijer, Asa; Noegel, Angelika A.] Univ Cologne, Fac Med, Inst Biochem 1, Ctr Mol Med, D-50931 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Daugherty, Rebecca L.; Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Karakesisoglou, Iakowos] Univ Durham, Sch Biol & Biomed Sci, Dept Biol Sci, Durham DH1 3LE, England	University of Cologne; University of Cologne; Northwestern University; Feinberg School of Medicine; Durham University	Noegel, AA (corresponding author), Univ Cologne, Fac Med, Inst Biochem 1, Ctr Mol Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	noegel@uni-koeln.de; iakowos.karakesisoglou@durham.ac.uk	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617; Karakesisoglou, Iakowos (Akis)/0000-0002-8549-0728	Center for Molecular Medicine, University of Cologne; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases; Bundesministerium fur Bildung und Forschung-Deutsches Zentrum fur Luft- und Raumfahrt [MD-NET R23]; National Institutes of Health [GMS076561]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561] Funding Source: NIH RePORTER	Center for Molecular Medicine, University of Cologne; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases; Bundesministerium fur Bildung und Forschung-Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the Center for Molecular Medicine, University of Cologne, the Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases, and Bundesministerium fur Bildung und Forschung-Deutsches Zentrum fur Luft- und Raumfahrt Grant MD-NET R23 (to A. A. N. and I. K.), National Institutes of Health Grant GMS076561 (to C. J. G.), and an American Heart Association predoctoral award (to R. L. D.).	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Inge LJ, 2008, MOL CANCER THER, V7, P1386, DOI 10.1158/1535-7163.MCT-07-2029; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; LU KEY, 2008, J CELL SCI */* A A J, V121, P1887; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Mexal S, 2008, AM J MED GENET B, V147B, P759, DOI 10.1002/ajmg.b.30679; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207	28	59	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34932	34938		10.1074/jbc.M110.119651	http://dx.doi.org/10.1074/jbc.M110.119651			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801886	Green Published, hybrid			2022-12-27	WOS:000283659100067
J	Park, YD; Panepinto, J; Shin, S; Larsen, P; Giles, S; Williamson, PR				Park, Yoon-Dong; Panepinto, John; Shin, Soowan; Larsen, Peter; Giles, Steven; Williamson, Peter R.			Mating Pheromone in Cryptococcus neoformans Is Regulated by a Transcriptional/Degradative "Futile" Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL PATHOGEN CRYPTOCOCCUS; MESSENGER-RNA; PROTEIN-KINASE; SEXUAL REPRODUCTION; GENE-EXPRESSION; STRESS-RESPONSE; VIRULENCE; DIFFERENTIATION; HELICASE; YEAST	Sexual reproduction in fungi requires induction of signaling pheromones within environments that are conducive to mating. The fungus Cryptococcus neoformans is currently the fourth greatest cause of infectious death in regions of Africa and undergoes mating in phytonutrient-rich environments to create spores with infectious potential. Here we show that under conditions where sexual development is inhibited, a similar to 17-fold excess of MF alpha pheromone transcript is synthesized and then degraded by a DEAD box protein, Vad1, resulting in low steady state transcript levels. Transfer to mating medium or deletion of the VAD1 gene resulted in high level accumulation of MF alpha transcripts and enhanced mating, acting in concert with the mating-related HOG1 pathway. We then investigated whether the high metabolic cost of this apparently futile transcriptional cycle could be justified by a more rapid induction of mating. Maintenance of Vad1 activity on inductive mating medium by constitutive expression resulted in repressed levels of MF alpha that did not prevent but rather prolonged the time to successful mating from 5-6 h to 15 h (p < 0.0001). In sum, these data suggest that VAD1 negatively regulates the sexual cell cycle via degradation of constitutive high levels of MF alpha transcripts in a synthetic/degradative cycle, providing a mechanism of mRNA induction for time-critical cellular events, such as mating induction.	NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Panepinto, John] SUNY Buffalo, Dept Microbiol & Immunol, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA; [Shin, Soowan; Williamson, Peter R.] Univ Illinois, Infect Dis Sect, Dept Med, Chicago, IL 60612 USA; [Larsen, Peter] Argonne Natl Lab, Biosci Div, Lemont, IL 60439 USA; [Giles, Steven] Univ Wisconsin, Dept Bacteriol, Madison, WI 53701 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Argonne National Laboratory; University of Wisconsin System; University of Wisconsin Madison	Williamson, PR (corresponding author), 9000 Rockville Pike,Bldg 10,Rm 11N234,MSC 1888, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov			National Institutes of Health [AI45995, AI49371]; National Institutes of Health, NIAID; American Heart Association [0725736Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049371, ZIAAI001123, R01AI045995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI45995 and AI49371 and by the Intramural Research Program of the National Institutes of Health, NIAID. This work was also supported by American Heart Association Grant 0725736Z.	Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Davidson RC, 2000, MOL MICROBIOL, V38, P1017, DOI 10.1046/j.1365-2958.2000.02213.x; Del Poeta M, 1999, INFECT IMMUN, V67, P1812; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; ELION EA, 1986, MOL CELL BIOL, V6, P2089, DOI 10.1128/MCB.6.6.2089; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hata H, 1998, GENETICS, V148, P571; Hicks JK, 2004, EUKARYOT CELL, V3, P14, DOI 10.1128/EC.3.1.14-26.2004; HORSTHEMKE W, 1977, PHYS LETT A, V64, P19, DOI 10.1016/0375-9601(77)90512-6; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Kebaara B, 2003, NUCLEIC ACIDS RES, V31, P3157, DOI 10.1093/nar/gkg430; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; KWONCHUNG KJ, 1975, MYCOLOGIA, V67, P1197, DOI 10.2307/3758842; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; KWONCHUNG KJ, 1994, MOL BIOL PATHOGENIC, P341; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Mao HY, 1999, NAT STRUCT BIOL, V6, P1139; MOORE TDE, 1993, MOL CELL BIOL, V13, P1962, DOI 10.1128/MCB.13.3.1962; Morrow CA, 2009, FEMS YEAST RES, V9, P161, DOI 10.1111/j.1567-1364.2008.00475.x; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Panepinto J, 2005, J CLIN INVEST, V115, P632, DOI 10.1172/JCI200523048; Panepinto JC, 2007, INFECT IMMUN, V75, P4769, DOI 10.1128/IAI.00536-07; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Sakuno T, 2004, J BIOCHEM, V136, P805, DOI 10.1093/jb/mvh190; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; Suh SH, 2007, MOL CELLS, V23, P272; Sunnarborg SW, 2001, YEAST, V18, P1505; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; Wichroski Michael J., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020041; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; YOAV B, 1995, H J R Stat Soc Ser B, V57, P289; Zhu XD, 2003, MOL MICROBIOL, V50, P1271, DOI 10.1046/j.1365-2958.2003.03752.x	59	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34746	34756		10.1074/jbc.M110.136812	http://dx.doi.org/10.1074/jbc.M110.136812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801870	Green Published, hybrid			2022-12-27	WOS:000283659100050
J	Harada, Y; Li, H; Wall, JS; Li, HL; Lennarz, WJ				Harada, Yoichiro; Li, Hua; Wall, Joseph S.; Li, Huilin; Lennarz, William J.			Structural Studies and the Assembly of the Heptameric Post-translational Translocon Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL SEQUENCE RECOGNITION; PROTEIN-TRANSLOCATION; ENDOPLASMIC-RETICULUM; SEC PROTEINS; BINDING; YEAST; TRANSPORT; RIBOSOME; ATPASE; COMPONENT	In Saccharomyces cerevisiae, some of the nascent chains can be post-translationally translocated into the endoplasmic reticulum through the heptameric post-translational translocon complex (post-translocon). This membrane-protein complex is composed of the protein-conducting channel and the tetrameric Sec62/63 complex. The Sec62/63 complex plays crucial roles in targeting of the signal recognition particle-independent protein substrate to the protein-conducting channel and in assembly of the post-translocon. Although the molecular mechanism of the post-translational translocation process has been well established, the structure of the post-translocon and how the channel and the Sec62/63 complex form the heptameric complex are largely uncharacterized. Here, we report a 20-angstrom resolution cryo-electron microscopy structure of the post-translocon. The purified post-translocon was found to have a mass of 287 kDa, which is consistent with the unit stoichiometry of the seven sub-units as determined by a cysteine labeling experiment. We demonstrated that Triton X-100 dissociated the heptameric complex into three subcomplexes identified as the trimeric translocon Sec61-Sbh1-Sss1, the Sec63-Sec71-Sec72 trimer, and the heterotetramer Sec62-Sec63-Sec71-Sec72, respectively. Additionally, a role of the sixth cytosolic loop of Sec61 in assembly of the post-translocon was demonstrated. Mutations of conserved, positively charged amino acid residues in the loop caused decreased formation of the post-translocon. These studies provide the first architectural description of the yeast post-translocon.	[Lennarz, William J.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Li, Hua; Wall, Joseph S.; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Lennarz, WJ (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	wlennarz@notes.cc.sunysb.edu	Li, Hua/N-6658-2017	Li, Hua/0000-0002-8786-4295; Li, Huilin/0000-0001-8085-8928	National Institutes of Health [GM33185, GM74985]; Brookhaven National Laboratory Laboratory-directed Research and Development [10-016]; Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033185, R01GM074985, R01GM033185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brookhaven National Laboratory Laboratory-directed Research and Development; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33185 (to W. J. L.) and GM74985 (to H. L.). This work was also supported by Brookhaven National Laboratory Laboratory-directed Research and Development Grant 10-016 (to H. L.) and in part by the Department of Energy.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; McClellan AJ, 2000, GENETICS, V156, P501; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Stroud RM, 1999, CURR OPIN STRUC BIOL, V9, P754, DOI 10.1016/S0959-440X(99)00040-8; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tziatzios C, 2004, J MOL BIOL, V340, P513, DOI 10.1016/j.jmb.2004.04.076; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wall JS, 2000, METH MOL B, V148, P589; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	37	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2956	2965		10.1074/jbc.M110.159517	http://dx.doi.org/10.1074/jbc.M110.159517			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20826819	Green Published, hybrid			2022-12-27	WOS:000286464300059
J	Lee, HW; Brice, AR; Wright, CB; Dominy, BN; Cao, WG				Lee, Hyun-Wook; Brice, Allyn R.; Wright, Charles B.; Dominy, Brian N.; Cao, Weiguo			Identification of Escherichia coli Mismatch-specific Uracil DNA Glycosylase as a Robust Xanthine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDONUCLEASE-V; NITRIC-OXIDE; BASE DAMAGE; CRYSTAL-STRUCTURE; PRIMARY SUBSTRATE; NITROUS-ACID; HUMAN-CELLS; REPAIR; THYMINE; RECOGNITION	The gene for the mismatch-specific uracil DNA glycosylase (MUG) was identified in the Escherichia coli genome as a sequence homolog of the human thymine DNA glycosylase with activity against mismatched uracil base pairs. Examination of cell extracts led us to detect a previously unknown xanthine DNA glycosylase (XDG) activity in E. coli. DNA glycosylase assays with purified enzymes indicated the novel XDG activity is attributable to MUG. Here, we report a biochemical characterization of xanthine DNA glycosylase activity in MUG. The wild type MUG possesses more robust activity against xanthine than uracil and is active against all xanthine-containing DNA (C/X, T/X, G/X, A/X and single-stranded X). Analysis of potentials of mean force indicates that the double-stranded xanthine base pairs have a relatively narrow energetic difference in base flipping, whereas the tendency for uracil base flipping follows the order of C/U > G/U > T/U > A/U. Site-directed mutagenesis performed on conserved motifs revealed that Asn-140 and Ser-23 are important determinants for XDG activity in E. coli MUG. Molecular modeling and molecular dynamics simulations reveal distinct hydrogen-bonding patterns in the active site of E. coli MUG that account for the specificity differences between E. coli MUG and human thymine DNA glycosylase as well as that between the wild type MUG and the Asn-140 and Ser-23 mutants. This study underscores the role of the favorable binding interactions in modulating the specificity of DNA glycosylases.	[Lee, Hyun-Wook; Wright, Charles B.; Cao, Weiguo] Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Clemson, SC 29634 USA; [Brice, Allyn R.; Dominy, Brian N.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, WG (corresponding author), Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Rm 219 Biosyst Res Complex,51 New Cherry St, Clemson, SC 29634 USA.	wgc@clemson.edu	Dominy, Brian/AAA-4541-2020	Dominy, Brian/0000-0002-5635-2879	National Institutes of Health [GM090141]; Cooperative State Research, Education, and Extension Service/United States Department of Agriculture [SC-1700274]; Department of Defense [W911NF-05-10335, W911NF-07-1-0141, W81XWH-10-1-0385]; National Science Foundation [MCB-0953783]; SC-Life; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative State Research, Education, and Extension Service/United States Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); SC-Life; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090141 (to W.C.). This project was also supported in part by the Cooperative State Research, Education, and Extension Service/United States Department of Agriculture (SC-1700274, technical contribution no. 5805), Department of Defense Grants W911NF-05-10335, W911NF-07-1-0141, and W81XWH-10-1-0385 (to W.C.), National Science Foundation Grant MCB-0953783 (to B.N.D.), and SC-Life.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CHAKRAVARTI D, 1991, J BIOL CHEM, V266, P15710; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; Coligan JE., 1998, CURRENT PROTOCOLS PR; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Dong L, 2008, DNA REPAIR, V7, P1962, DOI 10.1016/j.dnarep.2008.08.006; Dong M, 2006, MUTAT RES-FUND MOL M, V594, P120, DOI 10.1016/j.mrfmmm.2005.08.008; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Feng H, 2005, BIOCHEMISTRY-US, V44, P11486, DOI 10.1021/bi050837c; Feng H, 2005, BIOCHEMISTRY-US, V44, P675, DOI 10.1021/bi048752j; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hang B, 2002, BIOCHEMISTRY-US, V41, P2158, DOI 10.1021/bi011542b; He B, 2000, MUTAT RES-DNA REPAIR, V459, P109, DOI 10.1016/S0921-8777(99)00063-4; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hitchcock TM, 2004, J BIOL CHEM, V279, P38177, DOI 10.1074/jbc.M405882200; Huang JM, 2001, BIOCHEMISTRY-US, V40, P8738, DOI 10.1021/bi010183h; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Jaruga P, 1996, NUCLEIC ACIDS RES, V24, P1389, DOI 10.1093/nar/24.8.1389; KAWASE Y, 1986, NUCLEIC ACIDS RES, V14, P7727, DOI 10.1093/nar/14.19.7727; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu PF, 2008, J BIOL CHEM, V283, P8829, DOI 10.1074/jbc.M707174200; Lutsenko E, 1999, J BIOL CHEM, V274, P31034, DOI 10.1074/jbc.274.43.31034; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mi RJ, 2009, J MOL BIOL, V385, P761, DOI 10.1016/j.jmb.2008.09.038; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; SAMSON L, 1991, P NATL ACAD SCI USA, V88, P9127, DOI 10.1073/pnas.88.20.9127; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; Saparbaev M, 2002, J BIOL CHEM, V277, P26987, DOI 10.1074/jbc.M111100200; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Shapiro R., 1981, CHROMOSOME DAMAGE RE; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P8013, DOI 10.1021/bi970166l; Suzuki T, 1996, J AM CHEM SOC, V118, P2515, DOI 10.1021/ja952550g; Terato H, 2002, NUCLEIC ACIDS RES, V30, P4975, DOI 10.1093/nar/gkf630; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Vongchampa V, 2003, NUCLEIC ACIDS RES, V31, P1045, DOI 10.1093/nar/gkg177; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Wuenschell GE, 2003, BIOCHEMISTRY-US, V42, P3608, DOI 10.1021/bi0205597; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004	46	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41483	41490		10.1074/jbc.M110.150003	http://dx.doi.org/10.1074/jbc.M110.150003			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20852254	Green Published, hybrid			2022-12-27	WOS:000285622600034
J	Zhu, YJ; Zhang, W; Veerapen, N; Besra, G; Cresswell, P				Zhu, Yajuan; Zhang, Wei; Veerapen, Natacha; Besra, Gurdyal; Cresswell, Peter			Calreticulin Controls the Rate of Assembly of CD1d Molecules in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER T-CELLS; CLASS-I MOLECULES; NKT CELLS; ANTIGEN PRESENTATION; ALPHA-GALACTOSYLCERAMIDE; LIPID-BINDING; MOUSE CD1; CRYSTAL-STRUCTURE; HEAVY-CHAIN; RECOGNITION	CD1d is an MHC class I-like molecule comprised of a transmembrane glycoprotein (heavy chain) associated with beta(2)-microglobulin (beta(2)m) that presents lipid antigens to NKT cells. Initial folding of the heavy chain involves its glycan-dependent association with calreticulin (CRT), calnexin (CNX), and the thiol oxidoreductase ERp57, and is followed by assembly with beta(2)m to form the heterodimer. Here we show that in CRT-deficient cells CD1d heavy chains convert to beta(2)m-associated dimers at an accelerated rate, indicating faster folding of the heavy chain, while the rate of intracellular transport after assembly is unaffected. Unlike the situation with MHC class I molecules, antigen presentation by CD1d is not impaired in the absence of CRT. Instead, there are elevated levels of stable and functional CD1d on the surface of CRT-deficient cells. Association of the heavy chains with the ER chaperones Grp94 and Bip is observed in the absence of CRT, and these may replace CRT in mediating CD1d folding and assembly. ER retention of free CD1d heavy chains is impaired in CRT-deficient cells, allowing their escape and subsequent expression on the plasma membrane. However, these free heavy chains are rapidly internalized and degraded in lysosomes, indicating that beta(2)m association is required for the exceptional resistance of CD1d to lysosomal degradation that is normally observed.	[Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Veerapen, Natacha; Besra, Gurdyal] Univ Birmingham, Sch Biosci, Dept Microbial Physiol & Chem, Birmingham B15 2TT, W Midlands, England	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; University of Birmingham	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 300 Cedar St,POB 208011, New Haven, CT 06520 USA.	peter.cresswell@yale.edu		Besra, Gurdyal/0000-0002-5605-0395	National Institutes of Health [R01 AI059167]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI059167 (to P. C.) and the Howard Hughes Medical Institute.	Amano M, 1998, J IMMUNOL, V161, P1710; BALK SP, 1994, SCIENCE, V265, P259, DOI 10.1126/science.7517575; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Brossay L, 1997, J IMMUNOL, V159, P1216; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; Burdin N, 1998, J IMMUNOL, V161, P3271; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; Chefalo PJ, 2003, J IMMUNOL, V170, P5825, DOI 10.4049/jimmunol.170.12.5825; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Elewaut D, 2003, J EXP MED, V198, P1133, DOI 10.1084/jem.20030143; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2005.00364.x; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim HS, 1999, J BIOL CHEM, V274, P9289, DOI 10.1074/jbc.274.14.9289; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Liu JY, 2010, J IMMUNOL, V184, P4973, DOI 10.4049/jimmunol.0901448; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mintz M, 2008, J PROTEOME RES, V7, P2435, DOI 10.1021/pr700842m; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Somnay-Wadgaonkar K, 1999, INT IMMUNOL, V11, P383, DOI 10.1093/intimm/11.3.383; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	54	9	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38283	38292		10.1074/jbc.M110.170530	http://dx.doi.org/10.1074/jbc.M110.170530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861015	Green Published, hybrid			2022-12-27	WOS:000284625600035
J	Berna, MJ; Seiz, O; Nast, JF; Benten, D; Blaker, M; Koch, J; Lohse, AW; Pace, A				Berna, Marc J.; Seiz, Oliver; Nast, Jan Friso; Benten, Daniel; Blaeker, Michael; Koch, Johannes; Lohse, Ansgar W.; Pace, Andrea			CCK1 and CCK2 Receptors Are Expressed on Pancreatic Stellate Cells and Induce Collagen Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNAL-REGULATED KINASE; ACINAR-CELLS; MAP-KINASE; CHOLECYSTOKININ; ACTIVATION; PROLIFERATION; FIBROGENESIS; PATHWAYS; FIBROSIS	The gastrointestinal hormone cholecystokinin (CCK) can induce acute pancreatitis in rodents through its action on acinar cells. Treatment with CCK, in combination with other agents, represents the most commonly used model to induce experimental chronic pancreatitis. Pancreatic stellate cells (PSC) are responsible for pancreatic fibrosis and therefore play a predominant role in the genesis of chronic pancreatitis. However, it is not known whether PSC express CCK receptors. Using real time PCR techniques, we demonstrate that CCK1 and CCK2 receptors are expressed on rat PSC. Interestingly both CCK and gastrin significantly induced type I collagen synthesis. Moreover, both inhibit proliferation. These effects are comparable with TGF-beta-stimulated PSC. Furthermore, the natural agonists CCK and gastrin induce activation of pro-fibrogenic pathways Akt, ERK, and Src. Using specific CCK1 and CCK2 receptor (CCK2R) inhibitors, we found that Akt activation is mainly mediated by CCK2R. Akt activation by CCK and gastrin could be inhibited by the PI3K inhibitor wortmannin. Activation of ERK and the downstream target Elk-1 could be inhibited by the MEK inhibitor U0126. These data suggest that CCK and gastrin have direct activating effects on PSC, are able to induce collagen synthesis in these cells, and therefore appear to be important regulators of pancreatic fibrogenesis. Furthermore, similar to TGF-beta, both CCK and gastrin inhibit proliferation in PSC.	[Berna, Marc J.; Seiz, Oliver; Nast, Jan Friso; Benten, Daniel; Blaeker, Michael; Koch, Johannes; Lohse, Ansgar W.; Pace, Andrea] Univ Klinikum Eppendorf, Med Klin 1, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Pace, A (corresponding author), Univ Klinikum Eppendorf, Med Klin 1, D-20246 Hamburg, Germany.	pace@uke.de						ABDE M, 2008, EXPERT REV MOL MED, V10, pE19; Apte M, 2007, Novartis Found Symp, V285, P200; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 2000, GASTROENTEROLOGY, V118, P780, DOI 10.1016/S0016-5085(00)70148-X; Barrett LE, 2006, P NATL ACAD SCI USA, V103, P5155, DOI 10.1073/pnas.0510477103; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; Berna MJ, 2007, BBA-MOL CELL RES, V1773, P483, DOI 10.1016/j.bbamcr.2006.12.008; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Bourassa J, 1999, BIOCHEM BIOPH RES CO, V260, P820, DOI 10.1006/bbrc.1999.0988; Cayrol C, 2006, ONCOGENE, V25, P4421, DOI 10.1038/sj.onc.1209484; CEREZO JG, 1991, DIGESTION, V48, P134; Dabrowski A, 1997, DIGESTION, V58, P361, DOI 10.1159/000201466; Deng XY, 2005, AM J PATHOL, V166, P93, DOI 10.1016/S0002-9440(10)62235-3; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Ferrand A, 2004, EXP CELL RES, V301, P128, DOI 10.1016/j.yexcr.2004.07.037; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; Hama K, 2006, BIOCHEM BIOPH RES CO, V340, P742, DOI 10.1016/j.bbrc.2005.12.069; Jaster R, 2002, GUT, V51, P579, DOI 10.1136/gut.51.4.579; Kordes C, 2005, PANCREAS, V31, P156, DOI 10.1097/01.mpa.0000168222.05591.a0; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Li LW, 2006, J BIOL CHEM, V281, P3237, DOI 10.1074/jbc.M512167200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Masamune A, 2009, GUT, V58, P550, DOI 10.1136/gut.2008.154401; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Masamune A, 2005, WORLD J GASTROENTERO, V11, P6144, DOI 10.3748/wjg.v11.i39.6144; Masamune A, 2005, WORLD J GASTROENTERO, V11, P3385, DOI 10.3748/wjg.v11.i22.3385; Masamune A, 2010, DIGEST DIS SCI, V55, P204, DOI 10.1007/s10620-008-0695-y; McCarroll JA, 2003, PANCREAS, V27, P150, DOI 10.1097/00006676-200308000-00008; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Ohnishi H, 2004, J BIOL CHEM, V279, P8873, DOI 10.1074/jbc.M309698200; Pace A, 2006, BBA-MOL CELL RES, V1763, P356, DOI 10.1016/j.bbamcr.2006.03.004; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; SALUJA AK, 1989, P NATL ACAD SCI USA, V86, P8968, DOI 10.1073/pnas.86.22.8968; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHAFMAYER A, 1985, DIGESTION, V32, P136, DOI 10.1159/000199231; Schneider A, 2002, BEST PRACT RES CL GA, V16, P347, DOI 10.1053/bega.2002.0311; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Seva C, 1997, BIOCHEM BIOPH RES CO, V238, P202, DOI 10.1006/bbrc.1997.7163; Shiratori Keiko, 2002, Pancreas, V25, pe1, DOI 10.1097/00006676-200207000-00003; SLAFF J, 1984, GASTROENTEROLOGY, V87, P44; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vaquero E, 1999, GUT, V45, P269, DOI 10.1136/gut.45.2.269; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wan Y., 2005, J HUAZHONG U SCI TEC, V25, P306; Wan Yuantai, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P297; Williams JA, 2002, PHARMACOL TOXICOL, V91, P297, DOI 10.1034/j.1600-0773.2002.910606.x; Zieger M, 2000, BIOL CHEM, V381, P763, DOI 10.1515/BC.2000.097	50	50	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38905	38914		10.1074/jbc.M110.125534	http://dx.doi.org/10.1074/jbc.M110.125534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20843811	Green Published, hybrid			2022-12-27	WOS:000284941300020
J	Bortolozzi, M; Brini, M; Parkinson, N; Crispino, G; Scimemi, P; De Siati, RD; Di Leva, F; Parker, A; Ortolano, S; Arslan, E; Brown, SD; Carafoli, E; Mammano, F				Bortolozzi, Mario; Brini, Marisa; Parkinson, Nick; Crispino, Giulia; Scimemi, Pietro; De Siati, Romolo Daniele; Di Leva, Francesca; Parker, Andrew; Ortolano, Saida; Arslan, Edoardo; Brown, Steve D.; Carafoli, Ernesto; Mammano, Fabio			The Novel PMCA2 Pump Mutation Tommy Impairs Cytosolic Calcium Clearance in Hair Cells and Links to Deafness in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANOTRANSDUCER CHANNEL; MOUSE MUTANTS; HEARING-LOSS; CA2+ CONCENTRATION; DEAFWADDLER MICE; TRANSDUCTION; ENDOLYMPH; GENE; STEREOCILIA; CADHERIN-23	The mechanotransduction process in hair cells in the inner ear is associated with the influx of calcium from the endolymph. Calcium is exported back to the endolymph via the splice variant w/a of the PMCA2 of the stereocilia membrane. To further investigate the role of the pump, we have identified and characterized a novel ENU-induced mouse mutation, Tommy, in the PMCA2 gene. The mutation causes a non-conservative E629K change in the second intracellular loop of the pump that harbors the active site. Tommy mice show profound hearing impairment from P18, with significant differences in hearing thresholds between wild type and heterozygotes. Expression of mutant PMCA2 in CHO cells shows calcium extrusion impairment; specifically, the long term, non-stimulated calcium extrusion activity of the pump is inhibited. Calcium extrusion was investigated directly in neonatal organotypic cultures of the utricle sensory epithelium in Tommy mice. Confocal imaging combined with flash photolysis of caged calcium showed impairment of calcium export in both Tommy heterozygotes and homozygotes. Immunofluorescence studies of the organ of Corti in homozygous Tommy mice showed a progressive base to apex degeneration of hair cells after P40. Our results on the Tommy mutation along with previously observed interactions between cadherin-23 and PMCA2 mutations in mouse and humans underline the importance of maintaining the appropriate calcium concentrations in the endolymph to control the rigidity of cadherin and ensure the function of interstereocilia links, including tip links, of the stereocilia bundle.	[Bortolozzi, Mario; Mammano, Fabio] Univ Padua, Dept Phys G Galilei, I-35131 Padua, Italy; [Bortolozzi, Mario; Crispino, Giulia; Ortolano, Saida; Carafoli, Ernesto; Mammano, Fabio] Venetian Inst Mol Med, I-35129 Padua, Italy; [Brini, Marisa; Di Leva, Francesca] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy; [Parkinson, Nick; Parker, Andrew; Brown, Steve D.] MRC Harwell, MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; [Scimemi, Pietro; De Siati, Romolo Daniele; Arslan, Edoardo] Univ Padua, Dept Med & Surg Specialities, Audiol & Phoniatr Serv, I-35128 Padua, Italy	University of Padua; Veneto Institute Molecular Medicine; University of Padua; MRC Harwell; University of Padua	Mammano, F (corresponding author), Via G Orus 2, I-35129 Padua, Italy.	fabio.mammano@unipd.it	Mammano, Fabio/AAM-3902-2020; Scimemi, Pietro/T-5390-2017; Bortolozzi, Mario/H-6872-2015; Carafoli, Ernesto/K-5192-2016; Mammano, Fabio/I-5064-2012; Brini, Marisa/K-5189-2016	Mammano, Fabio/0000-0003-3751-1691; Scimemi, Pietro/0000-0001-5273-1938; Bortolozzi, Mario/0000-0001-7198-9838; Carafoli, Ernesto/0000-0002-7826-0094; Mammano, Fabio/0000-0003-3751-1691; ortolano, saida/0000-0002-1098-3376; Brini, Marisa/0000-0001-5141-0243; DI LEVA, Francesca/0000-0002-6167-0679	European Commission [LSHGCT20054512063]; Fondazione Cariparo (Progetti di Eccellenza), Telethon Italy [2007BZ4RX3_003]; Telethon Foundation [GGP04169]; Italian Ministry of University and Research [PRIN 2005]; MRC [MC_U142684175, MC_U142684172] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_U142684175] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Cariparo (Progetti di Eccellenza), Telethon Italy(Fondazione TelethonFondazione Cariparo); Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Commission under the Sixth Research Frame Program of the European Union (FP6 Integrated Project EuroHear, Grant LSHGCT20054512063) (to F. M., E. C., and S. D. B.), by the Fondazione Cariparo (Progetti di Eccellenza 2006-2007), Telethon Italy Grant GGP09137, by the Italian Ministry of Research (PRIN 2007, Grant 2007BZ4RX3_003) (to F. M.), and by Telethon Foundation Grant GGP04169 and the Italian Ministry of University and Research (PRIN 2005) (to M. Brini).	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; BOSHER SK, 1978, NATURE, V273, P377, DOI 10.1038/273377a0; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Crouch JJ, 1995, HEARING RES, V92, P112, DOI 10.1016/0378-5955(95)00201-4; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Furness DN, 2002, HEARING RES, V173, P10, DOI 10.1016/S0378-5955(02)00584-1; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Grati M, 2006, J CELL SCI, V119, P2995, DOI 10.1242/jcs.03030; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Isaacs AM, 2000, HUM MOL GENET, V9, P1865, DOI 10.1093/hmg/9.12.1865; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; KUBITSCHECK U, 1995, BIOPHYS J, V69, P30, DOI 10.1016/S0006-3495(95)79875-7; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Mammano F, 2010, NEUROMETHODS, V43, P57, DOI 10.1007/978-1-60761-476-0_3; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Parkinson N. J., 2003, TOMMY MOUSE MUTANT I; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Spiden SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000238; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Takahashi K, 1999, BIOCHEM BIOPH RES CO, V261, P773, DOI 10.1006/bbrc.1999.1102; Tsai YS, 2006, MAMM GENOME, V17, P716, DOI 10.1007/s00335-005-0191-z; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Wood JD, 2004, JARO-J ASSOC RES OTO, V5, P99, DOI 10.1007/s10162-003-4022-1	48	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37693	37703		10.1074/jbc.M110.170092	http://dx.doi.org/10.1074/jbc.M110.170092			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20826782	hybrid, Green Published			2022-12-27	WOS:000284424000061
J	Durrington, HJ; Upton, PD; Hoer, S; Boname, J; Dunmore, BJ; Yang, J; Crilley, TK; Butler, LM; Blackbourn, DJ; Nash, GB; Lehner, PJ; Morrell, NW				Durrington, Hannah J.; Upton, Paul D.; Hoer, Simon; Boname, Jessica; Dunmore, Benjamin J.; Yang, Jun; Crilley, Trina K.; Butler, Lynn M.; Blackbourn, David J.; Nash, Gerard B.; Lehner, Paul J.; Morrell, Nicholas W.			Identification of a Lysosomal Pathway Regulating Degradation of the Bone Morphogenetic Protein Receptor Type II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PRIMARY PULMONARY-HYPERTENSION; TGF-BETA RECEPTOR; MHC CLASS-I; KAPOSIS-SARCOMA; ARTERIAL-HYPERTENSION; CASTLEMANS-DISEASE; GERMLINE MUTATIONS; UBIQUITIN LIGASE; DOWN-REGULATION	Bone morphogenetic proteins (BMPs) are critically involved in early development and cell differentiation. In humans, dysfunction of the bone morphogenetic protein type II receptor (BMPR-II) is associated with pulmonary arterial hypertension (PAH) and neoplasia. The ability of Kaposi sarcoma-associated herpesvirus (KSHV), the etiologic agent of Kaposi sarcoma and primary effusion lymphoma, to down-regulate cell surface receptor expression is well documented. Here we show that KSHV infection reduces cell surface BMPR-II. We propose that this occurs through the expression of the viral lytic gene, K5, a ubiquitin E3 ligase. Ectopic expression of K5 leads to BMPR-II ubiquitination and lysosomal degradation with a consequent decrease in BMP signaling. The down-regulation by K5 is dependent on both its RING domain and a membrane-proximal lysine in the cytoplasmic domain of BMPR-II. We demonstrate that expression of BMPR-II protein is constitutively regulated by lysosomal degradation in vascular cells and provide preliminary evidence for the involvement of the mammalian E3 ligase, Itch, in the constitutive degradation of BMPR-II. Disruption of BMP signaling may therefore play a role in the pathobiology of diseases caused by KSHV infection, as well as KSHV-associated tumorigenesis and vascular disease.	[Durrington, Hannah J.; Hoer, Simon; Boname, Jessica; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Durrington, Hannah J.; Upton, Paul D.; Dunmore, Benjamin J.; Yang, Jun; Crilley, Trina K.; Morrell, Nicholas W.] Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Butler, Lynn M.; Blackbourn, David J.] Univ Birmingham, Canc Res UK Canc Ctr, Birmingham B15 2TT, W Midlands, England; [Butler, Lynn M.; Blackbourn, David J.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Butler, Lynn M.; Nash, Gerard B.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; University of Birmingham; University of Birmingham; University of Birmingham	Lehner, PJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	pjl30@cam.ac.uk; nwm23@cam.ac.uk	Durrington, Hannah/B-4564-2016; Nash, Gerard B/E-4182-2010	Durrington, Hannah/0000-0002-9990-9446; Nash, Gerard B/0000-0002-5935-2831; Lehner, Paul Joseph/0000-0001-9383-1054; Boname, Jessica/0000-0002-5149-5934; Blackbourn, David/0000-0002-6703-4497	Wellcome Trust; British Heart Foundation; Cancer Research UK [C7934/A9468]; British Heart Foundation [RG/08/002/24718] Funding Source: researchfish; Medical Research Council [G0800784, G1000847] Funding Source: researchfish; MRC [G0800784, G1000847] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust Research Training fellowship (to H. J. D.). Additional support was provided by a British Heart Foundation Programme Grant (to N. W. M.) and a Wellcome Trust grant (to P. J. L.). L. M. B. was supported by Cancer Research UK Project Grant C7934/A9468 (to D. J. B. and G. B. N.).	Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bull TM, 2003, EUR RESPIR J, V22, P403, DOI 10.1183/09031936.03.00006903; Cool CD, 2003, NEW ENGL J MED, V349, P1113, DOI 10.1056/NEJMoa035115; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Henke-Gendo C, 2005, AM J RESP CRIT CARE, V172, P1581, DOI 10.1164/rccm.200504-546OC; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Katano H, 2005, J INFECT DIS, V191, P743, DOI 10.1086/427824; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim IY, 2004, ONCOGENE, V23, P7651, DOI 10.1038/sj.onc.1207924; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Laney AS, 2005, CHEST, V127, P762, DOI 10.1378/chest.127.3.762; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Mansouri M, 2008, J VIROL, V82, P9615, DOI 10.1128/JVI.02633-07; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Pouliot F, 2003, CANCER RES, V63, P277; REGEZI JA, 1993, J ORAL PATHOL MED, V22, P292, DOI 10.1111/j.1600-0714.1993.tb01075.x; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; TUDER RM, 1994, AM J PATHOL, V144, P275; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	48	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37641	37649		10.1074/jbc.M110.132415	http://dx.doi.org/10.1074/jbc.M110.132415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870717	Green Published, hybrid			2022-12-27	WOS:000284424000056
J	Eid, AA; Ford, BM; Block, K; Kasinath, BS; Gorin, Y; Ghosh-Choudhury, G; Barnes, JL; Abboud, HE				Eid, Assaad A.; Ford, Bridget M.; Block, Karen; Kasinath, Balakuntalam S.; Gorin, Yves; Ghosh-Choudhury, Goutam; Barnes, Jeffrey L.; Abboud, Hanna E.			AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASES; MEMBRANE THICKNESS; PODOCYTE DEPLETION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SKELETAL-MUSCLE; TRANSGENIC MICE; GLUCOSE-UPTAKE; RAT-KIDNEY; YEAST SNF1	Diabetes and high glucose (HG) increase the generation of NADPH oxidase-derived reactive oxygen species and induce apoptosis of glomerular epithelial cells (podocytes). Loss of podocytes contributes to albuminuria, a major risk factor for progression of kidney disease. Here, we show that HG inactivates AMP-activated protein kinase (AMPK), up-regulates Nox4, enhances NADPH oxidase activity, and induces podocyte apoptosis. Activation of AMPK blocked HG-induced expression of Nox4, NADPH oxidase activity, and apoptosis. We also identified the tumor suppressor protein p53 as a mediator of podocyte apoptosis in cells exposed to HG. Inactivation of AMPK by HG up-regulated the expression and phosphorylation of p53, and p53 acted downstream of Nox4. To investigate the mechanism of podocyte apoptosis in vivo, we used OVE26 mice, a model of type 1 diabetes. Glomeruli isolated from these mice showed decreased phosphorylation of AMPK and enhanced expression of Nox4 and p53. Pharmacologic activation of AMPK by 5-aminoimidazole-4-carboxamide-1-riboside in OVE26 mice attenuated Nox4 and p53 expression. Administration of 5-aminoimidazole-4-carboxamide-1-riboside also prevented renal hypertrophy, glomerular basement thickening, foot process effacement, and podocyte loss, resulting in marked reduction in albuminuria. Our results uncover a novel function of AMPK that integrates metabolic input to Nox4 and provide new insight for activation of p53 to induce podocyte apoptosis. The data indicate the potential therapeutic utility of AMPK activators to block Nox4 and reactive oxygen species generation and to reduce urinary albumin excretion in type 1 diabetes.	[Abboud, Hanna E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA; [Block, Karen; Kasinath, Balakuntalam S.; Ghosh-Choudhury, Goutam; Barnes, Jeffrey L.; Abboud, Hanna E.] Vet Affairs Res, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Goutam] S Texas Vet Healthcare Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Abboud, HE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, MC 7882,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	abboud@uthscsa.edu		Gorin, Yves/0000-0003-4048-6925; Ford, Bridget/0000-0002-3923-3210	National Institutes of Health [CA131272, R01 DK079996, R01 DK50190, R01 DK080106, DK-R01-078971]; George O'Brien Kidney Center [DK061597]; National Kidney Foundation; Juvenile Diabetes Research Foundation; Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA131272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077295, R01DK050190, R01DK080106, P50DK061597, R01DK078971, R01DK079996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George O'Brien Kidney Center; National Kidney Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA131272 (to K. B.), R01 DK079996 (to Y. G.), R01 DK50190 (to G. G.-C.), R01 DK080106 (to J. L. B.), and DK-R01-078971 (to H. E. A.) and George O'Brien Kidney Center-Morphology Core Grant DK061597 (to J. L. B.). This work was also supported by a National Kidney Foundation postdoctoral fellowship grant and a Juvenile Diabetes Research Foundation grant (to A. A. E.), a Juvenile Diabetes Research Foundation regular research grant (to Y. G.), and a Juvenile Diabetes Research Foundation grant and a Veterans Affairs merit review grant (to H. E. A.).	ABBOUD HE, 1982, J CLIN INVEST, V69, P327, DOI 10.1172/JCI110456; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cammisotto PG, 2008, J MOL HISTOL, V39, P579, DOI 10.1007/s10735-008-9198-6; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Carlson EC, 1997, ANAT REC, V247, P9; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; DeRubertis FR, 2007, METABOLISM, V56, P1256, DOI 10.1016/j.metabol.2007.04.024; DISCHE FE, 1992, ARCH PATHOL LAB MED, V116, P43; Dong J, 2010, TOXICOL LETT, V193, P94, DOI 10.1016/j.toxlet.2009.12.012; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Faulkner JL, 2005, AM J PATHOL, V167, P1193, DOI 10.1016/S0002-9440(10)61208-4; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Hardie D. Grahame, 1994, Seminars in Cell Biology, V5, P409, DOI 10.1006/scel.1994.1048; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; HIROSE K, 1982, KIDNEY INT, V21, P689, DOI 10.1038/ki.1982.82; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; JENSEN EB, 1979, J MICROSC-OXFORD, V115, P19, DOI 10.1111/j.1365-2818.1979.tb00149.x; Jo YI, 2007, NEPHRON EXP NEPHROL, V107, P87, DOI 10.1159/000108653; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kanwar YS, 1996, J CLIN INVEST, V98, P2478, DOI 10.1172/JCI119066; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim J, 2007, EXP EYE RES, V84, P886, DOI 10.1016/j.exer.2007.01.009; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Lemieux K, 2003, FASEB J, V17, P1658, DOI 10.1096/fj.02-1125com; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Moir H, 2010, J APPL PHYSIOL, V108, P1284, DOI 10.1152/japplphysiol.00737.2009; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sanden SK, 2003, J AM SOC NEPHROL, V14, P2484, DOI 10.1097/01.ASN.0000089829.45296.7C; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6	71	207	216	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37503	37512		10.1074/jbc.M110.136796	http://dx.doi.org/10.1074/jbc.M110.136796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861022	Green Published, hybrid			2022-12-27	WOS:000284424000042
J	Tamboli, IY; Barth, E; Christian, L; Siepmann, M; Kumar, S; Singh, S; Tolksdorf, K; Heneka, MT; Lutjohann, D; Wunderlich, P; Walter, J				Tamboli, Irfan Y.; Barth, Esther; Christian, Leonie; Siepmann, Martin; Kumar, Sathish; Singh, Sandesh; Tolksdorf, Karen; Heneka, Michael T.; Luetjohann, Dieter; Wunderlich, Patrick; Walter, Jochen			Statins Promote the Degradation of Extracellular Amyloid beta-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A REDUCTASE INHIBITORS; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; PROTEOLYTIC DEGRADATION; MULTIVESICULAR BODIES; PRECURSOR PROTEIN; LIPID RAFTS; MOUSE-BRAIN; CHOLESTEROL; CLEARANCE	Epidemiological studies indicate that intake of statins decrease the risk of developing Alzheimer disease. Cellular and in vivo studies suggested that statins might decrease the generation of the amyloid beta-peptide (A beta) from the beta-amyloid precursor protein. Here, we show that statins potently stimulate the degradation of extracellular A beta by microglia. The statin-dependent clearance of extracellular A beta is mainly exerted by insulindegrading enzyme (IDE) that is secreted in a nonconventional pathway in association with exosomes. Stimulated IDE secretion and A beta degradation were also observed in blood of mice upon peripheral treatment with lovastatin. Importantly, increased IDE secretion upon lovastatin treatment was dependent on protein isoprenylation and up-regulation of exosome secretion by fusion of multivesicular bodies with the plasma membrane. These data demonstrate a novel pathway for the nonconventional secretion of IDE via exosomes. The modulation of this pathway could provide a new strategy to enhance the extracellular clearance of A beta.	[Tamboli, Irfan Y.; Barth, Esther; Christian, Leonie; Siepmann, Martin; Kumar, Sathish; Singh, Sandesh; Tolksdorf, Karen; Heneka, Michael T.; Wunderlich, Patrick; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Luetjohann, Dieter] Univ Bonn, Dept Clin Pharmacol & Biochem, D-53127 Bonn, Germany	University of Bonn; University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	Jochen.Walter@ukb.uni-bonn.de	Kumar, Sathish/L-1367-2019; Wang, Caihong/T-5837-2019; Walter, Jochen/B-3677-2014; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047; Heneka, Michael/0000-0003-4996-1630	Deutsche Forschungsgemeinschaft [SFB645, KFO177]; Federal Ministry for Education and Research (BMBF) [01GI0708]; BONFOR; NICHD, National Institutes of Health; Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BONFOR; NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hans and Ilse Breuer Foundation	This work was supported in part by the Deutsche Forschungsgemeinschaft, Grants SFB645 and KFO177, the Federal Ministry for Education and Research (BMBF), Grant 01GI0708, and the BONFOR program.; Recipient of a fellowship from the Hans and Ilse Breuer Foundation.; We thank Dr. Sascha Weggen for advice with the transfection of N9 cells. The E7 antibody against beta-tubulin developed by Dr. Klymkowsky was obtained from the Developmental Studies Hybridoma Bank developed under auspices of the NICHD, National Institutes of Health, and maintained by the Department of Biology, University of Iowa, Iowa City, IA 52242.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Bales K R, 2002, Mol Interv, V2, P363, DOI 10.1124/mi.2.6.363; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Boche D, 2008, BRAIN PATHOL, V18, P267, DOI 10.1111/j.1750-3639.2008.00134.x; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Brendza RP, 2002, MOL PSYCHIATR, V7, P132, DOI 10.1038/sj.mp.4001006; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Cleves AE, 1996, CURR BIOL, V6, P276, DOI 10.1016/S0960-9822(02)00477-3; Cole SL, 2006, NEUROBIOL DIS, V22, P209, DOI 10.1016/j.nbd.2005.11.007; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Eckert GP, 2005, SUB CELL BIOCHEM, V38, P319; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Hoglund K, 2007, CNS DRUGS, V21, P449; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Ledesma MD, 2006, FEBS LETT, V580, P5525, DOI 10.1016/j.febslet.2006.06.038; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; McGuinness B, 2010, J ALZHEIMERS DIS, V20, P925, DOI 10.3233/JAD-2010-091570; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Mukherjee A, 2000, J NEUROSCI, V20, P8745; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Parsons RB, 2007, BIOCHEM SOC T, V35, P577, DOI 10.1042/BST0350577; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Taylor DR, 2007, SEMIN CELL DEV BIOL, V18, P638, DOI 10.1016/j.semcdb.2007.07.008; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Whitfield JF, 2007, EXPERT OPIN THER TAR, V11, P1257, DOI 10.1517/14728222.11.10.1257; Wolazin B, 2006, ACTA NEUROL SCAND, V114, P63; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com	66	152	161	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37405	37414		10.1074/jbc.M110.149468	http://dx.doi.org/10.1074/jbc.M110.149468			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876579	Green Published, hybrid			2022-12-27	WOS:000284424000033
J	Henard, CA; Bourret, TJ; Song, M; Vazquez-Torres, A				Henard, Calvin A.; Bourret, Travis J.; Song, Miryoung; Vazquez-Torres, Andres			Control of Redox Balance by the Stringent Response Regulatory Protein Promotes Antioxidant Defenses of Salmonella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CHRONIC GRANULOMATOUS-DISEASE; NADPH PHAGOCYTE OXIDASE; ESCHERICHIA-COLI; PATHOGENICITY ISLAND; OXIDATIVE STRESS; ANTIMICROBIAL ACTIONS; DNA-DAMAGE; DKSA; PPGPP	We report herein a critical role for the stringent response regulatory DnaK suppressor protein (DksA) in the coordination of antioxidant defenses. DksA helps fine-tune the expression of glutathione biosynthetic genes and discrete steps in the pentose phosphate pathway and tricarboxylic acid cycle that are associated with the generation of reducing power. Control of NAD(P)H/NAD(P)(+) redox balance by DksA fuels downstream antioxidant enzymatic systems in nutritionally starving Salmonella. Conditional expression of the glucose-6-phosphate dehydrogenase-encoding gene zwf, shown here to be under DksA control, increases both the NADPH pool and antioxidant defenses of dksA mutant Salmonella. The DksA-mediated coordination of redox balance boosts the antioxidant defenses of stationary phase bacteria. Not only does DksA increase resistance of Salmonella against hydrogen peroxide (H2O2), but it also promotes fitness of this intracellular pathogen when exposed to oxyradicals produced by the NADPH phagocyte oxidase in an acute model of infection. Given the role of DksA in the adjustment of gene expression in most bacteria undergoing nutritional deprivation, our findings raise the possibility that the control of central metabolic pathways by this regulatory protein maintains redox homeostasis essential for antioxidant defenses in phylogenetically diverse bacterial species.	[Henard, Calvin A.; Bourret, Travis J.; Song, Miryoung; Vazquez-Torres, Andres] Univ Colorado, Sch Med, Anschutz Med Ctr, Dept Microbiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Vazquez-Torres, A (corresponding author), Mail Box 8333,POB 6511,Rm P18-9120, Aurora, CO 80045 USA.	andres.vazquez-torres@ucdenver.edu	Bourret, Travis/J-4673-2019	Bourret, Travis/0000-0002-4154-929X	National Institute of Health [AI54959]; Burroughs Welcome Fund; Institutional Training Grant [T32 AI052066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054959, T32AI052066, R56AI054959] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); Institutional Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health Grant AI54959. This work was also supported by the Burroughs Welcome Fund and the Institutional Training Grant T32 AI052066.	Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bourret TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001833; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CLARK WM, 1960, OXIDATION REDUCTION, P487; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean RT, 1997, BIOCHEM J, V324, P1; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Grose JH, 2006, P NATL ACAD SCI USA, V103, P7601, DOI 10.1073/pnas.0602494103; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; LUNDQUIST R, 1971, J BIOL CHEM, V246, P1107; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Woodmansee AN, 2003, MOL MICROBIOL, V49, P11, DOI 10.1046/j.1365-2958.2003.03530.x; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9	47	55	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36785	36793		10.1074/jbc.M110.160960	http://dx.doi.org/10.1074/jbc.M110.160960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851888	hybrid, Green Published			2022-12-27	WOS:000284146100056
J	Ichi, S; Costa, FF; Bischof, JM; Nakazaki, H; Shen, YW; Boshnjaku, V; Sharma, S; Mania-Farnell, B; McLone, DG; Tomita, T; Soares, MB; Mayanil, CSK				Ichi, Shunsuke; Costa, Fabricio F.; Bischof, Jared M.; Nakazaki, Hiromichi; Shen, Yueh-Wei; Boshnjaku, Vanda; Sharma, Saurabh; Mania-Farnell, Barbara; McLone, David G.; Tomita, Tadanori; Soares, Marcelo B.; Mayanil, Chandra S. K.			Folic Acid Remodels Chromatin on Hes1 and Neurog2 Promoters during Caudal Neural Tube Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MOUSE MUTANT; PAX-3 GENE; MICRORNA; DIFFERENTIATION; DEFECTS; SUPPLEMENTATION; TGF-BETA-2; EXPRESSION; RESPONSES	The mechanism(s) behind folate rescue of neural tube closure are not well understood. In this study we show that maternal intake of folate prior to conception reverses the proliferation potential of neural crest stem cells in homozygous Splotch embryos (Sp(-/-)) via epigenetic mechanisms. It is also shown that the pattern of differentiation seen in these cells is similar to wild-type (WT). Cells from open caudal neural tubes of Sp(-/-) embryos exhibit increased H3K27 methylation and decreased expression of KDM6B possibly due to up-regulation of KDM6B targeting micro-RNAs such as miR-138, miR-148a, miR-185, and miR-339-5p. In our model, folate reversed these epigenetic marks in folate-rescued Sp(-/-) embryos. Using tissue from caudal neural tubes of murine embryos we also examined H3K27me2 and KDM6B association with Hes1 and Neurog2 promoters at embryonic day E10.5, the proliferative stage, and E12.5, when neural differentiation begins. In Sp(-/-) embryos compared with WT, levels of H3K27me2 associated with the Hes1 promoter were increased at E10.5, and levels associated with the Neurog2 promoter were increased at E12.5. KDM6B association with Hes1 and Neurog2 promoters was inversely related to H3K27me2 levels. These epigenetic changes were reversed in folate-rescued Sp(-/-) embryos. Thus, one of the mechanisms by which folate may rescue the Sp(-/-) phenotype is by increasing the expression of KDM6B, which in turn decreases H3K27 methylation marks on Hes1 and Neurog2 promoters thereby affecting gene transcription.	[Sharma, Saurabh; McLone, David G.; Tomita, Tadanori; Mayanil, Chandra S. K.] Childrens Mem Res Ctr, Dev Neurobiol Lab, Dept Pediat Neurosurg, Dev Biol Program, Chicago, IL 60614 USA; [Costa, Fabricio F.; Bischof, Jared M.; Soares, Marcelo B.] Childrens Mem Res Ctr, Canc Biol & Epigenom Program, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60614 USA; [Mania-Farnell, Barbara] Purdue Univ Calumet, Dept Biol, Hammond, IN 46323 USA; [Ichi, Shunsuke] Univ Tokyo, Dept Neurosurg, Tokyo 1138656, Japan; [Nakazaki, Hiromichi] Jikei Univ, Dept Neurosurg, Sch Med, Tokyo 1058461, Japan	Northwestern University; Feinberg School of Medicine; Purdue University System; Purdue University; University of Tokyo; Jikei University	Mayanil, CSK (corresponding author), Childrens Mem Res Ctr, Dev Neurobiol Lab, Dept Pediat Neurosurg, Dev Biol Program, Box 204,2430 N Halsted St, Chicago, IL 60614 USA.	smayanil@northwestern.edu	Costa, Fabricio/M-5309-2017; Sharma, Saurabh/E-1221-2011		McLone; State of Illinois; Spina Bifida Association; Spastic Paralysis Research Foundation of Illinois-Eastern Iowa District of Kiwanis; Maeve McNicholas Memorial Foundation; Institute of Child Health, London	McLone; State of Illinois; Spina Bifida Association; Spastic Paralysis Research Foundation of Illinois-Eastern Iowa District of Kiwanis; Maeve McNicholas Memorial Foundation; Institute of Child Health, London	This work was supported by grants from the McLone Professorship Fund (to C. S. K. M.), a State of Illinois Excellence in Academic Medicine award (to C. S. K. M.), the Spina Bifida Association (to C. S. K. M.), the Spastic Paralysis Research Foundation of Illinois-Eastern Iowa District of Kiwanis (to C. S. K. M. and D. G. M.), and the Maeve McNicholas Memorial Foundation (to F. F. C.).; We thank Dr. M. Calissano, Institute of Child Health, London, for the generous gift of ND7 cells, Dr. Mary Hendrix for critical reading of the manuscript, and Dr. Elio F. Vanin for valuable discussions.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Burren KA, 2008, HUM MOL GENET, V17, P3675, DOI 10.1093/hmg/ddn262; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Gray JD, 2009, BIRTH DEFECTS RES A, V85, P314, DOI 10.1002/bdra.20542; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Latchman D. S., 1995, Methods (Orlando), V7, P277, DOI 10.1006/meth.1995.1033; Lo LC, 2002, DEVELOPMENT, V129, P1553; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mayanil CSK, 2006, J BIOL CHEM, V281, P24544, DOI 10.1074/jbc.M512449200; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakazaki H, 2008, DEV BIOL, V316, P510, DOI 10.1016/j.ydbio.2008.01.008; Nakazaki H, 2009, INT J DEV BIOL, V53, P69, DOI 10.1387/ijdb.082682hn; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Wlodarczyk BJ, 2006, TOXICOL APPL PHARM, V213, P55, DOI 10.1016/j.taap.2005.09.008; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017	31	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36922	36932		10.1074/jbc.M110.126714	http://dx.doi.org/10.1074/jbc.M110.126714			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833714	hybrid, Green Published			2022-12-27	WOS:000284146100019
J	Kanamori, Y; Hayakawa, Y; Matsumoto, H; Yasukochi, Y; Shimura, S; Nakahara, Y; Kiuchi, M; Kamimura, M				Kanamori, Yasushi; Hayakawa, Yoichi; Matsumoto, Hitoshi; Yasukochi, Yuji; Shimura, Sachiko; Nakahara, Yuichi; Kiuchi, Makoto; Kamimura, Manabu			A Eukaryotic (Insect) Tricistronic mRNA Encodes Three Proteins Selected by Context-dependent Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILKWORM PARALYTIC PEPTIDE; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; BICISTRONIC TRANSCRIPT; NERVOUS-SYSTEM; GENE; TRANSLATION; INITIATION; MECHANISM; EXPRESSION	Eukaryotic mRNAs are generally considered monocistronic and encode only one protein. Although dicistronic mRNAs encoding two proteins were found in fungi, plants, and animals, polycistronic mRNAs encoding more than two proteins have remained elusive so far in any eukaryote. Here we demonstrate that a single mRNA from silkworm encodes the precursor of an insect cytokine paralytic peptide (PP) and two new cytokine precursor-like proteins, uENF1 and uENF2. RT-PCR analysis showed that this mRNA is widely conserved in moths. Western blot analyses and reporter assays using its modified mRNAs, created by replacing each one of the three ORFs with the firefly luciferase ORF, showed that all three proteins were translated from this mRNA in cell lines, larval tissues, and cell-free systems. Insertion experiments using the Renilla luciferase ORF or a stem loop ruled out the possible involvement of internal ribosome entry site in the three protein translation. On the other hand, systematic mutation analysis of the translation initiation sequence of the 5'-proximal uENF1 ORF suggested that the context-dependent leaky-scanning mechanism is involved in translation of the downstream uENF2 and PP ORFs. In vitro, a synthetic peptide corresponding to the putative mature form of uENF1 stimulated spreading of hemocytes as did the synthetic PP, whereas that of uENF2 antagonized the stimulating activities of PP and the uENF1 peptide, suggesting that the three proteins control cellular immunity interactively. Thus, eukaryotes have a cellular tricistronic mRNA that encodes three functionally related proteins as in an operon.	[Kamimura, Manabu] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki 3058634, Japan; [Hayakawa, Yoichi; Matsumoto, Hitoshi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan	National Institute of Agrobiological Sciences - Japan; Saga University	Kamimura, M (corresponding author), Natl Inst Agrobiol Sci, Div Insect Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	kamimura@affrc.go.jp			Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Education, Culture, Sports, Science, and Technology, Japan [22380039]	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and Grants-in-aid for Scientific Research 22380039 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ADHYA S, 2003, SCI STKE, pPE22; Andrews J, 1996, GENETICS, V143, P1699; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chung KR, 2003, CURR GENET, V43, P415, DOI 10.1007/s00294-003-0414-3; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; GarciaRios M, 1997, P NATL ACAD SCI USA, V94, P8249, DOI 10.1073/pnas.94.15.8249; GODA SK, 1995, NUCLEIC ACIDS RES, V23, P3357, DOI 10.1093/nar/23.16.3357; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Hayakawa Y, 1998, EUR J BIOCHEM, V253, P810, DOI 10.1046/j.1432-1327.1998.2530810.x; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 1981, Curr Top Microbiol Immunol, V93, P81; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Lee JM, 2005, CELL BIOL INT, V29, P976, DOI 10.1016/j.cellbi.2005.07.007; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Liu H, 2000, GENETICS, V154, P1735; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Mil'gotina EI, 2003, RUSS J BIOORG CHEM+, V29, P511, DOI 10.1023/B:RUBI.0000008891.51576.d0; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Pavlik P, 2006, GENOMICS, V88, P347, DOI 10.1016/j.ygeno.2006.04.009; Ramanathan P, 2008, RNA BIOL, V5, P149, DOI 10.4161/rna.5.3.6676; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Tsuzuki S, 2005, MECH DEVELOP, V122, P189, DOI 10.1016/j.mod.2004.10.005; Wall AA, 2005, J BIOL CHEM, V280, P27670, DOI 10.1074/jbc.M500255200; Wu C, 1999, MOL GEN GENET, V261, P698, DOI 10.1007/s004380050013	39	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36933	36944		10.1074/jbc.M110.180398	http://dx.doi.org/10.1074/jbc.M110.180398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829361	Green Published, hybrid			2022-12-27	WOS:000284146100077
J	Langbein, L; Eckhart, L; Rogers, MA; Praetzel-Wunder, S; Schweizer, J				Langbein, Lutz; Eckhart, Leopold; Rogers, Michael A.; Praetzel-Wunder, Silke; Schweizer, Juergen			Against the Rules: Human Keratin K80 TWO FUNCTIONAL ALTERNATIVE SPLICE VARIANTS, K80 AND K80.1, WITH SPECIAL CELLULAR LOCALIZATION IN A WIDE RANGE OF EPITHELIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HAIR FOLLICLE; INTERMEDIATE-FILAMENTS; SITE MUTATION; GENE FAMILY; PROTEINS; EXPRESSION; DESMOSOMES; MEMBERS; CELLS; ORGANIZATION	Of the 54 human keratins, five members have, at present, only been characterized at the gene level. In this study we have investigated the expression patterns of keratin K80, whose gene is located at the centromeric end of the type II keratin gene domain. K80 possesses a number of highly unusual properties. Structurally, it is distinctly closer to type II hair keratins than to type II epithelial keratins. Nonetheless, it is found in virtually all types of epithelia (stratified keratinizing/non-keratinizing, hard-keratinizing, as well as non-stratified tissues, and cell cultures thereof). This conspicuously broad expression range implies an unprecedented in vivo promiscuity of K80, which involves more than 20 different type I partners for intermediate filament (IF) formation. Throughout, K80 expression is related to advanced tissue or cell differentiation. However, instead of being part of the cytoplasmic IF network, K80 containing IFs are located at the cell margins close to the desmosomal plaques, where they are tightly interlaced with the cytoplasmic IF bundles abutting there. In contrast, in cells entering terminal differentiation, K80 adopts the "conventional" cytoplasmic distribution. In evolutionary terms, K80 is one of the oldest keratins, demonstrable down to fish. In addition, KRT80 mRNA is subject to alternative splicing. Besides K80, we describe a smaller but fully functional splice variant K80.1, which arose only during mammalian evolution. Remarkably, unlike the widely expressed K80, the expression of K80.1 is restricted to soft and hard keratinizing epithelial structures of the hair follicle and the filiform tongue papilla.	[Langbein, Lutz; Praetzel-Wunder, Silke] German Canc Res Ctr, Dept Genet Skin Carcinogenesis, D-69120 Heidelberg, Germany; [Rogers, Michael A.] German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany; [Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, A-1090 Vienna, Austria	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Vienna	Langbein, L (corresponding author), German Canc Res Ctr, Dept Genet Skin Carcinogenesis, A110,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	Langbein@dkfz.de	Rogers, Michael A./J-9803-2012	Rogers, Michael A./0000-0002-3728-2107; Eckhart, Leopold/0000-0002-5645-2036	Wilhelm Sander-Stiftung Munich [2007.133.1]	Wilhelm Sander-Stiftung Munich	This work was supported by Wilhelm Sander-Stiftung Munich Grant 2007.133.1 (to L. L.).	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Covaciu C, 2010, BRIT J DERMATOL, V162, P1384, DOI 10.1111/j.1365-2133.2010.09665.x; COWIN P, 1985, J CELL BIOL, V101, P1442, DOI 10.1083/jcb.101.4.1442; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; FRANKE WW, 1987, CIBA F SYMP, V125, P26; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; HOHL D, 1991, J BIOL CHEM, V266, P6626; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; Kellner JC, 2009, J CELL BIOL, V187, P157, DOI 10.1083/jcb.200909134; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; KURUC N, 1989, DIFFERENTIATION, V42, P111, DOI 10.1111/j.1432-0436.1989.tb00612.x; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Langbein L, 2004, METHOD CELL BIOL, V78, P413; Langbein L, 2005, J INVEST DERMATOL, V125, P428, DOI 10.1111/j.0022-202X.2005.23860.x; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Langbein L, 2006, J INVEST DERMATOL, V126, P2377, DOI 10.1038/sj.jid.5700494; Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lu H, 2006, EUR J CELL BIOL, V85, P803, DOI 10.1016/j.ejcb.2006.04.001; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Rogers MA, 2005, J INVEST DERMATOL, V124, P536, DOI 10.1111/j.0022-202X.2004.23530.x; Rogers MA, 2004, DIFFERENTIATION, V72, P527, DOI 10.1111/j.1432-0436.2004.07209006.x; Salas PJI, 1997, J CELL BIOL, V137, P359, DOI 10.1083/jcb.137.2.359; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Winter H, 1997, J BIOL CHEM, V272, P32345, DOI 10.1074/jbc.272.51.32345; Zhou ZL, 2010, MOL BIOL REP, V37, P2407, DOI 10.1007/s11033-009-9751-8	39	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36909	36921		10.1074/jbc.M110.161745	http://dx.doi.org/10.1074/jbc.M110.161745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843789	Green Published, hybrid			2022-12-27	WOS:000284146100015
J	Wang, Y; Liu, L; Davies, DR; Segal, DM				Wang, Yan; Liu, Lin; Davies, David R.; Segal, David M.			Dimerization of Toll-like Receptor 3 (TLR3) Is Required for Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RECOGNITION; SITE	TLR3 (Toll-like receptor 3) recognizes dsRNA, a potent indicator of viral infection. The extracellular domain of TLR3 dimerizes when it binds dsRNA, and the crystal structure of the dimeric complex reveals three sites of interaction on each extracellular domain, two that bind dsRNA and one that is responsible for dimer formation. The goal of this study was to determine which amino acid residues are essential for forming a stable receptor.ligand complex and whether dimerization of TLR3 is required for dsRNA binding. Using a novel ELISA to analyze dsRNA binding by mutant TLR3 constructs, we identified the essential interacting residues and determined that the simultaneous interaction of all three sites is required for ligand binding. In addition, we show that TLR3 is unable to bind dsRNA when dimerization is prevented by mutating residues in the dimerization site or by immobilizing TLR3 at low density. We conclude that dimerization of TLR3 is essential for ligand binding and that the three TLR3 contact sites individually interact weakly with their binding partners but together form a high affinity receptor.ligand complex.	[Segal, David M.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Liu, Lin; Davies, David R.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Segal, DM (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36,9000 Rockville Pike, Bethesda, MD 20892 USA.	dave_segal@nih.gov			National Institutes of Health (NCI and NIDDK); National Institutes of Health/Food and Drug Administration, NIAID; NATIONAL CANCER INSTITUTE [ZIABC009254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK034002] Funding Source: NIH RePORTER	National Institutes of Health (NCI and NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Food and Drug Administration, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health (NCI and NIDDK) and by a National Institutes of Health/Food and Drug Administration intramural biodefense award from NIAID.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Fukuda K, 2008, J BIOL CHEM, V283, P22787, DOI 10.1074/jbc.M802284200; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x	18	53	55	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36836	36841		10.1074/jbc.M110.167973	http://dx.doi.org/10.1074/jbc.M110.167973			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861016	Green Published, hybrid			2022-12-27	WOS:000284146100041
J	Foley, JF; Singh, SP; Cantu, M; Chen, LY; Zhang, HWH; Farber, JM				Foley, John F.; Singh, Satya P.; Cantu, Michelle; Chen, Lingye; Zhang, Hongwei H.; Farber, Joshua M.			Differentiation of Human T Cells Alters Their Repertoire of G Protein alpha-Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEIN; STIMULATING-HORMONE INCREASES; OPIOID RECEPTOR EXPRESSION; MESSENGER-RNA; SIGNALING PATHWAYS; ADENYLYL-CYCLASE; CALCIUM-CHANNELS; MICE DEFICIENT; SERTOLI CELLS; CUTTING EDGE	Because T cell differentiation leads to an expanded repertoire of chemokine receptors, a subgroup of G protein-coupled receptors, we hypothesized that the repertoire of G proteins might be altered in parallel. We analyzed the abundance of mRNA and/or protein of six G protein alpha-subunits in human CD4(+) and CD8(+) T cell subsets from blood. Although most G protein alpha-subunits were similarly expressed in all subsets, the abundance of G alpha(o), a protein not previously described in hematopoietic cells, was much higher in memory versus naive cells. Consistent with these data, activation of naive CD4(+) T cells in vitro significantly increased the abundance of G alpha(o) in cells stimulated under nonpolarizing or T(H)17 (but not T(H)1 or T(H)2)-polarizing conditions. In functional studies, the use of a chimeric G protein alpha-subunit, G alpha(qo5), demonstrated that chemokine receptors could couple to G alpha(o)-containing G proteins. We also found that G alpha(i1), another alpha-subunit not described previously in leukocytes, was expressed in naive T cells but virtually absent from memory subsets. Corresponding to their patterns of expression, siRNA-mediated knockdown of G alpha(o) in memory (but not naive) and G alpha(i1) in naive (but not memory) CD4(+) T cells inhibited chemokine-dependent migration. Moreover, although even in G alpha(o)- and G alpha(i1)-expressing cells mRNAs of these alpha-subunits were much less abundant than G alpha(i2) or G alpha(i3), knockdown of any of these subunits impaired chemokine receptor-mediated migration similarly. Together, our data reveal a change in the repertoire of G alpha(i/o) subunits during T cell differentiation and suggest functional equivalence among G alpha(i/o) subunits irrespective of their relative abundance.	[Foley, John F.; Singh, Satya P.; Cantu, Michelle; Chen, Lingye; Zhang, Hongwei H.; Farber, Joshua M.] NIAID, Inflammat Biol Sect, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Farber, JM (corresponding author), NIAID, Inflammat Biol Sect, Lab Mol Immunol, NIH, Rm 11N112,Bldg 10,MSC 1886,10 Ctr Dr, Bethesda, MD 20892 USA.	jfarber@niaid.nih.gov		Foley, John/0000-0003-0395-5390	National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000749] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health NIAID Intramural Research Program.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BAHOUTH SW, 1995, BIOCHEM J, V307, P831, DOI 10.1042/bj3070831; BERKE G, 1995, IMMUNOL TODAY, V16, P343, DOI 10.1016/0167-5699(95)80152-9; Cardoso A, 1998, J CELL BIOCHEM, V68, P62, DOI 10.1002/(SICI)1097-4644(19980101)68:1<62::AID-JCB6>3.0.CO;2-U; CARTER BD, 1993, P NATL ACAD SCI USA, V90, P4062, DOI 10.1073/pnas.90.9.4062; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Cho HH, 2006, STEM CELLS DEV, V15, P853, DOI 10.1089/scd.2006.15.853; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; El Ghamrawy C, 1999, PEPTIDES, V20, P305, DOI 10.1016/S0196-9781(99)00036-4; El Jamali A, 1998, J NEUROCHEM, V71, P2271; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; Farber DL, 2009, SEMIN IMMUNOL, V21, P84, DOI 10.1016/j.smim.2009.02.003; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; Fujii T, 2003, NEUROCHEM RES, V28, P423, DOI 10.1023/A:1022840416292; Fujino H, 1997, MOL PHARMACOL, V51, P1007, DOI 10.1124/mol.51.6.1007; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; GAVERIAUX C, 1995, FEBS LETT, V369, P272, DOI 10.1016/0014-5793(95)00766-3; GOLDMAN DW, 1985, J EXP MED, V162, P145, DOI 10.1084/jem.162.1.145; GOLDSMITH P, 1988, BIOCHEMISTRY-US, V27, P7085, DOI 10.1021/bi00418a062; HADCOCK JR, 1990, J BIOL CHEM, V265, P14784; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; HARRISWARRICK RM, 1988, NEURON, V1, P27, DOI 10.1016/0896-6273(88)90206-1; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; He JP, 2000, J EXP MED, V191, P1605, DOI 10.1084/jem.191.9.1605; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HSU WH, 1990, J BIOL CHEM, V265, P11220; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2006, P NATL ACAD SCI USA, V103, P6524, DOI 10.1073/pnas.0601853103; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; KUROSE H, 1986, J BIOL CHEM, V261, P6423; Li MD, 1999, J LEUKOCYTE BIOL, V65, P707, DOI 10.1002/jlb.65.5.707; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liao F, 1997, BIOCHEM BIOPH RES CO, V236, P212, DOI 10.1006/bbrc.1997.6936; Liao F, 1999, J IMMUNOL, V162, P186; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGANZO F, 1993, MOL ENDOCRINOL, V7, P434, DOI 10.1210/me.7.3.434; LOGANZO F, 1992, MOL ENDOCRINOL, V6, P1259, DOI 10.1210/me.6.8.1259; Luo AH, 2002, BRAIN RES, V941, P62, DOI 10.1016/S0006-8993(02)02566-0; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; McIntire WE, 1998, J BIOL CHEM, V273, P33135, DOI 10.1074/jbc.273.50.33135; Miller B, 1996, J IMMUNOL, V157, P5324; Miller RK, 2009, MOL BIOL CELL, V20, P3608, DOI 10.1091/mbc.E09-03-0208; Murphy PM, 2000, PHARMACOL REV, V52, P145; MURTAGH JJ, 1994, NUCLEIC ACIDS RES, V22, P842, DOI 10.1093/nar/22.5.842; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; NEER EJ, 1984, J BIOL CHEM, V259, P4222; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Ottoson NC, 2001, J IMMUNOL, V167, P1857, DOI 10.4049/jimmunol.167.4.1857; Preece G, 1996, J BIOL CHEM, V271, P11634, DOI 10.1074/jbc.271.20.11634; Rabin RL, 1999, J IMMUNOL, V162, P3840; Rabin RL, 2003, J IMMUNOL, V171, P2812, DOI 10.4049/jimmunol.171.6.2812; Ricci A, 2002, J NEUROIMMUNOL, V129, P178, DOI 10.1016/S0165-5728(02)00177-7; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Song KM, 2005, P NATL ACAD SCI USA, V102, P7916, DOI 10.1073/pnas.0409720102; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; Tanaka M, 1999, P NATL ACAD SCI USA, V96, P14106, DOI 10.1073/pnas.96.24.14106; Timm A, 2005, CURR TOP MICROBIOL, V290, P225; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yu CR, 2000, J IMMUNOL, V164, P1293, DOI 10.4049/jimmunol.164.3.1293	83	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35537	35550		10.1074/jbc.M110.128033	http://dx.doi.org/10.1074/jbc.M110.128033			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829352	Green Published, hybrid			2022-12-27	WOS:000283845300032
J	Kilbride, SM; Farrelly, AM; Bonner, C; Ward, MW; Nyhan, KC; Concannon, CG; Wollheim, CB; Byrne, MM; Prehn, JHM				Kilbride, Sean M.; Farrelly, Angela M.; Bonner, Caroline; Ward, Manus W.; Nyhan, Kristine C.; Concannon, Caoimhin G.; Wollheim, Claes B.; Byrne, Maria M.; Prehn, Jochen H. M.			RETRACTED: AMP-activated Protein Kinase Mediates Apoptosis in Response to Bioenergetic Stress through Activation of the Pro-apoptotic Bcl-2 Homology Domain-3-only Protein BMF (Retracted article. See vol. 295, pg. 671, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							DOMINANT-NEGATIVE SUPPRESSION; PANCREATIC BETA-CELLS; MITOCHONDRIAL DYSFUNCTION; EXPRESSION; METFORMIN; GENE; STIMULATION; HNF-1-ALPHA; METABOLISM; MUTATIONS	Heterozygous loss-of-function mutations in the hepatocyte nuclear factor 1A (HNF1A) gene result in the pathogenesis of maturity-onset diabetes-of-the-young type 3, (HNF1A-MODY). This disorder is characterized by a primary defect in metabolism-secretion coupling and decreased beta cell mass, attributed to excessive beta cell apoptosis. Here, we investigated the link between energy stress and apoptosis activation following HNF1A inactivation. This study employed single cell fluorescent microscopy, flow cytometry, gene expression analysis, and gene silencing to study the effects of overexpression of dominant-negative (DN)-HNF1A expression on cellular bioenergetics and apoptosis in INS-1 cells. Induction of DN-HNF1A expression led to reduced ATP levels and diminished the bioenergetic response to glucose. This was coupled with activation of the bioenergetic stress sensor AMP-activated protein kinase (AMPK), which preceded the onset of apoptosis. Pharmacological activation of AMPK using aminoimidazole carboxamide ribonucleotide (AICAR) was sufficient to induce apoptosis in naive cells. Conversely, inhibition of AMPK with compound C or AMPK alpha gene silencing protected against DN-HNF1A-induced apoptosis. Interestingly, AMPK mediated the induction of the pro-apoptotic Bcl-2 homology domain-3-only protein Bmf (Bcl-2-modifying factor). Bmf expression was also elevated in islets of DN-HNF1A transgenic mice. Furthermore, knockdown of Bmf expression in INS-1 cells using siRNA was sufficient to protect against DN-HNF1A-induced apoptosis. Our study suggests that overexpression of DN-HNF1A induces bioenergetic stress and activation of AMPK. This in turn mediates the transcriptional activation of the pro-apoptotic Bcl-2-homology protein BMF, coupling prolonged energy stress to apoptosis activation.	[Kilbride, Sean M.; Bonner, Caroline; Ward, Manus W.; Concannon, Caoimhin G.; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Farrelly, Angela M.; Nyhan, Kristine C.; Byrne, Maria M.] Mater Misericordiae Univ Hosp, Dublin 7, Ireland; [Wollheim, Claes B.] Univ Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Royal College of Surgeons - Ireland; Mater Misericordiae University Hospital; University College Dublin; University of Geneva	Prehn, JHM (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, 123 St Stephens Green, Dublin 2, Ireland.	prehn@rcsi.ie	Concannon, Caoimhin/B-2075-2010; Byrne, Maria/A-8310-2017; Pattou, Francois/O-6151-2017; Prehn, Jochen HM/A-3928-2010; Bonner, Caroline/A-9819-2015; Farrelly, Angela/E-8010-2017	Byrne, Maria/0000-0002-9394-8698; Pattou, Francois/0000-0001-8388-3766; Prehn, Jochen HM/0000-0003-3479-7794; Bonner, Caroline/0000-0002-4430-8280; Ward, Manus/0000-0002-7085-9668; Farrelly, Angela/0000-0002-1242-5693	Health Research Board [RP/2008/14]; Science Foundation Ireland [08/IN1/1949]; Swiss National Foundation [32-66907.01];  [RP/2004/220];  [RP/2007/316]	Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); ; 	This work was supported by Health Research Board Grant RP/2008/14 and Science Foundation Ireland Grant 08/IN1/1949 (to J. H. M. P.), Grants RP/2004/220 and RP/2007/316 (to M. M. B.), and Swiss National Foundation Grant 32-66907.01 (to C. B. W.).	BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Farrelly AM, 2009, DIABETOLOGIA, V52, P136, DOI 10.1007/s00125-008-1168-8; Ghanaat-Pour H, 2009, DIABETES-METAB RES, V25, P163, DOI 10.1002/dmrr.896; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Leclerc I, 2004, DIABETES, V53, pS67, DOI 10.2337/diabetes.53.suppl_3.S67; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Marmol P, 2009, J BIOL CHEM, V284, P515, DOI 10.1074/jbc.M806729200; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; Pongratz RL, 2009, J BIOL CHEM, V284, P16808, DOI 10.1074/jbc.M807723200; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Rachmani Rita, 2002, Eur J Intern Med, V13, P428, DOI 10.1016/S0953-6205(02)00131-0; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Schutte B, 1998, J NEUROSCI METH, V86, P63, DOI 10.1016/S0165-0270(98)00147-2; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Vaxillaire M, 2006, ENDOCRIN METAB CLIN, V35, P371, DOI 10.1016/j.ecl.2006.02.009; Viana R, 2008, BIOCHEM BIOPH RES CO, V369, P964, DOI 10.1016/j.bbrc.2008.02.126; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; Wobser H, 2006, DIABETOLOGIA, V49, P519, DOI 10.1007/s00125-005-0119-x; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	48	35	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36199	36206		10.1074/jbc.M110.138107	http://dx.doi.org/10.1074/jbc.M110.138107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20841353	Green Published, hybrid			2022-12-27	WOS:000283845300095
J	Nguyen, TN; Uemura, A; Shih, W; Yamada, S				Nguyen, Thuc Nghi; Uemura, Arisa; Shih, Wenting; Yamada, Soichiro			Zyxin-mediated Actin Assembly Is Required for Efficient Wound Closure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; CELL-CELL ADHESION; E-CADHERIN; ADHERENS JUNCTIONS; ENA/VASP PROTEINS; FOCAL ADHESIONS; ALPHA-ACTININ; POLYMERIZATION; VASP; CONTACTS	Cytoskeletal regulation of cell adhesion is vital to the organization of multicellular structures. The focal adhesion protein zyxin emerged as a key regulator of actin assembly because zyxin recruits Enabled/vasodilator-stimulated phospho-proteins (Ena/VASP) to promote actin assembly. Zyxin also localizes to the sites of cell-cell adhesion and is thought to promote actin assembly with Ena/VASP. Using shRNA targeted to zyxin, we analyzed the roles of zyxin at adhesive contacts. In zyxin-deficient cells, the actin assembly at both focal adhesion and cell-cell adhesion was limited, but their migration rate was unchanged. Cell spreading on E-cadherin-coated surfaces and the formation of cell clusters were slower for zyxin-deficient cells than wild type cells. By ablating a single cell within a cell monolayer, we quantified the rate of wound closure driven by a contractile circumferential actin ring. Zyxin-deficient cells failed to recruit VASP to cell-cell junctions at the wound edge and had a slower wound closure rate than wild type cells. Our results suggest that, by recruiting VASP, zyxin regulates actin assembly at the sites of force-bearing cell-cell adhesion.	[Nguyen, Thuc Nghi; Uemura, Arisa; Shih, Wenting; Yamada, Soichiro] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Yamada, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	syamada@ucdavis.edu	Yamada, Soichiro/B-7360-2019	Yamada, Soichiro/0000-0001-6413-0814; Nguyen, Thuc Nghi/0000-0002-6466-5883	Beckman Young Investigator Award; Hellman Family New Faculty Award; University of California Cancer Research Coordinating Committee; Achievement Rewards for College Scientists Award; Training Program in Biomolecular Technology [T32-GM08799]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094798, T32GM008799] Funding Source: NIH RePORTER	Beckman Young Investigator Award; Hellman Family New Faculty Award; University of California Cancer Research Coordinating Committee(University of California System); Achievement Rewards for College Scientists Award; Training Program in Biomolecular Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Beckman Young Investigator Award (to S. Y.), a Hellman Family New Faculty Award (to S. Y.), and by the University of California Cancer Research Coordinating Committee (S. Y.), the Achievement Rewards for College Scientists Award (to T. N. N.), and Training Program in Biomolecular Technology Fellowship T32-GM08799 (to T. N. N.).	Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Castellano F, 2001, EMBO J, V20, P5603, DOI 10.1093/emboj/20.20.5603; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; CRAWFORD AW, 1991, J BIOL CHEM, V266, P5847; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Danjo Y, 1998, J CELL SCI, V111, P3323; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Lambert M, 2007, EXP CELL RES, V313, P4025, DOI 10.1016/j.yexcr.2007.07.035; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Pasic L, 2008, J BIOL CHEM, V283, P9814, DOI 10.1074/jbc.M710475200; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Reinhard M, 1996, FEBS LETT, V399, P103, DOI 10.1016/S0014-5793(96)01295-1; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018	39	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35439	35445		10.1074/jbc.M110.119487	http://dx.doi.org/10.1074/jbc.M110.119487			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20801875	Green Published, hybrid			2022-12-27	WOS:000283845300021
J	Pacchiana, G; Chiriaco, C; Stella, MC; Petronzelli, F; De Santis, R; Galluzzo, M; Carminati, P; Comoglio, PM; Michieli, P; Vigna, E				Pacchiana, Giovanni; Chiriaco, Cristina; Stella, Maria C.; Petronzelli, Fiorella; De Santis, Rita; Galluzzo, Maria; Carminati, Paolo; Comoglio, Paolo M.; Michieli, Paolo; Vigna, Elisa			Monovalency Unleashes the Full Therapeutic Potential of the DN-30 Anti-Met Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TYROSINE KINASE; INVASIVE GROWTH; LIVER-REGENERATION; ALBUMIN-BINDING; DOWN-REGULATION; FUSION PROTEIN; GENE-TRANSFER; IN-VIVO; C-MET	Met, the high affinity receptor for hepatocyte growth factor, is one of the most frequently activated tyrosine kinases in human cancer and a validated target for cancer therapy. We previously developed a mouse monoclonal antibody directed against the extracellular portion of Met (DN-30) that induces Met proteolytic cleavage (receptor "shedding") followed by proteasome-mediated receptor degradation. This translates into inhibition of hepatocyte growth factor/Met-mediated biological activities. However, DN-30 binding to Met also results in partial activation of the Met kinase due to antibody-mediated receptor homodimerization. To safely harness the therapeutic potential of DN-30, its shedding activity must be disassociated from its agonistic activity. Here we show that the DN-30 Fab fragment maintains high affinity Met binding, elicits efficient receptor shedding and down-regulation, and does not promote kinase activation. In Met-addicted tumor cell lines, DN-30 Fab displays potent cytostatic and cytotoxic activity in a dose-dependent fashion. DN-30 Fab also inhibits anchorage-independent growth of several tumor cell lines. In mouse tumorigenesis assays using Met-addicted carcinoma cells, intratumor administration of DN-30 Fab or systemic delivery of a chemically stabilized form of the same molecule results in reduction of Met phosphorylation and inhibition of tumor growth. These data provide proof of concept that monovalency unleashes the full therapeutic potential of the DN-30 antibody and point at DN-30 Fab as a promising tool for Met-targeted therapy.	[Comoglio, Paolo M.; Michieli, Paolo; Vigna, Elisa] Univ Turin, Lab Expt Therapy & Gene Transfer, Inst Canc Res & Treatment, Sch Med, I-10060 Turin, Italy; [Comoglio, Paolo M.; Michieli, Paolo; Vigna, Elisa] Univ Turin, Dept Oncol Sci, Sch Med, I-10060 Turin, Italy; [Petronzelli, Fiorella; De Santis, Rita] Sigma Tau SpA R&D, I-00040 Rome, Italy; [Carminati, Paolo] Metheresis Translat Res SA, CH-6900 Lugano, Switzerland	University of Turin; University of Turin	Vigna, E (corresponding author), Univ Turin, Lab Expt Therapy & Gene Transfer, Inst Canc Res & Treatment, Sch Med, SP 142,Km 3-95, I-10060 Turin, Italy.	e.vigna@ircc.it	Michieli, Paolo/A-2588-2011	Michieli, Paolo/0000-0002-3093-8871; Comoglio, Paolo/0000-0002-7056-5328; DE SANTIS, Rita/0000-0002-5037-0611; Vigna, Elisa/0000-0001-9787-5732	Italian Association for Cancer Research (AIRC); European Commission [FP7-HEALTH-2007-A, 201640]; Fondazione Piemontese per la Ricerca sul Cancro; Italian Ministry of University and Research	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Piemontese per la Ricerca sul Cancro; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Association for Cancer Research (AIRC), European Commission FP7-HEALTH-2007-A Grant 201640, the Fondazione Piemontese per la Ricerca sul Cancro, and the Italian Ministry of University and Research.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Bardelli C, 2005, BIOCHEM BIOPH RES CO, V334, P1172, DOI 10.1016/j.bbrc.2005.07.020; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chambers RS, 2005, CURR OPIN CHEM BIOL, V9, P46, DOI 10.1016/j.cbpa.2004.10.011; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; GIORDANO S, 1988, MOL CELL BIOL, V8, P3510, DOI 10.1128/MCB.8.8.3510; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Labrijn AF, 2008, CURR OPIN IMMUNOL, V20, P479, DOI 10.1016/j.coi.2008.05.010; LONGATI P, 1994, ONCOGENE, V9, P49; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488; Ohashi K, 2000, NAT MED, V6, P327; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Prat M, 1998, J CELL SCI, V111, P237; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vigna E, 2008, CANCER RES, V68, P9176, DOI 10.1158/0008-5472.CAN-08-1688; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8	31	67	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36149	36157		10.1074/jbc.M110.134031	http://dx.doi.org/10.1074/jbc.M110.134031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833723	hybrid, Green Published			2022-12-27	WOS:000283845300091
J	Levesque, N; Leung, GP; Fok, AK; Schmidt, TI; Kobor, MS				Levesque, Nancy; Leung, Grace P.; Fok, Alexandra K.; Schmidt, Thorsten I.; Kobor, Michael S.			Loss of H3 K79 Trimethylation Leads to Suppression of Rtt107-dependent DNA Damage Sensitivity through the Translesion Synthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK RESTART; SACCHAROMYCES-CEREVISIAE; HISTONE H3; CHROMATIN MODIFICATIONS; PHOSPHATASE COMPLEX; BUDDING YEAST; METHYLATION; CHECKPOINT; REPAIR; DOT1	Genomic integrity is maintained by the coordinated interaction of many DNA damage response pathways, including checkpoints, DNA repair processes, and cell cycle restart. In Saccharomyces cerevisiae, the BRCA1 C-terminal domain-containing protein Rtt107/Esc4 is required for restart of DNA replication after successful repair of DNA damage and for cellular resistance to DNA-damaging agents. Rtt107 and its interaction partner Slx4 are phosphorylated during the initial phase of DNA damage response by the checkpoint kinases Mec1 and Tel1. Because the natural chromatin template plays an important role during the DNA damage response, we tested whether chromatin modifications affected the requirement for Rtt107 and Slx4 during DNA damage repair. Here, we report that the sensitivity to DNA-damaging agents of rtt107 Delta and slx4 Delta mutants was rescued by inactivation of the chromatin regulatory pathway leading to H3 K79 trimethylation. Further analysis revealed that lack of Dot1, the H3 K79 methyltransferase, led to activation of the translesion synthesis pathway, thereby allowing the survival in the presence of DNA damage. The DNA damage-induced phosphorylation of Rtt107 and Slx4, which was mutually dependent, was not restored in the absence of Dot1. The antagonistic relationship between Rtt107 and Dot1 was specific for DNA damage-induced phenotypes, whereas the genomic instability caused by loss of Rtt107 was not rescued. These data revealed a multifaceted functional relationship between Rtt107 and Dot1 in the DNA damage response and maintenance of genome integrity.	[Levesque, Nancy; Leung, Grace P.; Fok, Alexandra K.; Schmidt, Thorsten I.; Kobor, Michael S.] Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia	Kobor, MS (corresponding author), Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	msk@cmmt.ubc.ca		Kobor, Michael/0000-0003-4140-1743	Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by a scholar award from the Michael Smith Foundation for Health Research.; Supported by a fellowship from the Canadian Institutes of Health Research.; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; AMBERG DC, 2005, METHODS YEAST GENETI, P155; Andrulis ED, 2004, GENETICS, V166, P631, DOI 10.1534/genetics.166.1.631; Bassal S, 2005, HUM MUTAT, V25, P101, DOI 10.1002/humu.20130; Bazzi M, 2010, MOL CELL BIOL, V30, P131, DOI 10.1128/MCB.01000-09; Biswas D, 2008, GENETICS, V178, P649, DOI 10.1534/genetics.107.084202; Chambers AL, 2007, BIOCHEM SOC T, V35, P1519, DOI 10.1042/BST0351519; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chaudhuri S, 2009, NUCLEIC ACIDS RES, V37, P1690, DOI 10.1093/nar/gkp003; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Conde F, 2008, GENETICS, V179, P1197, DOI 10.1534/genetics.108.089003; Conde F, 2009, GENETICS, V182, P437, DOI 10.1534/genetics.109.101899; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Foster ER, 2009, J CELL BIOL, V184, P631, DOI 10.1083/jcb.200812088; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Haase SB, 1997, METHOD ENZYMOL, V283, P322; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Karagiannis TC, 2007, LEUKEMIA, V21, P195, DOI 10.1038/sj.leu.2404478; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lee KY, 2008, MOL CELLS, V26, P5; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Scholes DT, 2001, GENETICS, V159, P1449; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singer MS, 1998, GENETICS, V150, P613; Szyjka SJ, 2008, GENE DEV, V22, P1906, DOI 10.1101/gad.1660408; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yang B, 2008, J MOL BIOL, V381, P826, DOI 10.1016/j.jmb.2008.06.059; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	63	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35113	35122		10.1074/jbc.M110.116855	http://dx.doi.org/10.1074/jbc.M110.116855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810656	Green Published, hybrid			2022-12-27	WOS:000283659100085
J	Mollinedo, F; Janssen, H; de la Iglesia-Vicente, J; Villa-Pulgarin, JA; Calafat, J				Mollinedo, Faustino; Janssen, Hans; de la Iglesia-Vicente, Janis; Villa-Pulgarin, Janny A.; Calafat, Jero			Selective Fusion of Azurophilic Granules with Leishmania-containing Phagosomes in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERTIARY GRANULES; POLYMORPHONUCLEAR LEUKOCYTES; ENDOPLASMIC-RETICULUM; CYTOCHROME-B; MEMBRANE; GELATINASE; DONOVANI; PHAGOCYTOSIS; INHIBITION; PROMASTIGOTES	Leishmania parasites use polymorphonuclear neutrophils as intermediate hosts before their ultimate delivery to macrophages following engulfment of parasite-infected neutrophils. This leads to a silent and unrecognized entry of Leishmania into the macrophage host cell. Neutrophil function depends on its cytoplasmic granules, but their mobilization and role in how Leishmania parasites evade intracellular killing in neutrophils remain undetermined. Here, we have found by ultrastructural approaches that neutrophils ingested Leishmania major promastigotes, and azurophilic granules fused in a preferential way with parasite-containing phagosomes, without promoting parasite killing. Azurophilic granules, identified by the granule marker myeloperoxidase, also fused with Leishmania donovani-engulfed vacuoles in human neutrophils. In addition, the azurophilic membrane marker CD63 was also detected in the vacuole surrounding the parasite, and in the fusion of azurophilic granules with the parasite-engulfed phagosome. Tertiary and specific granules, involved in vacuole acidification and superoxide anion generation, hardly fused with Leishmania-containing phagosomes. L. major interaction with neutrophils did not elicit production of reactive oxygen species or mobilization of tertiary and specific granules. By using immunogold electron microscopy approaches in the engulfment of L. major and L. donovani by human neutrophils, we did not find a significant contribution of endoplasmic reticulum to the formation of Leishmania-containing vacuoles. Live Leishmania parasites were required to be optimally internalized by neutrophils. Our data suggest that Leishmania promastigotes modulate their uptake by neutrophils, and regulate granule fusion processes in a rather selective way to favor parasite survival in human neutrophils.	CSIC Univ Salamanca, Inst Biol Mol & Celular Canc, Ctr Invest Canc, E-37007 Salamanca, Spain; [Janssen, Hans; Calafat, Jero] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Villa-Pulgarin, Janny A.] Univ Salamanca, APOINTECH, Ctr Hispano Luso Invest Agr CIALE, E-37185 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Netherlands Cancer Institute; University of Salamanca		fmollin@usal.es; j.calafat@nki.nl	IBSAL, Secretaría/H-3719-2011; Villa-Pulgarin, Janny A/AAW-4592-2020	Villa-Pulgarin, Janny A/0000-0002-9916-5977	Spanish Ministry of Science and Innovation [SAF2008-02251]; Junta de Castilla y Leon [CSI01A08]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III [RD06/0020/1037]; Fondo Europeo de Desarrollo Regional of the European Union	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional of the European Union	This work was supported by Spanish Ministry of Science and Innovation (Grant SAF2008-02251, and Grant RD06/0020/1037 from Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union), and Junta de Castilla y Leon (CSI01A08, GR15-Experimental Therapeutics and Translational Oncology Program, and Biomedicine Project 2009).	AL T, 1990, J MED MICROBIOL */*, V32, P189; BORREGAARD N, 1997, J B BLOOD */* BLOOD, V89, P3503; Calafat J, 1997, BLOOD, V90, P1255, DOI 10.1182/blood.V90.3.1255.1255_1255_1266; ELON J, 1990, PARASITE IMMUNOL, V12, P285, DOI 10.1111/j.1365-3024.1990.tb00955.x; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Gueirard P, 2008, CELL MICROBIOL, V10, P100, DOI 10.1111/j.1462-5822.2007.01018.x; Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777; KJELDSEN L, 1992, EUR J HAEMATOL, V49, P180; KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220; KLEBANOFF SJ, 1982, PHAGOCYTIC CELLS, P111; KUIJPERS TW, 1991, BLOOD, V78, P1105; LACAL P, 1988, BIOCHEM BIOPH RES CO, V154, P641, DOI 10.1016/0006-291X(88)90187-8; LACAL P, 1988, J BIOL CHEM, V263, P9946; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; LILES WC, 1995, J IMMUNOL, V155, P2175; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Lodge R, 2006, EUR J IMMUNOL, V36, P2735, DOI 10.1002/eji.200636089; Martin-Martin B, 2000, BLOOD, V96, P2574; Matsubara S, 1999, PLACENTA, V20, P185, DOI 10.1053/plac.1998.0366; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; MOLLINEDO F, 1984, J BIOL CHEM, V259, P7143; MOLLINEDO F, 1987, FEBS LETT, V217, P158, DOI 10.1016/0014-5793(87)80655-5; Mollinedo F, 2003, J IMMUNOL, V170, P1034, DOI 10.4049/jimmunol.170.2.1034; Mollinedo F, 1999, IMMUNOL TODAY, V20, P535, DOI 10.1016/S0167-5699(99)01500-5; MOLLINEDO F, 1992, J IMMUNOL, V149, P323; MOLLINEDO F, 1991, SCAND J IMMUNOL, V34, P33, DOI 10.1111/j.1365-3083.1991.tb01518.x; MOLLINEDO F, 1991, MOL CELL BIOCHEM, V105, P49; MOLLINEDO F, 1989, MOL PHARMACOL, V36, P547; Mollinedo F, 1997, BIOCHEM J, V327, P917, DOI 10.1042/bj3270917; Mollinedo F., 2003, IMMUNOLOGIA, V22, P340; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; MU L, 2001, MED MICROBIOL IMMUN, V190, P73; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; NICHOLS BA, 1984, J HISTOCHEM CYTOCHEM, V32, P165, DOI 10.1177/32.2.6319482; NOIVA R, 1992, J BIOL CHEM, V267, P3553; PEARSON RD, 1981, J IMMUNOL, V127, P1438; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Staali L, 2006, CELL MICROBIOL, V8, P690, DOI 10.1111/j.1462-5822.2005.00662.x; STYRT B, 1988, J MED MICROBIOL, V25, P101, DOI 10.1099/00222615-25-2-101; Tapper H, 1997, J IMMUNOL, V159, P409; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; ULSAMER AG, 1971, J CELL BIOL, V51, P193, DOI 10.1083/jcb.51.1.193; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Varela RE, 2009, EXP PARASITOL, V122, P134, DOI 10.1016/j.exppara.2009.02.012	47	48	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34528	34536		10.1074/jbc.M110.125302	http://dx.doi.org/10.1074/jbc.M110.125302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801889	Green Published, hybrid			2022-12-27	WOS:000283659100028
J	Mori, T; Ono, K; Kariya, Y; Ogawa, T; Higashi, S; Miyazaki, K				Mori, Taizo; Ono, Kota; Kariya, Yoshinobu; Ogawa, Takashi; Higashi, Shouichi; Miyazaki, Kaoru			Laminin-3B11, a Novel Vascular-type Laminin Capable of Inducing Prominent Lamellipodial Protrusions in Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-3B CHAIN; CELLULAR ADHESION; CARCINOMA CELLS; HUMAN TISSUES; EXPRESSION; MIGRATION; DOMAINS; CLONING; GROWTH; MORPHOGENESIS	The basement membrane (BM) proteins laminins, which consist of alpha, beta, and gamma chains, support tissue structures and cellular functions. To date only alpha 4 and alpha 5 types of laminins have been identified in the BMs of blood vessels. Our recent study suggested the presence of novel alpha 3B-containing laminins in vascular BMs. Here we identified and characterized the third member of vascular laminins, laminin-3B11 (Lm3B11). RT-PCR analysis showed that microvascular endothelial (MVE) cells and umbilical vein endothelial cells expressed the messages for the alpha 3B, beta 1, beta 2, and gamma 1 chains. In the culture of MVE cells, alpha 3B was associated with beta 1 and gamma 1, producing Lm3B11. Recombinant Lm3B11 was overexpressed by introducing the cDNAs of the three chains into HEK-293 cells and purified to homogeneity. Purified Lm3B11 exhibited relatively weak cell adhesion activity through both alpha 3 beta 1 and alpha 6 beta 1 integrins. Most characteristically, Lm3B11 strongly stimulated MVE cells to extend many lamellipodial protrusions. This pseudopodial branching was blocked by an inhibitor for Src or phosphatidylinositol 3-kinase. Consistently, Lm3B11 stimulated the phosphorylation of Src and Akt more strongly than other laminins, suggesting that the integrin-derived signaling is mediated by these factors. The unique activity of Lm3B11 appears to be favorable to the branching of capillaries and venules.	[Kariya, Yoshinobu; Ogawa, Takashi; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Mori, Taizo; Ono, Kota; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Integrated Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University; Yokohama City University	Miyazaki, K (corresponding author), Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	miyazaki@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [17014077]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas 17014077 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325; Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Doliana R, 1997, FEBS LETT, V417, P65, DOI 10.1016/S0014-5793(97)01251-9; Ferrigno O, 1997, J BIOL CHEM, V272, P20502, DOI 10.1074/jbc.272.33.20502; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010; GALLIANO MF, 1995, J BIOL CHEM, V270, P21820, DOI 10.1074/jbc.270.37.21820; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; Hirosaki T, 2002, J BIOL CHEM, V277, P49287, DOI 10.1074/jbc.M111096200; Jakobsson L, 2008, FASEB J, V22, P1530, DOI 10.1096/fj.07-9617com; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kariya Y, 2008, J MOL HISTOL, V39, P435, DOI 10.1007/s10735-008-9183-0; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Mizushima H, 1996, J BIOCHEM-TOKYO, V120, P1196; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Spessotto P, 2001, CANCER RES, V61, P339; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770	34	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35068	35078		10.1074/jbc.M110.146126	http://dx.doi.org/10.1074/jbc.M110.146126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805229	hybrid, Green Published			2022-12-27	WOS:000283659100081
J	Weisbart, RH; Chan, G; Heinze, E; Mory, R; Nishimura, RN; Colburn, K				Weisbart, Richard H.; Chan, Grace; Heinze, Emil; Mory, Rachel; Nishimura, Robert N.; Colburn, Keith			BRAF Drives Synovial Fibroblast Transformation in Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; SIGNALING PATHWAY; JOINT DESTRUCTION; MUTATIONS; CANCER; GENE; ACTIVATION; MECHANISM; MELANOMA	Synovial fibroblasts destroy articular cartilage and bone in rheumatoid arthritis, but the mechanism of fibroblast transformation remains elusive. Because gain-of-function mutations of BRAF can transform fibroblasts, we examined BRAF in rheumatoid synovial fibroblasts. The strong gain-of-function mutation, V600R, of BRAF found in melanomas and other cancers was identified in first passage synovial fibroblasts from two of nine rheumatoid arthritis patients and confirmed by restriction site mapping. BRAF-specific siRNA inhibited proliferation of synovial fibroblasts with V600R mutations. A BRAF aberrant splice variant with an intact kinase domain and partial loss of the N-terminal autoinhibitory domain was identified in fibroblasts from an additional patient, and fibroblast proliferation was inhibited by BRAF-specific siRNA. Our finding is the first to establish mechanisms for fibroblast transformation responsible for destruction of articular cartilage and bone in rheumatoid arthritis and establishes a new target for therapeutic intervention.	[Weisbart, Richard H.; Chan, Grace] Vet Affairs Greater Los Angeles Hlth Care Syst, Dept Res, Sepulveda, CA 91343 USA; [Heinze, Emil; Mory, Rachel] Olive View UCLA Med Ctr, Dept Med, Sylmar, CA 91342 USA; [Nishimura, Robert N.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Colburn, Keith] Vet Affairs Med Ctr, Dept Med, Loma Linda, CA 92357 USA; [Colburn, Keith] Loma Linda Univ, Dept Med, Loma Linda, CA 92354 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Loma Linda University	Weisbart, RH (corresponding author), 16111 Plummer St, North Hills, CA 91343 USA.	rweisbar@ucla.edu						Auger I, 2009, ANN RHEUM DIS, V68, P591, DOI 10.1136/ard.2008.096917; Baitei EY, 2009, J PATHOL, V217, P707, DOI 10.1002/path.2496; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fensterle J, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-62; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Inazuka M, 2000, RHEUMATOLOGY, V39, P262, DOI 10.1093/rheumatology/39.3.262; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Karouzakis E, 2006, IMMUNOL LETT, V106, P8, DOI 10.1016/j.imlet.2006.04.011; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Li J, 2009, BIOCHEM SOC T, V37, P427, DOI 10.1042/BST0370427; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; MU L, 1996, Am J Pathol */* S AM, V149, P1607; MU L, 2005, Nat Clin Pract Rheum, V1, P102; Pap T, 2005, ANN RHEUM DIS, V64, P52, DOI 10.1136/ard.2005.042424; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Seth R, 2009, GUT, V58, P1234, DOI 10.1136/gut.2008.159137; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yamanishi Y, 2005, ARTHRITIS RES THER, V7, pR12, DOI 10.1186/ar1448; Yu H, 2009, AM J PATHOL, V174, P2367, DOI 10.2353/ajpath.2009.081057	22	13	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34299	34303		10.1074/jbc.C110.168195	http://dx.doi.org/10.1074/jbc.C110.168195			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20843808	Green Published, hybrid			2022-12-27	WOS:000283659100002
J	Ponugoti, B; Kim, DH; Xiao, Z; Smith, Z; Miao, J; Zang, MW; Wu, SY; Chiang, CM; Veenstra, TD; Kemper, JK				Ponugoti, Bhaskar; Kim, Dong-Hyun; Xiao, Zhen; Smith, Zachary; Miao, Ji; Zang, Mengwei; Wu, Shwu-Yuan; Chiang, Cheng-Ming; Veenstra, Timothy D.; Kemper, Jongsook Kim			SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; GAMMA COACTIVATOR 1-ALPHA; TRANSCRIPTIONAL COACTIVATOR; INSULIN REGULATION; GENE ACTIVATION; ACETYLATION; COMPLEX; PGC-1-ALPHA; EXPRESSION; GLUCOSE	The SIRT1 deacetylase inhibits fat synthesis and stimulates fat oxidation in response to fasting, but the underlying mechanisms remain unclear. Here we report that SREBP-1c, a key lipogenic activator, is an in vivo target of SIRT1. SIRT1 interaction with SREBP-1c was increased during fasting and decreased upon feeding, and consistently, SREBP-1c acetylation levels were decreased during fasting in mouse liver. Acetylated SREBP-1c levels were also increased in HepG2 cells treated with insulin and glucose to mimic feeding conditions, and down-regulation of p300 by siRNA decreased the acetylation. Depletion of hepatic SIRT1 by adenoviral siRNA increased acetylation of SREBP-1c with increased lipogenic gene expression. Tandem mass spectrometry and mutagenesis studies revealed that SREBP-1c is acetylated by p300 at Lys-289 and Lys-309. Mechanistic studies using acetylation-defective mutants showed that SIRT1 deacetylates and inhibits SREBP-1c transactivation by decreasing its stability and its occupancy at the lipogenic genes. Remarkably, SREBP-1c acetylation levels were elevated in diet-induced obese mice, and hepatic overexpression of SIRT1 or treatment with resveratrol, a SIRT1 activator, daily for 1 week decreased acetylated SREBP-1c levels with beneficial functional outcomes. These results demonstrate an intriguing connection between elevated SREBP-1c acetylation and increased lipogenic gene expression, suggesting that abnormally elevated SREBP-1c acetylation increases SREBP-1c lipogenic activity in obese mice. Reducing acetylation of SREBP-1c by targeting SIRT1 may be useful for treating metabolic disorders, including fatty liver, obesity, and type II diabetes.	[Ponugoti, Bhaskar; Kim, Dong-Hyun; Smith, Zachary; Miao, Ji; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiao, Zhen; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc,NIH, Frederick, MD 21702 USA; [Zang, Mengwei] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Biochem, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kemper, JK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	jongsook@uiuc.edu	Miao, Ji/F-9398-2015; Sanguansri, Luz/B-6630-2011; PONUGOTI, BHASKAR/H-2230-2011	Miao, Ji/0000-0003-0869-4492; Sanguansri, Luz/0000-0003-1908-7604; Zang, Mengwei/0000-0002-2502-2586	National Institutes of Health [CA103867, CA124760, DK062777, DK80032]; NCI [N01-CO-12400]; American Diabetes Association; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080032, R56DK062777, R01DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760 (to C.-M. C.), DK062777, and DK80032 (to J. K. K.) and National Institutes of Health, NCI, Contract N01-CO-12400 (to T. D. V.). This work was also supported by an American Diabetes Association basic research award (to J. K. K.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fang S, 2008, J BIOL CHEM, V283, P35086, DOI 10.1074/jbc.M803531200; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Im SS, 2009, MOL CELL BIOL, V29, P4864, DOI 10.1128/MCB.00553-09; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Sinclair DA, 2006, SCIENCE, V312, P195; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007	45	367	388	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33959	33970		10.1074/jbc.M110.122978	http://dx.doi.org/10.1074/jbc.M110.122978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20817729	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000283354000043
J	Zhang, CY; Booth, JW				Zhang, Christine Y.; Booth, James W.			Divergent Intracellular Sorting of Fc gamma RIIA and Fc gamma RIIB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; ANTIGEN PRESENTATION; DENDRITIC CELLS; IN-VIVO; IMMUNE-COMPLEXES; LIPID RAFTS; MDCK CELLS; B-CELLS; IGG; UBIQUITINATION	The human low affinity Fc gamma RII family includes both the activating receptor Fc gamma RIIA and the inhibitory receptor Fc gamma RIIB2. These receptors have opposing signaling functions but are both capable of internalizing IgG-containing immune complexes through clathrin-mediated endocytosis. We demonstrate that upon engagement by multivalent aggregated human IgG, Fc gamma RIIA expressed in ts20 Chinese hamster fibroblasts is delivered along with its ligand to lysosomal compartments for degradation, while Fc gamma RIIB2 dissociates from the ligand and is routed separately into the recycling pathway. Fc gamma RIIA sorting to lysosomes requires receptor multimerization, but does not require either Src family kinase activity or ubiquitylation of receptor lysine residues. The sorting of Fc gamma RIIB2 away from a degradative fate is not due to its lower affinity for IgG and occurs even upon persistent receptor aggregation. Upon co-engagement of Fc gamma RIIA and Fc gamma RIIB2, the receptors are sorted independently to distinct final fates after dissociation of co-clustering ligand. These results reveal fundamental differences in the trafficking behavior of different Fc gamma receptors.	[Zhang, Christine Y.; Booth, James W.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Zhang, Christine Y.; Booth, James W.] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Booth, JW (corresponding author), Univ Toronto, Dept Immunol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	james.booth@utoronto.ca			Canadian Institutes of Health Research [MOP66961, MOP84475]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants MOP66961 and MOP84475 from the Canadian Institutes of Health Research.	AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; Antoniou AN, 2002, EUR J IMMUNOL, V32, P530, DOI 10.1002/1521-4141(200202)32:2<530::AID-IMMU530>3.0.CO;2-X; Bazin R, 2004, BRIT J HAEMATOL, V127, P90, DOI 10.1111/j.1365-2141.2004.05105.x; Beekman JM, 2004, P NATL ACAD SCI USA, V101, P10392, DOI 10.1073/pnas.0401217101; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUDDE P, 1994, EUR J CELL BIOL, V64, P45; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dai XL, 2009, BLOOD, V114, P318, DOI 10.1182/blood-2008-10-184457; de Jong JMH, 2006, MOL IMMUNOL, V43, P2045, DOI 10.1016/j.molimm.2006.01.002; Desai DD, 2007, J IMMUNOL, V178, P6217, DOI 10.4049/jimmunol.178.10.6217; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; HARRISON PT, 1994, J BIOL CHEM, V269, P24396; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Marois L, 2009, J IMMUNOL, V182, P2374, DOI 10.4049/jimmunol.0801420; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Sardjono CT, 2003, IMMUNOL CELL BIOL, V81, P374, DOI 10.1046/j.1440-1711.2003.01182.x; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Syam S, 2010, J IMMUNOL, V184, P2966, DOI 10.4049/jimmunol.0900016; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; VANDENHERIKOUDIJK IE, 1994, J IMMUNOL, V152, P574; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Yada A, 2003, CELL IMMUNOL, V225, P21, DOI 10.1016/j.cellimm.2003.09.008	39	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34250	34258		10.1074/jbc.M110.143834	http://dx.doi.org/10.1074/jbc.M110.143834			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736173	Green Published, hybrid			2022-12-27	WOS:000283354000070
J	Zhang, SJ; Wang, JL; Wang, QA; Toyoda, T				Zhang, Shijian; Wang, Jinlan; Wang, Qiang; Toyoda, Tetsuya			Internal Initiation of Influenza Virus Replication of Viral RNA and Complementary RNA in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO INITIATION; MESSENGER-RNA; A-VIRUS; NUCLEOCAPSID PROTEIN; ABORTIVE INITIATION; VIRION RNA; 5' END; POLYMERASE; TRANSCRIPTION; IDENTIFICATION	Influenza virus transcription is a prototype of primer-dependent initiation. Its replication mechanism is thought to be primer-independent. The internal initiation and realignment model for influenza virus genome replication has been recently proposed (Deng, T., Vreede, F. T., and Brownlee, G. G. (2006) J. Virol. 80, 2337-2348). We obtained new results, which led us to propose a novel model for the initiation of viral RNA (vRNA) replication. In our study, we analyzed the initiation mechanisms of influenza virus vRNA and complementary RNA (cRNA) synthesis in vitro, using purified RNA polymerase (RdRp) and 84-nt model RNA templates. We found that, for vRNA -> cRNA ->, RdRp initiated replication from the second nucleotide of the 3'-end. Therefore, host RNA-specific ribonucleotidyltransferases are required to add one nucleotide (purine residues are preferred) to the 3'-end of vRNA to make the complete copy of vRNA. This hypothesis was experimentally proven using poly(A) polymerase. For cRNA -> vRNA, the dinucleotide primer AG was synthesized from UC (fourth and fifth from the 3'-end) by RdRp pausing at the sixth U of UUU and realigning at the 3'-end of cRNA template; then RdRp was able to read through the entire template RNA. The RdRp initiation complex was not stable until it had read through the UUU of cRNA and the UUUU of vRNA at their respective 3'-ends. This was because primers overlapping with the first U of the clusters did not initiate transcription efficiently, and the initiation product of v84+G (the v84 template with an extra G at its 3'-end), AGC, realigned to the 3'-end.	[Zhang, Shijian; Wang, Jinlan; Wang, Qiang; Toyoda, Tetsuya] Chinese Acad Sci, Unit Viral Genome Regulat, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Toyoda, T (corresponding author), Chinese Acad Sci, Unit Viral Genome Regulat, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, 411 Hefei Rd, Shanghai 200025, Peoples R China.	toyoda_tetsuya@yahoo.co.jp	Zhang, Shijian/P-9353-2015; WANG, QIANG/P-4519-2017	Zhang, Shijian/0000-0002-2017-6754; WANG, QIANG/0000-0002-6141-0068	Chinese Academy of Sciences [0514P51131]; National Science Foundation of China [30670090]; Li Ka Shing Foundation [0682P11131]; RESPARI [0581P14131]; FLUINNATE [SP5B-CT-2006-044161]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Foundation; RESPARI; FLUINNATE(European CommissionEuropean Commission Joint Research Centre)	This work was supported Chinese Academy of Sciences Grant 0514P51131, National Science Foundation of China Grant 30670090, Li Ka Shing Foundation Grant 0682P11131, RESPARI Grant 0581P14131, and FLUINNATE Grant SP5B-CT-2006-044161.	BALL LA, 2007, FIELDS VIROLOGY, P119; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; BEATON AR, 1981, NUCLEIC ACIDS RES, V9, P4423, DOI 10.1093/nar/9.17.4423; BEATON AR, 1986, P NATL ACAD SCI USA, V83, P6282, DOI 10.1073/pnas.83.17.6282; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; GARCIN D, 1992, J VIROL, V66, P1370, DOI 10.1128/JVI.66.3.1370-1376.1992; Honda A, 1998, VIRUS RES, V55, P199, DOI 10.1016/S0168-1702(98)00048-3; HONDA A, 1990, J BIOCHEM-TOKYO, V107, P624, DOI 10.1093/oxfordjournals.jbchem.a123097; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Honda A, 2001, J BIOL CHEM, V276, P31179, DOI 10.1074/jbc.M102856200; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; ISHIHAMA A, 1988, CRC CR REV BIOCH MOL, V23, P27, DOI 10.3109/10409238809103119; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; KAWAKAMI K, 1981, J BIOCHEM-TOKYO, V89, P1751, DOI 10.1093/oxfordjournals.jbchem.a133374; Kobayashi M, 1996, ARCH VIROL, V141, P525, DOI 10.1007/BF01718315; KRUG RM, 1983, GENETICS INFLUENZA V, P70; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; LING ML, 1989, NUCLEIC ACIDS RES, V17, P1605, DOI 10.1093/nar/17.4.1605; LUO GX, 1991, J VIROL, V65, P2861, DOI 10.1128/JVI.65.6.2861-2867.1991; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; MORONEY SE, 1991, BIOCHEMISTRY-US, V30, P10343, DOI 10.1021/bi00106a036; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Palese P., 2007, FIELDS VIROLOGY, P1647; PARVIN JD, 1989, J VIROL, V63, P5142, DOI 10.1128/JVI.63.12.5142-5152.1989; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; PLOTCH SJ, 1977, J VIROL, V21, P24, DOI 10.1128/JVI.21.1.24-34.1977; PLOTCH SJ, 1978, J VIROL, V25, P579, DOI 10.1128/JVI.25.2.579-586.1978; Poon LLM, 1998, J VIROL, V72, P8214, DOI 10.1128/JVI.72.10.8214-8219.1998; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; ROBERTSON HD, 1980, NUCLEIC ACIDS RES, V8, P925, DOI 10.1093/nar/8.5.925; Toyoda T, 2003, ARCH VIROL, V148, P1687, DOI 10.1007/s00705-003-0140-7; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; YAMANAKA K, 1991, P NATL ACAD SCI USA, V88, P5369, DOI 10.1073/pnas.88.12.5369; Yang Y, 2004, J BIOL CHEM, V279, P12659, DOI 10.1074/jbc.M312992200; Zhang SJ, 2010, BIOCHEM BIOPH RES CO, V391, P570, DOI 10.1016/j.bbrc.2009.11.100	40	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41194	41201		10.1074/jbc.M110.130062	http://dx.doi.org/10.1074/jbc.M110.130062			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20858902	hybrid, Green Published			2022-12-27	WOS:000285414400081
J	Morisaki, N; Moriwaki, S; Sugiyama-Nakagiri, Y; Haketa, K; Takema, Y; Imokawa, G				Morisaki, Naoko; Moriwaki, Shigeru; Sugiyama-Nakagiri, Yoriko; Haketa, Keiichi; Takema, Yoshinori; Imokawa, Genji			Neprilysin Is Identical to Skin Fibroblast Elastase ITS ROLE IN SKIN AGING AND UV RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL ENDOPEPTIDASE; NEUROGENIC INFLAMMATION; VISCOELASTIC PROPERTIES; ELASTOLYTIC ACTIVITY; ENKEPHALINASE; IRRADIATION; MODULATION; INHIBITION; EXPRESSION; CYTOKINES	Although human skin fibroblast (HSF) elastase has been characterized as a membrane-bound metalloproteinase, little is known about its structure, amino acid sequence, and encoding gene. As there are similarities in the molecular weights and inhibitory profiles of HSF elastase and neprilysin (neutral endopeptidase 24.11 (NEP)), in this study we tested the hypothesis that they are identical using immunoprecipitation and transfection methods. An immunoprecipitation study demonstrated that HSF elastase activity co-immunoprecipitated with anti-NEP in lysates of cultured HSF. Transfection of an NEP cDNA expression vector into COS-1 cells elicited the expression of HSF elastase and NEP activities in the transfected cells. These findings strongly suggest that HSF elastase is identical to NEP, which functions mainly in neuron-associated cells to degrade neuropeptides. Analysis of the expression pattern of NEP revealed that its expression was remarkably up-regulated at the gene, protein, and enzymatic activity levels during the replicative senescence of cultured HSF. Further, the activity of NEP was markedly enhanced in a pattern similar to elastase activity during the intrinsic aging of mouse skin, in UVA-exposed HSF as well as in HSF treated with conditioned medium from UVB-exposed human keratinocytes. Analysis of the cytokine profile for the stimulation of NEP and HSF elastase activities in HSF demonstrated that among the 11 cytokines tested, IL-1 alpha, IL-1 beta, IL-6, IL-8, and GM-CSF had the potential to significantly stimulate both activities similarly, again supporting the identity of HSF elastase and NEP.	[Imokawa, Genji] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo 1920982, Japan; [Morisaki, Naoko; Moriwaki, Shigeru; Sugiyama-Nakagiri, Yoriko; Haketa, Keiichi; Takema, Yoshinori] Kao Biol Sci Labs, Haga, Tochigi 3213497, Japan	Tokyo University of Technology	Imokawa, G (corresponding author), Tokyo Univ Technol, Sch Biosci & Biotechnol, 1404-1 Katakura, Tokyo 1920982, Japan.	imokawag@dream.ocn.ne.jp						AGUAYO SM, 1994, AM J RESP CELL MOL, V10, P635, DOI 10.1165/ajrcmb.10.6.8003340; BERANGER JY, 1994, CELL BIOL INT, V18, P715, DOI 10.1006/cbir.1994.1100; BOLOGNIA JL, 1995, AM J MED, V98, pS99, DOI 10.1016/S0002-9343(99)80066-7; BOUDIER C, 1991, AM J RESP CELL MOL, V4, P497, DOI 10.1165/ajrcmb/4.6.497; CAMPBELL EJ, 1988, J CELL BIOL, V106, P667, DOI 10.1083/jcb.106.3.667; CASEY ML, 1991, J BIOL CHEM, V266, P23041; Cohen AJ, 1996, CANCER RES, V56, P831; CONSTAM DB, 1995, J BIOL CHEM, V270, P26930; DELOMBAERT S, 1994, J MED CHEM, V37, P498, DOI 10.1021/jm00030a009; GODEAU G, 1988, PATHOL BIOL, V36, P1133; Graf K, 1998, BASIC RES CARDIOL, V93, P11, DOI 10.1007/s003950050056; Habig J, 1996, HAUTARZT, V47, P515, DOI 10.1007/s001050050462; HOMSY R, 1988, J INVEST DERMATOL, V91, P472, DOI 10.1111/1523-1747.ep12476608; KAO RC, 1988, J CLIN INVEST, V82, P1963, DOI 10.1172/JCI113816; KERR MA, 1974, BIOCHEM J, V137, P477, DOI 10.1042/bj1370477; Kletsas D, 1998, MECH AGEING DEV, V102, P15, DOI 10.1016/S0047-6374(98)00003-7; KONDEPUDI A, 1993, AM J RESP CELL MOL, V8, P43, DOI 10.1165/ajrcmb/8.1.43; Kramer HH, 2005, EXP NEUROL, V195, P179, DOI 10.1016/j.expneurol.2005.04.015; LABATROBERT J, 1992, ANN NY ACAD SCI, V673, P16, DOI 10.1111/j.1749-6632.1992.tb27431.x; LEARN DB, 1991, PHOTODERMATOL PHOTO, V8, P195; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; LORKOWSKI G, 1987, BIOCHEM J, V248, P345, DOI 10.1042/bj2480345; Mari B, 1997, FASEB J, V11, P869, DOI 10.1096/fasebj.11.11.9285485; MCKENZIE RC, 1994, PHOTODERMATOL PHOTO, V10, P74; Misery L, 1996, PATHOL BIOL, V44, P867; NADEL JA, 1991, EUR RESPIR J, V4, P745; Nakagawa K, 1987, SKIN RES, V29, P793; NOZAKI S, 1991, J INVEST DERMATOL, V97, P10, DOI 10.1111/1523-1747.ep12477727; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Oka T, 1993, Nihon Yakurigaku Zasshi, V101, P197; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Saria A, 1997, NEUROSCI LETT, V234, P27, DOI 10.1016/S0304-3940(97)00660-5; SCHWARTZ E, 1988, CLIN CHIM ACTA, V176, P219, DOI 10.1016/0009-8981(88)90211-2; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; Shipley JM, 1996, J BIOL CHEM, V271, P4335; Solan NJ, 1998, INFLAMMATION, V22, P107, DOI 10.1023/A:1022304025789; Solmi R, 1996, MECH AGEING DEV, V92, P31, DOI 10.1016/S0047-6374(96)01800-3; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; STEFANO GB, 1992, J NEUROIMMUNOL, V41, P9, DOI 10.1016/0165-5728(92)90189-R; SUDA H, 1973, J ANTIBIOT, V26, P621, DOI 10.7164/antibiotics.26.621; TAKEMA Y, 1994, BRIT J DERMATOL, V131, P641, DOI 10.1111/j.1365-2133.1994.tb04975.x; Takema Y, 1998, DERMATOLOGY, V196, P397, DOI 10.1159/000017931; Toyoda M, 2005, BRIT J DERMATOL, V153, P13, DOI 10.1111/j.1365-2133.2005.06965.x; Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2; VIJAYARAGHAVAN J, 1990, J BIOL CHEM, V265, P14150	47	41	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39819	39827		10.1074/jbc.M110.161547	http://dx.doi.org/10.1074/jbc.M110.161547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20876573	Green Published, hybrid			2022-12-27	WOS:000285185500026
J	Buosi, V; Placial, JP; Leroy, JL; Cherfils, J; Guittet, E; van Heijenoort, C				Buosi, Vanessa; Placial, Jean-Pierre; Leroy, Jean-Louis; Cherfils, Jacqueline; Guittet, Eric; van Heijenoort, Carine			Insight into the Role of Dynamics in the Conformational Switch of the Small GTP-binding Protein Arf1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; TIME-SCALE DYNAMICS; BACKBONE DYNAMICS; SEQUENCE HOMOLOGY; RELAXATION; ACTIVATION; MECHANISM; N-15; GDP; MILLISECOND	Activation of the small GTP-binding protein Arf1, a major regulator of cellular traffic, follows an ordered sequence of structural events, which have been pictured by crystallographic snapshots. Combined with biochemical analysis, these data lead to a model of Arf1 activation, in which opening of its N-terminal helix first translocates Arf1-GDP to membranes, where it is then secured by a register shift of the interswitch beta-strands, before GDP is eventually exchanged for GTP. However, how Arf1 rearranges its central beta-sheet, an event that involves the loss and re-formation of H-bonds deep within the protein core, is not explained by available structural data. Here, we used Delta 17Arf1, in which the N-terminal helix has been deleted, to address this issue by NMR structural and dynamics analysis. We first completed the assignment of Delta 17Arf1 bound to GDP, GTP, and GTP gamma S and established that NMR data are fully consistent with the crystal structures of Arf1-GDP and Delta 17Arf1-GTP. Our assignments allowed us to analyze the kinetics of both protein conformational transitions and nucleotide exchange by real-time NMR. Analysis of the dynamics over a very large range of timescale by N-15 relaxation, CPMG relaxation dispersion and H/D exchange reveals that while Delta 17Arf1-GTP and full-length Arf1-GDP dynamics is restricted to localized fast motions, Delta 17Arf1-GDP features unique intermediate and slow motions in the interswitch region. Altogether, the NMR data bring insight into how that membrane-bound Arf1-GDP, which is mimicked by the truncation of the N-terminal helix, acquires internal motions that enable the toggle of the interswitch.	[van Heijenoort, Carine] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Cherfils, Jacqueline] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cherfils, J (corresponding author), CNRS, LEBS, Ctr Rech Gif, Lab Chim & Biol Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	jacqueline.cherfils@lebs.cnrs-gif.fr; eric.guittet@icsn.cnrs-gif.fr; carine@icsn.cnrs-gif.fr	van Heijenoort, Carine/AAX-1041-2021; VAN HEIJENOORT, Carine/N-1986-2016	van Heijenoort, Carine/0000-0002-2839-1037; VAN HEIJENOORT, Carine/0000-0002-2839-1037; Guittet, Eric/0000-0002-8368-6719	Association pour la Recherche contre le Cancer; CNRS; Ministere de la Recherche; Institut de Chimie des Substances Naturelles; TGE RMN THC [FR3050]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Institut de Chimie des Substances Naturelles; TGE RMN THC	This work was supported by grants from the Association pour la Recherche contre le Cancer (to V.B. and J.C.) by the CNRS, the Ministere de la Recherche, and the Institut de Chimie des Substances Naturelles (to V.B., E.G., and C.v.H.). This work was also supported by TGE RMN THC FR3050.	Adams PD, 2004, BIOCHEMISTRY-US, V43, P9968, DOI 10.1021/bi0490901; Amor JC, 2002, J BIOMOL NMR, V23, P253, DOI 10.1023/A:1019839607202; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bruschweiler S, 2009, J AM CHEM SOC, V131, P3063, DOI 10.1021/ja809947w; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Gruschus JM, 2009, STRUCTURE, V17, P2, DOI 10.1016/j.str.2008.12.002; Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Loh AP, 1999, BIOCHEMISTRY-US, V38, P12547, DOI 10.1021/bi9913707; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Marshall CB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000029; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pasqualato S., 2003, GDP GTP CYCLE ARF PR; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Seidel RD, 2004, J BIOL CHEM, V279, P48307, DOI 10.1074/jbc.M402109200; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; van Tilborg PJA, 1999, BIOCHEMISTRY-US, V38, P1951, DOI 10.1021/bi982526q; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104	36	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37987	37994		10.1074/jbc.M110.134445	http://dx.doi.org/10.1074/jbc.M110.134445			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861011	hybrid, Green Published			2022-12-27	WOS:000284625600006
J	Keinath, NF; Kierszniowska, S; Lorek, J; Bourdais, G; Kessler, SA; Shimosato-Asano, H; Grossniklaus, U; Schulze, WX; Robatzek, S; Panstruga, R				Keinath, Nana F.; Kierszniowska, Sylwia; Lorek, Justine; Bourdais, Gildas; Kessler, Sharon A.; Shimosato-Asano, Hiroko; Grossniklaus, Ueli; Schulze, Waltraud X.; Robatzek, Silke; Panstruga, Ralph			PAMP (Pathogen-associated Molecular Pattern)-induced Changes in Plasma Membrane Compartmentalization Reveal Novel Components of Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS REVEALS; ARABIDOPSIS-THALIANA; QUANTITATIVE PROTEOMICS; SIGNAL-TRANSDUCTION; DISEASE RESISTANCE; CALLOSE SYNTHASE; INNATE IMMUNITY; PROTON PUMPS	Plasma membrane compartmentalization spatiotemporally regulates cell-autonomous immune signaling in animal cells. To elucidate immediate early protein dynamics at the plant plasma membrane in response to the bacterial pathogen-associated molecular pattern (PAMP) flagellin (flg22) we employed quantitative mass spectrometric analysis on detergent-resistant membranes (DRMs) of Arabidopsis thaliana suspension cells. This approach revealed rapid and profound changes in DRM protein composition following PAMP treatment, prominently affecting proton ATPases and receptor-like kinases, including the flagellin receptor FLS2. We employed reverse genetics to address a potential contribution of a subset of these proteins in flg22-triggered cellular responses. Mutants of three candidates (DET3, AHA1, FER) exhibited a conspicuous defect in the PAMP-triggered accumulation of reactive oxygen species. In addition, these mutants showed altered mitogen-activated protein kinase (MAPK) activation, a defect in PAMP-triggered stomatal closure as well as altered bacterial infection phenotypes, which revealed three novel players in elicitor-dependent oxidative burst control and innate immunity. Our data provide evidence for dynamic elicitor-induced changes in the membrane compartmentalization of PAMP signaling components.	[Keinath, Nana F.; Lorek, Justine; Robatzek, Silke; Panstruga, Ralph] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Kierszniowska, Sylwia; Schulze, Waltraud X.] Max Planck Inst Mol Plant Physiol, D-14476 Golm, Germany; [Bourdais, Gildas] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Kessler, Sharon A.; Shimosato-Asano, Hiroko; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Kessler, Sharon A.; Shimosato-Asano, Hiroko; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	Max Planck Society; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Zurich; University of Zurich	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	panstrug@mpiz-koeln.mpg.de	Robatzek, Silke/B-6844-2013; Kessler, Sharon A/T-4784-2017; Grossniklaus, Ueli/E-9995-2016; Schulze, Waltraud X/E-9800-2011; Grossniklaus, Ueli/A-2736-2012; Panstruga, Ralph/F-3340-2011	Kessler, Sharon A/0000-0002-7964-0451; Grossniklaus, Ueli/0000-0002-0522-8974; Schulze, Waltraud X/0000-0001-9957-7245; Panstruga, Ralph/0000-0002-3756-8957; Bourdais, Gildas/0000-0001-9409-1107; Kierszniowska, Sylwia/0000-0002-4736-9222	Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [SFB670]; University of Zurich; Swiss National Science Foundation; Emmy Noether-Programm (DFG); International Max Planck Research School (IMPRS); Forschungskredit der Universitat Zurich	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Emmy Noether-Programm (DFG)(German Research Foundation (DFG)); International Max Planck Research School (IMPRS); Forschungskredit der Universitat Zurich	This work was supported in part by grants from the Max Planck Society and the Deutsche Forschungsgemeinschaft (DFG; SFB670) (to R. P. and S. R.). This work was also supported by the University of Zurich and the Swiss National Science Foundation (to U. G.) and the Emmy Noether-Programm (DFG, to W. X. S.).; Supported by an International Max Planck Research School (IMPRS) fellowship. Present address: Heidelberg Institute for Plant Sciences (HIP), Universitat Heidelberg, Im Neuenheimer Feld 230, 69120 Heidelberg, Germany.; Supported by the Forschungskredit der Universitat Zurich. Present address: Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0192, Japan.; Supported by DFG and SFB670. Present address: The Sainsbury Laboratory, Norwich Research Park, Norwich NR4 7UH, UK.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Engelsberger WR, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-14; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kierszniowska S, 2009, PROTEOMICS, V9, P1916, DOI 10.1002/pmic.200800443; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000139; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Marmagne A, 2004, MOL CELL PROTEOMICS, V3, P675, DOI 10.1074/mcp.M400001-MCP200; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; Minami A, 2009, PLANT CELL PHYSIOL, V50, P341, DOI 10.1093/pcp/pcn202; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nelson CJ, 2006, MOL CELL PROTEOMICS, V5, P1382, DOI 10.1074/mcp.M500414-MCP200; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Schumacher K, 2006, CURR OPIN PLANT BIOL, V9, P595, DOI 10.1016/j.pbi.2006.09.001; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Stanislas T, 2009, MOL CELL PROTEOMICS, V8, P2186, DOI 10.1074/mcp.M900090-MCP200; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Varet A, 2002, MOL PLANT MICROBE IN, V15, P608, DOI 10.1094/MPMI.2002.15.6.608; Zappel NF, 2008, CURR OPIN PLANT BIOL, V11, P632, DOI 10.1016/j.pbi.2008.07.002; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	49	219	228	1	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39140	39149		10.1074/jbc.M110.160531	http://dx.doi.org/10.1074/jbc.M110.160531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20843791	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000284941300044
J	Nakamaru-Ogiso, E; Kao, MC; Chen, H; Sinha, SC; Yagi, T; Ohnishi, T				Nakamaru-Ogiso, Eiko; Kao, Mou-Chieh; Chen, Han; Sinha, Subhash C.; Yagi, Takao; Ohnishi, Tomoko			The Membrane Subunit NuoL(ND5) Is Involved in the Indirect Proton Pumping Mechanism of Escherichia coli Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; CONSERVED CHARGED RESIDUES; UBIQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; BINDING-SITE; PHOTOAFFINITY ANALOG; CRYSTAL-STRUCTURE; DOMAIN; IDENTIFICATION; INHIBITOR	Complex I pumps protons across the membrane by using downhill redox energy. Here, to investigate the proton pumping mechanism by complex I, we focused on the largest transmembrane subunit NuoL (Escherichia coli ND5 homolog). NuoL/ND5 is believed to have H+ translocation site(s), because of a high sequence similarity to multi-subunit Na+/H+ antiporters. We mutated thirteen highly conserved residues between NuoL/ND5 and MrpA of Na+/H+ antiporters in the chromosomal nuoL gene. The dNADH oxidase activities in mutant membranes were mostly at the control level or modestly reduced, except mutants of Glu-144, Lys-229, and Lys-399. In contrast, the peripheral dNADH-K3Fe(CN)(6) reductase activities basically remained unchanged in all the NuoL mutants, suggesting that the peripheral arm of complex I was not affected by point mutations in NuoL. The proton pumping efficiency (the ratio of H+/e(+)), however, was decreased in most NuoL mutants by 30-50%, while the IC50 values for asimicin (a potent complex I inhibitor) remained unchanged. This suggests that the H+/e(+) stoichiometry has changed from 4H(+)/2e(-) to 3H(+) or 2H(+)/2e(-) without affecting the direct coupling site. Furthermore, 50 mu M of 5-(N-ethyl-N-isopropyl)-amiloride (EIPA), a specific inhibitor for Na+/H+ antiporters, caused a 38 +/- 5% decrease in the initial H+ pump activity in the wild type, while no change was observed in D178N, D303A, and D400A mutants where the H+ pumping efficiency had already been significantly decreased. The electron transfer activities were basically unaffected by EIPA in both control and mutants. Taken together, our data strongly indicate that the NuoL subunit is involved in the indirect coupling mechanism.	[Nakamaru-Ogiso, Eiko] Univ Penn, Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA; [Kao, Mou-Chieh; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Sinha, Subhash C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Pennsylvania; Scripps Research Institute; Scripps Research Institute	Nakamaru-Ogiso, E (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, 36th & Hamilton Walk, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu			United States Public Health Service [R01GM33712, R01GM030736]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712, R01GM030736] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grants R01GM33712 (to T. Y.) and R01GM030736 (to T. O.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Benit P, 2008, MOL CELL BIOCHEM, V314, P45, DOI 10.1007/s11010-008-9763-z; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Fillingame RH, 1997, J EXP BIOL, V200, P217; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Gemperli AC, 2007, ARCH MICROBIOL, V188, P509, DOI 10.1007/s00203-007-0272-3; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Han HN, 2004, CHEM-EUR J, V10, P2149, DOI 10.1002/chem.200305557; Ito M, 2000, J BACTERIOL, V182, P5663, DOI 10.1128/JB.182.20.5663-5670.2000; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; KITA K, 1984, J BIOL CHEM, V259, P3375; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Moser CC, 2006, BBA-BIOENERGETICS, V1757, P1096, DOI 10.1016/j.bbabio.2006.04.015; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Oberlies NH, 1997, J MED CHEM, V40, P2102, DOI 10.1021/jm9700169; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Pedersen SF, 2007, J BIOL CHEM, V282, P19716, DOI 10.1074/jbc.M701637200; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Steuber J, 2003, J BIOL CHEM, V278, P26817, DOI 10.1074/jbc.M301682200; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; YAGI T, 1988, J BIOL CHEM, V263, P16150; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Zannoni D., 2004, RESP ARCHAEA BACTERI	64	67	70	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39070	39078		10.1074/jbc.M110.157826	http://dx.doi.org/10.1074/jbc.M110.157826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20826797	Green Published, hybrid			2022-12-27	WOS:000284941300037
J	Fraser, JA; Vojtesek, B; Hupp, TR				Fraser, Jennifer A.; Vojtesek, Borivoj; Hupp, Ted R.			A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal I. PHOSPHORYLATION AT SER269 IN VIVO IS LINKED TO INACTIVATION OF p53 FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSOR PROTEIN P53; DNA-BINDING DOMAIN; TRANSACTIVATION DOMAIN; P53-DEPENDENT TRANSCRIPTION; INTERACTION NETWORKS; TUMOR SUPPRESSION; POINT MUTATION; KINASE; ACTIVATION; APOPTOSIS	p53 is a thermodynamically unstable protein containing a conformationally flexible multiprotein docking site within the DNA-binding domain. A combinatorial peptide chip used to identify the novel kinase consensus site RXS Phi (K/D) led to the discovery of a homologous phosphorylation site in the S10 beta-strand of p53 at Ser(269). Overlapping peptide libraries confirmed that Ser(269) was a phosphoacceptor site in vitro, and immunochemical approaches evaluated whether p53 is phosphorylated in vivo at Ser(269). Mutation or phosphorylation of p53 at Ser(269) attenuates binding of the p53-specific monoclonal antibody DO-12, identifying an assay for measuring Ser(269) phosphorylation of p53 in vivo. The mAb DO-12 epitope of p53 is masked via phosphorylation in a range of human tumor cells with WT p53 status, as defined by increased mAb DO-12 binding to endogenous p53 after phosphatase treatment. Phospho-Ser(269)-specific monoclonal antibodies were generated and used to demonstrate that p53 phosphorylation is induced at Ser(269) after irradiation with kinetics similar to those of p53 protein induction. Phosphomimetic mutation at Ser(269) inactivated the transcription activation function and clonogenic suppressor activity of p53. These data suggest that the dynamic equilibrium between native and unfolded states of WT p53 can be modulated by phosphorylation of the conformationally flexible multiprotein binding site in the p53 DNA-binding domain.	[Fraser, Jennifer A.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, CRUK Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Vojtesek, Borivoj] Masaryk Mem Canc Inst, Brno 65653, Czech Republic	University of Edinburgh; Masaryk Memorial Cancer Institute	Hupp, TR (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, CRUK Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk		Fraser, Jennifer/0000-0001-5546-3916	Grant Agency of the Czech Republic [C483]; Ministry of Education, Youth, and Sports of the Czech Republic [6354]; Moravian-Biotechnology;  [301/08/1468];  [LC06035]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Moravian-Biotechnology; ; 	This work was supported by CRUK Programme Grants C483 (Grant Agency of the Czech Republic) and 6354 (Ministry of Education, Youth, and Sports of the Czech Republic) (to T. R. H.). Development of monoclonal antibodies was supported by Moravian-Biotechnology.; Supported by Grants 301/08/1468 and LC06035.	Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bruins W, 2007, CARCINOGENESIS, V28, P1814, DOI 10.1093/carcin/bgm041; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Burch LR, 2004, J MOL BIOL, V337, P115, DOI 10.1016/j.jmb.2003.10.081; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Craig A, 2003, EMBO REP, V4, P787, DOI 10.1038/sj.embor.embor901; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; Craig Ashley L, 2003, Methods Mol Biol, V234, P171; Craig AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-195; Diks SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000777; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Finlan LE, 2006, CELL CYCLE, V5, P2489, DOI 10.4161/cc.5.21.3393; Fraser JA, 2007, BIOCHEMISTRY-US, V46, P2655, DOI 10.1021/bi061562j; Fraser JA, 2010, J BIOL CHEM, V285, P37773, DOI 10.1074/jbc.M110.143107; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Horn HF, 2004, NATURE, V427, P110, DOI 10.1038/427110a; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Hupp TR, 2007, NAT STRUCT MOL BIOL, V14, P885, DOI 10.1038/nsmb1007-885; HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Maya R, 2000, ONCOGENE, V19, P3213, DOI 10.1038/sj.onc.1203658; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Nicholson J, 2010, CELL CYCLE, V9, P1878, DOI 10.4161/cc.9.10.11597; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Pospisilova S, 2004, BIOCHEM J, V378, P939, DOI 10.1042/BJ20030662; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shimizu H, 2006, BIOCHEM J, V397, P355, DOI 10.1042/BJ20051521; STEPHEN CW, 1995, J MOL BIOL, V248, P58, DOI 10.1006/jmbi.1995.0202; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; van Baal JWPM, 2006, CANCER RES, V66, P11605, DOI 10.1158/0008-5472.CAN-06-1370; Velentza AV, 2001, J BIOL CHEM, V276, P38956, DOI 10.1074/jbc.M104273200; VOJTESEK B, 1995, ONCOGENE, V10, P389; Wallace M, 2001, ONCOGENE, V20, P3597, DOI 10.1038/sj.onc.1204496; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	65	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37762	37772		10.1074/jbc.M110.143099	http://dx.doi.org/10.1074/jbc.M110.143099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851891	Green Published, hybrid			2022-12-27	WOS:000284424000068
J	Masuda, W; Betzenhauser, MJ; Yule, DI				Masuda, Wataru; Betzenhauser, Matthew J.; Yule, David I.			InsP(3)R-associated cGMP Kinase Substrate Determines Inositol 1,4,5-Trisphosphate Receptor Susceptibility to Phosphoregulation by Cyclic Nucleotide-dependent Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; CA2+ RELEASE; TRISPHOSPHATE RECEPTOR; MOLECULAR DETERMINANTS; RAT HEPATOCYTES; I-BETA; PHOSPHORYLATION; CAMP; TYPE-1	Ca2+ release through inositol 1,4,5-trisphosphate receptors (InsP(3)R) can be modulated by numerous factors, including input from other signal transduction cascades. These events shape the spatio-temporal characteristics of the Ca2+ signal and provide fidelity essential for the appropriate activation of effectors. In this study, we investigate the regulation of Ca2+ release via InsP(3)R following activation of cyclic nucleotide-dependent kinases in the presence and absence of expression of a binding partner InsP(3)R-associated cGMP kinase substrate (IRAG). cGMP-dependent kinase (PKG) phosphorylation of only the S2+ InsP(3)R-1 subtype resulted in enhanced Ca2+ release in the absence of IRAG expression. In contrast, IRAG bound to each InsP(3)R subtype, and phosphorylation of IRAG by PKG attenuated Ca2+ release through all InsP(3)R subtypes. Surprisingly, simply the expression of IRAG attenuated phosphorylation and inhibited the enhanced Ca2+ release through InsP(3)R-1 following cAMP-dependent protein kinase (PKA) activation. In contrast, IRAG expression did not influence the PKA-enhanced activity of the InsP(3)R-2. Phosphorylation of IRAG resulted in reduced Ca2+ release through all InsP(3)R subtypes during concurrent activation of PKA and PKG, indicating that IRAG modulation is dominant under these conditions. These studies yield mechanistic insight into how cells with various complements of proteins integrate and prioritize signals from ubiquitous signaling pathways.	[Yule, David I.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Betzenhauser, Matthew J.] Columbia Univ, Sch Med, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Masuda, Wataru] Kyushu Dent Coll, Dept Biosci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan	University of Rochester; Columbia University; Kyushu Dental University	Yule, DI (corresponding author), Univ Rochester, Sch Med, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	David_Yule@urmc.rochester.edu			National Institutes of Health [RO1-DK05458, RO1-DE14756]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK05458 and RO1-DE14756.	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Cavallini L, 1996, J BIOL CHEM, V271, P5545, DOI 10.1074/jbc.271.10.5545; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; Desch M, 2010, CARDIOVASC RES, V86, P496, DOI 10.1093/cvr/cvq008; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Geiselhoringer A, 2004, FEBS LETT, V575, P19, DOI 10.1016/j.febslet.2004.08.030; Giovannucci DR, 2000, J BIOL CHEM, V275, P33704, DOI 10.1074/jbc.M004278200; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; LINCOLN TM, 1990, AM J PHYSIOL, V258, pC399, DOI 10.1152/ajpcell.1990.258.3.C399; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG221, DOI 10.1152/ajpgi.00401.2002; Murthy KS, 2001, AM J PHYSIOL-GASTR L, V281, pG1238, DOI 10.1152/ajpgi.2001.281.5.G1238; NAKADE S, 1994, J BIOL CHEM, V269, P6735; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pieper AA, 2001, NEUROSCIENCE, V102, P433, DOI 10.1016/S0306-4522(00)00470-X; Quinton TM, 1996, BIOCHEM BIOPH RES CO, V224, P740, DOI 10.1006/bbrc.1996.1093; Quinton TM, 1996, BIOCHEMISTRY-US, V35, P6865, DOI 10.1021/bi960128m; Rooney TA, 1996, J BIOL CHEM, V271, P19817, DOI 10.1074/jbc.271.33.19817; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; SILVER PJ, 1979, J BIOL CHEM, V254, P9951; Soulsby MD, 2007, CELL CALCIUM, V42, P261, DOI 10.1016/j.ceca.2006.12.002; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; Soulsby MD, 2004, FEBS LETT, V557, P181, DOI 10.1016/S0014-5793(03)01487-X; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Tasker PN, 2000, BIOCHEM BIOPH RES CO, V273, P907, DOI 10.1006/bbrc.2000.3036; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Yaroslavskiy BB, 2010, LAB INVEST, V90, P1533, DOI 10.1038/labinvest.2010.120; Yule DI, 2010, CELL CALCIUM, V47, P469, DOI 10.1016/j.ceca.2010.04.005	53	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37927	37938		10.1074/jbc.M110.168989	http://dx.doi.org/10.1074/jbc.M110.168989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876535	hybrid, Green Published			2022-12-27	WOS:000284424000082
J	Schjoldager, KTBG; Vester-Christensen, MB; Bennett, EP; Levery, SB; Schwientek, T; Yin, W; Blixt, O; Clausen, H				Schjoldager, Katrine T. -B. G.; Vester-Christensen, Malene B.; Bennett, Eric Paul; Levery, Steven B.; Schwientek, Tilo; Yin, Wu; Blixt, Ola; Clausen, Henrik			O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 POSSIBLE ROLE OF POLYPEPTIDE GalNAc-TRANSFERASE-2 IN REGULATION OF CONCENTRATIONS OF PLASMA LIPIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL TUMORAL CALCINOSIS; ALPHA-D-GALACTOSAMINE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; BRAIN NATRIURETIC PEPTIDE; STRUCTURAL-CHARACTERIZATION; LINKED GLYCOSYLATION; LIPID CONCENTRATIONS; ENDOTHELIAL LIPASE; HDL METABOLISM; CELL-ADHESION	The angiopoietin-like protein 3 (ANGPTL3) is an important inhibitor of the endothelial and lipoprotein lipases and a promising drug target. ANGPTL3 undergoes proprotein convertase processing (RAPR(224) down arrow TT) for activation, and the processing site contains two potential GalNAc O-glycosylation sites immediately C-terminal (TT226). We developed an in vivo model system in CHO ldlD cells that was used to show that O-glycosylation in the processing site blocked processing of ANGPTL3. Genome-wide SNP association studies have identified the polypeptide GalNAc-transferase gene, GALNT2, as a candidate gene for low HDL and high triglyceride blood levels. We hypothesized that the GalNAc-T2 transferase performed critical O-glycosylation of proteins involved in lipid metabolism. Screening of a panel of proteins known to affect lipid metabolism for potential sites glycosylated by GalNAc-T2 led to identification of Thr(226) adjacent to the proprotein convertase processing site in ANGPTL3. We demonstrated that GalNAc-T2 glycosylation of Thr(226) in a peptide with the RAPR(224) down arrow TT processing site blocks in vitro furin cleavage. The study demonstrates that ANGPTL3 activation is modulated by O-glycosylation and that this step is probably controlled by GalNAc-T2.	[Schjoldager, Katrine T. -B. G.; Vester-Christensen, Malene B.; Bennett, Eric Paul; Levery, Steven B.; Blixt, Ola; Clausen, Henrik] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Yin, Wu] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Ctr, Dallas, TX 75390 USA; [Schjoldager, Katrine T. -B. G.; Vester-Christensen, Malene B.; Bennett, Eric Paul; Levery, Steven B.; Blixt, Ola; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Sch Dent, DK-2200 Copenhagen N, Denmark; [Schwientek, Tilo] Univ Cologne, D-50923 Cologne, Germany	University of Copenhagen; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Copenhagen; University of Cologne	Clausen, H (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	hclau@sund.ku.dk	Bennett, Eric/AAG-6120-2020; clausen, henrik/AAD-8016-2021	Bennett, Eric/0000-0002-4976-0647; Blixt, Ola/0000-0003-4143-6276; Clausen, Henrik/0000-0002-0915-5055	Carlsberg Foundation; Alfred Benzon Foundation; Danish Research Councils; University of Copenhagen	Carlsberg Foundation(Carlsberg Foundation); Alfred Benzon Foundation; Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen	This work was supported by the Carlsberg Foundation, the Alfred Benzon Foundation, The Danish Research Councils, and a Program of Excellence from the University of Copenhagen.	Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P61, DOI 10.1016/j.bbadis.2008.09.016; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hassan H, 2000, CARBOHYDRATES CHEM B, P273, DOI DOI 10.1002/9783527618255.CH55; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Jaye M, 2004, CURR OPIN LIPIDOL, V15, P183, DOI 10.1097/00041433-200404000-00011; Jiang JJ, 2010, CLIN CHEM, V56, P959, DOI 10.1373/clinchem.2009.140558; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Li C, 2009, CURR OPIN LIPIDOL, V20, P357, DOI 10.1097/MOL.0b013e32832dd55a; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; REMALEY AT, 1993, J BIOL CHEM, V268, P6785; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; SCHINDLER PA, 1995, PROTEIN SCI, V4, P791; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; SEGER MA, 1986, J STEROID BIOCHEM, V25, P703, DOI 10.1016/0022-4731(86)90298-0; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145	43	109	111	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36293	36303		10.1074/jbc.M110.156950	http://dx.doi.org/10.1074/jbc.M110.156950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837471	Green Published, hybrid			2022-12-27	WOS:000284146100034
J	Tong, X; Muchnik, M; Chen, Z; Patel, M; Wu, N; Joshi, S; Rui, LY; Lazar, MA; Yin, L				Tong, Xin; Muchnik, Marina; Chen, Zheng; Patel, Manish; Wu, Nan; Joshi, Shree; Rui, Liangyou; Lazar, Mitchell A.; Yin, Lei			Transcriptional Repressor E4-binding Protein 4 (E4BP4) Regulates Metabolic Hormone Fibroblast Growth Factor 21 (FGF21) during Circadian Cycles and Feeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WIDE EXPRESSION ANALYSIS; PPAR-ALPHA; GENE-EXPRESSION; MOUSE-LIVER; BZIP FACTOR; ERB-ALPHA; KINASE-B; CLOCK; INSULIN; RECEPTOR	Fibroblast growth factor 21 (FGF21) is a potent antidiabetic and triglyceride-lowering hormone whose hepatic expression is highly responsive to food intake. FGF21 induction in the adaptive response to fasting has been well studied, but the molecular mechanism responsible for feeding-induced repression remains unknown. In this study, we demonstrate a novel link between FGF21 and a key circadian output protein, E4BP4. Expression of Fgf21 displays a circadian rhythm, which peaks during the fasting phase and is anti-phase to E4bp4, which is elevated during feeding periods. E4BP4 strongly suppresses Fgf21 transcription by binding to a D-box element in the distal promoter region. Depletion of E4BP4 in synchronized Hepa1c1c-7 liver cells augments the amplitude of Fgf21 expression, and overexpression of E4BP4 represses FGF21 secretion from primary mouse hepatocytes. Mimicking feeding effects, insulin significantly increases E4BP4 expression and binding to the Fgf21 promoter through AKT activation. Thus, E4BP4 is a novel insulin-responsive repressor of FGF21 expression during circadian cycles and feeding.	[Tong, Xin; Muchnik, Marina; Chen, Zheng; Patel, Manish; Rui, Liangyou; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wu, Nan; Joshi, Shree; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Wu, Nan; Joshi, Shree; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leiyin@umich.edu	chen, zheng/J-4600-2014; Lazar, Mitchell A/AAF-3738-2019	chen, zheng/0000-0003-2161-6106; TONG, XIN/0000-0002-4832-8940	National Institutes of Health [K99/R00 DK 077449, R01 DK45586]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, K99DK077449, R00DK077449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K99/R00 DK 077449 (to L. Y.) and R01 DK45586 (to M. A. L.).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Ando H, 2006, BIOCHEM BIOPH RES CO, V346, P1297, DOI 10.1016/j.bbrc.2006.06.044; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bozek K, 2007, GENOME INFORM SER, V18, P65; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; COWELL IG, 1994, NUCLEIC ACIDS RES, V22, P59, DOI 10.1093/nar/22.1.59; Cowell IG, 1996, NUCLEIC ACIDS RES, V24, P3607, DOI 10.1093/nar/24.18.3607; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Cuevas-Ramos D, 2009, CURR DIABETES REV, V5, P216, DOI 10.2174/157339909789804396; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2004, CURR BIOL, V14, P975, DOI 10.1016/j.cub.2004.05.043; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Duguay D, 2009, CHRONOBIOL INT, V26, P1479, DOI 10.3109/07420520903497575; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Eto K, 2010, DIABETES RES CLIN PR, V89, P52, DOI 10.1016/j.diabres.2010.03.019; Feillet CA, 2006, J PHYSIOL-PARIS, V100, P252, DOI 10.1016/j.jphysparis.2007.05.002; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Fukuda H, 1999, FEBS LETT, V464, P113, DOI 10.1016/S0014-5793(99)01700-7; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hardin Paul E, 2003, Novartis Found Symp, V253, P140; HARDIN PE, 2003, NOVART FDN SYMP, V253, P150; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Hsieh MC, 2010, INT J OBESITY, V34, P227, DOI 10.1038/ijo.2009.228; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Innominato PF, 2010, ADV DRUG DELIVER REV, V62, P979, DOI 10.1016/j.addr.2010.06.002; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kotaka M, 2008, NEUROSCI RES, V60, P307, DOI 10.1016/j.neures.2007.11.014; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE126, DOI 10.1152/ajpendo.00020.2010; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Ohno T, 2007, BIOCHEM BIOPH RES CO, V354, P1010, DOI 10.1016/j.bbrc.2007.01.084; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Paschos GK, 2010, ANNU REV PHARMACOL, V50, P187, DOI 10.1146/annurev.pharmtox.010909.105621; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wu X, 2009, INT J OBESITY, V33, P971, DOI 10.1038/ijo.2009.137; Yang F, 2009, BIOCHEM BIOPH RES CO, V380, P22, DOI 10.1016/j.bbrc.2008.12.186; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	79	72	73	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36401	36409		10.1074/jbc.M110.172866	http://dx.doi.org/10.1074/jbc.M110.172866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851878	Green Published, hybrid			2022-12-27	WOS:000284146100031
J	Daily, NJ; Boswell, KL; James, DJ; Martin, TFJ				Daily, Neil J.; Boswell, Kristin L.; James, Declan J.; Martin, Thomas F. J.			Novel Interactions of CAPS (Ca2+-dependent Activator Protein for Secretion) with the Three Neuronal SNARE Proteins Required for Vesicle Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; COMPLEX-FORMATION; 3-DIMENSIONAL STRUCTURE; REGULATED EXOCYTOSIS; MUN DOMAIN; SYNTAXIN; BINDING; CORE; SYNAPTOBREVIN; PHOSPHORYLATION	CAPS (aka CADPS) is required for optimal vesicle exocytosis in neurons and endocrine cells where it functions to prime the exocytic machinery for Ca2+-triggered fusion. Fusion is mediated by trans complexes of the SNARE proteins VAMP-2, syntaxin-1, and SNAP-25 that bridge vesicle and plasma membrane. CAPS promotes SNARE complex formation on liposomes, but the SNARE binding properties of CAPS are unknown. The current work revealed that CAPS exhibits high affinity binding to syntaxin-1 and SNAP-25 and moderate affinity binding to VAMP-2. CAPS binding is specific for a subset of exocytic SNARE protein isoforms and requires membrane integration of the SNARE proteins. SNARE protein binding by CAPS is novel and mediated by interactions with the SNARE motifs in the three proteins. The C-terminal site for CAPS binding on syntaxin-1 does not overlap the Munc18-1 binding site and both proteins can coreside on membrane-integrated syntaxin-1. As expected for a C-terminal binding site on syntaxin-1, CAPS stimulates SNARE-dependent liposome fusion with N-terminal truncated syntaxin-1 but exhibits impaired activity with C-terminal syntaxin-1 mutants. Overall the results suggest that SNARE complex formation promoted by CAPS may be mediated by direct interactions of CAPS with each of the three SNARE proteins required for vesicle exocytosis.	[Daily, Neil J.; Boswell, Kristin L.; James, Declan J.; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	tfmartin@wisc.edu			National Institutes of Health [DK040428, S10 RR13790]; AHA; National Science Foundation [BIR-9512577]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK040428 (to T.F.J.M.) and by an AHA fellowship (to D.J.J.).; SPR data were obtained at the University of Wisconsin Biophysics Instrumentation Facility established with grants from the National Science Foundation (BIR-9512577) and National Institutes of Health (S10 RR13790).	Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Betz A, 1997, J BIOL CHEM, V272, P2520; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guan R, 2008, BIOCHEMISTRY-US, V47, P1474, DOI 10.1021/bi702345m; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nojiri M, 2009, J BIOL CHEM, V284, P18707, DOI 10.1074/jbc.M109.017483; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878	48	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35320	35329		10.1074/jbc.M110.145169	http://dx.doi.org/10.1074/jbc.M110.145169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826818	hybrid, Green Published			2022-12-27	WOS:000283845300010
J	Shen, SD; Chuck, MI; Zhu, MH; Fuller, DM; Yang, CWO; Zhang, WG				Shen, Shudan; Chuck, Mariana I.; Zhu, Minghua; Fuller, Deirdre M.; Yang, Chih-wen Ou; Zhang, Weiguo			The Importance of LAT in the Activation, Homeostasis, and Regulatory Function of T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; ADAPTER PROTEINS; ANTIGEN RECEPTOR; LYMPHOPROLIFERATIVE DISORDER; SIGNAL-TRANSDUCTION; MUTANT MICE; TCR-ZETA; PROLIFERATION; MUTATION; RAS	LAT (linker for activation of T cells) is a transmembrane adaptor protein that plays an essential role in TCR-mediated signaling and thymocyte development. Because LAT-deficient mice have an early block in thymocyte development, we utilized an inducible system to delete LAT in primary T cells to study LAT function in T cell activation, homeostasis, and survival. Deletion of LAT caused primary T cells to become unresponsive to stimulation from the TCR and impaired T cell homeostatic proliferation and long term survival. Furthermore, deletion of LAT led to reduced expression of Foxp3, CTLA-4, and CD25 in T-reg cells and impaired their function. Consequently, mice with LAT deleted developed a lymphoproliferative syndrome similar to that in LATY136F mice, although less severe. Our data implicate that LAT has positive and negative roles in the regulation of mature T cells.	[Shen, Shudan; Chuck, Mariana I.; Zhu, Minghua; Fuller, Deirdre M.; Yang, Chih-wen Ou; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Zhang, WG (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Box 3010, Durham, NC 27710 USA.	zhang033@mc.duke.edu	Zhu, Minghua/ABH-2671-2020		National Institutes of Health [AI048674, AI056156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI056156, R01AI056156, R01AI048674, R56AI048674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI048674 and AI056156.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Archambaud C, 2009, J IMMUNOL, V182, P2680, DOI 10.4049/jimmunol.0803257; Chau LA, 1999, J IMMUNOL, V163, P1853; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 2000, BLOOD, V95, P3199; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Shan XC, 2001, MOL CELL BIOL, V21, P7137, DOI 10.1128/MCB.21.21.7137-7149.2001; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; VANOERS NSC, 1993, MOL CELL BIOL, V13, P5771, DOI 10.1128/MCB.13.9.5771; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu MH, 2006, IMMUNITY, V25, P757, DOI 10.1016/j.immuni.2006.08.025	49	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35393	35405		10.1074/jbc.M110.145052	http://dx.doi.org/10.1074/jbc.M110.145052			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837489	Green Published, hybrid			2022-12-27	WOS:000283845300017
J	Wilhelm, AJ; Zabalawi, M; Owen, JS; Shah, D; Grayson, JM; Major, AS; Bhat, S; Gibbs, DP; Thomas, MJ; Sorci-Thomas, MG				Wilhelm, Ashley J.; Zabalawi, Manal; Owen, John S.; Shah, Dharika; Grayson, Jason M.; Major, Amy S.; Bhat, Shaila; Gibbs, Dwayne P., Jr.; Thomas, Michael J.; Sorci-Thomas, Mary G.			Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr-/-, ApoA-I-/- Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; WILD-TYPE; CHOLESTEROL HOMEOSTASIS; ENDOTHELIAL FUNCTION; DENDRITIC CELLS; INFLAMMATION; ATHEROSCLEROSIS; HDL; SUPPRESSION	The immune system is complex, with multiple layers of regulation that serve to prevent the production of self-antigens. One layer of regulation involves regulatory T cells (Tregs) that play an essential role in maintaining peripheral self-tolerance. Patients with autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis have decreased levels of HDL, suggesting that apoA-I concentrations may be important in preventing autoimmunity and the loss of self-tolerance. In published studies, hypercholesterolemic mice lacking HDL apoA-I or LDLr-/-, apoA-I-/- (DKO), exhibit characteristics of autoimmunity in response to an atherogenic diet. This phenotype is characterized by enlarged cholesterol-enriched lymph nodes (LNs), as well as increased T cell activation, proliferation, and the production of autoantibodies in plasma. In this study, we investigated whether treatment of mice with lipid-free apoA-I could attenuate the autoimmune phenotype. To do this, DKO mice were first fed an atherogenic diet containing 0.1% cholesterol, 10% fat for 6 weeks, after which treatment with apoA-I was begun. Subcutaneous injections of 500 mu g of lipid-free apoA-I was administered every 48 h during the treatment phase. These and control mice were maintained for an additional 6 weeks on the diet. At the end of the 12-week study, DKO mice showed decreased numbers of LN immune cells, whereas Tregs were proportionately increased. Accompanying this increase in Tregs was a decrease in the percentage of effector/effector memory T cells. Furthermore, lipid accumulation in LN and skin was reduced. These results suggest that treatment with apoA-I reduces inflammation in DKO mice by augmenting the effectiveness of the LN Treg response.	[Sorci-Thomas, Mary G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27157 USA; [Owen, John S.; Thomas, Michael J.; Sorci-Thomas, Mary G.] Wake Forest Univ, Bowman Gray Sch Med, Lipid Sci Res Ctr, Winston Salem, NC 27157 USA; [Grayson, Jason M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem Microbiol & Immunol, Winston Salem, NC 27157 USA; [Major, Amy S.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37240 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Vanderbilt University	Sorci-Thomas, MG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	msthomas@wfubmc.edu		Sorci-Thomas, Mary/0000-0002-6464-5006	National Institutes of Health [HL-49373, HL-64163, A1-068952, HL-089310, SR25HL092618-02]; NHLBI [T32HL091797]; American Heart Association; American Cancer Society [RSG-04-066-01 MBC]; Lupus Research Institute, New York; American Heart Association [09GRNT2280053]; North Carolina Biotechnology Shared Instrumentation Program; Winston-Salem Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092618, P01HL049373, R01HL088364, R01HL089310, T32HL091797, R01HL064163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); Lupus Research Institute, New York; American Heart Association(American Heart Association); North Carolina Biotechnology Shared Instrumentation Program; Winston-Salem Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-49373 and HL-64163 (to M. G. S.-T.).; Supported by National Institutes of Health Training Grant T32HL091797 from the NHLBI and in part by an American Heart Association predoctoral fellowship.; Supported by National Institutes of Health Grant A1-068952 and American Cancer Society Research Scholar Grant RSG-04-066-01 MBC.; Supported by National Institutes of Health Grant HL-089310 and The Lupus Research Institute, New York.; Supported by National Institutes of Health Training Grant SR25HL092618-02.; Supported by American Heart Association Grant 09GRNT2280053.; The Trace MS was purchased with funds from the North Carolina Biotechnology Shared Instrumentation Program and the Winston-Salem Foundation.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Angeli V, 2004, IMMUNITY, V21, P561, DOI 10.1016/j.immuni.2004.09.003; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bisoendial RJ, 2003, CIRCULATION, V107, P2944, DOI 10.1161/01.CIR.0000070934.69310.1A; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Cao D, 2004, ARTHRITIS RES THER, V6, pS14, DOI 10.1186/ar1084; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Charles-Schoeman C, 2008, CLIN IMMUNOL, V127, P234, DOI 10.1016/j.clim.2008.01.016; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Deng GM, 2010, J IMMUNOL, V184, P7154, DOI 10.4049/jimmunol.0902514; Escarcega RO, 2006, AUTOIMMUN REV, V6, P48, DOI 10.1016/j.autrev.2006.07.001; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; KALUZNY MA, 1985, J LIPID RES, V26, P135; Li HH, 2002, J BIOL CHEM, V277, P39093, DOI 10.1074/jbc.M206770200; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Mallat Z, 2009, J LIPID RES, V50, pS364, DOI 10.1194/jlr.R800092-JLR200; MILLER GJ, 1975, LANCET, V1, P16; MILLER NE, 1978, LIPIDS, V13, P914, DOI 10.1007/BF02533850; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Monte K, 2008, ARTHRITIS RHEUM-US, V58, P3730, DOI 10.1002/art.24048; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, pE36; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; NICHOLS AV, 1976, BIOCHIM BIOPHYS ACTA, V446, P226, DOI 10.1016/0005-2795(76)90113-6; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Owen JS, 2007, J LIPID RES, V48, P226, DOI 10.1194/jlr.D600031-JLR200; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Puranik R, 2008, ATHEROSCLEROSIS, V196, P240, DOI 10.1016/j.atherosclerosis.2007.05.008; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shaw J, 2008, CIRC RES, V103, pE63; Sorci-Thomas MG, 2000, J BIOL CHEM, V275, P12156, DOI 10.1074/jbc.275.16.12156; SorciThomas MG, 1996, J LIPID RES, V37, P673; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Stanic AK, 2006, P NATL ACAD SCI USA, V103, P7018, DOI 10.1073/pnas.0602311103; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vila J, 2009, CURR OPIN HEMATOL, V16, P274, DOI 10.1097/MOH.0b013e32832a9a01; Wade NS, 2010, LUPUS, V19, P34, DOI 10.1177/0961203309345785; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x; Wang L, 2010, CYTOKINE, V49, P194, DOI 10.1016/j.cyto.2009.08.008; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; Wing K, 2003, EUR J IMMUNOL, V33, P579, DOI 10.1002/eji.200323701; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059; Woo JMP, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3020; Zabalawi M, 2003, AM J PATHOL, V163, P1201, DOI 10.1016/S0002-9440(10)63480-3; Zabalawi M, 2007, J LIPID RES, V48, P52, DOI 10.1194/jlr.M600370-JLR200; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	63	93	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36158	36169		10.1074/jbc.M110.134130	http://dx.doi.org/10.1074/jbc.M110.134130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833724	hybrid, Green Published			2022-12-27	WOS:000283845300092
J	Foley, DA; Swartzentruber, KG; Thompson, MG; Mendiratta, SS; Colley, KJ				Foley, Deirdre A.; Swartzentruber, Kristin G.; Thompson, Matthew G.; Mendiratta, Shalu Shiv; Colley, Karen J.			Sequences from the First Fibronectin Type III Repeat of the Neural Cell Adhesion Molecule Allow O-Glycan Polysialylation of an Adhesion Molecule Chimera	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHASE; IN-VIVO; HUMAN POLYSIALYLTRANSFERASE; NEURITE OUTGROWTH; NERVOUS-SYSTEM; LUNG-CANCER; WILMS TUMOR; N-CAM; NCAM; EXPRESSION	Polysialic acid is a developmentally regulated, anti-adhesive polymer that is added to N-glycans on the fifth immunoglobulin domain (Ig5) of the neural cell adhesion molecule (NCAM). We found that the first fibronectin type III repeat (FN1) of NCAM is required for the polysialylation of N-glycans on the adjacent Ig5 domain, and we proposed that the polysialyltransferases recognize specific sequences in FN1 to position themselves for Ig5 N-glycan polysialylation. Other studies identified a novel FN1 acidic surface patch and alpha-helix that play roles in NCAM polysialylation. Here, we characterize the contribution of two additional FN1 sequences, Pro(510)-Tyr(511)-Ser(512) (PYS) and Gln(516)-Val(517)-Gln(518) (QVQ). Replacing PYS or the acidic patch dramatically decreases the O-glycan polysialylation of a truncated NCAM protein, and replacing the alpha-helix or QVQ shifts polysialic acid to FN1 O-glycans in full-length NCAM. We also found that the FN1 domain of the olfactory cell adhesion molecule, a homologous but unpolysialylated protein, could partially replace NCAM FN1. Inserting Pro(510)-Tyr(511) eliminated N-glycan polysialylation and enhanced O-glycosylation of an NCAM-olfactory cell adhesion molecule chimera, and inserting other FN1 sequences unique to NCAM, predominantly the acidic patch, created a new polysialyltransferase recognition site. Taken together, our results highlight the role of the FN1 alpha-helix and QVQ sequences in N-glycan polysialylation and demonstrate that the acidic patch primarily functions in O-glycan polysialylation.	[Foley, Deirdre A.; Swartzentruber, Kristin G.; Thompson, Matthew G.; Mendiratta, Shalu Shiv; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ash Land Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM063843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K. J. C.).	Alenius M, 1997, J BIOL CHEM, V272, P26083, DOI 10.1074/jbc.272.42.26083; Anderson AA, 2005, J NEUROCHEM, V95, P570, DOI 10.1111/j.1471-4159.2005.03417.x; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Asahina S, 2006, J BIOCHEM, V140, P687, DOI 10.1093/jb/mvj200; Campodonico PB, 2010, MOL CARCINOGEN, V49, P386, DOI 10.1002/mc.20611; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FERNA N, 2010, ONCOLOGY */* E ONCOL, V78, P196; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hamlin JA, 2004, J COMP NEUROL, V474, P438, DOI 10.1002/cne.20133; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; MU H, 1996, EMBO J */* R EMBO J, V15, P6943; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; PaoloniGiacobino A, 1997, GENOMICS, V43, P43, DOI 10.1006/geno.1997.4782; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; ZUBER C, 1992, J BIOL CHEM, V267, P9965	55	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35056	35067		10.1074/jbc.M110.170209	http://dx.doi.org/10.1074/jbc.M110.170209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805222	hybrid, Green Published			2022-12-27	WOS:000283659100080
J	Schirmer, SH; Bot, PT; Fledderus, JO; van der Laan, AM; Volger, OL; Laufs, U; Bohm, M; de Vries, CJM; Horrevoets, AJG; Piek, JJ; Hoefer, IE; van Royen, N				Schirmer, Stephan H.; Bot, Pieter T.; Fledderus, Joost O.; van der Laan, A. M.; Volger, Oscar L.; Laufs, Ulrich; Boehm, Michael; de Vries, Carlie J. M.; Horrevoets, Anton J. G.; Piek, Jan J.; Hoefer, Imo E.; van Royen, Niels			Blocking Interferon beta Stimulates Vascular Smooth Muscle Cell Proliferation and Arteriogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROSIS; APOPTOSIS	Increased interferon (IFN)-beta signaling in patients with insufficient coronary collateralization and an inhibitory effect of IFN beta on collateral artery growth in mice have been reported. The mechanisms of IFN beta-induced inhibition of arteriogenesis are unknown. In stimulated monocytes from patients with chronic total coronary artery occlusion and decreased arteriogenic response, whole genome expression analysis showed increased expression of IFN beta-regulated genes. Immunohistochemically, the IFN beta receptor was localized in the vascular media of murine collateral arteries. Treatment of vascular smooth muscle cells (VSMC) with IFN beta resulted in an attenuated proliferation, cell-cycle arrest, and increased expression of cyclin-dependent kinase inhibitor-1A (p21). The growth inhibitory effect of IFN beta was attenuated by inhibition of p21 by RNA interference. IFN beta-treated THP1 monocytes showed enhanced apoptosis. Subsequently, we tested if collateral artery growth can be stimulated by inhibition of IFN beta-signaling. RNA interference of the IFN beta receptor-1 (IFNAR1) increased VSMC proliferation, cell cycle progression, and reduced p21 gene expression. IFN beta signaling and FAS and TRAIL expression were attenuated in monocytes from IFNAR1(-/-) mice, indicating reduced monocyte apoptosis. Hindlimb perfusion restoration 1 week after femoral artery ligation was improved in IFNAR1(-/-) mice compared with wild-type mice as assessed by infusion of fluorescent microspheres. These results demonstrate that IFN beta inhibits collateral artery growth and VSMC proliferation through p21-dependent cell cycle arrest and induction of monocyte apoptosis. Inhibition of IFN beta stimulates VSMC proliferation and collateral artery growth.	[Schirmer, Stephan H.; Bot, Pieter T.; van der Laan, A. M.; Piek, Jan J.; van Royen, Niels] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Carlie J. M.; Horrevoets, Anton J. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Boehm, Michael] Saarland Univ Hosp, Dept Cardiol, D-66421 Homburg, Germany; [Fledderus, Joost O.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [Bot, Pieter T.; Hoefer, Imo E.] Univ Med Ctr Utrecht, Dept Expt Cardiol, NL-3584 CX Utrecht, Netherlands; [Volger, Oscar L.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, NL-1081 BT Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Universitatsklinikum des Saarlandes; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Schirmer, SH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands.	stephan.schirmer@uks.eu	Fledderus, Joost O/D-5279-2011; Böhm, Michael/C-3638-2011; van Royen, Niels/Q-1097-2017	Fledderus, Joost O/0000-0002-7353-2572; 	Deutsche Forschungsgemeinschaft [SCHI 1012/1-1]; Netherlands Organisation for Scientific Research (NWO) [916-66-019, 050-10<SUP>-014</SUP>]; EU (European Vascular Genomics Network) [LSHM-CT-2003-503254]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU (European Vascular Genomics Network)(European Commission)	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (to S. H. S.) (SCHI 1012/1-1), a VENI-grant by the Netherlands Organisation for Scientific Research (NWO) to N.v.R. (No. 916-66-019), and grants from the NWO (050-10<SUP>-014</SUP>) and the EU (European Vascular Genomics Network, LSHM-CT-2003-503254) (to A. J. G. H.).	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; BENJAMINI Y, 1995, Y J Royal Statist So, V57, P289; BRU HLT, 2004, CIRC RES */* L CIRC, V94, P686; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feau S, 2005, BLOOD, V105, P697, DOI 10.1182/blood-2004-03-1059; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Katayama T, 2007, INT J ONCOL, V31, P613; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; MU L, 1994, SCIENCE */* M SCI, V264, P1918; Oehadian A, 2005, CANCER LETT, V225, P85, DOI 10.1016/j.canlet.2004.11.054; Rehman J, 2008, CIRC RES, V102, P1146, DOI 10.1161/CIRCRESAHA.108.177311; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Schirmer SH, 2004, CARDIOVASC RES, V64, P356, DOI 10.1016/j.cardiores.2004.06.022; Schirmer SH, 2008, CIRC RES, V102, P1286, DOI 10.1161/CIRCRESAHA.108.171827; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Weyenbergh J, 2001, J LEUKOCYTE BIOL, V70, P745; Zhang LN, 2008, ATHEROSCLEROSIS, V197, P204, DOI 10.1016/j.atherosclerosis.2007.03.019	24	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34677	34685		10.1074/jbc.M110.164350	http://dx.doi.org/10.1074/jbc.M110.164350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736166	hybrid, Green Published			2022-12-27	WOS:000283659100043
J	Tang, KH; Feng, XY; Zhuang, WQ; Alvarez-Cohen, L; Blankenship, RE; Tang, YJ				Tang, Kuo-Hsiang; Feng, Xueyang; Zhuang, Wei-Qin; Alvarez-Cohen, Lisa; Blankenship, Robert E.; Tang, Yinjie J.			Carbon Flow of Heliobacteria Is Related More to Clostridia than to the Green Sulfur Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL METABOLIC PATHWAYS; FLUX ANALYSIS; ISOTOPOMER; MODESTICALDUM; PROTEIN; ENZYME; NOV	The recently discovered heliobacteria are the only Gram-positive photosynthetic bacteria that have been cultured. One of the unique features of heliobacteria is that they have properties of both the photosynthetic green sulfur bacteria (containing the type I reaction center) and Clostridia (forming heat-resistant endospores). Most of the previous studies of heliobacteria, which are strict anaerobes and have the simplest known photosynthetic apparatus, have focused on energy and electron transfer processes. It has been assumed that like green sulfur bacteria, the major carbon flow in heliobacteria is through the (incomplete) reductive (reverse) tricarboxylic acid cycle, whereas the lack of CO2-enhanced growth has not been understood. Here, we report studies to fill the knowledge gap of heliobacterial carbon metabolism. We confirm that the CO2-anaplerotic pathway is active during phototrophic growth and that isoleucine is mainly synthesized from the citramalate pathway. Furthermore, to our surprise, our results suggest that the oxidative (forward) TCA cycle is operative and more active than the previously reported reductive (reverse) tricarboxylic acid cycle. Both isotopomer analysis and activity assays suggest that citrate is produced by a putative (Re)-citrate synthase and then enters the oxidative (forward) TCA cycle. Moreover, in contrast to (Si)citrate synthase, (Re)-citrate synthase produces a different isomer of 2-fluorocitrate that is not expected to inhibit the activity of aconitase.	[Tang, Kuo-Hsiang] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Tang, Kuo-Hsiang; Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Feng, Xueyang; Tang, Yinjie J.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA; [Zhuang, Wei-Qin; Alvarez-Cohen, Lisa] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley	Tang, KH (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	j.tang@wustl.edu; yinjie.tang@seas.wustl.edu	Feng, Xueyang/G-1295-2015; Tang, Yinjie/AAI-5584-2020; ZHUANG, WEI-QIN/A-5235-2014	ZHUANG, WEI-QIN/0000-0001-9600-5225; Feng, Xueyang/0000-0003-4426-5732	National Science Foundation [MCB0954016]; NASA [NNX08AP62G]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by National Science Foundation Career Grant MCB0954016 (to Y. J. T.) and Exobiology Program of NASA Grant NNX08AP62G (to R. E. B.).	Asao M, 2010, PHOTOSYNTH RES, V104, P103, DOI 10.1007/s11120-009-9516-1; Baymann F, 2010, PHOTOSYNTH RES, V104, P177, DOI 10.1007/s11120-009-9524-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYSCH K, 1987, ARCH MICROBIOL, V148, P264, DOI 10.1007/BF00456703; Feng XY, 2009, APPL ENVIRON MICROB, V75, P5001, DOI 10.1128/AEM.00715-09; Golbeck JH, 2010, PHOTOSYNTH RES, V104, P101, DOI 10.1007/s11120-010-9557-5; Heinnickel M, 2007, PHOTOSYNTH RES, V92, P35, DOI 10.1007/s11120-007-9162-4; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; KIMBLE LK, 1995, ARCH MICROBIOL, V163, P259, DOI 10.1007/BF00393378; Lamzin VS, 1995, CURR OPIN STRUC BIOL, V5, P830, DOI 10.1016/0959-440X(95)80018-2; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Li FL, 2007, J BACTERIOL, V189, P4299, DOI 10.1128/JB.00198-07; Madigan MT, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P951, DOI 10.1007/0-387-30744-3_31; MARCUS A, 1956, J BIOL CHEM, V218, P823; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; PICKETT MW, 1994, PHOTOSYNTH RES, V41, P75, DOI 10.1007/BF02184147; Pingitore F, 2007, ANAL CHEM, V79, P2483, DOI 10.1021/ac061906b; Sattley WM, 2008, J BACTERIOL, V190, P4687, DOI 10.1128/JB.00299-08; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Widdel F, 1984, BERGEYS MANUAL SYSTE, P663; WOLIN EA, 1963, J BIOL CHEM, V238, P2882	28	22	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35104	35112		10.1074/jbc.M110.163303	http://dx.doi.org/10.1074/jbc.M110.163303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807773	Green Published, hybrid			2022-12-27	WOS:000283659100084
J	Vogel, S; Wottawa, M; Farhat, K; Zieseniss, A; Schnelle, M; Le-Huu, S; von Ahlen, M; Malz, C; Camenisch, G; Katschinski, DM				Vogel, Sabine; Wottawa, Marieke; Farhat, Katja; Zieseniss, Anke; Schnelle, Moritz; Le-Huu, Sinja; von Ahlen, Melanie; Malz, Cordula; Camenisch, Gieri; Katschinski, Doerthe M.			Prolyl Hydroxylase Domain (PHD) 2 Affects Cell Migration and F-actin Formation via RhoA/Rho-associated Kinase-dependent Cofilin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MESSENGER-RNA; UP-REGULATION; HIF-ALPHA; HYPOXIA; PROTEIN; INHIBITION; BINDING; 4-HYDROXYLASES; FAMILY	Cells are responding to hypoxia via prolyl-4-hydroxylase domain (PHD) enzymes, which are responsible for oxygen-dependent hydroxylation of the hypoxia-inducible factor (HIF)-1 alpha subunit. To gain further insight into PHD function, we generated knockdown cell models for the PHD2 isoform, which is the main isoform regulating HIF-1 alpha hydroxylation and thus stability in normoxia. Induction of a PHD2 knockdown in tetracycline-inducible HeLa PHD2 knockdown cells resulted in increased F-actin formation as detected by phalloidin staining. A similar effect could be observed in the stably transfected PHD2 knockdown cell clones 1B6 and 3B7. F-actin is at least in part responsible for shaping cell morphology as well as regulating cell migration. Cell migration was impaired significantly as a consequence of PHD2 knockdown in a scratch assay. Mechanistically, PHD2 knockdown resulted in activation of the RhoA (Ras homolog gene family member A)/Rho-associated kinase pathway with subsequent phosphorylation of cofilin. Because cofilin phosphorylation impairs its actin-severing function, this may explain the F-actin phenotype, thereby providing a functional link between PHD2-dependent signaling and cell motility.	[Vogel, Sabine; Wottawa, Marieke; Farhat, Katja; Zieseniss, Anke; Schnelle, Moritz; Le-Huu, Sinja; von Ahlen, Melanie; Malz, Cordula; Katschinski, Doerthe M.] Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, D-37073 Gottingen, Germany; [Camenisch, Gieri] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Camenisch, Gieri] Univ Zurich, Zurich Ctr Integrat Human Physiol ZHIP, CH-8057 Zurich, Switzerland	University of Gottingen; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Katschinski, DM (corresponding author), Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, Humboldtallee 23, D-37073 Gottingen, Germany.	katschinski@physiol.med.uni-goettingen.de		Schnelle, Moritz/0000-0001-5134-8347	Deutsche Forschungsgemeinschaft [Ka1269/9-1]; Wilhelm Sander Stiftung [2008.062.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Ka1269/9-1) and the Wilhelm Sander Stiftung (Project 2008.062.1) (to D. M. K.). This work was performed as collaborative project within the COST Action TD0901 "HypoxiaNet."	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailly M, 2003, CURR BIOL, V13, pR128, DOI 10.1016/S0960-9822(03)00072-1; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Brokers N, 2010, CANCER SCI, V101, P129, DOI 10.1111/j.1349-7006.2009.01367.x; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Cioffi CL, 2003, BIOCHEM BIOPH RES CO, V303, P947, DOI 10.1016/S0006-291X(03)00453-4; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Haffey WD, 2009, ADV ENZYME REGUL, V49, P121, DOI 10.1016/j.advenzreg.2008.12.004; Hewitson KS, 2003, BIOCHEM SOC T, V31, P510, DOI 10.1042/BST0310510; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Katschinski DM, 2009, ACTA PHYSIOL, V195, P407, DOI 10.1111/j.1748-1716.2008.01952.x; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; Menzies K, 2004, BIOCHEM BIOPH RES CO, V317, P801, DOI 10.1016/j.bbrc.2004.03.115; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Winder SJ, 2003, CURR OPIN CELL BIOL, V15, P14, DOI 10.1016/S0955-0674(02)00002-9; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	49	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33756	33763		10.1074/jbc.M110.132985	http://dx.doi.org/10.1074/jbc.M110.132985			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801873	Green Published, hybrid			2022-12-27	WOS:000283354000021
J	Lee, W; Zeng, XC; Zhou, HX; Bennett, V; Yang, WT; Marszalek, PE				Lee, Whasil; Zeng, Xiancheng; Zhou, Huan-Xiang; Bennett, Vann; Yang, Weitao; Marszalek, Piotr E.			Full Reconstruction of a Vectorial Protein Folding Pathway by Atomic Force Microscopy and Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-REPEAT PROTEIN; TITIN IMMUNOGLOBULIN DOMAINS; SINGLE-MOLECULE; ENERGY LANDSCAPE; MECHANICAL-PROPERTIES; TRANSITION-STATE; UNFOLDING PATHWAYS; POLYPEPTIDE-CHAINS; IN-VITRO; TRANSLOCATION	During co-translational folding, the nascent polypeptide chain is extruded sequentially from the ribosome exit tunnel and, under severe conformational constraints, is dictated by its one-dimensional geometry. How do such vectorial constraints impact the folding pathway? Here, we combine single-molecule atomic force spectroscopy and steered molecular dynamics simulations to examine protein folding in the presence of one-dimensional constraints that are similar to those imposed on the nascent polypeptide chain. The simulations exquisitely reproduced the experimental unfolding and refolding force extension relationships and led to the full reconstruction of the vectorial folding pathway of a large polypeptide, the 253-residue consensus ankyrin repeat protein, NI6C. We show that fully stretched and then relaxed NI6C starts folding by the formation of local secondary structures, followed by the nucleation of three N-terminal repeats. This rate-limiting step is then followed by the vectorial and sequential folding of the remaining repeats. However, after partial unfolding, when allowed to refold, the C-terminal repeats successively regain structures without any nucleation step by using the intact N-terminal repeats as a template. These results suggest a pathway for the co-translational folding of repeat proteins and have implications for mechanotransduction.	[Yang, Weitao] Duke Univ, Dept Chem, French Family Sci Ctr 5310, Durham, NC 27708 USA; [Lee, Whasil; Marszalek, Piotr E.] Duke Univ, Ctr Biologically Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Lee, Whasil; Marszalek, Piotr E.] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Bennett, Vann] Duke Univ, Howard Hughes Med Inst, Durham, NC 27708 USA; [Bennett, Vann] Duke Univ, Dept Cell Biol, Durham, NC 27708 USA; [Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Duke University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Yang, WT (corresponding author), Duke Univ, Dept Chem, French Family Sci Ctr 5310, Durham, NC 27708 USA.	weitao.yang@duke.edu; pemar@duke.edu	Zhou, Huan-Xiang/M-5170-2016; Yang, Weitao/C-1109-2008; zhou, huan/GYJ-4398-2022	Zhou, Huan-Xiang/0000-0001-9020-0302; Yang, Weitao/0000-0001-5576-2828; 	National Institutes of Health [GM079663, GM058187]; National Science Foundation [MCB-0717770]; Duke University Center of Theoretical and Mathematical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058187, R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Duke University Center of Theoretical and Mathematical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079663 (to P.E.M. and V.B.) and GM058187 (to H.-X.Z.). This work was also supported by National Science Foundation Grant MCB-0717770 (to P.E.M. and W.Y.) and a Duke University Center of Theoretical and Mathematical Sciences graduate fellowship (to X.Z.).	Ammenti A, 2009, J PHYS CHEM B, V113, P10348, DOI 10.1021/jp900947f; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Berezhkovskii A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139063; Berkovich R, 2010, BIOPHYS J, V98, P2692, DOI 10.1016/j.bpj.2010.02.053; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cabrita LD, 2010, CURR OPIN STRUC BIOL, V20, P33, DOI 10.1016/j.sbi.2010.01.005; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Corey DP, 2004, NATURE, V428, P901, DOI 10.1038/428901a; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dougan L, 2008, P NATL ACAD SCI USA, V105, P3185, DOI 10.1073/pnas.0706075105; Dougan L, 2008, CHEMPHYSCHEM, V9, P2836, DOI 10.1002/cphc.200800572; Du DG, 2006, BIOCHEMISTRY-US, V45, P13131, DOI 10.1021/bi0615745; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Ferreiro DU, 2008, P NATL ACAD SCI USA, V105, P9853, DOI 10.1073/pnas.0805287105; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; Gao M, 2001, BIOPHYS J, V81, P2268, DOI 10.1016/S0006-3495(01)75874-2; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10540, DOI 10.1073/pnas.0902090106; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Huang F, 2009, P NATL ACAD SCI USA, V106, P16239, DOI 10.1073/pnas.0909126106; Hyeon C, 2006, STRUCTURE, V14, P1633, DOI 10.1016/j.str.2006.09.002; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kirmizialtin S, 2004, J CHEM PHYS, V121, P10268, DOI 10.1063/1.1807832; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li LW, 2006, BIOPHYS J, V90, pL30, DOI 10.1529/biophysj.105.078436; Li MS, 2006, P NATL ACAD SCI USA, V103, P93, DOI 10.1073/pnas.0503758103; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; Makarov DE, 2009, ACCOUNTS CHEM RES, V42, P281, DOI 10.1021/ar800128x; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Mello CC, 2004, P NATL ACAD SCI USA, V101, P14102, DOI 10.1073/pnas.0403386101; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Movileanu L, 2009, TRENDS BIOTECHNOL, V27, P333, DOI 10.1016/j.tibtech.2009.02.008; Mukherjee S, 2008, J PHYS CHEM B, V112, P9146, DOI 10.1021/jp801721p; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Oukhaled G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158101; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Schaeffer RD, 2008, CURR OPIN STRUC BIOL, V18, P4, DOI 10.1016/j.sbi.2007.11.007; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Serquera D, 2010, BIOPHYS J, V98, P1294, DOI 10.1016/j.bpj.2009.12.4287; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Sharma D, 2007, P NATL ACAD SCI USA, V104, P9278, DOI 10.1073/pnas.0700351104; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2; Tian P, 2005, J MOL BIOL, V350, P1017, DOI 10.1016/j.jmb.2005.05.035; Tinoco I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025006; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Walther KA, 2007, P NATL ACAD SCI USA, V104, P7916, DOI 10.1073/pnas.0702179104; Wang Y, 2007, BIOCHEMISTRY-US, V46, P10767, DOI 10.1021/bi700657d; Weikl TR, 2004, PROTEIN SCI, V13, P822, DOI 10.1110/ps.03403604; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Werbeck ND, 2008, P NATL ACAD SCI USA, V105, P9982, DOI 10.1073/pnas.0705300105; Werbeck ND, 2007, P NATL ACAD SCI USA, V104, P7863, DOI 10.1073/pnas.0610315104; West DK, 2006, BIOPHYS J, V91, pL51, DOI 10.1529/biophysj.106.089490; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P15486, DOI 10.1073/pnas.2136623100	90	32	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38167	38172		10.1074/jbc.M110.179697	http://dx.doi.org/10.1074/jbc.M110.179697			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870713	Green Published, hybrid			2022-12-27	WOS:000284625600024
J	Schuckmann, MM; Marchand, B; Hachiya, A; Kodama, EN; Kirby, KA; Singh, K; Sarafianos, SG				Schuckmann, Matthew M.; Marchand, Bruno; Hachiya, Atsuko; Kodama, Eiichi N.; Kirby, Karen A.; Singh, Kamalendra; Sarafianos, Stefan G.			The N348I Mutation at the Connection Subdomain of HIV-1 Reverse Transcriptase Decreases Binding to Nevirapine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEPENDENT PRIMER UNBLOCKING; RNASE-H CLEAVAGE; NONNUCLEOSIDE INHIBITORS; DRUG-RESISTANCE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; TEMPLATE-PRIMER; 3'-AZIDO-3'-DEOXYTHYMIDINE RESISTANCE; CONFORMATIONAL-CHANGES	The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase (RT) confers clinically significant resistance to both nucleoside and non-nucleoside RT inhibitors (NNRTIs) by mechanisms that are not well understood. We used transient kinetics to characterize the enzymatic properties of N348I RT and determine the biochemical mechanism of resistance to the NNRTI nevirapine (NVP). We demonstrate that changes distant from the NNRTI binding pocket decrease inhibitor binding (increase Kd-NVP) by primarily decreasing the association rate of the inhibitor (k(on-NVP)). We characterized RTs mutated in either p66 (p66(N348I)/p51(WT)), p51 (p66(WT)/p51(N348I)), or both subunits (p66(N348I)/p51(N348I)). Mutation in either subunit caused NVP resistance during RNA-dependent and DNA-dependent DNA polymerization. Mutation in p66 alone (p66(N348I)/p51(WT)) caused NVP resistance without significantly affecting RNase H activity, whereas mutation in p51 caused NVP resistance and impaired RNase H, demonstrating that NVP resistance may occur independently from defects in RNase H function. Mutation in either subunit improved affinity for nucleic acid and enhanced processivity of DNA synthesis. Surprisingly, mutation in either subunit decreased catalytic rates (k(pol)) of p66(N348I)/p51(N348I), p66(N348I)/p51(WT), and p66(WT)/p51(N348I) without significantly affecting affinity for deoxynucleotide substrate (Kd-dNTP). Hence, in addition to providing structural integrity for the heterodimer, p51 is critical for fine tuning catalytic turnover, RNase H processing, and drug resistance. In conclusion, connection subdomain mutation N348I decreases catalytic efficiency and causes in vitro resistance to NVP by decreasing inhibitor binding.	[Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Christopher Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Hachiya, Atsuko] Natl Ctr Global Hlth & Med Int Med Ctr Japan, AIDS Clin Ctr, Shinjyuku Ku, Tokyo 1628655, Japan; [Kodama, Eiichi N.] Tohoku Univ, Div Emerging Infect Dis, Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	University of Missouri System; University of Missouri Columbia; Tohoku University	Sarafianos, SG (corresponding author), Univ Missouri, Sch Med, Christopher Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, 401 Bond Life Sci Ctr,1201 E Rollins St, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Kirby, Karen A./0000-0003-2468-4796; Sarafianos, Stefan G/0000-0002-5840-154X	National Institutes of Health [AI076119, AI074389, AI079801]; Korea Food and Drug Administration; Ministry of Knowledge and Economy, Republic of Korea; American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076119, R33AI079801, R01AI074389, R21AI079801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); American Foundation for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119 and AI074389 (to S. G. S.) and AI079801. This work was also supported by a grant from the Korea Food and Drug Administration and the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea.; Recipient of the American Foundation for AIDS Research Mathilde Krim Fellowship.	Biondi MJ, 2010, J BIOL CHEM, V285, P26966, DOI 10.1074/jbc.M110.105775; BOYER PL, 1994, ANTIMICROB AGENTS CH, V38, P1909, DOI 10.1128/AAC.38.9.1909; Das K, 1996, J MOL BIOL, V264, P1085, DOI 10.1006/jmbi.1996.0698; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; Delviks-Frankenberry KA, 2008, P NATL ACAD SCI USA, V105, P10943, DOI 10.1073/pnas.0804660105; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Ghosh M, 1997, BIOCHEMISTRY-US, V36, P5758, DOI 10.1021/bi963045e; Ghosh M, 1996, BIOCHEMISTRY-US, V35, P8553, DOI 10.1021/bi952773j; Girouard M, 2003, J BIOL CHEM, V278, P34403, DOI 10.1074/jbc.M303528200; Gotte M, 2010, BBA-PROTEINS PROTEOM, V1804, P1202, DOI 10.1016/j.bbapap.2009.07.020; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hachiya A, 2009, ANTIVIR RES, V82, P115, DOI 10.1016/j.antiviral.2009.02.189; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Hsiou Y, 2001, J MOL BIOL, V309, P437, DOI 10.1006/jmbi.2001.4648; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACQUES PS, 1994, J BIOL CHEM, V269, P26472; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; MartinHernandez AM, 1996, EMBO J, V15, P4434, DOI 10.1002/j.1460-2075.1996.tb00816.x; Menendez MA, 2001, ENFERM INFEC MICR CL, V19, P287; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2010, J VIROL, V84, P5238, DOI 10.1128/JVI.01545-09; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Parniak M A, 2000, Adv Pharmacol, V49, P67; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Powell MD, 1997, J BIOL CHEM, V272, P13262, DOI 10.1074/jbc.272.20.13262; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; Radzio J, 2010, AIDS, V24, P659, DOI 10.1097/QAD.0b013e328336781d; Ren J, 2004, J MOL BIOL, V336, P569, DOI 10.1016/j.jmb.2003.12.055; Ren J, 2001, J MOL BIOL, V312, P795, DOI 10.1006/jmbi.2001.4988; Ren JS, 2007, J MED CHEM, V50, P2301, DOI 10.1021/jm061117m; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; REN JS, 1995, STRUCTURE, V3, P915, DOI 10.1016/S0969-2126(01)00226-X; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2004, CURR OPIN STRUC BIOL, V14, P716, DOI 10.1016/j.sbi.2004.10.013; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Sluis-Cremer N, 2010, AIDS, V24, P317, DOI 10.1097/QAD.0b013e3283315697; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wang LZ, 2004, J BIOL CHEM, V279, P38424, DOI 10.1074/jbc.M406241200; Wisniewski M, 1999, J BIOL CHEM, V274, P28175, DOI 10.1074/jbc.274.40.28175; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	61	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38700	38709		10.1074/jbc.M110.153783	http://dx.doi.org/10.1074/jbc.M110.153783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876531	hybrid, Green Published			2022-12-27	WOS:000284625600075
J	Valnickova, Z; Sanglas, L; Arolas, JL; Petersen, SV; Schar, C; Otzen, D; Aviles, FX; Gomis-Ruth, FX; Enghild, JJ				Valnickova, Zuzana; Sanglas, Laura; Arolas, Joan L.; Petersen, Steen V.; Schar, Christine; Otzen, Daniel; Aviles, Francesc X.; Gomis-Rueth, F. Xavier; Enghild, Jan J.			Flexibility of the Thrombin-activatable Fibrinolysis Inhibitor Pro-domain Enables Productive Binding of Protein Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA PROCARBOXYPEPTIDASE-B; INTRINSIC ENZYMATIC-ACTIVITY; ACTIVABLE FIBRINOLYSIS; CARBOXYPEPTIDASE-B; 3-DIMENSIONAL STRUCTURE; MEDIATED ACTIVATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; U TAFI; MECHANISM	We have previously reported that thrombin-activatable fibrinolysis inhibitor (TAFI) exhibits intrinsic proteolytic activity toward large peptides. The structural basis for this observation was clarified by the crystal structures of human and bovine TAFI. These structures evinced a significant rotation of the pro-domain away from the catalytic moiety when compared with other pro-carboxypeptidases, thus enabling access of large peptide substrates to the active site cleft. Here, we further investigated the flexible nature of the pro-domain and demonstrated that TAFI forms productive complexes with protein carboxypeptidase inhibitors from potato, leech, and tick (PCI, LCI, and TCI, respectively). We determined the crystal structure of the bovine TAFI-TCI complex, revealing that the pro-domain was completely displaced from the position observed in the TAFI structure. It protruded into the bulk solvent and was disordered, whereas TCI occupied the position previously held by the pro-domain. The authentic nature of the presently studied TAFI-inhibitor complexes was supported by the trimming of the C-terminal residues from the three inhibitors upon complex formation. This finding suggests that the inhibitors interact with the active site of TAFI in a substrate-like manner. Taken together, these data show for the first time that TAFI is able to form a bona fide complex with protein carboxypeptidase inhibitors. This underlines the unusually flexible nature of the pro-domain and implies a possible mechanism for regulation of TAFI intrinsic proteolytic activity in vivo.	[Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Sanglas, Laura; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Bellaterra, Spain; [Sanglas, Laura; Aviles, Francesc X.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Bellaterra, Spain; [Arolas, Joan L.; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, E-08028 Barcelona, Spain; [Petersen, Steen V.] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Aarhus University	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jje@mb.au.dk	Aviles, Francesc Xavier/F-3482-2019; Avilés, Francesc Xavier/A-2664-2015	Aviles, Francesc Xavier/0000-0002-1399-6789; Avilés, Francesc Xavier/0000-0002-1399-6789; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Vang Petersen, Steen/0000-0002-9338-911X; Lopez Arolas, Joan/0000-0002-4198-5016; Otzen, Daniel/0000-0002-2918-8989; Enghild, Jan Johannes/0000-0001-9292-9172	Danish Natural Science Research Council; Spanish agency [BIO2007-68046, BIO2008-04080-E, PSE-010000-2009-8, 2009SGR1036, BIO2009-10334, CSD2006-00015]; Catalan agency [BIO2007-68046, BIO2008-04080-E, PSE-010000-2009-8, 2009SGR1036, BIO2009-10334, CSD2006-00015]; European Union [FP7-HEALTH-F3-2009-223101, FP7-HEALTH-2010-261460]	Danish Natural Science Research Council(Danish Natural Science Research Council); Spanish agency; Catalan agency; European Union(European Commission)	This work was supported by grants from the Danish Natural Science Research Council and by Grants BIO2007-68046, BIO2008-04080-E, PSE-010000-2009-8, 2009SGR1036, BIO2009-10334, and the CONSOLIDER-INGENIO 2010 Project "La Factor a de Cristalizacion" (CSD2006-00015) from Spanish and Catalan agencies, as well as FP7-HEALTH-F3-2009-223101 "AntiPathoGN" and FP7-HEALTH-2010-261460 "Gums&Joints" from the European Union.	Anand K, 2008, J BIOL CHEM, V283, P29416, DOI 10.1074/jbc.M804003200; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Bedaiwy MA, 2006, OBSTET GYNECOL, V108, P162, DOI 10.1097/01.AOG.0000220517.53892.0a; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Boffa MB, 1998, J BIOL CHEM, V273, P2127, DOI 10.1074/jbc.273.4.2127; Boffa MB, 2000, J BIOL CHEM, V275, P12868, DOI 10.1074/jbc.275.17.12868; Bouma BN, 2003, J THROMB HAEMOST, V1, P1566, DOI 10.1046/j.1538-7836.2003.00329.x; Buelens K, 2008, CIRC RES, V102, P295, DOI 10.1161/CIRCRESAHA.107.157099; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; CAMPBELL W, 1989, BIOCHEM BIOPH RES CO, V162, P933, DOI 10.1016/0006-291X(89)90762-6; Carranza C., 1999, 9039 CNRSUPR, P89; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; COLL M, 1991, EMBO J, V10, P1; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; EATON DL, 1991, J BIOL CHEM, V266, P21833; Foley JH, 2008, J BIOL CHEM, V283, P8863, DOI 10.1074/jbc.M800127200; Fujimoto H, 2006, AM J PATHOL, V168, P1086, DOI 10.2353/ajpath.2006.050610; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; HENDRIKS D, 1990, BIOCHIM BIOPHYS ACTA, V1034, P86, DOI 10.1016/0304-4165(90)90157-R; HENDRIKS D, 1989, CLIN CHEM, V35, P177; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; LACKO AG, 1970, BIOCHEMISTRY-US, V9, P4680; Leung LLK, 2008, MOL IMMUNOL, V45, P4080, DOI 10.1016/j.molimm.2008.07.010; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Mao SS, 1999, J BIOL CHEM, V274, P35046, DOI 10.1074/jbc.274.49.35046; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Marx PF, 2000, J BIOL CHEM, V275, P12410, DOI 10.1074/jbc.275.17.12410; Marx PF, 2002, BIOCHEMISTRY-US, V41, P6688, DOI 10.1021/bi015982e; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mosnier LO, 2001, THROMB HAEMOSTASIS, V85, P5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Redlitz A, 1996, CIRCULATION, V93, P1328, DOI 10.1161/01.CIR.93.7.1328; REECK GR, 1972, BIOCHEMISTRY-US, V11, P3947, DOI 10.1021/bi00771a018; Renckens R, 2005, J IMMUNOL, V175, P6764, DOI 10.4049/jimmunol.175.10.6764; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; Sakharov DV, 1997, J BIOL CHEM, V272, P14477, DOI 10.1074/jbc.272.22.14477; Sanglas L, 2010, J THROMB HAEMOST, V8, P1056, DOI 10.1111/j.1538-7836.2010.03740.x; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHINOHARA T, 1994, INT ARCH ALLERGY IMM, V103, P400, DOI 10.1159/000236661; Swaisgood CM, 2002, J CLIN INVEST, V110, P1275, DOI 10.1172/JCI200215082; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; Valnickova Z, 2006, BIOCHEMISTRY-US, V45, P1525, DOI 10.1021/bi051956v; Valnickova Z, 1998, J BIOL CHEM, V273, P27220, DOI 10.1074/jbc.273.42.27220; Valnickova Z, 1996, J BIOL CHEM, V271, P12937, DOI 10.1074/jbc.271.22.12937; Valnickova Z, 2007, J BIOL CHEM, V282, P3066, DOI 10.1074/jbc.M606559200; Valnickova Z, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-13; Velde EAT, 2003, J THROMB HAEMOST, V1, P2087, DOI 10.1046/j.1538-7836.2003.00404.x; Villanueva J, 1998, FEBS LETT, V440, P175, DOI 10.1016/S0014-5793(98)01447-1; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WANG W, 1994, J BIOL CHEM, V269, P15937; Willemse JL, 2007, J THROMB HAEMOST, V5, P1334, DOI 10.1111/j.1538-7836.2007.02539.x; Willemse JL, 2006, ANAL BIOCHEM, V356, P157, DOI 10.1016/j.ab.2006.05.020; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	70	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38243	38250		10.1074/jbc.M110.150342	http://dx.doi.org/10.1074/jbc.M110.150342			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880845	Green Published, hybrid			2022-12-27	WOS:000284625600032
J	Ahn, J; Vu, T; Novince, Z; Guerrero-Santoro, J; Rapic-Otrin, V; Gronenborn, AM				Ahn, Jinwoo; Vu, Thomas; Novince, Zach; Guerrero-Santoro, Jennifer; Rapic-Otrin, Vesna; Gronenborn, Angela M.			HIV-1 Vpr Loads Uracil DNA Glycosylase-2 onto DCAF1, a Substrate Recognition Subunit of a Cullin 4A-RING E3 Ubiquitin Ligase for Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-CYCLE ARREST; VIRAL-PROTEIN-R; TYPE-1 VPR; G(2) ARREST; BINDING-PROTEIN; V-PROTEIN; RECRUITING DCAF1/VPRBP; PREINTEGRATION COMPLEX; PRIMATE LENTIVIRUSES	The human immunodeficiency virus type 1 (HIV-1) accessory protein, Vpr, interacts with several host cellular proteins including uracil DNA glycosylase-2 (UNG2) and a cullin-RING E3 ubiquitin ligase assembly (CRL4(DCAF1)). The ligase is composed of cullin 4A (CUL4A), RING H2 finger protein (RBX1), DNA damage-binding protein 1 (DDB1), and a substrate recognition subunit, DDB1- and CUL4-associated factor 1 (DCAF1). Here we show that recombinant UNG2 specifically interacts with Vpr, but not with Vpx of simian immunodeficiency virus, forming a heterotrimeric complex with DCAF1 and Vpr in vitro as well as in vivo. Using reconstituted CRL4(DCAF1) and CRL4(DCAF1-Vpr) E3 ubiquitin ligases in vitro reveals that UNG2 ubiquitination (ubiquitylation) is facilitated by Vpr. Co-expression of DCAF1 and Vpr causes down-regulation of UNG2 in a proteasome-dependent manner, with Vpr mutants that are defective in UNG2 or DCAF1 binding abrogating this effect. Taken together, our results show that the CRL4(DCAF1) E3 ubiquitin ligase can be subverted by Vpr to target UNG2 for degradation.	[Ahn, Jinwoo; Vu, Thomas; Novince, Zach; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Guerrero-Santoro, Jennifer; Rapic-Otrin, Vesna] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Ahn, Jinwoo; Vu, Thomas; Novince, Zach; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; Inst Canc Res, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), 3501 5th Ave, Pittsburgh, PA 15260 USA.	jia12@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health through the NIGMS [P50GM082251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM082251 (to A.M.G.) through the NIGMS.	Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Bartz SR, 1996, J VIROL, V70, P2324, DOI 10.1128/JVI.70.4.2324-2331.1996; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Fenard D, 2009, NUCLEIC ACIDS RES, V37, P6008, DOI 10.1093/nar/gkp673; Goh WC, 2004, VIROLOGY, V318, P337, DOI 10.1016/j.virol.2003.10.007; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Iwatani Y, 2009, P NATL ACAD SCI USA, V106, P19539, DOI 10.1073/pnas.0906652106; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kamata M, 2008, J VIROL, V82, P5672, DOI 10.1128/JVI.01330-07; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; Langlois MA, 2008, J VIROL, V82, P4660, DOI 10.1128/JVI.02469-07; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Mansky LM, 2003, J VIROL, V77, P2071, DOI 10.1128/JVI.77.3.2071-2080.2003; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Morellet N, 2009, CURR HIV RES, V7, P184, DOI 10.2174/157016209787581490; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Stewart SA, 2000, J VIROL, V74, P3105, DOI 10.1128/JVI.74.7.3105-3111.2000; Stewart SA, 1999, P NATL ACAD SCI USA, V96, P12039, DOI 10.1073/pnas.96.21.12039; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Terada Y, 2006, MOL CELL BIOL, V26, P8149, DOI 10.1128/MCB.01170-06; Transy C, 2009, CELL CYCLE, V8, P2489, DOI 10.4161/cc.8.16.9129; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; Tristem M, 1998, VIROLOGY, V240, P232, DOI 10.1006/viro.1997.8929; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; WONGSTAAL F, 1987, AIDS RES HUM RETROV, V3, P33, DOI 10.1089/aid.1987.3.33; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	62	78	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37333	37341		10.1074/jbc.M110.133181	http://dx.doi.org/10.1074/jbc.M110.133181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870715	Green Published, hybrid			2022-12-27	WOS:000284424000026
J	Buchholz, K; Putrianti, ED; Rahlfs, S; Schirmer, RH; Becker, K; Matuschewski, K				Buchholz, Kathrin; Putrianti, Elyzana D.; Rahlfs, Stefan; Schirmer, R. Heiner; Becker, Katja; Matuschewski, Kai			Molecular Genetics Evidence for the in Vivo Roles of the Two Major NADPH-dependent Disulfide Reductases in the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM POSSESSES; GLUTATHIONE-REDUCTASE; THIOREDOXIN REDUCTASE; REDOX; TRYPANOTHIONE; METABOLISM; INHIBITORS; DIHYDROLIPOAMIDE; TRYPANOSOMES; SYSTEM	Malaria-associated pathology is caused by the continuous expansion of Plasmodium parasites inside host erythrocytes. To maintain a reducing intracellular milieu in an oxygen-rich environment, malaria parasites have evolved a complex antioxidative network based on two central electron donors, glutathione and thioredoxin. Here, we dissected the in vivo roles of both redox pathways by gene targeting of the respective NADPH-dependent disulfide reductases. We show that Plasmodium berghei glutathione reductase and thioredoxin reductase are dispensable for proliferation of the pathogenic blood stages. Intriguingly, glutathione reductase is vital for extracellular parasite development inside the insect vector, whereas thioredoxin reductase is dispensable during the entire parasite life cycle. Our findings suggest that glutathione reductase is the central player of the parasite redox network, whereas thioredoxin reductase fulfils a specialized and dispensable role for P. berghei. These results also indicate redundant roles of the Plasmodium redox pathways during the pathogenic blood phase and query their suitability as promising drug targets for antimalarial intervention strategies.	[Buchholz, Kathrin; Rahlfs, Stefan; Becker, Katja] Univ Giessen, Interdisciplinary Res Ctr, D-35390 Giessen, Germany; [Buchholz, Kathrin; Schirmer, R. Heiner] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Buchholz, Kathrin] Heidelberg Univ, Sch Med, Dept Parasitol, D-69120 Heidelberg, Germany; [Putrianti, Elyzana D.; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany	Justus Liebig University Giessen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Max Planck Society	Becker, K (corresponding author), Univ Giessen, Interdisciplinary Res Ctr, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	becker.katja@gmx.de; matuschewski@mpiib-berlin.mpg.de	Buchholz, Kathrin/O-3217-2017; Buchholz, Kathrin/GOK-0463-2022	Matuschewski, Kai/0000-0001-6147-8591	Deutsche Forschungsgemeinschaft [SFB 544, B2, B10, B1540/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 544, B2 and B10; B1540/15-1).	Andricopulo AD, 2006, BIOORG MED CHEM LETT, V16, P2283, DOI 10.1016/j.bmcl.2006.01.027; Becker K, 2005, MOLECULAR APPROACHES TO MALARIA, P365; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Becker K, 2003, EUR J BIOCHEM, V270, P1057, DOI 10.1046/j.1432-1033.2003.03495.x; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; BECKER K, 1994, HISTOCHEMISTRY, V102, P389, DOI 10.1007/BF00268910; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Buchholz K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002474; Davioud-Charvet E, 2001, J MED CHEM, V44, P4268, DOI 10.1021/jm010268g; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Friebolin W, 2008, J MED CHEM, V51, P1260, DOI 10.1021/jm7009292; Gallo V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007303; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; KrauthSiegel RL, 1996, EUR J BIOCHEM, V235, P345, DOI 10.1111/j.1432-1033.1996.00345.x; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Krnajski Z, 2001, MOL BIOCHEM PARASIT, V112, P219, DOI 10.1016/S0166-6851(00)00372-8; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; McMillan PJ, 2006, J BIOL CHEM, V281, P32967, DOI 10.1074/jbc.M601141200; McMillan PJ, 2005, MOL MICROBIOL, V55, P27, DOI 10.1111/j.1365-2958.2004.04398.x; Morin C, 2008, ORG BIOMOL CHEM, V6, P2731, DOI 10.1039/b802649c; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nickel C, 2006, ANTIOXID REDOX SIGN, V8, P1227, DOI 10.1089/ars.2006.8.1227; Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4; Rahlfs S, 2006, MINI-REV MED CHEM, V6, P163, DOI 10.2174/138955706775475911; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4; Schirmer R. H., 2002, WILEY ENCY MOL MED, P1471; Sobolewski P, 2005, INFECT IMMUN, V73, P6704, DOI 10.1128/IAI.73.10.6704-6710.2005; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302	39	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37388	37395		10.1074/jbc.M110.123323	http://dx.doi.org/10.1074/jbc.M110.123323			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20852334	Green Published, hybrid			2022-12-27	WOS:000284424000031
J	Crowley, CS; Cascio, D; Sawaya, MR; Kopstein, JS; Bobik, TA; Yeates, TO				Crowley, Christopher S.; Cascio, Duilio; Sawaya, Michael R.; Kopstein, Jeffery S.; Bobik, Thomas A.; Yeates, Todd O.			Structural Insight into the Mechanisms of Transport across the Salmonella enterica Pdu Microcompartment Shell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; BACTERIAL MICROCOMPARTMENTS; PROTEIN STRUCTURES; DIFFRACTION DATA; TYPHIMURIUM; ORGANELLES; CARBOXYSOMES; GENE; SEQUENCE; CYANOBACTERIA	Bacterial microcompartments are a functionally diverse group of proteinaceous organelles that confine specific reaction pathways in the cell within a thin protein-based shell. The propanediol utilizing (Pdu) microcompartment contains the reactions for metabolizing 1,2-propanediol in certain enteric bacteria, including Salmonella. The Pdu shell is assembled from a few thousand protein subunits of several different types. Here we report the crystal structures of two key shell proteins, PduA and PduT. The crystal structures offer insights into the mechanisms of Pdu microcompartment assembly and molecular transport across the shell. PduA forms a symmetric homohexamer whose central pore appears tailored for facilitating transport of the 1,2-propanediol substrate. PduT is a novel, tandem domain shell protein that assembles as a pseudohexameric homotrimer. Its structure reveals an unexpected site for binding an [Fe-S] cluster at the center of the PduT pore. The location of a metal redox cofactor in the pore of a shell protein suggests a novel mechanism for either transferring redox equivalents across the shell or for regenerating luminal [Fe-S] clusters.	[Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Crowley, Christopher S.; Yeates, Todd O.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Cascio, Duilio; Sawaya, Michael R.; Kopstein, Jeffery S.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Iowa State University	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles Young Dr E, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	National Institutes of Health [AI081146]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI081146.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Bricogne G., 2009, BUSTER; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2010, J BACTERIOL, V192, P5071, DOI 10.1128/JB.00575-10; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Dou ZC, 2008, J BIOL CHEM, V283, P10377, DOI 10.1074/jbc.M709285200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heinhorst S, 2006, J BACTERIOL, V188, P8087, DOI 10.1128/JB.00990-06; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Mori K, 1997, J BIOL CHEM, V272, P32034, DOI 10.1074/jbc.272.51.32034; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Ponstingl H, 2000, PROTEINS, V41, P47; RONDON MR, 1992, J BACTERIOL, V174, P2267, DOI 10.1128/JB.174.7.2267-2272.1992; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Tsai YS, 2009, ACTA CRYSTALLOGR D, V65, P980, DOI 10.1107/S0907444909025153; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2010, ANNU REV BIOPHYS, V39, P185, DOI 10.1146/annurev.biophys.093008.131418	49	100	105	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37838	37846		10.1074/jbc.M110.160580	http://dx.doi.org/10.1074/jbc.M110.160580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870711	hybrid, Green Published			2022-12-27	WOS:000284424000074
J	Saddic, LA; West, LE; Aslanian, A; Yates, JR; Rubin, SM; Gozani, O; Sage, J				Saddic, Louis A.; West, Lisandra E.; Aslanian, Aaron; Yates, John R., III; Rubin, Seth M.; Gozani, Or; Sage, Julien			Methylation of the Retinoblastoma Tumor Suppressor by SMYD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLATION; HISTONE-METHYLATION; DNA-DAMAGE; TRANSCRIPTIONAL REPRESSION; RECEPTOR-ALPHA; P53 ACTIVITY; RB FAMILY; PROTEIN; ACETYLATION; GENE	The retinoblastoma tumor suppressor (RB) is a central cell cycle regulator and tumor suppressor. RB cellular functions are known to be regulated by a diversity of post-translational modifications such as phosphorylation and acetylation, raising the possibility that RB may also be methylated in cells. Here we demonstrate that RB can be methylated by SMYD2 at lysine 860, a highly conserved and novel site of modification. This methylation event occurs in vitro and in cells, and it is regulated during cell cycle progression, cellular differentiation, and in response to DNA damage. Furthermore, we show that RB monomethylation at lysine 860 provides a direct binding site for the methyl-binding domain of the transcriptional repressor L3MBTL1. These results support the idea that a code of post-translational modifications exists for RB and helps guide its functions in mammalian cells.	[Saddic, Louis A.; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Saddic, Louis A.; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [West, Lisandra E.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Rubin, Seth M.; Sage, Julien] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Aslanian, Aaron] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Aslanian, Aaron] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Yates, John R., III] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	Stanford University; Stanford University; Stanford University; Stanford University; Scripps Research Institute; Salk Institute; University of California System; University of California Santa Cruz	Sage, J (corresponding author), 269 Campus Dr,CCSR1215A, Stanford, CA 94305 USA.	julsage@stanford.edu	Gozani, Or P/I-6157-2013	Rubin, Seth/0000-0002-1670-4147; Gozani, Or/0000-0002-1365-4463	National Institutes of Health [P41 RR011823, NCI T32 CA009523]; CIRM [RB1-01385, NIA F30 AG034741]; NATIONAL CANCER INSTITUTE [T32CA009523, R01CA132685, T32CA009302] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported, in whole or in part, by National Institutes of Health Grants P41 RR011823 (to J. R. Y.), NCI T32 CA009523 (to A. A.), CIRM RB1-01385 (to J. S. and O. G.), and NIA F30 AG034741 (to L. A. S.).	Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burkhart DL, 2010, MOL CELL BIOL, V30, P1729, DOI 10.1128/MCB.00952-09; Carvalho PC, 2009, BIOINFORMATICS, V25, P2734, DOI 10.1093/bioinformatics/btp489; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Ferreira R, 2001, ONCOGENE, V20, P3128, DOI 10.1038/sj.onc.1204337; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Huq MDM, 2007, MOL CELL PROTEOMICS, V6, P677, DOI 10.1074/mcp.M600223-MCP200; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Ledl A, 2005, ONCOGENE, V24, P3810, DOI 10.1038/sj.onc.1208539; Leduc C, 2006, ONCOGENE, V25, P4147, DOI 10.1038/sj.onc.1209446; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Markham D, 2006, EMBO REP, V7, P192, DOI 10.1038/sj.embor.7400591; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Wang YL, 2004, MOL CELL PROTEOMICS, V3, pS264; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; West LE, 2010, J BIOL CHEM, V285, P37725, DOI 10.1074/jbc.M110.139527; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; Yoshimoto T, 2006, EXP CELL RES, V312, P2040, DOI 10.1016/j.yexcr.2006.03.001; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	55	159	165	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37733	37740		10.1074/jbc.M110.137612	http://dx.doi.org/10.1074/jbc.M110.137612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870719	Green Published, hybrid			2022-12-27	WOS:000284424000065
J	Vendelin, M; Hoerter, JA; Mateo, P; Soboll, S; Gillet, B; Mazet, JL				Vendelin, Marko; Hoerter, Jacqueline A.; Mateo, Philippe; Soboll, Sibylle; Gillet, Brigitte; Mazet, Jean-Luc			Modulation of Energy Transfer Pathways between Mitochondria and Myofibrils by Changes in Performance of Perfused Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE FLUXES; RAT-HEART; MAGNETIZATION-TRANSFER; ATP; DIFFUSION; MUSCLE; MODEL; COMPARTMENTATION; PHOSPHOCREATINE; CELLS	In the heart, the energy supplied by mitochondria to myofibrils is continuously and finely tuned to the contraction requirement over a wide range of cardiac loads. This process is mediated both by the creatine kinase (CK) shuttle and by direct ATP transfer. The aim of this study was to identify the contribution of energy transfer pathways at different cardiac performance levels. For this, five protocols of P-31 NMR inversion and saturation transfer experiments were performed at different performance levels on Langendorff perfused rat hearts. The cardiac performance was changed either through variation of external calcium in the presence or absence of isoprenaline or through variation of LV balloon inflation. The recordings were analyzed by mathematical models composed on the basis of different energy transfer pathway configurations. According to our results, the total CK unidirectional flux was relatively stable when the cardiac performance was changed by increasing the calcium concentration or variation of LV balloon volume. The stability of total CK unidirectional flux is lost at extreme energy demand levels leading to a rise in inorganic phosphate, a drop of ATP and phosphocreatine, a drop of total CK unidirectional flux, and to a bypass of CK shuttle by direct ATP transfer. Our results provide experimental evidence for the existence of two pathways of energy transfer, direct ATP transfer, and PCr transfer through the CK shuttle, whose contribution may vary depending on the metabolic status of the heart.	[Vendelin, Marko] Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-12618 Tallinn, Estonia; [Hoerter, Jacqueline A.; Mateo, Philippe; Mazet, Jean-Luc] INSERM, UMR S 769, F-92296 Chatenay Malabry, France; [Soboll, Sibylle] Univ Dusseldorf, Inst Biochem Mol Biol 1, D-4000 Dusseldorf, Germany; [Gillet, Brigitte] Univ Paris 11, CNRS, IR4M, UMR 8081, F-91405 Orsay, France; [Hoerter, Jacqueline A.; Mateo, Philippe; Mazet, Jean-Luc] Univ Paris 11, IFR141, F-92296 Chatenay Malabry, France	Tallinn University of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Heinrich Heine University Dusseldorf; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Vendelin, M (corresponding author), Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, Akad 21, EE-12618 Tallinn, Estonia.	markov@ioc.ee	Vendelin, Marko/AAE-7137-2020	Vendelin, Marko/0000-0002-6459-0391	INSERM; CNRS; Wellcome Trust [WT081755MA]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Wellcome Trust(Wellcome Trust)	This work was supported by INSERM, CNRS (to J. -L. M.), and, in a later stage, by the Wellcome Trust (to M. V., Fellowship No. WT081755MA).	Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Birkedal R, 2006, AM J PHYSIOL-CELL PH, V291, pC1148, DOI 10.1152/ajpcell.00236.2006; BITTL JA, 1985, J BIOL CHEM, V260, P3512; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; De Sousa E, 1999, CIRC RES, V85, P68; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Hormann W., 2004, AUTOMATIC NONUNIFORM; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; JACOBUS WE, 1973, J BIOL CHEM, V248, P4803; Joubert F, 2000, BIOPHYS J, V79, P1, DOI 10.1016/S0006-3495(00)76269-2; Joubert F, 2004, MOL CELL BIOCHEM, V256, P43, DOI 10.1023/B:MCBI.0000009858.41434.fc; Joubert F, 2002, J BIOL CHEM, V277, P18469, DOI 10.1074/jbc.M200792200; Joubert F, 2002, MOL BIOL REP, V29, P171, DOI 10.1023/A:1020369627701; Joubert F, 2001, BIOPHYS J, V81, P2995, DOI 10.1016/S0006-3495(01)75940-1; Joubert F, 2008, J PHYSIOL-LONDON, V586, P5181, DOI 10.1113/jphysiol.2008.157677; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; KUPRIYANOV VV, 1984, BIOCHIM BIOPHYS ACTA, V805, P319, DOI 10.1016/0167-4889(84)90014-4; MARTIN JF, 1989, MAGNET RESON MED, V11, P64, DOI 10.1002/mrm.1910110106; MATTHEWS PM, 1982, BIOCHIM BIOPHYS ACTA, V721, P312, DOI 10.1016/0167-4889(82)90084-2; More J. J., 1984, SOURCES DEV MATH SOF; Nascimben L, 1996, CIRCULATION, V94, P1894, DOI 10.1161/01.CIR.94.8.1894; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; PORTMAN MA, 1992, AM J PHYSIOL, V263, pC453, DOI 10.1152/ajpcell.1992.263.2.C453; Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062; Rivals I, 2003, IEEE T NEURAL NETWOR, V14, P804, DOI 10.1109/TNN.2003.811356; Saks V, 2003, BIOPHYS J, V84, P3436, DOI 10.1016/S0006-3495(03)70065-4; Saks V. A., 1994, CELLULAR BIOENERGETI; SAKS VA, 1975, EUR J BIOCHEM, V57, P273, DOI 10.1111/j.1432-1033.1975.tb02299.x; Sepp M, 2010, BIOPHYS J, V98, P2785, DOI 10.1016/j.bpj.2010.03.025; Soboll S, 1979, Methods Enzymol, V56, P201; Spencer RGS, 1997, AM J PHYSIOL-HEART C, V272, pH409, DOI 10.1152/ajpheart.1997.272.1.H409; Spindler M, 1999, J MOL CELL CARDIOL, V31, P2175, DOI 10.1006/jmcc.1999.1044; Stepanov V, 1997, AM J PHYSIOL-CELL PH, V273, pC1397, DOI 10.1152/ajpcell.1997.273.4.C1397; UGURBIL K, 1986, BIOCHEMISTRY-US, V25, P100, DOI 10.1021/bi00349a015; Vendelin M, 2005, AM J PHYSIOL-CELL PH, V288, pC757, DOI 10.1152/ajpcell.00281.2004; Vendelin M, 2004, BIOPHYS J, V87, P696, DOI 10.1529/biophysj.103.036210; Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747; Vendelin M, 2008, AM J PHYSIOL-CELL PH, V295, pC1302, DOI 10.1152/ajpcell.00313.2008; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wallimann T, 1996, J MUSCLE RES CELL M, V17, P177, DOI 10.1007/BF00124240; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; ZAHLER R, 1992, AM J PHYSIOL, V262, pH1022, DOI 10.1152/ajpheart.1992.262.4.H1022	45	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37240	37250		10.1074/jbc.M110.147116	http://dx.doi.org/10.1074/jbc.M110.147116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847056	hybrid, Green Published			2022-12-27	WOS:000284424000017
J	Zhao, XL; Yamazaki, D; Park, KH; Komazaki, S; Tjondrokoesoemo, A; Nishi, M; Lin, PH; Hirata, Y; Brotto, M; Takeshima, H; Ma, JJ				Zhao, Xiaoli; Yamazaki, Daiju; Park, Ki Ho; Komazaki, Shinji; Tjondrokoesoemo, Andoria; Nishi, Miyuki; Lin, Peihui; Hirata, Yutaka; Brotto, Marco; Takeshima, Hiroshi; Ma, Jianjie			Ca2+ Overload and Sarcoplasmic Reticulum Instability in tric-a Null Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC ALTERNANS; CALCIUM; CHANNELS; RELEASE; MECHANISMS; RESPONSES; PROTEINS	The sarcoplasmic reticulum (SR) of skeletal muscle contains K+, Cl-, and H+ channels may facilitate charge neutralization during Ca2+ release. Our recent studies have identified trimeric intracellular cation (TRIC) channels on SR as an essential counter-ion permeability pathway associated with rapid Ca2+ release from intracellular stores. Skeletal muscle contains TRIC-A and TRIC-B isoforms as predominant and minor components, respectively. Here we test the physiological function of TRIC-A in skeletal muscle. Biochemical assay revealed abundant expression of TRIC-A relative to the skeletal muscle ryanodine receptor with a molar ratio of TRIC-A/ryanodine receptor similar to 5:1. Electron microscopy with the tric-a(-/-) skeletal muscle showed Ca2+ overload inside the SR with frequent formation of Ca2+ deposits compared with the wild type muscle. This elevated SR Ca2+ pool in the tric-a(-/-) muscle could be released by caffeine, whereas the elemental Ca2+ release events, e. g. osmotic stress-induced Ca2+ spark activities, were significantly reduced likely reflecting compromised counter-ion movement across the SR. Ex vivo physiological test identified the appearance of "alternan" behavior with isolated tric-a(-/-) skeletal muscle, i.e. transient and drastic increase in contractile force appeared within the decreasing force profile during repetitive fatigue stimulation. Inhibition of SR/endoplasmic reticulum Ca2+ ATPase function could lead to aggravation of the stress-induced alternans in the tric-a(-/-) muscle. Our data suggests that absence of TRIC-A may lead to Ca2+ overload in SR, which in combination with the reduced counter-ion movement may lead to instability of Ca2+ movement across the SR membrane. The observed alternan behavior with the tric-a(-/-) muscle may reflect a skeletal muscle version of store overload-induced Ca2+ release that has been reported in the cardiac muscle under stress conditions.	[Lin, Peihui; Hirata, Yutaka; Ma, Jianjie] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Yamazaki, Daiju; Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan; [Hirata, Yutaka] Hyogo Coll Med, Dept Physiol, Div Physiome, Nishinomiya, Hyogo 6638501, Japan; [Brotto, Marco] Univ Missouri, Dept Nursing & Med, Kansas City, MO 64108 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Kyoto University; Saitama Medical University; Hyogo College of Medicine; University of Missouri System; University of Missouri Kansas City		zhaox1@umdnj.edu; maj2@umdnj.edu	Park, Ki Ho/E-8921-2011; Park, Ki Ho/N-8153-2017; Lin, Pei-Hui/I-3011-2015	Park, Ki Ho/0000-0002-6193-9826; Lin, Pei-Hui/0000-0002-3894-5099; Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health [RO1-AG28856]; Takeda Science Foundation; American Heart Association; Nagai Foundation of Tokyo; NATIONAL INSTITUTE ON AGING [R01AG028856] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22790209] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Science Foundation(Takeda Science Foundation (TSF)); American Heart Association(American Heart Association); Nagai Foundation of Tokyo; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AG28856 (to J. M. and H. T.), grants from the Takeda Science Foundation (to H. T.), an American Heart Association National Scientist Development grant (to X. Z.), and the Nagai Foundation of Tokyo (to D. Y.).	CORONADO R, 1980, NATURE, V288, P495, DOI 10.1038/288495a0; Eisner DA, 2006, HEART RHYTHM, V3, P743, DOI 10.1016/j.hrthm.2005.12.020; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; HUCHET C, 1994, CAN J PHYSIOL PHARM, V72, P833, DOI 10.1139/y94-118; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Landeira-Fernandez AM, 2001, J EXP BIOL, V204, P909; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Li YT, 2009, J PHYSIOL-LONDON, V587, P1283, DOI 10.1113/jphysiol.2008.164368; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Pitt SJ, 2010, BIOPHYS J, V99, P417, DOI 10.1016/j.bpj.2010.04.051; RIOS E, 1991, J MUSCLE RES CELL M, V12, P127, DOI 10.1007/BF01774031; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SURAWICZ B, 1992, J AM COLL CARDIOL, V20, P483, DOI 10.1016/0735-1097(92)90122-4; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weisleder N, 2008, CELL CALCIUM, V43, P1, DOI 10.1016/j.ceca.2007.10.006; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Wilson LD, 2006, ANN NY ACAD SCI, V1080, P216, DOI 10.1196/annals.1380.018; Yamazaki D, 2009, DEVELOPMENT, V136, P2355, DOI 10.1242/dev.036798; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005	26	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37370	37376		10.1074/jbc.M110.170084	http://dx.doi.org/10.1074/jbc.M110.170084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858894	Green Published, hybrid			2022-12-27	WOS:000284424000029
J	Goldbourt, A; Day, LA; McDermott, AE				Goldbourt, Amir; Day, Loren A.; McDermott, Ann E.			Intersubunit Hydrophobic Interactions in Pf1 Filamentous Phage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAHN CROSS-POLARIZATION; FIBER DIFFRACTION DATA; ANGLE-SPINNING NMR; STRUCTURAL TRANSITION; COAT PROTEIN; CIRCULAR-DICHROISM; BACTERIAL-VIRUS; BACTERIOPHAGE; DNA; TEMPERATURE	Magic angle spinning solid-state NMR has been used to study the structural changes in the Pf1 filamentous bacteriophage, which occur near 10 degrees C. Comparisons of NMR spectra recorded above and below 10 degrees C reveal reversible perturbations in many NMR chemical shifts, most of which are assigned to atoms of hydrophobic side chains of the 46-residue subunit. The changes mainly involve groups located in patches on the interfaces between neighboring capsid subunits. The observations show that the transition adjusts the hydrophobic interfaces between fairly rigid subunits. The low temperature form has been generally more amenable to structure determination; spin diffusion experiments on this form revealed unambiguous contacts between side chains of neighboring subunits. These contacts are important constraints for structure modeling.	[McDermott, Ann E.] Columbia Univ, Dept Chem, New York, NY 10027 USA; Tel Aviv Univ, Sch Chem, IL-69978 Ramat Aviv, Israel; [Day, Loren A.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA	Columbia University; Tel Aviv University; Rutgers State University New Brunswick; Rutgers State University Medical Center	McDermott, AE (corresponding author), Columbia Univ, Dept Chem, 3000 Broadway,MC3113, New York, NY 10027 USA.	aem5@columbia.edu	Goldbourt, Amir/AAK-6625-2020	Goldbourt, Amir/0000-0002-7307-3417; McDermott, Ann/0000-0002-9249-1649	Public Health Research Institute; National Science Foundation [0316248]; European Union [IRG-FP7 224800]; National Institutes of Health, NIGMS [P41 GM66354]	Public Health Research Institute; National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Research Institute (to L. A. D.), National Science Foundation MCB Grant 0316248 (to A. E. M.), and European Union, Marie Curie Action Grant IRG-FP7 224800 (to A. G.).; Member of the New York Structural Biology Center, which is supported by National Institutes of Health Grant P41 GM66354 from NIGMS.	ANDREW EB, 1995, J CHEM PHYS, V103, P6951; Baldus M, 1996, J MAGN RESON SER A, V118, P140, DOI 10.1006/jmra.1996.0022; Blanch EW, 1999, J MOL BIOL, V290, P1, DOI 10.1006/jmbi.1999.2871; CASADEVALL A, 1988, BIOCHEMISTRY-US, V27, P3599, DOI 10.1021/bi00410a010; DAY LA, 1988, ANNU REV BIOPHYS BIO, V17, P509; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GODDARD TD, 2004, SPARKY VERSION 3 1 1; Goldbourt A, 2007, J AM CHEM SOC, V129, P2338, DOI 10.1021/ja066928u; GONZALEZ A, 1995, ACTA CRYSTALLOGR D, V51, P792, DOI 10.1107/S0907444995003027; HEDIGER S, 1995, CHEM PHYS LETT, V240, P449, DOI 10.1016/0009-2614(95)00505-X; HINZ HJ, 1980, J MOL BIOL, V144, P281, DOI 10.1016/0022-2836(80)90091-1; Jakeman DL, 1998, J BIOMOL NMR, V12, P417, DOI 10.1023/A:1008305118426; LIU DJ, 1994, SCIENCE, V265, P671, DOI 10.1126/science.8036516; MAHY BWJ, 2008, ENCY VIROLOGY, P117; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; MARVIN DA, 1990, INT J BIOL MACROMOL, V12, P125, DOI 10.1016/0141-8130(90)90064-H; MARVIN DA, 1992, PHASE TRANSIT, V39, P45, DOI 10.1080/01411599208203472; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; NAKASHIMA Y, 1980, J MOL BIOL, V138, P493, DOI 10.1016/S0022-2836(80)80014-3; NAVE C, 1979, NATURE, V281, P232, DOI 10.1038/281232a0; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; SPECTHRIE L, 1987, BIOPHYS J, V52, P199, DOI 10.1016/S0006-3495(87)83207-1; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; TAKEYA K, 1966, VIROLOGY, V28, P163, DOI 10.1016/0042-6822(66)90317-5; Thiriot DS, 2005, PROTEIN SCI, V14, P1064, DOI 10.1110/ps.041220305; Thiriot DS, 2004, J MOL BIOL, V341, P869, DOI 10.1016/j.jmb.2004.06.038; Tomar S, 2007, J AM CHEM SOC, V129, P3367, DOI 10.1021/ja068498d; TORBET J, 1981, BIOPOLYMERS, V20, P2657, DOI 10.1002/bip.1981.360201212; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; WACHTEL EJ, 1976, J MOL BIOL, V107, P379, DOI 10.1016/S0022-2836(76)80011-3; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Welsh LC, 1998, J MOL BIOL, V283, P155, DOI 10.1006/jmbi.1998.2081; Welsh LC, 2000, ACTA CRYSTALLOGR D, V56, P137, DOI 10.1107/S0907444999015334	34	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37051	37059		10.1074/jbc.M110.119339	http://dx.doi.org/10.1074/jbc.M110.119339			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20736177	Green Published, hybrid			2022-12-27	WOS:000284146100072
J	Smith, LK; Shah, RR; Cidlowski, JA				Smith, Lindsay K.; Shah, Ruchir R.; Cidlowski, John A.			Glucocorticoids Modulate MicroRNA Expression and Processing during Lymphocyte Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; REGULATED MICRORNAS; INDUCE APOPTOSIS; DICER; CELLS; THYMOCYTES; AUTOIMMUNITY; ACTIVATION; PATHWAYS; CLEAVAGE	Glucocorticoids modulate immune development and function through the induction of lymphocyte apoptosis via mechanisms requiring alterations in gene expression. Recently, short, noncoding, microRNAs have been identified as key regulators of lymphocyte function; however, it is unknown whether glucocorticoids regulate noncoding microRNAs and whether this regulation contributes to lymphocyte apoptosis. We now show by both microarray and deep sequencing analysis that microRNAs are substantially repressed during glucocorticoid-induced apoptosis of primary rat thymocytes. Mechanistic studies revealed that primary microRNA transcripts were not repressed, whereas the expression of the key microRNA processing enzymes: Dicer, Drosha, and DGCR8/Pasha, were significantly reduced at both the mRNA and protein levels during glucocorticoid-induced apoptosis. To delineate the role of Dicer depletion and microRNA repression in apoptosis, we silenced Dicer expression in two human leukemic cell lines and demonstrated that Dicer depletion significantly enhanced glucocorticoid-induced apoptosis in both model systems. Finally, in vitro and in vivo overexpression of the conserved miR-17-92 polycistron, which was repressed significantly by dexamethasone treatment in both our microarray and deep sequencing studies, blunted glucocorticoid-induced apoptosis. These studies provide evidence of altered post-transcriptional microRNA expression and the repression of the microRNA bioprocessing pathway during glucocorticoid-induced apoptosis of lymphocytes, suggesting a role for microRNA processors and specific microRNAs in cell life/death decisions.	NIEHS, Mol Endocrinol Grp, Lab Signal Transduct, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Smith, Lindsay K.] Univ N Carolina, Chapel Hill, NC USA; [Shah, Ruchir R.] SRA Int, Durham, NC 27713 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; SRA International	Cidlowski, JA (corresponding author), 111 TW Alexander Dr,Rm F349, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	National Institutes of Health [Z01E5090057-12]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZICES102506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01E5090057-12.	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Klinge CM, 2009, CURR GENOMICS, V10, P169, DOI 10.2174/138920209788185289; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kovalchuk O, 2007, CELL CYCLE, V6, P2010, DOI 10.4161/cc.6.16.4549; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Mann CL, 2000, ENDOCRINOLOGY, V141, P528, DOI 10.1210/en.141.2.528; Matskevich AA, 2008, BIOCHEM J, V412, P527, DOI 10.1042/BJ20071461; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Rainer J, 2009, LEUKEMIA, V23, P746, DOI 10.1038/leu.2008.370; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Riml S, 2004, CELL DEATH DIFFER, V11, pS65, DOI 10.1038/sj.cdd.4401413; SALMON P, 2007, CURR PROTOC HUM GENE, pCH12, DOI DOI 10.1002/0471142905.HG0808S52; Wang DP, 2006, J IMMUNOL, V176, P1695, DOI 10.4049/jimmunol.176.3.1695; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017	42	70	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36698	36708		10.1074/jbc.M110.162123	http://dx.doi.org/10.1074/jbc.M110.162123			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847043	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000284146100076
J	Tzeng, J; Lee, BL; Sykes, BD; Fliegel, L				Tzeng, Jennifer; Lee, Brian L.; Sykes, Brian D.; Fliegel, Larry			Structural and Functional Analysis of Transmembrane Segment VI of the NHE1 Isoform of the Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN STRUCTURE; PROLINE RESIDUES; AMINO-ACIDS; EXPRESSION; PEPTIDES; IV; RHODOPSIN; MECHANISM; INSIGHTS; PROGRAM	The Na+/H+ exchanger isoform 1 is a ubiquitously expressed integral membrane protein. It resides on the plasma membrane of cells and regulates intracellular pH in mammals by extruding an intracellular H+ in exchange for one extracellular Na+. We characterized structural and functional aspects of the transmembrane segment (TM) VI (residues 227-249) by using cysteine scanning mutagenesis and high resolution NMR. Each residue of TM VI was mutated to cysteine in the background of the cysteineless NHE1 protein, and the sensitivity to water-soluble sulfhydryl-reactive compounds (2-(trimethylammonium)ethyl)-methanethiosulfonate (MTSET) and (2-sulfonatoethyl) methanethiosulfonate (MTSES) was determined for those residues with significant activity remaining. Three residues were essentially inactive when mutated to Cys: Asp(238), Pro(239), and Glu(247). Of the remaining residues, proteins with the mutations N227C, I233C, and L243C were strongly inhibited by MTSET, whereas amino acids Phe(230), Gly(231), Ala(236), Val(237), Ala(244), Val(245), and Glu(248) were partially inhibited by MTSET. MTSES did not affect the activity of the mutant NHE1 proteins. The structure of a peptide representing TM VI was determined using high resolution NMR spectroscopy in dodecylphosphocholine micelles. TM VI contains two helical regions oriented at an approximate right angle to each other (residues 229-236 and 239-250) surrounding a central unwound region. This structure bears a resemblance to TM IV of the Escherichia coli protein NhaA. The results demonstrate that TM VI of NHE1 is a discontinuous pore-lining helix with residues Asn(227), Ile(233), and Leu(243) lining the translocation pore.	[Tzeng, Jennifer; Lee, Brian L.; Sykes, Brian D.; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, 347 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca			Canadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada; University of Alberta	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta(University of Alberta)	This work was supported by funding from the Canadian Institutes of Health Research (CIHR) (to L. F. and B. D. S.). The Canadian National High Field NMR Centre is funded by the Canadian Institutes of Health Research, the Natural Science and Engineering Research Council of Canada, and the University of Alberta.	Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; ARSENIEV AS, 1986, J MAGN RESON, V70, P427, DOI 10.1016/0022-2364(86)90131-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Cunningham F, 2007, METHODS, V41, P370, DOI 10.1016/j.ymeth.2006.07.003; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2001, BASIC RES CARDIOL, V96, P301, DOI 10.1007/s003950170036; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karmazyn M, 2003, HYPERTENSION, V42, P1171, DOI 10.1161/01.HYP.0000102863.23854.0B; KARMAZYN M, 2005, HAEMATOL DISORD, V5, P323; Katragadda M, 2001, BIOPHYS J, V81, P1029, DOI 10.1016/S0006-3495(01)75760-8; Kauko A, 2008, J MOL BIOL, V380, P170, DOI 10.1016/j.jmb.2008.04.052; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lang HJ, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P239; Lee BL, 2009, BBA-BIOMEMBRANES, V1788, P2481, DOI 10.1016/j.bbamem.2009.10.004; Lee BL, 2009, J BIOL CHEM, V284, P11546, DOI 10.1074/jbc.M809201200; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Naider F, 2005, BIOPOLYMERS, V80, P199, DOI 10.1002/bip.20183; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Rainey JK, 2006, BIOCHEM CELL BIOL, V84, P918, DOI 10.1139/O06-178; Reddy T, 2008, J BIOL CHEM, V283, P22018, DOI 10.1074/jbc.M803447200; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Slepkov E, 2007, BBA-BIOMEMBRANES, V1768, P2882, DOI 10.1016/j.bbamem.2007.08.011; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yeagle PL, 2001, BIOCHEMISTRY-US, V40, P11932, DOI 10.1021/bi015543f; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zangger K, 2009, J PHYS CHEM B, V113, P4400, DOI 10.1021/jp808501x; [No title captured]	54	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36656	36665		10.1074/jbc.M110.161471	http://dx.doi.org/10.1074/jbc.M110.161471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843797	hybrid, Green Published			2022-12-27	WOS:000284146100046
J	Yu, ASL; Cheng, MH; Coalson, RD				Yu, Alan S. L.; Cheng, Mary H.; Coalson, Rob D.			Calcium Inhibits Paracellular Sodium Conductance through Claudin-2 by Competitive Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-SELECTIVE CHANNELS; TIGHT JUNCTION; EPITHELIAL-CELLS; OCCLUDING JUNCTIONS; MEMBRANE-PROTEINS; ION PERMEATION; EXPRESSION; PERMEABILITY; GALLBLADDER; LOCALIZATION	Claudins form paracellular pores at the tight junction in epithelial cells. Profound depletion of extracellular calcium is well known to cause loosening of the tight junction with loss of transepithelial resistance. However, moderate variations in calcium concentrations within the physiological range can also regulate transepithelial permeability. To investigate the underlying molecular mechanisms, we studied the effects of calcium on the permeability of claudin-2, expressed in an inducible MDCK I cell line. We found that in the physiological range, calcium acts as a reversible inhibitor of the total conductance and Na+ permeability of claudin-2, without causing changes in tight junction structure. The effect of calcium is enhanced at low Na+ concentrations, consistent with a competitive effect. Furthermore, mutation of an intrapore negatively charged binding site, Asp-65, to asparagine partially abrogated the inhibitory effect of calcium. This suggests that calcium competes with Na+ for binding to Asp-65. Other polyvalent cations had similar effects, including La3+, which caused severe and irreversible inhibition of conductance. Brownian dynamics simulations demonstrated that such inhibition can be explained if Asp-65 has a relatively high charge density, thus favoring binding of Ca2+ over that of Na+, reducing Ca2+ permeation by inhibiting its dissociation from this site, and decreasing Na+ conductance through repulsive electrostatic interaction with Ca2+. These findings may explain why hypercalcemia inhibits Na+ reabsorption in the proximal tubule of the kidney.	Univ So Calif, Keck Sch Med, Div Nephrol, Dept Med, Los Angeles, CA 90089 USA; [Yu, Alan S. L.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Cheng, Mary H.; Coalson, Rob D.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Southern California; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, ASL (corresponding author), 2025 Zonal Ave,RMR 406, Los Angeles, CA 90089 USA.	alanyu@usc.edu	Cheng, Mary Hongying/AAU-3768-2021; Yu, Alan/AID-7467-2022	Cheng, Mary Hongying/0000-0001-5833-8221; Yu, Alan/0000-0002-1776-2533	National Institutes of Health [DK062283, 1S10RR024754]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062283 (to A. S. L. Y.) and 1S10RR024754 (shared instrumentation grant to the University of Southern California Multi-Photon Microscopy Core).	ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Cheng HY, 2005, J PHYS CHEM B, V109, P488, DOI 10.1021/jp047438w; Cheng MH, 2007, J PHYS CHEM B, V111, P5956, DOI 10.1021/jp063993h; Cheng MHY, 2005, BIOPHYS J, V89, P1669, DOI 10.1529/biophysj.105.060368; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; DIAMOND JM, 1966, J PHYSIOL-LONDON, V183, P37, DOI 10.1113/jphysiol.1966.sp007850; DIBONA GF, 1971, AM J PHYSIOL, V220, P49, DOI 10.1152/ajplegacy.1971.220.1.49; Enck AH, 2001, AM J PHYSIOL-RENAL, V281, pF966, DOI 10.1152/ajprenal.0021.2001; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; FIGUEROAQUINTANILLA D, 1993, NEW ENGL J MED, V328, P1653, DOI 10.1056/NEJM199306103282301; FROMM M, 1985, J MEMBRANE BIOL, V87, P141, DOI 10.1007/BF01870660; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gillespie D, 2002, EUR BIOPHYS J BIOPHY, V31, P454, DOI 10.1007/s00249-002-0239-x; Gillespie D, 2008, BIOPHYS J, V95, P2658, DOI 10.1529/biophysj.107.127977; Graf P, 2000, J PHYS CHEM B, V104, P12324, DOI 10.1021/jp001282s; GREENBERG RN, 1982, INFECT IMMUN, V35, P483, DOI 10.1128/IAI.35.2.483-488.1982; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, P309; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Laurila JJ, 2007, J HISTOCHEM CYTOCHEM, V55, P567, DOI 10.1369/jhc.6A7155.2007; MACHEN TE, 1972, J CELL BIOL, V54, P302, DOI 10.1083/jcb.54.2.302; MARTINEZ.A, 1971, J CELL BIOL, V50, P277, DOI 10.1083/jcb.50.2.277; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; MELDOLESI J, 1978, J CELL BIOL, V79, P156, DOI 10.1083/jcb.79.1.156; MORENO JH, 1975, J GEN PHYSIOL, V66, P97, DOI 10.1085/jgp.66.1.97; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nemeth Z, 2009, J HISTOCHEM CYTOCHEM, V57, P113, DOI 10.1369/jhc.2008.952291; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Tang VW, 2003, BIOPHYS J, V84, P1660, DOI 10.1016/S0006-3495(03)74975-3; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; WRIGHT EM, 1968, BIOCHIM BIOPHYS ACTA, V163, P57, DOI 10.1016/0005-2736(68)90033-3; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	46	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37060	37069		10.1074/jbc.M110.146621	http://dx.doi.org/10.1074/jbc.M110.146621			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20807759	Green Published, hybrid			2022-12-27	WOS:000284146100047
J	Gee, HY; Tang, BL; Kim, KH; Lee, MG				Gee, Heon Yung; Tang, Bor Luen; Kim, Kyung Hwan; Lee, Min Goo			Syntaxin 16 Binds to Cystic Fibrosis Transmembrane Conductance Regulator and Regulates Its Membrane Trafficking in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNELS; ENDOCYTIC TRAFFICKING; PROTEIN; GOLGI; LOCALIZATION; DEGRADATION; INTERACTS	The cystic fibrosis transmembrane conductance regulator (CFTR) is a key membrane protein in the complex network of epithelial ion transporters regulating epithelial permeability. Syntaxins are one of the major determinants in the intracellular trafficking and membrane targeting of secretory proteins. In the present study we demonstrate the biochemical and functional association between CFTR and syntaxin 16 (STX16) that mediates vesicle transport within the early/late endosomes and trans-Golgi network. Immunoprecipitation experiments in rat colon and T84 human colonic epithelial cells indicate that STX16 associates with CFTR. Further analyses using the domain-specific pulldown assay reveal that the helix domain of STX16 directly interacts with the N-terminal region of CFTR. Immunostainings in rat colon and T84 cells show that CFTR and STX16 highly co-localize at the apical and subapical regions of epithelial cells. Interestingly, CFTR-associated chloride current was reduced by the knockdown of STX16 expression in T84 cells. Surface biotinylation and recycling assays indicate that the reduction in CFTR chloride current is due to decreased CFTR expression on the plasma membrane. These results suggest that STX16 mediates recycling of CFTR and constitutes an important component of CFTR trafficking machinery in intestinal epithelial cells.	[Gee, Heon Yung; Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Inst Gastroenterol, Seoul 120752, South Korea; [Gee, Heon Yung; Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Tang, Bor Luen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National University of Singapore	Lee, MG (corresponding author), Yonsei Coll Med, Dept Pharmacol, 134 Sinchon Dong, Seoul 120752, South Korea.	mlee@yuhs.ac	Gee, Heon Yung/K-7781-2019; Lee, Min Goo/AAS-4636-2020; Lee, Min Goo/D-5635-2012; Tang, Bor Luen/E-4548-2012	Gee, Heon Yung/0000-0002-8741-6177; Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Tang, Bor Luen/0000-0002-1925-636X	Ministry of Education, Science, and Technology, Korea [2007-0055732, 2010-0001670, 2010-0017752]	Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grants 2007-0055732, 2010-0001670, and 2010-0017752 from the Ministry of Education, Science, and Technology, Korea.	Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Bilan F, 2008, EXP CELL RES, V314, P2199, DOI 10.1016/j.yexcr.2008.04.012; Chang SY, 2002, J CELL SCI, V115, P783; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Chua CEL, 2008, MOL MEMBR BIOL, V25, P35, DOI 10.1080/09687680701504649; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Namkung W, 2005, GASTROENTEROLOGY, V129, P1979, DOI 10.1053/j.gastro.2005.08.049; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Panek HR, 2000, J CELL SCI, V113, P4545; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Saxena S, 1999, J BIOL CHEM, V274, P20812, DOI 10.1074/jbc.274.30.20812; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P673, DOI 10.1006/bbrc.1997.8029; Teng FYH, 2001, GENOME BIOL, V2; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhang H, 2002, J BIOL CHEM, V277, P28948, DOI 10.1074/jbc.M111706200	39	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35519	35527		10.1074/jbc.M110.162438	http://dx.doi.org/10.1074/jbc.M110.162438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826815	hybrid, Green Published			2022-12-27	WOS:000283845300030
J	Fogel, AI; Li, Y; Giza, J; Wang, Q; Lam, TT; Modis, Y; Biederer, T				Fogel, Adam I.; Li, Yue; Giza, Joanna; Wang, Qing; Lam, TuKiet T.; Modis, Yorgo; Biederer, Thomas			N-Glycosylation at the SynCAM (Synaptic Cell Adhesion Molecule) Immunoglobulin Interface Modulates Synaptic Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID; NEUROLIGIN; NEUREXIN; BINDING; PROTEIN; SYNAPTOGENESIS; EXPRESSION; SYNAPSES; FAMILY; DOMAIN	Select adhesion molecules connect pre- and postsynaptic membranes and organize developing synapses. The regulation of these trans-synaptic interactions is an important neurobiological question. We have previously shown that the synaptic cell adhesion molecules (SynCAMs) 1 and 2 engage in homo- and heterophilic interactions and bridge the synaptic cleft to induce presynaptic terminals. Here, we demonstrate that site-specific N-glycosylation impacts the structure and function of adhesive SynCAM interactions. Through crystallographic analysis of SynCAM 2, we identified within the adhesive interface of its Ig1 domain an N-glycan on residue Asn(60). Structural modeling of the corresponding SynCAM 1 Ig1 domain indicates that its glycosylation sites Asn(70)/Asn(104) flank the binding interface of this domain. Mass spectrometric and mutational studies confirm and characterize the modification of these three sites. These site-specific N-glycans affect SynCAM adhesion yet act in a differential manner. Although glycosylation of SynCAM 2 at Asn(60) reduces adhesion, N-glycans at Asn(70)/Asn(104) of SynCAM 1 increase its interactions. The modification of SynCAM 1 with sialic acids contributes to the glycan-dependent strengthening of its binding. Functionally, N-glycosylation promotes the trans-synaptic interactions of SynCAM 1 and is required for synapse induction. These results demonstrate that N-glycosylation of SynCAM proteins differentially affects their binding interface and implicate post-translational modification as a mechanism to regulate trans-synaptic adhesion.	[Fogel, Adam I.; Li, Yue; Giza, Joanna; Wang, Qing; Modis, Yorgo; Biederer, Thomas] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Lam, TuKiet T.] Yale Univ, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA	Yale University; Yale University	Biederer, T (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	thomas.biederer@yale.edu	Biederer, Thomas/AAZ-6133-2021	Biederer, Thomas/0000-0003-0912-1514; Modis, Yorgo/0000-0002-6084-0429; Wang, Qing/0000-0003-1138-4575	National Institutes of Health [R01 DA018928, T32 GM007223]; Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease; National Institute on Drug Abuse [P30 DA018343]; Offices of Biological and of Basic Energy Sciences of the U.S. Department of Energy; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343, R01DA018928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease(Burroughs Wellcome Fund); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Offices of Biological and of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA018928 (to T. B.). This work was also supported by a Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease grant (to Y.M.), National Institutes of Health Predoctoral Program in Cellular and Molecular Biology Grant T32 GM007223, and by National Institutes of Health Grant P30 DA018343 from the National Institute on Drug Abuse. Use of the National Synchrotron Light Source is supported by the Offices of Biological and of Basic Energy Sciences of the U.S. Department of Energy.	ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Bai Y, 2007, ACTA CRYSTALLOGR F, V63, P135, DOI 10.1107/S1744309107002904; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bucior I, 2004, CURR OPIN STRUC BIOL, V14, P631, DOI 10.1016/j.sbi.2004.08.006; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Cooper CA, 2003, NUCLEIC ACIDS RES, V31, P511, DOI 10.1093/nar/gkg099; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Drescher B, 2003, IMMUNOLOGY, V110, P335, DOI 10.1046/j.1365-2567.2003.01743.x; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; GRAY EG, 1959, J ANAT, V93, P420; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Kwiatkowski AV, 2007, CURR OPIN CELL BIOL, V19, P551, DOI 10.1016/j.ceb.2007.08.005; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin PT, 2002, GLYCOBIOLOGY, V12, p1R, DOI 10.1093/glycob/12.1.1R; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morelle W, 2006, PROTEOMICS, V6, P3993, DOI 10.1002/pmic.200600129; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; SU D, 2008, NATURE */* T C NATUR, V455, P903; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Zaccai NR, 2007, J MOL BIOL, V365, P1469, DOI 10.1016/j.jmb.2006.10.084	56	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34864	34874		10.1074/jbc.M110.120865	http://dx.doi.org/10.1074/jbc.M110.120865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739279	Green Published, hybrid			2022-12-27	WOS:000283659100061
J	Hinault, MP; Cuendet, AFH; Mattoo, RUH; Mensi, M; Dietler, G; Lashuel, HA; Goloubinoff, P				Hinault, Marie-Pierre; Cuendet, America Farina Henriquez; Mattoo, Rayees U. H.; Mensi, Mounir; Dietler, Giovanni; Lashuel, Hilal A.; Goloubinoff, Pierre			Stable alpha-Synuclein Oligomers Strongly Inhibit Chaperone Activity of the Hsp70 System by Weak Interactions with J-domain Co-chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; IN-VITRO; ESCHERICHIA-COLI; FIBRIL FORMATION; DNAK CHAPERONE; LEWY BODIES; VESICLE PERMEABILIZATION; SUBSTRATE-SPECIFICITY; MOLECULAR CHAPERONES; INDUCED TOXICITY	alpha-Synuclein aggregation and accumulation in Lewy bodies are implicated in progressive loss of dopaminergic neurons in Parkinson disease and related disorders. In neurons, the Hsp70s and their Hsp40-like J-domain co-chaperones are the only known components of chaperone network that can use ATP to convert cytotoxic protein aggregates into harmless natively refolded polypeptides. Here we developed a protocol for preparing a homogeneous population of highly stable beta-sheet enriched toroid-shaped alpha-Syn oligomers with a diameter typical of toxic pore-forming oligomers. These oligomers were partially resistant to in vitro unfolding by the bacterial Hsp70 chaperone system (DnaK, DnaJ, GrpE). Moreover, both bacterial and human Hsp70/Hsp40 unfolding/refolding activities of model chaperone substrates were strongly inhibited by the oligomers but, remarkably, not by unstructured alpha-Syn monomers even in large excess. The oligomers acted as a specific competitive inhibitor of the J-domain co-chaperones, indicating that J-domain co-chaperones may preferably bind to exposed bulky misfolded structures in misfolded proteins and, thus, complement Hsp70s that bind to extended segments. Together, our findings suggest that inhibition of the Hsp70/Hsp40 chaperone system by alpha-Syn oligomers may contribute to the disruption of protein homeostasis in dopaminergic neurons, leading to apoptosis and tissue loss in Parkinson disease and related neurodegenerative diseases.	[Hinault, Marie-Pierre; Cuendet, America Farina Henriquez; Mattoo, Rayees U. H.; Goloubinoff, Pierre] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Mensi, Mounir; Dietler, Giovanni] Ecole Polytech Fed Lausanne, IPMC SB, Lab Phys Matiere Vivante, CH-1015 Lausanne, Switzerland; [Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, Brain Mind Inst, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Goloubinoff, P (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	pierre.goloubinoff@unil.ch	Mattoo, Rayees/AAK-5052-2021; Lashuel, Hilal/M-3500-2017	Mattoo, Rayees/0000-0002-3204-6367; Goloubinoff, Pierre/0000-0002-4802-0807	Swiss National Science Foundation [3100A0-109290]; Faculty of Biology and Medicine of Lausanne University	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine of Lausanne University	This work was supported by Swiss National Science Foundation Grant 3100A0-109290 and by a Zwahlen grant from the Faculty of Biology and Medicine of Lausanne University.	Ahmad A, 2010, INT J BIOL MACROMOL, V46, P275, DOI 10.1016/j.ijbiomac.2009.12.017; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Gur E, 2004, J BACTERIOL, V186, P7236, DOI 10.1128/JB.186.21.7236-7242.2004; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Han WJ, 2004, FEBS LETT, V563, P146, DOI 10.1016/S0014-5793(04)00290-X; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hirohata M, 2008, NEUROPHARMACOLOGY, V54, P620, DOI 10.1016/j.neuropharm.2007.11.010; Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Mezey E, 1998, MOL PSYCHIATR, V3, P493, DOI 10.1038/sj.mp.4000446; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; Svetlov MS, 2007, MOL BIOL+, V41, P86, DOI 10.1134/S0026893307010128; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	62	57	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38173	38182		10.1074/jbc.M110.127753	http://dx.doi.org/10.1074/jbc.M110.127753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20847048	Green Published, hybrid			2022-12-27	WOS:000284625600025
J	Lee, WY; Weber, DA; Laur, O; Stowell, SR; Mccall, I; Andargachew, R; Cummings, RD; Parkos, CA				Lee, Winston Y.; Weber, Dominique A.; Laur, Oskar; Stowell, Sean R.; Mccall, Ingrid; Andargachew, Rakieb; Cummings, Richard D.; Parkos, Charles A.			The Role of cis Dimerization of Signal Regulatory Protein alpha (SIRP alpha) in Binding to CD47	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL TRANSEPITHELIAL MIGRATION; T-CELL ACTIVATION; NEGATIVE REGULATION; N-GLYCOSYLATION; IN-VITRO; RECEPTOR; SHPS-1; ASSOCIATION; DOMAIN; MACROPHAGES	Interaction of SIRP alpha with its ligand, CD47, regulates leukocyte functions, including transmigration, phagocytosis, oxidative burst, and cytokine secretion. Recent progress has provided significant insights into the structural details of the distal IgV domain (D1) of SIRP alpha. However, the structural roles of proximal IgC domains (D2 and D3) have been largely unstudied. The high degree of conservation of D2 and D3 among members of the SIRP family as well as the propensity of known IgC domains to assemble in cis has led others to hypothesize that SIRP alpha forms higher order structures on the cell surface. Here we report that SIRP alpha forms noncovalently linked cis homodimers. Treatment of SIRP alpha-expressing cells with a membrane-impermeable cross-linker resulted in the formation of SDS-stable SIRP alpha dimers and oligomers. Biochemical analyses of soluble recombinant extracellular regions of SIRP alpha, including domain truncation mutants, revealed that each of the three extracellular immunoglobulin loops of SIRP alpha formed dimers in solution. Co-immunoprecipitation experiments using cells transfected with different affinity-tagged SIRP alpha molecules revealed that SIRP alpha forms cis dimers. Interestingly, in cells treated with tunicamycin, SIRP alpha dimerization but not CD47 binding was inhibited, suggesting that a SIRP alpha dimer is probably bivalent. Last, we demonstrate robust dimerization of SIRPa in adherent, stimulated human neutrophils. Collectively, these data are consistent with SIRP alpha being expressed on the cell surface as a functional cis-linked dimer.	[Parkos, Charles A.] Emory Univ, Sch Med, Epithelial Pathobiol Unit, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Laur, Oskar] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Stowell, Sean R.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Parkos, CA (corresponding author), 105-B Whitehead Bldg,615 Michael St, Atlanta, GA 30332 USA.	cparkos@emory.edu			National Institutes of Health [DK079392, DK72564]; Digestive Diseases Mini-center [DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK072564, R01DK079392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Mini-center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079392 and DK72564 (to C.A.P.) and Digestive Diseases Mini-center Grant DK064399 (epithelial cell culture core and microscopy core support).	ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; Dong LW, 2008, MOL IMMUNOL, V45, P3025, DOI 10.1016/j.molimm.2008.03.012; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Elkabetz Y, 2008, MOL IMMUNOL, V46, P97, DOI 10.1016/j.molimm.2008.07.005; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Lee WY, 2006, METH MOL B, V341, P205; Lee WY, 2007, J IMMUNOL, V179, P7741, DOI 10.4049/jimmunol.179.11.7741; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Liu Y, 2005, J BIOL CHEM, V280, P36132, DOI 10.1074/jbc.M506419200; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Miyake A, 2008, GENES CELLS, V13, P209, DOI 10.1111/j.1365-2443.2007.01161.x; Nagayama Y, 1998, J BIOL CHEM, V273, P33423, DOI 10.1074/jbc.273.50.33423; Nakaishi A, 2008, J MOL BIOL, V375, P650, DOI 10.1016/j.jmb.2007.10.085; Ogura T, 2004, J BIOL CHEM, V279, P13711, DOI 10.1074/jbc.M310276200; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Stefanidakis M, 2008, BLOOD, V112, P1280, DOI 10.1182/blood-2008-01-134429; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tomasello E, 2000, EUR J IMMUNOL, V30, P2147, DOI 10.1002/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493	63	18	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37953	37963		10.1074/jbc.M110.180018	http://dx.doi.org/10.1074/jbc.M110.180018			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20826801	hybrid, Green Published			2022-12-27	WOS:000284625600003
J	Grice, DM; Vetter, I; Faddy, HM; Kenny, PA; Roberts-Thomson, SJ; Monteith, GR				Grice, Desma M.; Vetter, Irina; Faddy, Helen M.; Kenny, Paraic A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Golgi Calcium Pump Secretory Pathway Calcium ATPase 1 (SPCA1) Is a Key Regulator of Insulin-like Growth Factor Receptor (IGF1R) Processing in the Basal-like Breast Cancer Cell Line MDA-MB-231	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; HAILEY-HAILEY-DISEASE; PROPROTEIN CONVERTASES; MAMMARY-GLAND; CA2+-ATPASE SPCA1; CA2+ HOMEOSTASIS; PLASMA-MEMBRANE; TUMOR-GROWTH; EXPRESSION; GENE	Calcium signaling is a key regulator of pathways important in tumor progression, such as proliferation and apoptosis. Most studies assessing altered calcium homeostasis in cancer cells have focused on alterations mediated through changes in cytoplasmic free calcium levels. Here, we show that basal-like breast cancers are characterized by an alteration in the secretory pathway calcium ATPase 1 (SPCA1), a calcium pump localized to the Golgi. Inhibition of SPCA1 in MDA-MB-231 cells produced pronounced changes in cell proliferation and morphology in three-dimensional culture, without alterations in sensitivity to endoplasmic reticulum stress induction or changes in global calcium signaling. Instead, the effects of SPCA1 inhibition in MDA-MB-231 cells reside in altered regulation of calcium-dependent enzymes located in the secretory pathway, such as proprotein convertases. Inhibition of SPCA1 produced a pronounced alteration in the processing of insulin-like growth factor receptor (IGF1R), with significantly reduced levels of functional IGF1R beta and accumulation of the inactive trans-Golgi network pro-IGF1R form. These studies identify for the first time a calcium transporter associated with the basal-like breast cancer subtype. The pronounced effects of SPCA1 inhibition on the processing of IGF1R in MDA-MB-231 cells independent of alterations in global calcium signaling also demonstrate that some calcium transporters can regulate the processing of proteins important in tumor progression without major alterations in cytosolic calcium signaling. Inhibitors of SPCA1 may offer an alternative strategy to direct inhibitors of IGF1R and attenuate the processing of other proprotein convertase substrates important in basal breast cancers.	[Grice, Desma M.; Faddy, Helen M.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Vetter, Irina] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Queensland; University of Queensland; Yeshiva University; Albert Einstein College of Medicine	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia.	gregm@uq.edu.au	Monteith, Gregory/B-1626-2008; Vetter, Irina/A-6035-2010; Grice, Desma M/A-7730-2011; Roberts-Thomson, Sarah/W-5676-2019; Faddy, Helen M/A-6541-2015; Roberts-Thomson, Sarah J/B-4282-2011	Monteith, Gregory/0000-0002-4345-530X; Vetter, Irina/0000-0002-3594-9588; Roberts-Thomson, Sarah/0000-0001-8202-5786; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Faddy, Helen/0000-0002-3446-8248	Cancer Council of Queensland [569644]; National Health and Medical Research Council of Australia [631347]; Australian postgraduate award; Susan G. Komen for the Cure [KG100888]; Department of Defense [W81XWH-09-1-0680]	Cancer Council of Queensland(Cancer Council Queensland); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense)	This work was supported in part by Cancer Council of Queensland Grant 569644, National Health and Medical Research Council of Australia Grant 631347, and an Australian postgraduate award (to D. M. G. and H. M. F.).; Supported by Susan G. Komen for the Cure Grant KG100888 and Department of Defense CDMRP Breast Cancer Research Program Grant W81XWH-09-1-0680.	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Callewaert G, 2003, CELL CALCIUM, V34, P157, DOI 10.1016/S0143-4160(03)00070-8; Carboni JM, 2005, CANCER RES, V65, P3781, DOI 10.1158/0008-5472.CAN-04-4602; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Fairclough RJ, 2004, J INVEST DERMATOL, V123, P67, DOI 10.1111/j.0022-202X.2004.22713.x; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Harper C, 2005, J CELL SCI, V118, P1673, DOI 10.1242/jcs.02297; Haupt B, 2010, ARCH PATHOL LAB MED, V134, P130, DOI 10.1043/1543-2165-134.1.130; Jones R, 2008, J MAMMARY GLAND BIOL, V13, P407, DOI 10.1007/s10911-008-9097-1; Kamath L, 2001, CANCER RES, V61, P5933; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Lehmann M, 1998, ENDOCRINOLOGY, V139, P3763, DOI 10.1210/en.139.9.3763; Lissandron V, 2010, P NATL ACAD SCI USA, V107, P9198, DOI 10.1073/pnas.1004702107; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Missiaen L, 2004, BIOCHEM BIOPH RES CO, V322, P1204, DOI 10.1016/j.bbrc.2004.07.128; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Porgpermdee S, 2005, J DERMATOL SCI, V40, P137, DOI 10.1016/j.jdermsci.2005.08.007; Ramos-Castaneda J, 2005, J BIOL CHEM, V280, P9467, DOI 10.1074/jbc.M413243200; Reinhardt TA, 2004, AM J PHYSIOL-CELL PH, V286, pC164, DOI 10.1152/ajpcell.00065.2003; Reinhardt TA, 1999, AM J PHYSIOL-CELL PH, V276, pC796, DOI 10.1152/ajpcell.1999.276.4.C796; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Sachdev D, 2010, ONCOGENE, V29, P251, DOI 10.1038/onc.2009.316; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Shennan DB, 2008, CELL MOL BIOL LETT, V13, P514, DOI 10.2478/s11658-008-0020-y; Sohn YS, 1998, J BACTERIOL, V180, P6736, DOI 10.1128/JB.180.24.6736-6742.1998; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Szigeti R, 2006, J INVEST DERMATOL, V126, P2370, DOI 10.1038/sj.jid.5700447; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yee D, 2008, J MAMMARY GLAND BIOL, V13, P351, DOI 10.1007/s10911-008-9096-2	52	61	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37458	37466		10.1074/jbc.M110.163329	http://dx.doi.org/10.1074/jbc.M110.163329			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20837466	Green Published, hybrid			2022-12-27	WOS:000284424000038
J	Yan, CG; Cao, J; Wu, M; Zhang, W; Jiang, T; Yoshimura, A; Gao, HW				Yan, Chunguang; Cao, Jay; Wu, Min; Zhang, Wei; Jiang, Tao; Yoshimura, Aihiko; Gao, Hongwei			Suppressor of Cytokine Signaling 3 Inhibits LPS-induced IL-6 Expression in Osteoblasts by Suppressing CCAAT/Enhancer-binding Protein beta Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TOLL-LIKE RECEPTORS; C/EBP FAMILY; OSTEOCLAST DIFFERENTIATION; PROINFLAMMATORY CYTOKINES; INFLAMMATORY ARTHRITIS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MESSENGER-RNA	Suppressor of cytokine signaling 3 (SOCS3) is an important intracellular protein that inhibits cytokine signaling in numerous cell types and has been implicated in several inflammatory diseases. However, the expression and function of SOCS3 in osteoblasts are not known. In this study, we demonstrated that SOCS3 expression was transiently induced by LPS in osteoblasts, and apparently contributed to the inhibition of IL-6 induction by LPS treatment. We found that tyrosine 204 of the SOCS box, the SH2 domain, and the N-terminal kinase inhibitory region (KIR) of SOCS3 were all involved in its IL-6 inhibition. Furthermore, we demonstrated that CCAAT/enhancerbinding protein (C/EBP) beta was activated by LPS (increased DNA binding activity), and played a key role in LPS-induced IL-6 expression in osteoblasts. We further provided the evidence that SOCS3 functioned as a negative regulator for LPS response in osteoblasts by suppressing C/EBP beta DNA binding activity. In addition, tyrosine 204 of the SOCS box, the SH2 domain, and the N-terminal kinase inhibitory region (KIR) of SOCS3 were all required for its C/EBP beta inhibition. These findings suggest that SOCS3 by interfering with C/EBP beta activation may have an important regulatory role during bone-associated inflammatory responses.	[Yan, Chunguang; Zhang, Wei; Gao, Hongwei] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med,Ctr Expt T, Boston, MA 02115 USA; [Yan, Chunguang; Wu, Min; Jiang, Tao; Gao, Hongwei] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA; [Cao, Jay] ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA; [Yoshimura, Aihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Yoshimura, Aihiko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Dakota Grand Forks; United States Department of Agriculture (USDA); Keio University; Japan Science & Technology Agency (JST)	Gao, HW (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med,Ctr Expt T, 20 Shattuck St, Boston, MA 02115 USA.	hgao@zeus.bwh.harvard.edu	Yoshimura, Akihiko/K-5515-2013		North Dakota Experimental Program to Stimulate Competitive Research (NSF); National Institute of Biomedical Innovation (NIBIO)	North Dakota Experimental Program to Stimulate Competitive Research (NSF); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This study was supported by North Dakota Experimental Program to Stimulate Competitive Research (NSF, to H. G.) and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO, to A. Y.).	Akira S, 1995, ANN NY ACAD SCI, V762, P15; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; Cao F, 2006, J NEUROCHEM, V98, P459, DOI 10.1111/j.1471-4159.2006.03890.x; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Ejarque-Ortiz A, 2007, GLIA, V55, P178, DOI 10.1002/glia.20446; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Hu HM, 1998, J IMMUNOL, V160, P2334; Jung WK, 2009, LIFE SCI, V85, P46, DOI 10.1016/j.lfs.2009.04.010; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kondo A, 2001, J INTERF CYTOK RES, V21, P943, DOI 10.1089/107999001753289550; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Liu X, 2008, MOL IMMUNOL, V45, P1405, DOI 10.1016/j.molimm.2007.08.018; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Lubis Adisaputra Ramadhinara, 2008, Acta Med Indones, V40, P89; Matsuda K, 1997, DIABETES, V46, P354, DOI 10.2337/diabetes.46.3.354; Morales O, 2002, J BIOL CHEM, V277, P34879, DOI 10.1074/jbc.M204819200; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Park SH, 2003, DNA CELL BIOL, V22, P131, DOI 10.1089/104454903321515931; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Shouda T, 2001, J CLIN INVEST, V108, P1781, DOI 10.1172/JCI200113568; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Stoiber D, 1999, J IMMUNOL, V163, P2640; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Wong PKK, 2003, ARTHRITIS RHEUM-US, V48, P1177, DOI 10.1002/art.10943; Yao CJ, 2008, BIOCHEM BIOPH RES CO, V371, P309, DOI 10.1016/j.bbrc.2008.04.065; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	44	34	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37227	37239		10.1074/jbc.M110.132084	http://dx.doi.org/10.1074/jbc.M110.132084			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876575	Green Published, hybrid			2022-12-27	WOS:000284424000016
J	Johnston, JB; Ouellet, H; de Montellano, PRO				Johnston, Jonathan B.; Ouellet, Hugues; de Montellano, Paul R. Ortiz			Functional Redundancy of Steroid C-26-monooxygenase Activity in Mycobacterium tuberculosis Revealed by Biochemical and Genetic Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGES; IDENTIFICATION; DEGRADATION; ADAPTATION; METABOLISM; VIRULENCE; SURVIVAL; RACEMASE; LIPIDS	One challenge to the development of new antitubercular drugs is the existence of multiple virulent strains that differ genetically. We and others have recently demonstrated that CYP125A1 is a steroid C-26-monooxygenase that plays a key role in cholesterol catabolism in Mycobacterium tuberculosis CDC1551 but, unexpectedly, not in the M. tuberculosis H37Rv strain. This discrepancy suggests that the H37Rv strain possesses compensatory activities. Here, we examined the roles in cholesterol metabolism of two other cytochrome P450 enzymes, CYP124A1 and CYP142A1. In vitro analysis, including comparisons of the binding affinities and catalytic efficiencies, demonstrated that CYP142A1, but not CYP124A1, can support the growth of H37Rv cells on cholesterol in the absence of cyp125A1. All three enzymes can oxidize the sterol side chain to the carboxylic acid state by sequential oxidation to the alcohol, aldehyde, and acid. Interestingly, CYP125A1 generates oxidized sterols of the (25S)-26-hydroxy configuration, whereas the opposite 25R stereochemistry is obtained with CYP124A1 and CYP142A1. Western blot analysis indicated that CYP124A1 was not detectably expressed in either the H37Rv or CDC1551 strains, whereas CYP142A1 was found in H37Rv but not CDC1551. Genetic complementation of CDC1551 Delta cyp125A1 cells with the cyp124A1 or cyp142A1 genes revealed that the latter can fully rescue the growth defect on cholesterol, whereas cells overexpressing CYP124A1 grow poorly and accumulate cholest-4-en-3-one. Our data clearly establish a functional redundancy in the essential C-26-monooxygenase activity of M. tuberculosis and validate CYP125A1 and CYP142A1 as possible drug targets.	[Johnston, Jonathan B.; Ouellet, Hugues; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Genentech Hall,N572D,600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu			National Institutes of Health [RO1 AI74824]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI74824 (to P. R. O. M.).	APPLEBY CA, 1969, BIOCHIM BIOPHYS ACTA, V172, P88, DOI 10.1016/0005-2728(69)90094-2; Bhaumik P, 2003, ACTA CRYSTALLOGR D, V59, P353, DOI 10.1107/S0907444902020735; Boshoff HI, 2005, NAT MED, V11, P599, DOI 10.1038/nm0605-599; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Jefcoate C R, 1978, Methods Enzymol, V52, P258; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Mougous JD, 2006, P NATL ACAD SCI USA, V103, P4258, DOI 10.1073/pnas.0510861103; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Norlin M, 2003, J LIPID RES, V44, P1515, DOI 10.1194/jlr.M300047-JLR200; Olsen L, 2006, J MED CHEM, V49, P6489, DOI 10.1021/jm060551l; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sakai Y, 2004, J BACTERIOL, V186, P7214, DOI 10.1128/JB.186.21.7214-7220.2004; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shen CF, 2004, J CHROMATOGR B, V810, P119, DOI 10.1016/j.jchromb.2004.07.020; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; *WHO, 2009, WHO FACTS SHEETS TUB; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	40	72	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36352	36360		10.1074/jbc.M110.161117	http://dx.doi.org/10.1074/jbc.M110.161117			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843794	Green Published, hybrid			2022-12-27	WOS:000284146100023
J	Yoshida, H; Teraoka, M; Nishi, N; Nakakita, SI; Nakamura, T; Hirashima, M; Kamitori, S				Yoshida, Hiromi; Teraoka, Misa; Nishi, Nozomu; Nakakita, Shin-ichi; Nakamura, Takanori; Hirashima, Mitsuomi; Kamitori, Shigehiro			X-ray Structures of Human Galectin-9 C-terminal Domain in Complexes with a Biantennary Oligosaccharide and Sialyllactose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; CRYSTAL-STRUCTURE; LECTIN; APOPTOSIS; FAMILY; ECALECTIN; INDUCTION; MECHANISM; REVEALS; PROGRAM	Galectin-9, a tandem-repeat-type beta-galactoside-specific animal lectin with two carbohydrate recognition domains (CRDs) at the N- and C-terminal ends, is involved in chemoattraction, apoptosis, and the regulation of cell differentiation and has anti-allergic effects. Its ability to recognize carbohydrates is essential for its biological functions. Human galectin-9 (hG9) has high affinity for branched N-glycan-type oligosaccharides (dissociation constants of 0.16-0.70 mu M) and linear beta 1-3-linked poly-N-acetyllactosamines (0.09-8.3 mu M) and significant affinity for the alpha 2-3-sialylated oligosaccharides (17-34 mu M). Further, its N-terminal CRD (hG9N) and C-terminal CRD (hG9C) differ in specificity. To elucidate this unique feature of hG9, x-ray structures of hG9C in the free form and in complexes with N-acetyllactosamine, the biantennary pyridylaminated oligosaccharide, and alpha 2-3-sialyllactose were determined. They are the first x-ray structural analysis of C-terminal CRD of the tandem-repeat-type galectin. The results clearly revealed the mechanism by which branched and alpha 2-3-sialylated oligosaccharides are recognized and explained the difference in specificity between hG9N and hG9C. Based on structural comparisons with other galectins, we propose that the wide entrance for ligand binding and the shallow binding site of hG9C are favorable for branched oligosaccharides and that Arg(221) is responsible for recognizing sialylated oligosaccharides.	[Yoshida, Hiromi; Teraoka, Misa; Nishi, Nozomu; Nakakita, Shin-ichi; Kamitori, Shigehiro] Kagawa Univ, Fac Med, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Nakamura, Takanori] Kagawa Univ, Fac Med, Dept Endocrinol, Miki, Kagawa 7610793, Japan; [Hirashima, Mitsuomi] Kagawa Univ, Fac Med, Dept Immunol & Immunopathol, Miki, Kagawa 7610793, Japan	Kagawa University; Kagawa University; Kagawa University	Kamitori, S (corresponding author), Kagawa Univ, Fac Med, Life Sci Res Ctr, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kamitori@med.kagawa-u.ac.jp		Kamitori, Shigehiro/0000-0002-3950-3372; Nishi, Nozomu/0000-0001-7050-3226; Yoshida, Hiromi/0000-0001-8333-8215	Kagawa University	Kagawa University	This work was supported in part by Kagawa University Characteristic Prior Research Fund 2009-2010.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; BRUNGER AT, 1993, X PLOR 3 1 SYSTEM X; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Hirashima M, 1999, INT ARCH ALLERGY IMM, V120, P7, DOI 10.1159/000053584; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; LASKOWSKI RA, 1992, PROCHECK VERSION 2 P; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Matsushita N, 2000, J BIOL CHEM, V275, P8355, DOI 10.1074/jbc.275.12.8355; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miyanishi N, 2007, GLYCOBIOLOGY, V17, P423, DOI 10.1093/glycob/cwm001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2008, J MOL BIOL, V375, P119, DOI 10.1016/j.jmb.2007.09.060; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Nagae M, 2009, GLYCOBIOLOGY, V19, P112, DOI 10.1093/glycob/cwn121; Nakakita SI, 2007, BIOCHEM BIOPH RES CO, V362, P639, DOI 10.1016/j.bbrc.2007.08.032; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	44	36	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36969	36976		10.1074/jbc.M110.163402	http://dx.doi.org/10.1074/jbc.M110.163402			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861009	hybrid, Green Published			2022-12-27	WOS:000284146100071
J	Devel, L; Garcia, S; Czarny, B; Beau, F; Lajeunesse, E; Vera, L; Georgiadis, D; Stura, E; Dive, V				Devel, Laurent; Garcia, Sandra; Czarny, Bertrand; Beau, Fabrice; Lajeunesse, Evelyne; Vera, Laura; Georgiadis, Dimitris; Stura, Enrico; Dive, Vincent			Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S-1 ' Loop Canonical Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; ZINC CHELATING INHIBITORS; MACROPHAGE ELASTASE; POTENTIAL TREATMENT; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; VARIABILITY; EXPRESSION; CHALLENGES; COMPLEXES	After the disappointment of clinical trials with early broad spectrum synthetic inhibitors of matrix metalloproteinases (MMPs), the field is now resurging with a new focus on the development of selective inhibitors that fully discriminate between different members of the MMP family with several therapeutic applications in perspective. Here, we report a novel class of highly selective MMP-12 inhibitors, without a phosphinic zinc-binding group, designed to plunge deeper into the S-1' cavity of the enzyme. The best inhibitor from this series, identified through a systematic chemical exploration, displays nanomolar potency toward MMP-12 and selectivity factors that range between 2 and 4 orders of magnitude toward a large set of MMPs. Comparison of the high resolution x-ray structures of MMP-12 in free state or bound to this new MMP-12 selective inhibitor reveals that this compound fits deeply within the S-1' specificity cavity, maximizing surface/volume ratios, without perturbing the S-1' loop conformation. This is in contrast with highly selective MMP-13 inhibitors that were shown to select a particular S-1' loop conformation. The search for such compounds that fit precisely to preponderant S-1' loop conformation of a particular MMP may prove to be an alternative effective strategy for developing selective inhibitors of MMPs.	[Stura, Enrico; Dive, Vincent] CEA, Serv Ingn Mol Prot, CE Saclay, F-91191 Gif Sur Yvette, France; [Georgiadis, Dimitris] Univ Athens, Dept Organ Chem, Organ Chem Lab, GR-15771 Athens, Greece	CEA; National & Kapodistrian University of Athens	Dive, V (corresponding author), CEA, Serv Ingn Mol Prot, CE Saclay, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Czarny, Bertrand/F-2001-2018; Georgiadis, Dimitris/AAB-1550-2020; Stura, Enrico A./A-2793-2010; CZARNY, bertrand/AAP-6603-2020	Czarny, Bertrand/0000-0002-9586-0913; Stura, Enrico A./0000-0001-6718-2118; CZARNY, bertrand/0000-0002-9586-0913	Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by funds from the Commissariat a l'Energie Atomique.	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; Brown S, 2004, CURR TOP MED CHEM, V4, P1227, DOI 10.2174/1568026043387854; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Dabert-Gay AS, 2008, J BIOL CHEM, V283, P31058, DOI 10.1074/jbc.M805795200; DeLano W.L, PYMOL MOL GRAPHICS S; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Jullien N, 2010, J MED CHEM, V53, P208, DOI 10.1021/jm9010803; Lagente V, 2009, EXPERT OPIN THER TAR, V13, P287, DOI [10.1517/14728220902751632, 10.1517/14728220902751632 ]; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li W, 2009, J MED CHEM, V52, P5408, DOI 10.1021/jm900809r; Li W, 2009, J MED CHEM, V52, P1799, DOI 10.1021/jm900093d; Liu MZ, 2004, ARTHRITIS RHEUM-US, V50, P3112, DOI 10.1002/art.20567; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Moy FJ, 2002, J AM CHEM SOC, V124, P12658, DOI 10.1021/ja027391x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Rodriguez-Pla A, 2009, RHEUMATOLOGY, V48, P1460, DOI 10.1093/rheumatology/kep271; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Tu GG, 2008, CURR MED CHEM, V15, P1388, DOI 10.2174/092986708784567680; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001	49	44	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35900	35909		10.1074/jbc.M110.139634	http://dx.doi.org/10.1074/jbc.M110.139634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817735	hybrid, Green Published			2022-12-27	WOS:000283845300067
J	Llop-Tous, I; Madurga, S; Giralt, E; Marzabal, P; Torrent, M; Ludevid, MD				Llop-Tous, Immaculada; Madurga, Sergio; Giralt, Ernest; Marzabal, Pablo; Torrent, Margarita; Ludevid, M. Dolors			Relevant Elements of a Maize gamma-Zein Domain Involved in Protein Body Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; TRANSIENT-EXPRESSION SYSTEM; N-TERMINAL DOMAIN; ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; QUALITY-CONTROL; RICE ENDOSPERM; RECOMBINANT PROTEINS; TRANSGENIC TOBACCO; STRUCTURAL DOMAINS	The N-terminal proline-rich domain of gamma-zein (Zera) plays an important role in protein body (PB) formation not only in the original host (maize seeds) but in a broad spectrum of eukaryotic cells. However, the elements within the Zera sequence that are involved in the biogenesis of PBs have not been clearly identified. Here, we focused on amino acid sequence motifs that could be involved in Zera oligomerization, leading to PB-like structures in Nicotiana benthamiana leaves. By using fusions of Zera with fluorescent proteins, we found that the lack of the repeat region (PPPVHL)(8) of Zera resulted in the secretion of the fusion protein but that this repeat by itself did not form PBs. Although the repeat region containing eight units was the most efficient for Zera self-assembly, shorter repeats of 4-6 units still formed small multimers. Based on site-directed mutagenesis of Zera cysteine residues and analysis of multimer formation, we conclude that the two N-terminal Cys residues of Zera (Cys(7) and Cys(9)) are critical for oligomerization. Immunoelectron microscopy and confocal studies on PB development over time revealed that early, small, Zera-derived oligomers were sequestered in buds along the rough ER and that the mature size of the PBs could be attained by both cross-linking of preformed multimers and the incorporation of new chains of Zera fusions synthesized by active membrane-bound ribosomes. Based on these results and on the behavior of the Zera structure determined by molecular dynamics simulation studies, we propose a model of Zera-induced PB biogenesis.	[Ludevid, M. Dolors] CSIC, Ctr Recerca Agrigenom, ES-08034 Barcelona, Spain; [Madurga, Sergio] Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain; [Madurga, Sergio] Univ Barcelona, IQTCUB, E-08028 Barcelona, Spain; [Giralt, Ernest] Inst Recerca Biomed, Barcelona 08028, Spain; [Marzabal, Pablo] ERA Biotech, Barcelona 08028, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Ludevid, MD (corresponding author), CSIC, Ctr Recerca Agrigenom, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	dlmgmd@cid.csic.es	giralt, ernest/N-1669-2014	giralt, ernest/0000-0001-8381-1797; Madurga, Sergio/0000-0002-8135-7057	Generalitat de Catalunya XRB [SGR00182]; XRB and Grup Consolidat; Ministerio de Ciencia y Tecnologia-Fondo Europeo de Desarrollo Regional (MCYT-FEDER) [Bio2008-00799]; ERA Biotech S.A.	Generalitat de Catalunya XRB; XRB and Grup Consolidat; Ministerio de Ciencia y Tecnologia-Fondo Europeo de Desarrollo Regional (MCYT-FEDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ERA Biotech S.A.	This work was supported by grants from the Generalitat de Catalunya XRB and SGR00182 (to M. D. L) and XRB and Grup Consolidat (to E. G.). This work was also supported by Ministerio de Ciencia y Tecnologia-Fondo Europeo de Desarrollo Regional (MCYT-FEDER) Grant Bio2008-00799 and ERA Biotech S.A. (to M. D. L).	Alvarez ML, 2010, PLANT MOL BIOL, V72, P75, DOI 10.1007/s11103-009-9552-4; Bagga S, 1997, PLANT CELL, V9, P1683; BAGGA S, 1995, PLANT PHYSIOL, V107, P13, DOI 10.1104/pp.107.1.13; Bicudo TC, 2008, BIOPOLYMERS, V89, P175, DOI 10.1002/bip.20884; Birk J, 2009, J CELL SCI, V122, P3994, DOI 10.1242/jcs.051136; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Brandizzi F, 2003, PLANT J, V34, P269, DOI 10.1046/j.1365-313X.2003.01728.x; Coleman CE, 1996, PLANT CELL, V8, P2335, DOI 10.1105/tpc.8.12.2335; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; Crofts AJ, 2004, PLANT PHYSIOL, V136, P3414, DOI 10.1104/pp.104.048934; Curtis RA, 2002, BIOPHYS CHEM, V98, P249, DOI 10.1016/S0301-4622(02)00071-6; Dalcol I, 1996, J ORG CHEM, V61, P6775, DOI 10.1021/jo960987g; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foresti O, 2008, MOL PLANT, V1, P1067, DOI 10.1093/mp/ssn066; GELI MI, 1994, PLANT CELL, V6, P1911; Goytia E, 2006, J GEN VIROL, V87, P3413, DOI 10.1099/vir.0.82301-0; Herman EM, 2008, CURR OPIN PLANT BIOL, V11, P672, DOI 10.1016/j.pbi.2008.08.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kawagoe Y, 2005, PLANT CELL, V17, P1141, DOI 10.1105/tpc.105.030668; Kogan MJ, 2004, BIOPOLYMERS, V73, P258, DOI 10.1002/bip.10578; Kogan MJ, 2001, J MOL BIOL, V312, P907, DOI 10.1006/jmbi.2001.4999; Kogan MJ, 2002, BIOPHYS J, V83, P1194, DOI 10.1016/S0006-3495(02)75243-0; LARKINS BA, 1978, PLANT PHYSIOL, V62, P256, DOI 10.1104/pp.62.2.256; Li CP, 1996, PLANT MOL BIOL, V30, P873, DOI 10.1007/BF00020800; LI XX, 1993, CELL, V72, P869, DOI 10.1016/0092-8674(93)90576-C; LUDEVID MD, 2004, Patent No. 2004003207; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mainieri D, 2004, PLANT PHYSIOL, V136, P3447, DOI 10.1104/pp.104.046409; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Muench DG, 1997, PLANT CELL PHYSIOL, V38, P404, DOI 10.1093/oxfordjournals.pcp.a029183; Muntz K, 1998, PLANT MOL BIOL, V38, P77, DOI 10.1023/A:1006020208380; Onda Y, 2009, P NATL ACAD SCI USA, V106, P14156, DOI 10.1073/pnas.0904429106; PEDRAZZINI E, 1994, PLANT J, V5, P103, DOI 10.1046/j.1365-313X.1994.5010103.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Pompa A, 2006, PLANT CELL, V18, P2608, DOI 10.1105/tpc.106.042226; PUEYO JJ, 1995, PLANTA, V196, P586, DOI 10.1007/BF00203660; Pujals S, 2006, BBA-BIOMEMBRANES, V1758, P264, DOI 10.1016/j.bbamem.2006.01.006; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; RABANAL F, 1993, BIOPOLYMERS, V33, P1019, DOI 10.1002/bip.360330704; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Saito Y, 2009, J EXP BOT, V60, P615, DOI 10.1093/jxb/ern311; SHORROSH BS, 1993, PLANT PHYSIOL, V103, P719, DOI 10.1104/pp.103.3.719; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Starkuviene V, 2007, TRAFFIC, V8, P1035, DOI 10.1111/j.1600-0854.2007.00582.x; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; TORRENT M, 1994, PLANTA, V192, P512, DOI 10.1007/BF00203589; Torrent Margarita, 2009, V483, P193, DOI 10.1007/978-1-59745-407-0_11; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; Vila JA, 2004, BIOPHYS J, V86, P731, DOI 10.1016/S0006-3495(04)74151-X; Vitale A, 2004, PLANT PHYSIOL, V136, P3420, DOI 10.1104/pp.104.050351; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Washida H, 2009, PLANT J, V60, P146, DOI 10.1111/j.1365-313X.2009.03944.x; WETZEL R, 1999, METHOD ENZYMOL, V309, P189; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690	63	42	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35633	35644		10.1074/jbc.M110.116285	http://dx.doi.org/10.1074/jbc.M110.116285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829359	Green Published, hybrid			2022-12-27	WOS:000283845300042
J	Long, JS; Fujiwara, Y; Edwards, J; Tannahill, CL; Tigyi, G; Pyne, S; Pyne, NJ				Long, Jaclyn S.; Fujiwara, Yuko; Edwards, Joanne; Tannahill, Claire L.; Tigyi, Gabor; Pyne, Susan; Pyne, Nigel J.			Sphingosine 1-Phosphate Receptor 4 Uses HER2 (ERBB2) to Regulate Extracellular Signal Regulated Kinase-1/2 in MDA-MB-453 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR RECEPTOR; LYSOPHOSPHATIDIC ACID; MAMMALIAN-CELLS; MOLECULAR-CLONING; PROLIFERATION; MIGRATION; PATHWAY; SPHINGOSINE-1-PHOSPHATE; ACTIVATION	We demonstrate here that the bioactive lipid sphingosine 1-phosphate (S1P) uses sphingosine 1-phosphate receptor 4 (S1P(4)) and human epidermal growth factor receptor 2 (HER2) to stimulate the extracellular signal regulated protein kinase 1/2 (ERK-1/2) pathway in MDA-MB-453 cells. This was based on several lines of evidence. First, the S1P stimulation of ERK-1/2 was abolished by JTE013, which we show here is an S1P(2/4) antagonist and reduced by siRNA knockdown of S1P(4). Second, the S1P-stimulated activation of ERK-1/2 was almost completely abolished by a HER2 inhibitor (ErbB2 inhibitor II) and reduced by siRNA knockdown of HER2 expression. Third, phyto-S1P, which is an S1P(4) agonist, stimulated ERK-1/2 activation in an S1P(4)- and HER2-dependent manner. Fourth, FTY720 phosphate, which is an agonist at S1P(1,3,4,5) but not S1P(2) stimulated activation of ERK-1/2. Fifth, S1P stimulated the tyrosine phosphorylation of HER2, which was reduced by JTE013. HER2 which is an orphan receptor tyrosine kinase is the preferred dimerization partner of the EGF receptor. However, EGF-stimulated activation of ERK-1/2 was not affected by siRNA knockdown of HER2 or by ErbB2 (epidermal growth factor receptor 2 (or HER2)) inhibitor II in MDA-MB-453 cells. Moreover, S1P stimulated activation of ERK-1/2 does not require an EGF receptor. Thus, S1P and EGF function in a mutually exclusive manner. In conclusion, the magnitude of the signaling gain on the ERK-1/2 pathway produced in response to S1P can be increased by HER2 in MDA-MB-453 cells. The linkage of S1P with an oncogene suggests that S1P and specifically S1P(4) may have an important role in breast cancer progression.	[Long, Jaclyn S.; Pyne, Susan; Pyne, Nigel J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland; [Fujiwara, Yuko; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Edwards, Joanne; Tannahill, Claire L.] Univ Glasgow, Glasgow Royal Infirm, Fac Med, Div Canc Sci & Mol Pathol,Sect Surg, Glasgow G31 2ER, Lanark, Scotland	University of Strathclyde; University of Tennessee System; University of Tennessee Health Science Center; University of Glasgow	Pyne, NJ (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Grp, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	n.j.pyne@strath.ac.uk	Edwards, Joanne/J-1903-2015; Pyne, Susan/AAF-5001-2019	Edwards, Joanne/0000-0002-7192-6906; Pyne, Susan/0000-0002-6608-9584; Pyne, Nigel/0000-0002-5657-4578	Cancer Research UK [23158/A7536]; National Institutes of Health [CA92160]; Royal College of Surgeons (Glasgow and Edinburgh branches); Glasgow Royal Infirmary endowment fund; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal College of Surgeons (Glasgow and Edinburgh branches); Glasgow Royal Infirmary endowment fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Research UK Grant 23158/A7536 (to S. P. and N. J. P.), National Institutes of Health Grant CA92160 from USPHS(to G. T.), the Royal College of Surgeons (Glasgow and Edinburgh branches), and a Glasgow Royal Infirmary endowment fund (to J. E.).	Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; An SZ, 1998, J CELL BIOCHEM, P147; An SZ, 1999, MOL PHARMACOL, V55, P787; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; BORG A, 1990, CANCER RES, V50, P4332; Cheng ZY, 2007, BIOORGAN MED CHEM, V15, P1533, DOI 10.1016/j.bmc.2006.09.041; Glickman M, 1999, MOL CELL NEUROSCI, V14, P141, DOI 10.1006/mcne.1999.0776; Goetzl EJ, 1999, CANCER RES, V59, P4732; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Gschwind A, 2002, CANCER RES, V62, P6329; HLA T, 1990, J BIOL CHEM, V265, P9308; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Koide Y, 2002, J MED CHEM, V45, P4629, DOI 10.1021/jm020080c; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Lu XQ, 2009, J ORG CHEM, V74, P3192, DOI 10.1021/jo900023u; McGlynn LM, 2009, CLIN CANCER RES, V15, P1487, DOI 10.1158/1078-0432.CCR-07-4967; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Ohmori T, 2003, CARDIOVASC RES, V58, P170, DOI 10.1016/S0008-6363(03)00260-8; OKAZAKI H, 1993, BIOCHEM BIOPH RES CO, V190, P1104, DOI 10.1006/bbrc.1993.1163; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pyne NJ, 2008, BBA-MOL CELL BIOL L, V1781, P467, DOI 10.1016/j.bbalip.2008.05.004; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; Shida D, 2005, BIOCHEM BIOPH RES CO, V327, P907, DOI 10.1016/j.bbrc.2004.12.088; Shida D, 2004, FEBS LETT, V577, P333, DOI 10.1016/j.febslet.2004.10.024; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Tovey SM, 2004, BREAST CANCER RES, V6, pR246, DOI 10.1186/bcr783; Wang F, 1999, CANCER RES, V59, P6185; Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	39	63	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35957	35966		10.1074/jbc.M110.117945	http://dx.doi.org/10.1074/jbc.M110.117945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837468	Green Published, hybrid			2022-12-27	WOS:000283845300072
J	Kawasaki, A; Nakano, H; Hosokawa, A; Nakatsu, T; Kato, H; Watanabe, K				Kawasaki, Akio; Nakano, Hiroaki; Hosokawa, Allin; Nakatsu, Toru; Kato, Hiroaki; Watanabe, Kunihiko			The Exquisite Structure and Reaction Mechanism of Bacterial Pz-peptidase A toward Collagenous Peptides X-RAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS OF PZ-PEPTIDASE A REVEALS DIFFERENCES FROM MAMMALIAN THIMET OLIGOPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIMET OLIGOPEPTIDASE; CRYSTAL-STRUCTURE; PROVIDES INSIGHT; SUBSTRATE; BINDING; THERMOPHILE; NEUROLYSIN; PROTEASE; ENZYMES	Pz-peptidase A, from the thermophilic bacterium Geobacillus collagenovorans MO-1, hydrolyzes a synthetic peptide substrate, 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-ProD-Arg (Pz-PLGPR), which contains a collagen-specific tripeptide sequence, -Gly-Pro-X-, but does not act on collagen proteins themselves. The mammalian enzyme, thimet oligopeptidase (TOP), which has comparable functions with bacterial Pz-peptidases but limited identity at the primary sequence level, has recently been subjected to x-ray crystallographic analysis; however, no crystal structure has yet been reported for complexes of TOP with substrate analogues. Here, we report crystallization of recombinant Pz-peptidase A in complex with two phosphinic peptide inhibitors (PPIs) that also function as inhibitors of TOP and determination of the crystal structure of these complexes at 1.80-2.00 angstrom resolution. The most striking difference between Pz-peptidase A and TOP is that there is no channel running the length of bacterial protein. Whereas the structure of TOP resembles an open bivalve, that of Pz-peptidase A is closed and globular. This suggests that collagenous peptide substrates enter the tunnel at the top gateway of the closed Pz-peptidase A molecule, and reactant peptides are released from the bottom gateway after cleavage at the active site located in the center of the tunnel. One of the two PPIs, PPI-2, which contains the collagen-specific sequence, helped to clarify the exquisite structure and reaction mechanism of Pz-peptidase A toward collagenous peptides. This study describes the mode of substrate binding and its implication for the mammalian enzymes.	[Kawasaki, Akio; Hosokawa, Allin; Watanabe, Kunihiko] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakyo Ku, Kyoto 6068522, Japan; [Nakano, Hiroaki; Nakatsu, Toru; Kato, Hiroaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sakyo Ku, Kyoto 6068501, Japan; [Nakano, Hiroaki] Hyogo Univ Hlth Sci, Dept Pharm, Chuo Ku, Kobe, Hyogo 6508530, Japan	Kyoto Prefectural University; Kyoto University	Watanabe, K (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakyo Ku, Kyoto 6068522, Japan.	kwatanab@kpu.ac.jp		Kato, Hiroaki/0000-0002-5993-4532; Nakatsu, Toru/0000-0002-9582-4023	Hyogo University of Health Sciences Research [2102]	Hyogo University of Health Sciences Research	This work was supported in part by the Hyogo University of Health Sciences Research grant for 2102 (to H. N.).	Barrett A J, 1992, Matrix Suppl, V1, P95; BARRETT AJ, 1991, J BIOCH J */* BIOCH, V277, P295; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Bruce LA, 2008, FEBS J, V275, P5607, DOI 10.1111/j.1742-4658.2008.06685.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMARAARTIGAS A, 2009, DRUG DESIGN ZINC ENZ, P751; *COLL COMP PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, pD760; Comellas-Bigier M, 2005, J MOL BIOL, V349, P99, DOI 10.1016/j.jmb.2005.03.016; Corazza A, 2006, PROTEINS, V62, P64, DOI 10.1002/prot.20703; DALI L, 1993, J MOL BIOL, V233, P123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Hay ED., 1991, CELL BIOL EXTRACELLU, P7; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; JIRA CEKJ, 1995, J BIOL CHEM */* V J, V270, P21701; JIRA CEKJ, 1996, J BIOL CHEM */* V J, V271, P19606; Kawasaki A, 2007, ACTA CRYSTALLOGR F, V63, P142, DOI 10.1107/S174430910700334X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Miyake R, 2005, J BACTERIOL, V187, P4140, DOI 10.1128/JB.187.12.4140-4148.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers LK, 1998, J IMMUNOL, V161, P3589; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Niemirowicz G, 2008, MOL MICROBIOL, V70, P853, DOI 10.1111/j.1365-2958.2008.06444.x; NIMNI ME, 1983, SEMIN ARTHRITIS RHEU, V13, P1, DOI 10.1016/0049-0172(83)90024-0; Okamoto M, 2001, APPL MICROBIOL BIOT, V57, P103, DOI 10.1007/s002530100731; PETERKOFSKY B, 1982, METHOD ENZYMOL, V82, P453; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Philominathan STL, 2009, J BIOL CHEM, V284, P10868, DOI 10.1074/jbc.M807684200; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Sugihara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P594, DOI 10.1271/bbb.60534; Suzuki Y, 2006, J BIOSCI BIOENG, V102, P73, DOI 10.1263/jbb.102.73; TISLJAR U, 1990, ANAL BIOCHEM, V186, P112, DOI 10.1016/0003-2697(90)90582-T; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	43	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34972	34980		10.1074/jbc.M110.141838	http://dx.doi.org/10.1074/jbc.M110.141838			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817732	Green Published, hybrid			2022-12-27	WOS:000283659100071
J	Lambrecht, JA; Browne, BA; Downs, DM				Lambrecht, Jennifer A.; Browne, Beth Ann; Downs, Diana M.			Members of the YjgF/YER057c/UK114 Family of Proteins Inhibit Phosphoribosylamine Synthesis in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; HIGHLY CONSERVED PROTEIN; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; ANTHRANILATE SYNTHETASE; THIAMINE SYNTHESIS; ISOLEUCINE BIOSYNTHESIS; THREONINE DEAMINASE; TRYPTOPHAN OPERON; ENZYME COMPLEX	The YjgF/YER057c/UK114 family of proteins is highly conserved across all three domains of life and currently lacks a consensus biochemical function. Analysis of Salmonella enterica strains lacking yjgF has led to a working model in which YjgF functions to remove potentially toxic secondary products of cellular enzymes. Strains lacking yjgF synthesize the thiamine precursor phosphoribosylamine (PRA) by a TrpD-dependent mechanism that is not present in wild-type strains. Here, PRA synthesis was reconstituted in vitro with anthranilate phosphoribosyltransferase (TrpD), threonine dehydratase (IlvA), threonine, and phosphoribosyl pyrophosphate. TrpD-dependent PRA formation in vitro was inhibited by S. enterica YjgF and the human homolog UK114. Thus, the work herein describes the first biochemical assay for diverse members of the highly conserved YjgF/YER057c/UK114 family of proteins and provides a means to dissect the cellular functions of these proteins.	[Lambrecht, Jennifer A.; Browne, Beth Ann; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), 1550 Linden Dr, Madison, WI 53706 USA.	downs@bact.wisc.edu			National Institutes of Health [GM47296, T32 GM07215]; J. S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM047296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. S. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Competitive Grant GM47296. This work was also supported by a 21st Century Scientist Scholars award from the J. S. McDonnell Foundation (to D. M. D.).; Supported by National Institutes of Health Molecular Biosciences Traineeship T32 GM07215.	BAUERLE RH, 1966, COLD SPRING HARB SYM, V31, P203, DOI 10.1101/SQB.1966.031.01.028; BLUME AJ, 1966, GENETICS, V53, P577; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Browne BA, 2006, J BACTERIOL, V188, P6786, DOI 10.1128/JB.00745-06; Burns RO., 1971, METHOD ENZYMOL, V17B, P555; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Chargaff E, 1943, J BIOL CHEM, V151, P273; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; D'Inca R, 2010, J PROTEOMICS, V73, P1542, DOI 10.1016/j.jprot.2010.03.017; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; EnosBerlage JL, 1996, J BACTERIOL, V178, P1476, DOI 10.1128/jb.178.5.1476-1479.1996; GoupilFeuillerat N, 1997, J BACTERIOL, V179, P6285, DOI 10.1128/JB.179.20.6285-6293.1997; GRIESHABER M, 1974, BIOCHEMISTRY-US, V13, P373, DOI 10.1021/bi00699a024; He ZG, 1998, J BACTERIOL, V180, P2502, DOI 10.1128/JB.180.9.2502-2506.1998; HENDERSON EJ, 1970, J BIOL CHEM, V245, P1416; Kim JM, 2001, GENES CELLS, V6, P507, DOI 10.1046/j.1365-2443.2001.00443.x; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Koenigsknecht MJ, 2007, J BIOL CHEM, V282, P28379, DOI 10.1074/jbc.M704024200; LUGINBUHL GH, 1974, J BACTERIOL, V120, P559, DOI 10.1128/JB.120.1.559-561.1974; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; NEWELL PC, 1968, BIOCHEM J, V106, P271, DOI 10.1042/bj1060271; NIERLICH.DP, 1965, J BIOL CHEM, V240, P366; Oxelmark E, 2000, MOL CELL BIOL, V20, P7784, DOI 10.1128/MCB.20.20.7784-7797.2000; Parsons L, 2003, BIOCHEMISTRY-US, V42, P80, DOI 10.1021/bi020541w; Petersen L, 1996, GENETICS, V143, P37; PHILLIPS AT, 1965, J BIOL CHEM, V240, P4703; Ramos I, 2003, J BACTERIOL, V185, P5125, DOI 10.1128/JB.185.17.5125-5132.2003; Ramos I, 2008, J BACTERIOL, V190, P815, DOI 10.1128/JB.00582-07; Rappu P, 1999, J BACTERIOL, V181, P3810, DOI 10.1128/JB.181.12.3810-3815.1999; Roberts GP, 1978, THESIS U CALIFORNIA; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; Schmiedeknecht G, 1996, EUR J BIOCHEM, V242, P339, DOI 10.1111/j.1432-1033.1996.0339r.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SCHMITZ G, 2006, THESIS U WISCONSIN M; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TSO JY, 1982, J BIOL CHEM, V257, P3532; UMBARGER HE, 1957, J BACTERIOL, V73, P105, DOI 10.1128/JB.73.1.105-112.1957; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; ZALKIN H, 1973, ADV ENZYMOL RAMB, V38, P1; Zelyas NJ, 2008, J BACTERIOL, V190, P7957, DOI 10.1128/JB.00698-08	45	33	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34401	34407		10.1074/jbc.M110.160515	http://dx.doi.org/10.1074/jbc.M110.160515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817725	Green Published, hybrid			2022-12-27	WOS:000283659100014
J	Su, XY; Agarwal, V; Dodd, D; Bae, B; Mackie, RI; Nair, SK; Cann, IKO				Su, Xiaoyun; Agarwal, Vinayak; Dodd, Dylan; Bae, Brian; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.			Mutational Insights into the Roles of Amino Acid Residues in Ligand Binding for Two Closely Related Family 16 Carbohydrate Binding Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOANAEROBACTERIUM-POLYSACCHAROLYTICUM; CELLOBIOHYDROLASE I; MOLECULAR-CLONING; RECOGNITION; CELLULOSE; DOMAINS; PURIFICATION; SPECIFICITY; SELECTIVITY; EXPRESSION	Carbohydrate binding modules (CBMs) are specialized proteins that bind to polysaccharides and oligosaccharides. Caldanaerobius polysaccharolyticus Man5ACBM16-1/CBM16-2 bind to glucose-, mannose-, and glucose/mannose-configured substrates. The crystal structures of the two proteins represent the only examples in CBM family 16, and studies that evaluate the roles of amino acid residues in ligand binding in this family are lacking. In this study, we probed the roles of amino acids (selected based on CBM16-1/ligand co-crystal structures) on substrate binding. Two tryptophan (Trp-20 and Trp-125) and two glutamine (Gln-81 and Gln-93) residues are shown to be critical in ligand binding. Additionally, several polar residues that flank the critical residues also contribute to ligand binding. The CBM16-1 Q121E mutation increased affinity for all substrates tested, whereas the Q21G and N97R mutants exhibited decreased substrate affinity. We solved CBM/substrate co-crystal structures to elucidate the molecular basis of the increased substrate binding by CBM16-1 Q121E. The Gln-121, Gln-21, and Asn-97 residues can be manipulated to fine-tune ligand binding by the Man5A CBMs. Surprisingly, none of the eight residues investigated was absolutely conserved in CBM family 16. Thus, the critical residues in the Man5A CBMs are either not essential for substrate binding in the other members of this family or the two CBMs are evolutionarily distinct from the members available in the current protein database. Man5A is dependent on its CBMs for robust activity, and insights from this study should serve to enhance our understanding of the interdependence of its catalytic and substrate binding modules.	[Su, Xiaoyun; Dodd, Dylan; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Su, Xiaoyun; Dodd, Dylan; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Dodd, Dylan; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Bae, Brian; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA.	snair@uiuc.edu; icann@illinois.edu	Nair, Satish/AAY-2510-2021; Agarwal, Vinayak/L-5688-2017	Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NIDDK [1F30DK084726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084726] Funding Source: NIH RePORTER	Energy Biosciences Institute; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Energy Biosciences Institute and in part by National Institutes of Health Fellowship 1F30DK084726 from NIDDK (to D. D.).	Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; BLAAK H, 1993, EUR J BIOCHEM, V214, P659, DOI 10.1111/j.1432-1033.1993.tb17966.x; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRU N, 1992, NATURE */* A T NATUR, V355, P472; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; COUGHLAN MP, 1985, BIOTECHNOL GENET ENG, V3, P39, DOI 10.1080/02648725.1985.10647809; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Gao PJ, 2001, ACTA BIOCH BIOPH SIN, V33, P13; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee YJ, 2008, INT J SYST EVOL MICR, V58, P666, DOI 10.1099/ijs.0.65329-0; Leng L, 1998, GENE, V222, P187, DOI 10.1016/S0378-1119(98)00496-X; Matsushima R, 2010, APPL MICROBIOL BIOT, V86, P567, DOI 10.1007/s00253-009-2278-z; Mattinen ML, 1997, PROTEIN SCI, V6, P294; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; TAKEO K, 1984, ELECTROPHORESIS, V5, P187, DOI 10.1002/elps.1150050402; Tomme P, 1996, BIOCHEMISTRY-US, V35, P13885, DOI 10.1021/bi961185i; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xie HF, 2001, BIOCHEMISTRY-US, V40, P5700, DOI 10.1021/bi010034z; Xie HF, 2001, BIOCHEMISTRY-US, V40, P9167, DOI 10.1021/bi0106742; Yamagishi K, 2003, J BIOL CHEM, V278, P25766, DOI 10.1074/jbc.M212183200	41	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34665	34676		10.1074/jbc.M110.168302	http://dx.doi.org/10.1074/jbc.M110.168302			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739280	hybrid, Green Published			2022-12-27	WOS:000283659100042
J	Morton, MJ; Farr, GA; Hull, M; Capendeguy, O; Horisberger, JD; Caplan, MJ				Morton, Michael J.; Farr, Glen A.; Hull, Michael; Capendeguy, Oihana; Horisberger, Jean-Daniel; Caplan, Michael J.			Association with beta-COP Regulates the Trafficking of the Newly Synthesized Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM RETENTION; SODIUM-POTASSIUM PUMP; NA-K-ATPASE; ALPHA-SUBUNIT; CELL-SURFACE; CRYSTAL-STRUCTURE; XENOPUS OOCYTES; PROTEINS; RAT; TRANSCRIPTION	Plasma membrane expression of the Na,K-ATPase requires assembly of its alpha- and beta-subunits. Using a novel labeling technique to identify Na,K-ATPase partner proteins, we detected an interaction between the Na,K-ATPase alpha-subunit and the coat protein, beta-COP, a component of the COP-I complex. When expressed in the absence of the Na,K-ATPase beta-subunit, the Na,K-ATPase alpha-subunit interacts with beta-COP, is retained in the endoplasmic reticulum, and is targeted for degradation. In the presence of the Na,K-ATPase beta-subunit, the alpha-subunit does not interact with beta-COP and traffics to the plasma membrane. Pulse-chase experiments demonstrate that in cells expressing both the Na,K-ATPase alpha- and beta-subunits, newly synthesized alpha-subunit associates with beta-COP immediately after its synthesis but that this interaction does not constitute an obligate intermediate in the assembly of the alpha- and beta-subunits to form the pump holoenzyme. The interaction with beta-COP was reduced by mutating a dibasic motif at Lys(54) in the Na,K-ATPase alpha-subunit. This mutant alpha-subunit is not retained in the endoplasmic reticulum and reaches the plasma membrane, even in the absence of Na,K-ATPase alpha-subunit expression. Although the Lys(54) alpha-subunit reaches the cell surface without need for beta-subunit assembly, it is only functional as an ion-transporting ATPase in the presence of the beta-subunit.	[Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Capendeguy, Oihana; Horisberger, Jean-Daniel] Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, CH-1005 Lausanne, Switzerland	Yale University; University of Lausanne	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	michael.caplan@yale.edu		Farr, Glen/0000-0002-5651-7995; Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK 072614]; Leducq Foundation Transatlantic Network for Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK072614, R01DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation Transatlantic Network for Hypertension(Leducq Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 072614 (to M. J. C.). This work was also supported by funds from the Leducq Foundation Transatlantic Network for Hypertension (to M. J. C. and J.-D. H.).	Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; Jain S, 1997, GENE, V190, P37, DOI 10.1016/S0378-1119(96)00746-9; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; KATZ AI, 1979, AM J PHYSIOL, V237, pF114, DOI 10.1152/ajprenal.1979.237.2.F114; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; LEMAS MV, 1994, J BIOL CHEM, V269, P8255; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Tirat A, 2006, INT J BIOL MACROMOL, V39, P66, DOI 10.1016/j.ijbiomac.2006.01.012; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Zatti A, 2005, MOL BIOL CELL, V16, P5087, DOI 10.1091/mbc.E05-03-0200; Zhuang Y, 2000, J BIOL CHEM, V275, P24173, DOI 10.1074/jbc.M002953200	29	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33737	33746		10.1074/jbc.M110.141119	http://dx.doi.org/10.1074/jbc.M110.141119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801885	Green Published, hybrid			2022-12-27	WOS:000283354000019
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			JBC Centennial 1905-2005 100 Years of Biochemistry and Molecular Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item														Kresge, Nicole/0000-0003-1551-6627					0	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34							e9	10.1074/jbc.O110.000232	http://dx.doi.org/10.1074/jbc.O110.000232			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20740724	Green Published, hybrid			2022-12-27	WOS:000280921000087
J	Lee, M; Partridge, NC				Lee, Minnkyong; Partridge, Nicola C.			Parathyroid Hormone Activation of Matrix Metalloproteinase-13 Transcription Requires the Histone Acetyltransferase Activity of p300 and PCAF and p300-dependent Acetylation of PCAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT COLLAGENASE-3 PROMOTER; BONE-FORMATION; OSTEOBLASTIC CELLS; COACTIVATORS P300; GENE-EXPRESSION; IN-VIVO; P300/CBP-ASSOCIATED FACTOR; MUSCLE DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; MESSENGER-RNA	Parathyroid hormone (PTH) regulates the transcription of many genes involved in bone remodeling in osteoblasts. One of these genes is matrix metalloproteinase-13 (MMP-13), which is involved in bone remodeling and early stages of endochondral bone formation. We have previously shown that Mmp-13 gene expression is highly induced by PTH treatment in osteoblastic UMR106-01 cells, as well as primary osteoblasts. Here, we show that p300/CBP-associated factor (PCAF), in addition to p300 and Runx2, is required for PTH activation of Mmp-13 transcription. PCAF was increasingly recruited to the MMP-13 proximal promoter region after PTH treatment, and this was associated with an increase in RNA polymerase II recruitment and histone acetylation. In addition, PTH treatment increased the acetylation of PCAF, a process that required p300. Knockdown of PCAF, p300, or Runx2 by siRNA decreased Mmp-13 mRNA expression after PTH treatment in both UMR 106-01 cells and primary osteoblasts. We found that there is a mutual dependence between p300 and PCAF to be recruited to the Mmp-13 promoter after PTH treatment. In promoter-reporter assays, p300 and PCAF had an additive effect on PTH stimulation of MMP-13 promoter activity, and this required their histone acetyltransferase activity. Our findings demonstrate that PCAF acts downstream of PTH signaling as a transcriptional coactivator that is required for PTH stimulation of MMP-13 transcription. PCAF cooperates with p300 and Runx2 to mediate PTH activation of MMP-13 transcription.	[Lee, Minnkyong; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Lee, Minnkyong] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Piscataway, NJ 08854 USA	New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420, R56DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47420 ( to N.C.P.).	Ala-aho R, 2004, ONCOGENE, V23, P5111, DOI 10.1038/sj.onc.1207678; Andereya S, 2006, RHEUMATOL INT, V26, P432, DOI 10.1007/s00296-005-0006-2; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kuninger D, 2006, AM J PHYSIOL-CELL PH, V291, pC699, DOI 10.1152/ajpcell.00056.2006; Lanske B, 1998, ENDOCRINOLOGY, V139, P5194, DOI 10.1210/en.139.12.5194; Lee KC, 1996, AM J PHYSIOL-RENAL, V270, pF186, DOI 10.1152/ajprenal.1996.270.1.F186; Lee M, 2009, CURR OPIN NEPHROL HY, V18, P298, DOI 10.1097/MNH.0b013e32832c2264; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tsai LN, 2008, MOL CELL BIOL, V28, P4240, DOI 10.1128/MCB.01489-07; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Uchida M, 2001, J BONE MINER METAB, V19, P207, DOI 10.1007/s007740170022; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	46	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38014	38022		10.1074/jbc.M110.142141	http://dx.doi.org/10.1074/jbc.M110.142141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870727	Green Published, hybrid			2022-12-27	WOS:000284625600009
J	Smyth, AM; Rickman, C; Duncan, RR				Smyth, Annya M.; Rickman, Colin; Duncan, Rory R.			Vesicle Fusion Probability Is Determined by the Specific Interactions of Munc18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX-FORMATION; PC12 CELLS; REGULATED EXOCYTOSIS; SECRETORY VESICLES; SYNTAXIN; PROTEINS; DOCKING; BINDING; ACTIVATION; MEMBRANE	Mammalian-regulated secretion is absolutely dependent on four evolutionarily conserved proteins: three SNARE proteins and munc18. Dissecting the functional outcomes of the spatially organized protein interactions between these factors has been difficult because of the close interrelationship between different binding modes. Here, we investigated the spatial distribution of single munc18 molecules at the plasma membrane of cells and the underlying interactions between syntaxin and munc18. Disruption of munc18 binding to the N-terminal peptide motif of syntaxin did not alter munc18 localization on the plasma membrane but had a pronounced influence on the behavior of secretory vesicles and their likelihood to undergo fusion. We therefore conclude that interaction with the syntaxin N-peptide can confer differential release probabilities to secretory vesicles and may contribute to the delineation of secretory vesicle pools.	Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Rickman, Colin] Heriot Watt Univ, Sch Engn & Phys Sci, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	University of Edinburgh; Heriot Watt University		rory.duncan@ed.ac.uk		Duncan, Rory/0000-0003-0693-910X; Rickman, Colin/0000-0001-8938-524X	Wellcome Trust; Medical Research Council	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Wellcome Trust and Medical Research Council project grant awards (to R.R.D. and C.R.).	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; DeLano W.L, PYMOL MOL GRAPHICS S; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Graham ME, 1997, J NEUROCHEM, V69, P2369; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Medine CN, 2007, MICROSC RES TECHNIQ, V70, P420, DOI 10.1002/jemt.20425; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Rowe J, 2001, J CELL SCI, V114, P3323; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	47	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38141	38148		10.1074/jbc.M110.164038	http://dx.doi.org/10.1074/jbc.M110.164038			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20801887	Green Published, hybrid			2022-12-27	WOS:000284625600021
J	Teutschbein, J; Gross, W; Nimtz, M; Milkowski, C; Hause, B; Strack, D				Teutschbein, Jenny; Gross, Wiltrud; Nimtz, Manfred; Milkowski, Carsten; Hause, Bettina; Strack, Dieter			Identification and Localization of a Lipase-like Acyltransferase in Phenylpropanoid Metabolism of Tomato (Solanum lycopersicum)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYCINNAMIC ACID-ESTERS; CHLOROGENIC ACID; GLUCARIC ACID; ENZYMATIC-SYNTHESIS; HYDROAROMATIC ACIDS; PROTEIN PREPARATION; GENE-EXPRESSION; COENZYME-A; CELL-WALL; PURIFICATION	We have isolated an enzyme classified as chlorogenate: glucarate caffeoyltransferase (CGT) from seedlings of tomato (Solanum lycopersicum) that catalyzes the formation of caffeoylglucarate and caffeoylgalactarate using chlorogenate (5-O-caffeoylquinate) as acyl donor. Peptide sequences obtained by trypsin digestion and spectrometric sequencing were used to isolate the SlCGT cDNA encoding a protein of 380 amino acids with a putative targeting signal of 24 amino acids indicating an entry of the SlCGT into the secretory pathway. Immunogold electron microscopy revealed the localization of the enzyme in the apoplastic space of tomato leaves. Southern blot analysis of genomic cDNA suggests that SlCGT is encoded by a single-copy gene. The SlCGT cDNA was functionally expressed in Nicotiana benthamiana leaves and proved to confer chlorogenate-dependent caffeoyltransferase activity in the presence of glucarate. Sequence comparison of the deduced amino acid sequence identified the protein unexpectedly as a GDSL lipase-like protein, representing a new member of the SGNH protein superfamily. Lipases of this family employ a catalytic triad of Ser-Asp-His with Ser as nucleophile of the GDSL motif. Site-directed mutagenesis of each residue of the assumed respective SlCGT catalytic triad, however, indicated that the catalytic triad of the GDSL lipase is not essential for SlCGT enzymatic activity. SlCGT is therefore the first example of a GDSL lipase-like protein that lost hydrolytic activity and has acquired a completely new function in plant metabolism, functioning in secondary metabolism as acyltransferase in synthesis of hydroxycinnamate esters by employing amino acid residues different from the lipase catalytic triad.	[Teutschbein, Jenny; Milkowski, Carsten; Hause, Bettina; Strack, Dieter] Leibniz Inst Plant Biochem, D-06120 Halle, Saale, Germany; [Gross, Wiltrud] Univ Cologne, Inst Bot, D-50674 Cologne, Germany; [Nimtz, Manfred] Ctr Infect Res, D-38124 Braunschweig, Germany	Leibniz Institut fur Pflanzenbiochemie; University of Cologne; German Center for Infection Research	Strack, D (corresponding author), POB 110432, D-06018 Halle, Germany.	dieter.strack@ipb-halle.de		Milkowski, Carsten/0000-0001-9758-6789	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (D. S. and B. H.).	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; BARZ W, 1985, BIOCH PLANT PHENOLIC, P307; Baumert A, 2005, PHYTOCHEMISTRY, V66, P1334, DOI 10.1016/j.phytochem.2005.02.031; Beisson F, 1997, PLANT PHYSIOL BIOCH, V35, P761; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brick DJ, 1995, FEBS LETT, V377, P475, DOI 10.1016/0014-5793(95)01405-5; CHEMINAT A, 1988, PHYTOCHEMISTRY, V27, P2787, DOI 10.1016/0031-9422(88)80664-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clauss K, 2008, PLANT J, V53, P802, DOI 10.1111/j.1365-313X.2007.03374.x; Cooper T., 1981, BIOCH ARBEITSMETHODE; Cummins I, 2004, PLANT J, V39, P894, DOI 10.1111/j.1365-313X.2004.02174.x; Dalrymple BP, 1997, MICROBIOL-SGM, V143, P2605, DOI 10.1099/00221287-143-8-2605; ELLIGER CA, 1981, PHYTOCHEMISTRY, V20, P1133, DOI 10.1016/0031-9422(81)83044-0; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Franke R, 1998, PLANT CELL REP, V17, P379, DOI 10.1007/s002990050410; FRY SC, 1995, ANNU REV PLANT PHYS, V46, P497, DOI 10.1146/annurev.pp.46.060195.002433; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; GROSS GG, 1974, EUR J BIOCHEM, V42, P453, DOI 10.1111/j.1432-1033.1974.tb03359.x; Harlow E., 1988, ANTIBODIES LAB MANUA; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; Ling H, 2006, J BIOCHEM MOL BIOL, V39, P297; LIU ZB, 1994, PLANT CELL, V6, P645, DOI 10.1105/tpc.6.5.645; Lo M, 2004, PLANT PHYSIOL, V135, P947, DOI 10.1104/pp.103.036376; Maas M, 2009, MOLECULES, V14, P36, DOI 10.3390/molecules14010036; MCBRIDE KE, 1990, PLANT MOL BIOL, V14, P269, DOI 10.1007/BF00018567; Milkowski C, 2004, PHYTOCHEMISTRY, V65, P517, DOI 10.1016/j.phytochem.2003.12.018; Milkowski C, 2010, PLANTA, V232, P19, DOI 10.1007/s00425-010-1168-z; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Outchkourov NS, 2003, PLANTA, V216, P1003, DOI 10.1007/s00425-002-0953-8; PERKINS HJ, 1956, ARCH BIOCHEM BIOPHYS, V64, P506, DOI 10.1016/0003-9861(56)90293-4; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RAVN H, 1988, PHYTOCHEMISTRY, V27, P3433, DOI 10.1016/0031-9422(88)80744-1; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; RHODES MJC, 1973, PHYTOCHEMISTRY, V12, P2381, DOI 10.1016/0031-9422(73)80443-1; Ruiz C, 2004, BBA-GEN SUBJECTS, V1672, P184, DOI 10.1016/j.bbagen.2004.03.010; Ruppert M, 2005, PLANTA, V222, P888, DOI 10.1007/s00425-005-0031-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Steffens J C, 2000, Plant Cell, V12, P1253; Stehle F, 2008, PHYTOCHEMISTRY, V69, P1826, DOI 10.1016/j.phytochem.2008.03.021; Stehle F, 2006, FEBS LETT, V580, P6366, DOI 10.1016/j.febslet.2006.10.046; STOCKIGT J, 1974, FEBS LETT, V42, P131, DOI 10.1016/0014-5793(74)80769-6; STRACK D, 1987, J PLANT PHYSIOL, V131, P61, DOI 10.1016/S0176-1617(87)80268-7; STRACK D, 1990, PLANT PHYSIOL, V92, P41, DOI 10.1104/pp.92.1.41; STRACK D, 1987, PLANT PHYSIOL, V83, P475, DOI 10.1104/pp.83.3.475; STRACK D, 1988, Z NATURFORSCH C, V43, P32; Strack D., 1993, ENZYMES SECONDARY ME, P45; TEISSERE M, 1995, BBA-LIPID LIPID MET, V1255, P105, DOI 10.1016/0005-2760(94)00222-K; ULBRICH B, 1979, PHYTOCHEMISTRY, V18, P929, DOI 10.1016/S0031-9422(00)91451-1; VILLEGAS RJA, 1987, PHYTOCHEMISTRY, V26, P1577, DOI 10.1016/S0031-9422(00)82248-7	58	25	26	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38374	38381		10.1074/jbc.M110.171637	http://dx.doi.org/10.1074/jbc.M110.171637			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880851	Green Published, hybrid			2022-12-27	WOS:000284625600043
J	Mai, T; Zan, H; Zhang, JS; Hawkins, JS; Xu, ZM; Casali, P				Mai, Thach; Zan, Hong; Zhang, Jinsong; Hawkins, J. Seth; Xu, Zhenming; Casali, Paolo			Estrogen Receptors Bind to and Activate the HOXC4/HoxC4 Promoter to Potentiate HoxC4-mediated Activation-induced Cytosine Deaminase Induction, Immunoglobulin Class Switch DNA Recombination, and Somatic Hypermutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOREACTIVE B-CELLS; BREAST-CANCER CELLS; NF-KAPPA-B; SEX-DIFFERENCES; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSES; DEPENDENT GENERATION; AID EXPRESSION; HOX GENES	Estrogen enhances antibody and autoantibody responses through yet to be defined mechanisms. It has been suggested that estrogen up-regulates the expression of activation-induced cytosine deaminase (AID), which is critical for antibody class switch DNA recombination (CSR) and somatic hypermutation (SHM), through direct activation of this gene. AID, as we have shown, is induced by the HoxC4 homeodomain transcription factor, which binds to a conserved HoxC4/Oct site in the AICDA/Aicda promoter. Here we show that estrogen-estrogen receptor (ER) complexes do not directly activate the AID gene promoter in B cells undergoing CSR. Rather, they bind to three evolutionarily conserved and cooperative estrogen response elements (EREs) we identified in the HOXC4/HoxC4 promoter. By binding to these EREs, ERs synergized with CD154 or LPS and IL-4 signaling to up-regulate HoxC4 expression, thereby inducing AID and CSR without affecting B cell proliferation or plasmacytoid differentiation. Estrogen administration in vivo significantly potentiated CSR and SHM in the specific antibody response to the 4-hydroxy-3-nitrophenylacetyl hapten conjugated with chicken gamma-globulin. Ablation of HoxC4 (HoxC4(-/-)) abrogated the estrogen-mediated enhancement of AID gene expression and decreased CSR and SHM. Thus, estrogen enhances AID expression by activating the HOXC4/HoxC4 promoter and inducing the critical AID gene activator, HoxC4.	[Mai, Thach; Zan, Hong; Zhang, Jinsong; Hawkins, J. Seth; Xu, Zhenming; Casali, Paolo] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Hawkins, J. Seth] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92697 USA; [Casali, Paolo] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Casali, P (corresponding author), Univ Calif Irvine, Inst Immunol, 3028 Hewitt Hall, Irvine, CA 92697 USA.	pcasali@uci.edu	ZHANG, JINSONG/E-1656-2011; Xu, Zhenming/C-4134-2012	ZHANG, JINSONG/0000-0002-2195-2997; 	National Institutes of Health [AI 045011, AI 060573, AI 079705, K12HD000849]; March of Dimes Birth Defects Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203, T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079705, R56AI045011, R56AI079705, T32AI060573, R01AI045011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 045011, AI 060573, and AI 079705 (to P. C.).; Supported by the Reproductive Scientist Development Program through National Institutes of Health Grant K12HD000849 and the March of Dimes Birth Defects Foundation.	Bhavanam S, 2008, VACCINE, V26, P6165, DOI 10.1016/j.vaccine.2008.08.045; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Chiba T, 2009, J MOL MED-JMM, V87, P1023, DOI 10.1007/s00109-009-0527-3; Cohen-Solal JFG, 2008, LUPUS, V17, P528, DOI 10.1177/0961203308089402; Cohen-Solal JFG, 2006, CURR TOP MICROBIOL, V305, P67, DOI 10.1007/3-540-29714-6_4; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; Cutolo M, 2010, ANN NY ACAD SCI, V1193, P36, DOI 10.1111/j.1749-6632.2009.05383.x; Daftary GS, 2006, ENDOCR REV, V27, P331, DOI 10.1210/er.2005-0018; Dai R, 2007, J IMMUNOL, V179, P1776, DOI 10.4049/jimmunol.179.3.1776; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Dhiman N, 2008, TISSUE ANTIGENS, V72, P211, DOI 10.1111/j.1399-0039.2008.01097.x; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Diaz M, 2002, CURR OPIN IMMUNOL, V14, P235, DOI 10.1016/S0952-7915(02)00327-8; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; GREEN MS, 1994, INT J EPIDEMIOL, V23, P1078, DOI 10.1093/ije/23.5.1078; Greenstein B, 2001, INT IMMUNOPHARMACOL, V1, P1025, DOI 10.1016/S1567-5769(01)00034-0; Grimaldi CM, 2006, CURR OPIN RHEUMATOL, V18, P456, DOI 10.1097/01.bor.0000240354.37927.dd; Grimaldi CM, 2005, MOL IMMUNOL, V42, P811, DOI 10.1016/j.molimm.2004.05.014; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hughes GC, 2009, ARTHRITIS RHEUM, V60, P1775, DOI 10.1002/art.24548; Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086; Kim EC, 2004, J BIOL CHEM, V279, P42258, DOI 10.1074/jbc.M407496200; Klein S. L., 2009, NY TIMES        1028, pA33; KRAUS WL, 1994, MOL ENDOCRINOL, V8, P952, DOI 10.1210/me.8.8.952; Levy N, 2007, ENDOCRINOLOGY, V148, P3449, DOI 10.1210/en.2006-1632; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MARTINEZ E, 1989, EMBO J, V8, P3781, DOI 10.1002/j.1460-2075.1989.tb08555.x; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Ovsyannikova IG, 2004, HUM IMMUNOL, V65, P1506, DOI 10.1016/j.humimm.2004.07.001; Papavasiliou FN, 2002, CELL, V109, pS35, DOI 10.1016/S0092-8674(02)00706-7; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pauklin S, 2009, J IMMUNOL, V183, P1238, DOI 10.4049/jimmunol.0803915; Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521; Peeva E, 2005, J IMMUNOL, V175, P1415, DOI 10.4049/jimmunol.175.3.1415; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pennock JW, 2009, VACCINE, V27, P5830, DOI 10.1016/j.vaccine.2009.07.052; Phinney DG, 2005, BIOCHEM BIOPH RES CO, V338, P1759, DOI 10.1016/j.bbrc.2005.10.140; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Ramsey TL, 2001, J MOL ENDOCRINOL, V27, P275, DOI 10.1677/jme.0.0270275; Rubtsov AV, 2010, AUTOIMMUN REV, V9, P494, DOI 10.1016/j.autrev.2010.02.008; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sathya G, 1997, MOL ENDOCRINOL, V11, P1994, DOI 10.1210/me.11.13.1994; Sawalha AH, 2009, J AUTOIMMUN, V33, P31, DOI 10.1016/j.jaut.2009.03.006; Schaffer A, 2003, J BIOL CHEM, V278, P23141, DOI 10.1074/jbc.M212952200; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Thomas C., 2009, TOXICOLOGY IN PRESS; Tyulmenkov VV, 2000, MOL CELL ENDOCRINOL, V165, P151, DOI 10.1016/S0303-7207(00)00250-1; Weissman S, 2006, J VIRAL HEPATITIS, V13, P81, DOI 10.1111/j.1365-2893.2005.00658.x; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wu XP, 2006, J IMMUNOL, V176, P5426, DOI 10.4049/jimmunol.176.9.5426; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; Xu ZM, 2007, ADV EXP MED BIOL, V596, P111; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367, DOI 10.1615/CritRevImmunol.v27.i4.60; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Xu ZM, 2005, ANN NY ACAD SCI, V1050, P146, DOI 10.1196/annals.1313.119; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zan H, 1998, J IMMUNOL, V161, P5217; Zan H, 2003, IMMUNITY, V18, P727, DOI 10.1016/S1074-7613(03)00151-1; Zan H, 2008, MOL IMMUNOL, V46, P45, DOI 10.1016/j.molimm.2008.07.003; Zan H, 2009, AUTOIMMUNITY, V42, P89, DOI 10.1080/08916930802629554	85	62	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37797	37810		10.1074/jbc.M110.169086	http://dx.doi.org/10.1074/jbc.M110.169086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855884	hybrid, Green Published			2022-12-27	WOS:000284424000071
J	Chen, JF; Sun, Y; Mao, X; Liu, QZ; Wu, H; Chen, YB				Chen, Jianfeng; Sun, Yong; Mao, Xia; Liu, Qizhan; Wu, Hui; Chen, Yabing			RANKL Up-regulates Brain-type Creatine Kinase via Poly(ADP-ribose) Polymerase-1 during Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCIRG1 GENE-EXPRESSION; OSTEOPETROSIS TYPE-II; ELEVATED SERUM LEVELS; NF-KAPPA-B; BONE-RESORPTION; TRANSCRIPTIONAL REGULATION; RESPONSIVE ELEMENT; RECEPTOR ACTIVATOR; DNA-BINDING; DIFFERENTIATION	Receptor activator of nuclear factor kappa B ligand (RANKL) is the key regulator for osteoclast formation and function. During osteoclastogenesis, RANKL-stimulated signals differentially modulate expression of a large number of proteins. Using proteomics approaches, we identified that brain-type cytoplasmic creatine kinase (Ckb) was greatly induced in mature osteoclasts. Ckb has been shown to contribute to osteoclast function. However, the mechanisms of Ckb regulation and the contribution of other isoforms of creatine kinase during RANKL-induced osteoclastogenesis are unknown. We found that Ckb was the predominant isoform of creatine kinase during osteoclastogenesis. Real-time PCR confirmed that RANKL induced ckb mRNA expression by over 40-fold in primary mouse bone marrow macrophages and Raw 264.7 cells. The RANKL-responsive region was identified within the -0.4- to -0.2-kb 5'-flanking region of the ckb gene. Affinity binding purification followed by mass spectrometry analysis revealed that poly(ADP-ribose) polymerase-1 (PARP-1) bound to the -0.4/-0.2-kb fragment that negatively regulated expression of ckb in response to RANKL stimulation. Electrophoretic mobility shift assays with PARP-1-specific antibody located the binding site of PARP-1 to the TTCCCA consensus sequence. The expression of PARP-1 was reduced during RANKL-induced osteoclastogenesis, concurrently with increased expression of Ckb. Consistently, knockdown of PARP-1 by lentivirus-delivered shRNA enhanced ckb mRNA expression. The activity of PARP-1 was determined to be required for its inhibitory effect on the ckb expression. In summary, we have demonstrated that PARP-1 is a negative regulator of the ckb expression. Down-regulation of PARP-1 is responsible for the up-regulation of ckb during RANKL-induced osteoclastogenesis.	Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Jianfeng; Liu, Qizhan; Wu, Hui] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Chen, Yabing] Vet Affairs Med Ctr Res Serv, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wu, H (corresponding author), 802 Sch Dent Bldg,1919 7th Ave S, Birmingham, AL 35294 USA.	hwu@uab.edu; ybchen@uab.edu	SUN, YONG/F-2365-2013		National Institutes of Health [AR055339, AR046031-080003]; University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R03AR055339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055339 (to Y. C.) and AR046031-080003 (H. W.). This work was also supported by a University of Alabama at Birmingham Center for Metabolic Bone Disease pilot project award (to Y. C.).	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; BARON R, 1986, AM J PATHOL, V122, P363; Beranger GE, 2008, J BONE MINER RES, V23, P564, DOI 10.1359/JBMR.071111; Beranger GE, 2007, J BONE MINER RES, V22, P975, DOI 10.1359/JBMR.070406; Beranger GE, 2006, J BONE MINER RES, V21, P1757, DOI 10.1359/JBMR.060809; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chen YB, 2008, J BIOL CHEM, V283, P29593, DOI 10.1074/jbc.M802493200; Chen YB, 2000, ARTERIOSCL THROM VAS, V20, P2696, DOI 10.1161/01.ATV.20.12.2696; CROMBIE DL, 1994, J STEROID BIOCHEM, V49, P123, DOI 10.1016/0960-0760(94)90002-7; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Francis MJO, 2002, INT J BIOCHEM CELL B, V34, P459, DOI 10.1016/S1357-2725(01)00142-X; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; GRAM J, 1991, CALCIFIED TISSUE INT, V48, P438, DOI 10.1007/BF02556458; HOBSON GM, 1988, NUCLEIC ACIDS RES, V16, P8925, DOI 10.1093/nar/16.18.8925; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kockx MM, 1998, AM J PATHOL, V152, P885; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; MITCHELL MT, 1990, J BIOL CHEM, V265, P8259; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Olabisi OA, 2008, MOL CELL BIOL, V28, P2860, DOI 10.1128/MCB.01746-07; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; RAIBLE DW, 1990, J NEUROSCI RES, V27, P43, DOI 10.1002/jnr.490270107; Ritchie ME, 1996, J BIOL CHEM, V271, P25485; SEVERSON AR, 1968, ANAT RECORD, V161, P57, DOI 10.1002/ar.1091610106; Shen W, 2002, BIOCHEM J, V367, P369, DOI 10.1042/BJ20020709; SPATZ M, 1992, J STEROID BIOCHEM, V41, P711, DOI 10.1016/0960-0760(92)90409-C; SUKOVICH DA, 1994, MOL CELL BIOL, V14, P7134, DOI 10.1128/MCB.14.11.7134; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wallimann T, 1998, BIOFACTORS, V8, P229, DOI 10.1002/biof.5520080310; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang F, 2002, J CELL BIOCHEM, V84, P156, DOI 10.1002/jcb.1276; Willis D, 2005, BBA-GENE STRUCT EXPR, V1728, P18, DOI 10.1016/j.bbaexp.2005.01.007; WUPENG XS, 1992, MOL ENDOCRINOL, V6, P231, DOI 10.1210/me.6.2.231; YONEYAMA T, 1992, CLIN GENET, V42, P39; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zhang Z, 2002, VIROLOGY, V296, P107, DOI 10.1006/viro.2002.1385; Zhao JQ, 1996, ONCOGENE, V13, P293	53	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36315	36321		10.1074/jbc.M110.157743	http://dx.doi.org/10.1074/jbc.M110.157743			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837480	Green Published, hybrid			2022-12-27	WOS:000284146100027
J	Dixon, DP; Edwards, R				Dixon, David P.; Edwards, Robert			Roles for Stress-inducible Lambda Glutathione Transferases in Flavonoid Metabolism in Plants as Identified by Ligand Fishing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASES; REGIOSELECTIVITY; REVERSIBILITY; CONJUGATION; BINDING; FAMILY	The glutathione transferases (GSTs) of plants are a superfamily of abundant enzymes whose roles in endogenous metabolism are largely unknown. For example, the lambda class of GSTs (GSTLs) have members that are selectively induced by chemical stress treatments and based on their enzyme chemistry are predicted to have roles in redox homeostasis. However, using conventional approaches these functions have yet to be determined. To address this, recombinant GSTLs from wheat and Arabidopsis were tagged with a Strep tag and after affinity-immobilization, incubated with extracts from Arabidopsis, tobacco, and wheat. Bound ligands were then recovered by solvent extraction and identified by mass spectrometry (MS). With the wheat enzyme TaGSTL1, the ligand profiles obtained with in vitro extracts from tobacco closely matched those observed after the protein had been expressed in planta, demonstrating that these associations were physiologically representative. The stress-inducible TaGSTL1 was found to selectively recognize flavonols (e. g. taxifolin; K-d = 25 nM), with this binding being dependent upon S-glutathionylation of an active site cysteine. In the case of the wheat extracts, this selectivity in ligand recognitions lead to the detection of flavonols that had not been previously described in this cereal. Subsequent in vitro assays showed that the co-binding of flavonols, such as quercetin, to the thiolated TaGSTL1 represented an intermediate step in the reduction of the respective S-glutathionylated quinone derivatives to yield free flavonols. These results suggest a novel role for GSTLs in maintaining the flavonoid pool under stress conditions.	[Dixon, David P.; Edwards, Robert] Univ Durham, Ctr Bioact Chem, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England.	robert.edwards@fera.gsi.gov.uk	Dixon, David P/B-5413-2008	Dixon, David P/0000-0003-4644-8399; Edwards, Robert/0000-0003-0809-5991	Biotechnology and Biological Sciences Research Council [BBG0017661]; Biotechnology and Biological Sciences Research Council [BB/G001766/1, BB/G001766/2] Funding Source: researchfish; BBSRC [BB/G001766/2, BB/G001766/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant Number BBG0017661.	Awad HM, 2002, CHEM RES TOXICOL, V15, P343, DOI 10.1021/tx010132l; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Boersma MG, 2000, CHEM RES TOXICOL, V13, P185, DOI 10.1021/tx990161k; Boots AW, 2005, BIOCHEM BIOPH RES CO, V338, P923, DOI 10.1016/j.bbrc.2005.10.031; Bouaziz M, 2002, PHYTOCHEMISTRY, V60, P515, DOI 10.1016/S0031-9422(02)00145-0; Cummins I, 2003, PLANT MOL BIOL, V52, P591, DOI 10.1023/A:1024858218804; Cummins I, 2006, PHYTOCHEMISTRY, V67, P1722, DOI 10.1016/j.phytochem.2006.01.012; Dangles O., 2006, Flavonoids: chemistry, biochemistry and applications, P443; Dixon DP, 2008, J BIOL CHEM, V283, P20268, DOI 10.1074/jbc.M802026200; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Dixon DP, 2009, J BIOL CHEM, V284, P21249, DOI 10.1074/jbc.M109.020107; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; DIXON DP, 2010, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0131; Faizi S, 2010, HELV CHIM ACTA, V93, P466, DOI 10.1002/hlca.200900249; HERSHEY HP, 1991, PLANT MOL BIOL, V17, P679, DOI 10.1007/BF00037053; Huang Y, 2008, J BACTERIOL, V190, P7595, DOI 10.1128/JB.00489-08; Jungbluth G, 2000, J CHEM SOC PERK T 2, P1946, DOI 10.1039/b002323j; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Reddy GVB, 2001, ARCH BIOCHEM BIOPHYS, V391, P271; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Theodoulou FL, 2003, PEST MANAG SCI, V59, P202, DOI 10.1002/ps.576	23	56	60	2	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36322	36329		10.1074/jbc.M110.164806	http://dx.doi.org/10.1074/jbc.M110.164806			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841361	hybrid, Green Published			2022-12-27	WOS:000284146100022
J	Henique, C; Mansouri, A; Fumey, G; Lenoir, V; Girard, J; Bouillaud, F; Prip-Buus, C; Cohen, I				Henique, Carole; Mansouri, Abdelhak; Fumey, Gwladys; Lenoir, Veronique; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle			Increased Mitochondrial Fatty Acid Oxidation Is Sufficient to Protect Skeletal Muscle Cells from Palmitate-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; CARNITINE-PALMITOYLTRANSFERASE-I; INTRAMYOCELLULAR LIPID-ACCUMULATION; GAS-LIQUID-CHROMATOGRAPHY; DIACYLGLYCEROL ACYLTRANSFERASE; OBESITY; METABOLISM; INHIBITION; GLUCOSE; CERAMIDE	The mechanisms underlying the protective effect of mono-unsaturated fatty acids (e.g. oleate) against the lipotoxic action of saturated fatty acids (e.g. palmitate) in skeletal muscle cells remain poorly understood. This study aimed to examine the role of mitochondrial long-chain fatty acid (LCFA) oxidation in mediating oleate's protective effect against palmitate-induced lipotoxicity. CPT1 (carnitine palmitoyltransferase 1), which is the key regulatory enzyme of mitochondrial LCFA oxidation, is inhibited by malonyl-CoA, an intermediate of lipogenesis. We showed that expression of a mutant form of CPT1 (CPT1mt), which is active but insensitive to malonyl-CoA inhibition, in C2C12 myotubes led to increased LCFA oxidation flux even in the presence of high concentrations of glucose and insulin. Furthermore, similar to preincubation with oleate, CPT1mt expression protected muscle cells from palmitate-induced apoptosis and insulin resistance by decreasing the content of deleterious palmitate derivates (i.e. diacylglycerols and ceramides). Oleate preincubation exerted its protective effect by two mechanisms: (i) in contrast to CPT1mt expression, oleate preincubation increased the channeling of palmitate toward triglycerides, as a result of enhanced diacylglycerol acyltransferase 2 expression, and (ii) oleate preincubation promoted palmitate oxidation through increasing CPT1 expression and modulating the activities of acetyl-CoA carboxylase and AMP-activated protein kinase. In conclusion, we demonstrated that targeting mitochondrial LCFA oxidation via CPT1mt expression leads to the same protective effect as oleate preincubation, providing strong evidence that redirecting palmitate metabolism toward oxidation is sufficient to protect against palmitate-induced lipotoxicity.	[Cohen, Isabelle] Univ Paris 05, Inst Cochin, CNRS, Dept Endocrinol Metab & Canc,Fac Med,UMRS1016,UMR, F-75014 Paris, France; [Henique, Carole; Mansouri, Abdelhak; Fumey, Gwladys; Lenoir, Veronique; Girard, Jean; Bouillaud, Frederic; Prip-Buus, Carina; Cohen, Isabelle] INSERM, U1016, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cohen, I (corresponding author), Univ Paris 05, Inst Cochin, CNRS, Dept Endocrinol Metab & Canc,Fac Med,UMRS1016,UMR, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	isabelle.cohen@inserm.fr	PRIP-BUUS, Carina/P-9084-2017; HENIQUE, Carole/AAR-2476-2020; Bouillaud, Frédéric R/L-3238-2017; Mansouri, Abdelhak/D-9100-2013	Bouillaud, Frédéric R/0000-0002-7518-9237; Mansouri, Abdelhak/0000-0003-4471-7276; HENIQUE GRECIET, Carole/0000-0001-5441-8662; Prip-Buus, Carina/0000-0002-2153-7857	Agence Nationale de la Recherche, ANR Mithycal; Association Francaise contre les Myopathies (AFM) [13714]; Ministere de l'Education Nationale, de la Recherche, et de la Technologie; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM)	Agence Nationale de la Recherche, ANR Mithycal(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de l'Education Nationale, de la Recherche, et de la Technologie; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM)	This research was funded by the Agence Nationale de la Recherche, ANR Mithycal and by Grant no. 13714 from the Association Francaise contre les Myopathies (AFM).; Supported by a graduate fellowship from the Ministere de l'Education Nationale, de la Recherche, et de la Technologie.; Supported by a Postdoctoral Award from the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM).	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Akkaoui M, 2009, BIOCHEM J, V420, P429, DOI 10.1042/BJ20081932; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kong JY, 2002, AM J PHYSIOL-HEART C, V282, pH717, DOI 10.1152/ajpheart.00257.2001; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; LILLINGTON JM, 1981, CLIN CHIM ACTA, V111, P91, DOI 10.1016/0009-8981(81)90425-3; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Paumen MB, 1997, J BIOL CHEM, V272, P3324, DOI 10.1074/jbc.272.6.3324; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; SCHALCH DS, 1965, J CLIN INVEST, V44, P2010, DOI 10.1172/JCI105308; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sol ERM, 2008, BIOCHEM BIOPH RES CO, V375, P517, DOI 10.1016/j.bbrc.2008.08.013; Sparagna GC, 2001, ANTIOXID REDOX SIGN, V3, P71, DOI 10.1089/152308601750100524; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Vieu C, 2002, J LIPID RES, V43, P510; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043	42	113	117	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36818	36827		10.1074/jbc.M110.170431	http://dx.doi.org/10.1074/jbc.M110.170431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837491	Green Published, hybrid			2022-12-27	WOS:000284146100052
J	Hsia, MM; Callis, J				Hsia, Mon Mandy; Callis, Judy			BRIZ1 and BRIZ2 Proteins Form a Heteromeric E3 Ligase Complex Required for Seed Germination and Post-germination Growth in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; RING-RING COMPLEX; CRYSTAL-STRUCTURE; BINDING PROTEINS; GENE; DEGRADATION; PLANTS; DOMAIN; CANCER; BRCA1	Ubiquitin pathway E3 ligases are an important component conferring specificity and regulation in ubiquitin attachment to substrate proteins. The Arabidopsis thaliana RING (Really Interesting New Gene) domain-containing proteins BRIZ1 and BRIZ2 are essential for normal seed germination and post-germination growth. Loss of either BRIZ1 (At2g42160) or BRIZ2 (At2g26000) results in a severe phenotype. Heterozygous parents produce progeny that segregate 3: 1 for wild-type: growth-arrested seedlings. Homozygous T-DNA insertion lines are recovered for BRIZ1 and BRIZ2 after introduction of a transgene containing the respective coding sequence, demonstrating that disruption of BRIZ1 or BRIZ2 in the T-DNA insertion lines is responsible for the observed phenotype. Both proteins have multiple predicted domains in addition to the RING domain as follows: a BRAP2 (BRCA1-Associated Protein 2), a ZnF UBP (Zinc Finger Ubiquitin Binding protein), and a coiled-coil domain. In vitro, both BRIZ1 and BRIZ2 are active as E3 ligases but only BRIZ2 binds ubiquitin. In vitro synthesized and purified recombinant BRIZ1 and BRIZ2 preferentially form hetero-oligomers rather than homo-oligomers, and the coiled-coil domain is necessary and sufficient for this interaction. BRIZ1 and BRIZ2 co-purify after expression in tobacco leaves, which also requires the coiled-coil domain. BRIZ1 and BRIZ2 coding regions with substitutions in the RING domain are inactive in vitro and, after introduction, fail to complement their respective mutant lines. In our current model, BRIZ1 and BRIZ2 together are required for formation of a functional ubiquitin E3 ligase in vivo, and this complex is required for germination and early seedling growth.	[Callis, Judy] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; Univ Calif Davis, Biochem & Mol Biol Grad Program, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Callis, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	jcallis@ucdavis.edu		Callis, Judy/0000-0002-0622-078X	National Science Foundation [MCB-0929100]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Arabidopsis 2010 Program Grant MCB-0929100 (to J. C.) and by the Paul K. and Ruth R. Stumpf Endowed Professorship in Plant Biochemistry (to J. C.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Ma QH, 2007, J PLANT GROWTH REGUL, V26, P369, DOI 10.1007/s00344-007-9022-7; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matheny SA, 2009, J BIOL CHEM, V284, P11007, DOI 10.1074/jbc.R800082200; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Scheich C, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-12; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Vlachostergios PJ, 2009, J CELL MOL MED, V13, P3006, DOI 10.1111/j.1582-4934.2009.00824.x; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488	56	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37070	37081		10.1074/jbc.M110.168021	http://dx.doi.org/10.1074/jbc.M110.168021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20810661	hybrid, Green Published			2022-12-27	WOS:000284146100075
J	Mellgren, RL				Mellgren, Ronald L.			A Plasma Membrane Wound Proteome REVERSIBLE EXTERNALIZATION OF INTRACELLULAR PROTEINS FOLLOWING REPARABLE MECHANICAL DAMAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCULAR-DYSTROPHY; A-TYPE; RHEUMATOID-ARTHRITIS; VIMENTIN EXPRESSION; SURFACE PROTEIN; SKELETAL-MUSCLE; CELL; DYSFERLIN; INJURY; MACROMOLECULES	Cells in mechanically active tissues undergo constant plasma membrane damage that must be repaired to allow survival. To identify wound-associated proteins, a cell-impermeant, thiol-reactive biotinylation reagent was used to label and subsequently isolate intracellular proteins that become exposed on the surface of cultured cells after plasma membrane damage induced by scraping from substratum or crushing with glass beads. Scrape-damaged cells survived injury and were capable of forming viable colonies. Proteins that were exposed to the cell surface were degraded or internalized a few seconds to several minutes after damage, except for vimentin, which was detectable on the cell surface for at least an hour after injury. Seven major biotinylated protein bands were identified on SDS-PAGE gels. Mass spectrometric studies identified cytoskeletal proteins (caldesmon-1 and vimentin), endoplasmic reticulum proteins (ERp57, ERp5, and HSP47), and nuclear proteins (lamin C, heterogeneous nuclear ribonucleoprotein F, and nucleophosmin-1) as major proteins exposed after injury. Although caldesmon was a major wound-associated protein in calpain small subunit knock-out fibroblasts, it was rapidly degraded in wildtype cells, probably by calpains. Lamin C exposure after wounding was most likely the consequence of nuclear envelope damage. These studies document major intracellular proteins associated with the cell surface of reversibly damaged somatic cells. The studies also show that externalization of some proteins reported to have physiologic or pathologic roles on the cell surface can occur in cells undergoing plasma membrane damage and subsequent repair.	[Mellgren, Ronald L.] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo	Mellgren, RL (corresponding author), Block Hlth Sci Bldg,3000 Arlington Ave, Toledo, OH 43614 USA.	ronald.mellgren@utoledo.edu						Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bement WM, 2007, CURR OPIN CELL BIOL, V19, P95, DOI 10.1016/j.ceb.2006.12.001; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Deng M, 2007, CELL MOTIL CYTOSKEL, V64, P951, DOI 10.1002/cm.20236; El-Gabalawy HS, 2004, ARTHRITIS RES THER, V6, P86, DOI 10.1186/ar1171; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; HARLOW E, 1999, USING ANTIBODIES LAB, P85; Higuchi I, 2007, NEUROMUSCULAR DISORD, V17, P221, DOI 10.1016/j.nmd.2006.11.008; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Iwaki-Egawa S, 2004, J RHEUMATOL, V31, P17; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; KURKINEN M, 1984, J BIOL CHEM, V259, P5915; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Marmiroli S, 2009, J CELL PHYSIOL, V220, P553, DOI 10.1002/jcp.21807; McNeil A, 2005, J CELL SCI, V118, P4701, DOI 10.1242/jcs.02593; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; MCNEIL PL, 1987, J CELL SCI, V88, P669; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; Mellgren RL, 2007, J BIOL CHEM, V282, P35868, DOI 10.1074/jbc.M706929200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Miyake K, 2001, J CELL SCI, V114, P3487; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Shen SS, 2005, J BIOL CHEM, V280, P1652, DOI 10.1074/jbc.M410136200; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Steinhardt RA, 2005, ANN NY ACAD SCI, V1066, P152, DOI 10.1196/annals.1363.017; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Togo T, 2003, MOL BIOL CELL, V14, P93, DOI 10.1091/mbc.E02-01-0056; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	50	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36597	36607		10.1074/jbc.M110.110015	http://dx.doi.org/10.1074/jbc.M110.110015			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20810652	Green Published, hybrid			2022-12-27	WOS:000284146100009
J	Zhou, F; Zhao, W; Zuo, ZX; Sheng, Y; Zhou, XA; Hou, Y; Cheng, HH; Zhou, RJ				Zhou, Fang; Zhao, Wei; Zuo, Zhixiang; Sheng, Yue; Zhou, Xiang; Hou, Yu; Cheng, Hanhua; Zhou, Rongjia			Characterization of Androgen Receptor Structure and Nucleocytoplasmic Shuttling of the Rice Field Eel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; CDNA CLONING; BINDING DOMAIN; PROTEIN-KINASE; LEPTOMYCIN B; EXPRESSION; TRANSCRIPTION; INSENSITIVITY; MUTATIONS; ACTIVATION	Androgen receptor (AR) plays a critical role in prostate cancer and male sexual differentiation. We have identified AR from a primitive vertebrate with a sex reversal characteristic, the rice field eel. AR of this species (eAR) is distinct from human AR, especially in the ligand binding domain (LBD), and its expression in gonads shows an increasing tendency during gonadal transformation from ovary via ovotestis to testis. eAR has a restricted androgen-dependent transactivation function after a nuclear translocation upon dihydrotestosterone exposure. A functional nuclear localization signal was further identified in the DNA binding domain and hinge region. Although nuclear export is CRM1-independent, eAR has a novel nuclear export signal, which is negatively charged, indicating that a nuclear export pathway may be mediated by electrostatic interaction. Further, our studies have identified critical sequences for ligand binding in the C terminus. A structure of three alpha-helices in the LBD has been conserved from eels to humans during vertebrate evolution, despite a distinct amino acid sequence. Mutation analysis confirmed that the LBD is essential for dihydrotestosterone-induced nuclear import of eAR and following transactivation function in the nucleus. In addition, eAR interacts with both Sox9a1 and Sox9a2, and their interaction regulates transactivation of eAR. Our data suggest that the primitive species conserves and especially acquires key novel domains, the nuclear export signal and LBD, for the eAR function in spite of a rapid sequence evolution.	[Zhou, Rongjia] Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China; Wuhan Univ, Coll Life Sci, Ctr Dev Biol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Zhou, RJ (corresponding author), Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China.	rjzhou@whu.edu.cn	Zhou, Rongjia/N-9739-2019; Zuo, Zhixiang/M-4441-2016; Zhou, Rongjia/G-4660-2013	Zhou, Rongjia/0000-0002-9701-8009; Zuo, Zhixiang/0000-0002-2492-2689; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research Project [2010CB126306]; Fundamental Research Funds for the Central Universities; Program of Wuhan Subject Chief Scientist; 111 Project [B06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Project(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program of Wuhan Subject Chief Scientist; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China, National Key Basic Research Project Grant 2010CB126306, the Fundamental Research Funds for the Central Universities, the Program of Wuhan Subject Chief Scientist, and the 111 Project Grant B06018.	Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Baron D, 2008, GEN COMP ENDOCR, V156, P369, DOI 10.1016/j.ygcen.2008.01.016; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Bergerat JP, 2009, HUM MUTAT, V30, P145, DOI 10.1002/humu.20848; Blazquez M, 2005, MOL CELL ENDOCRINOL, V237, P37, DOI 10.1016/j.mce.2005.04.001; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Cheng H, 2003, CYTOGENET GENOME RES, V101, P274, DOI 10.1159/000074348; Cui JZ, 2009, BIOCHEM BIOPH RES CO, V380, P115, DOI 10.1016/j.bbrc.2009.01.047; Culig Z, 2004, GROWTH FACTORS, V22, P179, DOI 10.1080/08977190412331279908; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; DEBELLIS A, 1992, MOL ENDOCRINOL, V6, P1909, DOI 10.1210/me.6.11.1909; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Hannema SE, 2004, J CLIN ENDOCR METAB, V89, P5815, DOI 10.1210/jc.2004-0709; He CL, 2003, BIOL REPROD, V69, P455, DOI 10.1095/biolreprod.102.015040; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heemers HV, 2009, CANCER CELL, V15, P245, DOI 10.1016/j.ccr.2009.03.009; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Hofman K, 2000, MOL CELL ENDOCRINOL, V168, P21, DOI 10.1016/S0303-7207(00)00311-7; Hossain MS, 2008, BIOL REPROD, V78, P361, DOI 10.1095/biolreprod.107.062018; Ikeuchi T, 1999, J BIOL CHEM, V274, P25205, DOI 10.1074/jbc.274.36.25205; Jorgensen A, 2007, COMP BIOCHEM PHYS C, V146, P561, DOI 10.1016/j.cbpc.2007.07.002; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Liu XC, 2009, GEN COMP ENDOCR, V160, P93, DOI 10.1016/j.ygcen.2008.10.026; Martyniuk CJ, 2009, J PROTEOME RES, V8, P2186, DOI 10.1021/pr800627n; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Melo Karla F.S., 2005, Arq Bras Endocrinol Metab, V49, P87, DOI 10.1590/S0004-27302005000100012; Melo KFS, 2003, J CLIN ENDOCR METAB, V88, P3241, DOI 10.1210/jc.2002-021658; Nguyen MM, 2009, MOL CELL ENDOCRINOL, V302, P65, DOI 10.1016/j.mce.2008.12.010; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Park CB, 2007, CHEMOSPHERE, V69, P32, DOI 10.1016/j.chemosphere.2007.04.072; PINSKY L, 1992, CLIN INVEST MED, V15, P456; Radmayr C, 1997, J UROLOGY, V158, P1553, DOI 10.1016/S0022-5347(01)64279-4; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Takeo J, 1999, J BIOL CHEM, V274, P5674, DOI 10.1074/jbc.274.9.5674; Todo T, 1999, BIOCHEM BIOPH RES CO, V254, P378, DOI 10.1006/bbrc.1998.9919; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; WEN W, 1994, J BIOL CHEM, V269, P32214; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zhou RJ, 2003, MOL REPROD DEV, V66, P211, DOI 10.1002/mrd.10271; Zhou RJ, 2002, REV FISH BIOL FISHER, V11, P331; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	50	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37030	37040		10.1074/jbc.M110.161968	http://dx.doi.org/10.1074/jbc.M110.161968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841357	Green Published, hybrid			2022-12-27	WOS:000284146100020
J	Keppler, BR; Archer, TK				Keppler, Brian R.; Archer, Trevor K.			Ubiquitin-dependent and Ubiquitin-independent Control of Subunit Stoichiometry in the SWI/SNF Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; HUMAN BREAST-CANCER; PROTEASOMAL DEGRADATION; NUCLEAR RECEPTORS; RHABDOID TUMORS; CELL-LINES; MUTATIONS; INI1; P53; EXPRESSION	The mammalian SWI/SNF chromatin remodeling complex is a key player in multiple chromatin transactions. Core subunits of this complex, including the ATPase, Brg-1, and various Brg-1-associated factors (BAFs), work in concert to maintain a functional remodeling complex. This intra-complex regulation is supervised by protein-protein interactions, as stoichiometric levels of BAF proteins are maintained by proteasomal degradation. We show that the mechanism of BAF155-mediated stabilization of BAF57 involves blocking its ubiquitination by preventing interaction with TRIP12, an E3 ubiquitin ligase. Consequently, as opposed to complexed BAF57, whose principal lysines are unavailable for ubiquitination, uncomplexed BAF57 can be freely ubiquitinated and degraded by the proteasome. Additionally, a BAF57 mutant, which contains no lysine residues, was found to retain its ability to be stabilized by interaction with BAF155, suggesting that in addition to the ubiquitin-dependent mechanism of BAF57 degradation, there exists a ubiquitin-independent mechanism that may involve the direct interaction of BAF57 with the proteasome. We propose that this regulatory mechanism exists to ensure functional fidelity of the complex and prevent the accumulation of uncomplexed proteins, which may disrupt the normal activity of the complex.	[Keppler, Brian R.; Archer, Trevor K.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, MD D4-01,POB 12233, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019	Keppler, Bernhard/0000-0003-0877-1822; Archer, Trevor K/0000-0001-7651-3644	National Institutes of Health [Z01 ES071006-10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES071006, Z01ES071006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01 ES071006-10 (Intramural Research Program of the NIEHS).	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Biegel JA, 1999, CANCER RES, V59, P74; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Buschmann T, 2001, J BIOL CHEM, V276, P13852, DOI 10.1074/jbc.M007955200; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; DeCristofaro MF, 1999, ONCOGENE, V18, P7559, DOI 10.1038/sj.onc.1203168; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; DELBOVE JN, 2005, P AM ASS CANC RES, V46; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fryer CJ, 2000, J BIOL CHEM, V275, P17771, DOI 10.1074/jbc.M908729199; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Iba H, 2003, REV MED VIROL, V13, P99, DOI 10.1002/rmv.378; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; KLOCHENDLERYEIV.A, 2002, M CURR OPIN GENET DE, V12, P73; Lecuyer E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703939200; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Oh J, 2008, J BIOL CHEM, V283, P11924, DOI 10.1074/jbc.M705401200; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507	43	32	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35665	35674		10.1074/jbc.M110.173997	http://dx.doi.org/10.1074/jbc.M110.173997			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829358	Green Published, hybrid			2022-12-27	WOS:000283845300045
J	Tondervik, A; Klinkenberg, G; Aarstad, OA; Drablos, F; Ertesvag, H; Ellingsen, TE; Skjak-Braek, G; Valla, S; Sletta, H				Tondervik, Anne; Klinkenberg, Geir; Aarstad, Olav A.; Drablos, Finn; Ertesvag, Helga; Ellingsen, Trond E.; Skjak-Braek, Gudmund; Valla, Svein; Sletta, Havard			Isolation of Mutant Alginate Lyases with Cleavage Specificity for Di-guluronic Acid Linkages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM SP; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SEQUENCE; BIOSYNTHESIS; FAMILY; OLIGOSACCHARIDES; POLYSACCHARIDES; C-5-EPIMERASE; RECOMBINANT	Alginates are commercially valuable and complex polysaccharides composed of varying amounts and distribution patterns of 1-4-linked beta-D-mannuronic acid (M) and alpha-L-guluronic acid (G). This structural variability strongly affects polymer physicochemical properties and thereby both commercial applications and biological functions. One promising approach to alginate fine structure elucidation involves the use of alginate lyases, which degrade the polysaccharide by cleaving the glycosidic linkages through a beta-elimination reaction. For such studies one would ideally like to have different lyases, each of which cleaves only one of the four possible linkages in alginates: G-G, G-M, M-G, and M-M. So far no lyase specific for only G-G linkages has been described, and here we report the construction of such an enzyme by mutating the gene encoding Klebsiella pneumoniae lyase AlyA (a polysaccharide lyase family 7 lyase), which cleaves both G-G and G-M linkages. After error-prone PCR mutagenesis and high throughput screening of similar to 7000 lyase mutants, enzyme variants with a strongly improved G-G specificity were identified. Furthermore, in the absence of Ca2+, one of these lyases (AlyA5) was found to display no detectable activity against G-M linkages. G-G linkages were cleaved with similar to 10% of the optimal activity under the same conditions. The substitutions conferring altered specificity to the mutant enzymes are located in conserved regions in the polysaccharide lyase family 7 alginate lyases. Structure-function analyses by comparison with the known three-dimensional structure of Sphingomonas sp. A1 lyase A1-II` suggests that the improved G-G specificity might be caused by increased affinity for nonproductive binding of the alternating G-M structure.	[Tondervik, Anne; Sletta, Havard] SINTEF Mat & Chem, Dept Biotechnol, N-7465 Trondheim, Norway; [Tondervik, Anne; Aarstad, Olav A.; Ertesvag, Helga; Skjak-Braek, Gudmund; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Drablos, Finn] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7491 Trondheim, Norway	SINTEF; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Tondervik, A (corresponding author), SINTEF Mat & Chem, Dept Biotechnol, Post Box 4760, N-7465 Trondheim, Norway.	Anne.Tondervik@sintef.no	Drablos, Finn/L-4970-2019	Drablos, Finn/0000-0001-5794-828X; Ertesvag, helga/0000-0001-9437-9469; Aarstad, Olav/0000-0003-3671-9060	Research Council of Norway Project [182695-I40]; FMC Biopolymer and Algipharma AS	Research Council of Norway Project(Research Council of Norway); FMC Biopolymer and Algipharma AS	The work was supported by The Research Council of Norway Project 182695-I40 and by FMC Biopolymer and Algipharma AS.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Ballance S, 2005, J CHROMATOGR A, V1093, P59, DOI 10.1016/j.chroma.2005.07.051; BARON AJ, 1994, GENE, V143, P61, DOI 10.1016/0378-1119(94)90605-X; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; BOYD J, 1977, CARBOHYD RES, V57, P163, DOI 10.1016/S0008-6215(00)81928-X; Campa C, 2004, J CHROMATOGR A, V1026, P271, DOI 10.1016/j.chroma.2003.11.045; Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200; Chavagnat F, 1998, CARBOHYD RES, V308, P409, DOI 10.1016/S0008-6215(98)00095-0; COTE GL, 1988, CARBOHYD RES, V181, P143, DOI 10.1016/0008-6215(88)84030-8; Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; GORIN P, 1966, J CAN J MICROBIOL, V44, P993; GOVAN JRW, 1981, J GEN MICROBIOL, V125, P217; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hashimoto T, 2005, J MATER SCI-MATER M, V16, P503, DOI 10.1007/s10856-005-0524-1; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; HAUG A, 1969, BIOCHIM BIOPHYS ACTA, V192, P557, DOI 10.1016/0304-4165(69)90414-0; HAUG A, 1971, CARBOHYD RES, V17, P297, DOI 10.1016/S0008-6215(00)82537-9; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; HAUGEN F, 1990, CARBOHYD RES, V198, P101, DOI 10.1016/0008-6215(90)84280-8; Holtan S, 2006, BIOMACROMOLECULES, V7, P2108, DOI 10.1021/bm050984q; Konno N, 2009, FEBS LETT, V583, P1323, DOI 10.1016/j.febslet.2009.03.034; LINKER A, 1964, NATURE, V204, P187, DOI 10.1038/204187a0; Matsubara Y, 1998, J PROTEIN CHEM, V17, P29, DOI 10.1023/A:1022534429792; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Onsoyen E, 1996, CARBOHYDR EUR, V46, P26; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Petrulyte S, 2008, DAN MED BULL, V55, P72; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Sambrook J., 2001, MOL CLONING LAB MANU; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; SKJAKBRAEK G, 1996, T CARBOHYDR EUR, V14, P19; Sletta H, 2007, APPL ENVIRON MICROB, V73, P906, DOI 10.1128/AEM.01804-06; Smelcerovic A, 2008, CURR PHARM DESIGN, V14, P3168, DOI 10.2174/138161208786404254; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Thomas S, 2000, J Wound Care, V9, P56; THOMPSON JD, 2003, CURR PROT BIOINFORM; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1	45	27	28	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35284	35292		10.1074/jbc.M110.162800	http://dx.doi.org/10.1074/jbc.M110.162800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826807	hybrid, Green Published			2022-12-27	WOS:000283845300006
J	Fischer, S; Benz, J; Spath, B; Maier, LK; Straub, J; Granzow, M; Raabe, M; Urlaub, H; Hoffmann, J; Brutschy, B; Allers, T; Soppa, J; Marchfelder, A				Fischer, Susan; Benz, Juliane; Spaeth, Bettina; Maier, Lisa-Katharina; Straub, Julia; Granzow, Michaela; Raabe, Monika; Urlaub, Henning; Hoffmann, Jan; Brutschy, Bernd; Allers, Thorsten; Soppa, Joerg; Marchfelder, Anita			The Archaeal Lsm Protein Binds to Small RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SM-LIKE PROTEINS; COMPLETE GENOME SEQUENCE; LASER MASS-SPECTROMETRY; HOST FACTOR-I; ESCHERICHIA-COLI; HALOFERAX-VOLCANII; CRYSTAL-STRUCTURE; HF-I; SALMONELLA-TYPHIMURIUM; RPOS TRANSLATION	Proteins of the Lsm family, including eukaryotic Sm proteins and bacterial Hfq, are key players in RNA metabolism. Little is known about the archaeal homologues of these proteins. Therefore, we characterized the Lsm protein from the haloarchaeon Haloferax volcanii using in vitro and in vivo approaches. H. volcanii encodes a single Lsm protein, which belongs to the Lsm1 subfamily. The lsm gene is co-transcribed and overlaps with the gene for the ribosomal protein L37e. Northern blot analysis shows that the lsm gene is differentially transcribed. The Lsm protein forms homoheptameric complexes and has a copy number of 4000 molecules/cell. In vitro analyses using electrophoretic mobility shift assays and ultrasoft mass spectrometry (laser-induced liquid bead ion desorption) showed a complex formation of the recombinant Lsm protein with oligo(U)-RNA, tRNAs, and an small RNA. Co-immunoprecipitation with a FLAG-tagged Lsm protein produced in vivo confirmed that the protein binds to small RNAs. Furthermore, the co-immunoprecipitation revealed several protein interaction partners, suggesting its involvement in different cellular pathways. The deletion of the lsm gene is viable, resulting in a pleiotropic phenotype, indicating that the haloarchaeal Lsm is involved in many cellular processes, which is in congruence with the number of protein interaction partners.	[Fischer, Susan; Benz, Juliane; Spaeth, Bettina; Maier, Lisa-Katharina; Marchfelder, Anita] Univ Ulm, D-89069 Ulm, Germany; [Straub, Julia; Granzow, Michaela; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Raabe, Monika; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Hoffmann, Jan; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Allers, Thorsten] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	Ulm University; Goethe University Frankfurt; Max Planck Society; Goethe University Frankfurt; University of Nottingham	Marchfelder, A (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de	Allers, Thorsten/G-5503-2010	Allers, Thorsten/0000-0002-7308-3332; Soppa, Jorg/0000-0002-6132-5840; Marchfelder, Anita/0000-0002-1382-1794	Deutsche Forschungsgemeinschaft [SPP 1258, DFG Ma1538/11-1, So264/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through SPP 1258 Priority Program "Sensory and Regulatory RNAs in Prokaryotes" Grants DFG Ma1538/11-1 and So264/14-1.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Baumann A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-21; Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Collins BM, 2001, J MOL BIOL, V309, P915, DOI 10.1006/jmbi.2001.4693; DE H, 1980, BIOCHEMISTRY */* O C, V19, P6146; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dyall-Smith ML., 2001, HALOHANDBOOK PROTOCO; Herrmann U, 2002, MOL MICROBIOL, V46, P395, DOI 10.1046/j.1365-2958.2002.03181.x; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kufel J, 2002, MOL CELL BIOL, V22, P5248, DOI 10.1128/MCB.22.14.5248-5256.2002; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Muffler A, 1997, J BACTERIOL, V179, P445; Mura C, 2003, PROTEIN SCI, V12, P832, DOI 10.1110/ps.0224703; Mura C, 2003, P NATL ACAD SCI USA, V100, P4539, DOI 10.1073/pnas.0538042100; Mura C, 2001, P NATL ACAD SCI USA, V98, P5532, DOI 10.1073/pnas.091102298; Nielsen JS, 2007, RNA, V13, P2213, DOI 10.1261/rna.689007; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; PU H, 1989, P Natl Acad Sci U S, V86, P4569; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Sambrook J., 2001, MOL CLONING LAB MANU; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; SENEAR AW, 1976, J BIOL CHEM, V251, P1902; Sharma AK, 2006, MOL MICROBIOL, V62, P469, DOI 10.1111/j.1365-2958.2006.05376.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimmin LC, 1996, J BACTERIOL, V178, P4737, DOI 10.1128/jb.178.15.4737-4741.1996; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Soppa J, 2009, BIOCHEM SOC T, V37, P133, DOI 10.1042/BST0370133; SPA THB, 2005, J BIOL CHEM */* A J, V280, P35440; Straub J, 2009, RNA BIOL, V6, P281, DOI 10.4161/rna.6.3.8357; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; TO RO, 2001, EMBO J */* D EMBO J, V20, P2293; TO RO, 2002, J MOL BIOL */* D J M, V320, P129; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; YOKOBORI S, 1995, P NATL ACAD SCI USA, V92, P10432, DOI 10.1073/pnas.92.22.10432; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061	75	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34429	34438		10.1074/jbc.M110.118950	http://dx.doi.org/10.1074/jbc.M110.118950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826804	Green Published, hybrid			2022-12-27	WOS:000283659100017
J	Grigg, JC; Cheung, J; Heinrichs, DE; Murphy, MEP				Grigg, Jason C.; Cheung, Johnson; Heinrichs, David E.; Murphy, Michael E. P.			Specificity of Staphyloferrin B Recognition by the SirA Receptor from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PERIPLASMIC-BINDING PROTEIN; IRON-HYDROXAMATE UPTAKE; ESCHERICHIA-COLI; SIDEROPHORE BINDING; CRYSTAL-STRUCTURE; TRANSPORT; HEME; IDENTIFICATION; ALIGNMENT	Many organisms use sophisticated systems to acquire growth-limiting iron. Iron limitation is especially apparent in bacterial pathogens of mammalian hosts where free iron concentrations are physiologically negligible. A common strategy is to secrete low molecular weight iron chelators, termed siderophores, and express high affinity receptors for the siderophore-iron complex. Staphylococcus aureus, a widespread pathogen, produces two siderophores, staphyloferrin A (SA) and staphyloferrin B (SB). We have determined the crystal structure of the staphyloferrin B receptor, SirA, at high resolution in both the apo and Fe(III)-SB (FeSB)-bound forms. SirA, a member of the class III binding protein family of metal receptors, has N- and C-terminal domains, each composed of mainly a beta-stranded core and alpha-helical periphery. The domains are bridged by a single alpha-helix and together form the FeSB binding site. SB coordinates Fe(III) through five oxygen atoms and one nitrogen atom in distorted octahedral geometry. SirA undergoes conformational change upon siderophore binding, largely securing two loops from the C-terminal domain to enclose FeSB with a low nanomolar dissociation constant. The staphyloferrin A receptor, HtsA, homologous to SirA, also encloses its cognate siderophore (FeSA); however, the largest conformational rearrangements involve a different region of the C-terminal domain. FeSB is uniquely situated in the binding pocket of SirA with few of the contacting residues being conserved with those of HtsA interacting with FeSA. Although both SirA and HtsA bind siderophores from the same alpha-hydroxycarboxylate class, the unique structural features of each receptor provides an explanation for their distinct specificity.	[Cheung, Johnson; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	Western University (University of Western Ontario); University of British Columbia		Michael.Murphy@ubc.ca	Heinrichs, David/ABD-5702-2021; Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research [MOP-102596, MOP-38002]; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council Canada; Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources, Biomedical Technology; NIGMS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources, Biomedical Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Canadian Institutes of Health Research Grants MOP-102596 (to M. E. P. M.) and MOP-38002 (to D. E. H.).; Supported by a Michael Smith Foundation for Health Research Junior Graduate Trainee Award.; Supported by a Natural Sciences and Engineering Research Council Canada Graduate Scholarship.; We thank Angele Arrieta for technical assistance, John Cooper for providing staphyloferrin A, Michael Tiedemann for help with atomic absorption spectroscopy, Suya Liu for performing mass spectrometry, and Stephanie Pfaffen for critical reading of the manuscript. Portions of the research described in this paper were performed at the Stanford Synchrotron Radiation Light Source, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health National Center for Research Resources, Biomedical Technology Program, and NIGMS.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Cabrera G, 2001, APPL ENVIRON MICROB, V67, P1001, DOI 10.1128/AEM.67.2.1001-1003.2001; Carter DM, 2006, J BIOL CHEM, V281, P35413, DOI 10.1074/jbc.M607611200; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DRECHSEL H, 1993, BIOMETALS, V6, P185; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; HAAG H, 1994, FEMS MICROBIOL LETT, V115, P125; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Hoegy FO, 2005, J BIOL CHEM, V280, P20222, DOI 10.1074/jbc.M500776200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOUGH E, 1974, BIOCHEM BIOPH RES CO, V57, P73, DOI 10.1016/S0006-291X(74)80358-X; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Kandt C, 2006, BIOCHEMISTRY-US, V45, P13284, DOI 10.1021/bi061280j; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Krewulak KD, 2005, BIOMETALS, V18, P375, DOI 10.1007/s10534-005-3712-z; Liu M, 2008, BIOPHYS CHEM, V138, P42, DOI 10.1016/j.bpc.2008.09.001; Liu M, 2008, BIOPHYS CHEM, V135, P19, DOI 10.1016/j.bpc.2008.02.017; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MEIWES J, 1990, FEMS MICROBIOL LETT, V67, P201, DOI 10.1111/j.1574-6968.1990.tb13863.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; Shi R, 2009, PROTEINS, V75, P598, DOI 10.1002/prot.22272; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TERWILLIGER TC, 2000, ACTA CRYSTALLOGR D *, V59, P38; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tseng CF, 2006, J BIOL INORG CHEM, V11, P419, DOI 10.1007/s00775-006-0088-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAN D, 1993, J J MOL BIOL */* J M, V229, P105; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691	71	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34579	34588		10.1074/jbc.M110.172924	http://dx.doi.org/10.1074/jbc.M110.172924			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810662	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000283659100033
J	Verma, V; Hasbi, A; O'Dowd, BF; George, SR				Verma, Vaneeta; Hasbi, Ahmed; O'Dowd, Brian F.; George, Susan R.			Dopamine D1-D2 Receptor Heteromer-mediated Calcium Release Is Desensitized by D1 Receptor Occupancy with or without Signal Activation DUAL FUNCTIONAL REGULATION BY G PROTEIN-COUPLED RECEPTOR KINASE 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RESONANCE ENERGY-TRANSFER; BETA-ARRESTIN RECRUITMENT; LIVING CELLS; ERK1/2 ACTIVATION; HOMOLOGY DOMAIN; D-1 RECEPTOR; D2 RECEPTOR; NEURONS; KINASE-2	We identified that activation of the G(q)-linked dopamine D1-D2 receptor hetero-oligomer generates a PLC-dependent intracellular calcium signal. Confocal FRET between endogenous dopamine D1 and D2 receptors in striatal neurons confirmed a physical interaction between them. Pretreatment with SKF 83959, which selectively activates the D1-D2 receptor heteromer, or SKF 83822, which only activates the D1 receptor homo-oligomer, led to rapid desensitization of the D1-D2 receptor heteromer-mediated calcium signal in both heterologous cells and striatal neurons. This desensitization response was mediated through selective occupancy of the D1 receptor binding pocket. Although SKF 83822 was unable to activate the D1-D2 receptor heteromer, it still permitted desensitization of the calcium signal. This suggested that occupancy of the D1 receptor binding pocket by SKF 83822 resulted in conformational changes sufficient for desensitization without heteromer activation. Bioluminescence resonance energy transfer and co-immunoprecipitation studies indicated an agonist-induced physical association between the D1-D2 receptor heteromeric complex and GRK2. Increased expression of GRK2 led to a decrease in the calcium signal with or without prior exposure to either SKF 83959 or SKF 83822. GRK2 knockdown by siRNA led to an increase in the signal after pretreatment with either agonist. Expression of the catalytically inactive and RGS (regulator of G protein signaling)-mutated GRK2 constructs each led to a partial recovery of the GRK2-attenuated calcium signal. These results indicated that desensitization of the dopamine D1-D2 receptor heteromer-mediated signal can occur by agonist occupancy even without activation and is dually regulated by both the catalytic and RGS domains of GRK2.	Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A8, Canada; [Verma, Vaneeta; Hasbi, Ahmed; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; [George, Susan R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto	George, SR (corresponding author), Med Sci Bldg,Rm 4358,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	s.george@utoronto.ca	George, Susan R/P-9669-2018; George, Susan/W-7494-2019		National Institutes of Health (National Institute on Drug Abuse) [DA007223]; Natural Sciences and Engineering Research Council; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007223] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA007223 (from the National Institute on Drug Abuse).; Supported by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council.	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Chen Y, 2005, MOL IMAGING FRET MIC; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; Gerfen CR, 1995, J NEUROSCI, V15, P8167; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Jackson A, 2002, J NEUROCHEM, V82, P683, DOI 10.1046/j.1471-4159.2002.01001.x; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kita K, 1999, EUR NEUROPSYCHOPHARM, V9, P1, DOI 10.1016/S0924-977X(97)00098-9; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lamey M, 2002, J BIOL CHEM, V277, P9415, DOI 10.1074/jbc.M111811200; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; O'Dowd BF, 2005, J BIOL CHEM, V280, P37225, DOI 10.1074/jbc.M504562200; Pivonello R, 2007, EUR J ENDOCRINOL, V156, pS13, DOI 10.1530/eje.1.02353; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Ryman-Rasmussen JP, 2005, MOL PHARMACOL, V68, P1039, DOI 10.1124/mol.105.012153; Sachpatzidis A, 2003, J BIOL CHEM, V278, P896, DOI 10.1074/jbc.M204667200; Schachter JB, 1996, BRIT J PHARMACOL, V118, P167, DOI 10.1111/j.1476-5381.1996.tb15381.x; So CH, 2005, MOL PHARMACOL, V68, P568, DOI 10.1124/mol.105.012229; So CH, 2007, MOL PHARMACOL, V72, P450, DOI 10.1124/mol.107.034884; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Svenningsson P, 2000, NEUROSCIENCE, V98, P749, DOI 10.1016/S0306-4522(00)00155-X; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tong JC, 2001, NEUROCHEM INT, V39, P117, DOI 10.1016/S0197-0186(01)00016-X; Truong K, 2001, NAT STRUCT BIOL, V8, P1069, DOI 10.1038/nsb728; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	44	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35092	35103		10.1074/jbc.M109.088625	http://dx.doi.org/10.1074/jbc.M109.088625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807772	Green Published, hybrid			2022-12-27	WOS:000283659100083
J	Bunse, S; Schmidt, M; Prochnow, N; Zoidl, G; Dermietzel, R				Bunse, Stefanie; Schmidt, Matthias; Prochnow, Nora; Zoidl, Georg; Dermietzel, Rolf			Intracellular Cysteine 346 Is Essentially Involved in Regulating Panx1 Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; NUCLEOTIDE-GATED CHANNEL; S-NITROSYLATION; NITRIC-OXIDE; PLASMA-MEMBRANE; P2X(7) RECEPTOR; PANNEXIN FAMILY; XENOPUS OOCYTES; CELL-DEATH; HEMICHANNELS	Pannexins constitute a family of proteins exhibiting predominantly hemichannel activity. Pannexin channels have been suggested to participate in a wide spectrum of biological functions such as propagation of calcium waves, release of IL-1 beta, and responses to ischemic conditions. At present, the molecular mechanisms regulating pannexin hemichannel activity are essentially unknown. Because cysteines have been shown to constitute key elements in regulating hemichannel properties of the connexin-type we performed site-directed mutagenesis of intracellular cysteine residues of Panx1. Cysteine to serine exchange (Cys 3 Ser) at the C-terminal position amino acid 346 led to a constitutively leaky hemichannel and subsequently to cell death. Increased channel activity was demonstrated by dye uptake and electrophysiological profiling in injected Xenopus laevis oocytes and transfected N2A cells. Mutations of the remaining intracellular cysteines did not result in major changes of Panx1 channel properties. From these data we conclude that the Cys-346 residue is important for proper functioning of the Panx1 channel.	Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44780 Bochum, Germany; [Zoidl, Georg] Ruhr Univ Bochum, Dept Cytol, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Dermietzel, R (corresponding author), Univ Str 150,MA,6-159, D-44780 Bochum, Germany.	Rolf.Dermietzel@rub.de			Graduiertenkolleg [GRK 736]; Deutsche Forschungsgemeinschaft [292/11-4]	Graduiertenkolleg(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Graduiertenkolleg GRK 736 "Development and Plasticity of the Nervous System: Molecular, Synaptic and Cellular mechanisms" (to S. B.) and by Deutsche Forschungsgemeinschaft Grant 292/11-4 (to R. D. and G. Z.).	Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bunse S, 2009, FEBS J, V276, P6258, DOI 10.1111/j.1742-4658.2009.07334.x; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Dvoriantchikova G, 2006, MOL VIS, V12, P1417; GOLDBERGER G, 1984, J BIOL CHEM, V259, P6492; Gonzalez D, 2006, FASEB J, V20, P2329, DOI 10.1096/fj.06-5828com; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Matos TD, 2008, HEARING RES, V240, P87, DOI 10.1016/j.heares.2008.03.004; MOUS JM, 1982, J BIOL CHEM, V257, P1822; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Renganathan M, 2002, J NEUROPHYSIOL, V87, P761, DOI 10.1152/jn.00369.2001; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Retamal MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1356, DOI 10.1152/ajpcell.00054.2009; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Stong BC, 2006, LARYNGOSCOPE, V116, P2205, DOI 10.1097/01.mlg.0000241944.77192.d2; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Zappala A, 2007, NEUROSCIENCE, V148, P653, DOI 10.1016/j.neuroscience.2007.06.028; Zhang L, 2008, J NEUROSCI RES, V86, P2281, DOI 10.1002/jnr.21675; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061; Zoidl G, 2002, J NEUROSCI RES, V69, P448, DOI 10.1002/jnr.10284	49	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38444	38452		10.1074/jbc.M110.101014	http://dx.doi.org/10.1074/jbc.M110.101014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20829356	Green Published, hybrid			2022-12-27	WOS:000284625600050
J	Tikhonov, A; Kazakov, T; Semenova, E; Serebryakova, M; Vondenhoff, G; Van Aerschot, A; Reader, JS; Govorun, VM; Severinov, K				Tikhonov, Anton; Kazakov, Teymur; Semenova, Ekaterina; Serebryakova, Marina; Vondenhoff, Gaston; Van Aerschot, Arthur; Reader, John S.; Govorun, Vadim M.; Severinov, Konstantin			The Mechanism of Microcin C Resistance Provided by the MccF Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; GENETIC-DETERMINANTS; ESCHERICHIA-COLI; AGROCIN 84; SPECIFICITY; IMMUNITY; CLONING; C51	The heptapeptide-nucleotide microcin C (McC) is a potent inhibitor of enteric bacteria growth. Inside a sensitive cell, McC is processed by aminopeptidases, which release a nonhydrolyzable aspartyl-adenylate, a strong inhibitor of aspartyl-tRNA synthetase. The mccABCDE operon is sufficient for McC production and resistance of the producing cell to McC. An additional gene, mccF, which is adjacent to but not part of the mccABCDE operon, also provides resistance to exogenous McC. MccF is similar to Escherichia coli LdcA, an L,D-carboxypeptidase whose substrate is monomeric murotetrapeptide L-Ala-D-Glu-meso-A(2)pm-D-Ala or its UDP-activated murein precursor. The mechanism by which MccF provides McC resistance remained unknown. Here, we show that MccF detoxifies both intact and processed McC by cleaving an amide bond between the C-terminal aspartate and the nucleotide moiety. MccF also cleaves the same bond in nonhydrolyzable aminoacyl sulfamoyl adenosines containing aspartyl, glutamyl, and, to a lesser extent, seryl aminoacyl moieties but is ineffective against other amino-acyl adenylates.	[Kazakov, Teymur; Semenova, Ekaterina; Govorun, Vadim M.; Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Serebryakova, Marina; Govorun, Vadim M.] Fed Agcy Hlth Care & Social Dev, Inst Phys & Chem Med, Moscow, Russia; [Vondenhoff, Gaston; Van Aerschot, Arthur] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Vondenhoff, Gaston; Van Aerschot, Arthur] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Reader, John S.; Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; KU Leuven; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Serebryakova, Marina/E-2986-2012; Severinov, Konstantin/C-8545-2016; Govorun, Vadim M/A-9043-2018	Serebryakova, Marina/0000-0002-5402-8215; Van Aerschot, Arthur/0000-0003-3528-8588	National Institutes of Health [U54 AI057158]; Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology; Rutgers University Technology Commercialization; Federal program Scientific and Scientific-Pedagogical Personnel of Innovative Russia [02.740.11.0771]; Russian Foundation for Basic Research [06-04-48865]; Dynasty Charitable Foundation; Belgian IWT [SB 81117]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology(Russian Academy of Sciences); Rutgers University Technology Commercialization; Federal program Scientific and Scientific-Pedagogical Personnel of Innovative Russia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Dynasty Charitable Foundation; Belgian IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 AI057158. This work was also supported by a Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology grant, a Rutgers University Technology Commercialization Fund grant, and federal program Scientific and Scientific-Pedagogical Personnel of Innovative Russia 2009-2013, State Contract 02.740.11.0771 (to K.S.), and Russian Foundation for Basic Research Grant 06-04-48865.; Supported in part by a scholarship from the Dynasty Charitable Foundation.; Recipient of Belgian IWT Fellowship SB 81117.	BAQUERO F, 1978, J BACTERIOL, V135, P342, DOI 10.1128/JB.135.2.342-347.1978; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; BENZ G, 1982, ANGEW CHEM INT EDIT, V21, P527, DOI 10.1002/anie.198205271; Bloch A, 1971, Biochemistry, V10, P4395; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; Destoumieux-Garzon D, 2002, BIOCHIMIE, V84, P511, DOI 10.1016/S0300-9084(02)01411-6; GONZALEZPASTOR JE, 1995, J BACTERIOL, V177, P7131, DOI 10.1128/jb.177.24.7131-7140.1995; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; KUREPINA NE, 1993, MOL GEN GENET, V241, P700, DOI 10.1007/BF00279914; LEGUINA JI, 1994, FEBS LETT, V339, P249, DOI 10.1016/0014-5793(94)80425-7; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; Metlitskaya A, 2009, J BACTERIOL, V191, P2380, DOI 10.1128/JB.00999-08; METLITSKAYA AZ, 1995, FEBS LETT, V357, P235, DOI 10.1016/0014-5793(94)01345-2; Murphy P. J., 1981, EUR J BIOCHEM, V11, P539; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; NOVOA MA, 1986, J BACTERIOL, V168, P1384, DOI 10.1128/jb.168.3.1384-1391.1986; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; ROBERTS WP, 1977, NATURE, V265, P379, DOI 10.1038/265379a0; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Tan D. S., 2006, U. S. Patent Application, Patent No. [11/ 911,525, 11911525]; TATE ME, 1979, NATURE, V280, P697, DOI 10.1038/280697a0; Van de Vijver P, 2009, J BACTERIOL, V191, P6273, DOI 10.1128/JB.00829-09	23	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37944	37952		10.1074/jbc.M110.179135	http://dx.doi.org/10.1074/jbc.M110.179135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876530	Green Published, hybrid			2022-12-27	WOS:000284625600002
J	Abbott, DW; Gilbert, HJ; Boraston, AB				Abbott, D. Wade; Gilbert, Harry J.; Boraston, Alisdair B.			The Active Site of Oligogalacturonate Lyase Provides Unique Insights into Cytoplasmic Oligogalacturonate beta-Elimination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI 3937; PECTATE LYASE; YERSINIA-PESTIS; BACTERIAL SYMBIONT; MOLECULAR-GRAPHICS; STRUCTURAL BASIS; CALCIUM; PECTIN; DEGRADATION; PROTEINS	Oligogalacturonate lyases (OGLs; now also classified as pectate lyase family 22) are cytoplasmic enzymes found in pectinolytic members of Enterobacteriaceae, such as the enteropathogen Yersinia enterocolitica. OGLs utilize a beta-elimination mechanism to preferentially catalyze the conversion of saturated and unsaturated digalacturonate into monogalacturonate and the 4,5-unsaturated monogalacturonate-like molecule, 5-keto-4-deoxyuronate. To provide mechanistic insights into the specificity of this enzyme activity, we have characterized the OGL from Y. enterocolitica, YeOGL, on oligogalacturonides and determined its three-dimensional x-ray structure to 1.65 angstrom. The model contains a Mn2+ atom in the active site, which is coordinated by three histidines, one glutamine, and an acetate ion. The acetate mimics the binding of the uronate group of galactourono-configured substrates. These findings, in combination with enzyme kinetics and metal supplementation assays, provide a framework for modeling the active site architecture of OGL. This enzyme appears to contain a histidine for the abstraction of the alpha-proton in the -1 subsite, a residue that is highly conserved throughout the OGL family and represents a unique catalytic base among pectic active lyases. In addition, we present a hypothesis for an emerging relationship observed between the cellular distribution of pectate lyase folding and the distinct metal coordination chemistries of pectate lyases.	Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University System of Georgia; University of Georgia; University of Victoria		wabbott@ccrc.uga.edu; boraston@uvic.ca		Boraston, Alisdair/0000-0001-6417-0592; Abbott, Wade/0000-0003-4893-5799	Georgia Research Alliance; Natural Sciences and Engineering Research Council of Canada	Georgia Research Alliance; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Georgia Research Alliance (to H. J. G.) and the Natural Sciences and Engineering Research Council of Canada (to A. B. B.).	Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07; Abbott DW, 2007, J BIOL CHEM, V282, P35328, DOI 10.1074/jbc.M705511200; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Drancourt M, 2006, LANCET INFECT DIS, V6, P234, DOI 10.1016/S1473-3099(06)70438-8; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; GILROY S, 1991, PLANT CELL, V3, P333, DOI 10.1105/tpc.3.4.333; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hugouvieux-Cotte-Pattat N., 1996, ANNU REV MICROBIOL, V50, P213; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINERS F, 1989, PLANT PHYSIOL, V91, P1419, DOI 10.1104/pp.91.4.1419; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V125, P734, DOI 10.1016/0003-9861(68)90508-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rodionov DA, 2000, MOL MICROBIOL, V38, P673, DOI 10.1046/j.1365-2958.2000.02115.x; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Seyedarabi A, 2010, BIOCHEMISTRY-US, V49, P539, DOI 10.1021/bi901503g; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; Shevchik VE, 1999, J BACTERIOL, V181, P1652, DOI 10.1128/JB.181.5.1652-1663.1999; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006	53	28	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39029	39038		10.1074/jbc.M110.153981	http://dx.doi.org/10.1074/jbc.M110.153981			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20851883	hybrid, Green Published			2022-12-27	WOS:000284941300033
J	Choi, SS; Syn, WK; Karaca, GF; Omenetti, A; Moylan, CA; Witek, RP; Agboola, KM; Jung, Y; Michelotti, GA; Diehl, AM				Choi, Steve S.; Syn, Wing-Kin; Karaca, Gamze F.; Omenetti, Alessia; Moylan, Cynthia A.; Witek, Rafal P.; Agboola, Kolade M.; Jung, Youngmi; Michelotti, Gregory A.; Diehl, Anna Mae			Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SIGNAL-TRANSDUCTION PATHWAYS; ADIPOCYTE DIFFERENTIATION; EXTRACELLULAR-MATRIX; UP-REGULATION; RECEPTOR; FIBROSIS; LIVER; MICE; RAT	Trans-differentiation of quiescent hepatic stellate cells (Q-HSCs), which exhibit epithelial and adipocytic features, into myofibroblastic-HSC (MF-HSCs) is a key event in liver fibrosis. Culture models demonstrated that Hedgehog (Hh) pathway activation is required for transition of epithelioid/adipocytic Q-HSCs into MF-HSCs. Hh signaling inhibits adiposity and promotes epithelial-to-mesenchymal transitions (EMTs). Leptin (anti-adipogenic, pro-EMT factor) promotes HSC trans-differentiation and liver fibrosis, suggesting that the pathways may interact to modulate cell fate. This study aimed to determine whether leptin activates Hh signaling and whether this is required for the fibrogenic effects of leptin. Cultures of primary HSCs from lean and fa/fa rats with an inherited ObRb defect were examined. Inhibitors of PI3K/Akt, JAK/STAT, and Hh signaling were used to delineate how ObRb activation influenced Hh signaling and HSC trans-differentiation. Fibrogenesis was compared in wild type and db/db mice (impaired ObRb function) to assess the profibrotic role of leptin. The results demonstrate that leptin-ObR interactions activate Hh signaling with the latter necessary to promote trans-differentiation. Leptin-related increases in Hh signaling required ObR induction of PI3K/Akt, which was sufficient for leptin to repress the epithelioid/adipocytic program. Leptin-mediated induction of JAK/STAT was required for mesenchymal gene expression. Leptin-ObRb interactions were not necessary for HSC trans-differentiation to occur in vitro or in vivo but are important because liver fibrogenesis was attenuated in db/db mice. These findings reveal that leptin activates Hh signaling to alter gene expression programs that control cell fate and have important implications for liver fibrosis and other leptin-regulated processes involving EMTs, including development, obesity, and cancer metastasis.	[Diehl, Anna Mae] Duke Univ, Div Gastroenterol, Med Ctr, Dept Med, Durham, NC 27710 USA; [Choi, Steve S.; Moylan, Cynthia A.] Durham Vet Affairs Med Ctr, Gastroenterol Sect, Durham, NC 27705 USA; [Jung, Youngmi] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Pusan National University	Diehl, AM (corresponding author), Duke Univ, Div Gastroenterol, Med Ctr, Dept Med, DUMC 3256,595 LaSalle St,Suite 1073, Durham, NC 27710 USA.	annamae.diehl@duke.edu	Choi, Steve/GZH-1598-2022; Omenetti, Alessia/K-5975-2016; Syn, Wing-Kin/AAB-8406-2020	Omenetti, Alessia/0000-0002-8220-0385; , Gregory/0000-0002-3936-4675; Michelotti, Gregory/0000-0002-7908-1979; Moylan, Cynthia/0000-0001-8454-7086	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080980, R01DK077794, R01DK053792] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK080980, R01 DK053792, R01 DK077794] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleffi S, 2005, HEPATOLOGY, V42, p254A; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Choi SS, 2006, HEPATOLOGY, V44, P1267, DOI 10.1002/hep.21375; Choi SS, 2010, HEPATOLOGY, V52, P278, DOI 10.1002/hep.23649; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Chua S, 2002, DIABETOLOGIA, V45, P976, DOI 10.1007/s00125-002-0880-z; De Minicis S, 2008, HEPATOLOGY, V48, p405A; El-Zaatari M, 2009, CURR OPIN ENDOCRINOL, V16, P60, DOI 10.1097/MED.0b013e328320a821; Fava G, 2008, CANCER RES, V68, P6752, DOI 10.1158/0008-5472.CAN-07-6682; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Handy JA, 2010, J CELL BIOCHEM, V110, P1195, DOI 10.1002/jcb.22634; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Honda H, 2002, HEPATOLOGY, V36, P12, DOI 10.1053/jhep.2002.33684; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Ikejima Kenichi, 2004, Comp Hepatol, V3 Suppl 1, pS12, DOI 10.1186/1476-5926-2-S1-S12; Jiang JX, 2008, HEPATOLOGY, V48, P1497, DOI 10.1002/hep.22515; Jung YM, 2008, GASTROENTEROLOGY, V134, pA785; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lang T, 2004, BIOCHEM BIOPH RES CO, V323, P1091, DOI 10.1016/j.bbrc.2004.08.192; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Nath AK, 2008, J CELL BIOL, V181, P367, DOI 10.1083/jcb.200708197; Niu LW, 2007, LIVER INT, V27, P1265, DOI 10.1111/j.1478-3231.2007.01582.x; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Qamar A, 2006, DIGEST DIS SCI, V51, P1697, DOI 10.1007/s10620-006-9244-8; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Sharma D, 2006, ENDOCR-RELAT CANCER, V13, P629, DOI 10.1677/erc.1.01169; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Si HF, 2007, EXP BIOL MED, V232, P427; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Tang YC, 2009, ENDOCRINOLOGY, V150, P3011, DOI 10.1210/en.2008-1601; Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xue Xiulan, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P655; Yamashita T, 1998, BIOCHEM BIOPH RES CO, V246, P752, DOI 10.1006/bbrc.1998.8689; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391	46	127	139	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36551	36560		10.1074/jbc.M110.168542	http://dx.doi.org/10.1074/jbc.M110.168542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843817	Green Published, hybrid			2022-12-27	WOS:000284146100008
J	Gao, XW; Wei, SS; Lai, KR; Sheng, JH; Su, JF; Zhu, JQ; Dong, HJ; Hu, H; Xu, ZP				Gao, Xiangwei; Wei, Saisai; Lai, Kairan; Sheng, Jinghao; Su, Jinfeng; Zhu, Junqiao; Dong, Haojie; Hu, Hu; Xu, Zhengping			Nucleolar Follistatin Promotes Cancer Cell Survival under Glucose-deprived Conditions through Inhibiting Cellular rRNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-I TRANSCRIPTION; NUCLEAR-LOCALIZATION; BINDING PROTEIN; GENES; MICE; RDNA; ANGIOGENESIS; DEFICIENT; RECEPTORS; HYPOXIA	Solid tumor development is frequently accompanied by energy-deficient conditions such as glucose deprivation and hypoxia. Follistatin (FST), a secretory protein originally identified from ovarian follicular fluid, has been suggested to be involved in tumor development. However, whether it plays a role in cancer cell survival under energy-deprived conditions remains elusive. In this study, we demonstrated that glucose deprivation markedly enhanced the expression and nucleolar localization of FST in HeLa cells. The nucleolar localization of FST relied on its nuclear localization signal (NLS) comprising the residues 64-87. Localization of FST to the nucleolus attenuated rRNA synthesis, a key process for cellular energy homeostasis and cell survival. Overexpression of FST delayed glucose deprivation-induced apoptosis, whereas down-regulation of FST exerted the opposite effect. These functions depended on the presence of an intact NLS because the NLS-deleted mutant of FST lost the rRNA inhibition effect and the cell protective effect. Altogether, we identified a novel nucleolar function of FST, which is of importance in the modulation of cancer cell survival in response to glucose deprivation.	[Gao, Xiangwei; Wei, Saisai; Sheng, Jinghao; Su, Jinfeng; Zhu, Junqiao; Dong, Haojie; Xu, Zhengping] Zhejiang Univ, Inst Environm Med, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Gao, Xiangwei; Xu, Zhengping] Zhejiang Univ, Sch Med, Res Ctr Environm Genom, Hangzhou 310058, Zhejiang, Peoples R China; [Hu, Hu] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Xu, ZP (corresponding author), Zhejiang Univ, Inst Environm Med, Sch Med, 388 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zpxu@zju.edu.cn	Gao, Xiangwei/J-3026-2015; Dong, Haojie/AAU-6510-2020	Gao, Xiangwei/0000-0002-8358-6320; 	National Natural Science Foundation of China [30171035, 30770470, 30900235]; Zhejiang Provincial Natural Science Foundation of China [Y2090095]; China Postdoctoral Science Foundation [20080430209, 200902638]; Program for New Century Excellent Talents in University; Ministry of Education [NCET-05-0521]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Education; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by National Natural Science Foundation of China Grants 30171035, 30770470, and 30900235 and Zhejiang Provincial Natural Science Foundation of China Grant Y2090095.; Supported by China Postdoctoral Science Foundation Grants 20080430209 and 200902638.; Supported by Program for New Century Excellent Talents in University, Ministry of Education Grant NCET-05-0521 and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. To whom correspondence should be addressed: Institute of Environmental Medicine, Zhejiang University School of Medicine, 388 Yuhangtang Rd., Hangzhou 310058, China. Tel.: 86-571-88208164; Fax: 86-571-88208163; E-mail: zpxu@zju.edu.cn.	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Bloise E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-320; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gao XW, 2007, FEBS LETT, V581, P5505, DOI 10.1016/j.febslet.2007.10.059; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HEMMATIBRIVANLO.A, 1994, D A CELL, V77, P283; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Hu HJ, 2005, BIOCHEM BIOPH RES CO, V329, P661, DOI 10.1016/j.bbrc.2005.01.158; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kang WQ, 2008, BIOCHEM BIOPH RES CO, V376, P573, DOI 10.1016/j.bbrc.2008.09.031; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mekhail K, 2006, CELL CYCLE, V5, P2401, DOI 10.4161/cc.5.20.3387; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Ogino H, 2008, CLIN CANCER RES, V14, P660, DOI 10.1158/1078-0432.CCR-07-1221; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Saito S, 2005, ENDOCRINOLOGY, V146, P5052, DOI 10.1210/en.2005-0833; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	42	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36857	36864		10.1074/jbc.M110.144477	http://dx.doi.org/10.1074/jbc.M110.144477			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843798	Green Published, hybrid			2022-12-27	WOS:000284146100013
J	Qiu, XX; Dul, BE; Walworth, NC				Qiu, Xinxing; Dul, Barbara E.; Walworth, Nancy C.			Activity of a C-terminal Plant Homeodomain (PHD) of Msc1 Is Essential for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; HISTONE-H3 LYSINE-4 METHYLATION; SISTER-CHROMATID SEPARATION; FISSION YEAST; H2A VARIANT; PROTEIN; FINGER; MICROTUBULE; DOMAIN; BINDING	Msc1, a member of the Jarid1 family of putative histone demethylases, is required for chromosome stability in fission yeast. Msc1 associates with the Swr1 complex that facilitates deposition of histone H2A.Z into chromatin. To assess the function of Msc1 in the Swr1 complex, domains of Msc1 necessary for interaction with Swr1 were identified. The C-terminal plant homeodomain (PHD) 2 and PHD3 of Msc1 are sufficient to confer association with Swr1 and allow Msc1 to function in the context of kinetochore mutants. On the other hand, a mutant with a single amino acid substitution in PHD2 within the full-length Msc1 protein retains the ability to bind to Swr1 but eliminates the function of Msc1 in combination with kinetochore mutants. Thus, Swr1 association is critical but not sufficient for Msc1 function. An activity of Msc1 that depends on the cysteine residue within PHD2 of Msc1 is likewise critical for function. On the basis of our observation that the PHDs of Msc1 act as E3 ubiquitin ligases and that mutations of cysteine residues within those domains abolish ligase activity, we speculate that the ability of Msc1 to facilitate ubiquitin transfer is critical for the function it mediates through its association with Swr1.	[Walworth, Nancy C.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Joint Grad Program Cellular & Mol Pharmacol, Grad Sch Biomed Sci, Piscataway, NJ 08854 USA; Rutgers State Univ, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Walworth, NC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	walworna@umdnj.edu		Walworth, Nancy/0000-0001-5940-8236	NIGMS [GM53194]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053194] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM53194 from NIGMS, National Institutes of Health.	Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Ahmed S, 2007, GENETICS, V177, P1487, DOI 10.1534/genetics.107.078691; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Buchanan L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000726; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Hou HT, 2010, J BIOL CHEM, V285, P1909, DOI 10.1074/jbc.M109.058487; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Lawrence RJ, 2009, P NATL ACAD SCI USA, V106, P1163, DOI 10.1073/pnas.0811161106; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Nakaseko Y, 1996, GENES CELLS, V1, P633, DOI 10.1046/j.1365-2443.1996.00253.x; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	50	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36828	36835		10.1074/jbc.M110.157792	http://dx.doi.org/10.1074/jbc.M110.157792			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858896	Green Published, hybrid			2022-12-27	WOS:000284146100012
J	Cornette, R; Kanamori, Y; Watanabe, M; Nakahara, Y; Gusev, O; Mitsumasu, K; Kadono-Okuda, K; Shimomura, M; Mita, K; Kikawada, T; Okuda, T				Cornette, Richard; Kanamori, Yasushi; Watanabe, Masahiko; Nakahara, Yuichi; Gusev, Oleg; Mitsumasu, Kanako; Kadono-Okuda, Keiko; Shimomura, Michihiko; Mita, Kazuei; Kikawada, Takahiro; Okuda, Takashi			Identification of Anhydrobiosis-related Genes from an Expressed Sequence Tag Database in the Cryptobiotic Midge Polypedilum vanderplanki (Diptera; Chironomidae)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; ENCYSTED EMBRYOS; ANTARCTIC MIDGE; MOLECULAR-BASIS; DEHYDRATION; TREHALOSE; RESPONSES; CHAPERONE	Some organisms are able to survive the loss of almost all their body water content, entering a latent state known as anhydrobiosis. The sleeping chironomid (Polypedilum vanderplanki) lives in the semi-arid regions of Africa, and its larvae can survive desiccation in an anhydrobiotic form during the dry season. To unveil the molecular mechanisms of this resistance to desiccation, an anhydrobiosis-related Expressed Sequence Tag (EST) database was obtained from the sequences of three cDNA libraries constructed from P. vanderplanki larvae after 0, 12, and 36 h of desiccation. The database contained 15,056 ESTs distributed into 4,807 UniGene clusters. ESTs were classified according to gene ontology categories, and putative expression patterns were deduced for all clusters on the basis of the number of clones in each library; expression patterns were confirmed by real-time PCR for selected genes. Among up-regulated genes, antioxidants, late embryogenesis abundant (LEA) proteins, and heat shock proteins (Hsps) were identified as important groups for anhydrobiosis. Genes related to trehalose metabolism and various transporters were also strongly induced by desiccation. Those results suggest that the oxidative stress response plays a central role in successful anhydrobiosis. Similarly, protein denaturation and aggregation may be prevented by marked up-regulation of Hsps and the anhydrobiosis-specific LEA proteins. A third major feature is the predicted increase in trehalose synthesis and in the expression of various transporter proteins allowing the distribution of trehalose and other solutes to all tissues.	[Cornette, Richard; Kanamori, Yasushi; Watanabe, Masahiko; Nakahara, Yuichi; Gusev, Oleg; Mitsumasu, Kanako; Kadono-Okuda, Keiko; Mita, Kazuei; Kikawada, Takahiro; Okuda, Takashi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Shimomura, Michihiko] Mitsubishi Space Software, Tsukuba, Ibaraki 3050032, Japan	National Institute of Agrobiological Sciences - Japan	Kikawada, T (corresponding author), Natl Inst Agrobiol Sci, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.	kikawada@affrc.go.jp; okuda@affrc.go.jp	Gusev, Oleg/D-9383-2011; Kikawada, Takahiro/A-1289-2010	Gusev, Oleg/0000-0002-6203-9758; Kikawada, Takahiro/0000-0002-2329-9282; CORNETTE, Richard/0000-0002-0185-1443	Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [21688004]	Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN), a grant-in-aid (Bio Design Program) from the Ministry of Agriculture, Forestry and Fisheries of Japan, and by Grant-in-aid for Scientific Research Number 21688004 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A part of this study is also the result of the project "Characterization of the Mechanisms Underlying the Radiation Resistance Associated with Cryptobiosis" carried out under the grant "Strategic Promotion Program for Basic Nuclear Research" by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Berjak P., 2007, PLANT DESICCATION TO, P151; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chen WH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-52; Clegg JS, 2006, COMP BIOCHEM PHYS B, V145, P119, DOI 10.1016/j.cbpb.2006.04.014; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; Cuming AC, 1999, SEED PROTEINS, P753; Danks HV, 2000, J INSECT PHYSIOL, V46, P837, DOI 10.1016/S0022-1910(99)00204-8; Denekamp NY, 2010, BIOL REPROD, V82, P714, DOI 10.1095/biolreprod.109.081091; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Eigenheer AL, 2003, GENE, V316, P127, DOI 10.1016/S0378-1119(03)00749-2; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012; Freitas DRJ, 2007, COMP BIOCHEM PHYS A, V146, P688, DOI 10.1016/j.cbpa.2006.04.032; Gibbs AG, 2002, COMP BIOCHEM PHYS A, V133, P781, DOI 10.1016/S1095-6433(02)00208-8; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; Hankeln T, 1998, J MOL EVOL, V46, P589, DOI 10.1007/PL00006339; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Hinault MP, 2007, ADV EXP MED BIOL, V594, P47; HINTON HE, 1960, J INSECT PHYSIOL, V5, P286, DOI 10.1016/0022-1910(60)90011-1; HINTON HE, 1951, P ZOOL SOC LOND, V121, P371; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; HOCHACHKA DW, 1987, METABOLIC ARREST CON, P146; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Kikawada T, 2005, INTEGR COMP BIOL, V45, P710, DOI 10.1093/icb/45.5.710; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Limon-Pacheco J, 2009, MUTAT RES-GEN TOX EN, V674, P137, DOI 10.1016/j.mrgentox.2008.09.015; Lopez-Martinez G, 2008, INSECT BIOCHEM MOLEC, V38, P796, DOI 10.1016/j.ibmb.2008.05.006; Lopez-Martinez G, 2009, J COMP PHYSIOL B, V179, P481, DOI 10.1007/s00360-008-0334-0; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Maulik N, 2008, BBA-GEN SUBJECTS, V1780, P1368, DOI 10.1016/j.bbagen.2007.12.008; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Mitsumasu K, 2010, FEBS J, V277, P4215, DOI 10.1111/j.1742-4658.2010.07811.x; Nakahara Y, 2008, J INSECT PHYSIOL, V54, P1220, DOI 10.1016/j.jinsphys.2008.05.007; Narayanaswami V, 2000, BBA-MOL CELL BIOL L, V1483, P15, DOI 10.1016/S1388-1981(99)00176-6; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Qiu Z, 2007, MECH DEVELOP, V124, P856, DOI 10.1016/j.mod.2007.09.001; Ricci C, 2001, HYDROBIOLOGIA, V446, P1, DOI 10.1023/A:1017548418201; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; SOMME L, 1995, INVERTEBRATES HOT CO, P95; Suemoto T, 2004, HYDROBIOLOGIA, V515, P107, DOI 10.1023/B:HYDR.0000027322.11005.20; Suetsugu Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-314; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Tagu D, 2004, INSECT BIOCHEM MOLEC, V34, P809, DOI 10.1016/j.ibmb.2004.05.001; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Viner RI, 2001, CELL STRESS CHAPERON, V6, P126, DOI 10.1379/1466-1268(2001)006<0126:IOTOTM>2.0.CO;2; Wajcman H, 2009, CR BIOL, V332, P273, DOI 10.1016/j.crvi.2008.07.026; Watanabe M, 2005, J INSECT PHYSIOL, V51, P727, DOI 10.1016/j.jinsphys.2005.02.008; Watanabe M, 2004, EUR J ENTOMOL, V101, P439, DOI 10.14411/eje.2004.063; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; Watanabe M, 2002, J EXP BIOL, V205, P2799; Wharton DA, 2003, J COMP PHYSIOL B, V173, P621, DOI 10.1007/s00360-003-0378-0; Wu-Scharf D, 2003, SOCIOBIOLOGY, V41, P479	73	43	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35889	35899		10.1074/jbc.M110.150623	http://dx.doi.org/10.1074/jbc.M110.150623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833722	Green Published, hybrid			2022-12-27	WOS:000283845300066
J	Kwak, TK; Kim, H; Jung, O; Lee, SA; Kang, M; Kim, HJ; Park, JM; Kim, SH; Lee, JW				Kwak, Tae Kyoung; Kim, Hyeonjung; Jung, Oisun; Lee, Sin-Ae; Kang, Minkyung; Kim, Hyun Jeong; Park, Ji-Min; Kim, Sung-Hoon; Lee, Jung Weon			Glucosamine Treatment-mediated O-GlcNAc Modification of Paxillin Depends on Adhesion State of Rat Insulinoma INS-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; POSTTRANSLATIONAL MODIFICATION; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; N-ACETYLGLUCOSAMINE; PROTEIN; GLYCOSYLATION; MIGRATION; APOPTOSIS; MATRIX	Protein-protein interactions and/or signaling activities at focal adhesions, where integrin-mediated adhesion to extracellular matrix occurs, are critical for the regulation of adhesion-dependent cellular functions. Although the phosphorylation and activities of focal adhesion molecules have been intensively studied, the effects of the O-GlcNAc modification of their Ser/Thr residues on cellular functions have been largely unexplored. We investigated the effects of O-GlcNAc modification on actin reorganization and morphology of rat insulinoma INS-1 cells after glucosamine (GlcN) treatment. We found that paxillin, a key adaptor molecule in focal adhesions, could be modified by O-GlcNAc in INS-1 cells treated with GlcN and in pancreatic islets from mice treated with streptozotocin. Ser-84/85 in human paxillin appeared to be modified by O-GlcNAc, which was inversely correlated to Ser-85 phosphorylation (Ser-83 in rat paxillin). Integrin-mediated adhesion signaling inhibited the GlcN treatment-enhanced O-GlcNAc modification of paxillin. Adherent INS-1 cells treated with GlcN showed restricted protrusions, whereas untreated cells showed active protrusions for multiple-elongated morphologies. Upon GlcN treatment, expression of a triple mutation (S83A/S84A/S85A) resulted in no further restriction of protrusions. Together these observations suggest that murine pancreatic beta cells may have restricted actin organization upon GlcN treatment by virtue of the O-GlcNAc modification of paxillin, which can be antagonized by a persistent cell adhesion process.	[Kwak, Tae Kyoung; Kim, Hyeonjung; Lee, Jung Weon] Seoul Natl Univ, Dept Tumor Biol, Canc Res Inst, Seoul 110799, South Korea; [Lee, Sin-Ae] Seoul Natl Univ, Dept Mol & Clin Oncol, Seoul 110799, South Korea; [Kang, Minkyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Kim, Hyun Jeong] Seoul Natl Univ, Sch Dent, Dept Dent Anesthesiol, Seoul 110799, South Korea; [Jung, Oisun; Lee, Jung Weon] Seoul Natl Univ, Dept Genet Engn, Seoul 151742, South Korea; [Park, Ji-Min; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Cell Dynam Res Ctr,Dept Pharm, Seoul 151742, South Korea; [Kim, Sung-Hoon] Kyung Hee Univ, Canc Prevent Mat Dev Res Ctr, Seoul 131701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University	Lee, JW (corresponding author), Seoul Natl Univ, Dept Tumor Biol, Canc Res Inst, Seoul 110799, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; kim, sunghoon/0000-0002-1570-3230	Korea Science and Engineering Foundation Ministry of Education, Science, and Technology [R01-2006-000-10248-0]; Cell Dynamics Research Center [R11-2007-007-01004-0]; Ministry of Education, Science, and Technology [010-00150029]	Korea Science and Engineering Foundation Ministry of Education, Science, and Technology; Cell Dynamics Research Center(Ministry of Science & Technology (MOST), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Ministry of Education, Science, and Technology Grant R01-2006-000-10248-0, Cell Dynamics Research Center Grant R11-2007-007-01004-0), and by the Support for Senior Researchers (Leap Research) program through National Research Foundation by the Ministry of Education, Science, and Technology Grant 010-00150029 (to J.W.L.).	Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Dehennaut V, 2008, BIOCHEM BIOPH RES CO, V369, P539, DOI 10.1016/j.bbrc.2008.02.063; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; GEIGER B, 1980, P NATL ACAD SCI-BIOL, V77, P4127, DOI 10.1073/pnas.77.7.4127; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Huang C, 2004, J CELL BIOL, V164, P593, DOI 10.1083/jcb.200307081; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; KELLY WG, 1993, J BIOL CHEM, V268, P10416; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Lee JW, 2004, MOL CELLS, V17, P188; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; MCEVOY RC, 1984, J CLIN INVEST, V74, P715, DOI 10.1172/JCI111487; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020; Sesti G, 2002, ANN MED, V34, P444, DOI 10.1080/078538902321012397; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Werstruck GH, 2006, DIABETES, V55, P93, DOI 10.2337/diabetes.55.01.06.db05-0633; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	40	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36021	36031		10.1074/jbc.M110.129601	http://dx.doi.org/10.1074/jbc.M110.129601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829364	Green Published, hybrid			2022-12-27	WOS:000283845300078
J	Abdallah, RT; Keum, JS; Lee, MH; Wang, B; Gooz, M; Luttrell, DK; Luttrell, LM; Jaffa, AA				Abdallah, Rany T.; Keum, Joo-Seob; Lee, Mi-Hye; Wang, Bing; Gooz, Monika; Luttrell, Deirdre K.; Luttrell, Louis M.; Jaffa, Ayad A.			Plasma Kallikrein Promotes Epidermal Growth Factor Receptor Transactivation and Signaling in Vascular Smooth Muscle through Direct Activation of Protease-activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; NITRIC-OXIDE PRODUCTION; SUBSTRATE-SPECIFICITY; THROMBIN RECEPTORS; CORONARY-ARTERIES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; EGF RECEPTOR; SHEAR-STRESS; PREKALLIKREIN	The kallikrein-kinin system, along with the interlocking reninangiotensin system, is a key regulator of vascular contractility and injury response. The principal effectors of the kallikrein-kinin system are plasma and tissue kallikreins, proteases that cleave high molecular weight kininogen to produce bradykinin. Most of the cellular actions of kallikrein (KK) are thought to be mediated by bradykinin, which acts via G protein-coupled B1 and B2 bradykinin receptors on VSMCs and endothelial cells. Here, we find that primary aortic vascular smooth muscle but not endothelial cells possess the ability to activate plasma prekallikrein. Surprisingly, exposing VSMCs to prekallikrein leads to activation of the ERK1/2 mitogen-activated protein kinase cascade via a mechanism that requires kallikrein activity but does not involve bradykinin receptors. In transfected HEK293 cells, we find that plasma kallikrein directly activates G protein-coupled protease-activated receptors (PARs) 1 and 2, which possess consensus kallikrein cleavage sites, but not PAR4. In vascular smooth muscles, KK stimulates ADAM (a disintegrin and metalloprotease) 17 activity via a PAR1/2 receptor-dependent mechanism, leading sequentially to release of the endogenous ADAM17 substrates, amphiregulin and tumor necrosis factor-alpha, metalloprotease-dependent transactivation of epidermal growth factor receptors, and metalloprotease and epidermal growth factor receptor-dependent ERK1/2 activation. These results suggest a novel mechanism of bradykinin-independent kallikrein action that may contribute to the regulation of vascular responses in pathophysiologic states, such as diabetes mellitus.	[Abdallah, Rany T.; Keum, Joo-Seob; Lee, Mi-Hye; Wang, Bing; Gooz, Monika; Luttrell, Deirdre K.; Luttrell, Louis M.; Jaffa, Ayad A.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Luttrell, Louis M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Jaffa, AA (corresponding author), Amer Univ Beirut, Fac Med, Dept Biochem, Beirut, Lebanon.	aj24@aub.edu.lb		Luttrell, Louis/0000-0003-2805-6949	National Institutes of Health [HL087986, HL077192, DK55524]; South Carolina Center for Biomedical Research Excellence in Cardiovascular Diseases; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077192, R01HL087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524, R56DK055524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Center for Biomedical Research Excellence in Cardiovascular Diseases; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL087986 and HL077192 (to A. A. J.), and DK55524 (to L. M. L.). This work was also supported by the South Carolina Center for Biomedical Research Excellence in Cardiovascular Diseases (to D. K. L.) and Department of Veterans Affairs Research Enhancement Award Program awards.	Al-Ani B, 2002, J PHARMACOL EXP THER, V300, P702, DOI 10.1124/jpet.300.2.702; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; BRINER VA, 1993, AM J PHYSIOL, V264, pF322, DOI 10.1152/ajprenal.1993.264.2.F322; Canault M, 2006, ATHEROSCLEROSIS, V187, P82, DOI 10.1016/j.atherosclerosis.2005.08.031; Carpenter G, 2000, SCI STKE, V2000, ppe1, DOI DOI 10.1126/SCISIGNAL.152000PE1; Chan AK, 2003, J VASC SURG, V37, P644, DOI 10.1067/mva.2003.92; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Damiano BP, 1999, THROMB HAEMOSTASIS, V81, P808; Derkach DN, 2000, BRIT J PHARMACOL, V131, P1635, DOI 10.1038/sj.bjp.0703737; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; GA B, 2004, TRENDS ENDOCRIN MET, V15, P286; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GARG UC, 1989, AM J PHYSIOL, V257, pF60, DOI 10.1152/ajprenal.1989.257.1.F60; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hermann A, 1999, IMMUNOPHARMACOLOGY, V45, P135, DOI 10.1016/S0162-3109(99)00066-1; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Hollenberg MD, 2008, BIOL CHEM, V389, P643, DOI 10.1515/BC.2008.077; Igura T, 1996, ARTERIOSCL THROM VAS, V16, P1524, DOI 10.1161/01.ATV.16.12.1524; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; KANTHOU C, 1995, THROMB HAEMOSTASIS, V74, P1340; Kanthou C, 1995, BLOOD COAGUL FIBRIN, V6, P753, DOI 10.1097/00001721-199512000-00010; Kato M, 2003, BIOCHEM BIOPH RES CO, V301, P1109, DOI 10.1016/S0006-291X(03)00093-7; Kawakami A, 2005, J ATHEROSCLER THROMB, V12, P73, DOI 10.5551/jat.12.73; Kichuk MR, 1996, CIRCULATION, V94, P44, DOI 10.1161/01.CIR.94.1.44; KU DD, 1993, J CARDIOVASC PHARM, V22, P609, DOI 10.1097/00005344-199310000-00015; Ku DD, 1997, J CARDIOVASC PHARM, V30, P649, DOI 10.1097/00005344-199711000-00016; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Mizuno O, 1998, EUR J PHARMACOL, V351, P67, DOI 10.1016/S0014-2999(98)00292-1; Mizuno O, 2000, BRIT J PHARMACOL, V130, P1140, DOI 10.1038/sj.bjp.0703420; MOMBOULI JV, 1995, ANNU REV PHARMACOL, V35, P679, DOI 10.1146/annurev.pa.35.040195.003335; MORITA T, 1993, BIOCHEM BIOPH RES CO, V197, P256, DOI 10.1006/bbrc.1993.2469; Motta G, 2001, THROMB HAEMOSTASIS, V86, P840; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Nakata A, 1996, CIRCULATION, V94, P2778, DOI 10.1161/01.CIR.94.11.2778; Napoli C, 2004, J CLIN PATHOL, V57, P513, DOI 10.1136/jcp.2003.015156; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schmaier AH, 2003, AM J PHYSIOL-REG I, V285, pR1, DOI 10.1152/ajpregu.00535.2002; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; Siragy HM, 1997, HYPERTENSION, V29, P757, DOI 10.1161/01.HYP.29.3.757; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; TESFAMARIAM B, 1994, AM J PHYSIOL-HEART C, V267, pH1962, DOI 10.1152/ajpheart.1994.267.5.H1962; Touyz RM, 2006, ARTERIOSCL THROM VAS, V26, P685, DOI 10.1161/01.ATV.0000216428.90962.60; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; WILCOX JN, 1994, CIRC RES, V75, P1029, DOI 10.1161/01.RES.75.6.1029; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	66	45	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35206	35215		10.1074/jbc.M110.171769	http://dx.doi.org/10.1074/jbc.M110.171769			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826789	Green Published, hybrid			2022-12-27	WOS:000283659100094
J	Ito, H; Oshiro, T; Fujita, Y; Kubota, S; Naito, C; Ohtsuka, H; Murakami, H; Aiba, H				Ito, Hirokazu; Oshiro, Tomoko; Fujita, Yasuyuki; Kubota, Sachiko; Naito, Chikako; Ohtsuka, Hokuto; Murakami, Hiroshi; Aiba, Hirofumi			Pma1, a P-type Proton ATPase, Is a Determinant of Chronological Life Span in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; COA SYNTHETASE GENE; SCHIZOSACCHAROMYCES-POMBE; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; STRESS RESISTANCE; IDENTIFICATION; LONGEVITY; ACTIVATION	Chronological life span is defined by how long a cell can survive in a non-dividing state. In yeast, it is measured by viability after entry into stationary phase. To date, some factors affecting chronological life span have been identified; however, the molecular details of how these factors regulate chronological life span have not yet been elucidated clearly. Because life span is a complicated phenomenon and is supposedly regulated by many factors, it is necessary to identify new factors affecting chronological life span to understand life span regulation. To this end, we have screened for long-lived mutants and identified Pma1, an essential P-type proton ATPase, as one of the determinants of chronological life span. We show that partial loss of Pma1 activity not only by mutations but also by treatment with the Pma1 inhibitory chemical vanadate resulted in the long-lived phenotype in Schizosaccharomyces pombe. These findings suggest a novel way to manipulate chronological life span by modulating Pma1 as a molecular target.	[Aiba, Hirofumi] Nagoya Univ, Mol Microbiol Lab, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Murakami, Hiroshi] Nagoya City Univ, Dept Biochem & Cell Biol, Grad Sch Med, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya University; Nagoya City University	Aiba, H (corresponding author), Nagoya Univ, Mol Microbiol Lab, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	aiba@agr.nagoya-u.ac.jp	Ohtsuka, Hokuto/I-6957-2014	Ohtsuka, Hokuto/0000-0001-7843-2602	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency (JST); Nagase Science and Technology Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Nagase Science and Technology Foundation	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. A.) and by Research for Promoting Technological Seeds from the Japan Science and Technology Agency (JST) and the Nagase Science and Technology Foundation (to H. A.).	Azuma K, 2009, BIOSCI BIOTECH BIOCH, V73, P2787, DOI 10.1271/bbb.90599; BRISKIN DP, 1987, METHOD ENZYMOL, V148, P542; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fujita Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3041, DOI 10.1271/bbb.70442; GHISLAIN M, 1992, EUR J BIOCHEM, V209, P275, DOI 10.1111/j.1432-1033.1992.tb17286.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; HO FERM, 1987, J GEN MICROBIOL */*, V133, P2163; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Ohmiya R, 1999, J BIOCHEM, V125, P1061, DOI 10.1093/oxfordjournals.jbchem.a022387; Ohtsuka H, 2008, FEMS YEAST RES, V8, P520, DOI 10.1111/j.1567-1364.2008.00379.x; Ohtsuka H, 2009, BIOSCI BIOTECH BIOCH, V73, P885, DOI 10.1271/bbb.80804; Oshiro T, 2003, MOL GENET GENOMICS, V269, P437, DOI 10.1007/s00438-003-0841-3; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Smith ED, 2007, MECH AGEING DEV, V128, P106, DOI 10.1016/j.mad.2006.11.017; ULASZEWSKI S, 1987, J BIOL CHEM, V262, P223; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993	24	22	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34616	34620		10.1074/jbc.M110.175562	http://dx.doi.org/10.1074/jbc.M110.175562			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20829365	Green Published, hybrid			2022-12-27	WOS:000283659100037
J	Murakami, E; Tolstykh, T; Bao, HY; Niu, CR; Steuer, HMM; Bao, DH; Chang, W; Espiritu, C; Bansal, S; Lam, AM; Otto, MJ; Sofia, MJ; Furman, PA				Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.			Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE ANALOG INHIBITORS; C VIRUS-REPLICATION; HEPATITIS-C; PHOSPHORAMIDATE DERIVATIVES; CARBOXYLESTERASE ISOZYMES; SUBSTRATE-SPECIFICITY; RNA-POLYMERASE; HUMAN-LIVER; HYDROLYSIS; HIV	A phosphoramidate prodrug of 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5'-monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo. PSI-7851 is a mixture of two diastereoisomers, PSI-7976 and PSI-7977, with PSI-7977 being the more active inhibitor of HCV RNA replication in the HCV replicon assay. To inhibit the HCV NS5B RNA-dependent RNA polymerase, PSI-7851 must be metabolized to the active triphosphate form. The first step, hydrolysis of the carboxyl ester by human cathepsin A (CatA) and/or carboxylesterase 1 (CES1), is a stereospecific reaction. Western blot analysis showed that CatA and CES1 are both expressed in primary human hepatocytes. However, expression of CES1 is undetectable in clone A replicon cells. Studies with inhibitors of CatA and/or CES1 indicated that CatA is primarily responsible for hydrolysis of the carboxyl ester in clone A cells, although in primary human hepatocytes, both CatA and CES1 contribute to the hydrolysis. Hydrolysis of the ester is followed by a putative nucleophilic attack on the phosphorus by the carboxyl group resulting in the spontaneous elimination of phenol and the production of an alaninyl phosphate metabolite, PSI-352707, which is common to both isomers. The removal of the amino acid moiety of PSI-352707 is catalyzed by histidine triad nucleotide-binding protein 1 (Hint1) to give the 5'-monophosphate form, PSI-7411. siRNA-mediated Hint1 knockdown studies further indicate that Hint1 is, at least in part, responsible for converting PSI-352707 to PSI-7411. PSI-7411 is then consecutively phosphorylated to the diphosphate, PSI-7410, and to the active triphosphate metabolite, PSI-7409, by UMP-CMP kinase and nucleoside diphosphate kinase, respectively.	[Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.] Pharmasset Inc, Princeton, NJ 08540 USA		Murakami, E (corresponding author), 303 A Coll Rd E, Princeton, NJ 08540 USA.	emurakami@pharmasset.com; pfurman@pharmasset.com		Chang, Wonsuk/0000-0003-4697-4663				Birkus G, 2007, ANTIMICROB AGENTS CH, V51, P543, DOI 10.1128/AAC.00968-06; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BLOCK W, 1978, BIOCHIM BIOPHYS ACTA, V524, P85, DOI 10.1016/0005-2744(78)90106-7; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Carroll S. S., 2006, Infectious Disorders - Drug Targets, V6, P17, DOI 10.2174/187152606776056698; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; Chou TF, 2007, J BIOL CHEM, V282, P15137, DOI 10.1074/jbc.M606972200; Chou TF, 2007, J MOL BIOL, V373, P978, DOI 10.1016/j.jmb.2007.08.023; Chou TF, 2007, MOL PHARMACEUT, V4, P208, DOI 10.1021/mp060070y; Crow JA, 2007, TOXICOL APPL PHARM, V221, P1, DOI 10.1016/j.taap.2007.03.002; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Derudas M, 2009, J MED CHEM, V52, P5520, DOI 10.1021/jm9007856; DUARTE MIS, 1989, J SUBMICR CYTOL PATH, V21, P275; FE RIRG, 2008, REV MED VIROL */* E, V18, P19; Forestier N, 2007, HEPATOLOGY, V46, P640, DOI 10.1002/hep.21774; Furman PA, 2009, FUTURE MED CHEM, V1, P1429, DOI 10.4155/FMC.09.88; Hewlett G, 2004, CURR OPIN PHARMACOL, V4, P453, DOI 10.1016/j.coph.2004.06.004; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; Huang HZ, 2005, CHEM RES TOXICOL, V18, P1371, DOI 10.1021/tx050072+; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Imai T, 2006, DRUG METAB DISPOS, V34, P1734, DOI 10.1124/dmd.106.009381; Kwong AD, 2008, CURR OPIN PHARMACOL, V8, P522, DOI 10.1016/j.coph.2008.09.007; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200; McGuigan C, 1998, ANTIVIR CHEM CHEMOTH, V9, P473, DOI 10.1177/095632029800900603; McGuigan C, 1998, ANTIVIR CHEM CHEMOTH, V9, P109, DOI 10.1177/095632029800900202; Murakami E, 2008, ANTIMICROB AGENTS CH, V52, P458, DOI 10.1128/AAC.01184-07; Murakami E, 2007, ANTIMICROB AGENTS CH, V51, P503, DOI 10.1128/AAC.00400-06; NAESENS L, 2001, E Herpes, V8, P12; Stuyver Lieven J., 2006, Antiviral Chemistry & Chemotherapy, V17, P79; Stuyver LJ, 2003, J VIROL, V77, P10689, DOI 10.1128/JVI.77.19.10689-10694.2003; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Valette G, 1996, J MED CHEM, V39, P1981, DOI 10.1021/jm9507338; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; Yang DF, 2009, BIOCHEM PHARMACOL, V77, P238, DOI 10.1016/j.bcp.2008.10.005; Yang J, 2007, MOL PHARMACOL, V72, P686, DOI 10.1124/mol.107.036889	36	210	257	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34337	34347		10.1074/jbc.M110.161802	http://dx.doi.org/10.1074/jbc.M110.161802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801890	hybrid, Green Published			2022-12-27	WOS:000283659100007
J	Vigil, D; Martin, TD; Williams, F; Yeh, JJ; Campbell, SL; Der, CJ				Vigil, Dominico; Martin, Timothy D.; Williams, Falina; Yeh, Jen Jen; Campbell, Sharon L.; Der, Channing J.			Aberrant Overexpression of the Rgl2 Ral Small GTPase-specific Guanine Nucleotide Exchange Factor Promotes Pancreatic Cancer Growth through Ral-dependent and Ral-independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; FAMILY GTPASES; CELL-GROWTH; DISSOCIATION STIMULATOR; GENE INDUCTION; ACTIVATION; EFFECTOR; PROTEIN; CORTACTIN; RLF	Our recent studies established essential and distinct roles for RalA and RalB small GTPase activation in K-Ras mutant pancreatic ductal adenocarcinoma (PDAC) cell line tumorigencity, invasion, and metastasis. However, the mechanism of Ral GTPase activation in PDAC has not been determined. There are four highly related mammalian RalGEFs (RalGDS, Rgl1, Rgl2, and Rgl3) that can serve as Ras effectors. Whether or not they share distinct or overlapping functions in K-Ras-mediated growth transformation has not been explored. We found that plasma membrane targeting to mimic persistent Ras activation enhanced the growth-transforming activities of RalGEFs. Unexpectedly, transforming activity did not correlate directly with total cell steady-state levels of Ral activation. Next, we observed elevated Rgl2 expression in PDAC tumor tissue and cell lines. Expression of dominant negative Ral, which blocks RalGEF function, as well as interfering RNA suppression of Rgl2, reduced PDAC cell line steady-state Ral activity, growth in soft agar, and Matrigel invasion. Surprisingly, the effect of Rgl2 on anchorage-independent growth could not be rescued by constitutively activated RalA, suggesting a novel Ral-independent function for Rgl2 in transformation. Finally, we determined that Rgl2 and RalB both localized to the leading edge, and this localization of RalB was dependent on endogenous Rgl2 expression. In summary, our observations support nonredundant roles for RalGEFs in Ras-mediated oncogenesis and a key role for Rgl2 in Ral activation and Ral-independent PDAC growth.	[Martin, Timothy D.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Vigil, Dominico; Martin, Timothy D.; Williams, Falina; Yeh, Jen Jen; Campbell, Sharon L.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, 201CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu		campbell, sharon/0000-0003-0311-409X; Der, Channing/0000-0002-7751-2747	National Institutes of Health [CA042978, CA67771]; National Institutes of Health, NCI [CA106991]; Emerald Foundation; Kimmel Foundation; American College of Surgeon; North Carolina University; NATIONAL CANCER INSTITUTE [R01CA140424, R01CA042978, P50CA106991, U19CA067771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Emerald Foundation; Kimmel Foundation; American College of Surgeon; North Carolina University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA042978 and CA67771 (to C. J. D.) and National Institutes of Health, NCI, SPORE in Gastrointestinal Cancer P50 Grant CA106991 (to C. J. D. and J. J. Y.). This work was also supported by the Emerald Foundation, the Kimmel Foundation, the American College of Surgeons, and the North Carolina University Cancer Research Fund.	ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Baines AT, 2006, METHOD ENZYMOL, V407, P556, DOI 10.1016/S0076-6879(05)07045-X; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; COX AD, 1994, METHOD ENZYMOL, V238, P277; DE R, 1997, J L ONCOGENE */* ONC, V14, P623; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Ehrhardt GRA, 2001, ONCOGENE, V20, P188, DOI 10.1038/sj.onc.1204053; Evelyn CR, 2009, J BIOMOL SCREEN, V14, P161, DOI 10.1177/1087057108328761; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goi T, 1999, MOL CELL BIOL, V19, P1731; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Isomura M, 1996, CYTOGENET CELL GENET, V74, P263, DOI 10.1159/000134431; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaksonen M, 2000, J CELL SCI, V113, P4421; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Lanigan TM, 2003, FASEB J, V17, P2048, DOI 10.1096/fj.02-1096com; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Lok W, 2010, ANTI-CANCER DRUG, V21, P339, DOI 10.1097/CAD.0b013e3283350dd1; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Murai H, 1997, J BIOL CHEM, V272, P10483; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Sood R, 2000, BBA-GENE STRUCT EXPR, V1491, P285, DOI 10.1016/S0167-4781(00)00031-2; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Yeh JJ, 2007, EXPERT OPIN THER TAR, V11, P673, DOI 10.1517/14728222.11.5.673; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	57	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34729	34740		10.1074/jbc.M110.116756	http://dx.doi.org/10.1074/jbc.M110.116756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801877	Green Published, hybrid			2022-12-27	WOS:000283659100048
J	Zhang, J; Ravichandran, KS; Garrison, JC				Zhang, Jun; Ravichandran, Kodi S.; Garrison, James C.			A Key Role for the Phosphorylation of Ser(440) by the Cyclic AMP-dependent Protein Kinase in Regulating the Activity of the Src Homology 2 Domain-containing Inositol 5 '-Phosphatase (SHIP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; TYROSINE PHOSPHORYLATION; POLYPHOSPHATE 5-PHOSPHATASE; LIPID PHOSPHATASES; MASS-SPECTROMETRY; IN-VIVO; CELLS; ACTIVATION; SHC; PI3K	The Src homology 2 domain-containing inositol 5'-phosphatase 1 (SHIP1) dephosphorylates phosphatidylinositol 3,4,5-trisphosphate to phophatidylinositol 3,4-bisphosphate in hematopoietic cells to regulate multiple cell signaling pathways. SHIP1 can be phosphorylated by the cyclic AMP-dependent protein kinase (PKA), resulting in an increase in SHIP1 activity (Zhang, J., Walk, S. F., Ravichandran, K. S., and Garrison, J. C. (2009) J. Biol. Chem. 284, 20070-20078). Using a combination of approaches, we identified the serine residue regulating SHIP1 activity. After mass spectrometric identification of 17 serine and threonine residues on SHIP1 as being phosphorylated by PKA in vitro, studies with truncation mutants of SHIP1 narrowed the phosphorylation site to the catalytic region between residues 400 and 866. Of the two candidate phosphorylation sites located in this region (Ser(440) and Ser(774)), only mutation of Ser(440) to Ala abolished the ability of PKA to phosphorylate the purified, catalytic domain of SHIP1 (residues 401-866). Mutation of Ser(440) to Ala in full-length SHIP1 abrogated the ability of PKA to increase the activity of SHIP1 in mammalian cells. Using flow cytometry, we found that the PKA activator, Sp-adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt hydrate (Sp-cAMPS) blunted the phosphorylation of Akt downstream of B cell antigen receptor engagement in SHIP1-null DT40 B lymphocytes expressing native mouse SHIP1. The inhibitory effect of Sp-cAMPS was absent in cells expressing the S440A mutant of SHIP1. These results suggest that activation of SHIP1 by PKA via phosphorylation on Ser(440) is an important regulatory event in hematopoietic cells.	[Zhang, Jun; Garrison, James C.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Garrison, JC (corresponding author), Univ Virginia, Dept Pharmacol, POB 800735, Charlottesville, VA 22908 USA.	jcg8w@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410; Zhang, Jun/0000-0002-3339-0346	Garrison laboratory; National Institutes of Health [R01 GM076236, DK199520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076236] Funding Source: NIH RePORTER	Garrison laboratory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Susan Taylor for providing the expression vector containing the catalytic subunit of PKA and the purified PKA catalytic subunit. We thank Dr. Nicholas E. Sherman of the University of Virginia Biomolecular Research Facility for identification of phosphorylation sites. We thank Dr. Paul Trampont for discussions and suggestions for the flow cytometry experiments. We also thank all the members of the Garrison laboratory for advice and support on this project.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076236 and DK199520.	Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Artemenko Y, 2007, J CELL PHYSIOL, V211, P598, DOI 10.1002/jcp.20965; Backers K, 2003, ADV ENZYME REGUL, V43, P15, DOI 10.1016/S0065-2571(02)00043-2; Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Harris SJ, 2008, J BIOL CHEM, V283, P2465, DOI 10.1074/jbc.R700044200; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Kagawa S, 2005, J CLIN ENDOCR METAB, V90, P2911, DOI 10.1210/jc.2004-1724; Kennah M, 2009, EXP HEMATOL, V37, P1274, DOI 10.1016/j.exphem.2009.08.001; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; LIU L, 1994, MOL CELL BIOL, V14, P6926, DOI 10.1128/MCB.14.10.6926; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Mandal A, 1999, BIOL REPROD, V61, P1184, DOI 10.1095/biolreprod61.5.1184; March ME, 2002, SEMIN IMMUNOL, V14, P37, DOI 10.1006/smim.2001.0340; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Pradhan M, 1997, J CELL BIOCHEM, V67, P32, DOI 10.1002/(SICI)1097-4644(19971001)67:1<32::AID-JCB4>3.0.CO;2-X; Prasad NK, 2009, BIOCHEMISTRY-US, V48, P6285, DOI 10.1021/bi900492d; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Zhang J, 2009, J BIOL CHEM, V284, P20070, DOI 10.1074/jbc.M109.016865	36	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34839	34849		10.1074/jbc.M110.128827	http://dx.doi.org/10.1074/jbc.M110.128827			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810657	Green Published, hybrid			2022-12-27	WOS:000283659100059
J	Suzuki, R; Katayama, T; Kim, BJ; Wakagi, T; Shoun, H; Ashida, H; Yamamoto, K; Fushinobu, S				Suzuki, Ryuichiro; Katayama, Takane; Kim, Byung-Jun; Wakagi, Takayoshi; Shoun, Hirofumi; Ashida, Hisashi; Yamamoto, Kenji; Fushinobu, Shinya			Crystal Structures of Phosphoketolase THIAMINE DIPHOSPHATE-DEPENDENT DEHYDRATION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XYLULOSE 5-PHOSPHATE; LACTOBACILLUS-PLANTARUM; TRANSKETOLASE; CRYSTALLOGRAPHY; CATALYSIS; CLEAVAGE; FRUCTOSE-6-PHOSPHATE; PURIFICATION; 6-PHOSPHATE; BACTERIAL	Thiamine diphosphate (ThDP)-dependent enzymes are ubiquitously present in all organisms and catalyze essential reactions in various metabolic pathways. ThDP-dependent phosphoketolase plays key roles in the central metabolism of heterofermentative bacteria and in the pentose catabolism of various microbes. In particular, bifidobacteria, representatives of beneficial commensal bacteria, have an effective glycolytic pathway called bifid shunt in which 2.5 mol of ATP are produced per glucose. Phosphoketolase catalyzes two steps in the bifid shunt because of its dual-substrate specificity; they are phosphorolytic cleavage of fructose 6-phosphate or xylulose 5-phosphate to produce aldose phosphate, acetyl phosphate, and H2O. The phosphoketolase reaction is different from other well studied ThDP-dependent enzymes because it involves a dehydration step. Although phosphoketolase was discovered more than 50 years ago, its three-dimensional structure remains unclear. In this study we report the crystal structures of xylulose 5-phosphate/ fructose 6-phosphate phosphoketolase from Bifidobacterium breve. The structures of the two intermediates before and after dehydration (alpha,beta-dihydroxyethyl ThDP and 2-acetylThDP) and complex with inorganic phosphate give an insight into the mechanism of each step of the enzymatic reaction.	[Suzuki, Ryuichiro; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Katayama, Takane] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Kim, Byung-Jun; Ashida, Hisashi; Yamamoto, Kenji] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	University of Tokyo; Ishikawa Prefecture University; Kyoto University	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Ashida, Hisashi/HCI-0293-2022; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; Ashida, Hisashi/0000-0001-5844-4075; Katayama, Takane/0000-0003-4009-7874	Program for the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	Program for the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan.	Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; BURGI HB, 1983, ACCOUNTS CHEM RES, V16, P153, DOI 10.1021/ar00089a002; Duggleby RG, 2006, ACCOUNTS CHEM RES, V39, P550, DOI 10.1021/ar068022z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler E, 2002, P NATL ACAD SCI USA, V99, P591, DOI 10.1073/pnas.022510999; FREY P A, 1989, Biofactors, V2, P1; GOLDBERG ML, 1962, J BIOL CHEM, V237, P3841; GRUYS KJ, 1987, BIOCHEMISTRY-US, V26, P7575, DOI 10.1021/bi00398a007; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; HEATH EC, 1958, J BIOL CHEM, V231, P1009; HURWITZ J, 1958, BIOCHIM BIOPHYS ACTA, V28, P599, DOI 10.1016/0006-3002(58)90526-2; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meile L, 2001, J BACTERIOL, V183, P2929, DOI 10.1128/JB.183.9.2929-2936.2001; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilsson U, 1997, J BIOL CHEM, V272, P1864, DOI 10.1074/jbc.272.3.1864; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panagiotou G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003847; Pang SS, 2004, J BIOL CHEM, V279, P2242, DOI 10.1074/jbc.M304038200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrareanu G, 2010, ACTA CRYSTALLOGR F, V66, P805, DOI 10.1107/S174430911001732X; Rappleye J, 2002, J APPL CRYSTALLOGR, V35, P374, DOI 10.1107/S0021889802005782; Reed GH, 1996, CURR OPIN STRUC BIOL, V6, P736, DOI 10.1016/S0959-440X(96)80002-9; Sanchez B, 2010, J MOL MICROB BIOTECH, V18, P37, DOI 10.1159/000274310; Scardovi V., 1965, ANN MICROBIOL ENZ, V15, P19; SCARDOVI V, 1986, BERGEYS MANUAL SYSTE, V2, P1418; Schneider G, 1998, BBA-PROTEIN STRUCT M, V1385, P387, DOI 10.1016/S0167-4838(98)00082-X; SCHRAMM M, 1958, J BIOL CHEM, V233, P1283; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SGORBATI B, 1976, A VAN LEEUW J MICROB, V42, P49, DOI 10.1007/BF00399448; Suzuki R, 2010, ACTA CRYSTALLOGR F, V66, P941, DOI 10.1107/S1744309110023845; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; Tittmann K, 2009, J MOL CATAL B-ENZYM, V61, P93, DOI 10.1016/j.molcatb.2009.02.019; Tittmann K, 2009, FEBS J, V276, P2454, DOI 10.1111/j.1742-4658.2009.06966.x; Vlkova E, 2005, J MICROBIOL METH, V60, P365, DOI 10.1016/j.mimet.2004.10.012; Wikner C, 1997, BIOCHEMISTRY-US, V36, P15643, DOI 10.1021/bi971606b; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788; Yevenes A, 2008, BIOORG CHEM, V36, P121, DOI 10.1016/j.bioorg.2008.03.002	45	40	41	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34279	34287		10.1074/jbc.M110.156281	http://dx.doi.org/10.1074/jbc.M110.156281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739284	Green Published, hybrid			2022-12-27	WOS:000283354000073
J	Matsuo, K; Delibegovic, M; Matsuo, I; Nagata, N; Liu, SM; Bettaieb, A; Xi, YN; Araki, K; Yang, WT; Kahn, BB; Neel, BG; Haj, FG				Matsuo, Kosuke; Delibegovic, Mirela; Matsuo, Izumi; Nagata, Naoto; Liu, Siming; Bettaieb, Ahmed; Xi, Yannan; Araki, Kazushi; Yang, Wentian; Kahn, Barbara B.; Neel, Benjamin G.; Haj, Fawaz G.			Altered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FACTOR-I RECEPTOR; INSULIN-RESISTANCE; TUBEROUS SCLEROSIS; GENE-EXPRESSION; DILATED CARDIOMYOPATHY; PHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; S6 KINASE; SHP2	The Src homology 2 domain-containing protein-tyrosine phosphatase Shp2 has been implicated in a variety of growth factor signaling pathways, but its role in insulin signaling has remained unresolved. In vitro studies suggest that Shp2 is both a negative and positive regulator of insulin signaling, although its physiological function in a number of peripheral insulin-responsive tissues remains unknown. To address the metabolic role of Shp2 in the liver, we generated mice with either chronic or acute hepatic Shp2 deletion using tissue-specific Cre-LoxP and adenoviral Cre approaches, respectively. We then analyzed insulin sensitivity, glucose tolerance, and insulin signaling in liver-specific Shp2-deficient and control mice. Mice with chronic Shp2 deletion exhibited improved insulin sensitivity and increased glucose tolerance compared with controls. Acute Shp2 deletion yielded comparable results, indicating that the observed metabolic effects are directly caused by the lack of Shp2 in the liver. These findings correlated with, and were most likely caused by, direct dephosphorylation of insulin receptor substrate (IRS) 1/2 in the liver, accompanied by increased PI3K/Akt signaling. In contrast, insulin-induced ERK activation was dramatically attenuated, yet there was no effect on the putative ERK site on IRS1 (Ser(612)) or on S6 kinase 1 activity. These studies show that Shp2 is a negative regulator of hepatic insulin action, and its deletion enhances the activation of PI3K/Akt pathway downstream of the insulin receptor.	[Matsuo, Kosuke; Matsuo, Izumi; Nagata, Naoto; Liu, Siming; Bettaieb, Ahmed; Xi, Yannan; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Delibegovic, Mirela; Araki, Kazushi; Yang, Wentian; Kahn, Barbara B.; Neel, Benjamin G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	University of California System; University of California Davis; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall, Davis, CA 95616 USA.	fghaj@ucdavis.edu	NAGATA, Naoto/D-9261-2012	NAGATA, Naoto/0000-0002-2389-2334; Delibegovic, Mirela/0000-0001-6193-3152	National Institutes of Health [R3749512, R01DK60838]; American Diabetes Association [7-06-JF-28]; Juvenile Diabetes Research Foundation [1-2009-337]; Ontario Ministry of Health and Long Term Care (OMHLTC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Ontario Ministry of Health and Long Term Care (OMHLTC)(Ministry of Health and Long-Term Care, Ontario); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R3749512 (to to B. G. N.) and R01DK60838 (to B. B. K.). This work was also supported by a grant from Center for Health and Nutrition Research, Junior Faculty Award 7-06-JF-28 from the American Diabetes Association, and Juvenile Diabetes Research Foundation Research Grant 1-2009-337 (to F. G. H.), and by the Ontario Ministry of Health and Long Term Care (OMHLTC). The views expressed do not necessarily reflect those of OMHLTC.	Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Binder G, 2005, J CLIN ENDOCR METAB, V90, P5377, DOI 10.1210/jc.2005-0995; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865; Ling Y, 2003, MOL ENDOCRINOL, V17, P1824, DOI 10.1210/me.2003-0143; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; MITTAL SK, 1993, VIRUS RES, V28, P67, DOI 10.1016/0168-1702(93)90090-A; Mussig K, 2005, J BIOL CHEM, V280, P32693, DOI 10.1074/jbc.M506549200; Myers MG, 1996, MOL CELL BIOL, V16, P4147; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Ouwens DM, 2001, MOL CELL ENDOCRINOL, V175, P131, DOI 10.1016/S0303-7207(01)00389-6; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Podar K, 2004, J BIOL CHEM, V279, P21658, DOI 10.1074/jbc.M305783200; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SUGIMOTO S, 1993, J BIOL CHEM, V268, P22771; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Zhang SS, 2009, P NATL ACAD SCI USA, V106, P7531, DOI 10.1073/pnas.0811715106; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	55	37	37	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39750	39758		10.1074/jbc.M110.153734	http://dx.doi.org/10.1074/jbc.M110.153734			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20841350	hybrid, Green Published			2022-12-27	WOS:000285185500019
J	Bharadwaj, KG; Hiyama, Y; Hu, YY; Huggins, LA; Ramakrishnan, R; Abumrad, NA; Shulman, GI; Blaner, WS; Goldberg, IJ				Bharadwaj, Kalyani G.; Hiyama, Yaeko; Hu, Yunying; Huggins, Lesley Ann; Ramakrishnan, Rajasekhar; Abumrad, Nada A.; Shulman, Gerald I.; Blaner, William S.; Goldberg, Ira J.			Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways IN VIVO EVIDENCE FOR RECEPTOR- AND NON-RECEPTOR-MEDIATED FATTY ACID UPTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RETINOL-BINDING-PROTEIN; KNOCKOUT MICE; RAT-HEART; RICH LIPOPROTEINS; MEMBRANE-PROTEIN; TRANSGENIC MICE; OLEATE UPTAKE; LIPASE; METABOLISM	Lipids circulate in the blood in association with plasma lipoproteins and enter the tissues either after hydrolysis or as non-hydrolyzable lipid esters. We studied cardiac lipids, lipoprotein lipid uptake, and gene expression in heart-specific lipoprotein lipase (LpL) knock-out (hLpL0), CD36 knock-out (Cd36(-/-)), and double knock-out (hLpL0/Cd36(-/-)-DKO) mice. Loss of either LpL or CD36 led to a significant reduction in heart total fatty acyl-CoA (control, 99.5 +/- 3.8; hLpL0, 36.2 +/- 3.5; Cd36(-/-), 57.7 +/- 5.5 nmol/g, p < 0.05) and an additive effect was observed in the DKO (20.2 +/- 1.4 nmol/g, p < 0.05). Myocardial VLDL-triglyceride (TG) uptake was reduced in the hLpL0 (31 +/- 6%) and Cd36(-/-) (47 +/- 4%) mice with an additive reduction in the DKO (64 +/- 5%) compared with control. However, LpL but not CD36 deficiency decreased VLDL-cholesteryl ester uptake. Endogenously labeled mouse chylomicrons were produced by tamoxifen treatment of beta-actin-MerCreMer/LpL(flox/flox) mice. Induced loss of LpL increased TG levels > 10-fold and reduced HDL by > 50%. After injection of these labeled chylomicrons in the different mice, chylomicron TG uptake was reduced by similar to 70% and retinyl ester by similar to 50% in hLpL0 hearts. Loss of CD36 did not alter either chylomicron TG or retinyl ester uptake. LpL loss did not affect uptake of remnant lipoproteins from ApoE knock-out mice. Our data are consistent with two pathways for fatty acid uptake; a CD36 process for VLDL-derived fatty acid and a non-CD36 process for chylomicron-derived fatty acid uptake. In addition, our data show that lipolysis is involved in uptake of core lipids from TG-rich lipoproteins.	[Bharadwaj, Kalyani G.; Hiyama, Yaeko; Hu, Yunying; Huggins, Lesley Ann; Blaner, William S.; Goldberg, Ira J.] Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, New York, NY 10032 USA; [Bharadwaj, Kalyani G.; Hiyama, Yaeko; Hu, Yunying; Huggins, Lesley Ann; Blaner, William S.; Goldberg, Ira J.] Columbia Univ, Dept Med, Coll Phys & Surg, Div Cardiol, New York, NY 10032 USA; [Ramakrishnan, Rajasekhar] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Atkins Ctr Excellence Obes Med, St Louis, MO 63110 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Columbia University; Columbia University; Columbia University; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Yale University	Goldberg, IJ (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, 630 W 168th St, New York, NY 10032 USA.	ijg3@columbia.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	National Institutes of Health [HL73029, HL45095, DK079221, AA019413, P01 HL057278]; American Heart Association [0725829T]; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL045095, R37HL045095, R01HL073029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, R01DK033301, R01DK040936, R01DK079221, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73029 and HL45095 (to I.J.G.), DK079221 and AA019413 (to W.S.B.), and P01 HL057278 (to N.A.A.).; Supported by American Heart Association Postdoctoral Fellowship 0725829T and a mentored postdoctoral fellowship from the American Diabetes Association.	ABUMRAD NA, 1984, J BIOL CHEM, V259, P8945; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Berk PD, 1999, MOL CELL BIOCHEM, V192, P17, DOI 10.1023/A:1006832001033; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Brinkmann JFF, 2002, BIOCHEM J, V367, P561, DOI 10.1042/BJ20020747; CLARK AB, 1985, J BIOL CHEM, V260, P4778; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; de Medina P, 2004, J PHARMACOL EXP THER, V308, P1165, DOI 10.1124/jpet.103.060426; DEGRELLA RF, 1980, J BIOL CHEM, V255, P9731; DEGRELLA RF, 1985, BASIC RES CARDIOL, V80, P107; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Dugi KA, 2000, ARTERIOSCL THROM VAS, V20, P793, DOI 10.1161/01.ATV.20.3.793; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; EVANS AJ, 1993, METABOLISM, V42, P105, DOI 10.1016/0026-0495(93)90180-V; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FIELDING CJ, 1978, J CLIN INVEST, V62, P141, DOI 10.1172/JCI109099; GOLDBERG IJ, 1990, J CLIN INVEST, V86, P463, DOI 10.1172/JCI114732; Hamilton JA, 2001, J MOL NEUROSCI, V16, P99, DOI 10.1385/JMN:16:2-3:99; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; HOROWITZ BS, 1993, J CLIN INVEST, V91, P1743, DOI 10.1172/JCI116384; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; KAMP F, 1995, BIOCHEMISTRY-US, V34, P11928, DOI 10.1021/bi00037a034; Kleinfeld AM, 1998, BIOCHEMISTRY-US, V37, P8011, DOI 10.1021/bi980301+; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; LEVY E, 1990, EUR J CLIN INVEST, V20, P422, DOI 10.1111/j.1365-2362.1990.tb01880.x; Maugeais C, 2003, CIRCULATION, V108, P2121, DOI 10.1161/01.CIR.0000092889.24713.DC; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Niu YG, 2004, J PHYSIOL-LONDON, V558, P225, DOI 10.1113/jphysiol.2004.061473; Noh HL, 2006, AM J PHYSIOL-ENDOC M, V291, pE755, DOI 10.1152/ajpendo.00111.2006; NUNES R, 1988, J HEPATOL, V7, pP15; O'Byrne SM, 2010, AM J PHYSIOL-ENDOC M, V298, pE862, DOI 10.1152/ajpendo.00491.2009; OSONO Y, 1995, J CLIN INVEST, V95, P1124, DOI 10.1172/JCI117760; Pohl J, 2004, BBA-MOL CELL BIOL L, V1686, P1, DOI 10.1016/j.bbalip.2004.06.004; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; SCHWIETERMAN W, 1988, P NATL ACAD SCI USA, V85, P359, DOI 10.1073/pnas.85.2.359; Seo T, 2000, J BIOL CHEM, V275, P30355, DOI 10.1074/jbc.M910327199; SORRENTINO D, 1988, J CLIN INVEST, V82, P928, DOI 10.1172/JCI113700; SPADY DK, 1983, J LIPID RES, V24, P303; STREMMEL W, 1989, BIOCHIM BIOPHYS ACTA, V1013, P218, DOI 10.1016/0167-4889(89)90138-9; STREMMEL W, 1988, J CLIN INVEST, V81, P844, DOI 10.1172/JCI113393; STUMP DD, 1992, HEPATOLOGY, V16, pA261; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Tetali SD, 2010, J LIPID RES, V51, P1273, DOI 10.1194/jlr.M000406; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; WISNESKI JA, 1987, J CLIN INVEST, V79, P359, DOI 10.1172/JCI112820; Xiang SQ, 1999, J LIPID RES, V40, P1655; Yamashita H, 2008, AM J PHYSIOL-ENDOC M, V295, pE705, DOI 10.1152/ajpendo.90338.2008; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6	65	88	89	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37976	37986		10.1074/jbc.M110.174458	http://dx.doi.org/10.1074/jbc.M110.174458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20852327	Green Published, hybrid			2022-12-27	WOS:000284625600005
J	Aker, M; Bomsztyk, K; Emery, DW				Aker, Mari; Bomsztyk, Karol; Emery, David W.			Poly(ADP-ribose) Polymerase-1 (PARP-1) Contributes to the Barrier Function of a Vertebrate Chromatin Insulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN INSULATOR; ENHANCER BLOCKING; DNA-BINDING; CTCF; TRANSCRIPTION; PROTEINS; VECTORS	The prototypic chromatin insulator cHS4 has proven effective in reducing silencing chromosomal position effects in a variety of settings. Most of this barrier insulator activity has been mapped to a 250-bp core region, as well as to several proteins that bind this region. However, recent studies from our laboratory demonstrated that an extended 400-bp core region of the cHS4 element is necessary to achieve full barrier insulator activity when used as a single copy in the context of recombinant gammaretroviral and lentiviral vectors. In this study, electrophoretic gel mobility shift assays revealed specific DNA-protein binding activities associated with the distal portion of this extended core region. Affinity purification and tandem mass spectrometry studies led to the identification of one of these proteins as poly(ADP-ribose) polymerase-1 (PARP-1). The identity of this binding activity as PARP-1 was subsequently verified by a variety of biochemical studies in vitro and by chromatin immunoprecipitation studies in vivo. Functional studies with gammaretroviral reporter vectors in cell lines and primary mouse bone marrow progenitor cultures showed that cHS4 barrier activity was abrogated upon mutation of the putative PARP1-binding site or upon treatment with a PARP inhibitor, respectively. The barrier activity of the cHS4 element was also found to be abrogated in studies using bone marrow from Parp1-null mice. Taken together, this study demonstrates that binding of PARP-1 plays a key functional role in the barrier activity of the extended cHS4 insulator core element.	[Aker, Mari; Emery, David W.] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Bomsztyk, Karol; Emery, David W.] Univ Washington, UW Med Lake Union, Dept Med, Seattle, WA 98195 USA; [Emery, David W.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Emery, DW (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, 815 Mercer St,Box 358056, Seattle, WA 98109 USA.	demery@uw.edu			National Institutes of Health [HL75713, HL53750, DK-R37-45978, GM45134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750, R01HL075713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL75713 and HL53750 (to D. W. E.) and DK-R37-45978 and GM45134 (to K. B.).	Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Emery DW, 2003, N COMP BIOC, V38, P381; Emery DW, 2000, GENE THER, V7, P359, DOI 10.1038/sj.gt.3301107; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gowher H, 2008, GENE DEV, V22, P2075, DOI 10.1101/gad.1658408; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Klenova E, 2005, CELL CYCLE, V4, P96, DOI 10.4161/cc.4.1.1398; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37589	37597		10.1074/jbc.M110.174532	http://dx.doi.org/10.1074/jbc.M110.174532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876582	Green Published, hybrid			2022-12-27	WOS:000284424000051
J	Soltoff, SP; Asara, JM; Hedden, L				Soltoff, Stephen P.; Asara, John M.; Hedden, Lee			Regulation and Identification of Na,K-ATPase alpha 1 Subunit Phosphorylation in Rat Parotid Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NA+-K+-ATPASE; DEPENDENT PHOSPHORYLATION; ANCHORING PROTEIN; EPITHELIAL-CELLS; SALIVARY-GLANDS; INTACT-CELLS; NA+,K+-ATPASE; STIMULATION; ERK1/2	The stimulation of fluid and electrolyte secretion in salivary cells results in ionic changes that promote rapid increases in the activity of the Na,K-ATPase. In many cell systems, there are conflicting findings concerning the regulation of the phosphorylation of the Na, K-ATPase alpha subunit, which is the catalytic moiety. Initially, we investigated the phosphorylation sites on the alpha 1 subunit in native rat parotid acinar cells using tandem mass spectrometry and identified two new phosphorylation sites (Ser(222), Ser(407)), three sites (Ser(217), Tyr(260), Ser(47)) previously found from large scale proteomic screens, and two sites (Ser(23), Ser(16)) known to be phosphorylated by PKC. Subsequently, we used phospho-specific antibodies to examine the regulation of phosphorylation on Ser(23) and Ser(16) and measured changes in ERK phosphorylation in parallel. The G-protein-coupled muscarinic receptor mimetic carbachol, the phorbol ester phorbol 12-myristate 13-acetate, the Ca2+ ionophore ionomycin, and the serine/threonine phosphatase inhibitor calyculin A increased Ser(23) alpha 1 phosphorylation. Inhibition of classical PKC proteins blocked carbachol-stimulated Ser(23) alpha 1 subunit phosphorylation but not ERK phosphorylation, which was blocked by an inhibitor of novel PKC proteins. The carbachol-initiated phosphorylation of Ser(23) alpha 1 subunit was not modified by ERK or PKA activity. The Na, K-ATPase inhibitor ouabain reduced and enhanced the carbachol-promoted phosphorylation of Ser(23) and Ser(16), respectively, the latter because ouabain itself increased Ser(16) phosphorylation; thus, both sites display conformational-dependent phosphorylation changes. Ouabain-initiated phosphorylation of Ser(16) alpha 1 was not blocked by PKC inhibitors, unlike carbachol-or phorbol 12-myristate 13-acetate-initiated phosphorylations, suggesting that this site was also a substrate for a kinase other than PKC.	[Soltoff, Stephen P.; Asara, John M.; Hedden, Lee] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, 330 Brookline Ave,EC CLS 406, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu			National Institutes of Health [DE-10877, 5P30CA006516-43, 1P01CA120964-01A]; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE-10877 (to S.P.S.), 5P30CA006516-43 (to J.M.A.), and 1P01CA120964-01A (J.M.A.).	Al-Khalili L, 2004, J BIOL CHEM, V279, P25211, DOI 10.1074/jbc.M402152200; Asara JM, 1999, J AM SOC MASS SPECTR, V10, P35, DOI 10.1016/S1044-0305(98)00129-9; Asghar M, 2003, AM J PHYSIOL-RENAL, V285, pF1100, DOI 10.1152/ajprenal.00198.2003; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1981, DOI 10.1152/ajpcell.1997.273.6.C1981; CHIBALIN AV, 1992, J BIOL CHEM, V267, P22378; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; COLLINS SA, 1987, BIOCHIM BIOPHYS ACTA, V927, P392, DOI 10.1016/0167-4889(87)90104-2; Efendiev R, 2000, BIOCHEMISTRY-US, V39, P9884, DOI 10.1021/bi0007831; Efendiev R, 2006, J AM SOC NEPHROL, V17, P31, DOI 10.1681/ASN.2005070681; El-Beialy W, 2010, J MEMBRANE BIOL, V233, P119, DOI 10.1007/s00232-010-9231-z; Feraille E, 1999, MOL BIOL CELL, V10, P2847, DOI 10.1091/mbc.10.9.2847; FERAILLE E, 1995, AM J PHYSIOL-CELL PH, V268, pC1277, DOI 10.1152/ajpcell.1995.268.5.C1277; FESCHENKO MS, 1994, J BIOL CHEM, V269, P30436; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Hatou S, 2010, INVEST OPHTH VIS SCI, V51, P3935, DOI 10.1167/iovs.09-4027; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Kazanietz MG, 2001, ARCH BIOCHEM BIOPHYS, V388, P74, DOI 10.1006/abbi.2000.2264; Kiroytcheva M, 1999, KIDNEY INT, V55, P1819, DOI 10.1046/j.1523-1755.1999.00414.x; Kurihara K, 2003, BIOCHEM PHARMACOL, V66, P239, DOI 10.1016/S0006-2952(03)00259-4; Kurihara K, 2008, ARCH ORAL BIOL, V53, P593, DOI 10.1016/j.archoralbio.2008.01.007; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lecuona E, 2007, J BIOENERG BIOMEMBR, V39, P391, DOI 10.1007/s10863-007-9102-1; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Michlig S, 2004, J BIOL CHEM, V279, P51002, DOI 10.1074/jbc.M405674200; Pedemonte CH, 1997, J MEMBRANE BIOL, V155, P219, DOI 10.1007/s002329900174; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Sano A, 2004, ANAL SCI, V20, P565, DOI 10.2116/analsci.20.565; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Soltoff SP, 2010, J BIOL CHEM, V285, P13337, DOI 10.1074/jbc.M110.112094; Sottejeau Y, 2010, BIOCHEMISTRY-US, V49, P3602, DOI 10.1021/bi9021999; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; White CN, 2010, J BIOL CHEM, V285, P13712, DOI 10.1074/jbc.M109.090225; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297	41	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36330	36338		10.1074/jbc.M110.136465	http://dx.doi.org/10.1074/jbc.M110.136465			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841356	hybrid, Green Published			2022-12-27	WOS:000284146100078
J	Alvarado, JJ; Betts, L; Moroco, JA; Smithgall, TE; Yeh, JI				Alvarado, John J.; Betts, Laurie; Moroco, Jamie A.; Smithgall, Thomas E.; Yeh, Joanne I.			Crystal Structure of the Src Family Kinase Hck SH3-SH2 Linker Regulatory Region Supports an SH3-dominant Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; C-SRC; SH3 DOMAINS; PROTEIN; ORIENTATION; DYNAMICS; RELEASE; COMPLEX; BINDING	Most mammalian cell types depend on multiple Src family kinases (SFKs) to regulate diverse signaling pathways. Strict control of SFK activity is essential for normal cellular function, and loss of kinase regulation contributes to several forms of cancer and other diseases. Previous x-ray crystal structures of the SFKs c-Src and Hck revealed that intramolecular association of their Src homology (SH) 3 domains and SH2 kinase linker regions has a key role in down-regulation of kinase activity. However, the amino acid sequence of the Hck linker represents a suboptimal ligand for the isolated SH3 domain, suggesting that it may form the polyproline type II helical conformation required for SH3 docking only in the context of the intact structure. To test this hypothesis directly, we determined the crystal structure of a truncated Hck protein consisting of the SH2 and SH3 domains plus the linker. Despite the absence of the kinase domain, the structures and relative orientations of the SH2 and SH3 domains in this shorter protein were very similar to those observed in near full-length, down-regulated Hck. However, the SH2 kinase linker adopted a modified topology and failed to engage the SH3 domain. This new structure supports the idea that these noncatalytic regions work together as a "conformational switch" that modulates kinase activity in a manner unique to the SH3 domain and linker topologies present in the intact Hck protein. Our results also provide fresh structural insight into the facile induction of Hck activity by HIV-1 Nef and other Hck SH3 domain binding proteins and implicate the existence of innate conformational states unique to individual Src family members that "fine-tune" their sensitivities to activation by SH3-based ligands.	[Alvarado, John J.; Betts, Laurie; Yeh, Joanne I.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Moroco, Jamie A.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Smithgall, Thomas E.; Yeh, Joanne I.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr Study HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yeh, JI (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 1036 BST3,3501 5th Ave, Pittsburgh, PA 15260 USA.	jiyeh@pitt.edu		Moroco, Jamie/0000-0001-8250-5923	National Institutes of Health (Pittsburgh Center for HIV-Protein Interactions) [AI077444, GM082251]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health (Pittsburgh Center for HIV-Protein Interactions)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants AI077444 and GM082251 (Pittsburgh Center for HIV-Protein Interactions).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DeLano W.L, PYMOL MOL GRAPHICS S; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guiet R, 2008, EUR J CELL BIOL, V87, P527, DOI 10.1016/j.ejcb.2008.03.008; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Hofmann G, 2005, BIOCHEMISTRY-US, V44, P13043, DOI 10.1021/bi050814y; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	38	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35455	35461		10.1074/jbc.M110.145102	http://dx.doi.org/10.1074/jbc.M110.145102			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20810664	Green Published, hybrid			2022-12-27	WOS:000283845300023
J	Chan, J; Yamazaki, H; Ishiyama, N; Seo, MD; Mal, TK; Michikawa, T; Mikoshiba, K; Ikura, M				Chan, Jenny; Yamazaki, Haruka; Ishiyama, Noboru; Seo, Min-Duk; Mal, Tapas K.; Michikawa, Takayuki; Mikoshiba, Katsuhiko; Ikura, Mitsuhiko			Structural Studies of Inositol 1,4,5-Trisphosphate Receptor COUPLING LIGAND BINDING TO CHANNEL GATING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE RECEPTOR; SEQUENTIAL ASSIGNMENT; BACKBONE ASSIGNMENT; RYANODINE RECEPTOR; CRYSTAL-STRUCTURE; PROTEINS; SYSTEM; DOMAINS; TYPE-2; SUITE	The three isoforms of the inositol 1,4,5-trisphosphate receptor (IP3R) exhibit distinct IP3 sensitivities and cooperativities in calcium (Ca2+) channel function. The determinants underlying this isoform-specific channel gating mechanism have been localized to the N-terminal suppressor region of IP3R. We determined the 1.9 angstrom crystal structure of the suppressor domain from type 3 IP3R (IP(3)R3(SUP), amino acids 1-224) and revealed structural features contributing to isoform-specific functionality of IP3R by comparing it with our previously determined structure of the type 1 suppressor domain (IP(3)R1(SUP)). The molecular surface known to associate with the ligand binding domain (amino acids 224-604) showed marked differences between IP3R3SUP and IP3R1SUP. Our NMR and biochemical studies showed that three spatially clustered residues (Glu-20, Tyr-167, and Ser-217 in IP(3)R1 and Glu-19, Trp-168, and Ser-218 in IP(3)R3) within the N-terminal suppressor domains of IP(3)R1SUP and IP(3)R3(SUP) interact directly with their respective C-terminal fragments. Together with the accompanying paper (Yamazaki, H., Chan, J., Ikura, M., Michikawa, T., and Mikoshiba, K. (2010) J. Biol. Chem. 285, 36081-36091), we demonstrate that the single aromatic residue in this region (Tyr-167 in IP(3)R1 and Trp-168 in IP(3)R3) plays a critical role in the coupling between ligand binding and channel gating.	[Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Chan, Jenny; Ishiyama, Noboru; Seo, Min-Duk; Mal, Tapas K.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Chan, Jenny; Ishiyama, Noboru; Seo, Min-Duk; Mal, Tapas K.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015; Mal, Tapas K/A-9453-2011	Mal, Tapas K/0000-0002-0625-2095; Ikura, Mitsuhiko/0000-0002-9524-1303	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research (CIHR); Special Postdoctoral Researchers Program in RIKEN; Ministry of Education, Science, Sports, and Culture of Japan [20370054, 20220007]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Special Postdoctoral Researchers Program in RIKEN; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Heart and Stroke Foundation of Ontario (to M. I.), a Canadian Institutes of Health Research (CIHR) doctoral award (to J. C.) and a CIHR postdoctoral fellowship (to N. I.) and was supported by grants from the Special Postdoctoral Researchers Program in RIKEN (to H. Y.) and Ministry of Education, Science, Sports, and Culture of Japan Grants 20370054 (to T. M.) and 20220007 (to K. M.).	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSH KT, 1994, J BIOL CHEM, V269, P23694; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELAGLIO F, 1995, NMRDRAW; DeSmedt H, 1997, BIOCHEM J, V322, P575; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hamada T, 2007, BIOCHEMISTRY-US, V46, P4272, DOI 10.1021/bi061557f; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; WANG AC, 1994, J MAGN RESON SER B, V105, P196, DOI 10.1006/jmrb.1994.1123; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	31	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36092	36099		10.1074/jbc.M110.140160	http://dx.doi.org/10.1074/jbc.M110.140160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843799	Green Published, hybrid			2022-12-27	WOS:000283845300085
J	Gan, NQ; Wu, YC; Brunet, M; Garrido, C; Chung, FL; Dai, CK; Mi, LX				Gan, Nanqin; Wu, Yu-Chieh; Brunet, Mathilde; Garrido, Carmen; Chung, Fung-Lung; Dai, Chengkai; Mi, Lixin			Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; ALPHA-B-CRYSTALLIN; TRANSCRIPTION FACTOR; INCREASED EXPRESSION; 26S PROTEASOME; CANCER CELLS; REDOX STATE; PROTEIN; DEGRADATION; INDUCTION	It is conceivable that stimulating proteasome activity for rapid removal of misfolded and oxidized proteins is a promising strategy to prevent and alleviate aging-related diseases. Sulforaphane (SFN), an effective cancer preventive agent derived from cruciferous vegetables, has been shown to enhance proteasome activities in mammalian cells and to reduce the level of oxidized proteins and amyloid beta-induced cytotoxicity. Here, we report that SFN activates heat shock transcription factor 1-mediated heat shock response. Specifically, SFN-induced expression of heat shock protein 27 (Hsp27) underlies SFN-stimulated proteasome activity. SFN-induced proteasome activity was significantly enhanced in Hsp27-overexpressing cells but absent in Hsp27-silenced cells. The role of Hsp27 in regulating proteasome activity was further confirmed in isogenic REG cells, in which SFN-induced proteasome activation was only observed in cells stably overexpressing Hsp27, but not in the Hsp27-free parental cells. Finally, we demonstrated that phosphorylation of Hsp27 is irrelevant to SFN-induced proteasome activation. This study provides a novel mechanism underlying SFN-induced proteasome activity. This is the first report to show that heat shock response by SFN, in addition to the antioxidant response mediated by the Keap1-Nrf2 pathway, may contribute to cytoprotection.	[Mi, Lixin] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Gan, Nanqin] Chinese Acad Sci, Inst Hydrobiol, Beijing 100864, Peoples R China; [Brunet, Mathilde; Garrido, Carmen] INSERM, Fac Med & Pharm, UMR 866, F-21049 Dijon, France; [Dai, Chengkai] Jackson Lab, Bar Harbor, ME 04609 USA	Georgetown University; Chinese Academy of Sciences; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Jackson Laboratory	Mi, LX (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3800 Reservoir Rd,LL 129,Box 571465, Washington, DC 20057 USA.	lm293@georgetown.edu	Garrido, carmen/G-1633-2018; Garrido, Carolina/GWM-5557-2022	Garrido, carmen/0000-0003-1368-1493; 	National Institutes of Health through the National Cancer Institute [CA100853]; NATIONAL CANCER INSTITUTE [R01CA100853] Funding Source: NIH RePORTER	National Institutes of Health through the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health Grant CA100853 through the National Cancer Institute (to F.-L. C.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Anderson SP, 2004, J BIOL CHEM, V279, P52390, DOI 10.1074/jbc.M409347200; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Arrigo AP, 2001, IUBMB LIFE, V52, P303, DOI 10.1080/152165401317291156; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; BRUCE JL, 1993, CANCER RES, V53, P12; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dong GZ, 2009, INT J HYPERTHER, V25, P477, DOI 10.1080/02656730903049836; Fowke JH, 2003, CANCER RES, V63, P3980; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.005; Hoffman L, 1996, CURR TOP CELL REGUL, V34, P1, DOI 10.1016/S0070-2137(96)80001-X; Ialenti A, 2005, MOL PHARMACOL, V67, P1620, DOI 10.1124/mol.104.004895; Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Kwak MK, 2007, LIFE SCI, V80, P2411, DOI 10.1016/j.lfs.2007.04.014; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lee YK, 2009, J CELL BIOCHEM, V106, P267, DOI 10.1002/jcb.21997; Liu H, 1996, J BIOL CHEM, V271, P4805; Manalo DJ, 2001, J BIOL CHEM, V276, P23554, DOI 10.1074/jbc.M011300200; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Mi LX, 2009, BIOCHEM BIOPH RES CO, V388, P456, DOI 10.1016/j.bbrc.2009.08.047; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Vallanat B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-16; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WHO, 2004, IARC HDB CANC PREV, V9; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185; Yu XC, 2009, CURR OPIN PHARMACOL, V9, P167, DOI 10.1016/j.coph.2008.11.005; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147	50	90	93	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35528	35536		10.1074/jbc.M110.152686	http://dx.doi.org/10.1074/jbc.M110.152686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833711	hybrid, Green Published			2022-12-27	WOS:000283845300031
J	Lin, WH; Nebhan, CA; Anderson, BR; Webb, DJ				Lin, Wan-Hsin; Nebhan, Caroline A.; Anderson, Bridget R.; Webb, Donna J.			Vasodilator-stimulated Phosphoprotein (VASP) Induces Actin Assembly in Dendritic Spines to Promote Their Development and Potentiate Synaptic Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; ENA/VASP PROTEINS; AMPA RECEPTORS; FIBROBLAST MOTILITY; FILOPODIA FORMATION; NMDA RECEPTORS; EVH1 DOMAIN; MYOSIN VB; F-ACTIN	Dendritic spines are small actin-rich structures that receive the majority of excitatory synaptic input in the brain. The actin-based dynamics of spines are thought to mediate synaptic plasticity, which underlies cognitive processes, such as learning and memory. However, little is known about the molecular mechanisms that regulate actin dynamics in spines and synapses. In this study we show the multifunctional actin-binding protein vasodilator-stimulated phosphoprotein (VASP) regulates the density, size, and morphology of dendritic spines by inducing actin assembly in these structures. Knockdown of endogenous VASP by siRNA led to a significant decrease in the density of spines and synapses, whereas expression of siRNA-resistant VASP rescued this defect. The ability of VASP to modulate spine and synapse formation, maturation, and spine head enlargement is dependent on its actin binding Ena/VASP homology 2 (EVH2) domain and its EVH1 domain, which contributes to VASP localization to actin-rich structures. Moreover, VASP increases the amount of PSD-scaffolding proteins and the number of surface GluR1-containing alpha-amino-3-hydroxy-5-methyl4-isoxazole propionic acid receptors (AMPARs) in spines. VASP knockdown results in a reduction in surface AMPAR density, suggesting a role for this protein in regulating synaptic strength. Consistent with this, VASP significantly enhances the retention of GluR1 in spines as determined by fluorescence recovery after photobleaching and increases AMPAR-mediated synaptic transmission. Collectively, our results suggest that actin polymerization and bundling by VASP are critical for spine formation, expansion, and modulating synaptic strength.	[Lin, Wan-Hsin; Nebhan, Caroline A.; Anderson, Bridget R.; Webb, Donna J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Lin, Wan-Hsin; Nebhan, Caroline A.; Anderson, Bridget R.; Webb, Donna J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37235 USA; [Webb, Donna J.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Webb, DJ (corresponding author), VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	donna.webb@vanderbilt.edu			National Institutes of Health [MH071674]; National Center for Research Resources [S10RR025524]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH071674 and by National Center for Research Resources Grant S10RR025524 (to D.J.W.).	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Allison DW, 1998, J NEUROSCI, V18, P2423; Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; Chan AY, 1998, J CELL SCI, V111, P199; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Goslin K., 1998, RAT HIPPOCAMPAL NEUR, P339; GRAY EG, 1959, J ANAT, V93, P420; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Kim CH, 1999, J NEUROSCI, V19, P4314; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shen L, 2000, J NEUROSCI, V20, P7932; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zimmermann J, 2002, BIOCHEMISTRY-US, V41, P11143, DOI 10.1021/bi020379x; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	67	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36010	36020		10.1074/jbc.M110.129841	http://dx.doi.org/10.1074/jbc.M110.129841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826790	hybrid, Green Published			2022-12-27	WOS:000283845300077
J	Shahzad, MMK; Arevalo, JM; Armaiz-Pena, GN; Lu, CH; Stone, RL; Moreno-Smith, M; Nishimura, M; Lee, JW; Jennings, NB; Bottsford-Miller, J; Vivas-Mejia, P; Lutgendorf, SK; Lopez-Berestein, G; Bar-Eli, M; Cole, SW; Sood, AK				Shahzad, Mian M. K.; Arevalo, Jesusa M.; Armaiz-Pena, Guillermo N.; Lu, Chunhua; Stone, Rebecca L.; Moreno-Smith, Myrthala; Nishimura, Masato; Lee, Jeong-Won; Jennings, Nicholas B.; Bottsford-Miller, Justin; Vivas-Mejia, Pablo; Lutgendorf, Susan K.; Lopez-Berestein, Gabriel; Bar-Eli, Menashe; Cole, Steven W.; Sood, Anil K.			Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; INTERFERING RNA DELIVERY; TUMOR-GROWTH; SOCIAL SUPPORT; MELANOMA-CELLS; BREAST-CANCER; NUDE-MICE; CARCINOMA CELLS; ANGIOGENESIS; AP-1	A growing number of studies indicate that chronic stress can accelerate tumor growth due to sustained sympathetic nervous system activation. Our recent findings suggest that chronic stress is associated with increased IL8 levels. Here, we examined the molecular and biological significance of IL8 in stress-induced tumor growth. Norepinephrine (NE) treatment of ovarian cancer cells resulted in a 250-300% increase in IL8 protein and 240-320% increase in its mRNA levels. Epinephrine treatment resulted in similar increases. Moreover, NE treatment resulted in a 3.5-4-fold increase in IL8 promoter activity. These effects were blocked by propranolol. Promoter deletion analyses suggested that AP1 transcription factors might mediate catecholamine-stimulated up-regulation of IL8. siRNA inhibition studies identified FosB as the pivotal component responsible for IL8 regulation by NE. In vivo chronic stress resulted in increased tumor growth (by 221 and 235%; p < 0.01) in orthotopic xenograft models involving SKOV3ip1 and HeyA8 ovarian carcinoma cells. This enhanced tumor growth was completely blocked by IL8 or FosB gene silencing using 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine nanoliposomes. IL8 and FosB silencing reduced microvessel density (based on CD31 staining) by 2.5- and 3.5-fold, respectively (p < 0.001). Our findings indicate that neurobehavioral stress leads to FosB-driven increases in IL8, which is associated with increased tumor growth and metastases. These findings may have implications for ovarian cancer management.	[Moreno-Smith, Myrthala; Nishimura, Masato; Lee, Jeong-Won; Jennings, Nicholas B.; Bottsford-Miller, Justin; Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Vivas-Mejia, Pablo; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Shahzad, Mian M. K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Obstet & Gynecol, Div Gynecol Oncol, Madison, WI 53792 USA; [Lutgendorf, Susan K.] Univ Iowa, Dept Psychol, Iowa City, IA 52241 USA; [Lee, Jeong-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul 135710, South Korea; [Arevalo, Jesusa M.; Cole, Steven W.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; University of Iowa; Sungkyunkwan University (SKKU); Samsung Medical Center; University of California System; University of California Los Angeles	Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, 1155 Herman Pressler,Unit 1362, Houston, TX 77030 USA.	asood@mdanderson.org	lee, jw/O-6237-2014	Armaiz-Pena, Guillermo N/0000-0002-9081-5339	National Institutes of Health [CA109298, CA110793, CA128797, RC2GM092599, CA151668]; Ovarian Cancer Research Fund, Inc.; Zarrow Foundation; Marcus Foundation; Alliance for Nanohealth; Meyer and Ida Gordon Foundation Number 2, Department of Defense [OC073399, W81XWH-10-1-0158]; University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer [P50 CA083639]; Blanton-Davis Ovarian Cancer Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD050128] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA110793, T32CA009614, R01CA128797, R01CA109298, T32CA101642, R01CA104825, P50CA083639, U54CA151668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund, Inc.; Zarrow Foundation; Marcus Foundation; Alliance for Nanohealth; Meyer and Ida Gordon Foundation Number 2, Department of Defense(United States Department of Defense); University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer; Blanton-Davis Ovarian Cancer Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109298, CA110793, CA128797, RC2GM092599, and CA151668. This work was also supported by a program project development grant from the Ovarian Cancer Research Fund, Inc., the Zarrow Foundation, the Marcus Foundation, a grant from the Alliance for Nanohealth, the Meyer and Ida Gordon Foundation Number 2, Department of Defense Grants OC073399 and W81XWH-10-1-0158, the University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer Grant P50 CA083639, and the Blanton-Davis Ovarian Cancer Research Program.	Andersen BL, 1998, JNCI-J NATL CANCER I, V90, P30, DOI 10.1093/jnci/90.1.30; Andersen BL, 2004, J CLIN ONCOL, V22, P3570, DOI 10.1200/JCO.2004.06.030; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Antoni MH, 2000, ANN BEHAV MED, V22, P29, DOI 10.1007/BF02895165; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Costanzo ES, 2005, CANCER-AM CANCER SOC, V104, P305, DOI 10.1002/cncr.21147; Drell TL, 2003, BREAST CANCER RES TR, V80, P63, DOI 10.1023/A:1024491219366; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Fawzy FI, 2003, ARCH GEN PSYCHIAT, V60, P100, DOI 10.1001/archpsyc.60.1.100; FIDLER I, 2001, J NATL CANC I MONOGR, V28, P10; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Glaser R, 2001, J GERONTOL A-BIOL, V56, pM477, DOI 10.1093/gerona/56.8.M477; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karashima T, 2003, CLIN CANCER RES, V9, P2786; Kassim SK, 2004, CLIN BIOCHEM, V37, P363, DOI 10.1016/j.clinbiochem.2004.01.014; Kim SJ, 2001, NEOPLASIA, V3, P33, DOI 10.1038/sj.neo.7900124; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lang K, 2004, INT J CANCER, V112, P231, DOI 10.1002/ijc.20410; Lee JW, 2009, JNCI-J NATL CANCER I, V101, P1193, DOI 10.1093/jnci/djp231; Lev DC, 2003, MOL CANCER THER, V2, P753; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Lokshin AE, 2006, GYNECOL ONCOL, V102, P244, DOI 10.1016/j.ygyno.2005.12.011; Lu C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.028; Luca M, 1997, AM J PATHOL, V151, P1105; Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015; Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514; Lutgendorf SK, 2002, CANCER, V94, P131, DOI 10.1002/cncr.10155; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; MARCHETTI B, 1991, J STEROID BIOCHEM, V38, P307, DOI 10.1016/0960-0760(91)90102-B; Masur K, 2001, CANCER RES, V61, P2866; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Page GG, 1999, DEV COMP IMMUNOL, V23, P87, DOI 10.1016/S0145-305X(98)00040-8; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Re G, 1996, PHARMACOL RES, V33, P255, DOI 10.1006/phrs.1996.0036; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Spiegel D, 2002, NAT REV CANCER, V2, P383, DOI 10.1038/nrc800; Thaker PH, 2005, CLIN CANCER RES, V11, P4923, DOI 10.1158/1078-0432.CCR-04-2060; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tulchinsky E, 2000, HISTOL HISTOPATHOL, V15, P921, DOI 10.14670/HH-15.921; Turner-Cobb JM, 2000, PSYCHOSOM MED, V62, P337, DOI 10.1097/00006842-200005000-00007; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDEWALLE B, 1990, J CANCER RES CLIN, V116, P303, DOI 10.1007/BF01612908; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567; Yoneda J, 1998, JNCI-J NATL CANCER I, V90, P447, DOI 10.1093/jnci/90.6.447	53	136	140	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35462	35470		10.1074/jbc.M110.109579	http://dx.doi.org/10.1074/jbc.M110.109579			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826776	Green Published, hybrid			2022-12-27	WOS:000283845300024
J	Zeng, L; Akasaki, Y; Sato, K; Ouchi, N; Izumiya, Y; Walsh, K				Zeng, Ling; Akasaki, Yuichi; Sato, Kaori; Ouchi, Noriyuki; Izumiya, Yasuhiro; Walsh, Kenneth			Insulin-like 6 Is Induced by Muscle Injury and Functions as a Regenerative Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; RELAXIN-FAMILY PEPTIDES; STEM-CELL FUNCTION; SKELETAL-MUSCLE; FACTOR-I; IGF-I; EXPRESSION; HYPERTROPHY; DIFFERENTIATION; MICE	The insulin-like family of factors are involved in the regulation of a variety of physiological processes, but the function of the family member termed insulin-like 6 (Insl6) in skeletal muscle has not been reported. We show that Insl6 is a myokine that is up-regulated in skeletal muscle downstream of Akt signaling and in regenerating muscle in response to cardiotoxin (CTX)-induced injury. In the CTX injury model, myofiber regeneration was improved by the intramuscular or systemic delivery of an adenovirus expressing Insl6. Skeletal muscle-specific Insl6 transgenic mice exhibited normal muscle mass under basal conditions but elevated satellite cell activation and enhanced muscle regeneration in response to CTX injury. The Insl6-mediated regenerative response was associated with reductions in muscle cell apoptosis and reduced serum levels of creatine kinase M. Overexpression of Insl6 stimulated proliferation and reduced apoptosis in cultured myogenic cells. Conversely, knockdown of Insl6 reduced proliferation and increased apoptosis. These data indicate that Insl6 is an injury-regulated myokine that functions as a myogenic regenerative factor.	[Walsh, Kenneth] Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Akasaki, Yuichi] Kagoshima Univ, Grad Sch Med, Dept Cardiovasc Resp & Metab Med, Kagoshima 8908520, Japan; [Izumiya, Yasuhiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Boston University; Kagoshima University; Kumamoto University	Walsh, K (corresponding author), Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Med Campus,715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	OUCHI, Noriyuki/I-7306-2014		NATIONAL INSTITUTE ON AGING [R01AG034972] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG034972] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Armand AS, 2003, DEV DYNAM, V227, P256, DOI 10.1002/dvdy.10306; Bathgate RA, 2005, ANN NY ACAD SCI, V1041, P61, DOI 10.1196/annals.1282.010; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brailoiu GC, 2005, BRAIN RES, V1040, P187, DOI 10.1016/j.brainres.2005.01.077; Burnicka-Turek O, 2009, ENDOCRINOLOGY, V150, P4348, DOI 10.1210/en.2009-0201; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen KC, 2008, TOXICON, V51, P624, DOI 10.1016/j.toxicon.2007.11.024; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Collins CA, 2006, CURR OPIN PHARMACOL, V6, P301, DOI 10.1016/j.coph.2006.01.006; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gonzalez-Cadavid NF, 2004, CURR OPIN CLIN NUTR, V7, P451, DOI 10.1097/01.mco.0000134365.99523.7f; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Hsu SYT, 2005, ANN NY ACAD SCI, V1041, P520, DOI 10.1196/annals.1282.078; Ivell R, 2009, ENDOCRINOLOGY, V150, P3986, DOI 10.1210/en.2009-0691; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Li Y, 2005, ANN NY ACAD SCI, V1041, P395, DOI 10.1196/annals.1282.060; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Lu CX, 2006, ENDOCRINOLOGY, V147, P5611, DOI 10.1210/en.2006-0503; MacGregor J, 1996, Can J Appl Physiol, V21, P236; Machida S, 2006, ANN NY ACAD SCI, V1067, P349, DOI 10.1196/annals.1354.049; Mackey AL, 2009, MUSCLE NERVE, V40, P455, DOI 10.1002/mus.21369; McArdle A, 2006, EXP GERONTOL, V41, P497, DOI 10.1016/j.exger.2006.02.002; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; MILLER JB, 2003, SCI AGING KNOWLEDGE, pPE34; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Mitchell CA, 1996, GROWTH FACTORS, V13, P37, DOI 10.3109/08977199609034565; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Patel K, 2005, NEUROMUSCULAR DISORD, V15, P117, DOI 10.1016/j.nmd.2004.10.018; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Peter AK, 2009, HUM MOL GENET, V18, P318, DOI 10.1093/hmg/ddn358; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Schiekofer S, 2008, ANGIOGENESIS, V11, P289, DOI 10.1007/s10456-008-9112-6; Schiekofer S, 2006, PHYSIOL GENOMICS, V27, P156, DOI 10.1152/physiolgenomics.00234.2005; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Sinha-Hikim I, 2007, APOPTOSIS, V12, P1965, DOI 10.1007/s10495-007-0120-6; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200	59	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36060	36069		10.1074/jbc.M110.160879	http://dx.doi.org/10.1074/jbc.M110.160879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807758	Green Published, hybrid			2022-12-27	WOS:000283845300082
J	Bae, JS; Yang, LK; Rezaie, AR				Bae, Jong-Sup; Yang, Likui; Rezaie, Alireza R.			Factor X/Xa Elicits Protective Signaling Responses in Endothelial Cells Directly via PAR-2 and Indirectly via Endothelial Protein C Receptor-dependent Recruitment of PAR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-THROMBOMODULIN COMPLEX; FACTOR-KAPPA-B; FACTOR-XA; BLOOD-COAGULATION; MOLECULAR-CLONING; TISSUE FACTOR; ACTIVATION; EXPRESSION; LIGAND; PATHWAY	We recently demonstrated that the Gla domain-dependent interaction of protein C with endothelial protein C receptor (EPCR) leads to dissociation of the receptor from caveolin-1 and recruitment of PAR-1 to a protective signaling pathway. Thus, the activation of PAR-1 by either thrombin or PAR-1 agonist peptide elicited a barrier-protective response if endothelial cells were preincubated with protein C. In this study, we examined whether other vitamin K-dependent coagulation protease zymogens can modulate PAR-dependent signaling responses in endothelial cells. We discovered that the activation of both PAR-1 and PAR-2 in endothelial cells pretreated with factor FX (FX)-S195A, but not other procoagulant protease zymogens, also results in initiation of protective intracellular responses. Interestingly, similar to protein C, FX interaction with endothelial cells leads to dissociation of EPCR from caveolin-1 and recruitment of PAR-1 to a protective pathway. Further studies revealed that, FX activated by factor VIIa on tissue factor bearing endothelial cells also initiates protective signaling responses through the activation of PAR-2 independent of EPCR mobilization. All results could be recapitulated by the receptor agonist peptides to both PAR-1 and PAR-2. These results suggest that a cross-talk between EPCR and an unknown FX/FXa receptor, which does not require interaction with the Gla domain of FX, recruits PAR-1 to protective signaling pathways in endothelial cells.	[Bae, Jong-Sup; Yang, Likui; Rezaie, Alireza R.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), 1100 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu	Bae, Jong-Sup/AAU-9724-2020		NHLBI [HL 101917, HL 68571]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101917, R01HL068571] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 101917 and HL 68571 from the NHLBI (to A. R. R.).	ALTIERI DC, 1994, J BIOL CHEM, V269, P3139; Ambrosini G, 1997, J BIOL CHEM, V272, P8340, DOI 10.1074/jbc.272.13.8340; Bae JS, 2010, J THROMB HAEMOST, V8, P1107, DOI 10.1111/j.1538-7836.2010.03812.x; Bae JS, 2008, THROMB HAEMOSTASIS, V100, P101, DOI 10.1160/TH08-02-0127; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bae JS, 2009, THROMB HAEMOSTASIS, V101, P513, DOI 10.1160/TH08-09-0568; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; DAHLBA CKB, 1991, THROMB HAEMOST */* B, V66, P49; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; ESMON CT, 1993, THROMB HAEMOSTASIS, V70, P29; Feistritzer C, 2005, J THROMB HAEMOST, V3, P2798, DOI 10.1111/j.1538-7836.2005.01610.x; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kouklis P, 2004, CIRC RES, V94, P159, DOI 10.1161/01.RES.0000110418.38500.31; Krupiczojc MA, 2008, INT J BIOCHEM CELL B, V40, P1228, DOI 10.1016/j.biocel.2008.02.026; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; REZAIE AR, 1993, J BIOL CHEM, V268, P8176; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Senden NHM, 1998, J IMMUNOL, V161, P4318; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; WALKER FJ, 1992, FASEB J, V6, P2561, DOI 10.1096/fasebj.6.8.1317308; Zaman GJR, 2000, BLOOD, V96, P145, DOI 10.1182/blood.V96.1.145.013k34_145_148	39	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34803	34812		10.1074/jbc.M110.163642	http://dx.doi.org/10.1074/jbc.M110.163642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826780	Green Published, hybrid			2022-12-27	WOS:000283659100056
J	Ohmine, S; Sakuma, R; Sakuma, T; Thatava, T; Solis, GP; Ikeda, Y				Ohmine, Seiga; Sakuma, Ryuta; Sakuma, Toshie; Thatava, Tayaramma; Solis, Gonzalo P.; Ikeda, Yasuhiro			Cytoplasmic Body Component TRIM5 alpha Requires Lipid-enriched Microdomains for Efficient HIV-1 Restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL RESTRICTION; MEMBRANE MICRODOMAINS; ENDOCYTIC PATHWAY; OLD-WORLD; PROTEINS; DROPLETS; BODIES; ENTRY; FAMILY	TRIM5 alpha is a member of the tripartite motif (TRIM) family of proteins and affects both early and late phases of the retroviral life cycle. Although TRIM5 alpha multimerizes to form cytoplasmic bodies, which are thought to play an important role in viral restriction, the identity of TRIM5 alpha-containing cytoplasmic bodies remains elusive. To better understand TRIM5 alpha cytoplasmic body constituents and the cellular proteins that could be involved in the TRIM5 alpha-mediated antiviral activities, we sought TRIM5 alpha-binding factors. We identified a lipid microdomain protein flotillin-1/Reggie-2 as an interacting partner of TRIM5 alpha via co-immunoprecipitation. Immunohistochemistry studies confirmed the co-localization of rhesus monkey TRIM5 alpha (TRIM5 alpha rh) cytoplasmic bodies with flotillin-1/Reggie-2. Caveolin-1, another lipid microdomain-associated protein, also co-localized with TRIM5 alpha cytoplasmic bodies. Intriguingly, disruption of cellular cholesterol by cyclodextrin perturbed TRIM5 alpha cytoplasmic body formation. Furthermore, lipid starvation partially relieved the endogenous post-entry restriction of HIV-1 infection, which could be subsequently restored by lipid repletion. These observations indicate the involvement of cellular lipids in TRIM5 alpha-mediated antiviral activities. Given that many viruses utilize cellular lipid microdomains for viral entry and assembly, it is plausible that lipid-enriched domains provide microenvironments where TRIM5 alpha recognizes retroviral components.	Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Solis, Gonzalo P.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Mayo Clinic; University of Konstanz	Ikeda, Y (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu	Solís Sánchez, Gonzalo/C-9088-2015	Solís Sánchez, Gonzalo/0000-0003-0363-831X; Solis, Gonzalo P./0000-0002-2359-3780	National Institutes of Health [1R56AI074363-01A1]; Mayo Foundation; Siebens Ph.D. training fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Siebens Ph.D. training fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI074363-01A1 (to Y.I.). This work was also supported by the Mayo Foundation (to Y.I.).; Recipient of a Siebens Ph.D. training fellowship.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Beer C, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-21; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; del Real G, 2002, J EXP MED, V196, P293, DOI 10.1084/jem.20020308; Diaz-Griffero F, 2006, VIROLOGY, V351, P404, DOI 10.1016/j.virol.2006.03.023; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Dremina ES, 2005, J NEUROCHEM, V93, P1262, DOI 10.1111/j.1471-4159.2005.03115.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hwang CY, 2010, J BIOL CHEM, V285, P7827, DOI 10.1074/jbc.M109.040618; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kaumanns P, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-79; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kim SY, 2009, PROTEOMICS, V9, P4321, DOI 10.1002/pmic.200900077; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; LUCIW PA, 1992, AIDS RES HUM RETROV, V8, P395, DOI 10.1089/aid.1992.8.395; Marchant D, 2005, J VIROL, V79, P9410, DOI 10.1128/JVI.79.15.9410-9418.2005; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; MO R, 1999, J VIROL */* E J VIRO, V73, P2343; NE GRED, 2000, Gene Ther */* F L GE, V7, P1613; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Quirin K, 2008, VIROLOGY, V378, P21, DOI 10.1016/j.virol.2008.04.046; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Reuter A, 2004, CELL MOL LIFE SCI, V61, P2092, DOI 10.1007/s00018-004-4193-x; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rojek JM, 2008, J VIROL, V82, P1505, DOI 10.1128/JVI.01331-07; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sakuma R, 2010, J BIOL CHEM, V285, P3784, DOI 10.1074/jbc.M109.059063; Sastri J, 2010, VIROLOGY, V405, P259, DOI 10.1016/j.virol.2010.06.015; Schmitz C, 2004, J VIROL, V78, P2006, DOI 10.1128/JVI.78.4.2006-2016.2004; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stuermer CAO, 2005, BIOCHEM SOC SYMP, V72, P109, DOI 10.1042/bss0720109; Waheed AA, 2008, J VIROL, V82, P9776, DOI 10.1128/JVI.00917-08; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235; Zhang XF, 2010, MICROBES INFECT, V12, P768, DOI 10.1016/j.micinf.2010.05.004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	73	5	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34508	34517		10.1074/jbc.M110.158188	http://dx.doi.org/10.1074/jbc.M110.158188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810659	Green Published, hybrid			2022-12-27	WOS:000283659100026
J	Pascual, MB; Mata-Cabana, A; Florencio, FJ; Lindahl, M; Cejudo, FJ				Pascual, Maria B.; Mata-Cabana, Alejandro; Florencio, Francisco J.; Lindahl, Marika; Cejudo, Francisco J.			Overoxidation of 2-Cys Peroxiredoxin in Prokaryotes CYANOBACTERIAL 2-CYS PEROXIREDOXINS SENSITIVE TO OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; THIOL-SPECIFIC ANTIOXIDANT; OXYR TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; ARABIDOPSIS-THALIANA; PHOTOOXIDATIVE STRESS; THIOREDOXIN; REDUCTASE; PLANTS; CYANOBACTERIA	In eukaryotic organisms, hydrogen peroxide has a dual effect; it is potentially toxic for the cell but also has an important signaling activity. According to the previously proposed floodgate hypothesis, the signaling activity of hydrogen peroxide in eukaryotes requires a transient increase in its concentration, which is due to the inactivation by overoxidation of 2-Cys peroxiredoxin (2-Cys Prx). Sensitivity to overoxidation depends on the structural GGLG and YF motifs present in eukaryotic 2-Cys Prxs and is believed to be absent from prokaryotic enzymes, thus representing a paradoxical gain of function exclusive to eukaryotic organisms. Here we show that 2-Cys Prxs from several prokaryotic organisms, including cyanobacteria, contain the GG(L/V/I) G and YF motifs characteristic of sensitive enzymes. In search of the existence of overoxidation-sensitive 2-Cys Prxs in prokaryotes, we have analyzed the sensitivity to overoxidation of 2-Cys Prxs from two cyanobacterial strains, Anabaena sp. PCC7120 and Synechocystis sp. PCC6803. In vitro analysis of wild type and mutant variants of the Anabaena 2-Cys Prx showed that this enzyme is overoxidized at the peroxidatic cysteine residue, thus constituting an exception among prokaryotes. Moreover, the 2-Cys Prx from Anabaena is readily and reversibly overoxidized in vivo in response to high light and hydrogen peroxide, showing higher sensitivity to overoxidation than the Synechocystis enzyme. These cyanobacterial strains have different strategies to cope with hydrogen peroxide. While Synechocystis has low content of less sensitive 2-Cys Prx and high catalase activity, Anabaena contains abundant and sensitive 2-Cys Prx, but low catalase activity, which is remarkably similar to the chloroplast system.	[Cejudo, Francisco J.] Univ Seville, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; CSIC, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC)	Cejudo, FJ (corresponding author), Univ Seville, Inst Bioquim Vegetal & Fotosintesis, Avda Amer Vespucio 49, Seville 41092, Spain.	fjcejudo@us.es	Cabana, Alejandro Mata/U-8388-2019; Pascual, Belén/H-5242-2015; Florencio, Francisco J/K-7716-2014; Cejudo, Francisco Javier/M-2749-2014; Lindahl, Marika/H-2259-2017	Cabana, Alejandro Mata/0000-0002-0179-2746; Florencio, Francisco J/0000-0002-2068-7861; Cejudo, Francisco Javier/0000-0002-3936-5491; Pascual/0000-0002-7988-1204; Lindahl, Marika/0000-0003-1627-0809	Ministerio de Educacion y Ciencia (Spain) [BIO2007-60644, BFU2007-60300]; Junta de Andalucia (Spain) [P06-CVI-01578, BIO-182, BIO-284]	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Junta de Andalucia (Spain)(Junta de Andalucia)	This work was supported by Grants BIO2007-60644 and BFU2007-60300 from the Ministerio de Educacion y Ciencia (Spain) and Grants P06-CVI-01578, BIO-182, and BIO-284 from the Junta de Andalucia (Spain).	Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Broin M, 2003, PLANT PHYSIOL, V132, P1335, DOI 10.1104/pp.103.021626; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Perez-Perez ME, 2009, J BACTERIOL, V191, P7477, DOI 10.1128/JB.00831-09; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Galvez-Valdivieso G, 2009, PLANT CELL, V21, P2143, DOI 10.1105/tpc.108.061507; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Huang CH, 2010, J BIOCHEM, V147, P661, DOI 10.1093/jb/mvp209; Iglesias-Baena I, 2010, J EXP BOT, V61, P1509, DOI 10.1093/jxb/erq016; Kirchsteiger K, 2009, MOL PLANT, V2, P298, DOI 10.1093/mp/ssn082; Laloi C, 2007, P NATL ACAD SCI USA, V104, P672, DOI 10.1073/pnas.0609063103; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Miller AG, 2000, PLANT PHYSIOL, V123, P625, DOI 10.1104/pp.123.2.625; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Mullineaux PM, 2006, PLANT PHYSIOL, V141, P346, DOI 10.1104/pp.106.078162; Parsonage D, 2010, P NATL ACAD SCI USA, V107, P6240, DOI 10.1073/pnas.0910057107; PE R, 2006, PLANT CELL */* F J P, V18, P2356; PE R, 2009, FEBS LETT */* F J FE, V583, P1399; Pitzschke A, 2006, ANTIOXID REDOX SIGN, V8, P1757, DOI 10.1089/ars.2006.8.1757; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Rey P, 2007, PLANT J, V49, P505, DOI 10.1111/j.1365-313X.2006.02969.x; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Tichy M, 1999, J BACTERIOL, V181, P1875, DOI 10.1128/JB.181.6.1875-1882.1999; Vandenabeele S, 2003, P NATL ACAD SCI USA, V100, P16113, DOI 10.1073/pnas.2136610100; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	44	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34485	34492		10.1074/jbc.M110.160465	http://dx.doi.org/10.1074/jbc.M110.160465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736168	Green Published, hybrid			2022-12-27	WOS:000283659100023
J	Rey, M; Man, P; Clemencon, B; Trezeguet, V; Brandolin, G; Forest, E; Pelosi, L				Rey, Martial; Man, Petr; Clemencon, Benjamin; Trezeguet, Veronique; Brandolin, Gerard; Forest, Eric; Pelosi, Ludovic			Conformational Dynamics of the Bovine Mitochondrial ADP/ATP Carrier Isoform 1 Revealed by Hydrogen/Deuterium Exchange Coupled to Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE CARRIER; ADP ATP CARRIER; PHOSPHOLIPASE A(2); DEUTERIUM-EXCHANGE; HEART-MITOCHONDRIA; MEMBRANE-PROTEINS; CYSTEINE RESIDUES; N-ETHYLMALEIMIDE; LIPID-MEMBRANE; TRANSPORT	The mitochondrial adenine nucleotide carrier (Ancp) catalyzes the transport of ADP and ATP across the mitochondrial inner membrane, thus playing an essential role in cellular energy metabolism. During the transport mechanism the carrier switches between two different conformations that can be blocked by two toxins: carboxyatractyloside (CATR) and bongkrekic acid. Therefore, our understanding of the nucleotide transport mechanism can be improved by analyzing structural differences of the individual inhibited states. We have solved the three-dimensional structure of bovine carrier isoform 1 (bAnc1p) in a complex with CATR, but the structure of the carrier-bongkrekic acid complex, and thus, the detailed mechanism of transport remains unknown. Improvements in sample processing in the hydrogen/deuterium exchange technique coupled to mass spectrometry (HDX-MS) have allowed us to gain novel insights into the conformational changes undergone by bAnc1p. This paper describes the first study of bAnc1p using HDX-MS. Results obtained with the CATR-bAnc1p complex were fully in agreement with published results, thus, validating our approach. On the other hand, the HDX kinetics of the two complexes displays marked differences. The bongkrekic acid-bAnc1p complex exhibits greater accessibility to the solvent on the matrix side, whereas the CATR-bAnc1p complex is more accessible on the intermembrane side. These results are discussed with respect to the structural and biochemical data available on Ancp.	[Man, Petr; Forest, Eric] Univ Grenoble 1, CEA, CNRS, LSMP,IBS,UMR 5075, F-38027 Grenoble 1, France; [Rey, Martial; Clemencon, Benjamin; Brandolin, Gerard; Pelosi, Ludovic] Univ Grenoble 1, Lab Biochim & Biophys Syst Integres, Inst Rech Technol & Sci Vivant, CNRS Commissariat Energie Atom,UMR 5092, F-38054 Grenoble 9, France; [Man, Petr] Acad Sci Czech Republ, Vvi, Inst Microbiol, CZ-14220 Prague 4, Czech Republic; [Trezeguet, Veronique] Univ Bordeaux 2, CNRS, UMR 5095, Lab Physiol Mol,Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Forest, E (corresponding author), Univ Grenoble 1, CEA, CNRS, LSMP,IBS,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	eric.forest@ibs.fr; ludovic.pelosi@cea.fr	Man, Petr/H-2451-2014; Pelosi, Ludovic/M-6406-2014; Pelosi, Ludovic/AAB-9832-2020; Forest, Eric/E-9042-2012	Man, Petr/0000-0002-1485-2197; Pelosi, Ludovic/0000-0002-4198-5681; Trezeguet, Veronique/0000-0003-2487-7571; Rey, Martial/0000-0002-7378-1106	University Joseph Fourier; CNRS; Commissariat a l'Energie Atomique; Institutional Research Concept of the Institute of Microbiology	University Joseph Fourier; CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Institutional Research Concept of the Institute of Microbiology	This work was supported by grants from the University Joseph Fourier, the CNRS, and the Commissariat a l'Energie Atomique (programme Signalisation et Transport Membranaires).; Supported by the Institutional Research Concept of the Institute of Microbiology and by a fellowship from the Commissariat a l'Energie Atomique.	AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; BLOCK MR, 1984, BIOCHIM BIOPHYS ACTA, V767, P369, DOI 10.1016/0005-2728(84)90207-X; BOULAY F, 1984, BIOCHEMISTRY-US, V23, P4807, DOI 10.1021/bi00315a042; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Busenlehner LS, 2004, BIOCHEMISTRY-US, V43, P11145, DOI 10.1021/bi048716k; Chenal A, 2005, J MOL BIOL, V349, P890, DOI 10.1016/j.jmb.2005.04.036; Cravello L, 2003, RAPID COMMUN MASS SP, V17, P2387, DOI 10.1002/rcm.1207; Falconi M, 2006, PROTEINS, V65, P681, DOI 10.1002/prot.21102; Feng JH, 2008, CARDIOVASC RES, V80, P20, DOI 10.1093/cvr/cvn161; Feng JH, 2010, AM J PHYSIOL-CELL PH, V298, pC740, DOI 10.1152/ajpcell.00310.2009; Halskau O, 2002, J MOL BIOL, V321, P99, DOI 10.1016/S0022-2836(02)00565-X; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Iwahashi A, 2006, MITOCHONDRION, V6, P245, DOI 10.1016/j.mito.2006.07.007; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kihira Y, 2005, BIOCHEMISTRY-US, V44, P184, DOI 10.1021/bi0488653; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2316, DOI 10.1021/bi00656a011; Lewandrowski U, 2008, FEBS LETT, V582, P1104, DOI 10.1016/j.febslet.2008.02.077; MAJIMA E, 1994, BIOCHEMISTRY-US, V33, P9530, DOI 10.1021/bi00198a019; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; Man P, 2007, J MOL BIOL, V368, P464, DOI 10.1016/j.jmb.2007.02.014; MARTY I, 1992, BIOCHEMISTRY-US, V31, P4058, DOI 10.1021/bi00131a023; Mazon H, 2005, BIOCHIMIE, V87, P1101, DOI 10.1016/j.biochi.2005.05.012; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pinheiro TJT, 2000, J MOL BIOL, V303, P617, DOI 10.1006/jmbi.2000.4159; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; Rey M, 2009, RAPID COMMUN MASS SP, V23, P3431, DOI 10.1002/rcm.4260; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; TREZE G, 2008, J Bioenerg Biomembr, V40, P435; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Wu Y, 2006, ANAL CHEM, V78, P1719, DOI 10.1021/ac0518497; Zhang X, 2010, ANAL CHEM, V82, P1100, DOI 10.1021/ac902484p; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	46	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34981	34990		10.1074/jbc.M110.146209	http://dx.doi.org/10.1074/jbc.M110.146209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805227	Green Published, hybrid			2022-12-27	WOS:000283659100072
J	Guerin, ME; Kordulakova, J; Alzari, PM; Brennan, PJ; Jackson, M				Guerin, Marcelo E.; Kordulakova, Jana; Alzari, Pedro M.; Brennan, Patrick J.; Jackson, Mary			Molecular Basis of Phosphatidyl-myo-inositol Mannoside Biosynthesis and Regulation in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BACILLUS-CALMETTE-GUERIN; HUMAN TUBERCLE-BACILLI; MANNOSYLTRANSFERASE PIMA; ESCHERICHIA-COLI; ACYLATION STATE; TUBERCULOSIS; LIPOARABINOMANNAN; GROWTH; IDENTIFICATION; LIPOMANNAN	Phosphatidyl-myo-inositol mannosides (PIMs) are unique glycolipids found in abundant quantities in the inner and outer membranes of the cell envelope of all Mycobacterium species. They are based on a phosphatidyl-myo-inositol lipid anchor carrying one to six mannose residues and up to four acyl chains. PIMs are considered not only essential structural components of the cell envelope but also the structural basis of the lipoglycans (lipomannan and lipoarabinomannan), all important molecules implicated in host-pathogen interactions in the course of tuberculosis and leprosy. Although the chemical structure of PIMs is now well established, knowledge of the enzymes and sequential events leading to their biosynthesis and regulation is still incomplete. Recent advances in the identification of key proteins involved in PIM biogenesis and the determination of the three-dimensional structures of the essential phosphatidyl-myo-inositol mannosyltransferase PimA and the lipoprotein LpqW have led to important insights into the molecular basis of this pathway.	[Guerin, Marcelo E.] CSIC UPV EHU, Unidad Biofis, Ctr Mixto, Leioa 48940, Bizkaia, Spain; [Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Pais Vasco 48940, Spain; [Guerin, Marcelo E.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Kordulakova, Jana] Comenius Univ, Dept Biochem, Fac Nat Sci, Bratislava 84215, Slovakia; [Alzari, Pedro M.] Inst Pasteur, CNRS, Unite Biochim Struct, URA 2185, F-75724 Paris 15, France; [Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Comenius University Bratislava; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Colorado State University	Guerin, ME (corresponding author), CSIC UPV EHU, Unidad Biofis, Ctr Mixto, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain.	mrcguerin@gmail.com; mary.jackson@colostate.edu	Guerin, Marcelo M/N-7245-2016; Kordulakova, Jana/I-3887-2014; Jackson, Mary/D-5345-2017; Brennan, Patrick J/G-6896-2017	Guerin, Marcelo M/0000-0001-9524-3184; Kordulakova, Jana/0000-0003-2834-0165; Jackson, Mary/0000-0002-9212-0258; Alzari, Pedro/0000-0002-4233-1903	NIAID [R01 AI064798, R37 AI018357]; IKERBASQUE; Basque Foundation for Science; Fundacion Biofisica Bizkaia; European Commission [LSHP-CT-2005-018923]; Infectious Disease SuperCluster (Colorado State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798, R37AI018357] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IKERBASQUE; Basque Foundation for Science; Fundacion Biofisica Bizkaia; European Commission(European CommissionEuropean Commission Joint Research Centre); Infectious Disease SuperCluster (Colorado State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI064798 and R37 AI018357 from NIAID. This work was also supported by IKERBASQUE, the Basque Foundation for Science, the Fundacion Biofisica Bizkaia, European Commission Contract LSHP-CT-2005-018923 (New Medicines for Tuberculosis), and the Infectious Disease SuperCluster (Colorado State University). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Anderson R. J, 1939, PROG CHEM ORG NAT PR, V3, P145; Anderson RJ, 1930, J AM CHEM SOC, V52, P1252, DOI 10.1021/ja01366a069; Anderson RJ, 1930, J AM CHEM SOC, V52, P5023, DOI 10.1021/ja01375a055; Anderson RJ, 1930, J AM CHEM SOC, V52, P1607, DOI 10.1021/ja01367a050; BALLOU CE, 1963, J BIOL CHEM, V238, P69; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; BRENNAN P, 1967, J BIOL CHEM, V242, P3046; Brennan PJ, 1988, MICROBIAL LIPIDS, V1, P203; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Chen L, 2002, BIOCHEMISTRY-US, V41, P6824, DOI 10.1021/bi0256678; Crellin PK, 2008, J BACTERIOL, V190, P3690, DOI 10.1128/JB.00200-08; DHARIWAL KR, 1977, CAN J MICROBIOL, V23, P7, DOI 10.1139/m77-002; Driessen NN, 2009, INFECT IMMUN, V77, P4538, DOI 10.1128/IAI.01256-08; Fenton MJ, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P405; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; GOREN MB, 1984, MYCOBACTERIA SOURCEB, V1, P379; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; HILL DL, 1966, J BIOL CHEM, V241, P895; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; LEE YC, 1964, J BIOL CHEM, V239, P1316; LEE YC, 1965, BIOCHEMISTRY-US, V4, P1395, DOI 10.1021/bi00883a026; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; Marland Z, 2006, J MOL BIOL, V359, P983, DOI 10.1016/j.jmb.2006.04.012; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Parish T, 1997, J BACTERIOL, V179, P7827, DOI 10.1128/jb.179.24.7827-7833.1997; Patterson JH, 2003, BIOCHEM J, V372, P77, DOI 10.1042/BJ20021700; PENUMARTI N, 1983, EXPERIENTIA, V39, P882, DOI 10.1007/BF01990417; Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; TANEJA R, 1979, J GEN MICROBIOL, V113, P413, DOI 10.1099/00221287-113-2-413; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; WIEPRECHT T, 2000, BIOCHEMISTRY-US, V39, P191	58	79	80	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33577	33583		10.1074/jbc.R110.168328	http://dx.doi.org/10.1074/jbc.R110.168328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801880	Green Published, hybrid			2022-12-27	WOS:000283354000002
J	Zhang, QA; Li, YW; Tang, CM				Zhang, Qian; Li, Yanwen; Tang, Christoph M.			The Role of the Exopolyphosphatase PPX in Avoidance by Neisseria meningitidis of Complement-mediated Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM BACTERICIDAL ACTIVITY; INORGANIC POLYPHOSPHATE; MENINGOCOCCAL DISEASE; FACTOR-H; ESCHERICHIA-COLI; SEROGROUP-B; LIPOOLIGOSACCHARIDE; RESISTANCE; BINDING; KINASE	The complement system is critical for immunity against the important human pathogen Neisseria meningitidis. We describe the isolation of a meningococcal mutant lacking PPX, an exopolyphosphatase responsible for cleaving cellular polyphosphate, a polymer of tens to hundreds of orthophosphate residues found in virtually all living cells. Bacteria lacking PPX exhibit increased resistance to complement-mediated killing. By site directed mutagenesis, we define amino acids necessary for the biochemical activity of meningococcal PPX, including a conserved glutamate (Glu(117)) and residues in the Walker B box predicted to be involved in binding to phosphate. We show that the biochemical activity of PPX is necessary for interactions with the complement. The relative resistance of the ppx mutant does not result from changes in structures (such as capsule, lipopolysaccharide, and factor H-binding protein), which are known to be required for evasion of this key aspect of host immunity. Instead, expression of PPX modifies the interaction of N. meningitidis with the alternative pathway of complement activation.	[Zhang, Qian; Li, Yanwen; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Tang, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, Flowers Bldg, London SW7 2AZ, England.	c.tang@imperial.ac.uk			MRC; Medical Research Council [G0900888] Funding Source: researchfish; MRC [G0900888] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Dr. Robert Wall and Dr. Rachel Exley for their support and advice. Work in C.M.T.'s laboratory is supported by the MRC.	Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Darton T, 2009, CLIN INFECT DIS, V48, P587, DOI 10.1086/596707; Drogari-Apiranthitou M, 2002, INFECT IMMUN, V70, P3752, DOI 10.1128/IAI.70.7.3752-3758.2002; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Geoffroy MC, 2003, GENOME RES, V13, P391, DOI 10.1101/gr.664303; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Herbert MA, 2002, MICROB PATHOGENESIS, V33, P211, DOI 10.1006/mpat.2002.0530; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Ishibashi Y, 2002, MICROB PATHOGENESIS, V33, P115, DOI 10.1006/mpat.2002.0517; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Mullan A, 2002, ANAL BIOCHEM, V308, P294, DOI 10.1016/S0003-2697(02)00249-X; NOEGEL A, 1983, J EXP MED, V157, P2049, DOI 10.1084/jem.157.6.2049; Ohtomo R, 2004, ANAL BIOCHEM, V328, P139, DOI 10.1016/j.ab.2004.03.004; Price-Carter M, 2005, J BACTERIOL, V187, P3088, DOI 10.1128/JB.187.9.3088-3099.2005; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; TINSLEY CR, 1993, INFECT IMMUN, V61, P3703, DOI 10.1128/IAI.61.9.3703-3710.1993; TINSLEY CR, 1995, INFECT IMMUN, V63, P1624, DOI 10.1128/IAI.63.5.1624-1630.1995; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Winzer K, 2002, INFECT IMMUN, V70, P2245, DOI 10.1128/IAI.70.4.2245-2248.2002; YAMASAKI R, 1991, MOL IMMUNOL, V28, P1233, DOI 10.1016/0161-5890(91)90010-H; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	41	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34259	34268		10.1074/jbc.M110.154393	http://dx.doi.org/10.1074/jbc.M110.154393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736171	hybrid, Green Published			2022-12-27	WOS:000283354000071
J	Brailoiu, E; Rahman, T; Churamani, D; Prole, DL; Brailoiu, GC; Hooper, R; Taylor, CW; Patel, S				Brailoiu, Eugen; Rahman, Taufiq; Churamani, Dev; Prole, David L.; Brailoiu, G. Cristina; Hooper, Robert; Taylor, Colin W.; Patel, Sandip			An NAADP-gated Two-pore Channel Targeted to the Plasma Membrane Uncouples Triggering from Amplifying Ca2+ Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; RYANODINE RECEPTOR; ACIDIC ORGANELLES; PANCREATIC ACINAR; MOBILIZES CA2+; BETA-CELLS; CALCIUM; RELEASE; LYSOSOMES	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a ubiquitous messenger proposed to stimulate Ca2+ release from acidic organelles via two-pore channels (TPCs). It has been difficult to resolve this trigger event from its amplification via endoplasmic reticulum Ca2+ stores, fuelling speculation that archetypal intracellular Ca2+ channels are the primary targets of NAADP. Here, we redirect TPC2 from lysosomes to the plasma membrane and show that NAADP evokes Ca2+ influx independent of ryanodine receptors and that it activates a Ca2+-permeable channel whose conductance is reduced by mutation of a residue within a putative pore. We there fore uncouple TPC2 from amplification pathways and prove that it is a pore-forming subunit of an NAADP-gated Ca2+ channel.	[Rahman, Taufiq; Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Brailoiu, Eugen; Brailoiu, G. Cristina] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Churamani, Dev; Hooper, Robert; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of London; University College London	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk; patel.s@ucl.ac.uk	rahman, taufiq/E-9806-2013; rahman, taufiq/GON-8210-2022; Taylor, Colin/G-2447-2010; Patel, Sandip/O-9591-2015	rahman, taufiq/0000-0003-3830-5160; rahman, taufiq/0000-0003-3830-5160; Taylor, Colin/0000-0001-7771-1044; Prole, David/0000-0003-2782-6665; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [HL90804]; Biotechnology and Biological Sciences Research Council [BB/G013721/1, BB/H009736/1]; Wellcome Trust [085295]; Isaac Newton Trust, Cambridge; BBSRC [BB/H009736/1, BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust, Cambridge; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL90804 (to E. B.). This work was also supported by the Biotechnology and Biological Sciences Research Council Grants BB/G013721/1 (to S. P.) and BB/H009736/1 (to C. W. T.), the Wellcome Trust Grant 085295 (to C. W. T.), and an equipment grant from the Isaac Newton Trust, Cambridge (to C. W. T).	BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Galione A, 2000, Sci STKE, V2000, ppe1; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe18; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Kusch J, 2004, J PHYSIOL-LONDON, V560, P605, DOI 10.1113/jphysiol.2004.070193; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; Lu T, 2001, J GEN PHYSIOL, V118, P509, DOI 10.1085/jgp.118.5.509; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mojzisova A., 2001, PFLUGERS ARCH, V441, P674; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Pitt S. J., 2010, J BIOL CHEM IN PRESS, P285; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Sakmann B., 1995, SINGLE CHANNEL RECOR; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	34	126	127	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38511	38516		10.1074/jbc.M110.162073	http://dx.doi.org/10.1074/jbc.M110.162073			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880839	hybrid, Green Published			2022-12-27	WOS:000284625600056
J	Moller, A; Pion, E; Narayan, V; Ball, KL				Moeller, Angeli; Pion, Emmanuelle; Narayan, Vikram; Ball, Kathryn L.			Intracellular Activation of Interferon Regulatory Factor-1 by Nanobodies to the Multifunctional (Mf1) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING FUNCTION; RNA-POLYMERASE-II; TRANSCRIPTION FACTOR; GROWTH-INHIBITION; TERMINAL REGION; IRF-1; EXPRESSION; PROTEASOME; ANTIBODIES; UBIQUITIN	IRF-1 is a tumor suppressor protein that activates gene expression from a range of promoters in response to stimuli spanning viral infection to DNA damage. Studies on the post-translational regulation of IRF-1 have been hampered by a lack of suitable biochemical tools capable of targeting the endogenous protein. In this study, phage display technology was used to develop a monoclonal nanobody targeting the C-terminal Mf1 domain (residues 301-325) of IRF-1. Intracellular expression of the nanobody demonstrated that the transcriptional activity of IRF-1 is constrained by the Mf1 domain as nanobody binding gave an increase in expression from IRF-1-responsive promoters of up to 8-fold. Furthermore, Mf1-directed nanobodies have revealed an unexpected function for this domain in limiting the rate at which the IRF-1 protein is degraded. Thus, the increase in IRF-1 transcriptional activity observed on nanobody binding is accompanied by a significant reduction in the half-life of the protein. In support of the data obtained using nanobodies, a single point mutation (P325A) involving the C-terminal residue of IRF-1 has been identified, which results in greater transcriptional activity and a significant increase in the rate of degradation. The results presented here support a role for the Mf1 domain in limiting both IRF-1-dependent transcription and the rate of IRF-1 turnover. In addition, the data highlight a route for activation of downstream genes in the IRF-1 tumor suppressor pathway using biologics.	[Moeller, Angeli; Pion, Emmanuelle; Narayan, Vikram; Ball, Kathryn L.] Univ Edinburgh Canc Res UK Ctr, Cell Signalling Unit, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Ball, KL (corresponding author), Univ Edinburgh Canc Res UK Ctr, Cell Signalling Unit, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Narayan, Vikram/AAF-3964-2020	Moller, Angeli/0000-0003-0409-1221; Narayan, Vikram/0000-0002-6128-7944	Cancer Research UK [377/A6355]	Cancer Research UK(Cancer Research UK)	This work was supported by Programme Grant 377/A6355 (to K. L. B.) from Cancer Research UK.	Bai JR, 2003, J BIOL CHEM, V278, P1433, DOI 10.1074/jbc.M208297200; BEERLI RR, 1994, J BIOL CHEM, V269, P23931; Beretta L, 1996, ONCOGENE, V12, P1593; BOULTWOOD J, 1993, BLOOD, V82, P2611; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Cohen PA, 1998, ONCOGENE, V17, P2445, DOI 10.1038/sj.onc.1202190; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Cossins AJ, 2007, PROTEIN EXPRES PURIF, V51, P253, DOI 10.1016/j.pep.2006.07.013; de Fromentel CC, 1999, ONCOGENE, V18, P551, DOI 10.1038/sj.onc.1202338; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Eckert M, 2006, J BIOL CHEM, V281, P23092, DOI 10.1074/jbc.M512589200; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Gongora C, 2000, NUCLEIC ACIDS RES, V28, P2333, DOI 10.1093/nar/28.12.2333; Green WB, 1999, LEUKEMIA, V13, P1960, DOI 10.1038/sj.leu.2401596; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1993, NUCLEIC ACIDS RES, V21, P3167, DOI 10.1093/nar/21.14.3167; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; KIRCHHOFF S, 1995, ONCOGENE, V11, P439; Kirchhoff S, 2000, EUR J BIOCHEM, V267, P6753, DOI 10.1046/j.1432-1327.2000.01750.x; Lee EJ, 2006, BIOCHEM BIOPH RES CO, V347, P882, DOI 10.1016/j.bbrc.2006.06.145; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Paz K, 2005, MOL CANCER THER, V4, P1801, DOI 10.1158/1535-7163.MCT-05-0174; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Riley CJ, 2009, CANCER RES, V69, P1933, DOI 10.1158/0008-5472.CAN-08-2707; Romeo G, 2002, J INTERF CYTOK RES, V22, P39, DOI 10.1089/107999002753452647; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tellez C, 2004, METHODS, V34, P233, DOI 10.1016/j.ymeth.2004.03.016; Visintin M, 2008, J BIOTECHNOL, V135, P1, DOI 10.1016/j.jbiotec.2008.02.012; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Zhou P, 1998, J IMMUNOL, V160, P1489	54	9	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38348	38361		10.1074/jbc.M110.149476	http://dx.doi.org/10.1074/jbc.M110.149476			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20817723	hybrid, Green Published			2022-12-27	WOS:000284625600041
J	Pham, Y; Kuhlman, B; Butterfoss, GL; Hu, H; Weinreb, V; Carter, CW				Pham, Yen; Kuhlman, Brian; Butterfoss, Glenn L.; Hu, Hao; Weinreb, Violetta; Carter, Charles W., Jr.			Tryptophanyl-tRNA synthetase Urzyme: a model to recapitulate molecular evolution and investigate intramolecular complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; CLASS-I; CATALYTIC DOMAIN; GLUTAMATE-DEHYDROGENASE; GENETIC-CODE; ACTIVE-SITE; ATP-BINDING; AMINO-ACIDS; PROTEIN	We substantiate our preliminary description of the Class I tryptophanyl-tRNA synthetase minimal catalytic domain with details of its construction, structure, and steady-state kinetic parameters. Generating that active fragment involved deleting 65% of the contemporary enzyme, including the anticodon-binding domain and Connecting Peptide 1, CP1, a 74-residue internal segment from within the Rossmann fold. We used protein design (Rosetta), rather than phylogenetic sequence alignments, to identify mutations to compensate the severe loss of modularity, restoring stability, as evidenced by renaturation described previously and by 70 ns Molecular Dynamics simulations. Sufficient solubility to enable biochemical studies was achieved by expressing the redesigned Urzyme as a maltose-binding protein fusion. Michaelis-Menten kinetic parameters from amino acid activation assays show that, compared to the native full-length enzyme, TrpRS Urzyme binds ATP with similar affinity. This suggests that neither of the two deleted structural modules has a strong influence on ground-state ATP binding. However, tryptophan has 40-103 lower affinity, and the Urzyme has comparably reduced specificity relative to the related amino acid, tyrosine. MD simulations reveal how CP1 may contribute significantly to cognate amino acid specificity. As Class Ia editing domains are nested within the CP1, this finding suggests that this module enhanced amino acid specificity continuously, throughout their evolution. We call this type of reconstructed protein catalyst an Urzyme (Ur-: prefix for original, primitive, earliest). It establishes a model for recapitulating very early steps in molecular evolution in which fitness may have been enhanced by accumulating entire modules, rather than by discrete amino acid sequence changes.	[Pham, Yen; Kuhlman, Brian; Weinreb, Violetta; Carter, Charles W., Jr.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Butterfoss, Glenn L.] NYU, Biol & Courant Comp Sci Dept, New York, NY 10003 USA; [Hu, Hao] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; New York University; University of Hong Kong	Carter, CW (corresponding author), 3092 Genet Med,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			NIH [GM078227]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078227] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grant GM078227	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; Benner Steven A., 2007, V75, P1; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; BURBAUM JJ, 1990, PROTEINS, V7, P99, DOI 10.1002/prot.340070202; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; CHUANG WJ, 1992, BIOCHEMISTRY-US, V31, P7915, DOI 10.1021/bi00149a024; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Dubois DY, 2009, BIOCHEMISTRY-US, V48, P6012, DOI 10.1021/bi801690f; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Hu H, 2008, J AM CHEM SOC, V130, P14493, DOI 10.1021/ja801202j; JAHN M, 1991, NATURE, V352, P258, DOI 10.1038/352258a0; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JOSEPH DR, 1971, J BIOL CHEM, V246, P7610; JOSEPH DR, 1971, J BIOL CHEM, V246, P7602; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; Korczak B, 2000, GLYCOBIOLOGY, V10, P595, DOI 10.1093/glycob/10.6.595; Kumar RK, 2001, BIOCHEMISTRY-US, V40, P6998, DOI 10.1021/bi010710x; Lechler A, 1997, NUCLEIC ACIDS RES, V25, P2737, DOI 10.1093/nar/25.14.2737; LEJOHN HB, 1994, J BIOL CHEM, V269, P4523; LEJOHN HB, 1994, J BIOL CHEM, V269, P4513; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Niwa N, 2009, BIOORG MED CHEM LETT, V19, P3892, DOI 10.1016/j.bmcl.2009.03.114; Nixon AE, 1997, P NATL ACAD SCI USA, V94, P1069, DOI 10.1073/pnas.94.4.1069; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Praetorius-Ibba M, 2000, BIOCHEMISTRY-US, V39, P13136; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Rodin AS, 2009, J MOL EVOL, V69, P555, DOI 10.1007/s00239-009-9288-4; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; ROGERS MJ, 1992, P NATL ACAD SCI USA, V89, P3463, DOI 10.1073/pnas.89.8.3463; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; STARZYK RM, 1989, BIOCHEMISTRY-US, V28, P8479, DOI 10.1021/bi00447a031; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Weinreb V, 2008, J AM CHEM SOC, V130, P1488, DOI 10.1021/ja076557x; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; Williams TA, 2009, MOL BIOL EVOL, V26, P445, DOI 10.1093/molbev/msn267; Wolfson AD, 1998, RNA, V4, P1019, DOI 10.1017/S1355838298980700; YANG BH, 1994, J BIOL CHEM, V269, P4506; YANIV M, 1974, J MOL BIOL, V86, P245, DOI 10.1016/0022-2836(74)90016-3	64	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38590	38601		10.1074/jbc.M110.136911	http://dx.doi.org/10.1074/jbc.M110.136911			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20864539	Green Published, hybrid			2022-12-27	WOS:000284625600084
J	Ichihashi, N; Matsuura, T; Hosoda, K; Yomo, T				Ichihashi, Norikazu; Matsuura, Tomoaki; Hosoda, Kazufumi; Yomo, Tetsuya			Identification of Two Forms of Q beta Replicase with Different Thermal Stabilities but Identical RNA Replication Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ENCODED REPLICASE; CELL-FREE SYSTEM; ESCHERICHIA-COLI; KINETIC-ANALYSIS; INFECTION CYCLE; QBETA-REPLICASE; VIRAL RNA; PROTEIN; AMPLIFICATION; BACTERIOPHAGE	The enzyme Q beta replicase is an RNA-dependent RNA polymerase, which plays a central role in infection by the simple single-stranded RNA virus bacteriophage Q beta. This enzyme has been used in a number of applications because of its unique activity in amplifying RNA from an RNA template. Determination of the thermal stability of Q beta replicase is important to gain an understanding of its function and potential applications, but data reported to date have been contradictory. Here, we provide evidence that these previous inconsistencies were due to the heterogeneous forms of the replicase with different stabilities. We purified two forms of replicase expressed in Escherichia coli, which differed in their thermal stability but showed identical RNA replication activity. Furthermore, we found that the replicase undergoes conversion between these forms due to oxidation, and the Cys-533 residue in the catalytic beta subunit and Cys-82 residue in the EF-Tu subunit of the replicase are essential prerequisites for this conversion to occur. These results strongly suggest that the thermal stable replicase contains the intersubunit disulfide bond between these cysteines. The established strategies for isolating and purifying a thermally stable replicase should increase the usefulness of Q beta replicase in various applications, and the data regarding thermal stability obtained in this study may yield insight into the precise mechanism of infection by bacteriophage Q beta	[Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Matsuura, Tomoaki] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Ichihashi, Norikazu; Matsuura, Tomoaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Ichihashi, Norikazu/AAY-6897-2020; matsuura, tomoaki/O-7368-2018; Matsuura, Tomoaki/W-6086-2019	matsuura, tomoaki/0000-0003-1015-6781; Matsuura, Tomoaki/0000-0003-1015-6781	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Global Centers of Excellence Program and Special Coordination Funds for Promoting Science and Technology: Yuragi Project from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Abramson Richard D., 1993, Current Opinion in Biotechnology, V4, P41, DOI 10.1016/0958-1669(93)90030-Z; BIEBRICHER CK, 1986, NATURE, V321, P89, DOI 10.1038/321089a0; BIEBRICHER CK, 1993, J MOL BIOL, V231, P175, DOI 10.1006/jmbi.1993.1271; BIEBRICHER CK, 1981, J MOL BIOL, V148, P391, DOI 10.1016/0022-2836(81)90183-2; Blumenthal T, 1979, Methods Enzymol, V60, P628; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; Brown D, 1996, P NATL ACAD SCI USA, V93, P11558, DOI 10.1073/pnas.93.21.11558; Chetverin AB, 1997, CELL, V88, P503, DOI 10.1016/S0092-8674(00)81890-5; EIGEN M, 1991, BIOCHEMISTRY-US, V30, P11005, DOI 10.1021/bi00110a001; Eoyang L., 1968, METHODS ENZYMOLOGY B, V12B, P530; HARUNA I, 1963, P NATL ACAD SCI USA, V50, P905, DOI 10.1073/pnas.50.5.905; HARUNA I, 1965, SCIENCE, V150, P884, DOI 10.1126/science.150.3698.884; Hosoda K, 2007, J BIOL CHEM, V282, P15516, DOI 10.1074/jbc.M700307200; Ichihashi N, 2008, CHEMBIOCHEM, V9, P3023, DOI 10.1002/cbic.200800518; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inokuchi Y, 1997, J BIOL CHEM, V272, P15339, DOI 10.1074/jbc.272.24.15339; Jacobson AB, 1998, J MOL BIOL, V275, P589, DOI 10.1006/jmbi.1997.1472; Johnson JL, 2001, PROTEIN SCI, V10, P2186, DOI 10.1110/ps.02401; KAMEN R, 1972, BIOCHIM BIOPHYS ACTA, V262, P88, DOI 10.1016/0005-2787(72)90221-3; Karlsson F, 2005, CAN J MICROBIOL, V51, P29, DOI 10.1139/W04-113; Karring H, 2004, J BIOL CHEM, V279, P1878, DOI 10.1074/jbc.M306605200; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; Kim H, 2004, BIOTECHNOL BIOENG, V88, P148, DOI 10.1002/bit.20226; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Kita H, 2006, J BIOSCI BIOENG, V101, P421, DOI 10.1263/jbb.101.421; KOLAKOFS.D, 1971, BIOCHIM BIOPHYS ACTA, V246, P596, DOI 10.1016/0005-2787(71)90799-4; Kono M, 1998, BIOCHEMISTRY-US, V37, P1302, DOI 10.1021/bi9721445; Kopsidas G, 2006, IMMUNOL LETT, V107, P163, DOI 10.1016/j.imlet.2006.09.004; MILLS DR, 1979, P NATL ACAD SCI USA, V76, P2232, DOI 10.1073/pnas.76.5.2232; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; MOODY MD, 1994, BIOCHEMISTRY-US, V33, P13836, DOI 10.1021/bi00250a038; MOROZOV IY, 1993, P NATL ACAD SCI USA, V90, P9325, DOI 10.1073/pnas.90.20.9325; Nakaishi T, 2002, J BIOSCI BIOENG, V93, P322, DOI 10.1263/jbb.93.322; OBERHOLZER T, 1995, BIOCHEM BIOPH RES CO, V207, P250, DOI 10.1006/bbrc.1995.1180; Pace N. R., 1968, METHODS ENZYMOLOGY B, V12B, P540; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Schuppli D, 2000, J MOL BIOL, V295, P149, DOI 10.1006/jmbi.1999.3373; Spiegelman S., 1968, S Quant Biol, V33, P101; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tsukada K, 2009, BBA-GEN SUBJECTS, V1790, P65, DOI 10.1016/j.bbagen.2008.08.007; Tyagi S, 1996, P NATL ACAD SCI USA, V93, P5395, DOI 10.1073/pnas.93.11.5395; Ugarov VI, 2003, J BIOL CHEM, V278, P44139, DOI 10.1074/jbc.M305992200; Ugarov VI, 2008, J MOL BIOL, V379, P414, DOI 10.1016/j.jmb.2008.03.074; Urabe H, 2010, BIOCHEMISTRY-US, V49, P1809, DOI 10.1021/bi901805u; VANDUIN J, 1988, BACTERIOPHAGES; WEISSMANN C, 1973, ANNU REV BIOCHEM, V42, P303, DOI 10.1146/annurev.bi.42.070173.001511; WEISSMANN C, 1974, FEBS LETT, V43, pS10; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zinder ND, 1975, RNA PHAGES	50	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37210	37217		10.1074/jbc.M110.117846	http://dx.doi.org/10.1074/jbc.M110.117846			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858892	Green Published, hybrid			2022-12-27	WOS:000284424000014
J	Kim, JY; Song, EH; Lee, HJ; Oh, YK; Park, YS; Park, JW; Kim, BJ; Kim, DJ; Lee, I; Song, J; Kim, WH				Kim, Ji Yeon; Song, Eun Hyun; Lee, Hyun Jung; Oh, Yeo Kyoung; Park, Yoon Shin; Park, Joo-Won; Kim, Bong Jo; Kim, Dae Jin; Lee, Inkyu; Song, Jihyun; Kim, Won-Ho			Chronic Ethanol Consumption-induced Pancreatic beta-Cell Dysfunction and Apoptosis through Glucokinase Nitration and Its Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; CHRONIC HIGH GLUCOSE; ALCOHOL-CONSUMPTION; TYROSINE NITRATION; SUPEROXIDE-DISMUTASE; INSULIN-RESISTANCE; FASTING GLUCOSE; ROS PRODUCTION; FATTY LIVER; KAPPA-B	Chronic ethanol consumption is known as an independent risk factor for type 2 diabetes, which is characterized by impaired glucose homeostasis and insulin resistance; however, there is a great deal of controversy concerning the relationships between alcohol consumption and the development of type 2 diabetes. We investigated the effects of chronic ethanol consumption on pancreatic beta-cell dysfunction and whether generated peroxynitrite participates in the impaired glucose homeostasis. Here we show that chronic ethanol feeding decreases the ability of pancreatic beta-cells to mediate insulin secretion and ATP production in coordination with the decrease of glucokinase, Glut2, and insulin expression. Specific blockade of ATF3 using siRNA or C-terminally deleted ATF3(Delta C) attenuated ethanol-induced pancreatic beta-cell apoptosis or dysfunction and restored the down-regulation of glucokinase (GCK), insulin, and pancreatic duodenal homeobox-1 induced by ethanol. GCK inactivation and down-regulation were predominantly mediated by ethanol metabolism-generated peroxynitrite, which were suppressed by the peroxynitrite scavengers N-gamma-monomethyl-L-arginine, uric acid, and deferoxamine but not by the S-nitrosylation inhibitor DTT, indicating that tyrosine nitration is the predominant modification associated with GCK down-regulation and inactivation rather than S-nitrosylation of cysteine. Tyrosine nitration of GCK prevented its association with pBad, and GCK translocation into the mitochondria results in subsequent proteasomal degradation of GCK following ubiquitination. This study identified a novel and efficient pathway by which chronic ethanol consumption may induce GCK down-regulation and inactivation by inducing tyrosine nitration of GCK, resulting in pancreatic beta-cell apoptosis and dysfunction. Peroxynitrite-induced ATF3 may also serve as a potent upstream regulator of GCK down-regulation and beta-cell apoptosis.	[Kim, Ji Yeon; Song, Eun Hyun; Lee, Hyun Jung; Oh, Yeo Kyoung; Song, Jihyun; Kim, Won-Ho] Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, Seoul 122701, South Korea; [Park, Yoon Shin] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Seoul 122701, South Korea; [Park, Joo-Won] Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc Dis, Seoul 122701, South Korea; [Kim, Bong Jo] Natl Inst Hlth, Ctr Genome Sci, Seoul 122701, South Korea; [Kim, Dae Jin] Catholic Univ, Coll Med, Dept Psychiat, Seoul 122701, South Korea; [Lee, Inkyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Catholic University of Korea; Kyungpook National University	Kim, WH (corresponding author), Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, 194 Tongillo, Seoul 122701, South Korea.	jhkwh@nih.go.kr	Lee, In-Kyu/AAR-6374-2021	Song, Eun Hyeon/0000-0001-9524-2595; Kim, Won-Ho/0000-0002-4849-472X	Korea Science and Engineering Foundation [R04-2002-000-20112-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grant R04-2002-000-20112-0.	Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Beck KF, 1999, J EXP BIOL, V202, P645; Cabrera-Valladares G, 1999, ENDOCRINOLOGY, V140, P3091, DOI 10.1210/en.140.7.3091; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Dembele K, 2009, CELL BIOL TOXICOL, V25, P141, DOI 10.1007/s10565-008-9067-9; Di Castelnuovo A, 2007, NUTR METAB CARDIOVAS, V17, P561, DOI 10.1016/j.numecd.2007.02.006; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; Djousse L, 2007, OBESITY, V15, P1758, DOI 10.1038/oby.2007.209; Elsner M, 2003, DIABETOLOGIA, V46, P1713, DOI 10.1007/s00125-003-1241-2; Fueki Y, 2007, CLIN CHIM ACTA, V382, P71, DOI 10.1016/j.cca.2007.03.027; Furuya DT, 2005, LIFE SCI, V77, P1813, DOI 10.1016/j.lfs.2004.12.046; Guichard C, 2008, BIOCHEM SOC T, V36, P920, DOI 10.1042/BST0360920; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, p97A; Kim BJ, 2006, PROTEOMICS, V6, P1250, DOI 10.1002/pmic.200500447; Kim JY, 2009, CELL SIGNAL, V21, P1758, DOI 10.1016/j.cellsig.2009.07.011; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kim SY, 2001, BIOCHIMIE, V83, P437, DOI 10.1016/S0300-9084(01)01258-5; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Knight TR, 2001, TOXICOL SCI, V62, P212, DOI 10.1093/toxsci/62.2.212; Lee HJ, 2007, J MOL BIOL, V369, P967, DOI 10.1016/j.jmb.2007.03.072; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Lee JR, 2009, ARCH PHARM RES, V32, P1109, DOI 10.1007/s12272-009-1802-0; Mishra DP, 2007, PROSTAG OTH LIPID M, V83, P75, DOI 10.1016/j.prostaglandins.2006.10.002; Pan HN, 2006, ALCOHOL CLIN EXP RES, V30, P1615, DOI 10.1111/j.1530-0277.2006.00194.x; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; Polikandriotis JA, 2007, ALCOHOL, V41, P309, DOI 10.1016/j.alcohol.2007.03.012; Roh WG, 2009, ALCOHOL, V43, P643, DOI 10.1016/j.alcohol.2009.10.005; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Sebastian BM, 2005, AM J PHYSIOL-ENDOC M, V289, pE1077, DOI 10.1152/ajpendo.00296.2005; Shaper AG, 1998, NOVART FDN SYMP, V216, P173; Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9; Strnad P, 2009, GASTROENTEROLOGY, V136, P1502, DOI 10.1053/j.gastro.2009.03.021; Tejedo JR, 2004, ENDOCRINOLOGY, V145, P2319, DOI 10.1210/en.2003-1489; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Walsh L, 2005, MUTAGENESIS, V20, P317, DOI 10.1093/mutage/gei044; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Yang ES, 2008, BIOCHIMIE, V90, P1316, DOI 10.1016/j.biochi.2008.03.001; Yang ES, 2009, BIOCHIMIE, V91, P1020, DOI 10.1016/j.biochi.2009.05.008	50	67	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37251	37262		10.1074/jbc.M110.142315	http://dx.doi.org/10.1074/jbc.M110.142315			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855893	hybrid, Green Published			2022-12-27	WOS:000284424000018
J	Huang, Y; Zhou, YB; Wong, HC; Castiblanco, A; Chen, YY; Brown, EM; Yang, JJ				Huang, Yun; Zhou, Yubin; Wong, Hing-Cheung; Castiblanco, Adriana; Chen, Yanyi; Brown, Edward M.; Yang, Jenny J.			Calmodulin Regulates Ca2+-sensing Receptor-mediated Ca2+ Signaling and Its Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING-RECEPTOR; RESIDUAL DIPOLAR COUPLINGS; PROTEIN-KINASE-C; EXTRACELLULAR CALCIUM; TARGET RECOGNITION; STRUCTURAL BASIS; BINDING DOMAIN; ACTIVATION; GLUTAMATE; PHOSPHORYLATION	The Ca2+-sensing receptor (CaSR) is a member of family C of the GPCRs responsible for sensing extracellular Ca2+ ([Ca2+](o)) levels, maintaining extracellular Ca2+ homeostasis, and transducing Ca2+ signaling from the extracellular milieu to the intracellular environment. In the present study, we have demonstrated a Ca2+-dependent, stoichiometric interaction between CaM and a CaM-binding domain (CaMBD) located within the C terminus of CaSR (residues 871-898). Our studies suggest a wrapping around 1-14-like mode of interaction that involves global conformational changes in both lobes of CaM with concomitant formation of a helical structure in the CaMBD. More importantly, the Ca2+-dependent association between CaM and the C terminus of CaSR is critical for maintaining proper responsiveness of intracellular Ca2+ responses to changes in extracellular Ca2+ and regulating cell surface expression of the receptor.	[Yang, Jenny J.] Georgia State Univ, Dept Chem, Ctr Drug Design & Adv Biotechnol, Atlanta, GA 30303 USA; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Univ Plaza, Atlanta, GA 30303 USA.	chejjy@langate.gsu.edu	Chen, Yanyi/H-7096-2013; Zhou, Yubin/D-4748-2011	Chen, Yanyi/0000-0002-7755-0882; Zhou, Yubin/0000-0001-7962-0517; Huang, Yun/0000-0001-5950-9168	National Institutes of Health [GM62999-1, GM081749-01, DK078331]; National Science Foundation [MCB-0092486]; American Heart Association [0655168B]; Brain and Behavior Program at Georgia State University; Molecular Basis of Disease at Georgia State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999, R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Brain and Behavior Program at Georgia State University; Molecular Basis of Disease at Georgia State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62999-1 and GM081749-01 (to J. J. Y.) and DK078331 (to E. M. B.), National Science Foundation Grant MCB-0092486, American Heart Association Grant 0655168B (to J. J. Y.), a predoctoral fellowship from the Brain and Behavior Program at Georgia State University (to Y. H.), and a predoctoral fellowship from the Molecular Basis of Disease at Georgia State University (to Y. Z.).	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Bai M, 1997, J CLIN INVEST, V99, P1917, DOI 10.1172/JCI119359; Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Bouschet T, 2008, TRENDS PHARMACOL SCI, V29, P633, DOI 10.1016/j.tips.2008.09.002; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chang WH, 2001, J BIOL CHEM, V276, P44129, DOI 10.1074/jbc.M104834200; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; Enz R, 2002, FEBS LETT, V514, P184, DOI 10.1016/S0014-5793(02)02361-X; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang C, 2007, J CELL MOL MED, V11, P923, DOI 10.1111/j.1582-4934.2007.00114.x; Huang Y, 2007, J BIOL CHEM, V282, P9517, DOI 10.1074/jbc.M609045200; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; IKURA M, 1992, CELL CALCIUM, V13, P391, DOI 10.1016/0143-4160(92)90052-T; Kubokawa K, 1996, FEBS LETT, V392, P71, DOI 10.1016/0014-5793(96)00786-7; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lienhardt A, 2000, J CLIN ENDOCR METAB, V85, P1695, DOI 10.1210/jc.85.4.1695; Liu YZ, 2009, J MAGN RESON, V200, P109, DOI 10.1016/j.jmr.2009.06.010; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Ray JM, 1997, J CLIN INVEST, V99, P2328, DOI 10.1172/JCI119413; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Reyes-Ibarra AP, 2007, MOL ENDOCRINOL, V21, P1394, DOI 10.1210/me.2006-0523; ROTH SM, 1991, BIOCHEMISTRY-US, V30, P10078, DOI 10.1021/bi00106a003; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Valafar H., 2004, Journal of Structural and Functional Genomics, V5, P241, DOI 10.1007/s10969-004-4899-x; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye CP, 2000, BONE, V27, P21, DOI 10.1016/S8756-3282(00)00288-X; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941	43	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35919	35931		10.1074/jbc.M110.147918	http://dx.doi.org/10.1074/jbc.M110.147918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826781	Green Published, hybrid			2022-12-27	WOS:000283845300069
J	Jiang, SX; Zagozdzon, R; Jorda, MA; Parmar, K; Fu, YG; Williams, JS; Wood, JAT; Makriyannis, A; Banu, N; Avraham, S; Groopman, JE; Avraham, HK				Jiang, Shuxian; Zagozdzon, Radoslaw; Jorda, Meritxell Alberich; Parmar, Kalindi; Fu, Yigong; Williams, John S.; Wood, Jodi Anne T.; Makriyannis, Alexandros; Banu, Naheed; Avraham, Shalom; Groopman, Jerome E.; Avraham, Hava Karsenty			Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID RECEPTORS; SELF-RENEWAL; MICE; MIGRATION; DIFFERENTIATION; TRANSPLANTATION; OPPORTUNITIES; MURINE; SYSTEM	Endocannabinoids are lipid signaling molecules that act via G-coupled receptors, CB1 and CB2. The endocannabinoid system is capable of activation of distinct signaling pathways on demand in response to pathogenic events or stimuli, hereby enhancing cell survival and promoting tissue repair. However, the role of endocannabinoids in hematopoietic stem and progenitor cells (HSPCs) and their interaction with hematopoietic stem cells (HSC) niches is not known. HSPCs are maintained in the quiescent state in bone marrow (BM) niches by intrinsic and extrinsic signaling. We report that HSPCs express the CB1 receptors and that BM stromal cells secrete endocannabinoids, anandamide (AEA) (35 pg/10(7) cells), and 2-AG (75.2 ng/10(7) cells). In response to the endotoxin lipopolysaccharide (LPS), elevated levels of AEA (75.6 pg/10(7) cells) and 2-AG (98.8 ng/10(7) cells) were secreted from BM stromal cells, resulting in migration and trafficking of HSPCs from the BM niches to the peripheral blood. Furthermore, administration of exogenous cannabinoid CB1 agonists in vivo induced chemotaxis, migration, and mobilization of human and murine HSPCs. Cannabinoid receptor knock-out mice Cnr1(-/-) showed a decrease in side population (SP) cells, whereas fatty acid amide hydrolase (FAAH)(-/-) mice, which have elevated levels of AEA, yielded increased colony formation as compared with WT mice. In addition, G-CSF-induced mobilization in vivo was modulated by endocannabinoids and was inhibited by specific cannabinoid antagonists as well as impaired in cannabinoid receptor knock-out mice Cnr1(-/-), as compared with WT mice. Thus, we propose a novel function of the endocannabinoid system, as a regulator of HSPC interactions with their BM niches, where endocannabinoids are expressed in HSC niches and under stress conditions, endocannabinoid expression levels are enhanced to induce HSPC migration for proper hematopoiesis.	[Jiang, Shuxian; Zagozdzon, Radoslaw; Fu, Yigong; Banu, Naheed; Avraham, Shalom; Groopman, Jerome E.; Avraham, Hava Karsenty] Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA; [Jiang, Shuxian; Zagozdzon, Radoslaw; Fu, Yigong; Banu, Naheed; Avraham, Shalom; Groopman, Jerome E.; Avraham, Hava Karsenty] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Parmar, Kalindi] Northeastern Univ, Dana Farber Canc Inst, Boston, MA 02215 USA; [Jorda, Meritxell Alberich] Northeastern Univ, Harvard Stem Cell Inst, Boston, MA 02215 USA; [Williams, John S.; Wood, Jodi Anne T.; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02215 USA; [Williams, John S.; Wood, Jodi Anne T.; Makriyannis, Alexandros] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Northeastern University; Harvard University; Northeastern University; Northeastern University; Northeastern University	Avraham, HK (corresponding author), 99 Brookline Ave,3rd Floor, Boston, MA 02115 USA.	havraham@bidmc.harvard.edu	Makriyannis, Alexandros/GRF-1518-2022; Banu, Naheed/U-1498-2019	Makriyannis, Alexandros/0000-0003-3272-3687; Banu, Naheed/0000-0002-6115-8042; Avraham, Hava/0000-0002-7545-3640; Alberich Jorda, Meritxell/0000-0002-8093-641X	National Institutes of Health [CA 096805, CA 135226]; Career Enhancement Award [K18 PAR-02-069]; National Blood Foundation; European Hematology Association; Department of Defense [BC086398]; NATIONAL CANCER INSTITUTE [R21CA135226, R01CA096805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Enhancement Award; National Blood Foundation; European Hematology Association; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 096805 (to H. A.) and CA 135226 (to H. A.), Career Enhancement Award K18 PAR-02-069 (to H. A.), the National Blood Foundation (to H. A.), an EHA research fellowship from The European Hematology Association (to M. A. J.), and Department of Defense Concept Award BC086398 (to S. J.).	Adams GB, 2009, NATURE, V459, P103, DOI 10.1038/nature07859; AIZAWA S, 1984, J RADIAT RES, V25, P91, DOI 10.1269/jrr.25.91; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; Bachstetter AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010496; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabral GA, 2005, J LEUKOCYTE BIOL, V78, P1192, DOI 10.1189/jlb.0405216; Can A, 2008, TRANSFUS APHER SCI, V38, P261, DOI 10.1016/j.transci.2008.04.006; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Fukuda Seiji, 2008, V430, P55, DOI 10.1007/978-1-59745-182-6_4; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Greineisen WE, 2010, INT IMMUNOPHARMACOL, V10, P547, DOI 10.1016/j.intimp.2010.02.012; Hanus LO, 2010, CURR MED CHEM, V17, P1341, DOI 10.2174/092986710790980096; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; JIANG S, 2010, PLOS ONE, V25, P641; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Klein TW, 2004, J NEUROIMMUNOL, V147, P91, DOI 10.1016/j.jneuroim.2003.10.019; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MUCCIOLI GG, 2010, DRUG DISCOV IN PRESS; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Murphy EA, 2010, BIOL BLOOD MARROW TR, V16, P147, DOI 10.1016/j.bbmt.2009.08.004; Otto A, 2009, J ANAT, V215, P477, DOI 10.1111/j.1469-7580.2009.01138.x; Park KS, 2006, MOL PHARMACOL, V69, P1066, DOI 10.1124/mol.105.018960; Parolaro D, 1999, LIFE SCI, V65, P637, DOI 10.1016/S0024-3205(99)00286-6; Patel KD, 2010, CURR MED CHEM, V17, P1394, DOI 10.2174/092986710790980041; Patinkin D, 2008, EUR J PHARMACOL, V595, P1, DOI 10.1016/j.ejphar.2008.05.002; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Reggio PH, 2010, CURR MED CHEM, V17, P1468, DOI 10.2174/092986710790980005; Rubinstein P, 2009, BONE MARROW TRANSPL, V44, P635, DOI 10.1038/bmt.2009.281; Sigvardsson M, 2009, J INTERN MED, V266, P311, DOI 10.1111/j.1365-2796.2009.02154.x; ter Huurne M, 2010, STEM CELLS DEV, V19, P1131, DOI 10.1089/scd.2010.0038; Trounson A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-29; Williams J, 2007, ANAL CHEM, V79, P5582, DOI 10.1021/ac0624086; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	44	14	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35471	35478		10.1074/jbc.M110.144758	http://dx.doi.org/10.1074/jbc.M110.144758			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826813	Green Published, hybrid			2022-12-27	WOS:000283845300025
J	Merrill, SA; Hanson, PI				Merrill, Samuel A.; Hanson, Phyllis I.			Activation of Human VPS4A by ESCRT-III Proteins Reveals Ability of Substrates to Relieve Enzyme Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE VPS4; STRUCTURAL BASIS; PORE LOOPS; COMPLEX; TRANSLOCATION; RECOGNITION; BINDING; RESIDUES; DOMAIN; IST1	VPS4 proteins are AAA(+) ATPases required to form multive-sicular bodies, release viral particles, and complete cytokinesis. They act by disassembling ESCRT-III heteropolymers during or after their proposed function in membrane scission. Here we show that purified human VPS4A is essentially inactive but can be stimulated to hydrolyze ATP by ESCRT-III proteins in a reaction that requires both their previously defined MIT interacting motifs and similar to 50 amino acids of the adjacent sequence. Importantly, C-terminal fragments of all ESCRT-III proteins tested, including CHMP2A, CHMP1B, CHMP3, CHMP4A, CHMP6, and CHMP5, activated VPS4A suggesting that it disassembles ESCRT-III heteropolymers by affecting each component protein. VPS4A is thought to act as a ring-shaped cylindrical oligomer like other AAA(+) ATPases, but this has been difficult to directly demonstrate. We found that concentrating His(6)-VPS4A on liposomes containing Ni2+-nitrilotriacetic acid-tagged lipid increased ATP hydrolysis, confirming the importance of inter-subunit interactions for activity. We also found that mutating pore loops expected to line the center of a cylindrical oligomer changed the response of VPS4A to ESCRT-III proteins. Based on these data, we propose that ESCRT-III proteins facilitate assembly of functional but transient VPS4A oligomers and interact with sequences inside the pore of the assembled enzyme. Deleting the N-terminal MIT domain and adjacent linker from VPS4A increased both basal and liposome-enhanced ATPase activity, indicating that these elements play a role in autoinhibiting VPS4A until it encounters ESCRT-III proteins. These findings reveal new ways in which VPS4 activity is regulated and specifically directed to ESCRT-III polymers.	[Merrill, Samuel A.; Hanson, Phyllis I.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hanson, PI (corresponding author), 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	phanson22@wustl.edu	Hanson, Phyllis/E-9420-2012		National Institutes of Health [R01 GM076686]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076686.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Farbman ME, 2008, BIOCHEMISTRY-US, V47, P13497, DOI 10.1021/bi801140y; Ghazi-Tabatabai S, 2009, BIOCHEM SOC T, V37, P151, DOI 10.1042/BST0370151; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Inoue M, 2008, TRAFFIC, V9, P2180, DOI 10.1111/j.1600-0854.2008.00831.x; Kaksonen M, 2008, J CELL BIOL, V180, P1059, DOI 10.1083/jcb.200802174; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; NICKERSON DP, 2006, J CELL BIOL, V175, pNIL1; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Strub C, 2003, FEBS LETT, V553, P125, DOI 10.1016/S0014-5793(03)00985-2; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	72	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35428	35438		10.1074/jbc.M110.126318	http://dx.doi.org/10.1074/jbc.M110.126318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20805225	hybrid, Green Published			2022-12-27	WOS:000283845300020
J	van Wieringen, T; Kalamajski, S; Liden, A; Bihan, D; Guss, B; Heinegard, D; Farndale, RW; Rubin, K				van Wieringen, Tijs; Kalamajski, Sebastian; Liden, Asa; Bihan, Dominique; Guss, Bengt; Heinegard, Dick; Farndale, Richard W.; Rubin, Kristofer			The Streptococcal Collagen-binding Protein CNE Specifically Interferes with alpha(V)beta(3)-mediated Cellular Interactions with Triple Helical Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BB; INTERSTITIAL FLUID PRESSURE; GEL CONTRACTION; IN-VITRO; INTEGRIN; FIBRONECTIN; RECEPTOR; NORMALIZATION; RECOGNITION; ACTIVATION	Collagen fibers expose distinct domains allowing for specific interactions with other extracellular matrix proteins and cells. To investigate putative collagen domains that govern integrin alpha(V)beta(3)-mediated cellular interactions with native collagen fibers we took advantage of the streptococcal protein CNE that bound native fibrillar collagens. CNE specifically inhibited alpha(V)beta(3)-dependent cell-mediated collagen gel contraction, PDGF BB-induced and alpha(V)beta(3)-mediated adhesion of cells, and binding of fibronectin to native collagen. Using a Toolkit composed of overlapping, 27-residue triple helical segments of collagen type II, two CNE-binding sites present in peptides II-1 and II-44 were identified. These peptides lack the major binding site for collagen-binding beta(1) integrins, defined by the peptide GFOGER. Peptide II-44 corresponds to a region of collagen known to bind collagenases, discoidin domain receptor 2, SPARC (osteonectin), and fibronectin. In addition to binding fibronectin, peptide II-44 but not II-1 inhibited alpha(V)beta(3)-mediated collagen gel contraction and, when immobilized on plastic, supported adhesion of cells. Reduction of fibronectin expression by siRNA reduced PDGF BB-induced alpha(V)beta(3)-mediated contraction. Reconstitution of collagen types I and II gels in the presence of CNE reduced collagen fibril diameters and fibril melting temperatures. Our data indicate that contraction proceeded through an indirect mechanism involving binding of cell-produced fibronectin to the collagen fibers. Furthermore, our data show that cell-mediated collagen gel contraction does not directly depend on the process of fibril formation.	[van Wieringen, Tijs; Kalamajski, Sebastian; Liden, Asa; Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Liden, Asa] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Guss, Bengt] Swedish Univ Agr Sci, Dept Microbiol, SE-75007 Uppsala, Sweden; [Heinegard, Dick] BMC C12 Lund Univ, Dept Clin Sci Lund, SE-22184 Lund, Sweden	Uppsala University; University of Bergen; University of Cambridge; Swedish University of Agricultural Sciences; Lund University	Rubin, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, SE-75123 Uppsala, Sweden.	Kristofer.Rubin@imbim.uu.se	Rubin, Kristofer/AAC-1810-2020	Rubin, Kristofer/0000-0003-2789-6276; Guss, Bengt/0000-0002-7044-0701; Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Science Council; Swedish Cancer Foundation; King Gustaf the V:s 80-arsfond; Swedish Research Council for Environment, Agricultural Sciences and Spatial planning [FORMAS 221-2006-989]; Swedish Horse Board [H0747197]; Medical Research Council [G0500707, G0400701] Funding Source: researchfish; MRC [G0500707, G0400701] Funding Source: UKRI	Swedish Science Council; Swedish Cancer Foundation; King Gustaf the V:s 80-arsfond; Swedish Research Council for Environment, Agricultural Sciences and Spatial planning(Swedish Research Council Formas); Swedish Horse Board; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Swedish Science Council (to K.R.), the Swedish Cancer Foundation (to K. R.), the King Gustaf the V:s 80-arsfond (to K.R.), the Swedish Research Council for Environment, Agricultural Sciences and Spatial planning Grant FORMAS 221-2006-989 (to B.G.), Swedish Horse Board Grant H0747197 (to B.G.), and the Wellcome Trust and Medical Research Council supported synthesis of the Toolkits (to R.W.F.).	Ahlen K, 1998, CELL ADHES COMMUN, V5, P461, DOI 10.3109/15419069809005604; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Berg A, 1998, AM J PHYSIOL-HEART C, V274, pH663, DOI 10.1152/ajpheart.1998.274.2.H663; Cooke ME, 2000, J CELL SCI, V113, P2375; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; GULLBERG D, 1989, J BIOL CHEM, V264, P12686; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; HAYASHI M, 1985, J BIOCHEM-TOKYO, V98, P1135, DOI 10.1093/oxfordjournals.jbchem.a135363; Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Liden A, 2006, BIOCHEM BIOPH RES CO, V340, P604, DOI 10.1016/j.bbrc.2005.12.043; Liden A, 2008, J BIOL CHEM, V283, P1234, DOI 10.1074/jbc.M704827200; LUNDGREN E, 1988, J CELL PHYSIOL, V136, P43, DOI 10.1002/jcp.1041360106; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Reed RK, 2010, J MOL CELL CARDIOL, V48, P518, DOI 10.1016/j.yjmcc.2009.06.023; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; RUBIN K, 1981, EXP CELL RES, V135, P127, DOI 10.1016/0014-4827(81)90305-0; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Svendsen OS, 2008, AM J PHYSIOL-HEART C, V295, pH555, DOI 10.1152/ajpheart.00161.2008; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; TINGSTROM A, 1992, J CELL SCI, V102, P315; van Wieringen T, 2009, EXP CELL RES, V315, P1745, DOI 10.1016/j.yexcr.2009.02.005; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779	36	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35803	35813		10.1074/jbc.M110.146001	http://dx.doi.org/10.1074/jbc.M110.146001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837478	Green Published, hybrid			2022-12-27	WOS:000283845300058
J	Blacketer, MJ; Feely, SJ; Shogren-Knaak, MA				Blacketer, Melissa J.; Feely, Sarah J.; Shogren-Knaak, Michael A.			Nucleosome Interactions and Stability in an Ordered Nucleosome Array Model System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROCHROMATIN PROTEIN-1 HP1; CHROMATIN FIBER STRUCTURE; HISTONE OCTAMER; CORE PARTICLE; PHO5 PROMOTER; TAIL DOMAIN; DNA; IDENTIFICATION; COMPACTION; TRANSCRIPTION	Although it is well established that the majority of eukaryotic DNA is sequestered as nucleosomes, the higher-order structure resulting from nucleosome interactions as well as the dynamics of nucleosome stability are not as well understood. To characterize the structural and functional contribution of individual nucleosomal sites, we have developed a chromatin model system containing up to four nucleosomes, where the array composition, saturation, and length can be varied via the ordered ligation of distinct mononucleosomes. Using this system we find that the ligated tetranucleosomal arrays undergo intra-array compaction. However, this compaction is less extensive than for longer arrays and is histone H4 tail-independent, suggesting that well ordered stretches of four or fewer nucleosomes do not fully compact to the 30-nm fiber. Like longer arrays, the tetranucleosomal arrays exhibit cooperative self-association to form species composed of many copies of the array. This propensity for self-association decreases when the fraction of nucleosomes lacking H4 tails is systematically increased. However, even tetranucleosomal arrays with only two octamers possessing H4 tails recapitulate most of the inter-array self-association. Varying array length shows that systems as short as dinucleosomes demonstrate significant self-association, confirming that relatively few determinants are required for inter-array interactions and suggesting that in vivo multiple interactions of short runs of nucleosomes might contribute to complex fiber-fiber interactions. Additionally, we find that the stability of nucleosomes toward octamer loss increases with array length and saturation, suggesting that in vivo stretches of ordered, saturated nucleosomes could serve to protect these regions from histone ejection.	[Blacketer, Melissa J.; Feely, Sarah J.; Shogren-Knaak, Michael A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Shogren-Knaak, MA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4214 Mol Biol Bldg, Ames, IA 50011 USA.	knaak@iastate.edu			National Institutes of Health [GM79663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79663 (to M. A. S.-K.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; KO H, 2008, Trends Cell Biol */*, V18, P236; Kwon SH, 2008, MOL CELLS, V26, P217; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; NOLL H, 1989, METHOD ENZYMOL, V170, P55; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THSTRO MA, 2004, J BIOCH */* BIOCHEMI, V43, P736; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; VAN H, 1978, BIOPOLYMERS */* W O, V17, P1387; van Holde K, 2007, SEMIN CELL DEV BIOL, V18, P651, DOI 10.1016/j.semcdb.2007.08.005; VANHOLDE KE, 1989, SPRINGER SERIES MOL, P289; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	48	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34597	34607		10.1074/jbc.M110.140061	http://dx.doi.org/10.1074/jbc.M110.140061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739276	Green Published, hybrid			2022-12-27	WOS:000283659100035
J	Ogino, K; Ramsden, SL; Keib, N; Schwarz, G; Harvey, RJ; Hirata, H				Ogino, Kazutoyo; Ramsden, Sarah L.; Keib, Natalie; Schwarz, Guenter; Harvey, Robert J.; Hirata, Hiromi			Duplicated Gephyrin Genes Showing Distinct Tissue Distribution and Alternative Splicing Patterns Mediate Molybdenum Cofactor Biosynthesis, Glycine Receptor Clustering, and Escape Behavior in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SPINAL-CORD; PROTEIN GEPHYRIN; BETA-SUBUNIT; ESCHERICHIA-COLI; INHIBITORY SYNAPSES; CRYSTAL-STRUCTURE; SPASMODIC MOUSE; SPASTIC MOUSE; MUTATION; EXPRESSION	Gephyrin mediates the postsynaptic clustering of glycine receptors (GlyRs) and GABA(A) receptors at inhibitory synapses and molybdenum-dependent enzyme (molybdoenzyme) activity in non-neuronal tissues. Gephyrin knock-out mice show a phenotype resembling both defective glycinergic transmission and molybdenum cofactor (Moco) deficiency and die within 1 day of birth due to starvation and dyspnea resulting from deficits in motor and respiratory networks, respectively. To address whether gephyrin function is conserved among vertebrates and whether gephyrin deficiency affects molybdoenzyme activity and motor development, we cloned and characterized zebrafish gephyrin genes. We report here that zebrafish have two gephyrin genes, gphna and gphnb. The former is expressed in all tissues and has both C3 and C4 cassette exons, and the latter is expressed predominantly in the brain and spinal cord and harbors only C4 cassette exons. We confirmed that all of the gphna and gphnb splicing isoforms have Moco synthetic activity. Antisense morpholino knockdown of either gphna or gphnb alone did not disturb synaptic clusters of GlyRs in the spinal cord and did not affect touch-evoked escape behaviors. However, on knockdown of both gphna and gphnb, embryos showed impairments in GlyR clustering in the spinal cord and, as a consequence, demonstrated touch-evoked startle response behavior by contracting antagonistic muscles simultaneously, instead of displaying early coiling and late swimming behaviors, which are executed by side-to-side muscle contractions. These data indicate that duplicated gephyrin genes mediate Moco biosynthesis and control postsynaptic clustering of GlyRs, thereby mediating key escape behaviors in zebrafish.	[Ogino, Kazutoyo; Hirata, Hiromi] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 4118540, Japan; [Ramsden, Sarah L.; Harvey, Robert J.] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Keib, Natalie; Schwarz, Guenter] Univ Cologne, Inst Biochem, D-50674 Cologne, Germany; [Keib, Natalie; Schwarz, Guenter] Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; [Hirata, Hiromi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Hirata, Hiromi] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of London; University College London; University of London School of Pharmacy; University of Cologne; University of Cologne; Graduate University for Advanced Studies - Japan; Nagoya University	Hirata, H (corresponding author), Natl Inst Genet, Frontier Res Ctr, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	hihirata@lab.nig.ac.jp	Schwarz, Guenter/ABE-9643-2021; Harvey, Robert/D-3994-2016; Zebrafish, UCL/A-3125-2009; Schwarz, Guenter/F-2217-2013	Schwarz, Guenter/0000-0002-2118-9338; Harvey, Robert/0000-0001-5956-6664; Hirata, Hiromi/0000-0002-3769-7441	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nakajima Foundation; Takeda Science Foundation; Human Frontier Science Program; Medical Research Council [G0800111]; MRC [G0500833] Funding Source: UKRI; Medical Research Council [G0500833] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakajima Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants-in-aid for young scientists (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Nakajima Foundation, Takeda Science Foundation, and Career Development Award of the Human Frontier Science Program (to H. H.).; Supported by a Medical Research Council DTG Studentship G0800111.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bedet C, 2006, J BIOL CHEM, V281, P30046, DOI 10.1074/jbc.M602155200; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Calamai M, 2009, J NEUROSCI, V29, P7639, DOI 10.1523/JNEUROSCI.5711-08.2009; David-Watine B, 1999, NEUROSCIENCE, V90, P303, DOI 10.1016/S0306-4522(98)00430-8; David-Watine B, 2001, GENE, V271, P239, DOI 10.1016/S0378-1119(01)00511-X; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Giesemann T, 2003, J NEUROSCI, V23, P8330; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hasona A, 1998, J BACTERIOL, V180, P1466, DOI 10.1128/JB.180.6.1466-1472.1998; Heck S, 1997, DEV BRAIN RES, V98, P211, DOI 10.1016/S0165-3806(96)00181-2; Hirata H, 2005, P NATL ACAD SCI USA, V102, P8345, DOI 10.1073/pnas.0500862102; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Hirata H, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.026.2009; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Paarmann I, 2006, BIOCHEM SOC T, V34, P45, DOI 10.1042/BST0340045; Paarmann I, 2006, J BIOL CHEM, V281, P34918, DOI 10.1074/jbc.M607764200; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Reiss J, 2001, AM J HUM GENET, V68, P208, DOI 10.1086/316941; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; SAUL B, 1994, FEBS LETT, V350, P71, DOI 10.1016/0014-5793(94)00736-5; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shankaran SS, 2007, DEV BIOL, V304, P615, DOI 10.1016/j.ydbio.2007.01.004; Smolinsky B, 2008, J BIOL CHEM, V283, P17370, DOI 10.1074/jbc.M800985200; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Triller A, 1997, NEUROSCIENCE, V80, P133, DOI 10.1016/S0306-4522(97)00092-4; Tsen G, 2000, NAT NEUROSCI, V3, P126, DOI 10.1038/72066; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; WHITE WF, 1982, NATURE, V298, P655, DOI 10.1038/298655a0; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	69	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					806	817		10.1074/jbc.M110.125500	http://dx.doi.org/10.1074/jbc.M110.125500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20843816	Green Published, hybrid			2022-12-27	WOS:000285782800080
J	Dixit, A; Singh, PK; Sharma, GP; Malhotra, P; Sharma, P				Dixit, Aparna; Singh, Prashant K.; Sharma, Guru Prasad; Malhotra, Pawan; Sharma, Pushkar			PfSRPK1, a Novel Splicing-related Kinase from Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SPECIFIC KINASES; B-LIKE ENZYME; SR PROTEINS; MALARIA PARASITES; SIGNALING PATHWAY; SEXUAL STAGE; RNA; PHOSPHORYLATION; INTERACTS; IDENTIFICATION	Even though it is increasingly evident that post-transcriptional events like mRNA processing and splicing may regulate gene expression and proteome diversity of malaria parasite Plasmodium, molecular mechanisms that regulate events like mRNA splicing in malaria parasite are poorly understood. Protein kinases control a wide variety of cellular events in almost all eukaryotes, including modulation of mRNA splicing, transport, and stability. We have identified a novel splicing-related protein kinase from Plasmodium falciparum, PfSRPK1. PfSRPK1 when incubated with parasite nuclear extracts inhibited RNA splicing, suggesting that it may control mRNA splicing in the parasite. PfSR1, a putative splicing factor from P. falciparum, was identified as a substrate of PfSRPK1. PfSR1 interacts with RNA and PfSRPK1 modulates its RNA binding. Early in the parasite development, PfSRPK1 and PfSR1 are present in the nucleus. These studies provide useful insights into the function of two potentially key components of P. falciparum mRNA splicing machinery.	Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Singh, Prashant K.; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi		pushkar@nii.ac.in	Sharma, Guruprasad/M-5256-2017	Sharma, Guruprasad/0000-0003-3197-4396	Department of Science and Technology, India; European Union; ICGEB; DBT	Department of Science and Technology, India(Department of Science & Technology (India)); European Union(European Commission); ICGEB; DBT(Department of Biotechnology (DBT) India)	This work was supported in part by a Swarnajayanti fellowship grant (to P. S.) by the Department of Science and Technology, India and in part by the MALSIG project, funded by the European Union under FP7. This work was also supported by ICGEB and DBT (to P. M.).	Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Breman JG, 2001, AM J TROP MED HYG, V64, pI; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; FU XD, 1995, RNA, V1, P663; Horrocks P, 1998, MOL BIOCHEM PARASIT, V95, P171, DOI 10.1016/S0166-6851(98)00110-8; Iriko H, 2009, PARASITOL INT, V58, P196, DOI 10.1016/j.parint.2009.02.002; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANZER M, 1992, EMBO J, V11, P1949, DOI 10.1002/j.1460-2075.1992.tb05248.x; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Li JL, 2001, INT J PARASITOL, V31, P387, DOI 10.1016/S0020-7519(01)00126-6; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Marshall AC, 2008, PRENATAL DIAG, V28, P1023, DOI 10.1002/pd.2114; McIntosh MT, 2007, J BIOL CHEM, V282, P11499, DOI 10.1074/jbc.M610974200; Militello KT, 2005, RNA, V11, P365, DOI 10.1261/rna.7940705; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Portal D, 2003, MOL BIOCHEM PARASIT, V127, P9, DOI 10.1016/S0166-6851(02)00299-2; Ranjan R, 2009, J BIOL CHEM, V284, P15267, DOI 10.1074/jbc.M900656200; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; Saenz FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002287; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Sims JS, 2009, EUKARYOT CELL, V8, P327, DOI 10.1128/EC.00340-08; Singh N, 2004, J MOL BIOL, V343, P589, DOI 10.1016/j.jmb.2004.08.047; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sunil S, 2008, BIOCHEM BIOPH RES CO, V372, P373, DOI 10.1016/j.bbrc.2008.05.033; Ta M, 2000, J VIROL, V74, P5108, DOI 10.1128/JVI.74.11.5108-5115.2000; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79	40	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38315	38323		10.1074/jbc.M110.119255	http://dx.doi.org/10.1074/jbc.M110.119255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870716	hybrid, Green Published			2022-12-27	WOS:000284625600038
J	Berlin, I; Higginbotham, KM; Dise, RS; Sierra, MI; Nash, PD				Berlin, Ilana; Higginbotham, Katherine M.; Dise, Rebecca S.; Sierra, Maria I.; Nash, Piers D.			The Deubiquitinating Enzyme USP8 Promotes Trafficking and Degradation of the Chemokine Receptor 4 at the Sorting Endosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-COUPLED RECEPTOR; DOWN-REGULATION; UBIQUITIN ISOPEPTIDASE; ESCRT MACHINERY; CXCR4; HRS; UBPY; LIGASE; INTERACTS	Reversible ubiquitination orchestrated by the opposition of ubiquitin ligases and deubiquitinating enzymes mediates endocytic trafficking of cell surface receptors for lysosomal degradation. Ubiquitin-specific protease 8 (USP8) has previously been implicated in endocytosis of several receptors by virtue of their deubiquitination. The present study explores an indirect role for USP8 in cargo trafficking through its regulation of the chemokine receptor 4 (CXCR4). Contrary to the effects of USP8 loss on enhanced green fluorescent protein, we find that USP8 depletion stabilizes CXCR4 on the cell surface and attenuates receptor degradation without affecting its ubiquitination status. In the presence of ligand, diminished CXCR4 turnover is accompanied by receptor accumulation on enlarged early endosomes and leads to enhancement of phospho-ERK signaling. Perturbation in CXCR4 trafficking, resulting from USP8 inactivation, occurs at the ESCRT-0 checkpoint, and catalytic mutation of USP8 specifically targeted to the ESCRT-0 complex impairs the spatial and temporal organization of the sorting endosome. USP8 functionally opposes the ubiquitin ligase AIP4 with respect to ESCRT-0 ubiquitination, thereby promoting trafficking of CXCR4. Collectively, our findings demonstrate a functional cooperation between USP8, AIP4, and the ESCRT-0 machinery at the early sorting phase of CXCR4 and underscore the versatility of USP8 in shaping trafficking events at the early-to-late endosome transition.	[Berlin, Ilana; Higginbotham, Katherine M.; Dise, Rebecca S.; Sierra, Maria I.; Nash, Piers D.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Nash, PD (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	pdnash@uchicago.edu			American Cancer Society, Illinois Division; Concern Foundation; V Foundation; Department of Defense; National Research Service	American Cancer Society, Illinois Division(American Cancer Society); Concern Foundation; V Foundation; Department of Defense(United States Department of Defense); National Research Service	This work was suported in part by grants from the American Cancer Society, Illinois Division, the Concern Foundation, and the V Foundation Scholars Program (to P. N.).; Recipient of a Department of Defense (Congressionally Directed Medical Research Programs) Breast Cancer pre-doctoral fellowship.; Recipient of a National Research Service Award pre-doctoral fellowship.	Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Berruti G, 2005, BIOL REPROD, V72, P14, DOI 10.1095/biolreprod.104.030866; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hu C. D., 2005, CURR PROTOC PROTEIN, P19101; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Kucia M, 2004, J MOL HISTOL, V35, P233; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2009, METHOD ENZYMOL, V460, P413, DOI 10.1016/S0076-6879(09)05221-5; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mukai A, 2008, J CELL SCI, V121, P1325, DOI 10.1242/jcs.027417; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Panner A, 2010, CANCER RES, V70, P5046, DOI 10.1158/0008-5472.CAN-09-3979; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	58	58	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37895	37908		10.1074/jbc.M110.129411	http://dx.doi.org/10.1074/jbc.M110.129411			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876529	hybrid, Green Published			2022-12-27	WOS:000284424000079
J	Lee, SH; Yu, SY; Nakayama, J; Khoo, KH; Stone, EL; Fukuda, MN; Marth, JD; Fukuda, M				Lee, Seung Ho; Yu, Shin-Yi; Nakayama, Jun; Khoo, Kai-Hooi; Stone, Erica L.; Fukuda, Michiko N.; Marth, Jamey D.; Fukuda, Minoru			Core2 O-Glycan Structure Is Essential for the Cell Surface Expression of Sucrase Isomaltase and Dipeptidyl Peptidase-IV during Intestinal Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; N-GLYCANS; COLORECTAL-CANCER; EPITHELIAL-CELLS; 2 BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; INTRACELLULAR TRAFFICKING; SECRETORY PATHWAY; MOLECULAR-CLONING; UDP-GLCNAC; GLYCOSYLATION	Alterations in glycosylation play an important role during intestinal cell differentiation. Here, we compared expression of mucin-type O-glycan synthases from proliferating and differentiated HT-29 and Caco-2 cells. Mucin-type O-glycan structures were analyzed at both stages by mass spectrometry. Core2 beta 1,6-N-acetylglucosaminyltransferase-2 (C2GnT-2) was markedly increased in differentiated HT-29 and Caco-2 cells, but the core3 structure was hardly detectable. To determine whether such differential expression of mucin-type O-glycan structures has physiological significance in intestinal cell differentiation, expression of sucrase isomaltase (SI) and dipeptidyl-peptidase IV (DPP-IV), two well known intestinal differentiation markers, was examined. Interestingly, the fully glycosylated mature form of SI was decreased in C2GnT-2 knock-out mice but not in core2 N-acetylglucosaminyltransferase-3 (C2GnT-3) nulls. In addition, expression of SI and DPP-IV was dramatically reduced in C2GnT-1-3 triple knock-out mice. These patterns were confirmed by RNAi analysis; C2GnT-2 knockdown significantly reduced cell surface expression of SI and DPP-IV in Caco-2 cells. Similarly, overexpression of the core3 structure in HT-29 cells attenuated cell surface expression of both enzymes. These findings indicate that core3 O-glycan structure regulates cell surface expression of SI and DPP-IV and that core2 O-glycan is presumably an essential mucin-type O-glycan structure found in both molecules in vivo. Finally, goblet cells in the upper part of the crypt showed impaired maturation in the core2 O-glycan-deficient mice. These studies are the first to clearly identify functional mucin-type O-glycan structures modulating cell surface expression of SI and DPP-IV during the intestinal cell differentiation.	[Lee, Seung Ho; Fukuda, Michiko N.; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Glycobiol Unit, Ctr Canc, La Jolla, CA 92037 USA; [Yu, Shin-Yi; Khoo, Kai-Hooi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan; [Stone, Erica L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Marth, Jamey D.] Univ Calif Santa Barbara, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA	Sanford Burnham Prebys Medical Discovery Institute; Academia Sinica - Taiwan; Shinshu University; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Glycobiol Unit, Ctr Canc, La Jolla, CA 92037 USA.	minoru@sanfordburnham.org	Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; YU, Shin-Yi/0000-0003-0197-9575	National Institutes of Health [CA33000, P01 CA71932]; NATIONAL CANCER INSTITUTE [R01CA033000, P01CA071932, R37CA033000] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390104] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grants CA33000 and P01 CA71932.	Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Alfalah M, 2002, J BIOL CHEM, V277, P10683, DOI 10.1074/jbc.M109357200; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Cosentino S, 2010, J NUTR BIOCHEM, V21, P247, DOI 10.1016/j.jnutbio.2008.12.016; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; GORVEL JP, 1991, GASTROENTEROLOGY, V101, P618, DOI 10.1016/0016-5085(91)90517-O; Gouyer V, 2001, J CELL SCI, V114, P1455; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Hein Z, 2009, EXP CELL RES, V315, P348, DOI 10.1016/j.yexcr.2008.10.038; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Keiser M, 2006, J BIOL CHEM, V281, P14393, DOI 10.1074/jbc.M513631200; Lee SH, 2009, J BIOL CHEM, V284, P17157, DOI 10.1074/jbc.M109.010934; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Machida E, 2001, CANCER RES, V61, P2226; Merzaban JS, 2005, J IMMUNOL, V174, P4051, DOI 10.4049/jimmunol.174.7.4051; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Naim HY, 1999, J BIOL CHEM, V274, P17961, DOI 10.1074/jbc.274.25.17961; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Patsos G, 2007, BIOCHEM SOC T, V35, P1372, DOI 10.1042/BST0351372; Patsos G, 2005, BIOCHEM SOC T, V33, P721, DOI 10.1042/BST0330721; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; SEMENZA G, 1983, CIBA F SYMP, V95, P92; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Tsuiji H, 2003, GLYCOBIOLOGY, V13, P521, DOI 10.1093/glycob/cwg065; VAVASSEUR F, 1995, GLYCOBIOLOGY, V5, P351, DOI 10.1093/glycob/5.3.351; VAVASSEUR F, 1994, EUR J BIOCHEM, V222, P415, DOI 10.1111/j.1432-1033.1994.tb18880.x; Vercoutter-Edouart AS, 2008, PROTEOMICS, V8, P3236, DOI 10.1002/pmic.200800151; Wetzel G, 2009, BIOL CHEM, V390, P545, DOI 10.1515/BC.2009.077; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yamashita K, 1999, BBA-GEN SUBJECTS, V1473, P147, DOI 10.1016/S0304-4165(99)00175-0; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3	42	21	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37683	37692		10.1074/jbc.M110.162735	http://dx.doi.org/10.1074/jbc.M110.162735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20841351	Green Published, hybrid			2022-12-27	WOS:000284424000060
J	Ogunrinu, TA; Sontheimer, H				Ogunrinu, Toyin Adeyemi; Sontheimer, Harald			Hypoxia Increases the Dependence of Glioma Cells on Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE; MITOCHONDRIAL COMPLEX-III; HYDROGEN DONOR SYSTEM; PRIMARY BRAIN-TUMORS; NITRIC-OXIDE; OXIDATIVE STRESS; IN-VIVO; KAPPA-B; CYSTINE; OXYGEN	Glutathione (GSH) is an essential antioxidant responsible for the maintenance of intracellular redox homeostasis. As tumors outgrow their blood supply and become hypoxic, their redox homeostasis is challenged by the production of nitric oxide and reactive oxygen species (ROS). In gliomas, the sustained import of L-cystine via the L-cystine/L-glutamate exchanger, system xc(-), is rate-limiting for the synthesis of GSH. We show that hypoxia causes a significant increase in NO and ROS but without affecting glioma cell growth. This is explained by a concomitant increase in the utilization of GSH, which is accompanied by an increase in the cell-surface expression of xCT, the catalytic subunit of system xc(-), and L-cystine uptake. Growth was inhibited when GSH synthesis was blocked by buthionine sulfoximine (BSO), an inhibitor of the enzyme required for GSH synthesis, or when cells were deprived of L-cystine. These findings suggest that glioma cells show an increased requirement for GSH to maintain growth under hypoxic conditions. Therefore, approaches that limit GSH synthesis such as blocking system xc(-) may be considered as an adjuvant to radiation or chemotherapy.	[Sontheimer, Harald] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Ctr Glial Biol Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), Univ Alabama, Dept Neurobiol, 1719 6th Ave S,CIRC 410, Birmingham, AL 35294 USA.	sontheimer@uab.edu		Sontheimer, Harald/0000-0002-5843-9871	National Institutes of Health [RO1 NS052634, T32MH18882]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS052634 and T32MH18882.	ANDERSON ME, 1989, FASEB J, V3, P2527, DOI 10.1096/fasebj.3.13.2572501; Anderson MF, 2004, NEUROCHEM INT, V44, P153, DOI 10.1016/S0197-0186(03)00133-5; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BUMP EA, 1990, PHARMACOL THERAPEUT, V47, P117, DOI 10.1016/0163-7258(90)90048-7; BURK RF, 1983, BIOCHEM J, V215, P441, DOI 10.1042/bj2150441; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; CHO ES, 1984, J NUTR, V114, P1853, DOI 10.1093/jn/114.10.1853; CHO Y, 1990, J NEUROCHEM, V55, P2091, DOI 10.1111/j.1471-4159.1990.tb05800.x; Choi CH, 2009, J MAGN RESON, V198, P160, DOI 10.1016/j.jmr.2009.02.002; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Davis GDJ, 2009, CELL BIOL TOXICOL, V25, P331, DOI 10.1007/s10565-008-9087-5; Dirven HAAM, 1996, CHEM RES TOXICOL, V9, P351, DOI 10.1021/tx950143c; Doxsee DW, 2007, PROSTATE, V67, P162, DOI 10.1002/pros.20508; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dun Y, 2006, CELL TISSUE RES, V324, P189, DOI 10.1007/s00441-005-0116-x; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Flynn J, 2000, NEUROCHEM INT, V36, P513, DOI 10.1016/S0197-0186(99)00151-5; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; GRIFFITH OW, 1978, P NATL ACAD SCI USA, V75, P5405, DOI 10.1073/pnas.75.11.5405; Guan J, 2009, CANCER CHEMOTH PHARM, V64, P463, DOI 10.1007/s00280-008-0894-4; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; KATO S, 1992, NEUROSCIENCE, V48, P903, DOI 10.1016/0306-4522(92)90278-A; Lakshmi VM, 2003, CHEM RES TOXICOL, V16, P367, DOI 10.1021/tx0200966; Liu RM, 1998, AM J PHYSIOL-LUNG C, V274, pL330, DOI 10.1152/ajplung.1998.274.3.L330; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; LUTHMAN M, 1979, P NATL ACAD SCI USA, V76, P2158, DOI 10.1073/pnas.76.5.2158; McBean G. J., 2001, BIOCHEM SOC T, V29, P6; MEISTER A, 1976, ANNU REV BIOCHEM, V45, P559, DOI 10.1146/annurev.bi.45.070176.003015; Na N, 2010, FASEB J, V24, P799, DOI 10.1096/fj.08-128967; Narang VS, 2007, CHEMOTHERAPY, V53, P210, DOI 10.1159/000100812; NORDSMARK M, 1994, ACTA ONCOL, V33, P383, DOI 10.3109/02841869409098433; Papandreou I, 2005, MUTAT RES-FUND MOL M, V569, P87, DOI 10.1016/j.mrfmmm.2004.06.054; RADI R, 1991, J BIOL CHEM, V266, P4244; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001; Sato H, 2001, J BIOL CHEM, V276, P10407, DOI 10.1074/jbc.M007216200; Schafer C, 2001, ACTA ONCOL, V40, P529, DOI 10.1080/028418601750288271; Schmidt C L, 1940, Science, V91, P18, DOI 10.1126/science.91.2349.18; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; Terpstra M, 2003, MAGN RESON MED, V50, P19, DOI 10.1002/mrm.10499; WANG GL, 1993, J BIOL CHEM, V268, P21513; Yamamoto Y, 2006, CELL TISSUE RES, V325, P3, DOI 10.1007/s00441-006-0178-4; Yang J, 2008, FREE RADICAL RES, V42, P1, DOI 10.1080/10715760701762407; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; YUAN F, 1994, CANCER RES, V54, P4564; Zhang W, 2005, CANCER RES, V65, P1554, DOI 10.1158/0008-5472.CAN-04-1554	51	66	68	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37716	37724		10.1074/jbc.M110.161190	http://dx.doi.org/10.1074/jbc.M110.161190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858898	Green Published, hybrid			2022-12-27	WOS:000284424000063
J	Pascal, TA; Abrol, R; Mittal, R; Wang, Y; Prasadarao, NV; Goddard, WA				Pascal, Tod A.; Abrol, Ravinder; Mittal, Rahul; Wang, Ying; Prasadarao, Nemani V.; Goddard, William A., III			Experimental Validation of the Predicted Binding Site of Escherichia coli K1 Outer Membrane Protein A to Human Brain Microvascular Endothelial Cells IDENTIFICATION OF CRITICAL MUTATIONS THAT PREVENT E. COLI MENINGITIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY; MOLECULAR-DYNAMICS; FORCE-FIELD; ENTROPY; RECEPTOR; COMPENSATION; EXPRESSION; EFFICIENT; LIGANDS; SEPSIS	Escherichia coli K1, the most common cause of meningitis in neonates, has been shown to interact with GlcNAc1-4GlcNAc epitopes of Ecgp96 on human brain microvascular endothelial cells (HBMECs) via OmpA (outer membrane protein A). However, the precise domains of extracellular loops of OmpA interacting with the chitobiose epitopes have not been elucidated. We report the loop-barrel model of these OmpA interactions with the carbohydrate moieties of Ecgp96 predicted from molecular modeling. To test this model experimentally, we generated E. coli K1 strains expressing OmpA with mutations of residues predicted to be critical for interaction with the HBMEC and tested E. coli invasion efficiency. For these same mutations, we predicted the interaction free energies (including explicit calculation of the entropy) from molecular dynamics (MD), finding excellent correlation (R-2 = 90%) with experimental invasion efficiency. Particularly important is that mutating specific residues in loops 1, 2, and 4 to alanines resulted in significant inhibition of E. coli K1 invasion in HBMECs, which is consistent with the complete lack of binding found in the MD simulations for these two cases. These studies suggest that inhibition of the interactions of these residues of Loop 1, 2, and 4 with Ecgp96 could provide a therapeutic strategy to prevent neonatal meningitis due to E. coli K1.	[Pascal, Tod A.; Abrol, Ravinder; Goddard, William A., III] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Mittal, Rahul; Wang, Ying; Prasadarao, Nemani V.] Childrens Hosp Los Angeles, Div Infect Dis, Saban Res Inst, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA	California Institute of Technology; Children's Hospital Los Angeles; University of Southern California	Goddard, WA (corresponding author), CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA.	wag@wag.caltech.edu	Abrol, Ravinder/R-3458-2019; Abrol, Ravinder/B-4980-2010	Abrol, Ravinder/0000-0001-7333-6793; 	National Institutes of Health [AI-040567, R01NS071112]; National Science Foundation [CMMI-072870, CTS-0608889]; U. S. Department of Energy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040567, R01AI040567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-040567 (to N. V. P.) and R01NS071112. This work was also supported by grants to Caltech from the National Science Foundation (CMMI-072870 and CTS-0608889).; Supported by a graduate fellowship from the U. S. Department of Energy Computational Science Graduate Fellowship (CSGF).	Allen M. D., 1987, COMPUTER SIMULATION, P71; BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; Cho AE, 2005, J COMPUT CHEM, V26, P48, DOI 10.1002/jcc.20118; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Datta D, 2003, PROTEINS, V50, P213, DOI 10.1002/prot.10257; GILLI P, 1994, J PHYS CHEM-US, V98, P1515, DOI 10.1021/j100056a024; GLADSTONE IM, 1990, PEDIATR INFECT DIS J, V9, P819, DOI 10.1097/00006454-199011000-00009; Goddard WA, 2007, J NUTR, V137, p1528S, DOI 10.1093/jn/137.6.1528S; Goddard WA, 2010, J STRUCT BIOL, V170, P10, DOI 10.1016/j.jsb.2010.01.001; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hummer G, 1998, J PHYS CHEM B, V102, P10469, DOI 10.1021/jp982873+; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kam VWT, 2008, J CHEM THEORY COMPUT, V4, P2160, DOI 10.1021/ct800196k; Kim S. K., 2008, COMPUTERS CHEM; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koedel U, 1999, INFECT DIS CLIN N AM, V13, P549, DOI 10.1016/S0891-5520(05)70094-5; Kong XJ, 1996, J CHEM PHYS, V105, P2414, DOI 10.1063/1.472109; Leib SL, 1999, INFECT DIS CLIN N AM, V13, P527, DOI 10.1016/S0891-5520(05)70093-3; Lin ST, 2010, J PHYS CHEM B, V114, P8191, DOI 10.1021/jp103120q; Lin ST, 2003, J CHEM PHYS, V119, P11792, DOI 10.1063/1.1624057; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McQuarrie D. A., 2000, STAT MECH, V1st, P194; Meirovitch H, 2007, CURR OPIN STRUC BIOL, V17, P181, DOI 10.1016/j.sbi.2007.03.016; Niemer RK, 2008, J RECEPT SIG TRANSD, V28, P138; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Prasadarao NV, 1996, INFECT IMMUN, V64, P154, DOI 10.1128/IAI.64.1.154-160.1996; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; Schlyer S. K., 2006, COMPUTERS CHEM B; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Taziarova M, 2007, NEUROENDOCRINOL LETT, V28, P18; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; UNHANAND M, 1993, J PEDIATR-US, V122, P15, DOI 10.1016/S0022-3476(05)83480-8; Vaidehi N, 2006, J BIOL CHEM, V281, P27613, DOI 10.1074/jbc.M601389200; WIDOM B, 1963, J CHEM PHYS, V39, P2808, DOI 10.1063/1.1734110; Williams DH, 2001, J AM CHEM SOC, V123, P737, DOI 10.1021/ja0029230; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7; 2007, JAGUAR VERSION 7 0	50	26	27	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37753	37761		10.1074/jbc.M110.122804	http://dx.doi.org/10.1074/jbc.M110.122804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851887	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-27	WOS:000284424000067
J	Bansal, K; Sinha, AY; Ghorpade, DS; Togarsimalemath, SK; Patil, SA; Kaveri, SV; Balaji, KN; Bayry, J				Bansal, Kushagra; Sinha, Akhauri Yash; Ghorpade, Devram Sampat; Togarsimalemath, Shambhuprasad Kotresh; Patil, Shripad A.; Kaveri, Srini V.; Balaji, Kithiganahalli Narayanaswamy; Bayry, Jagadeesh			Src Homology 3-interacting Domain of Rv1917c of Mycobacterium tuberculosis Induces Selective Maturation of Human Dendritic Cells by Regulating PI3K-MAPK-NF-kappa B Signaling and Drives Th2 Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; T-CELLS; PROTECTIVE IMMUNITY; SECRETING CD8(+); PE/PPE PROTEINS; INNATE IMMUNITY; KAPPA-B; ACTIVATION; INFECTION; TLR2	Mycobacterium tuberculosis, an etiological agent of pulmonary tuberculosis, causes significant morbidity and mortality worldwide. Pathogenic mycobacteria survive in the host by subverting host innate immunity. Dendritic cells (DCs) are professional antigen-presenting cells that are vital for eliciting immune responses to infectious agents, including pathogenic mycobacteria. DCs orchestrate distinct Th responses based on the signals they receive. In this perspective, deciphering the interactions of the proline-glutamic acid/proline-proline-glutamic acid (PE/PPE) family of proteins of M. tuberculosis with DCs assumes significant pathophysiological attributes. In this study, we demonstrate that Rv1917c (PPE34), a representative member of the proline-proline-glutamic-major polymorphic tandem repeat family, interacts with TLR2 and triggers functional maturation of human DCs. Signaling perturbations implicated a critical role for integrated cross-talk among PI3K-MAPK and NF-kappa B signaling cascades in Rv1917c-induced maturation of DCs. However, this maturation of DCs was associated with a secretion of high amounts of anti-inflammatory cytokine IL-10, whereas Th1-polarizing cytokine IL-12 was not induced. Consistent with these results, Rv1917c-matured DCs favored secretion of IL-4, IL-5, and IL-10 from CD4(+) T cells and contributed to Th2-skewed cytokine balance ex vivo in healthy individuals and in patients with pulmonary tuberculosis. Interestingly, the Rv1917c-skewed Th2 immune response involved induced expression of cyclooxygenase-2 (COX-2) in DCs. Taken together, these results indicate that Rv1917c facilitates a shift in the ensuing immunity toward the Th2 phenotype and could aid in immune evasion by mycobacteria.	[Kaveri, Srini V.; Bayry, Jagadeesh] INSERM, U872, F-75006 Paris, France; [Bansal, Kushagra; Sinha, Akhauri Yash; Ghorpade, Devram Sampat; Togarsimalemath, Shambhuprasad Kotresh; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Patil, Shripad A.] Natl Inst Mental Hlth & Neurosci, Dept Microbiol, Bangalore 560029, Karnataka, India; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, Equipe Immunopathol & Therapeut Immunointervent 1, Ctr Rech Cordeliers, Unite Mixte Rech Sante 872, F-75006 Paris, France; [Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 05, Unite Mixte Rech Sante 872, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indian Institute of Science (IISC) - Bangalore; National Institute of Mental Health & Neurosciences - India; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bayry, J (corresponding author), INSERM, U872, F-75006 Paris, France.	balaji@mcbl.iisc.ernet.in; jagadeesh.bayry@crc.jussieu.fr	Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; KOTRESH TOGARSIMALEMATH, SHAMBHUPRASAD/0000-0003-2935-5377; Kaveri, Srini/0000-0002-0837-4053	Indian Institute of Science, Departments of Biotechnology and Science and Technology, Council for Scientific and Industrial Research, India; INSERM; CNRS; Universite Pierre et Marie Curie; Universite Paris Descartes, France; Cooperation INSERM [ICMR-AO 2009/2010]	Indian Institute of Science, Departments of Biotechnology and Science and Technology, Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; Universite Paris Descartes, France; Cooperation INSERM	This work was supported in part by Indian Institute of Science, Departments of Biotechnology and Science and Technology, Council for Scientific and Industrial Research, India (to K. N. B.), INSERM, CNRS, and Universite Pierre et Marie Curie and Universite Paris Descartes, France (to S. V. K. and J. B.), and Cooperation INSERM-ICMR-AO 2009/2010 (to K. N. B. and J. B.).	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Anis MM, 2008, INFECT IMMUN, V76, P671, DOI 10.1128/IAI.01079-07; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Baliko Z, 1998, FEMS IMMUNOL MED MIC, V22, P199, DOI 10.1016/S0928-8244(98)00089-3; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Bayry J, 2008, P NATL ACAD SCI USA, V105, P10221, DOI 10.1073/pnas.0803453105; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P3093, DOI 10.1128/IAI.61.7.3093-3097.1993; Boisleve F, 2005, TOXICOLOGY, V206, P233, DOI 10.1016/j.tox.2004.08.015; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Chaitra MG, 2008, MICROBES INFECT, V10, P858, DOI 10.1016/j.micinf.2008.04.017; Chaitra MG, 2008, J MED MICROBIOL, V57, P1079, DOI 10.1099/jmm.0.47565-0; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Chandra BR, 2004, PROTEIN ENG DES SEL, V17, P175, DOI 10.1093/protein/gzh024; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coventry BJ, 2002, BRIT J CANCER, V86, P546, DOI 10.1038/sj.bjc.6600132; Daly LM, 2005, VACCINE, V23, P963, DOI 10.1016/j.vaccine.2004.03.072; Davies MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008084; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Feng CG, 1999, INFECT IMMUN, V67, P3242, DOI 10.1128/IAI.67.7.3242-3247.1999; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gordon SV, 2001, TUBERCULOSIS, V81, P157, DOI 10.1054/tube.2000.0269; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Liu LM, 1998, INT IMMUNOL, V10, P1017, DOI 10.1093/intimm/10.8.1017; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Means TK, 1999, J IMMUNOL, V163, P3920; Meyer F, 2003, J IMMUNOL, V171, P3913, DOI 10.4049/jimmunol.171.8.3913; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Brien R, 2000, J CLIN MICROBIOL, V38, P1723, DOI 10.1128/JCM.38.5.1723-1730.2000; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pathak SK, 2004, J BIOL CHEM, V279, P55127, DOI 10.1074/jbc.M409885200; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shelton H, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-24; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Sousa CRE, 2001, IMMUNITY, V14, P495; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Valentinis B, 2005, J BIOL CHEM, V280, P14264, DOI 10.1074/jbc.M410791200; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; *WHO, 2007, WHOHTMTB2007376 WHO; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	80	84	85	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36511	36522		10.1074/jbc.M110.158055	http://dx.doi.org/10.1074/jbc.M110.158055			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837474	hybrid, Green Published			2022-12-27	WOS:000284146100058
J	Ravenhill, L; Wagstaff, L; Edwards, DR; Ellis, V; Bass, R				Ravenhill, Lorna; Wagstaff, Laura; Edwards, Dylan R.; Ellis, Vincent; Bass, Rosemary			G-helix of Maspin Mediates Effects on Cell Migration and Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-6; MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSIVE MASPIN; BREAST-CANCER CELLS; PLASMINOGEN-ACTIVATOR; UROKINASE-TYPE; CRYSTAL-STRUCTURE; INHIBITION; SERPIN; PROSTATE	Maspin is a member of the serine protease inhibitor (serpin) superfamily that lacks protease inhibitory ability, although displaying tumor metastasis-suppressing activity resulting from its influence on cell migration, invasion, proliferation, apoptosis, and adhesion. The molecular mechanisms of these actions of maspin are as yet undefined. Here, we sought to identify critical functional motifs by the expression of maspin with point mutations at sites potentially involved in protein-protein interactions: the G alpha-helix (G-helix), an internal salt bridge or the P1 position of the reactive center loop. Our findings indicate that only mutations in the G-helix attenuated inhibition of cell migration by maspin and that this structural element is also involved in the effect of maspin on cell adhesion. The action of maspin on cell migration could be mimicked by a 15-mer G-helix peptide, indicating that the G-helix is both essential and sufficient for this effect. In addition, we provide evidence that the effects of the G-helix of maspin are dependent on beta 1 integrins. These data reveal that the major extracellular functions associated with the tumor suppressive action of maspin likely involve interactions in which the G-helix plays a key role.	[Ravenhill, Lorna; Wagstaff, Laura; Edwards, Dylan R.; Ellis, Vincent; Bass, Rosemary] Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Bass, R (corresponding author), Univ E Anglia, Sch Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England.	r.bass@uea.ac.uk	Ellis, Vincent/D-1860-2009; Bass, Rosemary A/A-5328-2009; Edwards, Dylan R/B-4734-2009	Ellis, Vincent/0000-0003-1956-073X; Bass, Rosemary A/0000-0003-4997-5207; Edwards, Dylan R/0000-0002-3292-2064	British Heart Foundation [FS/05/063]; Big C [07-27R]; BBSRC DTA; European Union [LSHC-CT-2003-503297]; Suzie Wright Fund	British Heart Foundation(British Heart Foundation); Big C; BBSRC DTA(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Suzie Wright Fund	This work was supported by grants from the British Heart Foundation Intermediate Research Fellowship FS/05/063 (to R. B.), the Big C Appeal Project Grant 07-27R (to L. W.), a BBSRC DTA studentship (to L. R.), European Union Framework Programme 6 Cancerdegradome Project LSHC-CT-2003-503297, and the Suzie Wright Fund.	Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Al-Ayyoubi M, 2007, J BIOL CHEM, V282, P19502, DOI 10.1074/jbc.M702445200; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, J BIOL CHEM, V284, P27712, DOI 10.1074/jbc.M109.038919; Biliran H, 2001, CANCER RES, V61, P8676; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; D'Andrea LD, 2006, CHEM BIOL DRUG DES, V67, P115, DOI 10.1111/j.1747-0285.2006.00356.x; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Khalkhali-Ellis Z, 2007, CANCER RES, V67, P3535, DOI 10.1158/0008-5472.CAN-06-4767; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Li ZG, 2005, ONCOGENE, V24, P2008, DOI 10.1038/sj.onc.1208449; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; McGowen R, 2000, CANCER RES, V60, P4771; Messent AJ, 1998, J CELL SCI, V111, P1127; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630; Shao L, 2008, CANCER RES, V68, P5143, DOI 10.1158/0008-5472.CAN-08-0163; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shi HY, 2001, CANCER RES, V61, P6945; Tan M, 1999, CANCER RES, V59, P1620; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	33	31	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36285	36292		10.1074/jbc.M110.177253	http://dx.doi.org/10.1074/jbc.M110.177253			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837467	Green Published, hybrid			2022-12-27	WOS:000284146100006
J	Sadykov, MR; Zhang, B; Halouska, S; Nelson, JL; Kreimer, LW; Zhu, YF; Powers, R; Somerville, GA				Sadykov, Marat R.; Zhang, Bo; Halouska, Steven; Nelson, Jennifer L.; Kreimer, Lauren W.; Zhu, Yefei; Powers, Robert; Somerville, Greg A.			Using NMR Metabolomics to Investigate Tricarboxylic Acid Cycle-dependent Signal Transduction in Staphylococcus epidermidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR ADHESIN PRODUCTION; CARBON CATABOLITE REPRESSION; VIRULENCE GENE-EXPRESSION; BIOFILM FORMATION; BACILLUS-SUBTILIS; SIGMA(B) REGULON; IRON LIMITATION; SIGB OPERON; AUREUS; GROWTH	Staphylococcus epidermidis is a skin-resident bacterium and a major cause of biomaterial-associated infections. The transition from residing on the skin to residing on an implanted biomaterial is accompanied by regulatory changes that facilitate bacterial survival in the new environment. These regulatory changes are dependent upon the ability of bacteria to "sense" environmental changes. In S. epidermidis, disparate environmental signals can affect synthesis of the biofilm matrix polysaccharide intercellular adhesin (PIA). Previously, we demonstrated that PIA biosynthesis is regulated by tricarboxylic acid (TCA) cycle activity. The observations that very different environmental signals result in a common phenotype (i.e. increased PIA synthesis) and that TCA cycle activity regulates PIA biosynthesis led us to hypothesize that S. epidermidis is "sensing" disparate environmental signals through the modulation of TCA cycle activity. In this study, we used NMR metabolomics to demonstrate that divergent environmental signals are transduced into common metabolomic changes that are "sensed" by metabolite-responsive regulators, such as CcpA, to affect PIA biosynthesis. These data clarify one mechanism by which very different environmental signals cause common phenotypic changes. In addition, due to the frequency of the TCA cycle in diverse genera of bacteria and the intrinsic properties of TCA cycle enzymes, it is likely the TCA cycle acts as a signal transduction pathway in many bacteria.	[Sadykov, Marat R.; Nelson, Jennifer L.; Zhu, Yefei; Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Zhang, Bo; Halouska, Steven; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Kreimer, Lauren W.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Powers, R (corresponding author), 722 Hamilton Hall, Lincoln, NE 68588 USA.	rpowers3@unl.edu; gsomerville3@unl.edu	Zhu, Yefei/F-8940-2013; Sadykov, Marat/H-3147-2011; Somerville, Greg A/B-1326-2013; Powers, Robert/AAK-3431-2020	Sadykov, Marat/0000-0001-7090-1929; Somerville, Greg A/0000-0002-0991-8737; Powers, Robert/0000-0001-9948-6837; Zhang, Bo/0000-0001-8858-1425	Hatch Act; National Institutes of Health [AI087668]; American Heart Association [0860033Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087668] Funding Source: NIH RePORTER	Hatch Act(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This manuscript is a contribution of the University of Nebraska Agricultural Research Division, supported in part by funds provided through the Hatch Act and from National Institutes of Health Grant AI087668 (to G. A. S.) and the American Heart Association Grant 0860033Z (to R. P.).	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1; COLLINS FM, 1962, J GEN MICROBIOL, V29, P531, DOI 10.1099/00221287-29-3-531; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; DEIGHTON M, 1993, INFECT IMMUN, V61, P4473, DOI 10.1128/IAI.61.10.4473-4479.1993; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forgue P, 2006, J PROTEOME RES, V5, P1916, DOI 10.1021/pr060114v; Goddard T. D., SPARKY 3; Halouska S, 2006, J MAGN RESON, V178, P88, DOI 10.1016/j.jmr.2005.08.016; Halouska S, 2007, J PROTEOME RES, V6, P4608, DOI 10.1021/pr0704332; Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001; Korem M, 2007, FEMS MICROBIOL LETT, V269, P153, DOI 10.1111/j.1574-6968.2006.00625.x; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Matinaho S, 2001, FEMS MICROBIOL LETT, V196, P177, DOI 10.1016/S0378-1097(01)00065-9; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x; Nguyen BD, 2007, J MAGN RESON, V184, P263, DOI 10.1016/j.jmr.2006.10.014; Otzen DE, 2007, BIOCHEMISTRY-US, V46, P4348, DOI 10.1021/bi700091r; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Presterl E, 2007, J ANTIMICROB CHEMOTH, V60, P417, DOI 10.1093/jac/dkm221; Retief J D, 2000, Methods Mol Biol, V132, P243; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; RUPP ME, 1997, STAPHYLOCOCCI HUMAN, P379; Sadykov MR, 2008, J BACTERIOL, V190, P7621, DOI 10.1128/JB.00806-08; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Somerville G, 1999, J BACTERIOL, V181, P1072, DOI 10.1128/JB.181.4.1072-1078.1999; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; Werth MT, 2010, ANAL BIOCHEM, V399, P58, DOI 10.1016/j.ab.2009.12.022; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	71	38	38	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36616	36624		10.1074/jbc.M110.152843	http://dx.doi.org/10.1074/jbc.M110.152843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861019	Green Published, hybrid			2022-12-27	WOS:000284146100050
J	Falkowski, MA; Thomas, DDH; Groblewski, GE				Falkowski, Michelle A.; Thomas, Diana D. H.; Groblewski, Guy E.			Complexin 2 Modulates Vesicle-associated Membrane Protein (VAMP) 2-regulated Zymogen Granule Exocytosis in Pancreatic Acini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX; REGULATED EXOCYTOSIS; EXOCRINE PANCREAS; CELLS; FUSION; IDENTIFICATION; DISTINCT; SECRETION; RELEASE; CRHSP-28	Complexins are soluble proteins that regulate the activity of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes necessary for vesicle fusion. Neuronal specific complexin 1 has inhibitory and stimulatory effects on exocytosis by clamping trans-SNARE complexes in a prefusion state and promoting conformational changes to facilitate membrane fusion following cell stimulation. Complexins are unable to bind to monomeric SNARE proteins but bind with high affinity to ternary SNARE complexes and with lower affinity to target SNARE complexes. Far less is understood about complexin function outside the nervous system. Pancreatic acini express the complexin 2 isoform by RT-PCR and immunoblotting. Immunofluorescence microscopy revealed complexin 2 localized along the apical plasma membrane consistent with a role in secretion. Accordingly, complexin 2 was found to interact with vesicle-associated membrane protein (VAMP) 2, syntaxins 3 and 4, but not with VAMP 8 or syntaxin 2. Introduction of recombinant complexin 2 into permeabilized acini inhibited Ca2+-stimulated secretion in a concentration-dependent manner with a maximal inhibition of nearly 50%. Mutations of the central alpha-helical domain reduced complexin 2 SNARE binding and concurrently abolished its inhibitory activity. Surprisingly, mutation of arginine 59 to histidine within the central alpha-helical domain did not alter SNARE binding and moreover, augmented Ca2+-stimulated secretion by 130% of control. Consistent with biochemical studies, complexin 2 colocalized with VAMP 2 along the apical plasma membrane following cholecystokinin-8 stimulation. These data demonstrate a functional role for complexin 2 outside the nervous system and indicate that it participates in the Ca2+-sensitive regulatory pathway for zymogen granule exocytosis.	[Falkowski, Michelle A.; Thomas, Diana D. H.; Groblewski, Guy E.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Groblewski, GE (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	groby@nutrisci.wisc.edu			National Institutes of Health [DK07088]; United States Department of Agriculture [WISO4958]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by National Institutes of Health Grant DK07088. This work was also supported by United States Department of Agriculture HATCH Grant WISO4958 (to G. E. G.).	BRAUN JEA, 1994, J BIOL CHEM, V269, P5328; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Cai HJ, 2008, P NATL ACAD SCI USA, V105, P19538, DOI 10.1073/pnas.0810232105; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chen Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1209, DOI 10.1152/ajpcell.00159.2005; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Fujita-Yoshigaki J, 2000, J THEOR BIOL, V204, P165, DOI 10.1006/jtbi.2000.2009; Gaisano HY, 1996, GASTROENTEROLOGY, V111, P1661, DOI 10.1016/S0016-5085(96)70030-6; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Groblewski GE, 1996, J BIOL CHEM, V271, P31502, DOI 10.1074/jbc.271.49.31502; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; Liu JG, 2006, BIOCHEM BIOPH RES CO, V347, P413, DOI 10.1016/j.bbrc.2006.06.085; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SINGH P, 1988, AM J PHYSIOL, V254, pG217, DOI 10.1152/ajpgi.1988.254.2.G217; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sutton R, 2003, PANCREATOLOGY, V3, P497, DOI 10.1159/000075581; Tadokoro S, 2005, J CELL SCI, V118, P2239, DOI 10.1242/jcs.02338; Tadokoro S, 2010, CELL IMMUNOL, V261, P51, DOI 10.1016/j.cellimm.2009.10.011; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Thomas DDH, 2004, AM J PHYSIOL-GASTR L, V287, pG253, DOI 10.1152/ajpgi.00033.2004; Thomas DDH, 2002, J BIOL CHEM, V277, P35496, DOI 10.1074/jbc.M110917200; Thomas DDH, 2001, J BIOL CHEM, V276, P28866, DOI 10.1074/jbc.M102214200; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Weng N, 2009, AM J PHYSIOL-GASTR L, V296, pG1030, DOI 10.1152/ajpgi.90592.2008; WILLIAMS JA, 1984, ANNU REV PHYSIOL, V46, P361; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446	44	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35558	35566		10.1074/jbc.M110.146597	http://dx.doi.org/10.1074/jbc.M110.146597			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829354	Green Published, hybrid			2022-12-27	WOS:000283845300034
J	Gajda, A; Towpik, J; Steuerwald, U; Muller, CW; Lefebvre, O; Boguta, M				Gajda, Anna; Towpik, Joanna; Steuerwald, Ulrich; Mueller, Christoph W.; Lefebvre, Olivier; Boguta, Magdalena			Full Repression of RNA Polymerase III Transcription Requires Interaction between Two Domains of Its Negative Regulator Maf1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ONCOGENIC TRANSFORMATION; RIBOSOME BIOSYNTHESIS; NUCLEAR-LOCALIZATION; YEAST; PREDICTION; DEPHOSPHORYLATION; PHOSPHORYLATION; PROLIFERATION; MACHINERY	Maf1, first identified in yeast Saccharomyces cerevisiae, is a general negative regulator of RNA polymerase III (Pol III). Transcription regulation by Maf1 is important under stress conditions and during the switch between fermentation and respiration. Maf1 is composed of two domains conserved during evolution. We report here that these two domains of human Maf1 are resistant to mild proteolysis and interact together as shown by pull-down and size-exclusion chromatography and that the comparable domains of yeast Maf1 interact in a two-hybrid assay. Additionally, in yeast, a mutation in the N-terminal domain is compensated by mutations in the C-terminal domain. Integrity of both domains and their direct interaction are necessary for Maf1 dephosphorylation and subsequent inhibition of Pol III transcription on a nonfermentable carbon source. These data relate Pol III transcription inhibition to Maf1 structural changes.	[Gajda, Anna; Lefebvre, Olivier] CEA, iBiTecS, F-91191 Gif Sur Yvette, France; [Gajda, Anna; Towpik, Joanna; Boguta, Magdalena] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Steuerwald, Ulrich; Mueller, Christoph W.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Boguta, Magdalena] Warsaw Univ Technol, Fac Chem, PL-00664 Warsaw, Poland	CEA; UDICE-French Research Universities; Universite Paris Saclay; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; European Molecular Biology Laboratory (EMBL); Warsaw University of Technology	Lefebvre, O (corresponding author), CEA, iBiTecS, F-91191 Gif Sur Yvette, France.	Olivier.Lefebvre@Cea.Fr; magda@ibb.waw.pl	Müller, Christoph W/I-7420-2012; LEFEBVRE, Olivier/C-3847-2014	Müller, Christoph W/0000-0003-2176-8337; LEFEBVRE, Olivier/0000-0002-3903-9450; Boguta, Magdalena/0000-0002-1545-0691	Ministry of Science and Higher Education, Poland [N301 023 32/1117, N301 243236]; French National Research Agency [ANR-07-BLAN-0039-01]; Association pour la Recherche contre le Cancer [1078]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); French National Research Agency(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Ministry of Science and Higher Education, Poland, Grants N301 023 32/1117 and N301 243236, French National Research Agency Grant ANR-07-BLAN-0039-01, and Association pour la Recherche contre le Cancer Grant 1078.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; HARPER JW, 1993, CELL, V75, P805; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Manaud N, 1998, MOL CELL BIOL, V18, P3191, DOI 10.1128/MCB.18.6.3191; Marshall L, 2008, CELL CYCLE, V7, P3327, DOI 10.4161/cc.7.21.6970; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Rollins J, 2007, INT J BIOL SCI, V3, P292; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; WERNER M, 1993, J BIOL CHEM, V268, P20721; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9	40	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35719	35727		10.1074/jbc.M110.125286	http://dx.doi.org/10.1074/jbc.M110.125286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817737	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000283845300050
J	Iwabu, Y; Kinomoto, M; Tatsumi, M; Fujita, H; Shimura, M; Tanaka, Y; Ishizaka, Y; Nolan, D; Mallal, S; Sata, T; Tokunaga, K				Iwabu, Yukie; Kinomoto, Masanobu; Tatsumi, Masashi; Fujita, Hideaki; Shimura, Mari; Tanaka, Yoshitaka; Ishizaka, Yukihito; Nolan, David; Mallal, Simon; Sata, Tetsutaro; Tokunaga, Kenzo			Differential Anti-APOBEC3G Activity of HIV-1 Vif Proteins Derived from Different Subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; HUMAN APOBEC3G; TYPE-1 VIF; ANTIVIRAL ACTIVITY; LINE-1 RETROTRANSPOSITION; MONONUCLEAR PHAGOCYTES; ANTIRETROVIRAL FACTOR; RETROVIRAL INFECTION; CYTIDINE DEAMINASES	Antiretroviral cytidine deaminase APOBEC3G, which is abundantly expressed in peripheral blood lymphocytes and macrophages, strongly protects these cells against HIV-1 infection. The HIV-1 Vif protein overcomes this antiviral effect by enhancing proteasome-mediated APOBEC3G degradation and is key for maintaining viral infectivity. The 579-bp-long vif gene displays high genetic diversity among HIV-1 subtypes. Therefore, it is intriguing to address whether Vif proteins derived from different subtypes differ in their viral defense activity against APOBEC3G. Expression plasmids encoding Vif proteins derived from subtypes A, B, C, CRF01_AE, and CRF02_AG isolates were created, and their anti-APOBEC3G activities were compared. Viruses produced from cells expressing APOBEC3G and Vif proteins from different subtypes showed relatively different viral infectivities. Notably, subtype C-derived Vif proteins tested had the highest activity against APOBEC3G that was ascribed to its increased binding activity, for which the N-terminal domain of the Vif protein sequences was responsible. These results suggest that the biological differences of Vif proteins belonging to different subtypes might affect viral fitness and quasispecies in vivo.	[Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Tatsumi, Masashi] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo 1628640, Japan; [Fujita, Hideaki; Tanaka, Yoshitaka] Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Fukuoka 8128582, Japan; [Shimura, Mari; Ishizaka, Yukihito] Int Med Ctr Japan, Dept Intractable Dis, Tokyo 1628655, Japan; [Nolan, David; Mallal, Simon] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; [Nolan, David; Mallal, Simon] Murdoch Univ, Perth, WA 6000, Australia	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kyushu University; National Center for Global Health & Medicine - Japan; Royal Perth Hospital; University of Western Australia; Murdoch University	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan.	tokunaga@nih.go.jp	Tokunaga, Kenzo/Q-9914-2018; Mallal, Simon Alexander/HDM-9561-2022	Tokunaga, Kenzo/0000-0002-2625-5322; Mallal, Simon Alexander/0000-0002-7036-1309; Fujita, Hideaki/0000-0002-4105-4430	Ministry of Health, Labor, and Welfare of Japan (Research on HIV/AIDS) [H21-009]; Ministry of Education, Science, Technology, Sports and Culture of Japan	Ministry of Health, Labor, and Welfare of Japan (Research on HIV/AIDS)(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (Research on HIV/AIDS; H21-009) and from the Ministry of Education, Science, Technology, Sports and Culture of Japan.	Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; BORMAN AM, 1995, VIROLOGY, V208, P601, DOI 10.1006/viro.1995.1191; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dang Y, 2010, J VIROL, V84, P8561, DOI 10.1128/JVI.00960-10; Dang Y, 2010, J VIROL, V84, P5741, DOI 10.1128/JVI.00079-10; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Donahue JP, 2008, VIROLOGY, V377, P49, DOI 10.1016/j.virol.2008.04.017; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; FITZGIBBON JE, 1993, AIDS RES HUM RETROV, V9, P833, DOI 10.1089/aid.1993.9.833; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P991, DOI 10.1089/aid.2008.0077; Janini M, 2001, J VIROL, V75, P7973, DOI 10.1128/JVI.75.17.7973-7986.2001; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Koulinska IN, 2003, AIDS RES HUM RETROV, V19, P1115, DOI 10.1089/088922203771881211; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Langlois MA, 2008, J VIROL, V82, P4660, DOI 10.1128/JVI.02469-07; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; MIYAGI E, 2010, J VIROL IN PRESS; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Mulder LCF, 2010, J VIROL, V84, P9613, DOI 10.1128/JVI.02630-09; Ndung'u T, 2006, VIROLOGY, V347, P247, DOI 10.1016/j.virol.2005.11.047; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Pollakis G, 2004, J VIROL, V78, P2841, DOI 10.1128/JVI.78.6.2841-2852.2004; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Salminen MO, 1996, AIDS RES HUM RETROV, V12, P1329, DOI 10.1089/aid.1996.12.1329; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stephens EB, 2001, AIDS RES HUM RETROV, V17, P169, DOI 10.1089/08892220150217256; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wieland U, 1997, J GEN VIROL, V78, P393, DOI 10.1099/0022-1317-78-2-393; WIELAND U, 1994, VIROLOGY, V203, P43, DOI 10.1006/viro.1994.1453; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	82	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35350	35358		10.1074/jbc.M110.173286	http://dx.doi.org/10.1074/jbc.M110.173286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833716	Green Published, hybrid			2022-12-27	WOS:000283845300013
J	Quintero, OA; Moore, JE; Unrath, WC; Manor, U; Salles, FT; Grati, M; Kachar, B; Yengo, CM				Quintero, Omar A.; Moore, Judy E.; Unrath, William C.; Manor, Uri; Salles, Felipe T.; Grati, M'hamed; Kachar, Bechara; Yengo, Christopher M.			Intermolecular Autophosphorylation Regulates Myosin IIIa Activity and Localization in Parallel Actin Bundles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; UNCONVENTIONAL MYOSIN; STRUCTURAL BASIS; ATPASE ACTIVITY; TAIL DOMAIN; CELL-CYCLE; MOTOR; STEREOCILIA; FILOPODIA; MUSCLE	Myosin IIIa (Myo3A) transports cargo to the distal end of actin protrusions and contains a kinase domain that is thought to autoregulate its activity. Because Myo3A tends to cluster at the tips of actin protrusions, we investigated whether intermolecular phosphorylation could regulate Myo3A biochemical activity, cellular localization, and cellular function. Inactivation of Myo3A 2IQ kinase domain with the point mutation K50R did not alter maximal ATPase activity, whereas phosphorylation of Myo3A 2IQ resulted in reduced maximal ATPase activity and actin affinity. The rate and degree of Myo3A 2IQ autophosphorylation was unchanged by the presence of actin but was found to be dependent upon Myo3A 2IQ concentration within the range of 0.1 to 1.2 mu M, indicating intermolecular autophosphorylation. In cultured cells, we observed that the filopodial tip localization of Myo3A lacking the kinase domain decreased when co-expressed with kinase-active, full-length Myo3A. The cellular consequence of reduced Myo3A tip localization was decreased filopodial density along the cell periphery, identifying a novel cellular function for Myo3A in mediating the formation and stability of actin-based protrusions. Our results suggest that Myo3A motor activity is regulated through a mechanism involving concentration-dependent autophosphorylation. We suggest that this regulatory mechanism plays an essential role in mediating the transport and actin bundle formation/stability functions of Myo3A.	[Yengo, Christopher M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Manor, Uri; Salles, Felipe T.; Grati, M'hamed; Kachar, Bechara] NIDCD, Lab Cell Struct & Dynam, NIH, Bethesda, MD 20894 USA; [Moore, Judy E.; Yengo, Christopher M.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of North Carolina; University of North Carolina Charlotte	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	cmy11@psu.edu	Salles, Felipe/H-7544-2013; Grati, M'hamed/C-9563-2011	Manor, Uri/0000-0002-9802-1955; Grati, M'hamed/0000-0002-4490-1682; Quintero-Carmona, Omar/0000-0002-9314-1704; Grati, Mhamed/0000-0001-5149-3245	National Institutes of Health [EY018141, HL093531]; NIH DIR [DC000002-22]; NATIONAL EYE INSTITUTE [R01EY018141] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018141 and HL093531 (to C.M.Y.) and NIH DIR Grant DC000002-22 (to B.K.).	Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Boger ET, 2008, MYOSINS SUPERFAMILY, P441; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cronin MA, 2004, J CELL SCI, V117, P4797, DOI 10.1242/jcs.01371; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Erickson FL, 2003, MOL BIOL CELL, V14, P4173, DOI 10.1091/mbc.e02-10-0656; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kambara T, 2006, J BIOL CHEM, V281, P37291, DOI 10.1074/jbc.M603823200; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Komaba S, 2003, J BIOL CHEM, V278, P21352, DOI 10.1074/jbc.M300757200; Komaba S, 2010, BIOCHEMISTRY-US, V49, P3695, DOI 10.1021/bi902211w; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Lu HL, 2006, J BIOL CHEM, V281, P31987, DOI 10.1074/jbc.M605181200; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; Naoz M, 2008, BIOPHYS J, V95, P5706, DOI 10.1529/biophysj.108.143453; Ng KP, 1996, BIOCHEMISTRY-US, V35, P9392, DOI 10.1021/bi960181a; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; Quintero OA, 2003, MOL BIOL CELL S, V14s, P1010; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; SELLERS JR, 1999, MYOSINS, P75; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699	46	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35770	35782		10.1074/jbc.M110.144360	http://dx.doi.org/10.1074/jbc.M110.144360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826793	Green Published, hybrid			2022-12-27	WOS:000283845300055
J	Yamaji, T; Nishikawa, K; Hanada, K				Yamaji, Toshiyuki; Nishikawa, Kiyotaka; Hanada, Kentaro			Transmembrane BAX Inhibitor Motif Containing (TMBIM) Family Proteins Perturbs a trans-Golgi Network Enzyme, Gb3 Synthase, and Reduces Gb3 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBO-SERIES GLYCOSPHINGOLIPIDS; HUMAN ENDOTHELIAL-CELLS; BREAST-CANCER CELLS; ENDOPLASMIC-RETICULUM; CERAMIDE GALACTOSYLTRANSFERASE; GENE-EXPRESSION; IN-VITRO; CLONING; BINDING; GLOBOTRIAOSYLCERAMIDE	Globotriaosylceramide (Gb3) is a well known receptor for Shiga toxin (Stx), produced by enterohemorrhagic Escherichia coli and Shigella dysenteriae. The expression of Gb3 also affects several diseases, including cancer metastasis and Fabry disease, which prompted us to look for factors involved in its metabolism. In the present study, we isolated two cDNAs that conferred resistance to Stx-induced cell death in HeLa cells by expression cloning: ganglioside GM3 synthase and the COOH terminus region of glutamate receptor, ionotropic, N-methyl-D-asparate-associated protein 1 (GRINA), a member of the transmembrane BAX inhibitor motif containing (TMBIM) family. Overexpression of the truncated form, named GRINA-C, and some members of the full-length TMBIM family, including FAS inhibitory molecule 2 (FAIM2), reduced Gb3, and lactosylceramide was accumulated instead. The change of glycolipid composition was restored by overexpression of Gb3 synthase, suggesting that the synthase is affected by GRINA-C and FAIM2. Interestingly, the mRNA level of Gb3 synthase was unchanged. Rather, localization of the synthase as well as TGN46, a trans-Golgi network marker, was perturbed to form punctate structures, and degradation of the synthase in lysosomes was enhanced. Furthermore, GRINA-C was associated with Gb3 synthase. These observations may demonstrate a new type of posttranscriptional regulation of glycosyltransferases.	[Yamaji, Toshiyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Nishikawa, Kiyotaka] Doshisha Univ, Dept Mol Life Sci, Kyoto 6100321, Japan	National Institute of Infectious Diseases (NIID); Doshisha University	Yamaji, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tyamaji@nih.go.jp		Hanada, Kentaro/0000-0003-1383-2781	Ministry of Education, Culture, Sports, Science and Technology of Japan [20770114]; Japan Society for the Promotion of Science [22370054]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-aid for Young Scientists (B) No. 20770114 (to T. Y.) and Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (B) No. 22370054 (to K. H.).	Aikawa H, 2003, TOHOKU J EXP MED, V199, P25, DOI 10.1620/tjem.199.25; Bao XD, 2001, NEUROSCI LETT, V315, P5, DOI 10.1016/S0304-3940(01)02317-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bucan V, 2010, CELL MOL BIOL LETT, V15, P296, DOI 10.2478/s11658-010-0009-1; CICCARELLI E, 1993, EUR J BIOCHEM, V213, P271, DOI 10.1111/j.1432-1033.1993.tb17759.x; Clarke JTR, 2007, ANN INTERN MED, V146, P425, DOI 10.7326/0003-4819-146-6-200703200-00007; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Di Sano F, 2007, J NEUROCHEM, V102, P345, DOI 10.1111/j.1471-4159.2007.04479.x; FARKASHIMSLEY H, 1995, P NATL ACAD SCI USA, V92, P6996, DOI 10.1073/pnas.92.15.6996; Fujimoto H, 2000, J BIOL CHEM, V275, P22623, DOI 10.1074/jbc.C000200200; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Harima Y, 2004, INT J RADIAT ONCOL, V60, P237, DOI 10.1016/j.ijrobp.2004.02.047; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; Lee I, 2004, J BIOL CHEM, V279, P53007, DOI 10.1074/jbc.M405717200; Lesniewski M, 2006, VIROLOGY, V354, P286, DOI 10.1016/j.virol.2006.06.035; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; NUDELMAN E, 1983, SCIENCE, V220, P509, DOI 10.1126/science.6836295; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Okemoto-Nakamura Y, 2008, MICROBIOL IMMUNOL, V52, P357, DOI 10.1111/j.1348-0421.2008.00046.x; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; Puri A, 1998, P NATL ACAD SCI USA, V95, P14435, DOI 10.1073/pnas.95.24.14435; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Uemura S, 2009, MOL BIOL CELL, V20, P3088, DOI 10.1091/mbc.E08-12-1219; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van der Bijl P, 1996, BIOCHEM J, V317, P589, DOI 10.1042/bj3170589; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yoshisue H, 2002, ATHEROSCLEROSIS, V162, P323, DOI 10.1016/S0021-9150(01)00735-3; Yoshizaki F, 2008, BBA-GEN SUBJECTS, V1780, P383, DOI 10.1016/j.bbagen.2007.11.004; Zheng Y, 2005, J MICROBIOL, V43, P529	56	46	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35505	35518		10.1074/jbc.M110.154229	http://dx.doi.org/10.1074/jbc.M110.154229			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837469	Green Published, hybrid			2022-12-27	WOS:000283845300029
J	Astuti, P; Boutros, R; Ducommun, B; Gabrielli, B				Astuti, Puji; Boutros, Rose; Ducommun, Bernard; Gabrielli, Brian			Mitotic Phosphorylation of Cdc25B Ser(321) Disrupts 14-3-3 Binding to the High Affinity Ser(323) Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SUBCELLULAR-LOCALIZATION; DEPENDENT DEGRADATION; DNA-DAMAGE; PHOSPHATASE; MITOSIS; A/CDK2; CHK1; ACTIVATION; TRIGGERS	Cdc25B is a key regulator of entry into mitosis, and its activity and localization are regulated by binding of the 14-3-3 dimer. There are three 14-3-3 binding sites on Cdc25B, with Ser(323) being the highest affinity binding and is highly homologous to the Ser(216) 14-3-3 binding site on Cdc25C. Loss of 14-3-3 binding to Ser(323) increases cyclin/Cdk substrate access to the catalytic site, thereby increasing its activity. It also affects the localization of Cdc25B. Thus, phosphorylation and 14-3-3 binding to this site is essential for down-regulating Cdc25B activity, blocking its mitosis promoting function. The question of how this inhibitory signal is relieved to allow Cdc25B activation and entry into mitosis is yet to be resolved. Here, we show that Ser(323) phosphorylation is maintained into mitosis, but phosphorylation of Ser(321) disrupts 14-3-3 binding to Ser(323), mimicking the effect of inhibiting Ser(323) phosphorylation on both Cdc25B activity and localization. The unphosphorylated Ser(321) appears to have a role in stabilizing 14-3-3 binding to Ser(323), and loss of the Ser hydroxyl group appears to be sufficient to significantly reduce 14-3-3 binding. A consequence of loss of 14-3-3 binding is dephosphorylation of Ser(323). Ser(321) is phosphorylated in mitosis by Cdk1. The mitotic phosphorylation of Ser(321) acts to maintain full activation of Cdc25B by disrupting 14-3-3 binding to Ser(323) and enhancing the dephosphorylation of Ser(323) to block 14-3-3 binding to this site.	Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Ducommun, Bernard] Univ Toulouse, LBCMCP, F-31062 Toulouse, France; [Ducommun, Bernard] CNRS, LBCMCP UMR5088, F-31062 Toulouse, France; [Ducommun, Bernard] CHU Purpan, F-31059 Toulouse, France; [Boutros, Rose] Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Queensland; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU de Toulouse; Children's Medical Research Institute - Australia		brianG@uq.edu.au	Gabrielli, Brian G/B-3655-2011; Astuti, Puji/GLV-5075-2022; DUCOMMUN, Bernard/B-3208-2008	Gabrielli, Brian G/0000-0003-3933-1651; Astuti, Puji/0000-0003-3316-6149; DUCOMMUN, Bernard/0000-0002-7126-8368; Boutros, Rose/0000-0001-9025-2057	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council; AusAID	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); AusAID(Australian Aid (AusAID))	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council.; Supported by a scholarship from AusAID.	Astuti P, 2009, J BIOL CHEM, V284, P33781, DOI 10.1074/jbc.M109.027516; ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; Baldin V, 1997, ONCOGENE, V14, P2485, DOI 10.1038/sj.onc.1201063; Bouche JP, 2008, J PROTEOME RES, V7, P1264, DOI 10.1021/pr700623p; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Forrest ARR, 1999, BIOCHEM BIOPH RES CO, V260, P510, DOI 10.1006/bbrc.1999.0870; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Giles N, 2003, J BIOL CHEM, V278, P28580, DOI 10.1074/jbc.M304027200; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Lammer C, 1998, J CELL SCI, V111, P2445; Lindqvist A, 2004, J CELL SCI, V117, P4979, DOI 10.1242/jcs.01395; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Schmitt E, 2006, J CELL SCI, V119, P4269, DOI 10.1242/jcs.03200; Sohn J, 2004, P NATL ACAD SCI USA, V101, P16437, DOI 10.1073/pnas.0407663101; SOHN J, 2005, J BIOCH */* BIOCHEMI, V44, P16563; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; Theis-Febvre N, 2003, ONCOGENE, V22, P220, DOI 10.1038/sj.onc.1206107; Uchida S, 2004, J CELL SCI, V117, P3011, DOI 10.1242/jcs.01086; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Xu X, 1996, J BIOL CHEM, V271, P5118	33	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34364	34370		10.1074/jbc.M110.138412	http://dx.doi.org/10.1074/jbc.M110.138412			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801879	hybrid, Green Published			2022-12-27	WOS:000283659100010
J	Duggan, KC; Walters, MJ; Musee, J; Harp, JM; Kiefer, JR; Oates, JA; Marnett, LJ				Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Harp, Joel M.; Kiefer, James R.; Oates, John A.; Marnett, Lawrence J.			Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; PROSTAGLANDIN H-2 SYNTHASE; ACTIVE-SITE; SELECTIVE-INHIBITION; ARACHIDONIC-ACID; STRUCTURAL BASIS; ARGININE 120; BINDING; CYCLO-OXYGENASE-2; DETERMINANTS	Naproxen ((S)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid) is a powerful non-selective non-steroidal anti-inflammatory drug that is extensively used as a prescription and over-the-counter medication. Naproxen exhibits gastrointestinal toxicity, but its cardiovascular toxicity may be reduced compared with other drugs in its class. Despite the fact that naproxen has been marketed for many years, the molecular basis of its interaction with cyclooxygenase (COX) enzymes is unknown. We performed a detailed study of naproxen-COX-2 interactions using site-directed mutagenesis, structure-activity analysis, and x-ray crystallography. The results indicate that each of the pendant groups of the naphthyl scaffold are essential for COX inhibition, and only minimal substitutions are tolerated. Mutation of Trp-387 to Phe significantly reduced inhibition by naproxen, a result that appears unique to this inhibitor. Substitution of S or CH2 for the O atom of the p-methoxy group yielded analogs that were not affected by the W387F substitution and that exhibited increased COX-2 selectivity relative to naproxen. Crystallization and x-ray analysis yielded structures of COX-2 complexed to naproxen and its methylthio analog at 1.7 and 2.3 angstrom resolution, respectively. The combination of mutagenesis, structure analysis, and x-ray crystallography provided comprehensive information on the unique interactions responsible for naproxen binding to COX-2.	[Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Biochem,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Nashville, TN 37232 USA; [Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Chem,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Nashville, TN 37232 USA; [Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Pharmacol,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Nashville, TN 37232 USA; [Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Harp, Joel M.] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Struct Biol Ctr, Nashville, TN 37232 USA; [Oates, John A.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Kiefer, James R.] Pfizer Inc, St Louis, MO 63141 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pfizer	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, 23rd Ave S Pierce,850 RRB, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu		Kiefer, James/0000-0001-6317-0902	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health [CA89450, GM15431, T90 DA022873]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to Pfizer Inc. and Karen Seibert for the release of internal protocols and reagents for the COX-2 crystallography. Data were collected at the Southeastern Regional Collaborative Access Team beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Life Sciences Collaborative Access Team Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.; This work was supported, in whole or in part, by National Institutes of Health Research Grant CA89450 and Center Grant GM15431.; Supported by National Institutes of Health Training Grant T90 DA022873.	Arewang CJ, 2007, CARBOHYD RES, V342, P970, DOI 10.1016/j.carres.2007.01.014; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2007, J BIOL CHEM, V282, P16379, DOI 10.1074/jbc.M609883200; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; Capone ML, 2007, J PHARMACOL EXP THER, V322, P453, DOI 10.1124/jpet.107.122283; Colloc'h N, 2008, BIOPHYS J, V95, P2415, DOI 10.1529/biophysj.107.122184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GANT TG, 2007, Patent No. 2007140189; Gierse JK, 1996, J BIOL CHEM, V271, P15810, DOI 10.1074/jbc.271.26.15810; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Gupta K, 2006, ACTA CRYSTALLOGR D, V62, P151, DOI 10.1107/S0907444905036309; HARRISON IT, 1970, J MED CHEM, V13, P203, DOI 10.1021/jm00296a008; Kalgutkar AS, 1998, SCIENCE, V280, P1268, DOI 10.1126/science.280.5367.1268; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; KOVA C, 2003, INORG CHEM */* A INO, V42, P2988; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Loll PJ, 1996, BIOCHEMISTRY-US, V35, P7330, DOI 10.1021/bi952776w; Lubet RA, 2010, J UROLOGY, V183, P1598, DOI 10.1016/j.juro.2009.12.001; MCGETTIGAN P, 2006, D JAMA, V296, P1633; Miners JO, 1996, BIOCHEM PHARMACOL, V51, P1003, DOI 10.1016/0006-2952(96)85085-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peretto I, 2005, J MED CHEM, V48, P5705, DOI 10.1021/jm0502541; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2004, BIOCHEMISTRY-US, V43, P15439, DOI 10.1021/bi048534q; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; ROME LH, 1975, W E P Natl Acad Sci, V72, P4863; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Steiner RA, 2010, P NATL ACAD SCI USA, V107, P657, DOI 10.1073/pnas.0909033107; Stevens AM, 1999, J CRYST GROWTH, V196, P350, DOI 10.1016/S0022-0248(98)00847-1; Stock N, 2006, BIOORG MED CHEM LETT, V16, P2219, DOI 10.1016/j.bmcl.2006.01.033; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022	38	154	161	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34950	34959		10.1074/jbc.M110.162982	http://dx.doi.org/10.1074/jbc.M110.162982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810665	Green Published, hybrid			2022-12-27	WOS:000283659100069
J	Goshima, T; Kume, K; Koyano, T; Ohya, Y; Toda, T; Hirata, D				Goshima, Tetsuya; Kume, Kazunori; Koyano, Takayuki; Ohya, Yoshikazu; Toda, Takashi; Hirata, Dai			Fission Yeast Germinal Center (GC) Kinase Ppk11 Interacts with Pmo25 and Plays an Auxiliary Role in Concert with the Morphogenesis Orb6 Network (MOR) in Cell Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; SCHIZOSACCHAROMYCES-POMBE; GROWTH POLARITY; PROTEIN-KINASE; MO25 PROTEIN; DROSOPHILA; COMPLEX; MOUSE; NAK1; GENE	How cell morphology and the cell cycle are coordinately regulated is a fundamental subject in cell biology. In fission yeast, 2 germinal center kinases (GCKs), Sid1 and Nak1, play an essential role in septation/cytokinesis and cell separation/cell polarity control, respectively, as components of the septation initiation network (SIN) and the morphogenesis Orb6 network (MOR). Here we show that a third GCK, Ppk11, is also required for efficient cell separation particularly, at a high temperature. Although Ppk11 is not essential for cell division, this kinase plays an auxiliary role in concert with MOR in cell morphogenesis. Ppk11 physically interacts with the MOR component Pmo25 and is localized to the septum, by which Ppk11 is crucial for Pmo25 targeting/accumulation to the septum. The conserved C-terminal WDF motif of Ppk11 is essential for both septum accumulation of Pmo25 and efficient cell separation. In contrast its kinase activity is required only for cell separation. Thus, both interaction of Ppk11 with Pmo25 and Ppk11 kinase activity are critical for efficient cell separation.	[Goshima, Tetsuya; Kume, Kazunori; Koyano, Takayuki; Hirata, Dai] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan; [Ohya, Yoshikazu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Toda, Takashi] Canc Res UK, London Res Inst, Lab Cell Regulat, London WC2A 3PX, England	Hiroshima University; University of Tokyo; Cancer Research UK	Hirata, D (corresponding author), 1-3-1 Kagamiyama, Higashihiroshima 7398530, Japan.	dhirata@hiroshima-u.ac.jp	Ohya, Yoshikazu/AAW-2200-2021; Kume, Kazunori/T-4061-2018	Ohya, Yoshikazu/0000-0003-0837-1239; Kume, Kazunori/0000-0002-0613-8081; Koyano, Takayuki/0000-0003-1675-2525	Ministry of Education, Science, and Culture of Japan; Cancer Research UK	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research UK(Cancer Research UK)	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (to K. K. and D. H.) and the Cancer Research UK (to T. T.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; BA H, 2001, EMBO J, V20, P1064; BA H, 1998, J R YEAST */* YEAST, V14, P943; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001347; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Huang TY, 2003, J BIOL CHEM, V278, P991, DOI 10.1074/jbc.M208993200; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Karos M, 1999, MOL GEN GENET, V260, P510, DOI 10.1007/s004380050924; Koyano T, 2010, BIOSCI BIOTECH BIOCH, V74, P1129, DOI 10.1271/bbb.100223; Kume K, 2007, BIOSCI BIOTECH BIOCH, V71, P615, DOI 10.1271/bbb.60574; MARKS J, 1986, J CELL SCI, P229; MATSUSAKA T, 1995, EMBO J, V14, P3325, DOI 10.1002/j.1460-2075.1995.tb07339.x; Mendoza M, 2005, EUR J CELL BIOL, V84, P915, DOI 10.1016/j.ejcb.2005.09.013; MITCHISON JM, 1985, J CELL SCI, V75, P357; Mitchison JM, 1970, METHOD CELL PHYSIOL, V4, P131; MIYAMOTO H, 1993, MOL REPROD DEV, V34, P1, DOI 10.1002/mrd.1080340102; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nozaki M, 1996, DNA CELL BIOL, V15, P505, DOI 10.1089/dna.1996.15.505; Simanis V, 2003, J CELL SCI, V116, P4263, DOI 10.1242/jcs.00807; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Yamamoto Y, 2008, BIOCHEM BIOPH RES CO, V366, P212, DOI 10.1016/j.bbrc.2007.11.128; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	30	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35196	35205		10.1074/jbc.M110.176867	http://dx.doi.org/10.1074/jbc.M110.176867			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826805	hybrid, Green Published			2022-12-27	WOS:000283659100093
J	Kale, AJ; McGlinchey, RP; Moore, BS				Kale, Andrew J.; McGlinchey, Ryan P.; Moore, Bradley S.			Characterization of 5-Chloro-5-Deoxy-D-Ribose 1-Dehydrogenase in Chloroethylmalonyl Coenzyme A Biosynthesis SUBSTRATE AND REACTION PROFILING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINOSE METABOLISM; ARCHAEON SULFOLOBUS-SOLFATARICUS; GLUCOSE-DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; ALTERNATIVE PATHWAY; STRUCTURAL BASIS; IDENTIFICATION; PROMISCUITY; LACTONASE; MECHANISM	SalM is a short-chain dehydrogenase/reductase enzyme from the marine actinomycete Salinispora tropica that is involved in the biosynthesis of chloroethylmalonyl-CoA, a novel halogenated polyketide synthase extender unit of the proteasome inhibitor salinosporamide A. SalM was heterologously overexpressed in Escherichia coli and characterized in vitro for its substrate specificity, kinetics, and reaction profile. A sensitive real-time C-13 NMR assay was developed to visualize the oxidation of 5-chloro-5-deoxy-D-ribose to 5-chloro-5-deoxy-D-ribono-gamma-lactone in an NAD(+)-dependent reaction, followed by spontaneous lactone hydrolysis to 5-chloro-5-deoxy-D-ribonate. Although short-chain dehydrogenase/reductase enzymes are widely regarded as metal-independent, a strong divalent metal cation dependence for Mg2+, Ca2+, or Mn2+ was observed with SalM. Oxidative activity was also measured with the alternative substrates D-erythrose and D-ribose, making SalM the first reported stereospecific non-phosphorylative ribose 1-dehydrogenase.	[Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Moore, BS (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu		Moore, Bradley/0000-0002-4652-1253	National Institutes of Health [CA127622]; NATIONAL CANCER INSTITUTE [R01CA127622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA127622 (to B. S. M.).	Angelov A, 2005, FEBS J, V272, P1054, DOI 10.1111/j.1742-4658.2004.04539.x; ANGYAL SJ, 1972, AUST J CHEM, V25, P1695, DOI 10.1071/CH9721695; Baker PJ, 2009, P NATL ACAD SCI USA, V106, P779, DOI 10.1073/pnas.0807529106; Blankenfeldt W, 2002, STRUCTURE, V10, P773, DOI 10.1016/S0969-2126(02)00770-0; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; Bouchez V, 1997, CARBOHYD RES, V300, P139, DOI 10.1016/S0008-6215(97)00044-X; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Eustaquio AS, 2008, ANGEW CHEM INT EDIT, V47, P3936, DOI 10.1002/anie.200800177; Eustaquio AS, 2008, NAT CHEM BIOL, V4, P69, DOI 10.1038/nchembio.2007.56; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; GULDER TA, 2010, ANGEW CHEM IN PRESS; HESTRIN S, 1949, J BIOL CHEM, V180, P249; Jacobsen NE, 2007, NMR SPECTROSCOPY EXPLAINED: SIMPLIFIED THEORY, APPLICATIONS AND EXAMPLES FOR ORGANIC CHEMISTRY AND STRUCTURAL BIOLOGY, P1, DOI 10.1002/9780470173350; JERMYN MA, 1960, BIOCHIM BIOPHYS ACTA, V37, P78, DOI 10.1016/0006-3002(60)90081-0; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; MATHIAS AL, 1989, J BACTERIOL, V171, P5206, DOI 10.1128/jb.171.9.5206-5209.1989; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Niefind K, 2003, J MOL BIOL, V327, P317, DOI 10.1016/S0022-2836(03)00081-0; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; SCHER BM, 1966, ARCH BIOCHEM BIOPHYS, V116, P117, DOI 10.1016/0003-9861(66)90020-8; SCHIWARA HW, 1968, H-S Z PHYSIOL CHEM, V349, P1575, DOI 10.1515/bchm2.1968.349.2.1575; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; SUZUKI Y, 1974, B CHEM SOC JPN, V47, P2077, DOI 10.1246/bcsj.47.2077; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2	33	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33710	33717		10.1074/jbc.M110.153833	http://dx.doi.org/10.1074/jbc.M110.153833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736169	hybrid, Green Published			2022-12-27	WOS:000283354000016
J	Rahajeng, J; Giridharan, SSP; Naslavsky, N; Caplan, S				Rahajeng, Juliati; Giridharan, Sai S. P.; Naslavsky, Naava; Caplan, Steve			Collapsin Response Mediator Protein-2 (Crmp2) Regulates Trafficking by Linking Endocytic Regulatory Proteins to Dynein Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EH-DOMAIN; RECYCLING COMPARTMENT; ENDOSOMAL TRANSPORT; CYTOPLASMIC DYNEIN; FAMILY PROTEINS; PLASMA-MEMBRANE; GOLGI-COMPLEX; IN-VIVO; RME-1; BINDS	Endocytosis is a conserved cellular process in which nutrients, lipids, and receptors are internalized and transported to early endosomes, where they are sorted and either channeled to degradative pathways or recycled to the plasma membrane. MICAL-L1 and EHD1 are important regulatory proteins that control key endocytic transport steps. However, the precise mechanisms by which they mediate transport, and particularly the mode by which they connect to motor proteins, have remained enigmatic. Here we have identified the collapsin response mediator protein-2 (Crmp2) as an interaction partner of MICAL-L1 in non-neuronal cells. Crmp2 interacts with tubulin dimers and kinesin and negatively regulates dynein-based transport in neuronal cells, but its expression and function in non-neuronal cells have remained poorly characterized. Upon Crmp2 depletion, we observed dramatic relocalization of internalized transferrin (Tf) from peripheral vesicles to the endocytic recycling compartment (ERC), similar to the effect of depleting either MICAL-L1 or EHD1. Moreover, Tf relocalization to the ERC could be inhibited by interfering with microtubule polymerization, consistent with a role for uncoupled motor protein-based transport upon depletion of Crmp2, MICAL-L1, or EHD1. Finally, transfection of dynamitin, a component of the dynactin complex whose overexpression inhibits dynein activity, prevented the relocalization of internalized Tf to the ERC upon depletion of Crmp2, MICAL-L1, or EHD1. These data provide the first trafficking regulatory role for Crmp2 in non-neuronal cells and support a model in which Crmp2 is an important endocytic regulatory protein that links MICAL-L1.EHD1-based vesicular transport to dynein motors.	[Naslavsky, Naava] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Naslavsky, N (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, 600 S 42nd St, Omaha, NE 68198 USA.	nnaslavsky@unmc.edu; scaplan@unmc.edu	giridharan, sai srinivas panapakkam/X-9083-2019		National Institutes of Health [R01GM074876, R01GM087455]; National Center for Research Resources [P20 RR018759]; Nebraska Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087455, R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074876 (to S. C. and N. N.) and R01GM087455 (S. C.) and National Center for Research Resources Grant P20 RR018759 (to N. N.). This work was also supported by a grant from the Nebraska Department of Health (to N. N.).	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Arimura N, 2009, J NEUROCHEM, V111, P380, DOI 10.1111/j.1471-4159.2009.06317.x; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Horgan CP, 2010, BIOCHEM BIOPH RES CO, V394, P387, DOI 10.1016/j.bbrc.2010.03.028; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254	41	46	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31918	31922		10.1074/jbc.C110.166066	http://dx.doi.org/10.1074/jbc.C110.166066			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20801876	hybrid, Green Published			2022-12-27	WOS:000282683000004
J	Guitart, T; Bernardo, TL; Sagales, J; Stratmann, T; Bernues, J; de Pouplana, LR				Guitart, Tanit; Leon Bernardo, Teresa; Sagales, Jessica; Stratmann, Thomas; Bernues, Jordi; Ribas de Pouplana, Lluis			New Aminoacyl-tRNA Synthetase-like Protein in Insecta with an Essential Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE GAMMA; ACCESSORY SUBUNIT; DROSOPHILA; GENE; SEQUENCES; IDENTIFICATION; RECOGNITION; PHYLOGENIES; EXPRESSION; MUTATION	Aminoacyl-tRNA synthetases (ARS) are modular enzymes that aminoacylate transfer RNAs (tRNA) for their use by the ribosome during protein synthesis. ARS are essential and universal components of the genetic code that were almost completely established before the appearance of the last common ancestor of all living species. This long evolutionary history explains the growing number of functions being discovered for ARS, and for ARS homologues, beyond their canonical role in gene translation. Here we present a previously uncharacterized paralogue of seryl-tRNA synthetase named SLIMP (seryl-tRNA synthetase-like insect mitochondrial protein). SLIMP is the result of a duplication of a mitochondrial seryl-tRNA synthetase (SRS) gene that took place in early metazoans and was fixed in Insecta. Here we show that SLIMP is localized in the mitochondria, where it carries out an essential function that is unrelated to the aminoacylation of tRNA. The knockdown of SLIMP by RNA interference (RNAi) causes a decrease in respiration capacity and an increase in mitochondrial mass in the form of aberrant mitochondria.	[Ribas de Pouplana, Lluis] IRB, Barcelona 08028, Spain; [Stratmann, Thomas] Univ Barcelona Biol, Dept Physiol, Barcelona 08028, Spain; [Bernues, Jordi] CSIC, Inst Biol Mol Barcelona, Barcelona 08028, Spain; [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA	de Pouplana, LR (corresponding author), IRB, C Baldiri Reixac 12, Barcelona 08028, Spain.	lluis.ribas@irbbarcelona.org	Bernues, Jordi/ABE-8360-2021; Guitart, Tanit/G-9772-2015; de Pouplana, Lluis Ribas/AAA-4738-2019; SEGALES, J/H-6434-2014	Bernues, Jordi/0000-0001-6218-8254; Guitart, Tanit/0000-0003-2992-9895; de Pouplana, Lluis Ribas/0000-0002-2087-0359; SEGALES, J/0000-0003-3565-0014; Stratmann, Thomas/0000-0001-6196-1487	Spanish Ministry of Science and Education [BIO2006-01558]; ICREA Funding Source: Custom	Spanish Ministry of Science and Education(Spanish Government); ICREA(ICREA)	This work was supported by Grant BIO2006-01558 from the Spanish Ministry of Science and Education.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ambrus AM, 2009, GENETICS, V183, P79, DOI 10.1534/genetics.109.104661; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bilokapic S, 2004, EUR J BIOCHEM, V271, P694, DOI 10.1111/j.1432-1033.2003.03971.x; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DeLano W.L, PYMOL MOL GRAPHICS S; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fukui H, 2009, CIRC RES, V104, P1253, DOI 10.1161/CIRCRESAHA.108.191189; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herzog W, 2009, CIRC RES, V104, P1260, DOI 10.1161/CIRCRESAHA.108.191718; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jaric J, 2009, J BIOL CHEM, V284, P30643, DOI 10.1074/jbc.M109.044099; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korencic D, 2004, J BIOL CHEM, V279, P48780, DOI 10.1074/jbc.M408753200; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sambrook J, 1989, MOL CLONING LAB MANU, V1 and 3; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	46	17	18	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38157	38166		10.1074/jbc.M110.167486	http://dx.doi.org/10.1074/jbc.M110.167486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870726	Green Published, hybrid			2022-12-27	WOS:000284625600023
J	Ishida, H; Vogel, HJ				Ishida, Hiroaki; Vogel, Hans J.			The Solution Structure of a Plant Calmodulin and the CaM-binding Domain of the Vacuolar Calcium-ATPase BCA1 Reveals a New Binding and Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; LIGHT-CHAIN KINASE; TARGET RECOGNITION; RELAXATION MEASUREMENTS; N-TERMINUS; NMR; ISOFORMS; PROTEINS; DYNAMICS; PEPTIDE	The type IIb class of plant Ca2+-ATPases contains a unique N-terminal extension that encompasses a calmodulin (CaM) binding domain and an auto-inhibitory domain. Binding of Ca2+-CaM to this region can release auto-inhibition and activates the calcium pump. Using multidimensional NMR spectroscopy, we have determined the solution structure of the complex of a plant CaM isoform with the CaM-binding domain of the well characterized Ca2+-ATPase BCA1 from cauliflower. The complex has a rather elongated structure in which the two lobes of CaM do not contact each other. The anchor residues Trp-23 and Ile-40 form a 1-8-18 interaction motif. Binding of Ca2+-CaM gives rise to the induction of two helical parts in this unique target peptide. The two helical portions are connected by a highly positively charged bend region, which represents a relatively fixed angle and positions the two lobes of CaM in an orientation that has not been seen before in any complex structure of calmodulin. The behavior of the complex was further characterized by heteronuclear NMR dynamics measurements of the isotope-labeled protein and peptide. These data suggest a unique calcium-driven activation mechanism for BCA1 and other plant Ca2+-ATPases that may also explain the action of calcium-CaM on some other target enzymes. Moreover, CaM activation of plant Ca2+-ATPases seems to occur in an organelle-specific manner.	[Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an operating grant from the Natural Science and Engineering Research Council of Canada.	Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Bolte S, 2004, J CELL SCI, V117, P943, DOI 10.1242/jcs.00920; Boonburapong B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-4; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P1640, DOI 10.1021/bi701987n; Boursiac Y, 2007, J BIOENERG BIOMEMBR, V39, P409, DOI 10.1007/s10863-007-9104-z; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evans DE, 1998, BBA-REV BIOMEMBRANES, V1376, P1, DOI 10.1016/S0304-4157(97)00009-9; Fushman D, 2004, PROG NUCL MAG RES SP, V44, P189, DOI 10.1016/j.pnmrs.2004.02.001; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jaroniec CP, 2005, BIOCHEMISTRY-US, V44, P16167, DOI 10.1021/bi051672a; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Kabala K, 2005, ACTA PHYSIOL PLANT, V27, P559, DOI 10.1007/s11738-005-0062-y; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Malmstrom S, 2000, PLANT PHYSIOL, V122, P517, DOI 10.1104/pp.122.2.517; Malmstrom S, 1997, FEBS LETT, V400, P324, DOI 10.1016/S0014-5793(96)01448-2; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; O'Connell DJ, 2010, MOL CELL PROTEOMICS, V9, P1118, DOI 10.1074/mcp.M900324-MCP200; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Penheiter AR, 2005, BIOCHEMISTRY-US, V44, P2009, DOI 10.1021/bi0488552; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Ryabov Y, 2006, MAGN RESON CHEM, V44, pS143, DOI 10.1002/mrc.1822; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZHANG MJ, 1993, PROTEIN SCI, V2, P1931, DOI 10.1002/pro.5560021114; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	58	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38502	38510		10.1074/jbc.M110.131201	http://dx.doi.org/10.1074/jbc.M110.131201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20880850	Green Published, hybrid			2022-12-27	WOS:000284625600055
J	Lyons, PJ; Fricker, LD				Lyons, Peter J.; Fricker, Lloyd D.			Substrate Specificity of Human Carboxypeptidase A6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-ACTIVATABLE FIBRINOLYSIS; REGULATED SECRETORY PATHWAY; RAT CARBOXYPEPTIDASE; GENE FAMILY; EXTRACELLULAR-MATRIX; CRYSTAL-STRUCTURES; U TAFIA; METALLOCARBOXYPEPTIDASE; PEPTIDES; CLONING	Carboxypeptidase A6 (CPA6) is an extracellular matrix-bound metallocarboxypeptidase (CP) that has been implicated in Duane syndrome, a neurodevelopmental disorder in which the lateral rectus extraocular muscle is not properly innervated. Consistent with a role in Duane syndrome, CPA6 is expressed in a number of chondrocytic and nervous tissues during embryogenesis. To better characterize the enzymatic function and specificity of CPA6 and to compare this with other CPs, CPA6 was expressed in HEK293 cells and purified. Kinetic parameters were determined using a panel of synthetic carboxypeptidase substrates, indicating a preference of CPA6 for large hydrophobic C-terminal amino acids and only very weak activity toward small amino acids and histidine. A quantitative peptidomics approach using a mixture of peptides representative of the neuropeptidome allowed the characterization of CPA6 preferences at the P1 substrate position and suggested that small and acidic P1 residues significantly inhibit CPA6 cleavage. Finally, a comparison of available kinetic data for CPA enzymes shows a gradient of specificity across the subfamily, from the very restricted specificity of CPA2 to the very broad activity of CPA4. Structural data and modeling for all CPA/B subfamily members suggests the structural basis for the unique specificities observed for each member of the CPA/B subfamily of metallocarboxypeptidases.	[Lyons, Peter J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445	Natural Sciences and Engineering Research Council of Canada [DA-004494]; NEI [EY-194332]; NATIONAL EYE INSTITUTE [F32EY019433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA-004494 (to L. D. F.) and postdoctoral fellowships (to P.J.L.) from the Natural Sciences and Engineering Research Council of Canada and the National Eye Institute of the National Institutes of Health Grant EY-194332 from the NEI.	Adler M, 2005, BIOCHEMISTRY-US, V44, P9339, DOI 10.1021/bi0501941; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; Berezniuk I, 2010, FASEB J, V24, P1813, DOI 10.1096/fj.09-147942; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; CHRISTIANSON DW, 1986, P NATL ACAD SCI USA, V83, P7568, DOI 10.1073/pnas.83.20.7568; CLAUSER E, 1988, J BIOL CHEM, V263, P17837; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Deiteren K, 2007, BBA-PROTEINS PROTEOM, V1774, P267, DOI 10.1016/j.bbapap.2006.11.017; DILLEN L, 1992, BIOCHIM BIOPHYS ACTA, V1120, P105, DOI 10.1016/0167-4838(92)90430-L; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 1999, TRENDS BIOCHEM SCI, V24, P390, DOI 10.1016/S0968-0004(99)01448-6; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; GARDELL SJ, 1988, J BIOL CHEM, V263, P17828; Geetha-Loganathan P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-32; GomezOrtiz M, 1997, FEBS LETT, V400, P336, DOI 10.1016/S0014-5793(96)01412-3; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; Gutowski NJ, 2000, EUR J NEUROL, V7, P145, DOI 10.1046/j.1468-1331.2000.00029.x; HARTSUCK JA, 1965, P NATL ACAD SCI USA, V53, P396, DOI 10.1073/pnas.53.2.396; Helle KB, 2010, RESULTS PROBL CELL D, V50, P21, DOI 10.1007/400_2009_26; Huang HJ, 1999, CANCER RES, V59, P2981; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Marx PF, 2008, BLOOD, V112, P2803, DOI 10.1182/blood-2008-03-146001; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; MORGAN BA, 1976, J PHARM PHARMACOL, V28, P660, DOI 10.1111/j.2042-7158.1976.tb02827.x; Morgan DJ, 2010, J NEUROCHEM, V113, P1275, DOI 10.1111/j.1471-4159.2010.06706.x; NATSUAKI M, 1992, J INVEST DERMATOL, V99, P138, DOI 10.1111/1523-1747.ep12616776; Novikova EG, 1999, BIOCHEM BIOPH RES CO, V256, P564, DOI 10.1006/bbrc.1999.0378; Novikova EG, 2000, J BIOL CHEM, V275, P4865, DOI 10.1074/jbc.275.7.4865; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; PETERSON LM, 1982, ANAL BIOCHEM, V125, P420, DOI 10.1016/0003-2697(82)90024-0; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; Qian YM, 1999, J BIOL CHEM, V274, P11582, DOI 10.1074/jbc.274.17.11582; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; RUPLEY JA, 1960, J BIOL CHEM, V235, P609; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; Schmidt C, 2004, DEV BIOL, V271, P198, DOI 10.1016/j.ydbio.2004.03.016; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Song LX, 1997, J BIOL CHEM, V272, P10543; SPRINGMAN EB, 1995, J BIOL CHEM, V270, P1300, DOI 10.1074/jbc.270.3.1300; Tan FL, 2003, BIOCHEM J, V370, P567, DOI 10.1042/BJ20021495; Tanco S, 2010, J BIOL CHEM, V285, P18385, DOI 10.1074/jbc.M109.060350; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Ventura S, 1999, J BIOL CHEM, V274, P19925, DOI 10.1074/jbc.274.28.19925; Ventura S, 1997, BIOL CHEM, V378, P161; Wang L, 2009, J BONE MINER RES, V24, P265, DOI [10.1359/jbmr.081014, 10.1359/JBMR.081014]; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Willemse J, 2005, ANAL BIOCHEM, V340, P106, DOI 10.1016/j.ab.2005.01.039; Willemse JL, 2009, J THROMB HAEMOST, V7, P1962, DOI 10.1111/j.1538-7836.2009.03596.x; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 	55	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38234	38242		10.1074/jbc.M110.158626	http://dx.doi.org/10.1074/jbc.M110.158626			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855895	Green Published, hybrid			2022-12-27	WOS:000284625600031
J	Herrera, F; Chen, Q; Schubert, D				Herrera, Federico; Chen, Qi; Schubert, David			Synergistic Effect of Retinoic Acid and Cytokines on the Regulation of Glial Fibrillary Acidic Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL PROGENITOR CELLS; HUMAN GLIOBLASTOMA T98G; EMBRYONIC STEM-CELLS; ASTROCYTIC DIFFERENTIATION; SUBVENTRICULAR ZONE; SIGNALING PATHWAY; REACTIVE GLIOSIS; DOWN-SYNDROME; U87MG CELLS; BRAIN	Glial fibrillary acidic protein (GFAP) is the main astroglial marker during astrogliogenesis, but it is also expressed in other cell types, including neural stem cells and old neurons. Activation of the JAK/STAT pathway by the IL-6 family of cytokines is the canonical pathway regulating GFAP expression, whereas retinoic acid is thought to be the only inducer of GFAP to operate independently of this pathway. Here, we show that retinoic acid receptor alpha not only links retinoic acid signaling to the canonical cytokine-stimulated pathway leading to GFAP expression but that it also plays a key role in the synergistic actions of retinoic acid and cytokines on this pathway. Cytokines both potentiate retinoic acid receptor alpha expression and enhance its binding to DNA and to the Stat3-p300/CBP-Smad transcriptional complex, the cornerstone of the canonical pathway. PI3K is upstream to all the key events leading to the expression of GFAP. Our results give new insights about the role of retinoic acid signaling in GFAP expression.	[Herrera, Federico; Chen, Qi; Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Schubert, D (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schubert@salk.edu	Herrera, Federico/F-2261-2011	Herrera, Federico/0000-0002-9596-9353				Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bouterfa H, 2000, NEUROSURGERY, V46, P419, DOI 10.1097/00006123-200002000-00029; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Das A, 2008, J NEURO-ONCOL, V87, P9, DOI 10.1007/s11060-007-9485-1; Das A, 2009, NEUROCHEM RES, V34, P87, DOI 10.1007/s11064-008-9669-x; Faigle R, 2008, J NEUROCHEM, V106, P1681, DOI 10.1111/j.1471-4159.2008.05525.x; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Goncalves MBC, 2005, DEV BIOL, V278, P60, DOI 10.1016/j.ydbio.2004.10.015; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Herrera F, 2009, CELL DEATH DIFFER, V16, P910, DOI 10.1038/cdd.2009.24; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Jang YK, 2004, J NEUROSCI RES, V75, P573, DOI 10.1002/jnr.10789; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; KEIDEL S, 1994, MOL CELL BIOL, V14, P287, DOI 10.1128/MCB.14.1.287; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; Liang XY, 2010, CHINESE MED J-PEKING, V123, P949, DOI 10.3760/cma.j.issn.0366-6999.2010.07.033; Martin-Ibanez R, 2007, J NEUROSCI RES, V85, P2686, DOI 10.1002/jnr.21228; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; MITO T, 1993, EXP NEUROL, V120, P170, DOI 10.1006/exnr.1993.1052; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prestegarden L, 2010, CANCER RES, V70, P4274, DOI 10.1158/0008-5472.CAN-09-3904; Rajan P, 1998, J NEUROSCI, V18, P3620; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Schubert D, 2006, J NEUROCHEM, V96, P444, DOI 10.1111/j.1471-4159.2005.03563.x; Silbereis J, 2010, MOL CELL NEUROSCI, V44, P362, DOI 10.1016/j.mcn.2010.05.001; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Yanagisawa M, 2001, FEBS LETT, V489, P139, DOI 10.1016/S0014-5793(01)02095-6; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yung WKA, 1996, CLIN CANCER RES, V2, P1931	40	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38915	38922		10.1074/jbc.M110.170274	http://dx.doi.org/10.1074/jbc.M110.170274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876578	hybrid, Green Published			2022-12-27	WOS:000284941300021
J	Akhtar, K; Broekelmann, TJ; Miao, M; Keeley, FW; Starcher, BC; Pierce, RA; Mecham, RP; Adair-Kirk, TL				Akhtar, Kamal; Broekelmann, Thomas J.; Miao, Ming; Keeley, Fred W.; Starcher, Barry C.; Pierce, Richard A.; Mecham, Robert P.; Adair-Kirk, Tracy L.			Oxidative and Nitrosative Modifications of Tropoelastin Prevent Elastic Fiber Assembly in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BRONCHOALVEOLAR LAVAGE FLUID; LYSINE SIDE-CHAINS; EXTRACELLULAR-MATRIX; CROSS-LINKING; HYDROPHOBIC DOMAINS; CIGARETTE-SMOKE; PROTEINS; DISEASE; COACERVATION	Elastic fibers are extracellular structures that provide stretch and recoil properties of tissues, such as lungs, arteries, and skin. Elastin is the predominant component of elastic fibers. Tropoelastin (TE), the precursor of elastin, is synthesized mainly during late fetal and early postnatal stages. The turnover of elastin in normal adult tissues is minimal. However, in several pathological conditions often associated with inflammation and oxidative stress, elastogenesis is re-initiated, but newly synthesized elastic fibers appear abnormal. We sought to determine the effects of reactive oxygen and nitrogen species (ROS/RNS) on the assembly of TE into elastic fibers. Immunoblot analyses showed that TE is oxidatively and nitrosatively modified by peroxynitrite (ONOO-) and hypochlorous acid (HOCl) and by activated monocytes and macrophages via release of ONOO- and HOCl. In an in vitro elastic fiber assembly model, oxidatively modified TE was unable to form elastic fibers. Oxidation of TE enhanced coacervation, an early step in elastic fiber assembly, but reduced cross-linking and interactions with other proteins required for elastic fiber assembly, including fibulin-4, fibulin-5, and fibrillin-2. These findings establish that ROS/RNS can modify TE and that these modifications affect the assembly of elastic fibers. Thus, we speculate that oxidative stress may contribute to the abnormal structure and function of elastic fibers in pathological conditions.	[Mecham, Robert P.; Adair-Kirk, Tracy L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Broekelmann, Thomas J.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Miao, Ming; Keeley, Fred W.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Starcher, Barry C.] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA	Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Adair-Kirk, TL (corresponding author), 660 S Euclid Ave,Box 8052, St Louis, MO 63110 USA.	tkirk@dom.wustl.edu			National Institutes of Health [HL29594]; Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL29594, the Alpha-1 Foundation, and the Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation.	Adair-Kirk TL, 2005, J IMMUNOL, V174, P1621, DOI 10.4049/jimmunol.174.3.1621; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; CLARK RA, 1986, BIOCHEM BIOPH RES CO, V135, P451, DOI 10.1016/0006-291X(86)90015-X; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; Deslee G, 2009, EUR RESPIR J, V34, P324, DOI 10.1183/09031936.00123008; Deslee G, 2010, AM J RESP CELL MOL, V43, P576, DOI 10.1165/rcmb.2009-0221OC; Deslee G, 2009, CHEST, V135, P965, DOI 10.1378/chest.08-2257; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Franzblau C, 1977, Adv Exp Med Biol, V79, P313; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Gole MD, 2000, AM J PHYSIOL-LUNG C, V278, pL961, DOI 10.1152/ajplung.2000.278.5.L961; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kalluri R, 2000, J BIOL CHEM, V275, P20027, DOI 10.1074/jbc.M904549199; Kanazawa H, 2003, THORAX, V58, P106, DOI 10.1136/thorax.58.2.106; Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Lamb NJ, 1999, CRIT CARE MED, V27, P1738, DOI 10.1097/00003246-199909000-00007; LAURENT P, 1983, CHEST, V83, pS63, DOI 10.1378/chest.83.5.63S; Lenz AG, 1999, EUR RESPIR J, V13, P169, DOI 10.1034/j.1399-3003.1999.13a31.x; Lin SY, 2005, PEPTIDES, V26, P543, DOI 10.1016/j.peptides.2004.11.005; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Maeda I, 2007, J BIOCHEM, V142, P627, DOI 10.1093/jb/mvm170; Mecham RP, 2008, METHODS, V45, P32, DOI 10.1016/j.ymeth.2008.01.007; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Morris JC, 1996, J BIOL CHEM, V271, P15468, DOI 10.1074/jbc.271.26.15468; Morton LW, 2003, BIOCHEM J, V370, P339, DOI 10.1042/BJ20020964; Narayanan A S, 1977, Adv Exp Med Biol, V79, P491; Osoata GO, 2009, CHEST, V135, P1513, DOI 10.1378/chest.08-2105; Petruzzelli S, 1997, AM J RESP CRIT CARE, V156, P1902, DOI 10.1164/ajrccm.156.6.9702075; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; RONGIOLETTI F, 1995, DERMATOLOGY, V191, P19, DOI 10.1159/000246478; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; STARCHER BC, 1973, BIOCHEM BIOPH RES CO, V53, P210, DOI 10.1016/0006-291X(73)91421-6; STARCHER BC, 1981, CONNECT TISSUE RES, V8, P255, DOI 10.3109/03008208109152385; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Tu YD, 2008, BIOMACROMOLECULES, V9, P1739, DOI 10.1021/bm7013153; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wachi H, 2005, CLIN BIOCHEM, V38, P643, DOI 10.1016/j.clinbiochem.2005.04.006; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Werneck CC, 2008, BLOOD, V111, P4137, DOI 10.1182/blood-2007-07-101733; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Yamaguchi Y, 2004, ATHEROSCLEROSIS, V172, P259, DOI 10.1016/j.atherosclerosis.2003.09.030; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	60	36	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37396	37404		10.1074/jbc.M110.126789	http://dx.doi.org/10.1074/jbc.M110.126789			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847053	Green Published, hybrid			2022-12-27	WOS:000284424000032
J	Federici, L; Arcovito, A; Scaglione, GL; Scaloni, F; Lo Sterzo, C; Di Matteo, A; Falini, B; Giardina, B; Brunori, M				Federici, Luca; Arcovito, Alessandro; Scaglione, Giovanni L.; Scaloni, Flavio; Lo Sterzo, Carlo; Di Matteo, Adele; Falini, Brunangelo; Giardina, Bruno; Brunori, Maurizio			Nucleophosmin C-terminal Leukemia-associated Domain Interacts with G-rich Quadruplex Forming DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; NUCLEOLAR PROTEIN B23; CATIONIC PORPHYRIN; DENATURED STATE; NUCLEIC-ACIDS; NPMC(+) AML; MYC; PROMOTER; ARF	Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling phosphoprotein, mainly localized at nucleoli, that plays a key role in ribogenesis, centrosome duplication, and response to stress stimuli. Mutations at the C-terminal domain of NPM1 are the most frequent genetic lesion in acute myeloid leukemia and cause the aberrant and stable translocation of the protein in the cytoplasm. The NPM1 C-terminal domain was previously shown to bind nucleic acids. Here we further investigate the DNA binding properties of the NPM1 C-terminal domain both at the protein and nucleic acid levels; we investigate the domain boundaries and identify key residues for high affinity recognition. Furthermore, we demonstrate that the NPM1 C-terminal domain has a preference for G-quadruplex forming DNA regions and induces the formation of G-quadruplex structures in vitro. Finally we show that a specific sequence found at the SOD2 gene promoter, which was previously shown to be a target of NPM1 in vivo, is indeed folded as a G-quadruplex in vitro under physiological conditions. Our data extend considerably present knowledge on the DNA binding properties of NPM1 and suggest a general role in the transcription of genes characterized by the presence of G-quadruplex forming regions at their promoters.	Univ G dAnnunzio, Dept Biomed Sci, I-66013 Chieti, Italy; Univ G dAnnunzio, Ce SI Ctr Excellence Aging, I-66013 Chieti, Italy; [Arcovito, Alessandro; Scaglione, Giovanni L.; Giardina, Bruno] Univ Cattolica Sacro Cuore, Haemostasis Res Ctr, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; [Scaglione, Giovanni L.] Univ Cattolica Sacro Cuore, Haemostasis Res Ctr, Dept Internal Med, I-00168 Rome, Italy; [Scaloni, Flavio; Lo Sterzo, Carlo; Brunori, Maurizio] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Scaloni, Flavio; Lo Sterzo, Carlo; Brunori, Maurizio] Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Di Matteo, Adele] CNR, Inst Biol & Mol Pathol, I-00185 Rome, Italy; [Falini, Brunangelo] Univ Perugia, Inst Hematol, I-06100 Perugia, Italy; [Giardina, Bruno] CNR, Inst Chem Mol Recognit, I-00168 Rome, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Fondazione Cenci Bolognetti; Consiglio Nazionale delle Ricerche (CNR); University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)		lfederici@unich.it	Di Matteo, Adele/AAC-8338-2019; Scaglione, Giovanni Luca/ABD-6776-2020; Arcovito, Alessandro/I-5552-2012	Di Matteo, Adele/0000-0002-5921-7365; Scaglione, Giovanni Luca/0000-0001-5622-7843; Arcovito, Alessandro/0000-0002-8384-4844; FALINI, Brunangelo/0000-0002-7198-5965; Brunori, Maurizio/0000-0002-7795-1635	Associazione Italiana Ricerca sul Cancro (AIRC); Universita Cattolica del Sacro Cuore; University of Chieti "G. D'Annunzio"	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Universita Cattolica del Sacro Cuore; University of Chieti "G. D'Annunzio"	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC) (to M. B. and B. F.), Research Programs D.1 2009-2010 "Kinetic Study of Nucleophosmin by Surface Plasmon Resonance" and D.2.2 2008-2009 "SPR of Biological Macromolecules" from the Universita Cattolica del Sacro Cuore (to A. A.) and grants from the University of Chieti "G. D'Annunzio" (to L. F.).	Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Falini B, 2009, CURR OPIN ONCOL, V21, P573, DOI 10.1097/CCO.0b013e3283313dfa; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; Freyer MW, 2007, BIOPHYS J, V92, P2007, DOI 10.1529/biophysj.106.097246; Fry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4336, DOI 10.2741/2391; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Grand CL, 2002, MOL CANCER THER, V1, P565; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scaloni F, 2010, P NATL ACAD SCI USA, V107, P5447, DOI 10.1073/pnas.0910516107; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; Szebeni A, 1999, PROTEIN SCI, V8, P905; WANG DR, 1994, J BIOL CHEM, V269, P30994; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wei CY, 2006, BIOCHEMISTRY-US, V45, P6681, DOI 10.1021/bi052356z; Wei CY, 2010, BIOPHYS CHEM, V148, P51, DOI 10.1016/j.bpc.2010.02.009; Xu Y, 2007, J BIOL CHEM, V282, P15981, DOI 10.1074/jbc.M608979200; YUNG BYM, 1985, BIOCHIM BIOPHYS ACTA, V826, P167, DOI 10.1016/0167-4781(85)90002-8	37	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37138	37149		10.1074/jbc.M110.166736	http://dx.doi.org/10.1074/jbc.M110.166736			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858903	Green Published, hybrid			2022-12-27	WOS:000284424000007
J	Mani, RS; Yu, YP; Fang, SJ; Lu, ML; Fanta, M; Zolner, AE; Tahbaz, N; Ramsden, DA; Litchfield, DW; Lees-Miller, SP; Weinfeld, M				Mani, Rajam S.; Yu, Yaping; Fang, Shujuan; Lu, Meiling; Fanta, Mesfin; Zolner, Angela E.; Tahbaz, Nasser; Ramsden, Dale A.; Litchfield, David W.; Lees-Miller, Susan P.; Weinfeld, Michael			Dual Modes of Interaction between XRCC4 and Polynucleotide Kinase/Phosphatase IMPLICATIONS FOR NONHOMOLOGOUS END JOINING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-LIGASE-IV; DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; IONIZING-RADIATION; RAT-LIVER; CELL; 3'-PHOSPHATASE; COMPLEX; GENE	XRCC4 plays a crucial role in the nonhomologous end joining (NHEJ) pathway of DNA double-strand break repair acting as a scaffold protein that recruits other NHEJ proteins to double-strand breaks. Phosphorylation of XRCC4 by protein kinase CK2 promotes a high affinity interaction with the forkhead-associated domain of the end-processing enzyme polynucleotide kinase/phosphatase (PNKP). Here we reveal that unphosphorylated XRCC4 also interacts with PNKP through a lower affinity interaction site within the catalytic domain and that this interaction stimulates the turnover of PNKP. Unexpectedly, CK2-phosphorylated XRCC4 inhibited PNKP activity. Moreover, the XRCC4.DNA ligase IV complex also stimulated PNKP enzyme turnover, and this effect was independent of the phosphorylation of XRCC4 at threonine 233. Our results reveal that CK2-mediated phosphorylation of XRCC4 can have different effects on PNKP activity, with implications for the roles of XRCC4 and PNKP in NHEJ.	[Mani, Rajam S.; Lu, Meiling; Fanta, Mesfin; Tahbaz, Nasser; Weinfeld, Michael] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Mani, Rajam S.; Lu, Meiling; Fanta, Mesfin; Tahbaz, Nasser; Weinfeld, Michael] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Yu, Yaping; Fang, Shujuan; Zolner, Angela E.; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Yu, Yaping; Fang, Shujuan; Zolner, Angela E.; Lees-Miller, Susan P.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Ramsden, Dale A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Litchfield, David W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada	University of Alberta; University of Alberta; University of Calgary; University of Calgary; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario)	Weinfeld, M (corresponding author), Cross Canc Inst, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	michaelw@cancerboard.ab.ca	Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620; Lees-Miller, Susan/0000-0001-5809-2516	Canadian Institutes of Health Research [15385, 13639]; Alberta Cancer Foundation [23817]; National Institutes of Health [CA 84442]; NATIONAL CANCER INSTITUTE [R01CA084442] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Canadian Institutes of Health Research Grants 15385(to M.W.) and 13639(to S.P.L.-M.) and Alberta Cancer Foundation Grant 23817 (to S.P.L.-M. and M. W.). This work was also supported, in whole or in part, by National Institutes of Health Grant CA 84442 (to D.A.R.).	Bernstein NK, 2008, ANTI-CANCER AGENT ME, V8, P358, DOI 10.2174/187152008784220311; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; GATICA M, 1995, BIOCHEMISTRY-US, V34, P122, DOI 10.1021/bi00001a015; Grawunder U, 1998, J BIOL CHEM, V273, P24708, DOI 10.1074/jbc.273.38.24708; HABRAKEN Y, 1988, EUR J BIOCHEM, V171, P59, DOI 10.1111/j.1432-1033.1988.tb13758.x; Harlow E, 1988, ANTIBODIES LABORATOR, P521; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Leber R, 1998, J BIOL CHEM, V273, P1794, DOI 10.1074/jbc.273.3.1794; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mani RS, 2007, J BIOL CHEM, V282, P28004, DOI 10.1074/jbc.M704867200; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; PHEIFFER BH, 1982, BIOCHEM BIOPH RES CO, V109, P1297, DOI 10.1016/0006-291X(82)91918-0; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Yu YP, 2003, DNA REPAIR, V2, P1239, DOI 10.1016/S1568-7864(03)00143-5	38	50	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37619	37629		10.1074/jbc.M109.058719	http://dx.doi.org/10.1074/jbc.M109.058719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20852255	Green Published, hybrid			2022-12-27	WOS:000284424000054
J	Mathews, JA; Gibb, DR; Chen, BH; Scherle, P; Conrad, DH				Mathews, Joel A.; Gibb, David R.; Chen, Bing-Hung; Scherle, Peggy; Conrad, Daniel H.			CD23 Sheddase A Disintegrin and Metalloproteinase 10 (ADAM10) Is Also Required for CD23 Sorting into B Cell-derived Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-CD23 MONOCLONAL-ANTIBODY; IGE-BINDING FACTORS; IN-VIVO; ECTODOMAIN CLEAVAGE; MEMBRANE-PROTEINS; RECEPTOR CD23; LIGAND; FC-EPSILON-RII/CD23; BIOGENESIS; COMPONENTS	The low affinity receptor for IgE, CD23, is the natural regulator of IgE synthesis, and understanding both the synthesis and the catabolism of CD23 are, thus, important issues. Membrane CD23 is cleaved by a disintegrin and metalloproteinase 10 (ADAM10) and this cleavage influences the ability of CD23 to regulate IgE. In contrast to the belief that cleavage is a cell surface event, endosomal neutralization with NH4Cl was found to dramatically reduce CD23 cleavage, suggesting that the majority of CD23 cleavage occurred subsequent to internalization in the endosomal pathway and not at the cell surface. In line with this, full-length CD23 was shown to be sorted in an ADAM10-dependent manner into exosomes. Greatly increased ADAM10-mediated CD23 cleavage was seen at endosomal pH. Additionally, the stalk region of CD23 was found to interact with ADAM10 and ADAM10 binding of CD23 was found to be protease independent. SPR analysis of the interaction indicated about a 10-fold increase in the R-max at endosomal pH (pH 5.8) compared with pH 7.4, whereas the affinity of the interaction was not significantly changed. The R-max change, combined with the increased cleavage at endosomal pH, indicates greater accessibility of the CD23 stalk region for ADAM10 at the lower pH. These results indicate a model where CD23 internalization results in ADAM10-dependent incorporation into exosomes, followed by partial cleavage of CD23 by ADAM10 prior to being released from the cell. The increased cleavage at endosomal pH also has implications for other ADAM10 substrates.	[Mathews, Joel A.; Gibb, David R.; Conrad, Daniel H.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA; [Chen, Bing-Hung] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung 807, Taiwan; [Scherle, Peggy] Incyte Corp, Wilmington, DE 19880 USA	Virginia Commonwealth University; Kaohsiung Medical University; Incyte	Conrad, DH (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, POB 980678, Richmond, VA 23298 USA.	dconrad@vcu.edu	Chen, Bing-Hung/F-4451-2010	Chen, Bing-Hung/0000-0001-5960-5176	National Institutes of Health [RO1AI18697, 1U19AI077435];  [P30 CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077435, R01AI018697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI18697 and 1U19AI077435 and imaging cytometry supported by Grant P30 CA16059.	BANSAL AS, 1993, IMMUNOLOGY, V79, P285; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BONNEFOY JY, 1995, INT ARCH ALLERGY IMM, V107, P40, DOI 10.1159/000236924; Chen BH, 2002, IMMUNOLOGY, V107, P373, DOI 10.1046/j.1365-2567.2002.01512.x; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Conrad DH, 2007, CURR ALLERGY ASTHM R, V7, P331, DOI 10.1007/s11882-007-0050-y; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; FLORESROMO L, 1993, SCIENCE, V261, P1038, DOI 10.1126/science.8351517; Ford JW, 2006, CELL IMMUNOL, V243, P107, DOI 10.1016/j.cellimm.2007.01.004; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Gauvreau ME, 2009, TRAFFIC, V10, P1518, DOI 10.1111/j.1600-0854.2009.00948.x; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jackson L, 2009, J IMMUNOL, V183, P2585, DOI 10.4049/jimmunol.0803660; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Karagiannis SN, 2001, IMMUNOLOGY, V103, P319, DOI 10.1046/j.1365-2567.2001.01238.x; KEEGAN AD, 1987, J IMMUNOL, V139, P1199; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kelly AE, 1998, J IMMUNOL, V161, P6696; Kilmon MA, 2004, J IMMUNOL, V172, P1065, DOI 10.4049/jimmunol.172.2.1065; Kilmon MA, 2001, J IMMUNOL, V167, P3139, DOI 10.4049/jimmunol.167.6.3139; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; LETELLIER M, 1989, MOL IMMUNOL, V26, P1105, DOI 10.1016/0161-5890(89)90054-0; LIU FT, 1980, J IMMUNOL, V124, P2728; Liu YL, 2009, AM J PATHOL, V174, P1415, DOI 10.2353/ajpath.2009.080861; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Montagnac G, 2005, J IMMUNOL, V174, P5562, DOI 10.4049/jimmunol.174.9.5562; Munoz O, 1998, J BIOL CHEM, V273, P31795, DOI 10.1074/jbc.273.48.31795; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Poole JA, 2005, J ALLERGY CLIN IMMUN, V116, P780, DOI 10.1016/j.jaci.2005.07.007; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; SARFATI M, 1988, BLOOD, V71, P94; Saunderson SC, 2008, J IMMUNOL, V180, P8146, DOI 10.4049/jimmunol.180.12.8146; Savina A, 2002, J CELL SCI, V115, P2505; Schwartz W., 2004, BIOPROCESSING J, V3, P53; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	50	36	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37531	37541		10.1074/jbc.M110.141556	http://dx.doi.org/10.1074/jbc.M110.141556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876574	hybrid, Green Published			2022-12-27	WOS:000284424000045
J	van der Weerden, NL; Hancock, REW; Anderson, MA				van der Weerden, Nicole L.; Hancock, Robert E. W.; Anderson, Marilyn A.			Permeabilization of Fungal Hyphae by the Plant Defensin NaD1 Occurs through a Cell Wall-dependent Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; CANDIDA-ALBICANS; ANTIFUNGAL ACTIVITY; GAMMA-PUROTHIONINS; PROTEIN; BACTERIA; LL-37; INHIBITORS; ENDOSPERM; MEMBRANE	The antifungal activity of the plant defensin NaD1 involves specific interaction with the fungal cell wall, followed by permeabilization of the plasma membrane and entry of NaD1 into the cytoplasm. Prior to this study, the role of membrane permeabilization in the activity of NaD1, as well as the relevance of cell wall binding, had not been investigated. To address this, the permeabilization of Fusarium oxysporum f. sp. vasinfectum hyphae by NaD1 was investigated and compared with that by other antimicrobial peptides, including the cecropin-melittin hybrid peptide CP-29, the bovine peptide BMAP-28, and the human peptide LL-37, which are believed to act largely through membrane disruption. NaD1 appeared to permeabilize cells via a novel mechanism that required the presence of the fungal cell wall. NaD1 and Bac2A, a linear variant of the bovine peptide bactenecin, were able to enter the cytoplasm of treated hyphae, indicating that cell death is accelerated by interaction with intracellular targets.	La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	La Trobe University; University of British Columbia		m.anderson@latrobe.edu.au	Anderson, Marilyn A/A-4259-2012; Hancock, Robert E. W./E-1145-2013; van der Weerden, Nicole L/C-3705-2014	Anderson, Marilyn A/0000-0002-8257-5128; Hancock, Robert E. W./0000-0001-5989-8503; 	Australian Research Council; Victoria fellowship; Canadian Institutes of Health Research	Australian Research Council(Australian Research Council); Victoria fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by an Australian Research Council grant (to M. A. A.).; Supported by a Victoria fellowship.; Supported by a grant from the Canadian Institutes of Health Research. Holds a Canada Research Chair.	Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753; Benincasa M, 2006, J ANTIMICROB CHEMOTH, V58, P950, DOI 10.1093/jac/dkl382; BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Chen GH, 2005, J AGR FOOD CHEM, V53, P982, DOI 10.1021/jf0402227; COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P; den Hertog AL, 2006, BIOL CHEM, V387, P1495, DOI 10.1515/BC.2006.187; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Ibeas JI, 2000, PLANT J, V23, P375, DOI 10.1046/j.1365-313x.2000.00792.x; LARRICK JW, 1995, IMMUNOTECHNOLOGY, V1, P65, DOI 10.1016/1380-2933(95)00006-2; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lee DG, 2001, BIOCHEM BIOPH RES CO, V282, P570, DOI 10.1006/bbrc.2001.4602; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; Lopez-Garcia B, 2005, J INVEST DERMATOL, V125, P108, DOI 10.1111/j.0022-202X.2005.23713.x; MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Oren Z, 1998, BIOPOLYMERS, V47, P451; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200; Zhang Y, 1997, FEMS MICROBIOL LETT, V149, P59, DOI 10.1111/j.1574-6968.1997.tb10308.x	36	122	125	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37513	37520		10.1074/jbc.M110.134882	http://dx.doi.org/10.1074/jbc.M110.134882			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861017	hybrid, Green Published			2022-12-27	WOS:000284424000043
J	Webb, KJ; Zurita-Lopez, CI; Al-Hadid, Q; Laganowsky, A; Young, BD; Lipson, RS; Souda, P; Faull, KF; Whitelegge, JP; Clarke, SG				Webb, Kristofor J.; Zurita-Lopez, Cecilia I.; Al-Hadid, Qais; Laganowsky, Arthur; Young, Brian D.; Lipson, Rebecca S.; Souda, Puneet; Faull, Kym F.; Whitelegge, Julian P.; Clarke, Steven G.			A Novel 3-Methylhistidine Modification of Yeast Ribosomal Protein Rpl3 Is Dependent upon the YIL110W Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; AMINO-ACID-SEQUENCE; ARGININE METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MUTANT LACKING; METHYL-ESTER; IDENTIFICATION; ACTIN	We have shown that Rpl3, a protein of the large ribosomal subunit from baker's yeast (Saccharomyces cerevisiae), is stoichiometrically monomethylated at position 243, producing a 3-methylhistidine residue. This conclusion is supported by top-down and bottom-up mass spectrometry of Rpl3, as well as by biochemical analysis of Rpl3 radiolabeled in vivo with S-adenosyl-L-[methyl-H-3] methionine. The results show that a + 14-Da modification occurs within the GTKKLPRKTHRGLRKVAC sequence of Rpl3. Using high-resolution cation-exchange chromatography and thin layer chromatography, we demonstrate that neither lysine nor arginine residues are methylated and that a 3-methylhistidine residue is present. Analysis of 37 deletion strains of known and putative methyltransferases revealed that only the deletion of the YIL110W gene, encoding a seven + -strand methyltransferase, results in the loss of the + 14-Da modification of Rpl3. We suggest that YIL110W encodes a protein histidine methyltransferase responsible for the modification of Rpl3 and potentially other yeast proteins, and now designate it Hpm1 (Histidine protein methyltransferase 1). Deletion of the YIL110W/HPM1 gene results in numerous phenotypes including some that may result from abnormal interactions between Rpl3 and the 25 S ribosomal RNA. This is the first report of a methylated histidine residue in yeast cells, and the first example	[Webb, Kristofor J.; Zurita-Lopez, Cecilia I.; Al-Hadid, Qais; Laganowsky, Arthur; Young, Brian D.; Lipson, Rebecca S.; Faull, Kym F.; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Webb, Kristofor J.; Zurita-Lopez, Cecilia I.; Al-Hadid, Qais; Laganowsky, Arthur; Young, Brian D.; Lipson, Rebecca S.; Faull, Kym F.; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Souda, Puneet; Faull, Kym F.; Whitelegge, Julian P.] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Laganowsky, Arthur/0000-0001-5012-5547; Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM026020 from the National Institutes of Health.	Arnold RJ, 1999, J BIOL CHEM, V274, P37035, DOI 10.1074/jbc.274.52.37035; BAUER K, 1994, EUR J BIOCHEM, V219, P43, DOI 10.1111/j.1432-1033.1994.tb19912.x; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bengtsson O, 2008, YEAST, V25, P835, DOI 10.1002/yea.1638; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; CLARKE S, 1984, METHOD ENZYMOL, V106, P330; Clarke SG, 2006, ENZYMES, V24, P1; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; ELZINGA M, 1971, BIOCHEMISTRY-US, V10, P224, DOI 10.1021/bi00778a005; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; Hirs C. H. W., 1970, HDB BIOCH SELECTED D, pC; HORAKOVA M, 1978, J CHROMATOGR, V159, P227, DOI 10.1016/S0021-9673(00)93923-2; HUSZAR G, 1971, BIOCHEMISTRY-US, V10, P229, DOI 10.1021/bi00778a006; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; KLEIN PD, 1967, ANAL CHEM, V39, P1276, DOI 10.1021/ac60255a005; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; LHOEST J, 1981, EUR J BIOCHEM, V121, P33, DOI 10.1111/j.1432-1033.1981.tb06425.x; LHOEST J, 1977, MOL GEN GENET, V154, P175, DOI 10.1007/BF00330833; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Lipson RS, 2010, BIOCHEM BIOPH RES CO, V391, P1658, DOI 10.1016/j.bbrc.2009.12.112; MAITA T, 1991, J BIOCHEM-TOKYO, V110, P68, DOI 10.1093/oxfordjournals.jbchem.a123545; Meskauskas A, 2005, MOL CELL BIOL, V25, P10863, DOI 10.1128/MCB.25.24.10863-10874.2005; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P6175, DOI 10.1093/nar/gkn642; Meskauskas A, 2007, MOL CELL, V25, P877, DOI 10.1016/j.molcel.2007.02.015; MEYER HE, 1987, BIOL CHEM H-S, V368, P1607, DOI 10.1515/bchm3.1987.368.2.1607; Miranda TB, 2004, FEBS LETT, V577, P181, DOI 10.1016/j.febslet.2004.09.080; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; NAKAYAMA S, 1994, J BIOCHEM-TOKYO, V115, P909, DOI 10.1093/oxfordjournals.jbchem.a124439; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; PAIVA ACM, 1976, J AM CHEM SOC, V98, P7645, DOI 10.1021/ja00440a033; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Raftery MJ, 1996, BIOCHEM J, V316, P285, DOI 10.1042/bj3160285; RAGHAVAN M, 1992, EUR J BIOCHEM, V210, P311, DOI 10.1111/j.1432-1033.1992.tb17423.x; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Smith I., 1960, CHROMATOGR ELECTROPH, VI, P212; SUSSMAN DJ, 1984, J BIOL CHEM, V259, P7349; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; VIJAYASARATHY C, 1987, BIOCHIM BIOPHYS ACTA, V923, P156, DOI 10.1016/0304-4165(87)90139-5; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P121; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	64	52	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37598	37606		10.1074/jbc.M110.170787	http://dx.doi.org/10.1074/jbc.M110.170787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864530	Green Published, hybrid			2022-12-27	WOS:000284424000052
J	Fernandez-Funez, P; Zhang, Y; Casas-Tinto, S; Xiao, XZ; Zou, WQ; Rincon-Limas, DE				Fernandez-Funez, Pedro; Zhang, Yan; Casas-Tinto, Sergio; Xiao, Xiangzhu; Zou, Wen-Quan; Rincon-Limas, Diego E.			Sequence-dependent Prion Protein Misfolding and Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; MUSHROOM BODIES; STRAINS; GLYCOSYLATION; INFECTION; DISEASE; CELLS; ACQUISITION; RESISTANCE; RESIDUES	Prion diseases are neurodegenerative disorders caused by misfolding of the normal prion protein (PrP) into a pathogenic "scrapie" conformation. To better understand the cellular and molecular mechanisms that govern the conformational changes (conversion) of PrP, we compared the dynamics of PrP from mammals susceptible (hamster and mouse) and resistant (rabbit) to prion diseases in transgenic flies. We recently showed that hamster PrP induces spongiform degeneration and accumulates into highly aggregated, scrapie-like conformers in transgenic flies. We show now that rabbit PrP does not induce spongiform degeneration and does not convert into scrapie-like conformers. Surprisingly, mouse PrP induces weak neurodegeneration and accumulates small amounts of scrapie-like conformers. Thus, the expression of three highly conserved mammalian prion proteins in transgenic flies uncovered prominent differences in their conformational dynamics. How these properties are encoded in the amino acid sequence remains to be elucidated.	[Fernandez-Funez, Pedro] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA; [Rincon-Limas, Diego E.] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32610 USA; [Casas-Tinto, Sergio] Ctr Nacl Invest Oncol, Dept Mol Oncol, E-28029 Madrid, Spain; [Xiao, Xiangzhu; Zou, Wen-Quan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Case Western Reserve University	Fernandez-Funez, P (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA.	pedro.fernandez@neurology.ufl.edu; diego.rincon@neurology.ufl.edu	Zou, Wenquan/GWQ-3489-2022; Casas-Tinto, Sergio/G-8220-2015; ZHANG, YAN/J-7862-2012; xiao, xiangzhu/B-9300-2014; Zou, Wenquan/ABF-2875-2020	Casas-Tinto, Sergio/0000-0002-9589-9981; xiao, xiangzhu/0000-0002-8013-9074; Rincon-Limas, Diego/0000-0003-3099-0642	National Institutes of Health [R01NS062787, DP2 OD002721-01]; McGregor Foundation; Discretionary Fund; John Sealy Memorial Endowment Fund [CON 15431]; Alliance BioSecure; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGregor Foundation; Discretionary Fund; John Sealy Memorial Endowment Fund; Alliance BioSecure; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS062787 and Grant DP2 OD002721-01 (to P. F.-F.). This work was also supported by the McGregor Foundation and the President's Discretionary Fund and Alliance BioSecure (to W.-Q. Z.) and the John Sealy Memorial Endowment Fund Grant CON 15431 (to D. E. R.-L.).	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; BARLOW RM, 1976, RES VET SCI, V21, P110, DOI 10.1016/S0034-5288(18)33406-4; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fernandez-Funez P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000507; Gavin BA, 2006, J NEUROSCI, V26, P12408, DOI 10.1523/JNEUROSCI.3372-06.2006; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Jenkins DC, 2008, FEBS J, V275, P1323, DOI 10.1111/j.1742-4658.2008.06293.x; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Moore RA, 2009, CURR OPIN STRUC BIOL, V19, P14, DOI 10.1016/j.sbi.2008.12.007; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; Nitrini R, 1997, ANN NEUROL, V42, P138, DOI 10.1002/ana.410420203; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Robinson PJ, 2009, BIOCHEMISTRY-US, V48, P8551, DOI 10.1021/bi901070t; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200	41	26	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36897	36908		10.1074/jbc.M110.174391	http://dx.doi.org/10.1074/jbc.M110.174391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20817727	Green Published, hybrid			2022-12-27	WOS:000284146100068
J	Pasztor, L; Ziebandt, AK; Nega, M; Schlag, M; Haase, S; Franz-Wachtel, M; Madlung, J; Nordheim, A; Heinrichs, DE; Gotz, F				Pasztor, Linda; Ziebandt, Anne-Kathrin; Nega, Mulugeta; Schlag, Martin; Haase, Sabine; Franz-Wachtel, Mirita; Madlung, Johannes; Nordheim, Alfred; Heinrichs, David E.; Goetz, Friedrich			Staphylococcal Major Autolysin (Atl) Is Involved in Excretion of Cytoplasmic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE PROTEOME ANALYSIS; BACILLUS-SUBTILIS; MEMBRANE-VESICLES; EXTRACELLULAR PROTEINS; GEL-ELECTROPHORESIS; VIRULENCE FACTORS; GENE-EXPRESSION; AUREUS; EPIDERMIDIS; SECRETION	Many microorganisms excrete typical cytoplasmic proteins into the culture supernatant. As none of the classical secretion systems appears to be involved, this type of secretion was referred to as "nonclassical protein secretion." Here, we demonstrate that in Staphylococcus aureus the major autolysin plays a crucial role in release of cytoplasmic proteins. Comparative secretome analysis revealed that in the wild type S. aureus strain, 22 typical cytoplasmic proteins were excreted into the culture supernatant, although in the atl mutant they were significantly decreased. The presence or absence of prophages had little influence on the secretome pattern. In the atl mutant, secondary peptidoglycan hydrolases were increased in the secretome; the corresponding genes were transcriptionally up-regulated suggesting a compensatory mechanism for the atl mutation. Using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a cytoplasmic indicator enzyme, we showed that all clinical isolates tested excreted this protein. In the wall teichoic acid-deficient tagO mutant with its increased autolysis activity, GAPDH was excreted in even higher amounts than in the WT, confirming the importance of autolysis in excretion of cytoplasmic proteins. To answer the question of how discriminatory the excretion of cytoplasmic proteins is, we performed a two-dimensional PAGE of cytoplasmic proteins isolated from WT. Surprisingly, the most abundant proteins in the cytoplasm were not found in the secretome of the WT, suggesting that there exists a selection mechanism in the excretion of cytoplasmic proteins. As the major autolysin binds at the septum site, we assume that the proteins are preferentially released at and during septum formation.	[Goetz, Friedrich] Univ Tubingen, Dept Microbial Genet, Proteome Ctr, D-72076 Tubingen, Germany; [Franz-Wachtel, Mirita; Madlung, Johannes; Nordheim, Alfred] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr, D-72076 Tubingen, Germany; [Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Western University (University of Western Ontario)	Gotz, F (corresponding author), Univ Tubingen, Dept Microbial Genet, Proteome Ctr, D-72076 Tubingen, Germany.	friedrich.goetz@uni-tuebingen.de	Heinrichs, David/ABD-5702-2021	Nordheim, Alfred/0000-0003-4680-0778; Heinrichs, David/0000-0002-7217-2456	Deutsche Forschungsgemeinschaft [SFB 766]; Graduate College [GKI 685]; Ministerium fur Wissenschaft und Kunst; Landesstiftung Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate College; Ministerium fur Wissenschaft und Kunst; Landesstiftung Baden-Wurttemberg	This work was supported by the Deutsche Forschungsgemeinschaft, SFB 766, and Graduate College Grant GKI 685.; We thank Regine Stemmler, Silke Wahl, and Inga Buchen for excellent technical assistance and the Ministerium fur Wissenschaft und Kunst and the Landesstiftung Baden-Wurttemberg for financial support of the Proteome Center Tubingen.	Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chatterjee I, 2009, PROTEOMICS, V9, P1152, DOI 10.1002/pmic.200800586; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; DUTHIE ES, 1952, J GEN MICROBIOL, V7, P320, DOI 10.1099/00221287-7-3-4-320; DYKE KGH, 1966, LANCET, V1, P835; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Hala M, 2008, PLANT CELL, V20, P1330, DOI 10.1105/tpc.108.059105; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Kohler C, 2005, INT J MED MICROBIOL, V295, P547, DOI 10.1016/j.ijmm.2005.08.002; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; MAJUMDAR D, 1991, BIOTECHNIQUES, V11, P94; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Otto M, 1998, FEMS MICROBIOL LETT, V166, P203, DOI 10.1016/S0378-1097(98)00333-4; Otto M, 2001, RES MICROBIOL, V152, P351, DOI 10.1016/S0923-2508(01)01206-2; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Resch A, 2005, FEMS MICROBIOL LETT, V252, P89, DOI 10.1016/j.femsle.2005.08.048; Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SCHLEIFER KH, 1982, INT J SYST BACTERIOL, V32, P153, DOI 10.1099/00207713-32-2-153; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; Vitikainen M, 2004, J BIOL CHEM, V279, P19302, DOI 10.1074/jbc.M400861200; Walker SA, 2001, APPL ENVIRON MICROB, V67, P251, DOI 10.1128/AEM.67.1.251-259.2001; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Xia XX, 2008, PROTEOMICS, V8, P2089, DOI 10.1002/pmic.200700826; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; Zell C, 2008, INT J FOOD MICROBIOL, V127, P246, DOI 10.1016/j.ijfoodmicro.2008.07.016; Ziebandt AK, 2004, PROTEOMICS, V4, P3034, DOI 10.1002/pmic.200400937; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	60	86	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36794	36803		10.1074/jbc.M110.167312	http://dx.doi.org/10.1074/jbc.M110.167312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847047	Green Published, hybrid			2022-12-27	WOS:000284146100057
J	Perreault, ML; Hasbi, A; Alijaniaram, M; Fan, T; Varghese, G; Fletcher, PJ; Seeman, P; O'Dowd, BF; George, SR				Perreault, Melissa L.; Hasbi, Ahmed; Alijaniaram, Mohammed; Fan, Theresa; Varghese, George; Fletcher, Paul J.; Seeman, Philip; O'Dowd, Brian F.; George, Susan R.			The Dopamine D1-D2 Receptor Heteromer Localizes in Dynorphin/Enkephalin Neurons INCREASED HIGH AFFINITY STATE FOLLOWING AMPHETAMINE AND IN SCHIZOPHRENIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; COCAINE-SEEKING; AMPA RECEPTORS; RAT STRIATUM; SUBSTANCE-P; D1; PHOSPHORYLATION; ACTIVATION	The distribution and function of neurons coexpressing the dopamine D1 and D2 receptors in the basal ganglia and mesolimbic system are unknown. We found a subset of medium spiny neurons coexpressing D1 and D2 receptors in varying densities throughout the basal ganglia, with the highest incidence in nucleus accumbens and globus pallidus and the lowest incidence in caudate putamen. These receptors formed D1-D2 receptor heteromers that were localized to cell bodies and presynaptic terminals. In rats, selective activation of D1-D2 heteromers increased grooming behavior and attenuated AMPA receptor GluR1 phosphorylation by calcium/calmodulin kinase II alpha in nucleus accumbens, implying a role in reward pathways. D1-D2 heteromer sensitivity and functional activity was up-regulated in rat striatum by chronic amphetamine treatment and in globus pallidus from schizophrenia patients, indicating that the dopamine D1-D2 heteromer may contribute to psychopathologies of drug abuse, schizophrenia, or other disorders involving elevated dopamine transmission.	[Perreault, Melissa L.; Hasbi, Ahmed; Alijaniaram, Mohammed; Fan, Theresa; Varghese, George; Seeman, Philip; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; [George, Susan R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Fletcher, Paul J.] Univ Toronto, Dept Psychiat & Psychol, Toronto, ON M5S 1A8, Canada; [Perreault, Melissa L.; Hasbi, Ahmed; Alijaniaram, Mohammed; Fan, Theresa; Varghese, George; Fletcher, Paul J.; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	George, SR (corresponding author), Univ Toronto, Dept Pharmacol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	s.george@utoronto.ca	Perreault, Melissa L/N-2867-2017; George, Susan R/P-9669-2018; George, Susan/W-7494-2019	Perreault, Melissa L/0000-0002-5775-8950; Fletcher, Paul/0000-0001-8906-2280	National Institute on Drug Abuse [DA007223]; Ontario Mental Health Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007223] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Ontario Mental Health Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse DA007223 (to S. R. G., B. F. O., and P. S.) and an Ontario Mental Health Foundation postdoctoral fellowship (to M. L. P.).	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Aubert I, 2000, J COMP NEUROL, V418, P22; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Chen Y., 2005, MOL IMAGING FRET MIC, P126; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Crombag HS, 2008, BEHAV BRAIN RES, V191, P178, DOI 10.1016/j.bbr.2008.03.026; Culver KE, 2000, PSYCHOPHARMACOLOGY, V151, P202, DOI 10.1007/s002139900346; Deng YP, 2006, J CHEM NEUROANAT, V32, P101, DOI 10.1016/j.jchemneu.2006.07.001; Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025; Geldwert D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-53; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Guzman JN, 2003, J NEUROSCI, V23, P8931; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Kegeles LS, 2008, NEUROPSYCHOPHARMACOL, V33, P3111, DOI 10.1038/npp.2008.33; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Lidow MS, 2003, BRAIN RES REV, V43, P70, DOI 10.1016/S0165-0173(03)00203-0; Mizuno Takeo, 2007, BMC Neurosci, V8, P8, DOI 10.1186/1471-2202-8-8; Neumeyer JL, 2003, EUR J PHARMACOL, V474, P137, DOI 10.1016/S0014-2999(03)02008-9; Ping AS, 2008, BRAIN RES, V1215, P173, DOI 10.1016/j.brainres.2008.03.088; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Reiner A, 1999, NEUROSCIENCE, V88, P775, DOI 10.1016/S0306-4522(98)00254-1; Seeman P, 2008, SYNAPSE, V62, P819, DOI 10.1002/syn.20561; Seeman P, 2009, SYNAPSE, V63, P935, DOI 10.1002/syn.20704; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Wang HB, 2006, J CHEM NEUROANAT, V31, P178, DOI 10.1016/j.jchemneu.2006.01.003; Wang JQ, 2006, J NEUROSCI RES, V84, P1621, DOI 10.1002/jnr.21050	32	135	138	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36625	36634		10.1074/jbc.M110.159954	http://dx.doi.org/10.1074/jbc.M110.159954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864528	Green Published, hybrid			2022-12-27	WOS:000284146100067
J	Enomoto, Y; Yamanishi, Y; Izawa, K; Kaitani, A; Takahashi, M; Maehara, A; Oki, T; Takamatsu, R; Kajikawa, M; Takai, T; Kitamura, T; Kitaura, J				Enomoto, Yutaka; Yamanishi, Yoshinori; Izawa, Kumi; Kaitani, Ayako; Takahashi, Mariko; Maehara, Akie; Oki, Toshihiko; Takamatsu, Reiko; Kajikawa, Masunori; Takai, Toshiyuki; Kitamura, Toshio; Kitaura, Jiro			Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor ITS SIMILARITIES TO AND DIFFERENCES FROM LMIR4/CLM-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; MAST-CELL SURVIVAL; GAMMA-CHAIN; CMRF-35-LIKE MOLECULE-1; GENE SUPERFAMILY; IMMUNE-SYSTEM; ASSOCIATION; EXPRESSION; SUBUNIT	Here we characterize leukocyte mono-Ig-like receptor 7 (LMIR7)/CLM-3 and compare it with an activating receptor, LMIR4/CLM-5, that is a counterpart of an inhibitory receptor LMIR3/CLM-1. LMIR7 shares high homology with LMIR4 in the amino acid sequences of its Ig-like and transmembrane domains. Flow cytometric analysis demonstrated that LMIR4 was predominantly expressed in neutrophils, whereas LMIR7 was highly expressed in mast cells and monocytes/macrophages. Importantly, LMIR7 engagement induced cytokine production in bone marrow-derived mast cells (BMMCs). Although FcR gamma deficiency did not affect surface expression levels of LMIR7, it abolished LMIR7-mediated activation of BMMCs. Consistently we found significant interaction of LMIR7-FcR gamma, albeit with lower affinity compared with that of LMIR4-FcR gamma. Our results showed that LMIR7 transmits an activating signal through interaction with FcR gamma. In addition, like LMIR4, LMIR7 synergizes with TLR4 in signaling. Analysis of several chimera receptors composed of LMIR4 and LMIR7 revealed these findings: 1) the transmembrane of LMIR7 with no charged residues maintained its surface expression at high levels in the absence of FcR gamma; 2) the extracellular juxtamembrane region of LMIR7 had a negative effect on its surface expression levels; and 3) the strong interaction of LMIR4 with FcR gamma depended on the extracellular juxtamembrane region as well as the transmembrane domain of LMIR4. Thus, LMIR7 shares similarities with LMIR4, although they are differentially regulated in their distribution, expression, and function.	[Enomoto, Yutaka; Yamanishi, Yoshinori; Izawa, Kumi; Kaitani, Ayako; Takahashi, Mariko; Maehara, Akie; Oki, Toshihiko; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, Tokyo 1088639, Japan; [Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Therapy, Div Stem Cell Signaling,Minato Ku, Tokyo 1088639, Japan; [Takamatsu, Reiko; Kajikawa, Masunori] ACTGen Inc, Komagane, Nagano 3994117, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan	University of Tokyo; University of Tokyo; Tohoku University	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Cellular Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp; kitaura-tky@umin.ac.jp	Kitamura, Toshio/AAA-2071-2021	Enomoto, Yutaka/0000-0002-6346-9362	Ministry of Education, Science, Technology, Sports, and Culture; Ministry of Health and Welfare, Japan	Ministry of Education, Science, Technology, Sports, and Culture; Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Education, Science, Technology, Sports, and Culture and the Ministry of Health and Welfare, Japan.	Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Bori-Sanz T, 2003, J BIOL CHEM, V278, P35914, DOI 10.1074/jbc.M301826200; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; DAISH A, 1993, IMMUNOLOGY, V79, P55; Fujimoto M, 2006, INT IMMUNOL, V18, P1499, DOI 10.1093/intimm/dxl083; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Luo K, 2001, BIOCHEM BIOPH RES CO, V287, P35, DOI 10.1006/bbrc.2001.5539; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MORTON HC, 1995, J BIOL CHEM, V270, P29781; PFEFFERKORN LC, 1994, J IMMUNOL, V153, P3228; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; SCHOLL PR, 1993, P NATL ACAD SCI USA, V90, P8847, DOI 10.1073/pnas.90.19.8847; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Takai T, 2001, IMMUNOL REV, V181, P215, DOI 10.1034/j.1600-065X.2001.1810118.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Wines BD, 2006, J BIOL CHEM, V281, P17108, DOI 10.1074/jbc.M601640200; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	35	17	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35274	35283		10.1074/jbc.M110.137166	http://dx.doi.org/10.1074/jbc.M110.137166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817736	hybrid, Green Published			2022-12-27	WOS:000283845300005
J	Gencheva, M; Lin, TY; Wu, XW; Yang, LX; Richard, C; Jones, M; Lin, SB; Lin, RJ				Gencheva, Marieta; Lin, Ting-Yu; Wu, Xiwei; Yang, Lixin; Richard, Caroline; Jones, Matthew; Lin, Shwu-Bin; Lin, Ren-Jang			Nuclear Retention of Unspliced Pre-mRNAs by Mutant DHX16/hPRP2, a Spliceosomal DEAH-box Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSENSE-MEDIATED DECAY; FISSION YEAST; SPLICING REGULATORS; PROTEOMIC ANALYSIS; TRANSCRIPTION; INTRONS; GENES; IDENTIFICATION; MICROARRAY; COMPONENTS	Defective or imbalanced expression of spliceosomal factors has been linked to human disease; however, how a defective spliceosome affects intron-containing gene transcripts in human cells is largely unknown. DEAH-box protein DHX16 is a human orthologue of Saccharomyces cerevisiae spliceosomal protein Prp2, an RNA-dependent ATPase that activates the spliceosome before the first catalytic step of splicing. Yeast prp2 mutants accumulate unspliced RNAs from the vast majority of intron-containing genes. Here we used a genomic tiling microarray to screen transcripts from four chromosomes in human cells expressing a dominant negative DHX16 mutant and identified a number of gene transcripts that retained their introns. The mutant protein also affected gene transcripts that are sensitive to pladienolide, an SF3b inhibitor. The unspliced RNAs were retained in the nucleus, and block of nonsense-mediated decay did not affect their accumulation. Thus, a perturbation of human PRP2/DHX16 results in accumulation of unspliced transcripts, similar to the outcome in yeast prp2 mutants. The results further suggest that mutant DHX16/hPRP2 causes a defective spliceosome to retain unspliced gene transcripts in the nuclei of human cells.	[Lin, Ren-Jang] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Wu, Xiwei] Beckman Res Inst City Hope, Dept Bioinformat, Duarte, CA 91010 USA; [Richard, Caroline; Lin, Ren-Jang] Beckman Res Inst City Hope, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Lin, Ting-Yu; Lin, Shwu-Bin] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 10016, Taiwan	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; National Taiwan University	Lin, RJ (corresponding author), Beckman Res Inst City Hope, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RLin@coh.org	Lin, Ting-Yu/O-5781-2015; Lin, Ren-Jang/G-2052-2014	Lin, Ting-Yu/0000-0001-7914-2164; Lin, Ren-Jang/0000-0002-2738-2438	National Institutes of Health [GM40639]; City of Hope Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of Hope Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40639. This work was also supported by a City of Hope Cancer Center grant (to R.-J. L.).	Abelson J, 1989, Harvey Lect, V85, P1; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOUSQUETANTONEL.C, 2000, D CELL, V102, P765; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Burckin T, 2005, NAT STRUCT MOL BIOL, V12, P175, DOI 10.1038/nsmb891; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; FOUSER LA, 1986, CELL, V45, P81, DOI 10.1016/0092-8674(86)90540-4; Gencheva M, 2010, BIOCHEM J, V429, P25, DOI 10.1042/BJ20100266; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Imamura O, 1998, NUCLEIC ACIDS RES, V26, P2063, DOI 10.1093/nar/26.9.2063; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaufer NF, 2000, NUCLEIC ACIDS RES, V28, P3003, DOI 10.1093/nar/28.16.3003; KIM SH, 1993, P NATL ACAD SCI USA, V90, P888, DOI 10.1073/pnas.90.3.888; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Ner-Gaon H, 2006, DNA RES, V13, P111, DOI 10.1093/dnares/dsl003; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Nilsen TW, 2007, MOL CELL, V28, P715, DOI 10.1016/j.molcel.2007.11.017; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Paz A, 2007, J MOL EVOL, V64, P248, DOI 10.1007/s00239-006-0135-6; PIKIELNY CW, 1985, CELL, V41, P119, DOI 10.1016/0092-8674(85)90066-2; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; PLUMPTON M, 1994, EMBO J, V13, P879, DOI 10.1002/j.1460-2075.1994.tb06331.x; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rigo F, 2009, RNA, V15, P823, DOI 10.1261/rna.1409209; ROSBASH M, 1981, CELL, V24, P679, DOI 10.1016/0092-8674(81)90094-5; RUBY SW, 1991, TRENDS GENET, V7, P79; Rutz B, 2000, EMBO J, V19, P1873, DOI 10.1093/emboj/19.8.1873; Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005; Sharp PA, 2005, TRENDS BIOCHEM SCI, V30, P279, DOI 10.1016/j.tibs.2005.04.002; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhang ZH, 2007, GENOME RES, V17, P503, DOI 10.1101/gr.6049107; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	50	17	18	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35624	35632		10.1074/jbc.M110.122309	http://dx.doi.org/10.1074/jbc.M110.122309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20841358	hybrid, Green Published			2022-12-27	WOS:000283845300041
J	Goto, E; Yamanaka, Y; Ishikawa, A; Aoki-Kawasumi, M; Mito-Yoshida, M; Ohmura-Hoshino, M; Matsuki, Y; Kajikawa, M; Hirano, H; Ishido, S				Goto, Eiji; Yamanaka, Yuko; Ishikawa, Akiyo; Aoki-Kawasumi, Masami; Mito-Yoshida, Mari; Ohmura-Hoshino, Mari; Matsuki, Yohei; Kajikawa, Mizuho; Hirano, Hisashi; Ishido, Satoshi			Contribution of Lysine 11-linked Ubiquitination to MIR2-mediated Major Histocompatibility Complex Class I Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; DOWN-REGULATION; MEMBRANE-PROTEINS; DEGRADATION; ENDOCYTOSIS; LIGASES; RECEPTOR; RECOGNITION; MOLECULES; SIGNALS	The polyubiquitin chain is generated by the sequential addition of ubiquitin moieties to target molecules, a reaction between specific lysine residues that is catalyzed by E3 ubiquitin ligase. The Lys(48)-linked and Lys(63)-linked polyubiquitin chains are well established inducers of proteasome-dependent degradation and signal transduction, respectively. The concept has recently emerged that polyubiquitin chain-mediated regulation is even more complex because various types of atypical polyubiquitin chains have been discovered in vivo. Here, we demonstrate that a novel complex ubiquitin chain functions as an internalization signal for major histocompatibility complex class I (MHCI) membrane proteins in vivo. Using a tetracycline-inducible expression system and quantitative mass spectrometry, we show that the polyubiquitin chain generated by the viral E3 ubiquitin ligase of Kaposi sarcoma-associated herpesvirus, MIR2, is a Lys(11) and Lys(63) mixed-linkage chain. This novel ubiquitin chain can function as an internalization signal for MHC I through its association with epsin1, an adaptor molecule containing ubiquitin-interacting motifs.	[Goto, Eiji; Aoki-Kawasumi, Masami; Mito-Yoshida, Mari; Ohmura-Hoshino, Mari; Matsuki, Yohei; Kajikawa, Mizuho; Ishido, Satoshi] RIKEN Res Ctr Allergy & Immunol, Lab Infect Immun, Tsurumi Ku, Kanagawa 230045, Japan; [Yamanaka, Yuko; Ishikawa, Akiyo; Matsuki, Yohei; Hirano, Hisashi; Ishido, Satoshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Tsurumi Ku, Kanagawa 2300045, Japan	RIKEN; Yokohama City University	Ishido, S (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Kanagawa 2300045, Japan.	ishido@rcai.riken.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Japan Society for the Promotion of Science.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Adhikari A, 2009, DEV CELL, V16, P485, DOI 10.1016/j.devcel.2009.04.001; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gay DL, 2008, IMMUNOL RES, V42, P51, DOI 10.1007/s12026-008-8034-0; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; GOMEZMARTIN D, 2008, J AUTOIMMUN REV, V7, P284; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda H, 2008, MOL BIOL CELL, V19, P4588, DOI 10.1091/mbc.E08-05-0496; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Ishido S, 2009, CURR OPIN IMMUNOL, V21, P78, DOI 10.1016/j.coi.2009.01.002; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	41	49	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35311	35319		10.1074/jbc.M110.112763	http://dx.doi.org/10.1074/jbc.M110.112763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833710	hybrid, Green Published			2022-12-27	WOS:000283845300009
J	Haeusler, RA; Kaestner, KH; Accili, D				Haeusler, Rebecca A.; Kaestner, Klaus H.; Accili, Domenico			FoxOs Function Synergistically to Promote Glucose Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; MOLECULAR PHYSIOLOGY; HOMEOSTASIS; MICE; LIVER; GLUCONEOGENESIS; PHOSPHORYLATION; GLUCOKINASE; METABOLISM; GROWTH	Hepatic glucose production (HGP) plays a vital role in maintaining the supply of glucose to the body, and transcription factor FoxO1 is known to confer hormone responsiveness onto HGP. Mice with a liver-specific FoxO1 deletion (L-FoxO1) show reduced HGP and reduced expression of glucose production genes. To determine the contribution of additional transcription factors to HGP, we created double and triple liver-specific knock-outs lacking FoxO1, FoxO3, and FoxO4 or the related protein FoxA2. We show that, when compared with single knock-out of FoxO1, triple ablation of FoxO genes causes more pronounced fasting hypoglycemia, increased glucose tolerance, and enhanced insulin sensitivity, with decreased plasma insulin levels. In contrast, combined ablation of FoxO1 and FoxA2 phenocopied the single knock-out of FoxO1. These data indicate that FoxOs work in concert to regulate multiple aspects of hepatic glucose metabolism.	Columbia Univ, Dept Med, New York, NY 10032 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	Columbia University; University of Pennsylvania	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Haeusler, Rebecca/0000-0002-6973-9845	National Institutes of Health [P01HL87123, R01DK57539, P30DK63608, T32DK07328]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608, T32DK007328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL87123, R01DK57539, and P30DK63608 (to D.A.), and T32DK07328 (to R.A.H.).	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Barrett EJ, 2003, J CLIN INVEST, V111, P434, DOI 10.1172/JCI200317881; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cherrington AD, 2005, J CLIN INVEST, V115, P1136, DOI 10.1172/JCI200525152; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hume R, 2005, EARLY HUM DEV, V81, P95, DOI 10.1016/j.earlhumdev.2004.10.005; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Wang JC, 2000, J BIOL CHEM, V275, P14717, DOI 10.1074/jbc.275.19.14717; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	34	132	142	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35245	35248		10.1074/jbc.C110.175851	http://dx.doi.org/10.1074/jbc.C110.175851			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20880840	hybrid, Green Published			2022-12-27	WOS:000283845300001
J	Amin, ARMR; Wang, DS; Zhang, HZ; Peng, SF; Shin, HJC; Brandes, JC; Tighiouart, M; Khuri, FR; Chen, ZG; Shin, DM				Amin, A. R. M. Ruhul; Wang, Dongsheng; Zhang, Hongzheng; Peng, Shifang; Shin, Hyung Ju C.; Brandes, Johann C.; Tighiouart, Mourad; Khuri, Fadlo R.; Chen, Zhuo Georgia; Shin, Dong M.			Enhanced Anti-tumor Activity by the Combination of the Natural Compounds (-)-Epigallocatechin-3-gallate and Luteolin POTENTIAL ROLE OF p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GREEN TEA EXTRACT; PHASE-I TRIAL; CANCER PREVENTION; CARCINOMA-CELLS; BREAST-CANCER; TUMOR-GROWTH; POLYPHENON-E; HIGH-RISK; APOPTOSIS	Natural dietary agents have drawn a great deal of attention toward cancer prevention because of their wide safety margin. However, single agent intervention has failed to bring the expected outcome in clinical trials; therefore, combinations of chemopreventive agents are gaining increasingly popularity. In the present study, we investigated a combinatorial approach using two natural dietary polyphenols, luteolin and EGCG, and found that their combination at low doses (at which single agents induce minimal apoptosis) synergistically increased apoptosis (3-5-fold more than the additive level of apoptosis) in both head and neck and lung cancer cell lines. This combination also significantly inhibited growth of xenografted tumors in nude mice. The in vivo findings also were supported by significant inhibition of Ki-67 expression and increase in TUNEL-positive cells in xenografted tissues. Mechanistic studies revealed that the combination induced mitochondria-dependent apoptosis in some cell lines and mitochondria-independent apoptosis in others. Moreover, we found more efficient stabilization and ATM-dependent Ser(15) phosphorylation of p53 due to DNA damage by the combination, and ablation of p53 using shRNA strongly inhibited apoptosis as evidenced by decreased poly-(ADP-ribose) polymerase and caspase-3 cleavage. In addition, we observed mitochondrial translocation of p53 after treatment with luteolin or the combination of EGCG and luteolin. Taken together, our results for the first time suggest that the combination of luteolin and EGCG has synergistic/additive growth inhibitory effects and provides an important rationale for future chemoprevention trials of head and neck and lung cancers.	[Tighiouart, Mourad; Khuri, Fadlo R.; Chen, Zhuo Georgia; Shin, Dong M.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Shin, Hyung Ju C.] Quest Diagnost, Atlanta, GA 30084 USA	Emory University	Shin, DM (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	dmshin@emory.edu	Shin, Dong Moon/G-9649-2013; Ray, Dana M/C-3470-2013; Khuri, Fadlo R./AAU-4942-2020	Shin, Dong Moon/0000-0002-8245-4174; Khuri, Fadlo R./0000-0002-8638-7618; Brandes, Johann/0000-0002-1815-8311; AMIN, ARM/0000-0001-9144-2960	National Institutes of Health [P50 CA128613, U01 CA101244, R01 CA112643]; NATIONAL CANCER INSTITUTE [R01CA112643, P50CA128613, U01CA101244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA128613, U01 CA101244, and R01 CA112643.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Amin ARMR, 2009, CANCER PREV RES, V2, P538, DOI 10.1158/1940-6207.CAPR-09-0063; Antonakopoulos N, 2007, HEPATO-GASTROENTEROL, V54, P1694; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bode AM, 2009, CANCER PREV RES, V2, P514, DOI 10.1158/1940-6207.CAPR-09-0083; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; Ciardiello F, 1999, CLIN CANCER RES, V5, P909; Fabian CJ, 2005, J CLIN ONCOL, V23, P1644, DOI 10.1200/JCO.2005.11.005; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Hawk E, 1999, CANCER-AM CANCER SOC, V86, P2551, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2551::AID-CNCR12>3.3.CO;2-T; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Horinaka M, 2005, ONCOGENE, V24, P7180, DOI 10.1038/sj.onc.1208874; Horinaka M, 2005, BIOCHEM BIOPH RES CO, V333, P833, DOI 10.1016/j.bbrc.2005.05.179; Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Meslin F, 2007, J BIOL CHEM, V282, P32991, DOI 10.1074/jbc.M705290200; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981, DOI 10.1271/bbb.61.1981; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Pisters KMW, 2001, J CLIN ONCOL, V19, P1830, DOI 10.1200/JCO.2001.19.6.1830; Qin JC, 2008, CANCER RES, V68, P4150, DOI 10.1158/0008-5472.CAN-08-0839; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3808, DOI 10.1200/JCO.2008.21.1284; Shimoi K, 2000, BIOFACTORS, V12, P181, DOI 10.1002/biof.5520120129; Shin DM, 2009, CANCER PREV RES, V2, P919, DOI 10.1158/1940-6207.CAPR-09-0207; Sun SY, 1997, CANCER RES, V57, P4931; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Zhang X, 2005, CLIN CANCER RES, V11, P6261, DOI 10.1158/1078-0432.CCR-04-2102; Zhang X, 2008, INT J CANCER, V123, P1005, DOI 10.1002/ijc.23585; Zhao Y, 2010, CANCER LETT, V288, P42, DOI 10.1016/j.canlet.2009.06.021	42	89	92	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34557	34565		10.1074/jbc.M110.141135	http://dx.doi.org/10.1074/jbc.M110.141135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826787	Green Published, hybrid			2022-12-27	WOS:000283659100031
J	Bove, PF; Grubb, BR; Okada, SF; Ribeiro, CMP; Rogers, TD; Randell, SH; O'Neal, WK; Boucher, RC				Bove, Peter F.; Grubb, Barbara R.; Okada, Seiko F.; Ribeiro, Carla M. P.; Rogers, Troy D.; Randell, Scott H.; O'Neal, Wanda K.; Boucher, Richard C.			Human Alveolar Type II Cells Secrete and Absorb Liquid in Response to Local Nucleotide Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN AIRWAY EPITHELIA; ACUTE LUNG INJURY; CYSTIC-FIBROSIS; FLUID TRANSPORT; ION-TRANSPORT; SODIUM-CHANNELS; MUCUS CLEARANCE; NA+ TRANSPORT; ATP RELEASE	A balance sheet describing the integrated homeostasis of secretion, absorption, and surface movement of liquids on pulmonary surfaces has remained elusive. It remains unclear whether the alveolus exhibits an intra-alveolar ion/liquid transport physiology or whether it secretes ions/liquid that may communicate with airway surfaces. Studies employing isolated human alveolar type II (AT2) cells were utilized to investigate this question. Human AT2 cells exhibited both epithelial Na+ channel-mediated Na+ absorption and cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion, both significantly regulated by extracellular nucleotides. In addition, we observed in normal AT2 cells an absence of cystic fibrosis transmembrane conductance regulator regulation of epithelial Na+ channel activity and an absence of expression/activity of reported calcium-activated chloride channels (TMEM16A, Bestrophin-1, ClC2, and SLC26A9), both features strikingly different from normal airway epithelial cells. Measurements of alveolar surface liquid volume revealed that normal AT2 cells: 1) achieved an extracellular nucleotide concentration-dependent steady state alveolar surface liquid height of similar to 4 mu m in vitro; 2) absorbed liquid when the lumen was flooded; and 3) secreted liquid when treated with UTP or forskolin or subjected to cyclic compressive stresses mimicking tidal breathing. Collectively, our studies suggest that human AT2 cells in vitro have the capacity to absorb or secrete liquid in response to local alveolar conditions.	[Bove, Peter F.; Grubb, Barbara R.; Okada, Seiko F.; Ribeiro, Carla M. P.; Rogers, Troy D.; Randell, Scott H.; O'Neal, Wanda K.; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Boucher, RC (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Dept Med, 7011 Thurston Bowles Bldg,96 Manning Dr, Chapel Hill, NC 27599 USA.	R_Boucher@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009		National Institutes of Health [HL34322, 2P30DK065988, P50HL084934]; Cystic Fibrosis Foundation [RDP R026-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, P50HL084934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL34322, 2P30DK065988, and P50HL084934. This work was also supported by Cystic Fibrosis Foundation Grant RDP R026-CR07.	Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010; Blouquit S, 2006, AM J RESP CRIT CARE, V174, P299, DOI 10.1164/rccm.200506-987OC; Boncoeur E, 2010, AM J PHYSIOL-LUNG C, V298, pL417, DOI 10.1152/ajplung.00170.2009; Borok Z, 2002, AM J PHYSIOL-LUNG C, V282, pL599, DOI 10.1152/ajplung.00130.2000; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8; Dobbs LG, 2007, RESP PHYSIOL NEUROBI, V159, P283, DOI 10.1016/j.resp.2007.06.011; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Eaton Douglas C, 2004, Proc Am Thorac Soc, V1, P10, DOI 10.1513/pats.2306008; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Factor P, 1998, J CLIN INVEST, V102, P1421, DOI 10.1172/JCI3214; Factor P, 2007, P NATL ACAD SCI USA, V104, P4083, DOI 10.1073/pnas.0601117104; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Faria D, 2009, PFLUG ARCH EUR J PHY, V457, P1373, DOI 10.1007/s00424-008-0606-2; Folkesson HG, 1998, AM J PHYSIOL-LUNG C, V275, pL478, DOI 10.1152/ajplung.1998.275.3.L478; Grubb BR, 2009, AM J PHYSIOL-CELL PH, V296, pC1301, DOI 10.1152/ajpcell.00578.2008; GRUBB BR, 1995, AM J PHYSIOL-GASTR L, V268, pG505, DOI 10.1152/ajpgi.1995.268.3.G505; Gutierrez JA, 2003, AM J RESP CELL MOL, V29, P81, DOI 10.1165/rcmb.2002-0135OC; Ingbar DH, 2009, AM J PHYSIOL-LUNG C, V297, pL813, DOI 10.1152/ajplung.00324.2009; Inglis SK, 1996, AM J PHYSIOL-LUNG C, V270, pL289, DOI 10.1152/ajplung.1996.270.2.L289; Jain L, 1999, CLIN PERINATOL, V26, pXI, DOI 10.1016/S0095-5108(18)30035-6; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008; KIM KJ, 1991, RESP PHYSIOL, V85, P245, DOI 10.1016/0034-5687(91)90065-Q; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KO NIGJ, 2001, EMBO REP */* K EMBO, V2, P1047; KROUSE ME, 1989, AM J PHYSIOL, V257, pC129, DOI 10.1152/ajpcell.1989.257.1.C129; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL233, DOI 10.1152/ajplung.2000.278.2.L233; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Matthay MA, 1996, AM J PHYSIOL-LUNG C, V270, pL487, DOI 10.1152/ajplung.1996.270.4.L487; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; NAMKUNG W, MOL BIOL CELL, V21, P2639; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; RICE WR, 1995, AM J RESP CELL MOL, V12, P27, DOI 10.1165/ajrcmb.12.1.7811468; Rich PB, 2003, J TRAUMA, V55, P290, DOI 10.1097/01.TA.0000078882.11919.AF; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Rollins BM, 2008, AM J RESP CELL MOL, V39, P190, DOI 10.1165/rcmb.2007-0450OC; Roomans Godfried M, 2004, J Cyst Fibros, V3 Suppl 2, P135, DOI 10.1016/j.jcf.2004.05.029; Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731; Song WF, 2009, J BIOL CHEM, V284, P7294, DOI 10.1074/jbc.M806816200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Yan WS, 2004, J BIOL CHEM, V279, P23183, DOI 10.1074/jbc.M402373200; Yang CX, 2009, AM J PHYSIOL-LUNG C, V297, pL439, DOI 10.1152/ajplung.90268.2008; YUE G, 1995, P NATL ACAD SCI USA, V92, P8418, DOI 10.1073/pnas.92.18.8418; Zuo PY, 2008, J BIOL CHEM, V283, P26805, DOI 10.1074/jbc.M801516200	61	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34939	34949		10.1074/jbc.M110.162933	http://dx.doi.org/10.1074/jbc.M110.162933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801871	Green Published, hybrid			2022-12-27	WOS:000283659100068
J	Li, XJ; Marchal, CC; Stull, ND; Stahelin, RV; Dinauer, MC				Li, Xing Jun; Marchal, Christophe C.; Stull, Natalie D.; Stahelin, Robert V.; Dinauer, Mary C.			p47(phox) Phox Homology Domain Regulates Plasma Membrane but Not Phagosome Neutrophil NADPH Oxidase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PHOSPHORYLATION-INDUCED ACTIVATION; PX DOMAIN; PROTEIN P40(PHOX); SH3 DOMAIN; INTRAMOLECULAR INTERACTION; RESPIRATORY BURST; RESTING STATE; CLASS-III; CLASS-I	The assembly of cytosolic subunits p47(phox), p67(phox), and p40(phox) with flavocytochrome b(558) at the membrane is required for activating the neutrophil NADPH oxidase that generates superoxide for microbial killing. The p47(phox) subunit plays a critical role in oxidase assembly. Recent studies showed that the p47(phox) Phox homology (PX) domain mediates phosphoinositide binding in vitro and regulates phorbol ester-induced NADPH oxidase activity in a K562 myeloid cell model. Because the importance of the p47(phox) PX domain in neutrophils is unclear, we investigated its role using p47(phox) knock-out (KO) mouse neutrophils to express human p47(phox) and derivatives harboring R90A mutations in the PX domain that result in loss of phosphoinositide binding. Human p47(phox) proteins were expressed at levels similar to endogenous murine p47(phox), with the exception of a chronic granulomatous disease-associated R42Q mutant that was poorly expressed, and wild type human p47(phox) rescued p47(phox) KO mouse neutrophil NADPH oxidase activity. Plasma membrane NAPDH oxidase activity was reduced in neutrophils expressing p47(phox) with Arg(90) substitutions, with substantial effects on responses to either phorbol ester or formyl-Met-Leu-Phe and more modest effects to particulate stimuli. In contrast, p47(phox) Arg(90) mutants supported normal levels of intracellular NADPH oxidase activity during phagocytosis of a variety of particles and were recruited to phagosome membranes. This study defines a differential and agonist-dependent role of the p47(phox) PX domain for neutrophil NADPH oxidase activation.	[Dinauer, Mary C.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Li, Xing Jun; Marchal, Christophe C.; Stull, Natalie D.; Dinauer, Mary C.] Indiana Univ Sch Med, Riley Hosp Children, Dept Pediat Hematol Oncol, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Dinauer, Mary C.] Indiana Univ Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA; [Stahelin, Robert V.] Univ Sch Med S Bend, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University Bloomington; University of Notre Dame	Dinauer, MC (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Box 8208, St Louis, MO 63100 USA.	Dinauer_m@kids.wustl.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	Lilly Endowment Inc.; National Institutes of Health [R01 HL45635, P30 CA082709]; Riley Children's Foundation; American Heart Association [SDG 0735350N]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER	Lilly Endowment Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Catherine M. Matthews for assistance with manuscript preparation. We also thank the Indiana Center for Biological Microscopy, which was supported in part by a grant (Indiana Genomics Initiative (INGEN)) from Lilly Endowment Inc.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL45635 (to M. C. D. and S. Atkinson) and P30 CA082709 (to the Indiana University Simon Cancer Center Grant). This work was also supported by a grant from the Riley Children's Foundation (to M. C. D.) and American Heart Association Grant SDG 0735350N (to R. V. S.).	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Ago T, 2001, BIOCHEM BIOPH RES CO, V287, P733, DOI 10.1006/bbrc.2001.5629; Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen J, 2007, J BIOL CHEM, V282, P30273, DOI 10.1074/jbc.M704416200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; DE MI, 1996, EMBO J, V15, P1211; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; EL B, 1994, J BIOL CHEM */* B M, V269, P23431; Ellson CD, 2002, J CELL SCI, V115, P1099; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hawkins PT, 2007, BIOCHEM SOC SYMP, V74, P59, DOI 10.1042/BSS2007c06; Heyworth PG, 2002, NAT CELL BIOL, V4, pE110, DOI 10.1038/ncb0502-e110a; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Johnson JL, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-28; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620; Li XJ, 2005, J BIOL CHEM, V280, P14962, DOI 10.1074/jbc.M500226200; Mardiney M, 1997, BLOOD, V89, P2268, DOI 10.1182/blood.V89.7.2268; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Mizuki K, 2005, ARCH BIOCHEM BIOPHYS, V444, P185, DOI 10.1016/j.abb.2005.10.012; Mizuki K, 1998, EUR J BIOCHEM, V251, P573, DOI 10.1046/j.1432-1327.1998.2510573.x; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Noack D, 2001, BLOOD, V97, P305, DOI 10.1182/blood.V97.1.305; Petersen JE, 2002, J INVEST DERMATOL, V118, P424, DOI 10.1046/j.0022-202x.2001.01691.x; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shmelzer Z, 2008, J BIOL CHEM, V283, P31898, DOI 10.1074/jbc.M804674200; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wientjes FB, 1996, BIOCHEM J, V317, P919, DOI 10.1042/bj3170919; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Yaffe MB, 2002, STRUCTURE, V10, P1288, DOI 10.1016/S0969-2126(02)00860-2; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200	65	38	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35169	35179		10.1074/jbc.M110.164475	http://dx.doi.org/10.1074/jbc.M110.164475			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817944	Green Published, hybrid			2022-12-27	WOS:000283659100090
J	Wu, YY; Zhang, YQ; Zhang, HW; Yang, X; Wang, YY; Ren, FL; Liu, HT; Zhai, YG; Jia, BQ; Yu, J; Chang, ZJ				Wu, Yinyuan; Zhang, Yanquan; Zhang, Haiwei; Yang, Xi; Wang, Yinyin; Ren, Fangli; Liu, Huitu; Zhai, Yonggong; Jia, Baoqing; Yu, Jun; Chang, Zhijie			p15RS Attenuates Wnt/beta-Catenin Signaling by Disrupting beta-Catenin.TCF4 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; ARMADILLO/BETA-CATENIN; COLON-CARCINOMA; BINDING PROTEIN; TCF COMPLEX; CYCLIN D1; PATHWAY; TARGET; CELLS; GENE	The formation of a beta-catenin.TCF4 complex in the nucleus of cells is well known as a prerequisite for the transcription of Wnt target genes. Although many co-factors have been identified to regulate the activity of the beta-catenin.TCF4 complex, it remains unclear how the complex association is negatively regulated. In this study, we report that p15RS, a negative regulator of the cell cycle, blocks beta-catenin.TCF4 complex formation and inhibits Wnt signaling. We observed that p15RS interacts with beta-catenin and TCF4. Interestingly, whereas the interaction of p15RS with beta-catenin is increased, its interaction with TCF4 is decreased upon Wnt1 stimulation. Moreover, overexpression of p15RS reduces the interaction of beta-catenin with TCF4, whereas the depletion of p15RS enhances their interaction. We further demonstrate that overexpression of p15RS suppresses canonical Wnt signaling and results in retarded cell growth, whereas depletion of p15RS shows an enhanced effect on Wnt signaling. We analyzed that inhibition of Wnt signaling by p15RS leads to decreased expression of CYCLIN D1 and c-MYC, two Wnt targeted genes critical for cell growth. Our data suggest that p15RS inhibits Wnt signaling by interrupting beta-catenin.TCF4 complex formation and that Wnt signaling initiates downstream gene expression by removing p15RS from promoters.	[Chang, Zhijie] Tsinghua Univ, Sch Med, Sch Life Sci,Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Liu, Huitu; Zhai, Yonggong] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Coll Life Sci, Beijing 100875, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing 100853, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Tsinghua University; Beijing Normal University; Chinese People's Liberation Army General Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, Sch Life Sci,Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Zhang, Yanquan/D-5615-2017; Chang, Zhijie/AAH-8109-2019; Yu, Jun/D-8569-2015; Wu, Yinyuan/H-5682-2013	Zhang, Yanquan/0000-0003-3527-9972; Yu, Jun/0000-0001-5008-2153; Chang, Zhijie/0000-0003-1567-3227	Tsinghua Yue-Yuen Medical Sciences Fund; National Science Foundation of China [30530420, 30470888, 30518002]; Chinese National Support Project [2006CB910102, 2010CB529305]; 863 project [2007AA021505]; Ministry of Science and Technology of China [2008ZX1011-006]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021505] Funding Source: NIH RePORTER	Tsinghua Yue-Yuen Medical Sciences Fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Support Project; 863 project(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Tsinghua Yue-Yuen Medical Sciences Fund and National Science Foundation of China Grants 30530420, 30470888, and 30518002, Chinese National Support Project Grants 2006CB910102 and 2010CB529305, 863 project Grant 2007AA021505, and Ministry of Science and Technology of China project Grant 2008ZX1011-006.	Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Hirose Y, 2000, GENE DEV, V14, P1415; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Zhang XY, 2005, PROG BIOCHEM BIOPHYS, V32, P771	38	34	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34621	34631		10.1074/jbc.M110.148791	http://dx.doi.org/10.1074/jbc.M110.148791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739273	Green Published, hybrid			2022-12-27	WOS:000283659100038
J	Zhang, ZC; Florez, S; Gutierrez-Hartmann, A; Martin, JF; Amendt, BA				Zhang, Zichao; Florez, Sergio; Gutierrez-Hartmann, Arthur; Martin, James F.; Amendt, Brad A.			MicroRNAs Regulate Pituitary Development, and MicroRNA 26b Specifically Targets Lymphoid Enhancer Factor 1 (Lef-1), Which Modulates Pituitary Transcription Factor 1 (Pit-1) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; GENE-EXPRESSION; PITX2; MORPHOGENESIS; ACTIVATION; REPRESSORS; SECRETION; INTERACT; PROMOTER; DOMAIN	To understand the role of microRNAs (miRNAs) in pituitary development, a group of pituitary-specific miRNAs were identified, and Dicer1 was then conditionally knocked out using the Pitx2-Cre mouse, resulting in the loss of mature miRNAs in the anterior pituitary. The Pitx2-Cre/Dicer1 mutant mice demonstrate growth retardation, and the pituitaries are hypoplastic with an abnormal branching of the anterior lobe, revealing a role for microRNAs in pituitary development. Growth hormone, prolactin, and thyroid-stimulating hormone beta-subunit expression were decreased in the Dicer1 mutant mouse, whereas proopiomelanocortin and luteinizing hormone beta-subunit expression were normal in the mutant pituitary. Further analyses revealed decreased Pit-1 and increased Lef-1 expression in the mutant mouse pituitary, consistent with the repression of the Pit-1 promoter by Lef-1. Lef-1 directly targets and represses the Pit-1 promoter. miRNA-26b (miR-26b) was identified as targeting Lef-1 expression, and miR-26b represses Lef-1 in pituitary and non-pituitary cell lines. Furthermore, miR-26b up-regulates Pit-1 and growth hormone expression by attenuating Lef-1 expression in GH3 cells. This study demonstrates that microRNAs are critical for anterior pituitary development and that miR-26b regulates Pit-1 expression by inhibiting Lef-1 expression and may promote Pit-1 lineage differentiation during pituitary development.	[Zhang, Zichao; Florez, Sergio; Martin, James F.; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Environm & Genet Med, Houston, TX 77030 USA; [Gutierrez-Hartmann, Arthur] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Gutierrez-Hartmann, Arthur] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Amendt, BA (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Environm & Genet Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	bamendt@ibt.tamhsc.edu	Gutierrez-Hartmann, Arthur/F-1295-2011	Amendt, Brad A./0000-0001-6524-1006	National Institutes of Health, NIDCR [DE 13941]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health, NIDCR, Grant DE 13941 (to B. A. A.).	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; Gruszka A, 2007, ENDOCRINOLOGY, V148, P6107, DOI 10.1210/en.2007-0378; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jimenez J, 2005, RNA, V11, P1385, DOI 10.1261/rna.7226105; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; *NAT RES COUNC, 1996, NIH PUBL, V8623; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; VAN G, 1994, Genes Dev, V8, P2691; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	34	72	77	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34718	34728		10.1074/jbc.M110.126441	http://dx.doi.org/10.1074/jbc.M110.126441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807761	Green Published, hybrid			2022-12-27	WOS:000283659100047
J	Soria-Castro, I; Krzyzanowska, A; Pelaez, ML; Regadera, J; Ferrer, G; Montoliu, L; Rodreguez-Ramos, R; Fernandez, M; Alemany, S				Soria-Castro, Irene; Krzyzanowska, Agnieszka; Lopez Pelaez, Marta; Regadera, Javier; Ferrer, Gema; Montoliu, Lluis; Rodreguez-Ramos, Rosario; Fernandez, Margarita; Alemany, Susana			Cot/tpl2 (MAP3K8) Mediates Myeloperoxidase Activity and Hypernociception following Peripheral Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-KINASE; SIGNAL-REGULATED KINASE; NECROSIS-FACTOR-ALPHA; NERVE GROWTH-FACTOR; IN-VIVO; NEUTROPHIL MIGRATION; IMMUNE-SYSTEM; TPL2 KINASE; TNF-ALPHA; CD11B/CD18 INTEGRINS	Cot/tpl2 (also known as MAP3K8) has emerged as a new and potentially interesting therapeutic anti-inflammatory target. Here, we report the first study of Cot/tpl2 involvement in acute peripheral inflammation in vivo. Six hours after an intraplantar injection of zymosan, Cot/tpl2(-/-) mice showed a 47% reduction in myeloperoxidase activity, concomitant with a 46% lower neutrophil recruitment and a 40% decreased luminol-mediated bioluminescence imaging in vivo. Accordingly, Cot/tpl2 deficiency provoked a 25-30% reduction in luminol-mediated bioluminescence and neutrophil recruitment together with a 65% lower macrophage recruitment 4 h following zymosan-induced peritonitis. Significantly impaired levels of G-CSF and GM-CSF and of other cytokines such as TNF alpha, IL-1 beta, and IL-6, as well as some chemokines such as MCP-1, MIP-1 beta, and keratinocyte-derived chemokine, were detected during the acute zymosan-induced intraplantar inflammatory response in Cot/tpl2(-/-) mice. Moreover, Cot/tpl2 deficiency dramatically decreased the production of the hypernociceptive ligand NGF at the inflammatory site during the course of inflammation. Most importantly, Cot/tpl2 deficiency significantly reduced zymosan-induced inflammatory hypernociception in mice, with a most pronounced effect of a 50% decrease compared with wild type (WT) at 24 h following intraplantar injection of zymosan. At this time, Cot/tpl2(-/-) mice showed significantly reduced NGF, TNF alpha, and prostaglandin E-2 levels compared with WT littermates. In conclusion, our study demonstrates an important role of Cot/tpl2 in the NGF, G-CSF, and GM-CSF production and myeloperoxidase activity in the acute inflammatory response process and its implication in inflammatory hypernociception.	[Fernandez, Margarita; Alemany, Susana] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Krzyzanowska, Agnieszka; Regadera, Javier] Univ Autonoma Madrid, Dept Anat Histol & Neurociencia, Fac Med, E-28049 Madrid, Spain; [Montoliu, Lluis] Univ San Pablo, Fac Med, Dept Biol Mol & Celular, CNB,CSIC,CEU, Madrid 28668, Spain; [Rodreguez-Ramos, Rosario] Univ San Pablo, Fac Med, CEU, Dept Ciencias Med, Madrid 28668, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); San Pablo CEU University; San Pablo CEU University	Alemany, S (corresponding author), IIBm CSIC UAM, Arturo Duperier 4, Madrid 28029, Spain.	salemany@iib.uam.es	Montoliu, Lluis/I-2039-2015; Alemany, Susana/J-6307-2014	Montoliu, Lluis/0000-0003-3941-1176; Alemany, Susana/0000-0002-4089-7620; krzyzanowska, agnieszka/0000-0002-1288-7054; Lopez Pelaez, Marta/0000-0003-3892-9694	Comunidad de Madrid [SAF 2008-00819]; Mutua Madrilena; Formacion Personal Investigador fellowship	Comunidad de Madrid(Comunidad de Madrid); Mutua Madrilena; Formacion Personal Investigador fellowship	This work was supported by Comunidad de Madrid Grants SAF 2008-00819 and Mutua Madrilena.; Recipient of the Formacion Personal Investigador fellowship.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caivano M, 2003, J BIOL CHEM, V278, P52124, DOI 10.1074/jbc.M306583200; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; Coxon A, 1999, J EXP MED, V190, P923, DOI 10.1084/jem.190.7.923; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Cusack K, 2009, BIOORG MED CHEM LETT, V19, P1722, DOI 10.1016/j.bmcl.2009.01.088; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Eliopoulos AG, 2002, J VIROL, V76, P4567, DOI 10.1128/JVI.76.9.4567-4579.2002; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Frossard JL, 2002, AM J PHYSIOL-LUNG C, V283, pL541, DOI 10.1152/ajplung.00413.2001; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gandara ML, 2003, MOL CELL BIOL, V23, P7377, DOI 10.1128/MCB.23.20.7377-7390.2003; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; George D, 2008, BIOORG MED CHEM LETT, V18, P4952, DOI 10.1016/j.bmcl.2008.08.037; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Guerrero ATG, 2008, J LEUKOCYTE BIOL, V83, P122, DOI 10.1189/jlb.0207123; Haegens A, 2009, J IMMUNOL, V182, P7990, DOI 10.4049/jimmunol.0800377; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Handoyo H, 2009, BIOCHEM J, V424, P109, DOI 10.1042/BJ20091271; Haqqani AS, 1999, ANAL BIOCHEM, V273, P126, DOI 10.1006/abio.1999.4206; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Kaila N, 2007, BIOORGAN MED CHEM, V15, P6425, DOI 10.1016/j.bmc.2007.06.054; Kingery WS, 2001, BRAIN RES, V913, P140, DOI 10.1016/S0006-8993(01)02763-9; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Li YL, 2007, BIOCHIMIE, V89, P1257, DOI 10.1016/j.biochi.2007.07.002; Li YL, 2009, FEBS J, V276, P303, DOI 10.1111/j.1742-4658.2008.06780.x; Loniewski KJ, 2007, MOL IMMUNOL, V44, P3715, DOI 10.1016/j.molimm.2007.04.002; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Perruche S, 2004, J IMMUNOL METHODS, V294, P53, DOI 10.1016/j.jim.2004.08.011; Ribeiro RA, 1997, INT ARCH ALLERGY IMM, V112, P27, DOI 10.1159/000237427; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Rodriguez C, 2008, CELL SIGNAL, V20, P1625, DOI 10.1016/j.cellsig.2008.05.008; Rodriguez C, 2006, CELL SIGNAL, V18, P1376, DOI 10.1016/j.cellsig.2005.10.016; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; SOUZA GEP, 1988, AGENTS ACTIONS, V24, P377, DOI 10.1007/BF02028296; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Traves PG, 2007, MOL PHARMACOL, V71, P1545, DOI 10.1124/mol.106.031906; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2009, N-S ARCH PHARMACOL, V379, P271, DOI 10.1007/s00210-008-0360-1; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	67	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33805	33815		10.1074/jbc.M110.169409	http://dx.doi.org/10.1074/jbc.M110.169409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736176	Green Published, hybrid			2022-12-27	WOS:000283354000027
J	Yan, J; Jin, SQ; Li, J; Zhan, QM				Yan, Jie; Jin, Shunqian; Li, Jia; Zhan, Qimin			Aurora B Interaction of Centrosomal Nlp Regulates Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; CELL-DIVISION; ANIMAL CYTOKINESIS; GAMMA-TUBULIN; PROTEIN; PHOSPHORYLATION; MIDBODY; CANCER; SPINDLE; SEGREGATION	Cytokinesis is a fundamental cellular process, which ensures equal abscission and fosters diploid progenies. Aberrant cytokinesis may result in genomic instability and cell transformation. However, the underlying regulatory machinery of cytokinesis is largely undefined. Here, we demonstrate that Nlp (Ninein-like protein), a recently identified BRCA1-associated centrosomal protein that is required for centrosomes maturation at interphase and spindle formation in mitosis, also contributes to the accomplishment of cytokinesis. Through immunofluorescent analysis, Nlp is found to localize at midbody during cytokinesis. Depletion of endogenous Nlp triggers aborted division and subsequently leads to multinucleated phenotypes. Nlp can be recruited by Aurora B to the midbody apparatus via their physical association at the late stage of mitosis. Disruption of their interaction induces aborted cytokinesis. Importantly, Nlp is characterized as a novel substrate of Aurora B and can be phosphorylated by Aurora B. The specific phosphorylation sites are mapped at Ser-185, Ser-448, and Ser-585. The phosphorylation at Ser-448 and Ser-585 is likely required for Nlp association with Aurora B and localization at midbody. Meanwhile, the phosphorylation at Ser-185 is vital to Nlp protein stability. Disruptions of these phosphorylation sites abolish cytokinesis and lead to chromosomal instability. Collectively, these observations demonstrate that regulation of Nlp by Aurora B is critical for the completion of cytokinesis, providing novel insights into understanding the machinery of cell cycle progression.	[Yan, Jie; Jin, Shunqian; Li, Jia; Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Yan, Jie; Jin, Shunqian; Li, Jia; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jin, Shunqian] Univ Pittsburgh, Sch Med, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	Zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [30730046, 30721001]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 National Key Fundamental Research Program of China Grant 2009CB521801 and National Natural Science Foundation of China Grants 30730046 and 30721001.	Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Jin SQ, 2009, J BIOL CHEM, V284, P22970, DOI 10.1074/jbc.M109.009134; JULIAN M, 1993, J CELL SCI, V105, P145; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qu D, 2008, GYNECOL ONCOL, V110, P230, DOI 10.1016/j.ygyno.2008.04.015; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Shao SJ, 2010, J CLIN INVEST, V120, P498, DOI 10.1172/JCI39447; SHU HB, 1995, J CELL SCI, V108, P2955; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Terada Y, 2001, CELL STRUCT FUNCT, V26, P653, DOI 10.1247/csf.26.653; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Vernos I, 2004, DEV CELL, V7, P145, DOI 10.1016/j.devcel.2004.07.016; Yu LL, 2009, ONCOL REP, V22, P789, DOI 10.3892/or_00000501; ZHAO X, 2010, CANC BIOL T IN PRESS; Zhu CJ, 2005, BIOCHEM J, V389, P373, DOI 10.1042/BJ20050097	32	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40230	40239		10.1074/jbc.M110.140541	http://dx.doi.org/10.1074/jbc.M110.140541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20864540	hybrid, Green Published			2022-12-27	WOS:000285185500067
J	Grace, CRR; Perrin, MH; Gulyas, J; Rivier, JE; Vale, WW; Riek, R				Grace, Christy Rani R.; Perrin, Marilyn H.; Gulyas, Jozsef; Rivier, Jean E.; Vale, Wylie W.; Riek, Roland			NMR Structure of the First Extracellular Domain of Corticotropin-releasing Factor Receptor 1 (ECD1-CRF-R1) Complexed with a High Affinity Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; N-TERMINAL DOMAIN; LIGAND-BINDING; COMPETITIVE ANTAGONISTS; 1ST-EXTRACELLULAR DOMAIN; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; CHIMERIC RECEPTORS; ASTRESSIN ANALOGS	The corticotropin-releasing factor (CRF) peptide hormone family members coordinate endocrine, behavioral, autonomic, and metabolic responses to stress and play important roles within the cardiovascular, gastrointestinal, and central nervous systems, among others. The actions of the peptides are mediated by activation of two G-protein-coupled receptors of the B1 family, CRF receptors 1 and 2 (CRF-R1 and CRF-R2 alpha,beta). The recently reported three-dimensional structures of the first extracellular domain (ECD1) of both CRF-R1 and CRF-R2 beta (Pioszak, A. A., Parker, N. R., Suino-Powell, K., and Xu, H. E. (2008) J. Biol. Chem. 283, 32900-32912; Grace, C. R., Perrin, M. H., Gulyas, J., Digruccio, M. R., Cantle, J. P., Rivier, J. E., Vale, W. W., and Riek, R. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 4858-4863) complexed with peptide antagonists provided a starting point in understanding the binding between CRF ligands and receptors at a molecular level. We now report the three-dimensional NMR structure of the ECD1 of human CRF-R1 complexed with a high affinity agonist, alpha-helical cyclic CRF. In the structure of the complex, the C-terminal residues (23-41) of alpha-helical cyclic CRF bind to the ECD1 of CRF-R1 in a helical conformation mainly along the hydrophobic face of the peptide in a manner similar to that of the antagonists in their corresponding ECD1 complex structures. Unique to this study is the observation that complex formation between an agonist and the ECD1-CRF-R1 promotes the helical conformation of the N terminus of the former, important for receptor activation (Gulyas, J., Rivier, C., Perrin, M., Koerber, S. C., Sutton, S., Corrigan, A., Lahrichi, S. L., Craig, A. G., Vale, W., and Rivier, J. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 10575-10579).	[Perrin, Marilyn H.; Gulyas, Jozsef; Rivier, Jean E.; Vale, Wylie W.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Grace, Christy Rani R.; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Rivier, JE (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrivier@salk.edu; vale@salk.edu; riek@salk.edu		Riek, Roland/0000-0002-6333-066X	National Institutes of Health [DK026741]; Clayton Medical Research Foundation, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Medical Research Foundation, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK026741 from the NIDDK. This work was also supported by Clayton Medical Research Foundation, Inc.	Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh C., 1996, PROTEIN NMR SPECTROS; Cervini L, 1999, J MED CHEM, V42, P761, DOI 10.1021/jm980607e; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; COY DH, 1987, J MED CHEM, V30, P219, DOI 10.1021/jm00384a039; Dautzenberg FM, 1998, P NATL ACAD SCI USA, V95, P4941, DOI 10.1073/pnas.95.9.4941; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Grace CRR, 2007, BIOPOLYMERS, V87, P196, DOI 10.1002/bip.20818; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; IKURA K, 1990, J MAGN RESON, V86, P204; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; KELLER RL, 2003, CANTINA COMPUTER AID; KORNREICH WD, 1992, J MED CHEM, V35, P1870, DOI 10.1021/jm00088a024; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Manhart S, 2003, BIOCHEMISTRY-US, V42, P3081, DOI 10.1021/bi026868e; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; Murage EN, 2008, BIOORGAN MED CHEM, V16, P10106, DOI 10.1016/j.bmc.2008.10.006; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rijkers DTS, 2004, CHEMBIOCHEM, V5, P340, DOI 10.1002/cbic.200300769; Rivier J, 1998, J MED CHEM, V41, P5012, DOI 10.1021/jm980426c; Rivier J, 1998, J MED CHEM, V41, P2614, DOI 10.1021/jm980164e; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Rivier JE, 1999, J MED CHEM, V42, P3175, DOI 10.1021/jm9902133; Rivier J, 2007, J MED CHEM, V50, P1668, DOI 10.1021/jm0613875; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Shimizu M, 2000, J BIOL CHEM, V275, P19456, DOI 10.1074/jbc.M001596200; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; SUN C, 2007, P NATL ACAD SCI USA, V104, P7835; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Wille S, 1999, J NEUROCHEM, V72, P388, DOI 10.1046/j.1471-4159.1999.0720388.x; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yamada Y, 2004, J MED CHEM, V47, P1075, DOI 10.1021/jm034180+	58	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38580	38589		10.1074/jbc.M110.121897	http://dx.doi.org/10.1074/jbc.M110.121897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20843795	Green Published, hybrid			2022-12-27	WOS:000284625600063
J	Petit, D; Mir, AM; Petit, JM; Thisse, C; Delannoy, P; Oriol, R; Thisse, B; Harduin-Lepers, A				Petit, Daniel; Mir, Anne-Marie; Petit, Jean-Michel; Thisse, Christine; Delannoy, Philippe; Oriol, Rafael; Thisse, Bernard; Harduin-Lepers, Anne			Molecular Phylogeny and Functional Genomics of beta-Galactoside alpha 2,6-Sialyltransferases That Explain Ubiquitous Expression of st6gal1 Gene in Amniotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; IN-SITU HYBRIDIZATION; SIALIC ACIDS; N-GLYCANS; CATALYTIC-ACTIVITY; NERVOUS-SYSTEM; SIALYLTRANSFERASE; EVOLUTION; GOLGI; IDENTIFICATION	Sialyltransferases are key enzymes in the biosynthesis of sialoglycoconjugates that catalyze the transfer of sialic residue from its activated form to an oligosaccharidic acceptor. beta-Galactoside alpha 2,6-sialyltransferases ST6Gal I and ST6Gal II are the two unique members of the ST6Gal family described in higher vertebrates. The availability of genome sequences enabled the identification of more distantly related invertebrates' st6gal gene sequences and allowed us to propose a scenario of their evolution. Using a phylogenomic approach, we present further evidence of an accelerated evolution of the st6gal1 genes both in their genomic regulatory sequences and in their coding sequence in reptiles, birds, and mammals known as amniotes, whereas st6gal2 genes conserve an ancestral profile of expression throughout vertebrate evolution.	[Mir, Anne-Marie; Delannoy, Philippe; Harduin-Lepers, Anne] Univ Lille 1, CNRS UMR 8576, IFR 147, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Petit, Daniel; Petit, Jean-Michel] Univ Limoges, Fac Sci & Tech, INRA UMR 1061, Unite Genet Mol Anim, F-87060 Limoges, France; [Thisse, Christine; Thisse, Bernard] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Oriol, Rafael] Univ Paris 11, INSERM, U1004, Unite Microenvironm & Physiol Differenciat, F-94807 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; INRAE; Universite de Limoges; University of Virginia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Harduin-Lepers, A (corresponding author), Univ Lille 1, CNRS UMR 8576, IFR 147, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France.	anne.harduin@univ-lille1.fr	Anne, Harduin-Lepers/O-7503-2017	Anne, Harduin-Lepers/0000-0002-1233-3799; Delannoy, Philippe/0000-0001-6467-7553; THISSE, Christine/0000-0002-8684-1681	CNRS; Institut National de la Recherche Agronomique (INRA); INSERM; PPF-Bioinformatique de Lille	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique (INRA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); PPF-Bioinformatique de Lille	This work was supported in part by CNRS, Institut National de la Recherche Agronomique (INRA), INSERM, and the PPF-Bioinformatique de Lille.	Altheide TK, 2006, J BIOL CHEM, V281, P25689, DOI 10.1074/jbc.M604221200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aparicio S, 2000, TRENDS GENET, V16, P54, DOI 10.1016/S0168-9525(99)01934-4; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; BAUM LG, 1990, ACTA HISTOCHEM, P35; Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chang LY, 2009, GLYCOCONJUGATE J, V26, P263, DOI 10.1007/s10719-008-9165-1; Chen TLL, 2003, GLYCOBIOLOGY, V13, P109, DOI 10.1093/glycob/cwg015; Chiricolo M, 2006, GLYCOBIOLOGY, V16, P146, DOI 10.1093/glycob/cwj045; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dall'Olio F, 2000, INT J CANCER, V88, P58, DOI 10.1002/1097-0215(20001001)88:1<58::AID-IJC9>3.0.CO;2-Q; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; Danchin EGJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-5; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; Datta AK, 2009, CURR DRUG TARGETS, V10, P483, DOI 10.2174/138945009788488422; Ding GH, 2008, NUCLEIC ACIDS RES, V36, pD255, DOI 10.1093/nar/gkm924; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Ehrlich J, 1997, GENETICS, V147, P289; Ermonval M, 2009, GLYCOCONJUGATE J, V26, P477, DOI 10.1007/s10719-008-9198-5; Felsenstein J., 2002, PHYLIP PHYLOGENY INF; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Force A, 1999, GENETICS, V151, P1531; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hardham AR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-63; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harduin-Lepers A., 2010, GLYCOBIOL INSIGHTS, V2, P29, DOI [10.4137/GBI.S3123, DOI 10.4137/GBI.S3123, 10.4137/gbi.s3123]; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; INOHAYA K, 1995, DEV BIOL, V171, P374, DOI 10.1006/dbio.1995.1289; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JAMIESON JC, 1993, COMP BIOCHEM PHYS B, V105, P29, DOI 10.1016/0305-0491(93)90165-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kitazume S, 2005, J BIOL CHEM, V280, P8589, DOI 10.1074/jbc.M409417200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2002, SEIKAGAKU, V74, P1180; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Koles K, 2007, GLYCOBIOLOGY, V17, P1388, DOI 10.1093/glycob/cwm097; Koles K, 2009, GLYCOCONJUGATE J, V26, P313, DOI 10.1007/s10719-008-9154-4; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUROSAWA N, 1994, EUR J BIOCHEM, V219, P375, DOI 10.1111/j.1432-1033.1994.tb19949.x; Laporte B, 2009, GLYCOBIOLOGY, V19, P1082, DOI 10.1093/glycob/cwp094; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Legaigneur P, 2001, J BIOL CHEM, V276, P21608, DOI 10.1074/jbc.M100860200; Lehoux S, 2010, GLYCOCONJUGATE J, V27, P99, DOI 10.1007/s10719-009-9260-y; Lo NW, 1999, GLYCOBIOLOGY, V9, P907, DOI 10.1093/glycob/9.9.907; Ma JY, 1997, J BIOL CHEM, V272, P672; Ma JY, 1999, J BIOL CHEM, V274, P8046, DOI 10.1074/jbc.274.12.8046; Mannherz O, 2006, GENOMICS, V87, P665, DOI 10.1016/j.ygeno.2005.12.009; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Martin Renaud, 2009, Recent Pat DNA Gene Seq, V3, P63; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mercier D, 1999, GLYCOBIOLOGY, V9, P851, DOI 10.1093/glycob/9.9.851; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; MULLER WEG, 1977, J BIOL CHEM, V252, P3836; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; OHANLON TP, 1989, J BIOL CHEM, V264, P17389; Ohno S., 1970, EVOLUTION GENE DUPLI; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Patel RY, 2007, PROTEIN PEPTIDE LETT, V14, P601; Patel RY, 2006, GLYCOBIOLOGY, V16, P108, DOI 10.1093/glycob/cwj046; Petit D, 2006, J MOL EVOL, V63, P353, DOI 10.1007/s00239-005-0189-x; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Repnikova E, 2010, J NEUROSCI, V30, P6466, DOI 10.1523/JNEUROSCI.5253-09.2010; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; Robinson-Rechavi M, 2004, MOL BIOL EVOL, V21, P580, DOI 10.1093/molbev/msh046; Rohfritsch PF, 2006, BBA-GEN SUBJECTS, V1760, P685, DOI 10.1016/j.bbagen.2005.12.012; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Takashima S, 2003, J BIOCHEM, V134, P287, DOI 10.1093/jb/mvg142; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; Taylor JS, 2001, CURR BIOL, V11, pR1005, DOI 10.1016/S0960-9822(01)00610-8; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C., 1998, ZEBRAFISH SCI MON, V5, P8; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomsa JM, 1999, DEV BIOL, V207, P26, DOI 10.1006/dbio.1998.9163; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; WANG XC, 1993, J BIOL CHEM, V268, P4355; Wang YF, 2000, J MOL EVOL, V51, P88, DOI 10.1007/s002390010069; Wang Z, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-2; WEN DX, 1992, J BIOL CHEM, V267, P2512; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385	123	19	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38399	38414		10.1074/jbc.M110.163931	http://dx.doi.org/10.1074/jbc.M110.163931			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855889	Green Published, hybrid			2022-12-27	WOS:000284625600046
J	Du, W; Li, J; Sipple, J; Chen, JJ; Pang, QS				Du, Wei; Li, Jie; Sipple, Jared; Chen, Jianjun; Pang, Qishen			Cytoplasmic FANCA-FANCC Complex Interacts and Stabilizes the Cytoplasm-dislocalized Leukemic Nucleophosmin Protein (NPMc)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; E3 UBIQUITIN LIGASE; ANEMIA PROTEIN; MUTATED NUCLEOPHOSMIN; NES MOTIF; CELLS; GENE; DEGRADATION; PATHWAY	Eight of the Fanconi anemia (FA) proteins form a core complex that activates the FA pathway. Some core complex components also form subcomplexes for yet-to-be-elucidated functions. Here, we have analyzed the interaction between a cytoplasmic FA subcomplex and the leukemic nucleophosmin (NPMc). Exogenous NPMc was degraded rapidly in FA acute myeloid leukemia bone marrow cells. Knockdown of FANCA or FANCC in leukemic OCI/AML3 cells induced rapid degradation of endogenous NPMc. NPMc degradation was mediated by the ubiquitin-proteasome pathway involving the IBR-type RING-finger E3 ubiquitin ligase IBRDC2, and genetic correction of FA-A or FA-C lymphoblasts prevented NPMc ubiquitination. Moreover, cytoplasmic FANCA and FANCC formed a cytoplasmic complex and interacted with NPMc. Using a patient-derived FANCC mutant and a nuclearized FANCC, we demonstrated that the cytoplasmic FANCA-FANCC complex was essential for NPMc stability. Finally, depletion of FANCA and FANCC in NPMc-positive leukemic cells significantly increased inflammation and chemoresistance through NF-kappa B activation. Our findings not only reveal the molecular mechanism involving cytoplasmic retention of NPMc but also suggest cytoplasmic function of FANCA and FANCC in NPMc-related leukemogenesis.	[Du, Wei; Li, Jie; Sipple, Jared; Pang, Qishen] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Chen, Jianjun] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Pang, Qishen] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University of Chicago; University System of Ohio; University of Cincinnati	Du, W (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	wei.du@cchmc.org	Du, Wei/AAW-7158-2021; chen, JJ/HGB-6029-2022; Li, Jie/L-1737-2015; Du, Wei/ABD-4748-2020	Du, Wei/0000-0003-3669-537X; Li, Jie/0000-0002-0590-9817; Du, Wei/0000-0003-3669-537X	National Institutes of Health [R01 CA109641, R01 HL076712]; Fanconi Anemia Research Fund; Leukemia and Lymphoma Scholar award; NATIONAL CANCER INSTITUTE [R01CA109641] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Fund; Leukemia and Lymphoma Scholar award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA109641 and R01 HL076712.; Supported by a Fanconi Anemia Research Fund grant. To whom correspondence should be addressed: Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229. Tel.: 513-636-9222; Fax: 513-636-3768; E-mail: wei.du@cchmc.org.; Supported by a Leukemia and Lymphoma Scholar award.	Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Cilloni D, 2008, LEUKEMIA, V22, P1234, DOI 10.1038/leu.2008.68; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Du W, 2008, ANTIOXID REDOX SIGN, V10, P1909, DOI 10.1089/ars.2008.2129; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2007, LEUKEMIA, V21, P2052, DOI 10.1038/sj.leu.2404839; Falini B, 2008, HAEMATOLOGICA, V93, P775, DOI 10.3324/haematol.12225; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; GAVISH H, 1993, HUM MOL GENET, V2, P123, DOI 10.1093/hmg/2.2.123; Gordon SM, 2005, J BIOL CHEM, V280, P36118, DOI 10.1074/jbc.M507758200; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Green AM, 2009, HEMATOL ONCOL CLIN N, V23, P193, DOI 10.1016/j.hoc.2009.01.008; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hussain S, 2003, HUM MOL GENET, V12, P2503, DOI 10.1093/hmg/ddg266; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Lensch MW, 1999, LEUKEMIA, V13, P1784, DOI 10.1038/sj.leu.2401586; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Meani N, 2009, EXPERT REV ANTICANC, V9, P1283, DOI 10.1586/ERA.09.84; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Pasqualucci L, 2006, BLOOD, V108, P4146, DOI 10.1182/blood-2006-06-026716; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Rego MA, 2009, MUTAT RES-FUND MOL M, V668, P27, DOI 10.1016/j.mrfmmm.2008.11.018; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Zhou Y, 2008, BLOOD, V112, P2474, DOI 10.1182/blood-2007-12-130211	35	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37436	37444		10.1074/jbc.M110.113209	http://dx.doi.org/10.1074/jbc.M110.113209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864535	hybrid, Green Published			2022-12-27	WOS:000284424000036
J	Khan, S; Nagarajan, SN; Parikh, A; Samantaray, S; Singh, A; Kumar, D; Roy, RP; Bhatt, A; Nandicoori, VK				Khan, Shazia; Nagarajan, Sathya Narayanan; Parikh, Amit; Samantaray, Sharmishtha; Singh, Albel; Kumar, Devanand; Roy, Rajendra P.; Bhatt, Apoorva; Nandicoori, Vinay Kumar			Phosphorylation of Enoyl-Acyl Carrier Protein Reductase InhA Impacts Mycobacterial Growth and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; SER/THR KINASE; SERINE/THREONINE KINASES; MYCOLIC ACIDS; TUBERCULOSIS; SUBSTRATE; IDENTIFICATION; BIOSYNTHESIS; SYSTEM; TARGET	InhA, the primary target for the first line anti-tuberculosis drug isoniazid, is a key enzyme of the fatty-acid synthase II system involved in mycolic acid biosynthesis in Mycobacterium tuberculosis. In this study, we show that InhA is a substrate for mycobacterial serine/threonine protein kinases. Using a novel approach to validate phosphorylation of a substrate by multiple kinases in a surrogate host (Escherichia coli), we have demonstrated efficient phosphorylation of InhA by PknA, PknB, and PknH, and to a lower extent by PknF. Additionally, the sites targeted by PknA/PknB have been identified and shown to be predominantly located at the C terminus of InhA. Results demonstrate in vivo phosphorylation of InhA in mycobacteria and validate Thr-266 as one of the key sites of phosphorylation. Significantly, our studies reveal that the phosphorylation of InhA by kinases modulates its biochemical activity, with phosphorylation resulting in decreased enzymatic activity. Co-expression of kinase and InhA alters the growth dynamics of Mycobacterium smegmatis, suggesting that InhA phosphorylation in vivo is an important event in regulating its activity. An InhA-T266E mutant, which mimics constitutive phosphorylation, is unable to rescue an M. smegmatis conditional inhA gene replacement mutant, emphasizing the critical role of Thr-266 in mediating post-translational regulation of InhA activity. The involvement of various serine/threonine kinases in modulating the activity of a number of enzymes of the mycolic acid synthesis pathway, including InhA, accentuates the intricacies of mycobacterial signaling networks in parallel with the changing environment.	[Khan, Shazia; Nagarajan, Sathya Narayanan; Parikh, Amit; Samantaray, Sharmishtha; Roy, Rajendra P.; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Singh, Albel; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Kumar, Devanand] Univ Delhi S Campus, Dept Microbiol, New Delhi 110021, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Birmingham; University of Delhi	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.res.in		Nandicoori, Vinay/0000-0002-5682-4178; NAGARAJAN, Sathya Narayanan/0000-0002-3902-3678	Department of Biotechnology, India; Medical Research Council, United Kingdom; MRC [G0600105] Funding Source: UKRI; Medical Research Council [G0600105] Funding Source: researchfish	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Department of Biotechnology, India (to V. K. N. and R. P. R.).; Supported by a career development award from the Medical Research Council, United Kingdom.	Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; ASSELINEAU J, 1950, NATURE, V166, P782, DOI 10.1038/166782a0; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cohen-Gonsaud M, 2009, J BIOL CHEM, V284, P19290, DOI 10.1074/jbc.M109.019653; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; DeLano W. L., 2002, PYMOL MOL GRAPHIES S; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384	44	55	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37860	37871		10.1074/jbc.M110.143131	http://dx.doi.org/10.1074/jbc.M110.143131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864541	Green Published, hybrid			2022-12-27	WOS:000284424000076
J	Nakamura, S; Hayashi, K; Iwasaki, K; Fujioka, T; Egusa, H; Yatani, H; Sobue, K				Nakamura, Seiji; Hayashi, Ken'ichiro; Iwasaki, Kazuhiro; Fujioka, Tomoaki; Egusa, Hiroshi; Yatani, Hirofumi; Sobue, Kenji			Nuclear Import Mechanism for Myocardin Family Members and Their Correlation with Vascular Smooth Muscle Cell Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MEGAKARYOBLASTIC LEUKEMIA; ACTIN; LOCALIZATION; DIFFERENTIATION; GROWTH; COFACTOR; ALPHA	Myocardin (IMycd), which is essential for the differentiation of the smooth muscle cell lineage, is constitutively located in the nucleus, although its family members, myocardin-related transcription factors A and B (MRTF-A/B), mostly reside in the cytoplasm and translocate to the nucleus in response to Rho signaling. The mechanism for their nuclear import is unclear. Here we investigated the mechanism for the nuclear import of Mycd family members and demonstrated any correlation between such mechanism and the phenotype of vascular smooth muscle cells (IVSMCs). In cultured VSMCs, the knockdown of importin beta 1 inhibited the nuclear import of Mycd and MRTF-A/B. Their NH2-terminal basic domain was identified as a binding site for importin alpha/Chi 1 by in vitro analyses. However, Mycd had a higher affinity for importin alpha/beta 1 than did MRTF-A/B, even in the absence of G-actin, and Mycd affinity for importin alpha 1/beta 1 was stronger than for any other importin alpha/beta 1 heterodimers. The binding of Mycd to importin alpha/beta 1 was insensitive to G-actin, whereas that of MRTF-A/B was differently inhibited by G-actin. In dedifferentiated VSMCs, the levels of importins alpha 1 and beta 1 were reduced concomitant with down-regulation of Mycd, serum response factor, and smooth muscle cell markers. By contrast, in differentiated VSMCs, their expressions were up-regulated. Thus, the nuclear import of Mycd family members in VSMCs depends on importin alpha/beta 1, and their relative affinities for importin alpha/beta 1 heterodimers determine Mycd nuclear import. The expression of Mycd nuclear import machineries is related to the expression levels of VSMC phenotype-dependent smooth muscle cell markers.	[Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Suita, Osaka 5650871, Japan; [Sobue, Kenji] Osaka Univ, Grad Sch Med, Res Ctr Child Mental Dev, Suita, Osaka 5650871, Japan; [Nakamura, Seiji; Egusa, Hiroshi; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka 5650871, Japan; [Iwasaki, Kazuhiro; Fujioka, Tomoaki] Iwate Med Univ, Dept Urol, Morioka, Iwate 0208505, Japan	Osaka University; Osaka University; Osaka University; Iwate Medical University	Sobue, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp	Egusa, Hiroshi/AFT-9694-2022	Egusa, Hiroshi/0000-0002-0200-8132	Ministry of Education, Science, Sports, and Culture of Japan [20590279, 15GS0312]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan 20590279 (to K. H.) and 15GS0312 (to K. S.).	Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; THIERBACH G, 1990, APPL MICROBIOL BIOT, V32, P443, DOI 10.1007/BF00903780; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yoneda Y, 1997, J BIOCHEM, V121, P811	29	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37314	37323		10.1074/jbc.M110.180786	http://dx.doi.org/10.1074/jbc.M110.180786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847050	hybrid, Green Published			2022-12-27	WOS:000284424000024
J	Varma, H; Yamamoto, A; Sarantos, MR; Hughes, RE; Stockwell, BR				Varma, Hemant; Yamamoto, Ai; Sarantos, Melissa R.; Hughes, Robert E.; Stockwell, Brent R.			Mutant Huntingtin Alters Cell Fate in Response to Microtubule Depolymerization via the GEF-H1-RhoA-ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRIATAL SPINY NEURONS; FAST AXONAL-TRANSPORT; MITOTIC SPINDLE; GENE-EXPRESSION; WILD-TYPE; DISEASE; SURVIVAL; PROTEIN; DEATH; RHO	Cellular responses to drug treatment show tremendous variations. Elucidating mechanisms underlying these variations is critical for predicting therapeutic responses and developing personalized therapeutics. Using a small molecule screening approach, we discovered how a disease causing allele leads to opposing cell fates upon pharmacological perturbation. Diverse microtubule-depolymerizing agents protected mutant huntingtin-expressing cells from cell death, while being toxic to cells lacking mutant huntingtin or those expressing wild-type huntingtin. Additional neuronal cell lines and primary neurons from Huntington disease mice also showed altered survival upon microtubule depolymerization. Transcription profiling revealed that microtubule depolymerization induced the auto-crine growth factor connective tissue growth factor and activated ERK survival signaling. The genotype-selective rescue was dependent upon increased RhoA protein levels in mutant huntingtin-expressing cells, because inhibition of RhoA, its downstream effector, Rho-associated kinase ( ROCK), or a microtubule-associated RhoA activator, guanine nucleotide exchange factor-H1 (GEF-H1), all attenuated the rescue. Conversely, RhoA overexpression in cells lacking mutant huntingtin conferred resistance to microtubule-depolymerizer toxicity. This study elucidates a novel pathway linking microtubule stability to cell survival and provides insight into how genetic context can dramatically alter cellular responses to pharmacological interventions.	Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, Fairchild Ctr 614, New York, NY 10027 USA; [Yamamoto, Ai] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Sarantos, Melissa R.; Hughes, Robert E.] Buck Inst Age Res, Novato, CA 94945 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Buck Institute for Research on Aging	Stockwell, BR (corresponding author), Columbia Univ, Dept Chem, Fairchild Ctr 614, MC 2406,1212 Amsterdam Ave, New York, NY 10027 USA.	bstockwell@columbia.edu	Stockwell, Brent R/AAE-7200-2019; Yamamoto, Ai/D-1100-2011	Stockwell, Brent R/0000-0002-3532-3868; 	National Institutes of Health [5R01GM085081, RO1NS050199, R01NS055247, T32 AG000266-10]; Parkinson's Disease Foundation; High Q Foundation; Arnold and Mabel Beckman Foundation; Cure Huntington Disease Initiative, Inc.; Hereditary Disease Foundation; Burroughs Wellcome Fund; Buck Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055247, R01NS050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; High Q Foundation; Arnold and Mabel Beckman Foundation; Cure Huntington Disease Initiative, Inc.; Hereditary Disease Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Buck Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM085081 (to B. R. S.), RO1NS050199 (to A. Y.), R01NS055247, and Training Grant T32 AG000266-10 (to M. R. S.), grants from the Parkinson's Disease Foundation (to A. Y.), the High Q Foundation (to H. V.), a Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation, Cure Huntington Disease Initiative, Inc., Hereditary Disease Foundation, a Burroughs Wellcome Fund Career Award at the Scientific Interface (to B. R. S.), and the Buck Trust (to R. E. H.).	Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bell J, 2004, NATURE, V429, P453, DOI 10.1038/nature02624; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chatterjee K, 2007, J MOL CELL CARDIOL, V43, P327, DOI 10.1016/j.yjmcc.2007.06.005; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Chowdhury I, 2004, EUR J BIOCHEM, V271, P4436, DOI 10.1111/j.1432-1033.2004.04382.x; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Feng GP, 2000, J CLIN INVEST, V105, P329, DOI 10.1172/JCI7398; Ferrante R. J., 2009, J BIOCHIM BIOPHYS AC, P506; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Godin JD, 2010, EMBO J, V29, P2433, DOI 10.1038/emboj.2010.117; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Makaryus JN, 2007, HEMATOLOGY, V12, P349, DOI 10.1080/10245330701255254; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakamura K, 2001, J CEREBR BLOOD F MET, V21, P876, DOI 10.1097/00004647-200107000-00013; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Ogawa M, 2007, P NATL ACAD SCI USA, V104, P14789, DOI 10.1073/pnas.0706945104; Orso G, 2005, J CLIN INVEST, V115, P3026, DOI 10.1172/JCI24694; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Picard C, 2006, CURR OPIN IMMUNOL, V18, P383, DOI 10.1016/j.coi.2006.05.005; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Ross CA, 2004, CELL, V118, P4, DOI 10.1016/j.cell.2004.06.022; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Saji K, 2007, TOHOKU J EXP MED, V213, P139, DOI 10.1620/tjem.213.139; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; STAHELIN HF, 1991, CANCER RES, V51, P5; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; TOBEY RA, 1972, EXP CELL RES, V75, P460, DOI 10.1016/0014-4827(72)90453-3; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Varani K, 2007, NEUROBIOL DIS, V27, P36, DOI 10.1016/j.nbd.2007.03.011; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Varma H, 2007, NAT CHEM BIOL, V3, P99, DOI 10.1038/nchembio852; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zuchner T, 2008, CELL DEATH DIFFER, V15, P435, DOI 10.1038/sj.cdd.4402261	81	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37445	37457		10.1074/jbc.M110.125542	http://dx.doi.org/10.1074/jbc.M110.125542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858895	Green Published, hybrid			2022-12-27	WOS:000284424000037
J	Bourguignon, LYW; Wong, G; Earle, C; Krueger, K; Spevak, CC				Bourguignon, Lilly Y. W.; Wong, Gabriel; Earle, Christine; Krueger, Katherine; Spevak, Christina C.			Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD44 INTERACTION; HYALURONIC-ACID; GENE-EXPRESSION; TYROSINE KINASES; FOCAL ADHESIONS; STRESS FIBERS; CANCER CELLS; MIGRATION; PHOSPHORYLATION; METASTASIS	Dysregulation of microRNAs is observed in many cancers, including breast cancer. In particular, miR-10b appears to play an important role in tumor cell invasion and breast cancer progression. In this study, we investigated hyaluronan (HA)-induced CD44 (a primary HA receptor) interaction with c-Src kinase and the transcriptional factor, Twist, in breast tumor cells (MDA-MB-231 cells). Our results indicate that HA binding to CD44 promotes c-Src kinase activation, which, in turn, increases Twist phosphorylation, leading to the nuclear translocation of Twist and transcriptional activation. Further analyses reveal that miR-10b is controlled by an upstream promoter containing the Twist binding site(s), whereas ChIP assays demonstrate that stimulation of miR-10b expression by HA/CD44-activated c-Src is Twist-dependent in breast tumor cells. This process results in the reduction of a tumor suppressor protein (HOXD10), RhoA/RhoC up-regulation, Rho-kinase (ROK) activation, and breast tumor cell invasion. Treatment of MDA-MB-231 cells with PP2 (a c-Src inhibitor) or Twist-specific siRNAs effectively blocks HA-mediated Twist signaling events, abrogates miR-10b production, and increases HOXD10 expression. Subsequently, this c-Src/Twist signaling inhibition causes down-regulation of RhoA/RhoC expression and impairment of ROK-regulated cytoskeleton function (e.g. tumor cell invasion). To further evaluate the role of miR-10b in RhoGTPase signaling, MD-AMB-231 cells were also transfected with a specific anti-miR-10b inhibitor in order to silence miR-10b expression and block its target functions. Our results demonstrate that anti-miR-10b inhibitor not only enhances HOXD10 expression but also abrogates HA/CD44-mediated tumor cell behaviors in breast tumor cells. Taken together, these findings indicate that the HA-induced CD44 interaction with c-Src-activated Twist plays a pivotal role in miR-10b production, leading to the down-regulation of tumor suppressor protein (HOXD10), RhoGTPase-ROK activation, and tumor cell invasion. All of these events are critical prerequisite steps for the acquisition of metastatic properties by human breast cancer cells.	[Bourguignon, Lilly Y. W.] Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA; [Bourguignon, Lilly Y. W.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			National Institutes of Health [R01 CA66163, R01 CA78633, P01 AR39448]; Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA66163, R01 CA78633, and P01 AR39448. This work was also supported by a Veterans Affairs merit review grant.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Auvinen P, 2005, HISTOPATHOLOGY, V47, P420, DOI 10.1111/j.1365-2559.2005.02220.x; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2009, HYALURONAN IN CANCER BIOLOGY, 1ST EDITION, P89, DOI 10.1016/B978-012374178-3.10006-7; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; Ilangumaran S, 1998, BLOOD, V91, P3901; JAN YN, 1993, P NATL ACAD SCI USA, V90, P8305, DOI 10.1073/pnas.90.18.8305; JIANG WG, 1994, BRIT J SURG, V81, P1576, DOI 10.1002/bjs.1800811107; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Li XY, 2003, ONCOL RES, V13, P323; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Parker BS, 2003, CANCER BIOL THER, V2, P14; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Singleton PA, 2002, CELL MOTIL CYTOSKEL, V53, P293, DOI 10.1002/cm.10078; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Taher TEI, 1996, J BIOL CHEM, V271, P2863, DOI 10.1074/jbc.271.5.2863; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Torre C, 2010, ARCH OTOLARYNGOL, V136, P493, DOI 10.1001/archoto.2010.25; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu M, 2010, CANCER-AM CANCER SOC, V116, P2768, DOI 10.1002/cncr.25181; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	76	167	172	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36721	36735		10.1074/jbc.M110.162305	http://dx.doi.org/10.1074/jbc.M110.162305			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843787	hybrid, Green Published			2022-12-27	WOS:000284146100084
J	Zhang, W; Na, T; Wu, GJ; Jing, HY; Peng, JB				Zhang, Wei; Na, Tao; Wu, Guojin; Jing, Haiyan; Peng, Ji-Bin			Down-regulation of Intestinal Apical Calcium Entry Channel TRPV6 by Ubiquitin E3 Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; LIDDLE SYNDROME; DISTAL NEPHRON; WW DOMAINS; TRANSPORTER; PATHWAY; BINDING; HYPERTENSION; EXPRESSION; MEMBRANE	Nedd4-2 is an archetypal HECT ubiquitin E3 ligase that disposes target proteins for degradation. Because of the proven roles of Nedd4-2 in degradation of membrane proteins, such as epithelial Na+ channel, we examined the effect of Nedd4-2 on the apical Ca2+ channel TRPV6, which is involved in transcellular Ca2+ transport in the intestine using the Xenopus laevis oocyte system. We demonstrated that a significant amount of Nedd4-2 protein was distributed to the absorptive epithelial cells in ileum, cecum, and colon along with TRPV6. When co-expressed in oocytes, Nedd4-2 and, to a lesser extent, Nedd4 down-regulated the protein abundance and Ca2+ influx of TRPV6 and TRPV5, respectively. TRPV6 ubiquitination was increased, and its stability was decreased by Nedd4-2. The Nedd4-2 inhibitory effects on TRPV6 were partially blocked by proteasome inhibitor MG132 but not by the lysosome inhibitor chloroquine. The rate of TRPV6 internalization was not significantly altered by Nedd4-2. The HECT domain was essential to the inhibitory effect of Nedd4-2 on TRPV6 and to their association. The WW1 and WW2 domains interacted with TRPV6 terminal regions, and a disruption of the interactions by D204H and D376H mutations in the WW1 and WW2 domains increased TRPV6 ubiquitination and degradation. Thus, WW1 and WW2 may serve as a molecular switch to limit the ubiquitination of TRPV6 by the HECT domain. In conclusion, Nedd4-2 may regulate TRPV6 protein abundance in intestinal epithelia by controlling TRPV6 ubiquitination.	[Zhang, Wei; Na, Tao; Wu, Guojin; Jing, Haiyan; Peng, Ji-Bin] Univ Alabama Birmingham, Div Nephrol, Dept Med, Nephrol Res & Training Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Peng, JB (corresponding author), Univ Alabama Birmingham, Div Nephrol, Dept Med, Nephrol Res & Training Ctr, 1900 Univ Blvd,ZRB 625, Birmingham, AL 35294 USA.	jpeng@uab.edu			National Institutes of Health [R01DK072154]; American Heart Association [09GRNT2160024]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK072154 (to J.-B. P.). This work was also supported by American Heart Association Greater SE Affiliate Grant 09GRNT2160024 (to J.-B. P.).	Araki N, 2008, HYPERTENSION, V51, P773, DOI 10.1161/HYPERTENSIONAHA.107.102061; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Boehmer C, 2007, FEBS LETT, V581, P5586, DOI 10.1016/j.febslet.2007.11.006; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Jiang Y, 2008, BIOCHEM BIOPH RES CO, V375, P225, DOI 10.1016/j.bbrc.2008.08.010; Jiang Y, 2007, AM J PHYSIOL-RENAL, V292, pF545, DOI 10.1152/ajprenal.00187.2006; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Na T, 2009, AM J PHYSIOL-RENAL, V296, pF1042, DOI 10.1152/ajprenal.90771.2008; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Palmada M, 2004, BIOCHEM BIOPH RES CO, V321, P1001, DOI 10.1016/j.bbrc.2004.07.064; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Peng JB, 2000, J BIOL CHEM, V275, P28186; Peng JB, 2001, GENOMICS, V76, P99, DOI 10.1006/geno.2001.6606; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Qi H, 2003, MOL CELL ENDOCRINOL, V210, P51, DOI 10.1016/j.mce.2003.08.009; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Van Cromphaut SJ, 2003, J BONE MINER RES, V18, P1725, DOI 10.1359/jbmr.2003.18.10.1725; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wood R J, 2001, BMC Physiol, V1, P11, DOI 10.1186/1472-6793-1-11; ZHANG W, 2009, FASEB J, V23; Zhang W, 2008, AM J PHYSIOL-RENAL, V295, pF1472, DOI 10.1152/ajprenal.90229.2008; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	46	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36586	36596		10.1074/jbc.M110.175968	http://dx.doi.org/10.1074/jbc.M110.175968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843805	hybrid, Green Published			2022-12-27	WOS:000284146100045
J	Bowman, BR; Lee, S; Wang, SY; Verdine, GL				Bowman, Brian R.; Lee, Seongmin; Wang, Shuyu; Verdine, Gregory L.			Structure of Escherichia coli AlkA in Complex with Undamaged DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-METHYLADENINE DNA; SACCHAROMYCES-CEREVISIAE; BASE-EXCISION; GLYCOSYLASE-I; INTRAHELICAL LESION; DUPLEX DNA; REPAIR; RECOGNITION; ENZYME; POLYMERASE	Because DNA damage is so rare, DNA glycosylases interact for the most part with undamaged DNA. Whereas the structural basis for recognition of DNA lesions by glycosylases has been studied extensively, less is known about the nature of the interaction between these proteins and undamaged DNA. Here we report the crystal structures of the DNA glycosylase AlkA in complex with undamaged DNA. The structures revealed a recognition mode in which the DNA is nearly straight, with no amino acid side chains inserted into the duplex, and the target base pair is fully intrahelical. A comparison of the present structures with that of AlkA recognizing an extrahelical lesion revealed conformational changes in both the DNA and protein as the glycosylase transitions from the interrogation of undamaged DNA to catalysis of nucleobase excision. Modeling studies with the cytotoxic lesion 3-methyladenine and accompanying biochemical experiments suggested that AlkA actively interrogates the minor groove of the DNA while probing for the presence of lesions.	[Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bowman, Brian R.; Lee, Seongmin; Wang, Shuyu; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	Gregory_verdine@harvard.edu	Wang, shuyu/GZM-3462-2022		National Institutes of Health [GM044853]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077935, R01GM044853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM044853 (to G.L.V.).; We thank Frank Murphy, Narayanasami Sukumar, and all of the staff of the Northeastern Collaborative Access Team (NE-CAT) at the Advanced Photon Source for assistance during data collection. We also thank Yevgeny Brudno for help with the melting temperature studies and Hariharan Jayaram, Danaya Pakotiprapha, Marie Spong, Rou-Jia Sung, Yan Qi, and members of the Verdine laboratory for useful discussions. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allan JM, 1998, CANCER RES, V58, P3965; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; BJELLAND S, 1993, NUCLEIC ACIDS RES, V21, P2045, DOI 10.1093/nar/21.9.2045; BJELLAND S, 1994, J BIOL CHEM, V269, P30489; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelward BP, 1998, J BIOL CHEM, V273, P5412, DOI 10.1074/jbc.273.9.5412; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; Ezaz-Nikpay K, 1994, Chem Biol, V1, P235, DOI 10.1016/1074-5521(94)90016-7; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; HABRAKEN Y, 1989, CARCINOGENESIS, V10, P489, DOI 10.1093/carcin/10.3.489; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Hollis T, 2000, EMBO J, V19, P758, DOI 10.1093/emboj/19.4.758; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Lee S, 2008, J AM CHEM SOC, V130, P11570, DOI 10.1021/ja8025328; Lindahl T, 2004, NATURE, V427, P598, DOI 10.1038/427598a; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; NAKABEPPU Y, 1984, J BIOL CHEM, V259, P3730; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Peng XH, 2006, NUCLEIC ACIDS RES, V34, P5987, DOI 10.1093/nar/gkl719; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; SAPARBAEV M, 1994, P NATL ACAD SCI USA, V91, P5873, DOI 10.1073/pnas.91.13.5873; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; THOMAS L, 1982, BIOCHEMISTRY-US, V21, P1162, DOI 10.1021/bi00535a009; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35783	35791		10.1074/jbc.M110.155663	http://dx.doi.org/10.1074/jbc.M110.155663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843803	Green Published, hybrid			2022-12-27	WOS:000283845300056
J	Li, D; Jackson, RA; Yusoff, P; Guy, GR				Li, Dan; Jackson, Rebecca A.; Yusoff, Permeen; Guy, Graeme R.			Direct Association of Sprouty-related Protein with an EVH1 Domain (SPRED) 1 or SPRED2 with DYRK1A Modifies Substrate/Kinase Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR STIMULATION; KINASE DYRK1A; DOWN-SYNDROME; DUAL-SPECIFICITY; ERK ACTIVATION; SUBCELLULAR-LOCALIZATION; PHOSPHORYLATION SITE; EXPRESSION PATTERN; DROSOPHILA-SPROUTY; RAS	The mammalian SPRED (Sprouty-related protein with an EVH1 domain) proteins include a family of three members, SPRED1-3. Currently, little is known about their biochemistry. The best described, SPRED1, has been shown to inhibit the Ras/ERK pathway downstream of Ras. All three SPREDs have a cysteine-rich domain (CRD) that has high homology to the CRD of the Sprouty family of proteins, several of which are also Ras/ERK inhibitors. In the belief that binding partners would clarify SPRED function, we assayed for their associated proteins. Here, we describe the direct and endogenous interaction of SPRED1 and SPRED2 with the novel kinase, DYRK1A. DYRK1A has become the subject of recent research focus as it plays a central role in Caenorhabditis elegans oocyte maturation and egg activation, and there is strong evidence that it could be involved in Down syndrome in humans. Both SPRED1 and SPRED2 inhibit the ability of DYRK1A to phosphorylate its substrates, Tau and STAT3. This inhibition occurs via an interaction of the CRD of the SPREDs with the kinase domain of DYRK1A. DYRK1A substrates must bind to the kinase to enable phosphorylation, and SPRED proteins compete for the same binding site to modify this process. Our accumulated evidence indicates that the SPRED proteins are likely physiological modifiers of DYRK1A.	[Li, Dan; Jackson, Rebecca A.; Yusoff, Permeen; Guy, Graeme R.] Inst Mol & Cell Biol, Signal Transduct Lab, Proteos 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Guy, GR (corresponding author), Inst Mol & Cell Biol, Signal Transduct Lab, 61 Biopolis Dr, Proteos 138673, Singapore.	mcbgg@imcb.a-star.edu.sg			Agency of Science and Technology Research, A*Star, Singapore	Agency of Science and Technology Research, A*Star, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Agency of Science and Technology Research, A*Star, Singapore.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Chow SY, 2009, J BIOL CHEM, V284, P19623, DOI 10.1074/jbc.M109.021600; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kirsch DG, 1998, J CLIN ONCOL, V16, P3158, DOI 10.1200/JCO.1998.16.9.3158; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Maenz B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-30; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Mardakheh FK, 2009, J CELL BIOL, V187, P265, DOI 10.1083/jcb.200905118; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Midgley RS, 2002, CRIT REV ONCOL HEMAT, V44, P109, DOI 10.1016/S1040-8428(01)00189-5; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Raich WB, 2003, GENETICS, V163, P571; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wiechmann S, 2003, BIOCHEM BIOPH RES CO, V302, P403, DOI 10.1016/S0006-291X(03)00148-7; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	67	18	19	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35374	35385		10.1074/jbc.M110.148445	http://dx.doi.org/10.1074/jbc.M110.148445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20736167	hybrid, Green Published			2022-12-27	WOS:000283845300015
J	Lu, LC; Hou, XH; Shi, SL; Korner, C; Stanley, P				Lu, Linchao; Hou, Xinghua; Shi, Shaolin; Koerner, Christian; Stanley, Pamela			Slc35c2 Promotes Notch1 Fucosylation and Is Required for Optimal Notch Signaling in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE-ADHESION-DEFICIENCY; NUCLEOTIDE-SUGAR TRANSPORTERS; GDP-FUCOSE TRANSPORTER; SIALIC ACID TRANSPORTER; FACTOR-LIKE REPEATS; O-FUCOSYLATION; PROTEIN O-FUCOSYL-TRANSFERASE-1; SUBSTRATE RECOGNITION; ENDOPLASMIC-RETICULUM; CONGENITAL DISORDER	Mammalian Notch receptors require modification by fucose on epidermal growth factor-like (EGF) repeats of their extracellular domain to respond optimally to signal induction by canonical Notch ligands. Inactivation of the Golgi GDP-fucose transporter Slc35c1 in mouse or human does not cause marked defects in Notch signaling during development, and shows milder fucosylation defects than those observed in mice unable to synthesize GDP-fucose, indicating the existence of another mechanism for GDP-fucose transport into the secretory pathway. We show here that fibroblasts from mice or humans lacking Slc35c1 exhibit robust Notch signaling in co-culture signaling assays. A potential candidate for a second GDP-fucose transporter is the related gene Slc35c2. Overexpression of Slc35c2 reduces expression of the fucosylated epitopes Lewis X and sialylated Lewis X in CHO cells, indicating competition with Slc35c1. The fucosylation of a Notch1 EGF repeat fragment that occurs in the endoplasmic reticulum was increased in CHO transfectants overexpressing Slc35c2. In CHO cells with low levels of Slc35c2, both Delta1- and Jagged1-induced Notch signaling were reduced, and the fucosylation of a Notch1 fragment was also decreased. Immunofluorescence microscopy of rat intestinal epithelial cells and HeLa cells, and analysis of rat liver membrane fractions showed that Slc35c2 is primarily colocalized with markers of the cis-Golgi network and endoplasmic reticulum-Golgi intermediate compartment (ERGIC). The combined results suggest that Slc35c2 is either a GDP-fucose transporter that competes with Slc35c1 for GDP-fucose, or a factor that otherwise enhances the fucosylation of Notch and is required for optimal Notch signaling in mammalian cells.	Yeshiva Univ, Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Koerner, Christian] Ctr Metab Dis Heidelberg Dept 1, Ctr Child & Adolescent Med, D-69120 Heidelberg, Germany	Yeshiva University; Albert Einstein College of Medicine		pamela.stanley@einstein.yu.edu	Lu, Linchao/F-5778-2014	Lu, Linchao/0000-0002-5560-0025; Shi, Shaolin/0000-0003-2297-6496; Stanley, Pamela/0000-0001-5704-3747	National Institutes of Health [RO1 95022]; NCI [RO1 36434, PO1 13330]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 95022 and RO1 36434 from the NCI (to P. S.) and NCI Grant PO1 13330 (to the Albert Einstein Cancer Center)	Aoki K, 2003, J BIOL CHEM, V278, P22887, DOI 10.1074/jbc.M302620200; Aoki K, 2001, J BIOL CHEM, V276, P21555, DOI 10.1074/jbc.M101462200; Aoki K, 1999, J BIOCHEM, V126, P940, DOI 10.1093/oxfordjournals.jbchem.a022538; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen W, 2005, GLYCOBIOLOGY, V15, P259, DOI 10.1093/glycob/cwi011; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; GINSBURG V, 1960, J BIOL CHEM, V235, P2196; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; Kim ML, 2008, MOL CELL NEUROSCI, V39, P452, DOI 10.1016/j.mcn.2008.07.026; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Maggioni A, 2007, BIOCHEM BIOPH RES CO, V362, P779, DOI 10.1016/j.bbrc.2007.08.070; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moran JL, 2009, DEV DYNAM, V238, P1803, DOI 10.1002/dvdy.21982; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Patnaik SK, 2004, J BIOL CHEM, V279, P49716, DOI 10.1074/jbc.M408755200; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Sturla L, 2003, J BIOL CHEM, V278, P26727, DOI 10.1074/jbc.M304068200; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Waterhouse CCM, 2010, GASTROENTEROLOGY, V138, P1079, DOI 10.1053/j.gastro.2009.10.049; WATZELE G, 1991, EUR J CELL BIOL, V56, P451; Yakubenia S, 2008, BLOOD, V112, P1472, DOI 10.1182/blood-2008-01-132035; YURCHENCO PD, 1977, BIOCHEMISTRY-US, V16, P944, DOI 10.1021/bi00624a021; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439; Zhou L, 2008, BLOOD, V112, P308, DOI 10.1182/blood-2007-11-115204	59	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36245	36254		10.1074/jbc.M110.126003	http://dx.doi.org/10.1074/jbc.M110.126003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837470	Green Published, hybrid			2022-12-27	WOS:000283845300100
J	Cho, HJ; Kim, K; Sohn, SY; Cho, HY; Kim, KJ; Kim, MH; Kim, D; Kim, E; Kang, BS				Cho, Hyo Je; Kim, Kyungsun; Sohn, Seo Yean; Cho, Ha Yeon; Kim, Kyung Jin; Kim, Myung Hee; Kim, Dockyu; Kim, Eungbin; Kang, Beom Sik			Substrate Binding Mechanism of a Type I Extradiol Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE; CATALYTIC MECHANISMS; O-XYLENE; CLEAVAGE; TOLUENE; METABOLISM; CATECHOLS; ENZYMES; FAMILY	A meta-cleavage pathway for the aerobic degradation of aromatic hydrocarbons is catalyzed by extradiol dioxygenases via a two-step mechanism: catechol substrate binding and dioxygen incorporation. The binding of substrate triggers the release of water, thereby opening a coordination site for molecular oxygen. The crystal structures of AkbC, a type I extradiol dioxygenase, and the enzyme substrate (3-methylcatechol) complex revealed the substrate binding process of extradiol dioxygenase. AkbC is composed of an N-domain and an active C-domain, which contains iron coordinated by a 2-His-1-carboxylate facial triad motif. The C-domain includes a beta-hairpin structure and a C-terminal tail. In substrate-bound AkbC, 3-methylcatechol interacts with the iron via a single hydroxyl group, which represents an intermediate stage in the substrate binding process. Structure-based mutagenesis revealed that the C-terminal tail and beta-hairpin form part of the substrate binding pocket that is responsible for substrate specificity by blocking substrate entry. Once a substrate enters the active site, these structural elements also play a role in the correct positioning of the substrate. Based on the results presented here, a putative substrate binding mechanism is proposed.	[Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Kyung Jin] POSTECH, Pohang Accelerator Lab, Pohang 790784, South Korea; [Kim, Kyungsun; Sohn, Seo Yean; Kim, Eungbin] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Kim, Dockyu] KORDI, Polar BioCtr, Korea Polar Res Inst, Inchon 406840, South Korea	Kyungpook National University; Pohang University of Science & Technology (POSTECH); Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Kim, E (corresponding author), 262 Seongsanno, Seoul 120749, South Korea.	eungbin@yonsei.ac.kr; bskang2@knu.ac.kr		, Eungbin/0000-0002-4851-4743	Ministry of Education, Science and Technology of the Republic of Korea; Brain Korea 21 scholarship; NRF [2010-0001440]	Ministry of Education, Science and Technology of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 scholarship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NRF	This work was supported by a grant from the Ministry of Education, Science and Technology of the Republic of Korea through the 21C Frontier Microbial Genomics and Applications Center Program.; Recipient of the Brain Korea 21 scholarship.; Recipient of the support of NRF through Basic Science Research Program Grants (2010-0001440).	BAYLY RC, 1966, BIOCHEM J, V101, P293, DOI 10.1042/bj1010293; Brivio M, 2009, ORG BIOMOL CHEM, V7, P1368, DOI 10.1039/b821559f; Broderick JB, 1999, ESSAYS BIOCHEM, V34, P173, DOI 10.1042/bse0340173; Bugg TDH, 2003, TETRAHEDRON, V59, P7075, DOI 10.1016/S0040-4020(03)00944-X; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRITSCHE W, 2005, ENV BIOTECHNOLOGY; FURUKAWA K, 1983, J BACTERIOL, V154, P1356, DOI 10.1128/JB.154.3.1356-1362.1983; Ishida T, 2004, J BIOCHEM, V135, P721, DOI 10.1093/jb/mvh089; Kim D, 2002, APPL ENVIRON MICROB, V68, P3270, DOI 10.1128/AEM.68.7.3270-3278.2002; Kim D, 2005, BIOCHEM BIOPH RES CO, V326, P880, DOI 10.1016/j.bbrc.2004.11.123; Kim DY, 2004, APPL ENVIRON MICROB, V70, P7086, DOI 10.1128/AEM.70.12.7086-7092.2004; Lin G, 2001, J AM CHEM SOC, V123, P5030, DOI 10.1021/ja004280u; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3882, DOI 10.1128/AEM.67.9.3882-3887.2001; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Siegbahn PEM, 2004, J AM CHEM SOC, V126, P8919, DOI 10.1021/ja0493805; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Vaillancourt FH, 2002, J BIOL CHEM, V277, P2019, DOI 10.1074/jbc.M106890200; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422	28	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34643	34652		10.1074/jbc.M110.130310	http://dx.doi.org/10.1074/jbc.M110.130310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810655	Green Published, hybrid			2022-12-27	WOS:000283659100040
J	Guo, SS; Bao, SL				Guo, Shaoshi; Bao, Shilai			srGAP2 Arginine Methylation Regulates Cell Migration and Cell Spreading through Promoting Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BAR PROTEINS; MEMBRANE INVAGINATION; SIGNAL-TRANSDUCTION; NEURONAL MIGRATION; ACTIN CYTOSKELETON; RHO-GTPASES; DOMAIN; PRMT5; METHYLTRANSFERASE; METASTASIS	The Slit-Robo GTPase-activating proteins (srGAPs) are critical for neuronal migration through inactivation of Rho GTPases Cdc42, Rac1, and RhoA. Here we report that srGAP2 physically interacts with protein arginine methyltransferase 5 (PRMT5). srGAP2 localizes to the cytoplasm and plasma membrane protrusion. srGAP2 knockdown reduces cell adhesion spreading and increases cell migration, but has no effect on cell proliferation. PRMT5 binds to the N terminus of srGAP2 (225-538 aa) and methylates its C-terminal arginine residue Arg-927. The methylation mutant srGAP2-R927A fails to rescue the cell spreading rate, is unable to localize to the plasma membrane leading edge, and perturbs srGAP2 homodimer formation mediated by the F-BAR domain. These results suggest that srGAP2 arginine methylation plays important roles in cell spreading and cell migration through influencing membrane protrusion.	[Bao, Shilai] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Guo, Shaoshi] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bao, SL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol & Dev Biol, Key Lab Mol & Dev Biol, 1 W Beichen Rd, Beijing 100101, Peoples R China.	slbao@genetics.ac.cn			National Basic Research Program of China [2005CB22400]; National High Technology Development Program [2006AA02Z140]; Chinese Academy of Sciences [KSCX1-YW-R-59]; National Natural Sciences Foundation of China [30670479]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Development Program(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2005CB22400), National High Technology Development Program (2006AA02Z140), Chinese Academy of Sciences (KSCX1-YW-R-59), and National Natural Sciences Foundation of China (30670479).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; ASPENSTRO MP, 1997, CURR BIOL, V7, P479; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; CHARI A, 2008, U Cell, V135, P497; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; DELA H, 1959, J BIOL CHEM */* G L, V234, P603; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shu S, 2006, P NATL ACAD SCI USA, V103, P19788, DOI 10.1073/pnas.0609385103; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Takenawa T, 2001, J CELL SCI, V114, P1801; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56	43	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35133	35141		10.1074/jbc.M110.153429	http://dx.doi.org/10.1074/jbc.M110.153429			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810653	Green Published, hybrid			2022-12-27	WOS:000283659100087
J	Haque, ME; Spremulli, LL; Fecko, CJ				Haque, Md Emdadul; Spremulli, Linda L.; Fecko, Christopher J.			Identification of Protein-Protein and Protein-Ribosome Interacting Regions of the C-terminal Tail of Human Mitochondrial Inner Membrane Protein Oxa1L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; XANTHENE DYES; FLUCTUATIONS; TRANSLATION; RHODAMINE; INSERTION; MOLECULE; BINDING	The mammalian mitochondrial inner membrane protein Oxa1L is involved in the insertion of a number of mitochondrial translation products into the inner membrane. During this process, the C-terminal tail of Oxa1L (Oxa1L-CTT) binds mitochondrial ribosomes and is believed to coordinate the synthesis and membrane insertion of the nascent chains into the membrane. The C-terminal tail of Oxa1L does not contain any Cys residues. Four variants of this protein with a specifically placed Cys residue at position 4, 39, 67, or 94 of Oxa1L-CTT have been prepared. These Cys residues have been derivatized with a fluorescent probe, tetramethylrhodamine-5-maleimide, for biophysical studies. Oxa1L-CTT forms oligomers cooperatively with a binding constant in the submicromolar range. Fluorescence anisotropy and fluorescence lifetime measurements indicate that contacts near a long helix close to position 39 of Oxa1L-CTT occur during oligomer formation. Fluorescence correlation spectroscopy measurements demonstrate that all of the Oxa1L-CTT derivatives bind to mammalian mitochondrial ribosomes. Steady-state fluorescence quenching and fluorescence lifetime data indicate that there are extensive contacts between Oxa1L-CTT and the ribosome-encompassing regions around positions 39, 67, and 94. The results of this study suggest that Oxa1L-CTT undergoes conformational changes and induced oligomer formation when it binds to the ribosome.	[Haque, Md Emdadul; Spremulli, Linda L.; Fecko, Christopher J.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Fecko, CJ (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	cfecko@email.unc.edu			National Institutes of Health [GM32734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32734 (to L. L. S.).	Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; CASEY KG, 1988, J PHYS CHEM-US, V92, P6590, DOI 10.1021/j100334a023; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; Hamman BD, 1996, J BIOL CHEM, V271, P7568, DOI 10.1074/jbc.271.13.7568; Haque ME, 2010, J BIOL CHEM, V285, P28353, DOI 10.1074/jbc.M110.148262; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Jermutus L, 2002, EUR BIOPHYS J BIOPHY, V31, P179, DOI 10.1007/s00249-001-0204-0; Jia YW, 1997, P NATL ACAD SCI USA, V94, P7932, DOI 10.1073/pnas.94.15.7932; Kao PH, 2007, TOXICON, V50, P952, DOI 10.1016/j.toxicon.2007.07.011; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; MACDONALD RI, 1990, J BIOL CHEM, V265, P13533; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Magde D, 1999, PHOTOCHEM PHOTOBIOL, V70, P737, DOI 10.1111/j.1751-1097.1999.tb08277.x; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Nomura Y, 2001, CYTOMETRY, V44, P1; OBRIEN TW, 1993, TRANSLATIONAL APPARATUS, P575; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Sato T, 2009, J BIOL CHEM, V284, P14819, DOI 10.1074/jbc.M809520200; Sherman E, 2008, BIOPHYS J, V94, P4819, DOI 10.1529/biophysj.107.120220; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623	26	24	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34991	34998		10.1074/jbc.M110.163808	http://dx.doi.org/10.1074/jbc.M110.163808			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739282	Green Published, hybrid			2022-12-27	WOS:000283659100073
J	Park, J; Kang, SI; Lee, SY; Zhang, XF; Kim, MS; Beers, LF; Lim, DS; Avruch, J; Kim, HS; Lee, SB				Park, Jikyoung; Kang, Soo Im; Lee, Sun-Young; Zhang, Xian F.; Kim, Myoung Shin; Beers, Lisa F.; Lim, Dae-Sik; Avruch, Joseph; Kim, Ho-Shik; Lee, Sean Bong			Tumor Suppressor Ras Association Domain Family 5 (RASSF5/NORE1) Mediates Death Receptor Ligand-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN CONDENSATION; NUCLEAR TRANSLOCATION; HIPPO PATHWAY; KINASE MST1; RASSF1A; ACTIVATION; PROTEIN; IDENTIFICATION; NORE1; PHOSPHORYLATION	Epigenetic silencing of RASSF (Ras association domain family) genes RASSF1 and RASSF5 (also called NORE1) by CpG hypermethylation is found frequently in many cancers. Although the physiological roles of RASSF1 have been studied in some detail, the exact functions of RASSF5 are not well understood. Here, we show that RASSF5 plays an important role in mediating apoptosis in response to death receptor ligands, TNF-alpha and TNF-related apoptosis-inducing ligand. Depletion of RASSF5 by siRNA significantly reduced TNF-alpha-mediated apoptosis, likely through its interaction with proapoptotic kinase MST1, a mammalian homolog of Hippo. Consistent with this, siRNA knockdown of MST1 also resulted in resistance to TNF-alpha-induced apoptosis. To further study the role of Rassf5 in vivo, we generated Rassf5-deficient mouse. Inactivation of Rassf5 in mouse embryonic fibroblasts (MEFs) resulted in resistance to TNF-alpha- and TNF-related apoptosis-inducing ligand-mediated apoptosis. Importantly, Rassf5-null mice were significantly more resistant to TNF-alpha-induced apoptosis and failed to activate Mst1. Loss of Rassf5 also resulted in spontaneous immortalization of MEFs at earlier passages than the control MEFs, and Rassf5-null immortalized MEFs, but not the immortalized wild type MEFs, were fully transformed by K-RasG12V. Together, our results demonstrate a direct role for RASSF5 in death receptor ligand-mediated apoptosis and provide further evidence for RASSF5 as a tumor suppressor.	[Park, Jikyoung; Kang, Soo Im; Kim, Myoung Shin; Beers, Lisa F.; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Lee, Sun-Young; Kim, Ho-Shik] Catholic Univ Korea, Coll Med, Dept Biochem, Seoul 137701, South Korea; [Zhang, Xian F.; Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Dept Biol Sci, Natl Res Lab Mol Genet, Taejon 305701, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Catholic University of Korea; Harvard University; Massachusetts General Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Lee, SB (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, 9000 Rockville Pike,Bldg 10,9D11, Bethesda, MD 20892 USA.	seanL@intra.niddk.nih.gov	Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Lee, Sean/0000-0001-6211-3498	National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056002] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a grant the National Institutes of Health NIDDK Intramural Research Program (to S. B. L.).	Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hesson L, 2003, ONCOGENE, V22, P947, DOI 10.1038/sj.onc.1206191; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Kakeya H, 1998, CANCER RES, V58, P4888; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; LEIST M, 1994, J IMMUNOL, V153, P1778; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Morris MR, 2003, ONCOGENE, V22, P6794, DOI 10.1038/sj.onc.1206914; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; PRASKOVA M, 2004, J BIOCH J */* BIOCH, V381, P453; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tommasi S, 2005, CANCER RES, V65, P92; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; VANDER W, 2005, MOL CELL BIOL */* A, V25, P8356; VANDER WL, 2007, BIOCHIM BIOPHYS ACTA, V1776, P58; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339	43	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35029	35038		10.1074/jbc.M110.165506	http://dx.doi.org/10.1074/jbc.M110.165506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810663	Green Published, hybrid			2022-12-27	WOS:000283659100077
J	Riedinger, C; Boehringer, J; Trempe, JF; Lowe, ED; Brown, NR; Gehring, K; Noble, MEM; Gordon, C; Endicott, JA				Riedinger, Christiane; Boehringer, Jonas; Trempe, Jean-Francois; Lowe, Edward D.; Brown, Nicholas R.; Gehring, Kalle; Noble, Martin E. M.; Gordon, Colin; Endicott, Jane A.			Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBA DOMAIN; REGULATORY PARTICLE; 26S PROTEASOME; UBIQUITIN RECOGNITION; PROTEIN COMPLEXES; BINDING PROTEIN; DEGRADATION; SPECIFICITY; REVEALS; RAP80	Schizosaccharomyces pombe Rpn10 (SpRpn10) is a proteasomal ubiquitin (Ub) receptor located within the 19 S regulatory particle where it binds to subunits of both the base and lid subparticles. We have solved the structure of full-length SpRpn10 by determining the crystal structure of the von Willebrand factor type A domain and characterizing the full-length protein by NMR. We demonstrate that the single Ub-interacting motif (UIM) of SpRpn10 forms a 1:1 complex with Lys(48)-linked diUb, which it binds selectively over monoUb and Lys(63)-linked diUb. We further show that the SpRpn10 UIM binds to SpRpn12, a subunit of the lid subparticle, with an affinity comparable with Lys(48)-linked diUb. This is the first observation of a UIM binding other than a Ub fold and suggests that SpRpn12 could modulate the activity of SpRpn10 as a proteasomal Ub receptor.	[Riedinger, Christiane; Boehringer, Jonas; Lowe, Edward D.; Brown, Nicholas R.; Noble, Martin E. M.; Endicott, Jane A.] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England; [Trempe, Jean-Francois; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Gordon, Colin] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Oxford; McGill University; University of Edinburgh	Endicott, JA (corresponding author), Univ Oxford, Dept Biochem, Lab Mol Biophys, S Parks Rd, Oxford OX1 3QU, England.	jane.endicott@bioch.ox.ac.uk	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013; Lowe, Edward/AAP-5381-2021	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Lowe, Edward/0000-0002-1757-0208; Riedinger, Christiane/0000-0002-9310-9894; Endicott, Jane/0000-0003-4868-0116; Noble, Martin/0000-0002-3595-9807	United Kingdom Medical Research Council; Canadian Institutes of Health Research; Wellcome Trust; MRC [G0700053, MC_U127584486] Funding Source: UKRI; Medical Research Council [MC_U127584486, G0700053] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom Medical Research Council, the Canadian Institutes of Health Research, and the Wellcome Trust.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Drews O, 2007, PROTEOMICS, V7, P1047, DOI 10.1002/pmic.200600574; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Walters KJ, 2009, EMBO J, V28, P2307, DOI 10.1038/emboj.2009.221; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010	50	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33992	34003		10.1074/jbc.M110.134510	http://dx.doi.org/10.1074/jbc.M110.134510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739285	Green Published, hybrid			2022-12-27	WOS:000283354000046
J	Ding, Y; Kim, JK; Kim, SI; Na, HJ; Jun, SY; Lee, SJ; Choi, ME				Ding, Yan; Kim, Jin Kuk; Kim, Sung Il; Na, Hee-Jun; Jun, Soo Young; Lee, Seon Jin; Choi, Mary E.			TGF-beta 1 Protects against Mesangial Cell Apoptosis via Induction of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; I-KAPPA-B; DEPENDENT-KINASE; TRANSFORMING GROWTH-FACTOR-BETA-1; SMAD PATHWAYS; BETA; ACTIVATION; DEATH; INHIBITION; TAK1	Autophagy can lead to cell death in response to stress, but it can also act as a protective mechanism for cell survival. We show that TGF-beta 1 induces autophagy and protects glomerular mesangial cells from undergoing apoptosis during serum deprivation. Serum withdrawal rapidly induced autophagy within 1 h in mouse mesangial cells (MMC) as determined by increased microtubule-associated protein 1 light chain 3 (LC3) levels and punctate distribution of the autophagic vesicle-associated-form LC3-II. We demonstrate that after 1 h there was a time-dependent decrease in LC3 levels that was accompanied by induction of apoptosis, evidenced by increases in cleaved caspase 3. However, treatment with TGF-beta 1 resulted in induction of the autophagy protein LC3 while suppressing caspase 3 activation. TGF-beta 1 failed to rescue MMC from serum deprivation-induced apoptosis upon knockdown of LC3 by siRNA and in MMC from LC3 null (LC3(-/-)) mice. We show that TGF-beta 1 induced autophagy through TAK1 and Akt activation, and inhibition of PI3K-Akt pathway by LY294002 or dominant-negative Akt suppressed LC3 levels and enhanced caspase 3 activation. TGF-beta 1 also up-regulated cyclin D1 and E protein levels while down-regulating p27, thus stimulating cell cycle progression. Bafilomycin A1, but not MG132, blocked TGF-beta 1 down-regulation of p27, suggesting that p27 levels were regulated through autophagy. Taken together, our data indicate that TGF-beta 1 rescues MMC from serum deprivation-induced apoptosis via induction of autophagy through activation of the Akt pathway. The autophagic process may constitute an adaptive mechanism to glomerular injury by inhibiting apoptosis and promoting mesangial cell survival.	[Ding, Yan; Kim, Jin Kuk; Kim, Sung Il; Na, Hee-Jun; Jun, Soo Young; Choi, Mary E.] Harvard Univ, Sch Med, Dept Med, Div Renal,Brigham & Womens Hosp, 4 Black Fan Circle,HIM-5, Boston, MA 02115 USA; [Ding, Yan] Harbin Med Univ, Affiliated Hosp 4, Dept Nephrol, Harbin 150001, Peoples R China; [Kim, Jin Kuk] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon 420767, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harbin Medical University; Soonchunhyang University	Choi, ME (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Renal,Brigham & Womens Hosp, 4 Black Fan Circle,HIM-5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu	Lee, Seon-Jin/AAJ-8258-2020	JUN, SOO YOUNG`/0000-0001-6516-3140; Lee, Seon-Jin/0000-0001-7214-7536	National Institutes of Health [R01 DK57661 (NIDDK)]; American Heart Association [0665379U]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK57661 (NIDDK; to M. E. C.). This work was also supported by American Heart Association Beginning Grant-in-aid 0665379U and by the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (to S. I. K.).	Andjelic S, 1997, J IMMUNOL, V158, P2527; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brown TL, 1999, J BIOL CHEM, V274, P23256, DOI 10.1074/jbc.274.33.23256; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen HH, 2003, CELL DEATH DIFFER, V10, P516, DOI 10.1038/sj.cdd.4401171; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Gajewska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P143; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Godlewski MM, 2007, J PHYSIOL PHARMACOL, V58, P97; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Huang Y, 2000, J BIOL CHEM, V275, P18234, DOI 10.1074/jbc.M909431199; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim G, 2002, ARTHRITIS RHEUM-US, V46, P1504, DOI 10.1002/art.10314; Kim SM, 2007, AM J PHYSIOL-RENAL, V292, pF415, DOI 10.1152/ajprenal.00317.2006; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; LOTEM J, 1992, BLOOD, V80, P1750; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Narita Y, 2002, CANCER RES, V62, P6764; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; Ren Y, 2009, BMB REP, V42, P599, DOI 10.5483/BMBRep.2009.42.9.599; Roberts A.B., 2001, SCI STKE, V113, ppe43, DOI [10.1126/stke.2001.113.pe43, DOI 10.1126/STKE.2001.113.PE43]; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Robson CN, 1999, J ENDOCRINOL, V160, P257, DOI 10.1677/joe.0.1600257; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schoecklmann HO, 1997, KIDNEY INT, V51, P1228, DOI 10.1038/ki.1997.168; Shankland SJ, 1996, KIDNEY INT, V50, P1230, DOI 10.1038/ki.1996.432; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zeng XH, 2008, CANCER RES, V68, P2384, DOI 10.1158/0008-5472.CAN-07-6163; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	82	114	123	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37909	37919		10.1074/jbc.M109.093724	http://dx.doi.org/10.1074/jbc.M109.093724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876581	hybrid, Green Published			2022-12-27	WOS:000284424000080
J	Frijns, E; Sachs, N; Kreft, M; Wilhelmsen, K; Sonnenberg, A				Frijns, Evelyne; Sachs, Norman; Kreft, Maaike; Wilhelmsen, Kevin; Sonnenberg, Arnoud			EGF-induced MAPK Signaling Inhibits Hemidesmosome Formation through Phosphorylation of the Integrin beta 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH; ALPHA-6-BETA-4 INTEGRIN; EPIDERMOLYSIS-BULLOSA; S6 KINASE; IN-VITRO; SUBUNIT; PLECTIN; DOMAIN; ADHESION	Migration of keratinocytes requires a regulated and dynamic turnover of hemidesmosomes (HDs). We and others have previously identified three serine residues on the integrin beta 4 cytoplasmic domain that play a critical role in the regulation of HD disassembly. In this study we show that only two of these residues (Ser-1356 and Ser-1364) are phosphorylated in keratinocytes after stimulation with either PMA or EGF. Furthermore, in direct contrast to previous studies performed in vitro, we found that the PMA- and EGF-stimulated phosphorylation of beta 4 is not mediated by PKC, but by ERK1/2 and its downstream effector kinase p90RSK1/2. EGF-stimulated phosphorylation of beta 4 increased keratinocyte migration, and reduced the number of stable HDs. Furthermore, mutation of the two serines in beta 4 to phospho-mimicking aspartic acid decreased its interaction with the cytoskeletal linker protein plectin, as well as the strength of alpha 6 beta 4-mediated adhesion to laminin-332. During mitotic cell rounding, when the overall cell-substrate area is decreased and the number of HDs is reduced, beta 4 was only phosphorylated on Ser-1356 by a distinct, yet unidentified, kinase. Collectively, these data demonstrate an important role of beta 4 phosphorylation on residues Ser-1356 and Ser-1364 in the formation and/or stability of HDs.	[Frijns, Evelyne; Sachs, Norman; Kreft, Maaike; Wilhelmsen, Kevin; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Sonnenberg, A (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.sonnenberg@nki.nl		Sachs, Norman/0000-0002-5467-7151	Dutch Cancer Society; Netherlands Science Organization (NWO/ALW)	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Science Organization (NWO/ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Dutch Cancer Society and the Netherlands Science Organization (NWO/ALW).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; BUTT E, 1994, J BIOL CHEM, V269, P14509; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chung HJ, 2010, DERMATOL CLIN, V28, P43, DOI 10.1016/j.det.2009.10.005; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Koster J, 2001, J INVEST DERMATOL, V117, P1405, DOI 10.1046/j.0022-202x.2001.01567.x; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Litjens SHM, 2003, MOL BIOL CELL, V14, P4039, DOI 10.1091/mbc.E03-05-0268; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Malecz N, 1996, J BIOL CHEM, V271, P8203, DOI 10.1074/jbc.271.14.8203; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Niessen CM, 1997, J CELL SCI, V110, P1705; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; OrianRousseau V, 1996, DEV DYNAM, V206, P12, DOI 10.1002/(SICI)1097-0177(199605)206:1<12::AID-AJA2>3.0.CO;2-3; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shah BH, 2005, MOL PHARMACOL, V67, P184, DOI 10.1124/mol.104.003533; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; UEMATSU J, 1994, J BIOCHEM-TOKYO, V115, P469, DOI 10.1093/oxfordjournals.jbchem.a124361; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	42	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37650	37662		10.1074/jbc.M110.138818	http://dx.doi.org/10.1074/jbc.M110.138818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870721	Green Published, hybrid			2022-12-27	WOS:000284424000057
J	Mao, P; Smerdon, MJ				Mao, Peng; Smerdon, Michael J.			Yeast Deubiquitinase Ubp3 Interacts with the 26 S Proteasome to Facilitate Rad4 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UV-INDUCED UBIQUITYLATION; UBIQUITIN LIGASE COMPLEX; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; PROTEIN; DAMAGE; RECOGNITION; PATHWAY; ENZYME	Deubiquitinating enzymes (DUBs) function in a variety of cellular processes by removing ubiquitin moieties from substrates, but their role in DNA repair has not been elucidated. Yeast Rad4-Rad23 heterodimer is responsible for recognizing DNA damage in nucleotide excision repair (NER). Rad4 binds to UV damage directly while Rad23 stabilizes Rad4 from proteasomal degradation. Here, we show that disruption of yeast deubiquitinase UBP3 leads to enhanced UV resistance, increased repair of UV damage and Rad4 levels in rad23 Delta cells, and elevated Rad4 stability. A catalytically inactive Ubp3 (Ubp3-C469A), however, is unable to affect NER or Rad4. Consistent with its role in down-regulating Rad4, Ubp3 physically interacts with Rad4 and the proteasome, both in vivo and in vitro, suggesting that Ubp3 associates with the proteasome to facilitate Rad4 degradation and thus suppresses NER.	[Mao, Peng; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu			NIEHS [ES002614]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002614, R01ES002614] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES002614 from NIEHS.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; den Dulk B, 2008, DNA REPAIR, V7, P858, DOI 10.1016/j.dnarep.2008.02.004; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Friedberg E. C., 2006, DNA REPAIR MUTAGENES, P317; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kaiser P, 2005, METHOD ENZYMOL, V399, P243, DOI 10.1016/S0076-6879(05)99016-2; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kvint K, 2008, MOL CELL, V30, P498, DOI 10.1016/j.molcel.2008.04.018; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Lommel L, 2002, CURR GENET, V42, P9, DOI 10.1007/s00294-002-0332-9; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mueller JP, 1996, MOL CELL BIOL, V16, P2361; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Papa FR, 1999, MOL BIOL CELL, V10, P741, DOI 10.1091/mbc.10.3.741; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2006, J MOL HISTOL, V37, P189, DOI 10.1007/s10735-006-9044-7; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang YQ, 2008, J BIOL CHEM, V283, P1954, DOI 10.1074/jbc.M705682200; Xie ZW, 2004, NUCLEIC ACIDS RES, V32, P5981, DOI 10.1093/nar/gkh934; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	34	26	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37542	37550		10.1074/jbc.M110.170175	http://dx.doi.org/10.1074/jbc.M110.170175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876584	Green Published, hybrid			2022-12-27	WOS:000284424000046
J	Mancuso, DJ; Sims, HF; Yang, K; Kiebish, MA; Su, XO; Jenkins, CM; Guan, SP; Moon, SH; Pietka, T; Nassir, F; Schappe, T; Moore, K; Han, XL; Abumrad, NA; Gross, RW				Mancuso, David J.; Sims, Harold F.; Yang, Kui; Kiebish, Michael A.; Su, Xiong; Jenkins, Christopher M.; Guan, Shaoping; Moon, Sung Ho; Pietka, Terri; Nassir, Fatiha; Schappe, Timothy; Moore, Kristin; Han, Xianlin; Abumrad, Nada A.; Gross, Richard W.			Genetic Ablation of Calcium-independent Phospholipase A(2)gamma Prevents Obesity and Insulin Resistance during High Fat Feeding by Mitochondrial Uncoupling and Increased Adipocyte Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDIMENSIONAL MASS-SPECTROMETRY; SKELETAL-MUSCLE; PANCREATIC-ISLETS; A(2) IPLA(2); SHOTGUN LIPIDOMICS; ADIPOSE-TISSUE; IDENTIFICATION; BETA; CARDIOLIPIN; EXPRESSION	Phospholipases are critical enzyme mediators participating in many aspects of cellular function through modulating the generation of lipid 2nd messengers, membrane physical properties, and cellular bioenergetics. Here, we demonstrate that mice null for calcium-independent phospholipase A(2)gamma (iPLA(2)gamma(-/-)) are completely resistant to high fat diet-induced weight gain, adipocyte hypertrophy, hyperinsulinemia, and insulin resistance, which occur in iPLA(2)gamma(+/+) mice after high fat feeding. Notably, iPLA(2)gamma(-/-) mice were lean, demonstrated abdominal lipodystrophy, and remained insulin-sensitive despite having a marked impairment in glucose-stimulated insulin secretion after high fat feeding. Respirometry of adipocyte explants from iPLA(2)gamma(-/-) mice identified increased rates of oxidation of multiple different substrates in comparison with adipocyte explants from wild-type littermates. Shotgun lipidomics of adipose tissue from wild-type mice demonstrated the anticipated 2-fold increase in triglyceride content after high fat feeding. In sharp contrast, the adipocyte triglyceride content was identical in iPLA(2)gamma(-/-) mice fed either a standard diet or a high fat diet. Respirometry of skeletal muscle mitochondria from iPLA(2)gamma(-/-) mice demonstrated marked decreases in state 3 respiration using multiple substrates whose metabolism was uncoupled from ATP production. Shotgun lipidomics of skeletal muscle revealed a decreased content of cardiolipin with an altered molecular species composition thereby identifying the mechanism underlying mitochondrial uncoupling in the iPLA(2)gamma(-/-) mouse. Collectively, these results identify iPLA(2)gamma as an obligatory upstream enzyme that is necessary for efficient electron transport chain coupling and energy production through its participation in the alterations of cellular bioenergetics that promote the development of the metabolic syndrome.	[Mancuso, David J.; Sims, Harold F.; Yang, Kui; Kiebish, Michael A.; Jenkins, Christopher M.; Guan, Shaoping; Moon, Sung Ho; Han, Xianlin; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Su, Xiong; Pietka, Terri; Nassir, Fatiha; Schappe, Timothy; Moore, Kristin; Abumrad, Nada A.] Washington Univ, Sch Med, Div Nutr Sci, St Louis, MO 63110 USA; [Mancuso, David J.; Sims, Harold F.; Yang, Kui; Kiebish, Michael A.; Su, Xiong; Jenkins, Christopher M.; Guan, Shaoping; Moon, Sung Ho; Pietka, Terri; Nassir, Fatiha; Schappe, Timothy; Moore, Kristin; Han, Xianlin; Abumrad, Nada A.; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Su, Xiong; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu		Nassir, Fatiha/0000-0002-3653-3621	National Institutes of Health [5PO1HL57278, RO1HL41250.]; American Heart Association [DK56351, 835140N]; NIDDK [P30 DK56341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. This work was also supported by Clinical Nutrition Research Unit Grant DK56351 and Scientist Development Grant 835140N from the American Heart Association (to X. S.).; The access to equipment for the DEXA and Oxy-max analyses was provided by National Institutes of Health Grant P30 DK56341 from the NIDDK.	Argiles JM, 2005, MED RES REV, V25, P49, DOI 10.1002/med.20010; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Cannon B, 2000, METH MOL B, V155, P295; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; FOURNIER B, 1994, J INHERIT METAB DIS, V17, P470, DOI 10.1007/BF00711362; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jullig M, 2008, PROTEOMICS, V8, P2556, DOI 10.1002/pmic.200700977; Kennedy A, 2009, J LIPID RES, V50, P225, DOI 10.1194/jlr.M800258-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lettner A, 2008, CURR DIABETES REP, V8, P185, DOI 10.1007/s11892-008-0032-z; Liu YQ, 2010, AM J PHYSIOL-CELL PH, V298, pC921, DOI 10.1152/ajpcell.00541.2009; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, DIABETES, V53, pS179, DOI 10.2337/diabetes.53.2007.S179; Rasmussen UF, 2004, COMP BIOCHEM PHYS A, V137, P435, DOI 10.1016/j.cbpb.2003.11.002; Sahlin K, 2007, AM J PHYSIOL-ENDOC M, V292, pE223, DOI 10.1152/ajpendo.00266.2006; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Song HW, 2010, AM J PHYSIOL-ENDOC M, V298, pE1097, DOI 10.1152/ajpendo.00780.2009; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Su X, 2004, J BIOL CHEM, V279, P21740, DOI 10.1074/jbc.M314166200; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078; Tchoukalova YD, 2003, J LIPID RES, V44, P1795, DOI 10.1194/jlr.D300001-JLR200; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	62	60	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36495	36510		10.1074/jbc.M110.115766	http://dx.doi.org/10.1074/jbc.M110.115766			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20817734	Green Published, hybrid			2022-12-27	WOS:000284146100003
J	Vyas, AK; Koster, JC; Tzekov, A; Hruz, PW				Vyas, Arpita Kalla; Koster, Joseph C.; Tzekov, Anatoly; Hruz, Paul W.			Effects of the HIV Protease Inhibitor Ritonavir on GLUT4 Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL INSULIN-RESISTANCE; GLUCOSE-TRANSPORTER; CELLULAR MECHANISMS; RAT ADIPOCYTES; BETA-CELLS; SECRETION; INDINAVIR; HEALTHY; EXPRESSION; DIFFERENTIATION	HIV protease inhibitors acutely block glucose transporters (GLUTs) in vitro, and this may contribute to altered glucose homeostasis in vivo. However, several GLUT-independent mechanisms have been postulated. To determine the contribution of GLUT blockade to protease inhibitor-mediated glucose dysregulation, the effects of ritonavir were investigated in mice lacking the insulin-sensitive glucose transporter GLUT4 (G4KO). G4KO and control C57BL/6J mice were administered ritonavir or vehicle at the start of an intraperitoneal glucose tolerance test and during hyperinsulinemic-euglycemic clamps. G4KO mice exhibited elevated fasting blood glucose compared with C57BL/6J mice. Ritonavir impaired glucose tolerance in control mice but did not exacerbate glucose intolerance in G4KO mice. Similarly, ritonavir reduced peripheral insulin sensitivity in control mice but not in G4KO mice. Serum insulin levels were reduced in vivo in ritonavir-treated mice. Ritonavir reduced serum leptin levels in C57BL/6J mice but had no effect on serum adiponectin. No change in these adipokines was observed following ritonavir treatment of G4KO mice. These data confirm that a primary effect of ritonavir on peripheral glucose disposal is mediated through direct inhibition of GLUT4 activity in vivo. The ability of GLUT4 blockade to contribute to derangements in the other molecular pathways that influence insulin sensitivity remains to be determined.	[Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Koster, Joseph C.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hruz, PW (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu		Hruz, Paul/0000-0002-1478-3355	National Institutes of Health [DK064572, HL092798]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064572, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK064572 and HL092798.	Ben-Romano R, 2003, AIDS, V17, P23, DOI 10.1097/00002030-200301030-00005; Carper MJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE558, DOI 10.1152/ajpendo.00167.2007; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dube MP, 2001, J ACQ IMMUN DEF SYND, V27, P130, DOI 10.1097/00126334-200106010-00006; Evans SA, 2009, ENDOCRINOLOGY, V150, P5302, DOI 10.1210/en.2009-0747; Flint OP, 2009, TOXICOL PATHOL, V37, P65, DOI 10.1177/0192623308327119; Foisy ML, 1999, J CHROMATOGR B, V721, P239, DOI 10.1016/S0378-4347(98)00451-4; Grunfeld Carl, 2008, Circulation, V118, pe20, DOI 10.1161/CIRCULATIONAHA.107.189623; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hruz PW, 2006, JAIDS-J ACQ IMM DEF, V43, P624, DOI 10.1097/01.qai.0000245883.66509.b4; Hruz PW, 2008, CURR OPIN HIV AIDS, V3, P660, DOI 10.1097/COH.0b013e3283139134; Hruz PW, 2002, DIABETES, V51, P937, DOI 10.2337/diabetes.51.4.937; Jones SP, 2008, AIDS, V22, P1293, DOI 10.1097/QAD.0b013e3283021a4f; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kim RJ, 2006, OBESITY, V14, P994, DOI 10.1038/oby.2006.114; Koster JC, 2003, DIABETES, V52, P1695, DOI 10.2337/diabetes.52.7.1695; Lagathu C, 2005, BIOCHIMIE, V87, P65, DOI 10.1016/j.biochi.2004.12.007; Lagathu C, 2007, ANTIVIR THER, V12, P489; Lee GA, 2006, CLIN INFECT DIS, V43, P658, DOI 10.1086/505974; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Murata H, 2002, AIDS, V16, P859, DOI 10.1097/00002030-200204120-00005; Neye Y, 2006, J PHARMACOL EXP THER, V316, P106, DOI 10.1124/jpet.105.090589; Nolte LA, 2001, DIABETES, V50, P1397, DOI 10.2337/diabetes.50.6.1397; NOOR M, 2000, ANTIVIR THER S, V5, P8; Noor Mustafa A, 2007, Curr HIV/AIDS Rep, V4, P126, DOI 10.1007/s11904-007-0019-4; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pao VY, 2010, AIDS, V24, P265, DOI 10.1097/QAD.0b013e328333af1c; PAQUET MR, 1992, MOL CELL BIOCHEM, V109, P149; Rudich A, 2005, ACTA PHYSIOL SCAND, V183, P75, DOI 10.1111/j.1365-201X.2004.01383.x; Schuit FC, 1997, DIABETOLOGIA, V40, P104, DOI 10.1007/s001250050651; Schutt M, 2004, J ENDOCRINOL, V183, P445, DOI 10.1677/joe.1.05620; Schwarz JM, 2004, AIDS, V18, P1852, DOI 10.1097/00002030-200409030-00017; Shulman GI, 1999, AM J CARDIOL, V84, p3J; Tan QY, 2005, JAIDS-J ACQ IMM DEF, V40, P398, DOI 10.1097/01.qai.0000176654.97392.c7; *THOMS PDR, 2008, PHYS DESK REF, P479; Tomaka F, 2009, HIV MED, V10, P318, DOI 10.1111/j.1468-1293.2008.00690.x; Woerle H, 2003, DIABETES, V52, pA351; Yarasheski KE, 1999, J ACQ IMMUN DEF SYND, V21, P209, DOI 10.1097/00126334-199907010-00005	42	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36395	36400		10.1074/jbc.M110.176321	http://dx.doi.org/10.1074/jbc.M110.176321			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864532	Green Published, hybrid			2022-12-27	WOS:000284146100049
J	Sung, BK; Ravindran, J; Prasad, S; Pandey, MK; Aggarwal, BB				Sung, Bokyung; Ravindran, Jayaraj; Prasad, Sahdeo; Pandey, Manoj K.; Aggarwal, Bharat B.			RETRACTED: Gossypol Induces Death Receptor-5 through Activation of the ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL (Retracted article. See vol. 291, pg. 16923, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NF-KAPPA-B; INDUCED APOPTOSIS; MEDIATED APOPTOSIS; UP-REGULATION; CARCINOMA-CELLS; LIGAND TRAIL; APO-2 LIGAND; EXPRESSION; MITOCHONDRIA; APO2L/TRAIL	Development of resistance to TRAIL, an apoptosis-inducing cytokine, is one of the major problems in its development for cancer treatment. Thus, pharmacological agents that are safe and can sensitize the tumor cells to TRAIL are urgently needed. We investigated whether gossypol, a BH3 mimetic that is currently in the clinic, can potentiate TRAIL-induced apoptosis. Intracellular esterase activity, sub-G(1) cell cycle arrest, and caspase-8, -9, and -3 activity assays revealed that gossypol potentiated TRAIL-induced apoptosis in human colon cancer cells. Gossypol also down-regulated cell survival proteins (BclxL, Bcl-2, survivin, XIAP, and cFLIP) and dramatically up-regulated TRAIL death receptor (DR)-5 expression but had no effect on DR4 and decoy receptors. Gossypol-induced receptor induction was not cell type-specific, as DR5 induction was observed in other cell types. Deletion of DR5 by siRNA significantly reduced the apoptosis induced by TRAIL and gossypol. Gossypol induction of the death receptor required the induction of CHOP, and thus, gene silencing of CHOP abolished gossypol-induced DR5 expression and associated potentiation of apoptosis. ERK1/2 (but not p38 MAPK or JNK) activation was also required for gossypol-induced TRAIL receptor induction; gene silencing of ERK abolished both DR5 induction and potentiation of apoptosis by TRAIL. We also found that reactive oxygen species produced by gossypol treatment was critical for TRAIL receptor induction and apoptosis potentiation. Overall, our results show that gossypol enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and the up-regulation of TRAIL death receptors through the ROS-ERK-CHOP-DR5 pathway.	[Sung, Bokyung; Ravindran, Jayaraj; Prasad, Sahdeo; Pandey, Manoj K.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Pandey, Manoj K/K-9706-2015; Aggarwal, Bharat B/G-3388-2013	Pandey, Manoj K/0000-0002-2767-2929; 	National Institutes of Health [CA-16672]; M.D. Anderson Center for Targeted Therapy;  [CA-124787-01A2]; NATIONAL CANCER INSTITUTE [P01CA124787, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.D. Anderson Center for Targeted Therapy; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Core Grant CA-16672 and Program Project Grant CA-124787-01A2. This work was also supported by a grant from the M.D. Anderson Center for Targeted Therapy.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2004, VITAM HORM, V67, P453; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Azuhata T, 2006, J PEDIATR SURG, V41, P1431, DOI 10.1016/j.jpedsurg.2006.04.020; Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Cheson BD, 2009, CURR OPIN HEMATOL, V16, P299, DOI 10.1097/MOH.0b013e32832ad69a; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Inoue S, 2004, CELL DEATH DIFFER, V11, pS193, DOI 10.1038/sj.cdd.4401535; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Kroemer G, 1998, CELL DEATH DIFFER, V5, P547, DOI 10.1038/sj.cdd.4400387; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Moon DO, 2008, CANCER LETT, V264, P192, DOI 10.1016/j.canlet.2008.01.030; Nguyen DM, 2006, CANCER J, V12, P257, DOI 10.1097/00130404-200607000-00004; Oliver CL, 2005, MOL CANCER THER, V4, P23; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sarker M, 2001, CELL DEATH DIFFER, V8, P172, DOI 10.1038/sj.cdd.4400791; Seol DW, 2001, CANCER RES, V61, P1138; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Siegelin MD, 2008, MOL CANCER THER, V7, P3566, DOI 10.1158/1535-7163.MCT-08-0236; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; STEIN RC, 1992, CANCER CHEMOTH PHARM, V30, P480, DOI 10.1007/BF00685601; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; WU YW, 1989, CANCER RES, V49, P3754; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yeow WS, 2006, J THORAC CARDIOV SUR, V132, P1356, DOI 10.1016/j.jtcvs.2006.07.025; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X; Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200; Zhu HB, 2005, CANCER BIOL THER, V4, P393; Ziauddin MF, 2006, NEOPLASIA, V8, P446, DOI 10.1593/neo.05823	51	92	93	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35418	35427		10.1074/jbc.M110.172767	http://dx.doi.org/10.1074/jbc.M110.172767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837473	Green Published, hybrid			2022-12-27	WOS:000283845300019
J	Jiang, SX; Heller, B; Tagliabracci, VS; Zhai, LM; Irimia, JM; DePaoli-Roach, AA; Wells, CD; Skurat, AV; Roach, PJ				Jiang, Sixin; Heller, Brigitte; Tagliabracci, Vincent S.; Zhai, Lanmin; Irimia, Jose M.; DePaoli-Roach, Anna A.; Wells, Clark D.; Skurat, Alexander V.; Roach, Peter J.			Starch Binding Domain-containing Protein 1/Genethonin 1 Is a Novel Participant in Glycogen Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE CLYCOGEN PARTICLE; PHOSPHORYLASE ACTIVITY; MYOCLONUS EPILEPSY; MEMBRANE-PROTEINS; LAFORA-DISEASE; PHOSPHATASE; AUTOPHAGY; SYNTHASE; MICE; ACCUMULATION	Stbd1 is a protein of previously unknown function that is most prevalent in liver and muscle, the major sites for storage of the energy reserve glycogen. The protein is predicted to contain a hydrophobic N terminus and a C-terminal CBM20 glycan binding domain. Here, we show that Stbd1 binds to glycogen in vitro and that endogenous Stbd1 locates to perinuclear compartments in cultured mouse FL83B or Rat1 cells. When overexpressed in COSM9 cells, Stbd1 concentrated at enlarged perinuclear structures, co-localized with glycogen, the late endosomal/lysosomal marker LAMP1 and the autophagy protein GABARAPL1. Mutant Stbd1 lacking the N-terminal hydrophobic segment had a diffuse distribution throughout the cell. Point mutations in the CBM20 domain did not change the perinuclear localization of Stbd1, but glycogen was no longer concentrated in this compartment. Stable overexpression of glycogen synthase in Rat1WT4 cells resulted in accumulation of glycogen as massive perinuclear deposits, where a large fraction of the detectable Stbd1 co-localized. Starvation of Rat1WT4 cells for glucose resulted in dissipation of the massive glycogen stores into numerous and much smaller glycogen deposits that retained Stbd1. In vitro, in cells, and in animal models, Stbd1 consistently tracked with glycogen. We conclude that Stbd1 is involved in glycogen metabolism by binding to glycogen and anchoring it to membranes, thereby affecting its cellular localization and its intracellular trafficking to lysosomes.	[Jiang, Sixin; Heller, Brigitte; Tagliabracci, Vincent S.; Zhai, Lanmin; Irimia, Jose M.; DePaoli-Roach, Anna A.; Wells, Clark D.; Skurat, Alexander V.; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Roach, PJ (corresponding author), 635 Barnhill Dr,MS405A, Indianapolis, IN 46202 USA.	proach@iupui.edu			National Institutes of Health [DK27221, NS56454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027221, R37DK027221, R56DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 and NS56454.	Andrade D M, 2007, Acta Myol, V26, P83; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Bouju S, 1998, BIOCHEM J, V335, P549, DOI 10.1042/bj3350549; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESLOW JL, 1973, EXP CELL RES, V78, P441, DOI 10.1016/0014-4827(73)90089-X; CARDELL RR, 1985, J CELL BIOL, V101, P201, DOI 10.1083/jcb.101.1.201; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; HASCHKE RH, 1970, J BIOL CHEM, V245, P6657; HEILMEYER LM, 1970, J BIOL CHEM, V245, P6649; Hu ZZ, 2007, INT J MASS SPECTROM, V259, P147, DOI 10.1016/j.ijms.2006.09.024; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Janecek S, 2002, BIOINFORMATICS, V18, P1534, DOI 10.1093/bioinformatics/18.11.1534; Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; MEYER F, 1970, J BIOL CHEM, V245, P6642; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; RABEN N, 2010, AUTOPHAGY IN PRESS; RABEN N, 2007, H Acta Myol, V26, P45; Raben Nina, 2002, Current Molecular Medicine (Hilversum), V2, P145, DOI 10.2174/1566524024605789; REUSER AJ, 1995, MUSCLE NERVE, V3, pS61; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Roach PJ, 2001, HDB PHYSL 7, VII, P609, DOI DOI 10.1002/CPHY.CP070219; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; ROSENFELD EL, 1975, PATHOL BIOL, V23, P71; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Schaart G, 2004, HISTOCHEM CELL BIOL, V122, P161, DOI 10.1007/s00418-004-0690-0; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	51	93	102	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34960	34971		10.1074/jbc.M110.150839	http://dx.doi.org/10.1074/jbc.M110.150839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810658	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000283659100070
J	Sakabe, K; Hart, GW				Sakabe, Kaoru; Hart, Gerald W.			O-GlcNAc Transferase Regulates Mitotic Chromatin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; MITOSIS-SPECIFIC PHOSPHORYLATION; HISTONE H3; ALZHEIMERS-DISEASE; CELL-CYCLE; AURORA-B; NUCLEOCYTOPLASMIC PROTEINS; CHROMOSOME CONDENSATION; MONOCLONAL-ANTIBODY; X-CHROMOSOME	Mitosis must faithfully divide the genome such that each progeny inherits the same genetic material. DNA condensation is crucial in ensuring that chromosomes are correctly attached to the mitotic spindle for segregation, preventing DNA breaks or constrictions from the contractile ring. Histones form an octameric complex of basic proteins important in regulating DNA organization and accessibility. Histone post-translational modifications are altered during mitosis, although the roles of these post-translational modifications remain poorly characterized. Here, we report that N-acetylglucosamine (O-GlcNAc) transferase (OGT), the enzyme catalyzing the addition of O-GlcNAc moieties to nuclear and cytoplasmic proteins at serine and threonine residues, regulates some aspects of mitotic chromatin dynamics. OGT protein amounts decrease during M phase. Modest overexpression of OGT alters mitotic histone post-translational modifications at Lys-9, Ser-10, Arg-17, and Lys-27 of histone H3. Overexpression of OGT also prevents mitotic phosphorylation of coactivator-associated arginine methyltransferase 1 (CARM1) and prevents its correct cellular localization during mitosis. Moreover, OGT overexpression results in an increase in abnormal chromosomal bridge formation. Together, these results show that regulating the amount of OGT during mitosis is important in ensuring correct chromosomal segregation during mitosis.	[Sakabe, Kaoru; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	National Institutes of Health [R01 DK61671, R01 CA2486]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01 DK61671 and R01 CA2486, to G. W. H.).	Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Feng Q, 2009, J BIOL CHEM, V284, P36167, DOI 10.1074/jbc.M109.065524; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Georgatos SD, 2009, FRONT BIOSCI-LANDMRK, V14, P2017, DOI 10.2741/3360; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jayne S, 2009, J MOL BIOL, V394, P485, DOI 10.1016/j.jmb.2009.09.032; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; ME T, 2003, F Cell, V115, P751; Monaco EA, 2005, FRONT BIOSCI-LANDMRK, V10, P143, DOI 10.2741/1516; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Ruchaud S, 2007, CELL, V131, P230, DOI 10.1016/j.cell.2007.10.002; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shin HJ, 2003, ONCOGENE, V22, P3853, DOI 10.1038/sj.onc.1206502; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yamashita YM, 2009, FRONT BIOSCI-LANDMRK, V14, P3003, DOI 10.2741/3430; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96	63	89	92	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34460	34468		10.1074/jbc.M110.158170	http://dx.doi.org/10.1074/jbc.M110.158170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805223	hybrid, Green Published			2022-12-27	WOS:000283659100020
J	Wilson, PW; Osterday, KE; Heneghan, AF; Haymet, ADJ				Wilson, Peter W.; Osterday, Katie E.; Heneghan, Aaron F.; Haymet, Anthony D. J.			Type I Antifreeze Proteins Enhance Ice Nucleation above Certain Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAG-TIME APPARATUS; HETEROGENEOUS NUCLEATION; SUPERCOOLED LIQUIDS; THERMAL HYSTERESIS; AQUEOUS-SOLUTIONS; DEVITRIFICATION; GLYCOPROTEINS; INHIBITION; AGENTS; WATER	In this study, we examined the effects that antifreeze proteins have on the supercooling and ice-nucleating abilities of aqueous solutions. Very little information on such nucleation currently exists. Using an automated lag time apparatus and a new analysis, we show several dilution series of Type I antifreeze proteins. Our results indicate that, above a concentration of similar to 8 mg/ml, ice nucleation is enhanced rather than hindered. We discuss this unexpected result and present a new hypothesis outlining three components of polar fish blood that we believe affect its solution properties in certain situations.	Univ Tsukuba, Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Osterday, Katie E.; Haymet, Anthony D. J.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Heneghan, Aaron F.] Univ Wisconsin, Dept Surg, Madison, WI 53792 USA	University of Tsukuba; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Wisconsin System; University of Wisconsin Madison		wilson.peter.ge@u.tsukuba.ac.jp	Wilson, Peter W.F./J-2455-2016; FTSE, Tony Haymet PhD/A-9881-2009; Wilson, Peter/AAT-6428-2020	FTSE, Tony Haymet PhD/0000-0002-5617-2106; Wilson, Peter/0000-0002-1535-6398				ANANTHANARAYANA.VS, 1989, Rep, V7, P1; BARLOW TW, 1995, REV SCI INSTRUM, V66, P2996, DOI 10.1063/1.1145586; CHANG ZH, 1991, CRYO-LETT, V12, P215; Cheng C.C., 1991, P1; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; Du N, 2003, J BIOL CHEM, V278, P36000, DOI 10.1074/jbc.M305222200; Du N, 2006, J PHYS CHEM B, V110, P20562, DOI 10.1021/jp061969y; FRANKS F, 1987, NATURE, V325, P146, DOI 10.1038/325146a0; Heneghan AF, 2004, CHEM PHYS LETT, V385, P441, DOI 10.1016/j.cplett.2004.01.025; HEW CL, 1986, EUR J BIOCHEM, V15, P267; Holt CB, 2003, CRYOLETTERS, V24, P323; Liu XY, 2004, J BIOL CHEM, V279, P6124, DOI 10.1074/jbc.M310487200; PARODYMORREALE A, 1988, NATURE, V333, P782, DOI 10.1038/333782a0; Praebel K, 2009, COMP BIOCHEM PHYS A, V154, P564, DOI 10.1016/j.cbpa.2009.09.005; SUTTON RL, 1993, CRYO-LETT, V14, P13; Wilson PW, 2009, PHYS CHEM CHEM PHYS, V11, P2679, DOI 10.1039/b817585c; Wilson PW, 2003, CRYOBIOLOGY, V46, P88, DOI 10.1016/S0011-2240(02)00182-7; WILSON PW, 1993, CRYO-LETT, V14, P31; WILSON PW, 1995, BIOPHYS J, V68, P2098, DOI 10.1016/S0006-3495(95)80389-9; Wowk B, 2000, CRYOBIOLOGY, V40, P228, DOI 10.1006/cryo.2000.2243; WU DW, 1991, BIOCHIM BIOPHYS ACTA, V1076, P416, DOI 10.1016/0167-4838(91)90485-I; Zachariassen KE, 2004, CRYOBIOLOGY, V48, P309, DOI 10.1016/j.crybiol.2004.02.005; Zachariassen KE, 2002, CRYOBIOLOGY, V44, P132, DOI 10.1016/S0011-2240(02)00014-7; Zobrist B, 2008, J PHYS CHEM A, V112, P3965, DOI 10.1021/jp7112208	26	33	35	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34741	34745		10.1074/jbc.M110.171983	http://dx.doi.org/10.1074/jbc.M110.171983			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20837472	Green Published, hybrid			2022-12-27	WOS:000283659100049
J	Xu, YF; Sengupta, T; Kukreja, L; Minella, AC				Xu, Yanfei; Sengupta, Tanushri; Kukreja, Lokesh; Minella, Alex C.			MicroRNA-223 Regulates Cyclin E Activity by Modulating Expression of F-box and WD-40 Domain Protein 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; E DEGRADATION; C-MYC; MULTISITE PHOSPHORYLATION; DEPENDENT DEGRADATION; FEEDBACK LOOP; DIFFERENTIATION; INSTABILITY	F-box and WD-40 domain protein 7 (Fbw7) provides substrate specificity for the Skp1-Cullin1-F-box protein (SCF) ubiquitin ligase complex that targets multiple oncoproteins for degradation, including cyclin E, c-Myc, c-Jun, Notch, and mammalian target of rapamycin (mTOR). Fbw7 is a bona fide tumor suppressor, and loss-of-function mutations in FBXW7 have been identified in diverse human tumors. Although much is known about targets of the Fbw7 ubiquitin ligase pathway, relatively little is known about the regulation of Fbw7 expression. We identified a panel of candidate microRNA regulators of Fbw7 expression within a study of gene expression alterations in primary erythroblasts obtained from cyclin E-T74A T393A knock-in mice, which have markedly dysregulated cyclin E expression. We found that overexpression of miR-223, in particular, significantly reduces FBXW7 mRNA levels, increases endogenous cyclin E protein and activity levels, and increases genomic instability. We next confirmed that miR-223 targets the FBXW7 3'-untranslated region. We then found that reduced miR-223 expression in primary mouse embryonic fibroblasts leads to increased Fbw7 expression and decreased cyclin E activity. Finally, we found that miR-223 expression is responsive to acute alterations in cyclin E regulation by the Fbw7 pathway. Together, our data indicate that miR-223 regulates Fbw7 expression and provide the first evidence that activity of the SCFFbw7 ubiquitin ligase can be modulated directly by the microRNA pathway.	Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Minella, Alex C.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center		a-minella@northwestern.edu	Sengupta, Tanushri/G-1725-2011	Minella, Alex/0000-0001-6693-3362	National Institutes of Health [R01HL098608, K22CA130984]; Sidney Kimmel Foundation; Schweppe Foundation; Zell Family Foundation; NATIONAL CANCER INSTITUTE [K22CA130984] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation; Schweppe Foundation; Zell Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL098608 and K22CA130984. This work was also supported by a Sidney Kimmel Foundation Translational Scholar Award, and funding from the Schweppe and Zell Family Foundations.	Anzi S, 2008, CELL SIGNAL, V20, P862, DOI 10.1016/j.cellsig.2007.12.020; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiaretti S, 2010, HAEMATOL-HEMATOL J, V95, P1114, DOI 10.3324/haematol.2009.015099; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cohen EEW, 2009, CANCER RES, V69, P65, DOI 10.1158/0008-5472.CAN-08-0377; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-8; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Loeb KR, 2005, CANCER CELL, V8, P35, DOI 10.1016/j.ccr.2005.06.010; Ma Y, 2007, P NATL ACAD SCI USA, V104, P4089, DOI 10.1073/pnas.0606537104; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Minella AC, 2007, ONCOGENE, V26, P6948, DOI 10.1038/sj.onc.1210518; Minella AC, 2005, P NATL ACAD SCI USA, V102, P9649, DOI 10.1073/pnas.0503677102; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Smith APL, 2006, ONCOGENE, V25, P7245, DOI 10.1038/sj.onc.1209713; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x	57	72	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34439	34446		10.1074/jbc.M110.152306	http://dx.doi.org/10.1074/jbc.M110.152306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826802	Green Published, hybrid			2022-12-27	WOS:000283659100018
J	Donkin, JJ; Stukas, S; Hirsch-Reinshagen, V; Namjoshi, D; Wilkinson, A; May, S; Chan, J; Fan, JJ; Collins, J; Wellington, CL				Donkin, James J.; Stukas, Sophie; Hirsch-Reinshagen, Veronica; Namjoshi, Dhananjay; Wilkinson, Anna; May, Sharon; Chan, Jeniffer; Fan, Jianjia; Collins, Jon; Wellington, Cheryl L.			ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MOUSE MODEL; APOLIPOPROTEIN-E; TANGIER-DISEASE; LIPID-METABOLISM; IN-VITRO; BETA; ABCA1; CHOLESTEROL	The cholesterol transpoter ATP-binding cassette transporter A1 (ABCA1) moves lipids onto apolipoproteins including apolipoprotein E (apoE), which is the major cholesterol carrier in the brain and an established genetic risk factor for late-onset Alzheimer disease (AD). In amyloid mouse models of AD, ABCA1 deficiency exacerbates amyloidogenesis, whereas ABCA1 overexpression ameliorates amyloid load, suggesting a role for ABCA1 in A beta metabolism. Agonists of liver X receptors (LXR), including GW3965, induce transcription of several genes including ABCA1 and apoE, and reduce A beta levels and improve cognition in AD mice. However, the specific role of ABCA1 in mediating beneficial responses to LXR agonists in AD mice is unknown. We evaluated behavioral and neuropathogical outcomes in GW3965-treated female APP/PS1 mice with and without ABCA1. Treatment of APP/PS1 mice with GW3965 increased ABCA1 and apoE protein levels. ABCA1 was required to observe significantly elevated apoE levels in brain tissue and cerebrospinal fluid upon therapeutic (33 mg/kg/day) GW3965 treatment. At 33 mg/kg/day, GW3965 was also associated with a trend toward redistribution of A beta to the carbonate-soluble pool independent of ABCA1. APP/PS1 mice treated with either 2.5 or 33 mg/kg/day of GW3965 showed a clear trend toward reduced amyloid burden in hippocampus and whole brain, whereas APP/PS1-treated mice lacking ABCA1 failed to display reduced amyloid load in the whole brain and showed trends toward increased hippocampal amyloid. Treatment of APP/PS1 mice with either dose of GW3965 completely restored novel object recognition memory to wild-type levels, which required ABCA1. These results suggest that ABCA1 contributes to several beneficial effects of the LXR agonist GW3965 in APP/PS1 mice.	[Donkin, James J.; Stukas, Sophie; Hirsch-Reinshagen, Veronica; Namjoshi, Dhananjay; Wilkinson, Anna; May, Sharon; Chan, Jeniffer; Fan, Jianjia; Wellington, Cheryl L.] Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Collins, Jon] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA	Child & Family Research Institute; University of British Columbia; GlaxoSmithKline	Wellington, CL (corresponding author), 980 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	Cheryl@cmmt.ubc.ca	Stukas, Sophie/GQO-7639-2022	Namjoshi, Dhananjay/0000-0003-1753-5581; Reece, Sharon Christine May/0000-0001-8251-8409; Stukas, Sophie/0000-0001-8819-8821	Canadian Institutes of Health Research; Pacific Alzheimer's Research Foundation; New Scientist Award; University of British Columbia; Alzheimer's Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pacific Alzheimer's Research Foundation; New Scientist Award; University of British Columbia; Alzheimer's Society of Canada	This work was supported in part by operating grants from the Canadian Institutes of Health Research and the Pacific Alzheimer's Research Foundation and a New Scientist Award (to C. L. W.).; Supported by University of British Columbia Arthur and June Williams Postdoctoral Fellowship and the Roy Congdon fellowship from the Alzheimer's Society of Canada.; Supported by a Vanier Canada Graduate Scholarship (Canadian Institutes of Health Research) and a University of British Columbia Ph.D. fellowship.	Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Bellgowan PSF, 2009, LEARN MEMORY, V16, P433, DOI 10.1101/lm.1357309; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Burns MP, 2006, J NEUROCHEM, V98, P792, DOI 10.1111/j.1471-4159.2006.03925.x; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Genest J, 1999, J INVEST MED, V47, P31; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Lund EG, 2006, BIOCHEM PHARMACOL, V71, P453, DOI 10.1016/j.bcp.2005.11.004; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Morris JC, 1997, NEUROLOGY, V49, pS7, DOI 10.1212/WNL.49.3_Suppl_3.S7; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; VANMIERLO T, 2009, NEUROBIOL AGING; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	43	148	152	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34144	34154		10.1074/jbc.M110.108100	http://dx.doi.org/10.1074/jbc.M110.108100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739291	Green Published, hybrid			2022-12-27	WOS:000283354000060
J	Kassel, KM; Au, DR; Higgins, MJ; Hines, M; Graves, LM				Kassel, Karen M.; Au, Da Ryung; Higgins, Matthew J.; Hines, Maria; Graves, Lee M.			Regulation of Human Cytidine Triphosphate Synthetase 2 by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CTP SYNTHETASE; PROTEIN-KINASE-A; ALLOSTERIC EFFECTOR GTP; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GLUTAMINE HYDROLYSIS; LACTOCOCCUS-LACTIS; URA7 GENE; SYNTHASE; IDENTIFICATION	Cytidine triphosphate synthetase (CTPS) is the rate-limiting enzyme in de novo CTP synthesis and is required for the formation of RNA, DNA, and phospholipids. This study determined the kinetic properties of the individual human CTPS isozymes (hCTPS1 and hCTPS2) and regulation through substrate concentration, oligomerization, and phosphorylation. Kinetic analysis demonstrated that both hCTPS1 and hCTPS2 were maximally active at physiological concentrations of ATP, GTP, and glutamine, whereas the K-m and IC50 values for the substrate UTP and the product CTP, respectively, were close to their physiological concentrations, indicating that the intracellular concentrations of UTP and CTP may precisely regulate hCTPS activity. Low serum treatment increased hCTPS2 phosphorylation, and five probable phosphorylation sites were identified in the hCTPS2 C-terminal domain. Metabolic labeling of hCTPS2 with [P-32]H3PO4 demonstrated that Ser(568) and Ser(571) were two major phosphorylation sites, and additional studies demonstrated that Ser(568) was phosphorylated by casein kinase 1 both in vitro and in vivo. Interestingly, mutation of Ser(568) (S568A) but not Ser(571) significantly increased hCTPS2 activity, demonstrating that Ser(568) is a major inhibitory phosphorylation site. The S568A mutation had a greater effect on the glutamine than ammonia-dependent activity, indicating that phosphorylation of this site may influence the glutaminase domain of hCTPS2. Deletion of the C-terminal regulatory domain of hCTPS1 also greatly increased the V-max of this enzyme. In summary, this is the first study to characterize the kinetic properties of hCTPS1 and hCTPS2 and to identify Ser(568) as a major site of CTPS2 regulation by phosphorylation.	[Graves, Lee M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hines, Maria] Univ N Carolina, Univ N Carolina Michael Hooker Prote Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Graves, LM (corresponding author), Univ N Carolina, Dept Pharmacol, 4111 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	lmg@med.unc.edu	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AFQ-7201-2022		National Institutes of Health [R01-GM069976]; Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM069976 (to L. M. G.).; Supported by a post-doctoral fellowship from the Pharmaceutical Research and Manufacturers of America Foundation. Present address: University of Kansas Medical Center, 3901 Rainbow Blvd., MS-1018, Kansas City, KS 66160.	Bearne SL, 2001, BIOCHEM J, V356, P223, DOI 10.1042/0264-6021:3560223; Chang YF, 2007, J BIOL CHEM, V282, P17613, DOI 10.1074/jbc.M702799200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Endrizzi JA, 2005, BIOCHEMISTRY-US, V44, P13491, DOI 10.1021/bi051282o; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Goto M, 2004, STRUCTURE, V12, P1413, DOI 10.1016/j.str.2004.05.013; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Huang M, 2003, CELL MOL LIFE SCI, V60, P321, DOI 10.1007/s000180300027; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P247, DOI 10.1021/bi00752a016; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P241, DOI 10.1021/bi00752a015; LONG CW, 1970, J BIOL CHEM, V245, P80; LONG CW, 1967, J BIOL CHEM, V242, P4715; Lunn FA, 2008, BIOCHEM J, V412, P113, DOI 10.1042/BJ20071163; MacDonnell JE, 2004, BBA-PROTEINS PROTEOM, V1699, P213, DOI 10.1016/j.bbapap.2004.03.002; MacLeod TJ, 2006, BBA-PROTEINS PROTEOM, V1764, P199, DOI 10.1016/j.bbapap.2005.11.021; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Pappas A, 1998, J BIOL CHEM, V273, P15954, DOI 10.1074/jbc.273.26.15954; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Kuilenburg ABP, 2000, BBA-GENE STRUCT EXPR, V1492, P548, DOI 10.1016/S0167-4781(00)00141-X; VONDERSAAL W, 1985, J AM CHEM SOC, V107, P703, DOI 10.1021/ja00289a031; VONDERSAAL W, 1985, J BIOL CHEM, V260, P4993; Wadskov-Hansen SLL, 2001, J BIOL CHEM, V276, P38002; Willemoes M, 2002, EUR J BIOCHEM, V269, P4772, DOI 10.1046/j.1432-1033.2002.03175.x; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113; YANG WL, 1994, BIOCHEMISTRY-US, V33, P10785, DOI 10.1021/bi00201a028; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	38	25	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33727	33736		10.1074/jbc.M110.178566	http://dx.doi.org/10.1074/jbc.M110.178566			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739275	hybrid, Green Published			2022-12-27	WOS:000283354000018
J	Kamata, T; Handa, M; Ito, S; Sato, Y; Ohtani, T; Kawai, Y; Ikeda, Y; Aiso, S				Kamata, Tetsuji; Handa, Makoto; Ito, Sonomi; Sato, Yukiko; Ohtani, Toshimitsu; Kawai, Yohko; Ikeda, Yasuo; Aiso, Sadakazu			Structural Requirements for Activation in alpha IIb beta 3 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; PLATELET GPIIB-IIIA; LIGAND-BINDING; ELECTRON-MICROSCOPY; EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; COMPLEX; AFFINITY; ALPHA(IIB)BETA(3); ALPHA-V-BETA-3	Integrins are postulated to undergo structural rearrangement from a low affinity bent conformer to a high affinity extended conformer upon activation. However, some reports have shown that a bent conformer is capable of binding a ligand, whereas another report has shown that integrin extension does not absolutely lead to activation. To clarify whether integrin affinity is indeed regulated by the so-called switchblade-like movement, we have engineered a series of mutant alpha IIb beta 3 integrins that are constrained specifically in either a bent or an extended conformation. These mutant alpha IIb beta 3 integrins were expressed in mammalian cells, and fibrinogen binding to these cells was examined. The bent integrins were created through the introduction of artificial disulfide bridges in the beta-head/beta-tail interface. Cells expressing bent integrins all failed to bind fibrinogen unless pretreated with DTT to disrupt the disulfide bridges. The extended integrins were created by introducing N-glycosylation sites in amino acid residues located close to the alpha-genu, where the integrin legs fold backward. Among these mutants, activation was maximized in one integrin with an N-glycosylation site located behind the alpha-genu. This extension-induced activation was completely blocked when the swing-out of the hybrid domain was prevented. These results suggest that the bent and extended conformers represent low affinity and high affinity conformers, respectively, and that extension-induced activation depends on the swing-out of the hybrid domain. Taken together, these results are consistent with the current hypothesis that integrin affinity is regulated by the switchblade-like movement of the integrin legs.	[Kamata, Tetsuji; Ito, Sonomi; Sato, Yukiko; Ohtani, Toshimitsu; Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo 1608582, Japan; [Handa, Makoto] Keio Univ, Sch Med, Dept Transfus Med & Cell Therapy, Shinjuku Ku, Tokyo 1608582, Japan; [Kawai, Yohko] Int Univ Hlth & Welf, Prevent Hlth Examinat Ctr, Minato Ku, Tokyo 1070052, Japan; [Ikeda, Yasuo] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Keio University; Keio University; International University of Health & Welfare; Waseda University	Kamata, T (corresponding author), Keio Univ, Sch Med, Dept Anat 3S1, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kamata@sc.itc.keio.ac.jp	Handa, Makoto/B-1121-2014		Ministry of Health, Labour and Welfare; Fukuzawa Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Fukuzawa Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Labor Sciences research grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare (to T. K. and M. H.), a grant from the Fukuzawa Memorial Foundation (to T. K.), and a grant-in-aid for scientific research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (to S. A.).	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Adair BD, 2007, METHOD ENZYMOL, V426, P337, DOI 10.1016/S0076-6879(07)26015-X; Blue R, 2010, J BIOL CHEM, V285, P17604, DOI 10.1074/jbc.M110.107763; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Gupta V, 2007, BLOOD, V109, P3513, DOI 10.1182/blood-2005-11-056689; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Matsumoto A, 2008, BIOPHYS J, V95, P2895, DOI 10.1529/biophysj.108.131045; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; TOMIYAMA Y, 1992, J BIOL CHEM, V267, P18085; TOMIYAMA Y, 1992, BLOOD, V79, P2303; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; YLANNE J, 1988, BLOOD, V72, P1478; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	33	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38428	38437		10.1074/jbc.M110.139667	http://dx.doi.org/10.1074/jbc.M110.139667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20884611	hybrid, Green Published			2022-12-27	WOS:000284625600048
J	Batt, SM; Jabeen, T; Mishra, AK; Veerapen, N; Krumbach, K; Eggeling, L; Besra, GS; Futterer, K				Batt, Sarah M.; Jabeen, Talat; Mishra, Arun K.; Veerapen, Natacha; Krumbach, Karin; Eggeling, Lothar; Besra, Gurdyal S.; Fuetterer, Klaus			Acceptor Substrate Discrimination in Phosphatidyl-myo-inositol Mannoside Synthesis STRUCTURAL AND MUTATIONAL ANALYSIS OF MANNOSYLTRANSFERASE CORYNEBACTERIUM GLUTAMICUM PimB '	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; PIMA; IDENTIFICATION; REFINEMENT; CATALYSIS; INSIGHTS; SYNTHASE; REVEALS	Long term survival of the pathogen Mycobacterium tuberculosis in humans is linked to the immunomodulatory potential of its complex cell wall glycolipids, which include the phosphatidylinositol mannoside (PIM) series as well as the related lipomannan and lipoarabinomannan glycoconjugates. PIM biosynthesis is initiated by a set of cytosolic alpha-mannosyltransferases, catalyzing glycosyl transfer from the activated saccharide donor GDP-alpha-D-mannopyranose to the acceptor phosphatidyl-myoinositol (PI) in an ordered and regio-specific fashion. Herein, we report the crystal structure of mannosyltransferase Corynebacterium glutamicum PimB' in complex with nucleotide to a resolution of 2.0 A. PimB' attaches mannosyl selectively to the 6-OH of the inositol moiety of PI. Two crystal forms and GD-Pversus GDP-alpha-D-mannopyranose-bound complexes reveal flexibility of the nucleotide conformation as well as of the structural framework of the active site. Structural comparison, docking of the saccharide acceptor, and site-directed mutagenesis pin regio-selectivity to a conserved Asp residue in the N-terminal domain that forces presentation of the correct inositol hydroxyl to the saccharide donor.	[Batt, Sarah M.; Jabeen, Talat; Mishra, Arun K.; Veerapen, Natacha; Besra, Gurdyal S.; Fuetterer, Klaus] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Krumbach, Karin; Eggeling, Lothar] Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	University of Birmingham; Helmholtz Association; Research Center Julich	Besra, GS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	G.Besra@bham.ac.uk; K.Futterer@bham.ac.uk		Besra, Gurdyal/0000-0002-5605-0395; Futterer, Klaus/0000-0001-7445-5372	Wellcome Trust [081569/Z/06/Z]; Advantage West Midlands through the Birmingham Science City Translational Medicine Platform; James Bardrick; Royal Society; MRC [G0500590] Funding Source: UKRI; Medical Research Council [G0500590] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Advantage West Midlands through the Birmingham Science City Translational Medicine Platform; James Bardrick; Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Wellcome Trust Grant 081569/Z/06/Z, and by Advantage West Midlands through the Birmingham Science City Translational Medicine Platform.; Recipient of support in the form of a Personal Research Chair from James Bardrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow. To whom correspondence may be addressed: School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. Tel.: 44-121-4145895; Fax: 44-121-4145925; E-mail: G. Besra@bham.ac.uk.	Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Collier A, 2008, CHEM COMMUN, P178, DOI 10.1039/b714379f; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dobson G., 1985, CHEM METHODS BACTERI, P237; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Driessen NN, 2009, INFECT IMMUN, V77, P4538, DOI 10.1128/IAI.01256-08; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Frantom PA, 2010, J AM CHEM SOC, V132, P6626, DOI 10.1021/ja101231a; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Mahon RN, 2009, INFECT IMMUN, V77, P4574, DOI 10.1128/IAI.00222-09; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton GL, 2006, J BIOL CHEM, V281, P33910, DOI 10.1074/jbc.M604724200; Patterson JH, 2003, BIOCHEM J, V372, P77, DOI 10.1042/BJ20021700; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; Schaeffer ML, 1999, J BIOL CHEM, V274, P31625, DOI 10.1074/jbc.274.44.31625; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Steiner K, 2010, J MOL BIOL, V397, P436, DOI 10.1016/j.jmb.2010.01.035; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5	54	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37741	37752		10.1074/jbc.M110.165407	http://dx.doi.org/10.1074/jbc.M110.165407			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20843801	Green Published, hybrid			2022-12-27	WOS:000284424000066
J	Choi, YJ; Im, E; Chung, HK; Pothoulakis, C; Rhee, SH				Choi, Yoon Jeong; Im, Eunok; Chung, Hyo Kyun; Pothoulakis, Charalabos; Rhee, Sang Hoon			TRIF Mediates Toll-like Receptor 5-induced Signaling in Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROINFLAMMATORY GENE-EXPRESSION; BACTERIAL FLAGELLIN; TOLL-LIKE-RECEPTOR-5 ENGAGEMENT; ACTIVATION; RECOGNITION; IMMUNITY; DISEASE; MOUSE; IPAF; TLR5	Toll-like receptors (TLRs) associate with adaptor molecules (MyD88, Mal/TIRAP, TRAM, and TRIF) to mediate signaling of host-microbial interaction. For instance, TLR4 utilizes the combination of both Mal/TIRAP-MyD88 (MyD88-dependent pathway) and TRAM-TRIF (MyD88-independent pathway). However, TLR5, the specific receptor for flagellin, is known to utilize only MyD88 to elicit inflammatory responses, and an involvement of other adaptor molecules has not been suggested in TLR5-dependent signaling. Here, we found that TRIF is involved in mediating TLR5-induced nuclear factor kappa B (NF kappa B) and mitogen-activated protein kinases (MAPKs), specifically JNK1/2 and ERK1/2, activation in intestinal epithelial cells. TLR5 activation by flagellin permits the physical interaction between TLR5 and TRIF in human colonic epithelial cells (NCM460), whereas TLR5 does not interact with TRAM upon flagellin stimulation. Both primary intestinal epithelial cells from TRIF-KO mice and TRIF-silenced NCM460 cells significantly reduced flagellin-induced NF kappa B (p105 and p65), JNK1/2, and ERK1/2 activation compared with control cells. However, p38 activation by flagellin was preserved in these TRIF-deficient cells. TRIF-KO intestinal epithelial cells exhibited substantially reduced inflammatory cytokine (keratinocyte-derived cytokine, macrophage inflammatory protein 3 alpha, and IL-6) expression upon flagellin, whereas control cells from TRIF-WT mice showed robust cytokine expression by flagellin. Compare with TRIF-WT mice, TRIF-KO mice were resistant to in vivo intestinal inflammatory responses: flagellin-mediated exacerbation of colonic inflammation and dextran sulfate sodium-induced experimental colitis. We conclude that in addition to MyD88, TRIF mediates TLR5-dependent responses and, thereby regulates inflammatory responses elicited by flagellin/TLR5 engagement. Our findings suggest an important role of TRIF in regulating host-microbial communication via TLR5 in the gut epithelium.	[Choi, Yoon Jeong; Im, Eunok; Chung, Hyo Kyun; Pothoulakis, Charalabos; Rhee, Sang Hoon] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rhee, SH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, MRL1240,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	shrhee@mednet.ucla.edu	Lee, Kee-Joon/AAA-4090-2022		National Institutes of Health [DK072471, DK083336, DK079015]; Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079015, K01DK083336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health signaling. Grants DK072471 (to C. P.), DK083336 (to E. I.), and DK079015 (S. H. R.). This work was also supported by a Young Clinical Scientist Award (to S. H. R. and E. I.) from the Flight Attendant Medical Research Institute, Inc.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; EVANS GS, 1992, J CELL SCI, V101, P219; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Im E, 2009, J NUTR, V139, P1848, DOI 10.3945/jn.109.108613; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanaya T, 2008, AM J PHYSIOL-GASTR L, V295, pG273, DOI 10.1152/ajpgi.00378.2007; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kitajima S, 1999, J VET MED SCI, V61, P67, DOI 10.1292/jvms.61.67; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macartney KK, 2000, J VIROL, V74, P5597, DOI 10.1128/JVI.74.12.5597-5603.2000; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2004, J BIOL CHEM, V279, P25179, DOI 10.1074/jbc.M400967200; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622	32	65	72	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37570	37578		10.1074/jbc.M110.158394	http://dx.doi.org/10.1074/jbc.M110.158394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855887	hybrid, Green Published			2022-12-27	WOS:000284424000049
J	Steinberg, F; Gerber, SD; Rieckmann, T; Trueb, B				Steinberg, Florian; Gerber, Simon D.; Rieckmann, Thorsten; Trueb, Beat			Rapid Fusion and Syncytium Formation of Heterologous Cells upon Expression of the FGFRL1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MYOBLAST FUSION; MACROPHAGE MULTINUCLEATION; MEMBRANE-FUSION; C-ELEGANS; DROSOPHILA; PROTEIN; GENE; MICE; DISRUPTION	The fusion of mammalian cells into syncytia is a developmental process that is tightly restricted to a limited subset of cells. Besides gamete and placental trophoblast fusion, only macrophages and myogenic stem cells fuse into multinucleated syncytia. In contrast to viral cell fusion, which is mediated by fusogenic glycoproteins that actively merge membranes, mammalian cell fusion is poorly understood at the molecular level. A variety of mammalian transmembrane proteins, among them many of the immunoglobulin superfamily, have been implicated in cell-cell fusion, but none has been shown to actively fuse cells in vitro. Here we report that the FGFRL1 receptor, which is up-regulated during the differentiation of myoblasts into myotubes, fuses cultured cells into large, multinucleated syncytia. We used luciferase and GFP-based reporter assays to confirm cytoplasmic mixing and to identify the fusion inducing domain of FGFRL1. These assays revealed that Ig-like domain III and the transmembrane domain are both necessary and sufficient to rapidly fuse CHO cells into multinucleated syncytia comprising several hundred nuclei. Moreover, FGFRL1 also fused HEK293 and HeLa cells with untransfected CHO cells. Our data show that FGFRL1 is the first mammalian protein that is capable of inducing syncytium formation of heterologous cells in vitro.	[Steinberg, Florian; Gerber, Simon D.; Trueb, Beat] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Rieckmann, Thorsten] Univ Med Ctr Hamburg Eppendorf, Lab Radiobiol & Expt Radiooncol, D-20246 Hamburg, Germany; [Trueb, Beat] Univ Hosp Bern, Dept Rheumatol, CH-3010 Bern, Switzerland	University of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bern; University Hospital of Bern	Trueb, B (corresponding author), Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland.	beat.trueb@dkf.unibe.ch	Trueb, Beat/AAL-9621-2020	Trueb, Beat/0000-0001-8684-6856; Rieckmann, Thorsten/0000-0001-8426-107X	Swiss National Science Foundation [31003A-127046]; Swiss Foundation for Research on Muscular Diseases; Olga Mayenfisch Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscular Diseases; Olga Mayenfisch Foundation	This study was supported by grants from the Swiss National Science Foundation (31003A-127046) and the Swiss Foundation for Research on Muscular Diseases as well as by the Olga Mayenfisch Foundation.	Artero RD, 2001, DEVELOPMENT, V128, P4251; Baertschi S, 2007, FEBS J, V274, P6241, DOI 10.1111/j.1742-4658.2007.06143.x; Berger S, 2008, J CELL SCI, V121, P1303, DOI 10.1242/jcs.022269; Bertrand S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-226; Catela C, 2009, DIS MODEL MECH, V2, P283, DOI 10.1242/dmm.002287; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; DeFife KM, 1999, FASEB J, V13, P823, DOI 10.1096/fasebj.13.8.823; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; Gildor B, 2009, EMBO REP, V10, P1043, DOI 10.1038/embor.2009.129; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huerta L, 2002, CYTOMETRY, V47, P100, DOI 10.1002/cyto.10051; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McShane Marisa P, 2005, Methods Mol Biol, V292, P187; O'Donnell CD, 2009, J BIOL CHEM, V284, P29654, DOI 10.1074/jbc.M109.037960; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Richardson BE, 2008, TRAFFIC, V9, P1050, DOI 10.1111/j.1600-0854.2008.00756.x; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rieckmann T, 2009, BBA-MOL BASIS DIS, V1792, P112, DOI 10.1016/j.bbadis.2008.11.006; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Trueb B, 2006, INT J MOL MED, V17, P617; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; Zhuang L, 2010, EXP THER MED, V1, P161, DOI 10.3892/etm_00000026	40	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37704	37715		10.1074/jbc.M110.140517	http://dx.doi.org/10.1074/jbc.M110.140517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851884	Green Published, hybrid			2022-12-27	WOS:000284424000062
J	Yagi, H; Yanagisawa, M; Suzuki, Y; Nakatani, Y; Ariga, T; Kato, K; Yu, RK				Yagi, Hirokazu; Yanagisawa, Makoto; Suzuki, Yusuke; Nakatani, Yoshihiko; Ariga, Toshio; Kato, Koichi; Yu, Robert K.			HNK-1 Epitope-carrying Tenascin-C Spliced Variant Regulates the Proliferation of Mouse Embryonic Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; BINDING-PROTEIN; MICE DEFICIENT; UP-REGULATION; CARBOHYDRATE; EXPRESSION; GLYCOLIPIDS; GENERATION; MOLECULE; ISOFORMS	Neural stem cells (NSCs) possess high proliferative potential and the capacity for self-renewal with retention of multipotency to differentiate into neuronal and glial cells. NSCs are the source for neurogenesis during central nervous system development from fetal and adult stages. Although the human natural killer-1 (HNK-1) carbohydrate epitope is expressed predominantly in the nervous system and involved in intercellular adhesion, cell migration, and synaptic plasticity, the expression patterns and functional roles of HNK-1-containing glycoconjugates in NSCs have not been fully recognized. We found that HNK-1 was expressed in embryonic mouse NSCs and that this expression was lost during the process of differentiation. Based on proteomics analysis, it was revealed that the HNK-1 epitopes were almost exclusively displayed on an extracellular matrix protein, tenascin-C (TNC), in the mouse embryonic NSCs. Furthermore, the HNK-1 epitope was found to be present only on the largest isoform of the TNC molecules. In addition, the expression of HNK-1 was dependent on expression of the largest TNC variant but not by enzymes involved in the biosynthesis of HNK-1. By knocking down HNK-1 sulfotransferase or TNC by small interfering RNA, we further demonstrated that HNK-1 on TNC was involved in the proliferation of NSCs via modulation of the expression level of the epidermal growth factor receptor. Our finding provides insights into the function of HNK-1 carbohydrate epitopes in NSCs to maintain stemness during neural development.	[Yagi, Hirokazu; Yanagisawa, Makoto; Suzuki, Yusuke; Nakatani, Yoshihiko; Ariga, Toshio; Yu, Robert K.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Yagi, Hirokazu; Yanagisawa, Makoto; Suzuki, Yusuke; Nakatani, Yoshihiko; Ariga, Toshio; Yu, Robert K.] Med Coll Georgia, Inst Neurosci, Augusta, GA 30912 USA; [Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Yu, RK (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, 1120 15th St, Augusta, GA 30912 USA.	ryu@mcg.edu	Yagi, Hirokazu/ABH-6151-2020	Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225	U. S. Public Health Service [NS11853-34, NS26994-20]; Childrens' Medical Research Foundation, Chicago, IL; Medical College of Georgia; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22790076]; Japan Society; Naito Foundation, Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853, R01NS026994] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Childrens' Medical Research Foundation, Chicago, IL; Medical College of Georgia; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation, Japan(Naito Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by U. S. Public Health Service Grants NS11853-34 and NS26994-20. This work was also supported by a grant from the Childrens' Medical Research Foundation, Chicago, IL (to R. K. Y.), a start-up fund from Medical College of Georgia (to M. Y.), and Grant-in-aid for Young Scientists B 22790076 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. Y.).; Supported by the Japan Society for the Japan-United States Brain Research Cooperative Program and the Naito Foundation, Japan.	ABO T, 1981, J IMMUNOL, V127, P1024; ARIGA T, 1987, J BIOL CHEM, V262, P848; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chou DKH, 2001, J NEUROCHEM, V77, P120, DOI 10.1046/j.1471-4159.2001.t01-1-00209.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; DORRIES U, 1994, J NEUROSCI RES, V37, P336, DOI 10.1002/jnr.490370306; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Garcion E, 2001, DEVELOPMENT, V128, P2485; GATES MA, 1995, J COMP NEUROL, V361, P249, DOI 10.1002/cne.903610205; Gurevicius K, 2007, MOL CELL NEUROSCI, V34, P189, DOI 10.1016/j.mcn.2006.10.014; HALL H, 1995, EUR NEUROPSYCHOPHARM, V5, P19, DOI 10.1016/0924-977X(94)00127-W; Hamanoue M, 2009, J NEUROCHEM, V110, P1575, DOI 10.1111/j.1471-4159.2009.06256.x; Joester A, 1999, J BIOL CHEM, V274, P17144, DOI 10.1074/jbc.274.24.17144; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; Klassen H, 2001, NEUROSCI LETT, V312, P180, DOI 10.1016/S0304-3940(01)02215-7; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Learish RD, 2000, DEV BRAIN RES, V122, P97; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Miura R, 2001, J NEUROCHEM, V76, P413, DOI 10.1046/j.1471-4159.2001.00042.x; Moritz S, 2008, STEM CELLS, V26, P2321, DOI 10.1634/stemcells.2007-1095; Nagase T, 2001, DEV GROWTH DIFFER, V43, P683; Nair SM, 1998, NEUROSCIENCE, V85, P759, DOI 10.1016/S0306-4522(97)00666-0; Nakatani Y, 2010, GLYCOBIOLOGY, V20, P78, DOI 10.1093/glycob/cwp149; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Suzuki Y, 2010, J BIOL CHEM, V285, P18443, DOI 10.1074/jbc.M110.114645; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tokuda A, 1998, J CARBOHYD CHEM, V17, P535, DOI 10.1080/07328309808002335; Treloar HB, 2009, J NEUROSCI, V29, P9405, DOI 10.1523/JNEUROSCI.2356-09.2009; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; VINCENT M, 1984, DEV BIOL, V103, P468, DOI 10.1016/0012-1606(84)90334-8; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Yagi H, 2008, GLYCOBIOLOGY, V18, P145, DOI 10.1093/glycob/cwm128; Yagi H, 2010, GLYCOBIOLOGY, V20, P976, DOI 10.1093/glycob/cwq054; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yamawaki M, 1996, J NEUROSCI RES, V44, P586, DOI 10.1002/(SICI)1097-4547(19960615)44:6<586::AID-JNR9>3.0.CO;2-7; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yanagisawa M, 1999, MOL BIOCHEM PARASIT, V102, P225, DOI 10.1016/S0166-6851(99)00102-4; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yanagisawa M, 2010, ASN NEURO, V2, DOI 10.1042/AN20090063; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170	49	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37293	37301		10.1074/jbc.M110.157081	http://dx.doi.org/10.1074/jbc.M110.157081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855890	Green Published, hybrid			2022-12-27	WOS:000284424000022
J	Abdelkarim, M; Caron, S; Duhem, C; Prawitt, J; Dumont, J; Lucas, A; Bouchaert, E; Briand, O; Brozek, J; Kuipers, F; Fievet, C; Cariou, B; Staels, B				Abdelkarim, Mouaadh; Caron, Sandrine; Duhem, Christian; Prawitt, Janne; Dumont, Julie; Lucas, Anthony; Bouchaert, Emmanuel; Briand, Olivier; Brozek, John; Kuipers, Folkert; Fievet, Catherine; Cariou, Bertrand; Staels, Bart			The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-gamma and Interfering with the Wnt/beta-Catenin Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; BILE-ACIDS; ADIPOGENESIS; BETA; EXPRESSION; LIGANDS; PROTEIN; IDENTIFICATION; FIBROBLASTS; MYC	The bile acid receptor farnesoid X receptor (FXR) is expressed in adipose tissue, but its function remains poorly defined. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a master regulator of adipocyte differentiation and function. The aim of this study was to analyze the role of FXR in adipocyte function and to assess whether it modulates PPAR gamma action. Therefore, we tested the responsiveness of FXR-deficient mice (FXR-/-) and cells to the PPAR gamma activator rosiglitazone. Our results show that genetically obese FXR-/-/ob/ob mice displayed a resistance to rosiglitazone treatment. In vitro, rosiglitazone treatment did not induce normal adipocyte differentiation and lipid droplet formation in FXR-/- mouse embryonic fibroblasts (MEFs) and preadipocytes. Moreover, FXR-/- MEFs displayed both an increased lipolysis and a decreased de novo lipogenesis, resulting in reduced intracellular triglyceride content, even upon PPAR gamma activation. Retroviral-mediated FXR re-expression in FXR-/- MEFs restored the induction of adipogenic marker genes during rosiglitazone-forced adipocyte differentiation. The expression of Wnt/beta-catenin pathway and target genes was increased in FXR-/- adipose tissue and MEFs. Moreover, the expression of several endogenous inhibitors of this pathway was decreased early during the adipocyte differentiation of FXR-/- MEFs. These findings demonstrate that FXR regulates adipocyte differentiation and function by regulating two counteracting pathways of adipocyte differentiation, the PPAR gamma and Wnt/beta-catenin pathways.	[Staels, Bart] Inst Pasteur, INSERM, UMR1011, F-59019 Lille, France; [Abdelkarim, Mouaadh; Caron, Sandrine; Duhem, Christian; Prawitt, Janne; Dumont, Julie; Lucas, Anthony; Bouchaert, Emmanuel; Briand, Olivier; Fievet, Catherine; Cariou, Bertrand; Staels, Bart] Univ Lille Nord France, F-59000 Lille, France; [Abdelkarim, Mouaadh; Caron, Sandrine; Duhem, Christian; Prawitt, Janne; Dumont, Julie; Lucas, Anthony; Bouchaert, Emmanuel; Briand, Olivier; Fievet, Catherine; Cariou, Bertrand; Staels, Bart] Univ Lille 2, F-59000 Lille, France; [Brozek, John] Genfit, F-59120 Loos, France; [Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab, NL-9713 GZ Groningen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Groningen	Staels, B (corresponding author), Inst Pasteur, INSERM, UMR1011, 1 Rue Prof Calmette,BP245, F-59019 Lille, France.	Bart.Staels@pasteur-lille.fr	Briand, Olivier/AGV-1669-2022; BOUCHAERT, Emmanuel/AFU-7112-2022; CARON, Sandrine/R-6624-2018; Staels, Bart/N-9497-2016	Briand, Olivier/0000-0003-2979-0395; BOUCHAERT, Emmanuel/0000-0003-2558-9862; CARON, Sandrine/0000-0002-4660-7436; Staels, Bart/0000-0002-3784-1503; Dumont, Julie/0000-0001-5893-0022; Abdelkarim, Mouaadh/0000-0003-3538-2566; Kuipers, Folkert/0000-0003-2518-737X; Duhem, Christian/0000-0003-0931-3815; Cariou, Bertrand/0000-0002-1580-8040	European Union [HEPADIP 018734]; Agence Nationale de la Recherche [A05056GS]; Fondation pour la Recherche Medicale; COST Action [BM0602]	European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); COST Action(European Cooperation in Science and Technology (COST))	This work was supported by European Union Grant HEPADIP 018734, COST Action Grant BM0602, and Agence Nationale de la Recherche Grant A05056GS. This work was also supported by a grant from the Fondation pour la Recherche Medicale (to M. A.).	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bhat RA, 2004, PROTEIN EXPRES PURIF, V37, P327, DOI 10.1016/j.pep.2004.06.029; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cariou B, 2007, FEBS LETT, V581, P5191, DOI 10.1016/j.febslet.2007.09.064; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fiorucci S, 2005, J PHARMACOL EXP THER, V315, P58, DOI 10.1124/jpet.105.085597; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Lagathu C, 2009, DIABETES, V58, P609, DOI 10.2337/db08-1180; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rizzo G, 2006, MOL PHARMACOL, V70, P1164, DOI 10.1124/mol.106.023820; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	42	67	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36759	36767		10.1074/jbc.M110.166231	http://dx.doi.org/10.1074/jbc.M110.166231			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851881	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000284146100011
J	Lazarou, M; Stojanovski, D; Frazier, AE; Kotevski, A; Dewson, G; Craigen, WJ; Kluck, RM; Vaux, DL; Ryan, MT				Lazarou, Michael; Stojanovski, Diana; Frazier, Ann E.; Kotevski, Aneta; Dewson, Grant; Craigen, William J.; Kluck, Ruth M.; Vaux, David L.; Ryan, Michael T.			Inhibition of Bak Activation by VDAC2 Is Dependent on the Bak Transmembrane Anchor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; GENERAL IMPORT PORE; CYTOCHROME-C; ANION CHANNEL; MAMMALIAN MITOCHONDRIA; OLIGOMERIZES BAK; PROTEIN IMPORT; CELL-DEATH; COMPLEX-I; APOPTOSIS	Bax and Bak are pro-apoptotic factors that are required for cell death by the mitochondrial or intrinsic pathway. Bax is found in an inactive state in the cytosol and upon activation is targeted to the mitochondrial outer membrane where it releases cytochrome c and other factors that cause caspase activation. Although Bak functions in the same way as Bax, it is constitutively localized to the mitochondrial outer membrane. In the membrane, Bak activation is inhibited by the voltage-dependent anion channel isoform 2 (VDAC2) by an unknown mechanism. Using blue native gel electrophoresis, we show that in healthy cells endogenous inactive Bak exists in a 400-kDa complex that is dependent on the presence of VDAC2. Activation of Bak is concomitant with its release from the 400-kDa complex and the formation of lower molecular weight species. Furthermore, substitution of the Bak transmembrane anchor with that of the mitochondrial outer membrane tail-anchored protein hFis1 prevents association of Bak with the VDAC2 complex and increases the sensitivity of cells to an apoptotic stimulus. Our results suggest that VDAC2 interacts with the hydrophobic tail of Bak to sequester it in an inactive state in the mitochondrial outer membrane, thereby raising the stimulation threshold necessary for permeabilization of the mitochondrial outer membrane and cell death.	[Ryan, Michael T.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia; [Stojanovski, Diana; Ryan, Michael T.] La Trobe Univ, Ctr Excellence Coherent Xray Sci, Bundoora, Vic 3086, Australia; [Dewson, Grant; Kluck, Ruth M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Craigen, William J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	La Trobe University; La Trobe University; Walter & Eliza Hall Institute; Baylor College of Medicine	Ryan, MT (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia.	M.Ryan@latrobe.edu.au	Ryan, Michael/X-2152-2019; Ryan, Michael T/C-6673-2011; Lazarou, Michael/G-7143-2011; Vaux, David L/C-7249-2013; Kluck, Ruth M/C-8413-2013; dewson, grant/C-7646-2013	Ryan, Michael/0000-0003-2586-8829; Ryan, Michael T/0000-0003-2586-8829; Vaux, David L/0000-0003-2703-1651; Kluck, Ruth M/0000-0002-7101-1925; dewson, grant/0000-0003-4251-8898; Lazarou, Michael/0000-0003-2150-5545; Stojanovski, Diana/0000-0002-0199-3222; Frazier, Ann/0000-0002-6491-3437	National Health and Medical Research Council; Association for International Cancer Research; Clive and Vera Ramaciotti Foundation; Australian Research Council Centre of Excellence for Coherent X-ray Science; Australian Research Council; La Trobe University	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research; Clive and Vera Ramaciotti Foundation; Australian Research Council Centre of Excellence for Coherent X-ray Science(Australian Research Council); Australian Research Council(Australian Research Council); La Trobe University	This work was supported in part by grants from the National Health and Medical Research Council, Association for International Cancer Research, the Clive and Vera Ramaciotti Foundation, and the Australian Research Council Centre of Excellence for Coherent X-ray Science.; Supported by an Australian Research Council postdoctoral fellowship.; Supported by a La Trobe University postdoctoral fellowship. Present address: Murdoch Childrens Research Institute, Royal Children's Hospital, 3052 Melbourne, Australia.	Baker MJ, 2009, MOL BIOL CELL, V20, P769, DOI 10.1091/mbc.E08-09-0903; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kozjak-Pavlovic V, 2010, J MOL BIOL, V397, P219, DOI 10.1016/j.jmb.2010.01.047; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LITHGOW T, 1993, FEBS LETT, V332, P277, DOI 10.1016/0014-5793(93)80649-F; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Ren DC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000274; Ross K, 2009, CELL DEATH DIFFER, V16, P697, DOI 10.1038/cdd.2008.194; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31	55	71	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36876	36883		10.1074/jbc.M110.159301	http://dx.doi.org/10.1074/jbc.M110.159301			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851889	hybrid, Green Published			2022-12-27	WOS:000284146100014
J	Salameh, MA; Soares, AS; Navaneetham, D; Sinha, D; Walsh, PN; Radisky, ES				Salameh, Moh'd A.; Soares, Alexei S.; Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.; Radisky, Evette S.			Determinants of Affinity and Proteolytic Stability in Interactions of Kunitz Family Protease Inhibitors with Mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; FACTOR PATHWAY INHIBITOR; COAGULATION-FACTOR-XIA; HUMAN BRAIN TRYPSIN; SERINE PROTEINASES; PLASMINOGEN-ACTIVATOR; INTERSCAFFOLDING ADDITIVITY; GEL-ELECTROPHORESIS; NEUTROPHIL ELASTASE; CRYSTAL-STRUCTURES	An important functional property of protein protease inhibitors is their stability to proteolysis. Mesotrypsin is a human trypsin that has been implicated in the proteolytic inactivation of several protein protease inhibitors. We have found that bovine pancreatic trypsin inhibitor (BPTI), a Kunitz protease inhibitor, inhibits mesotrypsin very weakly and is slowly proteolyzed, whereas, despite close sequence and structural homology, the Kunitz protease inhibitor domain of the amyloid precursor protein (APPI) binds to mesotrypsin 100 times more tightly and is cleaved 300 times more rapidly. To define features responsible for these differences, we have assessed the binding and cleavage by mesotrypsin of APPI and BPTI reciprocally mutated at two nonidentical residues that make direct contact with the enzyme. We find that Arg at P-1 (versus Lys) favors both tighter binding and more rapid cleavage, whereas Met (versus Arg) at P'(2) favors tighter binding but has minimal effect on cleavage. Surprisingly, we find that the APPI scaffold greatly enhances proteolytic cleavage rates, independently of the binding loop. We draw thermodynamic additivity cycles analyzing the interdependence of P-1 and P'(2) substitutions and scaffold differences, finding multiple instances in which the contributions of these features are nonadditive. We also report the crystal structure of the mesotrypsin.APPI complex, in which we find that the binding loop of APPI displays evidence of increased mobility compared with BPTI. Our data suggest that the enhanced vulnerability of APPI to mesotrypsin cleavage may derive from sequence differences in the scaffold that propagate increased flexibility and mobility to the binding loop.	[Salameh, Moh'd A.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Navaneetham, Duraiswamy; Sinha, Dipali; Walsh, Peter N.] Temple Univ, Sch Med, Dept Biochem, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Radisky, ES (corresponding author), 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Paditz, Ekkehart/F-5351-2015; Radisky, Evette S/C-8526-2012; Soares, Alexei S/F-4800-2014	Radisky, Evette S/0000-0003-3121-109X; Soares, Alexei S/0000-0002-6565-8503	National Institutes of Health [P50 CA091956-08, HL74124, HL46213]; Bankhead-Coley Florida Biomedical Research Program [07BN-07]; Department of Defense [PC094054]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL046213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Florida Biomedical Research Program; Department of Defense(United States Department of Defense); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA091956-08 (to E. S. R.) and HL74124 and HL46213 (to P. N. W.). This work was also supported by Bankhead-Coley Florida Biomedical Research Program Grant 07BN-07 (to E. S. R.) and Department of Defense Grant PC094054 (to E. S. R.). Diffraction data were measured at beamlines X12-B, X12-C, and X25 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER, V42; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Badellino KO, 2000, BIOCHEMISTRY-US, V39, P4769, DOI 10.1021/bi9925468; Baum B, 2010, J MOL BIOL, V397, P1042, DOI 10.1016/j.jmb.2010.02.007; Belaaouaj AA, 2000, J BIOL CHEM, V275, P27123; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; DeLano W.L, PYMOL MOL GRAPHICS S; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Devy L, 2007, NEOPLASIA, V9, P927, DOI 10.1593/neo.07544; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; EVNIN LB, 1990, P NATL ACAD SCI USA, V87, P6659, DOI 10.1073/pnas.87.17.6659; Frank BT, 2001, J IMMUNOL, V166, P2783, DOI 10.4049/jimmunol.166.4.2783; Gallagher S. R., 2001, CURRENT PROTOCOLS MO; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; GRAF L, 1988, P NATL ACAD SCI USA, V85, P4961, DOI 10.1073/pnas.85.14.4961; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HIGUCHI DA, 1992, BLOOD, V79, P1712; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Kantyka T, 2009, BIOL CHEM, V390, P1313, DOI 10.1515/BC.2009.136; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Koistinen H, 2009, NEUROSCIENCE, V160, P97, DOI 10.1016/j.neuroscience.2009.02.042; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; LASKOWSKI M, 1953, J BIOL CHEM, V204, P797; LASKOWSKI M, 1971, ENZYMES, V3, P375; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li W, 2009, CANCER RES, V69, P8395, DOI 10.1158/0008-5472.CAN-09-1995; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Nyberg P, 2006, EXP CELL RES, V312, P1219, DOI 10.1016/j.yexcr.2005.12.024; Ohkura N, 1997, BLOOD, V90, P1883, DOI 10.1182/blood.V90.5.1883; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Qasim MA, 1999, BIOCHEMISTRY-US, V38, P7142, DOI 10.1021/bi990265u; Qasim MA, 1997, BIOCHEMISTRY-US, V36, P1598, DOI 10.1021/bi9620870; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rowen L, 2005, MOL BIOL EVOL, V22, P1712, DOI 10.1093/molbev/msi166; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Sun ZF, 2004, LANCET ONCOL, V5, P182, DOI 10.1016/S1470-2045(04)01414-7; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Travis J, 2000, BBA-PROTEIN STRUCT M, V1477, P35, DOI 10.1016/S0167-4838(99)00278-2; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Vindigni A, 1998, PROTEIN SCI, V7, P1728, DOI 10.1002/pro.5560070807; Wang YF, 2006, J NEUROCHEM, V99, P759, DOI 10.1111/j.1471-4159.2006.04105.x; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Yang L, 2008, J BIOL CHEM, V283, P35295, DOI 10.1074/jbc.M806965200; Yun TH, 2009, BLOOD, V113, P1139, DOI 10.1182/blood-2008-05-157180; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	93	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36884	36896		10.1074/jbc.M110.171348	http://dx.doi.org/10.1074/jbc.M110.171348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20861008	Green Published, hybrid			2022-12-27	WOS:000284146100026
J	Liao, MC; Hoos, MD; Aucoin, D; Ahmed, M; Davis, J; Smith, SO; Van Nostrand, WE				Liao, Mei-Chen; Hoos, Michael D.; Aucoin, Darryl; Ahmed, Mahiuddin; Davis, Judianne; Smith, Steven O.; Van Nostrand, William E.			N-terminal Domain of Myelin Basic Protein Inhibits Amyloid beta-Protein Fibril Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; IN-VITRO; CDNA CLONING; GENE; PRECURSOR; PEPTIDE; ANGIOPATHY; POLYPEPTIDE	Accumulation of amyloid beta-protein (A beta) into brain parenchymal plaques and the cerebral vasculature is a pathological feature of Alzheimer disease and related disorders. A beta peptides readily form beta-sheet-containing oligomers and fibrils. Previously, we reported a strong interaction between myelin basic protein (MBP) and A beta peptides that resulted in potent inhibition of fibril assembly (Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2007) J. Biol. Chem. 282, 9952-9961; Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2009) Biochemistry 48, 4720-4727). MBP is recognized as a highly post-translationally modified protein. In the present study, we demonstrate that human MBP purified from either brain or a bacterial recombinant expression system comparably bound to A beta and inhibited A beta fibril assembly indicating that post-translational modifications are not required for this activity. We also show that purified mouse brain MBP and recombinantly expressed mouse MBP similarly inhibited A beta fibril formation. Through a combination of biochemical and ultrastructural techniques, we demonstrate that the binding site for A beta is located in the N-terminal 64 amino acids of MBP and that a stable peptide (MBP1) comprising these residues was sufficient to inhibit A beta fibrillogenesis. Under conditions comparable with those used for A beta, the fibrillar assembly of amylin, another amyloidogenic peptide, was not inhibited by MBP1, although MBP1 still bound to it. This observation suggests that the potent inhibitory effect of MBP on fibril formation is not general to amyloidogenic peptides. Finally, MBP1 could prevent the cytotoxic effects of A beta in primary cortical neurons. Our findings suggest that inhibition of A beta fibril assembly by MBP, mediated through its N-terminal domain, could play a role in influencing amyloid formation in Alzheimer disease brain and corresponding mouse models.	[Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA; [Aucoin, Darryl; Ahmed, Mahiuddin; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Nostrand, WE (corresponding author), SUNY Stony Brook, Dept Neurosurg, HSC T-12-089, Stony Brook, NY 11794 USA.	William.VanNostrand@stonybrook.edu	Smith, Steven/HDM-9496-2022		National Institutes of Health [NS35781, AG27317]; Alzheimer's Association [IIRG-06-26805]; Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027317, RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS35781 (to W. E. V. N.) and AG27317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant IIRG-06-26805, a Collaborative MS Research Award, and a grant from the Cure Alzheimer's Disease Fund.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; BARBARESE E, 1978, J NEUROCHEM, V31, P779, DOI 10.1111/j.1471-4159.1978.tb00110.x; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BETSHOLTZ C, 1989, EXP CELL RES, V183, P484, DOI 10.1016/0014-4827(89)90407-2; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; DEFERRA F, 1985, R A CELL, V43, P721; Givogri MI, 2000, J NEUROSCI RES, V59, P153, DOI 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.3.CO;2-6; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hoos MD, 2007, J BIOL CHEM, V282, P9952, DOI 10.1074/jbc.M603494200; Hoos MD, 2009, BIOCHEMISTRY-US, V48, P4720, DOI 10.1021/bi900037s; HOPPENER JWM, 1994, J CELL BIOCHEM, V55, P39, DOI 10.1002/jcb.240550006; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; KAMHOLZ J, 1988, J NEUROSCI RES, V21, P62, DOI 10.1002/jnr.490210110; KAMINO K, 1992, AM J HUM GENET, V51, P998; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Miravalle L, 2000, J BIOL CHEM, V275, P27110; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROTH HJ, 1987, J NEUROSCI RES, V17, P321, DOI 10.1002/jnr.490170402; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; WOOD DD, 1989, J BIOL CHEM, V264, P5121; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c; Zand R, 1998, BIOCHEMISTRY-US, V37, P2441, DOI 10.1021/bi972347t	44	22	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35590	35598		10.1074/jbc.M110.169599	http://dx.doi.org/10.1074/jbc.M110.169599			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807757	Green Published, hybrid			2022-12-27	WOS:000283845300037
J	Nishioka, T; Frohman, MA; Matsuda, M; Kiyokawa, E				Nishioka, Teruko; Frohman, Michael A.; Matsuda, Michiyuki; Kiyokawa, Etsuko			Heterogeneity of Phosphatidic Acid Levels and Distribution at the Plasma Membrane in Living Cells as Visualized by a Forster Resonance Energy Transfer (FRET) Biosensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D ACTIVITY; PROTEIN-KINASE-C; STIMULATED PC12 CELLS; HUMAN CANCER-CELLS; TYROSINE PHOSPHORYLATION; RECEPTOR ENDOCYTOSIS; TRANSFORMED CELLS; ACTIVATION; RAS; DYNAMICS	Phosphatidic acid (PA) is one of the major phospholipids in the plasma membrane. Although it has been reported that PA plays key roles in cell survival and morphology, it remains unknown when and where PA is produced in the living cell. Based on the principle of Forster resonance energy transfer (FRET), we generated PA biosensor, and named Pii (phosphatidic acid indicator). In these biosensors, the lipid-binding domain of DOCK2 is sandwiched with the cyan fluorescent protein and yellow fluorescent protein and is tagged with the plasma membrane-targeting sequence of K-Ras. The addition of synthetic PA, or the activation of phospholipase D or diacylglycerol kinase at the plasma membrane, changed the level of FRET in Pii-expressing cells, demonstrating the response of Pii to PA. The biosensor also detected divergent PA content among various cell lines as well as within one cell line. Interestingly, the growth factor-induced increment in PA content correlated negatively with the basal PA content before stimulation, suggesting the presence of an upper threshold in the PA concentration at the plasma membrane. The biosensor also revealed uneven PA distribution within the cell, i.e. the basal level and growth factor-induced accumulation of PA was higher at the cell-free edges than at the cell-cell contact region. An insufficient increase in PA may account for ineffective Ras activation at areas of cell-cell contact. In conclusion, the PA biosensor Pii is a versatile tool for examining heterogeneity in the content and distribution of PA in single cells as well as among different cells.	[Matsuda, Michiyuki; Kiyokawa, Etsuko] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; [Nishioka, Teruko; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA	Kyoto University; Kyoto University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kiyokawa, E (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	kiyokawa@lif.kyoto-u.ac.jp		Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Health [GM0171520, GM084251]; Japan Society for the Promotion of Science for Young Scientists; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084251] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported in part by National Institute of Health Awards GM0171520 and GM084251 (to M. A. F.).; Supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Craske ML, 2005, J CELL BIOL, V170, P1147, DOI 10.1083/jcb.200503118; Du GW, 2009, MOL BIOL CELL, V20, P200, DOI 10.1091/mbc.E08-06-0555; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Frankel P, 1999, BIOCHEM BIOPH RES CO, V255, P502, DOI 10.1006/bbrc.1999.0234; Freyberg Z, 2003, TRENDS CELL BIOL, V13, P540, DOI 10.1016/j.tcb.2003.08.004; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kurokawa K, 2001, J BIOL CHEM, V276, P31305, DOI 10.1074/jbc.M104341200; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sung TC, 1999, J BIOL CHEM, V274, P494, DOI 10.1074/jbc.274.1.494; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Yamaguchi Y, 2006, J BIOL CHEM, V281, P31627, DOI 10.1074/jbc.M606992200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	47	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35979	35987		10.1074/jbc.M110.153007	http://dx.doi.org/10.1074/jbc.M110.153007			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826779	Green Published, hybrid			2022-12-27	WOS:000283845300074
J	Chalabaev, S; Kim, TH; Ross, R; Derian, A; Kasper, DL				Chalabaev, Sabina; Kim, Tae-Hyun; Ross, Robin; Derian, Alec; Kasper, Dennis L.			3-Deoxy-D-manno-octulosonic Acid (Kdo) Hydrolase Identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LIPID-A; SIALIC ACIDS; CELL-WALL; CAPSULAR POLYSACCHARIDE; RHAMNOGALACTURONAN-II; LIPOPOLYSACCHARIDE; ANTIGEN; BIOSYNTHESIS; SEQUENCES	3-Deoxy-D-manno-octulosonic acid (Kdo) is an eight-carbon sugar ubiquitous in Gram-negative bacterial lipopolysaccharides (LPS). Although its biosynthesis is well described, no protein has yet been identified as a Kdo hydrolase. However, Kdo hydrolase enzymatic activity has been detected in membranes of Helicobacter pylori and Francisella tularensis and may be responsible for the removal of side-chain Kdo from the LPS core saccharides. We now report the identification of genes encoding a Kdo hydrolase in F. tularensis Schu S4 and live vaccine strain strains, in H. pylori 26695 strain and in Legionella pneumophila Philadelphia 1 strain. We have renamed the genes kdhA for keto-deoxyoctulosonate hydrolase A. Deletion of kdhA abolished Kdo hydrolase activity in membranes of F. tularensis live vaccine strain. The F. tularensis kdhA mutant synthesized a core oligosaccharide containing a Kdo disaccharide with one of the Kdo residues being a terminal side chain. This side-chain Kdo monosaccharide was absent in the wild-type core oligosaccharide. Expression in Escherichia coli of recombinant KdhA from F. tularensis, H. pylori, and L. pneumophila resulted in a reduction of membrane-associated side-chain Kdo. The identification of this previously faceless enzyme will accelerate study of the biosynthetic basis and biologic impact for postbiosynthetic LPS structural modification.	[Chalabaev, Sabina; Kim, Tae-Hyun; Ross, Robin; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [Chalabaev, Sabina; Kim, Tae-Hyun; Ross, Robin; Derian, Alec; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kasper, DL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, 180 Longwood Ave, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu			National Institutes of Health, NIAID [AI057159]; New England Center of Excellence in Biodefense and Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New England Center of Excellence in Biodefense and Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057159 from the NIAID (to D. L. K.). This work was also supported by the New England Center of Excellence in Biodefense and Emerging Infectious Disease.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Baron G S, 1995, Methods Mol Biol, V47, P149; BECKER B, 1989, EUR J BIOCHEM, V182, P153, DOI 10.1111/j.1432-1033.1989.tb14811.x; Bernard A, 2001, CURR PROTOC PROTEIN; BHATTACHARJEE AK, 1978, BIOCHEMISTRY-US, V17, P645, DOI 10.1021/bi00597a013; Cipolla Laura, 2009, Curr Drug Discov Technol, V6, P19; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; GHALAMBOR MA, 1966, J BIOL CHEM, V241, P3222; Girard R, 2003, J CELL SCI, V116, P293, DOI 10.1242/jcs.00212; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Hardy E, 1997, ANAL BIOCHEM, V244, P28, DOI 10.1006/abio.1996.9719; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kiang J, 1997, ANAL BIOCHEM, V245, P97, DOI 10.1006/abio.1996.9951; Kim TH, 2010, J BIOL CHEM, V285, P27839, DOI 10.1074/jbc.M110.143859; Lauriano CM, 2003, FEMS MICROBIOL LETT, V229, P195, DOI 10.1016/S0378-1097(03)00820-6; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; LENTER M, 1990, CARBOHYD RES, V197, P197, DOI 10.1016/0008-6215(90)84142-H; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Li YT, 1997, J BIOL CHEM, V272, P26419, DOI 10.1074/jbc.272.42.26419; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Moll H, 1997, CARBOHYD RES, V304, P91, DOI 10.1016/S0008-6215(97)00210-3; Nimtz M, 1997, EUR J BIOCHEM, V250, P608, DOI 10.1111/j.1432-1033.1997.0608a.x; Palmer JD, 2004, AM J BOT, V91, P1437, DOI 10.3732/ajb.91.10.1437; PEREZPEREZ GI, 1995, INFECT IMMUN, V63, P1183; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Pupo E, 2007, ELECTROPHORESIS, V28, P2351, DOI 10.1002/elps.200600744; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; SANDSTROM G, 1992, FEMS MICROBIOL IMMUN, V105, P201, DOI 10.1111/j.1574-6968.1992.tb05902.x; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; Stead CM, 2010, MOL MICROBIOL, V78, P837, DOI 10.1111/j.1365-2958.2010.07304.x; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; WARREN L, 1959, J BIOL CHEM, V234, P1971; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9; Zahringer U, 1995, Prog Clin Biol Res, V392, P113; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zhao JS, 2010, MOL MICROBIOL, V78, P820, DOI 10.1111/j.1365-2958.2010.07305.x	45	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34330	34336		10.1074/jbc.M110.166314	http://dx.doi.org/10.1074/jbc.M110.166314			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801884	Green Published, hybrid			2022-12-27	WOS:000283659100006
J	Hammad, MM; Kuang, YQ; Yan, R; Allen, H; Dupre, DJ				Hammad, Maha M.; Kuang, Yi-Qun; Yan, Ronald; Allen, Heather; Dupre, Denis J.			Na+/H+ Exchanger Regulatory Factor-1 Is Involved in Chemokine Receptor Homodimer CCR5 Internalization and Signal Transduction but Does Not Affect CXCR4 Homodimer or CXCR4-CCR5 Heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARATHYROID-HORMONE RECEPTOR; BINDING PHOSPHOPROTEIN-50 EBP50; PDZ DOMAINS; CELL-SURFACE; BETA(1)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; ACTIN REORGANIZATION; SCAFFOLD PROTEINS; ASSOCIATION; EZRIN	Chemokine receptors are members of the G protein-coupled receptor (GPCR) family. CCR5 is also the principal co-receptor for macrophage-tropic strains of human immunodeficiency virus, type 1 (HIV-1), and efforts have been made to develop ligands to inhibit HIV-1 infection by promoting CCR5 receptor endocytosis. Given the nature of GPCRs and their propensity to form oligomers, one can consider ligand-based therapies as unselective in terms of the oligomeric composition of complexes. For example, a ligand targeting a CCR5 homomer could likely induce signal transduction on a heteromeric CCR5-CXCR4. Other avenues could therefore be explored. We identified a receptor adaptor interacting specifically with one receptor complex but not others. NHERF1, an adaptor known for its role in desensitization, internalization, and regulation of the ERK signaling cascade for several GPCRs, interacts via its PDZ2 domain with the CCR5 homodimer but not with the CXCR4-CCR5 heterodimer or CXCR4 homodimer. To further characterize this interaction, we also show that NHERF1 increases the CCR5 recruitment of arrestin2 following stimulation. NHERF1 is also involved in CCR5 internalization, as we demonstrate that co-expression of constructs bearing the PDZ2 domain can block CCR5 internalization. We also show that NHERF1 potentiates RANTES (regulated on activation normal T cell expressed and secreted)-induced ERK1/2 phosphorylation via CCR5 activation and that this activation requires NHERF1 but not arrestin2. Taken together, our results suggest that oligomeric receptor complexes can associate specifically with partners and that in this case NHERF1 could represent an interesting new target for the regulation of CCR5 internalization and potentially HIV infection.	[Hammad, Maha M.; Kuang, Yi-Qun; Yan, Ronald; Allen, Heather; Dupre, Denis J.] Dalhousie Univ, Dept Pharmacol, Fac Med, Halifax, NS B3H 1X5, Canada	Dalhousie University	Dupre, DJ (corresponding author), Dalhousie Univ, Dept Pharmacol, Fac Med, Rm 6C,Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 1X5, Canada.	denis.dupre@dal.ca	Dupre, Denis J/AAI-2631-2021; Kuang, Yi-Qun/AAW-4884-2021; Kuang, Yi-Qun/K-6161-2013	Dupre, Denis J/0000-0001-6401-6157; Kuang, Yi-Qun/0000-0002-1452-4388; Hammad, Maha/0000-0002-8974-8255	Canadian Institutes of Health Research [HOP-86863]; Natural Sciences and Engineering Research Council of Canada [EQPEQ-3591097-2008]; Canada Foundation for Innovation; Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation	This work was supported in part by Canadian Institutes of Health Research Grant HOP-86863, Natural Sciences and Engineering Research Council of Canada Grant EQPEQ-3591097-2008, and Canada Foundation for Innovation (to D. J. D.).; Holds a Nova Scotia Health Research Foundation graduate student award.; Holds a Natural Sciences and Engineering Research Council of Canada undergraduate research award.; Recipient of a Canadian Institutes of Health Research New Investigator award and Dalhousie Medical Research Foundation New Investigator award.	Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Di Marzio P, 2005, BIOCHEM BIOPH RES CO, V331, P909, DOI 10.1016/j.bbrc.2005.04.015; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Harris BZ, 2001, J CELL SCI, V114, P3219; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hu C. D., 2005, CURR PROTOC PROTEIN, P19101; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Mayasundari A, 2008, BIOORG MED CHEM LETT, V18, P942, DOI 10.1016/j.bmcl.2007.12.038; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Mueller A, 2004, EUR J BIOCHEM, V271, P243, DOI 10.1046/j.1432-1033.2003.03918.x; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sneddon WB, 2007, ENDOCRINOLOGY, V148, P4073, DOI 10.1210/en.2007-0343; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun C, 2005, J PEPT RES, V65, P411, DOI 10.1111/j.1399-3011.2005.00240.x; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903	50	31	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34653	34664		10.1074/jbc.M110.106591	http://dx.doi.org/10.1074/jbc.M110.106591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801883	Green Published, hybrid			2022-12-27	WOS:000283659100041
J	Mermelekas, G; Georgopoulou, E; Kallis, A; Botou, M; Vlantos, V; Frillingos, S				Mermelekas, George; Georgopoulou, Ekaterini; Kallis, Alexander; Botou, Maria; Vlantos, Vassilios; Frillingos, Stathis			Cysteine-scanning Analysis of Helices TM8, TM9a, and TM9b and Intervening Loops in the YgfO Xanthine Permease A CARBOXYL GROUP IS ESSENTIAL AT ASP-276	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER SIGNATURE MOTIF; ESCHERICHIA-COLI; LACTOSE PERMEASE; FUNCTIONAL-CHARACTERIZATION; MEMBRANE-PROTEINS; BACTERIAL; FAMILY; SPECIFICITY; MUTAGENESIS; MECHANISM	Bacterial and fungal members of the ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family use the NAT signature motif, a conserved 11-amino acid sequence between amphipathic helices TM9a and TM9b, to define function and selectivity of the purine binding site. To examine the role of flanking helices TM9a, TM9b, and TM8, we employed Cys-scanning analysis of the xanthine-specific homolog YgfO from Escherichia coli. Using a functional mutant devoid of Cys residues (C-less), each amino acid residue in sequences (259)FLVVG-TIYLLSVLEAVGDITATAMVSRRPIQGEEYQSRLKGGVLAD-GLVSVIASAV(314) and (342)TIAVMLVILGLFP(354) including these TMs(underlined) was replaced individually with Cys, except the irreplaceable Glu-272 and Asp-304, which had been studied previously. Of 67 single Cys mutants, 55 accumulate xanthine to 35-140% of the steady state observed with C-less, five (I265C, D276C, I277C, G299C, L350C) accumulate to low levels (10-20%) and seven (T278C, A279C, T280C, A281C, G305C, G351C, P354C) show negligible expression in the membrane. Extensive mutagenesis reveals that a carboxyl group is needed at Asp-276 for high activity and that D276E differs from wild type as it recognizes 8-methylxanthine (K-t 79 mu M) but fails to recognize 2-thioxanthine, 3-methylxanthine or 6-thioxanthine; bulky replacements of Ala-279 or Thr-280 and replacements of Gly-305, Gly-351, or Pro-354 impair activity or expression. Single Cys mutants V261C, A273C, G275C, and S284C are sensitive to inactivation by N-ethylmaleimide and sensitivity of G275C(IC50 15 mu M) is enhanced in the presence of substrate. The data suggest that residues crucial for the transport mechanism cluster in two conserved motifs, at the cytoplasmic end of TM8 (EXXG-DXXAT) and in TM9a (GXXXDG).	[Mermelekas, George; Georgopoulou, Ekaterini; Kallis, Alexander; Botou, Maria; Vlantos, Vassilios; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021; Kallis, Aristotle/A-5717-2016		Greek Ministry of Development, General Secretariat for Research and Technology; European Union	Greek Ministry of Development, General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); European Union(European Commission)	This work is part of the 03ED204 research project, implemented within the framework of the "Reinforcement Programme of Human Research Manpower" (PENED) and co-financed by National and Community Funds (25% from the Greek Ministry of Development, General Secretariat for Research and Technology, and 75% from the European Union European Social Fund).	Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P10166, DOI 10.1021/bi960995r; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Velho AM, 2009, EXP CELL RES, V315, P2312, DOI 10.1016/j.yexcr.2009.04.007; Weinglass AB, 2002, J MOL BIOL, V315, P561, DOI 10.1006/jmbi.2001.5289; Weinglass AB, 2001, BIOCHEMISTRY-US, V40, P769, DOI 10.1021/bi002171m; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	24	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35011	35020		10.1074/jbc.M110.170415	http://dx.doi.org/10.1074/jbc.M110.170415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20802252	Green Published, hybrid			2022-12-27	WOS:000283659100075
J	Nonaka, T; Watanabe, ST; Iwatsubo, T; Hasegawa, M				Nonaka, Takashi; Watanabe, Sayuri T.; Iwatsubo, Takeshi; Hasegawa, Masato			Seeded Aggregation and Toxicity of alpha-Synuclein and Tau CELLULAR MODELS OF NEURODEGENERATIVE DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; HUMAN BRAIN; PROTEIN; FILAMENTS; TRANSMISSION; INCLUSIONS; MECHANISM	The deposition of amyloid-like filaments in the brain is the central event in the pathogenesis of neurodegenerative diseases. Here we report cellular models of intracytoplasmic inclusions of alpha-synuclein, generated by introducing nucleation seeds into SH-SY5Y cells with a transfection reagent. Upon introduction of preformed seeds into cells overexpressing alpha-synuclein, abundant, highly filamentous alpha-synuclein-positive inclusions, which are extensively phosphorylated and ubiquitinated and partially thioflavin-positive, were formed within the cells. SH-SY5Y cells that formed such inclusions underwent cell death, which was blocked by small molecular compounds that inhibit beta-sheet formation. Similar seed-dependent aggregation was observed in cells expressing four-repeat Tau by introducing four-repeat Tau fibrils but not three-repeat Tau fibrils or alpha-synuclein fibrils. No aggregate formation was observed in cells overexpressing three-repeat Tau upon treatment with four-repeat Tau fibrils. Our cellular models thus provide evidence of nucleation-dependent and protein-specific polymerization of intracellular amyloid-like proteins in cultured cells.	[Nonaka, Takashi] Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, Tokyo 1568585, Japan; [Watanabe, Sayuri T.; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan	Tokyo Institute of Psychiatry; University of Tokyo; University of Tokyo	Nonaka, T (corresponding author), Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, 2-1-8 Kamikitazawa, Tokyo 1568585, Japan.	nonaka-tk@igakuken.or.jp; hasegawa-ms@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19590297, 22500345]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on Priority Areas, Research on Pathomechanisms of Brain Disorders (to T. I. and M. H.) and Grant-in-aid for Scientific Research (C) 19590297 and 22500345 (to T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NGUYEN JT, 1995, J MOL BIOL, V252, P412, DOI 10.1006/jmbi.1995.0507; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Olesen OF, 1997, MOL BRAIN RES, V44, P105, DOI 10.1016/S0169-328X(96)00196-9; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200	42	231	239	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34885	34898		10.1074/jbc.M110.148460	http://dx.doi.org/10.1074/jbc.M110.148460			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805224	Green Published, hybrid			2022-12-27	WOS:000283659100063
J	Pathak, A; Goyal, R; Sinha, A; Sarkar, D				Pathak, Anuj; Goyal, Rajni; Sinha, Akesh; Sarkar, Dibyendu			Domain Structure of Virulence-associated Response Regulator PhoP of Mycobacterium tuberculosis ROLE OF THE LINKER REGION IN REGULATOR-PROMOTER INTERACTION(S)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; TRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; TUBERCLE BACILLUS; RECEIVER DOMAIN; OMPR; BIOSYNTHESIS; PHOSPHORYLATION; LIPIDS; HELIX	The PhoP and PhoR proteins from Mycobacterium tuberculosis form a highly specific two-component system that controls expression of genes involved in complex lipid biosynthesis and regulation of unknown virulence determinants. The several functions of PhoP are apportioned between a C-terminal effector domain (PhoPC) and an N-terminal receiver domain (PhoPN), phosphorylation of which regulates activation of the effector domain. Here we show that PhoPN, on its own, demonstrates PhoR-dependent phosphorylation. PhoPC, the truncated variant bearing the DNA binding domain, binds in vitro to the target site with affinity similar to that of the full-length protein. To complement the finding that residues spanning Met(1) to Arg(138) of PhoP constitute the minimal functional PhoPN, we identified Arg(150) as the first residue of the distal PhoPC domain capable of DNA binding on its own, thereby identifying an interdomain linker. However, coupling of two functional domains together in a single polypeptide chain is essential for phosphorylation-coupled DNA binding by PhoP. We discuss consequences of tethering of two domains on DNA binding and demonstrate that linker length and not individual residues of the newly identified linker plays a critical role in regulating interdomain interactions. Together, these results have implications for the molecular mechanism of transmission of conformation change associated with phosphorylation of PhoP that results in the altered DNA recognition by the C-terminal domain.	[Pathak, Anuj; Goyal, Rajni; Sinha, Akesh; Sarkar, Dibyendu] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sarkar, D (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	dibyendu@imtech.res.in			Council of Scientific and Industrial Research (CSIR) Network [NWP-05]; Supra Institutional Project [SIP-10]; Government of India Department of Science and Technology [SR/SO/BB-16/2007]; Department of Biotechnology [BT/PR8545/Med/14/1262/2006]; CSIR; Indian Council for Medical Research	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India); Supra Institutional Project; Government of India Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council for Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by Council of Scientific and Industrial Research (CSIR) Network Project NWP-05 and Supra Institutional Project SIP-10 and by Government of India Department of Science and Technology Grant SR/SO/BB-16/2007 and Department of Biotechnology Grant BT/PR8545/Med/14/1262/2006 (both to D. S.).; Predoctoral student supported by a research fellowship from CSIR.; Predoctoral student supported by a research fellowship from the Indian Council for Medical Research.	Allen MP, 2001, J BACTERIOL, V183, P2204, DOI 10.1128/JB.183.7.2204-2211.2001; Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cardona PJ, 2006, MICROBES INFECT, V8, P183, DOI 10.1016/j.micinf.2005.06.011; CASON J, 1956, J BIOL CHEM, V220, P893; Chen YH, 2004, J BACTERIOL, V186, P1493, DOI 10.1128/JB.186.5.1493-1502.2004; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1988, EUR J BIOCHEM, V172, P579, DOI 10.1111/j.1432-1033.1988.tb13928.x; Das AK, 2010, J MOL BIOL, V398, P647, DOI 10.1016/j.jmb.2010.03.056; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Fontan PA, 2004, CURR SCI INDIA, V86, P122; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Goren M. B., 1979, TUBERCULOSIS, P63; GOREN MB, 1990, HDB LIPID RES, V6, P363; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gupta S, 2006, FEBS LETT, V580, P5328, DOI 10.1016/j.febslet.2006.09.004; Gupta S, 2009, J BACTERIOL, V191, P7466, DOI 10.1128/JB.00669-09; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; JANIN J, 1985, C METHODS ENZYMOL, V115, P420; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lejona S, 2004, J BACTERIOL, V186, P2476, DOI 10.1128/JB.186.8.2476-2480.2004; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; MIDDLEBROOK G, 1959, P NATL ACAD SCI USA, V45, P1801, DOI 10.1073/pnas.45.12.1801; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Perron-Savard P, 2005, MICROBIOL-SGM, V151, P3979, DOI 10.1099/mic.0.28236-0; Pragai Z, 2004, J BACTERIOL, V186, P1182, DOI 10.1128/JB.186.4.1182-1190.2004; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Sambrook J., 2002, MOL CLONING LAB MANU; Schulz G. E., 1979, PRINCIPLES PROTEIN S; Sinha A, 2008, J BACTERIOL, V190, P1317, DOI 10.1128/JB.01074-07; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Walthers D, 2003, J BACTERIOL, V185, P317, DOI 10.1128/JB.185.1.317-324.2003; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a	54	16	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34309	34318		10.1074/jbc.M110.135822	http://dx.doi.org/10.1074/jbc.M110.135822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20814030	hybrid, Green Published			2022-12-27	WOS:000283659100004
J	Yampolsky, P; Pacifici, PG; Lomb, L; Giese, G; Rudolf, R; Roder, IV; Witzemann, V				Yampolsky, Pessah; Pacifici, Pier Giorgio; Lomb, Lukas; Giese, Guenter; Rudolf, Ruediger; Roeder, Ira V.; Witzemann, Veit			Time Lapse in Vivo Visualization of Developmental Stabilization of Synaptic Receptors at Neuromuscular Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRAJUNCTIONAL ACETYLCHOLINE-RECEPTORS; TO-EPSILON-SWITCH; SKELETAL-MUSCLE; AMPA RECEPTORS; MYOSIN VA; SUBUNIT; RAPSYN; PHOSPHORYLATION; IDENTIFICATION; DEGRADATION	The lifetime of nicotinic acetylcholine receptors (AChRs) in neuromuscular junctions (NMJs) is increased from < 1 day to > 1 week during early postnatal development. However, the exact timing of AChR stabilization is not known, and its correlation to the concurrent embryonic to adult AChR channel conversion, NMJ remodeling, and neuromuscular diseases is unclear. Using a novel time lapse in vivo imaging technology we show that replacement of the entire receptor population of an individual NMJ occurs end plate-specifically within hours. This makes it possible to follow directly in live animals changing stabilities of end plate receptors. In three different, genetically modified mouse models we demonstrate that the metabolic half-life values of synaptic AChRs increase from a few hours to several days after postnatal day 6. Developmental stabilization is independent of receptor subtype and apparently regulated by an intrinsic muscle-specific maturation program. Myosin Va, an F-actin-dependent motor protein, is also accumulated synaptically during postnatal development and thus could mediate the stabilization of end plate AChR.	[Yampolsky, Pessah; Pacifici, Pier Giorgio; Witzemann, Veit] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Lomb, Lukas] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Giese, Guenter] Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; [Rudolf, Ruediger; Roeder, Ira V.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76131 Karlsruhe, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology	Witzemann, V (corresponding author), Jahnstr 29, D-69120 Heidelberg, Germany.	witzeman@mpimf-heidelberg.mpg.de	Rudolf, Rüdiger/A-6476-2009	Rudolf, Rüdiger/0000-0002-0833-1053				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; BERG DK, 1974, SCIENCE, V184, P473, DOI 10.1126/science.184.4135.473; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; CHANG CC, 1975, NATURE, V253, P643, DOI 10.1038/253643a0; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Eckler SA, 2005, NEUROSCIENCE, V131, P661, DOI 10.1016/j.neuroscience.2004.11.035; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Gervasio OL, 2007, DEV BIOL, V305, P262, DOI 10.1016/j.ydbio.2007.02.008; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Prakash YS, 1998, MUSCLE NERVE, V21, P887, DOI 10.1002/(SICI)1097-4598(199807)21:7<887::AID-MUS6>3.0.CO;2-2; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Sadasivam G, 2005, J NEUROSCI, V25, P10479, DOI 10.1523/JNEUROSCI.2103-05.2005; SALPETER MM, 1986, J CELL BIOL, V103, P1399, DOI 10.1083/jcb.103.4.1399; Santos AF, 2003, J NEUROCYTOL, V32, P849, DOI 10.1023/B:NEUR.0000020628.36013.88; STEINBACH JH, 1979, P NATL ACAD SCI USA, V76, P3547, DOI 10.1073/pnas.76.7.3547; Turney SG, 2008, METHOD CELL BIOL, V89, P309, DOI 10.1016/S0091-679X(08)00611-0; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014; Yampolsky P, 2010, EUR J NEUROSCI, V31, P646, DOI 10.1111/j.1460-9568.2010.07096.x; Yumoto N, 2005, BIOCHEM BIOPH RES CO, V331, P1522, DOI 10.1016/j.bbrc.2005.04.081	31	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34589	34596		10.1074/jbc.M110.168880	http://dx.doi.org/10.1074/jbc.M110.168880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813841	hybrid, Green Published			2022-12-27	WOS:000283659100034
J	Fujimoto, Z; Ichinose, H; Maehara, T; Honda, M; Kitaoka, M; Kaneko, S				Fujimoto, Zui; Ichinose, Hitomi; Maehara, Tomoko; Honda, Mariko; Kitaoka, Motomitsu; Kaneko, Satoshi			Crystal Structure of an Exo-1,5-alpha-L-arabinofuranosidase from Streptomyces avermitilis Provides Insights into the Mechanism of Substrate Discrimination between Exo- and Endo-type Enzymes in Glycoside Hydrolase Family 43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; CARBOHYDRATE-BINDING MODULE; GEOBACILLUS-STEAROTHERMOPHILUS; CATALYTIC RESIDUES; ASPERGILLUS-NIGER; ARABINANASE 43A; PURIFICATION; ARABINOSE; SPECIFICITY; REVEALS	Exo-1,5-alpha-L-arabinofuranosidases belonging to glycoside hydrolase family 43 have strict substrate specificity. These enzymes hydrolyze only the alpha-1,5-linkages of linear arabinan and arabino-oligosaccharides in an exo-acting manner. The enzyme from Streptomyces avermitilis contains a core catalytic domain belonging to glycoside hydrolase family 43 and a C-terminal arabinan binding module belonging to carbohydrate binding module family 42. We determined the crystal structure of intact exo-1,5-alpha-L-arabinofuranosidase. The catalytic module is composed of a 5-bladed beta-propeller topologically identical to the other family 43 enzymes. The arabinan binding module had three similar subdomains assembled against one another around a pseudo-3-fold axis, forming a beta-trefoil-fold. A sugar complex structure with alpha-1,5-L-arabinofuranotriose revealed three subsites in the catalytic domain, and a sugar complex structure with alpha-L-arabinofuranosyl azide revealed three arabinose-binding sites in the carbohydrate binding module. A mutagenesis study revealed that substrate specificity was regulated by residues Asn-159, Tyr-192, and Leu-289 located at the aglycon side of the substrate-binding pocket. The exo-acting manner of the enzyme was attributed to the strict pocket structure of subsite -1, formed by the flexible loop region Tyr-281-Arg-294 and the side chain of Tyr-40, which occupied the positions corresponding to the catalytic glycon cleft of GH43 endo-acting enzymes.	[Ichinose, Hitomi; Maehara, Tomoko; Honda, Mariko; Kitaoka, Motomitsu; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Fujimoto, Zui] Natl Inst Agrobiol Sci, Prot Res Unit, Tsukuba, Ibaraki 3058602, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan	Kaneko, S (corresponding author), Natl Food Res Inst, Food Biotechnol Div, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	sakaneko@affrc.go.jp	Kitaoka, Motomitsu/R-1536-2019	Kitaoka, Motomitsu/0000-0002-0083-1838; Fujimoto, Zui/0000-0002-3551-6854	Ministry of Agriculture, Forestry, and Fisheries of Japan	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported, in part, by a grant-in-aid (Development of Biomass Utilization Technologies for Revitalizing Rural Areas) from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Berlin W, 1996, ANAL BIOCHEM, V243, P171, DOI 10.1006/abio.1996.0497; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Fujimoto Z, 2008, ACTA CRYSTALLOGR F, V64, P1007, DOI 10.1107/S1744309108029692; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P695, DOI 10.1271/bbb.62.695; KANEKO S, 1993, BIOSCI BIOTECH BIOCH, V57, P1161, DOI 10.1271/bbb.57.1161; KANEKO S, 1994, APPL ENVIRON MICROB, V60, P3425, DOI 10.1128/AEM.60.9.3425-3428.1994; KANEKO S, 1995, BIOSCI BIOTECH BIOCH, V59, P2132, DOI 10.1271/bbb.59.2132; Kaneko S, 1998, APPL ENVIRON MICROB, V64, P4021; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P2205, DOI 10.1271/bbb.62.2205; Kaneko S, 1998, J FERMENT BIOENG, V85, P518, DOI 10.1016/S0922-338X(98)80073-1; KAWABATA Y, 1995, CARBOHYD RES, V267, P39, DOI 10.1016/0008-6215(94)00290-V; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Miyanaga A, 2006, BIOCHEM J, V399, P503, DOI 10.1042/BJ20060567; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Osaki S, 2001, J NUTR, V131, P796, DOI 10.1093/jn/131.3.796; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pitson SM, 1996, FEBS LETT, V398, P7, DOI 10.1016/S0014-5793(96)01153-2; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sanai K., 1997, Nippon Eiyo Shokuryo Gakkaishi = Journal of the Japanese Society of Nutrition and Food Science, V50, P133; Seri K, 1996, METABOLISM, V45, P1368, DOI 10.1016/S0026-0495(96)90117-1; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; SKOOG K, 1988, ENZYME MICROB TECH, V10, P66, DOI 10.1016/0141-0229(88)90001-4; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	40	35	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34134	34143		10.1074/jbc.M110.164251	http://dx.doi.org/10.1074/jbc.M110.164251			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739278	hybrid, Green Published			2022-12-27	WOS:000283354000059
J	Su, YC; Hong, JR				Su, Yu-Chin; Hong, Jiann-Ruey			Betanodavirus B2 Causes ATP Depletion-induced Cell Death via Mitochondrial Targeting and Complex II Inhibition in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-NECROSIS-VIRUS; CYTOCHROME-C RELEASE; ALZHEIMERS-DISEASE; FISH CELLS; PROTEIN TRANSLOCATION; EMBRYONIC-DEVELOPMENT; MARINE FISH; APOPTOSIS; MEMBRANE; INDUCTION	The betanodavirus non-structural protein B2 is a newly discovered necrotic death factor with a still unknown role in regulation of mitochondrial function. In the present study, we examined protein B2-mediated inhibition of mitochondrial complex II activity, which results in ATP depletion and thereby in a bioenergetic crisis in vitro and in vivo. Expression of protein B2 was detected early at 24 h postinfection with red-spotted grouper nervous necrosis virus in the cytoplasm. Later B2 was found in mitochondria using enhanced yellow fluorescent protein (EYFP) and immuno-EM analysis. Furthermore, the B2 mitochondrial targeting signal peptide was analyzed by serial deletion and specific point mutation. The sequence of the B2 targeting signal peptide ((41)RTFVISAHAA(50)) was identified and its presence correlated with loss of mitochondrial membrane potential in fish cells. Protein B2 also was found to dramatically inhibit complex II (succinate dehydrogenase) activity, which impairs ATP synthesis in fish GF-1 cells as well as human embryonic kidney 293T cells. Furthermore, when B2 was injected into zebrafish embryos at the one-cell stage to determine its cytotoxicity and ability to inhibit ATP synthesis, we found that B2 caused massive embryonic cell death and depleted ATP resulting in further embryonic death at 10 and 24 h post-fertilization. Taken together, our results indicate that betanodavirus protein B2-induced cell death is due to direct targeting of the mitochondrial matrix by a specific signal peptide that targets mitochondria and inhibits mitochondrial complex II activity thereby reducing ATP synthesis.	[Su, Yu-Chin; Hong, Jiann-Ruey] Natl Cheng Kung Univ, Lab Mol Virol & Biotechnol, Inst Biotechnol, Tainan 701, Taiwan	National Cheng Kung University	Hong, JR (corresponding author), Natl Cheng Kung Univ, Lab Mol Virol & Biotechnol, Inst Biotechnol, Tainan 701, Taiwan.	jrhong@mail.ncku.edu.tw			National Science Council, Taiwan, Republic of China [NSC 98-2313-B-006-004-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC 98-2313-B-006-004-MY3 (to J.-R. H.) from the National Science Council, Taiwan, Republic of China.	Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Bovo G, 1999, VIRUS RES, V63, P143, DOI 10.1016/S0168-1702(99)00068-4; Chen LJ, 2009, VIROLOGY, V385, P444, DOI 10.1016/j.virol.2008.11.048; Chen SP, 2007, APOPTOSIS, V12, P1043, DOI 10.1007/s10495-006-0032-x; Chen SP, 2006, VIROLOGY, V347, P379, DOI 10.1016/j.virol.2005.11.052; de Castro IP, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001456; Delsert C, 1997, ARCH VIROL, V142, P2359, DOI 10.1007/s007050050248; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Fenner BJ, 2006, J VIROL, V80, P6822, DOI 10.1128/JVI.00079-06; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; GREEN JD, 1980, J HISTOCHEM CYTOCHEM, V28, P408, DOI 10.1177/28.5.6966645; Guo YX, 2003, VIROLOGY, V308, P74, DOI 10.1016/S0042-6822(02)00098-3; Higuchi Y, 2004, J CELL MOL MED, V8, P455, DOI 10.1111/j.1582-4934.2004.tb00470.x; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; JONES DP, 1982, AM J PHYSIOL, V243, pC247, DOI 10.1152/ajpcell.1982.243.5.C247; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Kroemer G, 2007, PLOS BIOL, V5, P1409, DOI 10.1371/journal.pbio.0050206; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuczynski B, 2006, NEUROCHEM RES, V31, P639, DOI 10.1007/s11064-006-9061-7; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Mokranjac D, 2008, BBA-BIOENERGETICS, V1777, P758, DOI 10.1016/j.bbabio.2008.04.009; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neve EPA, 2001, J BIOL CHEM, V276, P11317, DOI 10.1074/jbc.M008640200; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Reddy PH, 2006, NEUROBIOL AGING, V27, P1060, DOI 10.1016/j.neurobiolaging.2005.04.014; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Roise D, 1997, J BIOENERG BIOMEMBR, V29, P19, DOI 10.1023/A:1022403604273; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Su YC, 2009, VIROLOGY, V385, P143, DOI 10.1016/j.virol.2008.11.036; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tan C, 2001, J GEN VIROL, V82, P647, DOI 10.1099/0022-1317-82-3-647; Tanaka S, 2003, J FISH DIS, V26, P109, DOI 10.1046/j.1365-2761.2003.00440.x; Toffolo V, 2007, MOL PHYLOGENET EVOL, V43, P298, DOI 10.1016/j.ympev.2006.08.003; Valmas N, 2008, TOXICOLOGY, V252, P33, DOI 10.1016/j.tox.2008.07.060; Voos W, 1999, BBA-REV BIOMEMBRANES, V1422, P235, DOI 10.1016/S0304-4157(99)00007-6; Wu HC, 2008, FISH SHELLFISH IMMUN, V24, P436, DOI 10.1016/j.fsi.2008.01.001; Wu HC, 2010, FISH SHELLFISH IMMUN, V29, P451, DOI 10.1016/j.fsi.2010.05.003; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	59	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39801	39810		10.1074/jbc.M110.164988	http://dx.doi.org/10.1074/jbc.M110.164988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20870718	hybrid, Green Published			2022-12-27	WOS:000285185500024
J	Lotz, GP; Legleiter, J; Aron, R; Mitchell, EJ; Huang, SY; Ng, CP; Glabe, C; Thompson, LM; Muchowski, PJ				Lotz, Gregor P.; Legleiter, Justin; Aron, Rebecca; Mitchell, Emily J.; Huang, Shao-Yi; Ng, Cheping; Glabe, Charles; Thompson, Leslie M.; Muchowski, Paul J.			Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; MOUSE MODEL; EXPANSION PROTEINS; CELLULAR TOXICITY; AMYLOID OLIGOMERS; IN-VITRO; POLYGLUTAMINE; DISEASE; AGGREGATION; MECHANISM	Inclusion bodies of aggregated mutant huntingtin (htt) fragments are a neuropathological hallmark of Huntington disease (HD). The molecular chaperones Hsp70 and Hsp40 colocalize to inclusion bodies and are neuroprotective in HD animal models. How these chaperones suppress mutant htt toxicity is unclear but might involve direct effects on mutant htt misfolding and aggregation. Using size exclusion chromatography and atomic force microscopy, we found that mutant htt fragments assemble into soluble oligomeric species with a broad size distribution, some of which reacted with the conformation-specific antibody A11. Hsp70 associated with A11-reactive oligomers in an Hsp40- and ATP-dependent manner and inhibited their formation coincident with suppression of caspase 3 activity in PC12 cells. Thus, Hsp70 and Hsp40 (DNAJB1) dynamically target specific subsets of soluble oligomers in a classic ATP-dependent reaction cycle, supporting a pathogenic role for these structures in HD.	[Lotz, Gregor P.; Legleiter, Justin; Aron, Rebecca; Huang, Shao-Yi; Ng, Cheping; Muchowski, Paul J.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Lotz, Gregor P.; Legleiter, Justin; Aron, Rebecca; Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Mitchell, Emily J.; Thompson, Leslie M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Muchowski, PJ (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Sontag, Emily/L-5232-2019	Sontag, Emily/0000-0003-3068-6253; Legleiter, Justin/0000-0002-5262-1867; Lotz, Gregor/0000-0002-0231-5503	National Institutes of Health [R01NS054753, R01NS047237]; HighQ Foundation; Deutsche Forschungsgemeinschaft; Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237, R01NS054753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HighQ Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hereditary Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS054753 and R01NS047237. This work was also supported by the HighQ Foundation.; Supported by a research fellowship from the Deutsche Forschungsgemeinschaft.; Supported by a postdoctoral fellowship from the Hereditary Disease Foundation.	Adachi H, 2003, J NEUROSCI, V23, P2203; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Gekko K., 1979, J PHYS CHEM, V83; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; Miller J, 2009, STRUCTURE, V17, P1151, DOI 10.1016/j.str.2009.08.004; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	48	57	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38183	38193		10.1074/jbc.M110.160218	http://dx.doi.org/10.1074/jbc.M110.160218			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20864533	hybrid, Green Published			2022-12-27	WOS:000284625600026
J	Miserez, A; Rubin, D; Waite, JH				Miserez, Ali; Rubin, Daniel; Waite, J. Herbert			Cross-linking Chemistry of Squid Beak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; CUTICLE; QUINONE; SHELL; TRANSITION; MORPHOLOGY; ADHESION; DESIGN; NEREIS; CHITIN	In stark contrast to most aggressive predators, Dosidicus gigas (jumbo squids) do not use minerals in their powerful mouthparts known as beaks. Their beaks instead consist of a highly sclerotized chitinous composite with incremental hydration from the tip to the base. We previously reported L-3,4-dihydroxyphenylalanine (dopa)-histidine (dopa-His) as an important covalent cross-link providing mechanical strengthening to the beak material. Here, we present a more complete characterization of the sclerotization chemistry and describe additional cross-links from D. gigas beak. All cross-links presented in this report share common building blocks, a family of di-, tri-, and tetra-histidine-catecholic adducts, that were separated by affinity chromatography and high performance liquid chromatography (HPLC) and identified by tandem mass spectroscopy and proton nuclear magnetic resonance (H-1 NMR). The data provide additional insights into the unusually high cross-link density found in mature beaks. Furthermore, we propose both a low molecular weight catechol, and peptidyl-dopa, to be sclerotization agents of squid beak. This appears to represent a new strategy for forming hard tissue in animals. The interplay between covalent cross-linking and dehydration on the graded properties of the beaks is discussed.	[Waite, J. Herbert] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Rubin, Daniel; Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cell & Dev Biol, Santa Barbara, CA 93106 USA; [Miserez, Ali; Rubin, Daniel; Waite, J. Herbert] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Miserez, A (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	ali.miserez@ntu.edu.sg	Miserez, Ali/D-1074-2010; Miserez, Ali/CAF-2662-2022	Miserez, Ali/0000-0003-0864-8170; Miserez, Ali/0000-0003-0864-8170	National Institutes of Health [R01DE018468]; Nanyang Technological University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nanyang Technological University(Nanyang Technological University); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE018468. This work was also supported by a Nanyang Technological University start-up grant (to A.M.).	ANDERSEN SO, 1981, J INSECT PHYSIOL, V27, P393, DOI 10.1016/0022-1910(81)90017-2; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Barnes HH, 1999, BIOMETALS, V12, P83, DOI 10.1023/A:1009223615607; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Birkedal H, 2006, CHEMBIOCHEM, V7, P1392, DOI 10.1002/cbic.200600160; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; FETTERER RH, 1994, J PARASITOL, V80, P952, DOI 10.2307/3283445; Hamodrakas SJ, 2002, INSECT BIOCHEM MOLEC, V32, P1577, DOI 10.1016/S0965-1748(02)00079-6; Hernandez-Garcia V., 2003, COLEID CEPHALOPODS T; Hopkins Theodore L., 1991, P213; Iconomidou VA, 2005, INSECT BIOCHEM MOLEC, V35, P553, DOI 10.1016/j.ibmb.2005.01.017; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; KEAR AJ, 1994, J MAR BIOL ASSOC UK, V74, P801, DOI 10.1017/S0025315400090068; Kerwin JL, 1999, ANAL BIOCHEM, V268, P229, DOI 10.1006/abio.1998.3069; Khan RK, 2006, LANGMUIR, V22, P8465, DOI 10.1021/la061027k; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Miserez A, 2007, ACTA BIOMATER, V3, P139, DOI 10.1016/j.actbio.2006.09.004; Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H; Paris O, 2010, MRS BULL, V35, P219, DOI 10.1557/mrs2010.655; Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332; Pryor M.G.M., 1962, COMP BIOCHEM PHYSIOL, V4, P371; Pryor MGM, 1940, PROC R SOC SER B-BIO, V128, P393, DOI 10.1098/rspb.1940.0018; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Rubin DJ, 2010, ADV INSECT PHYSIOL, V38, P75, DOI 10.1016/S0065-2806(10)38003-9; SCHAEFER J, 1987, SCIENCE, V235, P1200, DOI 10.1126/science.3823880; Schofield RMS, 2003, J INSECT PHYSIOL, V49, P31, DOI 10.1016/S0022-1910(02)00224-X; SUGUMARAN M, 1992, J BIOL CHEM, V267, P10355; Sugumaran Manickam, 1991, P141; Uyeno TA, 2005, J MORPHOL, V264, P211, DOI 10.1002/jmor.10330; Vincent J. F. V., 2001, ENCY MAT SCI TECHNOL, P1924; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; VINCENT JFV, 1987, J INSECT PHYSIOL, V33, P973, DOI 10.1016/0022-1910(87)90010-2; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WAITE JH, 1981, ANAL BIOCHEM, V111, P131, DOI 10.1016/0003-2697(81)90240-2; Weaver JC, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70016-X; Wu LQ, 2006, ADV FUNCT MATER, V16, P1967, DOI 10.1002/adfm.200500792; Wu LQ, 2005, ADV FUNCT MATER, V15, P189, DOI 10.1002/adfm.200400279; Xu RD, 1996, ARCH BIOCHEM BIOPHYS, V329, P56, DOI 10.1006/abbi.1996.0191; Yamauchi A, 2009, MACROMOL BIOSCI, V9, P875, DOI 10.1002/mabi.200900032; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhao H, 2005, BIOCHEMISTRY-US, V44, P15915, DOI 10.1021/bi051530g; [No title captured]	48	74	78	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38115	38124		10.1074/jbc.M110.161174	http://dx.doi.org/10.1074/jbc.M110.161174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870720	Green Published, hybrid			2022-12-27	WOS:000284625600019
J	Pallavi, R; Roy, N; Nageshan, RK; Talukdar, P; Pavithra, SR; Reddy, R; Venketesh, S; Kumar, R; Gupta, AK; Singh, RK; Yadav, SC; Tatu, U				Pallavi, Rani; Roy, Nainita; Nageshan, Rishi Kumar; Talukdar, Pinaki; Pavithra, Soundara Raghavan; Reddy, Raghunath; Venketesh, S.; Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra; Tatu, Utpal			Heat Shock Protein 90 as a Drug Target against Protozoan Infections BIOCHEMICAL CHARACTERIZATION OF HSP90 FROM PLASMODIUM FALCIPARUM AND TRYPANOSOMA EVANSI AND EVALUATION OF ITS INHIBITOR AS A CANDIDATE DRUG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; PLASMODIUM-FALCIPARUM; HUMAN ERYTHROCYTES; ATPASE ACTIVITY; INHIBITION; GROWTH; HEAT-SHOCK-PROTEIN-90; CELLS; GELDANAMYCIN; EXPRESSION	Using a pharmacological inhibitor of Hsp90 in cultured malarial parasite, we have previously implicated Plasmodium falciparum Hsp90 (PfHsp90) as a drug target against malaria. In this study, we have biochemically characterized PfHsp90 in terms of its ATPase activity and interaction with its inhibitor geldanamycin (GA) and evaluated its potential as a drug target in a preclinical mouse model of malaria. In addition, we have explored the potential of Hsp90 inhibitors as drugs for the treatment of Trypanosoma infection in animals. Our studies with full-length PfHsp90 showed it to have the highest ATPase activity of all known Hsp90s; its ATPase activity was 6 times higher than that of human Hsp90. Also, GA brought about more robust inhibition of PfHsp90 ATPase activity as compared with human Hsp90. Mass spectrometric analysis of PfHsp90 expressed in P. falciparum identified a site of acetylation that overlapped with Aha1 and p23 binding domain, suggesting its role in modulating Hsp90 multichaperone complex assembly. Indeed, treatment of P. falciparum cultures with a histone deacetylase inhibitor resulted in a partial dissociation of PfHsp90 complex. Furthermore, we found a well known, semisynthetic Hsp90 inhibitor, namely 17-(allylamino)-17-demethoxygeldanamycin, to be effective in attenuating parasite growth and prolonging survival in a mouse model of malaria. We also characterized GA binding to Hsp90 from another protozoan parasite, namely Trypanosoma evansi. We found 17-(allylamino)-17-demethoxygeldanamycin to potently inhibit T. evansi growth in a mouse model of trypanosomiasis. In all, our biochemical characterization, drug interaction, and animal studies supported Hsp90 as a drug target and its inhibitor as a potential drug against protozoan diseases.	[Pallavi, Rani; Roy, Nainita; Nageshan, Rishi Kumar; Pavithra, Soundara Raghavan; Reddy, Raghunath; Venketesh, S.; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Talukdar, Pinaki] Indian Inst Sci Educ & Res, Pune 411021, Maharashtra, India; [Kumar, Rajender; Gupta, Ashok Kumar; Singh, Raj Kumar; Yadav, Suresh Chandra] Natl Res Ctr Equines, Hisar 125001, Haryana, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) Pune; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines	Tatu, U (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in	Viswanath, Pavithra/I-4318-2015; Sivaramakrishnan, Venketesh/J-2025-2012; Talukdar, Pinaki/B-5966-2011; Pallavi, Rani/AAR-7824-2020; Bhowmick, Nainita Roy/AAS-2908-2021	Viswanath, Pavithra/0000-0003-2980-3109; Sivaramakrishnan, Venketesh/0000-0003-3094-5905; Talukdar, Pinaki/0000-0003-3951-4335; Tatu, Utpal/0000-0003-0404-8872; Singh, Rajkumar/0000-0003-4649-2015; Nageshan, Rishi Kumar/0000-0003-1592-4452	Department of Biotechnology, New Delhi, India; Malaria Signalling Consortium; Roche (University of Bern); DST; Council of Scientific and Industrial Research; United Grants Commission, New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Malaria Signalling Consortium; Roche (University of Bern)(Roche Holding); DST(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); United Grants Commission, New Delhi, India	This work was supported in part by the Department of Biotechnology, New Delhi, India; Malaria Signalling Consortium; Roche (University of Bern) and the Indo-Swiss Joint Research Programme of DST.; Supported by a junior research fellowship from the Council of Scientific and Industrial Research and United Grants Commission, New Delhi, India.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; CHULAY JD, 1983, EXP PARASITOL, V55, P138, DOI 10.1016/0014-4894(83)90007-3; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; David CL, 2003, CELL STRESS CHAPERON, V8, P93, DOI 10.1379/1466-1268(2003)8<93:EOAUDH>2.0.CO;2; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Echeverria PC, 2005, J MOL BIOL, V350, P723, DOI 10.1016/j.jmb.2005.05.031; Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Graefe SEB, 2002, EUKARYOT CELL, V1, P936, DOI 10.1128/EC.1.6.936-943.2002; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Onuoha SC, 2007, J MOL BIOL, V372, P287, DOI 10.1016/j.jmb.2007.06.065; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rao R, 2008, BLOOD, V112, P1886, DOI 10.1182/blood-2008-03-143644; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Roy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009796; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; Usmani SZ, 2009, CURR MOL MED, V9, P654, DOI 10.2174/156652409788488757; Vali Shireen, 2010, Syst Synth Biol, V4, P25, DOI 10.1007/s11693-009-9046-3; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wider D, 2009, MOL BIOCHEM PARASIT, V164, P147, DOI 10.1016/j.molbiopara.2008.12.011; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644	41	131	132	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37964	37975		10.1074/jbc.M110.155317	http://dx.doi.org/10.1074/jbc.M110.155317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20837488	hybrid, Green Published			2022-12-27	WOS:000284625600004
J	Zibaee, S; Fraser, G; Jakes, R; Owen, D; Serpell, LC; Crowther, RA; Goedert, M				Zibaee, Shahin; Fraser, Graham; Jakes, Ross; Owen, David; Serpell, Louise C.; Crowther, R. Anthony; Goedert, Michel			Human beta-Synuclein Rendered Fibrillogenic by Designed Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; A-BETA; AMINO-ACIDS; SEQUENCE DETERMINANTS; NACP/ALPHA-SYNUCLEIN; GENE DUPLICATION; FIBRIL FORMATION; AMYLOID FIBRILS; LEWY BODIES	Filamentous inclusions made of alpha-synuclein are found in nerve cells and glial cells in a number of human neurodegenerative diseases, including Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. The assembly and spreading of these inclusions are likely to play an important role in the etiology of common dementias and movement disorders. Both alpha-synuclein and the homologous beta-synuclein are abundantly expressed in the central nervous system; however, beta-synuclein is not present in the pathological inclusions. Previously, we observed a poor correlation between filament formation and the presence of residues 73-83 of alpha-synuclein, which are absent in beta-synuclein. Instead, filament formation correlated with the mean beta-sheet propensity, charge, and hydrophilicity of the protein (global physicochemical properties) and beta-strand contiguity calculated by a simple algorithm of sliding averages (local physicochemical property). In the present study, we rendered beta-synuclein fibrillogenic via one set of point mutations engineered to enhance global properties and a second set engineered to enhance predominantly beta-strand contiguity. Our findings show that the intrinsic physicochemical properties of synucleins influence their fibrillogenic propensity via two distinct but overlapping modalities. The implications for filament formation and the pathogenesis of neurodegenerative diseases are discussed.	[Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Serpell, Louise C.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	MRC Laboratory Molecular Biology; University of Sussex	Goedert, M (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk	zibaee, shahin/AAK-9497-2021	Serpell, Louise/0000-0001-9335-7751	Alzheimer's Research Trust; Multiple System Atrophy Trust; MRC [MC_U105178803, MC_U105184319, MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2004A-5, ART-PG2007-3] Funding Source: researchfish; Medical Research Council [MC_U105178803, MC_U105184291, MC_U105184319] Funding Source: researchfish	Alzheimer's Research Trust; Multiple System Atrophy Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Alzheimer's Research Trust and the Multiple System Atrophy Trust.	Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FERRONE FA, 1980, BIOPHYS J, V32, P361, DOI 10.1016/S0006-3495(80)84962-9; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lewy FH, 1912, PATHOLOGISCHE ANATOM, P920; Lin XJ, 2006, BIOPOLYMERS, V83, P226, DOI 10.1002/bip.20550; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shoji M, 2000, J NEUROL NEUROSUR PS, V68, P605, DOI 10.1136/jnnp.68.5.605; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sopher BL, 2001, CYTOGENET CELL GENET, V93, P117, DOI 10.1159/000056962; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tiunova AA, 2000, MECH DEVELOP, V99, P195, DOI 10.1016/S0925-4773(00)00484-6; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Yoshida H, 2006, BIOCHEMISTRY-US, V45, P2599, DOI 10.1021/bi051993m; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zibaee S., 2007, THESIS U CAMBRIDGE C; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	80	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38555	38567		10.1074/jbc.M110.160721	http://dx.doi.org/10.1074/jbc.M110.160721			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20833719	Green Published, hybrid			2022-12-27	WOS:000284625600061
J	Gruenig, MC; Stohl, EA; Chitteni-Pattu, S; Seifert, HS; Cox, MM				Gruenig, Marielle C.; Stohl, Elizabeth A.; Chitteni-Pattu, Sindhu; Seifert, H. Steven; Cox, Michael M.			Less Is More: Neisseria gonorrhoeae RecX Protein Stimulates Recombination by Inhibiting RecA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; PILUS ANTIGENIC VARIATION; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; BINDING-PROTEIN; ATP HYDROLYSIS; NUCLEOPROTEIN FILAMENTS; GENE CONVERSION; REGULATORY GENE	Escherichia coli RecX (RecX(Ec)) is a negative regulator of RecA activities both in the bacterial cell and in vitro. In contrast, the Neisseria gonorrhoeae RecX protein (RecX(Ng)) enhances all RecA-related processes in N. gonorrhoeae. Surprisingly, the RecX(Ng) protein is not a RecA protein activator in vitro. Instead, RecX(Ng) is a much more potent inhibitor of all RecA(Ng) and RecA(Ec) activities than is the E. coli RecX ortholog. A series of RecX(Ng) mutant proteins representing a gradient of functional deficiencies provide a direct correlation between RecA(Ng) inhibition in vitro and the enhancement of RecA(Ng) function in N. gonorrhoeae. Unlike RecX(Ec), RecX(Ng) does not simply cap the growing ends of RecA filaments, but it directly facilitates a more rapid RecA filament disassembly. Thus, in N. gonorrhoeae, recombinational processes are facilitated by RecX(Ng) protein-mediated limitations on RecA(Ng) filament presence and/or length to achieve maximal function.	[Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Stohl, Elizabeth A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu			National Institutes of Health [GM32335, R37 AI033493, R01 AI044239]; Dr. James Chieh-Hsia Mao Distinguished Graduate Fellowship; William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; American Cancer Society [PF-00-016-01-GMC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R37AI033493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. James Chieh-Hsia Mao Distinguished Graduate Fellowship; William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32335 (to M. M. C.) and R37 AI033493 and R01 AI044239 (to H. S. S.). This work was also supported by the Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowships (to M. C. G.) and partially supported by American Cancer Society Postdoctoral Fellowship PF-00-016-01-GMC (to E. A. S.).	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Baitin DM, 2008, J BIOL CHEM, V283, P14198, DOI 10.1074/jbc.M801511200; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DEMOT R, 1994, NUCLEIC ACIDS RES, V22, P1313, DOI 10.1093/nar/22.7.1313; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; KOOMEY JM, 1987, J BACTERIOL, V169, P790, DOI 10.1128/jb.169.2.790-795.1987; KOOMEY M, 1987, GENETICS, V117, P391; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MOREAU PL, 1987, J MOL BIOL, V194, P621, DOI 10.1016/0022-2836(87)90239-7; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Papavinasasundaram KG, 1997, MOL MICROBIOL, V24, P141, DOI 10.1046/j.1365-2958.1997.3441697.x; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; Ragone S, 2008, EMBO J, V27, P2259, DOI 10.1038/emboj.2008.145; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Schnos M, 2000, MOL BIOTECHNOL, V16, P77, DOI 10.1385/MB:16:1:77; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Stohl EA, 2002, MICROBIOL-SGM, V148, P1821, DOI 10.1099/00221287-148-6-1821; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; SWANSON J, 1986, CELL, V47, P267, DOI 10.1016/0092-8674(86)90449-6; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; VanLoock MS, 2003, J MOL BIOL, V333, P345, DOI 10.1016/j.jmb.2003.08.053; Vierling S, 2000, J BACTERIOL, V182, P4005, DOI 10.1128/JB.182.14.4005-4011.2000; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L	55	26	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37188	37197		10.1074/jbc.M110.171967	http://dx.doi.org/10.1074/jbc.M110.171967			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20851893	hybrid, Green Published			2022-12-27	WOS:000284424000012
J	Jules, J; Shi, ZQ; Liu, JZ; Xu, DR; Wang, SQ; Feng, X				Jules, Joel; Shi, Zhenqi; Liu, Jianzhong; Xu, Duorong; Wang, Shunqing; Feng, Xu			Receptor Activator of NF-kappa B (RANK) Cytoplasmic IVVY535-538 Motif Plays an Essential Role in Tumor Necrosis Factor-alpha (TNF)-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-RESORPTION; OSTEOPROTEGERIN LIGAND; T-CELLS; ESTROGEN DEFICIENCY; FAMILY-MEMBERS; KEY REGULATOR; STROMAL CELLS; TNF RECEPTOR; IN-VIVO; DIFFERENTIATION	Tumor necrosis factor-alpha (TNF) enhances osteoclast formation and activity leading to bone loss in various pathological conditions, but its precise role in osteoclastogenesis remains controversial. Although several groups showed that TNF can promote osteoclastogenesis independently of the receptor activator of NF-kappa B (RANK) ligand (RANKL), others demonstrated that TNF-mediated osteoclastogenesis needs permissive levels of RANKL. Here, we independently reveal that although TNF cannot stimulate osteoclastogenesis on bone slices, it can induce the formation of functional osteoclasts on bone slices in the presence of permissive levels of RANKL or from bone marrow macrophages (BMMs) pretreated by RANKL. TNF can still promote the formation of functional osteoclasts 2 days after transient RANKL pretreatment. These data have confirmed that TNF-mediated osteoclastogenesis requires priming of BMMs by RANKL. Moreover, we investigated the molecular mechanism underlying the dependence of TNF-mediated osteoclastogenesis on RANKL. RANK, the receptor for RANKL, contains an IVVY535-538 motif that has been shown to play a vital role in osteoclastogenesis by committing BMMs to the osteoclast lineage. We show that TNF-induced osteoclastogenesis depends on RANKL to commit BMMs to the osteoclast lineage and RANKL regulates the lineage commitment through the IVVY motif. Mechanistically, the IVVY motif controls the lineage commitment by reprogramming osteoclast genes into an inducible state in which they can be activated by TNF. Our findings not only provide important mechanistic insights into the action of RANKL in TNF-mediated osteoclastogenesis but also establish that the IVVY motif may serve as an attractive therapeutic target for bone loss in various bone disorders.	[Jules, Joel; Shi, Zhenqi; Liu, Jianzhong; Xu, Duorong; Wang, Shunqing; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Wang, Shunqing] Guangzhou Med Univ, Municipal Peoples Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China	University of Alabama System; University of Alabama Birmingham; Guangzhou Medical University	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	xufeng@uab.edu			National Institutes of Health through the NIAMS [AR47830]; Research and Education Foundation of American College of Rheumatology; National Institutes of Health/NIAMS University of Alabama at Birmingham Core Center for Basic Skeletal Research (CCBSR) [5P30 AR046031]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047830, P30AR046031] Funding Source: NIH RePORTER	National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Research and Education Foundation of American College of Rheumatology; National Institutes of Health/NIAMS University of Alabama at Birmingham Core Center for Basic Skeletal Research (CCBSR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant AR47830 through the NIAMS (to X. F.). This work was also supported by a National Institutes of Health/NIAMS graduate research supplement to AR47830 (to J. J.), a Within Our Reach innovative basic research grant from Research and Education Foundation of American College of Rheumatology (to X. F.), and National Institutes of Health/NIAMS University of Alabama at Birmingham Core Center for Basic Skeletal Research (CCBSR) Grant 5P30 AR046031.	Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Beyaert R, 1998, CYTOKINES, P335, DOI 10.1016/B978-012498340-3/50025-7; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Fouque-Aubert A, 2008, JOINT BONE SPINE, V75, P5, DOI 10.1016/j.jbspin.2007.05.004; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; HOROWITZ MC, 1993, SCIENCE, V260, P626, DOI 10.1126/science.8480174; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Kitaura H, 2004, J IMMUNOL, V173, P4838, DOI 10.4049/jimmunol.173.8.4838; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Quinn JMW, 2000, J BONE MINER RES, V15, P1459, DOI 10.1359/jbmr.2000.15.8.1459; Rho J, 2002, DNA CELL BIOL, V21, P541, DOI 10.1089/104454902320308915; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; THOMSON BM, 1987, J IMMUNOL, V138, P775; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961	49	32	35	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37427	37435		10.1074/jbc.M110.149484	http://dx.doi.org/10.1074/jbc.M110.149484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870724	hybrid, Green Published			2022-12-27	WOS:000284424000035
J	Couoh-Cardel, SJ; Uribe-Carvajal, S; Wilkens, S; Garcia-Trejo, JJ				Couoh-Cardel, Sergio J.; Uribe-Carvajal, Salvador; Wilkens, Stephan; Garcia-Trejo, Jose J.			Structure of Dimeric F1F0-ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ATP SYNTHASE; SUPRAMOLECULAR ORGANIZATION; GXXXG MOTIF; SUBUNIT-E; TRANSMEMBRANE DOMAIN; RESPIRATORY-CHAIN; PROTEIN COMPLEXES; STATOR; SACCHAROMYCES; DIMERIZATION	The structure of the dimeric ATP synthase from yeast mitochondria was analyzed by transmission electron microscopy and single particle image analysis. In addition to the previously reported side views of the dimer, top view and intermediate projections served to resolve the arrangement of the rotary c(10) ring and the other stator subunits at the F-0-F-0 dimeric interface. A three-dimensional reconstruction of the complex was calculated from a data set of 9960 molecular images at a resolution of 27 angstrom. The structural model of the dimeric ATP synthase shows the two monomers arranged at an angle of similar to 45 degrees, consistent with our earlier analysis of the ATP synthase from bovine heart mitochondria (Minauro-Sanmiguel, F., Wilkens, S., and Garcia, J. J. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 12356-12358). In the ATP synthase dimer, the two peripheral stalks are located near the F-1-F-1 interface but are turned away from each other so that they are not in contact. Based on the three-dimensional reconstruction, a model of how dimeric ATP synthase assembles to form the higher order oligomeric structures that are required for mitochondrial cristae biogenesis is discussed.	[Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Couoh-Cardel, Sergio J.; Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Dept Biol, Fac Chem, Mexico City 04510, DF, Mexico; [Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Inst Cell Physiol, Dept Mol Genet, Mexico City 04510, DF, Mexico	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu; jjgartre@unam.mx		Uribe-Carvajal, Salvador/0000-0002-7028-8121; Couoh-Cardel, Sergio/0000-0002-5186-4648	National Institutes of Health [GM58600]; Universidad Nacional Autonoma de Mexico [IN213809-3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM58600. This work was also supported by a grant from Universidad Nacional Autonoma de Mexico under the program Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica 2009, Project IN213809-3.	ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cano-Estrada A, 2010, BBA-BIOENERGETICS, V1797, P1439, DOI 10.1016/j.bbabio.2010.02.024; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Carbajo RJ, 2005, J MOL BIOL, V351, P824, DOI 10.1016/j.jmb.2005.06.012; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P272, DOI 10.1016/j.bbabio.2009.11.004; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; Everard-Gigot V, 2005, EUKARYOT CELL, V4, P346, DOI 10.1128/EC.4.2.346-355.2005; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; GARCIA JJ, 2006, J S BIOCH, V45, P12695; Garcia-Trejo JJ, 2008, J BIOL PHYS, V34, P197, DOI 10.1007/s10867-008-9114-z; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; Giraud MF, 2002, BBA-BIOENERGETICS, V1555, P174, DOI 10.1016/S0005-2728(02)00274-8; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; MINAUROSANMIGUE.F, 2005, J J P NATL ACAD SCI, V102, P12356; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Morales-Rios E, 2010, FASEB J, V24, P599, DOI 10.1096/fj.09-137356; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PENA A, 1977, FEBS LETT, V80, P209, DOI 10.1016/0014-5793(77)80441-9; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Spannagel C, 1998, BBA-BIOMEMBRANES, V1414, P260, DOI 10.1016/S0005-2736(98)00174-6; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Velours J, 2009, INT J BIOCHEM CELL B, V41, P1783, DOI 10.1016/j.biocel.2009.01.011; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Weimann T, 2008, BIOCHEMISTRY-US, V47, P3556, DOI 10.1021/bi702000g; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Yao H, 2008, BIOCHEMISTRY-US, V47, P1910, DOI 10.1021/bi7015475	53	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36447	36455		10.1074/jbc.M110.144907	http://dx.doi.org/10.1074/jbc.M110.144907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833715	Green Published, hybrid			2022-12-27	WOS:000284146100002
J	Fan, QP; He, MA; Sheng, T; Zhang, XL; Sinha, M; Luxon, B; Zhao, XB; Xie, JW				Fan, Qipeng; He, Miao; Sheng, Tao; Zhang, Xiaoli; Sinha, Mala; Luxon, Bruce; Zhao, Xingbo; Xie, Jingwu			Requirement of TGF beta Signaling for SMO-mediated Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; MOUSE MODEL; IN-VITRO; ACTIVATION; PATHWAY; CANCER; DIFFERENTIATION; EXPRESSION; GENES	Hedgehog (Hh) signaling, via the key signal transducer Smoothened (SMO) and Gli transcription factors, is essential for embryonic development and carcinogenesis. At present, the molecular mechanism of Hh signaling-mediated carcinogenesis is not completely understood. Using a mouse model (K14cre/R26SmoM2) of SMO-mediated basal cell carcinoma development, we identified TGF beta 2 as a major Hh-regulated gene. TGF beta 2 expression was high in the keratinocytes, with activated TGF beta signaling (indicated by elevated expression of phosphorylated SMAD2/3) detected in both tumor and stroma. The significance of TGF beta signaling for SMO function was demonstrated in two assays. Down-regulation of TGF beta 2 expression prevented Hh signaling-dependent osteoblast differentiation and motor neuron differentiation. Furthermore, inhibition of TGF beta signaling by TGF beta receptor I inhibitor SD208 significantly reduced tumor area in K14cre/R26SmoM2 mice. Tumor shrinkage in mice was associated with an increased number of lymphocytes, suggesting an immune suppression role of TGF beta signaling. The relevance of our results to human cancer is reflected by the fact that human basal cell carcinomas, which almost always harbor activated Hh signaling, have activated TGF beta signaling, as indicated by high levels of phosphorylated SMAD2 and SMAD3 in tumor and stroma. Together, our data indicate that TGF beta signaling is critical for Hh signaling-mediated carcinogenesis.	China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Fan, Qipeng; He, Miao; Sheng, Tao; Zhang, Xiaoli; Xie, Jingwu] Indiana Univ, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Fan, Qipeng; He, Miao; Sheng, Tao; Zhang, Xiaoli; Xie, Jingwu] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46202 USA; [He, Miao] Wuhan Univ, Sch Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China; [He, Miao] Wuhan Univ, Hosp Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China; [Sinha, Mala; Luxon, Bruce] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	China Agricultural University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Wuhan University; Wuhan University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston		zhxb@cau.edu.cn; jinxie@iupui.edu	He, Miao/AAK-8617-2020; Luxon, Bruce A/C-9140-2012	He, Miao/0000-0001-8255-8072; Zhao, Xingbo/0000-0002-5576-349X	National Institutes of Health [R01-CA94160]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA094160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA94160 (to J.X.) and by a grant from the China Scholarship Council.	Alvarez J, 2002, DEVELOPMENT, V129, P1913; Athar M, 2004, CANCER RES, V64, P7545, DOI 10.1158/0008-5472.CAN-04-1393; Chen YG, 2009, CELL RES, V19, P1, DOI 10.1038/cr.2009.3; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; He J, 2006, J BIOL CHEM, V281, P35598, DOI 10.1074/jbc.C600200200; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; Mao JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni146; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Owens P, 2008, J INVEST DERMATOL, V128, P783, DOI 10.1038/sj.jid.5700969; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; XIE J, 2009, Patent No. 2009000737; Xie JW, 2008, ACTA BIOCH BIOPH SIN, V40, P670, DOI 10.1111/j.1745-7270.2008.00431.x; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281	28	49	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36570	36576		10.1074/jbc.C110.164442	http://dx.doi.org/10.1074/jbc.C110.164442			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858897	hybrid, Green Published			2022-12-27	WOS:000284146100082
J	Qi, RS; Hoose, S; Schreiter, J; Sawant, KV; Lamb, R; Ranjith-Kumar, CT; Mills, J; Mateo, LS; Jordan, JL; Kao, CC				Qi, Rongsu; Hoose, Scott; Schreiter, Jessica; Sawant, Kirti V.; Lamb, Roberta; Ranjith-Kumar, C. T.; Mills, Juliane; Mateo, Lani San; Jordan, Jarrat L.; Kao, C. Cheng			Secretion of the Human Toll-like Receptor 3 Ectodomain Is Affected by Single Nucleotide Polymorphisms and Regulated by Unc93b1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MONOCLONAL-ANTIBODY; MOLECULAR-STRUCTURE; FUNCTIONAL ANALYSES; DENDRITIC CELLS; HUMAN UNC-93B; HUMAN-DISEASE; HEPATITIS-C; TLR3; GENE	The innate immune receptor Toll-like receptor 3 (TLR3) can be present on the surface of the plasma membranes of cells and in endolysosomes. The Unc93b1 protein has been reported to facilitate localization of TLR7 and 9 and is required for TLR3, -7, and -9 signaling. We demonstrate that siRNA knockdown of Unc93b1 reduced the abundance of TLR3 on the cell surface without altering total TLR3 accumulation. In addition, siRNA to Unc93b1 reduced the secretion of the TLR3 ectodomain (T3ECD) into the cell medium. Furthermore, two human single nucleotide polymorphisms that affected herpesvirus and influenza virus encephalopathy as well as a natural isoform generated by alternative splicing were found to be impaired for T3ECD secretion and decreased the abundance of TLR3 on the cell surface. The locations of the SNP P554S and the deletion in the isoform led to the identification of a loop in the TLR3 ectodomain that is required for secretion and a second whose presence decreased secretion. Finally, a truncated protein containing the N-terminal 10 leucine-rich repeats of T3ECD was sufficient for secretion in an Unc93b1-dependent manner.	[Qi, Rongsu; Sawant, Kirti V.; Ranjith-Kumar, C. T.; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA; [Hoose, Scott] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Schreiter, Jessica; Lamb, Roberta; Mills, Juliane; Mateo, Lani San; Jordan, Jarrat L.] Centocor Res & Dev Inc, Discovery Res, Radnor, PA 19087 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station; Johnson & Johnson; Johnson & Johnson USA	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47401 USA.	ckao@indiana.edu	Kumar CT, Ranjith/J-5701-2016; Sawant, Kirti/L-1602-2013; Sawant, Kirti V/H-3778-2013	Jordan, Jarrat/0000-0002-0699-3774	National Institutes of Health [RAI075015A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RAI075015A (to R. Q. and C. T. R.-K.).	Askar E, 2009, J MED VIROL, V81, P1204, DOI 10.1002/jmv.21491; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2006, J ENDOTOXIN RES, V12, P375, DOI 10.1179/096805106X118780; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dhiman N, 2007, J INFECT DIS, V195, P21, DOI 10.1086/510596; Duffy KE, 2007, CELL IMMUNOL, V248, P103, DOI 10.1016/j.cellimm.2007.10.002; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koehn J, 2007, HUM IMMUNOL, V68, P871, DOI 10.1016/j.humimm.2007.07.007; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rodgers UR, 2009, MATRIX BIOL, V28, P263, DOI 10.1016/j.matbio.2009.04.006; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Schroder NWJ, 2005, GENES IMMUN, V6, P448, DOI 10.1038/sj.gene.6364221; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tantisira K, 2004, GENES IMMUN, V5, P343, DOI 10.1038/sj.gene.6364096; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Yang EJ, 2004, YONSEI MED J, V45, P359, DOI 10.3349/ymj.2004.45.2.359; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	47	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36635	36644		10.1074/jbc.M110.144402	http://dx.doi.org/10.1074/jbc.M110.144402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855885	hybrid, Green Published			2022-12-27	WOS:000284146100039
J	Crumbley, C; Wang, YJ; Kojetin, DJ; Burris, TP				Crumbley, Christine; Wang, Yongjun; Kojetin, Douglas J.; Burris, Thomas P.			Characterization of the Core Mammalian Clock Component, NPAS2, as a REV-ERB alpha/ROR alpha Target Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; CIRCADIAN-RHYTHMS; TRANSCRIPTION FACTOR; HORMONE-RECEPTORS; MOUSE-LIVER; EXPRESSION; HEME; IDENTIFICATION; PATHWAYS; LIGAND	The mammalian clock is regulated at the cellular level by a transcriptional/translational feedback loop. BMAL1/CLOCK (or NPAS2) heterodimers activate the expression of the PERIOD (PER) and CRYPTOCHROME (CRY) genes acting as transcription factors directed to the PER and CRY promoters via E-box elements. PER and CRY proteins form heterodimers and suppress the activity of the BMAL1/CLOCK (or NPAS2) completing the feedback loop. The circadian expression of BMAL1 is influenced by retinoic acid receptor-related orphan receptor alpha (ROR alpha) and REV-ERB alpha, two nuclear receptors that target a ROR-response element in the promoter of the BMAL1 gene. Given that BMAL1 functions as an obligate heterodimer with either CLOCK or NPAS2, it is unclear how the expression of the partner is coordinated with BMAL1 expression. Here, we demonstrate that NPAS2 is also a ROR alpha and REV-ERB alpha target gene. Using a ChIP/microarray screen, we identified both ROR alpha and REV-ERB alpha occupancy of the NPAS2 promoter. We identified two functional ROREs within the NPAS2 promoter and also demonstrate that both ROR alpha and REV-ERB alpha regulate the expression of NPAS2 mRNA. These data suggest a mechanism by which ROR alpha and REV-ERB alpha coordinately regulate the expression of the positive arm of the circadian rhythm feedback loop.	[Crumbley, Christine; Wang, Yongjun; Kojetin, Douglas J.; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health [DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080201 (to T. P. B.).	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Delerive P, 2002, J BIOL CHEM, V277, P35013, DOI 10.1074/jbc.M202979200; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Ishida M, 2008, BIOCHEM BIOPH RES CO, V368, P292, DOI 10.1016/j.bbrc.2008.01.053; Koudo R, 2005, FEBS J, V272, P4153, DOI 10.1111/j.1742-4658.2005.04828.x; Koyanagi S, 2006, MOL ENDOCRINOL, V20, P573, DOI 10.1210/me.2005-0165; Koyanagi S, 2002, MOL PHARMACOL, V62, P1393, DOI 10.1124/mol.62.6.1393; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; LEE YH, 1994, J BIOL CHEM, V269, P14681; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Mukaiyama Y, 2006, FEBS J, V273, P2528, DOI 10.1111/j.1742-4658.2006.05259.x; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Raspe E, 2002, J BIOL CHEM, V277, P49275, DOI 10.1074/jbc.M206215200; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Rudic RD, 2005, METHOD ENZYMOL, V393, P524, DOI 10.1016/S0076-6879(05)93027-9; Stayrook KR, 2008, MOL PHARMACOL, V73, P607, DOI 10.1124/mol.107.039099; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835	43	97	99	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35386	35392		10.1074/jbc.M110.129288	http://dx.doi.org/10.1074/jbc.M110.129288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20817722	hybrid, Green Published			2022-12-27	WOS:000283845300016
J	Zheng, YB; Zhao, YD; Gibbons, M; Abramova, T; Chu, PY; Ash, JD; Cunningham, JM; Skapek, SX				Zheng, Yanbin; Zhao, Yi D.; Gibbons, Melissa; Abramova, Tatiana; Chu, Patricia Y.; Ash, John D.; Cunningham, John M.; Skapek, Stephen X.			Tgf beta Signaling Directly Induces Arf Promoter Remodeling by a Mechanism Involving Smads 2/3 and p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; GROWTH-FACTOR-BETA; CELL-CYCLE ARREST; TRANSCRIPTION FACTOR; HISTONE ACETYLATION; EYE DEVELOPMENT; FAMILY MEMBERS; MOUSE EYE; EXPRESSION; P19(ARF)	We have investigated how the Arf gene product, p19(Arf), is activated by Tgf beta during mouse embryo development to better understand how this important tumor suppressor is controlled. Taking advantage of new mouse models, we provide genetic evidence that Arf lies downstream of Tgf beta signaling in cells arising from the Wnt1-expressing neural crest and that the anti-proliferative effects of Tgf beta depend on Arf in vivo. Tgf beta 1, -2, and -3 (but not BMP-2, another member of the Tgf beta superfamily) induce p19(Arf) expression in wild type mouse embryo fibroblasts (MEFs), and they enhance Arf promoter activity in Arf(dacZ/lacZ) MEFs. Application of chemical inhibitors of Smad-dependent and -independent pathways show that SB431542, a Tgf beta type I receptor (T beta rI) inhibitor, and SB203580, a p38 MAPK inhibitor, impede Tgf beta 2 induction of Arf. Genetic studies confirm the findings; transient knockdown of Smad2, Smad3, or p38 MAPK blunt Tgf beta 2 effects, as does Cre recombinase treatment of Tgfbr(2fl/fl) MEFs to delete Tgf beta receptor II. Chromatin immunoprecipitation reveals that Tgf beta rapidly induces Smads 2/3 binding and histone H3 acetylation at genomic DNA proximal to Arf exon 1 beta. This is followed by increased RNA polymerase II binding and progressively increased Arf primary and mature transcripts from 24 through 72 h, indicating that increased transcription contributes to p19(Arf) increase. Last, Arf induction by oncogenic Ras depends on p38 MAPK but is independent of T beta rI activation of Smad 2. These findings add to our understanding of how developmental and tumorigenic signals control Arf expression in vivo and in cultured MEFs.	[Cunningham, John M.; Skapek, Stephen X.] Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, Chicago, IL 60637 USA; [Ash, John D.] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA	University of Chicago; University of Oklahoma System; University of Oklahoma Health Sciences Center	Skapek, SX (corresponding author), Univ Chicago, Dept Pediat, Sect Hematol Oncol & Stem Cell Transplantat, KCBD-5102,900 E 57th St, Chicago, IL 60637 USA.	sskapek@peds.bsd.uchicago.edu		Ash, John/0000-0002-8330-7301	National Institutes of Health [R01 EY0194368, EY019942]; American Diabetes Association [1-06-RA-05]; NATIONAL EYE INSTITUTE [R01EY019942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY0194368 and EY019942 (NEI, to S. X. S.).; Supported by American Diabetes Association Grant 1-06-RA-05) (to J. D. A.).	ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Euler-Taimor G, 2006, CARDIOVASC RES, V69, P15, DOI 10.1016/j.cardiores.2005.07.007; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; Freeman-Anderson NE, 2009, DEVELOPMENT, V136, P2081, DOI 10.1242/dev.033548; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Gromley A, 2009, P NATL ACAD SCI USA, V106, P6285, DOI 10.1073/pnas.0902310106; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Ittner L., 2005, J BIOL, V4, P111; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Katuri V, 2005, ONCOGENE, V24, P8012, DOI 10.1038/sj.onc.1208946; Khaliq S, 2001, INVEST OPHTH VIS SCI, V42, P2225; Ki KD, 2009, J GYNECOL ONCOL, V20, P117, DOI 10.3802/jgo.2009.20.2.117; Kimoto K, 2004, INVEST OPHTH VIS SCI, V45, P2431, DOI 10.1167/iovs.03-1276; Kiss A, 1997, CLIN CANCER RES, V3, P1059; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; LIN AE, 1990, OPHTHALMIC PAED GEN, V11, P121, DOI 10.3109/13816819009012956; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; MARQUARDT H, 1983, P NATL ACAD SCI-BIOL, V80, P4684; Martin AC, 2004, INVEST OPHTH VIS SCI, V45, P3387, DOI 10.1167/iovs.04-0349; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Saika S, 2001, DEV BIOL, V240, P419, DOI 10.1006/dbio.2001.0480; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sebastian T, 2009, CANCER RES, V69, P2588, DOI 10.1158/0008-5472.CAN-08-2312; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Srinivasan Y, 1998, J CLIN INVEST, V101, P625, DOI 10.1172/JCI1360; ten Hove T, 2002, GUT, V50, P507, DOI 10.1136/gut.50.4.507; Thornton JD, 2007, INVEST OPHTH VIS SCI, V48, P491, DOI 10.1167/iovs.06-0765; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WANG MK, 1973, ACTA OPHTHALMOL, V51, P434; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Zhao SL, 2001, DEV BIOL, V237, P45, DOI 10.1006/dbio.2001.0360; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	62	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35654	35664		10.1074/jbc.M110.128959	http://dx.doi.org/10.1074/jbc.M110.128959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826783	Green Published, hybrid			2022-12-27	WOS:000283845300044
J	Kocher, O; Birrane, G; Tsukamoto, K; Fenske, S; Yesilaltay, A; Pal, R; Daniels, K; Ladias, JAA; Krieger, M				Kocher, Olivier; Birrane, Gabriel; Tsukamoto, Kosuke; Fenske, Sara; Yesilaltay, Ayce; Pal, Rinku; Daniels, Kathleen; Ladias, John A. A.; Krieger, Monty			In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; SURFACE LOCALIZATION; TARGETED DISRUPTION; INTERACTING DOMAIN; CRYSTAL-STRUCTURE; LIPID-METABOLISM; APOLIPOPROTEIN-E; CYSTIC-FIBROSIS; EXPRESSION; RECOGNITION	The PDZ1 domain of the four PDZ domain-containing protein PDZK1 has been reported to bind the C terminus of the HDL receptor scavenger receptor class B, type I (SR-BI), and to control hepatic SR-BI expression and function. We generated wild-type (WT) and mutant murine PDZ1 domains, the mutants bearing single amino acid substitutions in their carboxylate binding loop (Lys(14)-Xaa(4)-Asn(19)-Tyr-Gly-Phe-Phe-Leu(24)), and measured their binding affinity for a 7-residue peptide corresponding to the C terminus of SR-BI ((503)VLQEAKL(509)). The Y20A and G21Y substitutions abrogated all binding activity. Surprisingly, binding affinities (K-d) of the K14A and F22A mutants were 3.2 and 4.0 mu M, respectively, similar to 2.6 mu M measured for the WT PDZ1. To understand these findings, we determined the high resolution structure of WT PDZ1 bound to a 5-residue sequence from the C-terminal SR-BI ((505)QEAKL(509)) using x-ray crystallography. In addition, we incorporated the K14A and Y20A substitutions into full-length PDZK1 liver-specific transgenes and expressed them in WT and PDZK1 knock-out mice. In WT mice, the transgenes did not alter endogenous hepatic SR-BI protein expression (intracellular distribution or amount) or lipoprotein metabolism (total plasma cholesterol, lipoprotein size distribution). In PDZK1 knock-out mice, as expected, the K14A mutant behaved like wild-type PDZK1 and completely corrected their hepatic SR-BI and plasma lipoprotein abnormalities. Unexpectedly, the 10-20-fold overexpressed Y20A mutant also substantially, but not completely, corrected these abnormalities. The results suggest that there may be an additional site(s) within PDZK1 that bind(s) SR-BI and mediate(s) productive SR-BI-PDZK1 interaction previously attributed exclusively to the canonical binding of the C-terminal SR-BI to PDZ1.	[Kocher, Olivier; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Kocher, Olivier; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Birrane, Gabriel; Ladias, John A. A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med,Mol Med Lab, Boston, MA 02215 USA; [Birrane, Gabriel; Ladias, John A. A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med,Macromol Crystallog Unit, Boston, MA 02215 USA; [Tsukamoto, Kosuke; Fenske, Sara; Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Kocher, O (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	okocher@bidmc.harvard.edu		Birrane, Gabriel/0000-0002-1759-5499	National Institutes of Health [HL077780, HL52212, HL66105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212, P01HL066105, R01HL077780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077780 (to O. K.) and HL52212 and HL66105 (to M. K.).	Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; VAN HAMM, 2003, MOL BIOL REP */* W M, P69; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	48	19	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34999	35010		10.1074/jbc.M110.164418	http://dx.doi.org/10.1074/jbc.M110.164418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739281	Green Published, hybrid			2022-12-27	WOS:000283659100074
J	Sethi, N; Yan, Y; Quek, D; Schupbach, T; Kang, YB				Sethi, Nilay; Yan, Yan; Quek, Debra; Schupbach, Trudi; Kang, Yibin			Rabconnectin-3 Is a Functional Regulator of Mammalian Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; OSTEOCLAST PRECURSORS; CELL FATE; ACTIVATION; CANCER; DROSOPHILA; RECEPTOR; PATHWAY; TUMOR; RAVE	The Notch signaling pathway is important for cell fate decisions in embryonic development and adult life. Defining the functional importance of the Notch pathway in these contexts requires the elucidation of essential signal transduction components that have not been fully characterized. Here, we show that Rabconnectin-3B is required for the Notch pathway in mammalian cells. siRNA-mediated silencing of Rabconnectin-3B in mammalian cells attenuated Notch signaling and disrupted the activation and nuclear accumulation of the Notch target Hes1. Rabconnectin-3B knockdown also disrupted V-ATPase activity in mammalian cells, consistent with previous observations in Drosophila. Pharmacological inhibition of the V-ATPase complex significantly reduced Notch signaling in mammalian cells. Finally, Rabconnectin-3B knockdown phenocopied functional disruption of Notch signaling during osteoclast differentiation. Collectively, these findings define an important role for Rabconnectin-3 and V-ATPase activity in the Notch signaling pathway in mammalian cells.	[Sethi, Nilay; Yan, Yan; Quek, Debra; Schupbach, Trudi; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Schupbach, Trudi] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Quek, Debra] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA	Princeton University; Howard Hughes Medical Institute; Princeton University; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, LTL 255,Washington Rd, Princeton, NJ 08544 USA.	ykang@princeton.edu		Kang, Yibin/0000-0002-1626-6730	National Institutes of Health [R01CA134519]; Department of Defense [BC051647]; New Jersey Commission on Cancer Research [09-1075-CCR-EO]; USPHS [R01GM077620]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA134519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); New Jersey Commission on Cancer Research; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134519 (to Y.K.). This work was also supported by Department of Defense Grant BC051647 and the New Jersey Commission on Cancer Research Grant 09-1075-CCR-EO.; Supported by a predoctoral fellowship from New Jersey Commission on Cancer Research.; Supported by National Institutes of Health Grant R01GM077620 from USPHS and the Howard Hughes Medical Institute.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; JE K, 2003, EMBO REP, V4, P1163; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Tao JN, 2010, ANN NY ACAD SCI, V1192, P257, DOI 10.1111/j.1749-6632.2009.05307.x; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wu YC, 2009, BIOCHEM BIOPH RES CO, V382, P451, DOI 10.1016/j.bbrc.2009.03.051; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	27	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34757	34764		10.1074/jbc.M110.158634	http://dx.doi.org/10.1074/jbc.M110.158634			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810660	hybrid, Green Published			2022-12-27	WOS:000283659100051
J	Bora, NS; Jha, P; Lyzogubov, VV; Kaliappan, S; Liu, JA; Tytarenko, RG; Fraser, DA; Morgan, BP; Bora, PS				Bora, Nalini S.; Jha, Purushottam; Lyzogubov, Valeriy V.; Kaliappan, Sankaranarayanan; Liu, Juan; Tytarenko, Ruslana G.; Fraser, Deborah A.; Morgan, B. Paul; Bora, Puran S.			Recombinant Membrane-targeted Form of CD59 Inhibits the Growth of Choroidal Neovascular Complex in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOCHOROIDAL HEALING-PROCESSES; MACULAR DEGENERATION; ATTACK COMPLEX; CELL APOPTOSIS; MOUSE MODEL; AGE; REGULATOR; ACTIVATION; INJECTION	This study was designed to explore the effect of recombinant, membrane-targeted CD59 (rCD59-APT542) on the growth and size of fully developed neovascular complex using the murine model of laser-induced choroidal neovascularization (CNV). CNV was induced by laser photocoagulation in C57BL/6 mice using an argon laser, and the animals received rCD59-APT542 via intravitreal (ivt) route. Western blot analysis, immunohistochemistry, and total complement hemolytic assay demonstrated that exogenously administered rCD59-APT542 was incorporated as well as retained in RPE and choroid and was functionally active in vivo. Single ivt injection during the growth of the CNV (i.e. at day 3 post-laser) resulted in similar to 79% inhibition of the further growth of neovascular complex. The size of the CNV complex was significantly (p< 0.05) reduced by the administration of rCD59-APT542 after the CNV complex has fully developed (i.e. at day 7 post-laser). Treatment with rCD59-APT542 blocked the formation of membrane attack complex (MAC), increased apoptosis and decreased cell proliferation in the neovascular complex. On the basis of results presented here we conclude that recombinant membrane targeted CD59 inhibited the growth of the CNV complex and reduced the size of fully developed CNV in the laser-induced mouse model. We propose that a combination of two mechanisms: increased apoptosis and decreased cell proliferation, both resulting from local inhibition of MAC, may be responsible for inhibition of CNV by rCD59-APT542.	[Bora, Nalini S.; Jha, Purushottam; Lyzogubov, Valeriy V.; Kaliappan, Sankaranarayanan; Liu, Juan; Tytarenko, Ruslana G.; Bora, Puran S.] Univ Arkansas Med Sci, Jones Eye Inst, Dept Ophthalmol, Pat & Willard Walker Eye Res Ctr, Little Rock, AR 72205 USA; [Fraser, Deborah A.; Morgan, B. Paul] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales	University of Arkansas System; University of Arkansas Medical Sciences; Cardiff University	Bora, NS (corresponding author), Univ Arkansas Med Sci, Jones Eye Inst, Dept Ophthalmol, Pat & Willard Walker Eye Res Ctr, 4301 W Markham,523, Little Rock, AR 72205 USA.	NBora@UAMS.edu; PBora@UAMS.edu		Bora, Puran/0000-0003-4781-1217; Morgan, Paul/0000-0003-4075-7676	National Institutes of Health [EY014623, EY018812, 2P20 RR16460]; Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR; National Institutes of Health/NCRR [1 S10 RR 19395]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460, S10RR019395] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018812, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR; National Institutes of Health/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in, whole or in part, by National Institutes of Health Grants EY014623 and EY018812, and the Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; We thank Dr. Claire L. Harris and Dr. Richard A. Smith for helpful comments. The Digital and Confocal Microscopy Laboratory, University of Arkansas for Medical Sciences was supported by National Institutes of Health Grant 2P20 RR16460 and National Institutes of Health/NCRR Grant 1 S10 RR 19395.	Acosta J, 2000, P NATL ACAD SCI USA, V97, P5450, DOI 10.1073/pnas.97.10.5450; Baalasubramanian S, 2004, J IMMUNOL, V173, P3684, DOI 10.4049/jimmunol.173.6.3684; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora PS, 2006, FEBS J, V273, P1403, DOI 10.1111/j.1742-4658.2006.05163.x; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Capey S, 2007, MOL IMMUNOL, V44, P608, DOI 10.1016/j.molimm.2006.01.014; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; Dot C, 2007, EXP EYE RES, V84, P1081, DOI 10.1016/j.exer.2007.01.024; Dot C, 2009, MOL VIS, V15, P670; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Fraser DA, 2002, PROTEIN SCI, V11, P2512, DOI 10.1110/ps.0212402; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Harris CL, 2003, IMMUNOLOGY, V109, P117, DOI 10.1046/j.1365-2567.2003.01628.x; Hughes J, 2000, AM J PHYSIOL-RENAL, V278, pF747, DOI 10.1152/ajprenal.2000.278.5.F747; Husain Deeba, 2002, Ophthalmol Clin North Am, V15, P87, DOI 10.1016/S0896-1549(01)00009-8; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Lewis RD, 2010, MOL IMMUNOL, V47, P1098, DOI 10.1016/j.molimm.2009.10.035; Lyzogubov VV, 2009, CELL BIOL INT, V33, P765, DOI 10.1016/j.cellbi.2009.04.013; Nauta AJ, 2002, EUR J IMMUNOL, V32, P783, DOI 10.1002/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Sato T, 1999, J AM SOC NEPHROL, V10, P1242; Schmack I, 2009, MOL VIS, V15, P146; Smith GP, 2001, MOL IMMUNOL, V38, P249, DOI 10.1016/S0161-5890(01)00047-5; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195	29	41	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33826	33833		10.1074/jbc.M110.153130	http://dx.doi.org/10.1074/jbc.M110.153130			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736175	hybrid, Green Published			2022-12-27	WOS:000283354000029
J	Shichi, D; Arimura, T; Ishikawa, T; Kimura, A				Shichi, Daisuke; Arimura, Takuro; Ishikawa, Taisuke; Kimura, Akinori			Heart-specific Small Subunit of Myosin Light Chain Phosphatase Activates Rho-associated Kinase and Regulates Phosphorylation of Myosin Phosphatase Target Subunit 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN-KINASE; SMOOTH-MUSCLE; BINDING SUBUNIT; CA2+ SENSITIVITY; IN-VIVO; IDENTIFICATION; ISOFORM; MYPT2; CARDIOMYOPATHY; CONTRACTION	Phosphorylation of myosin regulatory light chain (MLC) plays a regulatory role in muscle contraction, and the level of MLC phosphorylation is balanced by MLC kinase and MLC phosphatase (MLCP). MLCP consists of a catalytic subunit, a large subunit (MYPT1 or MYPT2), and a small subunit. MLCP activity is regulated by phosphorylation of MYPTs, whereas the role of small subunit in the regulation remains unknown. We previously characterized a human heart-specific small subunit (hHS-M-21) that increased the sensitivity to Ca2+ in muscle contraction. In this study, we investigated the role of hHS-M-21 in the regulation of MLCP phosphorylation. Two isoforms of hHS-M-21, hHS-M(21)A and hHS-M21B, preferentially bound the C-terminal one-third region of MYPT1 and MYPT2, respectively. Amino acid substitutions at a phosphorylation site of MYPT1, Ser-852, impaired the binding of MYPT1 and hHS-M-21. The hHS-M21 increased the phosphorylation level of MYPT1 at Thr-696, which was attenuated by Rho-associated kinase (ROCK) inhibitors and small interfering RNAs for ROCK. In addition, hHS-M-21 bound ROCK and enhanced the ROCK activity. These findings suggest that hHS-M-21 is a heart-specific effector of ROCK and plays a regulatory role in the MYPT1 phosphorylation at Thr-696 by ROCK.	[Shichi, Daisuke; Arimura, Takuro; Ishikawa, Taisuke; Kimura, Akinori] Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Kimura, Akinori] Tokyo Med & Dent Univ, Lab Genome Divers, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Kimura, A (corresponding author), Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan.	akitis@mri.tmd.ac.jp	Kimura, Akinori/I-5989-2018; Ishikawa, Taisuke/D-1567-2019; Arimura, Takuro/AAA-2745-2022	Kimura, Akinori/0000-0002-4933-2132; Ishikawa, Taisuke/0000-0001-8195-4700; Arimura, Takuro/0000-0002-0929-3140	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Ministry of Health, Labour, and Welfare, Japan; Health Sciences of the National Institute of Biomedical Innovation; Medical Research Institute, Tokyo Medical and Dental University [11737]; Institute of Life Science; Tokyo Medical and Dental University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Medical Research Institute, Tokyo Medical and Dental University; Institute of Life Science; Tokyo Medical and Dental University	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, grants for Japan-France collaboration research and Japan-Korea collaboration research from the Japan Society for the Promotion of Science, research grants from the Ministry of Health, Labour, and Welfare, Japan, grants from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Grant 11737 from the "Association Francaise Contre les Myopathies," a research grant for young investigators from Medical Research Institute, Tokyo Medical and Dental University, research grants from the Institute of Life Science, and by follow-up grants provided from the Tokyo Medical and Dental University.	Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Aoki H, 2000, NAT MED, V6, P183, DOI 10.1038/72287; Arimura T, 2001, J BIOL CHEM, V276, P6073, DOI 10.1074/jbc.M008566200; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Endo A, 2004, J BIOL CHEM, V279, P42055, DOI 10.1074/jbc.M403676200; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fujioka M, 1998, GENOMICS, V49, P59, DOI 10.1006/geno.1998.5222; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsumura F, 2001, CELL STRUCT FUNCT, V26, P639, DOI 10.1247/csf.26.639; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murata-Hori M, 2001, ONCOGENE, V20, P8175, DOI 10.1038/sj.onc.1205055; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Zhou YB, 1999, BIOCHEM BIOPH RES CO, V254, P158, DOI 10.1006/bbrc.1998.9915	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33680	33690		10.1074/jbc.M110.122390	http://dx.doi.org/10.1074/jbc.M110.122390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801872	hybrid, Green Published			2022-12-27	WOS:000283354000013
J	Clarke, DL; Clifford, RL; Jindarat, S; Proud, D; Pang, LH; Belvisi, M; Knox, AJ				Clarke, Deborah L.; Clifford, Rachel L.; Jindarat, Sarawut; Proud, David; Pang, Linhua; Belvisi, Maria; Knox, Alan J.			TNF alpha and IFN gamma Synergistically Enhance Transcriptional Activation of CXCL10 in Human Airway Smooth Muscle Cells via STAT-1, NF-kappa B, and the Transcriptional Coactivator CREB-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HISTONE H4 ACETYLATION; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; RNA-POLYMERASE-II; INTERFERON-GAMMA; GENE-TRANSCRIPTION; GLUCOCORTICOID-RECEPTOR; DEPENDENT TRANSCRIPTION; INDUCIBLE PROTEIN-10	Asthmatic airway smooth muscle (ASM) expresses interferon-gamma-inducible protein-10 (CXCL10), a chemokine known to mediate mast cell migration into ASM bundles that has been reported in the airways of asthmatic patients. CXCL10 is elevated in patients suffering from viral exacerbations of asthma and in patients with chronic obstructive pulmonary disease (COPD), diseases in which corticosteroids are largely ineffective. IFN gamma and TNF alpha synergistically induce CXCL10 release from human ASM cells in a steroid-insensitive manner, via an as yet undefined mechanism. We report that TNF alpha activates the classical NF-kappa B (nuclear factor kappa B) pathway, whereas IFN gamma activates JAK2/STAT-1 alpha and that inhibition of the JAK/STAT pathway is more effective in abrogating CXCL10 release than the steroid fluticasone. The synergy observed with TNF alpha and IFN gamma together, however, did not lie at the level of NF-kappa B activation, STAT-1 alpha phosphorylation, or in vivo binding of these transcription factors to the CXCL10 promoter. Stimulation of human ASM cells with TNF alpha and IFN gamma induced histone H4 but not histone H3 acetylation at the CXCL10 promoter, although no synergism was observed when both cytokines were combined. We show, however, that TNF alpha and IFN gamma exert a synergistic effect on the recruitment of CREB-binding protein (CBP) to the CXCL10, which is accompanied by increased RNA polymerase II. Our results provide evidence that synergism between TNF alpha and IFN gamma lies at the level of coactivator recruitment in human ASM and suggest that inhibition of JAK/STAT signaling may be of therapeutic benefit in steroid-resistant airway disease.	[Clifford, Rachel L.; Jindarat, Sarawut; Pang, Linhua; Knox, Alan J.] Univ Nottingham, City Hosp, Nottingham Resp Biomed Res Unit, Nottingham NG5 1PB, England; [Proud, David] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Clarke, Deborah L.; Belvisi, Maria] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Calgary; Imperial College London	Clarke, DL (corresponding author), MedImmune, Granta Pk, Cambridge CB21 6GH, England.	ClarkeD@MedImmune.com	Belvisi, Maria G/A-3055-2009	Clifford, Rachel/0000-0002-8677-452X; Knox, Alan/0000-0002-5906-4143	Asthma UK [06/016] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: Medline; BBSRC [BB/E52708X/1] Funding Source: UKRI	Asthma UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Boorsma DM, 1998, ARCH DERMATOL RES, V290, P335, DOI 10.1007/s004030050314; Borie DC, 2005, TRANSPLANTATION, V80, P1756, DOI 10.1097/01.tp.0000184634.25042.ea; Bradbury D, 2005, J BIOL CHEM, V280, P29993, DOI 10.1074/jbc.M414530200; Bradding P, 2007, RESP MED, V101, P1045, DOI 10.1016/j.rmed.2007.01.004; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Clarke DL, 2005, AM J PHYSIOL-LUNG C, V288, pL238, DOI 10.1152/ajplung.00313.2004; Clarke DL, 2004, BRIT J PHARMACOL, V141, P1141, DOI 10.1038/sj.bjp.0705716; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; El-Haroun H, 2008, AM J PHYSIOL-LUNG C, V294, pL553, DOI 10.1152/ajplung.00044.2006; Frangogiannis NG, 2000, CELL TISSUE RES, V302, P365, DOI 10.1007/s004410000274; Gasperini S, 1999, J IMMUNOL, V162, P4928; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Heim MH, 1999, J VIROL, V73, P8469, DOI 10.1128/JVI.73.10.8469-8475.1999; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Hogan JC, 2001, BIOCHEM BIOPH RES CO, V287, P484, DOI 10.1006/bbrc.2001.5606; John M, 1997, J IMMUNOL, V158, P1841; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Keslacy S, 2007, MOL PHARMACOL, V71, P609, DOI 10.1124/mol.106.030171; Kost ER, 1999, GYNECOL ONCOL, V72, P392, DOI 10.1006/gyno.1998.5257; KRAKAUER T, 1993, J IMMUNOL, V150, P1205; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Majumder S, 1998, J IMMUNOL, V161, P4736; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Milici AJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2365; Mullan CS, 2008, AM J RESP CELL MOL, V38, P600, DOI 10.1165/rcmb.2007-0082OC; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Nie M, 2005, J IMMUNOL, V175, P478, DOI 10.4049/jimmunol.175.1.478; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pang LH, 2001, FASEB J, V15, P261, DOI 10.1096/fj.00-0103com; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ren XD, 2002, SHOCK, V17, P513, DOI 10.1097/00024382-200206000-00013; Romagnani P, 2002, J AM SOC NEPHROL, V13, P53, DOI 10.1681/ASN.V13153; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Sauty A, 1999, J IMMUNOL, V162, P3549; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Stocks J, 2005, FEBS LETT, V579, P2551, DOI 10.1016/j.febslet.2005.02.083; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suk K, 2001, FEBS LETT, V495, P66, DOI 10.1016/S0014-5793(01)02335-3; Sukkar MB, 2004, AM J PHYSIOL-LUNG C, V287, pL1230, DOI 10.1152/ajplung.00014.2004; Tliba O, 2006, MOL PHARMACOL, V69, P588, DOI 10.1124/mol.105.019679; Tliba O, 2004, MOL PHARMACOL, V66, P322, DOI 10.1124/mol.104.001040; Tliba O, 2003, J BIOL CHEM, V278, P50615, DOI 10.1074/jbc.M303680200; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Wada H, 2005, BIOCHEM BIOPH RES CO, V331, P93, DOI 10.1016/j.bbrc.2005.03.138; Wagner AH, 2002, BRIT J PHARMACOL, V136, P143, DOI 10.1038/sj.bjp.0704678; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Zhu YM, 2003, J BIOL CHEM, V278, P29366, DOI 10.1074/jbc.M301785200	63	107	113	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29101	29110		10.1074/jbc.M109.0999952	http://dx.doi.org/10.1074/jbc.M109.0999952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20833730	Green Published, Bronze			2022-12-27	WOS:000281740100011
J	Kim, EO; Kim, TJ; Kim, N; Kim, ST; Kumar, V; Lee, KM				Kim, Eun-Ok; Kim, Tae-Jin; Kim, Nayoung; Kim, Sung Tae; Kumar, Vinay; Lee, Kyung-Mi			Homotypic Cell to Cell Cross-talk Among Human Natural Killer Cells Reveals Differential and Overlapping Roles of 2B4 and CD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NK CELLS; IMMUNOLOGICAL SYNAPSE; 2B4/CD48 INTERACTIONS; MOLECULAR-BASIS; CUTTING EDGE; ACTIVATION; RECEPTOR; SAP; CYTOTOXICITY; PROTEIN	Human natural killer (NK) cells express an abundant level of 2B4 and CD2 on their surface. Their counter-receptors, CD48 and CD58, are also expressed on the NK cell surface, raising a question about the functional consequences of potential 2B4/CD48 and CD2/CD58 interactions. Using blocking antibodies specific to each receptor, we demonstrated that both 2B4/CD48 and CD2/CD58 interactions were essential for the development of NK effector functions: cytotoxicity and cytokine secretion. However, only 2B4/CD48, but not CD2/CD58, interactions were shown to be critical for the optimal NK cell proliferation in response to interleukin (IL)-2. IL-2-activated NK cells cultured in the absence of 2B4/CD48 or CD2/CD58 interactions were severely impaired for their ability to induce intracellular calcium mobilization and subsequent ERK activation upon tumor target exposure, suggesting that the early signaling pathway of NK receptors leading to impaired cytolysis and interferon (IFN)-gamma secretion was inhibited. Nevertheless, these defects did not fully account for the reduced proliferation of NK cells in the absence of 2B4/CD48 interactions, because anti-CD2 or anti-CD58 monoclonal antibody (mAb)-treated NK cells, showing defective signaling and effector functions, displayed normal proliferation upon IL-2 stimulation. These results propose the signaling divergence between pathways leading to cell proliferation and cytotoxicity/cytokine release, which can be differentially regulated by 2B4 and CD2 during IL-2-driven NK cell activation. Collectively, these results reveal the importance of homotypic NK-to-NK cell cross-talk through 2B4/CD48 and CD2/CD58 pairs and further present their differential and overlapping roles in human NK cells.	[Kim, Eun-Ok; Kim, Tae-Jin; Kim, Nayoung; Kim, Sung Tae; Lee, Kyung-Mi] Korea Univ, Coll Med, Dept Biochem, Seoul 136705, South Korea; [Kim, Eun-Ok; Kim, Tae-Jin; Kim, Nayoung; Kim, Sung Tae; Lee, Kyung-Mi] Korea Univ, Coll Med, Global Res Lab, Div Brain Korea Program Biomed Sci 21, Seoul 136705, South Korea; [Kumar, Vinay] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Chicago	Lee, KM (corresponding author), Korea Univ, Coll Med, Dept Biochem, Seoul 136705, South Korea.	kyunglee@korea.ac.kr		Lee, Kyung-Mi/0000-0002-5378-9258	Korea Foundation for International Cooperation of Science and Technology [K20704000007-09A0500-00710, K20601000002-09E0100-00210]; Innovative Research Institute for Cell Therapy [A062260]; National Nuclear RD program; Seoul RBD Program [10920]	Korea Foundation for International Cooperation of Science and Technology; Innovative Research Institute for Cell Therapy; National Nuclear RD program; Seoul RBD Program(Seoul RBD program)	This work was supported in part by Korea Foundation for International Cooperation of Science and Technology Grants K20704000007-09A0500-00710 and K20601000002-09E0100-00210.; Supported by Innovative Research Institute for Cell Therapy Grant A062260.; Supported by the National Nuclear R&D program grant BAERI.; Supported by Seoul R&BD Program Grant 10920.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Assarsson E, 2005, MOL IMMUNOL, V42, P419, DOI 10.1016/j.molimm.2004.07.021; Assarsson E, 2005, J IMMUNOL, V175, P2045, DOI 10.4049/jimmunol.175.4.2045; Assarsson E, 2004, J IMMUNOL, V173, P174, DOI 10.4049/jimmunol.173.1.174; Bachmann MF, 1999, J EXP MED, V190, P1383, DOI 10.1084/jem.190.10.1383; Betser-Cohen G, 2010, J IMMUNOL, V184, P2761, DOI 10.4049/jimmunol.0901572; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Crawford K, 2003, BLOOD, V102, P1745, DOI 10.1182/blood-2002-07-2206; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG612, DOI 10.1152/ajpgi.90576.2008; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Endt J, 2007, EUR J IMMUNOL, V37, P193, DOI 10.1002/eji.200636341; Espagnolle N, 2007, INT IMMUNOL, V19, P239, DOI 10.1093/intimm/dxl141; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Kambayashi T, 2001, J IMMUNOL, V167, P6706, DOI 10.4049/jimmunol.167.12.6706; KANNER SB, 1992, J IMMUNOL, V148, P2023; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; Mahajan S, 2001, EXP HEMATOL, V29, P209, DOI 10.1016/S0301-472X(00)00652-4; Mathew SO, 2009, EUR J IMMUNOL, V39, P1632, DOI 10.1002/eji.200838733; McNerney ME, 2005, MOL IMMUNOL, V42, P489, DOI 10.1016/j.molimm.2004.07.032; Messmer B, 2006, J IMMUNOL, V176, P4646, DOI 10.4049/jimmunol.176.8.4646; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; Saborit-Villarroya I, 2008, MOL IMMUNOL, V45, P3446, DOI 10.1016/j.molimm.2008.03.021; Saborit-Villarroya IN, 2005, J IMMUNOL, V175, P4226, DOI 10.4049/jimmunol.175.7.4226; SADELAIN M, 1995, P NATL ACAD SCI USA, V92, P6728, DOI 10.1073/pnas.92.15.6728; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; Stark S, 2006, INT IMMUNOL, V18, P241, DOI 10.1093/intimm/dxh358; Tangye SG, 1999, J IMMUNOL, V162, P6981; Taniguchi RT, 2007, BLOOD, V110, P2020, DOI 10.1182/blood-2007-02-076927; Vaidya SV, 2005, J IMMUNOL, V174, P800, DOI 10.4049/jimmunol.174.2.800; Vaidya SV, 2006, IMMUNOL LETT, V105, P180, DOI 10.1016/j.imlet.2006.02.006; VALIANTE NM, 1993, J EXP MED, V178, P1397, DOI 10.1084/jem.178.4.1397; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Wahle JA, 2007, J IMMUNOL, V179, P8009, DOI 10.4049/jimmunol.179.12.8009; Yoon SH, 2009, EXP MOL MED, V41, P161, DOI 10.3858/emm.2009.41.3.019; Zheng XD, 2009, J BIOL CHEM, V284, P21280, DOI 10.1074/jbc.M807053200	42	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41755	41764		10.1074/jbc.M110.137976	http://dx.doi.org/10.1074/jbc.M110.137976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20813844	Green Published, hybrid			2022-12-27	WOS:000285622600063
J	Lin, W; Chai, J; Love, J; Fu, D				Lin, Wei; Chai, Jin; Love, James; Fu, Dax			Selective Electrodiffusion of Zinc Ions in a Zrt-, Irt-like Protein, ZIPB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL TRANSPORTER YIIP; ESCHERICHIA-COLI; FUNCTIONAL EXPRESSION; BINDING; CELLS; FAMILY; TRAFFICKING; HOMEOSTASIS; PHYSIOLOGY; MECHANISM	All living cells need zinc ions to support cell growth. Zrt-, Irt-like proteins (ZIPs) represent a major route for entry of zinc ions into cells, but how ZIPs promote zinc uptake has been unclear. Here we report the molecular characterization of ZIPB from Bordetella bronchiseptica, the first ZIP homolog to be purified and functionally reconstituted into proteoliposomes. Zinc flux through ZIPB was found to be nonsaturable and electrogenic, yielding membrane potentials as predicted by the Nernst equation. Conversely, membrane potentials drove zinc fluxes with a linear voltage-flux relationship. Direct measurements of metal uptake by inductively coupled plasma mass spectroscopy demonstrated that ZIPB is selective for two group 12 transition metal ions, Zn2+ and Cd2+, whereas rejecting transition metal ions in groups 7 through 11. Our results provide the molecular basis for cellular zinc acquisition by a zinc-selective channel that exploits in vivo zinc concentration gradients to move zinc ions into the cytoplasm.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Love, James] New York Struct Biol Ctr, New York, NY 10027 USA	United States Department of Energy (DOE); Brookhaven National Laboratory		dax@bnl.gov	Lin, Wei/M-6202-2013	Fu, Dax/0000-0002-2663-1316; chai, jin/0000-0002-4760-5811	National Institutes of Health [R01 GM065137, 5U54GM075026]; Office of Basic Energy Sciences, United States Department of Energy [DOE KC0304000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM075026, R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065137 (to D. F.) and by the Office of Basic Energy Sciences, United States Department of Energy, Grant DOE KC0304000 (to D. F.).; We thank Bill Studier for comments, Marco Punta for bioinformatics support, Renato Bruni for cloning and expression of ZIPB homologs, and Babak Andi for proofreading of the manuscript. NYCOMPS is supported by the National Institutes of Health (Grant 5U54GM075026 to W. Hendrickson). Brookhaven National Laboratory (BNL) is managed by Brookhaven Science Associates for the United States Department of Energy.	APELL HJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P480, DOI 10.1016/0005-2736(87)90055-1; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Elias CL, 2001, AM J PHYSIOL-CELL PH, V281, pC993, DOI 10.1152/ajpcell.2001.281.3.C993; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Hille B, 2001, ION CHANNELS EXCITAB, V3rd, P445; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; King J. C., 2005, NUTR HLTH, P271; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; MAGNESON GR, 1987, J BIOL CHEM, V262, P11140; Mancia F, 2010, J STRUCT BIOL, V172, P85, DOI 10.1016/j.jsb.2010.03.021; NEGULESCU PA, 1990, METHOD ENZYMOL, V192, P38; Nies DH, 2007, SCIENCE, V317, P1695, DOI 10.1126/science.1149048; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; PRESSMAN BC, 1967, P NATL ACAD SCI USA, V58, P1949, DOI 10.1073/pnas.58.5.1949; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Schmitt BM, 2005, J BIOL CHEM, V280, P24481, DOI 10.1074/jbc.M414550200; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	45	77	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39013	39020		10.1074/jbc.M110.180620	http://dx.doi.org/10.1074/jbc.M110.180620			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876577	Green Published, hybrid			2022-12-27	WOS:000284941300031
J	Brailoiu, GC; Gurzu, B; Gao, X; Parkesh, R; Aley, PK; Trifa, DI; Galione, A; Dun, NJ; Madesh, M; Patel, S; Churchill, GC; Brailoiu, E				Brailoiu, G. Cristina; Gurzu, Bogdan; Gao, Xin; Parkesh, Raman; Aley, Parvinder K.; Trifa, Diana I.; Galione, Antony; Dun, Nae J.; Madesh, Muniswamy; Patel, Sandip; Churchill, Grant C.; Brailoiu, Eugen			Acidic NAADP-sensitive Calcium Stores in the Endothelium AGONIST-SPECIFIC RECRUITMENT AND ROLE IN REGULATING BLOOD PRESSURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; MOBILIZES CALCIUM; PANCREATIC ACINAR; ANGIOTENSIN-II; SMOOTH-MUSCLE; CA2+ SIGNALS; NITRIC-OXIDE; RECEPTORS; RELEASE; CELLS	Accumulating evidence implicates nicotinic acid adenine dinucleotide phosphate (NAADP) in the control of Ca2+-dependent functions. Little, however, is known concerning its role in the vascular endothelium, a major regulator of blood pressure. Here, we show that NAADP acetoxymethyl ester (NAADP-AM), a cell-permeant NAADP analog, increases cytosolic Ca2+ concentration in aortic endothelial cells. We demonstrate that these signals and those evoked by acetylcholine are blocked by disrupting acidic organelles with bafilomycin A1. In contrast, Ca2+ signals in response to thrombin are only partially inhibited by bafilomycin A1 treatment, and those to ATP were insensitive, suggesting that recruitment of acidic stores is agonist-specific. We further show that NAADP-evoked Ca2+ signals hyperpolarize endothelial cells and generate NO. Additionally, we demonstrate that NAADP dilates aortic rings in an endothelium- and NO-dependent manner. Finally, we show that intravenous administration of NAADP-AM into anesthetized rats decreases mean arterial pressure. Our data extend the actions of NAADP to the endothelium both in vitro and in vivo, pointing to a previously unrecognized role for this messenger in controlling blood pressure.	[Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Brailoiu, G. Cristina; Gurzu, Bogdan; Gao, Xin; Dun, Nae J.; Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Madesh, Muniswamy] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Parkesh, Raman; Aley, Parvinder K.; Galione, Antony; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Trifa, Diana I.] Coney Isl Hosp, Dept Internal Med, Brooklyn, NY 11235 USA	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Oxford	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	patel.s@ucl.ac.uk; grant.churchill@pharm.ox.ac.uk; ebrailou@temple.edu	Galione, Antony/E-5884-2011; Patel, Sandip/O-9591-2015	Galione, Antony/0000-0002-4132-7646; Patel, Sandip/0000-0001-7247-2013; Aley, Parvinder/0000-0002-0749-8329	National Institutes of Health [HL90804, HL51314, HL086699]; Biotechnology and Biological Sciences Research Council [BB/D012694/1, BB/G013721/1]; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804, R01HL051314, R01HL086699] Funding Source: NIH RePORTER; BBSRC [BB/D012694/1, BB/G013721/1, BB/G008523/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants HL90804 (to E. B.), HL51314 (to N. J. D.), and HL086699 (to M. M.). This work was also supported by the Biotechnology and Biological Sciences Research Council Grants BB/D012694/1 (to G. C. C.) and BB/G013721/1 (to S. P.).	Aley PK, 2010, J PHARMACOL EXP THER, V333, P726, DOI 10.1124/jpet.110.165837; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brailoiu E, 1999, BRIT J PHARMACOL, V126, P1133, DOI 10.1038/sj.bjp.0702421; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2008, NEUROSCIENCE, V151, P701, DOI 10.1016/j.neuroscience.2007.11.031; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Cordiglieri C, 2010, BRAIN, V133, P1930, DOI 10.1093/brain/awq135; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe18; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Leikert JF, 2001, FEBS LETT, V506, P131, DOI 10.1016/S0014-5793(01)02901-5; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF169, DOI 10.1152/ajprenal.00079.2009; Tran QK, 2000, CARDIOVASC RES, V48, P13, DOI 10.1016/S0008-6363(00)00172-3; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	38	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37133	37137		10.1074/jbc.C110.169763	http://dx.doi.org/10.1074/jbc.C110.169763			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876534	Green Published, hybrid			2022-12-27	WOS:000284424000006
J	Carra, S; Boncoraglio, A; Kanon, B; Brunsting, JF; Minoia, M; Rana, A; Vos, MJ; Seidel, K; Sibon, OCM; Kampinga, HH				Carra, Serena; Boncoraglio, Alessandra; Kanon, Bart; Brunsting, Jeanette F.; Minoia, Melania; Rana, Anil; Vos, Michel J.; Seidel, Kay; Sibon, Ody C. M.; Kampinga, Harm H.			Identification of the Drosophila Ortholog of HSPB8 IMPLICATION OF HSPB8 LOSS OF FUNCTION IN PROTEIN FOLDING DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; HEAT-SHOCK-PROTEIN; NEURODEGENERATIVE DISEASE; CHAPERONE ACTIVITY; MISSENSE MUTATION; OXIDATIVE STRESS; MOTOR NEUROPATHY; GENE-EXPRESSION; MELANOGASTER; AUTOPHAGY	Protein aggregation is a hallmark of many neuronal disorders, including the polyglutamine disorder spinocerebellar ataxia 3 and peripheral neuropathies associated with the K141E and K141N mutations in the small heat shock protein HSPB8. In cells, HSPB8 cooperates with BAG3 to stimulate autophagy in an eIF2 alpha-dependent manner and facilitates the clearance of aggregate-prone proteins (Carra, S., Seguin, S. J., Lambert, H., and Landry, J. (2008) J. Biol. Chem. 283, 1437-1444; Carra, S., Brunsting, J. F., Lambert, H., Landry, J., and Kampinga, H. H. (2009) J. Biol. Chem. 284, 5523-5532). Here, we first identified Drosophila melanogaster HSP67Bc (Dm-HSP67Bc) as the closest functional ortholog of human HSPB8 and demonstrated that, like human HSPB8, Dm-HSP67Bc induces autophagy via the eIF2 alpha pathway. In vitro, both Dm-HSP67Bc and human HSPB8 protected against mutated ataxin-3-mediated toxicity and decreased the aggregation of a mutated form of HSPB1 (P182L-HSPB1) associated with peripheral neuropathy. Upregulation of both Dm-HSP67Bc and human HSPB8 protected and down-regulation of endogenous Dm-HSP67Bc significantly worsened SCA3-mediated eye degeneration in flies. The K141E and K141N mutated forms of human HSPB8 that are associated with peripheral neuropathy were significantly less efficient than wild-type HSPB8 in decreasing the aggregation of both mutated ataxin 3 and P182L-HSPB1. Our current data further support the link between the HSPB8-BAG3 complex, autophagy, and folding diseases and demonstrate that impairment or loss of function of HSPB8 might accelerate the progression and/or severity of folding diseases.	[Carra, Serena; Boncoraglio, Alessandra; Kanon, Bart; Brunsting, Jeanette F.; Minoia, Melania; Rana, Anil; Vos, Michel J.; Sibon, Ody C. M.; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, NL-9713 AV Groningen, Netherlands; [Seidel, Kay] Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 RB Groningen, Netherlands	University of Groningen; University of Groningen	Carra, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat & Stress Cell Biol, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	s.carra@med.umcg.nl	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140; Sibon, Ody/0000-0002-6836-6063; Kampinga, Harm/0000-0002-8966-8466; Vos, Michel/0000-0001-9379-2219	National Ataxia Foundation; Marie Curie International Reintegration; Prinses Beatrix Foundation/Dutch Huntington Association [WAR09-23]; Netherlands Organisation for Scientific Research NWO [917-36-400]; NWO [911-06-001]; Senter (IOP Genomics) [IGE03018]; Prinses Beatrix Foundation [WAR05-0129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045011, R56AI079705, R01AI079705, T32AI060573, R01AI045011] Funding Source: NIH RePORTER	National Ataxia Foundation; Marie Curie International Reintegration(European Commission); Prinses Beatrix Foundation/Dutch Huntington Association; Netherlands Organisation for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Senter (IOP Genomics); Prinses Beatrix Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Ataxia Foundation Young Investigator Award, by the Marie Curie International Reintegration and the Prinses Beatrix Foundation/Dutch Huntington Association WAR09-23 (to S. C.), by a VIDI grant from the Netherlands Organisation for Scientific Research NWO (917-36-400), by NWO Middelgroot Grant 911-06-001 (to O. C. M. S.), by Senter (IOP Genomics Grant IGE03018), and by the Prinses Beatrix Foundation WAR05-0129 (to H. H. K.).	Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Coulson M, 2005, GENETICS, V171, P1799, DOI 10.1534/genetics.105.043265; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fortun J, 2006, NEUROBIOL DIS, V22, P153, DOI 10.1016/j.nbd.2005.10.010; Fortun J, 2003, J NEUROSCI, V23, P10672; Fortun J, 2007, NEUROBIOL DIS, V25, P252, DOI 10.1016/j.nbd.2006.09.018; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Irobi J, 2006, NEUROMOL MED, V8, P131, DOI 10.1385/NMM:8:1:131; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Marin R, 1996, CHROMOSOMA, V105, P142, DOI 10.1007/s004120050169; Michaud S, 1997, J CELL SCI, V110, P1989; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Morrow G, 2003, SEMIN CELL DEV BIOL, V14, P291, DOI 10.1016/j.semcdb.2003.09.023; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saifi GM, 2005, HUM MUTAT, V25, P372, DOI 10.1002/humu.20153; Sharma MC, 2005, NEUROL INDIA, V53, P273; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vos M. J., 2010, HUM MOL GEN IN PRESS; Warner LE, 1999, ANNU REV MED, V50, P263, DOI 10.1146/annurev.med.50.1.263; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	63	65	67	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37811	37822		10.1074/jbc.M110.127498	http://dx.doi.org/10.1074/jbc.M110.127498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858900	Green Published, hybrid			2022-12-27	WOS:000284424000072
J	Lee, GE; Kim, JH; Taylor, M; Muller, MT				Lee, Gun E.; Kim, Joo Hee; Taylor, Michael; Muller, Mark T.			DNA Methyltransferase 1-associated Protein (DMAP1) Is a Co-repressor That Stimulates DNA Methylation Globally and Locally at Sites of Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC REGULATION; X-CHROMOSOME; SRA DOMAIN; DE-NOVO; 5-AZA-2'-DEOXYCYTIDINE; DEMETHYLATION; CELLS; DNMT1; REPLICATION; INSTABILITY	Correction of double strand DNA breaks proceeds in an error-free pathway of homologous recombination (HR), which can result in gene silencing of half of the DNA molecules caused by action by DNA methyltransferase 1 (DNMT1) (Cuozzo, C., Porcellini, A., Angrisano, T., Morano, A., Lee, B., Di Pardo, A., Messina, S., Iuliano, R., Fusco, A., Santillo, M. R., Muller, M. T., Chiariotti, L., Gottesman, M. E., and Avvedimento, E. V. (2007) PLoS Genet. 3, e110). To explore the mechanism that leads to HR-induced silencing, a genetic screen was carried out based on the silencing of a GFP reporter to identify potential partners. DMAP1, a DNMT1 interacting protein, was identified as a mediator of this process. DMAP1 is a potent activator of DNMT1 methylation in vitro, suggesting that DMAP1 is a corepressor that supports the maintenance and de novo action of DNMT1. To examine critical roles for DMAP1 in vivo, lentiviral shRNA was used to conditionally reduce cellular DMAP1 levels. The shRNA transduced cells grew poorly and eventually ceased their growth. Analysis of the tumor suppressor gene p16 methylation status revealed a clear reduction in methylated CpGs in the shRNA cells, suggesting that reactivation of a tumor suppressor gene pathway caused the slow growth phenotype. Analysis of HR, using a fluorescence-based reporter, revealed that knocking down DMAP1 also caused hypomethylation of the DNA repair products following gene conversion. DMAP1 was selectively enriched in recombinant GFP chromatin based on chromatin immunoprecipitation analysis. The picture that emerges is that DMAP1 activates DNMT1 preferentially at sites of HR repair. Because DMAP1 depleted cells display enhanced HR, we conclude that it has additional roles in genomic stability.	[Lee, Gun E.; Kim, Joo Hee; Taylor, Michael; Muller, Mark T.] Univ Cent Florida, Dept Mol Biol & Microbiol, Coll Med, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida	Muller, MT (corresponding author), 12722 Res Pkwy, Orlando, FL 32826 USA.	mtmuller@mail.ucf.edu			National Institutes of Health [CA098214, CA127416]; NATIONAL CANCER INSTITUTE [R21CA127416, R01CA098214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098214 and CA127416 (to M. T. M.).	Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bender CM, 1998, CANCER RES, V58, P95; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Haruki M, 1997, J BIOL CHEM, V272, P22015, DOI 10.1074/jbc.272.35.22015; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee B, 2009, BIOCHEM J, V421, P449, DOI 10.1042/BJ20090142; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Luo W, 2010, CANCER RES, V70, P5953, DOI 10.1158/0008-5472.CAN-10-0617; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Missiaglia E, 2005, ONCOGENE, V24, P199, DOI 10.1038/sj.onc.1208018; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Negishi M, 2009, GENES CELLS, V14, P1347, DOI 10.1111/j.1365-2443.2009.01352.x; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Palii SS, 2007, CRIT REV EUKAR GENE, V17, P295; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Qian CM, 2008, J BIOL CHEM, V283, P34490, DOI 10.1074/jbc.C800169200; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Renodon-Corniere A, 2002, BIOCHEMISTRY-US, V41, P13395, DOI 10.1021/bi0263614; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970	43	51	53	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37630	37640		10.1074/jbc.M110.148536	http://dx.doi.org/10.1074/jbc.M110.148536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20864525	Green Published, hybrid			2022-12-27	WOS:000284424000055
J	Glosson, NL; Gonyo, P; May, NA; Schneider, CL; Ristow, LC; Wang, QH; Hudson, AW				Glosson, Nicole L.; Gonyo, Patrick; May, Nathan A.; Schneider, Christine L.; Ristow, Laura C.; Wang, Qiuhong; Hudson, Amy W.			Insight into the Mechanism of Human Herpesvirus 7 U21-mediated Diversion of Class I MHC Molecules to Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; LUMINAL ER PROTEINS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; HEAVY-CHAINS; ANTIGEN PRESENTATION; MEMBRANE-PROTEIN; N-GLYCOSYLATION; DOWN-REGULATION; CELL-SURFACE	The U21 open reading frame from human herpesvirus-7 encodes a membrane protein that associates with and redirects class I MHC molecules to the lysosomal compartment. The mechanism by which U21 accomplishes this trafficking excursion is unknown. Here we have examined the contribution of localization, glycosylation, domain structure, and the absence of substrate class I MHC molecules on the ability of U21 to traffic to lysosomes. Our results suggest the existence of a cellular protein necessary for U21-mediated rerouting of class I MHC molecules.	[Glosson, Nicole L.; Gonyo, Patrick; May, Nathan A.; Schneider, Christine L.; Ristow, Laura C.; Wang, Qiuhong; Hudson, Amy W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Hudson, AW (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ahudson@mcw.edu		Ristow, Laura/0000-0002-3569-1492	National Institutes of Health [1R01AI069099]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI069099 (to A. W. H.).	Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2009, TRAFFIC; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; DEWHURST S, 1997, EXPERT REV MOL MED, P1; EICHHOLTZ T, 1992, J BIOL CHEM, V267, P22490; Glosson NL, 2007, VIROLOGY, V365, P125, DOI 10.1016/j.virol.2007.03.048; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hudson AW, 2003, TRAFFIC, V4, P824, DOI 10.1046/j.1398-9219.2003.0137.x; Hudson AW, 2001, J VIROL, V75, P12347, DOI 10.1128/JVI.75.24.12347-12358.2001; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; LITTLE AM, 1995, J IMMUNOL, V154, P5205; May NA, 2010, J VIROL, V84, P3738, DOI 10.1128/JVI.01782-09; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Reusch U, 2002, TRAFFIC, V3, P752, DOI 10.1034/j.1600-0854.2002.31007.x; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Ward KN, 2005, CURR OPIN INFECT DIS, V18, P247, DOI 10.1097/01.qco.0000168386.16519.93; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; ZERR DM, 2006, M HERPES, V13, P20	36	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37016	37029		10.1074/jbc.M110.125849	http://dx.doi.org/10.1074/jbc.M110.125849			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20833720	Green Published, hybrid			2022-12-27	WOS:000284146100017
J	Ormazabal, V; Zuniga, FA; Escobar, E; Aylwin, C; Salas-Burgos, A; Godoy, A; Reyes, AM; Vera, JC; Rivas, CI				Ormazabal, Valeska; Zuniga, Felipe A.; Escobar, Elizabeth; Aylwin, Carlos; Salas-Burgos, Alexis; Godoy, Alejandro; Reyes, Alejandro M.; Carlos Vera, Juan; Rivas, Coralia I.			Histidine Residues in the Na+-coupled Ascorbic Acid Transporter-2 (SVCT2) Are Central Regulators of SVCT2 Function, Modulating pH Sensitivity, Transporter Kinetics, Na+ Cooperativity, Conformational Stability, and Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-C TRANSPORTERS; URINARY ACIDIFICATION; CELLULAR MECHANISMS; EPITHELIAL-CELLS; ENERGY-METABOLISM; INTRACELLULAR PH; SKELETAL-MUSCLE; PROTEIN; PHOSPHORYLATION; DIFFERENTIATION	Na+-coupled ascorbic acid transporter-2 (SVCT2) activity is impaired at acid pH, but little is known about the molecular determinants that define the transporter pH sensitivity. SVCT2 contains six histidine residues in its primary sequence, three of which are exofacial in the transporter secondary structure model. We used site-directed mutagenesis and treatment with diethylpyrocarbonate to identify histidine residues responsible for SVCT2 pH sensitivity. We conclude that five histidine residues, His(109), His(203), His(206), His(269), and His(413), are central regulators of SVCT2 function, participating to different degrees in modulating pH sensitivity, transporter kinetics, Na+ cooperativity, conformational stability, and subcellular localization. Our results are compatible with a model in which (i) a single exofacial histidine residue, His413, localized in the exofacial loop IV that connects transmembrane helices VII-VIII defines the pH sensitivity of SVCT2 through a mechanism involving a marked attenuation of the activation by Na+ and loss of Na+ cooperativity, which leads to a decreased V-max without altering the transport K-m; (ii) exofacial histidine residues His(203), His(206), and His(413) may be involved in maintaining a functional interaction between exofacial loops II and IV and influence the general folding of the transporter; (iii) histidines 203, 206, 269, and 413 affect the transporter kinetics by modulating the apparent transport K-m; and (iv) histidine 109, localized at the center of transmembrane helix I, might be fundamental for the interaction of SVCT2 with the transported substrate ascorbic acid. Thus, histidine residues are central regulators of SVCT2 function.	[Ormazabal, Valeska; Zuniga, Felipe A.; Escobar, Elizabeth; Aylwin, Carlos; Salas-Burgos, Alexis; Godoy, Alejandro; Carlos Vera, Juan; Rivas, Coralia I.] Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Concepcion, Chile; [Reyes, Alejandro M.] Univ Austral Chile, Fac Ciencias, Inst Bioquim, Valdivia, Chile	Universidad de Concepcion; Universidad Austral de Chile	Rivas, CI (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Casilla 160C, Concepcion, Chile.	corivas@udec.cl	Salas Burgos, Alexis/GWC-2563-2022; Godoy, Alejandro/GPS-4942-2022; Zuniga, Felipe/Q-8035-2019; Zuniga, Felipe A/L-7885-2013	Zuniga, Felipe A./0000-0003-0286-565X; Salas-Burgos, Alexis/0000-0002-6577-9970; Escobar Sagredo, Maria Elizabeth/0000-0002-9706-4312	Anillo de Investigacion en Ciencia y Tecnologia, Programa Bicentenario de Ciencia y Tecnologia, Chile [PBCT-ACT28]; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) [1090501, 1060198, 11080144]; Comision Nacional de Investigacion Cientificay Tecnologica, Chile; Chilean Education Ministry	Anillo de Investigacion en Ciencia y Tecnologia, Programa Bicentenario de Ciencia y Tecnologia, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientificay Tecnologica, Chile; Chilean Education Ministry	This work was supported in part by Anillo de Investigacion en Ciencia y Tecnologia, Programa Bicentenario de Ciencia y Tecnologia, Chile, Grant PBCT-ACT28; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) Grants 1090501, 1060198, and 11080144; doctoral fellowships from the Comision Nacional de Investigacion Cientificay Tecnologica, Chile; and equipment grants by the Mecesup program from the Chilean Education Ministry.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Boyer JC, 2005, BIOCHEM BIOPH RES CO, V334, P150, DOI 10.1016/j.bbrc.2005.06.069; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Daruwala R, 1999, FEBS LETT, V460, P480, DOI 10.1016/S0014-5793(99)01393-9; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Godoy A, 2007, J BIOL CHEM, V282, P615, DOI 10.1074/jbc.M608300200; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; HONEGGER CG, 1988, INT J CANCER, V41, P690, DOI 10.1002/ijc.2910410509; Jiang M, 1999, AM J PHYSIOL-HEART C, V277, pH1283, DOI 10.1152/ajpheart.1999.277.4.H1283; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Lee AH, 1998, CANCER RES, V58, P1901; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; Liang WJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1696, DOI 10.1152/ajpcell.00461.2001; Lichty BD, 2006, J GEN VIROL, V87, P3379, DOI 10.1099/vir.0.81762-0; Mackenzie B, 2008, AM J PHYSIOL-CELL PH, V294, pC451, DOI 10.1152/ajpcell.00439.2007; Maulen NP, 2003, J BIOL CHEM, V278, P9035, DOI 10.1074/jbc.M205119200; MCKINNEY TD, 1977, J CLIN INVEST, V60, P766, DOI 10.1172/JCI108830; Miles E W, 1977, Methods Enzymol, V47, P431; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Parente P, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-34; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Rajan DP, 1999, BIOCHEM BIOPH RES CO, V262, P762, DOI 10.1006/bbrc.1999.1272; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Rivas CI, 2008, J PHYSIOL BIOCHEM, V64, P357, DOI 10.1007/BF03174092; ROSEN S, 1974, J MEMBRANE BIOL, V15, P193, DOI 10.1007/BF01870087; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; SHOSHANBARMATZ V, 1994, BIOCHEM J, V299, P177, DOI 10.1042/bj2990177; Spielholz C, 1997, CANCER RES, V57, P2529; STEINMETZ PR, 1974, PHYSIOL REV, V54, P890, DOI 10.1152/physrev.1974.54.4.890; Subramanian VS, 2008, BIOCHEM BIOPH RES CO, V374, P123, DOI 10.1016/j.bbrc.2008.06.120; Subramanian VS, 2004, J BIOL CHEM, V279, P27719, DOI 10.1074/jbc.M400876200; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Varma S, 2008, BIOCHEMISTRY-US, V47, P2952, DOI 10.1021/bi701666q; Varma S, 2009, BIOCHEMISTRY-US, V48, P2969, DOI 10.1021/bi802294v; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Wang HP, 1999, BBA-BIOMEMBRANES, V1461, P1, DOI 10.1016/S0005-2736(99)00182-0; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; WOLF B, 1970, EUR J BIOCHEM, V13, P519, DOI 10.1111/j.1432-1033.1970.tb00955.x; Wright ME, 2005, CANCER CAUSE CONTROL, V16, P1117, DOI 10.1007/s10552-005-0348-9; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Wu XM, 2003, ARCH BIOCHEM BIOPHYS, V420, P114, DOI 10.1016/j.abb.2003.09.013; Ziane R, 2010, BIOCHEMISTRY-US, V49, P166, DOI 10.1021/bi901086v	54	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36471	36485		10.1074/jbc.M110.155630	http://dx.doi.org/10.1074/jbc.M110.155630			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843809	hybrid, Green Published			2022-12-27	WOS:000284146100044
J	Dufour, A; Zucker, S; Sampson, NS; Kuscu, C; Cao, JA				Dufour, Antoine; Zucker, Stanley; Sampson, Nicole S.; Kuscu, Cem; Cao, Jian			Role of Matrix Metalloproteinase-9 Dimers in Cell Migration DESIGN OF INHIBITORY PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; TISSUE INHIBITOR; HEMOPEXIN DOMAIN; COMPLEX-FORMATION; IV COLLAGENASE; TGF-BETA; SURFACE; CANCER; ACTIVATION; GROWTH	Non-proteolytic activities of matrix metalloproteinases (MMPs) have recently been shown to impact cell migration, but the precise mechanism remains to be understood. We previously demonstrated that the hemopexin (PEX) domain of MMP-9 is a prerequisite for enhanced cell migration. Using a biochemical approach, we now report that dimerization of MMP-9 through the PEX domain appears necessary for MMP-9-enhanced cell migration. Following a series of substitution mutations within the MMP-9 PEX domain, blade IV was shown to be critical for homodimerization, whereas blade I was required for heterodimerization with CD44. Blade I and IV mutants showed diminished enhancement of cell migration compared with wild type MMP-9-transfected cells. Peptides mimicking motifs in the outermost strands of the first and fourth blades of the MMP-9 PEX domain were designed. These peptides efficiently blockedMMP-9 dimer formation and inhibited motility of COS-1 cells overexpressing MMP-9, HT-1080, and MDA-MB-435 cells. Using a shRNA approach, CD44 was found to be a critical molecule in MMP-9-mediated cell migration. Furthermore, an axis involving a MMP-9-CD44-EGFR signaling pathway in cell migration was identified using antibody array and specific receptor tyrosine kinase inhibitors. In conclusion, we dissected the mechanism of pro-MMP-9-enhanced cell migration and developed structure-based inhibitory peptides targeting MMP-9-mediated cell migration.	[Dufour, Antoine; Kuscu, Cem; Cao, Jian] SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA; [Zucker, Stanley] SUNY Stony Brook, Div Hematol Oncol, Stony Brook, NY 11794 USA; [Dufour, Antoine; Sampson, Nicole S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cao, JA (corresponding author), SUNY Stony Brook, Canc Prevent Div, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu	Sampson, Nicole/C-4598-2014; Dufour, Antoine/AAB-7886-2019	Sampson, Nicole/0000-0002-2835-7760; KUSCU, CEM/0000-0001-7154-6762	National Institutes of Health [5RO1CA11355301A1]; Walk-for-Beauty Foundation; NYSTAR Faculty Development Program [C040076]; Veterans Affairs Merit Review; Carol Baldwin Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA113553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walk-for-Beauty Foundation; NYSTAR Faculty Development Program; Veterans Affairs Merit Review(US Department of Veterans Affairs); Carol Baldwin Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1CA11355301A1 and a Walk-for-Beauty Foundation grant (to J.C.), NYSTAR Faculty Development Program Grant C040076 (to N. S. S.), a Veterans Affairs Merit Review grant, and the Carol Baldwin Breast Cancer Foundation grant (to S. Z.).	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Burg-Roderfeld M, 2007, INT J ONCOL, V30, P985; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cao JA, 1996, J BIOL CHEM, V271, P30174, DOI 10.1074/jbc.271.47.30174; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Davis BG, 2004, SCIENCE, V303, P480, DOI 10.1126/science.1093449; Dufour A, 2008, J CELL PHYSIOL, V217, P643, DOI 10.1002/jcp.21535; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Imai K, 2008, NAT PROTOC, V3, P1111, DOI 10.1038/nprot.2008.74; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Olson MW, 1998, J BIOL CHEM, V273, P10672, DOI 10.1074/jbc.273.17.10672; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Owen CA, 2003, AM J RESP CELL MOL, V29, P283, DOI 10.1165/rcmb.2003-0034OC; Partridge JJ, 2007, J BIOL CHEM, V282, P35964, DOI 10.1074/jbc.M705993200; Pavlaki M, 2003, CANCER METAST REV, V22, P177, DOI 10.1023/A:1023047431869; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Roderfeld M, 2007, BIOL CHEM, V388, P1227, DOI 10.1515/BC.2007.123; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Stefanidakis M, 2009, BLOOD, V114, P3008, DOI 10.1182/blood-2008-04-148643; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Toth M, 1997, CANCER RES, V57, P3159; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Yao JHS, 2004, CIRC RES, V95, P364, DOI 10.1161/01.RES.0000138581.04174.2f; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097; ZUCKER S, 1993, CANCER RES, V53, P140; ZUCKER S, 1987, CANCER RES, V47, P1608	47	103	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35944	35956		10.1074/jbc.M109.091769	http://dx.doi.org/10.1074/jbc.M109.091769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837483	Green Published, hybrid			2022-12-27	WOS:000283845300071
J	Hammond, DJ; Singh, SK; Thompson, JA; Beeler, BW; Rusinol, AE; Pangburn, MK; Potempa, LA; Agrawal, A				Hammond, David J.; Singh, Sanjay K.; Thompson, James A.; Beeler, Bradley W.; Rusinol, Antonio E.; Pangburn, Michael K.; Potempa, Lawrence A.; Agrawal, Alok			Identification of Acidic pH-dependent Ligands of Pentameric C-reactive Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; STREPTOCOCCUS-PNEUMONIAE INFECTION; COMPLEMENT FACTOR-H; MONOCLONAL-ANTIBODIES; ALTERNATIVE PATHWAY; ALZHEIMERS-DISEASE; BINDING; CRP; FIBRONECTIN; CALCIUM	C-reactive protein (CRP) is a phylogenetically conserved protein; in humans, it is present in the plasma and at sites of inflammation. At physiological pH, native pentameric CRP exhibits calcium-dependent binding specificity for phosphocholine. In this study, we determined the binding specificities of CRP at acidic pH, a characteristic of inflammatory sites. We investigated the binding of fluid-phase CRP to six immobilized proteins: complement factor H, oxidized low-density lipoprotein, complement C3b, IgG, amyloid beta, and BSA immobilized on microtiter plates. At pH 7.0, CRP did not bind to any of these proteins, but, at pH ranging from 5.2 to 4.6, CRP bound to all six proteins. Acidic pH did not monomerize CRP but modified the pentameric structure, as determined by gel filtration, 1-anili-nonaphthalene-8-sulfonic acid-binding fluorescence, and phosphocholine-binding assays. Some modifications in CRP were reversible at pH 7.0, for example, the phosphocholine-binding activity of CRP, which was reduced at acidic pH, was restored after pH neutralization. For efficient binding of acidic pH-treated CRP to immobilized proteins, it was necessary that the immobilized proteins, except factor H, were also exposed to acidic pH. Because immobilization of proteins on microtiter plates and exposure of immobilized proteins to acidic pH alter the conformation of immobilized proteins, our findings suggest that conformationally altered proteins form a CRP-ligand in acidic environment, regardless of the identity of the protein. This ligand binding specificity of CRP in its acidic pH-induced pentameric state has implications for toxic conditions involving protein misfolding in acidic environments and favors the conservation of CRP throughout evolution.	[Agrawal, Alok] E Tennessee State Univ, Dept Pharmacol, Quillen Coll Med, Johnson City, TN 37614 USA; [Rusinol, Antonio E.] E Tennessee State Univ, Dept Biochem & Mol Biol, Quillen Coll Med, Johnson City, TN 37614 USA; [Pangburn, Michael K.] Univ Texas Hlth Sci Ctr, Ctr Biomed Res, Dept Biochem, Tyler, TX 75708 USA; [Potempa, Lawrence A.] Acphazin Inc, Deerfield, IL 60015 USA	East Tennessee State University; East Tennessee State University; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Agrawal, A (corresponding author), E Tennessee State Univ, Dept Pharmacol, Quillen Coll Med, POB 70577, Johnson City, TN 37614 USA.	agrawal@etsu.edu			National Institutes of Health [R01HL071233, R01DK35081]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL071233 (to A. A.) and R01DK35081 (to M. K. P.).	Agrawal A, 2002, J IMMUNOL, V169, P3217, DOI 10.4049/jimmunol.169.6.3217; AGRAWAL A, 1994, J IMMUNOL, V152, P5404; Agrawal Alok, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P231, DOI 10.2174/187153008786848321; Andersson SE, 1999, J RHEUMATOL, V26, P2018; Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blizniukov OP, 2003, MOL BIOL+, V37, P912, DOI 10.1023/B:MBIL.0000008361.22136.c8; Bliznyukov OP, 2003, BIOFIZIKA+, V48, P844; Boncler M, 2009, ACTA BIOCHIM POL, V56, P17; Brown AJ, 1997, J LIPID RES, V38, P1730; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; DeFilippis V, 1996, BIOCHEMISTRY-US, V35, P11503, DOI 10.1021/bi9604587; Duong TH, 1997, BRAIN RES, V749, P152, DOI 10.1016/S0006-8993(96)01359-5; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; IWAMOTO N, 1994, NEUROSCI LETT, V177, P23, DOI 10.1016/0304-3940(94)90035-3; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; KILPATRICK JM, 1982, MOL IMMUNOL, V19, P1159, DOI 10.1016/0161-5890(82)90326-1; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Krijnen PAJ, 2005, J CLIN PATHOL, V58, P382, DOI 10.1136/jcp.2004.022988; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Kushner I, 2010, ARTHRIT CARE RES, V62, P442, DOI 10.1002/acr.20052; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; McGeer EG, 2001, NEUROBIOL AGING, V22, P843, DOI 10.1016/S0197-4580(01)00288-3; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; MIYAZAWA K, 1990, J IMMUNOL, V145, P650; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; MOLD C, 1984, J IMMUNOL, V133, P882; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; PANGBURN MK, 1983, BIOCHEMISTRY-US, V22, P178, DOI 10.1021/bi00270a026; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; REYNOLDS GD, 1987, ARCH PATHOL LAB MED, V111, P265; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Rusinol AE, 2000, J BIOL CHEM, V275, P7296, DOI 10.1074/jbc.275.10.7296; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; SCHWALBE RA, 1992, BIOCHEMISTRY-US, V31, P4907, DOI 10.1021/bi00135a023; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Singh SK, 2008, J IMMUNOL, V180, P4316, DOI 10.4049/jimmunol.180.6.4316; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Singh SK, 2009, CLIN CHIM ACTA, V409, P143, DOI 10.1016/j.cca.2009.08.013; Singh SK, 2009, CLIN CHIM ACTA, V406, P151, DOI 10.1016/j.cca.2009.06.018; Singh U, 2008, J LIPID RES, V49, P1015, DOI 10.1194/jlr.M700535-JLR200; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2008, VACCINE, V26, pI9, DOI 10.1016/j.vaccine.2008.11.021; Sneck M, 2005, J BIOL CHEM, V280, P37449, DOI 10.1074/jbc.M508565200; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; STEINBUCH M, 1969, ARCH BIOCHEM BIOPHYS, V134, P279, DOI 10.1016/0003-9861(69)90285-9; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Suresh MV, 2006, J IMMUNOL, V176, P4369, DOI 10.4049/jimmunol.176.7.4369; Suresh MV, 2004, J BIOL CHEM, V279, P52552, DOI 10.1074/jbc.M409054200; SZALAI AJ, 1995, J IMMUNOL, V155, P2557; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Torzewski M, 2008, THROMB HAEMOSTASIS, V99, P196, DOI 10.1160/TH07-10-0595; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; TSENG J, 1988, MOL IMMUNOL, V25, P679, DOI 10.1016/0161-5890(88)90103-4; TSENG J, 1989, EXP CELL RES, V180, P303, DOI 10.1016/0014-4827(89)90059-1; van Tits L, 2005, ARTERIOSCL THROM VAS, V25, P717, DOI 10.1161/01.ATV.0000157979.51673.2c; Verma S, 2004, CIRCULATION, V109, P1914, DOI 10.1161/01.CIR.0000127085.32999.64; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wang HW, 2002, INT J MOL MED, V9, P665; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; YING SC, 1992, MOL IMMUNOL, V29, P677, DOI 10.1016/0161-5890(92)90205-C; YOTHER J, 1982, J IMMUNOL, V128, P2374	86	56	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36235	36244		10.1074/jbc.M110.142026	http://dx.doi.org/10.1074/jbc.M110.142026			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843812	Green Published, hybrid			2022-12-27	WOS:000283845300099
J	Ko, S; Kang, GB; Song, SM; Lee, JG; Shin, DY; Yun, JH; Sheng, Y; Cheong, C; Jeon, YH; Jung, YK; Arrowsmith, CH; Avvakumov, GV; Dhe-Paganon, S; Yoo, YJ; Eom, SH; Lee, W				Ko, Sunggeon; Kang, Gil Bu; Song, Sung Min; Lee, Jung-Gyu; Shin, Dong Yeon; Yun, Ji-Hye; Sheng, Yi; Cheong, Chaejoon; Jeon, Young Ho; Jung, Yong-Keun; Arrowsmith, Cheryl H.; Avvakumov, George V.; Dhe-Paganon, Sirano; Yoo, Yung Joon; Eom, Soo Hyun; Lee, Weontae			Structural Basis of E2-25K/UBB+1 Interaction Leading to Proteasome Inhibition and Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME E2-25K; AMYLOID PRECURSOR PROTEIN; UBIQUITIN CHAIN SYNTHESIS; UBA DOMAIN; MUTANT UBIQUITIN; NEURODEGENERATIVE DISEASES; MACROMOLECULAR STRUCTURES; MOLECULAR REPLACEMENT; ALZHEIMERS-DISEASE; BETA NEUROTOXICITY	E2-25K/Hip2 is an unusual ubiquitin-conjugating enzyme that interacts with the frameshift mutant of ubiquitin B(UBB+1) and has been identified as a crucial factor regulating amyloid-beta neurotoxicity. To study the structural basis of the neurotoxicity mediated by the E2-25K-UBB+1 interaction, we determined the three-dimensional structures of UBB+1, E2-25K and the E2-25K/ubiquitin, and E2-25K/UBB+1 complex. The structures revealed that ubiquitin or UBB+1 is bound to E2-25K via the enzyme MGF motif and residues in alpha 9 of the enzyme. Poly-ubiquitylation assays together with analyses of various E2-25K mutants showed that disrupting UBB+1 binding markedly diminishes synthesis of neurotoxic UBB+1-anchored polyubiquitin. These results suggest that the interaction between E2-25K and UBB+1 is critical for the synthesis and accumulation of UBB+1-anchored polyubiquitin, which results in proteasomal inhibition and neuronal cell death.	[Kang, Gil Bu; Lee, Jung-Gyu; Shin, Dong Yeon; Yoo, Yung Joon; Eom, Soo Hyun] Gwangju Inst Sci & Technol, Steitz Ctr Struct Biol, Sch Life Sci, Kwangju 500712, South Korea; Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Song, Sung Min; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, Bio Max Inst, Seoul 151742, South Korea; [Sheng, Yi; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Sheng, Yi; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Cheong, Chaejoon; Jeon, Young Ho] Korea Basic Sci Inst, Magnet Resonance Team, Ochang 363883, South Korea; [Arrowsmith, Cheryl H.; Avvakumov, George V.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.; Avvakumov, George V.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	Gwangju Institute of Science & Technology (GIST); Yonsei University; Seoul National University (SNU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Korea Basic Science Institute (KBSI); University of Toronto; Structural Genomics Consortium; University of Toronto	Eom, SH (corresponding author), Gwangju Inst Sci & Technol, Steitz Ctr Struct Biol, Sch Life Sci, Kwangju 500712, South Korea.	eom@gist.ac.kr; wlee@spin.yonsei.ac.kr	Cheong, Chaejoon/GWC-3135-2022; Yoo, Yung Joon/AAH-5002-2020; Jeon, Young Ho/F-4483-2011; LEE, WEON TAE/AAQ-9088-2021	Arrowsmith, Cheryl/0000-0002-4971-3250; Lee, Weontae/0000-0003-2347-1262; Jung, Yong-Keun/0000-0002-9686-3120	Ministry of Education, Science, and Technology [R33-2009-000-10123-0]; National Research Foundation of Korea Ministry of Education, Science and Technology [R01-2007-000-10592-0, R11-2007-007-03001-0]; Brain Korea project; Ministry of Science and Technology of the Republic of Korea; Structural Genomics Consortium, a registered charity [1097737]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Brain Korea project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Science and Technology of the Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Structural Genomics Consortium, a registered charity(University of Toronto)	This work was supported by a World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant R33-2009-000-10123-0) and by National Research Foundation of Korea Ministry of Education, Science and Technology Grants R01-2007-000-10592-0 and R11-2007-007-03001-0 (to S. H. E.). This work was supported in part by a Brain Korea project and by the Basic Science Research Program (to C. C.) from the Ministry of Science and Technology of the Republic of Korea. This work was also supported in part by the Structural Genomics Consortium, a registered charity (number 1097737).	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mastrandrea LD, 1998, BIOCHEMISTRY-US, V37, P9784, DOI 10.1021/bi9800911; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Leeuwen FW, 2006, J ALZHEIMERS DIS, V9, P319; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Wilson RC, 2009, ACTA CRYSTALLOGR F, V65, P440, DOI 10.1107/S1744309109011117; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	49	39	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36070	36080		10.1074/jbc.M110.145219	http://dx.doi.org/10.1074/jbc.M110.145219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826778	hybrid, Green Published			2022-12-27	WOS:000283845300083
J	Morley, S; Thakur, V; Danielpour, D; Parker, R; Arai, H; Atkinson, J; Barnholtz-Sloan, J; Klein, E; Manor, D				Morley, Samantha; Thakur, Varsha; Danielpour, David; Parker, Robert; Arai, Hiroyuki; Atkinson, Jeffrey; Barnholtz-Sloan, Jill; Klein, Eric; Manor, Danny			Tocopherol Transfer Protein Sensitizes Prostate Cancer Cells to Vitamin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOCOPHEROL; OXIDATIVE STRESS; E-DEFICIENCY; CARCINOMA-CELLS; E TRANSPORT; IN-VIVO; MODEL; MICE; ANTIOXIDANTS; ATAXIA	Prostate cancer is a major cause of mortality in men in developed countries. It has been reported that the naturally occurring antioxidant alpha-tocopherol (vitamin E) attenuates prostate cancer cell proliferation in cultured cells and mouse models. We hypothesized that overexpression of the tocopherol transfer protein (TTP), a vitamin E-binding protein that regulates tocopherol status, will sensitize prostate cancer cells to the anti-proliferative actions of the vitamin. To test this notion, we manipulated the expression levels of TTP in cultured prostate cells (LNCaP, PC3, DU145, and RWPE-1) using overexpression and knockdown approaches. Treatment of cells with tocopherol caused a time-and dose-dependent inhibition of cell proliferation. Overexpression of TTP dramatically sensitized the cells to the apoptotic effects of alpha-tocopherol, whereas reduction ("knockdown") of TTP expression resulted in resistance to the vitamin. TTP levels also augmented the inhibitory effects of vitamin E on proliferation in semi-solid medium. The sensitizing effects of TTP were paralleled by changes in the intracellular accumulation of a fluorescent analog of vitamin E and by a reduction in intracellular levels of reactive oxygen species and were not observed when a naturally occurring, ligand binding-defective mutant of TTP was used. We conclude that TTP sensitizes prostate cancer cells to the anti-proliferative effects of vitamin E and that this activity stems from the ability of protein to increase the intracellular accumulation of the antioxidant. These observations support the notion that individual changes in the expression level or activity of TTP may determine the responsiveness of prostate cancer patients to intervention strategies that utilize vitamin E.	[Manor, Danny] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Danielpour, David; Manor, Danny] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Danielpour, David; Barnholtz-Sloan, Jill; Klein, Eric; Manor, Danny] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Parker, Robert] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Arai, Hiroyuki] Univ Tokyo, Dept Hlth Chem, Tokyo 1130033, Japan; Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada; [Klein, Eric] Cleveland Clin Fdn, Glickman Urol Inst, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cornell University; University of Tokyo; Brock University; Cleveland Clinic Foundation	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.	dxm178@case.edu	Barnholtz-Sloan, Jill/A-4817-2011	Barnholtz-Sloan, Jill/0000-0001-6190-9304; Atkinson, Jeffrey/0000-0003-3710-4893	National Institutes of Health [DK067494, P30-CA4370]; Case Comprehensive Cancer Center [CA59366]; American Institute for Cancer [09A107]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Comprehensive Cancer Center; American Institute for Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK067494 (to D. M.) and Award P30-CA4370 (to Cytometry Core of the Case Comprehensive Cancer Center).; Recipient of National Institutes of Health Postdoctoral Fellowship CA59366 from the Case Comprehensive Cancer Center and of American Institute for Cancer Research Award 09A107.	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Blatt DH, 2001, NUTRITION, V17, P799, DOI 10.1016/S0899-9007(01)00637-2; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; deRijk MC, 1997, ARCH NEUROL-CHICAGO, V54, P762, DOI 10.1001/archneur.1997.00550180070015; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Factor VM, 2000, P NATL ACAD SCI USA, V97, P2196, DOI 10.1073/pnas.040428797; FIELDS RD, 1993, AM BIOTECHNOL LAB, V11, P48; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gabsi S, 2001, EUR J NEUROL, V8, P477, DOI 10.1046/j.1468-1331.2001.00273.x; Goodman GE, 2003, CANCER EPIDEM BIOMAR, V12, P518; GUARNIERI C, 1980, ITAL J BIOCHEM, V29, P176; Gunawardena K, 2000, PROSTATE, V44, P287, DOI 10.1002/1097-0045(20000901)44:4&lt;287::AID-PROS5&gt;3.0.CO;2-Z; Gunawardena K, 2004, PROSTATE, V59, P319, DOI 10.1002/pros.20018; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kelly FJ, 2004, ANN NY ACAD SCI, V1031, P22, DOI 10.1196/annals.1331.003; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Leonard SW, 2002, AM J CLIN NUTR, V75, P555, DOI 10.1093/ajcn/75.3.555; Li X, 2003, MITOCHONDRION, V3, P29, DOI 10.1016/S1567-7249(03)00058-8; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Ma Q, 2009, P NATL ACAD SCI USA, V106, P8683, DOI 10.1073/pnas.0812688106; Malins DC, 2001, CANCER RES, V61, P6025; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; Morley S, 2008, J BIOL CHEM, V283, P17797, DOI 10.1074/jbc.M800121200; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; Ni J, 2007, PROSTATE, V67, P463, DOI 10.1002/pros.20517; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Pathak SK, 2005, EUR J CANCER, V41, P61, DOI 10.1016/j.ejca.2004.09.028; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; PRINCEN HMG, 1995, ARTERIOSCL THROM VAS, V15, P325, DOI 10.1161/01.ATV.15.3.325; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; Ripple MO, 1999, ANTIOXID REDOX SIGN, V1, P71, DOI 10.1089/ars.1999.1.1-71; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Ripple MO, 1999, JNCI-J NATL CANCER I, V91, P1227, DOI 10.1093/jnci/91.14.1227; RUPAR CA, 1992, BIOCHEM CELL BIOL, V70, P486, DOI 10.1139/o92-075; Sano M, 1996, ALZ DIS ASSOC DIS, V10, P132, DOI 10.1097/00002093-199601030-00004; Shimohara T, 1998, ANN NEUROL, V43, P273, DOI 10.1002/ana.410430222; Sigounas G, 1997, NUTR CANCER, V28, P30, DOI 10.1080/01635589709514549; Siler U, 2004, FASEB J, V18, P1019, DOI 10.1096/fj.03-1116fje; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Sung SY, 2006, CANCER RES, V66, P9519, DOI 10.1158/0008-5472.CAN-05-4375; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; Thompson TA, 2003, MOL CANCER THER, V2, P797; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Valastyan S, 2008, BIOCHEMISTRY-US, V47, P744, DOI 10.1021/bi701432q; Venkateswaran V, 2004, CANCER RES, V64, P5891, DOI 10.1158/0008-5472.CAN-04-0690; Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045; Wright ME, 2009, CANCER RES, V69, P1429, DOI 10.1158/0008-5472.CAN-08-2343; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Zhang DX, 1997, CANCER RES, V57, P2410	69	19	19	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35578	35589		10.1074/jbc.M110.169664	http://dx.doi.org/10.1074/jbc.M110.169664			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826775	Green Published, hybrid			2022-12-27	WOS:000283845300036
J	Suresh, B; Ramakrishna, S; Kim, YS; Kim, SM; Kim, MS; Baek, KH				Suresh, Bharathi; Ramakrishna, Suresh; Kim, Yong-Soo; Kim, Sun-Myoung; Kim, Myung-Sun; Baek, Kwang-Hyun			Stability and Function of Mammalian Lethal Giant Larvae-1 Oncoprotein Are Regulated by the Scaffolding Protein RanBPM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEINS; BINDING-PROTEIN; CELL POLARITY; CYTOSKELETAL PROTEIN; INTERACTING PROTEIN; NUCLEAR-PROTEIN; HUMAN HOMOLOG; GENE L(2)GL; DROSOPHILA; EXPRESSION	The evolutionarily conserved lethal giant larvae (Lgl) tumor suppressor gene has an essential role in establishing apical-basal cell polarity, cell proliferation, differentiation, and tissue organization. However, the precise molecular mechanism by which the Lgl carries out its function remains obscure. In the current study, we have identified Ran-binding protein M (RanBPM) as a novel binding partner of Mgl-1, a mammalian homolog of Drosophila tumor suppressor protein lethal (2) giant larvae (L(2)gl) by yeast two-hybrid screening. RanBPM seems to act as a scaffolding protein with a modulatory function with respect to Mgl-1. The Mgl-1 and RanBPM association was confirmed by co-immunoprecipitation and GST pull-down experiments. Additionally, expression of RanBPM resulted in inhibition of Mgl-1 degradation, and thereby extended the half-life of Mgl-1. Furthermore, the ability of Mgl-1 activity in cell migration and colony formation assay was enhanced by RanBPM. Taken together, our findings reveal that RanBPM plays a novel role in regulating Mgl-1 stability and contributes to its biological function as a tumor suppressor.	[Baek, Kwang-Hyun] CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Seoul 135081, South Korea	Pochon Cha University	Baek, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, 606-16 Yeoksam 1 Dong, Seoul 135081, South Korea.	baek@cha.ac.kr	Ramakrishna, Suresh/AAX-4096-2021	Baek, Kwang-Hyun/0000-0001-7662-7190	Ministry for Health, Welfare and Family affairs, Republic of Korea [00001602]	Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (00001602).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Baek KH, 2004, INT J ONCOL, V24, P1257; Baek KH, 1999, MUTAT RES-REV MUTAT, V436, P131, DOI 10.1016/S1383-5742(98)00027-1; Baek KH, 2002, INT J ONCOL, V20, P739; Bai D, 2003, BIOCHEM BIOPH RES CO, V309, P552, DOI 10.1016/j.bbrc.2003.08.033; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bilder D, 2001, CURR BIOL, V11, pR132, DOI 10.1016/S0960-9822(01)00060-4; Chang Y, 2010, DEV NEUROBIOL, V70, P1, DOI 10.1002/dneu.20750; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Emberley ED, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-28; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gong XW, 2009, ACTA BIOCH BIOPH SIN, V41, P883, DOI 10.1093/abbs/gmp082; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Kim YK, 2005, BIOCHEM BIOPH RES CO, V331, P922, DOI 10.1016/j.bbrc.2005.04.017; Kim YS, 2003, INT J ONCOL, V23, P1515; Kim YS, 2002, INT J ONCOL, V20, P1219; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; KUWABARA K, 1994, GENOMICS, V20, P337, DOI 10.1006/geno.1994.1184; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lu XF, 2009, CLIN CANCER RES, V15, P3287, DOI 10.1158/1078-0432.CCR-08-2078; Lutz W, 2003, BIOCHEM BIOPH RES CO, V303, P1186, DOI 10.1016/S0006-291X(03)00499-6; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1995, ONCOGENE, V11, P291; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Tsuruga T, 2007, ONCOL RES, V16, P431, DOI 10.3727/000000007783980855; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang Y, 2002, BIOCHEM BIOPH RES CO, V297, P148, DOI 10.1016/S0006-291X(02)02020-X; Woodhouse EC, 2003, P NATL ACAD SCI USA, V100, P11463, DOI 10.1073/pnas.2031202100; Wu Y, 2006, BIOCHEM J, V396, P23, DOI 10.1042/BJ20051568; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059	58	30	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35340	35349		10.1074/jbc.M110.156836	http://dx.doi.org/10.1074/jbc.M110.156836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829363	Green Published, hybrid			2022-12-27	WOS:000283845300012
J	Horst, D; Gu, XS; Bhasin, M; Yang, QL; Verzi, M; Lin, DX; Joseph, M; Zhang, XB; Chen, W; Li, YP; Shivdasani, RA; Libermann, TA				Horst, David; Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Verzi, Michael; Lin, Dongxu; Joseph, Marie; Zhang, Xiaobo; Chen, Wei; Li, Yi-Ping; Shivdasani, Ramesh A.; Libermann, Towia A.			Requirement of the Epithelium-specific Ets Transcription Factor Spdef for Mucous Gland Cell Function in the Gastric Antrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDEF EXPRESSION; BINDING DOMAIN; NECK CELLS; GENE; FAMILY; CANCER; MEMBER; INTERACTS; RECEPTOR; DEFENSE	Mucus-secreting cells of the stomach epithelium provide a protective barrier against damage that might result from bacterial colonization or other stimuli. Impaired barrier function contributes to chronic inflammation and cancer. Knock-out mice for the epithelium-specific transcription factor Spdef (also called Pdef) have defects in terminal differentiation of intestinal and bronchial secretory cells. We sought to determine the physiologic function of Spdef in the stomach, another site of significant levels of Spdef expression. We used in situ hybridization and immunohistochemistry to localize Spdef-expressing cells in the mouse stomach; targeted gene disruption to generate mice lacking Spdef; and histologic, immunologic, and transcriptional profiling approaches to determine the requirements of Spdef in stomach epithelial homeostasis. In wild-type mice, Spdef RNA and protein are expressed predominantly in mucous gland cells of the antrum and in mucous neck cells of the glandular corpus. Within 1.5 years, nearly half of homozygous mutant mice developed profound mucosal hyperplasia of the gastric antrum. Submucosal infiltration of inflammatory cells preceded antral hyperplasia by several weeks. The absence of Spdef impaired terminal maturation of antral mucous gland cells, as reflected in reduced expression of Muc6 and Tff2 and reduced numbers of secretory granules. Antral gene expression abnormalities overlapped significantly with those in Spdef(-/-) colon, including genes implicated in secretory granule traffic and functions. Spdef is required for terminal maturation of antral mucous gland cells to protect animals from gastric inflammation and resulting hyperplasia. These requirements parallel Spdef functions in secretory intestinal cells and suggest a common molecular mechanism for maturation of gastrointestinal secretory lineages.	[Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Lin, Dongxu; Joseph, Marie; Shivdasani, Ramesh A.; Libermann, Towia A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Lin, Dongxu; Joseph, Marie; Libermann, Towia A.] Harvard Univ, Sch Med, BIDMC Genom & Prote Ctr, Boston, MA 02115 USA; [Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Lin, Dongxu; Joseph, Marie; Libermann, Towia A.] Harvard Univ, Sch Med, Div Interdisciplinary Med & Biotechnol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Zhang, Xiaobo] Massachusetts Gen Hosp, Gastrointestinal Unit, Charlestown, MA 02114 USA; [Zhang, Xiaobo] Massachusetts Gen Hosp, MGH Weight Ctr, Charlestown, MA 02114 USA; [Chen, Wei; Li, Yi-Ping] Forsyth Inst, Dept Cytokine Biol, Boston, MA 02115 USA; [Chen, Wei; Li, Yi-Ping] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Shivdasani, RA (corresponding author), 44 Binney St, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu; tliberma@bidmc.harvard.edu		Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X	National Institutes of Health [CA85467, DK081113, AR44741]; Prostate Cancer Foundation; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [R01CA085467] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA85467 (to T. A. L.), DK081113 (to R. A. S.), and AR44741 (to Y. P. L.). This work was also supported by a Prostate Cancer Foundation award (to X. G.), and a fellowship from the Deutsche Forschungsgemeinschaft (to D. H.).	Akbarali Y, 1996, J BIOL CHEM, V271, P26007, DOI 10.1074/jbc.271.42.26007; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Baus-Loncar M, 2005, CELL PHYSIOL BIOCHEM, V16, P31, DOI 10.1159/000087729; Beckwith CS, 1997, J CLIN MICROBIOL, V35, P1620, DOI 10.1128/JCM.35.6.1620-1623.1997; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; FALK P, 1994, AM J PHYSIOL, V266, pG987, DOI 10.1152/ajpgi.1994.266.6.G987; Feldman RJ, 2003, CANCER RES, V63, P4626; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghadersohi A, 2008, INT J CANCER, V123, P1376, DOI 10.1002/ijc.23667; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hartigan J., 1975, CLUSTERING ALGORITHM; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; HO SB, 1995, GASTROENTEROLOGY, V109, P735, DOI 10.1016/0016-5085(95)90380-1; HUGHES NR, 1994, J CLIN PATHOL, V47, P53, DOI 10.1136/jcp.47.1.53; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain R, 2009, DIGEST DIS SCI, V54, P1839, DOI 10.1007/s10620-008-0572-8; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Labrie C, 2008, J STEROID BIOCHEM, V108, P237, DOI 10.1016/j.jsbmb.2007.09.008; LAMONT JT, 1992, ANN NY ACAD SCI, V664, P190, DOI 10.1111/j.1749-6632.1992.tb39760.x; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Poulsen SS, 1999, GUT, V45, P516, DOI 10.1136/gut.45.4.516; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Verzi MP, 2008, GASTROENTEROLOGY, V135, P591, DOI 10.1053/j.gastro.2008.04.019; Yamada N, 2000, GENE, V241, P267, DOI 10.1016/S0378-1119(99)00484-9; YAMAZAKI Y, 1992, EUR J HISTOCHEM, V36, P161	45	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35047	35055		10.1074/jbc.M110.164541	http://dx.doi.org/10.1074/jbc.M110.164541			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801882	hybrid, Green Published			2022-12-27	WOS:000283659100079
J	Jha, KN; Wong, L; Zerfas, PM; De Silva, RS; Fan, YX; Spiridonov, NA; Johnson, GR				Jha, Kula N.; Wong, Lily; Zerfas, Patricia M.; De Silva, Rukman S.; Fan, Ying-Xin; Spiridonov, Nikolay A.; Johnson, Gibbes R.			Identification of a Novel HSP70-binding Cochaperone Critical to HSP90-mediated Activation of Small Serine/Threonine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 CHAPERONE MACHINERY; MOLECULAR CHAPERONES; SIGNAL-TRANSDUCTION; MALE-INFERTILITY; PROTEIN-KINASES; CO-CHAPERONE; BINDING; CELL; SPERMATOGENESIS; RECEPTOR	We previously reported the identification of small serine/threonine kinase (SSTK) that is expressed in postmeiotic germ cells, associates with HSP90, and is indispensable for male fertility. Sperm from SSTK-null mice cannot fertilize eggs in vitro and are incapable of fusing with eggs that lack zona pellucida. Here, using the yeast two-hybrid screen, we have discovered a novel SSTK-interacting protein (SIP) that is expressed exclusively in testis. The gene encoding SIP is restricted to mammals and encodes a 125-amino acid polypeptide with a predicted tetratricopeptide repeat domain. SIP is co-localized with SSTK in the cytoplasm of spermatids as they undergo restructuring and chromatin condensation, but unlike SSTK, is not retained in the mature sperm. SIP binds to SSTK with high affinity (K-d similar to 10 nM), and the proteins associate with each other when co-expressed in cells. In vitro, SIP inhibited SSTK kinase activity, whereas the presence of SIP in cells resulted in enzymatic activation of SSTK without affecting Akt or MAPK activity. SIP was found to be associated with cellular HSP70, and analyses with purified proteins revealed that SIP directly bound HSP70. Importantly, SSTK recruited SIP onto HSP90, and treatment of cells with the specific HSP90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, completely abolished SSTK catalytic activity. Hence, these findings demonstrate that HSP90 is essential for functional maturation of the kinase and identify SIP as a cochaperone that is critical to the HSP90-mediated activation of SSTK.	[Jha, Kula N.; Wong, Lily; De Silva, Rukman S.; Fan, Ying-Xin; Spiridonov, Nikolay A.; Johnson, Gibbes R.] US FDA, Chem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Zerfas, Patricia M.] NIH, Div Vet Resources, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA	Johnson, GR (corresponding author), US FDA, Chem Lab, Div Therapeut Prot, Ctr Drug Evaluat & Res, 29 Lincoln Dr,Bldg 29A,HFD 122, Bethesda, MD 20892 USA.	gibbes.johnson@fda.hhs.gov	Spiridonov, Nikolay/B-6287-2014					Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; CRAIG EA, 1994, CELL, V78, P365, DOI 10.1016/0092-8674(94)90416-2; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Hao ZL, 2004, MOL HUM REPROD, V10, P433, DOI 10.1093/molehr/gah052; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kierszenbaum AL, 2006, MOL REPROD DEV, V73, P399, DOI 10.1002/mrd.20456; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kueng P, 1997, J CELL BIOL, V139, P1851, DOI 10.1083/jcb.139.7.1851; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Melling CWJ, 2009, CELL STRESS CHAPERON, V14, P141, DOI 10.1007/s12192-008-0065-x; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Ogurtsov AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003599; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; PRADEEPA MM, 2007, M R Soc Reprod Ferti, V63, P1; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Rajapandi T, 2000, J BIOL CHEM, V275, P22597, DOI 10.1074/jbc.M002035200; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; Sosnik J, 2009, J CELL SCI, V122, P2741, DOI 10.1242/jcs.047225; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Visconti PE, 2001, GENOMICS, V77, P163, DOI 10.1006/geno.2001.6628; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Xu BF, 2008, DEV BIOL, V319, P211, DOI 10.1016/j.ydbio.2008.03.047	39	8	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35180	35187		10.1074/jbc.M110.134767	http://dx.doi.org/10.1074/jbc.M110.134767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20829357	hybrid, Green Published			2022-12-27	WOS:000283659100091
J	Murakami, T; Takano, R; Takeo, S; Taniguchi, R; Ogawa, K; Ohashi, E; Tsurimoto, T				Murakami, Takeshi; Takano, Ryuji; Takeo, Satoshi; Taniguchi, Rina; Ogawa, Kaori; Ohashi, Eiji; Tsurimoto, Toshiki			Stable Interaction between the Human Proliferating Cell Nuclear Antigen Loader Complex Ctf18-Replication Factor C (RFC) and DNA Polymerase epsilon Is Mediated by the Cohesion-specific Subunits, Ctf18, Dcc1, and Ctf8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; MITOTIC CHROMOSOME TRANSMISSION; SACCHAROMYCES-CEREVISIAE; REPLICATION FORK; CLAMP LOADER; CATALYTIC DOMAINS; YEAST; IDENTIFICATION; CLONING; PCNA	One of the proliferating cell nuclear antigen loader complexes, Ctf18-replication factor C (RFC), is involved in sister chromatid cohesion. To examine its relationship with factors involved in DNA replication, we performed a proteomics analysis of Ctf18-interacting proteins. We found that Ctf18 interacts with a replicative DNA polymerase, DNA polymerase epsilon (pol epsilon). Co-immunoprecipitation with recombinant Ctf18-RFC and pol epsilon demonstrated that their binding is direct and mediated by two distinct interactions, one weak and one stable. Three subunits that are specifically required for cohesion in yeast, Ctf18, Dcc1, and Ctf8, formed a trimeric complex (18-1-8) and together enabled stable binding with pol epsilon. The C-terminal 23-amino acid stretch of Ctf18 was necessary for the trimeric association of 18-1-8 and was required for the stable interaction. The weak interaction was observed with alternative loader complexes including Ctf18-RFC(5), which lacks Dcc1 and Ctf8, suggesting that the common loader structures, including the RFC small subunits (RFC2-5), are responsible for the weak interaction. The two interaction modes, mediated through distinguishable structures of Ctf18-RFC, both occurred through the N-terminal half of pol epsilon, which includes the catalytic domain. The addition of Ctf18-RFC or Ctf18-RFC(5) to the DNA synthesis reaction caused partial inhibition and stimulation, respectively. Thus, Ctf18-RFC has multiple interactions with pol epsilon that promote polymorphic modulation of DNA synthesis. We propose that their interaction alters the DNA synthesis mode to enable the replication fork to cooperate with the establishment of cohesion.	[Murakami, Takeshi; Takano, Ryuji; Takeo, Satoshi; Taniguchi, Rina; Ogawa, Kaori; Ohashi, Eiji; Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan	Kyushu University	Tsurimoto, T (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ttsurimoto@kyudai.jp	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585; Tsurimoto, Toshiki/0000-0001-7597-2216	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20370069, 17080006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants-in-aid 20370069 and 17080006 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Feng WY, 2003, MOL BIOL CELL, V14, P3427, DOI 10.1091/mbc.E03-02-0088; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kim JY, 2003, CURR BIOL, V13, pR873, DOI 10.1016/j.cub.2003.10.048; KOUPRINA N, 1993, YEAST, V9, P11, DOI 10.1002/yea.320090103; KOUPRINA N, 1994, GENETICS, V138, P1067; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Maki S, 1998, J BIOL CHEM, V273, P21332, DOI 10.1074/jbc.273.33.21332; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Ohta S, 2002, J BIOL CHEM, V277, P40362, DOI 10.1074/jbc.M206194200; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; Pospiech Helmut, 2003, ScientificWorldJournal, V3, P87; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Shiomi Y, 2004, GENES CELLS, V9, P279, DOI 10.1111/j.1356-9597.2004.00724.x; Shiomi Y, 2007, J BIOL CHEM, V282, P20906, DOI 10.1074/jbc.M610102200; SJO G, 2010, EXP CELL RES */* L E, V316, P1445; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; SPENCER F, 1990, GENETICS, V124, P237; Spiga MG, 2004, NUCLEIC ACIDS RES, V32, P4945, DOI 10.1093/nar/gkh811; SUGINO A, 1995, TRENDS BIOCHEM SCI, V20, P319, DOI 10.1016/S0968-0004(00)89059-3; Takeishi Y, 2010, GENES CELLS, V15, P761, DOI 10.1111/j.1365-2443.2010.01418.x; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; TO THA, 1999, Genes Dev */* K GENE, V13, P320; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004	44	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34608	34615		10.1074/jbc.M110.166710	http://dx.doi.org/10.1074/jbc.M110.166710			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826785	Green Published, hybrid			2022-12-27	WOS:000283659100036
J	Zhou, Y; Plowman, SJ; Lichtenberger, LM; Hancock, JF				Zhou, Yong; Plowman, Sarah J.; Lichtenberger, Lenard M.; Hancock, John F.			The Anti-inflammatory Drug Indomethacin Alters Nanoclustering in Synthetic and Cell Plasma Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE MICROSCOPY; PHOSPHOLIPID-VESICLES; MULTIFREQUENCY PHASE; ARACHIDONIC-ACID; RAS PROTEINS; LIPID RAFTS; H-RAS; K-RAS; LAURDAN; DOMAINS	The nonsteroidal anti-inflammatory drug indomethacin exhibits diverse biological effects, many of which have no clear molecular mechanism. Membrane-bound receptors and enzymes are sensitive to their phospholipid microenvironment. Amphipathic indomethacin could therefore potentially modulate cell signaling by changing membrane properties. Here we examined the effect of indomethacin on membrane lateral heterogeneity. Fluorescence lifetime imaging of cells expressing lipid-anchored probes revealed that treatment of BHK cells with therapeutic levels of indomethacin enhances cholesterol-dependent nanoclustering, but not cholesterol-independent nanoclustering. Immuno-electron microscopy and quantitative spatial mapping of intact plasma membrane sheets similarly showed a selective effect of indomethacin on promoting cholesterol-dependent, but not cholesterol-independent, nanoclustering. To further evaluate the biophysical effects of indomethacin, we measured fluorescence polarization of the phase-sensitive probe Laurdan and FRET between phase-partitioning probes in model bilayers. Therapeutic levels of indomethacin enhanced phase seperation in DPPC/DOPC/Chol (1:1:1) and DPPC/Chol membranes in a temperature-dependent manner, but had minimal effect on the phase behavior of pure DOPC at any temperature. Taken together, the imaging results on intact epithelial cells and the biophysical assays of model membranes suggest that indomethacin can enhance phase separation and stabilize cholesterol-dependent nanoclusters in biological membranes. These effects on membrane lateral heterogeneity may have significant consequences for cell signaling cascades that are assembled on the plasma membrane.	[Zhou, Yong; Plowman, Sarah J.; Lichtenberger, Lenard M.; Hancock, John F.] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Lichtenberger, LM (corresponding author), 6431 Fannin St,MSB 4-098, Houston, TX 77030 USA.	lenard.m.lichtenberger@uth.tmc.edu; john.f.hancock@uth.tmc.edu		Zhou, Yong/0000-0002-0214-8151; Hancock, John/0000-0003-0542-4710	National Institutes of Health [F-32 DK07664, R01 GM066717]; Texas Medical Center Digestive Disease Center [PHS P-30DK56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007664, F32DK007664, P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Medical Center Digestive Disease Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F-32 DK07664 and R01 GM066717 and the Texas Medical Center Digestive Disease Center PHS P-30DK56338.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; BESAG JE, 1977, E J Royal Statist So, V39, P193; CHONG PLG, 1993, BIOCHIM BIOPHYS ACTA, V1149, P260, DOI 10.1016/0005-2736(93)90209-I; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; EVANS EA, 1972, NOUV REV FR HEMATOL, V12, P851; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; GREENBERG RN, 1980, INFECT IMMUN, V29, P908; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Jacob M, 2001, CLIN SCI, V101, P493, DOI 10.1042/CS20010085; JORGENSEN K, 1991, BIOCHIM BIOPHYS ACTA, V1067, P241, DOI 10.1016/0005-2736(91)90050-I; KENNEDY TG, 1985, BIOL REPROD, V33, P140, DOI 10.1095/biolreprod33.1.140; KENNEDY TG, 1986, BIOL REPROD, V34, P327, DOI 10.1095/biolreprod34.2.327; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; LASONER E, 1990, W D J Colloid Int Sc, V139, P469; LEIDY C, 2001, J H BIOPHYS J */* BI, V80, P1819; Lichtenberger LM, 2006, J PHARM PHARMACOL, V58, P1421, DOI 10.1211/jpp.58.10.0001; PARASASSI T, 1986, CELL MOL BIOL, V32, P261; PARASASSI T, 1984, J BIOL CHEM, V259, P4011; PARASASSI T, 1993, BIOCHIM BIOPHYS ACTA, V1153, P143, DOI 10.1016/0005-2736(93)90399-K; PARASASSI T, 1984, CELL BIOCHEM FUNCT, V2, P85, DOI 10.1002/cbf.290020206; PARASASSI T, 1991, INT J RADIAT BIOL, V59, P59, DOI 10.1080/09553009114550061; PARASASSI T, 1986, CELL MOL BIOL, V32, P103; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Parasassi T, 1997, BIOPHYS J, V72, pTH322; PARASASSI T, 1992, EXP CELL RES, V202, P432, DOI 10.1016/0014-4827(92)90096-Q; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior I. A., 2003, SCI STKE, V2003, pPL9; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; STADLER P, 1991, DIGEST DIS SCI, V36, P594, DOI 10.1007/BF01297025; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Tenenbaum J, 1999, CAN J GASTROENTEROL, V13, P119, DOI 10.1155/1999/361651; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Veatch SL, 2004, BIOPHYS J, V86, p201A; Ward GR, 1998, J NUTR, V128, P2473; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhou Y, 2005, BIOPHYS J, V89, P1789, DOI 10.1529/biophysj.104.054510; Zhou Y, 2009, BBA-BIOMEMBRANES, V1788, P507, DOI 10.1016/j.bbamem.2008.12.008	48	31	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35188	35195		10.1074/jbc.M110.141200	http://dx.doi.org/10.1074/jbc.M110.141200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826816	Green Published, hybrid			2022-12-27	WOS:000283659100092
J	Dinkova-Kostova, AT; Talalay, P; Sharkey, J; Zhang, Y; Holtzclaw, WD; Wang, XJ; David, E; Schiavoni, KH; Finlayson, S; Mierke, DF; Honda, T				Dinkova-Kostova, Albena T.; Talalay, Paul; Sharkey, John; Zhang, Ying; Holtzclaw, W. David; Wang, Xiu Jun; David, Emilie; Schiavoni, Katherine H.; Finlayson, Stewart; Mierke, Dale F.; Honda, Tadashi			An Exceptionally Potent Inducer of Cytoprotective Enzymes ELUCIDATION OF THE STRUCTURAL FEATURES THAT DETERMINE INDUCER POTENCY AND REACTIVITY WITH Keap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; MICHAEL REACTION ACCEPTORS; HIGHLY-ACTIVE INHIBITORS; TRANSGENIC MOUSE MODEL; CDDO-METHYL ESTER; MOLECULAR-MECHANISM; TRICYCLIC COMPOUNDS; SULFHYDRYL-GROUPS; ETHYL AMIDE; RING-A	The Keap1/Nrf2/ARE pathway controls a network of cytoprotective genes that defend against the damaging effects of oxidative and electrophilic stress, and inflammation. Induction of this pathway is a highly effective strategy in combating the risk of cancer and chronic degenerative diseases, including atherosclerosis and neurodegeneration. An acetylenic tricyclic bis(cyano enone) bearing two highly electrophilic Michael acceptors is an extremely potent inducer in cells and in vivo. We demonstrate spectroscopically that both cyano enone functions of the tricyclic molecule react with cysteine residues of Keap1 and activate transcription of cytoprotective genes. Novel monocyclic cyano enones, representing fragments of rings A and C of the tricyclic compound, reveal that the contribution to inducer potency of the ring C Michael acceptor is much greater than that of ring A, and that potency is further enhanced by spatial proximity of an acetylenic function. Critically, the simultaneous presence of two cyano enone functions in rings A and C within a rigid three-ring system results in exceptionally high inducer potency. Detailed understanding of the structural elements that contribute to the reactivity with the protein sensor Keap1 and to high potency of induction is essential for the development of specific and selective lead compounds as clinically relevant chemoprotective agents.	[Finlayson, Stewart] Univ Dundee, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Dinkova-Kostova, Albena T.; Talalay, Paul; Holtzclaw, W. David] Johns Hopkins Univ, Sch Med, Lewis B & Dorothy Cullman Chemoprotect Ctr, Baltimore, MD 21205 USA; [Dinkova-Kostova, Albena T.; Talalay, Paul; Holtzclaw, W. David] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [David, Emilie; Schiavoni, Katherine H.; Mierke, Dale F.; Honda, Tadashi] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	University of Dundee; Johns Hopkins University; Johns Hopkins University; Dartmouth College	Dinkova-Kostova, AT (corresponding author), Ninewells Hosp & Med Sch, Biomed Res Inst, Level 5, Dundee DD1 9SY, Scotland.	a.dinkovakostova@dundee.ac.uk; tadashi.honda@stonybrook.edu		Dinkova-Kostova, Albena/0000-0003-0316-9859; Sharkey, John/0000-0001-8288-1857	National Institutes of Health [CA06793, CA93780, CA105294]; American Cancer Society [RSG-07-157-01-CNE]; Research Councils UK, Cancer Research UK [C20953/A10270]; Royal Society; Anonymous Trust; Tenovus Scotland; American Institute for Cancer Research; Lewis B. and Dorothy Cullman Foundation; W. Patrick McMullan and the McMullan Family Fund; Reata Pharmaceuticals Inc, Irving, TX; NATIONAL CANCER INSTITUTE [R01CA093780, R03CA105294] Funding Source: NIH RePORTER; Cancer Research UK [10270] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research Councils UK, Cancer Research UK(UK Research & Innovation (UKRI)Cancer Research UK); Royal Society(Royal Society of London); Anonymous Trust; Tenovus Scotland; American Institute for Cancer Research; Lewis B. and Dorothy Cullman Foundation; W. Patrick McMullan and the McMullan Family Fund; Reata Pharmaceuticals Inc, Irving, TX; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported, in whole or in part, by the National Institutes of Health (Grants CA06793, CA93780, and CA105294). This work was also supported by the American Cancer Society (Grant RSG-07-157-01-CNE), Research Councils UK, Cancer Research UK (C20953/A10270), the Royal Society, the Anonymous Trust, Tenovus Scotland, the American Institute for Cancer Research, the Lewis B. and Dorothy Cullman Foundation, W. Patrick McMullan and the McMullan Family Fund, and Reata Pharmaceuticals Inc, Irving, TX.	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Dinkova-Kostova AT, 1998, J MED CHEM, V41, P5287, DOI 10.1021/jm980424s; Dumont M, 2009, J NEUROCHEM, V109, P502, DOI 10.1111/j.1471-4159.2009.05970.x; Fahey JW, 2004, METHOD ENZYMOL, V382, P243; Favaloro FG, 2002, J MED CHEM, V45, P4801, DOI 10.1021/jm025565f; Habig W H, 1981, Methods Enzymol, V77, P218; HAYES JD, 2010, ANTIOXID RE IN PRESS; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Honda T., 2010, Patent No. [WO 2010011782 A1, 2010011782]; Honda T, 2007, J MED CHEM, V50, P1731, DOI 10.1021/jm070141c; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Kelly VP, 2000, CANCER RES, V60, P957; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Liby K, 2008, CANCER RES, V68, P6727, DOI 10.1158/0008-5472.CAN-08-1123; Liby K, 2008, CLIN CANCER RES, V14, P4556, DOI 10.1158/1078-0432.CCR-08-0040; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu HJ, 2000, SYNLETT, P1119; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; PAQUETTE LA, 1989, TETRAHEDRON, V45, P107, DOI 10.1016/0040-4020(89)80038-9; POSNER GH, 1994, J MED CHEM, V37, P170, DOI 10.1021/jm00027a021; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Schwartz S. L., 2009, AM DIAB ASS M NEW OR; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Yang LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005757; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	43	92	94	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33747	33755		10.1074/jbc.M110.163485	http://dx.doi.org/10.1074/jbc.M110.163485			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801881	Green Published, hybrid			2022-12-27	WOS:000283354000020
J	Presley, T; Vedam, K; Druhan, LJ; Ilangovan, G				Presley, Tennille; Vedam, Kaushik; Druhan, Lawrence J.; Ilangovan, Govindasamy			Hyperthermia-induced Hsp90.eNOS Preserves Mitochondrial Respiration in Hyperglycemic Endothelial Cells by Down-regulating Glut-1 and Up-regulating G6PD Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NATURAL PROTECTIVE MECHANISM; SMOOTH-MUSCLE-CELLS; HIGH-GLUCOSE; HEAT-SHOCK; OXIDATIVE STRESS; NAD(P)H OXIDASE; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; NO SYNTHASE	Uncoupling of NO production from NADPH oxidation by endothelial nitric-oxide synthase (eNOS) is enhanced in hyperglycemic endothelium, potentially due to dissociation of heat shock proteins 90 (Hsp90), and cellular glucose homeostasis is enhanced by a ROS-induced positive feed back mechanism. In this study we investigated how such an uncoupling impacts oxygen metabolism and how the oxidative phosphorylation can be preserved by heat shock (42 degrees C for 2 h, hyperthermia) in bovine aortic endothelial cells. Normal and heat-shocked bovine aortic endothelial cells were exposed to normoglycemia (NG, 5.0 mM) or hyperglycemia (30 mM). With hyperglycemia treatment, O-2 consumption rate was reduced (from V-O2max = 7.51 +/- 0.54 to 2.35 +/- 0.27 mm Hg/min/10(6) cells), whereas in heat-shocked cells, O-2 consumption rate remained unaltered (8.19 +/- 1.01 mm Hg/min/10 x 10(6) cells). Heat shock was found to enhance Hsp90/endothelial NOS interactions and produce higher NO. Moreover, ROS generation in the hyperglycemic condition was also reduced in heat-shocked cells. Interestingly, glucose uptake was reduced in heat-shocked cells as a result of decrease in Glut-1 protein level. Glucose phosphate dehydrogenase activity that gives rise to NADPH generation was increased by hyperthermia, and mitochondrial oxidative metabolism was preserved. In conclusion, the present study provides a novel mechanism wherein the reduced oxidative stress in heat-shocked hyperglycemic cells down-regulates Glut-1 and glucose uptake, and fine-tuning of this pathway may be a potential approach to use for therapeutic benefit of diabetes mellitus.	[Presley, Tennille; Ilangovan, Govindasamy] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA; [Vedam, Kaushik; Ilangovan, Govindasamy] Ohio State Univ, Div Cardiovasc Med, Dept Internal Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Druhan, Lawrence J.] Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	Ilangovan, G (corresponding author), Rm 392,Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Govindasamy.Ilangovan@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [R21 EB004658, R01 HL078796, F31 GM078772-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB004658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM078772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 EB004658, R01 HL078796 (to G. I.), and F31 GM078772-01 (to T. P.).	Alpert E, 2005, DIABETOLOGIA, V48, P752, DOI 10.1007/s00125-005-1681-y; Alpert E, 2004, BIOCHEM PHARMACOL, V67, P1985, DOI 10.1016/j.bcp.2004.02.005; Averna M, 2008, J BIOL CHEM, V283, P29069, DOI 10.1074/jbc.M803638200; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; BELT JA, 1979, BIOCHEMISTRY-US, V18, P3506, DOI 10.1021/bi00583a011; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen Y, 2004, AM J PHYSIOL-HEART C, V287, pH1104, DOI 10.1152/ajpheart.00102.2004; Cohen G., 2007, Archives of Physiology and Biochemistry, V113, P259, DOI 10.1080/13813450701783513; Cosentino F, 1997, CIRCULATION, V96, P25; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Harris MB, 2003, AM J PHYSIOL-HEART C, V285, pH333, DOI 10.1152/ajpheart.00726.2002; Hink U, 2001, CIRC RES, V88, pE14; Ilangovan G, 2004, AM J PHYSIOL-CELL PH, V287, pC1472, DOI 10.1152/ajpcell.00103.2004; Ilangovan G, 2004, METHOD ENZYMOL, V381, P747; Jones CI, 2008, AM J PHYSIOL-CELL PH, V295, pC180, DOI 10.1152/ajpcell.00549.2007; Konduri GG, 2003, AM J PHYSIOL-HEART C, V285, pH204, DOI 10.1152/ajpheart.00837.2002; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200; Leopold JA, 2003, ARTERIOSCL THROM VAS, V23, P411, DOI 10.1161/01.ATV.0000056744.26901.BA; Lin LY, 2005, J CELL BIOCHEM, V94, P194, DOI 10.1002/jcb.20195; Mohan S, 2009, AM J PHYSIOL-CELL PH, V296, pC182, DOI 10.1152/ajpcell.00575.2007; Oishi PE, 2008, AM J PHYSIOL-LUNG C, V295, pL756, DOI 10.1152/ajplung.00146.2007; Presley T, 2006, BIOPHYS J, V91, P4623, DOI 10.1529/biophysj.106.090175; Presley T, 2009, CELL STRESS CHAPERON, V14, P611, DOI 10.1007/s12192-009-0114-0; Presley T, 2008, AM J PHYSIOL-CELL PH, V295, pC1281, DOI 10.1152/ajpcell.00550.2007; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; Riahi Y, 2010, DIABETES, V59, P808, DOI 10.2337/db09-1207; Salt IP, 2003, J BIOL CHEM, V278, P18791, DOI 10.1074/jbc.M210618200; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Serpillon S, 2009, AM J PHYSIOL-HEART C, V297, pH153, DOI 10.1152/ajpheart.01142.2008; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461; Song Y, 2002, BIOCHEMISTRY-US, V41, P10616, DOI 10.1021/bi026060u; Srinivasan S, 2004, DIABETOLOGIA, V47, P1727, DOI 10.1007/s00125-004-1525-1; Sweet IR, 2009, DIABETOLOGIA, V52, P921, DOI 10.1007/s00125-009-1272-4; Totary-Jain H, 2005, CIRC RES, V97, P1001, DOI 10.1161/01.RES.0000189260.46084.e5; Wang H, 2009, MOL ENDOCRINOL, V23, P1613, DOI 10.1210/me.2009-0115; White RL, 2000, AM J PHYSIOL-HEART C, V279, pH1849, DOI 10.1152/ajpheart.2000.279.4.H1849; Wink DA, 2001, ANTIOXID REDOX SIGN, V3, P203, DOI 10.1089/152308601300185179; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Zhang ZY, 2010, FASEB J, V24, P1497, DOI 10.1096/fj.09-136572	53	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38194	38203		10.1074/jbc.M110.147728	http://dx.doi.org/10.1074/jbc.M110.147728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861020	hybrid, Green Published			2022-12-27	WOS:000284625600027
J	Sims, K; Haynes, CA; Kelly, S; Allegood, JC; Wang, E; Momin, A; Leipelt, M; Reichart, D; Glass, CK; Sullards, MC; Merrill, AH				Sims, Kacee; Haynes, Christopher A.; Kelly, Samuel; Allegood, Jeremy C.; Wang, Elaine; Momin, Amin; Leipelt, Martina; Reichart, Donna; Glass, Christopher K.; Sullards, M. Cameron; Merrill, Alfred H., Jr.			Kdo(2)-Lipid A, a TLR4-specific Agonist, Induces de Novo Sphingolipid Biosynthesis in RAW264.7 Macrophages, Which Is Essential for Induction of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; TOLL-LIKE RECEPTORS; ACID SPHINGOMYELINASE; ENDOPLASMIC-RETICULUM; GLYCOSPHINGOLIPID METABOLISM; SERINE PALMITOYLTRANSFERASE; MURINE MACROPHAGES; MEMBRANE-STRUCTURE; GOLGI-COMPLEX; CANCER-CELLS	Activation of RAW264.7 cells with a lipopolysaccharide specific for the TLR4 receptor, Kdo(2)-lipid A (KLA), causes a large increase in cellular sphingolipids, from 1.5 to 2.6 x 10(9) molecules per cell in 24 h, based on the sum of subspecies analyzed by "lipidomic" mass spectrometry. Thus, this study asked the following question. What is the cause of this increase and is there a cell function connected with it? The sphingolipids arise primarily from de novo biosynthesis based on [U-C-13] palmitate labeling, inhibition by ISP1 (myriocin), and an apparent induction of many steps of the pathway (according to the distribution of metabolites and microarray analysis), with the exception of ceramide, which is also produced from pre-existing sources. Nonetheless, the activated RAW264.7 cells have a higher number of sphingolipids per cell because KLA inhibits cell division; thus, the cells are larger and contain increased numbers of membrane vacuoles termed autophagosomes, which were detected by the protein marker GFP-LC3. Indeed, de novo biosynthesis of sphingolipids performs an essential structural and/or signaling function in autophagy because autophagosome formation was eliminated by ISP1 in KLA-stimulated RAW264.7 cells (and mutation of serine palmitoyltransferase in CHO-LYB cells); furthermore, an anti-ceramide antibody co-localizes with autophagosomes in activated RAW264.7 cells versus the Golgi in unstimulated or ISP1-inhibited cells. These findings establish that KLA induces profound changes in sphingolipid metabolism and content in this macrophage-like cell line, apparently to produce sphingolipids that are necessary for formation of autophagosomes, which are thought to play important roles in the mechanisms of innate immunity.	[Haynes, Christopher A.; Kelly, Samuel; Wang, Elaine; Momin, Amin; Leipelt, Martina; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sims, Kacee; Allegood, Jeremy C.; Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Haynes, Christopher A.; Kelly, Samuel; Wang, Elaine; Momin, Amin; Leipelt, Martina; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Reichart, Donna; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego	Merrill, AH (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	al.merrill@biology.gatech.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069338 (to LIPID MAPS).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Berenson CS, 2002, J LEUKOCYTE BIOL, V72, P492; Blom T, 2010, CIRC RES, V106, P720, DOI 10.1161/CIRCRESAHA.109.204396; Cho JY, 2007, BIOL PHARM BULL, V30, P2105, DOI 10.1248/bpb.30.2105; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Emoto M, 2010, INFECT IMMUN, V78, P2667, DOI 10.1128/IAI.01441-09; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; Fazi B, 2008, AUTOPHAGY, V4, P435, DOI 10.4161/auto.5669; Feingold KR, 2010, ATHEROSCLEROSIS, V209, P81, DOI 10.1016/j.atherosclerosis.2009.08.042; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; GAL D, 1981, CANCER RES, V41, P473; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Grabowski Gregory A, 2006, Expert Opin Drug Deliv, V3, P771, DOI 10.1517/17425247.3.6.771; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hamasaki M, 2010, FEBS LETT, V584, P1296, DOI 10.1016/j.febslet.2010.02.061; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; HOFFMANN PM, 1993, EUR J CELL BIOL, V60, P371; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Knapp KM, 2000, J LEUKOCYTE BIOL, V67, P735, DOI 10.1002/jlb.67.5.735; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; MacKichan ML, 1999, J BIOL CHEM, V274, P1767, DOI 10.1074/jbc.274.3.1767; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Memon RA, 1999, J BIOL CHEM, V274, P19707, DOI 10.1074/jbc.274.28.19707; Memon RA, 2001, J LIPID RES, V42, P452; MERRILL AH, 1988, BIOCHEMISTRY-US, V27, P340, DOI 10.1021/bi00401a051; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Mijaljica D, 2006, TRAFFIC, V7, P1590, DOI 10.1111/j.1600-0854.2006.00495.x; Momin AA, 2009, LIPIDS, V44, P725, DOI 10.1007/s11745-009-3316-4; Monick MM, 2004, J IMMUNOL, V173, P123, DOI 10.4049/jimmunol.173.1.123; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Sakata A, 2007, IMMUNOLOGY, V122, P54, DOI 10.1111/j.1365-2567.2007.02612.x; Saxena RK, 2003, J BIOSCIENCES, V28, P129, DOI 10.1007/BF02970143; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schaade L, 1999, IUBMB LIFE, V48, P353, DOI 10.1080/713803512; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Xu KD, 2010, J LIPID RES, V51, P2581, DOI 10.1194/jlr.M005702; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamaji T, 2008, IUBMB LIFE, V60, P511, DOI 10.1002/iub.83; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142; Yin XL, 2009, CELL PHYSIOL BIOCHEM, V24, P219, DOI 10.1159/000233248; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	75	89	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38568	38579		10.1074/jbc.M110.170621	http://dx.doi.org/10.1074/jbc.M110.170621			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876532	Green Published, hybrid			2022-12-27	WOS:000284625600062
J	Kartner, N; Yao, YQ; Li, KY; Crasto, GJ; Datti, A; Manolson, MF				Kartner, Norbert; Yao, Yeqi; Li, Keying; Crasto, Gazelle J.; Datti, Alessandro; Manolson, Morris F.			Inhibition of Osteoclast Bone Resorption by Disrupting Vacuolar H+-ATPase a3-B2 Subunit Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; AMINO-TERMINAL DOMAIN; BREAST-CANCER CELLS; THERMUS-THERMOPHILUS; PARATHYROID-HORMONE; A3 ISOFORM; PLASMA-MEMBRANE; PROTON PUMPS; IN-VIVO; (H+)-ATPASES	VacuolarH(+)-ATPases (V-ATPases) are highly expressed in ruffled borders of bone-resorbing osteoclasts, where they play a crucial role in skeletal remodeling. To discover protein-protein interactions with the a subunit in mammalian V-ATPases, a GAL4 activation domain fusion library was constructed from an in vitro osteoclast model, receptor activator of NF-kappa B ligand-differentiated RAW 264.7 cells. This library was screened with a bait construct consisting of a GAL4 binding domain fused to the N-terminal domain of V-ATPase a3 subunit (NTa3), the a subunit isoform that is highly expressed in osteoclasts(a1 and a2 are also expressed, to a lesser degree, whereas a4 is kidney-specific). One of the prey proteins identified was the V-ATPase B2 subunit, which is also highly expressed in osteoclasts (B1 is not expressed). Further characterization, using pulldown and solid-phase binding assays, revealed an interaction between NTa3 and the C-terminal domains of both B1 and B2 subunits. Dual B binding domains of equal affinity were observed in NTa, suggesting a possible model for interaction between these subunits in the V-ATPase complex. Furthermore, the a3-B2 interaction appeared to be moderately favored over a1, a2, and a4 interactions with B2, suggesting a mechanism for the specific subunit assembly of plasma membrane V-ATPase in osteoclasts. Solid-phase binding assays were subsequently used to screen a chemicallibrary for inhibitors of the a3-B2 interaction. A small molecule benzohydrazide derivative was found to inhibit osteoclast resorption with an IC50 of similar to 1.2 mu M on both synthetic hydroxyapatite surfaces and dentin slices, without significantly affecting RAW 264.7 cell viability or receptor activator of NF-kappa B ligand-mediated osteoclast differentiation. Further understanding of these interactions and inhibitors may contribute to the design of novel therapeutics for bone loss disorders, such as osteoporosis and rheumatoid arthritis.	[Manolson, Morris F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON M5G 1G6, Canada; [Manolson, Morris F.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5G 1G6, Canada; [Datti, Alessandro] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Datti, Alessandro] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Perugia	Manolson, MF (corresponding author), Univ Toronto, Fac Dent, Dent Res Inst, 124 Edward St, Toronto, ON M5G 1G6, Canada.	m.manolson@dentistry.utoronto.ca	Datti, Alessandro/ABA-1108-2021	Datti, Alessandro/0000-0001-6824-7382; Manolson, Morris/0000-0001-8755-5460	Canadian Arthritis Network [2008-02-DAP-02]; Canadian Institutes for Health Research [MOP-79322, PDD-86132]	Canadian Arthritis Network; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Arthritis Network Grant 2008-02-DAP-02 and Canadian Institutes for Health Research Grant MOP-79322 and PDD-86132.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Diepholz M, 2008, BIOCHEM SOC T, V36, P1027, DOI 10.1042/BST0361027; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Drory O, 2006, PHYSIOLOGY, V21, P317, DOI 10.1152/physiol.00017.2006; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Ettinger B, 2004, J BONE MINER RES, V19, P745, DOI 10.1359/JBMR.040117; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Forgac M, 2000, J EXP BIOL, V203, P71; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gluck SL, 1996, ANNU REV PHYSIOL, V58, P427, DOI 10.1146/annurev.physiol.58.1.427; Gruber G, 2001, J EXP BIOL, V204, P2597; Heinemann T, 1999, GENOMICS, V57, P398, DOI 10.1006/geno.1999.5751; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Landolt-Marticorena C, 1999, J BIOL CHEM, V274, P26057, DOI 10.1074/jbc.274.37.26057; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1996, AM J PHYSIOL-CELL PH, V270, pC382, DOI 10.1152/ajpcell.1996.270.1.C382; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merkulova M, 2010, BBA-BIOENERGETICS, V1797, P1398, DOI 10.1016/j.bbabio.2010.02.009; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nakamura I, 1997, FEBS LETT, V401, P207, DOI 10.1016/S0014-5793(96)01454-8; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Saroussi S, 2009, J EXP BIOL, V212, P1604, DOI 10.1242/jeb.025866; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	61	53	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37476	37490		10.1074/jbc.M110.123281	http://dx.doi.org/10.1074/jbc.M110.123281			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20837476	Green Published, hybrid			2022-12-27	WOS:000284424000040
J	Ozalp, VC; Pedersen, TR; Nielsen, LJ; Olsen, LF				Ozalp, Veli C.; Pedersen, Tina R.; Nielsen, Lise J.; Olsen, Lars F.			Time-resolved Measurements of Intracellular ATP in the Yeast Saccharomyces cerevisiae using a New Type of Nanobiosensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; GLYCOLYTIC OSCILLATIONS; MITOCHONDRIAL RESPIRATION; MAGNETIC-RESONANCE; CELLULAR ATP; GLUCOSE; FLUORESCENT; ACTIVATION; APTAMERS; CELLS	Adenosine 5'-triphosphate is a universal molecule in all living cells, where it functions in bioenergetics and cell signaling. To understand how the concentration of ATP is regulated by cell metabolism and in turn how it regulates the activities of enzymes in the cell it would be beneficial if we could measure ATP concentration in the intact cell in real time. Using a novel aptamer-based ATP nanosensor, which can readily monitor intracellular ATP in eukaryotic cells with a time resolution of seconds, we have performed the first on-line measurements of the intracellular concentration of ATP in the yeast Saccharomyces cerevisiae. These ATP measurements show that the ATP concentration in the yeast cell is not stationary. In addition to an oscillating ATP concentration, we also observe that the concentration is high in the starved cells and starts to decrease when glycolysis is induced. The decrease in ATP concentration is shown to be caused by the activity of membrane-bound ATPases such as the mitochondrial F0F1 ATPase-hydrolyzing ATP and the plasma membrane ATPase (PMA1). The activity of these two ATPases are under strict control by the glucose concentration in the cell. Finally, the measurements of intracellular ATP suggest that 2-deoxyglucose (2-DG) may have more complex function than just a catabolic block. Surprisingly, addition of 2-DG induces only a moderate decline in ATP. Furthermore, our results suggest that 2-DG may inhibit the activation of PMA1 after addition of glucose.	[Ozalp, Veli C.; Pedersen, Tina R.; Nielsen, Lise J.; Olsen, Lars F.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Olsen, LF (corresponding author), Campusvej 55, DK-5230 Odense M, Denmark.	lfo@bmb.sdu.dk	Özalp, Veli/B-2940-2009	Özalp, Veli/0000-0002-7659-5990; Olsen, Lars Folke/0000-0001-7391-2340	Danish Natural Science Research Council [09-062275]; Danish Research Council for Technology and Production [274-07-0172]	Danish Natural Science Research Council(Danish Natural Science Research Council); Danish Research Council for Technology and Production	This research was supported by the Danish Natural Science Research Council (J. no. 09-062275) and the Danish Research Council for Technology and Production (Grant no. 274-07-0172).	ALDRIDGE J, 1976, NATURE, V259, P670, DOI 10.1038/259670a0; Andersen AZ, 2007, YEAST, V24, P731, DOI 10.1002/yea.1508; AON MA, 1992, J GEN MICROBIOL, V138, P2219, DOI 10.1099/00221287-138-10-2219; Bell PD, 2009, PURINERG SIGNAL, V5, P461, DOI 10.1007/s11302-009-9148-0; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bertram R, 2007, BIOPHYS J, V92, P1544, DOI 10.1529/biophysj.106.097154; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; DAUBRESSE C, 1994, J COLLOID INTERF SCI, V168, P222, DOI 10.1006/jcis.1994.1412; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; Fellin T, 2004, J PHYSIOL-LONDON, V559, P3, DOI 10.1113/jphysiol.2004.063214; FROMM HJ, 1962, J BIOL CHEM, V237, P3027; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Hara KY, 2006, J BIOMOL SCREEN, V11, P310, DOI 10.1177/1087057105285112; HARRIS DA, 1989, BIOCHIM BIOPHYS ACTA, V974, P156, DOI 10.1016/S0005-2728(89)80368-8; HERVE M, 1993, EUR J BIOCHEM, V218, P221, DOI 10.1111/j.1432-1033.1993.tb18368.x; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; KARCZMAR GS, 1992, CANCER RES, V52, P71; Kim JH, 2010, ANGEW CHEM INT EDIT, V49, P1456, DOI 10.1002/anie.200906251; Kunzelmann S, 2010, ACS CHEM BIOL, V5, P415, DOI 10.1021/cb9003173; Kunzelmann S, 2009, J BIOL CHEM, V284, P33130, DOI 10.1074/jbc.M109.047118; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Madsen MF, 2005, FEBS J, V272, P2648, DOI 10.1111/j.1742-4658.2005.04639.x; Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Nielsen LJ, 2010, ACS NANO, V4, P4361, DOI 10.1021/nn100635j; Olsen LF, 2009, BIOPHYS J, V96, P3850, DOI 10.1016/j.bpj.2009.02.026; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Poulsen AK, 2004, FEMS MICROBIOL LETT, V236, P261, DOI 10.1016/j.femsle.2004.05.044; Poulsen AK, 2008, BIOCHEMISTRY-US, V47, P7477, DOI 10.1021/bi800396e; Poulsen AK, 2007, BIOPHYS CHEM, V125, P275, DOI 10.1016/j.bpc.2006.08.009; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Richard P, 1996, YEAST, V12, P731; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Stoltenburg R, 2005, ANAL BIOANAL CHEM, V383, P83, DOI 10.1007/s00216-005-3388-9; Tang ZW, 2008, J AM CHEM SOC, V130, P11268, DOI 10.1021/ja804119s; Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2; VIARENGO A, 1986, EXPERIENTIA, V42, P1234, DOI 10.1007/BF01946400; Warnke C, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046011; WEBB J, 1966, ENZYME METABOLIC INH, V3; Wochner A, 2007, BIOTECHNIQUES, V42, P578, DOI 10.2144/000112472	45	83	83	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37579	37588		10.1074/jbc.M110.155119	http://dx.doi.org/10.1074/jbc.M110.155119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20880841	Green Published, hybrid			2022-12-27	WOS:000284424000050
J	Talhaoui, I; Bui, C; Oriol, R; Mulliert, G; Gulberti, S; Netter, P; Coughtrie, MWH; Ouzzine, M; Fournel-Gigleux, S				Talhaoui, Ibtissam; Bui, Catherine; Oriol, Rafael; Mulliert, Guillermo; Gulberti, Sandrine; Netter, Patrick; Coughtrie, Michael W. H.; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie			Identification of Key Functional Residues in the Active Site of Human beta 1, 4-Galactosyltransferase 7 A MAJOR ENZYME IN THE GLYCOSAMINOGLYCAN SYNTHESIS PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCURONOSYLTRANSFERASE-I GLCAT-I; HEPARAN-SULFATE BIOSYNTHESIS; PROTEIN LINKAGE REGION; GALACTOSYLTRANSFERASE-I; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; SEQUENCE ALIGNMENT; GENE FAMILY; PROTEOGLYCANS; BINDING	Glycosaminoglycans (GAGs) play a central role in many pathophysiological events, and exogenous xyloside substrates of beta 1,4-galactosyltransferase 7 (beta 4GalT7), a major enzyme of GAG biosynthesis, have interesting biomedical applications. To predict functional peptide regions important for substrate binding and activity of human beta 4GalT7, we conducted a phylogenetic analysis of the beta 1,4-galactosyltransferase family and generated a molecular model using the x-ray structure of Drosophila beta 4GalT7-UDP as template. Two evolutionary conserved motifs, (DVD165)-D-163 and (221)FWGWGREDDE(230), are central in the organization of the enzyme active site. This model was challenged by systematic engineering of point mutations, combined with in vitro and ex vivo functional assays. Investigation of the kinetic properties of purified recombinant wild-type beta 4GalT7 and selected mutants identified Trp(224) as a key residue governing both donor and acceptor substrate binding. Our results also suggested the involvement of the canonical carboxylate residue Asp(228) acting as general base in the reaction catalyzed by human beta 4GalT7. Importantly, ex vivo functional tests demonstrated that regulation of GAG synthesis is highly responsive to modification of these key active site amino acids. Interestingly, engineering mutants at position 224 allowed us to modify the affinity and to modulate the specificity of human beta 4GalT7 toward UDP-sugars and xyloside acceptors. Furthermore, the W224H mutant was able to sustain decorin GAG chain substitution but not GAG synthesis from exogenously added xyloside. Altogether, this study provides novel insight into human beta 4GalT7 active site functional domains, allowing manipulation of this enzyme critical for the regulation of GAG synthesis. A better understanding of the mechanism underlying GAG assembly paves the way toward GAG-based therapeutics.	[Talhaoui, Ibtissam; Bui, Catherine; Gulberti, Sandrine; Netter, Patrick; Ouzzine, Mohamed; Fournel-Gigleux, Sylvie] Univ Nancy 1, UMR CNRS 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France; [Oriol, Rafael] Univ Paris 11, INSERM, U1004, Inst Andre Lwoff, F-94807 Villejuif, France; [Mulliert, Guillermo] Univ Nancy 1, UMR CNRS 7036, Fac Sci & Tech, F-54505 Vandoeuvre Les Nancy, France; [Coughtrie, Michael W. H.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland	Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Lorraine; University of Dundee	Fournel-Gigleux, S (corresponding author), Univ Nancy 1, UMR CNRS 7561, Fac Med, BP 184, F-54505 Vandoeuvre Les Nancy, France.	sfg@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013; Coughtrie, Michael/C-3855-2009	Coughtrie, Michael/0000-0003-1989-1416	Agence Nationale de la Recherche [ANR-08-PCVI-0023-01]; INSERM-University of Dundee; Royal Society; Region Lorraine; GAG Network; CNRS-UHP Nancy I; University of Dundee	Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM-University of Dundee; Royal Society(Royal Society of London); Region Lorraine(Region Grand-Est); GAG Network; CNRS-UHP Nancy I; University of Dundee	This work was supported by Agence Nationale de la Recherche, GAG Network Grant ANR-08-PCVI-0023-01, INSERM-University of Dundee International Collaboration Contract C2I, Royal Society International Joint Grant (to M. W. H. C. and S. F.-G.), and the Region Lorraine. Part of this work was performed under the auspices of a European-associated laboratory between CNRS-UHP Nancy I and the University of Dundee.	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; BANSAL SK, 1980, ANAL BIOCHEM, V109, P321, DOI 10.1016/0003-2697(80)90655-7; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Case D. A., 2021, AMBER 2022; CASE DA, 2004, AMBER 8; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ciocchini AE, 2006, GLYCOBIOLOGY, V16, P679, DOI 10.1093/glycob/cwj113; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; DeAngelis PL, 1998, J BIOL CHEM, V273, P8454, DOI 10.1074/jbc.273.14.8454; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Fondeur-Gelinotte M, 2006, PROTEIN SCI, V15, P1667, DOI 10.1110/ps.062089106; FOURNELGIGLEUX S, 1989, FEBS LETT, V243, P119, DOI 10.1016/0014-5793(89)80111-5; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kisilevsky R, 2004, J MOL NEUROSCI, V24, P167, DOI 10.1385/JMN:24:1:167; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li D, 2007, J BIOL CHEM, V282, P36514, DOI 10.1074/jbc.M703107200; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Mani K, 1998, CANCER RES, V58, P1099; Martin NB, 1996, SEMIN THROMB HEMOST, V22, P247, DOI 10.1055/s-2007-999015; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Prydz K, 2000, J CELL SCI, V113, P193; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ramakrishnan B, 2010, J BIOL CHEM, V285, P15619, DOI 10.1074/jbc.M109.099564; Ramasamy V, 2003, J MOL BIOL, V331, P1065, DOI 10.1016/S0022-2836(03)00790-3; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Terrak M, 2008, J BIOL CHEM, V283, P28464, DOI 10.1074/jbc.M803223200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r	54	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37342	37358		10.1074/jbc.M110.151951	http://dx.doi.org/10.1074/jbc.M110.151951			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20843813	Green Published, hybrid			2022-12-27	WOS:000284424000027
J	Ahsberg, J; Tsapogas, P; Qian, H; Zetterblad, J; Zandi, S; Mansson, R; Jonsson, JI; Sigvardsson, M				Ahsberg, Josefine; Tsapogas, Panagiotis; Qian, Hong; Zetterblad, Jenny; Zandi, Sasan; Mansson, Robert; Jonsson, Jan-Ingvar; Sigvardsson, Mikael			Interleukin-7-induced Stat-5 Acts in Synergy with Flt-3 Signaling to Stimulate Expansion of Hematopoietic Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON LYMPHOID PROGENITORS; PROMOTES B-LYMPHOPOIESIS; RECEPTOR-DEFICIENT MICE; HEAVY-CHAIN GENE; STEM-CELLS; LINEAGE COMMITMENT; BONE-MARROW; LIGAND SUPPORTS; FACTOR EBF; C-KIT	The development of lymphoid cells from bone marrow progenitors is dictated by interplay between internal cues such as transcription factors and external signals like the cytokines Flt-3 ligand and Il-7. These proteins are both of large importance for normal lymphoid development; however, it is unclear if they act in direct synergy to expand a transient Il-7R(+)Flt-3(+) population or if the collaboration is created through sequential activities. We report here that Flt-3L and Il-7 synergistically stimulated the expansion of primary Il-7R(+)Flt-3(+) progenitor cells and a hematopoietic progenitor cell line ectopically expressing the receptors. The stimulation resulted in a reduced expression of pro-apoptotic genes and also mediated survival of primary progenitor cells in vitro. However, functional analysis of single cells suggested that the anti-apoptotic effect was additive indicating that the synergy observed mainly depends on stimulation of proliferation. Analysis of downstream signaling events suggested that although Il-7 induced Stat-5 phosphorylation, Flt-3L caused activation of the ERK and AKT signaling pathways. Flt-3L could also drive proliferation in synergy with ectopically expressed constitutively active Stat-5. This synergy could be inhibited with either receptor tyrosine kinase or MAPK inhibitors suggesting that Flt-3L and Il-7 act in synergy by activation of independent signaling pathways to expand early hematopoietic progenitors.	[Ahsberg, Josefine; Tsapogas, Panagiotis; Qian, Hong; Zetterblad, Jenny; Zandi, Sasan; Mansson, Robert; Jonsson, Jan-Ingvar; Sigvardsson, Mikael] IKE Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med, S-58185 Linkoping, Sweden	Linkoping University	Sigvardsson, M (corresponding author), IKE Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.	mikael.sigvardsson@med.lu.se	Tsapogas, Panagiotis/AAN-2465-2020; Mansson, Robert/D-4372-2014; Qian, Hong/D-5588-2014	Mansson, Robert/0000-0003-0738-0328; Qian, Hong/0000-0002-2512-9199; Sigvardsson, Mikael/0000-0001-8527-7276; Tsapogas, Panagiotis/0000-0002-9450-2604; Jonsson, Jan-Ingvar/0000-0003-4814-978X	Swedish Cancer Foundation (Cancer-fonden); The Swedish Research Council (Vetenskapsradet); The Childhood Cancer Foundation (Barncancerfonden); Linkoping University	Swedish Cancer Foundation (Cancer-fonden)(Swedish Cancer Society); The Swedish Research Council (Vetenskapsradet)(Swedish Research Council); The Childhood Cancer Foundation (Barncancerfonden); Linkoping University	This work was supported by the Swedish Cancer Foundation (Cancer-fonden), The Swedish Research Council (Vetenskapsradet), The Childhood Cancer Foundation (Barncancerfonden), and Linkoping University.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; HIRAYAMA F, 1995, BLOOD, V85, P1762, DOI 10.1182/blood.V85.7.1762.bloodjournal8571762; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jensen CT, 2008, BLOOD, V111, P2083, DOI 10.1182/blood-2007-08-108563; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Maraskovsky E, 1998, INT IMMUNOL, V10, P1367, DOI 10.1093/intimm/10.9.1367; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ray RJ, 1996, EUR J IMMUNOL, V26, P1504, DOI 10.1002/eji.1830260715; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Tagoh H, 2004, EMBO J, V23, P4275, DOI 10.1038/sj.emboj.7600421; Veiby OP, 1996, BLOOD, V88, P1256, DOI 10.1182/blood.V88.4.1256.bloodjournal8841256; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364	44	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36275	36284		10.1074/jbc.M110.155531	http://dx.doi.org/10.1074/jbc.M110.155531			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20829349	Green Published, hybrid			2022-12-27	WOS:000284146100037
J	Benedix, J; Lajoie, P; Jaiswal, H; Burgard, C; Greiner, M; Zimmermann, R; Rospert, S; Snapp, EL; Dudek, J				Benedix, Julia; Lajoie, Patrick; Jaiswal, Himjyot; Burgard, Carsten; Greiner, Markus; Zimmermann, Richard; Rospert, Sabine; Snapp, Erik L.; Dudek, Johanna			BiP Modulates the Affinity of Its Co-chaperone ERj1 for Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN TRANSLOCATION; ATP-BINDING; YEAST; MEMBRANE; COMPLEX; SEC63P; MECHANISMS; TRANSPORT; HOMOLOGS	Ribosomes synthesizing secretory and membrane proteins are bound to the endoplasmic reticulum (ER) membrane and attach to ribosome-associated membrane proteins such as the Sec61 complex, which forms the protein-conducting channel in the membrane. The ER membrane-resident Hsp40 protein ERj1 was characterized as being able to recruit BiP to ribosomes in solution and to regulate protein synthesis in a BiP-dependent manner. Here, we show that ERj1 and Sec61 are associated with ribosomes at the ER of human cells and that the binding of ERj1 to ribosomes occurs with a binding constant in the picomolar range and is prevented by pretreatment of ribosomes with RNase. However, the affinity of ERj1 for ribosomes dramatically changes upon binding of BiP. This modulation by BiP may be responsible for the dual role of ERj1 at the ribosome, i.e. acting as a recruiting factor for BiP and regulating translation.	[Dudek, Johanna] Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Lajoie, Patrick; Snapp, Erik L.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Jaiswal, Himjyot; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Jaiswal, Himjyot; Rospert, Sabine] Univ Freiburg, Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	Saarland University; Yeshiva University; Albert Einstein College of Medicine; University of Freiburg; University of Freiburg	Dudek, J (corresponding author), Univ Saarland, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany.	johanna.dudek@uks.eu	Snapp, Erik Lee/H-7152-2019	Snapp, Erik Lee/0000-0001-9482-2272; Rospert, Sabine/0000-0002-3089-9614; Lajoie, Patrick/0000-0002-1614-176X	Homburger Forschungsfor-derungsprogramm (HOMFOR); Deutsche Forschungsgemein-schaft [FOR 967, SFB530]; BiP expression plasmids; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	Homburger Forschungsfor-derungsprogramm (HOMFOR); Deutsche Forschungsgemein-schaft(German Research Foundation (DFG)); BiP expression plasmids; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants from Homburger Forschungsfor-derungsprogramm (HOMFOR) and the Deutsche Forschungsgemein-schaft (FOR 967 and SFB530).; We are grateful to Linda Hendershot for the kind gift of the BiP expression plasmids. We thank A. Muller, S. Amann, and M. Lerner for expert technical assistance.	Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Dierks T, 1996, EMBO J, V15, P6931, DOI 10.1002/j.1460-2075.1996.tb01085.x; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Dudek J, 2002, EMBO J, V21, P2958, DOI 10.1093/emboj/cdf315; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; Kroczynska B, 2004, J BIOL CHEM, V279, P11432, DOI 10.1074/jbc.M310903200; MATSUMOTOTANIUR.N, 1996, J M MOL BIOL CELL, V7, P1455; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Tyedmers J, 2003, EMBO REP, V4, P505, DOI 10.1038/sj.embor.embor826; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmermann R, 2006, TRENDS MOL MED, V12, P567, DOI 10.1016/j.molmed.2006.10.004	30	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36427	36433		10.1074/jbc.M110.143263	http://dx.doi.org/10.1074/jbc.M110.143263			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864538	Green Published, hybrid			2022-12-27	WOS:000284146100007
J	Kartberg, F; Asp, L; Dejgaard, SY; Smedh, M; Fernandez-Rodriguez, J; Nilsson, T; Presley, JF				Kartberg, Fredrik; Asp, Lennart; Dejgaard, Selma Y.; Smedh, Maria; Fernandez-Rodriguez, Julia; Nilsson, Tommy; Presley, John F.			ARFGAP2 and ARFGAP3 Are Essential for COPI Coat Assembly on the Golgi Membrane of Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; BREFELDIN-A; BINDING-PROTEIN; ARF GAPS; VESICLES; TRANSPORT; APPARATUS; DYNAMICS; HYDROLYSIS	Coat protein complex I (COPI) vesicles play a central role in the recycling of proteins in the early secretory pathway and transport of proteins within the Golgi stack. Vesicle formation is initiated by the exchange of GDP for GTP on ARF1 (ADP-ribosylation factor 1), which, in turn, recruits the coat protein coatomer to the membrane for selection of cargo and membrane deformation. ARFGAP1 (ARF1 GTPase-activating protein 1) regulates the dynamic cycling of ARF1 on the membrane that results in both cargo concentration and uncoating for the generation of a fusion-competent vesicle. Two human orthologues of the yeast ARFGAP Glo3p, termed ARFGAP2 and ARFGAP3, have been demonstrated to be present on COPI vesicles generated in vitro in the presence of guanosine 5'-3-O-(thio) triphosphate. Here, we investigate the function of these two proteins in living cells and compare it with that of ARFGAP1. We find that ARFGAP2 and ARFGAP3 follow the dynamic behavior of coatomer upon stimulation of vesicle budding in vivo more closely than does ARFGAP1. Electron microscopy of ARFGAP2 and ARFGAP3 knockdowns indicated Golgi unstacking and cisternal shortening similarly to conditions where vesicle uncoating was blocked. Furthermore, the knockdown of both ARFGAP2 and ARFGAP3 prevents proper assembly of the COPI coat lattice for which ARFGAP1 does not seem to play a major role. This suggests that ARFGAP2 and ARFGAP3 are key components of the COPI coat lattice and are necessary for proper vesicle formation.	[Nilsson, Tommy] Univ Gothenburg, Dept Med & Clin Genet, Inst Biomed, S-40530 Gothenburg, Sweden; [Smedh, Maria; Fernandez-Rodriguez, Julia; Nilsson, Tommy] Univ Gothenburg, Ctr Cellular Imaging, S-40530 Gothenburg, Sweden; [Nilsson, Tommy] McGill Univ, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ H3A 1A1, Canada; [Nilsson, Tommy] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Dejgaard, Selma Y.; Presley, John F.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	University of Gothenburg; University of Gothenburg; McGill University; McGill University; McGill University	Presley, JF (corresponding author), 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	john.presley@mcgill.ca		Fernandez-Rodriguez, Julia/0000-0003-4522-0966	Swedish Research Council; Canadian Institutes for Health Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Swedish Research Council and by the Canadian Institutes for Health Research.	ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DeRegis CJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-3; Dogic D, 1999, EUR J CELL BIOL, V78, P305, DOI 10.1016/S0171-9335(99)80064-8; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kartberg F, 2005, BBA-MOL CELL RES, V1744, P351, DOI 10.1016/j.bbamcr.2005.05.003; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.e04-04-0316; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Liu XQ, 2001, FEBS LETT, V490, P79, DOI 10.1016/S0014-5793(01)02134-2; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Pepperkok R, 2000, J CELL SCI, V113, P135; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SIMIONESCU N, 1976, J CELL BIOL, V70, pA186; Singh J, 2001, J BIOL CHEM, V276, P11852, DOI 10.1074/jbc.M006931200; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x; Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	61	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36709	36720		10.1074/jbc.M110.180380	http://dx.doi.org/10.1074/jbc.M110.180380			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858901	Green Published, hybrid			2022-12-27	WOS:000284146100010
J	Kim, S; Jho, EH				Kim, Sewoon; Jho, Eek-hoon			The Protein Stability of Axin, a Negative Regulator of Wnt Signaling, Is Regulated by Smad Ubiquitination Regulatory Factor 2 (Smurf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; DEGRADATION; PATHWAY; CANCER; LIGASE; COMPLEX; INHIBITION; ACTIVATION; TARGETS; KINASE	Axin is a negative regulator of Wnt/beta-catenin signaling via regulating the level of beta-catenin, which is a key effector molecule. Therefore, controlling the level of Axin is a critical step for the regulation of Wnt/beta-catenin signaling. It has been shown that ubiquitination-mediated proteasomal degradation may play a critical role in the regulation of Axin; however, the E3 ubiquitin ligase(s), which attaches ubiquitin to a target protein in combination with an E2 ubiquitin-conjugating enzyme, for Axin has not yet been identified. Here, we show that Smurf2 is an E3 ubiquitin ligase for Axin. Transient expression of Smurf2 down-regulated the level of Axin and increased the ubiquitination of Axin. Conversely, shRNA specific to Smurf2 blocked Axin ubiquitination. Essential domains of Axin responsible for Smurf2 interaction as well as Smurf2-mediated down-regulation and ubiquitination were identified. In vitro ubiquitination assays followed by analysis using mass spectroscopy revealed that Smurf2 specifically ubiquitinylated Lys(505) of Axin and that the Axin(K505R) mutant resisted degradation. Knockdown of endogenous Smurf2 increased the level of endogenous Axin and resulted in reduced beta-catenin/Tcf reporter activity. Overall, our data strongly suggest that Smurf2 is a genuine E3 ligase for Axin.	[Kim, Sewoon; Jho, Eek-hoon] Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	University of Seoul	Jho, EH (corresponding author), Univ Seoul, Dept Life Sci, 90 Jeonnong Dong, Seoul 130743, South Korea.	ej70@uos.ac.kr		Jho, Eek-hoon/0000-0003-2414-6234	Ministry of Education, Science, and Technology; Brain Korea 21 Program; Seoul Science Fellowship	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Seoul Science Fellowship	This work was supported in part by Grants 2006-2004046 and R01-2007-000-20944-0 from the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology.; Supported by the Brain Korea 21 Program and a Seoul Science Fellowship.	Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu QQ, 2009, EXP CELL RES, V315, P2386, DOI 10.1016/j.yexcr.2009.05.019; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	27	62	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36420	36426		10.1074/jbc.M110.137471	http://dx.doi.org/10.1074/jbc.M110.137471			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20858899	hybrid, Green Published			2022-12-27	WOS:000284146100081
J	Mita, R; Beaulieu, MJ; Field, C; Godbout, R				Mita, Raja; Beaulieu, Michael J.; Field, Catherine; Godbout, Roseline			Brain Fatty Acid-binding Protein and omega-3/omega-6 Fatty Acids MECHANISTIC INSIGHT INTO MALIGNANT GLIOMA CELL MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; BREAST-CANCER CELLS; PPAR-GAMMA; GENE-EXPRESSION; GLIOBLASTOMA-MULTIFORME; GROWTH-INHIBITION; STRUCTURAL BASIS; MOUSE-LIVER; NUDE-MICE; B-FABP	Malignant gliomas (MG) are highly infiltrative tumors that consistently recur despite aggressive treatment. Brain fatty acid-binding protein (FABP7), which binds docosahexaenoic acid (DHA) and arachidonic acid (AA), localizes to sites of tumor infiltration and is associated with a poor prognosis in MG. Manipulation of FABP7 expression in MG cell lines affects cell migration, suggesting a role for FABP7 in tumor infiltration and recurrence. Here, we show that DHA inhibits and AA stimulates migration in an FABP7-dependent manner in U87 MG cells. We demonstrate that DHA binds to and sequesters FABP7 to the nucleus, resulting in decreased cell migration. This anti-migratory effect is partially dependent on peroxisome proliferator-activated receptor gamma, a DHA-activated transcription factor. Conversely, AA-bound FABP7 stimulates cell migration by activating cyclooxygenase-2 and reducing peroxisome proliferator-activated receptor gamma levels. Our data provide mechanistic insight as to why FABP7 is associated with a poor prognosis in MG and suggest that relative levels of DHA and AA in the tumor environment can make a profound impact on tumor growth properties. We propose that FABP7 and its fatty acid ligands may be key therapeutic targets for controlling the dissemination of MG cells within the brain.	[Mita, Raja; Beaulieu, Michael J.; Godbout, Roseline] Univ Alberta, Dept Oncol, Cross Canc Inst, Sch Canc Engn & Imaging Sci, Edmonton, AB T6G 1Z2, Canada; [Field, Catherine] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada	University of Alberta; University of Alberta	Godbout, R (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, Sch Canc Engn & Imaging Sci, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	Godbout, Roseline/I-4639-2016	Godbout, Roseline/0000-0002-4779-9265; Field, Catherine/0000-0001-7285-4767	Alberta Cancer Research Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research	Alberta Cancer Research Institute; Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Alberta Cancer Research Institute (to R. G.) and studentships from the Alberta Cancer Foundation (to R. M.) and the Canadian Institutes of Health Research (to M. J. B.).	Adida A, 2006, BBA-MOL CELL BIOL L, V1761, P172, DOI 10.1016/j.bbalip.2006.02.006; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Benedetti E, 2010, INT J IMMUNOPATH PH, V23, P235, DOI 10.1177/039463201002300121; Biondo PD, 2008, J NUTR BIOCHEM, V19, P787, DOI 10.1016/j.jnutbio.2008.02.003; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chearwae W, 2008, BRIT J CANCER, V99, P2044, DOI 10.1038/sj.bjc.6604786; Connolly JM, 1999, NUTR CANCER, V35, P44, DOI 10.1207/S1532791444-49; Coras R, 2007, MOL CANCER THER, V6, P1745, DOI 10.1158/1535-7163.MCT-06-0763; Cormack B, 2002, METHOD ENZYMOL, V350, P199, DOI 10.1016/S0076-6879(02)50964-2; Crawford MA, 2003, LIPIDS, V38, P303, DOI 10.1007/s11745-003-1065-1; Fujishiro K, 2002, MOL CELL BIOCHEM, V239, P165, DOI 10.1023/A:1020546606429; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Giese A, 1999, Neuro Oncol, V1, P3, DOI 10.1093/neuonc/1.1.3; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Grommes C, 2006, MOL PHARMACOL, V70, P1524, DOI 10.1124/mol.106.022194; Hau P, 2007, ONCOLOGY-BASEL, V73, P21, DOI 10.1159/000120028; Helledie T, 2002, MOL CELL BIOCHEM, V239, P157, DOI 10.1023/A:1020538404612; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Joki T, 2000, CANCER RES, V60, P4926; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Marszalek R, 2010, ACTA POL PHARM, V67, P129; Martin DD, 1996, LIPIDS, V31, P1283, DOI 10.1007/BF02587914; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Motojima K, 2000, INT J BIOCHEM CELL B, V32, P1085, DOI 10.1016/S1357-2725(00)00046-7; Noguchi M, 1997, BRIT J CANCER, V75, P348, DOI 10.1038/bjc.1997.57; Papi A, 2009, J NEUROCHEM, V109, P1779, DOI 10.1111/j.1471-4159.2009.06111.x; Perdiki M, 2007, MOL CELL BIOCHEM, V295, P75, DOI 10.1007/s11010-006-9275-7; Poirier H, 2001, BIOCHEM J, V355, P481, DOI 10.1042/0264-6021:3550481; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Rose DP, 1996, CLIN CANCER RES, V2, P1751; Seliger B, 2005, PROTEOMICS, V5, P2631, DOI 10.1002/pmic.200401264; Simopoulos Artemis P., 2009, V99, P1, DOI 10.1159/000192755; Slipicevic A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-276; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; Spagnolo A, 2007, J NEUROSURG, V106, P299, DOI 10.3171/jns.2007.106.2.299; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Wang MS, 2000, CANCER RES, V60, P6482; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Wu T, 2006, CANCER TREAT REV, V32, P28, DOI 10.1016/j.ctrv.2005.10.004; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Zang CB, 2003, J NEURO-ONCOL, V65, P107, DOI 10.1023/B:NEON.0000003728.80052.a8; Zhang H, 2010, BREAST CANCER RES TR, V121, P41, DOI 10.1007/s10549-009-0450-x	57	61	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37005	37015		10.1074/jbc.M110.170076	http://dx.doi.org/10.1074/jbc.M110.170076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20834042	hybrid, Green Published			2022-12-27	WOS:000284146100042
J	Chen, W; Lou, JZ; Zhu, C				Chen, Wei; Lou, Jizhong; Zhu, Cheng			Forcing Switch from Short- to Intermediate- and Long-lived States of the alpha A Domain Generates LFA-1/ICAM-1 Catch Bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; I-LIKE DOMAIN; HIGH-AFFINITY CONFORMATION; LIGAND BINDING-KINETICS; HIGH-STRENGTH STATES; INTEGRIN ALPHA(L)BETA(2); ADHESION RECEPTORS; MOLECULAR-DYNAMICS; BETA(2) INTEGRIN; STRUCTURAL BASIS	Binding of lymphocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1) mediates leukocyte adhesion under force. Using a biomembrane force probe capable of measuring single bond interactions, we showed ICAM-1 binding to LFA-1 at different conformations, including the bent conformation with the lowest affinity. We quantify how force and conformations of LFA-1 regulate its kinetics with ICAM-1. At zero-force, on-rates were substantially changed by conditions that differentially favor a bent or extended LFA-1 with a closed or open headpiece; but off-rates were identical. With increasing force, LFA-1/ICAM-1 bond lifetimes (reciprocal off-rates) first increased (catch bonds) and then decreased (slip bonds). Three states with distinct off-rates were identified from lifetime distributions. Force shifted the associated fractions from the short-to intermediate- and long-lived states, producing catch bonds at low forces, but increased their off-rates exponentially, converting catch to slip bonds at high forces. An internal ligand antagonist that blocks pulling of the alpha(7)-helix suppressed the intermediate-/long-lived states and eliminated catch bonds, revealing an internal catch bond between the alpha A and beta A domains. These results elucidate an allosteric mechanism for the mechanochemistry of LFA-1/ICAM-1 binding.	[Chen, Wei; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Chen, Wei; Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Lou, Jizhong; Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhu, C (corresponding author), 315 Ferst Dr,IBB Bldg 3312, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Chen, Wei/C-4823-2009	Chen, Wei/0000-0001-5366-7253	National Institutes of Health [AI44902]; American Heart Association [0735224N]; Chinese Academy of Sciences; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044902, R01AI044902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Chinese Academy of Sciences(Chinese Academy of Sciences); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44902 (to C. Z.), an American Heart Association Scientist Development Grant 0735224N and the "Hundred Talents Program" of the Chinese Academy of Sciences (to J. L.), and an American Heart Association Predoctoral Fellowship (to W. C.).	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Blue R, 2010, J BIOL CHEM, V285, P17604, DOI 10.1074/jbc.M110.107763; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6; Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698; Evans E, 2010, BIOPHYS J, V98, P1458, DOI 10.1016/j.bpj.2009.09.067; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gaillard T, 2009, PROTEINS, V76, P977, DOI 10.1002/prot.22404; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Labadia ME, 1998, J IMMUNOL, V161, P836; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lomax RG, 2007, STAT CONCEPTS 2 COUR, P10; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MILLER LJ, 1986, J IMMUNOL, V137, P2891; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; [No title captured]; [No title captured]	54	131	139	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35967	35978		10.1074/jbc.M110.155770	http://dx.doi.org/10.1074/jbc.M110.155770			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20819952	Green Published, hybrid			2022-12-27	WOS:000283845300073
J	French, JB; Ealick, SE				French, Jarrod B.; Ealick, Steven E.			Structural and Mechanistic Studies on Klebsiella pneumoniae 2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline Decarboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; URIC-ACID DEGRADATION; MOLECULAR MECHANICS; URATE OXIDASE; SOFTWARE; PATHWAY; STABILIZATION; CATALYSIS; PROTEINS; SYSTEM	The stereospecific oxidative degradation of uric acid to (S)-allantoin was recently shown to proceed via three enzymatic steps. The final conversion is a decarboxylation of the unstable intermediate 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) and is catalyzed by OHCU decarboxylase. Here we present the structures of Klebsiella pneumoniae OHCU decarboxylase in unliganded form and with bound allantoin. These structures provide evidence that ligand binding organizes the active site residues for catalysis. Modeling of the substrate and intermediates provides additional support for this hypothesis. In addition we characterize the steady state kinetics of this enzyme and report the first OHCU decarboxylase inhibitor, allopurinol, a structural isomer of hypoxanthine. This molecule is a competitive inhibitor of K. pneumoniae OHCU decarboxylase with a K-i of 30 +/- 2 mu M. Circular dichroism measurements confirm structural observations that this inhibitor disrupts the necessary organization of the active site. Our structural and biochemical studies also provide further insights into the mechanism of catalysis of OHCU decarboxylation.	[Ealick, Steven E.] Cornell Univ, Baker Lab 120, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University	Ealick, SE (corresponding author), Cornell Univ, Baker Lab 120, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	see3@cornell.edu	French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309	National Institutes of Health [GM73220, RR-15301]; National Institutes of Health (NIH) under National Science Foundation [DMR-0225180]; National Center for Research Resources, NIH [RR-01646]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) under National Science Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM73220.; We thank the staff at the Cornell High Energy Synchrotron Source (CHESS) and Northeastern Collaborative Access Team for advice with data collection and processing. The data collection performed at the CHESS was supported by the National Science Foundation and the NIGMS, National Institutes of Health (NIH) under National Science Foundation Award DMR-0225180 using the Macromolecular Diffraction at the CHESS (MacCHESS) facility, which is supported by National Center for Research Resources, NIH Award RR-01646. Data collected at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source are supported by National Center for Research Resources, National Institutes of Health Award RR-15301. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357. We acknowledge Cynthia Kinsland of the Protein Production Facility in the Department of Chemistry and Chemical Biology for help with molecular biology and Leslie Kinsland for help with manuscript preparation. We thank M. V. Airola and K. O. Gee of the B. R. Crane laboratory for assistance with the CD data collection.	ALBERY WJ, 1986, BIOCHEMISTRY-US, V25, P2572, DOI 10.1021/bi00357a043; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Begley TP, 2004, CURR OPIN CHEM BIOL, V8, P508, DOI 10.1016/j.cbpa.2004.08.004; Begley TP, 2000, CURR OPIN STRUC BIOL, V10, P711, DOI 10.1016/S0959-440X(00)00148-2; Borges F, 2002, CURR MED CHEM, V9, P195, DOI 10.2174/0929867023371229; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; DeLano W.L, PYMOL MOL GRAPHICS S; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Doukov TI, 2007, J BIOL CHEM, V282, P6609, DOI 10.1074/jbc.M609828200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; Frey P. A., 2007, ENZYMATIC REACTION M, P387; Gabison L, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-32; Heck SD, 1996, P NATL ACAD SCI USA, V93, P4036, DOI 10.1073/pnas.93.9.4036; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Kahn K, 1997, BIOCHEMISTRY-US, V36, P4731, DOI 10.1021/bi963184w; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kahn K, 2000, BIOORG CHEM, V28, P62, DOI 10.1006/bioo.2000.1162; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCMURRY JE, 2005, ORGANIC CHEM BIOL PA, P134; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Rudik I, 2001, ARCH BIOCHEM BIOPHYS, V392, P341, DOI 10.1006/abbi.2001.2467; STILL WC, 1999, MACROMODEL; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wood BM, 2009, BIOCHEMISTRY-US, V48, P5510, DOI 10.1021/bi9006226; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	39	17	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35446	35454		10.1074/jbc.M110.156034	http://dx.doi.org/10.1074/jbc.M110.156034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826786	Green Published, hybrid			2022-12-27	WOS:000283845300022
J	Gresset, A; Hicks, SN; Harden, TK; Sondek, J				Gresset, Aurelie; Hicks, Stephanie N.; Harden, T. Kendall; Sondek, John			Mechanism of Phosphorylation-induced Activation of Phospholipase C-gamma Isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC HOMOLOGY-2 DOMAIN; SH2 DOMAIN; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; Y-DOMAIN; RESIDUES; SITE; RAC	The lipase activity of most phospholipases C (PLCs) is basally repressed by a highly degenerate and mostly disordered X/Y linker inserted within the catalytic domain. Release of this auto-inhibition is driven by electrostatic repulsion between the plasma membrane and the electronegative X/Y linker. In contrast, PLC-gamma isozymes (PLC-gamma 1 and -gamma 2) are structurally distinct from other PLCs because multiple domains are present in their X/Y linker. Moreover, although many tyrosine kinases directly phosphorylate PLC-gamma isozymes to enhance their lipase activity, the underlying molecular mechanism of this activation remains unclear. Here we define the mechanism for the unique regulation of PLC-gamma isozymes by their X/Y linker. Specifically, we identify the C-terminal SH2 domain within the X/Y linker as the critical determinant for auto-inhibition. Tyrosine phosphorylation of the X/Y linker mediates high affinity intramolecular interaction with the C-terminal SH2 domain that is coupled to a large conformational rearrangement and release of auto-inhibition. Consequently, PLC-gamma isozymes link phosphorylation to phospholipase activation by elaborating upon primordial regulatory mechanisms found in other PLCs.	[Gresset, Aurelie; Hicks, Stephanie N.; Harden, T. Kendall; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Harden, T. Kendall; Sondek, John] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sondek, John] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 120 Mason Farm Rd,4009 Genet Med,CB 4365, Chapel Hill, NC 27599 USA.	sondek@med.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [R01-GM57391]; American Heart Association (AHA) [AHA 0715332U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, R01GM062299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM57391 (to J.S. and T. K. H.). This work was also supported by American Heart Association Pre-doctoral Fellowship AHA 0715332U (to A. G.).	Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FERNALD AW, 1994, BIOCHEM J, V302, P503, DOI 10.1042/bj3020503; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Homma MK, 1996, CELL GROWTH DIFFER, V7, P281; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; HORSTMAN DA, 1995, PROTEIN EXPRES PURIF, V6, P278, DOI 10.1006/prep.1995.1036; Horstman DA, 1996, P NATL ACAD SCI USA, V93, P7518, DOI 10.1073/pnas.93.15.7518; Horstman DA, 1999, ARCH BIOCHEM BIOPHYS, V361, P149, DOI 10.1006/abbi.1998.0978; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; Jones GA, 2000, ARCH BIOCHEM BIOPHYS, V375, P229, DOI 10.1006/abbi.1999.1670; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KOBLAN KS, 1995, BIOCHEM J, V305, P745, DOI 10.1042/bj3050745; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; Serrano CJ, 2005, J IMMUNOL, V174, P6233, DOI 10.4049/jimmunol.174.10.6233; WAHL MI, 1990, J BIOL CHEM, V265, P3944; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200	37	78	78	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35836	35847		10.1074/jbc.M110.166512	http://dx.doi.org/10.1074/jbc.M110.166512			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807769	Green Published, hybrid			2022-12-27	WOS:000283845300061
J	Yao, ZX; Jogunoori, W; Choufani, S; Rashid, A; Blake, T; Yao, WG; Kreishman, P; Amin, R; Sidawy, AA; Evans, SRT; Finegold, M; Reddy, EP; Mishra, B; Weksberg, R; Kumar, R; Mishra, L				Yao, Zhi-Xing; Jogunoori, Wilma; Choufani, Sanaa; Rashid, Asif; Blake, Tiffany; Yao, Wenguo; Kreishman, Peter; Amin, Rupen; Sidawy, Anton A.; Evans, Stephen R. T.; Finegold, Milton; Reddy, E. Premkumar; Mishra, Bibhuti; Weksberg, Rosanna; Kumar, Rakesh; Mishra, Lopa			Epigenetic Silencing of beta-Spectrin, a TGF-beta Signaling/Scaffolding Protein in a Human Cancer Stem Cell Disorder BECKWITH-WIEDEMANN SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLABI-BEHMEL SYNDROME; IMPRINTED GENES; MOUSE MODEL; GROWTH; DISRUPTION; P57(KIP2); IGF2; OVERGROWTH; ELF; DIFFERENTIATION	Hereditary cancer syndromes provide powerful insights into dysfunctional signaling pathways that lead to sporadic cancers. Beckwith-Wiedemann syndrome (BWS) is a hereditary human cancer stem cell syndrome currently linked to deregulated imprinting at chromosome 11p15 and uniparental disomy. However, causal molecular defects and genetic models have remained elusive to date in the majority of cases. The non-pleckstrin homology domain beta-spectrin (beta 2SP) (the official name for human is Spectrin, beta, nonerythrocytic 1 (SPTBN1), isoform 2; the official name for mouse is Spectrin beta 2 (Spnb2), isoform 2), a scaffolding protein, functions as a potent TGF-beta signaling member adaptor in tumor suppression and development. Yet, the role of the beta 2SP in human tumor syndromes remains unclear. Here, we report that beta 2SP(+/-) mice are born with many phenotypic characteristics observed in BWS patients, suggesting that beta 2SP mutant mice phenocopy BWS, and beta 2SP loss could be one of the mechanisms associated with BWS. Our results also suggest that epigenetic silencing of beta 2SP is a new potential causal factor in human BWS patients. Furthermore, beta 2SP(+/-) mice provide an important animal model for BWS, as well as sporadic cancers associated with it, including lethal gastrointestinal and pancreatic cancer. Thus, these studies could lead to further insight into defects generated by dysfunctional stem cells and identification of new treatment strategies and functional markers for the early detection of these lethal cancers that otherwise cannot be detected at an early stage.	[Yao, Zhi-Xing; Jogunoori, Wilma; Blake, Tiffany; Yao, Wenguo; Amin, Rupen; Mishra, Bibhuti; Mishra, Lopa] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Rashid, Asif] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Evans, Stephen R. T.] Georgetown Univ, Dept Surg, Washington, DC 20057 USA; [Kumar, Rakesh] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Finegold, Milton] Baylor Univ, Dept Pathol, Houston, TX 77030 USA; [Sidawy, Anton A.] Dept Vet Affairs Med Ctr, Washington, DC 20422 USA; [Reddy, E. Premkumar] Mt Sinai Med Ctr, New York, NY 10029 USA; [Choufani, Sanaa; Weksberg, Rosanna] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kreishman, Peter] Walter Reed Army Med Ctr, Washington, DC 20307 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Georgetown University; George Washington University; Baylor University; Icahn School of Medicine at Mount Sinai; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Mishra, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	lmishra@mdanderson.org	Choufani, Sanaa/GWC-1820-2022; Reddy, E. Premkumar/F-6233-2011; Kumar, Rakesh/ABD-1065-2020	Choufani, Sanaa/0000-0002-5241-2213; Kumar, Rakesh/0000-0001-7664-0803; Mishra, Lopa/0000-0002-6850-0808	National Institutes of Health [P01 CA130821, R01 CA106614A, R01 CA042857, R01 DK58637]; Veterans Affairs merit award; R. Robert and Sally D. Funderburg Research Scholar award; NATIONAL CANCER INSTITUTE [P01CA130821, R01CA042857, R01CA106614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); R. Robert and Sally D. Funderburg Research Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA130821, R01 CA106614A, and R01 CA042857 (to L. M.) and R01 DK58637 (to B. M.). This work was also supported by a Veterans Affairs merit award (to L. M.), the R. Robert and Sally D. Funderburg Research Scholar award (to L. M.)	Allen C, 2005, BJOG-INT J OBSTET GY, V112, P1589, DOI 10.1111/j.1471-0528.2005.00784.x; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115; COMBS JT, 1966, NEW ENGL J MED, V275, P236, DOI 10.1056/NEJM196608042750502; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Enklaar Thorsten, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000020; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; GARGANTA CL, 1992, AM J MED GENET, V44, P129, DOI 10.1002/ajmg.1320440202; Gosden R, 2003, LANCET, V361, P1975, DOI 10.1016/S0140-6736(03)13592-1; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; HughesBenzie RM, 1996, AM J MED GENET, V66, P227, DOI 10.1002/(SICI)1096-8628(19961211)66:2<227::AID-AJMG20>3.0.CO;2-U; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; John RM, 2001, HUM MOL GENET, V10, P1601, DOI 10.1093/hmg/10.15.1601; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Lapunzina P, 2005, AM J MED GENET C, V137C, P53, DOI 10.1002/ajmg.c.30064; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li M, 1998, CLIN GENET, V53, P165; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Luton D, 1996, FETAL DIAGN THER, V11, P154, DOI 10.1159/000264296; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Miles HL, 2005, REV ENDOCR METAB DIS, V6, P261, DOI 10.1007/s11154-005-6184-0; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Neri G, 1998, AM J MED GENET, V79, P279, DOI 10.1002/(SICI)1096-8628(19981002)79:4<279::AID-AJMG9>3.0.CO;2-H; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Song HH, 1997, J BIOL CHEM, V272, P7574, DOI 10.1074/jbc.272.12.7574; SPENCER GSG, 1980, ARCH DIS CHILD, V55, P151, DOI 10.1136/adc.55.2.151; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Tang Y, 2005, CANCER RES, V65, P4228, DOI 10.1158/0008-5472.CAN-04-4585; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; WENG EY, 1995, AM J MED GENET, V56, P366, DOI 10.1002/ajmg.1320560405; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	49	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36112	36120		10.1074/jbc.M110.162347	http://dx.doi.org/10.1074/jbc.M110.162347			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20739274	Green Published, hybrid			2022-12-27	WOS:000283845300087
J	Gandhi, M; Jangi, M; Goode, BL				Gandhi, Meghal; Jangi, Mohini; Goode, Bruce L.			Functional Surfaces on the Actin-binding Protein Coronin Revealed by Systematic Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTITATIVE-ANALYSIS; ARP2/3 COMPLEX; IN-VIVO; F-ACTIN; MICROTUBULE CYTOSKELETONS; LEADING-EDGE; COFILIN; YEAST; FILAMENT; DYNAMICS	Coronin is a conserved actin-binding protein that co-functions with ADF/cofilin and Arp2/3 complex to govern cellular actin dynamics. Despite emerging roles for coronin in a range of physiological processes and disease states, a detailed understanding of the molecular interactions of coronin with actin and other binding partners has been lacking. Here, we performed a systematic mutational analysis of surfaces on the yeast coronin beta-propeller domain, which binds to F-actin and is conserved in all coronin family members. We generated 21 mutant alleles and analyzed their biochemical effects on actin binding and ADF/cofilin activity. Conserved actin-binding residues mapped to a discrete ridge stretching across one side of the beta-propeller. Mutants defective in actin binding showed loss of synergy with ADF/cofilin in severing filaments, diminished localization to actin structures in vivo, and loss of coronin overexpression growth defects. In addition, one allele showed normal actin binding but impaired functional interactions with ADF/cofilin. Another allele showed normal actin binding but failed to cause coronin overexpression defects. Together, these results indicate that actin binding is critical for many of the biochemical and cellular functions of coronin and that the beta-propeller domain mediates additional functional interactions with ADF/cofilin and possibly other ligands. Conservation of the actin-binding surfaces across distant species and in all three major classes of coronin isoforms suggests that the nature of the coronin-actin association may be similar in other family members.	[Gandhi, Meghal; Jangi, Mohini; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.	goode@brandeis.edu		, Mohini/0000-0003-3138-4484	National Institutes of Health [GM63691, GM083137]; National Science Foundation, Materials Research Science and Engineering Centers; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063691, R01GM083137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation, Materials Research Science and Engineering Centers(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63691 and GM083137. This work was also supported by funds from the National Science Foundation, Materials Research Science and Engineering Centers (to B. L. G.).	Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; DE H, 1993, J CELL BIOL */* G J, V120, P163; DE H, 1991, EMBO J */* G EMBO J, V10, P4097; FO GERN, 2006, SCIENCE */* A C SCI, V313, P839; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Mishima M, 1999, J CELL SCI, V112, P2833; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Oku T, 2003, BIOL PHARM BULL, V26, P409; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; SMITH TF, 2008, F Subcell BIOCH, V48, P20; Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; WERTMAN KF, 1992, GENETICS, V132, P337	33	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34899	34908		10.1074/jbc.M110.171496	http://dx.doi.org/10.1074/jbc.M110.171496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813846	Green Published, hybrid			2022-12-27	WOS:000283659100064
J	Magli, A; Angelelli, C; Ganassi, M; Baruffaldi, F; Matafora, V; Battini, R; Bachi, A; Messina, G; Rustighi, A; Del Sal, G; Ferrari, S; Molinari, S				Magli, Alessandro; Angelelli, Cecilia; Ganassi, Massimo; Baruffaldi, Fiorenza; Matafora, Vittoria; Battini, Renata; Bachi, Angela; Messina, Graziella; Rustighi, Alessandra; Del Sal, Giannino; Ferrari, Stefano; Molinari, Susanna			Proline Isomerase Pin1 Represses Terminal Differentiation and Myocyte Enhancer Factor 2C Function in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; MEF2; PHOSPHORYLATION; MYOGENESIS; FAMILY; LOCALIZATION; INHIBITION; ACTIVATION	Reversible proline-directed phosphorylation at Ser/Thr-Pro motifs has an essential role in myogenesis, a multistep process strictly regulated by several signaling pathways that impinge on two families of myogenic effectors, the basic helix-loop-helix myogenic transcription factors and the MEF2 (myocyte enhancer factor 2) proteins. The question of how these signals are deciphered by the myogenic effectors remains largely unaddressed. In this study, we show that the peptidyl-prolyl isomerase Pin1, which catalyzes the isomerization of phosphorylated Ser/Thr-Pro peptide bonds to induce conformational changes of its target proteins, acts as an inhibitor of muscle differentiation because its knockdown in myoblasts promotes myotube formation. With the aim of clarifying the mechanism of Pin1 function in skeletal myogenesis, we investigated whether MEF2C, a critical regulator of the myogenic program that is the end point of several signaling pathways, might serve as a/the target for the inhibitory effects of Pin1 on muscle differentiation. We show that Pin1 interacts selectively with phosphorylated MEF2C in skeletal muscle cells, both in vitro and in vivo. The interaction with Pin1 requires two novel critical phospho-Ser/Thr-Pro motifs in MEF2C, Ser(98) and Ser(110), which are phosphorylated in vivo. Overexpression of Pin1 decreases MEF2C stability and activity and its ability to cooperate with MyoD to activate myogenic conversion. Collectively, these findings reveal a novel role for Pin1 as a regulator of muscle terminal differentiation and suggest that Pin1-mediated repression of MEF2C function could contribute to this function.	[Molinari, Susanna] Univ Modena & Reggio Emilia, Dept Biomed Sci, Biochem Sect, I-41100 Modena, Italy; [Matafora, Vittoria; Bachi, Angela] H San Raffaele Sci Inst, Mass Spectrometry Unit, I-20132 Milan, Italy; [Messina, Graziella] H San Raffaele Sci Inst, Stem Cell Res Inst, I-20132 Milan, Italy; [Messina, Graziella] Univ Milan, Dept Biol, I-20129 Milan, Italy; [Rustighi, Alessandra; Del Sal, Giannino] Univ Trieste, Lab Nazl Consorzio Interuniv Biotecnol, I-34100 Trieste, Italy; [Rustighi, Alessandra; Del Sal, Giannino] Univ Trieste, Dept Life Sci, I-34012 Trieste, Italy	Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; University of Trieste; University of Trieste	Molinari, S (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Sci, Biochem Sect, Via G Campi 287, I-41100 Modena, Italy.	susanna.molinari@unimore.it	bachi, angela/B-3527-2015; Messina, Graziella/A-1469-2014; Battini, Renata/F-2113-2015; Molinari, Susanna/E-1670-2015; Magli, Alessandro/K-5961-2019	bachi, angela/0000-0003-4842-6556; Messina, Graziella/0000-0001-8189-0727; Battini, Renata/0000-0003-0876-4294; Molinari, Susanna/0000-0003-1649-4407; Magli, Alessandro/0000-0003-3874-2838; DEL SAL, GIANNINO/0000-0003-2185-6003; Ganassi, Massimo/0000-0003-3163-9707; matafora, vittoria/0000-0002-4311-998X	MURST; EC [223098]; Telethon and Associazione Italiana per la Ricerca sul Cancro	MURST(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre); Telethon and Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancroFondazione Telethon)	This work was supported by grants from MURST COFIN'06 and EC FP7-Health-2007-B Grant 223098 (OPTISTEM) (to S. F.) and by grants from Telethon and Associazione Italiana per la Ricerca sul Cancro (to G. D. S.).	Angelelli C, 2008, NUCLEIC ACIDS RES, V36, P915, DOI 10.1093/nar/gkm1114; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Borghi S, 2001, J CELL SCI, V114, P4477; Cox DM, 2003, J BIOL CHEM, V278, P15297, DOI 10.1074/jbc.M211312200; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Lazaro JB, 1997, J CELL SCI, V110, P1251; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Molkentin JD, 1996, J BIOL CHEM, V271, P17199, DOI 10.1074/jbc.271.29.17199; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Naya FJ, 1999, DEVELOPMENT, V126, P2045; PINSET C, 1988, DIFFERENTIATION, V38, P28, DOI 10.1111/j.1432-0436.1988.tb00588.x; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Puente LG, 2006, MOL CELL PROTEOMICS, V5, P2244, DOI 10.1074/mcp.M600134-MCP200; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; Suelves M, 2004, EMBO J, V23, P365, DOI 10.1038/sj.emboj.7600056; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	43	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34518	34527		10.1074/jbc.M110.104133	http://dx.doi.org/10.1074/jbc.M110.104133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801874	Green Published, hybrid			2022-12-27	WOS:000283659100027
J	Rajagopal, C; Stone, KL; Mains, RE; Eipper, BA				Rajagopal, Chitra; Stone, Kathryn L.; Mains, Richard E.; Eipper, Betty A.			Secretion Stimulates Intramembrane Proteolysis of a Secretory Granule Membrane Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; AMYLOID PRECURSOR PROTEIN; PEPTIDE-PROCESSING ENZYME; GAMMA-SECRETASE; CYTOSOLIC DOMAIN; ENDOCRINE-CELLS; INHIBITOR DAPT; PAM EXPRESSION; ATT-20 CELLS; RAT-HEART	Regulated intramembrane proteolysis, a highly conserved process employed by diverse regulatory pathways, can release soluble fragments that directly or indirectly modulate gene expression. In this study we used pharmacological tools to identify peptidylglycine alpha-amidating monooxygenase (PAM), a type I secretory granule membrane protein, as a gamma-secretase substrate. PAM, an essential enzyme, catalyzes the final step in the synthesis of the majority of neuropeptides that control metabolic homeostasis. Mass spectroscopy was most consistent with the presence of multiple closely spaced NH2 termini, suggesting that cleavage occurred near the middle of the PAM transmembrane domain. The luminal domains of PAM must undergo a series of prohormone convertase or gamma-secretase-mediated cleavages before the remaining transmembrane domain/cytosolic domain fragment can undergo a gamma-secretase-like cleavage. Cleavage by gamma-secretase generates a soluble fragment of the cytosolic domain (sf-CD) that is known to localize to the nucleus. Although PAM sf-CD is unstable in AtT-20 corticotroph tumor cells, it is readily detected in primary rat anterior pituitary cells. PAM isoform expression, which is tissue-specific and developmentally regulated, affects the efficiency with which sf-CD is produced. sf-CD levels are also modulated by the phosphorylation status of the cytosolic domain and by the ability of the cytosolic domain to interact with cytosolic proteins. sf-CD is produced by primary rat anterior pituitary cells in response to secretogogue, suggesting that sf-CD acts as a signaling molecule relaying information about secretion from the secretory granule to the nucleus.	[Mains, Richard E.; Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA; [Stone, Kathryn L.] Yale Univ, WM Keck Facil, New Haven, CT 06511 USA	University of Connecticut; University of Connecticut; Yale University	Eipper, BA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	eipper@uchc.edu	, Chitra/AAC-9698-2021	, Chitra/0000-0003-2962-459X	National Institutes of Health (NIDDK) [DK32949]; National Institute on Drug Abuse Neuroproteomics Center [P30 DA018343]; National Institutes of Health National Center for Research Resources Clinical and Translational Science [UL1 RR024139, 1S10RR024617]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024617, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032949, R01DK032949, R37DK032949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Drug Abuse Neuroproteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health National Center for Research Resources Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DK32949 (NIDDK) and National Institute on Drug Abuse Neuroproteomics Center Grant P30 DA018343.; We thank Dr. Erol Gulcicek for titanium enrichment of phosphopeptides and Yanping Wang and Darlene D'Amato for invaluable technical assistance. Instrumentation was obtained with funds from National Institutes of Health National Center for Research Resources Clinical and Translational Science Award UL1 RR024139 and Shared Instrumentation Grant 1S10RR024617.	Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Arnaoutova I, 2008, MOL ENDOCRINOL, V22, P1924, DOI 10.1210/me.2007-0434; BA CKN, 2010, TRAFFIC */* B A TRAF, V11, P972; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; BENGOECHEAALONS.MT, 2007, J CURR OPIN CELL BIO, V19, P215; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; El Meskini R, 2001, J BIOL CHEM, V276, P3384, DOI 10.1074/jbc.M008062200; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Ferraro F, 2005, J BIOL CHEM, V280, P25424, DOI 10.1074/jbc.M414156200; Francone VP, 2010, MOL ENDOCRINOL, V24, P1543, DOI 10.1210/me.2009-0381; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Hojilla CV, 2007, J CELL SCI, V120, P1050, DOI 10.1242/jcs.003335; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kanungo J, 2008, J NEUROCHEM, V106, P2236, DOI 10.1111/j.1471-4159.2008.05551.x; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; MAINS RE, 2006, PEPTIDES, P317; MALTESE JY, 1992, MOL ENDOCRINOL, V6, P1998, DOI 10.1210/me.6.12.1998; Meskini RE, 2000, ENDOCRINOLOGY, V141, P3020; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nagai N, 2007, J BIOL CHEM, V282, P14942, DOI 10.1074/jbc.M610691200; OUAFIK L, 1989, J BIOL CHEM, V264, P5839; Rajagopal C, 2009, J BIOL CHEM, V284, P25723, DOI 10.1074/jbc.M109.035782; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Schiller M R, 2000, Pituitary, V3, P141, DOI 10.1023/A:1011491324117; SEIDAH NG, 1993, BIOCHEM SOC T, V21, P685, DOI 10.1042/bst0210685; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626; Steveson TC, 2001, J BIOL CHEM, V276, P40326, DOI 10.1074/jbc.M011460200; Steveson TC, 1999, J BIOL CHEM, V274, P21128, DOI 10.1074/jbc.274.30.21128; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200	40	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34632	34642		10.1074/jbc.M110.145334	http://dx.doi.org/10.1074/jbc.M110.145334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817724	hybrid, Green Published			2022-12-27	WOS:000283659100039
J	Casteel, DE; Smith-Nguyen, EV; Sankaran, B; Roh, SH; Pilz, RB; Kim, C				Casteel, Darren E.; Smith-Nguyen, Eric V.; Sankaran, Banumathi; Roh, Sung H.; Pilz, Renate B.; Kim, Choel			A Crystal Structure of the Cyclic GMP-dependent Protein Kinase I beta Dimerization/Docking Domain Reveals Molecular Details of Isoform-specific Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN4 LEUCINE-ZIPPER; TFII-I; CIRCULAR-DICHROISM; TERMINAL DOMAIN; BLOOD-PRESSURE; COILED-COIL; CGMP KINASE; IRAG; RELAXATION; REGULATOR	Cyclic GMP-dependent protein kinase (PKG) is a key mediator of the nitric oxide/cGMP signaling pathway and plays a central role in regulating cardiovascular and neuronal functions. The N-terminal similar to 50 amino acids of the kinase are required for homodimerization and association with isoform-specific PKG-anchoring proteins (GKAPs), which target the kinase to specific substrates. To understand the molecular details of PKG dimerization and gain insight into its association with GKAPs, we solved a crystal structure of the PKG I beta dimerization/docking domain. Our structure provides molecular details of this unique leucine/isoleucine zipper, revealing specific hydrophobic and ionic interactions that mediate dimerization and demonstrating the topology of the GKAP interaction surface.	[Roh, Sung H.; Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Casteel, Darren E.; Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Casteel, Darren E.; Pilz, Renate B.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Smith-Nguyen, Eric V.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kim, C (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.	ckim@bcm.edu			National Institutes of Health [R01-AR051300, K22-CA124517]; American Heart Grant [09SDG2150143]; National Institutes of Health (NIGMS); Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [K22CA124517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Grant; National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR051300 (to R. B. P.) and K22-CA124517 (to D. E. C.). This work was also supported by American Heart Grant 09SDG2150143 (to C. K.).; We thank Susan. S. Taylor, Jens Schlossmann, and I. V. Khavrutskii for insights and helpful discussions; T. Koller for verifying Se-Met substitution by mass spectrometry; S. Lesley for technical support; E. Larson at Bio-Rad Laboratories for supplying the Profinia protein purification system; and P. D. Stewart for in-depth discussion on optimizing crystallization conditions using the Oryx 8 crystallization robot. Portions of this research were conducted at the Advanced Light Source operated by Lawrence Berkeley National Laboratory (on behalf of the United States Department of Energy, Office of Basic Energy Sciences). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health (NIGMS) and the Howard Hughes Medical Institute.	ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; LANDGRAF W, 1990, BIOCHEMISTRY-US, V29, P9921, DOI 10.1021/bi00494a024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schlossmann Jens, 2009, V191, P163, DOI 10.1007/978-3-540-68964-5_9; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	25	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32684	32688		10.1074/jbc.C110.161430	http://dx.doi.org/10.1074/jbc.C110.161430			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20826808	Green Published, hybrid			2022-12-27	WOS:000283048200002
J	Sawesi, O; Spillmann, D; Lunden, A; Wernersson, S; Abrink, M				Sawesi, Osama; Spillmann, Dorothe; Lunden, Anna; Wernersson, Sara; Abrink, Magnus			Serglycin-independent Release of Active Mast Cell Proteases in Response to Toxoplasma gondii Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY GRANULE; CARBOXYPEPTIDASE-A; TRICHINELLA-SPIRALIS; TRYPTASE MMCP-6; INNATE IMMUNITY; MICE LACKING; IN-VITRO; HEPARIN; PROTEOGLYCAN; MOUSE	Earlier studies identified serglycin proteoglycan and its heparin chains to be important for storage and activity of mast cell proteases. However, the importance of serglycin for secretion and activity of mast cell proteases in response to parasite infection has been poorly investigated. To address this issue, we studied the effects on mast cell proteases in serglycin-deficient and wild type mice after peritoneal infection with the obligate intracellular parasite Toxoplasma gondii. In line with previous results, we found severely reduced levels of cell-bound mast cell proteases in both noninfected and infected serglycin-deficient mice. However, serglycin-deficient mice secreted mast cell proteases at wild type levels at the site of infection, and enzymatic activities associated with mast cell proteases were equally up-regulated in wild type and serglycin-deficient mice 48 h after infection. In both wild type and serglycin-deficient mice, parasite infection resulted in highly increased extracellular levels of glycosaminoglycans, including hyaluronan and chondroitin sulfate A, suggesting a role of these substances in the general defense mechanism. In contrast, heparan sulfate/heparin was almost undetectable in serglycin-deficient mice, and in wild type mice, it was mainly confined to the cellular fraction and was not increased upon infection. Furthermore, the heparan sulfate/heparin population was less sulfated in serglycin-deficient than in wild type mice indicative for the absence of heparin, which supports that heparin production is dependent on the serglycin core protein. Together, our results suggest that serglycin proteoglycan is dispensable for normal secretion and activity of mast cell proteases in response to peritoneal infection with T. gondii.	[Abrink, Magnus] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, SE-75123 Uppsala, Sweden; [Lunden, Anna] Sect Parasitol SWEPAR, Dept Biomed Sci & Vet Publ Hlth, SE-75189 Uppsala, Sweden; [Sawesi, Osama; Wernersson, Sara] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Abrink, M (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC, Box 582, SE-75123 Uppsala, Sweden.	Magnus.Abrink@imbim.uu.se	Wernersson, Sara/D-4580-2011; Lunden, Anna/H-3778-2012; Wernersson, Sara/N-8830-2019; Åbrink, Magnus/AAK-8346-2020	Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Abrink, Magnus/0000-0002-1335-3927	FORMAS; Goran Gustafsson Foundation; Medical Research Council; Ivar and Elsa Sandberg Foundation; Polysackaridforskning AB; Vardal Foundation; Libyan Higher Education Board	FORMAS(Swedish Research Council Formas); Goran Gustafsson Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ivar and Elsa Sandberg Foundation; Polysackaridforskning AB(HOGANAS ABStatisticon AB); Vardal Foundation; Libyan Higher Education Board	This work was supported by FORMAS (to M.A.), the Goran Gustafsson Foundation (to M.A.), the Medical Research Council (to M.A.), the Ivar and Elsa Sandberg Foundation (to A.L.), Polysackaridforskning AB (to D.S.), and the Vardal Foundation (to S.W.).; Supported by the Libyan Higher Education Board.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Bjorkman C, 1998, INT J PARASITOL, V28, P187, DOI 10.1016/S0020-7519(97)00174-4; Bliss SK, 1999, J IMMUNOL, V163, P2081; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Ferreira GLS, 2004, MICROBES INFECT, V6, P172, DOI 10.1016/j.micinf.2003.11.007; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Hallgren J, 2001, BIOCHEMISTRY-US, V40, P7342, DOI 10.1021/bi001988c; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Henningsson F, 2005, J CELL SCI, V118, P2035, DOI 10.1242/jcs.02333; Henningsson F, 2003, BIOL CHEM, V384, P1527, DOI 10.1515/BC.2003.169; Henningsson F, 2002, BIOL CHEM, V383, P793, DOI 10.1515/BC.2002.083; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Lawrence CE, 2004, GASTROENTEROLOGY, V127, P155, DOI 10.1053/j.gastro.2004.04.004; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; LeDoux JM, 1996, J VIROL, V70, P6468, DOI 10.1128/JVI.70.9.6468-6473.1996; Lunden A, 1998, PARASITE IMMUNOL, V20, P519, DOI 10.1046/j.1365-3024.1998.00184.x; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Muramatsu T, 2008, PROTEOMICS, V8, P3350, DOI 10.1002/pmic.200800042; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; PEJLER G, 1994, J BIOL CHEM, V269, P14451; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Raja SM, 2005, J BIOL CHEM, V280, P20752, DOI 10.1074/jbc.M501181200; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Sayles PC, 1997, NAT IMMUN, V15, P249; SCHWARTZ LB, 1981, J IMMUNOL, V126, P2071; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Srinoulprasert Y, 2006, MICROB PATHOGENESIS, V40, P126, DOI 10.1016/j.micpath.2005.12.001; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; TANTRAVAHI RV, 1986, P NATL ACAD SCI USA, V83, P9207, DOI 10.1073/pnas.83.23.9207; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Wernersson S., 2008, J LEUKOC BIOL; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703	45	11	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38005	38013		10.1074/jbc.M110.118471	http://dx.doi.org/10.1074/jbc.M110.118471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20864536	Green Published, hybrid			2022-12-27	WOS:000284625600008
J	Oberoi, J; Richards, MW; Crumpler, S; Brown, N; Blagg, J; Bayliss, R				Oberoi, Jasmeen; Richards, Mark W.; Crumpler, Simon; Brown, Nathan; Blagg, Julian; Bayliss, Richard			Structural Basis of Poly(ADP-ribose) Recognition by the Multizinc Binding Domain of Checkpoint with Forkhead-associated and RING Domains (CHFR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER DOMAIN; PROTEIN; ENTRY; IDENTIFICATION; TANKYRASE-1; MITOSIS; LIGASE; MOTIFS; DELAYS; APLF	Cellular stress in early mitosis activates the antephase checkpoint, resulting in the decondensation of chromosomes and delayed mitotic progression. Checkpoint with forkhead-associated and RING domains (CHFR) is central to this checkpoint, and its activity is ablated in many tumors and cancer cell lines through promoter hypermethylation or mutation. The interaction between the PAR-binding zinc finger (PBZ) of CHFR and poly(ADP-ribose) (PAR) is crucial for a functional antephase checkpoint. We determined the crystal structure of the cysteine-rich region of human CHFR (amino acids 425-664) to 1.9 angstrom resolution, which revealed a multizinc binding domain of elaborate topology within which the PBZ is embedded. The PBZ of CHFR closely resembles the analogous motifs from aprataxin-like factor and CG1218-PA, which lie within unstructured regions of their respective proteins. Based on co-crystal structures of CHFR bound to several different PAR-like ligands (adenosine 5'-diphosphoribose, adenosine monophosphate, and (PP2)-P-1-diadenosine 5'-pyrophosphate), we made a model of the CHFR-PAR interaction, which we validated using site-specific mutagenesis and surface plasmon resonance. The PBZ motif of CHFR recognizes two adenine-containing subunits of PAR and the phosphate backbone that connects them. More generally, PBZ motifs may recognize different numbers of PAR subunits as required to carry out their functions.	[Oberoi, Jasmeen; Richards, Mark W.; Bayliss, Richard] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Crumpler, Simon; Brown, Nathan; Blagg, Julian] Inst Canc Res, Haddow Labs, Canc Res UK Canc Therapeut Unit, Sutton SM2 5NG, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK	Bayliss, R (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	richard.bayliss@icr.ac.uk	Brown, Nathan/I-7711-2016	Brown, Nathan/0000-0001-9243-8699; Oberoi, Jasmeen/0000-0001-8216-3898; Bayliss, Richard/0000-0003-0604-2773; Richards, Mark/0000-0003-1108-2825	Cancer Research UK [C24461/A9549, C309/A8274]	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK Project Grant C24461/A9549 (to R. B.) and Cancer Research UK Centre Grant C309/A8274.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chaturvedi P, 2002, CANCER RES, V62, P1797; Chin CF, 2010, MOL CELL BIOL, V30, P22, DOI 10.1128/MCB.00687-09; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Isogai S, 2010, GENES CELLS, V15, P101, DOI 10.1111/j.1365-2443.2009.01369.x; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Maddika S, 2009, J BIOL CHEM, V284, P12998, DOI 10.1074/jbc.M900333200; Mariatos G, 2003, CANCER RES, V63, P7185; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millo E, 2008, SYNTHETIC COMMUN, V38, P3260, DOI 10.1080/00397910802116583; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Oh YM, 2009, NAT CELL BIOL, V11, P295, DOI 10.1038/ncb1837; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	32	50	51	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39348	39358		10.1074/jbc.M110.159855	http://dx.doi.org/10.1074/jbc.M110.159855			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20880844	hybrid, Green Published			2022-12-27	WOS:000284941300062
J	Brew, K; Tumbale, P; Acharya, KR				Brew, Keith; Tumbale, Percy; Acharya, K. Ravi			Family 6 Glycosyltransferases in Vertebrates and Bacteria: Inactivation and Horizontal Gene Transfer May Enhance Mutualism between Vertebrates and Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HISTO-BLOOD GROUP; INFLAMMATORY-BOWEL-DISEASE; STRUCTURAL BASIS; PARACHLAMYDIA-ACANTHAMOEBAE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; GROUP-A; ALPHA-1,3-GALACTOSYLTRANSFERASE; SUBSTRATE	Glycosyltransferases (GTs) control the synthesis and structures of glycans. Inactivation and intense allelic variation in members of the GT6 family generate species-specific and individual variations in carbohydrate structures, including histoblood group oligosaccharides, resulting in anti-glycan antibodies that target glycan-decorated pathogens. GT6 genes are ubiquitous in vertebrates but are otherwise rare, existing in a few bacteria, one protozoan, and cyanophages, suggesting lateral gene transfer. Prokaryotic GT6 genes correspond to one exon of vertebrate genes, yet their translated protein sequences are strikingly similar. Bacterial and phage GT6 genes influence the surface chemistry of bacteria, affecting their interactions, including those with vertebrate hosts.	[Brew, Keith; Tumbale, Percy] Florida Atlantic Univ, Coll Med, Dept Basic Sci, Boca Raton, FL 33431 USA; [Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	State University System of Florida; Florida Atlantic University; University of Bath	Brew, K (corresponding author), Florida Atlantic Univ, Coll Med, Dept Basic Sci, Boca Raton, FL 33431 USA.	kbrew@ad.fau.edu; bsskra@bath.ac.uk	Brew, Keith/W-1643-2019; Brew, Keith/A-6746-2009	Brew, Keith/0000-0003-1306-1032; Acharya, K. Ravi/0000-0002-3009-4058				Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Casals F, 2009, GLYCOBIOLOGY, V19, P583, DOI 10.1093/glycob/cwp017; Casson N, 2006, MICROBES INFECT, V8, P1294, DOI 10.1016/j.micinf.2005.12.011; Cohen M, 2009, BLOOD, V114, P3668, DOI 10.1182/blood-2009-06-227041; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Elliott SP, 2003, INFECT IMMUN, V71, P6543, DOI 10.1128/IAI.71.11.6543-6552.2003; Flores J, 2009, CURR OPIN INFECT DIS, V22, P471, DOI 10.1097/QCO.0b013e3283304eb6; Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96; GALILI U, 1988, J BIOL CHEM, V263, P17755; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hertel LA, 2002, INT J PARASITOL, V32, P1183, DOI 10.1016/S0020-7519(02)00066-8; Holmner A, 2010, FEBS LETT, V584, P2548, DOI 10.1016/j.febslet.2010.03.050; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; JOHNSON LN, 1990, J MOL BIOL, V211, P645, DOI 10.1016/0022-2836(90)90271-M; KELLY RJ, 1994, P NATL ACAD SCI USA, V91, P5843, DOI 10.1073/pnas.91.13.5843; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P1829, DOI 10.3748/wjg.v12.i12.1829; Lee HJ, 2005, J BIOL CHEM, V280, P525, DOI 10.1074/jbc.M410245200; Leipold MD, 2007, J BIOL CHEM, V282, P1257, DOI 10.1074/jbc.M608164200; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Persson M, 2007, J BIOL CHEM, V282, P9564, DOI 10.1074/jbc.M610998200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rogers MB, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-26; SCHUMACHER W, 1992, ARCH MICROBIOL, V157, P464, DOI 10.1007/BF00249106; Seymour RM, 2004, P ROY SOC B-BIOL SCI, V271, P1065, DOI 10.1098/rspb.2004.2674; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a; Tumbale P, 2009, J BIOL CHEM, V284, P25126, DOI 10.1074/jbc.M109.033878; Tumbale P, 2008, GLYCOBIOLOGY, V18, P1036, DOI 10.1093/glycob/cwn083; Turcot-Dubois AL, 2007, GLYCOBIOLOGY, V17, P516, DOI 10.1093/glycob/cwm016; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Xu HJ, 1999, J BIOL CHEM, V274, P29390, DOI 10.1074/jbc.274.41.29390; YAMAMOTO F, 1995, GLYCOBIOLOGY, V5, P51, DOI 10.1093/glycob/5.1.51; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y; Yi W, 2008, J AM CHEM SOC, V130, P14420, DOI 10.1021/ja805844y; Yi W, 2006, CARBOHYD RES, V341, P2254, DOI 10.1016/j.carres.2006.06.009; Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r; Zhang YN, 2004, GLYCOBIOLOGY, V14, P1295, DOI 10.1093/glycob/cwh119; Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200	60	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37121	37127		10.1074/jbc.R110.176248	http://dx.doi.org/10.1074/jbc.R110.176248			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20870714	Green Published, hybrid			2022-12-27	WOS:000284424000004
J	Cheung, MY; Xue, Y; Zhou, LA; Li, MW; Sun, SSM; Lam, HM				Cheung, Ming-Yan; Xue, Yan; Zhou, Liang; Li, Man-Wah; Sun, Samuel Sai-Ming; Lam, Hon-Ming			An Ancient P-Loop GTPase in Rice Is Regulated by a Higher Plant-specific Regulatory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBG-LIKE ATPASE; DISEASE RESISTANCE; BINDING; DOMAIN; EXPRESSION; EVOLUTION; REVEALS; DEFINES; SYSTEM; YCHF	YchF is a subfamily of the Obg family in the TRAFAC class of P-loop GTPases. The wide distribution of YchF homologues in both eukarya and bacteria suggests that they are descendents of an ancient protein, yet their physiological roles remain unclear. Using the OsYchF1-OsGAP1 pair from rice as the prototype, we provide evidence for the regulation of GTPase/ATPase activities and RNA binding capacity of a plant YchF (OsYchF1) by its regulatory protein (OsGAP1). The effects of OsGAP1 on the subcellular localization/cycling and physiological functions of OsYchF1 are also discussed. The finding that OsYchF1 and OsGAP1 are involved in plant defense response might shed light on the functional roles of YchF homologues in plants. This work suggests that during evolution, an ancestral P-loop GTPase/ATPase may acquire new regulation and function(s) by the evolution of a lineage-specific regulatory protein.	[Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Lam, Hon-Ming/A-9866-2008; Li, Man-Wah/AAZ-5631-2021; Zhou, Liang/P-4174-2015	Lam, Hon-Ming/0000-0002-6673-8740; Li, Man-Wah/0000-0003-4859-5683; Zhou, Liang/0000-0001-5973-7873	Hong Kong Research Grants Council [467608]; Hong Kong University Grants Committee Area of Excellence [AoE-B-07/09]; Shanghai-Hong Kong-Anson Research Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong University Grants Committee Area of Excellence; Shanghai-Hong Kong-Anson Research Foundation	This work was supported by Hong Kong Research Grants Council General Research Fund Grant 467608 (to H.-M. L.), Hong Kong University Grants Committee Area of Excellence Plant and Agricultural Biotechnology Project AoE-B-07/09, and the Shanghai-Hong Kong-Anson Research Foundation Grant (to H.-M. L. and S. S.-M. S.).	Bechtold N, 1998, METH MOL B, V82, P259; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BREARS T, 1993, PLANT PHYSIOL, V103, P1285, DOI 10.1104/pp.103.4.1285; Byun-McKay SA, 2007, TRENDS ECOL EVOL, V22, P338, DOI 10.1016/j.tree.2007.05.002; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Hitchcock C., 1971, PLANT LIPID BIOCH, P279; Jensen RB, 2000, PLANT MOL BIOL, V44, P799, DOI 10.1023/A:1026509002161; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Katagiri F., 2002, ARABIDOPSIS BOOK, P28; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; Koonin EV, 2000, ADV PROTEIN CHEM, V54, P245, DOI 10.1016/S0065-3233(00)54008-X; Kopka J, 1998, PLANT MOL BIOL, V36, P627, DOI 10.1023/A:1005915020760; Lam SK, 2007, PLANT CELL, V19, P296, DOI 10.1105/tpc.106.045708; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Ma L, 2008, PLANT PHYSIOL, V148, P223, DOI 10.1104/pp.108.120527; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P21; Ober D, 2005, TRENDS PLANT SCI, V10, P444, DOI 10.1016/j.tplants.2005.07.007; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Rohn TT, 1999, FREE RADICAL BIO MED, V26, P1321, DOI 10.1016/S0891-5849(98)00332-3; Scamardella J M, 1999, Int Microbiol, V2, P207; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Spangler C, 2009, ANAL BIOANAL CHEM, V394, P989, DOI 10.1007/s00216-008-2517-7; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Suzuma S, 1999, FEMS MICROBIOL LETT, V180, P271, DOI 10.1016/S0378-1097(99)00498-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teplyakov A, 2003, J BACTERIOL, V185, P4031, DOI 10.1128/JB.185.14.4031-4037.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venables JP, 2001, NUCLEIC ACIDS RES, V29, P2479, DOI 10.1093/nar/29.12.2479; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; Wicker-Planquart C, 2008, J BACTERIOL, V190, P681, DOI 10.1128/JB.01193-07; Wolf YI, 1999, GENOME RES, V9, P689; Young SA, 1996, PLANT CELL, V8, P1079, DOI 10.1105/tpc.8.6.1079; Zhang J, 2009, P NATL ACAD SCI USA, V106, P15356, DOI 10.1073/pnas.0907213106; Zhang Qi, 1996, Acta Agronomica Sinica, V22, P135; Zhou L, 2009, PLANT CELL ENVIRON, V32, P1804, DOI 10.1111/j.1365-3040.2009.02039.x; Zhu Q, 1996, CURR OPIN GENET DEV, V6, P624, DOI 10.1016/S0959-437X(96)80093-1	45	25	28	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37359	37369		10.1074/jbc.M110.172080	http://dx.doi.org/10.1074/jbc.M110.172080			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876569	Green Published, hybrid			2022-12-27	WOS:000284424000028
J	Fraser, JA; Madhumalar, A; Blackburn, E; Bramham, J; Walkinshaw, MD; Verma, C; Hupp, TR				Fraser, Jennifer A.; Madhumalar, Arumugam; Blackburn, Elizabeth; Bramham, Janice; Walkinshaw, Malcolm D.; Verma, Chandra; Hupp, Ted R.			A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal II. A MODEL IN WHICH PHOSPHORYLATION AT SER269 INDUCES A MUTANT CONFORMATION TO p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; DNA-BINDING DOMAIN; CORE DOMAIN; P53-DEPENDENT APOPTOSIS; DEPENDENT ACETYLATION; TYROSINE-PHOSPHATASE; CRYSTAL-STRUCTURE; COACTIVATOR P300; POINT MUTATION; WILD-TYPE	The p53 DNA-binding domain harbors a conformationally flexible multiprotein binding site that regulates p53 ubiquitination. A novel phosphorylation site exists within this region at Ser(269), whose phosphomimetic mutation inactivates p53. The phosphomimetic p53 (S269D) exhibits characteristics of mutant p53: stable binding to Hsp70 in vivo, elevated ubiquitination in vivo, inactivity in DNA binding and transcription, increased thermoinstability using thermal shift assays, and lambda(max) of intrinsic tryptophan fluorescence at 403 nm rather than 346 nm, characteristic of wild type p53. These data indicate that p53 conformational stability is regulated by a phosphoacceptor site within an exposed flexible surface loop and that this can be destabilized by phosphorylation. To test whether other motifs within p53 have similarly evolved, we analyzed the effect of Ser(215) mutation on p53 function because Ser(215) is another inactivating phosphorylation site in the conformationally flexible PAb240 epitope. The p53(S215D) protein is inactive like p53(S269D), whereas p53(S215A) is as active as p53(S269A). However, the double mutant p53(S215A/S269A) was transcriptionally inactive and more thermally unstable than either individual Ser-Ala loop mutant. Molecular dynamics simulations suggest that (i) solvation of phospho-Ser(215) and phospho-Ser(269) by positive charged residues or solvent water leads to local unfolding, which is accompanied by local destabilization of the N-terminal loop and global destabilization of p53, and (ii) the double alanine 215/269 mutation disrupts hydrogen bonding normally stabilized by both Ser(215) and Ser(269). These data indicate that p53 has evolved two serine phosphoacceptor residues within conformationally flexible epitopes that normally stabilize the p53 DNA-binding domain but whose phosphorylation	[Fraser, Jennifer A.; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, CRUK Signal Transduct Grp P53, Cell Signaling Unit, Edinburgh EH4 2XR, Midlothian, Scotland; [Blackburn, Elizabeth; Bramham, Janice; Walkinshaw, Malcolm D.] Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Madhumalar, Arumugam; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore 138671, Singapore	University of Edinburgh; University of Edinburgh; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Verma, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	chandra@bii.a-star.edu.sg; ted.hupp@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019	Fraser, Jennifer/0000-0001-5546-3916; walkinshaw, malcolm/0000-0001-5955-9325; Madhumalar, Arumugam/0000-0001-5314-7194; Blackburn, Elizabeth A/0000-0003-1325-9575	Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council; CRUK [C483/A6354]	Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CRUK(Cancer Research UK)	We acknowledge the use of the Edinburgh Biophysical Characterization Facility (supported by the Scottish University Life Sciences Alliance and the Biotechnology and Biological Sciences Research Council).; This work was supported by CRUK Programme Grant C483/A6354 (to T. R. H.).	Allende-Vega N, 2007, ONCOGENE, V26, P4234, DOI 10.1038/sj.onc.1210209; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Brown CJ, 2008, CELL CYCLE, V7, P608, DOI 10.4161/cc.7.5.5488; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L, PYMOL MOL GRAPHICS S; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Fraser JA, 2007, BIOCHEMISTRY-US, V46, P2655, DOI 10.1021/bi061562j; Fraser JA, 2010, J BIOL CHEM, V285, P37762, DOI 10.1074/jbc.M110.143099; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Huggins DJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000880; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUPP TR, 1995, J BIOL CHEM, V270, P18165, DOI 10.1074/jbc.270.30.18165; Jabbur JR, 2002, CANCER BIOL THER, V1, P277, DOI 10.4161/cbt.81; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Jorgensen W L, 1986, Ann N Y Acad Sci, V482, P198, DOI 10.1111/j.1749-6632.1986.tb20951.x; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lin SR, 1996, DNA CELL BIOL, V15, P793, DOI 10.1089/dna.1996.15.793; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Pan Y, 2000, ONCOGENE, V19, P3095, DOI 10.1038/sj.onc.1203663; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Shimizu H, 2006, BIOCHEM J, V397, P355, DOI 10.1042/BJ20051521; STEPHEN CW, 1995, J MOL BIOL, V248, P58, DOI 10.1006/jmbi.1995.0202; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; VOJTESEK B, 1995, ONCOGENE, V10, P389; VOJTESEK B, 1993, J CELL SCI, V105, P607; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Walker R. C., 2003, THESIS IMPERIAL COLL; Walker RC, 2007, J COMPUT CHEM, V28, P478, DOI 10.1002/jcc.20559; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; WANG Y, 1995, ONCOGENE, V10, P779; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Worrall Erin G, 2009, J Chem Biol, V2, P113, DOI 10.1007/s12154-009-0019-5; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	72	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37773	37786		10.1074/jbc.M110.143107	http://dx.doi.org/10.1074/jbc.M110.143107			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20847049	Green Published, hybrid			2022-12-27	WOS:000284424000069
J	Andres, D; Hanke, C; Baxa, U; Seul, A; Barbirz, S; Seckler, R				Andres, Dorothee; Hanke, Christin; Baxa, Ulrich; Seul, Anait; Barbirz, Stefanie; Seckler, Robert			Tailspike Interactions with Lipopolysaccharide Effect DNA Ejection from Phage P22 Particles in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAD-BINDING DOMAIN; BASE-PLATE PARTS; TAIL NEEDLE GP26; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; INFECTED CELL; PROTEIN; P22; BACTERIOPHAGE-P22	Initial attachment of bacteriophage P22 to the Salmonella host cell is known to be mediated by interactions between lipopolysaccharide (LPS) and the phage tailspike proteins (TSP), but the events that subsequently lead to DNA injection into the bacterium are unknown. We used the binding of a fluorescent dye and DNA accessibility to DNase and restriction enzymes to analyze DNA ejection from phage particles in vitro. Ejection was specifically triggered by aggregates of purified Salmonella LPS but not by LPS with different O-antigen structure, by lipid A, phospholipids, or soluble O-antigen polysaccharide. This suggests that P22 does not use a secondary receptor at the bacterial outer membrane surface. Using phage particles reconstituted with purified mutant TSP in vitro, we found that the endorhamnosidase activity of TSP degrading the O-antigen polysaccharide was required prior to DNA ejection in vitro and DNA replication in vivo. If, however, LPS was pre-digested with soluble TSP, it was no longer able to trigger DNA ejection, even though it still contained five O-antigen oligosaccharide repeats. Together with known data on the structure of LPS and phage P22, our results suggest a molecular model. In this model, tail-spikes position the phage particles on the outer membrane surface for DNA ejection. They force gp26, the central needle and plug protein of the phage tail machine, through the core oligosaccharide layer and into the hydrophobic portion of the outer membrane, leading to refolding of the gp26 lazo-domain, release of the plug, and ejection of DNA and pilot proteins.	[Andres, Dorothee; Hanke, Christin; Baxa, Ulrich; Seul, Anait; Barbirz, Stefanie; Seckler, Robert] Univ Potsdam, Lab Phys Biochem, Dept Biol & Biochem, D-14476 Potsdam, Germany	University of Potsdam	Seckler, R (corresponding author), Univ Potsdam, Lab Phys Biochem, Dept Biol & Biochem, Karl Liebknecht Str 24-25,Haus 25, D-14476 Potsdam, Germany.	seckler@uni-potsdam.de	Barbirz, Stefanie/S-9158-2019	Barbirz, Stefanie/0000-0001-6101-9862; Baxa, Ulrich/0000-0002-7263-5078	Deutsche Forschungsgemeinschaft [Se517/16, Ba4046/1]; Leibniz Graduate School of Molecular Biophysics	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Graduate School of Molecular Biophysics	This work was supported in part by Grants Se517/16 and Ba4046/1 from the Deutsche Forschungsgemeinschaft.; Supported by a fellowship of the Leibniz Graduate School of Molecular Biophysics.	Andres D, 2010, BIOCHEM SOC T, V38, P1386, DOI 10.1042/BST0381386; Baxa U, 1996, BIOPHYS J, V71, P2040, DOI 10.1016/S0006-3495(96)79402-X; Baxa U, 2001, BIOCHEMISTRY-US, V40, P5144, DOI 10.1021/bi0020426; BERGET PB, 1980, J VIROL, V34, P234, DOI 10.1128/JVI.34.1.234-243.1980; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; CASJENS S, 1988, J MOL BIOL, V199, P467, DOI 10.1016/0022-2836(88)90618-3; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Chua JEH, 1999, MICROBIOL-UK, V145, P1649, DOI 10.1099/13500872-145-7-1649; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Eriksson M, 2007, J PHYS CHEM B, V111, P1139, DOI 10.1021/jp064322m; Freeman GG, 1942, BIOCHEM J, V36, P340, DOI 10.1042/bj0360340; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Inamdar MM, 2006, BIOPHYS J, V91, P411, DOI 10.1529/biophysj.105.070532; ISRAEL JV, 1967, P NATL ACAD SCI USA, V57, P284, DOI 10.1073/pnas.57.2.284; ISRAEL V, 1978, J GEN VIROL, V40, P669, DOI 10.1099/0022-1317-40-3-669; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; IWASHITA S, 1976, EUR J BIOCHEM, V65, P87, DOI 10.1111/j.1432-1033.1976.tb10392.x; Kamei DT, 2002, BIOTECHNOL BIOENG, V78, P190, DOI 10.1002/bit.10193; KASTOWSKY M, 1992, J BACTERIOL, V174, P4798, DOI 10.1128/JB.174.14.4798-4806.1992; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Lindberg AA, 1977, SURFACE CARBOHYDRATE, P289; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Miller S, 1998, PROTEIN SCI, V7, P2223, DOI 10.1002/pro.5560071021; MITRAKI A, 1993, J BIOL CHEM, V268, P20071; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Molineux IJ, 2006, BACTERIOPHAGES, P277; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PREVELIGE PE, 2006, BACTERIOPHAGES, P00457; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Roucourt B, 2009, ENVIRON MICROBIOL, V11, P2789, DOI 10.1111/j.1462-2920.2009.02029.x; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schwarzer D, 2009, J BIOL CHEM, V284, P9465, DOI 10.1074/jbc.M808475200; Seckler R, 1998, J STRUCT BIOL, V122, P216, DOI 10.1006/jsbi.1998.3974; SECKLER R, 1989, J BIOL CHEM, V264, P11750; Snyder S, 1999, BIOCHEMISTRY-US, V38, P10758, DOI 10.1021/bi990867d; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; STRAUSS H, 1984, J MOL BIOL, V172, P523, DOI 10.1016/S0022-2836(84)80021-2; SUSSKIND MM, 1974, VIROLOGY, V62, P350, DOI 10.1016/0042-6822(74)90398-5; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979	54	67	72	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36768	36775		10.1074/jbc.M110.169003	http://dx.doi.org/10.1074/jbc.M110.169003			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20817910	Green Published, hybrid			2022-12-27	WOS:000284146100064
J	Chen, JX; Olivares-Navarrete, R; Wang, Y; Herman, TR; Boyan, BD; Schwartz, Z				Chen, Jiaxuan; Olivares-Navarrete, Rene; Wang, Yun; Herman, Tyler R.; Boyan, Barbara D.; Schwartz, Zvi			Protein-disulfide Isomerase-associated 3 (Pdia3) Mediates the Membrane Response to 1,25-Dihydroxyvitamin D-3 in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; GROWTH-PLATE CHONDROCYTES; MESENCHYMAL STEM-CELLS; KINASE-C; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; ALKALINE-PHOSPHATASE; CARTILAGE CELLS; BINDING-PROTEIN; GENE-EXPRESSION; D METABOLITES	Protein-disulfide isomerase-associated 3 (Pdia3) is a multi-functional protein hypothesized to be a membrane receptor for 1,25(OH)(2)D-3. In intestinal epithelium and chondrocytes, 1,25(OH)(2)D-3 stimulates rapid membrane responses that are different from genomic effects via the vitamin D receptor (VDR). In this study, we show that 1,25(OH)(2)D-3 stimulates phospholipase A(2) (PLA(2))-dependent rapid release of prostaglandin E-2 (PGE(2)), activation of protein kinase C (PKC), and regulation of bone-related gene transcription and mineralization in osteoblast-like MC3T3-E1 cells (WT) via a mechanism involving Pdia3. Pdia3 was present in caveolae based on co-localization with lipid rafts and caveolin-1. In Pdia3-silenced (Sh-Pdia3) cells, 1,25(OH)(2)D-3 failed to stimulate PKC and PGE(2) responses; in Pdia3-overexpressing cells (Ov-Pdia3), responses to 1,25(OH)(2)D-3 were augmented. Downstream mediators of Pdia3, PLA(2)-activating protein (PLAA) and arachidonic acid, stimulated similar PKC activation in wild-type, Sh-Pdia3, and Ov-Pdia3 cells supporting the hypothesis that Pdia3 mediates the membrane action of 1,25(OH)(2)D-3. Treatment of MC3T3-E1 cells with 1,25(OH)(2)D-3 for 9 min stimulated rapid phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and increased expression of alkaline phosphatase, MMP-13, and osteopontin but decreased expression of osteocalcin, osteoprotegerin (mRNA and protein), and smad2. These effects were attenuated in Sh-Pdia3 cells. Sh-Pdia3 cells produced higher numbers of von Kossa-positive nodules and alizarin red-positive nodules compared with WT cells with or without 1,25(OH)(2)D-3 treatment whereas Ov-Pdia3 did not show any mineralization. Our data suggest Pdia3 is an important initiator of 1,25(OH)(2)D-3-stimulated membrane signaling pathways, which have both genomic and non genomic effects during osteoblast maturation.	[Chen, Jiaxuan; Olivares-Navarrete, Rene; Wang, Yun; Herman, Tyler R.; Boyan, Barbara D.; Schwartz, Zvi] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Boyan, BD (corresponding author), 315 Ferst Dr NW, Atlanta, GA 30332 USA.	barbara.boyan@bme.gatech.edu		Olivares-Navarrete, Rene/0000-0003-1232-9164; Chen, Jiaxuan/0000-0001-5801-9052	Price Gilbert, Jr. Foundation	Price Gilbert, Jr. Foundation	This work was supported by the Price Gilbert, Jr. Foundation.	BARAN DT, 1994, J CELL BIOCHEM, V56, P303, DOI 10.1002/jcb.240560305; Boland R, 2002, STEROIDS, V67, P477, DOI 10.1016/S0039-128X(01)00182-9; Boyan BD, 2006, J BONE MINER RES, V21, P1637, DOI 10.1359/JBMR.060713; Boyan BD, 2006, STEROIDS, V71, P286, DOI 10.1016/j.steroids.2005.09.018; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Boyan BD, 2002, STEROIDS, V67, P235, DOI 10.1016/S0039-128X(01)00160-X; BREEN EC, 1994, P NATL ACAD SCI USA, V91, P12902, DOI 10.1073/pnas.91.26.12902; BRONCKERS ALJJ, 1987, BONE MINER, V2, P361; Buitrago CG, 2003, J BIOL CHEM, V278, P2199, DOI 10.1074/jbc.M205732200; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Farach-Carson MC, 2004, STEROIDS, V69, P543, DOI 10.1016/j.steroids.2004.05.002; Farach-Carson MC, 2002, STEROIDS, V67, P467, DOI 10.1016/S0039-128X(01)00168-4; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Kraichely Dennis M., 1998, Frontiers in Bioscience, V3, pD821; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Li J, 2009, J CELL BIOCHEM, V107, P1031, DOI 10.1002/jcb.22206; LIAN JB, 1985, J BIOL CHEM, V260, P8706; Liu RT, 2000, J BIOL CHEM, V275, P8711, DOI 10.1074/jbc.275.12.8711; Nemere I, 2000, STEROIDS, V65, P451, DOI 10.1016/S0039-128X(00)00107-0; NEMERE I, 1994, J BIOL CHEM, V269, P23750; Nemere I, 2004, P NATL ACAD SCI USA, V101, P7392, DOI 10.1073/pnas.0402207101; Ono N, 2008, J BIOL CHEM, V283, P19400, DOI 10.1074/jbc.M800005200; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Schwartz Z, 2005, J CELL PHYSIOL, V203, P54, DOI 10.1002/jcp.20212; Schwartz Z, 2003, STEROIDS, V68, P423, DOI 10.1016/S0039-128X(03)00044-8; Schwartz Z, 2002, ENDOCRINOLOGY, V143, P2775, DOI 10.1210/en.143.7.2775; Schwartz Z, 2002, J BIOL CHEM, V277, P11828, DOI 10.1074/jbc.M110398200; SCHWARTZ Z, 1989, J BONE MINER RES, V4, P199; Schwartz Z, 1999, BONE, V24, P475, DOI 10.1016/S8756-3282(99)00014-9; SCHWARTZ Z, 1992, BONE, V13, P51, DOI 10.1016/8756-3282(92)90361-Y; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SYLVIA VL, 1993, J CELL PHYSIOL, V157, P271, DOI 10.1002/jcp.1041570209; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Veldman CM, 1997, BONE, V21, P41, DOI 10.1016/S8756-3282(97)00077-X; Wali RK, 2003, J CELL BIOCHEM, V88, P794, DOI 10.1002/jcb.10432; Wang Y, 2010, J STEROID BIOCHEM, V121, P257, DOI 10.1016/j.jsbmb.2010.05.004; Yarram SJ, 2004, MOL CELL ENDOCRINOL, V220, P9, DOI 10.1016/j.mce.2004.04.005; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zanello LP, 1997, J BIOL CHEM, V272, P22617, DOI 10.1074/jbc.272.36.22617; Zanello LP, 2006, STEROIDS, V71, P291, DOI 10.1016/j.steroids.2005.09.012; Zanello LP, 2004, STEROIDS, V69, P561, DOI 10.1016/j.steroids.2004.05.003; Zanello LP, 2004, P NATL ACAD SCI USA, V101, P1589, DOI 10.1073/pnas.0305802101; ZERNIK J, 1990, DIFFERENTIATION, V44, P207, DOI 10.1111/j.1432-0436.1990.tb00619.x	50	63	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37041	37050		10.1074/jbc.M110.157115	http://dx.doi.org/10.1074/jbc.M110.157115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843786	Green Published, hybrid			2022-12-27	WOS:000284146100088
J	Veesler, D; Robin, G; Lichiere, J; Auzat, I; Tavares, P; Bron, P; Campanacci, V; Cambillau, C				Veesler, David; Robin, Gautier; Lichiere, Julie; Auzat, Isabelle; Tavares, Paulo; Bron, Patrick; Campanacci, Valerie; Cambillau, Christian			Crystal Structure of Bacteriophage SPP1 Distal Tail Protein (gp19.1) A BASEPLATE HUB PARADIGM IN GRAM-POSITIVE INFECTING PHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; LACTOCOCCUS-LACTIS PHAGES; LAMBDA TAIL; REVEALS; MECHANISM; MODEL; BACTERIAL; PHENIX; FIBER; IDENTIFICATION	Siphophage SPP1 infects the Gram-positive bacterium Bacillus subtilis using its long non-contractile tail and tail-tip. Electron microscopy (EM) previously allowed a low resolution assignment of most orf products belonging to these regions. We report here the structure of the SPP1 distal tail protein (Dit, gp19.1). The combination of x-ray crystallography, EM, and light scattering established that Dit is a back-to-back dimer of hexamers. However, Dit fitting in the virion EM maps was only possible with a hexamer located between the tail-tube and the tail-tip. Structure comparison revealed high similarity between Dit and a central component of lactophage baseplates. Sequence similarity search expanded its relatedness to several phage proteins, suggesting that Dit is a docking platform for the tail adsorption apparatus in Siphoviridae infecting Gram-positive bacteria and that its architecture is a paradigm for these hub proteins. Dit structural similarity extends also to non-contractile and contractile phage tail proteins (gpV(N) and XkdM) as well as to components of the bacterial type 6 secretion system, supporting an evolutionary connection between all these devices.	[Veesler, David; Lichiere, Julie; Campanacci, Valerie; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Veesler, David; Lichiere, Julie; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Veesler, David; Lichiere, Julie; Campanacci, Valerie; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [Robin, Gautier; Bron, Patrick] CNRS, UMR 5048, INSERM, Ctr Biochim Struct,U554, F-34090 Montpellier, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, IFR 115, F-91190 Gif Sur Yvette, France; [Auzat, Isabelle; Tavares, Paulo] CNRS, Unite Virol Mol & Struct, UPR3296, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cambillau, C (corresponding author), CNRS, UMR 6098, Campus Luminy,Case 932, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr	Veesler, David/HCH-3986-2022	Campanacci, Valerie/0000-0001-6407-6395; Tavares, Paulo/0000-0002-2566-4546	Ministere francais de l'Enseignement Superieur et de la Recherche [ANR BLAN07-1_191968, ANR-07-BLAN-0095, 22976-2006]	Ministere francais de l'Enseignement Superieur et de la Recherche	This work was supported by Grant ANR BLAN07-1_191968 "Structural Insights on Siphoviridae Bacteriophages Infection," Grant ANR-07-BLAN-0095, "Siphophages," and Ph.D. Grant 22976-2006 from the "Ministere francais de l'Enseignement Superieur et de la Recherche" (to D. V.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babu KS, 1995, DEV BIOL STAND, V85, P569; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; HARAUZ G, 1986, OPTIK, V73, P146; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KATSURA I, 1976, J MOL BIOL, V107, P307, DOI 10.1016/S0022-2836(76)80007-1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; ROUSSEL A, 1991, TURBO FRODO GRAPHICS; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2009, J BIOL CHEM, V284, P30718, DOI 10.1074/jbc.M109.037812; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; VINGA I, 2006, BACTERIOPHAGE BIOL B, P161	52	56	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36666	36673		10.1074/jbc.M110.157529	http://dx.doi.org/10.1074/jbc.M110.157529			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843802	hybrid, Green Published			2022-12-27	WOS:000284146100069
J	Alfaro, MP; Vincent, A; Saraswati, S; Thorne, CA; Hong, CC; Lee, E; Young, PP				Alfaro, Maria P.; Vincent, Alicia; Saraswati, Sarika; Thorne, Curtis A.; Hong, Charles C.; Lee, Ethan; Young, Pampee P.			sFRP2 Suppression of Bone Morphogenic Protein (BMP) and Wnt Signaling Mediates Mesenchymal Stem Cell (MSC) Self-renewal Promoting Engraftment and Myocardial Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; DISRUPTION; ANTAGONIST; INDUCTION; APOPTOSIS; TARGETS; FAMILY; CBFA1	Transplantation of mesenchymal stem cells (MSCs) is a promising therapy for ischemic injury; however, inadequate survival of implanted cells in host tissue is a substantial impediment in the progress of cellular therapy. Secreted Frizzled-related protein 2 (sFRP2) has recently been highlighted as a key mediator of MSC-driven myocardial and wound repair. Notably, sFRP2 mediates significant enhancement of MSC engraftment in vivo. We hypothesized that sFRP2 improves MSC engraftment by modulating self-renewal through increasing stem cell survival and by inhibiting differentiation. In previous studies we demonstrated that sFRP2-expressing MSCs exhibited an increased proliferation rate. In the current study, we show that sFRP2 also decreased MSC apoptosis and inhibited both osteogenic and chondrogenic lineage commitment. sFRP2 activity occurred through the inhibition of both Wnt and bone morphogenic protein (BMP) signaling pathways. sFRP2-mediated inhibition of BMP signaling, as assessed by levels of pSMAD 1/5/8, was independent of its effects on the Wnt pathway. We further hypothesized that sFRP2 inhibition of MSC lineage commitment may reduce heterotopic osteogenic differentiation within the injured myocardium, a reported adverse side effect. Indeed, we found that sFRP2-MSC-treated hearts and wound tissue had less ectopic calcification. This work provides important new insight into the mechanisms by which sFRP2 increases MSC self-renewal leading to superior tissue engraftment and enhanced wound healing.	[Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Thorne, Curtis A.; Lee, Ethan] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hong, Charles C.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Internal Med, Nashville, TN 37232 USA; [Hong, Charles C.; Young, Pampee P.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Sch Med, 1161 21st Ave S,C2217A MCN, Nashville, TN 37232 USA.	pampee.young@vanderbilt.edu			National Institutes of Health [R01-HL088424, HL08842402S1, R01-GM081635]; Veterans Affairs merit award; National Cancer Institute [GI SPORE P50CA95103]; American Heart Association [09PRE2010035]; NIDDK, National Institutes of Health [U24 DK-59637]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040, R01HL088424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL088424, HL08842402S1, and R01-GM081635; Veterans Affairs merit award (to P. P. Y.); National Cancer Institute GI SPORE P50CA95103 (to E. L.); and American Heart Association Grant 09PRE2010035 (to M. P. A.).; MI surgeries were performed in the Cardiovascular Pathophysiology and Complications Core of the Vanderbilt Mouse Metabolic Phenotyping Center, supported by NIDDK, National Institutes of Health Grant U24 DK-59637.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Collavin L, 2003, DEVELOPMENT, V130, P805, DOI 10.1242/dev.00306; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gaur T, 2006, J CELL PHYSIOL, V208, P87, DOI 10.1002/jcp.20637; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jorgensen C, 2004, CURR OPIN BIOTECH, V15, P406, DOI 10.1016/j.copbio.2004.08.003; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Misra K, 2010, DEV BIOL, V337, P74, DOI 10.1016/j.ydbio.2009.10.015; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; SCHOFIELD R, 1983, BIOMED PHARMACOTHER, V37, P375; Suzuki T, 2005, INT J HEMATOL, V82, P285, DOI 10.1532/IJH97.05115; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang ZY, 2009, J MOL CELL CARDIOL, V46, P370, DOI 10.1016/j.yjmcc.2008.11.016; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	34	92	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35645	35653		10.1074/jbc.M110.135335	http://dx.doi.org/10.1074/jbc.M110.135335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826809	Green Published, hybrid			2022-12-27	WOS:000283845300043
J	Into, T; Inomata, M; Niida, S; Murakami, Y; Shibata, K				Into, Takeshi; Inomata, Megumi; Niida, Shumpei; Murakami, Yukitaka; Shibata, Ken-ichiro			Regulation of MyD88 Aggregation and the MyD88-dependent Signaling Pathway by Sequestosome 1 and Histone Deacetylase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PATHOGEN RECOGNITION; GENE-EXPRESSION; PROTEIN; UBIQUITIN; APOPTOSIS; AUTOPHAGY; ADAPTER; FAMILY; TRAF6	MyD88 is an essential adaptor molecule for Toll-like receptors (TLRs) and interleukin (IL)-1 receptor. MyD88 is thought to be present as condensed forms or aggregated structures in the cytoplasm, although the reason has not yet been clear. Here, we show that endogenous MyD88 is present as small speckle-like condensed structures, formation of which depends on MyD88 dimerization. In addition, formation of large aggregated structures is related to cytoplasmic accumulation of sequestosome 1 (SQSTM1; also known as p62) and histone deacetylase 6 (HDAC6), which are involved in accumulation of polyubiquitinated proteins. A gene knockdown study revealed that SQSTM1 and HDAC6 were required for MyD88 aggregation and exhibited a suppressive effect on TLR ligand-induced expression of IL-6 and NOS2 in RAW264.7 cells. SQSTM1 and HDAC6 were partially involved in suppression of several TLR4-mediated signaling events, including activation of p38 and JNK, but they hardly affected degradation of I kappa B alpha (inhibitor of nuclear factor kappa B). Biochemical induction of MyD88 oligomerization induced recruitment of SQSTM1 and HDAC6 to the MyD88-TRAF6 signaling complex. Repression of SQSTM1 and HDAC6 enhanced formation of the MyD88-TRAF6 complex and conversely decreased interaction of the ubiquitin-specific negative regulator CYLD with the complex. Furthermore, ubiquitin-binding regions on SQSTM1 and HDAC6 were essential for MyD88 aggregation but were not required for interaction with the MyD88 complex. Thus, our study reveals not only that SQSTM1 and HDAC6 are important determinants of aggregated localization of MyD88 but also that MyD88 activates a machinery of polyubiquitinated protein accumulation that has a modulatory effect on MyD88-dependent signal transduction.	[Into, Takeshi; Inomata, Megumi; Murakami, Yukitaka] Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, Gifu 5010296, Japan; [Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Lab Genom & Prote, Aichi 4748522, Japan; [Shibata, Ken-ichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol Sci, Lab Oral Mol Microbiol, Sapporo, Hokkaido 0608586, Japan	Asahi University; National Center for Geriatrics & Gerontology; Hokkaido University	Into, T (corresponding author), Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, 1851-1 Hozumi, Gifu 5010296, Japan.	into@dent.asahi-u.ac.jp	Shibata, Ken-ichiro/A-4814-2012		Promotion and Mutual Aid Corporation for Private Schools of Japan; Miyata Science Research Foundation in Asahi University	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Miyata Science Research Foundation in Asahi University	This work was supported by the Science Research Promotion Fund (2010) (to T.I.) from the Promotion and Mutual Aid Corporation for Private Schools of Japan and a grant from the Miyata Science Research Foundation in Asahi University (to T.I.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Fujita M, 2003, J IMMUNOL, V171, P3675, DOI 10.4049/jimmunol.171.7.3675; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hardiman G, 1997, GENOMICS, V45, P332, DOI 10.1006/geno.1997.4940; Hayashi T, 2010, J BIOL CHEM, V285, P18586, DOI 10.1074/jbc.M110.106468; Into T, 2008, MOL CELL BIOL, V28, P1338, DOI 10.1128/MCB.01412-07; Into T, 2007, J BIOL CHEM, V282, P8134, DOI 10.1074/jbc.M609962200; Jaunin F, 1998, EXP CELL RES, V243, P67, DOI 10.1006/excr.1998.4131; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; LORD KA, 1990, CELL GROWTH DIFFER, V1, P637; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	44	66	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35759	35769		10.1074/jbc.M110.126904	http://dx.doi.org/10.1074/jbc.M110.126904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837465	Green Published, hybrid			2022-12-27	WOS:000283845300054
J	Zhao, W; Jaganathan, S; Turkson, J				Zhao, Wei; Jaganathan, Soumya; Turkson, James			A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER DRUG DISCOVERY; DNA-BINDING ACTIVITY; SMALL-MOLECULE; SIGNAL TRANSDUCER; TRANSCRIPTIONAL ACTIVITY; PHOSPHOTYROSYL MIMETICS; SRC ONCOPROTEIN; GENE-REGULATION; TARGETS; PROTEIN	Given the role of constitutively active Signal Transducer and Activator of Transcription (Stat) 3 in human tumors, Stat3 inhibitors would be useful as novel therapeutics and as tools for probing Stat3-mediated tumor processes. We here in report that a 28-mer peptide, SPI, derived from the Stat3 SH2 domain, replicates Stat3 biochemical properties. Studies show SPI and Stat3 (or Stat3 SH2 domain) bind with similar affinities to known Stat3-binding phosphotyrosine (pY) peptide motifs, including those of the epidermal growth factor receptor (EGFR) and the high-affinity, IL-6R/gp130-derived pY-peptide, GpYLPQTV-NH2. Consequently, SPI functions as a potent and selective inhibitor of Stat3 SH2 domain: pTyr interactions and disrupts the binding of Stat3 to the IL-6R/gp130 peptide, GpYLPQTV-NH2. Fluorescence imaging and immunofluorescence staining/laser-scanning confocal microscopy show SPI is cell membrane-permeable, associates with the cytoplasmic tail of EGFR in NIH3T3/hEGFR, and is present in the cytoplasm, but strongly localized at the plasma membrane and in the nucleus in malignant cells harboring persistently active Stat3. Moreover, SPI specifically blocks constitutive Stat3 phosphorylation, DNA binding activity, and transcriptional function in malignant cells, with little or no effect on the induction of Stat1, Stat5, and Erk1/2(MAPK) pathways, or on general pTyr profile at the concentrations that inhibit Stat3 activity. Significantly, treatment with SPI of human breast, pancreatic, prostate, and non-small cell lung cancer cells harboring constitutively active Stat3 induced extensive morphology changes, associated with viability loss and apoptosis. Our study identifies SPI as a novel molecular probe for interrogating Stat3 signaling and that functions as a selective inhibitor of Stat3 activation with antitumor cell effects.	[Zhao, Wei; Jaganathan, Soumya; Turkson, James] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Turkson, J (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	jturkson@mail.ucf.edu		Zhao, Wei/0000-0003-1516-9493	NCI, National Institutes of Health [CA106439, CA128865]; NATIONAL CANCER INSTITUTE [R01CA128865, R01CA106439] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants CA106439 and CA128865 (to J. T.).	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; Bromberg J, 2000, BREAST CANCER RES, V2, P86, DOI 10.1186/bcr38; Burke TR, 1999, BIOORG MED CHEM LETT, V9, P347, DOI 10.1016/S0960-894X(98)00740-9; BURKE TR, 1994, BIOCHEMISTRY-US, V33, P6490, DOI 10.1021/bi00187a015; Chen JY, 2010, ACS MED CHEM LETT, V1, P85, DOI 10.1021/ml100010j; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dharmawardana PG, 2006, ANTI-CANCER DRUG, V17, P13, DOI 10.1097/01.cad.0000185180.72604.ac; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FARR AG, 1989, CELL IMMUNOL, V119, P427, DOI 10.1016/0008-8749(89)90256-6; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GOUILLEUX F, 1995, ENDOCRINOLOGY, V136, P5700, DOI 10.1210/en.136.12.5700; Gunning PT, 2008, CHEMBIOCHEM, V9, P2800, DOI 10.1002/cbic.200800291; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren ZY, 2003, BIOORG MED CHEM LETT, V13, P633, DOI 10.1016/S0960-894X(02)01050-8; Sawyer TK, 1998, BIOPOLYMERS, V47, P243, DOI 10.1002/(SICI)1097-0282(1998)47:3<243::AID-BIP4>3.0.CO;2-P; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Turkson J, 2004, MOL CANCER THER, V3, P261; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200	41	50	64	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35855	35865		10.1074/jbc.M110.154088	http://dx.doi.org/10.1074/jbc.M110.154088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807764	Green Published, hybrid			2022-12-27	WOS:000283845300063
J	Kim, H; Jung, Y; Shin, BS; Kim, H; Song, H; Bae, SH; Rhee, SG; Jeong, W				Kim, Hojin; Jung, Yuyeon; Shin, Bong Soo; Kim, Hyeryeon; Song, Hyunsook; Bae, Soo Han; Rhee, Sue Goo; Jeong, Woojin			Redox Regulation of Lipopolysaccharide-mediated Sulfiredoxin Induction, Which Depends on Both AP-1 and Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ANTIOXIDANT RESPONSE ELEMENT; PEROXIREDOXIN III; OXIDATIVE STRESS; SUBUNIT GENE; KAPPA-B; REVERSIBLE OXIDATION; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INDUCED EXPRESSION	Sulfiredoxin (Srx) is an enzyme that catalyzes the reduction of cysteine sulfinic acid of hyperoxidized peroxiredoxins and exerts a protective antioxidant role. Here we investigated the regulatory mechanism of Srx induction by lipopolysaccharide (LPS) in mouse macrophages. LPS up-regulated Srx expression on the transcriptional level. The promoter region of the Srx gene contained putative NF-kappa B and AP-1 (activator protein-1) sites, and the proximal site of three AP-1 sites was embedded within the antioxidant response element (ARE), a cis-acting element for Nrf2 (nuclear factor erythroid 2-related factor). Mutational analysis of the Srx promoter revealed that Srx induction is dependent on AP-1 sites and ARE but not on NF-kappa B sites. Consistently, both transcription factors, AP-1 and Nrf2, were required for LPS-mediated Srx induction, as revealed by chromatin immunoprecipitation using antibodies specific for c-Jun and c-Fos and little Srx induction in Nrf2-null bone marrow-derived macrophages. Among mitogen-activated protein kinases that mediate the signal transduction by LPS, JNK played a major role in Srx induction. Moreover, chemical antioxidants, such as N-acetylcysteine and butylated hydroxyanisole, and the NADPH oxidase inhibitor diphenyleneiodonium inhibited Srx induction as well as generation of reactive oxygen species, both of which were also suppressed in Nox2 (NADPH oxidase 2)-deficient bone marrow-derived macrophages. These results suggest that LPS-mediated Srx induction is dependent on both AP-1 and Nrf2, which is regulated by Nox2-derived reactive oxygen species.	Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University	Jeong, W (corresponding author), Sci Bldg C,Rm 207,11-1 Daehyun Dong, Seoul 120750, South Korea.	jeongw@ewha.ac.kr			Ministry of Education, Science, and Technology [M10642040002-07N4204-00210, R01-2008-000-11321-0, R15-2006-020]; Brain Korea 21 Scholars Program	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 Scholars Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Bio R&D Program Grant M10642040002-07N4204-00210, Grant R01-2008-000-11321-0 and National Core Research Center Program Grant R15-2006-020 through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science, and Technology, and by funds from the Brain Korea 21 Scholars Program (to Y. J. and H. K.).	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Abbas K, 2009, FREE RADICAL BIO MED, V47, P794, DOI 10.1016/j.freeradbiomed.2009.06.018; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bast A, 2010, BBA-GENE REGUL MECH, V1799, P402, DOI 10.1016/j.bbagrm.2009.11.015; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Glauser DA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-54; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Li LQ, 2009, J BIOCHEM, V145, P425, DOI 10.1093/jb/mvp011; LI Y, 1992, J BIOL CHEM, V267, P15097; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Moinova HR, 1998, J BIOL CHEM, V273, P14683, DOI 10.1074/jbc.273.24.14683; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Roussel X, 2008, J BIOL CHEM, V283, P22371, DOI 10.1074/jbc.M800493200; Rushworth SA, 2005, J IMMUNOL, V175, P4408, DOI 10.4049/jimmunol.175.7.4408; Rushworth SA, 2008, J IMMUNOL, V181, P6730, DOI 10.4049/jimmunol.181.10.6730; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x; Soriano FX, 2009, MOL CELLS, V27, P279, DOI 10.1007/s10059-009-0050-y; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wei Q, 2008, P NATL ACAD SCI USA, V105, P19738, DOI 10.1073/pnas.0810676105; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Yang HP, 2002, J BIOL CHEM, V277, P35232, DOI 10.1074/jbc.M203812200; Yang HP, 2001, BIOCHEM J, V357, P447, DOI 10.1042/0264-6021:3570447; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830	80	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34419	34428		10.1074/jbc.M110.126839	http://dx.doi.org/10.1074/jbc.M110.126839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826812	hybrid, Green Published			2022-12-27	WOS:000283659100016
J	Salomonsson, E; Carlsson, MC; Osla, V; Hendus-Altenburger, R; Kahl-Knutson, B; Oberg, CT; Sundin, A; Nilsson, R; Nordberg-Karlsson, E; Nilsson, UJ; Karlsson, A; Rini, JM; Leffler, H				Salomonsson, Emma; Carlsson, Michael C.; Osla, Veronica; Hendus-Altenburger, Ruth; Kahl-Knutson, Barbro; Oberg, Christopher T.; Sundin, Anders; Nilsson, Rickard; Nordberg-Karlsson, Eva; Nilsson, Ulf J.; Karlsson, Anna; Rini, James M.; Leffler, Hakon			Mutational Tuning of Galectin-3 Specificity and Biological Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING PROTEIN-35; CELL-SURFACE; SUGAR CHAINS; BLOOD-GROUP; N-GLYCANS; RECOMBINANT POLYPEPTIDE; HUMAN-GRANULOCYTES; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; STRUCTURAL BASIS	Galectins are defined by a conserved beta-galactoside binding site that has been linked to many of their important functions in e. g. cell adhesion, signaling, and intracellular trafficking. Weak adjacent sites may enhance or decrease affinity for natural beta-galactoside-containing glycoconjugates, but little is known about the biological role of this modulation of affinity (fine specificity). We have now produced 10 mutants of human galectin-3, with changes in these adjacent sites that have altered carbohydrate-binding fine specificity but that retain the basic beta-galactoside binding activity as shown by glycan-array binding and a solution-based fluorescence anisotropy assay. Each mutant was also tested in two biological assays to provide a correlation between fine specificity and function. Galectin-3 R186S, which has selectively lost affinity for LacNAc, a disaccharide moiety commonly found on glycoprotein glycans, has lost the ability to activate neutrophil leukocytes and intracellular targeting into vesicles. K176L has increased affinity for beta-galactosides substituted with GlcNAc beta 1-3, as found in poly-N-acetyllactosaminoglycans, and increased potency to activate neutrophil leukocytes even though it has lost other aspects of galectin-3 fine specificity. G182A has altered carbohydrate-binding fine specificity and altered intracellular targeting into vesicles, a possible link to the intracellular galectin-3-mediated anti-apoptotic effect known to be lost by this mutant. Finally, the mutants have helped to define the differences in fine specificity shown by Xenopus, mouse, and human galectin-3 and, as such, the evidence for adaptive change during evolution.	[Nilsson, Rickard] Lund Univ, Dept Lab Med, Sect MIG Microbiol Immunol Glycobiol, S-22362 Lund, Sweden; [Osla, Veronica; Karlsson, Anna] Gothenburg Univ, Dept Rheumatol & Inflammat Res, Phagocyte Res Lab, S-41346 Gothenburg, Sweden; [Nordberg-Karlsson, Eva] Lund Univ, S-22200 Lund, Sweden; [Oberg, Christopher T.; Sundin, Anders; Nilsson, Ulf J.] Lund Univ, SE-22100 Lund, Sweden; [Rini, James M.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Rini, James M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	Lund University; University of Gothenburg; Lund University; Lund University; University of Toronto; University of Toronto	Leffler, H (corresponding author), Lund Univ, ILM, MIG, Solvegatan 23, SE-22362 Lund, Sweden.	Hakon.Leffler@med.lu.se	Nordberg Karlsson, Eva/D-1426-2015; Hendus-Altenburger, Ruth/M-4943-2016; Leffler, Hakon/A-2416-2019; Hendus-Altenburger, Ruth/AAT-1249-2021; Karlsson, Anna/A-4130-2012; Nilsson, Ulf J./L-3219-2014	Nordberg Karlsson, Eva/0000-0002-8597-7050; Hendus-Altenburger, Ruth/0000-0001-5183-1507; Hendus-Altenburger, Ruth/0000-0001-5183-1507; Nilsson, Ulf J./0000-0001-5815-9522; Leffler, Hakon/0000-0003-4482-8945; Oberg, Christopher T./0000-0002-8804-829X; Sundin, Anders/0000-0001-6615-2419; Karlsson, Anna/0000-0001-6796-1154	NIGMS, National Institutes of Health [GM62116]; Lund University Research School in Pharmaceutical Sciences; Swedish Research Council; Swedish Strategic Research Foundation; Royal Physiographic Society in Lund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lund University Research School in Pharmaceutical Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Royal Physiographic Society in Lund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The glycan-array analysis was performed by the Consortium for Functional Glycomics (CoreH, Emory School of Medicine, Atlanta, GA) funded by NIGMS, National Institutes of Health Grant GM62116.; This work was funded by the Lund University Research School in Pharmaceutical Sciences, the Swedish Research Council, the programs "Glycoconjugates in Biological Systems" and "Chemistry for the Life Sciences" sponsored by the Swedish Strategic Research Foundation, and the Royal Physiographic Society in Lund.	AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Akahani S, 1997, CANCER RES, V57, P5272; Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; ASADA M, 1991, BIOCHEMISTRY-US, V30, P1561, DOI 10.1021/bi00220a017; Ban M, 2005, J MOL BIOL, V351, P695, DOI 10.1016/j.jmb.2005.06.045; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Cumpstey I, 2008, CHEM-EUR J, V14, P4233, DOI 10.1002/chem.200701932; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Delacour D, 2008, J CELL SCI, V121, P458, DOI 10.1242/jcs.020800; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Diehl C, 2009, J BIOMOL NMR, V45, P157, DOI 10.1007/s10858-009-9356-5; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; FINNE J, 1989, J BIOL CHEM, V264, P5720; Forsman H, 2008, GLYCOBIOLOGY, V18, P905, DOI 10.1093/glycob/cwn081; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1984, J BIOL CHEM, V259, P925; FUKUDA MN, 1985, J BIOL CHEM, V260, P1067; Furukawa K, 1998, EUR J BIOCHEM, V251, P288, DOI 10.1046/j.1432-1327.1998.2510288.x; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Henrick K, 1998, GLYCOBIOLOGY, V8, P45, DOI 10.1093/glycob/8.1.45; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P23648; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; John CM, 2002, CELL MICROBIOL, V4, P649, DOI 10.1046/j.1462-5822.2002.00219.x; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Karlsson A, 2001, GLYCOCONJUGATE J, V18, P231, DOI 10.1023/A:1013183124004; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; Koch A, 2010, MOL BIOL CELL, V21, P219, DOI 10.1091/mbc.E09-03-0193; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lin CL, 2009, MOL CANCER RES, V7, P1655, DOI 10.1158/1541-7786.MCR-09-0274; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rudd PM, 1999, BIOCHEMISTRY-US, V38, P13937, DOI 10.1021/bi991162e; Ruebel KH, 2005, CANCER RES, V65, P1136, DOI 10.1158/0008-5472.CAN-04-3578; SATO S, 1992, J BIOL CHEM, V267, P6983; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Shalom-Feuerstein R, 2005, CANCER RES, V65, P7292, DOI 10.1158/0008-5472.CAN-05-0775; Shoji H, 2003, J BIOL CHEM, V278, P12285, DOI 10.1074/jbc.M209008200; SO RMEP, 2005, J Am Chem Soc */* U, V127, P1737; SO RMEP, 2004, ANAL BIOCH */* H ANA, V334, P36; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Theilgaard-Monch K, 2005, J LEUKOCYTE BIOL, V78, P462, DOI 10.1189/jlb.0105042; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Yang N, 2009, J MOL BIOL, V387, P694, DOI 10.1016/j.jmb.2009.02.002; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	70	84	84	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35079	35091		10.1074/jbc.M109.098160	http://dx.doi.org/10.1074/jbc.M109.098160			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807768	hybrid, Green Published			2022-12-27	WOS:000283659100082
J	Shingu-Vazquez, M; Camacho-Villasana, Y; Sandoval-Romero, L; Butler, CA; Fox, TD; Perez-Martinez, X				Shingu-Vazquez, Miguel; Camacho-Villasana, Yolanda; Sandoval-Romero, Luisa; Butler, Christine A.; Fox, Thomas D.; Perez-Martinez, Xochitl			The Carboxyl-terminal End of Cox1 Is Required for Feedback Assembly Regulation of Cox1 Synthesis in Saccharomyces cerevisiae Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MESSENGER-RNA; INNER MEMBRANE; SUBUNIT-III; HUMAN-CELLS; IN-VIVO; YEAST; GENE; TRANSLATION; CHLOROPLAST	Synthesis of the largest cytochrome c oxidase (CcO) subunit, Cox1, on yeast mitochondrial ribosomes is coupled to assembly of CcO. The translational activator Mss51 is sequestered in early assembly intermediate complexes by an interaction with Cox14 that depends on the presence of newly synthesized Cox1. If CcO assembly is prevented, the level of Mss51 available for translational activation is reduced. We deleted the C-terminal 11 or 15 residues of Cox1 by site-directed mutagenesis of mtDNA. Although these deletions did not prevent respiratory growth of yeast, they eliminated the assembly-feedback control of Cox1 synthesis. Furthermore, these deletions reduced the strength of the Mss51-Cox14 interaction as detected by co-immunoprecipitation, confirming the importance of the Cox1 C-terminal residues for Mss51 sequestration. We surveyed a panel of mutations that block CcO assembly for the strength of their effect on Cox1 synthesis, both by pulse labeling and expression of the ARG8(m) reporter fused to COX1. Deletion of the nuclear gene encoding Cox6, one of the first subunits to be added to assembling CcO, caused the most severe reduction in Cox1 synthesis. Deletion of the C-terminal 15 amino acids of Cox1 increased Cox1 synthesis in the presence of each of these mutations, except pet54. Our data suggest a novel activity of Pet54 required for normal synthesis of Cox1 that is independent of the Cox1 C-terminal end.	[Shingu-Vazquez, Miguel; Camacho-Villasana, Yolanda; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico; [Sandoval-Romero, Luisa] Inst Nacl Rehabil, Dept Morfol Celular & Mol, Mexico City 14389, DF, Mexico; [Butler, Christine A.; Fox, Thomas D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidad Nacional Autonoma de Mexico; Cornell University	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx		Fox, Thomas/0000-0001-7629-3661	National Institutes of Health [GM029362]; CONACyT [47514]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT); UNAM [IN215008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); UNAM(Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM029362 (to T. D. F.), research grants from CONACyT (47514) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), and UNAM Grant IN215008 (to X. P.-M.).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2003, J BIOL CHEM, V278, P8881, DOI 10.1074/jbc.M212427200; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Bonnefoy N, 2001, MOL CELL BIOL, V21, P2359, DOI 10.1128/MCB.21.7.2359-2372.2001; Bonnefoy N, 2000, MOL GEN GENET, V262, P1036, DOI 10.1007/PL00008646; Bonnefoy N, 2007, METHOD CELL BIOL, V80, P525, DOI 10.1016/S0091-679X(06)80026-9; Broadley SA, 2001, MOL CELL BIOL, V21, P7663, DOI 10.1128/MCB.21.22.7663-7672.2001; Burke D., 2000, METHODS YEAST GENETI; CABRAL F, 1978, J BIOL CHEM, V253, P297; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; Choquet Y, 2003, PLANT CELL, V15, P1443, DOI 10.1105/tpc.011692; Church C, 2005, J BIOL CHEM, V280, P1854, DOI 10.1074/jbc.M410726200; COSTANZO MC, 1986, EMBO J, V5, P3637, DOI 10.1002/j.1460-2075.1986.tb04693.x; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Drapier D, 2007, EMBO J, V26, P3581, DOI 10.1038/sj.emboj.7601802; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Gawryluk RMR, 2010, MOL BIOL EVOL, V27, P7, DOI 10.1093/molbev/msp223; Guthrie C., 2002, GUIDE YEAST GENETICS; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffbuhr KC, 2000, J BIOL CHEM, V275, P13994, DOI 10.1074/jbc.275.18.13994; Horan S, 2005, BIOCHEM J, V390, P703, DOI 10.1042/BJ20050598; Khalimonchuk O, 2008, EUKARYOT CELL, V7, P1427, DOI 10.1128/EC.00132-08; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaire C, 1998, CURR GENET, V34, P138, DOI 10.1007/s002940050378; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; MEUNIER B, 1993, EUR J BIOCHEM, V213, P129, DOI 10.1111/j.1432-1033.1993.tb17742.x; Meunier B, 2001, BIOCHEM J, V354, P407, DOI 10.1042/0264-6021:3540407; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Minai L, 2006, PLANT CELL, V18, P159, DOI 10.1105/tpc.105.037705; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Pecina P, 2004, PHYSIOL RES, V53, pS213; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; VALENCIK ML, 1991, MOL CELL BIOL, V11, P2399, DOI 10.1128/MCB.11.5.2399; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Wostrikoff K, 2004, EMBO J, V23, P2696, DOI 10.1038/sj.emboj.7600266	53	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34382	34389		10.1074/jbc.M110.161976	http://dx.doi.org/10.1074/jbc.M110.161976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807763	Green Published, hybrid			2022-12-27	WOS:000283659100012
J	Tholanikunnel, BG; Joseph, K; Kandasamy, K; Baldys, A; Raymond, JR; Luttrell, LM; McDermott, PJ; Fernandes, DJ				Tholanikunnel, Baby G.; Joseph, Kusumam; Kandasamy, Karthikeyan; Baldys, Aleksander; Raymond, John R.; Luttrell, Louis M.; McDermott, Paul J.; Fernandes, Daniel J.			Novel Mechanisms in the Regulation of G Protein-coupled Receptor Trafficking to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; MESSENGER-RNA LOCALIZATION; ELAV-LIKE PROTEIN; BETA(2)-ADRENERGIC RECEPTOR; BINDING PROTEINS; SIGNAL PEPTIDE; IN-VIVO; HUR; TRANSLATION; CELLS	beta(2)-Adrenergic receptors (beta(2)-AR) are low abundance, integral membrane proteins that mediate the effects of catecholamines at the cell surface. Whereas the processes governing desensitization of activated beta(2)-ARs and their subsequent removal from the cell surface have been characterized in considerable detail, little is known about the mechanisms controlling trafficking of neo-synthesized receptors to the cell surface. Since the discovery of the signal peptide, the targeting of the integral membrane proteins to plasma membrane has been thought to be determined by structural features of the amino acid sequence alone. Here we report that localization of translationally silenced beta(2)-AR mRNA to the peripheral cytoplasmic regions is critical for receptor localization to the plasma membrane. beta(2)-AR mRNA is recognized by the nucleocytoplasmic shuttling RNA-binding protein HuR, which silences translational initiation while chaperoning the mRNA-protein complex to the cell periphery. When HuR expression is down-regulated, beta(2)-AR mRNA translation is initiated prematurely in perinuclear polyribosomes, leading to overproduction of receptors but defective trafficking to the plasma membrane. Our results underscore the importance of the spatiotemporal relationship between beta(2)-AR mRNA localization, translation, and trafficking to the plasma membrane, and establish a novel mechanism whereby G protein-coupled receptor (GPCR) responsiveness is regulated by RNA-based signals.	[Tholanikunnel, Baby G.; Joseph, Kusumam; Luttrell, Louis M.; Fernandes, Daniel J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Joseph, Kusumam; Kandasamy, Karthikeyan; Baldys, Aleksander; Raymond, John R.; Luttrell, Louis M.; McDermott, Paul J.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Tholanikunnel, BG (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 86 Jonathan Lucas St,HCC 709, Charleston, SC 29425 USA.	tholanik@musc.edu		Luttrell, Louis/0000-0003-2805-6949	National Institutes of Health; American Heart Association [0555470U, 0765356U]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by grants from the National Institutes of Health (to B. G. T.) and the American Heart Association (0555470U, to B. G. T. and 0765356U, to K. J.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Antic D, 1998, J CELL SCI, V111, P183; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104; Blaxall BC, 2000, J BIOL CHEM, V275, P4290, DOI 10.1074/jbc.275.6.4290; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; DELOPEZ ZM, 2004, P NATL ACAD SCI USA, V101, P2987; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lingappa V R, 1980, Recent Prog Horm Res, V36, P451; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Paquin N, 2005, NAT STRUCT MOL BIOL, V12, P1026, DOI 10.1038/nsmb1205-1026; RANDS E, 1990, J BIOL CHEM, V265, P10759; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Subramaniam K, 2004, J BIOL CHEM, V279, P27108, DOI 10.1074/jbc.M401352200; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	36	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33816	33825		10.1074/jbc.M110.168229	http://dx.doi.org/10.1074/jbc.M110.168229			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739277	Green Published, hybrid			2022-12-27	WOS:000283354000028
J	Song, B; Lai, BQ; Zheng, ZH; Zhang, YY; Luo, JY; Wang, C; Chen, YA; Woodgett, JR; Li, MT				Song, Bin; Lai, Bingquan; Zheng, Zhihao; Zhang, Yuying; Luo, Jingyan; Wang, Chong; Chen, Yuan; Woodgett, James R.; Li, Mingtao			Inhibitory Phosphorylation of GSK-3 by CaMKII Couples Depolarization to Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CEREBELLAR GRANULE NEURONS; DEPENDENT PROTEIN-KINASE; MYOCYTE ENHANCER FACTOR-2; NERVE GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; POTASSIUM DEPOLARIZATION; SUBSTRATE-SPECIFICITY; NEURITE-OUTGROWTH	Glycogen synthase kinase-3 (GSK-3) plays a critical role in neuronal apoptosis. The two mammalian isoforms of the kinase, GSK-3 alpha and GSK-3 beta, are inhibited by phosphorylation at Ser-21 and Ser-9, respectively. Depolarization, which is vital for neuronal survival, causes both an increase in Ser-21/9 phosphorylation and an inhibition of GSK-3 alpha/beta. However, the role of GSK-3 phosphorylation in depolarization-dependent neuron survival and the signaling pathway contributing to GSK-3 phosphorylation during depolarization remain largely unknown. Using several approaches, we showed that both isoforms of GSK-3 are important for mediating neuronal apoptosis. Non-phosphorylatable GSK-3 alpha/beta mutants (S21A/S9A) promoted apoptosis, whereas a peptide encompassing Ser-9 of GSK-3 beta protected neurons in a phosphorylation-dependent manner; these results indicate a critical role for Ser-21/9 phosphorylation on depolarization-dependent neuron survival. We found that Ser-21/9 phosphorylation of GSK-3 was mediated by Ca2+/calmodulin-dependent protein kinase II (CaMKII) but not by Akt/PKB, PKA, or p90(RSK). CaMKII associated with and phosphorylated GSK-3 alpha/beta. Furthermore, the pro-survival effect of CaMKII was mediated by GSK-3 phosphorylation and inactivation. These findings identify a novel Ca2+/calmodulin/CaMKII/GSK-3 pathway that couples depolarization to neuronal survival.	[Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510080, Guangdong, Peoples R China; [Song, Bin; Lai, Bingquan; Zheng, Zhihao; Zhang, Yuying; Luo, Jingyan; Wang, Chong; Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Prote Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Song, Bin; Lai, Bingquan; Zheng, Zhihao; Zhang, Yuying; Luo, Jingyan; Wang, Chong; Chen, Yuan; Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Ctr Neurosci, Guangzhou 510080, Guangdong, Peoples R China; [Woodgett, James R.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X5, Canada	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Li, MT (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	limt@mail.sysu.edu.cn	Woodgett, Jim/F-1087-2010; Chen, Yuan/D-1462-2011	Woodgett, Jim/0000-0003-3731-5797; Chen, Yuan/0000-0002-9412-4623; Zheng, Zhihao/0000-0001-9406-9073	National Natural Science Foundation of China [30870786, U0632006, 81030024]; Ministry of Science and Technology of China [2009ZX09103-043]; Natural Science Foundation of Guangdong Province China [9351008901000003]; National Basic Research Program of China (973 Program) [2011CB504105]; Canadian Institutes of Health [FRN 12858]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Guangdong Province China(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by National Natural Science Foundation of China Grants 30870786, U0632006 and 81030024, the Ministry of Science and Technology of China Grant 2009ZX09103-043, the Natural Science Foundation of Guangdong Province China Grant 9351008901000003, National Basic Research Program of China (973 Program) 2011CB504105, and the Canadian Institutes of Health Research Grant FRN 12858.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Borodinsky LN, 2002, J NEUROCHEM, V80, P1062, DOI 10.1046/j.1471-4159.2002.00795.x; Borsello T, 2000, NEUROSCIENCE, V95, P163; Bulleit RF, 2008, NEURON, V60, P401, DOI 10.1016/j.neuron.2008.10.024; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chin PC, 2005, MOL BRAIN RES, V137, P193, DOI 10.1016/j.molbrainres.2005.03.004; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Erxleben C, 2006, P NATL ACAD SCI USA, V103, P3932, DOI 10.1073/pnas.0511322103; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLIRESTA L, 1993, J NEUROSCI, V13, P243; GALLO V, 1987, J NEUROSCI, V7, P2203; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Griffith LC, 2004, J NEUROSCI, V24, P8391, DOI 10.1523/JNEUROSCI.2888-04.2004; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; HACK N, 1993, NEUROSCIENCE, V57, P9, DOI 10.1016/0306-4522(93)90108-R; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200; Hetman M, 2000, J NEUROSCI, V20, P2567; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kumari S, 2001, MOL BRAIN RES, V96, P157, DOI 10.1016/S0006-8993(01)03045-1; Lafon-Cazal M, 2002, EUR J NEUROSCI, V16, P575, DOI 10.1046/j.1460-9568.2002.02124.x; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Miller TM, 1996, J NEUROSCI, V16, P7487; Miller TM, 1997, J BIOL CHEM, V272, P9847; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Shimoke K, 1999, DEV BRAIN RES, V112, P245, DOI 10.1016/S0165-3806(98)00172-2; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08; Zhao Z, 2009, J NEUROSCI, V29, P1350, DOI 10.1523/JNEUROSCI.3770-08.2009; Zhong J, 2004, J NEUROSCI RES, V75, P794, DOI 10.1002/jnr.20024; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	82	62	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41122	41134		10.1074/jbc.M110.130351	http://dx.doi.org/10.1074/jbc.M110.130351			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20841359	Green Published, hybrid			2022-12-27	WOS:000285414400074
J	Launay, N; Tarze, A; Vicart, P; Lilienbaum, A				Launay, Nathalie; Tarze, Agathe; Vicart, Patrick; Lilienbaum, Alain			Serine 59 Phosphorylation of alpha B-Crystallin Down-regulates Its Anti-apoptotic Function by Binding and Sequestering Bcl-2 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SIGNALING PATHWAYS; HSP27; ACTIVATION; CASPASE-3; KINASE; DIFFERENTIATION; TRANSLOCATION; MITOCHONDRIA; EXPRESSION	The small heat shock protein (sHSP) alpha B-crystallin is a new oncoprotein in breast carcinoma that predicts poor clinical outcome in breast cancer. However, although several reports have demonstrated that phosphorylation of sHSPs modify their structural and functional properties, the significance of alpha B-crystallin phosphorylation in cancer cells has not yet been investigated. In this study, we have characterized the phosphorylation status of alpha B-crystallin in breast epithelial carcinoma cells line MCF7 submitted to anti-cancer agents like vinblastine. We have showed that the main phosphorylation site of alpha B-crystallin in response to vinblastine is serine 59 and determined a correlation between this post-translational modification and higher apoptosis level. The overexpression of the serine 59 "pseudophosphorylated" mutant (S59E) induces a significant increase in the apoptosis level of vinblastine-treated MCF7 cells. In contrast, overexpression of wild-type alpha B-crystallin or "nonphosphorylatable" mutant (S59A) result in a resistance to this microtubule-depolymerizing agent, while inhibition of endogenous levels of alpha B-crystallin by expression of shRNA lowers it. Analyzing further the molecular mechanism of this phenomenon, we report for the first time that phosphorylated alpha B-crystallin preferentially interacts with Bcl-2, an anti-apoptotic protein, and this interaction prevents the translocation of Bcl-2 to mitochondria. Hence, this study identifies serine 59 phosphorylation as an important key in the down-regulation of alpha B-crystallin antiapoptotic function in breast cancer and suggests new strategies to improve anti-cancer treatments.	[Lilienbaum, Alain] Univ Paris 07, BFA, Unite Biol Fonct & Adaptat BFA, EAC4413,CNRS,Lab Stress & Pathol Crytosquelette, F-75250 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Lilienbaum, A (corresponding author), Univ Paris 07, BFA, Unite Biol Fonct & Adaptat BFA, EAC4413,CNRS,Lab Stress & Pathol Crytosquelette, Case 7006,4 Rue MarieAndree Lagroua Weill Halle, F-75250 Paris 13, France.	alain.lilienbaum@univ-paris-diderot.fr	Tarze, Agathe/R-4379-2018; Launay, Nathalie/G-1387-2016	Tarze, Agathe/0000-0001-6101-069X; Launay, Nathalie/0000-0002-7498-217X	Association Francaise contre les Myopathies (AFM); Association pour la Recherche contre le Cancer (ARC)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by grants from Association Francaise contre les Myopathies (AFM) and Association pour la Recherche contre le Cancer (ARC).	Arrigo AP, 2005, J CELL BIOCHEM, V94, P241, DOI 10.1002/jcb.20349; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Casado P, 2007, CANCER LETT, V247, P273, DOI 10.1016/j.canlet.2006.05.005; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Chelouche-Lev D, 2004, CANCER-AM CANCER SOC, V100, P2543, DOI 10.1002/cncr.20304; Dimberg A, 2008, BLOOD, V111, P2015, DOI 10.1182/blood-2007-04-087841; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Gaestel M, 2002, Prog Mol Subcell Biol, V28, P151; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Gruvberger-Saal SK, 2006, J CLIN INVEST, V116, P30, DOI 10.1172/JCI27462; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Hoover HE, 2000, J BIOL CHEM, V275, P23825, DOI 10.1074/jbc.M003864200; Inaguma Y, 2001, EUR J CELL BIOL, V80, P741, DOI 10.1078/0171-9335-00203; Ivanov O, 2008, BREAST CANCER RES TR, V111, P411, DOI 10.1007/s10549-007-9796-0; Jin JK, 2008, AM J PHYSIOL-HEART C, V294, pH337, DOI 10.1152/ajpheart.00881.2007; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kase S, 2009, ARCH OPHTHALMOL-CHIC, V127, P187, DOI 10.1001/archophthalmol.2008.580; Kato K, 1996, J BIOL CHEM, V271, P26989, DOI 10.1074/jbc.271.43.26989; Kruczynski A, 2001, CRIT REV ONCOL HEMAT, V40, P159, DOI 10.1016/S1040-8428(01)00183-4; Laudanski K, 2006, ARCH IMMUNOL THER EX, V54, P103, DOI 10.1007/s00005-006-0013-3; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Maddala R, 2005, EXP CELL RES, V306, P203, DOI 10.1016/j.yexcr.2005.01.026; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Sitterding SM, 2008, ANN DIAGN PATHOL, V12, P33, DOI 10.1016/j.anndiagpath.2007.02.004; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Takai S, 2007, LIFE SCI, V81, P585, DOI 10.1016/j.lfs.2007.06.018; Tan Q, 2009, HUM PATHOL, V40, P300, DOI 10.1016/j.humpath.2008.09.002; van den Ijssel PRLA, 1998, BIOCHEM BIOPH RES CO, V247, P518, DOI 10.1006/bbrc.1998.8699; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Watanabe G, 2009, CANCER SCI, V100, P2368, DOI 10.1111/j.1349-7006.2009.01316.x; Welsh MJ, 1998, ANN NY ACAD SCI, V851, P28, DOI 10.1111/j.1749-6632.1998.tb08973.x; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com	43	42	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37324	37332		10.1074/jbc.M110.124388	http://dx.doi.org/10.1074/jbc.M110.124388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20841355	Green Published, hybrid			2022-12-27	WOS:000284424000025
J	Steinberg, GR; O'Neill, HM; Dzamko, NL; Galic, S; Naim, T; Koopman, R; Jorgensen, SB; Honeyman, J; Hewitt, K; Chen, ZP; Schertzer, JD; Scott, JW; Koentgen, F; Lynch, GS; Watt, MJ; van Denderen, BJW; Campbell, DJ; Kemp, BE				Steinberg, Gregory R.; O'Neill, Hayley M.; Dzamko, Nicolas L.; Galic, Sandra; Naim, Tim; Koopman, Rene; Jorgensen, Sebastian B.; Honeyman, Jane; Hewitt, Kimberly; Chen, Zhi-Ping; Schertzer, Jonathan D.; Scott, John W.; Koentgen, Frank; Lynch, Gordon S.; Watt, Matthew J.; van denderen, Bryce J. W.; Campbell, Duncan J.; Kemp, Bruce E.			Whole Body Deletion of AMP-activated Protein Kinase beta 2 Reduces Muscle AMPK Activity and Exercise Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; HUMAN SKELETAL-MUSCLE; GLUCOSE-UPTAKE; INSULIN-RESISTANCE; LIFE-STYLE; ISOFORM; CONTRACTION; TRANSPORT; PHOSPHORYLATION	AMP-activated protein kinase (AMPK) beta subunits (beta 1 and beta 2) provide scaffolds for binding alpha and gamma subunits and contain a carbohydrate-binding module important for regulating enzyme activity. We generated C57Bl/6 mice with germline deletion of AMPK beta 2 (beta 2 KO) and examined AMPK expression and activity, exercise capacity, metabolic control during muscle contractions, aminoimidazole carboxamide ribonucleotide (AICAR) sensitivity, and susceptibility to obesity-induced insulin resistance. We find that beta 2 KO mice are viable and breed normally. beta 2 KO mice had a reduction in skeletal muscle AMPK alpha 1 and alpha 2 expression despite up-regulation of the beta 1 isoform. Heart AMPK alpha 2 expression was also reduced but this did not affect resting AMPK alpha 1 or alpha 2 activities. AMPK alpha 1 and alpha 2 activities were not changed in liver, fat, or hypothalamus. AICAR-stimulated glucose uptake but not fatty acid oxidation was impaired in beta 2 KO mice. During treadmill running beta 2 KO mice had reduced maximal and endurance exercise capacity, which was associated with lower muscle and heart AMPK activity and reduced levels of muscle and liver glycogen. Reductions in exercise capacity of beta 2 KO mice were not due to lower muscle mitochondrial content or defects in contraction-stimulated glucose uptake or fatty acid oxidation. When challenged with a high-fat diet beta 2 KO mice gained more weight and were more susceptible to the development of hyperinsulinemia and glucose intolerance. In summary these data show that deletion of AMPK beta 2 reduces AMPK activity in skeletal muscle resulting in impaired exercise capacity and the worsening of diet-induced obesity and glucose intolerance.	[Schertzer, Jonathan D.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Steinberg, Gregory R.; O'Neill, Hayley M.; Dzamko, Nicolas L.; Galic, Sandra; Jorgensen, Sebastian B.; Honeyman, Jane; Hewitt, Kimberly; Chen, Zhi-Ping; Scott, John W.; van denderen, Bryce J. W.; Campbell, Duncan J.; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Steinberg, Gregory R.; O'Neill, Hayley M.; Dzamko, Nicolas L.; Galic, Sandra; Jorgensen, Sebastian B.; Honeyman, Jane; Hewitt, Kimberly; Chen, Zhi-Ping; Scott, John W.; van denderen, Bryce J. W.; Campbell, Duncan J.; Kemp, Bruce E.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Naim, Tim; Koopman, Rene; Schertzer, Jonathan D.; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Jorgensen, Sebastian B.] Novo Nordisk AS, Diabet Res Unit, DK-2760 Malov, Denmark; [Koentgen, Frank] Ozgene Pty Ltd, Perth, WA, Australia; Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia	McMaster University; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; University of Melbourne; Novo Nordisk; Monash University	Steinberg, GR (corresponding author), 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	gsteinberg@mcmaster.ca	Dzamko, Nicolas/AAD-6922-2019; Scott, John W/AAA-2676-2021; Watt, Matthew J/B-2089-2014; Galic, Sandra/C-6098-2014; Scott, John W/P-1170-2018; Kemp, Bruce/G-9602-2019; Lynch, Gordon/G-9553-2015; van Denderen, Bryce/AAW-5454-2021; Kemp, Bruce E/L-2633-2014; Schertzer, Jonathan/P-3395-2017	Scott, John W/0000-0002-1896-9798; Galic, Sandra/0000-0002-7611-5619; Scott, John W/0000-0002-1896-9798; Kemp, Bruce/0000-0001-6735-5082; Lynch, Gordon/0000-0001-9220-9810; Kemp, Bruce E/0000-0001-6735-5082; Dzamko, Nicolas/0000-0002-9121-0294; Steinberg, Gregory/0000-0001-5425-8275; Schertzer, Jonathan/0000-0002-1547-5856; O'Neill, Hayley/0000-0001-6812-6580	Australian Research Council; National Health and Medical Research Council; Natural Science and Engineering Research Council of Canada; Diabetes Australia Research Trust; National Heart Foundation of Australia; National Heart Foundation; Danish Medical Research Council [271-05-0697]; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Diabetes Australia Research Trust; National Heart Foundation of Australia(National Heart Foundation of Australia); National Heart Foundation(National Heart Foundation of Australia); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the Australian Research Council (to B. E. K.), National Health and Medical Research Council (to D. J. C., B. E. K., G. R. S., and M. J. W.), Natural Science and Engineering Research Council of Canada (to G. R. S.), Diabetes Australia Research Trust (to G. R. S.), and the National Heart Foundation of Australia (to B. E. K. and D. J. C.).; Supported by a scholarship from the National Heart Foundation.; Supported by Research Fellowship 271-05-0697 from the Danish Medical Research Council.; Supported by research fellowships from the National Health and Medical Research Council of Australia.	Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; Dean DJ, 2000, DIABETES, V49, pA11; Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Hayashi T, 1998, DIABETES, V47, pA3; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2009, DIABETOLOGIA, V52, P2395, DOI 10.1007/s00125-009-1483-8; Jorgensen SB, 2005, FASEB J, V19, P1146, DOI 10.1096/fj.04-3144fje; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mu J, 2003, BIOCHEM SOC T, V31, P236, DOI 10.1042/bst0310236; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Steinberg GR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1374, DOI 10.1152/ajpendo.2000.279.6.E1374; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V282, pE593, DOI 10.1152/ajpendo.00303.2001; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Steinberg GR, 2009, DIABETES, V58, P829, DOI 10.2337/db08-0659; Stephens TJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE688, DOI 10.1152/ajpendo.00101.2001; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x	63	122	122	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37198	37209		10.1074/jbc.M110.102434	http://dx.doi.org/10.1074/jbc.M110.102434			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20855892	hybrid, Green Published			2022-12-27	WOS:000284424000013
J	Bonivento, D; Milczek, EM; McDonald, GR; Binda, C; Holt, A; Edmondson, DE; Mattevi, A				Bonivento, Daniele; Milczek, Erika M.; McDonald, G. Reid; Binda, Claudia; Holt, Andrew; Edmondson, Dale E.; Mattevi, Andrea			Potentiation of Ligand Binding through Cooperative Effects in Monoamine Oxidase B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; PICHIA-PASTORIS; IMIDAZOLINE LIGANDS; HUMAN BRAIN; RAT-LIVER; HUMAN-MAO; SITES; TRANYLCYPROMINE; INHIBITION; BFI	Crystallographic and biochemical studies have been employed to identify the binding site and mechanism for potentiation of imidazoline binding in human monoamine oxidase B (MAO B). 2-(2-Benzofuranyl)-2-imidazoline (2-BFI) inhibits recombinant human MAO B with a K-i of 8.3 +/- 0.6 mu M, whereas tranylcypromine-inhibited MAO B binds 2-BFI with a K-d of 9 +/- 2 nM, representing an increase in binding energy Delta(Delta G) of -3.9 kcal/mol. Crystal structures show the imidazoline ligand bound in a site that is distinct from the substrate-binding cavity. Contributions to account for the increase in binding affinity upon tranylcypromine inhibition include a conformational change in the side chain of Gln(206) and a "closed conformation" of the side chain of Ile(199), forming a hydrophobic "sandwich" with the side chain of Ile(316) on each face of the benzofuran ring of 2-BFI. Data with the I199A mutant of human MAO B and failure to observe a similar binding potentiation with rat MAO B, where Ile316 is replaced with a Val residue, support an allosteric mechanism where the increased binding affinity of 2-BFI results from a cooperative increase in H-bond strength through formation of a more hydrophobic milieu. These insights should prove valuable in the design of high affinity and specific reversible MAO B inhibitors.	[McDonald, G. Reid; Holt, Andrew] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; [Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, PV, Italy; [Milczek, Erika M.; Edmondson, Dale E.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Milczek, Erika M.; Edmondson, Dale E.] Emory Univ, Dept Biochem, Rollins Res Ctr, Atlanta, GA 30322 USA	University of Alberta; University of Pavia; Emory University; Emory University	Holt, A (corresponding author), Univ Alberta, Dept Pharmacol, 9-58 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	aholt@pmcol.ualberta.ca; deedmon@emory.edu; andrea.mattevi@unipv.it	mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019	mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Binda, Claudia/0000-0003-2038-9845	National Institutes of Health [GM 29433]; National Institutes of Health through NINDS [F31NS063648]; Fondazione Cariplo; MIUR-PRIN09; Fondazone Bussolera; Canadian Institutes of Health Research [MOP77529]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fondazione Cariplo(Fondazione Cariplo); MIUR-PRIN09; Fondazone Bussolera; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 29433 (to D. E. E.) and a predoctoral fellowship from the National Institutes of Health through NINDS Award F31NS063648 (to E. M. M.). This work was also supported by grants from the Fondazione Cariplo (to D. E. E. and A. M.), MIUR-PRIN09 and Fondazone Bussolera (to A. M.), and Canadian Institutes of Health Research (Grant MOP77529) to A. H.	ALEMANY R, 1995, BRIT J PHARMACOL, V114, P837, DOI 10.1111/j.1476-5381.1995.tb13280.x; Anderson NJ, 2006, J NEUROCHEM, V96, P1551, DOI 10.1111/j.1471-4159.2006.03662.x; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; DUNN SMJ, 1993, BIOCHEMISTRY-US, V32, P8608, DOI 10.1021/bi00084a031; Edmondson DE, 2009, BIOCHEMISTRY-US, V48, P4220, DOI 10.1021/bi900413g; Hubalek F, 2005, J BIOL CHEM, V280, P15761, DOI 10.1074/jbc.M500949200; Imbrici P, 2009, CHANNELS, V3, P39, DOI 10.4161/chan.3.1.7548; Jones TZE, 2007, FEBS J, V274, P1567, DOI 10.1111/j.1742-4658.2007.05704.x; Lanier S M, 1995, Ann N Y Acad Sci, V763, P106, DOI 10.1111/j.1749-6632.1995.tb32395.x; Li M, 2002, PROTEIN EXPRES PURIF, V24, P152, DOI 10.1006/prep.2001.1546; Muley L, 2010, J MED CHEM, V53, P2126, DOI 10.1021/jm9016416; Newton-Vinson P, 2000, PROTEIN EXPRES PURIF, V20, P334, DOI 10.1006/prep.2000.1309; Ozaita A, 1997, BRIT J PHARMACOL, V121, P901, DOI 10.1038/sj.bjp.0701214; Parini A, 1996, TRENDS PHARMACOL SCI, V17, P13, DOI 10.1016/0165-6147(96)81564-1; Raddatz R, 1997, MOL PHARMACOL, V52, P549, DOI 10.1124/mol.52.4.549; Raddatz R, 2000, J PHARMACOL EXP THER, V292, P1135; RADDATZ R, 1995, J BIOL CHEM, V270, P27961, DOI 10.1074/jbc.270.46.27961; Remaury A, 2000, MOL PHARMACOL, V58, P1085, DOI 10.1124/mol.58.5.1085; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Steinberg MI, 1999, ANN NY ACAD SCI, V881, P193, DOI 10.1111/j.1749-6632.1999.tb09359.x; TESSON F, 1995, J BIOL CHEM, V270, P9856, DOI 10.1074/jbc.270.17.9856; Upadhyay AK, 2008, PROTEIN EXPRES PURIF, V59, P349, DOI 10.1016/j.pep.2008.03.002; VOET DG, 2004, BIOCHEMISTRY-US, P1303; Wang J, 2010, PROTEIN EXPRES PURIF, V70, P211, DOI 10.1016/j.pep.2009.10.013; Wiest SA, 1999, N-S ARCH PHARMACOL, V360, P209, DOI 10.1007/s002109900065; Wiest SA, 1997, LIFE SCI, V60, P605, DOI 10.1016/S0024-3205(96)00639-X; Zhou MJ, 1997, ANAL BIOCHEM, V253, P169, DOI 10.1006/abio.1997.2392	29	84	83	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36849	36856		10.1074/jbc.M110.169482	http://dx.doi.org/10.1074/jbc.M110.169482			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20855894	hybrid, Green Published			2022-12-27	WOS:000284146100025
J	Lefterov, I; Fitz, NF; Cronican, AA; Fogg, A; Lefterov, P; Kodali, R; Wetzel, R; Koldamova, R				Lefterov, Iliya; Fitz, Nicholas F.; Cronican, Andrea A.; Fogg, Allison; Lefterov, Preslav; Kodali, Ravindra; Wetzel, Ronald; Koldamova, Radosveta			Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1 Delta E9 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR RISK-FACTORS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MOUSE MODEL; PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN; CEREBROSPINAL-FLUID; CHOLESTEROL EFFLUX; ENDOTHELIAL-CELLS; BETA PEPTIDE	A hallmark of Alzheimer disease (AD) is the deposition of amyloid beta (A beta) in brain parenchyma and cerebral blood vessels, accompanied by cognitive decline. Previously, we showed that human apolipoprotein A-I (apoA-I) decreases A beta(40) aggregation and toxicity. Here we demonstrate that apoA-I in lipidated or non-lipidated form prevents the formation of high molecular weight aggregates of A beta(42) and decreases A beta(42) toxicity in primary brain cells. To determine the effects of apoA-I on AD phenotype in vivo, we crossed APP/PS1 Delta E9 to apoA-I-KO mice. Using a Morris water maze, we demonstrate that the deletion of mouse Apoa-I exacerbates memory deficits in APP/PS1 Delta E9 mice. Further characterization of APP/PS1 Delta E9/apoA-I-KO mice showed that apoA-I deficiency did not affect amyloid precursor protein processing, soluble A beta oligomer levels, A beta plaque load, or levels of insoluble A beta in brain parenchyma. To examine the effect of Apoa-I deletion on cerebral amyloid angiopathy, we measured insoluble A beta isolated from cerebral blood vessels. Our data show that in APP/PS1 Delta E9/apoA-I-KO mice, insoluble A beta(40) is increased more than 10-fold, and A beta(42) is increased 1.5-fold. The increased levels of deposited amyloid in the vessels of cortices and hippocampi of APP/PS1 Delta E9/apoA-I-KO mice, measured by X-34 staining, confirmed the results. Finally, we demonstrate that lipidated and non-lipidated apoA-I significantly decreased A beta toxicity against brain vascular smooth muscle cells. We conclude that lack of apoA-I aggravates the memory deficits in APP/PS1 Delta E9 mice in parallel to significantly increased cerebral amyloid angiopathy.	[Lefterov, Iliya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Disorders, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lefterov, I (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, BRIDG Bldg,100 Technol Dr, Pittsburgh, PA 15219 USA.	iliyal@pitt.edu; radak@pitt.edu	Lefterov, Iliya/B-4767-2008; kodali, ravi/D-1148-2011; Wetzel, Ronald/G-7453-2011	Lefterov, Iliya/0000-0002-0249-0280; Koldamova, Radosveta/0000-0002-6761-0984; Fitz, Nicholas/0000-0001-6938-6536	National Institutes of Health, NIA [AG027973, AG031956, F32]; Alzheimer's Association [IIRG-0627077]; NATIONAL INSTITUTE ON AGING [R01AG027973, R21AG031956] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grants AG027973 (to R. K.) and AG031956 (to I. L.). This work was also supported by Alzheimer's Association Grant IIRG-0627077 (to R. K.).; Supported by NIA, National Institutes of Health, Fellowship F32.	Alonzo NC, 1998, J NEUROPATH EXP NEUR, V57, P353, DOI 10.1097/00005072-199804000-00008; Bates KA, 2009, J ALZHEIMERS DIS, V17, P305, DOI 10.3233/JAD-2009-1050; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bonarek M, 2000, NEUROEPIDEMIOLOGY, V19, P141, DOI 10.1159/000026249; Bouwman FH, 2009, NEUROBIOL AGING, V30, P1895, DOI 10.1016/j.neurobiolaging.2008.02.007; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Fagan AM, 2004, AM J PATHOL, V165, P1413, DOI 10.1016/S0002-9440(10)63399-8; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hsu MJ, 2010, BBA-GEN SUBJECTS, V1800, P290, DOI 10.1016/j.bbagen.2009.08.003; Jordan J, 1997, J NEUROCHEM, V68, P1612; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kivipelto M, 2002, CNS DRUGS, V16, P435, DOI 10.2165/00023210-200216070-00001; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; KURIYAMA M, 1994, JPN J PSYCHIAT NEUR, V48, P589; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Lefterov I, 2009, ASN NEURO, V1, DOI 10.1042/AN20090015; Lesser G, 2001, DEMENT GERIATR COGN, V12, P138, DOI 10.1159/000051248; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; PITAS RE, 1987, J BIOL CHEM, V262, P14352; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; WEILERGUTTLER H, 1990, J NEUROCHEM, V54, P444, DOI 10.1111/j.1471-4159.1990.tb01892.x; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283	53	91	94	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36945	36957		10.1074/jbc.M110.127738	http://dx.doi.org/10.1074/jbc.M110.127738			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20739292	Green Published, hybrid			2022-12-27	WOS:000284146100061
J	Xia, HP; Cheung, WKC; Sze, J; Lu, G; Jiang, SS; Yao, H; Bian, XW; Poon, WS; Kung, HF; Lin, MC				Xia, Hongping; Cheung, William K. C.; Sze, Johnny; Lu, Gang; Jiang, Songshan; Yao, Hong; Bian, Xiu-Wu; Poon, Wai Sang; Kung, Hsiang-fu; Lin, Marie C.			miR-200a Regulates Epithelial-Mesenchymal to Stem-like Transition via ZEB2 and beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; E-CADHERIN; NASOPHARYNGEAL CARCINOMA; REPRESSORS ZEB1; LUNG-CANCER; IDENTIFICATION; FAMILY; MICRORNAS; MARKER; INVASION	The emerging concept of generating cancer stem cells from epithelial-mesenchymal transition has attracted great interest; however, the factors and molecular mechanisms that govern this putative tumor-initiating process remain largely elusive. We report here that miR-200a not only regulates epithelial-mesenchymal transition but also stem-like transition in nasopharyngeal carcinoma cells. We first showed that stable knockdown of miR-200a promotes the transition of epithelium-like CNE-1 cells to the mesenchymal phenotype. More importantly, it also induced several stem cell-like traits, including CD133(+) side population, sphere formation capacity, in vivo tumorigenicity in nude mice, and stem cell marker expression. Consistently, stable overexpression of miR-200a switched mesenchyme-like C666-1 cells to the epithelial state, accompanied by a significant reduction of stem-like cell features. Furthermore, in vitro differentiation of the C666-1 tumor sphere resulted in diminished stem-like cell population and miR-200a induction. To investigate the molecular mechanism, we demonstrated that miR-200a controls epithelial-mesenchymal transition by targeting ZEB2, although it regulates the stem-like transition differentially and specifically by beta-catenin signaling. Our findings reveal for the first time the function of miR-200a in shifting nasopharyngeal carcinoma cell states via a reversible process coined as epithelial-mesenchymal to stem-like transition through differential and specific mechanisms.	[Xia, Hongping; Lu, Gang; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Brain Tumour Ctr, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Xia, Hongping; Lu, Gang; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Div Neurosurg, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Lin, Marie C.] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Lab Integrated Biosci, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Hong; Bian, Xiu-Wu] Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Yao, Hong; Bian, Xiu-Wu] Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, State Key Lab Oncol S China, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Sun Yat Sen University; Army Medical University; Army Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong	Lin, MC (corresponding author), Chinese Univ Hong Kong, Brain Tumour Ctr, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	mcllin@surgery.cuhk.edu.hk	XIA, HONGPING/AAK-7100-2020; Poon, Wai S/HGD-3084-2022; Bian, Xiuwu/F-1569-2011; Poon, Wai Sang/F-1558-2011; Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197; LU, Gang/0000-0001-5921-1839	Research Grants Council of Hong Kong [467109]; National Basic Research Program of China (973 Program) [2010CB529400, 2010CB912800]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Research Grants Council of Hong Kong Grant 467109 and National Basic Research Program of China (973 Program) Grants 2010CB529400 and 2010CB912800.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Visus C, 2007, CANCER RES, V67, P10538, DOI 10.1158/0008-5472.CAN-07-1346; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Zhang QZ, 2010, CANCER LETT, V289, P151, DOI 10.1016/j.canlet.2009.08.010; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	51	88	96	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36995	37004		10.1074/jbc.M110.133744	http://dx.doi.org/10.1074/jbc.M110.133744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20826811	Green Published, hybrid			2022-12-27	WOS:000284146100016
J	Anthony, CS; Corradi, HR; Schwager, SLU; Redelinghuys, P; Georgiadis, D; Dive, V; Acharya, KR; Sturrock, ED				Anthony, Colin S.; Corradi, Hazel R.; Schwager, Sylva L. U.; Redelinghuys, Pierre; Georgiadis, Dimitris; Dive, Vincent; Acharya, K. Ravi; Sturrock, Edward D.			The N Domain of Human Angiotensin-I-converting Enzyme THE ROLE OF N-GLYCOSYLATION AND THE CRYSTAL STRUCTURE IN COMPLEX WITH AN N DOMAIN-SPECIFIC PHOSPHINIC INHIBITOR, RXP407	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASP-LYS-PRO; INHIBITOR; MODEL; PEPTIDE; SITES; ASSAY; ACE	Angiotensin-I-converting enzyme (ACE) plays a critical role in the regulation of blood pressure through its central role in the renin-angiotensin and kallikrein-kinin systems. ACE contains two domains, the N and C domains, both of which are heavily glycosylated. Structural studies of ACE have been fraught with severe difficulties because of surface glycosylation of the protein. In order to investigate the role of glycosylation in the N domain and to create suitable forms for crystallization, we have investigated the importance of the 10 potential N-linked glycan sites using enzymatic deglycosylation, limited proteolysis, and mass spectrometry. A number of glycosylation mutants were generated via site-directed mutagenesis, expressed in CHO cells, and analyzed for enzymatic activity and thermal stability. At least eight of 10 of the potential glycan sites are glycosylated; three C-terminal sites were sufficient for expression of active N domain, whereas two N-terminal sites are important for its thermal stability. The minimally glycosylated Ndom389 construct was highly suitable for crystallization studies. The structure in the presence of an N domain-selective phosphinic inhibitor RXP407 was determined to 2.0 angstrom resolution. The Ndom389 structure revealed a hinge region that may contribute to the breathing motion proposed for substrate binding.	[Corradi, Hazel R.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Sturrock, Edward D.] Univ Cape Town, Div Med Biochem, Inst Infect Dis & Mol Med, ZA-7925 Observatory, South Africa; [Redelinghuys, Pierre] Univ Aberdeen, Inst Med Sci, Sect Infect & Immunol, Aberdeen AB25 2ZD, Scotland; [Georgiadis, Dimitris] Univ Athens, Dept Chem, Organ Chem Lab, Athens 15771, Greece; [Dive, Vincent] CEA, iBiTecS, SIMOPRO, F-91191 Gif Sur Yvette, France	University of Bath; University of Cape Town; University of Aberdeen; National & Kapodistrian University of Athens; CEA; UDICE-French Research Universities; Universite Paris Saclay	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk; Edward.Sturrock@uct.ac.za	Georgiadis, Dimitris/AAB-1550-2020	Acharya, K. Ravi/0000-0002-3009-4058	Wellcome Trust (United Kingdom) [070060]; National Research Foundation of South Africa; Ernst and Ethel Erikson Trust; Deutscher Austauschdienst; University of Cape Town; Medical Research Council (United Kingdom) [81272]; Royal Society (United Kingdom); MRC [G0601973] Funding Source: UKRI; Medical Research Council [G0601973] Funding Source: researchfish	Wellcome Trust (United Kingdom)(Wellcome Trust); National Research Foundation of South Africa(National Research Foundation - South Africa); Ernst and Ethel Erikson Trust; Deutscher Austauschdienst; University of Cape Town; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society (United Kingdom)(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (United Kingdom) through Senior International Research Fellowship 070060, the National Research Foundation of South Africa, the Ernst and Ethel Erikson Trust, the Deutscher Austauschdienst, and the University of Cape Town (to E. D. S.). This work was also supported by Medical Research Council (United Kingdom) Grant 81272 and a Royal Society (United Kingdom) Industry Fellowship (to K. R. A.).	Akif M, 2010, J MOL BIOL, V400, P502, DOI 10.1016/j.jmb.2010.05.024; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEDDISH PA, 1994, P NATL ACAD SCI USA, V91, P7807, DOI 10.1073/pnas.91.16.7807; Dive V, 1999, P NATL ACAD SCI USA, V96, P4330, DOI 10.1073/pnas.96.8.4330; Ehlers M R, 1991, Protein Expr Purif, V2, P1, DOI 10.1016/1046-5928(91)90001-Y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Gordon K, 2003, BIOCHEM J, V371, P437, DOI 10.1042/BJ20021842; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Junot C, 2001, J PHARMACOL EXP THER, V297, P606; Kost OA, 2003, BIOCHEMISTRY-US, V42, P6965, DOI 10.1021/bi034645y; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroger WL, 2009, BIOCHEMISTRY-US, V48, P8405, DOI 10.1021/bi9011226; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill HG, 2008, BIOL CHEM, V389, P1153, DOI 10.1515/BC.2008.131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Peng HM, 2007, HYPERTENSION, V49, P695, DOI 10.1161/01.HYP.0000258406.66954.4f; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Sadhukhan R, 1996, J BIOL CHEM, V271, P6429, DOI 10.1074/jbc.271.11.6429; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwager SL, 2006, NAT PROTOC, V1, P1961, DOI 10.1038/nprot.2006.305; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Voronov S, 2002, FEBS LETT, V522, P77, DOI 10.1016/S0014-5793(02)02888-0; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	37	59	60	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35685	35693		10.1074/jbc.M110.167866	http://dx.doi.org/10.1074/jbc.M110.167866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826823	Green Published, hybrid			2022-12-27	WOS:000283845300047
J	Golubkov, VS; Chekanov, AV; Cieplak, P; Aleshin, AE; Chernov, AV; Zhu, WH; Radichev, IA; Zhang, DH; Dong, PD; Strongin, AY				Golubkov, Vladislav S.; Chekanov, Alexei V.; Cieplak, Piotr; Aleshin, Alexander E.; Chernov, Andrei V.; Zhu, Wenhong; Radichev, Ilian A.; Zhang, Danhua; Dong, P. Duc; Strongin, Alex Y.			The Wnt/Planar Cell Polarity Protein-tyrosine Kinase-7 (PTK7) Is a Highly Efficient Proteolytic Target of Membrane Type-1 Matrix Metalloproteinase IMPLICATIONS IN CANCER AND EMBRYOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-MATRIX METALLOPROTEINASE; EXTENSION MOVEMENTS; ACTS DOWNSTREAM; RHO-KINASE; OFF-TRACK; MT1-MMP; CD44; ZEBRAFISH; INVASION; CONVERGENCE	PTK7 is an essential component of the Wnt/planar cell polarity (PCP) pathway. We provide evidence that the Wnt/PCP pathway converges with pericellular proteolysis in both normal development and cancer. Here, we demonstrate that membrane type-1 matrix metalloproteinase (MT1-MMP), a key proinvasive proteinase, functions as a principal sheddase of PTK7. MT1-MMP directly cleaves the exposed PKP621 down arrow LI sequence of the seventh Ig-like domain of the full-length membrane PTK7 and generates, as a result, an N-terminal, soluble PTK7 fragment (sPTK7). The enforced expression of membrane PTK7 in cancer cells leads to the actin cytoskeleton reorganization and the inhibition of cell invasion. MT1-MMP silencing and the analysis of the uncleavable L622D PTK7 mutant confirm the significance of MT1-MMP proteolysis of PTK7 in cell functions. Our data also demonstrate that a fine balance between the metalloproteinase activity and PTK7 levels is required for normal development of zebrafish (Danio rerio). Aberration of this balance by the proteinase inhibition or PTK7 silencing results in the PCP-dependent convergent extension defects in the zebrafish. Overall, our data suggest that the MT1-MMP-PTK7 axis plays an important role in both cancer cell invasion and normal embryogenesis in vertebrates. Further insight into these novel mechanisms may promote understanding of directional cell motility and lead to the identification of therapeutics to treat PCP-related developmental disorders and malignancy.	[Golubkov, Vladislav S.; Chekanov, Alexei V.; Cieplak, Piotr; Aleshin, Alexander E.; Chernov, Andrei V.; Zhu, Wenhong; Radichev, Ilian A.; Zhang, Danhua; Dong, P. Duc; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@burnham.org	Chernov, Andrei/I-1623-2019; Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016; 	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A.Y.S.).	Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cantrell VA, 2010, CANCER LETT, V287, P54, DOI 10.1016/j.canlet.2009.05.041; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Goodrich LV, 2008, NEURON, V60, P9, DOI 10.1016/j.neuron.2008.09.003; Grassot J, 2006, MOL BIOL EVOL, V23, P1232, DOI 10.1093/molbev/msk007; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hirayama K, 2004, INVEST OPHTH VIS SCI, V45, pU480; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Jung JW, 2004, GENE, V328, P75, DOI 10.1016/j.gene.2003.12.006; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Katoh M, 2005, ONCOL REP, V14, P1583; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Murai S, 2004, VIRCHOWS ARCH, V445, P271, DOI 10.1007/s00428-004-1029-x; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Park SK, 1996, J BIOCHEM, V119, P235; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Roghi C, 2010, FEBS J, V277, P3158, DOI 10.1111/j.1742-4658.2010.07723.x; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tada M, 2009, ZEBRAFISH, V6, P29, DOI 10.1089/zeb.2008.0566; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8; Zhang JS, 2003, MATRIX BIOL, V22, P279, DOI 10.1016/S0945-053X(03)00020-9; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	80	63	69	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35740	35749		10.1074/jbc.M110.165159	http://dx.doi.org/10.1074/jbc.M110.165159			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837484	hybrid, Green Published			2022-12-27	WOS:000283845300052
J	Gupta, SC; Prasad, S; Reuter, S; Kannappan, R; Yadav, VR; Ravindran, J; Hema, PS; Chaturvedi, MM; Nair, M; Aggarwal, BB				Gupta, Subash C.; Prasad, Sahdeo; Reuter, Simone; Kannappan, Ramaswamy; Yadav, Vivek R.; Ravindran, Jayaraj; Hema, Padmanabhan S.; Chaturvedi, Madan M.; Nair, Mangalam; Aggarwal, Bharat B.			Modification of Cysteine 179 of I kappa B alpha Kinase by Nimbolide Leads to Down-regulation of NF-kappa B-regulated Cell Survival and Proliferative Proteins and Sensitization of Tumor Cells to Chemotherapeutic Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEEM LIMONOIDS AZADIRACHTIN; GENE-EXPRESSION; DIRECT INHIBITION; ACTIVATION; APOPTOSIS; SUPPRESSION; INVASION; PRODUCTS; BETA; P65	Reverse pharmacology, also called the "bedside to bench" approach, that deals with new uses for a well known molecular entity has been used extensively in cancer drug development to identify novel compounds and delineate their mechanisms of action. Here, we show that nimbolide, a triterpenoid isolated from Azadirachta indica, enhanced the apoptosis induced by inflammatory cytokines and chemotherapeutic agents in tumor cells. This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappa B. Nimbolide inhibited the activation of NF-kappa B induced by carcinogens and inflammatory stimuli. Constitutively active NF-kappa B found in most tumor cells was also inhibited. We found that suppression of NF-kappa B activation by nimbolide was caused by inhibition of I kappa B kinase (IKK), which led to suppression of I kappa B alpha phosphorylation and degradation, nuclear translocation, DNA binding, and gene transcription. Reducing agent reversed the action of the limonoid, suggesting the involvement of a cysteine residue. Replacement of Cys(179) of IKK-beta with alanine abolished the effect of nimbolide, suggesting that Cys(179) plays a critical role in inhibiting the NF-kappa B activation. Overall, our results indicate that nimbolide can sensitize tumor cells to chemotherapeutic agents through interaction with IKK, leading to inhibition of NF-kappa B-regulated proteins.	[Gupta, Subash C.; Prasad, Sahdeo; Reuter, Simone; Kannappan, Ramaswamy; Yadav, Vivek R.; Ravindran, Jayaraj; Chaturvedi, Madan M.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA; [Hema, Padmanabhan S.; Nair, Mangalam] CSIR, Natl Inst Interdisciplinary Sci & Technol, Organ Chem Sect, Trivandrum 695019, Kerala, India	University of Texas System; UTMD Anderson Cancer Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013; Gupta, Subash/AAF-2563-2019	Gupta, Subash/0000-0002-0418-1940	National Institutes of Health [CA-16672]; Clayton Foundation for Research; Center for Targeted Therapy of MD Anderson Cancer Center;  [CA-124787-01A2]; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Center for Targeted Therapy of MD Anderson Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Core Grant CA-16672 and Program Project Grant CA-124787-01A2. This work was also supported by a grant from the Clayton Foundation for Research (to B. B. A.) and a grant from the Center for Targeted Therapy of MD Anderson Cancer Center. Downloaded from www.jbc.org at ISI, Thomson Scientific, on November 7, 2010	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Ahn KS, 2007, BLOOD, V110, P2286, DOI 10.1182/blood-2007-04-084996; Anitha G, 2006, J ASIAN NAT PROD RES, V8, P445, DOI 10.1080/10286020500173267; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Biswas K, 2002, CURR SCI INDIA, V82, P1336; Bose D, 2010, LANCET ONCOL, V11, P373, DOI 10.1016/S1470-2045(09)70341-9; Castro AC, 2003, BIOORG MED CHEM LETT, V13, P2419, DOI 10.1016/S0960-894X(03)00408-6; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cohen E, 1996, LIFE SCI, V58, P1075, DOI 10.1016/0024-3205(96)00061-6; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; EKONG DEU, 1967, CHEM COMMUN, P808; GUPTA SC, 2010, BIOCH BIOPHYS ACTA; Ha KH, 2009, BIOCHEMISTRY-US, V48, P7271, DOI 10.1021/bi900660f; Harikumar KB, 2009, BLOOD, V113, P2003, DOI 10.1182/blood-2008-04-151944; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; KIGODI PGK, 1989, J NAT PROD, V52, P1246, DOI 10.1021/np50066a008; Kim DW, 2000, CARCINOGENESIS, V21, P871, DOI 10.1093/carcin/21.5.871; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Kumar GH, 2009, INVEST NEW DRUG, V27, P246, DOI 10.1007/s10637-008-9170-z; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Nair MS, 1997, PHYTOCHEMISTRY, V46, P1177, DOI 10.1016/S0031-9422(97)80006-4; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.M700890200; Park MH, 2005, BIOCHEMISTRY-US, V44, P8326, DOI 10.1021/bi050156h; PEZZUTO JM, 1986, NEW TRENDS NATURAL P, V26, P371; Priyadarsini RV, 2009, FREE RADICAL RES, V43, P492, DOI 10.1080/10715760902870637; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; ROCHANAKIJ S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P66; ROJANPO W, 1985, SCI SOC THAILAND, V11, P177; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roy MK, 2007, PHYTOTHER RES, V21, P245, DOI 10.1002/ptr.2058; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sartore-Bianchi A, 2007, INT J BIOL MARKER, V22, pS77, DOI 10.5301/JBM.2008.4310; Sastry BS, 2006, BIOORG MED CHEM LETT, V16, P4391, DOI 10.1016/j.bmcl.2006.05.105; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Siddiqui S, 1942, CURR SCI, V11, P278; Singh S, 2007, CELL, V130, P765, DOI 10.1016/j.cell.2007.08.024; Subapriya R., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P149, DOI 10.2174/1568011053174828; Suresh G, 2002, J AGR FOOD CHEM, V50, P4484, DOI 10.1021/jf025534t; Takada Y, 2004, J BIOL CHEM, V279, P26287, DOI 10.1074/jbc.M400963200; Takada Y, 2003, J IMMUNOL, V171, P3278, DOI 10.4049/jimmunol.171.6.3278; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	50	81	84	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35406	35417		10.1074/jbc.M110.161984	http://dx.doi.org/10.1074/jbc.M110.161984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829362	Green Published, hybrid			2022-12-27	WOS:000283845300018
J	Khandelwal, S; Roche, PA				Khandelwal, Sanjay; Roche, Paul A.			Distinct MHC Class II Molecules Are Associated on the Dendritic Cell Surface in Cholesterol-dependent Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; PEPTIDE COMPLEXES; PLASMA-MEMBRANE; TETRASPANIN PROTEINS; ANTIGEN PRESENTATION; T-CELLS; ACTIVATION; CD81; PALMITOYLATION; TRANSPORT	Very small amounts of MHC class II-peptide complexes expressed on the surface of antigen-presenting cells (APCs) are capable of stimulating antigen-specific CD4 T cells. There is intense interest to elucidate the molecular mechanisms by which these small amounts of MHC-II can cluster, cross-link T cell receptors, and promote T cell proliferation. We now demonstrate that a significant fraction of the total pool of MHC-II molecules on the surface of dendritic cells is physically associated in macromolecular aggregates. These MHC-II/MHC-II interactions have been probed by co-immunoprecipitation analysis of the MHC-II I-A molecule with the related I-E molecule. These molecular associations are maintained in gentle detergents but are disrupted in harsh detergents such as Triton X-100. MHC-II I-A/I-E interactions are disrupted when plasma membrane cholesterol is extracted using methyl beta-cyclodextrin, suggesting that lipid raft microdomains are important mediators of these MHC-II interactions. Although it has been proposed that tetraspanin proteins regulate molecular clustering, aggregation, and co-immunoprecipitation in APCs, genetic deletion of the tetraspanin family members CD9 or CD81 had no effect on MHC-II I-A/I-E binding. These data demonstrate that the presence of distinct forms of MHC-II with plasma membrane lipid rafts is required for MHC-II aggregation in APCs and provides a molecular mechanism allowing dendritic cells expressing small amounts of MHC-II-peptide complexes to cross-link and stimulate CD4 T cells.	[Khandelwal, Sanjay; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Rm 4B36,Bldg 10, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; ANGELISOVA P, 1994, IMMUNOGENETICS, V39, P249; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bouillon M, 2003, J BIOL CHEM, V278, P7099, DOI 10.1074/jbc.M211566200; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cherukuri A, 2004, J BIOL CHEM, V279, P31973, DOI 10.1074/jbc.M404410200; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Delandre C, 2009, EXP CELL RES, V315, P1953, DOI 10.1016/j.yexcr.2009.03.013; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Engering A, 2001, INT IMMUNOL, V13, P127, DOI 10.1093/intimm/13.2.127; Eren E, 2006, SCAND J IMMUNOL, V63, P7, DOI 10.1111/j.1365-3083.2006.01700.x; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Hammond C, 1998, J IMMUNOL, V161, P3282; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jenei A, 1997, P NATL ACAD SCI USA, V94, P7269, DOI 10.1073/pnas.94.14.7269; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maecker HT, 2000, HYBRIDOMA, V19, P15, DOI 10.1089/027245700315752; Melkonian KA, 1995, BIOCHEMISTRY-US, V34, P16161, DOI 10.1021/bi00049a031; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; Poloso NJ, 2006, J IMMUNOL, V177, P5451, DOI 10.4049/jimmunol.177.8.5451; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; Setterblad N, 2003, J LEUKOCYTE BIOL, V74, P40, DOI 10.1189/jlb.0103045; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tai XG, 1997, J IMMUNOL, V159, P3799; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; Witherden DA, 2000, J IMMUNOL, V165, P1902, DOI 10.4049/jimmunol.165.4.1902; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Zilber MT, 2005, BLOOD, V106, P3074, DOI 10.1182/blood-2004-10-4094	50	20	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35303	35310		10.1074/jbc.M110.147793	http://dx.doi.org/10.1074/jbc.M110.147793			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833718	Green Published, hybrid			2022-12-27	WOS:000283845300008
J	Maier, PJ; Marin, I; Grampp, T; Sommer, A; Benke, D				Maier, Patrick J.; Marin, Isabel; Grampp, Thomas; Sommer, Andrea; Benke, Dietmar			Sustained Glutamate Receptor Activation Down-regulates GABA(B) Receptors by Shifting the Balance from Recycling to Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RECEPTOR; SUBCELLULAR-LOCALIZATION; RAT HIPPOCAMPUS; ION CHANNELS; NEURONS; SYNAPSES; SUBUNITS; TRANSMISSION; INHIBITION; DEPRESSION	Metabotropic GABA(B) receptors are abundantly expressed at glutamatergic synapses where they control excitability of the synapse. Here, we tested the hypothesis that glutamatergic neurotransmission may regulate GABA(B) receptors. We found that application of glutamate to cultured cortical neurons led to rapid down-regulation of GABA(B) receptors via lysosomal degradation. This effect was mimicked by selective activation of AMPA receptors and further accelerated by coactivation of group I metabotropic glutamate receptors. Inhibition of NMDA receptors, blockade of L-type Ca2+ channels, and removal of extracellular Ca2+ prevented glutamate-induced down-regulation of GABA(B) receptors, indicating that Ca2+ influx plays a critical role. We further established that glutamate-induced down-regulation depends on the internalization of GABA(B) receptors. Glutamate did not affect the rate of GABA(B) receptor endocytosis but led to reduced recycling of the receptors back to the plasma membrane. Blockade of lysosomal activity rescued receptor recycling, indicating that glutamate redirects GABA(B) receptors from the recycling to the degradation pathway. In conclusion, the data indicate that sustained activation of AMPA receptors down-regulates GABA(B) receptors by sorting endocytosed GABA(B) receptors preferentially to lysosomes for degradation on the expense of recycling. This mechanism may relieve glutamatergic synapses from GABA(B) receptor-mediated inhibition resulting in increased synaptic excitability.	[Maier, Patrick J.; Marin, Isabel; Grampp, Thomas; Sommer, Andrea; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch			Swiss Science Foundation [31003A_121963]	Swiss Science Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss Science Foundation Grant 31003A_121963.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BENKE D, 1991, J RECEPTOR RES, V11, P407, DOI 10.3109/10799899109066418; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chen L, 2004, J COMP NEUROL, V474, P340, DOI 10.1002/cne.20143; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kulik A, 2003, J NEUROSCI, V23, P11026; Lacey CJ, 2005, NEUROSCIENCE, V136, P1083, DOI 10.1016/j.neuroscience.2005.07.013; Lujan R, 2004, J COMP NEUROL, V475, P36, DOI 10.1002/cne.20160; MORRISETT RA, 1991, J NEUROSCI, V11, P203; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pan BX, 2009, NEURON, V61, P917, DOI 10.1016/j.neuron.2009.01.029; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Ziakopoulos Z, 2000, EUR J NEUROSCI, V12, P803, DOI 10.1046/j.1460-9568.2000.00965.x	29	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35606	35614		10.1074/jbc.M110.142406	http://dx.doi.org/10.1074/jbc.M110.142406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826795	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000283845300039
J	Marais, A; Ji, ZL; Child, ES; Krause, E; Mann, DJ; Sharrocks, AD				Marais, Anett; Ji, Zongling; Child, Emma S.; Krause, Eberhard; Mann, David J.; Sharrocks, Andrew D.			Cell Cycle-dependent Regulation of the Forkhead Transcription Factor FOXK2 by CDK.Cyclin Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC PROGRAM; BINDING-FACTOR; FHA DOMAIN; PROTEIN; PHOSPHORYLATION; FKH2P; RECRUITMENT; GENES; FOXM1; YEAST	Several mammalian forkhead transcription factors have been shown to impact on cell cycle regulation and are themselves linked to cell cycle control systems. Here we have investigated the little studied mammalian forkhead transcription factor FOXK2 and demonstrate that it is subject to control by cell cycle-regulated protein kinases. FOXK2 exhibits a periodic rise in its phosphorylation levels during the cell cycle, with hyperphosphorylation occurring in mitotic cells. Hyperphosphorylation occurs in a cyclin-dependent kinase (CDK).cyclin-dependent manner with CDK1.cyclin B as the major kinase complex, although CDK2 and cyclin A also appear to be important. We have mapped two CDK phosphorylation sites, serines 368 and 423, which play a role in definingFOXK2 function through regulating its stability and its activity as a transcriptional repressor protein. These two CDK sites appear vital for FOXK2 function because expression of a mutant lacking these sites cannot be tolerated and causes apoptosis.	[Marais, Anett; Ji, Zongling; Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Marais, Anett] Univ Leipzig, Max Burger Forschungszentrum, Med Klin 2, D-04103 Leipzig, Germany; [Child, Emma S.; Mann, David J.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Krause, Eberhard] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	University of Manchester; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Imperial College London; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Sharrocks, AD (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	a.d.sharrocks@manchester.ac.uk	Sharrocks, Andrew/J-6756-2013		Biotechnology and Biological Sciences Research Council; Wellcome Trust; Royal Society-Wolfson; Interdisziplinares Zentrum fur Klinische Forschung at the University of Leipzig [D02]; Biotechnology and Biological Sciences Research Council [BB/C508134/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society-Wolfson(Royal Society of London); Interdisziplinares Zentrum fur Klinische Forschung at the University of Leipzig; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (to D.J.M.), by the Wellcome Trust and a Royal Society-Wolfson award (to A.D.S.), and by an overseas research scholarship of Interdisziplinares Zentrum fur Klinische Forschung at the University of Leipzig (D02) (to A.M.).	Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; Cooper K, 2006, ONCOGENE, V25, P5228, DOI 10.1038/sj.onc.1209630; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Jarviluoma A, 2006, MOL CELL BIOL, V26, P2430, DOI 10.1128/MCB.26.6.2430-2440.2006; Klemm C, 2006, J MASS SPECTROM, V41, P1623, DOI 10.1002/jms.1129; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; LI C, 1991, P NATL ACAD SCI USA, V88, P7739, DOI 10.1073/pnas.88.17.7739; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nirula A, 1997, J BIOL CHEM, V272, P7736, DOI 10.1074/jbc.272.12.7736; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	38	55	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35728	35739		10.1074/jbc.M110.154005	http://dx.doi.org/10.1074/jbc.M110.154005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20810654	Green Published, hybrid			2022-12-27	WOS:000283845300051
J	Williams, TL; Levy, DL; Maki-Yonekura, S; Yonekura, K; Blackburn, EH				Williams, Tanya L.; Levy, Daniel L.; Maki-Yonekura, Saori; Yonekura, Koji; Blackburn, Elizabeth H.			Characterization of the Yeast Telomere Nucleoprotein Core Rap1 BINDS INDEPENDENTLY TO EACH RECOGNITION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN RAP1; SACCHAROMYCES-CEREVISIAE; LENGTH REGULATION; CHROMATIN STRUCTURE; FISSION YEAST; DNA; COMPLEX; TRF1; ASSOCIATION; ELONGATION	At the core of Saccharomyces cerevisiae telomeres is an array of tandem telomeric DNA repeats bound site-specifically by multiple Rap1 molecules. There, Rap1 orchestrates the binding of additional telomere-associated proteins and negatively regulates both telomere fusion and length homeostasis. Using electron microscopy, viscosity, and light scattering measurements, we show that purified Rap1 is a monomer in solution that adopts a ringlike or C shape with a central cavity. Rap1 could orchestrate telomere function by binding multiple telomere array sites through either cooperative or independent mechanisms. To determine the mechanism, we analyze the distribution of Rap1 monomers on defined telomeric DNA arrays. This analysis clearly indicates that Rap1 binds independently to each non-overlapping site in an array, regardless of the spacing between sites, the total number of sites, the affinity of the sites for Rap1, and over a large concentration range. Previous experiments have not clearly separated the effects of affinity from repeat spacing on telomere function. We clarify these results by testing in vivo the function of defined telomere arrays containing the same Rap1 binding site separated by spacings that were previously defined as low or high activity. We find that Rap1 binding affinity in vitro correlates with the ability of telomeric repeat arrays to regulate telomere length in vivo. We suggest that Rap1 binding to multiple sites in a telomere array does not, by itself, promote formation of a more energetically stabile complex.	[Williams, Tanya L.; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Levy, Daniel L.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Maki-Yonekura, Saori] RIKEN SPring 8 Ctr, Harima Inst, Prot Crystallog Res Grp, Sayo, Hyogo 6795148, Japan; [Yonekura, Koji] RIKEN SPring 8 Ctr, Harima Inst, Biostruct Mech Lab, Sayo, Hyogo 6795148, Japan	University of California System; University of California San Francisco; University of California System; University of California Berkeley; RIKEN; RIKEN	Blackburn, EH (corresponding author), 600 16th St,S312F, San Francisco, CA 94158 USA.	elizabeth.blackburn@ucsf.edu	Levy, Daniel/AAA-7205-2019; YONEKURA, Koji/N-5060-2015	Levy, Daniel/0000-0002-7853-3275; 	National Research Service Award; Howard Hughes Medical Institute	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by a postdoctoral National Research Service Award fellowship.; Supported by a predoctoral fellowship from the Howard Hughes Medical Institute.	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bianchi A, 2007, GENE DEV, V21, P1726, DOI 10.1101/gad.438907; BJORK I, 1973, EUR J BIOCHEM, V36, P178, DOI 10.1111/j.1432-1033.1973.tb02899.x; BLACKBURN EH, 1981, P NATL ACAD SCI-BIOL, V78, P2263, DOI 10.1073/pnas.78.4.2263; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P849; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Feeser EA, 2008, J MOL BIOL, V380, P520, DOI 10.1016/j.jmb.2008.04.078; FERSHT A, 1999, STRUCTURE MECH PROTE, P140; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; GOTTSCHLING DE, 1984, CELL, V38, P501, DOI 10.1016/0092-8674(84)90505-1; Grossi S, 2001, MOL CELL BIOL, V21, P8117, DOI 10.1128/MCB.21.23.8117-8128.2001; HAMMERSTEDT RH, 1971, J BIOL CHEM, V246, P2069; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; KHAN MY, 1990, J BIOSCIENCE, V15, P361; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Lascaris RF, 1999, BIOINFORMATICS, V15, P267, DOI 10.1093/bioinformatics/15.4.267; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Moser BA, 2009, BIOCHEM CELL BIOL, V87, P747, DOI 10.1139/O09-037; MULLER T, 1994, J STRUCT BIOL, V113, P1, DOI 10.1006/jsbi.1994.1027; Negrini S, 2007, GENE DEV, V21, P292, DOI 10.1101/gad.400907; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Ray A, 1999, MOL CELL BIOL, V19, P31; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Taylor HOB, 2000, J MOL BIOL, V303, P693, DOI 10.1006/jmbi.2000.4161; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VIGNAIS ML, 1987, EMBO J, V6, P1451, DOI 10.1002/j.1460-2075.1987.tb02386.x; VIGNAIS ML, 1990, J BIOL CHEM, V265, P14669; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197	59	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35814	35824		10.1074/jbc.M110.170167	http://dx.doi.org/10.1074/jbc.M110.170167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826803	Green Published, hybrid			2022-12-27	WOS:000283845300059
J	Rao, VA; Klein, SR; Bonar, SJ; Zielonka, J; Mizuno, N; Dickey, JS; Keller, PW; Joseph, J; Kalyanaraman, B; Shacter, E				Rao, V. Ashutosh; Klein, Sarah R.; Bonar, Spencer J.; Zielonka, Jacek; Mizuno, Naoko; Dickey, Jennifer S.; Keller, Paul W.; Joseph, Joy; Kalyanaraman, Balaraman; Shacter, Emily			The Antioxidant Transcription Factor Nrf2 Negatively Regulates Autophagy and Growth Arrest Induced by the Anticancer Redox Agent Mitoquinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE ADAPTER PROTEIN; MALIGNANT GLIOMA-CELLS; CANCER-CELLS; TARGETED ANTIOXIDANTS; OXIDATIVE DAMAGE; ARSENIC TRIOXIDE; TOPOISOMERASE-I; DT-DIAPHORASE; MCF-7 CELLS; DNA-DAMAGE	Mitoquinone (MitoQ) is a synthetically modified, redox-active ubiquinone compound that accumulates predominantly in mitochondria. We found that MitoQ is 30-fold more cytotoxic to breast cancer cells than to healthy mammary cells. MitoQ treatment led to irreversible inhibition of clonogenic growth of breast cancer cells through a combination of autophagy and apoptotic cell death mechanisms. Relatively limited cytotoxicity was seen with the parent ubiquinone coenzyme Q(10). Inhibition of cancer cell growth by MitoQ was associated with G(1)/S cell cycle arrest and phosphorylation of the checkpoint kinases Chk1 and Chk2. The possible role of oxidative stress in MitoQ activity was investigated by measuring the products of hydroethidine oxidation. Increases in ethidium and dihydroethidium levels, markers of one-electron oxidation of hydroethidine, were observed at cytotoxic concentrations of MitoQ. Keap1, an oxidative stress sensor protein that regulates the antioxidant transcription factor Nrf2, underwent oxidation, degradation, and dissociation from Nrf2 in MitoQ-treated cells. Nrf2 protein levels, nuclear localization, and transcriptional activity also increased following MitoQ treatment. Knockdown of Nrf2 caused a 2-fold increase in autophagy and an increase in G(1) cell cycle arrest in response to MitoQ but had no apparent effect on apoptosis. The Nrf2-regulated enzyme NQO1 is partly responsible for controlling the level of autophagy. Keap1 and Nrf2 act as redox sensors for oxidative perturbations that lead to autophagy. MitoQ and similar compounds should be further evaluated for novel anticancer activity.	[Rao, V. Ashutosh; Klein, Sarah R.; Bonar, Spencer J.; Dickey, Jennifer S.; Shacter, Emily] US FDA, Biochem Lab, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Mizuno, Naoko; Keller, Paul W.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Rao, VA (corresponding author), 29 Lincoln Dr,Bldg 29A,Rm 2A-09,HFD-122, Bethesda, MD 20892 USA.	ashutosh.rao@fda.hhs.gov; emily.shacter@fda.hhs.gov	Mizuno, Naoko/AAY-1926-2021; Zielonka, Jacek/N-9546-2014; Rao, V Ashutosh/A-3569-2013	Mizuno, Naoko/0000-0002-1594-2821; Zielonka, Jacek/0000-0002-2524-0145; Rao, V Ashutosh/0000-0001-6817-8049	NIAMS; NCI; National Institutes of Health [RO1CA125112, RO1CA136799]; NATIONAL CANCER INSTITUTE [R01CA152810, R01CA136799, R01CA125112] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Intramural Research Programs of NIAMS and NCI and by National Institutes of Health Grants RO1CA125112 and RO1CA136799.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; BERNAL SD, 1982, SCIENCE, V218, P1117, DOI 10.1126/science.7146897; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; Facompre Michael, 2000, Molecular Cell Biology Research Communications, V4, P37, DOI 10.1006/mcbr.2000.0251; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Hoke EM, 2005, FREE RADICAL BIO MED, V39, P403, DOI 10.1016/j.freeradbiomed.2005.03.029; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; JAISWAL AK, 1988, J BIOL CHEM, V263, P13572; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kelso GF, 2002, ANN NY ACAD SCI, V959, P263, DOI 10.1111/j.1749-6632.2002.tb02098.x; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McDonald Kent L, 2007, Methods Mol Biol, V369, P143; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Paglin S, 2001, CANCER RES, V61, P439; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Rao VA, 2007, CANCER RES, V67, P9971, DOI 10.1158/0008-5472.CAN-07-0804; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Ross D, 2004, METHOD ENZYMOL, V382, P115; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; VANDENABEELE P, 2006, SCI STKE, pPE44; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; WARBURG O, 1956, SCIENCE, V124, P269; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	58	106	109	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34447	34459		10.1074/jbc.M110.133579	http://dx.doi.org/10.1074/jbc.M110.133579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805228	Green Published, hybrid			2022-12-27	WOS:000283659100019
J	Salaun, C; Leroy, C; Rousseau, A; Boitez, V; Beck, L; Friedlander, G				Salauen, Christine; Leroy, Christine; Rousseau, Alice; Boitez, Valerie; Beck, Laurent; Friedlander, Gerard			Identification of a Novel Transport-independent Function of PiT1/SLC20A1 in the Regulation of TNF-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; APE LEUKEMIA-VIRUS; INDUCED CELL-DEATH; ALPHA-INDUCED APOPTOSIS; JNK ACTIVATION; SIGNAL-TRANSDUCTION; CANCER DEVELOPMENT; SURFACE-RECEPTORS; NA+/K+-ATPASE	PiT1/SLC20A1 is a sodium-dependent Pi transporter expressed by most mammalian cells. Interestingly, PiT1 transcription has been shown to be up-regulated by the tumor necrosis factor alpha (TNF), and we have now investigated the possible involvement of PiT1 in TNF-induced apoptosis. We show that PiT1-depleted cells are more sensitive to the proapoptotic activity of TNF (i.e. when the antiapoptotic NF kappa B pathway is inactivated). These observations were made in the human HeLa cancer cell line either transiently or stably depleted in PiT1 by RNA interference and in immortalized mouse embryonic fibroblasts isolated from PiT1 knock-out embryos. Depletion of the closely related family member PiT2 had no effect on TNF-induced apoptosis, showing that this effect was specific to PiT1. The increased sensitivity of PiT1-depleted cells was evident regardless of the presence or absence of extracellular Pi, suggesting that a defect in Pi uptake was not involved in the observed phenotype. Importantly, we show that the re-expression of a Pi uptake mutant of PiT1 in PiT1(-/-) mouse embryonic fibroblasts delays apoptosis as efficiently as the WT protein, showing that this function of PiT1 is unrelated to its transport activity. Caspase-8 is more activated in PiT1-depleted cells, and our data reveal that the sustained activation of the MAPK JNK is up-regulated in response to TNF. JNK activity is actually involved in PiT1-depleted cell death because specific JNK inhibitors delay apoptosis.	[Salauen, Christine] Univ Paris 05, Fac Med, INSERM, Ctr Rech,U845, F-75015 Paris, France; INSERM, Growth & Signaling Res Ctr, U845, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Salaun, C (corresponding author), Univ Paris 05, Fac Med, INSERM, Ctr Rech,U845, 156 Rue Vaugirard, F-75015 Paris, France.	christine.salaun@inserm.fr	BECK, Laurent/P-2952-2014	BECK, Laurent/0000-0002-6730-2762; Friedlander, Gerard/0000-0002-6854-4261; Salaun, Christine/0000-0003-3002-6810	INSERM; Universite Paris Descartes; Association Laboratoires de Recherches Physiologiques	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; Association Laboratoires de Recherches Physiologiques	This study was supported by grants from INSERM, the Universite Paris Descartes, and the Association Laboratoires de Recherches Physiologiques.	Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BLESA JM, 2008, CANC THER, V6, P923; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Festing MH, 2009, GENESIS, V47, P858, DOI 10.1002/dvg.20577; Horn Z, 2010, EUR J NEUROSCI, V31, P2142, DOI 10.1111/j.1460-9568.2010.07258.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Lamb JA, 2003, MOL CELL, V11, P1479, DOI 10.1016/S1097-2765(03)00203-X; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin AN, 2006, DEV CELL, V10, P277, DOI 10.1016/j.devcel.2006.02.006; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Nagy A., 2003, MANIPULATING MOUSE E; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; PINC ON, 1991, Dev Biol */* D DEV B, V148, P517; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Ruaud AF, 2007, DEVELOPMENT, V134, P867, DOI 10.1242/dev.02790; Sabatino DE, 1997, BLOOD CELL MOL DIS, V23, P422, DOI 10.1006/bcmd.1997.0161; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SALAU NC, 2004, J M J MOL BIOL */* J, V340, P39; Salaun C, 2002, J VIROL, V76, P4304, DOI 10.1128/JVI.76.9.4304-4311.2002; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walters ZS, 2009, J PHYSIOL-LONDON, V587, P521, DOI 10.1113/jphysiol.2008.161562; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010	66	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34408	34418		10.1074/jbc.M110.130989	http://dx.doi.org/10.1074/jbc.M110.130989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817733	Green Published, hybrid			2022-12-27	WOS:000283659100015
J	Unciuleac, MC; Shuman, S				Unciuleac, Mihaela-Carmen; Shuman, Stewart			Double Strand Break Unwinding and Resection by the Mycobacterial Helicase-Nuclease AdnAB in the Presence of Single Strand DNA-binding Protein (SSB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RECBCD ENZYME; MOTOR-NUCLEASE; RECA PROTEIN; TRANSLOCATION; DOMAIN; RECOMBINATION; ASSOCIATION; VARIABILITY; COMPLEXES; MECHANISM	Mycobacterial AdnAB is a heterodimeric DNA helicase-nuclease and 3' to 5' DNA translocase implicated in the repair of double strand breaks (DSBs). The AdnA and AdnB subunits are each composed of an N-terminal motor domain and a C-terminal nuclease domain. Inclusion of mycobacterial single strand DNA-binding protein (SSB) in reactions containing linear plasmid dsDNA allowed us to study the AdnAB helicase under conditions in which the unwound single strands are coated by SSB and thereby prevented from reannealing or promoting ongoing ATP hydrolysis. We found that the AdnAB motor catalyzed processive unwinding of 2.7-11.2-kbp linear duplex DNAs at a rate of similar to 250 bp s(-1), while hydrolyzing similar to 5 ATPs per bp unwound. Crippling the AdnA phosphohydrolase active site did not affect the rate of unwinding but lowered energy consumption slightly, to similar to 4.2 ATPs bp(-1). Mutation of the AdnB phosphohydrolase abolished duplex unwinding, consistent with a model in which the "leading" AdnB motor propagates a Y-fork by translocation along the 3' DNA strand, ahead of the "lagging" AdnA motor domain. By tracking the resection of the 5' and 3' strands at the DSB ends, we illuminated a division of labor among the AdnA and AdnB nuclease modules during dsDNA unwinding, whereby the AdnA nuclease processes the unwound 5' strand to liberate a short oligonucleotide product, and the AdnB nuclease incises the 3' strand on which the motor translocates. These results extend our understanding of presynaptic DSB processing by AdnAB and engender instructive comparisons with the RecBCD and AddAB clades of bacterial helicase-nuclease machines.	[Unciuleac, Mihaela-Carmen; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [AI64693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI64693.	Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Cromie GA, 2009, J BACTERIOL, V191, P5076, DOI 10.1128/JB.00254-09; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fili N, 2010, NUCLEIC ACIDS RES, V38, P4448, DOI 10.1093/nar/gkq173; Haijema BJ, 1996, J BACTERIOL, V178, P5086, DOI 10.1128/jb.178.17.5086-5091.1996; Haijema BJ, 1996, J BACTERIOL, V178, P5130, DOI 10.1128/jb.178.17.5130-5137.1996; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Reddy MS, 2001, J BIOL CHEM, V276, P45959, DOI 10.1074/jbc.M103523200; Reuter M, 2010, NUCLEIC ACIDS RES, V38, P3721, DOI 10.1093/nar/gkq100; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200	25	25	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34319	34329		10.1074/jbc.M110.162925	http://dx.doi.org/10.1074/jbc.M110.162925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736178	Green Published, hybrid			2022-12-27	WOS:000283659100005
J	Ribeiro-Resende, VT; Ribeiro-Guimaraes, ML; Lemes, RMR; Nascimento, IC; Alves, L; Mendez-Otero, R; Pessolani, MCV; Lara, FA				Ribeiro-Resende, Victor Tulio; Ribeiro-Guimaraes, Michelle Lopes; Rodrigues Lemes, Robertha Mariana; Nascimento, Isis Cristina; Alves, Lucineia; Mendez-Otero, Rosalia; Vidal Pessolani, Maria Cristina; Lara, Flavio Alves			Involvement of 9-O-Acetyl GD3 Ganglioside in Mycobacterium leprae Infection of Schwann Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE; FUNCTIONAL-ROLE; NEURONAL MIGRATION; ALPHA-DYSTROGLYCAN; ENDOTHELIAL-CELLS; GROWTH-FACTOR; GLYCOSPHINGOLIPIDS; DEMYELINATION; LOCALIZATION; ORGANIZATION	Mycobacterium leprae (ML), the etiologic agent of leprosy, mainly affects the skin and peripheral nerves, leading to demyelization and loss of axonal conductance. Schwann cells (SCs) are the main cell population infected by ML in the nerves, and infection triggers changes in the SC phenotype from a myelinated to a nonmyelinated state. In the present study, we show that expression of 9-O-acetyl GD3, a ganglioside involved in cellular anti-apoptotic signaling and nerve regeneration, increases in SCs following infection with ML. Observation by confocal microscopy together with coimmunoprecipitation suggested that this ganglioside participates in ML attachment and internalization by SC. Immunoblockage of 9-O-acetyl GD3 in vitro significantly reduced adhesion of ML to SC surfaces. Finally, we show that activation of the MAPK (ERK 1/2) pathway and SC proliferation, two known effects of ML on SCs that result in demyelization, are significantly reduced when the 9-O-acetyl GD3 ganglioside is immunoblocked. Taken together, these data suggest the involvement of 9-O-acetyl GD3 in ML infection on SCs.	[Alves, Lucineia; Vidal Pessolani, Maria Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Microbiol Celular, BR-21045900 Rio De Janeiro, Brazil; [Ribeiro-Resende, Victor Tulio; Nascimento, Isis Cristina; Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Neurobiol Celular & Mol, BR-21941902 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Ribeiro-Resende, VT (corresponding author), Pavilhao Hanseniase IOC, Av Brasil 4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.	vtulio@biof.ufrj.br	Lara, Flavio Alves/L-1861-2013; Lemes, Robertha/AAE-8757-2019; Mendez-Otero, Rosalia/AAL-7551-2020; Neurociencia, Inct/I-1011-2013	Lemes, Robertha/0000-0001-9322-4262; Mendez-Otero, Rosalia/0000-0002-1798-9930; Nascimento, Isis/0000-0002-2633-8216	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; American Leprosy Missions; Order of St. Lazarus; Universidade Federal do Rio de Janeiro	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz; American Leprosy Missions; Order of St. Lazarus; Universidade Federal do Rio de Janeiro	This work was supported by grants from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and from the Fundacao Oswaldo Cruz and by funds from the American Leprosy Missions and the Order of St. Lazarus.; We thank Dr. Janet W. Reid for the English revision, Dr. Jose Oswaldo Previato and Dr. Adriane Todeschini from Universidade Federal do Rio de Janeiro for the excellent scientific support, the American Leprosy Missions and the Order of St. Lazarus, which support Dr. James Krahenbuhl and Dr. Ramanuj Lahiri from National Hansen's Disease Program, who kindly donated the Mycobacterium leprae used in this work and trained us to produce ML in the nude mice model, and Dr. Patrick Brennan from Colorado State University for kindly providing the IgG anti-alpha-HLP and IgG anti-alpha-Lam.	COLSTON MJ, 1976, NATURE, V262, P399, DOI 10.1038/262399a0; Gong Y, 2002, BRAIN, V125, P2491, DOI 10.1093/brain/awf258; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; HARRIS EB, 1986, INT J LEPROSY, V54, P289; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Katoch V M, 1999, Indian J Lepr, V71, P45; KHANOLKAR VR, 1964, INDIAN J MED RES, V52, P139; Kniep B, 2006, INT J CANCER, V119, P67, DOI 10.1002/ijc.21788; Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6; MANZI AE, 1990, J BIOL CHEM, V265, P8094; Marques MAM, 2001, J MED MICROBIOL, V50, P23, DOI 10.1099/0022-2615-50-1-23; Mendez-Otero R, 2003, Prog Mol Subcell Biol, V32, P97; Mendez-Otero R, 2003, BRAZ J MED BIOL RES, V36, P1003, DOI 10.1590/S0100-879X2003000800006; MendezOtero R, 1996, EUR J CELL BIOL, V71, P192; Miyakoshi LM, 2001, BRAZ J MED BIOL RES, V34, P669, DOI 10.1590/S0100-879X2001000500016; Mukhejee P, 2008, J LIPID RES, V49, P929, DOI 10.1194/jlr.R800006-JLR200; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Rambukkana A, 2000, LEPROSY REV, V71, pS168; Ribeiro-Resende VT, 2007, NEUROSCIENCE, V147, P97, DOI 10.1016/j.neuroscience.2007.03.046; Rodrigues LS, 2010, CELL MICROBIOL, V12, P42, DOI 10.1111/j.1462-5822.2009.01377.x; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Santiago MF, 2004, J NEUROSCI, V24, P474, DOI 10.1523/JNEUROSCI.0116-03.2004; Santiago MF, 2001, MOL CELL NEUROSCI, V17, P488, DOI 10.1006/mcne.2000.0943; SCHLOSSHAUER B, 1988, J NEUROSCI, V8, P580; Scollard DM, 1999, AM J PATHOL, V154, P1611, DOI 10.1016/S0002-9440(10)65414-4; Scollard DM, 2000, MICROBES INFECT, V2, P1835, DOI 10.1016/S1286-4579(00)01335-6; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Shepard C C, 1968, Int J Lepr Other Mycobact Dis, V36, P78; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; VANLENTEN L, 1971, J BIOL CHEM, V246, P1889; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Vyas AA, 2001, BIOCHIMIE, V83, P677, DOI 10.1016/S0300-9084(01)01308-6; Vyas KA, 2001, BIOL CHEM, V382, P241, DOI 10.1515/BC.2001.031; Yang CR, 2007, J NEUROSCI RES, V85, P1381, DOI 10.1002/jnr.21264	43	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34086	34096		10.1074/jbc.M110.147272	http://dx.doi.org/10.1074/jbc.M110.147272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739294	hybrid, Green Published			2022-12-27	WOS:000283354000054
J	Coudevylle, N; Geist, L; Hotzinger, M; Hartl, M; Kontaxis, G; Bister, K; Konrat, R				Coudevylle, Nicolas; Geist, Leonhard; Hoetzinger, Matthias; Hartl, Markus; Kontaxis, Georg; Bister, Klaus; Konrat, Robert			The v-myc-induced Q83 Lipocalin Is a Siderocalin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; PROTEIN FAMILY; INTERMOLECULAR NOES; IRON; ENTEROBACTIN; RECOGNITION; INFECTION; ALIGNMENT; RECEPTOR; HADDOCK	Siderocalins are atypical lipocalins able to capture siderophores with high affinity. They contribute to the innate immune response by interfering with bacterial siderophore-mediated iron uptake but are also involved in numerous physiological processes such as inflammation, iron delivery, tissue differentiation, and cancer progression. The Q83 lipocalin was originally identified based on its overexpression in quail embryo fibroblasts transformed by the v-myc oncogene. We show here that Q83 is a siderocalin, binding the siderophore enterobactin with an affinity and mode of binding nearly identical to that of neutrophil gelatinase-associated lipocalin (NGAL), the prototypical siderocalin. This strengthens the role of siderocalins in cancer progression and inflammation. In addition, we also present the solution structure of Q83 in complex with intact enterobactin and a detailed analysis of the Q83 binding mode, including mutagenesis of the critical residues involved in enterobactin binding. These data provide a first insight into the molecular details of siderophore binding and delineate the common molecular properties defining the siderocalin protein family.	[Coudevylle, Nicolas; Geist, Leonhard; Hoetzinger, Matthias; Kontaxis, Georg; Konrat, Robert] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Hartl, Markus; Bister, Klaus] Univ Innsbruck, Inst Biochem, Ctr Mol Biosci CMBI, A-6020 Innsbruck, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Innsbruck	Coudevylle, N (corresponding author), Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, Campus Vienna,Bioctr 5-1, A-1030 Vienna, Austria.	nicolas.coudevylle@univie.ac.at; robert.konrat@univie.ac.at	Bister, Klaus/AFA-9400-2022; Hoetzinger, Matthias/R-3818-2017; Hartl, Markus/O-4655-2014	Hoetzinger, Matthias/0000-0002-1932-6479; Hartl, Markus/0000-0001-7447-5920; Bister, Klaus/0000-0001-6545-5653	Austrian Science Fund (FWF) [P20549-N19, P22125-B12, P17041, P18148]; Lise Meitner FWF fellowship; Austrian Science Fund (FWF) [P 22125] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Lise Meitner FWF fellowship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grants P20549-N19, P22125-B12, P17041, and P18148.; Recipient of a Lise Meitner FWF fellowship.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Auguin D, 2004, J BIOL CHEM, V279, P35890, DOI 10.1074/jbc.M400364200; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Basler T, 2008, IMMUNOBIOLOGY, V213, P879, DOI 10.1016/j.imbio.2008.07.009; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; CANCEDDA FD, 1988, J CELL BIOL, V107, P2455, DOI 10.1083/jcb.107.6.2455; CARRANO CJ, 1979, J AM CHEM SOC, V101, P5401, DOI 10.1021/ja00512a047; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Cermelli S, 2000, EUR J CELL BIOL, V79, P155, DOI 10.1078/S0171-9335(04)70018-7; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Cornilescu G, 2000, J AM CHEM SOC, V122, P10143, DOI 10.1021/ja0016194; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eichmuller C, 2001, J BIOMOL NMR, V21, P107, DOI 10.1023/A:1012480532569; Fang WK, 2007, BIOCHEM J, V403, P297, DOI 10.1042/BJ20060836; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Hartl M, 2003, J MOL BIOL, V333, P33, DOI 10.1016/j.jmb.2003.08.018; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; KARPISHIN TB, 1992, ANGEW CHEM INT EDIT, V31, P466, DOI 10.1002/anie.199204661; Keller R., 2004, COMPUTER AIDED RESON, V1; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; MANDUCA P, 1989, EUR J CELL BIOL, V50, P154; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; OBRIEN IG, 1970, BIOCHIM BIOPHYS ACTA, V215, P393, DOI 10.1016/0304-4165(70)90038-3; Ottiger M, 1998, J BIOMOL NMR, V12, P361, DOI 10.1023/A:1008366116644; Pagano A, 2002, EUR J CELL BIOL, V81, P264, DOI 10.1078/0171-9335-00243; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sheng Z, 2009, EMBO J, V28, P866, DOI 10.1038/emboj.2009.35; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Slijper M, 1996, J MAGN RESON SER B, V111, P199, DOI 10.1006/jmrb.1996.0083; Xu SY, 2000, BBA-PROTEIN STRUCT M, V1482, P298, DOI 10.1016/S0167-4838(00)00163-1; Yang J, 2003, AM J PHYSIOL-RENAL, V285, pF9, DOI 10.1152/ajprenal.00008.2003; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	57	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41646	41652		10.1074/jbc.M110.123331	http://dx.doi.org/10.1074/jbc.M110.123331			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20826777	hybrid, Green Published			2022-12-27	WOS:000285622600052
J	Simonin, A; Fuster, D				Simonin, Alexandre; Fuster, Daniel			Nedd4-1 and beta-Arrestin-1 Are Key Regulators of Na+/H+ Exchanger 1 Ubiquitylation, Endocytosis, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE NEDD4-1; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; TRAFFICKING; NHE1; DEGRADATION; INTERNALIZATION; ACTIVATION; TRANSLOCATION; SUFFICIENT	The ubiquitously expressed mammalian Na+/H+ exchanger 1 (NHE1) controls cell volume and pH but is also critically involved in complex biological processes like cell adhesion, cell migration, cell proliferation, and mechanosensation. Pathways controlling NHE1 turnover at the plasma membrane, however, are currently unclear. Here, we demonstrate that NHE1 undergoes ubiquitylation at the plasma membrane by a process that is unprecedented for a mammalian ion transport protein. This process requires the adapter protein beta-arrestin-1 that interacts with both the E3 ubiquitin ligase Nedd4-1 and the NHE1 C terminus. Truncation of NHE1 C terminus to amino acid 550 abolishes binding to beta-arrestin-1 and NHE1 ubiquitylation. Overexpression of beta-arrestin-1 or of wild type but not ligase-dead Nedd4-1 increases NHE1 ubiquitylation. siRNA-mediated knockdown of Nedd4-1 or beta-arrestin-1 reduces NHE1 ubiquitylation and endocytosis leading to increased NHE1 surface levels. Fibroblasts derived from beta-arrestin-1 and Nedd4-1 knock-out mice show loss of NHE1 ubiquitylation, increased plasmalemmal NHE1 levels and greatly enhanced NHE1 transport compared with wild-type fibroblasts. These findings reveal Nedd4-1 and beta-arrestin-1 as key regulators of NHE1 ubiquitylation, endocytosis, and function. Our data suggest a broader role for beta-arrestins in the regulation of membrane ion transport proteins than currently known.	Univ Hosp Bern, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland; [Simonin, Alexandre; Fuster, Daniel] Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	University of Bern; University Hospital of Bern	Fuster, D (corresponding author), Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	Daniel.Fuster@mci.unibe.ch	Fuster, Daniel G/AAA-7079-2021	Fuster, Daniel G/0000-0001-7220-1803	European Union [41400]; Swiss National Science Foundation [3100A0-117732]; Foundation Prof. Dr. Max Cloetta	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Prof. Dr. Max Cloetta	This work was supported in part by a European Union Intra-European Marie-Curie Fellowship (Grant 41400, to D. F.), the Swiss National Science Foundation (Grant 3100A0-117732, to D. F.), and by a Medical Research Position Award of the Foundation Prof. Dr. Max Cloetta (to D. F.).	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; ALPERN RJ, 1985, J GEN PHYSIOL, V86, P613, DOI 10.1085/jgp.86.5.613; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; BAUM M, 1993, AM J PHYSIOL, V264, pF1027, DOI 10.1152/ajprenal.1993.264.6.F1027; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bobulescu IA, 2005, AM J PHYSIOL-RENAL, V289, pF685, DOI 10.1152/ajprenal.00447.2004; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Fuster DG, 2007, AM J PHYSIOL-RENAL, V292, pF577, DOI 10.1152/ajprenal.00240.2006; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Lagana A, 2000, J CELL SCI, V113, P3649; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lipsky R, 2008, J BIOL CHEM, V283, P17221, DOI 10.1074/jbc.C800061200; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	47	57	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38293	38303		10.1074/jbc.M110.115089	http://dx.doi.org/10.1074/jbc.M110.115089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855896	Green Published, hybrid			2022-12-27	WOS:000284625600036
J	Chang, CY; Hsieh, YC; Wang, TY; Chen, YC; Wang, YK; Chiang, TW; Chen, YJ; Chang, CH; Chen, CJ; Wu, TK				Chang, Chin-Yuan; Hsieh, Yin-Cheng; Wang, Ting-Yi; Chen, Yi-Chin; Wang, Yu-Kuo; Chiang, Ting-Wei; Chen, Yi-Ju; Chang, Cheng-Hsiang; Chen, Chun-Jung; Wu, Tung-Kung			Crystal Structure and Mutational Analysis of Aminoacylhistidine Dipeptidase from Vibrio alginolyticus Reveal a New Architecture of M20 Metallopeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-CARNOSINASE DEFICIENCY; CARBOXYPEPTIDASE G(2); NUCLEOTIDE-SEQUENCE; MENTAL-RETARDATION; DATA QUALITY; ENZYME; AMINOPEPTIDASE; HOMOCARNOSINE; SUBSTRATE; THERAPY	Aminoacylhistidine dipeptidases (PepD, EC 3.4.13.3) belong to the family of M20 metallopeptidases from the metallopeptidase H clan that catalyze a broad range of dipeptide and tripeptide substrates, including L-carnosine and L-homocarnosine. Homocarnosine has been suggested as a precursor for the neurotransmitter gamma-aminobutyric acid (GABA) and may mediate the antiseizure effects of GABAergic therapies. Here, we report the crystal structure of PepD from Vibrio alginolyticus and the results of mutational analysis of substrate-binding residues in the C-terminal as well as substrate specificity of the PepD catalytic domain-alone truncated protein PepD(CAT). The structure of PepD was found to exist as a homodimer, in which each monomer comprises a catalytic domain containing two zinc ions at the active site center for its hydrolytic function and a lid domain utilizing hydrogen bonds between helices to form the dimer interface. Although the PepD is structurally similar to PepV, which exists as a monomer, putative substrate-binding residues reside in different topological regions of the polypeptide chain. In addition, the lid domain of the PepD contains an "extra" domain not observed in related M20 family metallopeptidases with a dimeric structure. Mutational assays confirmed both the putative di-zinc allocations and the architecture of substrate recognition. In addition, the catalytic domain-alone truncated PepD(CAT) exhibited substrate specificity to L-homocarnosine compared with that of the wild-type PepD, indicating a potential value in applications of PepD(CAT) for GABAergic therapies or neuroprotection.	[Chang, Chin-Yuan; Wang, Ting-Yi; Chen, Yi-Chin; Wang, Yu-Kuo; Chen, Yi-Ju; Chang, Cheng-Hsiang; Wu, Tung-Kung] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan; [Hsieh, Yin-Cheng; Chiang, Ting-Wei; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Hsieh, Yin-Cheng] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Chiang, Ting-Wei; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan	National Yang Ming Chiao Tung University; National Synchrotron Radiation Research Center; National Tsing Hua University; National Tsing Hua University; National Cheng Kung University	Chen, CJ (corresponding author), 101 Hsin Ann Rd, Hsinchu 30076, Taiwan.	cjchen@nsrrc.org.tw; tkwmll@mail.nctu.edu.tw	Chen, Chun-Jung/A-6880-2011; Chang, Chin-Yuan/AAM-5863-2021	Chen, Chun-Jung/0000-0002-5157-4288; Chang, Chin-Yuan/0000-0001-7314-3967; Wang, Ting-Yi/0000-0001-5536-925X	National Chiao Tung University; Ministry of Education; National Science Council [NSC-97-2627-M-009-002, NSC-97-2627-M-009-003, NSC 93-2321-B-213-001]; National Synchrotron Radiation Research Center [963RSB02]; Aiming for Top University Plan program	National Chiao Tung University; Ministry of Education; National Science Council(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Research Center; Aiming for Top University Plan program	This work was supported by the National Chiao Tung University, the Ministry of Education, Aiming for Top University Plan program, and National Science Council Grants NSC-97-2627-M-009-002 and NSC-97-2627-M-009-003, National Synchrotron Radiation Research Center Grant 963RSB02, and National Science Council Grant NSC 93-2321-B-213-001) (to C.-J.C.).	Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; Biagini A, 2001, COMP BIOCHEM PHYS B, V128, P469, DOI 10.1016/S1096-4959(00)00341-9; Boldyrev AA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P751; Bommarius A. S., 2002, ENZYME CATALYSIS ORG, P741; Chang CY, 2009, ACTA CRYSTALLOGR F, V65, P216, DOI 10.1107/S174430910900092X; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Csampai A, 2004, J CHROMATOGR A, V1031, P67, DOI 10.1016/j.chroma.2003.10.137; Decker EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P766; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Hellendoorn MA, 1997, J BACTERIOL, V179, P3410, DOI 10.1128/jb.179.11.3410-3415.1997; Hipkiss AR, 1998, INT J BIOCHEM CELL B, V30, P863, DOI 10.1016/S1357-2725(98)00060-0; Jozic D, 2002, STRUCTURE, V10, P1097, DOI 10.1016/S0969-2126(02)00805-5; Karita M, 1997, INFECT IMMUN, V65, P4158, DOI 10.1128/IAI.65.10.4158-4164.1997; Khan TH, 1999, J MED CHEM, V42, P951, DOI 10.1021/jm990004i; Klein J., 2004, HDB PROTEOLYTIC ENZY, P948; Krause AS, 2002, LEUKEMIA LYMPHOMA, V43, P2139, DOI 10.1080/1042819021000032953; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindner HA, 2003, J BIOL CHEM, V278, P44496, DOI 10.1074/jbc.M304233200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUNDE H, 1982, J NEUROCHEM, V38, P242, DOI 10.1111/j.1471-4159.1982.tb10876.x; Lundgren S, 2003, J BIOL CHEM, V278, P51851, DOI 10.1074/jbc.M308674200; Miller C. G., 2004, HDB PROTEOLYTIC ENZY, P946; MINTON NP, 1984, GENE, V31, P31, DOI 10.1016/0378-1119(84)90192-6; MURPHEY WH, 1973, PEDIATR RES, V7, P601, DOI 10.1203/00006450-197307000-00001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRY TL, 1967, NEW ENGL J MED, V277, P1219, DOI 10.1056/NEJM196712072772302; PERRY TL, 1968, LANCET, V1, P1229; Petroff OAC, 1999, NEUROLOGY, V52, P473, DOI 10.1212/WNL.52.3.473; Petroff OAC, 2001, NEUROLOGY, V56, P709, DOI 10.1212/WNL.56.6.709; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; SCHROEDER U, 1994, FEMS MICROBIOL LETT, V123, P153, DOI 10.1111/j.1574-6968.1994.tb07215.x; Seidler NW, 2000, J BIOCHEM MOL TOXIC, V14, P215, DOI 10.1002/(SICI)1099-0461(2000)14:4<215::AID-JBT6>3.0.CO;2-Z; SHERWOOD RF, 1985, EUR J BIOCHEM, V148, P447, DOI 10.1111/j.1432-1033.1985.tb08860.x; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; TERPLAN KL, 1972, NEUROLOGY, V22, P644, DOI 10.1212/WNL.22.6.644; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Unno H, 2008, J BIOL CHEM, V283, P27289, DOI 10.1074/jbc.M801657200; Vaughan FL, 2006, J INT NEUROPSYCH SOC, V12, P416, DOI 10.1017/S13556177060060504; VONGERICHTEN KF, 1994, MICROBIOL-SGM, V140, P2591, DOI 10.1099/00221287-140-10-2591; Wang TY, 2008, FEBS J, V275, P5007, DOI 10.1111/j.1742-4658.2008.06635.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227	46	14	15	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39500	39510		10.1074/jbc.M110.139683	http://dx.doi.org/10.1074/jbc.M110.139683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20819954	hybrid, Green Published			2022-12-27	WOS:000284941300076
J	Tsai, MF; Jih, KY; Shimizu, H; Li, M; Hwang, TC				Tsai, Ming-Feng; Jih, Kang-Yang; Shimizu, Hiroyasu; Li, Min; Hwang, Tzyh-Chang			Optimization of the Degenerated Interfacial ATP Binding Site Improves the Function of Disease-related Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC-TRANSPORTERS; CHLORIDE CHANNELS; NUCLEOTIDE; DOMAIN; DIMER; POTENTIATION; MECHANISM; MUTATION; ANALOGS	The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, an ATP binding cassette (ABC) protein whose defects cause the deadly genetic disease cystic fibrosis (CF), encompasses two nucleotide binding domains (NBD1 and NBD2). Recent studies indicate that in the presence of ATP, the two NBDs coalesce into a dimer, trapping an ATP molecule in each of the two interfacial composite ATP binding sites (site 1 and site 2). Experimental evidence also suggests that CFTR gating is mainly controlled by ATP binding and hydrolysis in site 2, whereas site 1, which harbors several non-canonical substitutions in ATP-interacting motifs, is considered degenerated. The CF-associated mutation G551D, by introducing a bulky and negatively charged side chain into site 2, completely abolishes ATP-induced openings of CFTR. Here, we report a strategy to optimize site 1 for ATP binding by converting two amino acid residues to ABC consensus (i.e. H1348G) or more commonly seen residues in other ABC proteins (i.e. W401Y, W401F). Introducing either one or both of these mutations into G551D-CFTR confers ATP responsiveness for this disease-associated mutant channel. We further showed that the same maneuver also improved the function of WT-CFTR and the most common CF-associated Delta F508 channels, both of which rely on site 2 for gating control. Thus, our results demonstrated that the degenerated site 1 can be rebuilt to complement or support site 2 for CFTR function. Possible approaches for developing CFTR potentiators targeting site 1 will be discussed.	[Tsai, Ming-Feng; Jih, Kang-Yang; Hwang, Tzyh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Tsai, Ming-Feng; Jih, Kang-Yang; Li, Min; Hwang, Tzyh-Chang] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Shimizu, Hiroyasu] Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka 5698686, Japan	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Osaka Medical College	Hwang, TC (corresponding author), 134 Res Pk Dr, Columbia, MO 65211 USA.	hwangt@health.missouri.edu		TSAI, MING-FENG/0000-0003-4277-1885	National Center for Research Resources, National Institutes of Health [C06 RR-016489-01]; National Institutes of Health [R01-HL53445, R01-DK55835]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055835] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shenghui Hu and Cindy Chu for technical assistance. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (Grant C06 RR-016489-01) from the National Center for Research Resources, National Institutes of Health.; This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL53445 and R01-DK55835 (to T.-C. H.).	Aleksandrov L, 2008, BIOCHEM J, V416, P129, DOI 10.1042/BJ20081068; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Tsai MF, 2009, J GEN PHYSIOL, V133, P405, DOI 10.1085/jgp.200810186; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	31	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37663	37671		10.1074/jbc.M110.172817	http://dx.doi.org/10.1074/jbc.M110.172817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861014	Green Published, hybrid			2022-12-27	WOS:000284424000058
J	Wahl, B; Reichmann, D; Niks, D; Krompholz, N; Havemeyer, A; Clement, B; Messerschmidt, T; Rothkegel, M; Biester, H; Hille, R; Mendel, RR; Bittner, F				Wahl, Bettina; Reichmann, Debora; Niks, Dimitri; Krompholz, Nina; Havemeyer, Antje; Clement, Bernd; Messerschmidt, Tania; Rothkegel, Martin; Biester, Harald; Hille, Russ; Mendel, Ralf R.; Bittner, Florian			Biochemical and Spectroscopic Characterization of the Human Mitochondrial Amidoxime Reducing Components hmARC-1 and hmARC-2 Suggests the Existence of a New Molybdenum Enzyme Family in Eukaryotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALIANA PROVIDES INSIGHT; HYDROXYLATED BASE ANALOGS; COFACTOR SULFURASE GENE; XANTHINURIA TYPE-II; NITRATE REDUCTASE; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; ALDEHYDE OXIDASE; SULFITE OXIDASE; MECHANISM	The mitochondrial amidoxime reducing componentm ARC is a newly discovered molybdenum enzyme that is presumed to form the catalytical part of a three-component enzyme system, consisting of mARC, heme/cytochrome b(5), and NADH/FAD-dependent cytochrome b5 reductase. mARC proteins share a significant degree of homology to the molybdenum cofactor-binding domain of eukaryotic molybdenum cofactor sulfurase proteins, the latter catalyzing the post-translational activation of aldehyde oxidase and xanthine oxidoreductase. The human genome harbors two mARC genes, referred to as hmARC-1/MOSC-1 and hmARC-2/MOSC-2, which are organized in a tandem arrangement on chromosome 1. Recombinant expression of hmARC-1 and hmARC-2 proteins in Escherichia coli reveals that both proteins are monomeric in their active forms, which is in contrast to all other eukaryotic molybdenum enzymes that act as homo-or heterodimers. Both hmARC-1 and hmARC-2 catalyze the N-reduction of a variety of N-hydroxylated substrates such as N-hydroxy-cytosine, albeit with different specificities. Reconstitution of active molybdenum cofactor onto recombinant hmARC-1 and hmARC-2 proteins in the absence of sulfur indicates that mARC proteins do not belong to the xanthine oxidase family of molybdenum enzymes. Moreover, they also appear to be different from the sulfite oxidase family, because no cysteine residue could be identified as a putative ligand of the molybdenum atom. This suggests that the hmARC proteins and sulfurase represent members of a new family of molybdenum enzymes.	[Wahl, Bettina; Reichmann, Debora; Mendel, Ralf R.; Bittner, Florian] Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38023 Braunschweig, Germany; [Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Krompholz, Nina; Havemeyer, Antje; Clement, Bernd] Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, D-24118 Kiel, Germany; [Messerschmidt, Tania; Rothkegel, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Dept Cellular Neurobiol, D-38023 Braunschweig, Germany; [Biester, Harald] Tech Univ Carolo Wilhelmina Braunschweig, Dept Environm Geol, D-38023 Braunschweig, Germany	Braunschweig University of Technology; University of California System; University of California Riverside; University of Kiel; Braunschweig University of Technology; Braunschweig University of Technology	Mendel, RR (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, Humboldtstr 1, D-38023 Braunschweig, Germany.	r.mendel@tu-bs.de		, Martin/0000-0001-5041-4429	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Altuve A, 2001, BIOCHEMISTRY-US, V40, P9469, DOI 10.1021/bi010636i; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Estabrook R W, 1978, Methods Enzymol, V52, P212; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; George GN, 2004, INORG CHEM, V43, P8456, DOI 10.1021/ic0489847; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; GUTTERIDGE S, 1983, BIOCHEM J, V213, P137, DOI 10.1042/bj2130137; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2010, DRUG METAB DISPOS, V38, P1917, DOI 10.1124/dmd.110.032813; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; Kotthaus J., BIOCH J IN PRESS; Kozmin SG, 2008, MOL MICROBIOL, V68, P51, DOI 10.1111/j.1365-2958.2008.06128.x; Kozmin SG, 2007, MUTAT RES-FUND MOL M, V619, P9, DOI 10.1016/j.mrfmmm.2006.12.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMY MT, 1980, BIOCHEM J, V185, P397, DOI 10.1042/bj1850397; MASSEY V, 1970, J BIOL CHEM, V245, P6595; Mihara K, 1978, Methods Enzymol, V52, P102; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STRITTMATTER P, 1956, J BIOL CHEM, V221, P253; Terao M, 2001, J BIOL CHEM, V276, P46347, DOI 10.1074/jbc.M105744200; VERGERES G, 1992, J BIOL CHEM, V267, P12583; Watanabe T, 2000, J BIOL CHEM, V275, P21789, DOI 10.1074/jbc.C000230200; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; Zhang Y, 2008, J MOL BIOL, V379, P881, DOI 10.1016/j.jmb.2008.03.051	42	83	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37847	37859		10.1074/jbc.M110.169532	http://dx.doi.org/10.1074/jbc.M110.169532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861021	Green Published, hybrid			2022-12-27	WOS:000284424000075
J	Xu, Y; Zuo, Y; Zhang, HZ; Kang, XL; Yue, F; Yi, ZF; Liu, MY; Yeh, ETH; Chen, GQ; Cheng, JK				Xu, Ying; Zuo, Yong; Zhang, Haizeng; Kang, Xunlei; Yue, Fei; Yi, Zhengfang; Liu, Mingyao; Yeh, Edward T. H.; Chen, Guoqiang; Cheng, Jinke			Induction of SENP1 in Endothelial Cells Contributes to Hypoxia-driven VEGF Expression and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; SUMO-SPECIFIC PROTEASE-1; TRANSCRIPTIONAL ACTIVITY; GROWTH-FACTOR; PROLYL HYDROXYLATION; ANDROGEN RECEPTOR; HIF-1-ALPHA; SUMOYLATION; PROTEIN; CANCER	SENP1 (SUMO-specific protease 1) has been shown to be essential for the stability and activity of hypoxia-inducible factor 1 (HIF-1 alpha) under hypoxia conditions. However, it is unknown how SENP1 activation and hypoxia signaling are coordinated in the cellular response to hypoxia. Here, we report the essential role of SENP1 in endothelial cells as a positive regulator of hypoxia-driven VEGF production and angiogenesis. SENP1 expression is increased in endothelial cells following exposure to hypoxia. Silencing of HIF-1 alpha blocks SENP1 expression in cell response to hypoxia. Mutation of the hypoxia response element (HRE) on the Senp1 promoter abolishes its transactivation in response to hypoxia. Moreover, silencing of SENP1 expression decreases VEGF production and abrogates the angiogenic functions of endothelial cell. We also find that the elongated endothelial cells in embryonic brain section and vascular endothelial cells in embryonic renal glomeruli in Senp1(-/-) mice are markedly reduced than those in wild-type. Thus, these results show that hypoxia implies a positive feedback loop mediated by SENP1. This feedback loop is important in VEGF production, which is essential for angiogenesis in endothelial cells.	[Chen, Guoqiang; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Key Lab Cell Differentiat & Apoptosis Chinese Min, Shanghai 200025, Peoples R China; [Xu, Ying; Chen, Guoqiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Zuo, Yong; Kang, Xunlei; Chen, Guoqiang; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200438, Peoples R China; [Zhang, Haizeng] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Zhang, Haizeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yue, Fei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, Shanghai 200025, Peoples R China; E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University; East China Normal University; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute	Chen, GQ (corresponding author), 280 Chongqing S Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn; jkcheng@shsmu.edu.cn		Liu, Mingyao/0000-0001-7339-5048; Kang, Xunlei/0000-0003-1853-1881; chen, guo qiang/0000-0003-4936-2363	State Key Laboratory of Oncogenes & Related Genes, National Natural Science Foundation of China [30772462]; National Basic Research Program of China [2009CB918403, 2010CB912104]; Shanghai Pujiang Program; National Institutes of Health [CA 239520]; NATIONAL CANCER INSTITUTE [R01CA139520] Funding Source: NIH RePORTER	State Key Laboratory of Oncogenes & Related Genes, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grant 30772462 from the State Key Laboratory of Oncogenes & Related Genes, National Natural Science Foundation of China (to J.C.), National Basic Research Program of China (973 Program) Grants 2009CB918403 and 2010CB912104 (to J.C.), the Shanghai Pujiang Program (to J.C.), and National Institutes of Health Grant CA 239520 (to E.T.H.Y.).	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kitamoto Y, 1997, J CLIN INVEST, V99, P2351, DOI 10.1172/JCI119416; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Raleigh JA, 1998, CANCER RES, V58, P3765; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	48	69	79	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36682	36688		10.1074/jbc.M110.164236	http://dx.doi.org/10.1074/jbc.M110.164236			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20841360	Green Published, hybrid			2022-12-27	WOS:000284146100083
J	Carrie, C; Giraud, E; Duncan, O; Xu, L; Wang, Y; Huang, SB; Clifton, R; Murcha, M; Filipovska, A; Rackham, O; Vrielink, A; Whelan, J				Carrie, Chris; Giraud, Estelle; Duncan, Owen; Xu, Lin; Wang, Yan; Huang, Shaobai; Clifton, Rachel; Murcha, Monika; Filipovska, Aleksandra; Rackham, Oliver; Vrielink, Alice; Whelan, James			Conserved and Novel Functions for Arabidopsis thaliana MIA40 in Assembly of Proteins in Mitochondria and Peroxisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE PROTEINS; HIGHER-PLANT MITOCHONDRIA; OUTER-MEMBRANE PROTEINS; DISULFIDE RELAY SYSTEM; ALTERNATIVE OXIDASE; COMPLEX-I; NAD(P)H DEHYDROGENASES; PROCESSING PEPTIDASE; SULFHYDRYL OXIDASE; IMPORT MACHINERY	The disulfide relay system of the mitochondrial intermembrane space has been extensively characterized in Saccharomyces cerevisiae. It contains two essential components, Mia40 and Erv1. The genome of Arabidopsis thaliana contains a single gene for each of these components. Although insertional inactivation of Erv1 leads to a lethal phenotype, inactivation of Mia40 results in no detectable deleterious phenotype. A. thaliana Mia40 is targeted to and accumulates in mitochondria and peroxisomes. Inactivation of Mia40 results in an alteration of several proteins in mitochondria, an absence of copper/zinc superoxide dismutase (CSD1), the chaperone for superoxide dismutase (Ccs1) that inserts copper into CSD1, and a decrease in capacity and amount of complex I. In peroxisomes the absence of Mia40 leads to an absence of CSD3 and a decrease in abnormal inflorescence meristem 1 (Aim1), a beta-oxidation pathway enzyme. Inactivation of Mia40 leads to an alteration of the transcriptome of A. thaliana, with genes encoding peroxisomal proteins, redox functions, and biotic stress significantly changing in abundance. Thus, the mechanistic operation of the mitochondrial disulfide relay system is different in A. thaliana compared with other systems, and Mia40 has taken on new roles in peroxisomes and mitochondria.	[Carrie, Chris; Giraud, Estelle; Duncan, Owen; Xu, Lin; Wang, Yan; Huang, Shaobai; Clifton, Rachel; Murcha, Monika; Whelan, James] Univ Western Australia, ARC COE PEB, Crawley, WA 6009, Australia; [Filipovska, Aleksandra; Rackham, Oliver] Univ Western Australia, Western Australian Inst Med Res, Med Res Ctr, Crawley, WA 6009, Australia; [Vrielink, Alice] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Whelan, J (corresponding author), Univ Western Australia, ARC COE PEB, 35 Stirling Highway, Crawley, WA 6009, Australia.	seamus@cyllene.uwa.edu.au	Huang, Shaobai/D-1225-2011; Rackham, Oliver/E-1264-2013; Whelan, James/F-6402-2011; Murcha, Monika W/C-3834-2011; Rackham, Oliver/AGO-0005-2022; Vrielink, Alice/D-3652-2013; Giraud, Estelle/C-3876-2011; Murcha, Monika W/H-5495-2014; Carrie, Chris/A-2638-2010	Huang, Shaobai/0000-0003-3667-611X; Rackham, Oliver/0000-0002-5301-9624; Whelan, James/0000-0001-5754-025X; Rackham, Oliver/0000-0002-5301-9624; Vrielink, Alice/0000-0001-8197-3725; Murcha, Monika W/0000-0002-3689-6158; Carrie, Chris/0000-0002-4240-4674; WANG, YAN/0000-0003-1600-2863; Filipovska, Aleksandra/0000-0002-6998-8403; Xu, Lin/0000-0001-7476-2655; Duncan, Owen/0000-0001-6999-1509				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Banhegyi G, 2003, BIOFACTORS, V17, P37, DOI 10.1002/biof.5520170105; BATHGATE B, 1989, EUR J BIOCHEM, V183, P303, DOI 10.1111/j.1432-1033.1989.tb14929.x; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2008, J BIOL CHEM, V283, P29723, DOI 10.1074/jbc.M805356200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Chu CC, 2005, PLANT PHYSIOL, V139, P425, DOI 10.1104/pp.105.065284; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Endo T, 2010, ANTIOXID REDOX SIGN, V13, P1359, DOI 10.1089/ars.2010.3099; Eubel H, 2008, PLANT PHYSIOL, V148, P1809, DOI 10.1104/pp.108.129999; Footitt S, 2007, J EXP BOT, V58, P2959, DOI 10.1093/jxb/erm146; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Glaser E, 1999, J BIOENERG BIOMEMBR, V31, P259, DOI 10.1023/A:1005475930477; Glaser E, 2006, BIOL CHEM, V387, P1441, DOI 10.1515/BC.2006.180; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2009, BBA-MOL CELL RES, V1793, P71, DOI 10.1016/j.bbamcr.2008.05.001; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Jansch L, 1996, PLANT J, V9, P357, DOI 10.1046/j.1365-313X.1996.09030357.x; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Kawamata H, 2010, ANTIOXID REDOX SIGN, V13, P1375, DOI 10.1089/ars.2010.3212; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Koehler CM, 2009, BBA-MOL CELL RES, V1793, P139, DOI 10.1016/j.bbamcr.2008.08.002; Kutik S, 2009, BBA-GEN SUBJECTS, V1790, P409, DOI 10.1016/j.bbagen.2009.04.004; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; Lister R, 2003, NUCLEIC ACIDS RES, V31, P325, DOI 10.1093/nar/gkg055; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Ma C, 2008, J EXP BOT, V59, P3767, DOI 10.1093/jxb/ern221; Meyer EH, 2008, J PROTEOME RES, V7, P786, DOI 10.1021/pr700595p; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Murcha MW, 2005, J BIOL CHEM, V280, P16476, DOI 10.1074/jbc.M413299200; Murcha MW, 2004, J MOL BIOL, V344, P443, DOI 10.1016/j.jmb.2004.09.045; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Reddehase S, 2009, J MOL BIOL, V385, P331, DOI 10.1016/j.jmb.2008.10.088; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; STUART RA, 1990, BIOCHIMIE, V72, P115, DOI 10.1016/0300-9084(90)90136-5; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Vogtle FN, 2010, METHODS MOL BIOL, V619, P425, DOI 10.1007/978-1-60327-412-8_26; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; WHELAN J, 1995, PLANT MOL BIOL, V27, P769, DOI 10.1007/BF00020229; WHELAN J, 1995, PLANT PHYSIOL, V107, P1469, DOI 10.1104/pp.107.4.1469; Wiszniewski AAG, 2009, PLANT MOL BIOL, V69, P503, DOI 10.1007/s11103-008-9431-4	77	87	88	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36138	36148		10.1074/jbc.M110.121202	http://dx.doi.org/10.1074/jbc.M110.121202			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829360	Green Published, hybrid			2022-12-27	WOS:000283845300090
J	Cid, M; Pedersen, HL; Kaneko, S; Coutinho, PM; Henrissat, B; Willats, WGT; Boraston, AB				Cid, Melissa; Pedersen, Henriette Lodberg; Kaneko, Satoshi; Coutinho, Pedro M.; Henrissat, Bernard; Willats, William G. T.; Boraston, Alisdair B.			Recognition of the Helical Structure of beta-1,4-Galactan by a New Family of Carbohydrate-binding Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; STREPTOCOCCUS-PNEUMONIAE; MOLECULAR-BASIS; PROTEIN; GLYCOGEN; IDENTIFICATION; SPECIFICITY; RESIDUES; AMYLOSE; WALLS	The microbial enzymes that depolymerize plant cell wall polysaccharides, ultimately promoting energy liberation and carbon recycling, are typically complex in their modularity and often contain carbohydrate-binding modules (CBMs). Here, through analysis of an unknown module from a Thermotoga maritima endo-beta-1,4-galactanase, we identify a new family of CBMs that are most frequently found appended to proteins with beta-1,4-galactanase activity. Polysaccharide microarray screening, immunofluorescence microscopy, and biochemical analysis of the isolated module demonstrate the specificity of the module, here called TmCBM61, for beta-1,4-linked galactose-containing ligands, making it the founding member of family CBM61. The ultra-high resolution x-ray crystal structures of TmCBM61 (0.95 and 1.4 angstrom resolution) in complex with beta-1,4-galactotriose reveal the molecular basis of the specificity of the CBM for beta-1,4-galactan. Analysis of these structures provides insight into the recognition of an unexpected helical galactan conformation through a mode of binding that resembles the recognition of starch.	[Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Pedersen, Henriette Lodberg; Willats, William G. T.] Univ Copenhagen, Fac Life Sci, DK-1870 Frederiksberg C, Denmark; [Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 1, Lab Architecture & Fonct Macromol Biol, CNRS, UMR6098, F-13288 Marseille 9, France; [Coutinho, Pedro M.; Henrissat, Bernard] Univ Aix Marseille 2, Lab Architecture & Fonct Macromol Biol, CNRS, UMR6098, F-13288 Marseille 9, France	University of Victoria; University of Copenhagen; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Boraston, Alisdair/0000-0001-6417-0592; Willats, William/0000-0003-2064-4025	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to A.B.B.). The CAZy data base is supported by GIS "IBiSA" (Infrastrutures en Biologie, Sante et Agronomie).	Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Caines MEC, 2008, J BIOL CHEM, V283, P31279, DOI 10.1074/jbc.C800150200; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; DUDA CA, 1991, MACROMOLECULES, V24, P431, DOI 10.1021/ma00002a014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2002, ACTA CRYSTALLOGR D, V58, P976, DOI 10.1107/S0907444902005486; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Nours J, 2009, PROTEINS, V75, P977, DOI 10.1002/prot.22310; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moller I, 2008, GLYCOCONJUGATE J, V25, P37, DOI 10.1007/s10719-007-9059-7; Montanier C, 2010, J BIOL CHEM, V285, P31742, DOI 10.1074/jbc.M110.142133; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROY R, 1984, CAN J BIOCHEM CELL B, V62, P270, DOI 10.1139/o84-037; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; van Bueren AL, 2007, J MOL BIOL, V365, P555, DOI 10.1016/j.jmb.2006.10.018; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2004, PLANTA, V218, P673, DOI 10.1007/s00425-003-1147-8; Yang H, 2006, BIOSCI BIOTECH BIOCH, V70, P538, DOI 10.1271/bbb.70.538; Yao JX, 2006, ACTA CRYSTALLOGR D, V62, P901, DOI 10.1107/S0907444906008122	48	27	27	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35999	36009		10.1074/jbc.M110.166330	http://dx.doi.org/10.1074/jbc.M110.166330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826814	Green Published, hybrid			2022-12-27	WOS:000283845300076
J	Diskar, M; Zenn, HM; Kaupisch, A; Kaufholz, M; Brockmeyer, S; Sohmen, D; Berrera, M; Zaccolo, M; Boshart, M; Herberg, FW; Prinz, A				Diskar, Mandy; Zenn, Hans-Michael; Kaupisch, Alexandra; Kaufholz, Melanie; Brockmeyer, Stefanie; Sohmen, Daniel; Berrera, Marco; Zaccolo, Manuela; Boshart, Michael; Herberg, Friedrich W.; Prinz, Anke			Regulation of cAMP-dependent Protein Kinases THE HUMAN PROTEIN KINASE X (PrKX) REVEALS THE ROLE OF THE CATALYTIC SUBUNIT alpha H-alpha I LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-TRANSFER BRET; MOLECULAR SIMULATION; SACCHAROMYCES-CEREVISIAE; LIVING CELLS; PKA; ACTIVATION; EXPRESSION; DYNAMICS; BINDING; KIDNEY	cAMP-dependent protein kinases are reversibly complexed with any of the four isoforms of regulatory (R) subunits, which contain either a substrate or a pseudosubstrate autoinhibitory domain. The human protein kinase X (PrKX) is an exemption as it is inhibited only by pseudosubstrate inhibitors, i.e. RI alpha or RI beta but not by substrate inhibitors RII alpha or RII beta. Detailed examination of the capacity of five PrKX-like kinases ranging from human to protozoa (Trypanosoma brucei) to form holoenzymes with human R subunits in living cells shows that this preference for pseudosubstrate inhibitors is evolutionarily conserved. To elucidate the molecular basis of this inhibitory pattern, we applied bioluminescence resonance energy transfer and surface plasmon resonance in combination with site-directed mutagenesis. We observed that the conserved alpha H-alpha I loop residue Arg-283 in PrKX is crucial for its RI over RII preference, as a R283L mutant was able to form a holoenzyme complex with wild type RII subunits. Changing the corresponding alpha H-alpha I loop residue in PKA C alpha (L277R), significantly destabilized holoenzyme complexes in vitro, as cAMP-mediated holoenzyme activation was facilitated by a factor of 2-4, and lead to a decreased affinity of the mutant C subunit for R subunits, significantly affecting RII containing holoenzymes.	[Herberg, Friedrich W.; Prinz, Anke] Univ Kassel, Dept Biochem, D-34132 Kassel, Germany; [Sohmen, Daniel; Boshart, Michael] Univ Munich, Bioctr, Genet Sect, D-82152 Planegg Martinsried, Germany; [Berrera, Marco; Zaccolo, Manuela] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland	Universitat Kassel; University of Munich; University of Glasgow	Prinz, A (corresponding author), Univ Kassel, Dept Biochem, Heinrich Plett Str 40, D-34132 Kassel, Germany.	ankeprinz@uni-kassel.de	Zaccolo, Manuela/B-3802-2011; Zaccolo, Manuela/AAP-6706-2020; Herberg, Friedrich W/B-5572-2015; Boshart, Michael/A-2700-2011	Zaccolo, Manuela/0000-0002-0934-3662; Herberg, Friedrich W/0000-0001-7117-7653; Boshart, Michael/0000-0002-5070-2663	National Science Foundation-NIH [R01 AA18060]; European Union [LSHB-CT-2006-037189]; Bundesministerium fur Bildung und Forschung NGFN2 [FKZ01GR0441]; Deutsche Forschungsgemeinschaft [BO1100/2]; Otto-Braun fonds of the University of Kassel; Fondation Leducq [O6 CVD 02]; British Heart Foundation [PG/07/091/23698]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018060] Funding Source: NIH RePORTER	National Science Foundation-NIH; European Union(European Commission); Bundesministerium fur Bildung und Forschung NGFN2(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Otto-Braun fonds of the University of Kassel; Fondation Leducq(Leducq Foundation); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AA18060 from the National Science Foundation-NIH Collaborative Research in Computational Neuroscience Program (to M. Z.), European Union Grant LSHB-CT-2006-037189 (to F. W. H. and M. Z.), Bundesministerium fur Bildung und Forschung NGFN2 Grant FKZ01GR0441 (to F. W. H.), and Deutsche Forschungsgemeinschaft BO1100/2 (to M. B.).; Supported by a Ph.D. grant of the Otto-Braun fonds of the University of Kassel.; Supported by Fondation Leducq Grant O6 CVD 02 and British Heart Foundation Grant PG/07/091/23698.	Anand GS, 2007, J MOL BIOL, V374, P487, DOI 10.1016/j.jmb.2007.09.035; ANJARD C, 1993, BIOCHEMISTRY-US, V32, P9532, DOI 10.1021/bi00088a003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berrera M, 2006, BIOPHYS J, V90, P3428, DOI 10.1529/biophysj.105.071621; Berrera M, 2007, J PHYS CHEM B, V111, P1496, DOI 10.1021/jp0667893; Berrera M, 2006, BIOPHYS J, V91, P2063, DOI 10.1529/biophysj.106.083519; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bertinetti Daniela, 2009, BMC Chem Biol, V9, P3, DOI 10.1186/1472-6769-9-3; Blaschke RJ, 2000, GENOMICS, V64, P187, DOI 10.1006/geno.2000.6116; Brown SHJ, 2009, J MOL BIOL, V393, P1070, DOI 10.1016/j.jmb.2009.09.014; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; da Cruz AB, 2008, J NEUROSCI, V28, P10885, DOI 10.1523/JNEUROSCI.3015-08.2008; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; Diskar M, 2007, CELL SIGNAL, V19, P2024, DOI 10.1016/j.cellsig.2007.05.012; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Etchebehere LC, 1997, EUR J BIOCHEM, V248, P820, DOI 10.1111/j.1432-1033.1997.t01-2-00820.x; Gesellchen F, 2006, EUR J CELL BIOL, V85, P663, DOI 10.1016/j.ejcb.2006.01.009; GIBBS CS, 1992, J BIOL CHEM, V267, P4806; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Junttila I, 2003, J LEUKOCYTE BIOL, V73, P281, DOI 10.1189/jlb.0702359; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Li W, 2005, J HISTOCHEM CYTOCHEM, V53, P1003, DOI 10.1369/jhc.4A6568.2005; Li XH, 2005, J AM SOC NEPHROL, V16, P3543, DOI 10.1681/ASN.2005030240; Li XH, 2002, P NATL ACAD SCI USA, V99, P9260, DOI 10.1073/pnas.132051799; Li XH, 2008, BBA-MOL BASIS DIS, V1782, P1, DOI 10.1016/j.bbadis.2007.09.003; Li XH, 2009, KIDNEY INT, V76, P54, DOI 10.1038/ki.2009.95; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; MELENDEZ A, 1995, GENETICS, V141, P1507; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prinz A, 2006, CHEMBIOCHEM, V7, P1007, DOI 10.1002/cbic.200600048; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; RUBIN CS, 1972, J BIOL CHEM, V247, P36; Sagui C, 1999, ANNU REV BIOPH BIOM, V28, P155, DOI 10.1146/annurev.biophys.28.1.155; Schiebel K, 1997, HUM MOL GENET, V6, P1985, DOI 10.1093/hmg/6.11.1985; Semizarov D, 1998, P NATL ACAD SCI USA, V95, P15412, DOI 10.1073/pnas.95.26.15412; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; SYMCOX MM, 1994, J BIOL CHEM, V269, P23025; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370	52	12	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35910	35918		10.1074/jbc.M110.155150	http://dx.doi.org/10.1074/jbc.M110.155150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20819953	Green Published, hybrid			2022-12-27	WOS:000283845300068
J	Nukaya, M; Lin, BC; Glover, E; Moran, SM; Kennedy, GD; Bradfield, CA				Nukaya, Manabu; Lin, Bernice C.; Glover, Edward; Moran, Susan M.; Kennedy, Gregory D.; Bradfield, Christopher A.			The Aryl Hydrocarbon Receptor-interacting Protein (AIP) Is Required for Dioxin-induced Hepatotoxicity but Not for the Induction of the Cyp1a1 and Cyp1a2 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-ASSOCIATED PROTEIN-2; DOSE-RESPONSE; AH RECEPTOR; SUBCELLULAR-LOCALIZATION; LIVER DEVELOPMENT; CORE COMPLEX; MICE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; RECOMBINASE; EXPRESSION	The aryl hydrocarbon receptor (AHR) plays an essential role in the toxic response to environmental pollutants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), in the adaptive up-regulation of xenobiotic metabolizing enzymes, and in hepatic vascular development. In our model of AHR signaling, the receptor is found in a cytosolic complex with a number of molecular chaperones, including Hsp90, p23, and the aryl hydrocarbon receptor-interacting protein (AIP), also known as ARA9 and XAP2. To understand the role of AIP in adaptive and toxic aspects of AHR signaling, we generated a conditional mouse model where the Aip locus can be deleted in hepatocytes. Using this model, we demonstrate two important roles for the AIP protein in AHR biology. (i) The expression of AIP in hepatocytes is essential to maintain high levels of functional cytosolic AHR protein in the mammalian liver. (ii) Expression of the AIP protein is essential for dioxin-induced hepatotoxicity. Interestingly, classical AHR-driven genes show differential dependence on AIP expression. The Cyp1b1 and Ahrr genes require AIP expression for normal up-regulation by dioxin, whereas Cyp1a1 and Cyp1a2 do not. This differential dependence on AIP provides evidence that the mammalian genome contains more than one class of AHR-responsive genes and suggests that a search for AIP-dependent, AHR-responsive genes may guide us to the targets of the dioxin-induced hepatotoxicity.	[Nukaya, Manabu; Lin, Bernice C.; Glover, Edward; Moran, Susan M.; Bradfield, Christopher A.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Nukaya, Manabu; Kennedy, Gregory D.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bradfield, CA (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	bradfield@oncology.wisc.edu	Kennedy, Gregory/S-2433-2016	Kennedy, Gregory/0000-0002-5981-3917; Nukaya, Manabu/0000-0002-6204-0978	National Institutes of Health [R01-ES-06883, R37-ES-05703, T32-CA-009135, P30-CA-014520, K08-ES-017283]; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES017283, R01ES006883, R37ES005703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-ES-06883, R37-ES-05703, T32-CA-009135, P30-CA-014520 (to C. A. B.), and K08-ES-017283 (to G. D. K.).	Abel J, 1996, ARCH TOXICOL, V70, P510, DOI 10.1007/s002040050307; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Bunger MK, 2003, J BIOL CHEM, V278, P17767, DOI 10.1074/jbc.M209594200; Carver LA, 1997, J BIOL CHEM, V272, P11452; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Harstad EB, 2006, MOL PHARMACOL, V69, P1534, DOI 10.1124/mol.105.020107; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Lin BC, 2008, MOL PHARMACOL, V74, P1367, DOI 10.1124/mol.108.047068; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; MEYER BK, 1999, G H BIOCH, V38, P8907; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nukaya M, 2009, P NATL ACAD SCI USA, V106, P4923, DOI 10.1073/pnas.0809613106; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Santostefano MJ, 1997, BIOCHEM BIOPH RES CO, V233, P20, DOI 10.1006/bbrc.1997.6389; SAVAS U, 1994, J BIOL CHEM, V269, P14905; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Thomas RS, 2002, PHARMACOGENETICS, V12, P151, DOI 10.1097/00008571-200203000-00009; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Walisser JA, 2004, P NATL ACAD SCI USA, V101, P16677, DOI 10.1073/pnas.0404379101; Walisser JA, 2004, J BIOL CHEM, V279, P16326, DOI 10.1074/jbc.M400784200; Walker NJ, 1999, TOXICOL APPL PHARM, V154, P279, DOI 10.1006/taap.1998.8595; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; Whitlock JP, 1997, DRUG METAB REV, V29, P1107, DOI 10.3109/03602539709002245; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103	35	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35599	35605		10.1074/jbc.M110.132043	http://dx.doi.org/10.1074/jbc.M110.132043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20829355	hybrid, Green Published			2022-12-27	WOS:000283845300038
J	Mohan, S; Tse, CM; Gabelli, SB; Sarker, R; Cha, BY; Fahie, K; Nadella, M; Zachos, NC; Tu-Sekine, B; Raben, D; Amzel, LM; Donowitz, M				Mohan, Sachin; Tse, Chung Ming; Gabelli, Sandra B.; Sarker, Rafiquel; Cha, Boyoung; Fahie, Kamau; Nadella, Mythili; Zachos, Nicholas C.; Tu-Sekine, Becky; Raben, Daniel; Amzel, L. Mario; Donowitz, Mark			NHE3 Activity Is Dependent on Direct Phosphoinositide Binding at the N Terminus of Its Intracellular Cytosolic Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER NHE3; PLASMA-MEMBRANE; BRUSH-BORDER; SENSITIVE PHOSPHATASE; MOLECULAR PHYSIOLOGY; CYTOPLASMIC DOMAIN; CHANNEL; PIP2; TRAFFICKING; PI(4,5)P-2	The small intestinal BB Na+/H+ antiporter NHE3 accounts for the majority of intestinal sodium and water absorption. It is highly regulated with both postprandial inhibition and stimulation sequentially occurring. Phosphatidylinositide 4,5-bisphosphate (PI(4,5)P-2) and phosphatidylinositide 3,4,5-trisphosphate (PI(3,4,5)P-3) binding is involved with regulation of multiple transporters. We tested the hypothesis that phosphoinositides bind NHE3 under basal conditions and are necessary for its acute regulation. His(6) proteins were made from the NHE3 C-terminal region divided into four parts as follows: F1 (amino acids 475-589), F2 (amino acids 590-667), F3 (amino acids 668-747), and F4 (amino acids 748-832) and purified by a nickel column. Mutations were made in the F1 region of NHE3 and cloned in pet30a and pcDNA3.1 vectors. PI(4,5)P-2 and PI(3,4,5)P-3 bound only to the NHE3 F1 fusion protein (amino acids 475-589) on liposomal pulldown assays. Mutations were made in the putative lipid binding region of the F1 domain and studied for alterations in lipid binding and Na+/H+ exchange as follows: Y501A/R503A/K505A; F509A/R511A/R512A; R511L/R512L; R520/FR527F; and R551L/R552L. Our results indicate the following. 1) The F1 domain of the NHE3 C terminus has phosphoinositide binding regions. 2) Mutations of these regions alter PI(4,5)P-2 and PI(3,4,5)P-3 binding and basal NHE3 activity. 3) The magnitude of serum stimulation of NHE3 correlates with PI(4,5)P-2 and PI(3,4,5)P-3 binding of NHE3. 4) Wortmannin inhibition of PI3K did not correlate with PI(4,5)P-2 or PI(3,4,5)P-3 binding of NHE3. Two functionally distinct phosphoinositide binding regions (Tyr501-Arg512 and Arg520-Arg552) are present in the NHE3 F1 domain; both regions are important for serum stimulation, but they display differences in phosphoinositide binding, and the latter but not the former alters NHE3 surface expression.	[Mohan, Sachin; Tse, Chung Ming; Sarker, Rafiquel; Cha, Boyoung; Zachos, Nicholas C.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Mohan, Sachin; Tse, Chung Ming; Sarker, Rafiquel; Cha, Boyoung; Zachos, Nicholas C.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Gabelli, Sandra B.; Fahie, Kamau; Nadella, Mythili; Amzel, L. Mario] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Tu-Sekine, Becky; Raben, Daniel] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Ross Res Bldg,720 Rutland Ave,Ross 925, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Gabelli, Sandra B/A-3705-2008; mohan, sachin/H-4017-2015; Zachos, Nicholas/GWC-7914-2022	Gabelli, Sandra B/0000-0003-1205-5204; Amzel, L. Mario/0000-0002-0129-9572; Mohan, Sachin/0000-0002-6798-4767	National Institutes of Health [R01-DK26523, R01-DK61765, PO1-DK72084, R24-DK64388]; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026523, K01DK080930, R24DK064388, P01DK072084, P30DK079637, R01DK061765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK26523, R01-DK61765, PO1-DK72084, and R24-DK64388 (the Hopkins Basic Research Digestive Diseases Development Core Center). This work was also supported by Hopkins Center for Epithelial Disorders.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Atkinson T, 2009, BIOCHEM BIOPH RES CO, V378, P394, DOI 10.1016/j.bbrc.2008.11.036; Cha B, 2003, J MEMBRANE BIOL, V191, P49, DOI 10.1007/s00232-002-1044-2; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Collins MO, 2009, SCIENCE, V325, P1635, DOI 10.1126/science.1180331; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Dynia DW, 2010, AM J PHYSIOL-RENAL, V298, pF745, DOI 10.1152/ajprenal.00182.2009; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gelman Marina S, 2003, Methods Mol Biol, V232, P27; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 2007, AM J PHYSIOL-RENAL, V293, pF1761, DOI 10.1152/ajprenal.00400.2007; Janecki AJ, 2000, J BIOL CHEM, V275, P8133, DOI 10.1074/jbc.275.11.8133; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2010, J BIOL CHEM, V285, P26652, DOI 10.1074/jbc.M110.130120; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	35	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34566	34578		10.1074/jbc.M110.165712	http://dx.doi.org/10.1074/jbc.M110.165712			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736165	Green Published, hybrid			2022-12-27	WOS:000283659100032
J	Stauber, T; Jentsch, TJ				Stauber, Tobias; Jentsch, Thomas J.			Sorting Motifs of the Endosomal/Lysosomal CLC Chloride Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PLASMA-MEMBRANE; ENDOSOMAL ACIDIFICATION; RENAL ENDOCYTOSIS; PROXIMAL TUBULE; CHANNEL; EXPRESSION; CELLS; DISEASE; PROTEIN	The CLC protein family contains plasma membrane chloride channels and the intracellular chloride-proton exchangers ClC-3-7. The latter proteins mainly reside on the various compartments of the endosomal-lysosomal system where they are involved in the luminal acidification or chloride accumulation. Although their partially overlapping subcellular distribution has been studied extensively, little is known about their targeting mechanism. In a comprehensive study we now performed pulldown experiments to systematically map the differential binding of adaptor proteins of the endosomal sorting machinery (adaptor proteins and GGAs (Golgi-localized, gamma-ear containing, Arf binding)) as well as clathrin to the cytosolic regions of the intracellular CLCs. The resulting interaction pattern fitted well to the known subcellular localizations of the CLCs. By mutating potential sorting motifs, we could locate almost all binding sites, including one already known for ClC-3 and several new motifs for ClC-5, -6, and -7. The impact of the identified binding sites on the subcellular localization of CLC transporters was determined by heterologous expression of mutants. Surprisingly, some vesicular CLCs retained their localization after disruption of interaction sites. However, ClC-7 could be partially shifted from lysosomes to the plasma membrane by combined mutation of N-terminal sorting motifs. The localization of its beta-subunit, Ostm1, was determined by that of ClC-7. Ostm1 was not capable of redirecting ClC-7 to lysosomes.	[Jentsch, Thomas J.] FMP MDC, Leibniz Inst Mol Pharmakol, D-13125 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jentsch, TJ (corresponding author), FMP MDC, Leibniz Inst Mol Pharmakol, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Stauber, Tobias/E-4005-2010	Stauber, Tobias/0000-0003-0727-6109; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich SFB 740, C5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within the Sonderforschungsbereich SFB 740 (project C5).	Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Cornejo I, 2009, J CELL PHYSIOL, V221, P650, DOI 10.1002/jcp.21900; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ESTE VEZR, 2001, NATURE */* T J NATUR, V414, P558; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; GU N, 2003, Arch, V445, P456; GU N, 1998, P Natl Acad Sci U S, V95, P8075; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Ignoul S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000474; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mohammad-Panah R, 2002, J BIOL CHEM, V277, P566, DOI 10.1074/jbc.M106968200; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; PEN AMU, 2005, J CELL SCI */* F V J, V118, P4243; Piccirillo R, 2006, J CELL SCI, V119, P2003, DOI 10.1242/jcs.02930; POE TM, 2006, P Natl Acad Sci U S, V103, P13854; Ponting CP, 1997, J MOL MED-JMM, V75, P160; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rickheit G, 2010, J BIOL CHEM, V285, P17595, DOI 10.1074/jbc.M110.115600; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Vandewalle A, 2001, AM J PHYSIOL-CELL PH, V280, pC373, DOI 10.1152/ajpcell.2001.280.2.C373; Wang YH, 2005, AM J PHYSIOL-RENAL, V289, pF850, DOI 10.1152/ajprenal.00011.2005; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Weylandt KH, 2007, MOL CANCER THER, V6, P979, DOI 10.1158/1535-7163.MCT-06-0475; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	53	56	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34537	34548		10.1074/jbc.M110.162545	http://dx.doi.org/10.1074/jbc.M110.162545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817731	Green Published, hybrid			2022-12-27	WOS:000283659100029
J	Nunn, CEM; Johnsen, U; Schonheit, P; Fuhrer, T; Sauer, U; Hough, DW; Danson, MJ				Nunn, Charlotte E. M.; Johnsen, Ulrike; Schoenheit, Peter; Fuhrer, Tobias; Sauer, Uwe; Hough, David W.; Danson, Michael J.			Metabolism of Pentose Sugars in the Hyperthermophilic Archaea Sulfolobus solfataricus and Sulfolobus acidocaldarius	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTNER-DOUDOROFF PATHWAY; 2-KETO-3-DEOXYGLUCONATE ALDOLASE; GLUCOSE-DEHYDROGENASE; SUBSTRATE PROMISCUITY; STRUCTURAL BASIS; GC-MS; BACTERIA; ENZYME; GENUS	We have previously shown that the hyperthermophilic archaeon, Sulfolobus solfataricus, catabolizes D-glucose and D-galactose to pyruvate and glyceraldehyde via a non-phosphorylative version of the Entner-Doudoroff pathway. At each step, one enzyme is active with both C6 epimers, leading to a metabolically promiscuous pathway. On further investigation, the catalytic promiscuity of the first enzyme in this pathway, glucose dehydrogenase, has been shown to extend to the C5 sugars, D-xylose and L-arabinose. In the current paper we establish that this promiscuity for C6 and C5 metabolites is also exhibited by the third enzyme in the pathway, 2-keto-3-deoxygluconate aldolase, but that the second step requires a specific C5-dehydratase, the gluconate dehydratase being active only with C6 metabolites. The products of this pathway for the catabolism of D-xylose and L-arabinose are pyruvate and glycolaldehyde, pyruvate entering the citric acid cycle after oxidative decarboxylation to acetyl-coenzyme A. We have identified and characterized the enzymes, both native and recombinant, that catalyze the conversion of glycolaldehyde to glycolate and then to glyoxylate, which can enter the citric acid cycle via the action of malate synthase. Evidence is also presented that similar enzymes for this pentose sugar pathway are present in Sulfolobus acidocaldarius, and metabolic tracer studies in this archaeon demonstrate its in vivo operation in parallel with a route involving no aldol cleavage of the 2-keto-3-deoxy-pentanoates but direct conversion to the citric acid cycle C5-metabolite, 2-oxoglutarate.	[Danson, Michael J.] Univ Bath, Ctr Extremophile Res, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Johnsen, Ulrike; Schoenheit, Peter] Univ Kiel, Inst Allgemeine Mikrobiol, D-24116 Kiel, Germany; [Fuhrer, Tobias; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Bath; University of Kiel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Danson, MJ (corresponding author), Univ Bath, Ctr Extremophile Res, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	m.j.danson@bath.ac.uk	Sauer, Uwe/Y-3556-2019; Fuhrer, Tobias/B-5667-2013	Fuhrer, Tobias/0000-0001-5006-6874	UK Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E020704/1] Funding Source: researchfish; BBSRC [BB/E020704/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a UK Biotechnology and Biological Sciences Research Council studentship.	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Danson MJ, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P260; Dauner M, 2000, BIOTECHNOL PROGR, V16, P642, DOI 10.1021/bp000058h; DEROSA M, 1984, BIOCHEM J, V224, P407, DOI 10.1042/bj2240407; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; Kardinahl S, 1999, EUR J BIOCHEM, V260, P540, DOI 10.1046/j.1432-1327.1999.00201.x; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Lamble HJ, 2005, FEBS LETT, V579, P6865, DOI 10.1016/j.febslet.2005.11.028; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; Lubelska JM, 2006, EXTREMOPHILES, V10, P383, DOI 10.1007/s00792-006-0510-7; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Potter JA, 2008, ACTA CRYSTALLOGR D, V64, P1283, DOI 10.1107/S0907444908036111; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; Uhrigshardt H, 2002, FEBS LETT, V513, P223, DOI 10.1016/S0014-5793(02)02317-7; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yoshikawa S, 2007, ACTA CRYSTALLOGR D, V63, P357, DOI 10.1107/S0907444906055442; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	28	61	62	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33701	33709		10.1074/jbc.M110.146332	http://dx.doi.org/10.1074/jbc.M110.146332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736170	Green Published, hybrid			2022-12-27	WOS:000283354000015
J	Gaiser, AM; Kretzschmar, A; Richter, K				Gaiser, Andreas M.; Kretzschmar, Anja; Richter, Klaus			Cdc37-Hsp90 Complexes Are Responsive to Nucleotide-induced Conformational Changes and Binding of Further Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP90; HEAT-SHOCK PROTEINS; ATPASE ACTIVITY; PROGESTERONE-RECEPTOR; CRYSTAL-STRUCTURE; COCHAPERONE AHA1; TERMINAL DOMAIN; CLIENT PROTEIN; CO-CHAPERONES; IN-VIVO	Hsp90 is an ATP-dependent molecular chaperone, which facilitates the activation and stabilization of hundreds of client proteins in cooperation with a defined set of cofactors. Many client proteins are protein kinases, which are activated and stabilized by Hsp90 in cooperation with the kinase-specific co-chaperone Cdc37. Other Hsp90 co-chaperones, like the ATPase activator Aha1, also are implicated in kinase activation, and it is not yet clear how Cdc37 is integrated into Hsp90 co-chaperone complexes. Here, we studied the interaction between Cdc37, Hsp90, and other Hsp90 co-chaperones from the nematode Caenorhabditis elegans. Nematode Cdc37 binds with high affinity to Hsp90 and strongly inhibits the ATPase activity. In contrast to the human Hsp90 system, we observed binding of Cdc37 to open and closed Hsp90 conformations, potentially reflecting two different binding modes. Using a novel ultracentrifugation setup, which allows accurate analysis of multifactorial protein complexes, we show that cooperative and competitive interactions exist between other co-chaperones and Cdc37-Hsp90 complexes in the C. elegans system. We observed strong competitive interactions between Cdc37 and the co-chaperones p23 and Sti1, whereas the binding of the phosphatase Pph5 and the ATPase activator Aha1 to Cdc37-Hsp90 complexes is possible. The ternary Aha1-Cdc37Hsp90 complex is disrupted by the nucleotide-induced closing reaction at the N terminus of Hsp90. This implies a carefully regulated exchange process of cofactors during the chaperoning of kinase clients by Hsp90.	Ctr Integrated Prot Sci Munchen, D-85747 Garching, Germany; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Technical University of Munich	Richter, K (corresponding author), Lichtenbergstr 4, D-85747 Garching, Germany.	klaus.richter@ch.tum.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642	Deutsche Forschungsgemeinschaft [RI1873/1-1]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant RI1873/1-1 (to K. R.) and a grant from the Fonds der Chemischen Industrie (to K. R.).	Abbas-Terki T, 2002, BIOL CHEM, V383, P1335, DOI 10.1515/BC.2002.152; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; HARTSON SD, 1994, BIOCHEMISTRY-US, V33, P8912, DOI 10.1021/bi00196a008; Hayes DB, 2010, MACROMOL BIOSCI, V10, P731, DOI 10.1002/mabi.201000075; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Johnson JL, 2009, CELL STRESS CHAPERON, V14, P83, DOI 10.1007/s12192-008-0058-9; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Leskovar A, 2008, J BIOL CHEM, V283, P11677, DOI 10.1074/jbc.M709516200; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pashtan I, 2008, CELL CYCLE, V7, P2936, DOI 10.4161/cc.7.18.6701; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 1999, CELL SIGNAL, V11, P839, DOI 10.1016/S0898-6568(99)00064-9; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; SMITH DF, 1992, J STEROID BIOCHEM, V41, P201, DOI 10.1016/0960-0760(92)90345-J; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	63	31	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40921	40932		10.1074/jbc.M110.131086	http://dx.doi.org/10.1074/jbc.M110.131086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20880838	Green Published, hybrid			2022-12-27	WOS:000285414400056
J	Tran, K; Gralla, JD				Tran, Khiem; Gralla, Jay D.			The TFIIB Tip Domain Couples Transcription Initiation to Events Involved in RNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START SITE SELECTION; CARBOXYL-TERMINAL DOMAIN; POLYMERASE-II; PROMOTER ESCAPE; HYDROGEN-PEROXIDE; STRUCTURAL BASIS; GENE-EXPRESSION; CAPPING ENZYME; ACTIVE-CENTER; IN-VITRO	TFIIB is the only factor within the multimegadalton transcription complex that is obligatorily required to undergo dissociation and re-association with each round of mRNA transcription. Here we show that a six-amino acid human TFIIB tip region is needed for appropriate levels of serine 5 C-terminal domain phosphorylation and mRNA capping and for retention of the required elongation factor TFIIF. We suggest that the broad functions of this tiny region are used to suppress transcription noise by restricting functional RNA synthesis from non-promoter sites on the genome, which will not contain TFIIB.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gralla, JD (corresponding author), 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	gralla@chem.ucla.edu			National Institutes of Health [GM49048]; UCLA Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM49048. This work was also supported by a grant from the UCLA Academic Senate.	Ahn SH, 2009, EMBO J, V28, P205, DOI 10.1038/emboj.2008.280; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CHAFIN DR, 1991, J BIOL CHEM, V266, P9256; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; CHANDLER DW, 1981, NUCLEIC ACIDS RES, V9, P6031, DOI 10.1093/nar/9.22.6031; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; CHI TH, 1995, NATURE, V377, P254, DOI 10.1038/377254a0; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Choi WS, 2004, J MOL BIOL, V340, P981, DOI 10.1016/j.jmb.2004.04.075; Choi WS, 2002, J MOL BIOL, V319, P1005, DOI 10.1016/S0022-2836(02)00329-7; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Eissenberg JC, 2007, MOL GENET GENOMICS, V277, P101, DOI 10.1007/s00438-006-0164-2; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; Kobor MS, 2000, MOL CELL BIOL, V20, P7438, DOI 10.1128/MCB.20.20.7438-7449.2000; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Mutoh N, 2005, J BIOCHEM, V138, P797, DOI 10.1093/jb/mvi179; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Szekvolgyi L, 2007, P NATL ACAD SCI USA, V104, P14964, DOI 10.1073/pnas.0702269104; Thompson NE, 2009, J BIOL CHEM, V284, P24754, DOI 10.1074/jbc.M109.030486; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Yan Q, 1999, J BIOL CHEM, V274, P35668, DOI 10.1074/jbc.274.50.35668; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhou MS, 2003, P NATL ACAD SCI USA, V100, P12666, DOI 10.1073/pnas.1835726100	55	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39580	39587		10.1074/jbc.M110.171850	http://dx.doi.org/10.1074/jbc.M110.171850			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20880846	Green Published, hybrid			2022-12-27	WOS:000285185500002
J	Wang, HC; Robinson, H; Ke, HM				Wang, Huanchen; Robinson, Howard; Ke, Hengming			Conformation Changes, N-terminal Involvement, and cGMP Signal Relay in the Phosphodiesterase-5 GAF Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; REGULATORY DOMAIN; CRYSTAL-STRUCTURE; A DOMAIN; BINDING; DIMERIZATION; LIGAND; 2A; PHOSPHORYLATION; DETERMINANTS	The activity of phosphodiesterase-5 (PDE5) is specific for cGMP and is regulated by cGMP binding to GAF-A in its regulatory domain. To better understand the regulatory mechanism, x-ray crystallographic and biochemical studies were performed on constructs of human PDE5A1 containing the N-terminal phosphorylation segment, GAF-A, and GAF-B. Superposition of this unliganded GAF-A with the previously reported NMR structure of cGMP-bound PDE5 revealed dramatic conformational differences and suggested that helix H4 and strand B3 probably serve as two lids to gate the cGMP-binding pocket in GAF-A. The structure also identified an interfacial region among GAF-A, GAF-B, and the N-terminal loop, which may serve as a relay of the cGMP signal from GAF-A to GAF-B. N-terminal loop 98-147 was physically associated with GAF-B domains of the dimer. Biochemical analyses showed an inhibitory effect of this loop on cGMP binding and its involvement in the cGMP-induced conformation changes.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Brookhaven National Laboratory		hke@med.unc.edu	, PEP-MX Core/AGV-4051-2022	Wang, Huanchen/0000-0003-2701-7155	National Institutes of Health [GM59791]; Office of Biological and Environmental Research; Office of Basic Energy Sciences, United States Department of Energy; National Center for Research Resources, National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM59791 (to H.K.). This work was also supported by the Office of Biological and Environmental Research and the Office of Basic Energy Sciences, United States Department of Energy, and by the National Center for Research Resources, National Institutes of Health (to H.R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blokland A, 2006, CURR PHARM DESIGN, V12, P2511, DOI 10.2174/138161206777698855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Corbin JD, 2009, CELL SIGNAL, V21, P1768, DOI 10.1016/j.cellsig.2009.07.012; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gross-Langenhoff M, 2008, FEBS J, V275, P1643, DOI 10.1111/j.1742-4658.2008.06319.x; Handa N, 2008, J BIOL CHEM, V283, P19657, DOI 10.1074/jbc.M800595200; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Hofbauer K, 2008, J BIOL CHEM, V283, P25164, DOI 10.1074/jbc.M800230200; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Liu L, 2002, CELL SIGNAL, V14, P45, DOI 10.1016/S0898-6568(01)00216-9; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Schultz Joachim E., 2009, V191, P93, DOI 10.1007/978-3-540-68964-5_6; Turko IV, 1998, BIOCHEM J, V329, P505; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	35	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38149	38156		10.1074/jbc.M110.141614	http://dx.doi.org/10.1074/jbc.M110.141614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20861010	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000284625600022
J	Diani-Moore, S; Ram, P; Li, XT; Mondal, P; Youn, DY; Sauve, AA; Rifkind, AB				Diani-Moore, Silvia; Ram, Payal; Li, Xintian; Mondal, Prosenjit; Youn, Dou Yeon; Sauve, Anthony A.; Rifkind, Arleen B.			Identification of the Aryl Hydrocarbon Receptor Target Gene TiPARP as a Mediator of Suppression of Hepatic Gluconeogenesis by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and of Nicotinamide as a Corrective Agent for This Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; MAMMALIAN-CELLS; ACUTE TOXICITY; TCDD; METABOLISM; ACTIVATION; EXPRESSION; ENZYMES; ALPHA; PGC-1	The environmental toxin TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, dioxin) produces diverse toxic effects including a lethal wasting syndrome whose hallmark is suppressed hepatic gluconeogenesis. All TCDD toxicities require activation of the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor. Whereas the mechanism for AHR induction of target genes is well understood, it is not known how AHR activation produces any TCDD toxicity. This report identifies for the first time an AHR target gene, TiPARP (TCDD-inducible poly(ADPribose) polymerase, PARP7) that can mediate a TCDD toxicity, i.e. suppression of hepatic gluconeogenesis. TCDD suppressed hepatic glucose production, expression of key gluconeogenic genes, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6Pase), and NAD(+) levels, and increased PARP activity and TiPARP expression. TCDD also increased acetylation and ubiquitin-dependent proteosomal degradation of the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1 alpha), a coactivator of PEPCK and G6Pase transcription. TiPARP overexpression reproduced TCDD effects on glucose output and NAD(+) levels whereas TiPARP silencing diminished them. TiPARP overexpression also increased PGC1 alpha acetylation and decreased PGC1 alpha levels. In contrast, silencing of cytochromes P450 (CYP) 1A, main AHR-induced genes, did not alter TCDD suppression of gluconeogenesis. The vitamin B3 constituent, nicotinamide (NAM), prevented TCDD suppression of glucose output, NAD(+), and gluconeogenic genes and stabilized PGC1 alpha. The corrective effects of NAM could be attributed to increased NAD(+) levels and suppression of AHR target gene induction. The results reveal that TiPARP can mediate a TCDD effect, that the AHR is linked to PGC1 alpha function and stability and that NAM has novel AHR antagonist activity.	[Diani-Moore, Silvia; Ram, Payal; Li, Xintian; Mondal, Prosenjit; Youn, Dou Yeon; Sauve, Anthony A.; Rifkind, Arleen B.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University	Rifkind, AB (corresponding author), 1300 York Ave, New York, NY 10065 USA.	arifkind@med.cornell.edu	Li, Xintian/HGA-0346-2022	MONDAL, PROSENJIT/0000-0001-8566-249X	National Institutes of Health [R01-ES03606, T32-CA062948, R01-DK73466]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01-ES03606 (to A.B.R.), T32-CA062948 (to S.D.-M.), R01-DK73466 (to A.A.S.), a gift from the Winston Foundation (to A.B.R.), and a New Scholar in Aging Award from the Ellison Medical Foundation (to A.A.S.).	Aoyagi S, 2008, MOL CELL BIOL, V28, P30, DOI 10.1128/MCB.01158-07; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; CANGA L, 1993, MOL PHARMACOL, V44, P1142; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Dolle C, 2009, ANAL BIOCHEM, V385, P377, DOI 10.1016/j.ab.2008.10.033; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; FAN F, 1994, ARCH TOXICOL, V69, P73, DOI 10.1007/s002040050140; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gilday D, 1996, J BIOL CHEM, V271, P33054, DOI 10.1074/jbc.271.51.33054; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; HSIA MTS, 1985, TOXICOL LETT, V25, P247, DOI 10.1016/0378-4274(85)90204-8; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Kitamura N, 2006, J BIOCHEM MOL TOXIC, V20, P151, DOI 10.1002/jbt.20131; Lee JS, 2009, TOXICOL APPL PHARM, V234, P1, DOI 10.1016/j.taap.2008.09.007; LENTNEK M, 1991, BIOCHEM BIOPH RES CO, V174, P1267, DOI 10.1016/0006-291X(91)91558-T; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin PH, 2007, TOXICOL LETT, V172, P146, DOI 10.1016/j.toxlet.2007.06.003; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Q, 2002, ARCH BIOCHEM BIOPHYS, V404, P309, DOI 10.1016/S0003-9861(02)00339-9; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; Morral N, 2002, HUM GENE THER, V13, P1561, DOI 10.1089/10430340260201653; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rifkind AB, 2006, DRUG METAB REV, V38, P291, DOI 10.1080/03602530600570107; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Stahl B U, 1992, Arch Toxicol Suppl, V15, P151; STAHL BU, 1993, TOXICOLOGY, V79, P81, DOI 10.1016/0300-483X(93)90207-9; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; WEBER LWD, 1991, TOXICOLOGY, V66, P133, DOI 10.1016/0300-483X(91)90214-L; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	46	83	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38801	38810		10.1074/jbc.M110.131573	http://dx.doi.org/10.1074/jbc.M110.131573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20876576	Green Published, hybrid			2022-12-27	WOS:000284941300009
J	Pagant, S; Halliday, JJ; Kougentakis, C; Miller, EA				Pagant, Silvere; Halliday, John J.; Kougentakis, Christos; Miller, Elizabeth A.			Intragenic Suppressing Mutations Correct the Folding and Intracellular Traffic of Misfolded Mutants of Yor1p, a Eukaryotic Drug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; DISEASE-ASSOCIATED MUTATIONS; MULTIDRUG ABC TRANSPORTER; CHLORIDE CHANNEL ACTIVITY; CYSTIC-FIBROSIS; P-GLYCOPROTEIN; ATP-BINDING; TRANSMEMBRANE SEGMENTS; PROMOTE MATURATION; CYTOPLASMIC LOOP	ATP-binding cassette (ABC) transporters play pivotal physiological roles in substrate transport across membranes, and defective assembly of these proteins can cause severe disease associated with improper drug or ion flux. The yeast protein Yor1p is a useful model to study the biogenesis of ABC transporters; deletion of a phenylalanine residue in the first nucleotide-binding domain (NBD1) causes misassembly and retention in the endoplasmic reticulum (ER) of the resulting protein Yor1p-Delta F670, similar to the predominant disease-causing allele in humans, CFTR-Delta F508. Here we describe two novel Yor1p mutants, G278R and I1084P, which fail to assemble and traffic similar to Yor1p-Delta F670. These mutations are located in the two intracellular loops (ICLs) that interface directly with NBD1, and thus disrupt a functionally important structural module. We isolated 2 second-site mutations, F270S and R1168M, which partially correct the folding injuries associated with the G278R, I1084P, and Delta F670 mutants and reinstate their trafficking. The position of both corrective mutations at the cytoplasmic face of a transmembrane helix suggests that they restore biogenesis by influencing the behavior of the transmembrane domains rather than by direct restoration of the ICL1-ICL4-NBD1 structural module. Given the conserved topology of many ABC transporters, our findings provide new understanding of functionally important inter-domain interactions and suggest new potential avenues for correcting folding defects caused by abrogation of those domain interfaces.	[Pagant, Silvere; Halliday, John J.; Kougentakis, Christos; Miller, Elizabeth A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Miller, EA (corresponding author), 617A Fairchild Ctr, MC 2264, New York, NY 10027 USA.	em2282@columbia.edu		Miller, Elizabeth/0000-0002-1033-8369	National Institutes of Health [GM078186]; Cystic Fibrosis Foundation [PAGANT08F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078186 (to E. A. M.) and Cystic Fibrosis Foundation Grant PAGANT08F0 (to S. P.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Graf GA, 2004, J BIOL CHEM, V279, P24881, DOI 10.1074/jbc.M402634200; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	40	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36304	36314		10.1074/jbc.M110.142760	http://dx.doi.org/10.1074/jbc.M110.142760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837481	Green Published, hybrid			2022-12-27	WOS:000284146100043
J	Germain, C; Bihl, F; Zahn, S; Poupon, G; Dumaurier, MJ; Rampanarivo, HH; Padkjaer, SB; Spee, P; Braud, VM				Germain, Claire; Bihl, Franck; Zahn, Stefan; Poupon, Gwenola; Dumaurier, Marie-Jeanne; Rampanarivo, Hariniaina Henintsoa; Padkjaer, Soren Berg; Spee, Pieter; Braud, Veronique M.			Characterization of Alternatively Spliced Transcript Variants of CLEC2D Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NKR-P1A; CUTTING EDGE; LIGAND; RECOGNITION; CELLS; ACTIVATION; EXPRESSION; RECEPTORS; FAMILY	Lectin-like transcript 1 (LLT1) encoded by CLEC2D gene is a C-type lectin-like molecule interacting with human CD161 (NKR-P1A) receptor expressed by natural killer cells and subsets of T cells. Using RT-PCR and sequencing, we identified several CLEC2D alternatively spliced transcript variants generated by exon skipping. In addition to the reported transcript variants 1 (LLT1) and 2, we identified a novel splice variant 4 and transcripts coding for putative soluble proteins. CLEC2D transcripts were detected primarily in hematopoietic cell lines and were found to be co-induced by the same activation signals. Although very low amounts of putative soluble CLEC2D protein isoforms could be produced by transfectants, CLEC2D isoforms 2 and 4 were efficiently expressed. By contrast to LLT1, which was detected on the cell surface, isoform 2 and 4 remained in the endoplasmic reticulum where they formed homodimers or heterodimers with LLT1. They failed to interact with CD161, leaving LLT1 as the sole ligand for this receptor. CLEC2D therefore uses gene splicing to generate protein isoforms that are structurally distinct and that have different biological activities.	[Rampanarivo, Hariniaina Henintsoa; Braud, Veronique M.] UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France; [Zahn, Stefan; Padkjaer, Soren Berg; Spee, Pieter] Novo Nordisk AS, Translat Immunol Dept, DK-2760 Malov, Denmark; [Zahn, Stefan; Padkjaer, Soren Berg; Spee, Pieter] Novo Nordisk AS, Prot Struture & Biophys Dept, DK-2760 Malov, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Novo Nordisk; Novo Nordisk	Braud, VM (corresponding author), UNSA, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	braud@ipmc.cnrs.fr	braud, veronique M/I-4597-2013; POUPON, Gwénola/M-4632-2016	braud, veronique M/0000-0001-8213-3947; POUPON, Gwénola/0000-0001-5772-2539; BIHL, Franck/0000-0002-8808-8152	Novo Nordisk S/A; Agence Nationale de Recherches sur le SIDA; Ensemble contre le SIDA	Novo Nordisk S/A; Agence Nationale de Recherches sur le SIDA(ANRSFrench National Research Agency (ANR)); Ensemble contre le SIDA	This work was supported by grants from Novo Nordisk S/A, Agence Nationale de Recherches sur le SIDA, and Ensemble contre le SIDA.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Atamas SP, 1996, J IMMUNOL, V156, P435; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Boles KS, 1999, IMMUNOGENETICS, V50, P1, DOI 10.1007/s002510050679; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Huarte E, 2008, BLOOD, V112, P1259, DOI 10.1182/blood-2007-12-130773; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; KOLENKO P, 2009, COMMUN, V65, P1258; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li YL, 2009, IMMUNITY, V31, P35, DOI 10.1016/j.immuni.2009.04.019; Natarajan K, 2000, BIOCHEMISTRY-US, V39, P14779, DOI 10.1021/bi0018180; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Roth P, 2007, CANCER RES, V67, P3540, DOI 10.1158/0008-5472.CAN-06-4783; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Spreu J, 2007, IMMUNOGENETICS, V59, P903, DOI 10.1007/s00251-007-0263-1; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; Tsytsikov VN, 1996, J BIOL CHEM, V271, P23055, DOI 10.1074/jbc.271.38.23055; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402	29	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36207	36215		10.1074/jbc.M110.179622	http://dx.doi.org/10.1074/jbc.M110.179622			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843815	Green Published, hybrid			2022-12-27	WOS:000283845300096
J	Kim, SM; Acharya, P; Engel, JC; Correia, MA				Kim, Sung-Mi; Acharya, Poulomi; Engel, Juan C.; Correia, Maria Almira			Liver Cytochrome P450 3A Ubiquitination in Vivo by gp78/Autocrine Motility Factor Receptor and C Terminus of Hsp70-interacting Protein (CHIP) E3 Ubiquitin Ligases PHYSIOLOGICAL AND PHARMACOLOGICAL RELEVANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; NITRIC-OXIDE SYNTHASE; ER-ASSOCIATED DEGRADATION; HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; RAT HEPATOCYTES; QUALITY-CONTROL; PROTEASOMAL DEGRADATION; TRIAGE DECISIONS	CYP3A4 is a dominant human liver cytochrome P450 enzyme engaged in the metabolism and disposition of >50% of clinically relevant drugs and held responsible for many adverse drug-drug interactions. CYP3A4 and its mammalian liver CYP3A orthologs are endoplasmic reticulum (ER)-anchored monotopic proteins that undergo ubiquitin (Ub)-dependent proteasomal degradation (UPD) in an ER-associated degradation (ERAD) process. These integral ER proteins are ubiquitinated in vivo, and in vitro studies have identified the ER-integral gp78 and the cytosolic co-chaperone, CHIP (C terminus of Hsp70-interacting protein), as the relevant E3 Ub-ligases, along with their cognate E2 Ub-conjugating enzymes UBC7 and UbcH5a, respectively. Using lentiviral shRNA templates targeted against each of these Ub-ligases, we now document that both E3s are indeed physiologically involved in CYP3A ERAD/UPD in cultured rat hepatocytes. Accordingly, specific RNAi resulted in approximate to 80% knockdown of each hepatic Ub-ligase, with a corresponding approximate to 2.5-fold CYP3A stabilization. Surprisingly, however, such stabilization resulted in increased levels of functionally active CYP3A, thereby challenging the previous notion that E3 recognition and subsequent ERAD of CYP3A proteins required ab initio their structural and/or functional inactivation. Furthermore, coexpression in HepG2 cells of both CYP3A4 and gp78, but not its functionally inactive RING-finger mutant, resulted in enhanced CYP3A4 loss greater than that in corresponding cells expressing only CYP3A4. Stabilization of a functionally active CYP3A after RNAi knockdown of either of the E3s, coupled with the increased CYP3A4 loss on gp78 or CHIP coexpression, suggests that ERAD-associated E3 Ub-ligases can influence clinically relevant drug metabolism by effectively regulating the physiological CYP3A content and consequently its function.	[Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Kim, Sung-Mi; Acharya, Poulomi; Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Engel, Juan C.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Box 2280,600 16th St, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu			National Institutes of Health [GM44037, DK26506]; National Institute of Digestive Diseases and Kidney Center [P30DK26743]; US Congress; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK026506, P30DK026743, R01DK026506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Digestive Diseases and Kidney Center; US Congress; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44037 and DK26506 and the UCSF Liver Center Core on Cell and Tissue Biology funded by the National Institute of Digestive Diseases and Kidney Center Grant P30DK26743. These studies were presented orally at the 2010 International Symposium on Microsomes and Drug Oxidations, Beijing, China (May 18, 2010) and in poster form at the 2010 FASEB Summer Research Conference on Ubiquitin and Cellular Regulation, Saxtons River, VT (June 16, 2010).; We are grateful to Chris Her, University of California San Francisco (UCSF) Liver Center Cell and Tissue Biology Core Facility (Dr. J. J. Maher, Director) for hepatocyte isolation. We gratefully acknowledge the US Congress for the NIGMS-ARRA funding, without which this work would not have been possible. We thank Drs. A. M. Weissman (National Institutes of Health, NCI, Frederick, MD), Cam Patterson (University of North Carolina, Chapel Hill), and R. A. DeBose-Boyd (University of Texas Southwestern Medical Center, Dallas) for generously providing some of the plasmids used in these studies. We also thank Dr. Alex Y. So (Keith Yamamoto laboratory, UCSF) for generous advice and training in the use of lentiviral shRNAi technology, Dr. Michelle Flanniken (Raul Andino laboratory, UCSF) for technical advice, and Dr. Allan M. Weissman for valuable discussions.	Acharya P, 2009, DRUG METAB REV, V41, P53; Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Acharya P, 2009, MOL PHARMACOL, V76, P503, DOI 10.1124/mol.109.056002; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chiu CG, 2008, EXPERT REV ANTICANC, V8, P207, DOI 10.1586/14737140.8.2.207; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Correia MA, 2003, DRUG METAB REV, V35, P107, DOI 10.1081/DMR-120023683; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Denisov IG, 2007, J BIOL CHEM, V282, P26865, DOI 10.1074/jbc.M704747200; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Han XM, 2005, J PHARMACOL EXP THER, V314, P128, DOI 10.1124/jpet.105.084699; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Joshi B, 2010, J BIOL CHEM, V285, P8830, DOI 10.1074/jbc.M109.074344; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lecluyse E, 1999, DRUG METAB DISPOS, V27, P909; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Liao MX, 2005, MOL PHARMACOL, V67, P1460, DOI 10.1124/mol.104.009654; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murray BP, 2002, MOL PHARMACOL, V61, P1146, DOI 10.1124/mol.61.5.1146; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Roberts BJ, 1997, J BIOL CHEM, V272, P9771; Shmueli A, 2009, BIOCHEM BIOPH RES CO, V390, P758, DOI 10.1016/j.bbrc.2009.10.045; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhang CH, 2005, AM J PHYSIOL-HEART C, V288, pH2154, DOI 10.1152/ajpheart.00987.2004; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhukov A, 1999, BIOCHEM J, V340, P453, DOI 10.1042/0264-6021:3400453	78	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35866	35877		10.1074/jbc.M110.167189	http://dx.doi.org/10.1074/jbc.M110.167189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20819951	Green Published, hybrid			2022-12-27	WOS:000283845300064
J	Liebl, J; Weitensteiner, SB; Vereb, G; Takacs, L; Furst, R; Vollmar, AM; Zahler, S				Liebl, Johanna; Weitensteiner, Sabine B.; Vereb, Gyoergy; Takacs, Lili; Fuerst, Robert; Vollmar, Angelika M.; Zahler, Stefan			Cyclin-dependent Kinase 5 Regulates Endothelial Cell Migration and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ACTIN POLYMERIZATION; NEURONAL MIGRATION; RAC1 ACTIVITY; RHO-GTPASES; CDK5; PHOSPHORYLATION; CANCER; ROSCOVITINE; METASTASIS	Angiogenesis contributes to various pathological conditions. Due to the resistance against existing antiangiogenic therapy, an urgent need exists to understand the molecular basis of vessel growth and to identify new targets for antiangiogenic therapy. Here we show that cyclin-dependent kinase 5 (Cdk5), an important modulator of neuronal processes, regulates endothelial cell migration and angiogenesis, suggesting Cdk5 as a novel target for antiangiogenic therapy. Inhibition or knockdown of Cdk5 reduces endothelial cell motility and blocks angiogenesis in vitro and in vivo. We elucidate a specific signaling of Cdk5 in the endothelium; in contrast to neuronal cells, the motile defects upon inhibition of Cdk5 are not caused by an impaired function of focal adhesions or microtubules but by the reduced formation of lamellipodia. Inhibition or down-regulation of Cdk5 decreases the activity of the small GTPase Rac1 and results in a disorganized actin cytoskeleton. Constitutive active Rac1 compensates for the inhibiting effects of Cdk5 knockdown on migration, suggesting that Cdk5 exerts its effects in endothelial cell migration via Rac1. Our work elucidates Cdk5 as a pivotal new regulator of endothelial cell migration and angiogenesis. It suggests Cdk5 as a novel, pharmacologically accessible target for antiangiogenic therapy and provides the basis for a new therapeutic application of Cdk5 inhibitors as antiangiogenic agents.	[Zahler, Stefan] Univ Munich, Ctr Drug Res, D-81377 Munich, Germany; [Takacs, Lili] Univ Debrecen, Dept Ophthalmol, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; [Vereb, Gyoergy] Univ Debrecen, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary	University of Munich; University of Debrecen; University of Debrecen	Zahler, S (corresponding author), Univ Munich, Ctr Drug Res, Butenandtstr 5-13, D-81377 Munich, Germany.	stefan.zahler@cup.uni-muenchen.de	Takács, Lili/L-6660-2014; Fuerst, Robert/B-5815-2011; Vereb, György/A-4241-2008	Takács, Lili/0000-0003-1641-0154; Vereb, György/0000-0003-2157-3265; Furst, Robert/0000-0002-9926-7578; Zahler, Stefan/0000-0002-5140-7287				Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Causeret F, 2007, MOL BIOL CELL, V18, P4327, DOI 10.1091/mbc.E07-04-0372; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Goodyear S, 2007, EXP MOL PATHOL, V82, P25, DOI 10.1016/j.yexmp.2006.09.002; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Koltermann A, 2007, CELL MOL LIFE SCI, V64, P1715, DOI 10.1007/s00018-007-7085-z; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Maggiorella L, 2009, CELL PROLIFERAT, V42, P38, DOI 10.1111/j.1365-2184.2008.00570.x; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mitsios N, 2007, BRAIN PATHOL, V17, P11, DOI 10.1111/j.1750-3639.2006.00031.x; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; NIH, 2010, GUIDE CARE USE LAB A, V8th, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sandal T, 2002, J BIOL CHEM, V277, P20783, DOI 10.1074/jbc.M112248200; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Slevin M, 2009, CURR OPIN PHARMACOL, V9, P119, DOI 10.1016/j.coph.2008.10.003; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Tripathi BK, 2009, MOL CELL BIOL, V29, P6488, DOI 10.1128/MCB.01098-09; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xin X, 2008, J CELL SCI, V121, P2601, DOI 10.1242/jcs.016089; Xin XN, 2004, J CELL SCI, V117, P4739, DOI 10.1242/jcs.01333; Yang HS, 2006, CANCER RES, V66, P2708, DOI 10.1158/0008-5472.CAN-05-3141; Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031	47	81	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35932	35943		10.1074/jbc.M110.126177	http://dx.doi.org/10.1074/jbc.M110.126177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826806	hybrid, Green Published			2022-12-27	WOS:000283845300070
J	Litzinger, S; Fischer, S; Polzer, P; Diederichs, K; Welte, W; Mayer, C				Litzinger, Silke; Fischer, Stefanie; Polzer, Patrick; Diederichs, Kay; Welte, Wolfram; Mayer, Christoph			Structural and Kinetic Analysis of Bacillus subtilis N-Acetylglucosaminidase Reveals a Unique Asp-His Dyad Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-3 BETA-GLUCOSIDASE; ACETYLMURAMIC ACID; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; GENERAL ACID/BASE; CATALYTIC DYAD; WILD-TYPE; IDENTIFICATION; PROTEIN; NUCLEOPHILE	Three-dimensional structures of NagZ of Bacillus subtilis, the first structures of a two-domain beta-N-acetylglucosaminidase of family 3 of glycosidases, were determined with and without the transition state mimicking inhibitor PUGNAc bound to the active site, at 1.84- and 1.40-angstrom resolution, respectively. The structures together with kinetic analyses of mutants revealed an Asp-His dyad involved in catalysis: His(234) of BsNagZ acts as general acid/base catalyst and is hydrogen bonded by Asp(232) for proper function. Replacement of both His234 and Asp(232) with glycine reduced the rate of hydrolysis of the fluorogenic substrate 4'-methylumbelliferyl N-acetyl-beta-D-glucosaminide 1900- and 4500-fold, respectively, and rendered activity pH-independent in the alkaline range consistent with a role of these residues in acid/base catalysis. N-Acetylglucosaminyl enzyme intermediate accumulated in the H234G mutant and beta-azide product was formed in the presence of sodium azide in both mutants. The Asp-His dyad is conserved within beta-N-acetylglucosaminidases but otherwise absent in beta-glycosidases of family 3, which instead carry a "classical" glutamate acid/base catalyst. The acid/base glutamate of Hordeum vulgare exoglucanase (Exo1) superimposes with His234 of the dyad of BsNagZ and, in contrast to the latter, protrudes from a second domain of the enzyme into the active site. This is the first report of an Asp-His catalytic dyad involved in hydrolysis of glycosides resembling in function the Asp-His-Ser triad of serine proteases. Our findings will facilitate the development of mechanism-based inhibitors that selectively target family 3 beta-N-acetylglucosaminidases, which are involved in bacterial cell wall turnover, spore germination, and induction of beta-lactamase.	[Litzinger, Silke; Mayer, Christoph] Univ Konstanz, Dept Mol Microbiol, D-78457 Constance, Germany; [Fischer, Stefanie; Diederichs, Kay; Welte, Wolfram] Univ Konstanz, Dept Biophys, Fachbereich Biol, D-78457 Constance, Germany; [Polzer, Patrick] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	University of Konstanz; University of Konstanz; Max Planck Society	Mayer, C (corresponding author), Univ Str 10, D-78457 Constance, Germany.	ch.mayer@uni-konstanz.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851	Deutsche Forschungsgemeinschaft [MA2436/4, MA2436/3]; Federal Government of Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Government of Germany	This work was supported in part by Grant MA2436/4 and a Heisenberg stipend (MA2436/3) from the Deutsche Forschungsgemeinschaft (to C. M.).; Supported by a fellowship of the federal government of Germany (Landesgraduiertenfordergesetz stipend).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ash EL, 1997, SCIENCE, V278, P1128, DOI 10.1126/science.278.5340.1128; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Chan PHW, 2009, BIOCHEMISTRY-US, V48, P11220, DOI 10.1021/bi901606n; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; Chir J, 2002, BIOCHEM J, V365, P857, DOI 10.1042/BJ20020186; Cournoyer B, 2003, J MOL MICROB BIOTECH, V5, P190, DOI 10.1159/000070269; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANK HS, 1957, DISCUSS FARADAY SOC, P133, DOI 10.1039/df9572400133; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; Jaeger T, 2008, CELL MOL LIFE SCI, V65, P928, DOI 10.1007/s00018-007-7399-x; Jaeger T, 2005, J BIOL CHEM, V280, P30100, DOI 10.1074/jbc.M502208200; Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Legler PM, 2002, BIOCHEMISTRY-US, V41, P10834, DOI 10.1021/bi020362e; Li H, 2006, BIOSCI BIOTECH BIOCH, V70, P1127, DOI 10.1271/bbb.70.1127; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.3.CO;2-T; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Paal K, 2004, BIOCHEM J, V378, P141, DOI 10.1042/BJ20031028; PHILLIPS DC, 1967, P NATL ACAD SCI USA, V57, P484; Quirk DJ, 1999, BIOPHYS J, V76, P1571, DOI 10.1016/S0006-3495(99)77316-9; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Schultz LW, 1998, BIOCHEMISTRY-US, V37, P8886, DOI 10.1021/bi972766q; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Stubbs KA, 2007, J BIOL CHEM, V282, P21382, DOI 10.1074/jbc.M700084200; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Uehara T, 2006, J BACTERIOL, V188, P1660, DOI 10.1128/JB.188.4.1660-1662.2006; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Whiteson KL, 2007, CHEM BIOL, V14, P121, DOI 10.1016/j.chembiol.2007.01.011; WOLFENDEN R, 1976, ANNU REV BIOPHYS BIO, V5, P271, DOI 10.1146/annurev.bb.05.060176.001415; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	54	89	94	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35675	35684		10.1074/jbc.M110.131037	http://dx.doi.org/10.1074/jbc.M110.131037			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826810	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000283845300046
J	Zhou, HY; Salih, E; Glimcher, MJ				Zhou, Hai-Yan; Salih, Erdjan; Glimcher, Melvin J.			The Isolation and Characterization of Glycosylated Phosphoproteins from Herring Fish Bones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; MATRIX PROTEINS; CRYSTAL-FORMATION; COLLAGEN FIBRILS; RAT OSTEOCLASTS; OSTEOPONTIN; SIALOPROTEIN; PHOSPHORYLATION; HYDROXYAPATITE; RESORPTION	Past studies of bone extracellular matrix phosphoproteins such as osteopontin and bone sialoprotein have yielded important biological information regarding their role in calcification and the regulation of cellular activity. Most of these studies have been limited to proteins extracted from mammalian and avian vertebrates and nonvertebrates. The present work describes the isolation and purification of two major highly glycosylated and phosphorylated extracellular matrix proteins of 70 and 22 kDa from herring fish bones. The 70-kDa phosphoprotein has some characteristics of osteopontin with respect to amino acid composition and susceptibility to thrombin cleavage. Unlike osteopontin, however, it was found to contain high levels of sialic acid similar to bone sialoprotein. The 22-kDa protein has very different properties such as very high content of phosphoserine (similar to 270 Ser(P) residues/1000 amino acid residues), Ala, and Asx residues. The N-terminal amino acid sequence analysis of both the 70-kDa (NPIMA(M) ETTS(M) DSKVNPLL) and the 22-kDa (NQDMAMEASSDPEAA) fish phosphoproteins indicate that these unique amino acid sequences are unlike any published in protein databases. An enzyme-linked immunosorbent assay revealed that the 70-kDa phosphoprotein was present principally in bone and in calcified scales, whereas the 22-kDa phosphoprotein was detected only in bone. Immunohistological analysis revealed diffusely positive immunostaining for both the 70-and 22-kDa phosphoproteins throughout the matrix of the bone. Overall, this work adds additional support to the concept that the mechanism of biological calcification has common evolutionary and fundamental bases throughout vertebrate species.	Harvard Univ, Sch Med, Dept Orthoped Surg, Lab Study Skeletal Disorders & Rehabil, Boston, MA 02115 USA; Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Salih, E (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, 700 Albany St, Boston, MA 02118 USA.	Salih@bu.edu		Salih, Erdjan/0000-0003-3322-2323	National Institutes of Health [AG17969-0H, R01 AG14701-16, 2R01 AG14701-17A2]; Peabody Foundation, Inc.; NATIONAL INSTITUTE ON AGING [R01AG014701, R01AG017969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peabody Foundation, Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG17969-0H (to E. S.), R01 AG14701-16, and 2R01 AG14701-17A2. This work was also supported by a grant from the Peabody Foundation, Inc. (to M. J. G.).	Alvares K, 2009, J BIOL CHEM, V284, P26149, DOI 10.1074/jbc.M109.024018; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Bayless KJ, 1998, J CELL SCI, V111, P1165; Bellahcene A, 1997, B CANCER, V84, P17; Bobe J, 2001, FEBS LETT, V489, P119, DOI 10.1016/S0014-5793(01)02090-7; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BUTTLER WT, 1996, OSTEOPONTIN PRINCIPL, P167; CHAMBERS TJ, 1986, BONE MINER, V1, P127; Cooper LF, 1998, J BONE MINER RES, V13, P620, DOI 10.1359/jbmr.1998.13.4.620; Curtin P, 2009, BIOCHEMISTRY-US, V48, P6876, DOI 10.1021/bi900066b; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; ENDO A, 1989, CONNECT TISSUE RES, V21, P509, DOI 10.3109/03008208909050008; FISHER LW, 1983, J BIOL CHEM, V258, P2723; FISHER LW, 1992, INT CONGR SER, V1002, P177; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; FUJISAWA R, 1993, J DENT RES, V72, P1222, DOI 10.1177/00220345930720081001; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; GLIMCHER MJ, 1979, CALCIFIED TISSUE INT, V27, P187, DOI 10.1007/BF02441183; GLIMCHER MJ, 1959, REV MOD PHYS, V31, P359, DOI 10.1103/RevModPhys.31.359; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; GORSKI JP, 1988, J BIOL CHEM, V263, P15938; HELFRICH MH, 1992, J BONE MINER RES, V7, P335; HORTON MA, 1995, ANN NY ACAD SCI, V760, P190, DOI 10.1111/j.1749-6632.1995.tb44630.x; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; KIDO J, 1995, ARCH ORAL BIOL, V40, P967, DOI 10.1016/0003-9969(95)00056-U; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE DD, 1991, J MOL BIOL, V217, P487, DOI 10.1016/0022-2836(91)90752-R; LOWENSTAM H. A., 1989, BIOMINERALISATION, P1; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; MIDURA RJ, 1990, J BIOL CHEM, V265, P5285; Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078; NISHIMOTO SK, 1992, J BIOL CHEM, V267, P11600; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Okada A, 2008, J BONE MINER RES, V23, P1629, DOI 10.1359/JBMR.080514; Raynal C, 1996, ENDOCRINOLOGY, V137, P2347, DOI 10.1210/en.137.6.2347; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; RENNARD SI, 1980, ANAL BIOCHEM, V104, P205, DOI 10.1016/0003-2697(80)90300-0; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Salih E, 1996, J BIOL CHEM, V271, P16897, DOI 10.1074/jbc.271.28.16897; Salih E, 2002, BIOCHEM J, V364, P465, DOI 10.1042/BJ20011272; Salih E, 1997, J BIOL CHEM, V272, P13966, DOI 10.1074/jbc.272.21.13966; Salih E, 1996, J BONE MINER RES, V11, P1461; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; Shanmugam V, 1997, BIOCHEMISTRY-US, V36, P5729, DOI 10.1021/bi961687w; SIMKISS K, 1989, CELL MINERAL DEPOSIT, P1; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Veis A, 1985, CHEM BIOL MINERALIZE, P170; von Kossa J, 1901, BEITR PATHOL ANAT AL, V29, P163; Wang J, 1998, BONE, V22, P621, DOI 10.1016/S8756-3282(98)00057-X; Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; ZHOU HY, 1995, CALCIFIED TISSUE INT, V56, P403, DOI 10.1007/BF00301610; Zhou HY, 1998, BIOCHEM J, V330, P1423, DOI 10.1042/bj3301423	69	5	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36170	36178		10.1074/jbc.M110.146910	http://dx.doi.org/10.1074/jbc.M110.146910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833721	Green Published, hybrid			2022-12-27	WOS:000283845300093
J	Akerfelt, M; Vihervaara, A; Laiho, A; Conter, A; Christians, ES; Sistonen, L; Henriksson, E				Akerfelt, Malin; Vihervaara, Anniina; Laiho, Asta; Conter, Annie; Christians, Elisabeth S.; Sistonen, Lea; Henriksson, Eva			Heat Shock Transcription Factor 1 Localizes to Sex Chromatin during Meiotic Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE Y-CHROMOSOME; LONG ARM; XY BODY; TARGETED DISRUPTION; SPERM DEVELOPMENT; EXPRESSION; GENE; HSF1; SPERMATOGENESIS; PROTEIN	Heat shock factor 1 (HSF1) is an important transcription factor in cellular stress responses, cancer, aging, and developmental processes including gametogenesis. Disruption of Hsf1, together with another HSF family member, Hsf2, causes male sterility and complete lack of mature sperm in mice, but the specific role of HSF1 in spermatogenesis has remained unclear. Here, we show that HSF1 is transiently expressed in meiotic spermatocytes and haploid round spermatids in mouse testis. The Hsf1(-/-) male mice displayed regions of seminiferous tubules containing only spermatogonia and increased morphological abnormalities in sperm heads. In search for HSF1 target genes, we identified 742 putative promoters in mouse testis. Among them, the sex chromosomal multicopy genes that are expressed in postmeiotic cells were occupied by HSF1. Given that the sex chromatin mostly is repressed during and after meiosis, it is remarkable that HSF1 directly regulates the transcription of sex-linked multicopy genes during postmeiotic repression. In addition, our results show that HSF1 localizes to the sex body prior to the meiotic divisions and to the sex chromocenter after completed meiosis. To the best of our knowledge, HSF1 is the first known transcription factor found at the repressed sex chromatin during meiosis.	[Sistonen, Lea] Abo Akad Univ, Dept Biosci, FI-20521 Turku, Finland; [Akerfelt, Malin; Vihervaara, Anniina; Laiho, Asta; Sistonen, Lea; Henriksson, Eva] Univ Turku, Turku Ctr Biotechnol, FI-20521 Turku, Finland; [Conter, Annie; Christians, Elisabeth S.] Univ Toulouse 3, Ctr Dev Biol, UMR 5547, F-31062 Toulouse, France	Abo Akademi University; University of Turku; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sistonen, L (corresponding author), Abo Akad Univ, Dept Biosci, POB 123, FI-20521 Turku, Finland.	lea.sistonen@abo.fi		Akerfelt, Malin/0000-0003-4810-7862; Henriksson, Eva/0000-0001-8320-4591; Vihervaara, Anniina/0000-0001-6256-4694; Sistonen, Lea/0000-0003-1341-2867	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Organizations; Abo Akademi University; Magnus Ehrnrooth Foundation; Foundation of Abo Akademi Research Institute; Turku Graduate School of Biomedical Sciences (TuBS)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Abo Akademi University; Magnus Ehrnrooth Foundation; Foundation of Abo Akademi Research Institute; Turku Graduate School of Biomedical Sciences (TuBS)	This work was supported by The Academy of Finland, The Sigrid Juselius Foundation, The Finnish Cancer Organizations, and Abo Akademi University (to L. S.), The Magnus Ehrnrooth Foundation and Foundation of Abo Akademi Research Institute (to M. A., A. V., and E. H.), and by the Turku Graduate School of Biomedical Sciences (TuBS) (to M. A. and A. V.).	Akerfelt M, 2008, P NATL ACAD SCI USA, V105, P11224, DOI 10.1073/pnas.0800620105; Alastalo TP, 1998, EXP CELL RES, V240, P16, DOI 10.1006/excr.1997.3926; ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; Bierkamp C, 2010, DEV BIOL, V339, P338, DOI 10.1016/j.ydbio.2009.12.037; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; CONWAY SJ, 1994, MAMM GENOME, V5, P203, DOI 10.1007/BF00360546; Crew FAE, 1922, J ANAT, V56, P98; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ellis Peter J I, 2006, Hum Fertil (Camb), V9, P1, DOI 10.1080/14647270500230114; Ellis PJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-171; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Hoyer-Fender S, 2003, CYTOGENET GENOME RES, V103, P245, DOI 10.1159/000076810; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Izu H, 2004, BIOL REPROD, V70, P18, DOI 10.1095/biolreprod.103.020065; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Kugel JF, 2006, MOL CELL, V22, P153, DOI 10.1016/j.molcel.2006.04.003; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Manuel M, 2002, EUR J BIOCHEM, V269, P2527, DOI 10.1046/j.1432-1033.2002.02917.x; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Moore CR, 1924, SCIENCE, V59, P41, DOI 10.1126/science.59.1515.41; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SCHWARTZ D, 1993, ONCOGENE, V8, P1487; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENETICS, V166, P901, DOI 10.1534/genetics.166.2.901; Toure A, 2004, GENOMICS, V83, P140, DOI 10.1016/S0888-7543(03)00216-7; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2005, CHROMOSOMA, V114, P300, DOI 10.1007/s00412-005-0007-7; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Ward MA, 2006, BIOL REPROD, V74, P652, DOI 10.1095/biolreprod.105.048090; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946	60	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34469	34476		10.1074/jbc.M110.157552	http://dx.doi.org/10.1074/jbc.M110.157552			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20802198	Green Published, hybrid			2022-12-27	WOS:000283659100021
J	Gavala, ML; Hill, LM; Lenertz, LY; Karta, MR; Bertics, PJ				Gavala, Monica L.; Hill, Lindsay M.; Lenertz, Lisa Y.; Karta, Maya R.; Bertics, Paul J.			Activation of the Transcription Factor FosB/Activating Protein-1 (AP-1) Is a Prominent Downstream Signal of the Extracellular Nucleotide Receptor P2RX7 in Monocytic and Osteoblastic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP KINASE; NF-KAPPA-B; GENE-EXPRESSION; DELTA-FOSB; P2X(7) RECEPTORS; BONE-FORMATION; ATP; MODULATION; MECHANISMS; RELEASE	Activation of the ionotropic P2RX7 nucleotide receptor by extracellular ATP has been implicated in modulating inflammatory disease progression. Continuous exposure of P2RX7 to ligand can result in apoptosis in many cell types, including monocytic cells, whereas transient activation of P2RX7 is linked to inflammatory mediator production and the promotion of cell growth. Given the rapid hydrolysis of ATP in the circulation and interstitial space, transient activation of P2RX7 appears critically important for its action, yet its effects on gene expression are unclear. The present study demonstrates that short-term stimulation of human and mouse monocytic cells as well as mouse osteoblasts with P2RX7 agonists substantially induces the expression of several activating protein-1 (AP-1) members, particularly FosB. The potent activation of FosB after P2RX7 stimulation is especially noteworthy considering that little is known concerning the role of FosB in immunological regulation. Interestingly, the magnitude of FosB activation induced by P2RX7 stimulation appears greater than that observed with other known inducers of FosB expression. In addition, we have identified a previously unrecognized role for FosB in osteoblasts with respect to nucleotide-induced expression of cyclooxygenase- 2 (COX-2), which is the rate-limiting enzyme in prostaglandin biosynthesis from arachidonic acid and is critical for osteoblastic differentiation and immune behavior. The present studies are the first to link P2RX7 action to FosB/AP-1 regulation in multiple cell types, including a role in nucleotide-induced COX-2 expression, and support a role for FosB in the control of immune and osteogenic function by P2RX7.	[Gavala, Monica L.; Hill, Lindsay M.; Lenertz, Lisa Y.; Karta, Maya R.; Bertics, Paul J.] Univ Wisconsin, Dept Biomol Chem, Sch Med, Madison, WI 53706 USA; [Gavala, Monica L.; Hill, Lindsay M.; Karta, Maya R.; Bertics, Paul J.] Univ Wisconsin, Sch Med, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bertics, PJ (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med, 1300 Univ Ave, Madison, WI 53706 USA.	pbertics@wisc.edu			National Institutes of Health [AI070503, HL069116]; Predoctoral Molecular and Cellular Pharmacology Training Grant [T32 HL07899]; University of Wisconsin (National Institutes of Health) [5 T32 HL07899-09]; Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069116, T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Molecular and Cellular Pharmacology Training Grant; University of Wisconsin (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070503 and HL069116.; Supported by Predoctoral Molecular and Cellular Pharmacology Training Grant T32 HL07899.; Supported by the Hematology Training 524 Program of the University of Wisconsin (National Institutes of Health Grant 5 T32 HL07899-09).; Supported by a postdoctoral fellowship from The Hartwell Foundation.	Aga M, 2004, AM J PHYSIOL-CELL PH, V286, pC923, DOI 10.1152/ajpcell.00417.2003; Aga M, 2002, J LEUKOCYTE BIOL, V72, P222; Aud D, 2006, NAT CLIN PRACT RHEUM, V2, P434, DOI 10.1038/ncprheum0222; Bowler WB, 1999, J BIOL CHEM, V274, P14315, DOI 10.1074/jbc.274.20.14315; Brautigam VM, 2005, J NEUROIMMUNOL, V166, P113, DOI 10.1016/j.jneuroim.2005.05.012; Buckley KA, 2003, FASEB J, V17, P1401, DOI 10.1096/fj.02-0940com; Budagian V, 2003, J BIOL CHEM, V278, P1549, DOI 10.1074/jbc.M206383200; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Desmet C, 2005, AM J RESP CRIT CARE, V172, P671, DOI 10.1164/rccm.200410-1431OC; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 1999, J LEUKOCYTE BIOL, V66, P723, DOI 10.1002/jlb.66.5.723; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Di Virgilio Francesco, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P85; DUBYAK GR, 1991, AM J RESP CELL MOL, V4, P295, DOI 10.1165/ajrcmb/4.4.295; Fernando KC, 1999, ARCH BIOCHEM BIOPHYS, V362, P197, DOI 10.1006/abbi.1998.1045; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Franco-Martinez S, 2006, CLIN EXP IMMUNOL, V146, P253, DOI 10.1111/j.1365-2249.2006.03213.x; Gavala ML, 2008, J LEUKOCYTE BIOL, V84, P1159, DOI 10.1189/jlb.0907612; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Guerra AN, 2007, PURINERG SIGNAL, V3, P39, DOI 10.1007/s11302-006-9035-x; Guo RF, 2002, AM J PATHOL, V161, P275, DOI 10.1016/S0002-9440(10)64179-X; Humphreys BD, 1998, J LEUKOCYTE BIOL, V64, P265, DOI 10.1002/jlb.64.2.265; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; Ke HZ, 2005, J BONE MINER METAB, V23, P84, DOI 10.1007/BF03026330; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Kveiborg M, 2004, MOL CELL BIOL, V24, P2820, DOI 10.1128/MCB.24.7.2820-2830.2004; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; Li X, 2007, GYNECOL ONCOL, V106, P233, DOI 10.1016/j.ygyno.2007.03.032; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; PADEH S, 1991, J IMMUNOL, V146, P1626; Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pfeiffer ZA, 2004, J LEUKOCYTE BIOL, V75, P1173, DOI 10.1189/jlb.1203648; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Picher M, 2004, J BIOL CHEM, V279, P20234, DOI 10.1074/jbc.M400305200; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sims NA, 2002, BONE, V30, P32, DOI 10.1016/S8756-3282(01)00622-6; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stefano L, 2007, J CELL PHYSIOL, V213, P36, DOI 10.1002/jcp.21085; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Watters JJ, 2001, DRUG DEVELOP RES, V53, P91, DOI 10.1002/ddr.1176; Woszczek G, 2008, J ALLERGY CLIN IMMUN, V121, P215, DOI 10.1016/j.jaci.2007.09.013	61	25	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34288	34298		10.1074/jbc.M110.142091	http://dx.doi.org/10.1074/jbc.M110.142091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20813842	hybrid, Green Published			2022-12-27	WOS:000283354000074
J	Cosker, F; Cheviron, N; Yamasaki, M; Menteyne, A; Lund, FE; Moutin, MJ; Galione, A; Cancela, JM				Cosker, Francois; Cheviron, Nathalie; Yamasaki, Michiko; Menteyne, Alexis; Lund, Frances E.; Moutin, Marie-Jo; Galione, Antony; Cancela, Jose-Manuel			The Ecto-enzyme CD38 Is a Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Synthase That Couples Receptor Activation to Ca2+ Mobilization from Lysosomes in Pancreatic Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; SEA-URCHIN EGGS; MESSENGER PATHWAYS; BETA-CELLS; IN-VIVO; CALCIUM; RELEASE; 2ND-MESSENGER; STORES; GENERATION	Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent Ca2+-mobilizing intracellular messenger and is linked to a variety of stimuli and cell surface receptors. However, the enzyme responsible for endogenous NAADP synthesis in vivo is unknown, and it has been proposed that another enzyme differing from ADP-ribosyl cyclase family members may exist. The ectoenzyme CD38, involved in many functions as diverse as cell proliferation and social behavior, represents an important alternative. In pancreatic acinar cells, the hormone cholecystokinin (CCK) stimulates NAADP production evoking Ca2+ signals by discharging acidic Ca2+ stores and leading to digestive enzyme secretion. From cells derived from CD38(-/-) mice, we provide the first physiological evidence that CD38 is required for endogenous NAADP generation in response to CCK stimulation. Furthermore, CD38 expression in CD38-deficient pancreatic AR42J cells remodels Ca2+-signaling pathways in these cells by restoring Ca2+ mobilization from lysosomes during CCK-induced Ca2+ signaling. In agreement with an intracellular site for messenger synthesis, we found that CD38 is expressed in endosomes. These CD38-containing vesicles, likely of endosomal origin, appear to be proximal to lysosomes but not colocalized with them. We propose that CD38 is an NAADP synthase required for coupling receptor activation to NAADP-mediated Ca2+ release from lysosomal stores in pancreatic acinar cells.	[Cosker, Francois; Cheviron, Nathalie; Menteyne, Alexis; Cancela, Jose-Manuel] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Mol,UPR9040, F-91198 Gif Sur Yvette, France; [Lund, Frances E.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Moutin, Marie-Jo] Univ Grenoble 1, CEA CHU, Ctr Rech INSERM 836, Grenoble Inst Neurosci Equipe 1,Grp Physiopathol, F-38042 Grenoble, France; [Yamasaki, Michiko; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Rochester; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Oxford	Cancela, JM (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Mol,UPR9040, F-91198 Gif Sur Yvette, France.	jose.cancela@nbcm.cnrs-gif.fr	Galione, Antony/E-5884-2011; Moutin, Marie-Jo/P-7518-2017	Moutin, Marie-Jo/0000-0003-2681-9818; Cancela, Jose-Manuel/0000-0002-6234-1500; Galione, Antony/0000-0002-4132-7646	CNRS; Association pour la Recherche sur le Cancer (ARC); Fondation de la Recherche Medicale (FRM); Association Francaise contre les Myopathies (AFM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by an ATIP program grant from the CNRS, by the Association pour la Recherche sur le Cancer (ARC), Fondation de la Recherche Medicale (FRM), and the Association Francaise contre les Myopathies (AFM) (to J.-M.C.).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Burdakov D, 2000, CURR BIOL, V10, P993, DOI 10.1016/S0960-9822(00)00649-7; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2002, DIABETES, V51, pS349, DOI 10.2337/diabetes.51.2007.S349; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lee H, 2003, CURR BIOL, V13, pR152, DOI 10.1016/S0960-9822(03)00080-0; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lewis AM, 2007, ANAL BIOCHEM, V371, P26, DOI 10.1016/j.ab.2007.08.030; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; Morgan AJ, 2007, J BIOL CHEM, V282, P37730, DOI 10.1074/jbc.M704630200; Palade P, 2007, AM J PHYSIOL-CELL PH, V292, pC4, DOI 10.1152/ajpcell.00390.2006; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; THORN P, 1994, EMBO J, V13, P2038, DOI 10.1002/j.1460-2075.1994.tb06478.x; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2005, FEBS J, V272, P4598, DOI 10.1111/j.1742-4658.2005.04860.x; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	41	82	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38251	38259		10.1074/jbc.M110.125864	http://dx.doi.org/10.1074/jbc.M110.125864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20870729	Green Published, hybrid			2022-12-27	WOS:000284625600033
J	Ros, S; Zafra, D; Valles-Ortega, J; Garcia-Rocha, M; Forrow, S; Dominguez, J; Calbo, J; Guinovart, JJ				Ros, Susana; Zafra, Delia; Valles-Ortega, Jordi; Garcia-Rocha, Mar; Forrow, Stephen; Dominguez, Jorge; Calbo, Joaquim; Guinovart, Joan J.			Hepatic Overexpression of a Constitutively Active Form of Liver Glycogen Synthase Improves Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SUBUNIT; RAT HEPATOCYTES; INTRACELLULAR-DISTRIBUTION; PROTEIN PHOSPHATASE-1; GLUCOKINASE; EXPRESSION; PHOSPHORYLASE; METABOLISM; TRANSLOCATION; ACTIVATION	In this study, we tested the efficacy of increasing liver glycogen synthase to improve blood glucose homeostasis. The overexpression of wild-type liver glycogen synthase in rats had no effect on blood glucose homeostasis in either the fed or the fasted state. In contrast, the expression of a constitutively active mutant form of the enzyme caused a significant lowering of blood glucose in the former but not the latter state. Moreover, it markedly enhanced the clearance of blood glucose when fasted rats were challenged with a glucose load. Hepatic glycogen stores in rats overexpressing the activated mutant form of liver glycogen synthase were enhanced in the fed state and in response to an oral glucose load but showed a net decline during fasting. In order to test whether these effects were maintained during long term activation of liver glycogen synthase, we generated liver-specific transgenic mice expressing the constitutively active LGS form. These mice also showed an enhanced capacity to store glycogen in the fed state and an improved glucose tolerance when challenged with a glucose load. Thus, we conclude that the activation of liver glycogen synthase improves glucose tolerance in the fed state without compromising glycogenolysis in the postabsorptive state. On the basis of these findings, we propose that the activation of liver glycogen synthase may provide a potential strategy for improvement of glucose tolerance in the postprandial state.	[Calbo, Joaquim; Guinovart, Joan J.] Univ Barcelona, Inst Biomed Res, E-08028 Barcelona, Spain; [Ros, Susana; Zafra, Delia; Valles-Ortega, Jordi; Garcia-Rocha, Mar; Dominguez, Jorge; Calbo, Joaquim; Guinovart, Joan J.] Univ Barcelona, CIBER Diabet & Enfermedades Metab, E-08028 Barcelona, Spain; [Ros, Susana; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; University of Barcelona	Guinovart, JJ (corresponding author), Univ Barcelona, Inst Biomed Res, Barcelona Sci Pk,Baldiri Reixac 10-12, E-08028 Barcelona, Spain.	guinovart@irbbarcelona.org	Ros, Susana/B-6350-2019; forrow, stephen/AAG-9403-2020	Ros, Susana/0000-0002-5451-1880; Garcia-Rocha, Mar/0000-0003-2467-2090; Zafra, Delia/0000-0003-4143-0659	Ministry of Education and Science, Spain [BFU2005-02253, SAF2007-64722]; Autonomous Government of Catalonia [2005-SGR-00570]; Fundacion MarcelinoBotin	Ministry of Education and Science, Spain(Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Fundacion MarcelinoBotin	This work was supported by Ministry of Education and Science, Spain, Grants BFU2005-02253 and SAF2007-64722, Autonomous Government of Catalonia Grant 2005-SGR-00570, and a grant from the Fundacion MarcelinoBotin. The CIBER de Diabetes y Enfermedades Metabolicas Asociadas is an ISCIII project.	Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Baker DJ, 2006, DIABETES, V55, P1855, DOI 10.2337/db05-1687; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gasa R, 2002, J BIOL CHEM, V277, P1524, DOI 10.1074/jbc.M107744200; Gomis RR, 2000, BIOCHEM J, V351, P811, DOI 10.1042/0264-6021:3510811; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Kelsall IR, 2007, FEBS LETT, V581, P4749, DOI 10.1016/j.febslet.2007.08.073; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Ros S, 2009, J BIOL CHEM, V284, P6370, DOI 10.1074/jbc.M808576200; SALAVERT A, 1982, J BIOL CHEM, V257, P13404; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Treadway JL, 2001, EXPERT OPIN INV DRUG, V10, P439, DOI 10.1517/13543784.10.3.439; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Yang RJ, 2003, J BIOL CHEM, V278, P23418, DOI 10.1074/jbc.M213112200; Yang RJ, 2002, J BIOL CHEM, V277, P1514, DOI 10.1074/jbc.M107001200	27	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37170	37177		10.1074/jbc.M110.157396	http://dx.doi.org/10.1074/jbc.M110.157396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20841354	Green Published, hybrid			2022-12-27	WOS:000284424000010
J	Beraldo, FH; Arantes, CP; Santos, TG; Queiroz, NGT; Young, K; Rylett, RJ; Markus, RP; Prado, MAM; Martins, VR				Beraldo, Flavio H.; Arantes, Camila P.; Santos, Tiago G.; Queiroz, Nicolle G. T.; Young, Kirk; Rylett, R. Jane; Markus, Regina P.; Prado, Marco A. M.; Martins, Vilma R.			Role of alpha 7 Nicotinic Acetylcholine Receptor in Calcium Signaling Induced by Prion Protein Interaction with Stress-inducible Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PRION; ALZHEIMERS-DISEASE; MOUSE MODEL; TRANSGENIC MICE; BETA OLIGOMERS; AMYLOID-BETA; CROSS-TALK; NEUROPROTECTION; EXPRESSION; LAMININ	The prion protein (PrPC) is a conserved glycosylphosphatidyl-inositol-anchored cell surface protein expressed by neurons and other cells. Stress-inducible protein 1 (STI1) binds PrPC extracellularly, and this activated signaling complex promotes neuronal differentiation and neuroprotection via the extracellular signal-regulated kinase 1 and 2 (ERK1/2) and cAMP-dependent protein kinase 1 (PKA) pathways. However, the mechanism by which the PrPC-STI1 interaction transduces extracellular signals to the intracellular environment is unknown. We found that in hippocampal neurons, STI1-PrPC engagement induces an increase in intracellular Ca2+ levels. This effect was not detected in PrPC-null neurons or wild-type neurons treated with an STI1 mutant unable to bind PrPC. Using a best candidate approach to test for potential channels involved in Ca2+ influx evoked by STI1-PrPC, we found that alpha-bungarotoxin, a specific inhibitor for alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR), was able to block PrPC-STI1-mediated signaling, neuroprotection, and neuritogenesis. Importantly, when alpha 7nAChR was transfected into HEK 293 cells, it formed a functional complex with PrPC and allowed reconstitution of signaling by PrPC-STI1 interaction. These results indicate that STI1 can interact with the PrPC.alpha 7nAChR complex to promote signaling and provide a novel potential target for modulation of the effects of prion protein in neurodegenerative diseases.	[Beraldo, Flavio H.; Young, Kirk; Rylett, R. Jane; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5K8, Canada; [Beraldo, Flavio H.; Arantes, Camila P.; Santos, Tiago G.; Queiroz, Nicolle G. T.; Martins, Vilma R.] Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, BR-01323903 Sao Paulo, Brazil; [Arantes, Camila P.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil; [Santos, Tiago G.; Queiroz, Nicolle G. T.; Martins, Vilma R.] Hosp AC Camargo Fund Antonio Prudente, Ctr Tratamento & Pesquisa, BR-01508010 Sao Paulo, Brazil; [Beraldo, Flavio H.; Young, Kirk; Rylett, R. Jane; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Markus, Regina P.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508090 Sao Paulo, Brazil; [Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Ludwig Institute for Cancer Research; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Western University (University of Western Ontario); Universidade de Sao Paulo; Western University (University of Western Ontario)	Prado, MAM (corresponding author), Univ Western Ontario, Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, POB 5015,100 Perth Dr, London, ON N6A 5K8, Canada.	mprado@robarts.ca; vmartins@ludwig.org.br	Neurociencia, Inct/I-1011-2013; Santos, Tiago Goss/AAQ-4272-2020; Queiroz-Hazarbassanov, Nicolle/P-4333-2014; Rylett, Rebecca Jane/K-3597-2013; Queiroz-Hazarbassanov, Nicolle/Q-6901-2019; dos Santos, Tiago Goss/A-1538-2019; Martins, Vilma/N-5446-2019; Markus, Regina P./AAC-1505-2021; Martins, Vilma R/E-2547-2012; Prado, Marco Antonio Maximo/K-7638-2013; Santos, Tiago/F-2387-2012; Markus, Regina P/K-2954-2012	Santos, Tiago Goss/0000-0001-6641-7413; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; Rylett, Rebecca Jane/0000-0002-9158-9599; Queiroz-Hazarbassanov, Nicolle/0000-0002-5692-0565; dos Santos, Tiago Goss/0000-0001-6641-7413; Markus, Regina P./0000-0003-4606-6120; Martins, Vilma R/0000-0002-2909-8502; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Santos, Tiago/0000-0001-6641-7413; Markus, Regina P/0000-0003-4606-6120	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [03-13189-2]; Programa Institutos Nacionais de Ciencia e Tecnologia, do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; PrioNet-Canada; Canadian Institutes for Health Research; Department of Foreign Affairs and International Trade-Canada	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa Institutos Nacionais de Ciencia e Tecnologia, do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PrioNet-Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Department of Foreign Affairs and International Trade-Canada	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 03-13189-2 and Programa Institutos Nacionais de Ciencia e Tecnologia, do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to V. R. M.). This work was also supported by grants from PrioNet-Canada (to M. A. M. P.) and Canadian Institutes for Health Research (to R. J. R. and M. A. M. P.) and fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to F. H. B., C. P. A., T. G. S., and N. G. T. Q.) and the Department of Foreign Affairs and International Trade-Canada (to F. H. B.).	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BERALDO FH, 2010, FASEB J IN PRESS; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Brini M, 2005, MOL BIOL CELL, V16, P2799, DOI 10.1091/mbc.E04-10-0915; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Dajas-Bailador FA, 2000, NEUROPHARMACOLOGY, V39, P2799, DOI 10.1016/S0028-3908(00)00127-1; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Fierro AF, 2004, J BIOL CHEM, V279, P25646, DOI 10.1074/jbc.M400296200; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jones IW, 2006, J MOL NEUROSCI, V30, P83, DOI 10.1385/JMN:30:1:83; Jonnala RR, 2001, J NEUROSCI RES, V66, P565, DOI 10.1002/jnr.10022; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Korte S, 2003, J NEUROCHEM, V87, P1037, DOI 10.1046/j.1471-4159.2003.02080.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Linden R., 2011, UCSD NATURE MOL 0729, DOI [10.1038/mp.a003935.01, DOI 10.1038/MP.A003935.01]; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nimmrich V, 2009, REV NEUROSCIENCE, V20, P1; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Petrakis S, 2008, EUR J NEUROSCI, V27, P612, DOI 10.1111/j.1460-9568.2008.06037.x; Ren K, 2007, NEUROSCIENCE, V148, P230, DOI 10.1016/j.neuroscience.2007.05.013; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Teaktong T, 2004, J NEUROL SCI, V225, P39, DOI 10.1016/j.jns.2004.06.015; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Whatley SA, 1995, NEUROREPORT, V6, P2333, DOI 10.1097/00001756-199511270-00015; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	62	80	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36542	36550		10.1074/jbc.M110.157263	http://dx.doi.org/10.1074/jbc.M110.157263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20837487	Green Published, hybrid			2022-12-27	WOS:000284146100059
J	Liu, ML; Wilk, SA; Wang, AP; Zhou, LJ; Wang, RH; Ogawa, W; Deng, CX; Dong, LQ; Liu, F				Liu, Meilian; Wilk, Sarah Ann; Wang, Anping; Zhou, Lijun; Wang, Rui-Hong; Ogawa, Wataru; Deng, Chuxia; Dong, Lily Q.; Liu, Feng			Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAMMALIAN TARGET; CELL-GROWTH; AMPK ACTIVATION; AMINO-ACIDS; INSULIN; RAPAMYCIN; PHOSPHORYLATION; METABOLISM; MECHANISM	Resveratrol (RSV) is a naturally occurring polyphenol that has been found to exert antioxidant, anti-inflammatory, and neuroprotective properties. However, how RSV exerts its beneficial health effects remains largely unknown. Here, we show that RSV inhibits insulin-and leucine-stimulated mTOR signaling in C2C12 fibroblasts via a Sirt1-independent mechanism. Treating C2C12 cells with RSV dramatically inhibited insulin-stimulated Akt, S6 kinase, and 4E-BP1 phosphorylation but had little effect on tyrosine phosphorylation of the insulin receptor and activation of the p44/42MAPK signaling pathway. RSV treatment also partially blocked mTOR and S6 kinase phosphorylation in TSC1/2-deficient mouse embryonic fibroblasts, suggesting the presence of an inhibitory site downstream of TSC1/2. Knocking out PDK1 or suppressing AMP-activated protein kinase had little effect on leucine-stimulated mTOR signaling. On the other hand, RSV significantly increased the association between mTOR and its inhibitor, DEPTOR. Furthermore, the inhibitory effect of RSV on leucine-stimulated mTOR signaling was greatly reduced in cells in which the expression levels of DEPTOR were suppressed by RNAi. Taken together, our studies reveal that RSV inhibits leucine-stimulated mTORC1 activation by promoting mTOR/DEPTOR interaction and thus uncover a novel mechanism by which RSV negatively regulates mTOR activity.	[Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Dong, Lily Q.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Wang, Rui-Hong; Deng, Chuxia] NIDDK, Mammalian Genet Sect, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Ogawa, Wataru] Kobe Univ, Grad Sch Med, Div Diabet Endocrinol & Kidney Dis, Dept Internal Med, Kobe, Hyogo 6500017, Japan	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kobe University		lium2@uthscsa.edu; liuf@uthscsa.edu	deng, chuxia/N-6713-2016; Liu, Feng/CAG-8962-2022; OGAWA, Wataru/AAQ-9586-2020; Zhou, Lijun/H-2229-2011		National Institutes of Health [RO1 DK76902, RO1 DK80344]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, ZIADK056010, ZIADK056011, ZIADK056009, ZIADK056004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK76902 (to F.L.) and RO1 DK80344 (to L.Q.D.).	Acharya SH, 2008, DIABETIC MED, V25, P360, DOI 10.1111/j.1464-5491.2007.02372.x; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chen HY, 2008, VISION RES, V48, P690, DOI 10.1016/j.visres.2007.10.014; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; JIANG H, 2010, J EXP THER ONCOL, V8, P25; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 2006, NATURE, V444, P280, DOI 10.1038/nature05308; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Kundu JK, 2004, MUTAT RES-FUND MOL M, V555, P65, DOI 10.1016/j.mrfmmm.2004.05.019; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valenzano MM, 2006, EUR J OBSTET GYN R B, V124, P246, DOI 10.1016/j.ejogrb.2005.06.041; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	44	133	136	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36387	36394		10.1074/jbc.M110.169284	http://dx.doi.org/10.1074/jbc.M110.169284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851890	Green Published, hybrid			2022-12-27	WOS:000284146100080
J	Niture, SK; Jaiswal, AK				Niture, Suryakant K.; Jaiswal, Anil K.			RETRACTED: Hsp90 Interaction with INrf2(Keap1) Mediates Stress-induced Nrf2 Activation (Retracted article. See vol. 289, pg. 11568, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							CUL3-BASED E3 LIGASE; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; GENE-EXPRESSION; KINASE-C; KEAP1; COMPLEX; BINDING; ADAPTER; PHOSPHORYLATION	INrf2(Keap1) functions as an adapter for Cul3/Rbx1-mediated degradation of Nrf2. In response to stress, Nrf2 is released from INrf2 and translocates inside the nucleus leading to activation of cytoprotective proteins critical in protection against adverse effects including cancer. We demonstrate here a novel role of heat shock protein 90 (Hsp90) in control of the INrf2 and Nrf2 activation. Hsp90 interacted with INrf2 that leds to stabilization of INrf2 during heat shock stress. Domain mapping showed the requirement of INrf2-NTR and the Hsp90-CLD region for interaction of Hsp90 with INrf2. Heat shock and antioxidants induced Hsp90, and casein kinase 2 (CK2) phosphorylated INrf2Thr55. This led to increased Hsp90-INrf2 interaction, dissociation of the Rbx1/Cul3 center dot INrf2 center dot Nrf2 complex, and activation of Nrf2. Inhibitors of CK2 and Hsp90, and mutation of INrf2Thr55 abolished the Hsp90-INrf2 interaction and downstream signaling. INrf2 is released from Hsp90 once the heat shock or antioxidant stress subsidized, thereby allowing INrf2 to interact with Nrf2 and facilitate Nrf2 ubiquitination and degradation. The results together demonstrate a novel role for the stress-induced Hsp90-INrf2 interaction in regulation of Nrf2 activation and induction of cytoprotective proteins.	[Niture, Suryakant K.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu		Niture, Suryakant/0000-0003-0613-9399	National Institutes of Health [RO1 ES012265]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES012265.	Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; MINAMI Y, 1991, J BIOL CHEM, V266, P10099; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548	36	34	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36865	36875		10.1074/jbc.M110.175802	http://dx.doi.org/10.1074/jbc.M110.175802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20864537	hybrid, Green Published			2022-12-27	WOS:000284146100087
J	Johnson, SS; Hanson, PK; Manoharlal, R; Brice, SE; Cowart, LA; Moye-Rowley, WS				Johnson, Soraya S.; Hanson, Pamela K.; Manoharlal, Raman; Brice, Sarah E.; Cowart, L. Ashley; Moye-Rowley, W. Scott			Regulation of Yeast Nutrient Permease Endocytosis by ATP-binding Cassette Transporters and a Seven-transmembrane Protein, RSB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRYPTOPHAN PERMEASE; AMINO-ACID; PLASMA-MEMBRANE; RECEPTOR; SPHINGOLIPIDS; TAT2; PHYTOSPHINGOSINE; TRAFFICKING; ACTIVATION	Ceramide is produced by the condensation of a long chain base with a very long chain fatty acid. In Saccharomyces cerevisiae, one of the two major long chain bases is called phytosphingosine (PHS). PHS has been shown to cause toxicity in tryptophan auxotrophic strains of yeast because this bioactive ceramide precursor causes diversion of the high affinity tryptophan permease Tat2 to the vacuole rather than the plasma membrane. Loss of the integral membrane protein Rsb1 increased PHS sensitivity, which was suggested to be due to this protein acting as an ATP-dependent long chain base efflux protein. More recent experiments demonstrated that loss of the genes encoding the ATP-binding cassette transporter proteins Pdr5 and Yor1 elevated PHS tolerance. This increased resistance was suggested to be due to increased expression of RSB1. Here, we provide an alternative view of PHS resistance influenced by Rsb1 and Pdr5/Yor1. Rsb1 has a seven-transmembrane domain topology more consistent with that of a regulatory protein like a G-protein-coupled receptor rather than a transporter. Importantly, an rsb1 Delta cell does not exhibit higher internal levels of PHS compared with isogenic wild-type cells. However, tryptophan transport is increased in pdr5 Delta yor1 strains and reduced in rsb1 Delta cells. Localization and vacuolar degradation of Tat2 are affected in these genetic backgrounds. Finally, internalization of FM4-64 dye suggests that loss of Pdr5 and Yor1 slows normal endocytic rates. Together, these data argue that Rsb1, Pdr5, and Yor1 regulate the endocytosis of Tat2 and likely other membrane transporter proteins.	[Hanson, Pamela K.; Manoharlal, Raman; Moye-Rowley, W. Scott] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Johnson, Soraya S.; Moye-Rowley, W. Scott] Univ Iowa, Carver Coll Med, Program Mol Biol, Iowa City, IA 52242 USA; [Brice, Sarah E.; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	University of Iowa; University of Iowa; Medical University of South Carolina	Moye-Rowley, WS (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, 6-530 Bowen Sci Bldg, Iowa City, IA 52242 USA.	scott-moye-rowley@uiowa.edu	Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120; Hanson, Pamela/0000-0002-9312-1682	National Institutes of Health [GM75120, GM49825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075120, R01GM049825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM75120 and GM49825 (to W.S.M.-R.).	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Abe F., 2007, INT C SER, V1304, P75; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHEN XH, 1994, MOL GEN GENET, V244, P260, DOI 10.1007/BF00285453; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Daicho K, 2009, FEMS MICROBIOL LETT, V298, P218, DOI 10.1111/j.1574-6968.2009.01722.x; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grote E, 2000, MOL BIOL CELL, V11, P4051, DOI 10.1091/mbc.11.12.4051; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Heenan EJ, 2009, BIOCHEMISTRY-US, V48, P6390, DOI 10.1021/bi900621w; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hiraki T, 2010, FEBS LETT, V584, P55, DOI 10.1016/j.febslet.2009.11.076; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; Khozoie C, 2009, J BIOL CHEM, V284, P17968, DOI 10.1074/jbc.M109.005843; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Panwar SL, 2006, J BIOL CHEM, V281, P6376, DOI 10.1074/jbc.M512115200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Skrzypek MS, 1998, J BIOL CHEM, V273, P2829, DOI 10.1074/jbc.273.5.2829; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sun Y, 2007, MOL BIOSYST, V3, P849, DOI 10.1039/b706343a; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Welsch CA, 2004, J BIOL CHEM, V279, P36720, DOI 10.1074/jbc.M406179200	40	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35792	35802		10.1074/jbc.M110.162883	http://dx.doi.org/10.1074/jbc.M110.162883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826817	hybrid, Green Published			2022-12-27	WOS:000283845300057
J	Goodman, B; Channels, W; Qiu, MH; Iglesias, P; Yang, G; Zheng, YX				Goodman, Benjamin; Channels, Wilbur; Qiu, Minhua; Iglesias, Pablo; Yang, Ge; Zheng, Yixian			Lamin B Counteracts the Kinesin Eg5 to Restrain Spindle Pole Separation during Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; MICROTUBULE FLUX; NUCLEAR LAMINS; IMPORTIN-BETA; RAN; MATRIX; PROTEIN; MITOSIS; CELL; ORGANIZATION	Lamin B is a component of the membranous spindle matrix isolated from Xenopus egg extracts, and it is required for proper spindle morphogenesis. Besides lamin B, the spindle matrix contains spindle assembly factors (SAFs) such as Eg5 and dynein which are known to regulate microtubule organization and SAFs known to promote microtubule assembly such as Maskin and XMAP215. Because lamin B does not bind directly to microtubules, it must affect spindle morphogenesis indirectly by influencing the function of spindle matrix-associated SAFs. Using different assays in Xenopus egg extracts, we found that depleting lamin B caused formation of elongated and multipolar spindles, which could be reversed by partially inhibiting the kinesin Eg5, revealing an antagonistic relationship between Eg5 and lamin B. However, lamin B only very weakly antagonizes Eg5 in mediating poleward microtubule-flux based on fluorescence speckle microscopy. Depleting lamin B led to a very small but statistically significant increase in flux. Furthermore, flux reduction caused by partial Eg5 inhibition is only slightly reversed by removing lamin B. Because lamin B does not bind to Eg5, our studies suggest two nonexclusive mechanisms by which lamin B can indirectly antagonize Eg5. It could function in a network that restricts Eg5-driven microtubule sliding only when microtubules come into transient contact with the network. Lamin B could also function to sequester microtubule polymerization activities within the spindle. Without lamin B, increased microtubule assembly caused by the released SAFs would lead to excessive microtubule sliding that results in formation of elongated and multipolar spindles.	[Qiu, Minhua; Yang, Ge] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Goodman, Benjamin; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA; [Goodman, Benjamin; Zheng, Yixian] Howard Hughes Med Inst, Baltimore, MD 21218 USA; [Channels, Wilbur; Iglesias, Pablo] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Carnegie Mellon University; Johns Hopkins University; Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Yang, G (corresponding author), Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	geyang@andrew.cmu.edu; zheng@ciwemb.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X	National Institutes of Health [GM56312]; National Science Foundation [0621740]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56312 (to Y. Z.). This work was also supported by National Science Foundation Grant 0621740 (to P. I.).	Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Civelekoglu-Scholey G, 2010, J CELL BIOL, V188, P49, DOI 10.1083/jcb.200908150; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Goodman B, 2006, BIOCHEM SOC T, V34, P716, DOI 10.1042/BST0340716; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; Lourim D, 1996, J CELL SCI, V109, P1775; Lourim D, 1998, J CELL SCI, V111, P3675; Ma L, 2009, NAT CELL BIOL, V11, P246, DOI 10.1038/ncb1832; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mogilner M, 2006, TRENDS CELL BIOL, V16, P88, DOI 10.1016/j.tcb.2005.12.007; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Qi HY, 2005, J CELL BIOCHEM, V95, P1284, DOI 10.1002/jcb.20495; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Zhang X, 2008, MOL BIOL CELL, V19, P2752, DOI 10.1091/mbc.E08-02-0198; Zheng YX, 2006, CELL CYCLE, V5, P2345, DOI 10.4161/cc.5.20.3365; Zheng YX, 2010, NAT REV MOL CELL BIO, V11, P529, DOI 10.1038/nrm2919; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	41	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35238	35244		10.1074/jbc.M110.140749	http://dx.doi.org/10.1074/jbc.M110.140749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20826821	hybrid, Green Published			2022-12-27	WOS:000283659100097
J	Burkart, A; Shi, XR; Chouinard, M; Corvera, S				Burkart, Alison; Shi, Xiarong; Chouinard, My; Corvera, Silvia			Adenylate Kinase 2 Links Mitochondrial Energy Metabolism to the Induction of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL DIFFERENTIATION; RESPIRATORY-CHAIN; CDNA CLONING; INSULIN; GENE; EXPRESSION; ADIPONECTIN; ADIPOCYTES; DISEASE	The unfolded protein response (UPR) is a homeostatic signaling mechanism that balances the protein folding capacity of the endoplasmic reticulum (ER) with the secretory protein load of the cell. ER protein folding capacity is dependent on the abundance of chaperones, which is increased in response to UPR signaling, and on a sufficient ATP supply for their activity. An essential branch of the UPR entails the splicing of XBP1 mRNA to form the XBP1 transcription factor. XBP1 has been shown to be required during adipocyte differentiation, enabling mature adipocytes to secrete adiponectin, and during differentiation of B cells into antibody-secreting plasma cells. Here we find that adenylate kinase 2 (AK2), a mitochondrial enzyme that regulates adenine nucleotide interconversion within the intermembrane space, is markedly induced during adipocyte and B cell differentiation. Depletion of AK2 by RNAi impairs adiponectin secretion in 3T3-L1 adipocytes, IgM secretion in BCL1 cells, and the induction of the UPR during differentiation of both cell types. These results reveal a new mechanism by which mitochondria support ER function and suggest that specific mitochondrial defects may give rise to impaired UPR signaling. The requirement for AK2 for UPR induction may explain the pathogenesis of the profound hematopoietic defects of reticular dysgenesis, a disease associated with mutations of the AK2 gene in humans.	[Burkart, Alison; Shi, Xiarong; Chouinard, My; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	silvia.corvera@umassmed.edu			National Institutes of Health [DK60837]; National Institutes of Health Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK089101, R01DK060837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK60837 (to S.C.) and core services supported by the National Institutes of Health Diabetes Endocrinology Research Center Grant DK32520.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Counago R, 2005, EXTREMOPHILES, V9, P135, DOI 10.1007/s00792-004-0428-x; DETIMARY P, 1995, J CLIN INVEST, V96, P1738, DOI 10.1172/JCI118219; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006; FukamiKobayashi K, 1996, FEBS LETT, V385, P214, DOI 10.1016/0014-5793(96)00367-5; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Janssen E, 2003, J BIOL CHEM, V278, P12937, DOI 10.1074/jbc.M211465200; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; KONRAD M, 1993, J BIOL CHEM, V268, P11326; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miron S, 2004, BIOCHEMISTRY-US, V43, P67, DOI 10.1021/bi0355995; Morimoto N, 2007, NEUROSCIENCE, V147, P957, DOI 10.1016/j.neuroscience.2007.04.017; Noma T, 1998, BBA-GENE STRUCT EXPR, V1395, P34, DOI 10.1016/S0167-4781(97)00193-0; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Shi XR, 2008, J BIOL CHEM, V283, P30658, DOI 10.1074/jbc.M800510200; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Van Rompay AR, 1999, EUR J BIOCHEM, V261, P509, DOI 10.1046/j.1432-1327.1999.00294.x; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	49	39	41	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4081	4089		10.1074/jbc.M110.134106	http://dx.doi.org/10.1074/jbc.M110.134106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	20876536	Green Published, hybrid			2022-12-27	WOS:000286975700006
J	Zhang, H; Pradhan, P; Kaur, P				Zhang, Han; Pradhan, Prajakta; Kaur, Parjit			The Extreme C Terminus of the ABC Protein DrrA Contains Unique Motifs Involved in Function and Assembly of the DrrAB Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING CASSETTE; ESCHERICHIA-COLI; STREPTOMYCES-PEUCETIUS; MALTOSE TRANSPORTER; EFFLUX PUMP; INDUCER EXCLUSION; CRYSTAL-STRUCTURE; DOXORUBICIN; EXPRESSION; DOMAINS	Two novel regulatory motifs, LDEVFL and C-terminal regulatory Glu (E)-rich motif (CREEM), are identified in the extreme C terminus of the ABC protein DrrA, which is involved in direct interaction with the N-terminal cytoplasmic tail of the membrane protein DrrB and in homodimerization of DrrA. Disulfide cross-linking analysis showed that the CREEM and the region immediately upstream of CREEM participate directly in forming an interaction interface with the N terminus of DrrB. A series of mutations created in the LDEVFL and CREEM motifs drastically affected overall function of the DrrAB transporter. Mutations in the LDEVFL motif also significantly impaired interaction between the C terminus of DrrA and the N terminus of DrrB as well as the ability of DrrA and DrrB to co-purify, therefore suggesting that the LDEVFL motif regulates CREEM-mediated interaction between DrrA and DrrB and plays a key role in biogenesis of the DrrAB complex. Modeling analysis indicated that the LDEVFL motif is critical for conformational integrity of the C-terminal domain of DrrA and confirmed that the C terminus of DrrA forms an independent domain. This is the first report which describes the presence of an assembly domain in an ABC protein and uncovers a novel mechanism whereby the ABC component facilitates the assembly of the membrane component. Homology sequence comparisons showed the presence of the LDEVFL and CREEM motifs in close prokaryotic and eukaryotic homologs of DrrA, suggesting that these motifs may play a similar role in other homologous drug and lipid export systems.	[Zhang, Han; Pradhan, Prajakta; Kaur, Parjit] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30303 USA.	pkaur@gsu.edu			National Institutes of Health [RO1 GM51981-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM51981-09 (to P. K.).	Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; ANGOV E, 1988, J BACTERIOL, V170, P459, DOI 10.1128/jb.170.1.459-462.1988; Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; BUKAU B, 1986, J BACTERIOL, V166, P884, DOI 10.1128/jb.166.3.884-891.1986; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Gandlur SM, 2004, J BIOL CHEM, V279, P27799, DOI 10.1074/jbc.M402898200; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; GUILFOILE PG, 1991, P NATL ACAD SCI USA, V88, P8553, DOI 10.1073/pnas.88.19.8553; Harrison RW, 1995, PROTEINS, V23, P463, DOI 10.1002/prot.340230402; Holland I.B., 2003, ABC PROTEINS BACTERI, P3; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Kaur P, 2005, BIOCHEMISTRY-US, V44, P2661, DOI 10.1021/bi048959c; Kaur P, 1997, J BACTERIOL, V179, P569, DOI 10.1128/jb.179.3.569-575.1997; Kaur P, 1998, J BIOL CHEM, V273, P17933, DOI 10.1074/jbc.273.28.17933; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mace S, 2005, NEUROBIOL DIS, V18, P119, DOI 10.1016/j.nbd.2004.09.011; Moody JE, 2005, J BIOENERG BIOMEMBR, V37, P475, DOI 10.1007/s10863-005-9494-8; Nehme D, 2004, J BACTERIOL, V186, P2973, DOI 10.1128/JB.186.10.2973-2983.2004; Nsahlai CJ, 2003, FEMS MICROBIOL LETT, V224, P113, DOI 10.1016/S0378-1097(03)00428-2; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Panagiotidis CH, 1998, MOL MICROBIOL, V30, P535, DOI 10.1046/j.1365-2958.1998.01084.x; Pradhan P, 2009, J MOL BIOL, V385, P831, DOI 10.1016/j.jmb.2008.11.027; Rao DK, 2008, BIOCHEMISTRY-US, V47, P3038, DOI 10.1021/bi701699a; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	42	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38324	38336		10.1074/jbc.M110.131540	http://dx.doi.org/10.1074/jbc.M110.131540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20876527	hybrid, Green Published			2022-12-27	WOS:000284625600039
J	Liu, XY; Ruan, LF; Hu, ZF; Peng, DH; Cao, SY; Yu, ZN; Liu, Y; Zheng, JS; Sun, M				Liu, Xiao-Yan; Ruan, Li-Fang; Hu, Zhen-Fei; Peng, Dong-Hai; Cao, Shi-Yun; Yu, Zi-Niu; Liu, Yao; Zheng, Jin-Shui; Sun, Ming			Genome-wide Screening Reveals the Genetic Determinants of an Antibiotic Insecticide in Bacillus thuringiensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL PROTEIN GENES; BETA-EXOTOXIN; STRAINS; PLASMIDS; IDENTIFICATION; PURIFICATION; LEPIDOPTERAN; EVOLUTION; CLONING	Thuringiensin is a thermostable secondary metabolite in Bacillus thuringiensis and has insecticidal activity against a wide range of insects. Until now, the regulatory mechanisms and genetic determinants involved in thuringiensin production have remained unclear. Here, we successfully used heterologous expression-guided screening in an Escherichia coli-Bacillus thuringiensis shuttle bacterial artificial chromosome library, to clone the intact thuringiensin synthesis (thu) cluster. Then the thu cluster was located on a 110-kb endogenous plasmid bearing insecticide crystal protein gene cry1Ba in strain CT-43. Furthermore, the plasmid, named pBMB0558, was indirectly cloned and sequenced. The gene functions on pBMB0558 were annotated by BLAST based on the GenBank (TM) and KEGG databases. The genes on pBMB0558 could be classified into three functional modules: a thuringiensin synthesis cluster, a type IV secretion system-like module, and mobile genetic elements. By HPLC coupling mass spectrometer, atmospheric pressure ionization with ion trap, and TOF technologies, biosynthetic intermediates of thuringiensin were detected. The thuE gene is proved to be responsible for the phosphorylation of thuringiensin at the last step by vivo and vitro activity assays. The thuringiensin biosynthesis pathway was deduced and clarified. We propose that thuringiensin is an adenine nucleoside oligosaccharide rather than an adenine nucleotide analog, as is traditionally believed, based on the predicted functions of the key enzymes, glycosyltransferase (ThuF) and exopolysaccharide polymerization protein (Thu1).	[Liu, Xiao-Yan; Ruan, Li-Fang; Hu, Zhen-Fei; Peng, Dong-Hai; Cao, Shi-Yun; Yu, Zi-Niu; Liu, Yao; Zheng, Jin-Shui; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Sun, M (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015	Ming, Sun/0000-0001-5465-5983	National Basic Research Program (973 Program) of China [2009CB118902]; National Natural Science Foundation of China [30400003, 30970037]; National High Technology Research and Development Program (863 Program) of China [2006AA02Z174, 2006AA10A212]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; Ministry of Forestry Project (948 Program) of China [2006-4-41]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Genetically Modified Organisms Breeding Major Projects of China; Ministry of Forestry Project (948 Program) of China	This work was supported by National Basic Research Program (973 Program) of China Grant 2009CB118902, National Natural Science Foundation of China Grants 30400003 and 30970037, National High Technology Research and Development Program (863 Program) of China Grants 2006AA02Z174 and 2006AA10A212, Genetically Modified Organisms Breeding Major Projects of China Grant 2009ZX08009-032B, and Ministry of Forestry Project (948 Program) of China Grant 2006-4-41.	ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; ARONSON AI, 1986, MICROBIOL REV, V50, P1; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cheng WC, 2005, J BACTERIOL, V187, P8156, DOI 10.1128/JB.187.23.8156-8163.2005; COHEN SS, 1951, J BIOL CHEM, V189, P617; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Donovan WP, 2006, APPL MICROBIOL BIOT, V72, P713, DOI 10.1007/s00253-006-0332-7; Draper O, 2006, J BIOL CHEM, V281, P37628, DOI 10.1074/jbc.M606403200; ENGEL HJ, 1969, BIOCHIM BIOPHYS ACTA, V191, P509, DOI 10.1016/0005-2744(69)90344-1; Espinasse S, 2002, J BACTERIOL, V184, P5848, DOI 10.1128/JB.184.21.5848-5854.2002; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; GLASER L, 1955, J BIOL CHEM, V216, P67; GONZALEZ JM, 1982, P NATL ACAD SCI-BIOL, V79, P6951, DOI 10.1073/pnas.79.22.6951; Grynberg M, 2007, TRENDS MICROBIOL, V15, P191, DOI 10.1016/j.tim.2007.03.002; Guo SX, 2008, APPL ENVIRON MICROB, V74, P6997, DOI 10.1128/AEM.01346-08; HOFTE H, 1989, MICROBIOL REV, V53, P242; Ji F, 2009, FEMS MICROBIOL LETT, V300, P11, DOI 10.1111/j.1574-6968.2009.01743.x; KALVODA L, 1973, TETRAHEDRON LETT, P4671; LEVINSON BL, 1990, J BACTERIOL, V172, P3172, DOI 10.1128/jb.172.6.3172-3179.1990; Liu XY, 2009, APPL MICROBIOL BIOT, V82, P765, DOI 10.1007/s00253-008-1854-y; Liu ZY, 2008, RAPID COMMUN MASS SP, V22, P1009, DOI 10.1002/rcm.3422; LOBNEROLESEN A, 1992, J BACTERIOL, V174, P525, DOI 10.1128/jb.174.2.525-529.1992; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MAXWELL ES, 1956, ARCH BIOCHEM BIOPHYS, V65, P2, DOI 10.1016/0003-9861(56)90171-0; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200; Ohba M, 2009, ANTICANCER RES, V29, P427; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; SABLE HZ, 1952, J BIOL CHEM, V196, P395; Sambrook J., 1989, MOL CLONING LAB MANU, P474; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SEBESTA K, 1970, BIOCHIM BIOPHYS ACTA, V209, P357, DOI 10.1016/0005-2787(70)90734-3; Song LL, 2008, J INVERTEBR PATHOL, V98, P169, DOI 10.1016/j.jip.2008.02.006; STABB EV, 1994, APPL ENVIRON MICROB, V60, P4404, DOI 10.1128/AEM.60.12.4404-4412.1994; STROMINGER JL, 1957, J BIOL CHEM, V224, P79; Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003; Tamez-Guerra P, 2004, J INVERTEBR PATHOL, V86, P7, DOI 10.1016/j.jip.2004.02.009; Toledo J, 1999, J ECON ENTOMOL, V92, P1052, DOI 10.1093/jee/92.5.1052; Tsai SF, 2006, TOXICOL APPL PHARM, V216, P347, DOI 10.1016/j.taap.2006.05.013; Tsai SF, 2004, TOXICOL APPL PHARM, V194, P34, DOI 10.1016/j.taap.2003.08.015; Tsuchiya S, 2002, J INVERTEBR PATHOL, V81, P122, DOI 10.1016/S0022-2011(02)00148-9; WAALWIJK C, 1985, NUCLEIC ACIDS RES, V13, P8207, DOI 10.1093/nar/13.22.8207; Wirth MC, 2010, ENVIRON MICROBIOL, V12, P1154, DOI 10.1111/j.1462-2920.2010.02156.x	48	38	43	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39191	39200		10.1074/jbc.M110.148387	http://dx.doi.org/10.1074/jbc.M110.148387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20864531	Green Published, hybrid			2022-12-27	WOS:000284941300049
J	Wiethaus, J; Busch, AWU; Kock, K; Leichert, LI; Herrmann, C; Frankenberg-Dinkel, N				Wiethaus, Jessica; Busch, Andrea W. U.; Kock, Klaus; Leichert, Lars I.; Herrmann, Christian; Frankenberg-Dinkel, Nicole			CpeS Is a Lyase Specific for Attachment of 3Z-PEB to Cys(82) of beta-phycoerythrin from Prochlorococcus marinus MED4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE ANALYSIS; BILIN BINDING-PROTEIN; ANABAENA SP PCC-7120; CHROMOPHORE ATTACHMENT; C-PHYCOCYANIN; FERREDOXIN OXIDOREDUCTASE; PHOTOSYNTHETIC PROKARYOTE; PHYCOBILIPROTEIN LYASE; CRYPTOPHYCEAN ALGAE; GENE ENCODES	In contrast to the majority of cyanobacteria, the unicellular marine cyanobacterium Prochlorococcus marinus MED4 uses an intrinsic divinyl-chlorophyll-dependent light-harvesting system for photosynthesis. Despite the absence of phycobilisomes, this high-light adapted strain possesses beta-phycoerythrin (CpeB), an S-type lyase (CpeS), and enzymes for the biosynthesis of phycoerythrobilin (PEB) and phycocyanobilin. Of all linear tetrapyrroles synthesized by Prochlorococcus including their 3Z-and 3E-isomers, CpeS binds both isomers of PEB and its biosynthetic precursor 15,16-dihydrobiliverdin (DHBV). However, dimerization of CpeS is independent of bilins, which are tightly bound in a complex at a ratio of 1:1. Although bilin binding by CpeS is fast, transfer to CpeB is rather slow. CpeS is able to attach 3E-PEB and 3Z-PEB to dimeric CpeB but not DHBV. CpeS transfer of 3Z-PEB exclusively yields correctly bound beta Cys(82)-PEB, whereas beta Cys(82)-DHBV is a side product of 3E-PEB transfer. Spontaneous 3E- and 3Z-PEB addition to CpeB is faulty, and products are in both cases beta Cys(82)-DHBV and likely a PEB bound at beta Cys(82) in a non-native configuration. Our data indicate that CpeS is specific for 3Z-PEB transfer to beta Cys(82) of phycoerythrin and essential for the correct configuration of the attachment product.	[Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Dept Physiol Microorganisms, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Kock, Klaus] Ruhr Univ Bochum, Fac Chem & Biochem, D-44780 Bochum, Germany; [Leichert, Lars I.] Ruhr Univ Bochum, Med Proteome Ctr, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Dept Physiol Microorganisms, Fac Biol & Biotechnol, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	Leichert, Lars I./B-4762-2009; Frankenberg-Dinkel, Nicole/C-1058-2011	Leichert, Lars I./0000-0002-5666-9681; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839	Deutsche Forschungsgemeinschaft; German-Israeli Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Deutsche Forschungsgemeinschaft and a German-Israeli Foundation Young Investigator grant (to N. F.-D.).	Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; COLE WJ, 1968, BIOCHEMISTRY-US, V7, P2929, DOI 10.1021/bi00848a033; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2007, FEMS MICROBIOL LETT, V271, P251, DOI 10.1111/j.1574-6968.2007.00715.x; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg N., 2003, PORPHYRIN HDB, P211; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1975, J BIOL CHEM, V250, P5487; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; GOSSAUER A, 1978, J AM CHEM SOC, V100, P5928, DOI 10.1021/ja00486a053; Grzenclowski M, 2010, NEURO-ONCOLOGY, V12, P243, DOI 10.1093/neuonc/nop025; HEIRWEGH KPM, 1991, ANAL BIOCHEM, V195, P273, DOI 10.1016/0003-2697(91)90329-R; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; HUBER R, 1987, J MOL BIOL, V195, P423, DOI 10.1016/0022-2836(87)90661-9; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; SCHARNAGL C, 1983, Z NATURFORSCH C, V38, P951; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Stec B, 1999, BIOPHYS J, V76, P2912, DOI 10.1016/S0006-3495(99)77446-1; Steglich C, 2003, ENVIRON MICROBIOL, V5, P681, DOI 10.1046/j.1462-2920.2003.00456.x; Steglich C, 2003, FEBS LETT, V553, P79, DOI 10.1016/S0014-5793(03)00971-2; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Terry M., 2002, HEME CHLOROPHYLL BIL, P273; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Ting CS, 2001, MICROBIOL-SGM, V147, P3171, DOI 10.1099/00221287-147-11-3171; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; WAHLEITHNER JA, 1991, P NATL ACAD SCI USA, V88, P10387, DOI 10.1073/pnas.88.23.10387; WEDEMAYER GJ, 1992, J BIOL CHEM, V267, P7315; WEMMER DE, 1993, J BIOL CHEM, V268, P1658; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X	63	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37561	37569		10.1074/jbc.M110.172619	http://dx.doi.org/10.1074/jbc.M110.172619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20876568	Green Published, hybrid			2022-12-27	WOS:000284424000048
J	Cho, YD; Yoon, WJ; Woo, KM; Baek, JH; Park, JC; Ryoo, HM				Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Park, Joo-Cheol; Ryoo, Hyun-Mo			The Canonical BMP Signaling Pathway Plays a Crucial Part in Stimulation of Dentin Sialophosphoprotein Expression by BMP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; ODONTOBLAST DIFFERENTIATION; RUNX2; DLX5; MSX2; TRANSCRIPTION; MOUSE; DSPP; PULP; DENTINOGENESIS	Dentin sialophosphoprotein (DSPP), a typical dentin-specific protein, is mainly expressed in the dentin extracellular matrix and plays a role in dentin mineralization. BMP-2 provides a strong signal for differentiation and mineralization of odontoblasts and osteoblasts. Previously, BMP-2 treatment is reported to stimulate Dspp expression in the MD10-F2 pre-odontoblast cells through activation of the heterotrimeric transcription factor Y (NF-Y). The canonical BMP signaling pathway is known to contribute greatly to biomineralization, however, it is not known whether it is involved in Dspp expression. Here, we investigated this question. Activation of the canonical BMP-2 signaling pathway in MDPC-23, preodontoblast cell, by overexpression of constitutively active Smad1/5 or downstream transcription factors Dlx5 and Runx2 stimulated Dspp expression. Conversely, knockdown of each element with siRNA significantly blocked the BMP-2-induced Dspp expression. To test whether these transcription factors downstream of BMP-2 are directly involved in regulating Dspp, we analyzed the mouse Dspp promoter. There are 5 well conserved homeodomain binding elements, H1 to H5, in Dspp proximal promoter regions (-791 to +54). A serial deletion of H1 and H2 greatly changed basal promoter activity and responsiveness to Dlx5 or Msx2. However, further deletions did not change the responsiveness to Dlx5 or Msx2. H1 and H2 sites can be suggested as specific response elements of Dlx5 and Msx2, respectively, based on their promoter activity modulation. Thus, the canonical BMP-2 signaling pathway plays a crucial part in the regulation of Dspp expression through the action of Smads, Dlx5, Runx2, and Msx2.	[Cho, Young-Dan; Yoon, Won-Joon; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Dept Mol Genet, Seoul 110749, South Korea; [Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Seoul 110749, South Korea; Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Cho, Young-Dan/AAR-4573-2021; Woo, Kyung Mi/A-2793-2009; Ryoo, Hyun-Mo/D-5839-2012; Park, Joo Cheol/D-6437-2012; Baek, Jeong-Hwa/A-8628-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341; Park, Joo Cheol/0000-0002-3162-7557; 	Ministry of Health and Welfare [A090913, A010252]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare Project numbers A090913 and A010252.	Barnes GL, 2003, CANCER RES, V63, P2631; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391; Choi KY, 2005, DEV DYNAM, V233, P115, DOI 10.1002/dvdy.20323; Davideau JL, 1999, PEDIATR RES, V46, P650, DOI 10.1203/00006450-199912000-00003; Dodig M, 1996, J BIOL CHEM, V271, P16422, DOI 10.1074/jbc.271.27.16422; Galler KM, 2007, J DENT RES, V86, P951, DOI 10.1177/154405910708601007; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Nadiri A, 2006, CELL TISSUE RES, V324, P33, DOI 10.1007/s00441-005-0120-1; Nadiri A, 2004, J HISTOCHEM CYTOCHEM, V52, P103, DOI 10.1177/002215540405200110; NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Patel PI, 2001, NAT GENET, V27, P129, DOI 10.1038/84728; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Ruhin-Poncet B, 2009, J HISTOCHEM CYTOCHEM, V57, P69, DOI 10.1369/jhc.2008.951707; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Unterbrink A, 2002, CONNECT TISSUE RES, V43, P354, DOI 10.1080/03008200290000565; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Yoon WJ, 2008, J BIOL CHEM, V283, P32751, DOI 10.1074/jbc.M803183200; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; ZHU W, 1994, MAMM GENOME, V5, P234, DOI 10.1007/BF00360552	36	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36369	36376		10.1074/jbc.M110.103093	http://dx.doi.org/10.1074/jbc.M110.103093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843790	Green Published, hybrid			2022-12-27	WOS:000284146100029
J	Gupta, S; Ghosh, SK; Scott, ME; Bainbridge, B; Jiang, B; Lamont, RJ; McCormick, TS; Weinberg, A				Gupta, Sanhita; Ghosh, Santosh K.; Scott, Mary E.; Bainbridge, Brian; Jiang, Bin; Lamont, Richard J.; McCormick, Thomas S.; Weinberg, Aaron			Fusobacterium nucleatum-associated beta-Defensin Inducer (FAD-I) IDENTIFICATION, ISOLATION, AND FUNCTIONAL EVALUATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ORAL EPITHELIAL-CELLS; ANTIMICROBIAL PEPTIDE EXPRESSION; TOLL-LIKE RECEPTOR-2; PORPHYROMONAS-GINGIVALIS; HUMAN BETA-DEFENSIN-2; DENDRITIC CELLS; INNATE IMMUNITY; PERIODONTAL BACTERIA; ENDOTHELIAL-CELLS	Human beta-defensins (hBDs) are small, cationic antimicrobial peptides, secreted by mucosal epithelial cells that regulate adaptive immune functions. We previously reported that Fusobacterium nucleatum, a ubiquitous Gram-negative bacterium of the human oral cavity, induces human beta-defensin 2 (hBD2) upon contact with primary oral epithelial cells. We now report the isolation and characterization of an F. nucleatum (ATCC 25586)-associated defensin inducer (FAD-I). Biochemical approaches revealed a cell wall fraction containing four proteins that stimulated the production of hBD2 in human oral epithelial cells (HOECs). Cross-referencing of the N-terminal sequences of these proteins with the F. nucleatum genome revealed that the genes encoding the proteins were FadA, FN1527, FN1529, and FN1792. Quantitative PCR of HOEC monolayers challenged with Escherichia coli clones expressing the respective cell wall proteins revealed that FN1527 was most active in the induction of hBD2 and hence was termed FAD-I. We tagged FN1527 with a c-myc epitope on the C-terminal end to identify and purify it from the E. coli clone. Purified FN1527 (FAD-I) induced hBD2 mRNA and protein expression in HOEC monolayers. F. nucleatum cell wall and FAD-I induced hBD2 via TLR2. Porphorymonas gingivalis, an oral pathogen that does not induce hBD2 in HOECs, was able to significantly induce expression of hBD2 in HOECs only when transformed to express FAD-I. FAD-I or its derivates offer a potentially new paradigm in immunoregulatory therapeutics because they may one day be used to bolster the innate defenses of vulnerable mucosae.	[Gupta, Sanhita; Ghosh, Santosh K.; Scott, Mary E.; Jiang, Bin; Weinberg, Aaron] Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH 44106 USA; [McCormick, Thomas S.] Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH 44106 USA; [Bainbridge, Brian; Lamont, Richard J.] Univ Florida, Sch Dent, Gainesville, FL 32611 USA	Case Western Reserve University; Case Western Reserve University; State University System of Florida; University of Florida	Weinberg, A (corresponding author), Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH 44106 USA.	aaron.weinberg@case.edu	Ghosh, Santosh K/I-5461-2019	Ghosh, Santosh K/0000-0001-5669-7853; Weinberg, Aaron/0000-0002-9960-7181; McCormick, Thomas/0000-0002-3294-0326	National Institutes of Health [DE018276, DE11111]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE011111, R56DE018276, R01DE018276, R01DE011111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE018276 (to A. W.) and DE11111 (to R. J. L.).	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Caamano J, 2000, J IMMUNOL, V165, P5720, DOI 10.4049/jimmunol.165.10.5720; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Dale BA, 2001, J PERIODONTAL RES, V36, P285, DOI 10.1034/j.1600-0765.2001.360503.x; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Dommisch H, 2007, INFECT IMMUN, V75, P4326, DOI 10.1128/IAI.00455-07; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; GANZ T, 1992, MED MICROBIOL IMMUN, V181, P99; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Ghosh SK, 2007, CLIN CHEM, V53, P757, DOI 10.1373/clinchem.2006.081430; Gong JL, 2009, J IMMUNOL, V183, P3092, DOI 10.4049/jimmunol.0901235; Gursoy UK, 2008, ORAL MICROBIOL IMMUN, V23, P432, DOI 10.1111/j.1399-302X.2008.00453.x; Haake SK, 2000, J BACTERIOL, V182, P1176, DOI 10.1128/JB.182.4.1176-1180.2000; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hasegawa Y, 2008, INFECT IMMUN, V76, P2420, DOI 10.1128/IAI.00156-08; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Jarnicki AG, 2008, J IMMUNOL, V180, P3797, DOI 10.4049/jimmunol.180.6.3797; Ji S, 2009, INFECT IMMUN, V77, P1044, DOI 10.1128/IAI.00449-08; Jin G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010993; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kawsar HI, 2010, PEPTIDES, V31, P195, DOI 10.1016/j.peptides.2009.12.008; KENNELL W, 1990, ORAL MICROBIOL IMMUN, V5, P121, DOI 10.1111/j.1399-302X.1990.tb00409.x; Kobayashi-Sakamoto M, 2003, CURR MICROBIOL, V46, P109, DOI 10.1007/s00284-002-3782-x; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Liang S, 2007, J BIOL CHEM, V282, P7532, DOI 10.1074/jbc.M611722200; Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Madianos PN, 1997, INFECT IMMUN, V65, P3983, DOI 10.1128/IAI.65.10.3983-3990.1997; O'Neil DA, 1999, J IMMUNOL, V163, P6718; ODA D, 1990, IN VITRO CELL DEV B, V26, P589; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park Y, 2007, FEMS MICROBIOL LETT, V273, P103, DOI 10.1111/j.1574-6968.2007.00782.x; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Peyret-Lacombe A, 2009, CYTOKINE, V46, P201, DOI 10.1016/j.cyto.2009.01.006; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; SELSTED ME, 1993, J BIOL CHEM, V268, P6641; Smith C J, 1995, Methods Mol Biol, V47, P161; Starner TD, 2005, J IMMUNOL, V174, P1608, DOI 10.4049/jimmunol.174.3.1608; Takahashi A, 2001, FEBS LETT, V508, P484, DOI 10.1016/S0014-5793(01)03088-5; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xie H, 2000, INFECT IMMUN, V68, P6574, DOI 10.1128/IAI.68.12.6574-6579.2000; Yadava P, 2006, INT J ANTIMICROB AG, V28, P132, DOI 10.1016/j.ijantimicag.2006.02.021; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje; Zasloff M, 2002, NEW ENGL J MED, V347, P1199, DOI 10.1056/NEJMe020106; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	74	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36523	36531		10.1074/jbc.M110.133140	http://dx.doi.org/10.1074/jbc.M110.133140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20847052	Green Published, hybrid			2022-12-27	WOS:000284146100055
J	Valenti, A; Perugino, G; Varriale, A; D'Auria, S; Rossi, M; Ciaramella, M				Valenti, Anna; Perugino, Giuseppe; Varriale, Antonio; D'Auria, Sabato; Rossi, Mose; Ciaramella, Maria			The Archaeal Topoisomerase Reverse Gyrase Is a Helix-destabilizing Protein That Unwinds Four-way DNA Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING-PROTEIN; INSIGHT; DOMAIN; IDENTIFICATION; REPLICATION; RESOLVASE; DAMAGE; HJC	Four-way junctions are non-B DNA structures that originate as intermediates of recombination and repair (Holliday junctions) or from the intrastrand annealing of palindromic sequences (cruciforms). These structures have important functional roles but may also severely interfere with DNA replication and other genetic processes; therefore, they are targeted by regulatory and architectural proteins, and dedicated pathways exist for their removal. Although it is well known that resolution of Holliday junctions occurs either by recombinases or by specialized helicases, less is known on the mechanisms dealing with secondary structures in nucleic acids. Reverse gyrase is a DNA topoisomerase, specific to microorganisms living at high temperatures, which comprises a type IA topoisomerase fused to an SF2 helicase-like module and catalyzes ATP hydrolysis-dependent DNA positive supercoiling. Reverse gyrase is likely involved in regulation of DNA structure and stability and might also participate in the cell response to DNA damage. By applying FRET technology to multiplex fluorophore gel imaging, we show here that reverse gyrase induces unwinding of synthetic four-way junctions as well as forked DNA substrates, following a mechanism independent of both the ATPase and the strand-cutting activity of the enzyme. The reaction requires high temperature and saturating protein concentrations. Our results suggest that reverse gyrase works like an ATP-independent helix-destabilizing protein specific for branched DNA structures. The results are discussed in light of reverse gyrase function and their general relevance for protein-mediated unwinding of complex DNA structures.	[Valenti, Anna; Perugino, Giuseppe; Varriale, Antonio; D'Auria, Sabato; Rossi, Mose; Ciaramella, Maria] CNR, Inst Prot Biochem, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Ciaramella, M (corresponding author), CNR, Inst Prot Biochem, Via Pietro Castellino 111, I-80131 Naples, Italy.	m.ciaramella@ibp.cnr.it	Perugino, Giuseppe/P-8147-2016; Varriale, Antonio/AAL-1439-2020; Ciaramella, Maria/O-1152-2015; d'auria, sabato/C-3565-2015	Ciaramella, Maria/0000-0003-1583-1694; d'auria, sabato/0000-0001-9320-494X; Valenti, Anna/0000-0002-5278-3524; Perugino, Giuseppe/0000-0003-3266-4744	Agenzia Spaziale Italiana [1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was partially supported by Agenzia Spaziale Italiana (Project MoMa Grant 1/014/06/0).	Bond CS, 2001, P NATL ACAD SCI USA, V98, P5509, DOI 10.1073/pnas.091613398; Briggs GS, 2004, PHILOS T R SOC B, V359, P49, DOI 10.1098/rstb.2003.1364; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cubeddu L, 2005, J MOL BIOL, V353, P507, DOI 10.1016/j.jmb.2005.08.050; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587; Fujikane R, 2005, J BIOL CHEM, V280, P12351, DOI 10.1074/jbc.M413417200; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; Kvaratskhelia M, 2000, J BIOL CHEM, V275, P25540, DOI 10.1074/jbc.M003420200; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lilley DMJ, 2010, BIOCHEM SOC T, V38, P399, DOI 10.1042/BST0380399; Lo YC, 2006, MOL CELL BIOL, V26, P4086, DOI 10.1128/MCB.00136-06; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Mikheikin AL, 2006, BIOCHEMISTRY-US, V45, P12998, DOI 10.1021/bi061002k; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Nadal M, 2007, BIOCHIMIE, V89, P447, DOI 10.1016/j.biochi.2006.12.010; Napoli A, 2005, NUCLEIC ACIDS RES, V33, P564, DOI 10.1093/nar/gki202; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Nishino T, 2001, STRUCTURE, V9, P197, DOI 10.1016/S0969-2126(01)00576-7; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Raja C, 2006, BIOCHEMISTRY-US, V45, P9254, DOI 10.1021/bi052560m; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; Salerno V, 2003, NUCLEIC ACIDS RES, V31, P6127, DOI 10.1093/nar/gkg831; Sharples GJ, 2001, MOL MICROBIOL, V39, P823, DOI 10.1046/j.1365-2958.2001.02284.x; Taraporewala ZF, 2001, J VIROL, V75, P4519, DOI 10.1128/JVI.75.10.4519-4527.2001; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Vindigni A, 2009, HFSP J, V3, P153, DOI 10.2976/1.3079540; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x; ZHANG HL, 1995, J BIOL CHEM, V270, P23700, DOI 10.1074/jbc.270.40.23700; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421	38	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36532	36541		10.1074/jbc.M110.169029	http://dx.doi.org/10.1074/jbc.M110.169029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20851892	Green Published, hybrid			2022-12-27	WOS:000284146100021
J	Lomash, S; Nagpal, S; Salunke, DM				Lomash, Suvendu; Nagpal, Sushma; Salunke, Dinakar M.			An Antibody as Surrogate Receptor Reveals Determinants of Activity of an Innate Immune Peptide Antibiotic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ANTIMICROBIAL PEPTIDE; MONOCLONAL-ANTIBODIES; T-CELLS; INDOLICIDIN; TRYPTOPHAN; PROTEINS; BINDING; ANTIBACTERIAL; PLASTICITY; MEMBRANES	Drug discovery initiatives often depend critically on knowledge of ligand-receptor interactions. However, the identity or structure of the target receptor may not be known in every instance. The concept of receptor surrogate, a molecular environment mimic of natural receptor, may prove beneficial under such circumstances. Here, we demonstrate the potential of monoclonal antibodies (mAbs) to act as surrogate receptors for a class of innate immune peptide antibiotics, a strategy that can help comprehend their action mechanism and identify chemical entities crucial for activity. A panel of antibody surrogates was raised against indolicidin, a tryptophan-rich cationic broad spectrum antimicrobial peptide of innate immune origin. Employing an elegant combination of thermodynamics, crystallography, and molecular modeling, interactions of the peptide with a high affinity anti-indolicidin monoclonal antibody were analyzed and were used to identify a motif that contained almost the entire antibiotic activity of native indolicidin. The analysis clarified the interaction of the peptide with previously proposed targets such as bacterial cell membrane and DNA and could further be correlated with antimicrobial compounds whose actions involve varied other mechanisms. These features suggest a multipronged assault pathway for indolicidin. Remarkably, the anti-indolicidin mAb surrogate was able to isolate additional independent bactericidal sequences from a random peptide library, providing compelling evidence as to the physiological relevance of surrogate receptor concept and suggesting applications in receptor-based pharmacophore research.	[Lomash, Suvendu; Nagpal, Sushma; Salunke, Dinakar M.] Natl Inst Immunol, Struct Biol Unit, New Delhi 110067, India; [Salunke, Dinakar M.] Reg Ctr Biotechnol, Gurgaon 122016, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology	Salunke, DM (corresponding author), Natl Inst Immunol, Struct Biol Unit, Aruna Asaf Ali Rd, New Delhi 110067, India.	dinakar.salunke@gmail.com			Department of Biotechnology from the Indian government	Department of Biotechnology from the Indian government	This work was funded by the Department of Biotechnology from the Indian government.	AHMAD I, 1995, BBA-BIOMEMBRANES, V1237, P109, DOI 10.1016/0005-2736(95)00087-J; Andersen PS, 1996, P NATL ACAD SCI USA, V93, P1820, DOI 10.1073/pnas.93.5.1820; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bright SW, 1997, LIFE SCI, V61, P2305, DOI 10.1016/S0024-3205(97)00934-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHANH TC, 1987, P NATL ACAD SCI USA, V84, P3891, DOI 10.1073/pnas.84.11.3891; Chong-Cerrillo C, 2003, J PEPT RES, V61, P237, DOI 10.1034/j.1399-3011.2003.00053.x; DeLano W.L, PYMOL MOL GRAPHICS S; Disney MD, 2005, ANTIMICROB AGENTS CH, V49, P1326, DOI 10.1128/AAC.49.4.1326-1330.2005; Efimov AV, 2003, FEBS LETT, V554, P389, DOI 10.1016/S0014-5793(03)01189-X; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Falla TJ, 1997, ANTIMICROB AGENTS CH, V41, P771, DOI 10.1128/AAC.41.4.771; Goel M, 2004, J IMMUNOL, V173, P7358, DOI 10.4049/jimmunol.173.12.7358; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Gorfe AA, 2008, BIOPHYS J, V95, P3269, DOI 10.1529/biophysj.108.136481; Harlow E., 1988, ANTIBODIES LAB MANUA; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kawaji N, 2001, J LIPID RES, V42, P1671; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LARRICK JW, 1989, PHARMACOL REV, V41, P539; Lee DG, 2003, BIOCHEM BIOPH RES CO, V305, P305, DOI 10.1016/S0006-291X(03)00755-1; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Loladze VV, 2001, PROTEIN SCI, V10, P1343, DOI 10.1110/ps.370101; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merienne K, 1997, J BIOL CHEM, V272, P23775, DOI 10.1074/jbc.272.38.23775; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nagpal S, 2002, PROTEIN SCI, V11, P2158, DOI 10.1110/ps.0211602; Oomen CJ, 2005, J MOL BIOL, V351, P1070, DOI 10.1016/j.jmb.2005.06.061; Rozek A, 2000, BIOCHEMISTRY-US, V39, P15765, DOI 10.1021/bi000714m; SCHLUESENER HJ, 1993, J NEUROIMMUNOL, V47, P199, DOI 10.1016/0165-5728(93)90030-3; Shaw JE, 2006, J STRUCT BIOL, V154, P42, DOI 10.1016/j.jsb.2005.11.016; Sitaram N, 2003, BIOCHEM BIOPH RES CO, V309, P879, DOI 10.1016/j.bbrc.2003.08.095; Staubitz P, 2001, J PEPT SCI, V7, P552, DOI 10.1002/psc.351; Subbalakshmi C, 2000, BIOCHEM BIOPH RES CO, V274, P714, DOI 10.1006/bbrc.2000.3214; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tanrikulu Y, 2008, NAT REV DRUG DISCOV, V7, P667, DOI 10.1038/nrd2615; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao HX, 2001, BIOPHYS J, V81, P2979, DOI 10.1016/S0006-3495(01)75938-3	45	6	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35750	35758		10.1074/jbc.M110.150516	http://dx.doi.org/10.1074/jbc.M110.150516			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837490	hybrid, Green Published			2022-12-27	WOS:000283845300053
J	Reiner, S; Ambrosio, M; Hoffmann, C; Lohse, MJ				Reiner, Susanne; Ambrosio, Manuela; Hoffmann, Carsten; Lohse, Martin J.			Differential Signaling of the Endogenous Agonists at the beta(2)-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; BETA-ARRESTIN; LIVING CELLS; BETA-2-ADRENERGIC RECEPTOR; MEDIATED ACTIVATION; ERK1/2 ACTIVATION; ADENYLYL-CYCLASE; PHOSPHORYLATION; REVEALS; DESENSITIZATION	The concept of "functional selectivity" or "biased signaling" suggests that a ligand can have distinct efficacies with regard to different signaling pathways. We have investigated the question of whether biased signaling may be related to distinct agonist-induced conformational changes in receptors using the beta(2)-adrenergic receptor (beta(2)AR) and its two endogenous ligands epinephrine and norepinephrine as a model system. Agonist-induced conformational changes were determined in a fluorescently tagged beta(2)ARFRET sensor. In this beta(2)AR sensor, norepinephrine caused signals that amounted to only approximate to 50% of those induced by epinephrine and the standard "full" agonist isoproterenol. Furthermore, norepinephrine-induced changes in the beta(2)AR FRET sensor were slower than those induced by epinephrine (rate constants, 47 versus 128 ms). A similar partial beta(2)AR activation signal was revealed for the synthetic agonists fenoterol and terbutaline. However, norepinephrine was almost as efficient as epinephrine (and isoproterenol) in causing activation of G(s) and adenylyl cyclase. In contrast, fenoterol was quite efficient in triggering beta-arrestin2 recruitment to the cell surface and its interaction with beta(2)AR, as well as internalization of the receptors, whereas norepinephrine caused partial and slow changes in these assays. We conclude that partial agonism of norepinephrine at the beta(2)AR is related to the induction of a different active conformation and that this conformation is efficient in signaling to Gs and less efficient in signaling to beta-arrestin2. These observations extend the concept of biased signaling to the endogenous agonists of the beta(2)AR and link it to distinct conformational changes in the receptor.	[Hoffmann, Carsten] Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany; [Ambrosio, Manuela] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy	University of Wurzburg; University of Milan	Hoffmann, C (corresponding author), Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.	C.Hoffmann@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510	Deutsche Forschungsgemeinschaft [SFB487]; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB487 and European Research Council Advanced Investigator Grant TOPAS.	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BENOVIC JL, 1988, J BIOL CHEM, V263, P3893; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LEVITZKI A, 1993, LIFE SCI, V52, P2093, DOI 10.1016/0024-3205(93)90724-H; Lewis MM, 1998, J PHARMACOL EXP THER, V286, P345; Liapakis G, 2004, MOL PHARMACOL, V65, P1181, DOI 10.1124/mol.65.5.1181; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; LOHSE MJ, 1992, N-S ARCH PHARMACOL, V345, P444; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Nikolaev VO, 2007, J BIOL CHEM, V282, P27126, DOI 10.1074/jbc.M703272200; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Reiner S, 2009, MOL PHARMACOL, V76, P1162, DOI 10.1124/mol.109.060467; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urban JD, 2007, NEUROPSYCHOPHARMACOL, V32, P67, DOI 10.1038/sj.npp.1301071; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276	49	87	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36188	36198		10.1074/jbc.M110.175604	http://dx.doi.org/10.1074/jbc.M110.175604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837485	hybrid, Green Published			2022-12-27	WOS:000283845300094
J	Eichelsdoerfer, JL; Evans, JA; Slaugenhaupt, SA; Cuajungco, MP				Eichelsdoerfer, Jonathan L.; Evans, Jeffrey A.; Slaugenhaupt, Susan A.; Cuajungco, Math P.			Zinc Dyshomeostasis Is Linked with the Loss of Mucolipidosis IV-associated TRPML1 Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; ENDOGENOUS ZINC; ENHANCED ZINC; CELL-CULTURE; BRAIN; AUTOPHAGY; MUTATION; RELEASE; NEURONS; INJURY	Chelatable zinc is important in brain function, and its homeostasis is maintained to prevent cytotoxic overload. However, certain pathologic events result in intracellular zinc accumulation in lysosomes and mitochondria. Abnormal lysosomes and mitochondria are common features of the human lysosomal storage disorder known as mucolipidosis IV (MLIV). MLIV is caused by the loss of TRPML1 ion channel function. MLIV cells develop large hyperacidic lysosomes, membranous vacuoles, mitochondrial fragmentation, and autophagic dysfunction. Here, we observed that RNA interference of mucolipin-1 gene (TRPML1) in HEK-293 cells mimics the MLIV cell phenotype consisting of large lysosomes and membranous vacuoles that accumulate chelatable zinc. To show that abnormal chelatable zinc levels are indeed correlated with MLIV pathology, we quantified its concentration in cultured MLIV patient fibroblast and control cells with a spectrofluorometer using N-(6-methoxy-8-quinolyl)-p-toluene sulfonamide fluorochrome. We found a significant increase of chelatable zinc levels in MLIV cells but not in control cells. Furthermore, we quantified various metal isotopes in whole brain tissue of TRPML1(-/-) null mice and wild-type littermates using inductively coupled plasma mass spectrometry and observed that the zinc-66 isotope is markedly elevated in the brain of TRPML1(-/-) mice when compared with controls. In conclusion, we show for the first time that the loss of TRPML1 function results in intracellular chelatable zinc dyshomeostasis. We propose that chelatable zinc accumulation in large lysosomes and membranous vacuoles may contribute to the pathogenesis of the disease and progressive cell degeneration in MLIV patients.	[Eichelsdoerfer, Jonathan L.; Evans, Jeffrey A.; Cuajungco, Math P.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92831 USA; [Eichelsdoerfer, Jonathan L.; Evans, Jeffrey A.; Cuajungco, Math P.] Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Fullerton, CA 92831 USA; [Slaugenhaupt, Susan A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Slaugenhaupt, Susan A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Cuajungco, Math P.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia	California State University System; California State University Fullerton; California State University System; California State University Fullerton; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Florey Institute of Neuroscience & Mental Health	Cuajungco, MP (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, 800 N State Coll Blvd, Fullerton, CA 92831 USA.	mcuajungco@fullerton.edu	Cuajungco, Math/B-2647-2008	Cuajungco, Math/0000-0003-0749-9564	National Institutes of Health [R01 NS39995]; Doris Howell-CSUPERB research scholarships; Howard Hughes Medical Institute; National Science Foundation [MCB 920127]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Howell-CSUPERB research scholarships; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS39995 (to S. A. S.). This work was also partially supported by Doris Howell-CSUPERB research scholarships (to J.L.E. and J.A.E.), the Howard Hughes Medical Institute undergraduate research program, and National Science Foundation Grant MCB 920127 (to M. P. C.). A preliminary account of this work was presented in the Experimental Biology 2010 meeting on April 26, 2010 in Anaheim, CA.	AMIR N, 1987, PEDIATRICS, V79, P953; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Chung H, 2009, TOXICOL APPL PHARM, V235, P163, DOI 10.1016/j.taap.2008.11.006; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; FALCO N, 2007, EXP CELL RES */* E C, V313, P1473; Flinn JM, 2005, PHYSIOL BEHAV, V83, P793, DOI 10.1016/j.physbeh.2004.10.009; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Hirose K, 2004, J COMP NEUROL, V470, P164, DOI 10.1002/cne.11046; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Jiang PJ, 2004, COORDIN CHEM REV, V248, P205, DOI 10.1016/j.cct.2003.10.013; Kogot-Levin A, 2009, PEDIATR RES, V65, P686, DOI 10.1203/PDR.0b013e3181a1681a; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Linkous DH, 2009, J ALZHEIMERS DIS, V18, P565, DOI 10.3233/JAD-2009-1162; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yanagisawa H, 2009, TOXICOL LETT, V191, P15, DOI 10.1016/j.toxlet.2009.07.024; Yoon YH, 2000, TOXICOL APPL PHARM, V162, P107, DOI 10.1006/taap.1999.8846; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587	34	72	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34304	34308		10.1074/jbc.C110.165480	http://dx.doi.org/10.1074/jbc.C110.165480			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20864526	Green Published, hybrid			2022-12-27	WOS:000283659100003
J	Gloor, JW; Balakrishnan, L; Bambara, RA				Gloor, Jason W.; Balakrishnan, Lata; Bambara, Robert A.			Flap Endonuclease 1 Mechanism Analysis Indicates Flap Base Binding Prior to Threading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-I; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; BLOOM PROTEIN; REPAIR; FEN-1; PCNA; REPLICATION; CLEAVAGE	FEN1 cleaves 5' flaps at their base to create a nicked product for ligation. FEN1 has been reported to enter the flap from the 5'-end and track to the base. Current binding analyses support a very different mechanism of interaction with the flap substrate. Measurements of FEN1 binding to a flap substrate show that the nuclease binds with similar high affinity to the base of a long flap even when the 5'-end is blocked with biotin/streptavidin. However, FEN1 bound to a blocked flap is more sensitive to sequestration by a competing substrate. These results are consistent with a substrate interaction mechanism in which FEN1 first binds the flap base and then threads the flap through an opening in the protein from the 5'-end to the base for cleavage. Significantly, when the unblocked flap length is reduced from five to two nucleotides, FEN1 can be sequestered from the substrate to a similar extent as a blocked, long flap substrate. Apparently, interactions related to threading occur only when the flap is greater than two to four nucleotides long, implying that short flaps are cleaved without a threading requirement.	[Gloor, Jason W.; Balakrishnan, Lata; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM024441 (to R. A. B.).; Supported by National Institutes of Health T32 Fellowship GM068411.	Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; Bartos JD, 2006, J BIOL CHEM, V281, P32227, DOI 10.1074/jbc.M606310200; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim CY, 2001, BIOCHEMISTRY-US, V40, P3208, DOI 10.1021/bi002100n; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; ROBINS P, 1994, J BIOL CHEM, V269, P28535; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sharma S, 2005, NUCLEIC ACIDS RES, V33, P6769, DOI 10.1093/nar/gki1002; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200	31	29	29	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34922	34931		10.1074/jbc.M110.165902	http://dx.doi.org/10.1074/jbc.M110.165902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739288	Green Published, hybrid			2022-12-27	WOS:000283659100066
J	Lv, P; Wei, DG; Yamoah, EN				Lv, Ping; Wei, Dongguang; Yamoah, Ebenezer N.			K(v)7-type Channel Currents in Spiral Ganglion Neurons INVOLVEMENT IN SENSORINEURAL HEARING LOSS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR-CELLS; INNER-EAR; POTASSIUM CHANNELS; K+ CURRENTS; ELECTRICAL-STIMULATION; DOMINANT DEAFNESS; AUDITORY NEURONS; EXPRESSION; CALCIUM; KCNQ4	Alterations in K(v)7-mediated currents in excitable cells result in several diseased conditions. A case in DFNA2, an autosomal dominant version of progressive hearing loss, involves degeneration of hair cells and spiral ganglion neurons (SGNs) from basal to apical cochlea, manifesting as high-to-low frequency hearing loss, and has been ascribed to mutations in K(v)7.4 channels. Analyses of the cellular mechanisms of K(v)7.4 mutations and progressive degeneration of SGNs have been hampered by the paucity of functional data on the role K(v)7 channels play in young and adult neurons. To understand the cellular mechanisms of the disease in SGNs, we examined temporal (young, 0.5 months old, and senescent, 17 months old) and spatial (apical and basal) roles of K(v)7-mediated currents. We report that differential contribution of K(v)7 currents in mice SGNs results in distinct and profound variations of the membrane properties of basal versus apical neurons. The current produces a major impact on the resting membrane potential of basal neurons. Inhibition of the current promotes membrane depolarization, resulting in activation of Ca2+ currents and a sustained rise in intracellular Ca2+. Using TUNEL assay, we demonstrate that a sustained increase in intracellular Ca2+ mediated by inhibition of K(v)7 current results in significant SGN apoptotic death. Thus, this study provides evidence of the cellular etiology and mechanisms of SGN degeneration in DFNA2.	[Lv, Ping; Wei, Dongguang; Yamoah, Ebenezer N.] Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, Davis, CA 95618 USA	University of California System; University of California Davis	Yamoah, EN (corresponding author), Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, 1515 Newton Ct, Davis, CA 95618 USA.	enyamoah@ucdavis.edu			National Institutes of Health [DC010386]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC010386 (to E. N. Y.).	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Adamson CL, 2002, J COMP NEUROL, V447, P331, DOI 10.1002/cne.10244; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Beisel KW, 2004, GENOMICS, V83, P1012, DOI 10.1016/j.ygeno.2004.01.006; Beisel KW, 2000, MOL BRAIN RES, V82, P137; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; CHOI DW, 1989, ANN NY ACAD SCI, V568, P219; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Eatock RA, 2003, CURR TOP DEV BIOL, V57, P389, DOI 10.1016/S0070-2153(03)57013-2; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Hisashi K, 1995, HEARING RES, V91, P196, DOI 10.1016/0378-5955(95)00191-3; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; HU B, 2002, HUM MOL GENET */* T, V11, P2435; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Jagger DJ, 2002, NEUROSCIENCE, V109, P169, DOI 10.1016/S0306-4522(01)00454-7; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jin Z, 2009, AUDIOL NEURO-OTOL, V14, P98, DOI 10.1159/000158538; Jung DK, 2005, NEUROL RES, V27, P436, DOI 10.1179/016164105X22011; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Leake PA, 1999, J COMP NEUROL, V412, P543, DOI 10.1002/(SICI)1096-9861(19991004)412:4<543::AID-CNE1>3.0.CO;2-3; Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104; Lin X, 1998, J NEUROPHYSIOL, V79, P2503, DOI 10.1152/jn.1998.79.5.2503; Martinez-Monedero R, 2006, J NEUROBIOL, V66, P319, DOI 10.1002/neu.20232; Mo ZL, 2002, J PHYSIOL-LONDON, V542, P763, DOI 10.1113/jphysiol.2002.017202; Nie LP, 2005, J NEUROSCI, V25, P8671, DOI 10.1523/JNEUROSCI.1422-05.2005; Ohyama H, 2001, PFLUG ARCH EUR J PHY, V442, P329, DOI 10.1007/s004240100547; Oliver D, 2003, J NEUROSCI, V23, P2141; Pirvola U, 1997, J NEUROBIOL, V33, P1019, DOI 10.1002/(SICI)1097-4695(199712)33:7<1019::AID-NEU11>3.0.CO;2-A; Rodriguez-Contreras A, 2001, J PHYSIOL-LONDON, V534, P669, DOI 10.1111/j.1469-7793.2001.00669.x; Roehm PC, 2008, MOL CELL NEUROSCI, V37, P376, DOI 10.1016/j.mcn.2007.10.014; SANTOS-SACCHI J, 1993, J NEUROSCI, V13, P3599; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Shen HY, 2007, HEARING RES, V226, P52, DOI 10.1016/j.heares.2006.12.011; Vollmer M, 1999, J NEUROPHYSIOL, V82, P2883, DOI 10.1152/jn.1999.82.6.2883; Wei D, 2007, DEV NEUROBIOL, V67, P108, DOI 10.1002/dneu.20336; Wildburger NC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-44; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	44	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34699	34707		10.1074/jbc.M110.136192	http://dx.doi.org/10.1074/jbc.M110.136192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739290	hybrid, Green Published			2022-12-27	WOS:000283659100045
J	Zhang, LP; Ten Hagen, KG				Zhang, Liping; Ten Hagen, Kelly G.			Dissecting the Biological Role of Mucin-type O-Glycosylation Using RNA Interference in Drosophila Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; UDP-GALNAC; CAENORHABDITIS-ELEGANS; EXPRESSION; FAMILY; GOLGI; CYTOKINESIS; SECRETION; ADHESION; HT-29	Mucin type O-glycosylation is a highly conserved form of post-translational modification initiated by the family of enzymes known as the polypeptide alpha-N-acetylgalactosaminyltransferases (ppGalNAcTs in mammals and PGANTs in Drosophila). To address the cellular functions of the many PGANT family members, RNA interference (RNAi) to each pgant gene was performed in two independent Drosophila cell culture lines. We demonstrate that RNAi to individual pgant genes results in specific reduction in gene expression without affecting the expression of other family members. Cells with reduced expression of individual pgant genes were then examined for changes in viability, morphology, adhesion, and secretion to assess the contribution of each family member to these cellular functions. Here we find that RNAi to pgant3, pgant6, or pgant7 resulted in reduced secretion, further supporting a role for O-glycosylation in proper secretion. Additionally, RNAi to pgant3 or pgant6 resulted in altered Golgi organization, suggesting a role for each in establishing or maintaining proper secretory apparatus structure. Other subcellular effects observed included multinucleated cells seen after RNAi to either pgant2 or pgant35A, suggesting a role for these genes in the completion of cytokinesis. These studies demonstrate the efficient and specific knockdown of pgant gene expression in two Drosophila cell culture systems, resulting in specific morphological and functional effects. Our work provides new information regarding the biological roles of O-glycosylation and illustrates a new platform for interrogating the cellular and subcellular effects of this form of post-translational modification.	[Zhang, Liping; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program of the NIDCR).	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Barr FA, 2009, SEMIN CELL DEV BIOL, V20, P780, DOI 10.1016/j.semcdb.2009.03.007; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Delannoy P, 1996, GLYCOCONJUGATE J, V13, P717, DOI 10.1007/BF00702335; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gouyer V, 2001, J CELL SCI, V114, P1455; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; KIGER AA, 2003, J Biol */* N J BIOL, V27, P1; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Robinett CC, 2009, J CELL SCI, V122, P4526, DOI 10.1242/jcs.054536; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Weber Y, 2004, EUKARYOT CELL, V3, P1164, DOI 10.1128/EC.3.5.1164-1168.2004; Wei JH, 2009, SEMIN CELL DEV BIOL, V20, P810, DOI 10.1016/j.semcdb.2009.03.010; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	44	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34477	34484		10.1074/jbc.M110.133561	http://dx.doi.org/10.1074/jbc.M110.133561			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807760	Green Published, hybrid			2022-12-27	WOS:000283659100022
J	Ward, SM; Fernando, SJ; Hou, TY; Duffield, GE				Ward, Sarah M.; Fernando, Shanik J.; Hou, Tim Y.; Duffield, Giles E.			The Transcriptional Repressor ID2 Can Interact with the Canonical Clock Components CLOCK and BMAL1 and Mediate Inhibitory Effects on mPer1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN GENE-EXPRESSION; CULTURED RAT-1 FIBROBLASTS; LOOP-HELIX PROTEINS; SUPRACHIASMATIC NUCLEUS; CELL-PROLIFERATION; PERIPHERAL-TISSUES; RESPONSE ELEMENT; FEEDBACK LOOP; PHASE-SHIFTS; IN-VIVO	ID2 is a rhythmically expressed HLH transcriptional repressor. Deletion of Id2 in mice results in circadian phenotypes, highlighted by disrupted locomotor activity rhythms and an enhanced photoentrainment response. ID2 can suppress the transactivation potential of the positive elements of the clock, CLOCK-BMAL1, on mPer1 and clock-controlled gene ( CCG) activity. Misregulation of CCGs is observed in Id2(-/-) liver, and mutant mice exhibit associated alterations in lipid homeostasis. These data suggest that ID2 contributes to both input and output components of the clock and that this may be via interaction with the bHLH clock proteins CLOCK and BMAL1. The aim of the present study was to explore this potential interaction. Coimmunoprecipitation analysis revealed the capability of ID2 to complex with both CLOCK and BMAL1, and mammalian two-hybrid analysis revealed direct interactions of ID2, ID1 and ID3 with CLOCK and BMAL1. Deletion of the ID2 HLH domain rendered ID2 ineffective at inhibiting CLOCK-BMAL1 transactivation, suggesting that interaction between the proteins is via the HLH region. Immunofluorescence analysis revealed overlapping localization of ID2 with CLOCK and BMAL1 in the cytoplasm. Overexpression of CLOCK and BMAL1 in the presence of ID2 resulted in a significant reduction in their nuclear localization, revealing that ID2 can sequester CLOCK and BMAL1 to the cytoplasm. Serum stimulation of Id2(-/-) mouse embryonic fibroblasts resulted in an enhanced induction of mPer1 expression. These data provide the basis for a molecular mechanism through which ID2 could regulate aspects of both clock input and output through a time-of-day specific interaction with CLOCK and BMAL1.	[Ward, Sarah M.; Fernando, Shanik J.; Hou, Tim Y.; Duffield, Giles E.] Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Duffield, GE (corresponding author), Univ Notre Dame, Galvin Life Sci Ctr, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu			NIGMS, National Institutes of Health [GM087508]; University of Notre Dame; University Research fellowship; Royal Society; University of Notre Dame Fisher Research fellowship; National Science Foundation Research Experience for Undergraduate (REU) [0453325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Notre Dame; University Research fellowship; Royal Society(Royal Society of London); University of Notre Dame Fisher Research fellowship; National Science Foundation Research Experience for Undergraduate (REU); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant GM087508 (to G. E. D.). This work was also supported by a grant from the University of Notre Dame (to G. E. D.), a University Research fellowship and grant from the Royal Society (to G. E. D.), a University of Notre Dame Fisher Research fellowship (to S. M. W.), and National Science Foundation Research Experience for Undergraduate (REU) Summer Research Fellowship Award 0453325 (to S. J. F.).	Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Andres-Barquin PJ, 2000, HISTOL HISTOPATHOL, V15, P603, DOI 10.14670/HH-15.603; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1; Chen BB, 1997, NUCLEIC ACIDS RES, V25, P423, DOI 10.1093/nar/25.2.423; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; FINKEL T, 1993, J BIOL CHEM, V268, P5; Florio M, 1998, MOL CELL BIOL, V18, P5435, DOI 10.1128/MCB.18.9.5435; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hou TY, 2009, J BIOL CHEM, V284, P31735, DOI 10.1074/jbc.M109.013961; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Jung HS, 2003, NEUROREPORT, V14, P15, DOI 10.1097/00001756-200301200-00003; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Masubuchi S, 2005, J NEUROSCI, V25, P4719, DOI 10.1523/JNEUROSCI.4761-04.2005; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; McNulty S, 1998, EUR J NEUROSCI, V10, P1063, DOI 10.1046/j.1460-9568.1998.00114.x; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Norton JD, 2000, J CELL SCI, V113, P3897; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 1999, NEUROREPORT, V10, P613, DOI 10.1097/00001756-199902250-00031; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; von Gall C, 1998, J NEUROSCI, V18, P10389; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	62	20	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38987	39000		10.1074/jbc.M110.175182	http://dx.doi.org/10.1074/jbc.M110.175182			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20861012	Green Published, hybrid			2022-12-27	WOS:000284941300029
J	Rodriguez, C; Tejera, P; Medina, B; Guillen, R; Dominguez, A; Ramos, J; Siverio, JM				Rodriguez, Celia; Tejera, Paula; Medina, Braulio; Guillen, Rosa; Dominguez, Angel; Ramos, Jose; Siverio, Jose M.			Ure2 Is Involved in Nitrogen Catabolite Repression and Salt Tolerance via Ca2+ Homeostasis and Calcineurin Activation in the Yeast Hansenula polymorpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UREIDOSUCCINIC ACID UPTAKE; GLUTATHIONE-S-TRANSFERASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PLASMA-MEMBRANE; PHOSPHATASE CALCINEURIN; METABOLITE REPRESSION; TRANSCRIPTION FACTORS; ASPERGILLUS-NIDULANS; NUCLEAR-LOCALIZATION	Disruption of HpURE2 resulted in a low expression of genes encoding nitrate-assimilatory proteins; sensitivity to Li+, Na+, and Cd2+; no induction of ENA1; low levels of the GATA-type transcription factor Gat1; and low intracellular Ca2+ levels. Gat1 levels were also very low in a Delta cnb1 mutant lacking the regulatory subunit of calcineurin. The strain Delta ure2 was very sensitive to the calcineurin inhibitor FK506 and displayed several phenotypes reminiscent of Delta cnb1. The reporter 4xCDRE-lacZ, containing calcineurin-dependent response elements in its promoter, revealed that calcineurin activation was reduced in Hp Delta ure2. Expression of ScURE2 in Delta ure2 rescued nitrogen catabolite repression and Cd2+ tolerance but not those phenotypes depending on calcineurin activation, such as salt tolerance and nitrate assimilation gene derepression. Hp Delta ure2 showed an increased expression of the gene PMR1 encoding the Golgi Ca2+-ATPase, whereas that of PMC1 encoding the vacuolar Ca2+-ATPase remained unaltered. PMR1 up-regulation was abolished by deletion of the GATA-type transcription factor GAT2 in a Hp Delta ure2 genetic background, and normal Ca2+ levels were recovered. Moreover, overexpression of GAT2 or PMR1 yielded strains mimicking the phenotype of the Hp Delta ure2. This suggests that the low Ca2+ levels in the Hp Delta ure2 mutant are due to the high levels of Pmr1 that replenish the Golgi Ca2+ content, thus acting as a negative signal for Ca2+ entry into the cell. We conclude that HpUre2 is involved in salt tolerance and also in nitrate assimilation gene derepression via Ca2+ homeostasis regulation and calcineurin activation, which control the levels of Gat1.	[Rodriguez, Celia; Tejera, Paula; Medina, Braulio; Guillen, Rosa; Siverio, Jose M.] Univ La Laguna, Dept Biochem & Mol Biol, Inst Biomed Technol, Nitrogen Metab Grp, E-38206 Tenerife, Canarias, Spain; [Dominguez, Angel] Univ Salamanca, IMB CSIC, CIETUS, Dpto Microbiol & Genet, E-37007 Salamanca, Spain; [Ramos, Jose] Univ Cordoba, Dept Microbiol, Lab Microbiol Agr, E-14071 Cordoba, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Universidad de Cordoba	Siverio, JM (corresponding author), Univ La Laguna, Dept Biochem & Mol Biol, Inst Biomed Technol, Nitrogen Metab Grp, Av Astrofis Fco Sanchez S-N, E-38206 Tenerife, Canarias, Spain.	jsiverio@ull.es	IBSAL, Secretaría/H-3719-2011; Rodríguez, Celia/HDL-7429-2022; Ramos, Jose/K-4307-2014; Siverio, José Manuel/K-7136-2014	Ramos, Jose/0000-0002-9797-1561; Siverio, José Manuel/0000-0001-9404-2655; Tejera, Paula/0000-0002-0317-890X	Ministerio de Ciencia e Innovacion, Spain [BFU2007-60172/BMC, BFU2008-04188-C03-03]; Junta de Castilla y Leon, Spain [GEN2006-27775-C2-E/PAT, SA141A08]; CajaCanarias; Ministerio de Educacion y Ciencia, Spain; Agencia Espanola de Cooperacion Iberoamericana; ACIISI from Gobierno de Canarias	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); CajaCanarias; Ministerio de Educacion y Ciencia, Spain(Spanish Government); Agencia Espanola de Cooperacion Iberoamericana; ACIISI from Gobierno de Canarias	This work was supported by Ministerio de Ciencia e Innovacion, Spain, Grants BFU2007-60172/BMC (to J. M. S.) and BFU2008-04188-C03-03 (to J. R.), and by Junta de Castilla y Leon, Spain, Grants GEN2006-27775-C2-E/PAT and (SA141A08) (to A. D.).; Recipient of predoctoral fellowships from CajaCanarias and the ACIISI from Gobierno de Canarias.; Recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia, Spain. Present address: Dept. of Environmental Health, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115. 3; Recipient of a predoctoral fellowship from the Agencia Espanola de Cooperacion Iberoamericana. Present address: Dpto. de Biologia Molecular y Genetica, Instituto de Investigaciones en Ciencia de la Salud, Universidad Nacional de Asuncion, Rio de la Plata y Lagerenza E-2511 Asuncion, Paraguay.	ABERG B, 1947, KUNGL LANTBRUKSHOGSK, V15, P37; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Andrianopoulos A, 1998, J BACTERIOL, V180, P1973, DOI 10.1128/JB.180.7.1973-1977.1998; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; AVILA J, 1995, FEBS LETT, V366, P137, DOI 10.1016/0014-5793(95)00511-7; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brito N, 1999, APPL MICROBIOL BIOT, V53, P23, DOI 10.1007/s002530051609; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Devasahayam G, 2007, GENETICS, V177, P231, DOI 10.1534/genetics.107.073577; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; FABER KN, 1994, CURR GENET, V25, P305, DOI 10.1007/BF00351482; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Halachmi D, 1996, FEBS LETT, V392, P194, DOI 10.1016/0014-5793(96)00799-5; HEITMAN J, 1994, TRANSPLANT P, V26, P2833; Jiang B, 1999, J BIOL CHEM, V274, P18543, DOI 10.1074/jbc.274.26.18543; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Leao-Helder AN, 2003, J BIOL CHEM, V278, P40749, DOI 10.1074/jbc.M304029200; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Pan H, 1997, MOL MICROBIOL, V26, P721, DOI 10.1046/j.1365-2958.1997.6041979.x; Park SY, 2001, J BIOL CHEM, V276, P28694, DOI 10.1074/jbc.M101185200; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; RAMOS J, 1990, BIOCHIM BIOPHYS ACTA, V1029, P211, DOI 10.1016/0005-2736(90)90156-I; Rowen DW, 1997, J BACTERIOL, V179, P3761, DOI 10.1128/jb.179.11.3761-3766.1997; Ruiz A, 2007, EUKARYOT CELL, V6, P2175, DOI 10.1128/EC.00337-07; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; Sambrook J., 2001, MOL CLONING LAB MANU; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Shewmaker F, 2007, GENETICS, V176, P1557, DOI 10.1534/genetics.107.074153; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wilkins BJ, 2002, J PHYSIOL-LONDON, V541, P1, DOI 10.1113/jphysiol.2002.017129; Withee JL, 1998, GENETICS, V149, P865; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; XIAO XD, 1995, BIOCHEMISTRY-US, V34, P8861, DOI 10.1021/bi00027a038	66	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37551	37560		10.1074/jbc.M110.146902	http://dx.doi.org/10.1074/jbc.M110.146902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20880842	Green Published, hybrid			2022-12-27	WOS:000284424000047
J	Zhu, QS; Kao, LY; Azimov, R; Abuladze, N; Newman, D; Pushkin, A; Liu, WX; Chang, C; Kurtz, I				Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Pushkin, Alexander; Liu, Weixin; Chang, Connie; Kurtz, Ira			Structural and Functional Characterization of the C-terminal Transmembrane Region of NBCe1-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; SCANNING MUTAGENESIS; COTRANSPORTER NBCE1; EXCHANGE PROTEIN; ANION TRANSPORT; RESIDUES; BAND-3; AE1; IDENTIFICATION; MECHANISM	NBCe1-A and AE1 both belong to the SLC4 HCO3- transporter family. The two transporters share 40% sequence homology in the C-terminal transmembrane region. In this study, we performed extensive substituted cysteine-scanning mutagenesis analysis of the C-terminal region of NBCe1-A covering amino acids Ala(800)-Lys(967). Location of the introduced cysteines was determined by whole cell labeling with a membrane-permeant biotin maleimide and a membrane-impermeant 2-((5(6)-tetramethylrhodamine) carboxylamino) ethyl methanethiosulfonate (MTS-TAMRA) cysteine-reactive reagent. The results show that the extracellular surface of the NBCe1-A C-terminal transmembrane region is minimally exposed to aqueous media with Met(858) accessible to both biotin maleimide and TAMRA and Thr(926)-Ala(929) only to TAMRA labeling. The intracellular surface contains a highly exposed (Met(813)-Gly(828)) region and a cryptic (Met(887)-Arg(904)) connecting loop. The lipid/aqueous interface of the last transmembrane segment is at Asp(960). Our data clearly determined that the C terminus of NBCe1-A contains 5 transmembrane segments with greater average size compared with AE1. Functional assays revealed only two residues in the region of Pro(868)-Leu(967) (a functionally important region in AE1) that are highly sensitive to cysteine substitution. Our findings suggest that the C-terminal transmembrane region of NBCe1-A is tightly folded with unique structural and functional features that differ from AE1.	[Zhu, Quansheng; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Newman, Debra; Pushkin, Alexander; Liu, Weixin; Chang, Connie; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurtz, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, 10833 Le Conte Ave,Rm 7-155,Factor Bldg, Los Angeles, CA 90095 USA.	ikurtz@mednet.ucla.edu			National Institutes of Health [DK077162, DK058563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077162 and DK058563.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; JENNINGS ML, 1982, J BIOL CHEM, V257, P7554; JENNINGS ML, 1985, ANNU REV PHYSIOL, V47, P519; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KAWANO Y, 1988, J BIOL CHEM, V263, P8232; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; OKUBO K, 1994, J BIOL CHEM, V269, P1918; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	23	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37178	37187		10.1074/jbc.M110.169201	http://dx.doi.org/10.1074/jbc.M110.169201			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20837482	hybrid, Green Published			2022-12-27	WOS:000284424000011
J	Morrish, F; Noonan, J; Perez-Olsen, C; Gafken, PR; Fitzgibbon, M; Kelleher, J; VanGilst, M; Hockenbery, D				Morrish, Fionnuala; Noonan, Jhoanna; Perez-Olsen, Carissa; Gafken, Philip R.; Fitzgibbon, Matthew; Kelleher, Joanne; VanGilst, Marc; Hockenbery, David			Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC NETWORKS; STRATEGIES; CITRATE	Cell reprogramming from a quiescent to proliferative state requires coordinate activation of multiple -omic networks. These networks activate histones, increase cellular bioenergetics and the synthesis of macromolecules required for cell proliferation. However, mechanisms that coordinate the regulation of these interconnected networks are not fully understood. The oncogene c-Myc (Myc) activates cellular metabolism and global chromatin remodeling. Here we tested for an interconnection between Myc regulation of metabolism and acetylation of histones. Using [C-13(6)]glucose and a combination of GC/MS and LC/ESI tandem mass spectrometry, we determined the fractional incorporation of C-13-labeled 2-carbon fragments into the fatty acid palmitate, and acetyl-lysines at the N-terminal tail of histone H4 in myc(-/-) and myc(+/+) Rat1A fibroblasts. Our data demonstrate that Myc increases mitochondrial synthesis of acetyl-CoA, as the de novo synthesis of C-13-labeled palmitate was increased 2-fold in Myc-expressing cells. Additionally, Myc induced a forty percent increase in C-13-labeled acetyl-CoA on H4-K16. This is linked to the capacity of Myc to increase mitochondrial production of acetyl-CoA, as we show that mitochondria provide 50% of the acetyl groups on H4-K16. These data point to a key role for Myc in directing the interconnection of -omic networks, and in particular, epigenetic modification of proteins in response to proliferative signals.	[Morrish, Fionnuala; Noonan, Jhoanna; Perez-Olsen, Carissa; Gafken, Philip R.; Fitzgibbon, Matthew; VanGilst, Marc; Hockenbery, David] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Perez-Olsen, Carissa] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA; [Kelleher, Joanne] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT)	Hockenbery, D (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	dhockenb@fhcrc.org			National Institutes of Health [R01CA10665-01]; Pilot funds [P30CA015704]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA106650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA10665-01 (to D. H.) and pilot funds (to D. H.) from P30CA015704 (to L. Hartwell).	BARTLEY JC, 1976, LIPIDS, V11, P774, DOI 10.1007/BF02533054; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Holleran AL, 1997, AM J PHYSIOL-ENDOC M, V272, pE945, DOI 10.1152/ajpendo.1997.272.6.E945; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; R Development Core Team, 2010, LANG ENV STAT COMP; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shia WJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-217; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; SRERE PA, 1962, BIOCHIM BIOPHYS ACTA, V59, P487, DOI 10.1016/0006-3002(62)90205-6; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Taplick J, 1998, FEBS LETT, V436, P349, DOI 10.1016/S0014-5793(98)01164-8; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoo H, 2004, J LIPID RES, V45, P1324, DOI 10.1194/jlr.M400031-JLR200	28	102	103	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36267	36274		10.1074/jbc.M110.141606	http://dx.doi.org/10.1074/jbc.M110.141606			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20813845	Green Published, hybrid			2022-12-27	WOS:000284146100048
J	Jenkins, RW; Canals, D; Idkowiak-Baldys, J; Simbari, F; Roddy, P; Perry, DM; Kitatani, K; Luberto, C; Hannun, YA				Jenkins, Russell W.; Canals, Daniel; Idkowiak-Baldys, Jolanta; Simbari, Fabio; Roddy, Patrick; Perry, David M.; Kitatani, Kazuyuki; Luberto, Chiara; Hannun, Yusuf A.			Regulated Secretion of Acid Sphingomyelinase IMPLICATIONS FOR SELECTIVITY OF CERAMIDE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; TRICYCLIC ANTIDEPRESSANT DESIPRAMINE; DELTA-MEDIATED PHOSPHORYLATION; TANDEM MASS-SPECTROMETRY; BETA-GLUCOSIDASE 1; LYSOSOMAL SPHINGOMYELINASE; ZN2+-STIMULATED SPHINGOMYELINASE; ELEVATED SPHINGOMYELINASE; BIOACTIVE SPHINGOLIPIDS; ENDOTHELIAL APOPTOSIS	The acid sphingomyelinase (aSMase) gene gives rise to two distinct enzymes, lysosomal sphingomyelinase (L-SMase) and secretory sphingomyelinase (S-SMase), via differential trafficking of a common protein precursor. However, the regulation of S-SMase and its role in cytokine-induced ceramide formation remain ill defined. To determine the role of S-SMase in cellular sphingolipid metabolism, MCF7 breast carcinoma cells stably transfected with V5-aSMase(WT) were treated with inflammatory cytokines. Interleukin-1 beta and tumor necrosis factor-alpha induced a time-and dose-dependent increase in S-SMase secretion and activity, coincident with selective elevations in cellular C-16-ceramide. To establish a role for S-SMase, we utilized a mutant of aSMase (S508A) that is shown to retain L-SMase activity, but is defective in secretion. MCF7 expressing V5-aSMaseWT exhibited increased S-SMase and L-SMase activity, as well as elevated cellular levels of specific long-chain and very long-chain ceramide species relative to vector control MCF7. Interestingly, elevated levels of only certain very long-chain ceramides were evident in V5-aSMase(S508A) MCF7. Secretion of the S508A mutant was also defective in response to IL-1 beta, as was the regulated generation of C-16-ceramide. Taken together, these data support a crucial role for Ser(508) in the regulation of S-SMase secretion, and they suggest distinct metabolic roles for S-SMase and L-SMase.	[Jenkins, Russell W.; Canals, Daniel; Idkowiak-Baldys, Jolanta; Roddy, Patrick; Perry, David M.; Kitatani, Kazuyuki; Luberto, Chiara; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Simbari, Fabio] CSIC, Dept Biomed Chem, Inst Adv Chem Catalonia, Barcelona, Spain; [Kitatani, Kazuyuki] Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori 6838504, Japan	Medical University of South Carolina; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Tottori University	Hannun, YA (corresponding author), 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021; Kitatani, Kazuyuki/H-7100-2019	Canals, Daniel/0000-0002-9293-5123; Kitatani, Kazuyuki/0000-0002-8516-6135	NCI [GM08716, P01 CA97132, 1P30 CA138313-01]; MUSC Hollings Cancer Center Abney Foundation; American Heart Association [081509E]; Ministerio de Educacion y Ciencia (Spain) [AP2006-02190]; Japan Society for the Promotion of Science [21890144]; NATIONAL CANCER INSTITUTE [P30CA138313, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MUSC Hollings Cancer Center Abney Foundation; American Heart Association(American Heart Association); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM08716 (MSTP to R. W. J.) and P01 CA97132 from the NCI (to Y. A. H.), MUSC Hollings Cancer Center Abney Foundation scholarship (to R. W. J.), American Heart Association Grant 081509E (to R. W. J.), Ministerio de Educacion y Ciencia (Spain) Predoctoral Fellowship AP2006-02190 (to F. S.) and Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (Start-up) Grant 21890144 (to K. K.).; Special thanks to the Medical University of South Carolina (MUSC) Analytical Lipidomics Core (Dr. Jacek Bielawski, Barbara Rembiesa, Justin Snider, and Jason Pierce), the MUSC Synthetic Lipidomics Core (Dr. Alicja Bielawska and Nalini Mayroo), and the MUSC Hollings Cancer Center Imaging Core supported by National Institutes of Health Grant 1P30 CA138313-01 from the NCI to Dr. Andrew Kraft. Additional thanks to Dr. Christopher J. Clarke (MUSC) for careful reading of this manuscript. We also thank Dr. Elizabeth Garrett-Mayer (MUSC) for assistance with statistical analyses.	Abe T, 1999, EUR J PEDIATR, V158, P953, DOI 10.1007/s004310051254; BARENHOLZ Y, 1980, BIOCHIM BIOPHYS ACTA, V604, P129, DOI 10.1016/0005-2736(80)90572-6; Bartelsen O, 1998, J BIOTECHNOL, V63, P29, DOI 10.1016/S0168-1656(98)00070-4; Bezombes C, 2001, FASEB J, V15, P297; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; CALLAHAN JW, 1983, J NEUROSCI RES, V10, P151, DOI 10.1002/jnr.490100205; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; Doehner W, 2007, EUR HEART J, V28, P821, DOI 10.1093/eurheartj/ehl541; Ferlinz K, 1997, EUR J BIOCHEM, V243, P511, DOI 10.1111/j.1432-1033.1997.511_1a.x; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Gorska M, 2003, HORM METAB RES, V35, P506; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Jones I, 2008, MOL GENET METAB, V95, P152, DOI 10.1016/j.ymgme.2008.08.004; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Lee CY, 2007, BIOCHEMISTRY-US, V46, P14969, DOI 10.1021/bi700817g; Lee CY, 2006, J LIPID RES, V47, P622, DOI 10.1194/jlr.M500487-JLR200; Lemaire R, 1997, BRIT J RHEUMATOL, V36, P735; LIPPINCOTTSCHWA.J, 1989, R D CELL, V56, P801; Liu B, 2000, METHOD ENZYMOL, V311, P164; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marathe S, 2000, HUM MOL GENET, V9, P1967, DOI 10.1093/hmg/9.13.1967; Marathe S, 1999, ARTERIOSCL THROM VAS, V19, P2648, DOI 10.1161/01.ATV.19.11.2648; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Marathe S, 2000, ARTERIOSCL THROM VAS, V20, P2607, DOI 10.1161/01.ATV.20.12.2607; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; McCollister BD, 2007, INFECT IMMUN, V75, P5346, DOI 10.1128/IAI.00689-07; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Romiti E, 2000, MOL CELL BIOCHEM, V205, P75, DOI 10.1023/A:1007041329052; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sathishkumar S, 2005, CANCER BIOL THER, V4, P979, DOI 10.4161/cbt.4.9.1915; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Segui B, 2000, FASEB J, V14, P36, DOI 10.1096/fasebj.14.1.36; Seto M, 2004, PROTEIN SCI, V13, P3172, DOI 10.1110/ps.04966204; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; Takahashi T, 2002, J PEDIAT HEMATOL ONC, V24, P401, DOI 10.1097/00043426-200206000-00016; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; WEITZ G, 1983, H-S Z PHYSIOL CHEM, V364, P863, DOI 10.1515/bchm2.1983.364.2.863; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	64	82	85	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35706	35718		10.1074/jbc.M110.125609	http://dx.doi.org/10.1074/jbc.M110.125609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807762	Green Published, hybrid			2022-12-27	WOS:000283845300049
J	Olsen, JS; Brown, C; Capule, CC; Rubinshtein, M; Doran, TM; Srivastava, RK; Feng, CY; Nilsson, BL; Yang, J; Dewhurst, S				Olsen, Joanna S.; Brown, Caitlin; Capule, Christina C.; Rubinshtein, Mark; Doran, Todd M.; Srivastava, Rajesh K.; Feng, Changyong; Nilsson, Bradley L.; Yang, Jerry; Dewhurst, Stephen			Amyloid-binding Small Molecules Efficiently Block SEVI (Semen-derived Enhancer of Virus Infection)- and Semen-mediated Enhancement of HIV-1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAGINAL MICROBICIDES; THIOFLAVIN-T; TYPE-1 TRANSMISSION; EPITHELIAL-CELLS; GENITAL HERPES; FIBRILS; NONOXYNOL-9; EXPRESSION; PREVENTION; MODEL	Semen was recently shown to contain amyloid fibrils formed from a self-assembling peptide fragment of the protein prostatic acid phosphatase. These amyloid fibrils, termed semen-derived enhancer of virus infection, or SEVI, have been shown to strongly enhance HIV infectivity and may play an important role in sexual transmission of HIV, making them a potential microbicide target. One novel approach to target these fibrils is the use of small molecules known to intercalate into the structure of amyloid fibrils, such as derivatives of thioflavin-T. Here, we show that the amyloid-binding small molecule BTA-EG(6) (the hexa(ethylene glycol) derivative of benzothiazole aniline) is able to bind SEVI fibrils and effectively inhibit both SEVI-mediated and semen-mediated enhancement of HIV infection. BTA-EG(6) also blocks the interactions of SEVI with HIV-1 virions and HIV-1 target cells but does not cause any inflammation or toxicity to cervical epithelial cells. These results suggest that an amyloid-binding small molecule may have utility as a microbicide, or microbicidal supplement, for HIV-1.	[Olsen, Joanna S.; Brown, Caitlin; Dewhurst, Stephen] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Feng, Changyong] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA; [Doran, Todd M.; Nilsson, Bradley L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Srivastava, Rajesh K.] Univ Rochester, Dept Obstet & Gynecol, Rochester, NY 14627 USA; [Capule, Christina C.; Rubinshtein, Mark; Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of California System; University of California San Diego	Dewhurst, S (corresponding author), Univ Rochester Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	Stephen_dewhurst@urmc.rochester.edu	Nilsson, Bradley/P-3718-2016	Nilsson, Bradley/0000-0003-1193-3693; Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health [R01AI084111, T32GM007356, T32DA007232, P30AI36214]; National Science Foundation [CHE-0847530]; DuPont; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R01AI084111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); DuPont; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI084111 (to S. D., B. L. N., C. B., and C. F.), T32GM007356 (to J. S. O.), T32DA007232 (to J. S. O.), and P30AI36214 (to C. C. C., M. R., and J. Y.) as well as by a National Science Foundation CAREER award CHE-0847530 (J. Y.) and a DuPont Young Professors Award (B. L. N.).	Alt C, 2009, CURR HIV RES, V7, P639, DOI 10.2174/157016209789973682; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Bourne N, 1999, J INFECT DIS, V180, P203, DOI 10.1086/314853; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; Inbar P, 2008, ANAL CHEM, V80, P3502, DOI 10.1021/ac702592f; Inbar P, 2006, CHEMBIOCHEM, V7, P1563, DOI 10.1002/cbic.200600119; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kiessling Ann A, 2005, Methods Mol Biol, V304, P71; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Levine H, 2005, AMYLOID, V12, P5, DOI 10.1080/13506120500032295; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Roan NR, 2010, J BIOL CHEM, V285, P1861, DOI 10.1074/jbc.M109.066167; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wilkinson D, 2002, LANCET INFECT DIS, V2, P613, DOI 10.1016/S1473-3099(02)00396-1	33	48	50	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35488	35496		10.1074/jbc.M110.163659	http://dx.doi.org/10.1074/jbc.M110.163659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20833717	Green Published, hybrid			2022-12-27	WOS:000283845300027
J	Sala-Rabanal, M; Kucheryavykh, LY; Skatchkov, SN; Eaton, MJ; Nichols, CG				Sala-Rabanal, Monica; Kucheryavykh, Lilia Y.; Skatchkov, Serguei N.; Eaton, Misty J.; Nichols, Colin G.			Molecular Mechanisms of EAST/SeSAME Syndrome Mutations in Kir4.1 (KCNJ10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNEL; ANTENATAL BARTTER-SYNDROME; ROMK K(IR)1.1 CHANNELS; RECTIFIER K+ CHANNELS; RETINAL GLIAL-CELLS; SEIZURE SUSCEPTIBILITY; SENSORINEURAL DEAFNESS; GLUTAMATE UPTAKE; BASOLATERAL MEMBRANE; CORTICAL ASTROCYTES	Inwardly rectifying potassium channel Kir4.1 is critical for glial function, control of neuronal excitability, and systemic K+ homeostasis. Novel mutations in Kir4.1 have been associated with EAST/SeSAME syndrome, characterized by mental retardation, ataxia, seizures, hearing loss, and renal salt waste. Patients are homozygous for R65P, G77R, C140R or T164I; or compound heterozygous for A167V/R297C or R65P/R199Stop, a deletion of the C-terminal half of the protein. We investigated the functional significance of these mutations by radiotracer efflux and inside-out membrane patch clamping in COSm6 cells expressing homomeric Kir4.1 or heteromeric Kir4.1/Kir5.1 channels. All of the mutations compromised channel function, but the underlying mechanisms were different. R65P, T164I, and R297C caused an alkaline shift in pH sensitivity, indicating that these positions are crucial for pH sensing and pore gating. In R297C, this was due to disruption of intersubunit salt bridge Glu(288)-Arg(297). C140R breaks the Cys(108)-Cys(140) disulfide bond essential for protein folding and function. A167V did not affect channel properties but may contribute to decreased surface expression in A167V/R297C. In G77R, introduction of a positive charge within the bilayer may affect channel structure or gating. R199 Stop led to a dramatic decrease in surface expression, but channel activity was restored by co-expression with intact subunits, suggesting remarkable tolerance for truncation of the cytoplasmic domain. These results provide an explanation for the molecular defects that underlie the EAST/SeSAME syndrome.	[Sala-Rabanal, Monica] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Nichols, Colin G.] Washington Univ, EXCITE Ctr, Ctr Invest Membrane Excitabil Diseases, St Louis, MO 63110 USA; [Kucheryavykh, Lilia Y.; Skatchkov, Serguei N.; Eaton, Misty J.] Univ Cent Caribe, Dept Biochem, Bayamon, PR 00960 USA; [Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, Bayamon, PR 00960 USA	Washington University (WUSTL); Washington University (WUSTL)	Sala-Rabanal, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	msala@wustl.edu	Nichols, Colin/D-6336-2012; Sala-Rabanal, Monica/AAU-2383-2021	Ghisays, Valentina/0000-0002-8434-9407	National Institutes of Health [HL54171, S11-NS48201, U54-NS039408, G12-RR03035]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039408, R01NS065201, S11NS048201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54171( to C. G. N.), S11-NS48201( to M. J. E.), U54-NS039408( to S. N. S.), and G12-RR03035.	Benfenati V, 2006, J NEUROCHEM, V98, P430, DOI 10.1111/j.1471-4159.2006.03877.x; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bolton S, 2006, EXP NEUROL, V202, P36, DOI 10.1016/j.expneurol.2006.05.009; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Hibino H, 2010, PFLUG ARCH EUR J PHY, V459, P521, DOI 10.1007/s00424-009-0754-z; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Jagger DJ, 2010, JARO-J ASSOC RES OTO, V11, P435, DOI 10.1007/s10162-010-0218-3; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kucheryavykh Lilia Y, 2009, Open Neurosci J, V3, P40; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Kucheryavykh YV, 2007, CHANNELS, V1, P172, DOI 10.4161/chan.4389; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Lachheb S, 2008, AM J PHYSIOL-RENAL, V294, pF1398, DOI 10.1152/ajprenal.00288.2007; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Olsen ML, 2007, J NEUROPHYSIOL, V98, P786, DOI 10.1152/jn.00340.2007; Peters M, 2003, KIDNEY INT, V64, P923, DOI 10.1046/j.1523-1755.2003.00153.x; Raap M, 2002, NEUROREPORT, V13, P1037, DOI 10.1097/00001756-200206120-00012; Rapedius M, 2007, CHANNELS, V1, P327, DOI 10.4161/chan.5176; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Rozengurt N, 2003, HEARING RES, V177, P71, DOI 10.1016/S0378-5955(02)00799-2; Satz JS, 2009, J NEUROSCI, V29, P13136, DOI 10.1523/JNEUROSCI.0474-09.2009; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Schulte U, 1998, J BIOL CHEM, V273, P34575, DOI 10.1074/jbc.273.51.34575; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Shang LJ, 2005, MOL BRAIN RES, V139, P178, DOI 10.1016/j.molbrainres.2005.05.003; Skatchkov SN, 2001, NEUROREPORT, V12, P1437, DOI 10.1097/00001756-200105250-00028; Tanemoto M, 2005, J AM SOC NEPHROL, V16, P2608, DOI 10.1681/ASN.2005030266; Tanemoto M, 2004, AM J PHYSIOL-RENAL, V287, pF1148, DOI 10.1152/ajprenal.00203.2004; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; Wagner CA, 2010, J NEPHROL, V23, P5; Wu J, 2004, MOL VIS, V10, P650; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014	55	83	84	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36040	36048		10.1074/jbc.M110.163170	http://dx.doi.org/10.1074/jbc.M110.163170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807765	Green Published, hybrid			2022-12-27	WOS:000283845300080
J	Jutabha, P; Anzai, N; Kitamura, K; Taniguchi, A; Kaneko, S; Yan, K; Yamada, H; Shimada, H; Kimura, T; Katada, T; Fukutomi, T; Tomita, K; Urano, W; Yamanaka, H; Seki, G; Fujita, T; Moriyama, Y; Yamada, A; Uchida, S; Wempe, MF; Endou, H; Sakurai, H				Jutabha, Promsuk; Anzai, Naohiko; Kitamura, Kenichiro; Taniguchi, Atsuo; Kaneko, Shuji; Yan, Kunimasa; Yamada, Hideomi; Shimada, Hidetaka; Kimura, Toru; Katada, Tomohisa; Fukutomi, Toshiyuki; Tomita, Kimio; Urano, Wako; Yamanaka, Hisashi; Seki, George; Fujita, Toshiro; Moriyama, Yoshinori; Yamada, Akira; Uchida, Shunya; Wempe, Michael F.; Endou, Hitoshi; Sakurai, Hiroyuki			Human Sodium Phosphate Transporter 4 (hNPT4/SLC17A3) as a Common Renal Secretory Pathway for Drugs and Urate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORT; URIC-ACID; HOMINOID EVOLUTION; APICAL MEMBRANE; IDENTIFICATION; GOUT; FAMILY; HYPERURICEMIA; EXCRETION; EXCHANGER	The evolutionary loss of hepatic urate oxidase (uricase) has resulted in humans with elevated serum uric acid (urate). Uricase loss may have been beneficial to early primate survival. However, an elevated serum urate has predisposed man to hyperuricemia, a metabolic disturbance leading to gout, hypertension, and various cardiovascular diseases. Human serum urate levels are largely determined by urate reabsorption and secretion in the kidney. Renal urate reabsorption is controlled via two proximal tubular urate transporters: apical URAT1 (SLC22A12) and basolateral URATv1/GLUT9 (SLC2A9). In contrast, the molecular mechanism(s) for renal urate secretion remain unknown. In this report, we demonstrate that an orphan transporter hNPT4 (human sodium phosphate transporter 4; SLC17A3) was a multispecific organic anion efflux transporter expressed in the kidneys and liver. hNPT4 was localized at the apical side of renal tubules and functioned as a voltage-driven urate transporter. Furthermore, loop diuretics, such as furosemide and bumetanide, substantially interacted with hNPT4. Thus, this protein is likely to act as a common secretion route for both drugs and may play an important role in diuretics-induced hyperuricemia. The in vivo role of hNPT4 was suggested by two hyperuricemia patients with missense mutations in SLC17A3. These mutated versions of hNPT4 exhibited reduced urate efflux when they were expressed in Xenopus oocytes. Our findings will complete a model of urate secretion in the renal tubular cell, where intracellular urate taken up via OAT1 and/or OAT3 from the blood exits from the cell into the lumen via hNPT4.	[Jutabha, Promsuk; Anzai, Naohiko; Kimura, Toru; Katada, Tomohisa; Fukutomi, Toshiyuki; Endou, Hitoshi; Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; [Yan, Kunimasa] Kyorin Univ, Sch Med, Dept Pediat, Tokyo 1818611, Japan; [Yamada, Akira] Kyorin Univ, Sch Med, Dept Nephrol, Tokyo 1818611, Japan; [Kitamura, Kenichiro; Tomita, Kimio] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Nephrol, Kumamoto 8608556, Japan; [Taniguchi, Atsuo; Urano, Wako; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1620054, Japan; [Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto 6068501, Japan; [Yamada, Hideomi; Seki, George; Fujita, Toshiro] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 1130033, Japan; [Shimada, Hidetaka] Shimada Hosp, Kumamoto 8600017, Japan; [Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan; [Uchida, Shunya; Endou, Hitoshi] Teikyo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 1738605, Japan; [Wempe, Michael F.] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80045 USA; [Yamada, Akira] J Pharma Co Ltd, Tokyo 1600022, Japan	Kyorin University; Kyorin University; Kyorin University; Kumamoto University; Tokyo Women's Medical University; Kyoto University; University of Tokyo; Okayama University; Teikyo University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Anzai, N (corresponding author), 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	anzai-path@umin.ac.jp	Jutabha, Promsuk/AFF-4363-2022; Kaneko, Shuji/AAR-1005-2021; Jutabha, Promsuk/AAE-9872-2022; ANZAI, NAOHIKO/K-9492-2017	ANZAI, NAOHIKO/0000-0003-0605-0458; Kaneko, Shuji/0000-0001-5152-5809	Japan Society for the Promotion; KAKENHI [21390073, 21659216, 21890245]; Nakatomi Foundation; Gout Research Foundation of Japan; Kyorin University School of Medicine	Japan Society for the Promotion(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatomi Foundation; Gout Research Foundation of Japan(Gout Research Foundation of Japan); Kyorin University School of Medicine	This work was supported in part by Japan Society for the Promotion of urate to the luminal (urine) space, is elusive. Science Grants KAKENHI 21390073, 21659216, and 21890245 and by the Nakatomi Foundation, the Gout Research Foundation of Japan, and Kyorin University School of Medicine Collaborative Project 2009.	Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; ANZAI N, 2010, CURR RHEUMA IN PRESS, V6; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Anzai N, 2006, J PHARMACOL SCI, V100, P411, DOI 10.1254/jphs.CRJ06006X; Anzai N, 2010, CURR HYPERTENS REV, V6, P148, DOI 10.2174/157340210791936732; Anzai N, 2007, EXPERT OPIN DRUG DIS, V2, P1251, DOI 10.1517/17460441.2.9.1251; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; AVNER ED, 1990, PEDIATR NEPHROL, V4, P372, DOI 10.1007/BF00862522; BURCKHARDT G, 2000, KIDNEY PHYSL PATHOPH, P193; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Dantzler WH, 2002, BBA-BIOMEMBRANES, V1566, P169, DOI 10.1016/S0005-2736(02)00599-0; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Ellison DH, 2008, BRENNER RECTORS KIDN, P1646; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Melis D, 2004, J INHERIT METAB DIS, V27, P725, DOI 10.1023/B:BOLI.0000045755.89308.2f; MOLLER JV, 1982, PHARMACOL REV, V34, P315; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Pascual E, 2006, ANN RHEUM DIS, V65, P981, DOI 10.1136/ard.2005.049023; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/00041552-200309000-00005; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Roch-Ramel F, 1999, NEWS PHYSIOL SCI, V14, P80; Ruddy DA, 1997, GENOME RES, V7, P441, DOI 10.1101/gr.7.5.441; Russel FGM, 2002, ANNU REV PHYSIOL, V64, P563, DOI 10.1146/annurev.physiol.64.081501.155913; Tsuchida H, 2010, CELL PHYSIOL BIOCHEM, V25, P511, DOI 10.1159/000303060; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Yamauchi Y, 2007, NEUROSCI LETT, V428, P72, DOI 10.1016/j.neulet.2007.09.037	43	101	112	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35123	35132		10.1074/jbc.M110.121301	http://dx.doi.org/10.1074/jbc.M110.121301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810651	hybrid, Green Published			2022-12-27	WOS:000283659100086
J	Erat, MC; Schwarz-Linek, U; Pickford, AR; Farndale, RW; Campbell, ID; Vakonakis, I				Erat, Michele C.; Schwarz-Linek, Ulrich; Pickford, Andrew R.; Farndale, Richard W.; Campbell, Iain D.; Vakonakis, Ioannis			Implications for Collagen Binding from the Crystallographic Structure of Fibronectin (6)FnI(1-2)FnII(7)FnI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA FIBRONECTIN; GELATIN-BINDING; I COLLAGEN; (6)F1(1)F2(2)F2 FRAGMENT; CRYSTAL-STRUCTURES; TRACE-ELEMENTS; BURN INJURY; PROTEIN; SITES; DOMAIN	Collagen and fibronectin (FN) are two abundant and essential components of the vertebrate extracellular matrix; they interact directly with cellular receptors and affect cell adhesion and migration. Past studies identified a FN fragment comprising six modules, (6)FnI(1-2)FnII(7-9)FnI, and termed the gelatin binding domain (GBD) as responsible for collagen interaction. Recently, we showed that the GBD binds tightly to a specific site within type I collagen and determined the structure of domains (8-9)FnI in complex with a peptide from that site. Here, we present the crystallographic structure of domains (6)FnI(1-2)FnII(7)FnI, which form a compact, globular unit through interdomain interactions. Analysis of NMR titrations with single-stranded collagen peptides reveals a dominant collagen interaction surface on domains (2)FnII and (7)FnI; a similar surface appears involved in interactions with triple-helical peptides. Models of the complete GBD, based on the new structure and the (8-9)FnI.collagen complex show a continuous putative collagen binding surface. We explore the implications of this model using long collagen peptides and discuss our findings in the context of FN interactions with collagen fibrils.	[Vakonakis, Ioannis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Schwarz-Linek, Ulrich] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Pickford, Andrew R.] Univ Portsmouth, Sch Biol Sci, Portsmouth PO1 2DY, Hants, England; [Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Oxford; University of St Andrews; University of Portsmouth; University of Cambridge	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk	Pickford, Andy/AGB-6901-2022	Schwarz-Linek, Ulrich/0000-0003-0526-223X; Pickford, Andy/0000-0002-7237-0030	EC; Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Medical Research Council [G0500707] Funding Source: researchfish; MRC [G0500707] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by EC Marie Curie Fellowship FP7.; Supported by the Biotechnology and Biological Sciences Research Council.; Supported by the Medical Research Council.; Supported by the Wellcome Trust Career Development fellowship program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BLUMENSTOCK FA, 1978, J BIOL CHEM, V253, P4287; BLUMENSTOCK FA, 1993, J LEUKOCYTE BIOL, V54, P56, DOI 10.1002/jlb.54.1.56; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DENO DC, 1984, J CLIN INVEST, V73, P20, DOI 10.1172/JCI111191; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; ERIKSEN HO, 1984, BURNS, V10, P422, DOI 10.1016/0305-4179(84)90083-4; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fallah S, 2009, CONTRACEPTION, V80, P40, DOI 10.1016/j.contraception.2009.01.010; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; Gehrmann ML, 2004, J BIOL CHEM, V279, P46921, DOI 10.1074/jbc.M408859200; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103; Hornebeck W, 2005, PATHOL BIOL, V53, P405, DOI 10.1016/j.patbio.2004.12.015; INGHAM KC, 1985, EUR J BIOCHEM, V148, P219, DOI 10.1111/j.1432-1033.1985.tb08828.x; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; IYENGAR V, 1988, CLIN CHEM, V34, P474; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; KAPLAN JE, 1976, J RETICULOENDOTH SOC, V20, P375; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; KLEINMAN HK, 1981, BIOCHEMISTRY-US, V20, P2325, DOI 10.1021/bi00511a039; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACELLE P, 1990, BLOOD, V75, P470; LANSER ME, 1980, ANN SURG, V192, P776, DOI 10.1097/00000658-198012000-00014; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; LiWang AC, 1999, BIOCHEMISTRY-US, V38, P442, DOI 10.1021/bi9812726; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Pagett A, 2005, BIOCHEMISTRY-US, V44, P14682, DOI 10.1021/bi050937i; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Tang C, 2008, J AM CHEM SOC, V130, P4048, DOI 10.1021/ja710493m; Trexler M, 2003, J BIOL CHEM, V278, P12241, DOI 10.1074/jbc.M210116200; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	59	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33764	33770		10.1074/jbc.M110.139394	http://dx.doi.org/10.1074/jbc.M110.139394			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739283	hybrid, Green Published			2022-12-27	WOS:000283354000022
J	Marcil, V; Seidman, E; Sinnett, D; Boudreau, F; Gendron, FP; Beaulieu, JF; Menard, D; Precourt, LP; Amre, D; Levy, E				Marcil, Valerie; Seidman, Ernest; Sinnett, Daniel; Boudreau, Francois; Gendron, Fernand-Pierre; Beaulieu, Jean-Francois; Menard, Daniel; Precourt, Louis-Philippe; Amre, Devendra; Levy, Emile			Modification in Oxidative Stress, Inflammation, and Lipoprotein Assembly in Response to Hepatocyte Nuclear Factor 4 alpha Knockdown in Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR NRF2; UPSTREAM PROMOTER REGION; LOW-DENSITY LIPOPROTEIN; EPIDERMAL GROWTH-FACTOR; HUMAN FETAL INTESTINE; ACUTE-PHASE RESPONSE; GENE-EXPRESSION	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a nuclear transcription factor mainly expressed in the liver, intestine, kidney, and pancreas. Many of its hepatic and pancreatic functions have been described, but limited information is available on its role in the gastrointestinal tract. The objectives of this study were to evaluate the anti-inflammatory and antioxidant functions of HNF4 alpha as well as its implication in intestinal lipid transport and metabolism. To this end, the HNF4A gene was knocked down by transfecting Caco-2 cells with a pGFP-V-RS lentiviral vector containing an shRNA against HNF4 alpha. Inactivation of HNF4 alpha in Caco-2 cells resulted in the following: (a) an increase in oxidative stress as demonstrated by the levels of malondialdehyde and conjugated dienes; (b) a reduction in secondary endogenous antioxidants (catalase, glutathione peroxidase, and heme oxygenase- 1); (c) a lower protein expression of nuclear factor erythroid 2-related factor that controls the antioxidant response elements- regulated antioxidant enzymes; (d) an accentuation of cellular inflammatory activation as shown by levels of nuclear factor-kappa B, interleukin-6, interleukin-8, and leukotriene B4; (e) a decrease in the output of high density lipoproteins and of their anti-inflammatory and anti-oxidative components apolipoproteins (apo) A-I and A-IV; (f) a diminution in cellular lipid transport revealed by a lower cellular secretion of chylomicrons and their apoB-48 moiety; and (g) alterations in the transcription factors sterol regulatory element-binding protein 2, peroxisome proliferator-activated receptor alpha, and liver X receptor alpha and beta. In conclusion, HNF4 alpha appears to play a key role in intestinal lipid metabolism as well as intestinal anti-oxidative and anti-inflammatory defense mechanisms.	[Marcil, Valerie; Seidman, Ernest] McGill Univ, Res Inst, Montreal, PQ H3G 1A4, Canada; [Seidman, Ernest; Boudreau, Francois; Gendron, Fernand-Pierre; Beaulieu, Jean-Francois; Menard, Daniel; Levy, Emile] Univ Sherbrooke, Fac Med & Hlth Sci, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Cellular Biol, Sherbrooke, PQ J1H 5N4, Canada; [Levy, Emile] CHU St Justine, GI Nutr Unit, Dept Pediat, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Precourt, Louis-Philippe; Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ H3T 1C5, Canada	McGill University; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Levy, E (corresponding author), CHU St Justine, GI Nutr Unit, Dept Pediat, Res Ctr, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	emile.levy@recherche-ste-Justine.qc.ca	sinnett, daniel/S-4589-2017; Gendron, Fernand-Pierre/AAN-2965-2021; AMRE, DEVENDRA K/D-4988-2015	sinnett, daniel/0000-0003-3625-6676; 	Canadian Institutes of Health Research Team [CTP-82942]; J. A. DeSeve Research Chair in Nutrition; Canadian Institutes of Health	Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR)); J. A. DeSeve Research Chair in Nutrition; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research Team Grant CTP-82942, the J. A. DeSeve Research Chair in Nutrition (to E. L.), and the Canadian Institutes of Health research fellowship award (to V. M.).	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Antes TJ, 2001, DNA CELL BIOL, V20, P67, DOI 10.1089/104454901750070265; Asghar M, 2007, AM J PHYSIOL-RENAL, V293, pF914, DOI 10.1152/ajprenal.00272.2007; Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Bernotti S, 2003, AM J PHYSIOL-GASTR L, V285, pG898, DOI 10.1152/ajpgi.00042.2003; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brandsch C, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-50; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521; Courtois F, 2000, AM J PHYSIOL-GASTR L, V279, pG12, DOI 10.1152/ajpgi.2000.279.1.G12; Crisafulli C, 2009, SHOCK, V32, P62, DOI 10.1097/SHK.0b013e31818bbad6; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Fiegel HC, 2003, STEM CELLS, V21, P98, DOI 10.1634/stemcells.21-1-98; Fraser JD, 1998, NUCLEIC ACIDS RES, V26, P2702, DOI 10.1093/nar/26.11.2702; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; GINSBURG GS, 1995, J CLIN INVEST, V96, P528, DOI 10.1172/JCI118065; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Guo HT, 2003, AM J PHYSIOL-CELL PH, V284, pC1090, DOI 10.1152/ajpcell.00394.2002; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kakinuma S, 2003, STEM CELLS, V21, P217, DOI 10.1634/stemcells.21-2-217; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; Kim YW, 2010, FREE RADICAL BIO MED, V48, P567, DOI 10.1016/j.freeradbiomed.2009.12.006; KLUCIS E, 1984, MOL CELL BIOCHEM, V65, P73; Kruidenier L, 2003, J PATHOL, V201, P17, DOI 10.1002/path.1408; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; KUTTY RK, 1982, J BIOL CHEM, V257, P9944; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; LEVY E, 1992, J LIPID RES, V33, P1607; Levy E, 1996, FEBS LETT, V393, P253, DOI 10.1016/0014-5793(96)00896-4; LEVY E, 1994, BIOCHEM BIOPH RES CO, V204, P1340, DOI 10.1006/bbrc.1994.2610; Levy E, 2002, J BIOL CHEM, V277, P16470, DOI 10.1074/jbc.M102385200; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Li JX, 2000, GENE DEV, V14, P464; Lian GW, 2006, EXP HEMATOL, V34, P348, DOI 10.1016/j.exphem.2005.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOIRDIGHI N, 1992, BIOCHIM BIOPHYS ACTA, V1175, P100, DOI 10.1016/0167-4889(92)90015-4; Loirdighi N, 1997, J CELL BIOCHEM, V66, P65, DOI 10.1002/(SICI)1097-4644(19970701)66:1<65::AID-JCB8>3.0.CO;2-W; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Mailhot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010446; Marcil V, 2006, CARDIOVASC RES, V72, P473, DOI 10.1016/j.cardiores.2006.08.024; Marcil VR, 2002, AM J PHYSIOL-GASTR L, V283, pG340, DOI 10.1152/ajpgi.00440.2001; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Mehran M, 1995, AM J PHYSIOL-GASTR L, V269, pG953, DOI 10.1152/ajpgi.1995.269.6.G953; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Natarajan R, 2001, J INTERF CYTOK RES, V21, P349, DOI 10.1089/107999001750277826; Nikolaidou-Neokosmidou V, 2006, BIOCHEM J, V398, P439, DOI 10.1042/BJ20060169; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olsen L, 2005, AM J PHYSIOL-GASTR L, V289, pG220, DOI 10.1152/ajpgi.00449.2004; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Petrescu AD, 2002, J BIOL CHEM, V277, P23988, DOI 10.1074/jbc.M201241200; Pippenger C E, 1998, Methods Mol Biol, V108, P299; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Precourt LP, 2009, INT J BIOCHEM CELL B, V41, P1628, DOI 10.1016/j.biocel.2009.02.013; Qadri I, 2009, TOXICOL APPL PHARM, V234, P281, DOI 10.1016/j.taap.2008.10.005; Qin B, 2010, EXP BIOL MED, V235, P199, DOI 10.1258/ebm.2009.009169; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rowley CW, 2006, AM J PHYSIOL-GASTR L, V290, pG466, DOI 10.1152/ajpgi.00431.2005; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sheena V, 2005, J LIPID RES, V46, P328, DOI 10.1194/jlr.M400371-JLR200; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; SLADEK FM, 1993, RECEPTOR, V3, P223; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Spalinger JH, 1998, AM J PHYSIOL-GASTR L, V275, pG652, DOI 10.1152/ajpgi.1998.275.4.G652; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Swenson ES, 1999, AM J PHYSIOL-GASTR L, V276, pG728, DOI 10.1152/ajpgi.1999.276.3.G728; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; Terasaka N, 2005, FEBS J, V272, P1546, DOI 10.1111/j.1742-4658.2005.04599.x; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; WARD PA, 1985, J CLIN INVEST, V76, P517, DOI 10.1172/JCI112001; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; Wild AC, 2000, FREE RADICAL RES, V32, P281, DOI 10.1080/10715760000300291; Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	105	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40448	40460		10.1074/jbc.M110.155358	http://dx.doi.org/10.1074/jbc.M110.155358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20871093	hybrid, Green Published			2022-12-27	WOS:000285414400007
J	Reuter, M; Caswell, CC; Lukomski, S; Zipfel, PF				Reuter, Michael; Caswell, Clayton C.; Lukomski, Slawomir; Zipfel, Peter F.			Binding of the Human Complement Regulators CFHR1 and Factor H by Streptococcal Collagen-like Protein 1 (Scl1) via Their Conserved C Termini Allows Control of the Complement Cascade at Multiple Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; SHORT CONSENSUS REPEAT; SURFACE PROTEIN; BORRELIA-BURGDORFERI; C4B-BINDING PROTEIN; CANDIDA-ALBICANS; IMMUNOGLOBULIN-A; FAMILY PROTEINS; IMMUNE EVASION; HUMAN-DISEASES	Group A streptococci (GAS) utilize soluble human complement regulators to evade host complement attack. Here, we characterized the binding of the terminal complement complex inhibitor complement Factor H-related protein 1 (CFHR1) and of the C3 convertase regulator Factor H to the streptococcal collagen-like proteins (Scl). CFHR1 and Factor H, but no other member of the Factor H protein family (CFHR2, CFHR3, or CFHR4A), bound to the two streptococcal proteins Scl1.6 and Scl1.55, which are expressed by GAS serotypes M6 and M55. The two human regulators bound to the Scl1 proteins via their conserved C-terminal attachment region, i.e. CFHR1 short consensus repeats 3-5 (SCR3-5) and Factor H SCR18-20. Binding was affected by ionic strength and by heparin. CFHR1 and the C-terminal attachment region of Factor H did not bind to Scl1.1 and Scl2.28 proteins but did bind to intact M1-type and M28-type GAS, which express Scl1.1 and Scl2.28, respectively, thus arguing for the presence of an additional binding mechanism to CFHR1 and Factor H. Furthermore mutations within the C-terminal heparin-binding region and Factor H mutations that are associated with the acute renal disease atypical hemolytic uremic syndrome blocked the interaction with the two streptococcal proteins. Binding of CFHR1 affected the complement regulatory functions of Factor H on the level of the C3 convertase. Apparently, streptococci utilize two types of complement regulator-acquiring surface proteins; type A proteins, as represented by Scl1.6 and Scl1.55, bind to CFHR1 and Factor H via their conserved C-terminal region and do not bind the Factor H-like protein 1 (FHL-1). On the contrary, type B proteins, represented by M-, M-like, and the fibronectin-binding protein Fba proteins, bind Factor H and FHL-1 via domain SCR7 and do not bind CFHR1. In conclusion, binding of CFHR1 is at the expense of Factor H-mediated regulatory function at the level of C3 convertase and at the gain of a regulator that controls complement at the level of the C5 convertase and formation of the terminal complement complex.	[Reuter, Michael; Zipfel, Peter F.] Hans Knoell Inst, Dept Infect Biol, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Caswell, Clayton C.; Lukomski, Slawomir] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Lukomski, Slawomir] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Hans Knoll Institute (HKI); West Virginia University; West Virginia University; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Dept Infect Biol, Leibniz Inst Nat Prod Res & Infect Biol, Beutenbergstr 11A, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de			National Institutes of Health [AI083683]; "Grundlagenfond" of the Leibniz Institute for Natural Product Research and Infection Biology; Office of Research and Graduate Education, West Virginia University Health Sciences Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Grundlagenfond" of the Leibniz Institute for Natural Product Research and Infection Biology; Office of Research and Graduate Education, West Virginia University Health Sciences Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083683 (to S. L.). This work was also supported by a grant from the "Grundlagenfond" of the Leibniz Institute for Natural Product Research and Infection Biology (to P. F. Z.) and an internal grant from the Office of Research and Graduate Education, West Virginia University Health Sciences Center (to S. L.).	AKERSTROM B, 1994, MOL IMMUNOL, V31, P393, DOI 10.1016/0161-5890(94)90117-1; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Dobrina A, 2002, BLOOD, V99, P185, DOI 10.1182/blood.V99.1.185; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 1997, BIOCHEM J, V326, P321, DOI 10.1042/bj3260321; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; HUSMANN LK, 1995, INFECT IMMUN, V63, P345, DOI 10.1128/IAI.63.1.345-348.1995; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Johnsson E, 1996, J IMMUNOL, V157, P3021; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Jozsi M, 2007, MOL IMMUNOL, V44, P2697, DOI 10.1016/j.molimm.2006.12.001; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; Kihlberg BM, 1999, INFECT IMMUN, V67, P1708; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; KUHN S, 1995, J IMMUNOL, V155, P5663; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pichichero M E, 1998, Pediatr Rev, V19, P291; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; SKERKA C, 1991, J BIOL CHEM, V266, P12015; Skerka C, 1997, J BIOL CHEM, V272, P5627, DOI 10.1074/jbc.272.9.5627; STENBERG L, 1994, J BIOL CHEM, V269, P13458; Taylor P, 1998, CURR BIOL, V8, pR259, DOI 10.1016/S0960-9822(98)70167-8; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; THERN A, 1995, J IMMUNOL, V154, P375; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Wieland GD, 2005, J CELL SCI, V118, P3203, DOI 10.1242/jcs.02445; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2009, INT J PEPT RES THER, V15, P87, DOI 10.1007/s10989-009-9180-5; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3	55	40	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38473	38485		10.1074/jbc.M110.143727	http://dx.doi.org/10.1074/jbc.M110.143727			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20855886	Green Published, hybrid			2022-12-27	WOS:000284625600053
J	Liu, CY; Zha, ZY; Zhou, X; Zhang, H; Huang, W; Zhao, D; Li, TT; Chan, SW; Lim, CJ; Hong, WJ; Zhao, SM; Xiong, Y; Lei, QY; Guan, KL				Liu, Chen-Ying; Zha, Zheng-Yu; Zhou, Xin; Zhang, Heng; Huang, Wei; Zhao, Di; Li, Tingting; Chan, Siew Wee; Lim, Chun Jye; Hong, Wanjin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCF beta-TrCP E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL DIFFERENTIATION; SIGNALING PATHWAY; PROLIFERATION; SUPPRESSOR; APOPTOSIS; DROSOPHILA; KINASE; GROWTH; TRANSCRIPTION	The TAZ transcription co-activator promotes cell proliferation and epithelial-mesenchymal transition. TAZ is inhibited by the Hippo tumor suppressor pathway, which promotes TAZ cytoplasmic localization by phosphorylation. We report here that TAZ protein stability is controlled by a phosphodegron recognized by the F-box protein beta-TrCP and ubiquitylated by the SCF/CRL1(beta-TrCPE) 3 ligase. The interaction between TAZ and beta-TrCP is regulated by the Hippo pathway. Phosphorylation of a phosphodegron in TAZ by LATS primes it for further phosphorylation by CK1 epsilon and subsequent binding by beta-TrCP. Therefore, the Hippo pathway negatively regulates TAZ function by both limiting its nuclear accumulation and promoting its degradation. The phosphodegron-mediated TAZ degradation plays an important role in negatively regulating TAZ biological functions.	[Liu, Chen-Ying; Zhao, Shimin; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Zhou, Xin; Zhang, Heng; Huang, Wei; Zhao, Di; Li, Tingting; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Zha, Zheng-Yu; Zhou, Xin; Zhang, Heng; Huang, Wei; Zhao, Di; Li, Tingting; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Chan, Siew Wee; Lim, Chun Jye; Hong, Wanjin] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Lei, QY (corresponding author), Fudan Univ, Sch Med, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Zhou, Xin/AAD-6937-2019; HONG, Wanjin/E-9927-2010; Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; Liu, Chen-Ying/0000-0002-8930-6182; zha, zhengyu/0000-0002-8619-3661; Zhao, Di/0000-0001-6253-7127	National Institutes of Health; Chinese Ministry of Education [NCET-09-0315]; NSFC [30600112, 30871255, 31071192]; Shanghai key project [09JC1402300]; Shanghai Leading Academic Discipline Project [B110]; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Education(Ministry of Education, China); NSFC(National Natural Science Foundation of China (NSFC)); Shanghai key project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants (to Y.X. and K.-L.G.). This work was also supported by the 985 Program and New Century Talent from the Chinese Ministry of Education (Grant No. NCET-09-0315) from the Chinese Ministry of Education, 863 (Grant No. 2006AA02A308), 973 (Grant No. 2009CB918401), NSFC (Grant No. 30600112, 30871255, 31071192), Shanghai key project (Grant No. 09JC1402300), Grant No. BK2006546, and the Shanghai Leading Academic Discipline Project, Project Number B110.	Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	34	357	368	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37159	37169		10.1074/jbc.M110.152942	http://dx.doi.org/10.1074/jbc.M110.152942			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20858893	hybrid, Green Published			2022-12-27	WOS:000284424000009
J	Zhu, L; Millen, L; Mendoza, JL; Thomas, PJ				Zhu, Li; Millen, Linda; Mendoza, Juan L.; Thomas, Philip J.			A Unique Redox-sensing Sensor II Motif in TorsinA Plays a Critical Role in Nucleotide and Partner Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA PLUS PROTEIN; TOR1A DYT1 GENE; NUCLEAR-ENVELOPE; ENDOPLASMIC-RETICULUM; MUTANT TORSINA; PC12 CELLS; CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEINS; ATP HYDROLYSIS; DYSTONIA	Early onset dystonia is commonly associated with the deletion of one of a pair of glutamate residues (Delta E302/303) near the C terminus of torsinA, a member of the AAA+ protein family (ATPases associated with a variety of cellular activities) located in the endoplasmic reticulum lumen. The functional consequences of the disease-causing mutation, Delta E, are not currently understood. By contrast to other AAA+ proteins, torsin proteins contain two conserved cysteine residues in the C-terminal domain, one of which is located in the nucleotide sensor II motif. Depending on redox status, an ATP hydrolysis mutant of torsinA interacts with lamina-associated polypeptide 1 (LAP1) and lumenal domain like LAP1 (LULL1). Substitution of the cysteine in sensor II diminishes the redox-regulated interaction of torsinA with these substrates. Significantly, the dystonia-causing mutation, Delta E, alters the ability of torsinA to mediate the redox-regulated interactions with LAP1 and LULL1. Limited proteolysis experiments reveal redox- and mutation-dependent changes in the local conformation of torsinA as a function of nucleotide binding. These results indicate that the cysteine-containing sensor II plays a critical role in redox sensing and the nucleotide and partner binding functions of torsinA and suggest that loss of this function of torsinA contributes to the development of DYT1 dystonia.	[Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zhu, Li] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhu, L (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	zhuli@moon.ibp.ac.cn; Philip.Thomas@utsouthwestern.edu	Thomas, Philip J/F-7115-2012	Mendoza, Juan/0000-0001-6972-7476	National Institutes of Health [DK49835]; Dystonia Medical Research Foundation; National Natural Science Foundation of China [30970570]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835, R01DK049835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dystonia Medical Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK49835 (to P. J. T.). This work was also supported by grants from the Dystonia Medical Research Foundation (to L. Z. and P. J. T.) and National Natural Science Foundation of China Grant 30970570 (to L. Z.).	Asanuma Kotaro, 2005, J Med Invest, V52 Suppl, P272, DOI 10.2152/jmi.52.272; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Basham SE, 2001, DEVELOPMENT, V128, P4645; Bragg DC, 2004, MOL CELL NEUROSCI, V27, P417, DOI 10.1016/j.mcn.2004.07.009; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Carbon M, 2008, MOVEMENT DISORD, V23, P234, DOI 10.1002/mds.21806; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Facundo HTF, 2007, FREE RADICAL BIO MED, V42, P1039, DOI 10.1016/j.freeradbiomed.2007.01.001; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Giles LM, 2008, HUM MOL GENET, V17, P2712, DOI 10.1093/hmg/ddn173; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Kuner R, 2003, NEUROSCI LETT, V350, P153, DOI 10.1016/S0304-3940(03)00904-2; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Naismith TV, 2009, J BIOL CHEM, V284, P27866, DOI 10.1074/jbc.M109.020164; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Neuwald AF, 1999, GENOME RES, V9, P27; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Shashidharan P, 2004, J NEUROCHEM, V88, P1019, DOI 10.1046/j.1471-4159.2003.02233.x; Tavakoli N, 2001, PLANT J, V28, P51, DOI 10.1046/j.1365-313X.2001.01130.x; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Wichmann T, 2008, EXP NEUROL, V212, P242, DOI 10.1016/j.expneurol.2008.04.020; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027; Zhu L, 2008, MOL BIOL CELL, V19, P3599, DOI 10.1091/mbc.E08-01-0015	55	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37271	37280		10.1074/jbc.M110.123471	http://dx.doi.org/10.1074/jbc.M110.123471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20861018	Green Published, hybrid			2022-12-27	WOS:000284424000020
J	Arsenieva, D; Symersky, J; Wang, YM; Pagadala, V; Mueller, DM				Arsenieva, Diana; Symersky, Jindrich; Wang, Yamin; Pagadala, Vijayakanth; Mueller, David M.			Crystal Structures of Mutant Forms of the Yeast F-1 ATPase Reveal Two Modes of Uncoupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL GENOME INTEGRITY; GAMMA-SUBUNIT; BETA-SUBUNIT; KLUYVEROMYCES-LACTIS; MOLECULAR REPLACEMENT; PERIPHERAL STALK; DELSEED MOTIF; MUTATIONS; SYNTHASE; F-1-ATPASE	The mitochondrial ATP synthase couples the flow of protons with the phosphorylation of ADP. A class of mutations, the mitochondrial genome integrity (mgi) mutations, has been shown to uncouple this process in the yeast mitochondrial ATP synthase. Four mutant forms of the yeast F-1 ATPase with mgi mutations were crystallized; the structures were solved and analyzed. The analysis identifies two mechanisms of structural uncoupling: one in which the empty catalytic site is altered and in doing so, apparently disrupts substrate (phosphate) binding, and a second where the steric hindrance predicted between gamma Leu83 and beta(DP) residues, Leu-391 and Glu-395, located in Catch 2 region, is reduced allowing rotation of the gamma-subunit with less impedance. Overall, the structures provide key insights into the critical interactions in the yeast ATP synthase involved in the coupling process.	[Arsenieva, Diana; Symersky, Jindrich; Wang, Yamin; Pagadala, Vijayakanth; Mueller, David M.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Mueller, DM (corresponding author), 3333 Green Bay Rd, N Chicago, IL 60064 USA.	david.mueller@rosalindfranklin.edu	Pagadala, Vijayakanth/ABI-8446-2020	Pagadala, Vijayakanth/0000-0001-7349-4230	National Institutes of Health [National Institutes of Health R01GM66223]; U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant National Institutes of Health R01GM66223 (to D. M. M.).; We thank the continued support and discussion of Drs. Andrew Leslie and John Walker, MRC, Cambridge, UK. Data were collected at GM/CA Collaborative Access Team (GM/CA-CAT) 23-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the U.S. Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number W-31-109-Eng-38.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boltz KW, 2005, BIOCHEMISTRY-US, V44, P9497, DOI 10.1021/bi050070o; Carbajo RJ, 2004, J MOL BIOL, V342, P593, DOI 10.1016/j.jmb.2004.07.013; Chen XJ, 1999, MOL GEN GENET, V262, P898, DOI 10.1007/s004380051156; CHEN XJ, 1995, EMBO J, V14, P3277, DOI 10.1002/j.1460-2075.1995.tb07331.x; Chen XJ, 1998, MOL GEN GENET, V259, P457, DOI 10.1007/s004380050836; Chen XJ, 1996, GENETICS, V144, P1445; CHEN XJ, 1993, GENETICS, V133, P517; DeLano W.L, PYMOL MOL GRAPHICS S; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Duvezin-Caubet S, 2003, P NATL ACAD SCI USA, V100, P13235, DOI 10.1073/pnas.2135169100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Ketchum CJ, 1998, BIOCHEM J, V330, P707; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mao HZ, 2008, J BIOL CHEM, V283, P24781, DOI 10.1074/jbc.M804142200; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Mueller DM, 2004, ACTA CRYSTALLOGR D, V60, P1441, DOI 10.1107/S0907444904012661; Mueller DM, 2000, J BIOENERG BIOMEMBR, V32, P391, DOI 10.1023/A:1005532104617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; SHIN K, 1992, J BIOL CHEM, V267, P20835; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200; WEBER ER, 1995, GENETICS, V140, P435; Xiao Y, 2000, J BIOL CHEM, V275, P6963, DOI 10.1074/jbc.275.10.6963; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104	41	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36561	36569		10.1074/jbc.M110.174383	http://dx.doi.org/10.1074/jbc.M110.174383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20843806	hybrid, Green Published			2022-12-27	WOS:000284146100004
J	Schmitz, S; Schaap, IAT; Kleinjung, J; Harder, S; Grainger, M; Calder, L; Rosenthal, PB; Holder, AA; Veigel, C				Schmitz, Stephan; Schaap, Iwan A. T.; Kleinjung, Jens; Harder, Simone; Grainger, Munira; Calder, Lesley; Rosenthal, Peter B.; Holder, Anthony A.; Veigel, Claudia			Malaria Parasite Actin Polymerization and Filament Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM ACTIN; RAY FIBER DIFFRACTION; F-ACTIN; TOXOPLASMA-GONDII; APICOMPLEXAN PARASITES; ADP-ACTIN; FLUORESCENCE MICROSCOPY; MICROFILAMENT DYNAMICS; GLIDING MOTILITY; BINDING PROTEINS	A novel form of acto-myosin regulation has been proposed in which polymerization of new actin filaments regulates motility of parasites of the apicomplexan class of protozoa. In vivo and in vitro parasite F-actin is very short and unstable, but the structural basis and details of filament dynamics remain unknown. Here, we show that long actin filaments can be obtained by polymerizing unlabeled rabbit skeletal actin (RS-actin) onto both ends of the short rhodamine-phalloidin-stabilized Plasmodium falciparum actin I (Pf-actin) filaments. Following annealing, hybrid filaments of micron length and "zebra-striped" appearance are observed by fluorescence microscopy that are stable enough to move over myosin class II motors in a gliding filament assay. Using negative stain electron microscopy we find that pure Pf-actin stabilized by jasplakinolide (JAS) also forms long filaments, indistinguishable in length from RS-actin filaments, and long enough to be characterized structurally. To compare structures in near physiological conditions in aqueous solution we imaged Pf-actin and RS-actin filaments by atomic force microscopy (AFM). We found the monomer stacking to be distinctly different for Pf-actin compared with RS-actin, such that the pitch of the double helix of Pf-actin filaments was 10% larger. Our results can be explained by a rotational angle between subunits that is larger in the parasite compared with RS-actin. Modeling of the AFM data using high-resolution actin filament models supports our interpretation of the data. The structural differences reported here may be a consequence of weaker inter-and intra-strand contacts, and may be critical for differences in filament dynamics and for regulation of parasite motility.	[Harder, Simone; Grainger, Munira; Holder, Anthony A.] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Schmitz, Stephan; Schaap, Iwan A. T.; Harder, Simone; Calder, Lesley; Rosenthal, Peter B.; Veigel, Claudia] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; [Kleinjung, Jens] Natl Inst Med Res, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research	Holder, AA (corresponding author), Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	aholder@nimr.mrc.ac.uk; claudia.veigel@med.uni-muenchen.de	Schaap, Iwan A. T./L-3177-2013; Holder, Anthony A/A-7554-2013	Schaap, Iwan A. T./0000-0001-6665-5104; Holder, Anthony A/0000-0002-8490-6058; Kleinjung, Jens/0000-0002-7875-5724	UK Medical Research Council [U117532067, U117570593, U117581331, U117581334]; NWO; EU; German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD); Karl-Enigk-Stiftung; MRC [MC_U117581334, MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117581334, MC_U117532067] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NWO(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Karl-Enigk-Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (Reference numbers: U117532067, U117570593, U117581331, and U117581334) and NWO and the EU through a Marie Curie Intra-European Fellowship (to I. A. T. S.).; Supported by the German Academic Exchange Service (Deutscher Akademischer Austausch Dienst, DAAD) and the Karl-Enigk-Stiftung.	Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Baum J, 2008, INT J PARASITOL, V38, pS52; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; BUBB MR, 1994, J BIOL CHEM, V269, P14869; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; COOKE R, 1975, BIOCHEMISTRY-US, V14, P3250, DOI 10.1021/bi00685a035; DANCKER P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P197, DOI 10.1016/0304-4165(90)90116-E; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Fowler RE, 2004, ADV PARASIT, V56, P213, DOI 10.1016/S0065-308X(03)56004-3; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gordon JL, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-179; HANSON J, 1967, NATURE, V213, P353, DOI 10.1038/213353a0; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lukoyanova N, 2000, BIOPHYS J, V78, p238A; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mizuno Y, 2002, PARASITOL RES, V88, P844, DOI 10.1007/s00436-002-0666-8; Oda T, 2001, BIOPHYS J, V80, P841, DOI 10.1016/S0006-3495(01)76063-8; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Poupel O, 1999, MICROBES INFECT, V1, P653, DOI 10.1016/S1286-4579(99)80066-5; Poupel O, 2000, MOL BIOL CELL, V11, P355, DOI 10.1091/mbc.11.1.355; Reisler E, 2007, J BIOL CHEM, V282, P36133, DOI 10.1074/jbc.R700030200; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schaap IAT, 2004, EUR BIOPHYS J BIOPHY, V33, P462, DOI 10.1007/s00249-003-0386-8; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2006, TRENDS PARASITOL, V22, P146, DOI 10.1016/j.pt.2006.02.005; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; STOKES DL, 1987, J CELL BIOL, V104, P1005, DOI 10.1083/jcb.104.4.1005; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Villarrubia JS, 1997, J RES NATL INST STAN, V102, P425, DOI 10.6028/jres.102.030; Visegrady B, 2005, FEBS LETT, V579, P6, DOI 10.1016/j.febslet.2004.11.023; WANG F, 1988, BIOPHYS J, V53, pA572; WESSELING JG, 1988, MOL BIOCHEM PARASIT, V27, P313, DOI 10.1016/0166-6851(88)90051-5; WESSELING JG, 1988, MOL BIOCHEM PARASIT, V30, P143, DOI 10.1016/0166-6851(88)90107-7; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; WIELAND T, 1978, CRC CR REV BIOCH MOL, V5, P185, DOI 10.3109/10409237809149870; ZIMMERLE CT, 1988, BIOCHEMISTRY-US, V27, P7766, DOI 10.1021/bi00420a027	64	46	46	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36577	36585		10.1074/jbc.M110.142638	http://dx.doi.org/10.1074/jbc.M110.142638			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20826799	hybrid, Green Published			2022-12-27	WOS:000284146100060
J	Coleman, SK; Moykkynen, T; Hinkkuri, S; Vaahtera, L; Korpi, ER; Pentikainen, OT; Keinanen, K				Coleman, Sarah K.; Moykkynen, Tommi; Hinkkuri, Sami; Vaahtera, Lauri; Korpi, Esa R.; Pentikainen, Olli T.; Keinanen, Kari			Ligand-binding Domain Determines Endoplasmic Reticulum Exit of AMPA Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; GLUTAMATE-RECEPTOR; REGULATORY PROTEINS; SYNAPTIC PLASTICITY; KINETIC-PROPERTIES; SUBUNIT; TRAFFICKING; CHANNELS; EXPRESSION; SUBTYPE	AMPA receptors (AMPARs) are tetrameric ion channels that mediate rapid glutamate signaling in neurons and many non-neuronal cell types. Endoplasmic reticulum (ER) quality control mechanisms permit only correctly folded functional receptors to be delivered to the cell surface. We analyzed the biosynthetic maturation and transport of all 12 GluA1-4 subunit splice variants as homomeric receptors and observed robust isoform-dependent differences in ER exit competence and surface expression. In contrast to inefficient ER exit of both GluA3 splice forms and the flop variants of GluA1 and GluA4, prominent plasma membrane expression was observed for the other AMPAR isoforms. Surprisingly, deletion of the entire N-terminal domain did not alter the transport phenotype, nor did the different cytosolic C-terminal tail splice variants. Detailed analysis of mutant receptors led to the identification of distinct residues in the ligand-binding domain as primary determinants for isoform-specific maturation. Considered together with the essential role of bound agonist, our findings reveal the ligand-binding domain as the critical quality control target in AMPAR biogenesis.	[Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, FI-00014 Helsinki, Finland; [Moykkynen, Tommi; Korpi, Esa R.] Univ Helsinki, Inst Biomed, Biomedicum, FI-00014 Helsinki, Finland; [Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland	University of Helsinki; University of Helsinki; University of Jyvaskyla	Keinanen, K (corresponding author), Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, POB 56,Viikinkaari 5, FI-00014 Helsinki, Finland.	kari.keinanen@helsinki.fi	Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Coleman, Sarah/0000-0002-1066-8296; Vaahtera, Lauri/0000-0003-4733-4430; Korpi, Esa R./0000-0003-0683-4009	Academy of Finland [110900]; Finnish Foundation for Alcohol Studies	Academy of Finland(Academy of Finland); Finnish Foundation for Alcohol Studies	This work was supported by Academy of Finland Grant 110900 (to K K.) and the Finnish Foundation for Alcohol Studies (to T.M.).	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Coleman SK, 2003, J NEUROSCI, V23, P798; Coombs ID, 2009, NEUROSCIENCE, V162, P656, DOI 10.1016/j.neuroscience.2009.01.004; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Koike M, 2000, J NEUROSCI, V20, P2166; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Sager C, 2009, NEUROSCIENCE, V158, P45, DOI 10.1016/j.neuroscience.2007.12.046; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sans N, 2003, J NEUROSCI, V23, P9367; Sekiguchi M, 2002, BRIT J PHARMACOL, V136, P1033, DOI 10.1038/sj.bjp.0704804; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200	39	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36032	36039		10.1074/jbc.M110.156943	http://dx.doi.org/10.1074/jbc.M110.156943			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20837486	Green Published, hybrid			2022-12-27	WOS:000283845300079
J	Kondrikov, D; Elms, S; Fulton, D; Su, YC				Kondrikov, Dmitry; Elms, Shawn; Fulton, David; Su, Yunchao			eNOS-beta-Actin Interaction Contributes to Increased Peroxynitrite Formation during Hyperoxia in Pulmonary Artery Endothelial Cells and Mouse Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CYTOSKELETON; PHOSPHORYLATION; ACTIVATION; GENERATION; MANAGEMENT; STATE	Oxygen toxicity is the most severe side effect of oxygen therapy in neonates and adults. Pulmonary damage of oxygen toxicity is related to the overproduction of reactive oxygen species (ROS). In the present study, we investigated the effect of hyperoxia on the production of peroxynitrite in pulmonary artery endothelial cells (PAEC) and mouse lungs. Incubation of PAEC under hyperoxia (95% O-2) for 24 h resulted in an increase in peroxynitrite formation. Uric acid, a peroxynitrite scavenger, prevented hyperoxia-induced increase in peroxynitrite. The increase in peroxynitrite formation is accompanied by increases in nitric oxide (NO) release and endothelial NO synthase (eNOS) activity. We have previously reported that association of eNOS with beta-actin increases eNOS activity and NO production in lung endothelial cells. To study whether eNOS-beta-actin association contributes to increased peroxynitrite production, eNOS-beta-actin interaction were inhibited by reducing beta-actin availability or by using a synthetic peptide (P326TAT) containing a sequence corresponding to the actin binding site on eNOS. We found that disruption of eNOS-beta-actin interaction prevented hyperoxia-induced increases in eNOS-beta-actin association, eNOS activity, NO and peroxynitrite production, and protein tyrosine nitration. Hyperoxia failed to induce the increases in eNOS activity, NO and peroxynitrite formation in COS-7 cells transfected with plasmids containing eNOS mutant cDNA in which amino acids leucine and tryptophan were replaced with alanine in the actin binding site on eNOS. Exposure of mice to hyperoxia resulted in significant increases in eNOS-beta-actin association, eNOS activity, and protein tyrosine nitration in the lungs. Our data indicate that increased association of eNOS with beta-actin in PAEC contributes to hyperoxia-induced increase in the production of peroxynitrite which may cause nitrosative stress in pulmonary vasculature.	[Kondrikov, Dmitry; Fulton, David; Su, Yunchao] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Elms, Shawn; Fulton, David; Su, Yunchao] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Su, Yunchao] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Su, YC (corresponding author), Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA.	ysu@mcg.edu			National Institutes of Health [R01HL088261]; Flight Attendants Medical Research Institute [072104]; American Heart Association Greater Southeast Affiliate [0555322B, 0855338E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; American Heart Association Greater Southeast Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL088261. This work was also supported by Flight Attendants Medical Research Institute Grant 072104, and American Heart Association Greater Southeast Affiliate Grants 0555322B and 0855338E.	Berkowitz Diane Schleyer, 2003, Crit Care Nurs Q, V26, P28; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Brueckl C, 2006, AM J RESP CELL MOL, V34, P453, DOI 10.1165/rcmb.2005-0223OC; Cao S, 2003, J BIOL CHEM, V278, P5894, DOI 10.1074/jbc.M212546200; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; De Backer TLM, 2001, BIODRUGS, V15, P801, DOI 10.2165/00063030-200115120-00003; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Imperatore F, 2004, INTENS CARE MED, V30, P1175, DOI 10.1007/s00134-003-2138-8; Ju H, 1998, J BIOL CHEM, V273, P24025, DOI 10.1074/jbc.273.37.24025; Kobayashi H, 2001, AM J RESP CELL MOL, V24, P390, DOI 10.1165/ajrcmb.24.4.4218; Kondrikov D, 2006, AM J PHYSIOL-LUNG C, V290, pL41, DOI 10.1152/ajplung.00444.2004; Kondrikov D, 2010, J BIOL CHEM, V285, P4319, DOI 10.1074/jbc.M109.063172; Li J, 2004, FREE RADICAL BIO MED, V36, P1460, DOI 10.1016/j.freeradbiomed.2004.03.005; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; MacFarlane C, 2000, J R Army Med Corps, V146, P185; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; PALEVSKY HI, 1991, JAMA-J AM MED ASSOC, V265, P1014, DOI 10.1001/jama.265.8.1014; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Radomski A, 1998, BRIT J PHARMACOL, V125, P1455, DOI 10.1038/sj.bjp.0702216; Saito S, 2006, PLANT CELL PHYSIOL, V47, P689, DOI 10.1093/pcp/pcj038; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; SU Y, 2007, SCI STKE; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Su YC, 2003, AM J PHYSIOL-CELL PH, V284, pC1542, DOI 10.1152/ajpcell.00248.2002; Su YC, 2000, AM J PHYSIOL-LUNG C, V278, pL1204, DOI 10.1152/ajplung.2000.278.6.L1204; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Zhang JL, 1997, RES COMMUN MOL PATH, V96, P71	33	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35479	35487		10.1074/jbc.M110.140269	http://dx.doi.org/10.1074/jbc.M110.140269			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20826796	Green Published, hybrid			2022-12-27	WOS:000283845300026
J	Louie, RJ; Pagant, S; Youn, JY; Halliday, JJ; Huyer, G; Michaelis, S; Miller, EA				Louie, Raymond J.; Pagant, Silvere; Youn, Ji-Young; Halliday, John J.; Huyer, Gregory; Michaelis, Susan; Miller, Elizabeth A.			Functional Rescue of a Misfolded Eukaryotic ATP-binding Cassette Transporter by Domain Replacement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; CLASS-II REGION; SACCHAROMYCES-CEREVISIAE; ABC-TRANSPORTER; ENDOPLASMIC-RETICULUM; MULTIDRUG-RESISTANCE; PROCESSING MUTANTS; NUCLEOTIDE-BINDING; ESCHERICHIA-COLI	ATP-binding cassette (ABC) transporters are integral membrane proteins that couple ATP binding/hydrolysis with the transport of hydrophilic substrates across lipid barriers. Deletion of Phe-670 in the first nucleotide-binding domain (NBD1) of the yeast ABC transporter, Yor1p, perturbs interdomain associations, reduces functionality, and hinders proper transport to the plasma membrane. Functionality of Yor1p-Delta F was restored upon co-expression of a peptide containing wild-type NBD1. To gain insight into the biogenesis of this important class of proteins, we defined the requirements for this rescue. We show that a misfolding lesion in NBD1 of the full-length protein is a prerequisite for functional rescue by exogenous NBD1, which is mediated by physical replacement of the dysfunctional domain by the soluble NBD1. This association does not restore trafficking of Yor1p-Delta F but instead confers catalytic activity to the small population of Yor1p-Delta F that escapes to the plasma membrane. An important coupling between the exogenous NBD1 and ICL4 within full-length aberrant Yor1p-Delta F is required for functional rescue but not for the physical interaction between the two polypeptides. Together, our genetic and biochemical data reveal that it is possible to modulate activity of ABC transporters by physically replacing dysfunctional domains.	[Miller, Elizabeth A.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Huyer, Gregory; Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA	Columbia University; Johns Hopkins University; Johns Hopkins Medicine	Miller, EA (corresponding author), 617A Fairchild Ctr,MC 2456, New York, NY 10027 USA.	em2282@columbia.edu		Miller, Elizabeth/0000-0002-1033-8369	National Institutes of Health [GM078186, GM51508]; Cystic Fibrosis Foundation [PAGANT08F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051508, R01GM078186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078186 (to E. A. M.) and GM51508 (to S. M.). This work was also supported by Cystic Fibrosis Foundation Grant PAGANT08F0 (to S. P.).	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Berkower C, 1996, J BIOL CHEM, V271, P22983, DOI 10.1074/jbc.271.38.22983; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Carvajal E, 1997, MOL GEN GENET, V256, P406, DOI 10.1007/s004380050584; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Clarke LL, 2004, AM J PHYSIOL-CELL PH, V287, pC192, DOI 10.1152/ajpcell.00337.2003; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; DANO K, 1973, BIOCHIM BIOPHYS ACTA, V323, P466, DOI 10.1016/0005-2736(73)90191-0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Doeven MK, 2004, J BIOL CHEM, V279, P32301, DOI 10.1074/jbc.M404343200; Epping EA, 2002, J BIOL CHEM, V277, P34860, DOI 10.1074/jbc.M202987200; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Grigoras I, 2008, BBA-BIOMEMBRANES, V1778, P68, DOI 10.1016/j.bbamem.2007.08.035; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Owsianik G, 2003, FEBS LETT, V554, P173, DOI 10.1016/S0014-5793(03)01162-1; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; PANAGIOTIDIS CH, 1993, J BIOL CHEM, V268, P23685; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Reyes CL, 2006, FEBS LETT, V580, P1042, DOI 10.1016/j.febslet.2005.11.033; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; SHEN DW, 1986, MOL CELL BIOL, V6, P4039, DOI 10.1128/MCB.6.11.4039; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	49	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36225	36234		10.1074/jbc.M110.160523	http://dx.doi.org/10.1074/jbc.M110.160523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20843810	hybrid, Green Published			2022-12-27	WOS:000283845300098
J	Kashlan, OB; Boyd, CR; Argyropoulos, C; Okumura, S; Hughey, RP; Grabe, M; Kleyman, TR				Kashlan, Ossama B.; Boyd, Cary R.; Argyropoulos, Christos; Okumura, Sora; Hughey, Rebecca P.; Grabe, Michael; Kleyman, Thomas R.			Allosteric Inhibition of the Epithelial Na+ Channel through Peptide Binding at Peripheral Finger and Thumb Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; GAMMA-SUBUNIT; SELF-INHIBITION; ALPHA-SUBUNIT; ENAC; FURIN; CLEAVAGE; PLASMIN	The epithelial Na+ channel (ENaC) mediates the rate-limiting step in transepithelial Na+ transport in the distal segments of the nephron and in the lung. ENaC subunits are cleaved by proteases, resulting in channel activation due to the release of inhibitory tracts. Peptides derived from these tracts inhibit channel activity. The mechanism by which these intrinsic inhibitory tracts reduce channel activity is unknown, as are the sites where these tracts interact with other residues within the channel. We performed site-directed mutagenesis in large portions of the predicted periphery of the extracellular region of the alpha subunit and measured the effect of mutations on an 8-residue inhibitory tract-derived peptide. Our data show that the inhibitory peptide likely binds to specific residues within the finger and thumb domains of ENaC. Pairwise interactions between the peptide and the channel were identified by double mutant cycle experiments. Our data suggest that the inhibitory peptide has a specific peptide orientation within its binding site. Extended to the intrinsic inhibitory tract, our data suggest that proteases activate ENaC by removing residues that bind at the finger-thumb domain interface.	[Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Grabe, Michael] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Argyropoulos, Christos/I-2803-2019	Argyropoulos, Christos/0000-0002-9679-7805	National Institutes of Health [DK078734, DK051391, DK065161, DK079307]; American Heart Association; PNC Charitable Trust Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R01DK065161, R37DK051391, P30DK079307, R56DK065161, K01DK078734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); PNC Charitable Trust Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078734 (to O. B. K.), DK051391 (to T. R. K.), DK065161 (to T. R. K. and R. P. H.), and DK079307 (Pittsburgh Center for Kidney Research). This work was also supported by a scientist development grant from the American Heart Association and a grant from the PNC Charitable Trust Foundation (to M. G.).	Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Fajac I, 2009, EUR RESPIR J, V34, P772, DOI 10.1183/09031936.00057309; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; PINHEIRO JC, 2000, MIXED EFFECTS MODELS, P271; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng S., 2008, KIDNEY PHYSL PATHOPH, P743; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	24	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35216	35223		10.1074/jbc.M110.167064	http://dx.doi.org/10.1074/jbc.M110.167064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20817728	hybrid, Green Published			2022-12-27	WOS:000283659100095
J	Bernhardt, A; Kuester, D; Roessner, A; Reinheckel, T; Krueger, S				Bernhardt, Anja; Kuester, Doerthe; Roessner, Albert; Reinheckel, Thomas; Krueger, Sabine			Cathepsin X-deficient Gastric Epithelial Cells in Co-culture with Macrophages CHARACTERIZATION OF CYTOKINE RESPONSE AND MIGRATION CAPABILITY AFTER HELICOBACTER PYLORI INFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYLORI INFECTION; PROCATHEPSIN-X; CANCER; DISEASE; CARCINOGENESIS; OSTEOPONTIN; PROGRESSION; METASTASIS; ACTIVATION; EXPRESSION	Our previous studies have shown an association between Helicobacter pylori infection, the strong up-regulation of cathepsin X (CTSX, also called cathepsin Z/P), and the development of gastric cancer. In the present study, we analyzed primary and conventional gastric epithelial cell lines to establish an optimal in vitro mouse model system for the examination of H. pylori-induced overexpression of Ctsx in a functional way. Gastric epithelial cells were isolated from stomachs of wild-type C57BL6/N and Ctsx(-/-) mice and compared with the gastric cancer cell line CLS103. Indirect co-cultures of epithelial cells and macrophages were infected with H. pylori strain SS1 and analyzed for the expression of cathepsins, cytokines, and adhesion factors. Cellular interactions, migration capability, and adherence of H. pylori were assessed using time-lapse video microscopy and colony-forming assays. Isolated primary cells from wild-type and transgenic mice revealed qualities and expression profiles similar to those of corresponding tissue samples. Adherence of H. pylori was significantly higher in primary compared with commercially cells. Thus, induction of cathepsins, cytokines, and adhesion proteins was detected solely in primary cells and co-cultured macrophages. Microarray and migration experiments indicated that Ctsx is involved in B/T-cell proliferation/migration and adhesion of macrophages. Primary epithelial cells from stomach of Ctsx(-/-) mice represent an excellent model of H. pylori gastritis to elaborate the special functions of Ctsx in regulating the immune response to H. pylori.	[Bernhardt, Anja; Kuester, Doerthe; Roessner, Albert; Krueger, Sabine] Otto Von Guericke Univ, Inst Pathol, D-39120 Magdeburg, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	Otto von Guericke University; University of Freiburg	Krueger, S (corresponding author), Leipziger St 44, D-39120 Magdeburg, Germany.	sabine.krueger@med.ovgu.de	Jechorek, Doerthe/J-4716-2014; Reinheckel, Thomas/AAL-9761-2021	Jechorek, Doerthe/0000-0002-1480-5200; Reinheckel, Thomas/0000-0001-9866-9105	Deutsche Forschungsgemeinschaft [KR 1901/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant KR 1901/4-1 from the Deutsche Forschungsgemeinschaft.	Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Buhling F, 2004, BIOL CHEM, V385, P439, DOI 10.1515/BC.2004.051; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; Gerber A, 2001, J INTERF CYTOK RES, V21, P11, DOI 10.1089/107999001459114; Goll R, 2005, SCAND J IMMUNOL, V61, P92, DOI 10.1111/j.0300-9475.2005.01537.x; GRAHAM DY, 1991, DIGEST DIS SCI, V36, P1084, DOI 10.1007/BF01297451; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Krueger S, 2005, J PATHOL, V207, P32, DOI 10.1002/path.1820; Krueger S, 2007, PATHOL RES PRACT, V203, P433, DOI 10.1016/j.prp.2007.04.003; Krueger S, 2009, J PATHOL, V217, P581, DOI 10.1002/path.2485; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; MARSHALL BJ, 1984, LANCET, V1, P1311; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Nascimento FD, 2005, ARCH BIOCHEM BIOPHYS, V436, P323, DOI 10.1016/j.abb.2005.01.013; Naumann M, 2004, TRENDS MICROBIOL, V12, P29, DOI 10.1016/j.tim.2003.11.005; Obermajer N, 2008, IMMUNOLOGY, V124, P76, DOI 10.1111/j.1365-2567.2007.02740.x; Obermajer N, 2009, EUR J CELL BIOL, V88, P461, DOI 10.1016/j.ejcb.2009.03.003; Peek RM, 2000, GASTROENTEROLOGY, V118, P48, DOI 10.1016/S0016-5085(00)70413-6; Schmausser B, 2000, CANCER LETT, V152, P145, DOI 10.1016/S0304-3835(99)00442-5; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Sivaraman J, 2000, J MOL BIOL, V295, P939, DOI 10.1006/jmbi.1999.3410; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wong BLW, 2009, AM J PATHOL, V174, P1319, DOI 10.2353/ajpath.2009.080708; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Xia HHX, 2001, AM J GASTROENTEROL, V96, P16, DOI 10.1111/j.1572-0241.2001.03447.x	32	24	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33691	33700		10.1074/jbc.M110.146183	http://dx.doi.org/10.1074/jbc.M110.146183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736174	Green Published, hybrid			2022-12-27	WOS:000283354000014
J	Otaki, N; Chikazawa, M; Nagae, R; Shimozu, Y; Shibata, T; Ito, S; Takasaki, Y; Fujii, J; Uchida, K				Otaki, Natsuki; Chikazawa, Miho; Nagae, Ritsuko; Shimozu, Yuki; Shibata, Takahiro; Ito, Sohei; Takasaki, Yoshinari; Fujii, Junichi; Uchida, Koji			Identification of a Lipid Peroxidation Product as the Source of Oxidation-specific Epitopes Recognized by Anti-DNA Autoantibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELL-SURFACE PROTEIN; MONOCLONAL-ANTIBODY; DSDNA ANTIBODIES; MICHAEL ADDUCTS; B-CELLS; BINDING; EXPRESSION; DISEASE; NEPHRITIS	Lipid peroxidation in tissue and in tissue fractions represents a degradative process, which is the consequence of the production and the propagation of free radical reactions primarily involving membrane polyunsaturated fatty acids, and has been implicated in the pathogenesis of numerous diseases, including systemic lupus erythematosus (SLE). We have found that bovine serum albumin incubated with peroxidized polyunsaturated fatty acids significantly cross-reacted with the sera from MRL-lpr mice, a representative murine model of SLE. To identify the active substances responsible for the generation of autoantigenic epitopes recognized by the SLE sera, we performed the activity-guiding separation of a principal source from 13-hydroperoxy-9Z, 11E-octadecadienoic acid and identified 4-oxo-2-nonenal ( ONE), a highly reactive aldehyde originating from the peroxidation of omega 6 polyunsaturated fatty acids, as the source of the autoantigenic epitopes. When the age-dependent change in the antibody titer against the ONE-modified protein was measured in the sera from MRL-lpr mice and control MRL-MpJ mice, all of the MRL-lpr mice developed an anti-ONE titer, which was comparable with the anti-DNA titer. Strikingly, a subset of the anti-DNA monoclonal antibodies generated from the SLE mice showing recognition specificity toward DNA cross-reacted with the ONE-specific epitopes. Furthermore, these dual-specific antibodies rapidly bound and internalized into living cells. These findings raised the possibility that the enhanced lipid peroxidation followed by the generation of ONE may be involved in the pathogenesis of autoimmune disorders.	[Otaki, Natsuki; Chikazawa, Miho; Nagae, Ritsuko; Shimozu, Yuki; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, Sohei] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Takasaki, Yoshinari] Juntendo Univ, Dept Internal Med & Rheumatol, Sch Med, Tokyo 1138421, Japan; [Fujii, Junichi] Yamagata Univ, Grad Sch Med Sci, Yamagata 9909985, Japan	Nagoya University; University of Shizuoka; Juntendo University; Yamagata University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Ito, Sohei/M-5930-2019; Shibata, Takahiro/I-6872-2014	Ito, Sohei/0000-0002-9937-3100; Fujii, Junichi/0000-0003-2267-7357; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antone SM, 1997, J IMMUNOL, V159, P5422; BALLARD DW, 1985, J IMMUNOL, V135, P3372; Binder CJ, 2005, SPRINGER SEMIN IMMUN, V26, P385, DOI 10.1007/s00281-004-0185-z; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; Brown JM, 1999, CANCER RES, V59, P1391; Budhai L, 1996, J CLIN INVEST, V98, P1585, DOI 10.1172/JCI118952; CHAN TM, 1995, CLIN EXP IMMUNOL, V100, P506; Chan TM, 2002, J AM SOC NEPHROL, V13, P1219, DOI 10.1097/01.ASN.0000014223.71109.13; CHEN C, 1994, J IMMUNOL, V152, P1970; CHEN LJ, 1995, CHEM RES TOXICOL, V8, P903, DOI 10.1021/tx00049a001; Deshmukh US, 2006, AUTOIMMUN REV, V5, P414, DOI 10.1016/j.autrev.2005.10.010; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Foote J, 2003, SCIENCE, V299, P1327, DOI 10.1126/science.1082717; FRANKEL EN, 1983, PROG LIPID RES, V22, P1, DOI 10.1016/0163-7827(83)90002-4; GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; HANSEN C, 1996, CLIN EXP RHEUMATOL, V15, P559; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; Iuchi Y, 2009, BIOCHEM J, V422, P313, DOI 10.1042/BJ20090176; JACOB L, 1987, P NATL ACAD SCI USA, V84, P2956, DOI 10.1073/pnas.84.9.2956; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; KATZ JB, 1994, J EXP MED, V180, P925, DOI 10.1084/jem.180.3.925; Kawai Y, 2004, FREE RADICAL BIO MED, V36, P529, DOI 10.1016/j.freeradbiomed.2003.12.006; Kawai Y, 2002, CARCINOGENESIS, V23, P485, DOI 10.1093/carcin/23.3.485; KOFFLER D, 1971, J EXP MED, V134, P294, DOI 10.1084/jem.134.1.294; Kowal C, 1999, EUR J IMMUNOL, V29, P1901, DOI 10.1002/(SICI)1521-4141(199906)29:06<1901::AID-IMMU1901>3.0.CO;2-L; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; Lin D, 2005, CHEM RES TOXICOL, V18, P1219, DOI 10.1021/tx050080q; Oe T, 2003, CHEM RES TOXICOL, V16, P1598, DOI 10.1021/tx034178l; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Pardridge WM, 1998, J PHARMACOL EXP THER, V286, P548; PISETSKY DS, 1990, ARTHRITIS RHEUM, V33, P153, DOI 10.1002/art.1780330202; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Rindgen D, 2000, CHEM RES TOXICOL, V13, P846, DOI 10.1021/tx0000771; SCHWARTZ RS, 1985, J CLIN INVEST, V75, P321, DOI 10.1172/JCI111704; Shimozu Y, 2009, CHEM RES TOXICOL, V22, P957, DOI 10.1021/tx900059k; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Spatz L, 1997, METHODS, V11, P70, DOI 10.1006/meth.1996.0389; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Toyoda K, 2007, J BIOL CHEM, V282, P25769, DOI 10.1074/jbc.M703039200; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Yocum AK, 2005, J MASS SPECTROM, V40, P754, DOI 10.1002/jms.847; Yung S, 2006, KIDNEY INT, V69, P272, DOI 10.1038/sj.ki.5000042; Yung S, 2005, J AM SOC NEPHROL, V16, P3281, DOI 10.1681/ASN.2004110917; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j	53	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33834	33842		10.1074/jbc.M110.165175	http://dx.doi.org/10.1074/jbc.M110.165175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736172	Green Published, hybrid			2022-12-27	WOS:000283354000030
